Citrus Sinensis ID: 019040

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------
Protein Sequence
MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVG
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccEEEcccccccccccEEEccccccccccEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHHHHcccccccEEEEEEEEEccccEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEccccEEEcccccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccHHHHHHHHHHHHHccHHHHHHHccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccHHHHEEccHHccccccEEEEEEEccccccEEEEHHHHHHHcccHHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEccccccccEEEccccEEEEccccEEEcccccHHHHcHHHHHHHEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccHHHcccHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
mgnccrspaavaredvksnysshdharkeagankkqpitvlagvpkeniedrylvdrelgrgefgvtylCIDRDTRELLACKSISkrklrtavdidDVRREVAIMKhlpknssivSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKhgvihrdlkpenflfankkensplkaidfglsiffkpgerfseivgspyymapevlkrnygpeidiwSAGVILYILLCgvppfwaesEQGVAQAILRGLidfkrdpwpnvsESAKSLVRQmlepdpklrlTAKQVlehpwlqnakkapnvplgdvVRSRLKQFSMMNRFKRKALRVG
Flexible Loop (DISEMBL)
mgnccrspaavaredvksnySSHDharkeagankkqpitvlagvpkeniedrylvdrelgrgefgvtylcidrdtRELLAcksiskrklrtavdiddvRREVAImkhlpknssivslKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEhpwlqnakkapnvplgdVVRSrlkqfsmmnrfkrkalrvg
Low Complexity Region (SEG)
MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVG
Disordered region (IsUnstruct)
*************************************ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP***********************AKQVLEHPWLQ***********************************
Disordered Region (DISOPRED)
*******************************************VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV*
Disordered Region (DISEMBL)
*********AVAR*******************NKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVG
Disordered Region (DISPRO)
***************************************VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKAL***
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	347	2.2.26 [Sep-21-2011]
Q8W4I7	528	Calcium-dependent protein	yes	no	0.997	0.655	0.910	0.0
Q42438	533	Calcium-dependent protein	no	no	0.991	0.645	0.715	1e-149
Q38873	535	Calcium-dependent protein	no	no	0.991	0.642	0.703	1e-149
Q9SSF8	541	Calcium-dependent protein	no	no	0.910	0.584	0.772	1e-148
Q6NLQ6	538	Calcium-dependent protein	no	no	0.997	0.643	0.693	1e-148
Q9M9V8	545	Calcium-dependent protein	no	no	0.979	0.623	0.718	1e-146
P93759	530	Calcium-dependent protein	no	no	0.997	0.652	0.665	1e-141
Q9SIQ7	582	Calcium-dependent protein	no	no	0.997	0.594	0.623	1e-130
Q9FMP5	528	Calcium-dependent protein	no	no	0.997	0.655	0.584	1e-121
Q3E9C0	523	Calcium-dependent protein	no	no	0.907	0.602	0.634	1e-118

>sp|Q8W4I7|CDPKD_ARATH Calcium-dependent protein kinase 13 OS=Arabidopsis thaliana GN=CPK13 PE=1 SV=2

 Score =  666 bits (1719), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/347 (91%), Positives = 336/347 (96%), Gaps = 1/347 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEA-GANKKQPITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKSNYS HDHARK+A G  K  PI VL+ VPKENIEDRYL+DREL
Sbjct: 1   MGNCCRSPAAVAREDVKSNYSGHDHARKDAAGGKKSAPIRVLSDVPKENIEDRYLLDREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCI+R +R+LLACKSISKRKLRTAVDI+DV+REVAIMKHLPK+SSIV+LKE
Sbjct: 61  GRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSSIVTLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA VT+TIVEVVQLCHKHGVIHRDLK
Sbjct: 121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGVIHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 181 PENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKR+PWPN+SE+AK+LVRQMLEPDPK R
Sbjct: 241 GVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLEPDPKRR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           LTAKQVLEHPW+QNAKKAPNVPLGDVV+SRLKQFS+MNRFKRKALRV
Sbjct: 301 LTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRV 347

May play a role in signal transduction pathways that involve calcium as a second messenger.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q42438|CDPK8_ARATH Calcium-dependent protein kinase 8 OS=Arabidopsis thaliana GN=CPK8 PE=1 SV=1

 Score =  528 bits (1359), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 252/352 (71%), Positives = 295/352 (83%), Gaps = 8/352 (2%)

Query: 1   MGNCCRSPAA-----VAREDVKSN-YSSHDHARKEAGANKKQPITVLAGVPKENIEDRYL 54
           MGNCC SP +       +  +KSN + S  +    +G   K  ++VL      +I   Y 
Sbjct: 1   MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTTNGSGTGFK--LSVLKDPTGHDISLMYD 58

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           + RE+GRGEFG+TYLC D  T E  ACKSISK+KLRTAVDI+DVRREV IMKH+P++ +I
Sbjct: 59  LGREVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNI 118

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           VSLK+A EDD+AVH+VMELCEGGELFDRIVARGHYTERAAAAV +TI+EVVQ+CHKHGV+
Sbjct: 119 VSLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVM 178

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEI 234
           HRDLKPENFLFANKKE S LKAIDFGLS+FFKPGE F+EIVGSPYYMAPEVL+RNYGPE+
Sbjct: 179 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEV 238

Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           DIWSAGVILYILLCGVPPFWAE+EQGVAQAI+R +IDFKRDPWP VSE+AK LVR+MLEP
Sbjct: 239 DIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEP 298

Query: 295 DPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           DPK RL+A QVLEH W+QNAKKAPNV LG+ V++RLKQFS+MN+ K++ALRV
Sbjct: 299 DPKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRV 350

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q38873|CDPK7_ARATH Calcium-dependent protein kinase 7 OS=Arabidopsis thaliana GN=CPK7 PE=1 SV=1

 Score =  527 bits (1358), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 249/354 (70%), Positives = 296/354 (83%), Gaps = 10/354 (2%)

Query: 1   MGNCCRSPAAVAREDVKSN--------YSSHDHARKEAGANKKQPITVLAGVPKENIEDR 52
           MGNCC +P++   +  +          YS+       +GA  K  ++VL      +I  +
Sbjct: 1   MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFK--LSVLKDPTGHDISLQ 58

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + RE+GRGEFG+TYLC D++T E  ACKSISK+KLRTAVDI+DVRREV IMKH+PK+ 
Sbjct: 59  YDLGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHP 118

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           ++VSLK++ EDD+AVH+VMELCEGGELFDRIVARGHYTERAAAAV +TIVEVVQ+CHK G
Sbjct: 119 NVVSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQG 178

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGP 232
           V+HRDLKPENFLFANKKE S LKAIDFGLS+FFKPGE+F+EIVGSPYYMAPEVL+RNYGP
Sbjct: 179 VMHRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGP 238

Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML 292
           EID+WSAGVILYILLCGVPPFWAE+EQGVAQAI+R +IDFKRDPWP VS+SAK LVR+ML
Sbjct: 239 EIDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKML 298

Query: 293 EPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           EPDPK RLTA QVLEH W+ NAKKAPNV LG+ V++RLKQFS+MN+ K++ALRV
Sbjct: 299 EPDPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRV 352

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SSF8|CDPKU_ARATH Calcium-dependent protein kinase 30 OS=Arabidopsis thaliana GN=CPK30 PE=1 SV=1

 Score =  524 bits (1349), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 244/316 (77%), Positives = 277/316 (87%)

Query: 31  GANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR 90
           G     P+ V+    +  I D+Y++ RELGRGEFG+TYLC DR+TRE LACKSISKRKLR
Sbjct: 37  GLRTHAPLRVIPMSHQSQISDKYILGRELGRGEFGITYLCTDRETREALACKSISKRKLR 96

Query: 91  TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT 150
           TAVD++DVRREV IM  LP++ ++V LK   ED+  VHLVMELCEGGELFDRIVARGHYT
Sbjct: 97  TAVDVEDVRREVTIMSTLPEHPNVVKLKATYEDNENVHLVMELCEGGELFDRIVARGHYT 156

Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
           ERAAA V RTI EVV++CH +GV+HRDLKPENFLFANKKENS LKAIDFGLS+ FKPGER
Sbjct: 157 ERAAATVARTIAEVVRMCHVNGVMHRDLKPENFLFANKKENSALKAIDFGLSVLFKPGER 216

Query: 211 FSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI 270
           F+EIVGSPYYMAPEVLKRNYGPE+D+WSAGVILYILLCGVPPFWAE+EQGVA AILRG++
Sbjct: 217 FTEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVALAILRGVL 276

Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           DFKRDPW  +SESAKSLV+QMLEPD   RLTA+QVL+HPW+QNAKKAPNVPLGD+VRSRL
Sbjct: 277 DFKRDPWSQISESAKSLVKQMLEPDSTKRLTAQQVLDHPWIQNAKKAPNVPLGDIVRSRL 336

Query: 331 KQFSMMNRFKRKALRV 346
           KQFSMMNR K+KALRV
Sbjct: 337 KQFSMMNRLKKKALRV 352

May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction. Acts as a calcium sensor involved in the hormone-signaling pathways.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6NLQ6|CDPKW_ARATH Calcium-dependent protein kinase 32 OS=Arabidopsis thaliana GN=CPK32 PE=1 SV=1

 Score =  523 bits (1347), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 247/356 (69%), Positives = 297/356 (83%), Gaps = 10/356 (2%)

Query: 1   MGNCCRSPAAVARED-------VKSNYSSHDHARKEAGANKKQ---PITVLAGVPKENIE 50
           MGNCC +  ++A+ D        K N  S D+     G +       + VL       IE
Sbjct: 1   MGNCCGTAGSLAQNDNKPKKGRKKQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREIE 60

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
            +Y + RELGRGEFGVTYLC D++T ++ ACKSI K+KLRTAVDI+DVRREV IM+H+P+
Sbjct: 61  SKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMPE 120

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + ++V+LKE  ED++AVHLVMELCEGGELFDRIVARGHYTERAAAAVT+TI+EVVQ+CHK
Sbjct: 121 HPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCHK 180

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           HGV+HRDLKPENFLF NKKE +PLKAIDFGLS+FFKPGERF+EIVGSPYYMAPEVLKRNY
Sbjct: 181 HGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNY 240

Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+DIWSAGVILYILLCGVPPFWAE+EQGVAQAI+R ++DF+RDPWP VSE+AK L+R+
Sbjct: 241 GPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIRK 300

Query: 291 MLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           ML+PD K RLTA+QVL+HPWLQNAK APNV LG+ VR+RLKQF++MN+ K++ALRV
Sbjct: 301 MLDPDQKRRLTAQQVLDHPWLQNAKTAPNVSLGETVRARLKQFTVMNKLKKRALRV 356

May play a role in signal transduction pathways that involve calcium as a second messenger. Functions as regulator of the calcium-mediated abscisic acid (ABA) signaling pathway. Phosphorylates ABA-responsive transcription factor ABF4 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M9V8|CDPKA_ARATH Calcium-dependent protein kinase 10 OS=Arabidopsis thaliana GN=CPK10 PE=1 SV=1

 Score =  519 bits (1336), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 260/362 (71%), Positives = 294/362 (81%), Gaps = 22/362 (6%)

Query: 1   MGNC--CRSP----------AAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGV-PKE 47
           MGNC  C  P                D K N  + D  R  A      PI VL  V P  
Sbjct: 1   MGNCNACVRPDSKESKPSSKPKKPNRDRKLNPFAGDFTRSPA------PIRVLKDVIPMS 54

Query: 48  N---IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           N   I D+Y++ RELGRGEFG+TYLC DR+T E LACKSISKRKLRTAVDI+DVRREVAI
Sbjct: 55  NQTQISDKYILGRELGRGEFGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAI 114

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           M  LP++ ++V LK + ED+  VHLVMELCEGGELFDRIVARGHYTERAAAAV RTI EV
Sbjct: 115 MSTLPEHPNVVKLKASYEDNENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEV 174

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           V +CH +GV+HRDLKPENFLFANKKENSPLKAIDFGLS+FFKPG++F+EIVGSPYYMAPE
Sbjct: 175 VMMCHSNGVMHRDLKPENFLFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPE 234

Query: 225 VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
           VLKR+YGP +D+WSAGVI+YILLCGVPPFWAE+EQGVA AILRG++DFKRDPWP +SESA
Sbjct: 235 VLKRDYGPGVDVWSAGVIIYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESA 294

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKAL 344
           KSLV+QML+PDP  RLTA+QVL HPW+QNAKKAPNVPLGD+VRSRLKQFSMMNRFK+K L
Sbjct: 295 KSLVKQMLDPDPTKRLTAQQVLAHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRFKKKVL 354

Query: 345 RV 346
           RV
Sbjct: 355 RV 356

May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P93759|CDPKE_ARATH Calcium-dependent protein kinase 14 OS=Arabidopsis thaliana GN=CPK14 PE=2 SV=1

 Score =  501 bits (1290), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 231/347 (66%), Positives = 287/347 (82%), Gaps = 1/347 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQ-PITVLAGVPKENIEDRYLVDREL 59
           MGNCC +  ++ ++  K  +   +    E G +     + VL       I+ +Y + REL
Sbjct: 1   MGNCCGTAGSLIQDKQKKGFKLPNPFSNEYGNHHDGLKLIVLKEPTGHEIKQKYKLGREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLC + +T E+ ACKSI K+KL+T++DI+DV+REV IM+ +P++ +IV+LKE
Sbjct: 61  GRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHPNIVTLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
             EDD AVHLVMELCEGGELFDRIVARGHYTERAAA+V +TI+EVVQ+CHKHGV+HRDLK
Sbjct: 121 TYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHGVMHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKE + LKAIDFGLS+FFKPGERF+EIVGSPYYMAPEVL+R+YG EIDIWSA
Sbjct: 181 PENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAE+E GVA+AIL+ +IDFKRDPWP VS++AK L+++ML PDP+ R
Sbjct: 241 GVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKMLHPDPRRR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           LTA+QVL+HPW+QN K A NV LG+ VR+RLKQFS+MN+ K++ALRV
Sbjct: 301 LTAQQVLDHPWIQNGKNASNVSLGETVRARLKQFSVMNKLKKRALRV 347

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SIQ7|CDPKO_ARATH Calcium-dependent protein kinase 24 OS=Arabidopsis thaliana GN=CPK24 PE=2 SV=1

 Score =  464 bits (1194), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 224/359 (62%), Positives = 282/359 (78%), Gaps = 13/359 (3%)

Query: 1   MGNCCRSP---AAVAREDVKSNYSSHDHA----RKEAGANKKQ------PITVLAGVPKE 47
           MG+C  SP   +   +  V+  +SS+       R ++  N  +      P  VL     +
Sbjct: 1   MGSCVSSPLKGSPFGKRPVRRRHSSNSRTSSVPRFDSSTNLSRRLIFQPPSRVLPEPIGD 60

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            I  +Y + +ELGRGEFGVT+ CI+  TRE  ACK ISK KLRT +D++DVRREV IM+ 
Sbjct: 61  GIHLKYDLGKELGRGEFGVTHECIEISTRERFACKRISKEKLRTEIDVEDVRREVEIMRC 120

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           LPK+ +IVS KEA ED +AV+LVME+CEGGELFDRIV+RGHYTERAAA+V +TI+EVV++
Sbjct: 121 LPKHPNIVSFKEAFEDKDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAKTILEVVKV 180

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK 227
           CH+HGVIHRDLKPENFLF+N  E + LKAIDFGLSIFFKP +RF+EIVGSPYYMAPEVL+
Sbjct: 181 CHEHGVIHRDLKPENFLFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEVLR 240

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           RNYGPEID+WSAGVILYILLCGVPPFWAE+E+G+A AI+RG IDF+RDPWP VS  AK L
Sbjct: 241 RNYGPEIDVWSAGVILYILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAKEL 300

Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           V+ ML+ +P  RLT ++VLEHPW++NA++APNV LGD VR++++QF +MNRFK+K LR+
Sbjct: 301 VKNMLDANPYSRLTVQEVLEHPWIRNAERAPNVNLGDNVRTKIQQFLLMNRFKKKVLRI 359

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1

 Score =  436 bits (1121), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 214/366 (58%), Positives = 256/366 (69%), Gaps = 20/366 (5%)

Query: 1   MGNCCRSPAAVARE-DVKSNYSSHDHARKEAG-------------------ANKKQPITV 40
           MGNCC      A   D   N +S  +A    G                   A K+ PI  
Sbjct: 1   MGNCCSHGRDSADNGDALENGASASNAANSTGPTAEASVPQSKHAPPSPPPATKQGPIGP 60

Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           + G P E+++  Y + +ELGRG+FGVT+LC  + T    ACK+I+KRKL    DI+DVRR
Sbjct: 61  VLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRR 120

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           EV IM HL    +IV LK A ED ++VHLVMELC GGELFDRI+A+GHY+ERAAA++ RT
Sbjct: 121 EVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRT 180

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           IV++V  CH  GVIHRDLKPENFL  NK ENSPLKA DFGLS+F+KPGE F +IVGS YY
Sbjct: 181 IVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYY 240

Query: 221 MAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           +APEVLKR YGPE DIWS GV+LYILLCGVPPFWAESE G+  AILRG +DF  DPWP++
Sbjct: 241 IAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSI 300

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFK 340
           S  AK LV++ML  DPK RLTA QVL HPW++   +AP+VPL + V SRLKQF  MN FK
Sbjct: 301 SPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFK 360

Query: 341 RKALRV 346
           + ALRV
Sbjct: 361 KVALRV 366

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3E9C0|CDPKY_ARATH Calcium-dependent protein kinase 34 OS=Arabidopsis thaliana GN=CPK34 PE=2 SV=1

 Score =  426 bits (1096), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 200/315 (63%), Positives = 241/315 (76%)

Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT 91
           A K+ PI  + G P E+++  Y + +ELGRG+FGVT+LC  + T    ACK+I+KRKL  
Sbjct: 47  ATKQGPIGPVLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVN 106

Query: 92  AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTE 151
             DI+DVRREV IM HL    +IV LK A ED ++VHLVMELC GGELFDRI+A+GHY+E
Sbjct: 107 KEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSE 166

Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
           RAAA++ RTIV+++  CH  GVIHRDLKPENFL  +K ENSPLKA DFGLS+F+KPGE F
Sbjct: 167 RAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVF 226

Query: 212 SEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID 271
            +IVGS YY+APEVL+R YGPE DIWS GV+LYILLCGVPPFWAESE G+  AIL G +D
Sbjct: 227 KDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVD 286

Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLK 331
           F  DPWP +S  AK LVR+ML  DPK RLTA QVL HPW++   +AP+VPL + V SRLK
Sbjct: 287 FSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLK 346

Query: 332 QFSMMNRFKRKALRV 346
           QF  MN FK+ ALRV
Sbjct: 347 QFKAMNNFKKVALRV 361

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	347
255585928	525	calcium-dependent protein kinase, putati	0.997	0.659	0.950	0.0
224140425	528	calcium dependent protein kinase 13 [Pop	0.997	0.655	0.933	0.0
225439418	527	PREDICTED: calcium-dependent protein kin	0.994	0.654	0.939	0.0
224091012	528	calcium dependent protein kinase 23 [Pop	0.997	0.655	0.930	0.0
307135929	527	calcium-dependent protein kinase [Cucumi	0.997	0.656	0.916	0.0
449525946	527	PREDICTED: calcium-dependent protein kin	0.997	0.656	0.916	0.0
449439886	527	PREDICTED: calcium-dependent protein kin	0.997	0.656	0.913	0.0
297816446	528	calcium-dependent protein kinase 13 [Ara	0.997	0.655	0.913	0.0
1314711	503	calcium-dependent protein kinase [Arabid	0.997	0.687	0.910	0.0
22331739	528	calcium-dependent protein kinase 13 [Ara	0.997	0.655	0.910	0.0

>gi|255585928|ref|XP_002533636.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223526474|gb|EEF28747.1| calcium-dependent protein kinase, putative [Ricinus communis]

 Score =  695 bits (1793), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/346 (95%), Positives = 339/346 (97%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELG 60
           MGNCCRSPAAVAREDVKSNYSSHDH++K+  A KKQPITVL GV KENIE++YLVDRELG
Sbjct: 1   MGNCCRSPAAVAREDVKSNYSSHDHSKKDNAATKKQPITVLTGVAKENIEEKYLVDRELG 60

Query: 61  RGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA 120
           RGEFGVTYLCIDRD RELLACKSISKRKLRTAVDI+DVRREVAIMKHLPKNSSIVSLKEA
Sbjct: 61  RGEFGVTYLCIDRDNRELLACKSISKRKLRTAVDIEDVRREVAIMKHLPKNSSIVSLKEA 120

Query: 121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
           CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP
Sbjct: 121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240
           ENFLFANKKENSPLKA DFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG
Sbjct: 181 ENFLFANKKENSPLKAFDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240

Query: 241 VILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           VILYILLCGVPPFWAESEQGVAQAILRG+IDFKRDPWPN+SESAKSLV+QMLEPDPKLRL
Sbjct: 241 VILYILLCGVPPFWAESEQGVAQAILRGIIDFKRDPWPNISESAKSLVKQMLEPDPKLRL 300

Query: 301 TAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           TAKQVLEHPWLQNAKKAPNVPLGDVV+SRLKQFSMMNRFKRKALRV
Sbjct: 301 TAKQVLEHPWLQNAKKAPNVPLGDVVKSRLKQFSMMNRFKRKALRV 346

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224140425|ref|XP_002323583.1| calcium dependent protein kinase 13 [Populus trichocarpa] gi|222868213|gb|EEF05344.1| calcium dependent protein kinase 13 [Populus trichocarpa]

 Score =  679 bits (1751), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/347 (93%), Positives = 337/347 (97%), Gaps = 1/347 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKK-QPITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKS++S  DH +K + A K  QPI VL GVPKENIE+RYLVDREL
Sbjct: 1   MGNCCRSPAAVAREDVKSSFSGQDHGKKNSTAKKTPQPIRVLTGVPKENIEERYLVDREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCI+RD+RELLACKSISKRKLRTAVDI+DVRREVAIMKHLPKNSSIVSLKE
Sbjct: 61  GRGEFGVTYLCIERDSRELLACKSISKRKLRTAVDIEDVRREVAIMKHLPKNSSIVSLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK
Sbjct: 121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 181 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKRDPWPN+SESAKSLVRQMLEPDPKLR
Sbjct: 241 GVILYILLCGVPPFWAESEQGVAQAILRGIIDFKRDPWPNISESAKSLVRQMLEPDPKLR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           LTA+QV+EHPWLQNAKKAPNVPLGDVV+SRLKQFSMMNRFKRKALRV
Sbjct: 301 LTARQVIEHPWLQNAKKAPNVPLGDVVKSRLKQFSMMNRFKRKALRV 347

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225439418|ref|XP_002264564.1| PREDICTED: calcium-dependent protein kinase 13 [Vitis vinifera]

 Score =  677 bits (1748), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/347 (93%), Positives = 337/347 (97%), Gaps = 2/347 (0%)

Query: 1   MGNCCRSPAAVAREDVKS-NYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKS NYS HDH RK+AGA KK  ITVL GV K+ IE++Y+VDREL
Sbjct: 1   MGNCCRSPAAVAREDVKSANYSGHDHGRKDAGAGKK-TITVLNGVSKDGIEEKYMVDREL 59

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD++DVRREVAIMKHLPKNSSIVSLKE
Sbjct: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDVEDVRREVAIMKHLPKNSSIVSLKE 119

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACED+NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK
Sbjct: 120 ACEDENAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN+SESAKSLVRQMLEPDPKLR
Sbjct: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNISESAKSLVRQMLEPDPKLR 299

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           LTAKQVLEH WLQNAKKAPNVPLGDVV++RLKQFSMMNRFKRKALRV
Sbjct: 300 LTAKQVLEHSWLQNAKKAPNVPLGDVVKARLKQFSMMNRFKRKALRV 346

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224091012|ref|XP_002309145.1| calcium dependent protein kinase 23 [Populus trichocarpa] gi|222855121|gb|EEE92668.1| calcium dependent protein kinase 23 [Populus trichocarpa]

 Score =  674 bits (1739), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 323/347 (93%), Positives = 337/347 (97%), Gaps = 1/347 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKK-QPITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKS++S HDH +K+  A K  QPITVL G PKENIE+RYLVDREL
Sbjct: 1   MGNCCRSPAAVAREDVKSSFSGHDHGKKDNTAKKTPQPITVLTGFPKENIEERYLVDREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCI+RD+RELLACKSISKRKLRTAVDI+DVRREVAIMKHLPK+SSIVSLKE
Sbjct: 61  GRGEFGVTYLCIERDSRELLACKSISKRKLRTAVDIEDVRREVAIMKHLPKSSSIVSLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK
Sbjct: 121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFA+KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 181 PENFLFASKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKRDPWPN+SE+AKSLVRQMLEPDPKLR
Sbjct: 241 GVILYILLCGVPPFWAESEQGVAQAILRGIIDFKRDPWPNISENAKSLVRQMLEPDPKLR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           LTAKQVLEHPWL NAKKAPNVPLGDVV+SRLKQFSMMNRFKRKALRV
Sbjct: 301 LTAKQVLEHPWLLNAKKAPNVPLGDVVKSRLKQFSMMNRFKRKALRV 347

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|307135929|gb|ADN33791.1| calcium-dependent protein kinase [Cucumis melo subsp. melo]

 Score =  672 bits (1734), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 317/346 (91%), Positives = 337/346 (97%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELG 60
           MGNCCRSPAAVAREDVKS++S  DH+R+++ A KK P+TVL GVPKENIE++Y+VDRELG
Sbjct: 1   MGNCCRSPAAVAREDVKSSFSGQDHSRRDSNAGKKVPVTVLNGVPKENIEEKYMVDRELG 60

Query: 61  RGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA 120
           RGEFGVTYLCIDR TR+LLACKSISKRKLRTAVDI+DVRREVAIMKHLPKNSSIVSLKEA
Sbjct: 61  RGEFGVTYLCIDRQTRDLLACKSISKRKLRTAVDIEDVRREVAIMKHLPKNSSIVSLKEA 120

Query: 121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
           CED+NAVHLVMELCEGGELFDRIVARGHYTERAAAAV RTIVEVVQLCHKHGVIHRDLKP
Sbjct: 121 CEDENAVHLVMELCEGGELFDRIVARGHYTERAAAAVMRTIVEVVQLCHKHGVIHRDLKP 180

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240
           ENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSAG
Sbjct: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240

Query: 241 VILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           VILYILLCGVPPFWAE+EQGVAQAILRGLIDFKRDPWP++SESAKSLV+QMLEPDPKLRL
Sbjct: 241 VILYILLCGVPPFWAETEQGVAQAILRGLIDFKRDPWPSISESAKSLVKQMLEPDPKLRL 300

Query: 301 TAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           TAKQVL+HPWLQN KKAPNVPLGDVV+SRLKQFSMMNRFKRKALRV
Sbjct: 301 TAKQVLDHPWLQNIKKAPNVPLGDVVKSRLKQFSMMNRFKRKALRV 346

Source: Cucumis melo subsp. melo

Species: Cucumis melo

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449525946|ref|XP_004169977.1| PREDICTED: calcium-dependent protein kinase 13-like [Cucumis sativus]

 Score =  672 bits (1734), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 317/346 (91%), Positives = 337/346 (97%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELG 60
           MGNCCRSPAAVAREDVKS++S  DH+R+++ A KK P+TVL GVPKENIE++Y+VDRELG
Sbjct: 1   MGNCCRSPAAVAREDVKSSFSGQDHSRRDSNAGKKVPVTVLNGVPKENIEEKYMVDRELG 60

Query: 61  RGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA 120
           RGEFGVTYLCIDR TR+LLACKSISKRKLRTAVDI+DVRREVAIMKHLPKNSSIVSLKEA
Sbjct: 61  RGEFGVTYLCIDRQTRDLLACKSISKRKLRTAVDIEDVRREVAIMKHLPKNSSIVSLKEA 120

Query: 121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
           CED+NAVHLVMELCEGGELFDRIVARGHYTERAAAAV RTIVEVVQLCHKHGVIHRDLKP
Sbjct: 121 CEDENAVHLVMELCEGGELFDRIVARGHYTERAAAAVMRTIVEVVQLCHKHGVIHRDLKP 180

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240
           ENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSAG
Sbjct: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240

Query: 241 VILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           VILYILLCGVPPFWAE+EQGVAQAILRGLIDFKRDPWP++SESAKSLV+QMLEPDPKLRL
Sbjct: 241 VILYILLCGVPPFWAETEQGVAQAILRGLIDFKRDPWPSISESAKSLVKQMLEPDPKLRL 300

Query: 301 TAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           TAKQVL+HPWLQN KKAPNVPLGDVV+SRLKQFSMMNRFKRKALRV
Sbjct: 301 TAKQVLDHPWLQNIKKAPNVPLGDVVKSRLKQFSMMNRFKRKALRV 346

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439886|ref|XP_004137716.1| PREDICTED: calcium-dependent protein kinase 13-like [Cucumis sativus]

 Score =  671 bits (1731), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/346 (91%), Positives = 337/346 (97%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELG 60
           MGNCCRSPAAVAREDVKS++S  DH+R+++ A KK P+TVL GVPKENIE++Y+VDRELG
Sbjct: 1   MGNCCRSPAAVAREDVKSSFSGQDHSRRDSNAGKKVPVTVLNGVPKENIEEKYMVDRELG 60

Query: 61  RGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA 120
           RGEFGVTYLCIDR TR+LLACKSISKRKLRTAVDI+DVRREVAIMKHLPKNSSIVSLKEA
Sbjct: 61  RGEFGVTYLCIDRQTRDLLACKSISKRKLRTAVDIEDVRREVAIMKHLPKNSSIVSLKEA 120

Query: 121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
           CED+NAVHLVMELCEGGELFDRIVARGHYTERAAAAV RTIVEVVQLCHKHGVIHRDLKP
Sbjct: 121 CEDENAVHLVMELCEGGELFDRIVARGHYTERAAAAVMRTIVEVVQLCHKHGVIHRDLKP 180

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240
           ENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSAG
Sbjct: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240

Query: 241 VILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           VILYILLCGVPPFWAE+EQGVAQAILRGLIDFKRDPWP++SESAKSLV+QMLEPDPKLRL
Sbjct: 241 VILYILLCGVPPFWAETEQGVAQAILRGLIDFKRDPWPSISESAKSLVKQMLEPDPKLRL 300

Query: 301 TAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           +AKQVL+HPWLQN KKAPNVPLGDVV+SRLKQFSMMNRFKRKALRV
Sbjct: 301 SAKQVLDHPWLQNIKKAPNVPLGDVVKSRLKQFSMMNRFKRKALRV 346

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297816446|ref|XP_002876106.1| calcium-dependent protein kinase 13 [Arabidopsis lyrata subsp. lyrata] gi|297321944|gb|EFH52365.1| calcium-dependent protein kinase 13 [Arabidopsis lyrata subsp. lyrata]

 Score =  669 bits (1725), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 317/347 (91%), Positives = 337/347 (97%), Gaps = 1/347 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQ-PITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKSNYS HDHARK+AG  KK  PI VL+ VPKENIEDRYL+DREL
Sbjct: 1   MGNCCRSPAAVAREDVKSNYSGHDHARKDAGGGKKSAPIRVLSDVPKENIEDRYLLDREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCI+R +R+LLACKSISKRKLRTAVDI+DV+REVAIMKHLPK+SSIV+LKE
Sbjct: 61  GRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSSIVTLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA VT+TIVEVVQLCHKHGVIHRDLK
Sbjct: 121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGVIHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 181 PENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKR+PWPN+SE+AK+LVRQMLEPDPK R
Sbjct: 241 GVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLEPDPKRR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           LTAKQVLEHPW+QNAKKAPNVPLGDVV+SRLKQFS+MNRFKRKALRV
Sbjct: 301 LTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRV 347

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|1314711|gb|AAA99794.1| calcium-dependent protein kinase [Arabidopsis thaliana] gi|3068712|gb|AAC14412.1| calcium dependent protein kinase [Arabidopsis thaliana]

 Score =  667 bits (1722), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/347 (91%), Positives = 336/347 (96%), Gaps = 1/347 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEA-GANKKQPITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKSNYS HDHARK+A G  K  PI VL+ VPKENIEDRYL+DREL
Sbjct: 1   MGNCCRSPAAVAREDVKSNYSGHDHARKDAAGGKKSAPIRVLSDVPKENIEDRYLLDREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCI+R +R+LLACKSISKRKLRTAVDI+DV+REVAIMKHLPK+SSIV+LKE
Sbjct: 61  GRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSSIVTLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA VT+TIVEVVQLCHKHGVIHRDLK
Sbjct: 121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGVIHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 181 PENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKR+PWPN+SE+AK+LVRQMLEPDPK R
Sbjct: 241 GVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLEPDPKRR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           LTAKQVLEHPW+QNAKKAPNVPLGDVV+SRLKQFS+MNRFKRKALRV
Sbjct: 301 LTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRV 347

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|22331739|ref|NP_190753.2| calcium-dependent protein kinase 13 [Arabidopsis thaliana] gi|223635148|sp|Q8W4I7.2|CDPKD_ARATH RecName: Full=Calcium-dependent protein kinase 13 gi|332645331|gb|AEE78852.1| calcium-dependent protein kinase 13 [Arabidopsis thaliana]

 Score =  666 bits (1719), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/347 (91%), Positives = 336/347 (96%), Gaps = 1/347 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEA-GANKKQPITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKSNYS HDHARK+A G  K  PI VL+ VPKENIEDRYL+DREL
Sbjct: 1   MGNCCRSPAAVAREDVKSNYSGHDHARKDAAGGKKSAPIRVLSDVPKENIEDRYLLDREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCI+R +R+LLACKSISKRKLRTAVDI+DV+REVAIMKHLPK+SSIV+LKE
Sbjct: 61  GRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSSIVTLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA VT+TIVEVVQLCHKHGVIHRDLK
Sbjct: 121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGVIHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 181 PENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKR+PWPN+SE+AK+LVRQMLEPDPK R
Sbjct: 241 GVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLEPDPKRR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           LTAKQVLEHPW+QNAKKAPNVPLGDVV+SRLKQFS+MNRFKRKALRV
Sbjct: 301 LTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRV 347

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	347
TAIR|locus:2074338	528	CPK13 "calcium-dependent prote	0.997	0.655	0.910	3e-172
TAIR|locus:2011201	545	CDPK1 "calcium-dependent prote	0.997	0.634	0.724	8.5e-136
TAIR|locus:2103498	538	CPK32 "calcium-dependent prote	0.997	0.643	0.693	2.6e-134
TAIR|locus:505006616	535	CPK7 "calmodulin-domain protei	0.991	0.642	0.709	4.2e-134
TAIR|locus:2150230	533	CDPK19 "calcium-dependent prot	0.991	0.645	0.715	6.9e-134
TAIR|locus:2027227	541	CPK30 "calcium-dependent prote	0.910	0.584	0.772	1.4e-133
TAIR|locus:2054386	530	CPK14 "calcium-dependent prote	0.997	0.652	0.665	2.6e-127
TAIR|locus:2061290	582	CPK24 "AT2G31500" [Arabidopsis	0.997	0.594	0.623	2.6e-118
TAIR|locus:2177023	528	CPK17 "calcium-dependent prote	0.907	0.596	0.644	3.4e-111
TAIR|locus:2150225	523	CPK34 "AT5G19360" [Arabidopsis	0.907	0.602	0.634	3.5e-107

TAIR|locus:2074338 CPK13 "calcium-dependent protein kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1674 (594.3 bits), Expect = 3.0e-172, P = 3.0e-172
 Identities = 316/347 (91%), Positives = 336/347 (96%)

Query:     1 MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQ-PITVLAGVPKENIEDRYLVDREL 59
             MGNCCRSPAAVAREDVKSNYS HDHARK+A   KK  PI VL+ VPKENIEDRYL+DREL
Sbjct:     1 MGNCCRSPAAVAREDVKSNYSGHDHARKDAAGGKKSAPIRVLSDVPKENIEDRYLLDREL 60

Query:    60 GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
             GRGEFGVTYLCI+R +R+LLACKSISKRKLRTAVDI+DV+REVAIMKHLPK+SSIV+LKE
Sbjct:    61 GRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSSIVTLKE 120

Query:   120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
             ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA VT+TIVEVVQLCHKHGVIHRDLK
Sbjct:   121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGVIHRDLK 180

Query:   180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
             PENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct:   181 PENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query:   240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
             GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKR+PWPN+SE+AK+LVRQMLEPDPK R
Sbjct:   241 GVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLEPDPKRR 300

Query:   300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
             LTAKQVLEHPW+QNAKKAPNVPLGDVV+SRLKQFS+MNRFKRKALRV
Sbjct:   301 LTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRV 347

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2011201 CDPK1 "calcium-dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1330 (473.2 bits), Expect = 8.5e-136, P = 8.5e-136
 Identities = 258/356 (72%), Positives = 295/356 (82%)

Query:     1 MGNC--CRSP-AAVAREDVKSNYSSHDHARKE-AG--ANKKQPITVLAGV-PKEN---IE 50
             MGNC  C  P +  ++   K    + D      AG       PI VL  V P  N   I 
Sbjct:     1 MGNCNACVRPDSKESKPSSKPKKPNRDRKLNPFAGDFTRSPAPIRVLKDVIPMSNQTQIS 60

Query:    51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
             D+Y++ RELGRGEFG+TYLC DR+T E LACKSISKRKLRTAVDI+DVRREVAIM  LP+
Sbjct:    61 DKYILGRELGRGEFGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAIMSTLPE 120

Query:   111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
             + ++V LK + ED+  VHLVMELCEGGELFDRIVARGHYTERAAAAV RTI EVV +CH 
Sbjct:   121 HPNVVKLKASYEDNENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEVVMMCHS 180

Query:   171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
             +GV+HRDLKPENFLFANKKENSPLKAIDFGLS+FFKPG++F+EIVGSPYYMAPEVLKR+Y
Sbjct:   181 NGVMHRDLKPENFLFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPEVLKRDY 240

Query:   231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             GP +D+WSAGVI+YILLCGVPPFWAE+EQGVA AILRG++DFKRDPWP +SESAKSLV+Q
Sbjct:   241 GPGVDVWSAGVIIYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESAKSLVKQ 300

Query:   291 MLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
             ML+PDP  RLTA+QVL HPW+QNAKKAPNVPLGD+VRSRLKQFSMMNRFK+K LRV
Sbjct:   301 MLDPDPTKRLTAQQVLAHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRFKKKVLRV 356

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;TAS

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2103498 CPK32 "calcium-dependent protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1316 (468.3 bits), Expect = 2.6e-134, P = 2.6e-134
 Identities = 247/356 (69%), Positives = 298/356 (83%)

Query:     1 MGNCCRSPAAVARED-------VKSNYSSHDHARKEAGAN---KKQPITVLAGVPKENIE 50
             MGNCC +  ++A+ D        K N  S D+     G +   +   + VL       IE
Sbjct:     1 MGNCCGTAGSLAQNDNKPKKGRKKQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREIE 60

Query:    51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
              +Y + RELGRGEFGVTYLC D++T ++ ACKSI K+KLRTAVDI+DVRREV IM+H+P+
Sbjct:    61 SKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMPE 120

Query:   111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
             + ++V+LKE  ED++AVHLVMELCEGGELFDRIVARGHYTERAAAAVT+TI+EVVQ+CHK
Sbjct:   121 HPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCHK 180

Query:   171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
             HGV+HRDLKPENFLF NKKE +PLKAIDFGLS+FFKPGERF+EIVGSPYYMAPEVLKRNY
Sbjct:   181 HGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNY 240

Query:   231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             GPE+DIWSAGVILYILLCGVPPFWAE+EQGVAQAI+R ++DF+RDPWP VSE+AK L+R+
Sbjct:   241 GPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIRK 300

Query:   291 MLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
             ML+PD K RLTA+QVL+HPWLQNAK APNV LG+ VR+RLKQF++MN+ K++ALRV
Sbjct:   301 MLDPDQKRRLTAQQVLDHPWLQNAKTAPNVSLGETVRARLKQFTVMNKLKKRALRV 356

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004698 "calcium-dependent protein kinase C activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0009651 "response to salt stress" evidence=IEP

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:505006616 CPK7 "calmodulin-domain protein kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1314 (467.6 bits), Expect = 4.2e-134, P = 4.2e-134
 Identities = 251/354 (70%), Positives = 302/354 (85%)

Query:     1 MGNCCRSPAAVAREDV------KSN-YSSHDHARKE-AGANKKQPITVLAGVPKENIEDR 52
             MGNCC +P++   +        K+N + S+++A  + +GA  K  ++VL      +I  +
Sbjct:     1 MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFK--LSVLKDPTGHDISLQ 58

Query:    53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
             Y + RE+GRGEFG+TYLC D++T E  ACKSISK+KLRTAVDI+DVRREV IMKH+PK+ 
Sbjct:    59 YDLGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHP 118

Query:   113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
             ++VSLK++ EDD+AVH+VMELCEGGELFDRIVARGHYTERAAAAV +TIVEVVQ+CHK G
Sbjct:   119 NVVSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQG 178

Query:   173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGP 232
             V+HRDLKPENFLFANKKE S LKAIDFGLS+FFKPGE+F+EIVGSPYYMAPEVL+RNYGP
Sbjct:   179 VMHRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGP 238

Query:   233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML 292
             EID+WSAGVILYILLCGVPPFWAE+EQGVAQAI+R +IDFKRDPWP VS+SAK LVR+ML
Sbjct:   239 EIDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKML 298

Query:   293 EPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
             EPDPK RLTA QVLEH W+ NAKKAPNV LG+ V++RLKQFS+MN+ K++ALRV
Sbjct:   299 EPDPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRV 352

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2150230 CDPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 1312 (466.9 bits), Expect = 6.9e-134, P = 6.9e-134
 Identities = 252/352 (71%), Positives = 295/352 (83%)

Query:     1 MGNCCRSPAAVA-----REDVKSN-YSSHDHARKEAGANKKQPITVLAGVPKENIEDRYL 54
             MGNCC SP +       +  +KSN + S  +    +G   K  ++VL      +I   Y 
Sbjct:     1 MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTTNGSGTGFK--LSVLKDPTGHDISLMYD 58

Query:    55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
             + RE+GRGEFG+TYLC D  T E  ACKSISK+KLRTAVDI+DVRREV IMKH+P++ +I
Sbjct:    59 LGREVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNI 118

Query:   115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
             VSLK+A EDD+AVH+VMELCEGGELFDRIVARGHYTERAAAAV +TI+EVVQ+CHKHGV+
Sbjct:   119 VSLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVM 178

Query:   175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEI 234
             HRDLKPENFLFANKKE S LKAIDFGLS+FFKPGE F+EIVGSPYYMAPEVL+RNYGPE+
Sbjct:   179 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEV 238

Query:   235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
             DIWSAGVILYILLCGVPPFWAE+EQGVAQAI+R +IDFKRDPWP VSE+AK LVR+MLEP
Sbjct:   239 DIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEP 298

Query:   295 DPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
             DPK RL+A QVLEH W+QNAKKAPNV LG+ V++RLKQFS+MN+ K++ALRV
Sbjct:   299 DPKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRV 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2027227 CPK30 "calcium-dependent protein kinase 30" [Arabidopsis thaliana (taxid:3702)]

 Score = 1309 (465.8 bits), Expect = 1.4e-133, P = 1.4e-133
 Identities = 244/316 (77%), Positives = 277/316 (87%)

Query:    31 GANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR 90
             G     P+ V+    +  I D+Y++ RELGRGEFG+TYLC DR+TRE LACKSISKRKLR
Sbjct:    37 GLRTHAPLRVIPMSHQSQISDKYILGRELGRGEFGITYLCTDRETREALACKSISKRKLR 96

Query:    91 TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT 150
             TAVD++DVRREV IM  LP++ ++V LK   ED+  VHLVMELCEGGELFDRIVARGHYT
Sbjct:    97 TAVDVEDVRREVTIMSTLPEHPNVVKLKATYEDNENVHLVMELCEGGELFDRIVARGHYT 156

Query:   151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
             ERAAA V RTI EVV++CH +GV+HRDLKPENFLFANKKENS LKAIDFGLS+ FKPGER
Sbjct:   157 ERAAATVARTIAEVVRMCHVNGVMHRDLKPENFLFANKKENSALKAIDFGLSVLFKPGER 216

Query:   211 FSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI 270
             F+EIVGSPYYMAPEVLKRNYGPE+D+WSAGVILYILLCGVPPFWAE+EQGVA AILRG++
Sbjct:   217 FTEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVALAILRGVL 276

Query:   271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
             DFKRDPW  +SESAKSLV+QMLEPD   RLTA+QVL+HPW+QNAKKAPNVPLGD+VRSRL
Sbjct:   277 DFKRDPWSQISESAKSLVKQMLEPDSTKRLTAQQVLDHPWIQNAKKAPNVPLGDIVRSRL 336

Query:   331 KQFSMMNRFKRKALRV 346
             KQFSMMNR K+KALRV
Sbjct:   337 KQFSMMNRLKKKALRV 352

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009612 "response to mechanical stimulus" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

TAIR|locus:2054386 CPK14 "calcium-dependent protein kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 1250 (445.1 bits), Expect = 2.6e-127, P = 2.6e-127
 Identities = 231/347 (66%), Positives = 287/347 (82%)

Query:     1 MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQ-PITVLAGVPKENIEDRYLVDREL 59
             MGNCC +  ++ ++  K  +   +    E G +     + VL       I+ +Y + REL
Sbjct:     1 MGNCCGTAGSLIQDKQKKGFKLPNPFSNEYGNHHDGLKLIVLKEPTGHEIKQKYKLGREL 60

Query:    60 GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
             GRGEFGVTYLC + +T E+ ACKSI K+KL+T++DI+DV+REV IM+ +P++ +IV+LKE
Sbjct:    61 GRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHPNIVTLKE 120

Query:   120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
               EDD AVHLVMELCEGGELFDRIVARGHYTERAAA+V +TI+EVVQ+CHKHGV+HRDLK
Sbjct:   121 TYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHGVMHRDLK 180

Query:   180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
             PENFLFANKKE + LKAIDFGLS+FFKPGERF+EIVGSPYYMAPEVL+R+YG EIDIWSA
Sbjct:   181 PENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQEIDIWSA 240

Query:   240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
             GVILYILLCGVPPFWAE+E GVA+AIL+ +IDFKRDPWP VS++AK L+++ML PDP+ R
Sbjct:   241 GVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKMLHPDPRRR 300

Query:   300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
             LTA+QVL+HPW+QN K A NV LG+ VR+RLKQFS+MN+ K++ALRV
Sbjct:   301 LTAQQVLDHPWIQNGKNASNVSLGETVRARLKQFSVMNKLKKRALRV 347

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

TAIR|locus:2061290 CPK24 "AT2G31500" [Arabidopsis thaliana (taxid:3702)]

 Score = 1165 (415.2 bits), Expect = 2.6e-118, P = 2.6e-118
 Identities = 224/359 (62%), Positives = 282/359 (78%)

Query:     1 MGNCCRSP---AAVAREDVKSNYSSHDHA----RKEAGANKKQ------PITVLAGVPKE 47
             MG+C  SP   +   +  V+  +SS+       R ++  N  +      P  VL     +
Sbjct:     1 MGSCVSSPLKGSPFGKRPVRRRHSSNSRTSSVPRFDSSTNLSRRLIFQPPSRVLPEPIGD 60

Query:    48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
              I  +Y + +ELGRGEFGVT+ CI+  TRE  ACK ISK KLRT +D++DVRREV IM+ 
Sbjct:    61 GIHLKYDLGKELGRGEFGVTHECIEISTRERFACKRISKEKLRTEIDVEDVRREVEIMRC 120

Query:   108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
             LPK+ +IVS KEA ED +AV+LVME+CEGGELFDRIV+RGHYTERAAA+V +TI+EVV++
Sbjct:   121 LPKHPNIVSFKEAFEDKDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAKTILEVVKV 180

Query:   168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK 227
             CH+HGVIHRDLKPENFLF+N  E + LKAIDFGLSIFFKP +RF+EIVGSPYYMAPEVL+
Sbjct:   181 CHEHGVIHRDLKPENFLFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEVLR 240

Query:   228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
             RNYGPEID+WSAGVILYILLCGVPPFWAE+E+G+A AI+RG IDF+RDPWP VS  AK L
Sbjct:   241 RNYGPEIDVWSAGVILYILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAKEL 300

Query:   288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
             V+ ML+ +P  RLT ++VLEHPW++NA++APNV LGD VR++++QF +MNRFK+K LR+
Sbjct:   301 VKNMLDANPYSRLTVQEVLEHPWIRNAERAPNVNLGDNVRTKIQQFLLMNRFKKKVLRI 359

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:1901979 "regulation of inward rectifier potassium channel activity" evidence=IDA

TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 1075 (383.5 bits), Expect = 3.4e-111, Sum P(2) = 3.4e-111
 Identities = 203/315 (64%), Positives = 243/315 (77%)

Query:    32 ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT 91
             A K+ PI  + G P E+++  Y + +ELGRG+FGVT+LC  + T    ACK+I+KRKL  
Sbjct:    52 ATKQGPIGPVLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVN 111

Query:    92 AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTE 151
               DI+DVRREV IM HL    +IV LK A ED ++VHLVMELC GGELFDRI+A+GHY+E
Sbjct:   112 KEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSE 171

Query:   152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
             RAAA++ RTIV++V  CH  GVIHRDLKPENFL  NK ENSPLKA DFGLS+F+KPGE F
Sbjct:   172 RAAASLLRTIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVF 231

Query:   212 SEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID 271
              +IVGS YY+APEVLKR YGPE DIWS GV+LYILLCGVPPFWAESE G+  AILRG +D
Sbjct:   232 KDIVGSAYYIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVD 291

Query:   272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLK 331
             F  DPWP++S  AK LV++ML  DPK RLTA QVL HPW++   +AP+VPL + V SRLK
Sbjct:   292 FSSDPWPSISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLK 351

Query:   332 QFSMMNRFKRKALRV 346
             QF  MN FK+ ALRV
Sbjct:   352 QFKAMNNFKKVALRV 366

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)]

 Score = 1060 (378.2 bits), Expect = 3.5e-107, P = 3.5e-107
 Identities = 200/315 (63%), Positives = 241/315 (76%)

Query:    32 ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT 91
             A K+ PI  + G P E+++  Y + +ELGRG+FGVT+LC  + T    ACK+I+KRKL  
Sbjct:    47 ATKQGPIGPVLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVN 106

Query:    92 AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTE 151
               DI+DVRREV IM HL    +IV LK A ED ++VHLVMELC GGELFDRI+A+GHY+E
Sbjct:   107 KEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSE 166

Query:   152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
             RAAA++ RTIV+++  CH  GVIHRDLKPENFL  +K ENSPLKA DFGLS+F+KPGE F
Sbjct:   167 RAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVF 226

Query:   212 SEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID 271
              +IVGS YY+APEVL+R YGPE DIWS GV+LYILLCGVPPFWAESE G+  AIL G +D
Sbjct:   227 KDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVD 286

Query:   272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLK 331
             F  DPWP +S  AK LVR+ML  DPK RLTA QVL HPW++   +AP+VPL + V SRLK
Sbjct:   287 FSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLK 346

Query:   332 QFSMMNRFKRKALRV 346
             QF  MN FK+ ALRV
Sbjct:   347 QFKAMNNFKKVALRV 361

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8W4I7	CDPKD_ARATH	2, ., 7, ., 1, 1, ., 1	0.9106	0.9971	0.6553	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	347
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-101
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-91
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-68
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-62
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-61
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-57
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-53
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-51
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-50
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-49
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-49
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-45
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-44
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-44
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-44
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-43
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-43
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-42
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-42
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-41
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-41
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-41
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-40
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-39
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-39
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-39
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-38
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-37
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-36
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-36
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-36
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-35
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-35
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-34
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-34
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-34
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-34
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-33
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-33
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-33
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-32
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-32
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-32
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-32
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-32
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-32
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-32
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-31
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-31
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	9e-31
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-30
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-30
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-30
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-30
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-30
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-30
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-29
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-29
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-29
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-29
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-29
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-29
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-29
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-29
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-29
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-29
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-29
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-28
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-28
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-28
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-28
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-28
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-28
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-28
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-28
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-27
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-27
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-27
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-27
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-27
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-27
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-27
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-26
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-26
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-26
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-26
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-26
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-26
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-26
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-26
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-26
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-26
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-26
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-26
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-26
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-26
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-26
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-26
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-25
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-25
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-25
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-25
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-25
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-25
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-25
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-25
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-25
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-24
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-24
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-24
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-24
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-24
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-24
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-24
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-23
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-23
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-23
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-23
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-23
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-23
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-23
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-23
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-23
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-23
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-22
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-22
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-22
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-22
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-22
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-22
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-22
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-22
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-21
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-21
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-21
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-21
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-21
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-21
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-21
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-21
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-21
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-21
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-21
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-20
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-20
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-20
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-20
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-20
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-20
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-20
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	9e-20
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-19
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-19
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-19
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-19
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-18
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-18
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-18
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-17
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-17
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-17
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-17
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-16
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-16
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-16
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-15
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-15
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-14
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-13
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-08
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	9e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-06
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-06
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-06
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	1e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-05
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	6e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	1e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	6e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	7e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.002
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	0.003
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  299 bits (767), Expect = e-101
 Identities = 108/260 (41%), Positives = 155/260 (59%), Gaps = 7/260 (2%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y +  +LG G FG  YL  D+ T +L+A K I K+K++   D + + RE+ I+K L K+ 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKL-KHP 57

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L +  ED++ ++LVME CEGG+LFD +  RG  +E  A    R I+  ++  H  G
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN-YG 231
           ++HRDLKPEN L     E+  +K  DFGL+    PGE+ +  VG+P YMAPEVL    YG
Sbjct: 118 IVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM 291
             +DIWS GVILY LL G PPF  + +       +         P  ++S  AK L+R++
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 292 LEPDPKLRLTAKQVLEHPWL 311
           L  DP+ RLTA++ L+HP+ 
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  272 bits (699), Expect = 3e-91
 Identities = 107/265 (40%), Positives = 155/265 (58%), Gaps = 11/265 (4%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + R+LG G FG  Y    + T +++A K + KR  ++  D    RRE+ I++ L  + 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-RREIRILRRL-SHP 58

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L +A ED + ++LVME CEGG+LFD +   G  +E  A  +   I+  ++  H +G
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVLK--RN 229
           +IHRDLKPEN L     EN  +K  DFGL+    K     +  VG+P+YMAPEVL     
Sbjct: 119 IIHRDLKPENILL---DENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQG---VAQAILRGLIDFKRDPWPNVSESAKS 286
           YGP++D+WS GVILY LL G PPF  E+      + + IL   ++F    W + SE AK 
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235

Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
           L+++ L  DP  R TA+++L+HPW 
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  213 bits (544), Expect = 6e-68
 Identities = 88/257 (34%), Positives = 136/257 (52%), Gaps = 13/257 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   +DT +L A K + K+K+    +++    E  I+  +  +  IV L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLH 59

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A + +  ++LV+E   GGELF  +   G ++E  A      IV  ++  H  G+I+RDL
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           KPEN L      +  +K  DFGL+      G R +   G+P Y+APEVL    YG  +D 
Sbjct: 120 KPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS GV+LY +L G PPF+AE  + + + IL+  + F       +S  A+ L+  +L+ DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDP 232

Query: 297 KLRLT---AKQVLEHPW 310
             RL    A+++  HP+
Sbjct: 233 TKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  198 bits (505), Expect = 7e-62
 Identities = 88/268 (32%), Positives = 134/268 (50%), Gaps = 19/268 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           + +G +G  +L   + T ++ A K I K  +     +D V  E  I+    ++  +V L 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLY 59

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +    ++LVME   GG+L   +   G   E  A      IV  ++  H +G+IHRDL
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119

Query: 179 KPENFLFANKKENSPLKAIDFGLSIF---------FKPGERFSEIVGSPYYMAPEV-LKR 228
           KP+N L  +   N  LK  DFGLS               +    IVG+P Y+APEV L +
Sbjct: 120 KPDNILIDS---NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176

Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +   +D WS G ILY  L G+PPF  E+ + + Q IL G I++  D    VS+ A  L+
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234

Query: 289 RQMLEPDPKLRLTAK---QVLEHPWLQN 313
            ++L PDP+ RL AK   ++  HP+ + 
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  193 bits (494), Expect = 7e-61
 Identities = 91/255 (35%), Positives = 126/255 (49%), Gaps = 44/255 (17%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG  YL  D+ T + +A K I K    + ++  ++ RE+ I+K L  + +IV L 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE--ELLREIEILKKL-NHPNIVKLY 57

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
              ED+N ++LVME CEGG L D +    G  +E     +   I+E ++  H +G+IHRD
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSPYYMAPEVLKRN--YGPEI 234
           LKPEN L  +      +K  DFGLS      +     IVG+P YMAPEVL     Y  + 
Sbjct: 118 LKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           DIWS GVILY L                                      K L+R+ML+ 
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200

Query: 295 DPKLRLTAKQVLEHP 309
           DP+ R +AK++LEH 
Sbjct: 201 DPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  186 bits (474), Expect = 3e-57
 Identities = 76/265 (28%), Positives = 132/265 (49%), Gaps = 16/265 (6%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           +Y + +++G+G FG  YL   +   +L   K I    +    + +D   EV I+K L  +
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKL-NH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQL 167
            +I+   E+ E+   + +VME  +GG+L  +I  +      + E         +   ++ 
Sbjct: 59  PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118

Query: 168 CHKHGVIHRDLKPEN-FLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEV 225
            H   ++HRD+KP+N FL +N      +K  DFG+S         ++ +VG+PYY++PE+
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGL----VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174

Query: 226 LKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            +   Y  + DIWS G +LY L     PF  E+   +A  IL+G   +   P    S   
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG--QYPPIP-SQYSSEL 231

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHP 309
           ++LV  +L+ DP+ R +  Q+L+ P
Sbjct: 232 RNLVSSLLQKDPEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  176 bits (449), Expect = 1e-53
 Identities = 86/262 (32%), Positives = 136/262 (51%), Gaps = 14/262 (5%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
             LGRG FG  YL +D+DT EL+A KS+ +    +  +++ + RE+ I+  L ++ +IV 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSL-QHPNIVR 63

Query: 117 LKEAC--EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
              +   E+ N +++ +E   GG L   +   G   E      TR I+E +   H +G++
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIV 123

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFK---PGERFSEIVGSPYYMAPEVLKRN-Y 230
           HRD+K  N L  +      +K  DFG +        GE    + G+PY+MAPEV++   Y
Sbjct: 124 HRDIKGANILVDSDGV---VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180

Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVR 289
           G   DIWS G  +  +  G PP W+E       A+ +     +    P ++SE AK  +R
Sbjct: 181 GRAADIWSLGCTVIEMATGKPP-WSELGN-PMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238

Query: 290 QMLEPDPKLRLTAKQVLEHPWL 311
           + L  DPK R TA ++L+HP+L
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  175 bits (443), Expect = 2e-51
 Identities = 91/293 (31%), Positives = 140/293 (47%), Gaps = 28/293 (9%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + R+LG G FG  YL  DR   +L+A K ++K+    + +++   RE+ I+  L    
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCH 169
           +IV L +  +D+ +++LVME  +GG L D +   G     +E  A  +   I+  ++  H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-------ERFSEIVGSPYYMA 222
             G+IHRD+KPEN L    ++   +K IDFGL+                S  VG+P YMA
Sbjct: 119 SKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 223 PEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL--------- 269
           PEVL            DIWS G+ LY LL G+PPF  E         L+ +         
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                     +S++A  L++++L  DPK RL++   L H  L + K   +   
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  168 bits (428), Expect = 2e-50
 Identities = 80/258 (31%), Positives = 133/258 (51%), Gaps = 14/258 (5%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
            ++G+G FG  Y    + T + +A K I   KL +    + +  E+ I+K   K+ +IV 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKC-KHPNIVK 61

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIH 175
              +    + + +VME C GG L D + +     TE   A V + +++ ++  H +G+IH
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEI 234
           RD+K  N L  +  E   +K IDFGLS      +  + +VG+PY+MAPEV+    Y  + 
Sbjct: 122 RDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178

Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILR-GLIDFKRDPWP-NVSESAKSLVRQML 292
           DIWS G+    L  G PP+   SE    +A+ +           P   S+  K  +++ L
Sbjct: 179 DIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL 235

Query: 293 EPDPKLRLTAKQVLEHPW 310
           + +P+ R TA+Q+L+HP+
Sbjct: 236 QKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  165 bits (421), Expect = 4e-49
 Identities = 79/280 (28%), Positives = 123/280 (43%), Gaps = 33/280 (11%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + +G G F    L  +++T +  A K + KR+L     +  V+ E  ++  L  +  I+ 
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    +D+  ++ V+E    GEL   I   G   E+        I+  ++  H  G+IHR
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHR 126

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---------------------RFSEIV 215
           DLKPEN L         +K  DFG +    P                       RF+  V
Sbjct: 127 DLKPENILLDKDMH---IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183

Query: 216 GSPYYMAPEVLKRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
           G+  Y++PE+L     G   D+W+ G I+Y +L G PPF   +E    Q IL+    F  
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF-- 241

Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLTAK----QVLEHPW 310
            P PN    AK L+ ++L  DP+ RL       ++  HP+
Sbjct: 242 -P-PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  165 bits (419), Expect = 5e-49
 Identities = 83/264 (31%), Positives = 131/264 (49%), Gaps = 16/264 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   +      A K + KR +      + +  E  I++    +  IV L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLY 59

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +D   ++++ME C GGEL+  +  RG + E  A      +V   +  H  G+I+RDL
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIW 237
           KPEN L  +   N  +K +DFG +   K G++     G+P Y+APE+ L + Y   +D W
Sbjct: 120 KPENLLLDS---NGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176

Query: 238 SAGVILYILLCGVPPFWAESE--QGVAQAILRGLIDFKRDPWPN-VSESAKSLVRQMLEP 294
           S G++LY LL G PPF  + E    +   IL+G    +   +PN + ++AK L++Q+L  
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---FPNYIDKAAKDLIKQLLRR 233

Query: 295 DPKLRL-----TAKQVLEHPWLQN 313
           +P+ RL       K + +H W   
Sbjct: 234 NPEERLGNLKGGIKDIKKHKWFNG 257

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  155 bits (393), Expect = 3e-45
 Identities = 84/264 (31%), Positives = 139/264 (52%), Gaps = 14/264 (5%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y +   +GRG FGV Y  ++ +T + +A K IS  K++    +  + +E+ ++K+L K+
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNL-KH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
            +IV    + E  +++++++E  E G L   I   G + E   A     +++ +   H+ 
Sbjct: 59  PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           GVIHRD+K  N L    K+   +K  DFG++       +  + +VG+PY+MAPEV+    
Sbjct: 119 GVIHRDIKAANILTT--KDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI-EMS 174

Query: 231 GPEI--DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSL 287
           G     DIWS G  +  LL G PP++   +     A+ R + D    P P  +S   K  
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYY---DLNPMAALFRIVQD-DHPPLPEGISPELKDF 230

Query: 288 VRQMLEPDPKLRLTAKQVLEHPWL 311
           + Q  + DP LR TAKQ+L+HPW+
Sbjct: 231 LMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  156 bits (395), Expect = 1e-44
 Identities = 89/278 (32%), Positives = 133/278 (47%), Gaps = 20/278 (7%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G+G +G  +L   +DT E++A K + K  L    ++  V  E  I+    K+  +V L
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKL 66

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             A +DD  ++L ME   GG+    +   G  +E  A      + E V   H+ G IHRD
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126

Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDI 236
           LKPENFL         +K  DFGLS         + +VGSP YMAPEVL+ + Y   +D 
Sbjct: 127 LKPENFLIDASGH---IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDY 181

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR----DPWPNVSESAKSLVRQML 292
           WS G +LY  LCG PPF   +     + +       +R    DP  N+S+ A  L+ +++
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241

Query: 293 EPDPKLRLTA-KQVLEHPWLQN-------AKKAPNVPL 322
             DP  R  + + +  HP+ +          K P VP 
Sbjct: 242 N-DPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPE 278

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  155 bits (395), Expect = 1e-44
 Identities = 95/310 (30%), Positives = 142/310 (45%), Gaps = 44/310 (14%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D + V + +GRG FG  +L  D+DT ++ A K + K  +     I  VR E  I+     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-AD 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  IV L  + +D+  ++LVME   GG+L + ++ +  + E  A      +V  +   HK
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSE---------------- 213
            G IHRD+KP+N L         +K  DFGL     K  +R                   
Sbjct: 120 LGFIHRDIKPDNILIDADGH---IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 214 -------------IVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ 259
                         VG+P Y+APEVL+   YG E D WS GVILY +L G PPF++++ Q
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236

Query: 260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT-AKQVLEHPWLQN----- 313
                I+      +  P P VS  A  L+ ++L  DP+ RL   +++  HP+ +      
Sbjct: 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWEN 295

Query: 314 --AKKAPNVP 321
               K P VP
Sbjct: 296 LRETKPPFVP 305

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  153 bits (388), Expect = 3e-44
 Identities = 84/288 (29%), Positives = 123/288 (42%), Gaps = 42/288 (14%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR--REVAIMKHLPKNSSI 114
            ++G G +GV Y   D+ T E++A K I   KLR   +       RE+ ++K L  + +I
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKEL-NHPNI 60

Query: 115 VSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           + L +       ++LV E  +    +L      +    E    +    +++ +  CH HG
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRN 229
           ++HRDLKPEN L         LK  DFGL+  F  P   ++  V + +Y APE+L   + 
Sbjct: 119 ILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESE-------------------QGVAQAILRGLI 270
           Y   +DIWS G I   LL   P F  +SE                               
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 271 DFK---RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            F      P     PN S  A  L+ QML  DP  R+TA+Q L HP+ 
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  150 bits (382), Expect = 2e-43
 Identities = 80/293 (27%), Positives = 138/293 (47%), Gaps = 45/293 (15%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHL 108
           Y    +LG G +GV Y   D+ T E++A K     K+R   + + +     RE++++K L
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL 55

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            K+ +IV L +    +  ++LV E C+    +  D+    G  +     ++   ++  + 
Sbjct: 56  -KHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLA 112

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEV 225
            CH H ++HRDLKP+N +  N+     LK  DFGL+  F  P   ++  V + +Y APE+
Sbjct: 113 YCHSHRILHRDLKPQN-ILINRDGV--LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169

Query: 226 L--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI--------------LRGL 269
           L   ++Y   +DIWS G I   ++ G P F  +SE      I              +  L
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229

Query: 270 IDFKRDP--W---------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            D+K     +         P +      L+ +ML+ +P  R++AK+ L+HP+ 
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  150 bits (381), Expect = 4e-43
 Identities = 87/287 (30%), Positives = 143/287 (49%), Gaps = 30/287 (10%)

Query: 38  ITVLAGVPKENIEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDID 96
             V  G P+E        + E +G G  G  Y   DR T + +A K +  RK       +
Sbjct: 10  DIVSEGDPRE-----LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN----KE 60

Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY---TERA 153
            +  E+ IMK   K+ +IV   ++    + + +VME  +GG L D  +   ++    E  
Sbjct: 61  LIINEILIMKDC-KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD--IITQNFVRMNEPQ 117

Query: 154 AAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFS 212
            A V R +++ ++  H   VIHRD+K +N L +       +K  DFG +    K   + +
Sbjct: 118 IAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRN 174

Query: 213 EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR---- 267
            +VG+PY+MAPEV+KR  YGP++DIWS G++   +  G PP+  E      +A+      
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITTK 231

Query: 268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           G+   K +P    S   K  + + L  DP+ R +A+++L+HP+L+ A
Sbjct: 232 GIPPLK-NP-EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  147 bits (374), Expect = 2e-42
 Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 8/262 (3%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + + R +G+G FG   +   RDT+++ A K ++K+K      + +V  E  I++ L  + 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V+L  + +D+  ++LV++L  GG+L   +  +  ++E         IV  ++  H  G
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYG 231
           +IHRD+KP+N L     E   +   DF ++    P    +   G+P YMAPEVL R  Y 
Sbjct: 121 IIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM 291
             +D WS GV  Y  L G  P+   S     Q I               S  A   + ++
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-IRAKQETADVLYPATWSTEAIDAINKL 236

Query: 292 LEPDPKLRL--TAKQVLEHPWL 311
           LE DP+ RL    K +  HP+ 
Sbjct: 237 LERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  148 bits (375), Expect = 3e-42
 Identities = 86/286 (30%), Positives = 142/286 (49%), Gaps = 25/286 (8%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D +   + LG G FG   L   + + +  A K +SK K+     ++ V  E  I++ + +
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-R 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  +V+L  + +DD+ ++LVME   GGELF  +   G + E  A      +V  ++  H 
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-LKRN 229
             +++RDLKPEN L  +   +  +K  DFG +   K   R   + G+P Y+APE+ L + 
Sbjct: 120 LDIVYRDLKPENLLLDS---DGYIKITDFGFAKRVK--GRTYTLCGTPEYLAPEIILSKG 174

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           YG  +D W+ G+++Y +L G PPF+ ++   + + IL G + F        S  AK L+R
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIR 230

Query: 290 QMLEPDPKLRL-----TAKQVLEHPW---------LQNAKKAPNVP 321
            +L+ D   RL         +  HPW         LQ   +AP +P
Sbjct: 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIP 276

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  146 bits (371), Expect = 1e-41
 Identities = 83/291 (28%), Positives = 131/291 (45%), Gaps = 37/291 (12%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY +   +G G  G+ +   DR+T E +A K ++ R+L   +  +   RE+  ++   ++
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQAC-QH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHK 170
             +V L +     +   LVME     +L + +        E    +  R +++ V   H 
Sbjct: 59  PYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGSPYYMAPEVL-- 226
           +G++HRDLKP N L +    +  LK  DFGL+  F   E   +S  V + +Y APE+L  
Sbjct: 118 NGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAES--EQ-----------------GVAQAILR 267
            R Y P +D+W+ G I   LL G P F  E+  EQ                 G+      
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234

Query: 268 GLIDF---KRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             I F   K  P     P+ S  A  L++ +L  DP  RL+A + L HP+ 
Sbjct: 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  145 bits (367), Expect = 1e-41
 Identities = 81/263 (30%), Positives = 125/263 (47%), Gaps = 10/263 (3%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + + +G FG  YL   R T +  A K + K  +     + +V+ E AIM    ++  +  
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L  + +  + ++LVME   GG+    I   G   E  A      +V  V+  H+ G+IHR
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEI-D 235
           D+KPEN L     +   LK  DFGLS   + G    + VG+P Y+APE +      ++ D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            WS G +++  L G PPF AE+   V   IL   I++  +     S  A  L+ ++L  D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235

Query: 296 PKLRLTAKQVLE---HPWLQNAK 315
           P  RL A    E   HP+ ++  
Sbjct: 236 PAKRLGANGYQEIKSHPFFKSIN 258

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  143 bits (364), Expect = 9e-41
 Identities = 92/294 (31%), Positives = 141/294 (47%), Gaps = 46/294 (15%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR--REV-AIMKHLP 109
           Y V ++LG G FG  YL  +++T EL+A K + K+K  +    ++    REV ++ K L 
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYS---WEECMNLREVKSLRK-LN 55

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQL 167
           ++ +IV LKE   +++ ++ V E  EG  L+  +  R    ++E    ++   I++ +  
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMAPEV 225
            HKHG  HRDLKPEN L +       +K  DFGL+  I  +P   +++ V + +Y APE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSG---PEVVKIADFGLAREIRSRP--PYTDYVSTRWYRAPEI 169

Query: 226 LKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW------ 277
           L R  +Y   +DIW+ G I+  L    P F   SE      I   L    +  W      
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229

Query: 278 --------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                               PN S  A  L++ ML  DPK R TA Q L+HP+ 
Sbjct: 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  141 bits (358), Expect = 5e-40
 Identities = 74/267 (27%), Positives = 123/267 (46%), Gaps = 18/267 (6%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI-MKHLPKNSS--I 114
            LG+G  GV Y    + T ++ A K I           ++ R+++   +K L    S  +
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKI------HVDGDEEFRKQLLRELKTLRSCESPYV 61

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ-LCHKHGV 173
           V    A   +  + +V+E  +GG L D +   G   E   A + R I++ +  L  K  +
Sbjct: 62  VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIVGSPYYMAPEVLK-RNYG 231
           IHRD+KP N L  N K    +K  DFG+S   +   ++ +  VG+  YM+PE ++  +Y 
Sbjct: 122 IHRDIKPSNLL-INSKGE--VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYS 178

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP--NVSESAKSLVR 289
              DIWS G+ L     G  PF     Q     +++ + D      P    S   +  + 
Sbjct: 179 YAADIWSLGLTLLECALGKFPF-LPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKK 316
             L+ DPK R +A ++L+HP+++ A  
Sbjct: 238 ACLQKDPKKRPSAAELLQHPFIKKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  140 bits (356), Expect = 1e-39
 Identities = 79/270 (29%), Positives = 124/270 (45%), Gaps = 30/270 (11%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G G FG  Y  ++ DT EL+A K I  +       I ++  E+ +++ L K+ ++V   
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELL-KHPNLVKYY 65

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
                   V++ ME C GG L + +       E      T  ++E +   H HG++HRD+
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKP-----GERFSEIVGSPYYMAPEVLKRN---- 229
           KP N        N  +K  DFG ++  K      GE    + G+P YMAPEV+       
Sbjct: 126 KPANIFLD---HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-----RDPWP---NVS 281
           +G   DIWS G ++  +  G  P W+E +           I F      + P P    +S
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRP-WSELDNEFQ-------IMFHVGAGHKPPIPDSLQLS 234

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              K  + + LE DPK R TA ++L+HP++
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  140 bits (355), Expect = 1e-39
 Identities = 81/272 (29%), Positives = 124/272 (45%), Gaps = 25/272 (9%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V   +G+G FG       +   ++L  K I    + T  +   +  EV I++ L K+ 
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KHP 59

Query: 113 SIVSL--KEACEDDNAVHLVMELCEGGELFDRI----VARGHYTERAAAAVTRTIVEVVQ 166
           +IV    +     +  +++VME CEGG+L   I      R +  E     +   ++  + 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 167 LCH-----KHGVIHRDLKPEN-FLFANKKENSPLKAIDFGLSIFFKPGERF-SEIVGSPY 219
            CH      + V+HRDLKP N FL AN      +K  DFGL+        F    VG+PY
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNN----VKLGDFGLAKILGHDSSFAKTYVGTPY 175

Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           YM+PE L    Y  + DIWS G ++Y L    PPF A ++  +A  I  G         P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF----RRIP 231

Query: 279 NV-SESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
              S     +++ ML  DP  R + +++L+ P
Sbjct: 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  139 bits (352), Expect = 5e-39
 Identities = 84/269 (31%), Positives = 133/269 (49%), Gaps = 17/269 (6%)

Query: 57  RELGRGEFGVTYLCIDR---DTRELLACKSISK-RKLRTAVDIDDVRREVAIMKHLPKNS 112
           R LG G +G  +L       D  +L A K + K   ++ A   +  R E  +++ + +  
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V+L  A + D  +HL+++   GGELF  +  R H+TE         IV  +   H+ G
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG 125

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVLKR-- 228
           +I+RD+K EN L         +   DFGLS  F   E  R     G+  YMAPEV++   
Sbjct: 126 IIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182

Query: 229 -NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
             +   +D WS GV+ + LL G  PF  + EQ  +Q+ +   I   + P+P  +S  A+ 
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSKPPFPKTMSAEARD 241

Query: 287 LVRQMLEPDPKLRL---TAKQVLEHPWLQ 312
            ++++LE DPK RL    A ++  HP+ Q
Sbjct: 242 FIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 3e-38
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 61/305 (20%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMK 106
           ++Y V   +G G +GV   C ++ T E++A K     K + + D +DV+    REV +++
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLR 55

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER-----AAAAVTRTI 161
            L ++ +IV+LKEA      ++LV E  E   L           E         AV   I
Sbjct: 56  QL-RHENIVNLKEAFRRKGRLYLVFEYVERTLL--------ELLEASPGGLPPDAVRSYI 106

Query: 162 VEVVQ---LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF--KPGERFSEIVG 216
            +++Q    CH H +IHRD+KPEN L     E+  LK  DFG +     +P    ++ V 
Sbjct: 107 WQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVA 163

Query: 217 SPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL----- 269
           + +Y APE+L    NYG  +D+W+ G I+  LL G P F  +S+      I + L     
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223

Query: 270 ---IDFKRDP-------------------WPN-VSESAKSLVRQMLEPDPKLRLTAKQVL 306
                F  +P                   +P  VS  A   ++  L  DPK RLT  ++L
Sbjct: 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283

Query: 307 EHPWL 311
           +HP+ 
Sbjct: 284 QHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  135 bits (341), Expect = 4e-37
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 45/298 (15%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-ID-DVRREVAIMKHLP 109
           RY   ++LG G + V Y   D++T  ++A K I   + + A D I+    RE+ +++ L 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL- 59

Query: 110 KNSSIVSLKEA-CEDDNAVHLVMELCEG---GELFDRIVARGHYTERAAAAVTRTIVEVV 165
           K+ +I+ L +      N ++LV E  E      + D+ +     T     +     +  +
Sbjct: 60  KHPNIIGLLDVFGHKSN-INLVFEFMETDLEKVIKDKSIV---LTPADIKSYMLMTLRGL 115

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPE 224
           +  H + ++HRDLKP N L A+      LK  DFGL+  F  P  + +  V + +Y APE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172

Query: 225 VL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------------------QGVAQ 263
           +L   R+YG  +D+WS G I   LL  VP    +S+                    GV  
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232

Query: 264 AILRGLIDFK-------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             L   ++FK       +  +P  S+ A  L++++L  +P  R+TA+Q LEHP+  N 
Sbjct: 233 --LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  132 bits (334), Expect = 3e-36
 Identities = 88/282 (31%), Positives = 139/282 (49%), Gaps = 25/282 (8%)

Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G P+  + D ++   ++G G  G+  +  D+ T   +A K +  RK +        R
Sbjct: 12  VDPGDPRSYL-DNFV---KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ--------R 59

Query: 100 RE-----VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
           RE     V IM+    + +IV +  +    + + +VME  EGG L D IV      E   
Sbjct: 60  RELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQI 117

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSE 213
           A V   +++ +   H  GVIHRD+K ++ L      +  +K  DFG  +   K   R   
Sbjct: 118 ATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKS 174

Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF 272
           +VG+PY+MAPEV+ R  YG E+DIWS G+++  ++ G PP++ E      + I   L   
Sbjct: 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK 234

Query: 273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
            ++    VS   +S + +ML  DP  R TA ++L HP+L  A
Sbjct: 235 LKNL-HKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  131 bits (333), Expect = 3e-36
 Identities = 83/284 (29%), Positives = 138/284 (48%), Gaps = 31/284 (10%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-IDDVRREVAIMKHLP 109
           + + +   +G+G FG  Y  ID+ T +++A K I    L  A D I+D+++E+  +    
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFLSQC- 56

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           ++  I     +    + + ++ME C GG   D ++  G   E   A + R ++  ++  H
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLH 115

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE------RFSEIVGSPYYMAP 223
           + G IHRD+K  N L +   E   +K  DFG+S     G+      + +  VG+P++MAP
Sbjct: 116 EEGKIHRDIKAANILLS---EEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAP 167

Query: 224 EVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP----WP 278
           EV+K++ Y  + DIWS G+    L  G PP        V   I       K +P      
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP------KNNPPSLEGN 221

Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             S+  K  V   L  DPK R +AK++L+H +++ AKK   + L
Sbjct: 222 KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTL 265

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 6e-36
 Identities = 75/260 (28%), Positives = 128/260 (49%), Gaps = 16/260 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G G FG  +L  DR +    A K ++  ++        V  E  ++K +  +  I+ L 
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLF 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
               D   ++++ME   GGELF  +   G ++          IV  ++  H   +++RDL
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIW 237
           KPEN L    KE   +K  DFG +   K  +R   + G+P Y+APEV++   +   +D W
Sbjct: 128 KPENILL--DKEGH-IKLTDFGFAK--KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWW 182

Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPK 297
           + G+++Y +L G PPF+ ++  G+ + IL G ++F R    ++   AK L++++L  D  
Sbjct: 183 ALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKKLLVVDRT 238

Query: 298 LRL-----TAKQVLEHPWLQ 312
            RL      A  V  H W +
Sbjct: 239 RRLGNMKNGADDVKNHRWFK 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  131 bits (330), Expect = 2e-35
 Identities = 79/267 (29%), Positives = 138/267 (51%), Gaps = 21/267 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV--RREVAIMKHLPKNSSIVS 116
           +G+G FG  Y    +DTR + A K +SK+++    ++      R + +   L ++  IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           LK + + D+ ++LV +   GGELF  +   G ++E  A      +V  ++  HK+ +++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKP----GERFSEIVGSPYYMAPEVL--KRNY 230
           DLKPEN L         +   DFGLS   K      +  +   G+  Y+APEVL  ++ Y
Sbjct: 121 DLKPENILL---DATGHIALCDFGLS---KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174

Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
              +D WS GV+++ + CG  PF+AE  Q + + I  G + F ++    +S+  +  V+ 
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKG 231

Query: 291 MLEPDPKLRL----TAKQVLEHPWLQN 313
           +L  +P+ RL     A ++ EHP+  +
Sbjct: 232 LLNRNPQHRLGAHRDAVELKEHPFFAD 258

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  128 bits (322), Expect = 6e-35
 Identities = 81/260 (31%), Positives = 128/260 (49%), Gaps = 17/260 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKL--RTAVDIDDVRREVAIMKHLPKNSSIVS 116
           LG+G FG  YLC D DT   LA K +        T  +++ +  E+ ++K+L ++  IV 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQ 68

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
                 DD  + + ME   GG + D++ A G  TE      TR I+E V+  H + ++HR
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128

Query: 177 DLKPENFLFANKKENSPLKAIDFG----LSIFFKPGERFSEIVGSPYYMAPEVLK-RNYG 231
           D+K  N L   +     +K  DFG    L      G     + G+PY+M+PEV+    YG
Sbjct: 129 DIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAKSLVR 289
            + D+WS G  +  +L   PP WAE E   A A +  +     +P    +VS  A++ +R
Sbjct: 186 RKADVWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPQLPSHVSPDARNFLR 241

Query: 290 QMLEPDPKLRLTAKQVLEHP 309
           +    + K R +A+++L H 
Sbjct: 242 RTFVENAKKRPSAEELLRHF 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  126 bits (318), Expect = 3e-34
 Identities = 73/270 (27%), Positives = 132/270 (48%), Gaps = 23/270 (8%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           E+ + +  +LG G +G  Y  I ++T +++A K +         D+ ++ +E++I+K   
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQC- 55

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLC 168
            +  IV    +   +  + +VME C  G + D +       TE   AA+    ++ ++  
Sbjct: 56  DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK 227
           H +  IHRD+K  N L   + +    K  DFG+S        + + ++G+P++MAPEV++
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQ---AKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172

Query: 228 R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-----RDPWPNVS 281
              Y  + DIWS G+    +  G PP+   S+    +AI   +I  K      DP    S
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPY---SDIHPMRAIF--MIPNKPPPTLSDP-EKWS 226

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                 V++ L  DP+ R +A Q+L+HP++
Sbjct: 227 PEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  127 bits (319), Expect = 3e-34
 Identities = 86/282 (30%), Positives = 141/282 (50%), Gaps = 26/282 (9%)

Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNSSI 114
           LG G +G  +L       D+ +L A K + K  + + A   +  R E  +++H+ ++  +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V+L  A + D  +HL+++   GGELF  +  R  + E+     +  IV  ++  HK G+I
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGII 127

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFF--KPGERFSEIVGSPYYMAPEVLK---RN 229
           +RD+K EN L      N  +   DFGLS  F     ER     G+  YMAP++++     
Sbjct: 128 YRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLV 288
           +   +D WS GV++Y LL G  PF  + E+     I R ++     P+P  +S  AK ++
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALAKDII 243

Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN-------AKKAP 318
           +++L  DPK RL      A ++ +HP+ Q        AKK P
Sbjct: 244 QRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVP 285

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 5e-34
 Identities = 79/297 (26%), Positives = 130/297 (43%), Gaps = 50/297 (16%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y    ++G G +G  Y   ++ T EL+A K I     +    I  +R E+ +++ L ++ 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKL-RHP 58

Query: 113 SIVSLKEAC--EDDNAVHLVMELCEGGELFD--RIVARG--HYTERAAAAVTRTIVEVVQ 166
           +IV LKE    +   ++++V E  +     D   ++      +TE       + ++E +Q
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP--GERFSEIVGSPYYMAPE 224
             H +G++HRD+K  N L  N      LK  DFGL+  +       ++  V + +Y  PE
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171

Query: 225 VL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR--GLIDFKRDPWPNV 280
           +L     YGPE+D+WS G IL  L  G P F   +E    + I    G      + WP V
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT--DENWPGV 229

Query: 281 ---------------------------SESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                                        SA  L+ ++L  DPK R++A Q L+H +
Sbjct: 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  126 bits (320), Expect = 8e-34
 Identities = 94/310 (30%), Positives = 135/310 (43%), Gaps = 66/310 (21%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKHL 108
           RY + + +G G +GV    +D+ T   +A K IS        D+ D +   RE+ +++HL
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS----NVFDDLIDAKRILREIKLLRHL 56

Query: 109 PKNSSIVSLK-----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
            ++ +I+ L       + ED N V++V EL E  +L   I +    T+            
Sbjct: 57  -RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFL----- 109

Query: 164 VVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSE 213
             Q+       H   VIHRDLKP N +  N   N  LK  DFGL+    P E      +E
Sbjct: 110 -YQILRGLKYLHSANVIHRDLKPSN-ILVN--SNCDLKICDFGLARGVDPDEDEKGFLTE 165

Query: 214 IVGSPYYMAPEVL--KRNYGPEIDIWSAGVIL--------------YI----LLC---GV 250
            V + +Y APE+L     Y   IDIWS G I               YI    L+    G 
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225

Query: 251 PP----FWAESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTA 302
           P      +  SE+  A+  L+ L    + P     P  S  A  L+ +ML  DPK R+TA
Sbjct: 226 PSEEDLKFITSEK--ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283

Query: 303 KQVLEHPWLQ 312
            + L HP+L 
Sbjct: 284 DEALAHPYLA 293

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  126 bits (317), Expect = 1e-33
 Identities = 77/243 (31%), Positives = 125/243 (51%), Gaps = 11/243 (4%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   +   + T E  A K + KR++     +  V +E +I+  L  +  IV++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMM 84

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D+N V+ ++E   GGELF  +   G +    A      +V   +  H   +I+RDL
Sbjct: 85  CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDL 144

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIW 237
           KPEN L  NK     +K  DFG +   K  +R   + G+P Y+APEV++ + +G  +D W
Sbjct: 145 KPENLLLDNKGH---VKVTDFGFAK--KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWW 199

Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPK 297
           + GV+LY  + G PPF+ ++   + + IL G + F    W      A+ LV+ +L+ D  
Sbjct: 200 TMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKGLLQTDHT 255

Query: 298 LRL 300
            RL
Sbjct: 256 KRL 258

Length = 329

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  124 bits (314), Expect = 3e-33
 Identities = 86/267 (32%), Positives = 133/267 (49%), Gaps = 31/267 (11%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA---IMKHLPKNSS-- 113
           LG+G FG   L  ++ T +  A K I K+++  A D      EVA       + +N+   
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMK-ILKKEVIIAKD------EVAHTLTESRVLQNTRHP 55

Query: 114 -IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            + +LK + +  + +  VME   GGELF  +     ++E  A      IV  +   H   
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLKRN 229
           V++RDLK EN +     ++  +K  DFGL    I    G       G+P Y+APEVL+ N
Sbjct: 116 VVYRDLKLENLML---DKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDN 170

Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            YG  +D W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLL 226

Query: 289 RQMLEPDPKLRL-----TAKQVLEHPW 310
             +L+ DPK RL      AK+++EH +
Sbjct: 227 AGLLKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  122 bits (309), Expect = 6e-33
 Identities = 78/274 (28%), Positives = 126/274 (45%), Gaps = 24/274 (8%)

Query: 51  DRYLVDRELGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           D Y +   +G G   V Y  +C+     E +A K I   K +T   +D++R+EV  M   
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPN--NEKVAIKRIDLEKCQT--SVDELRKEVQAMS-Q 55

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFD---RIVARGHYTERAAAAVTRTIVEVV 165
             + ++V    +    + + LVM    GG L D       RG   E   A V + +++ +
Sbjct: 56  CNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGL 115

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSE----IVGSPYY 220
           +  H +G IHRD+K  N L     E+  +K  DFG+S      G+R  +     VG+P +
Sbjct: 116 EYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 221 MAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG---LIDFKRD 275
           MAPEV++    Y  + DIWS G+    L  G  P+       V    L+     ++   D
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD 232

Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
                S+S + ++   L+ DP  R TA+++L+H 
Sbjct: 233 YKK-YSKSFRKMISLCLQKDPSKRPTAEELLKHK 265

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  124 bits (313), Expect = 1e-32
 Identities = 95/279 (34%), Positives = 139/279 (49%), Gaps = 23/279 (8%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
             ED + V + +GRG FG   L   + ++++ A K +SK ++    D      E  IM H
Sbjct: 41  KAED-FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99

Query: 108 LPKNSS-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
              NS  IV L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  + 
Sbjct: 100 --ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALD 156

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGE-RFSEIVGSPYYMAPE 224
             H  G IHRD+KP+N L     ++  LK  DFG  +     G  R    VG+P Y++PE
Sbjct: 157 AIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213

Query: 225 VLKRN-----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPW 277
           VLK       YG E D WS GV LY +L G  PF+A+S  G    I+  +  + F  D  
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD-- 271

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE---HPWLQN 313
             +S+ AK L+   L  D ++RL    V E   HP+ +N
Sbjct: 272 IEISKQAKDLICAFLT-DREVRLGRNGVDEIKSHPFFKN 309

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  121 bits (306), Expect = 2e-32
 Identities = 78/261 (29%), Positives = 129/261 (49%), Gaps = 18/261 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACK--SISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           LG G FG  Y  ++ D  +  A K  S++         +  + +E+A++  L ++ +IV 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQ 66

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
                 +++ +++ +EL  GG L   +   G + E      TR I+  ++  H    +HR
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---VGSPYYMAPEVLKR--NYG 231
           D+K  N L      N  +K  DFG++   K    FS      GSPY+MAPEV+ +   YG
Sbjct: 127 DIKGANILVDT---NGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKSLVRQ 290
              DIWS G  +  +  G PP W++ E     A+ +     +  P P+ +S+ AK  + +
Sbjct: 181 LAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVFKIGRSKELPPIPDHLSDEAKDFILK 237

Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L+ DP LR TA ++LEHP++
Sbjct: 238 CLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  123 bits (310), Expect = 2e-32
 Identities = 84/302 (27%), Positives = 146/302 (48%), Gaps = 22/302 (7%)

Query: 59  LGRGEFGVTYL---CIDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNSSI 114
           LG G +G  +L       DT +L A K + K  L + A  ++  R E  +++H+ ++  +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V+L  A + +  +HL+++   GGE+F  +  R +++E      +  I+  ++  HK G++
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIV 127

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFF--KPGERFSEIVGSPYYMAPEVL--KRNY 230
           +RD+K EN L  ++     +   DFGLS  F  +  ER     G+  YMAPE++  K  +
Sbjct: 128 YRDIKLENILLDSEGH---VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184

Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           G  +D WS G++++ LL G  PF  E E+     + R ++         +   A+ L+ +
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHK 244

Query: 291 MLEPDPKLRL-----TAKQVLEHP------WLQNAKKAPNVPLGDVVRSRLKQFSMMNRF 339
           +L  DPK RL      A ++ EHP      W   A +  N P    +R+ L   +    F
Sbjct: 245 LLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEF 304

Query: 340 KR 341
             
Sbjct: 305 TN 306

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  121 bits (304), Expect = 4e-32
 Identities = 85/280 (30%), Positives = 142/280 (50%), Gaps = 27/280 (9%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-IDDVRREVAIMKHL----PKNSS 113
           +GRG +G  Y      T  ++A K I+   L T  D + D++REVA++  L    P N  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQSQPPN-- 63

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHG 172
           I     +      + ++ME  EGG +  R + + G   E+  + + R ++  ++  HK G
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHKVG 121

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLK--RN 229
           VIHRD+K  N L  N      +K  DFG++        + S  VG+PY+MAPEV+   + 
Sbjct: 122 VIHRDIKAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL-- 287
           Y  + DIWS G+ +Y +  G PP+   S+    +A++  LI   + P    +  +K L  
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMM--LIPKSKPPRLEDNGYSKLLRE 233

Query: 288 -VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVV 326
            V   L+ +PK RL+A+++L+  W++   K P   L +++
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKELI 273

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  120 bits (303), Expect = 4e-32
 Identities = 83/266 (31%), Positives = 128/266 (48%), Gaps = 16/266 (6%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y+  R LG+G FG   L    +   L+  K ++  +L       D   E+ I+  L ++
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLL-QH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCH 169
            +I++      DDN + + ME   GG L+D+IV +    + E         IV  V   H
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS---EIVGSPYYMAPEVL 226
           K G++HRD+K  N +F  K     +K  DFG+S     G  +S    +VG+PYYM+PE+ 
Sbjct: 119 KAGILHRDIKTLN-IFLTKA--GLIKLGDFGISK--ILGSEYSMAETVVGTPYYMSPELC 173

Query: 227 K-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           +   Y  + DIW+ G +LY LL     F A +   +   I++G        +   S    
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELI 230

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
           SLV  +L+ DP+ R TA +VL+ P L
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  120 bits (303), Expect = 7e-32
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 46/288 (15%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSI----SKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           +LG G +   Y   +R T E++A K I     +    TA+      RE+++MK L K+ +
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI------REISLMKEL-KHEN 59

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV---TRTIVEVVQLCHK 170
           IV L +    +N + LV E  +  +L   +   G         V   T  +++ +  CH+
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL--K 227
           + V+HRDLKP+N L   + E   LK  DFGL+  F  P   FS  V + +Y AP+VL   
Sbjct: 119 NRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK-- 285
           R Y   IDIWS G I+  ++ G P F   + +     I R +       WP +S+  +  
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235

Query: 286 -----------------------SLVRQMLEPDPKLRLTAKQVLEHPW 310
                                   L+ ++L+ +P+LR++A   L+HPW
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  119 bits (300), Expect = 9e-32
 Identities = 82/264 (31%), Positives = 126/264 (47%), Gaps = 16/264 (6%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            + V ++LG+G +G  Y        +  A K +    +      D V  E+ I+  +  +
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASV-NH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIVEVVQL 167
            +I+S KEA  D N + +VME    G+L   I  R        E+    +   ++  +Q 
Sbjct: 59  PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK 227
            H+  ++HRDLK  N L      N  +K  D G+S   K     ++I G+P+YMAPEV K
Sbjct: 119 LHEQKILHRDLKSANILLVA---NDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWK 174

Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-SESAK 285
            R Y  + DIWS G +LY +    PPF A S Q +   + RG    K  P P + S+  +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG----KYPPIPPIYSQDLQ 230

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHP 309
           + +R ML+  PKLR    ++L  P
Sbjct: 231 NFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 1e-31
 Identities = 85/287 (29%), Positives = 134/287 (46%), Gaps = 34/287 (11%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G FG  Y    ++T    A K I   ++ +  +++D   E+ I+    K+ +IV L
Sbjct: 12  ELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSEC-KHPNIVGL 67

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHR 176
            EA   +N + +++E C+GG L   ++      TE     V R ++E +   H H VIHR
Sbjct: 68  YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIVGSPYYMAPEVL------KRN 229
           DLK  N L     +   +K  DFG+S   K   ++    +G+PY+MAPEV+         
Sbjct: 128 DLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP--------WPNVS 281
           Y  + DIWS G+ L  L    PP     E    + +L+ L   K +P        W   S
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP---HHELNPMRVLLKIL---KSEPPTLDQPSKW---S 235

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRS 328
            S    ++  L  DP  R TA ++L+HP++ +     N  + D++  
Sbjct: 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD--NKAIKDLLAE 280

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 3e-31
 Identities = 86/318 (27%), Positives = 139/318 (43%), Gaps = 62/318 (19%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + LG+G+ G  +L   + T +L A K + K+++     +  V  E  I+  L  +  + +
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPT 65

Query: 117 LKEACEDDNAVHLVMELCEGGELFD-RIVARGHY-TERAA---AAVTRTIVEVV---QLC 168
           L  + + +  + LVM+ C GGELF       G   +E  A   AA      EV+   +  
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA------EVLLALEYL 119

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------------------------- 202
           H  G+++RDLKPEN L     E+  +   DF LS                          
Sbjct: 120 HLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 203 ----IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAES 257
                  +P  R +  VG+  Y+APEV+  + +G  +D W+ G++LY +L G  PF   +
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL----TAKQVLEHPWLQN 313
                  IL+  + F     P VS SA+ L+R++L  DP  RL     A ++ +HP+ + 
Sbjct: 237 RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294

Query: 314 AK-------KAPNVPLGD 324
                      P +P  D
Sbjct: 295 VNWALIRHTTPPIIPRPD 312

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  117 bits (295), Expect = 9e-31
 Identities = 87/275 (31%), Positives = 145/275 (52%), Gaps = 12/275 (4%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   + + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 82

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141

Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 142 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  K      VS S K  + ++L  D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257

Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   +  VPL    R R
Sbjct: 258 PAQRATAAELLKHPFLAKAGPPSCIVPLMRQNRMR 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  116 bits (291), Expect = 2e-30
 Identities = 78/267 (29%), Positives = 131/267 (49%), Gaps = 21/267 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSI------SKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           +G G FG  YL ++  + EL+A K +      +  K R    +D + RE+A++K L ++ 
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV    +  D + +++ +E   GG +   +   G + E       R I++ +   H  G
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSEIVGSPYYMAPEV 225
           +IHRD+K  N L  NK     +K  DFG+S       +  K       + GS ++MAPEV
Sbjct: 127 IIHRDIKGANILVDNK---GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Query: 226 LKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
           +K+  Y  + DIWS G ++  +L G  P + +  Q   QAI +   +   +   N+S  A
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHP-FPDCTQ--LQAIFKIGENASPEIPSNISSEA 240

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              + +  E D   R TA ++L+HP+L
Sbjct: 241 IDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  117 bits (294), Expect = 3e-30
 Identities = 83/269 (30%), Positives = 135/269 (50%), Gaps = 23/269 (8%)

Query: 57  RELGRGEFGVTYLC---IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNS 112
           + LG+G +G  +        DT ++ A K + K  + R   D    + E  I++ + K+ 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHP 60

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            IV L  A +    ++L++E   GGELF  +   G + E  A      I   ++  H+ G
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLKRN 229
           +I+RDLKPEN L   +     +K  DFGL   SI    G       G+  YMAPE+L R+
Sbjct: 121 IIYRDLKPENILLDAQGH---VKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRS 175

Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +G  +D WS G ++Y +L G PPF AE+ +     IL+G ++      P ++  A+ L+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231

Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQ 312
           +++L+ +P  RL      A +V  HP+ +
Sbjct: 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  115 bits (291), Expect = 6e-30
 Identities = 80/267 (29%), Positives = 129/267 (48%), Gaps = 20/267 (7%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + LG+G FG   L   + T EL A K + K  +    D++    E  ++    K+  +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    +  + +  VME   GG+L   I   G + E  A      IV  +Q  H+ G+I+R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFK----PGERFSEIVGSPYYMAPEVLK-RNYG 231
           DLK +N L  ++     +K  DFG+    K     G   S   G+P Y+APE+L  + YG
Sbjct: 121 DLKLDNVLLDSEGH---IKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM 291
           P +D W+ GV+LY +L G  PF  + E  + Q+IL   + + R     +S+ AKS+++  
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSF 230

Query: 292 LEPDPKLRLTA-----KQVLEHPWLQN 313
           L  +P+ RL       + +  HP+ + 
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFRE 257

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  114 bits (286), Expect = 7e-30
 Identities = 82/260 (31%), Positives = 135/260 (51%), Gaps = 15/260 (5%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           +Y V R +G G FG   L    ++ +  A K I  R  +++  ++D R+E  ++  + K+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI--RLPKSSSAVEDSRKEAVLLAKM-KH 57

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGH-YTERAAAAVTRTIVEVVQLCH 169
            +IV+ KE+ E D  +++VME C+GG+L  +I + RG  + E         +   VQ  H
Sbjct: 58  PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKR 228
           +  V+HRD+K +N       +N  +K  DFG + +   PG      VG+PYY+ PE+ + 
Sbjct: 118 EKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174

Query: 229 -NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKS 286
             Y  + DIWS G ILY L     PF A S + +   + +G       P P + S   +S
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY----KPLPSHYSYELRS 230

Query: 287 LVRQMLEPDPKLRLTAKQVL 306
           L++QM + +P+ R +A  +L
Sbjct: 231 LIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  115 bits (290), Expect = 8e-30
 Identities = 84/285 (29%), Positives = 132/285 (46%), Gaps = 53/285 (18%)

Query: 62  GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC 121
           G +G  YL   ++TR+  A K I+K+ L     I  V  E  I+    +N  +VS+  + 
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAENPFVVSMFCSF 70

Query: 122 EDDNAVHLVMELCEGGE---LFDRI------VARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           E    + +VME  EGG+   L   I      +AR ++ E   A         ++  H +G
Sbjct: 71  ETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA---------LEYLHNYG 121

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFF--------------KPGERFS--EIVG 216
           ++HRDLKP+N L  +      +K  DFGLS                 K    F   ++ G
Sbjct: 122 IVHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178

Query: 217 SPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDFKR 274
           +P Y+APEV L++ YG  +D W+ G+ILY  L G  PF+ ++ E+   Q I   +     
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE---- 234

Query: 275 DPWPNVSES----AKSLVRQMLEPDPKLRL---TAKQVLEHPWLQ 312
             WP   E+    A+ L+ ++L  +P  RL    A +V +H +  
Sbjct: 235 --WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  115 bits (290), Expect = 9e-30
 Identities = 80/287 (27%), Positives = 131/287 (45%), Gaps = 40/287 (13%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G G +G+ Y   D  + E++A K +     R  + I  +R E+ ++ +L ++ +IV LK
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNL-RHPNIVELK 72

Query: 119 EACEDD--NAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           E       +++ LVME CE     L D +     ++E     +   ++  +Q  H++ +I
Sbjct: 73  EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHENFII 130

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRNYG 231
           HRDLK  N L  +K     LK  DFGL+  +  P +  +  V + +Y APE+L     Y 
Sbjct: 131 HRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESE-------------------QGVAQAILRGLIDF 272
             ID+W+ G IL  LL   P    +SE                    G +   L G    
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTL 247

Query: 273 KRDPWPN-------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            + P+ N       +SE+   L+  +L  DPK R TA++ LE  + +
Sbjct: 248 PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  115 bits (288), Expect = 1e-29
 Identities = 87/284 (30%), Positives = 144/284 (50%), Gaps = 27/284 (9%)

Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  ID  T + +A K ++   L+     + + 
Sbjct: 12  VSVGDPKK----KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELII 64

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   K+ +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 65  NEILVMREN-KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 122

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSP 218
             ++ ++  H + VIHRD+K +N L      +  +K  DFG      P +   S +VG+P
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179

Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGT 232

Query: 278 PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P +    K        + + LE D + R +AK++L+HP+L+ AK
Sbjct: 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  115 bits (288), Expect = 2e-29
 Identities = 81/262 (30%), Positives = 130/262 (49%), Gaps = 15/262 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 61

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +      +  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 122 KLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 234

Query: 297 KLRL-----TAKQVLEHPWLQN 313
           K RL      AK+V+EH +  +
Sbjct: 235 KQRLGGGPSDAKEVMEHRFFLS 256

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  113 bits (283), Expect = 3e-29
 Identities = 71/256 (27%), Positives = 119/256 (46%), Gaps = 10/256 (3%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG FG+ +LC  +  ++L+  K I   ++ T  +    + E  ++K L  + +I+ 
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLL-SHPNIIE 63

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVI 174
             E   +D A+ +VME   GG L + I  R +    E         I+  +   H   ++
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPE 233
           HRDLK +N L  +K +   +K  DFG+S       +   +VG+P Y++PE+ + + Y  +
Sbjct: 124 HRDLKTQNILL-DKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK 181

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
            DIW+ G +LY L      F A +   +   I+ G      D     S   + L+  ML 
Sbjct: 182 SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---RYSPDLRQLILSMLN 238

Query: 294 PDPKLRLTAKQVLEHP 309
            DP  R    Q++  P
Sbjct: 239 LDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  113 bits (284), Expect = 3e-29
 Identities = 78/272 (28%), Positives = 126/272 (46%), Gaps = 33/272 (12%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSI---SKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
            ELG G  GV    + R T +++A K+I       ++  +      RE+ I+     +  
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI-----LRELDILHKC-NSPY 60

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTRTIVE-VVQLCHK 170
           IV    A  ++  + + ME  +GG L D+I    +G   ER    +   +++ +  L  K
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVL 226
           H +IHRD+KP N L  ++ +   +K  DFG+S     G+  + +    VG+  YMAPE +
Sbjct: 120 HKIIHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171

Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-----NV 280
           + N Y  + DIWS G+ L  L  G  P+    E      I   L     +P P       
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYP--PENDPPDGIFELLQYIVNEPPPRLPSGKF 229

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           S   +  V   L  DP+ R + K++LEHP+++
Sbjct: 230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  113 bits (284), Expect = 3e-29
 Identities = 89/281 (31%), Positives = 144/281 (51%), Gaps = 27/281 (9%)

Query: 43  GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           G PK+    +Y    ++G+G  G  +  ID  T + +A K I+   L+     + +  E+
Sbjct: 15  GDPKK----KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEI 67

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            +MK L KN +IV+  ++    + + +VME   GG L D +V      E   AAV R  +
Sbjct: 68  LVMKEL-KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECL 125

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYM 221
           + ++  H + VIHRD+K +N L         +K  DFG      P + + S +VG+PY+M
Sbjct: 126 QALEFLHANQVIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  P +
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGTPEL 235

Query: 281 SESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
               K        + + LE D + R +AK++L+HP+L+ AK
Sbjct: 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 4e-29
 Identities = 77/258 (29%), Positives = 127/258 (49%), Gaps = 13/258 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG       RDT+ + A K+I K  + +  ++     E  ++  +     IV LK
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +    ++LV+    GGELF  +   G +    A   T  ++  ++  HK  VI+RDL
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDI 236
           KPEN L   +     +   DFGL  +  K  ++ +   G+P Y+APE+L    Y   +D 
Sbjct: 120 KPENILLDYQGH---IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W+ GV+LY +L G+PPF+ E+   + + IL+  + F           AK L+  +L  DP
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP 232

Query: 297 KLRL---TAKQVLEHPWL 311
             RL    A+++  HP+ 
Sbjct: 233 TRRLGYNGAQEIKNHPFF 250

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  113 bits (284), Expect = 4e-29
 Identities = 83/295 (28%), Positives = 142/295 (48%), Gaps = 45/295 (15%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMK 106
           ++Y    ++G G +GV + C +R+T +++A K     K   + D   ++    RE+ ++K
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLK 55

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVV 165
            L K+ ++V+L E       +HLV E C+   + + +        E     +    ++ V
Sbjct: 56  QL-KHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAV 113

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPE 224
             CHKH  IHRD+KPEN L     +   +K  DFG + I   PG+ +++ V + +Y APE
Sbjct: 114 NFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPE 170

Query: 225 VL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF---------- 272
           +L     YGP +D+W+ G +   LL G P +  +S+      I + L D           
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230

Query: 273 -------------KRDP----WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                         R+P    +PN+S  A S ++  L+ DP  RL+ +++LEHP+
Sbjct: 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  113 bits (284), Expect = 6e-29
 Identities = 88/304 (28%), Positives = 134/304 (44%), Gaps = 51/304 (16%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++ +  ++G G +G  Y   D+DT EL+A K +     +    I  +R E+ I++ L  
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQL-N 64

Query: 111 NSSIVSLKEACEDDN----------AVHLVMELCEG---GELFDRIVARGHYTERAAAAV 157
           + +IV+LKE   D            A +LV E  +    G L   +V   H++E    + 
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV---HFSEDHIKSF 121

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIV 215
            + ++E +  CHK   +HRD+K  N L  NK +   +K  DFGL+  +   E   ++  V
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYTNKV 178

Query: 216 GSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK 273
            + +Y  PE+L  +  YGP ID+WS G IL  L    P F A  E    + I R      
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238

Query: 274 RDPWPNVSE--------------------------SAKSLVRQMLEPDPKLRLTAKQVLE 307
              WP+V +                           A  L+  ML  DP  R TA++ L 
Sbjct: 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298

Query: 308 HPWL 311
            PWL
Sbjct: 299 SPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  112 bits (281), Expect = 6e-29
 Identities = 77/270 (28%), Positives = 136/270 (50%), Gaps = 24/270 (8%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
             + +++++G+G+F V Y  I      ++A K +   ++  A    D  +E+ ++K L  
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-D 60

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC- 168
           + +++    +  ++N +++V+EL + G+L   I    H+ ++      RTI +  VQLC 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTIWKYFVQLCS 117

Query: 169 -----HKHGVIHRDLKPEN-FLFANKKENSPLKAIDFGLSIFF--KPGERFSEIVGSPYY 220
                H   ++HRD+KP N F+ A       +K  D GL  FF  K     S +VG+PYY
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHS-LVGTPYY 172

Query: 221 MAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAE--SEQGVAQAILRGLIDFKRDPW 277
           M+PE +  N Y  + DIWS G +LY +     PF+ +  +   + + I +   D+   P 
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPA 230

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
            + SE  + LV + + PDP+ R     VL+
Sbjct: 231 DHYSEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  112 bits (281), Expect = 7e-29
 Identities = 78/261 (29%), Positives = 126/261 (48%), Gaps = 16/261 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKL--RTAVDIDDVRREVAIMKHLPKNSSIVS 116
           LG+G FG    C  + T ++ ACK + K++L  R    +    +++           IVS
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR---FIVS 57

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVI 174
           L  A E  + + LVM L  GG+L   I   G   + E  A      I+  ++  H+  ++
Sbjct: 58  LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPE 233
           +RDLKPEN L     ++  ++  D GL++  K G++     G+P YMAPEVL+   Y   
Sbjct: 118 YRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
           +D ++ G  LY ++ G  PF    E+   + + R  ++   +     S  AK L   +L+
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ 234

Query: 294 PDPKLRL-----TAKQVLEHP 309
            DP+ RL     +A +V EHP
Sbjct: 235 KDPEKRLGCRGGSADEVREHP 255

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  112 bits (282), Expect = 7e-29
 Identities = 78/286 (27%), Positives = 125/286 (43%), Gaps = 45/286 (15%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR--REVAIMKHLPKNSSIVS 116
           +G G F        R T +  A K + K        ++ V   RE+  ++ L  + +I+ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKH----FKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 117 LKEACED--DNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGV 173
           L E   D     + LV EL +   L++ I  R     E+   +    +++ +   H++G+
Sbjct: 63  LIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFSEIVGSPYYMAPEVLKRN-- 229
            HRD+KPEN L   K +   LK  DFG    I+ KP   ++E + + +Y APE L  +  
Sbjct: 122 FHRDIKPENILI--KDDI--LKLADFGSCRGIYSKP--PYTEYISTRWYRAPECLLTDGY 175

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL------IDFKRDPW------ 277
           YGP++DIW+ G + + +L   P F   +E      I   L      +  K          
Sbjct: 176 YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235

Query: 278 -------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                        PN S     L++++L  DP  R+TAKQ L HP+
Sbjct: 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  113 bits (284), Expect = 8e-29
 Identities = 80/281 (28%), Positives = 124/281 (44%), Gaps = 37/281 (13%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
             + V   +GRG FG   +  ++ T ++ A K + K  L     +     E  I+  +  
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISN 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGEL----------FDRIVARGHYTERAAAAVTRT 160
           +  I  L+ A +D + ++LVME   GG+L          FD  +A+ +  E         
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE--------- 110

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEI-VGSP 218
           +V  +   H+ G +HRD+KPEN L         +K  DFG +          S++ VG+P
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167

Query: 219 YYMAPEVL-------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGL 269
            Y+APEVL       K  YG E D WS GVI Y ++ G  PF   +       I+  +  
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF 227

Query: 270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
           + F  D  P VS     L++ +L    K RL  + +  HP+
Sbjct: 228 LKFPED--PKVSSDFLDLIQSLL-CGQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  112 bits (280), Expect = 2e-28
 Identities = 88/284 (30%), Positives = 144/284 (50%), Gaps = 27/284 (9%)

Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  ID  T + +A K ++   L+     + + 
Sbjct: 12  VSVGDPKK----KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELII 64

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 65  NEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 122

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSP 218
             ++ +   H + VIHRD+K +N L      +  +K  DFG      P + + S +VG+P
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179

Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGT 232

Query: 278 PN------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P       +S   +  + + LE D   R +AK++L+HP+L+ AK
Sbjct: 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 2e-28
 Identities = 80/294 (27%), Positives = 127/294 (43%), Gaps = 46/294 (15%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   L   +DT  + A K + K ++     +  VR E  I+     N  +V L 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVKLY 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D+N ++L+ME   GG++   ++ +  +TE          +  +   HK G IHRD+
Sbjct: 68  YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDI 127

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK---------------PGERFSEI--------- 214
           KP+N L   K     +K  DFGL    K               P      I         
Sbjct: 128 KPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184

Query: 215 ---------------VGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE 258
                          VG+P Y+APEV L+  Y  E D WS GVI+Y +L G PPF +++ 
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244

Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML-EPDPKL-RLTAKQVLEHPW 310
           Q   + I+      +      +S  AK L++++  E + +L      ++  HP+
Sbjct: 245 QETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  111 bits (278), Expect = 3e-28
 Identities = 78/265 (29%), Positives = 130/265 (49%), Gaps = 12/265 (4%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R LG+G FG    C  R T ++ ACK + K++++          E  I++ +  +  +V+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVN 64

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVI 174
           L  A E  +A+ LV+ +  GG+L   I   G+  + E  A      I+  ++  H+   +
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPE 233
           +RDLKPEN L     +   ++  D GL++    GE     VG+  YMAPEVL  + Y   
Sbjct: 125 YRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
            D W  G ++Y ++ G  PF    E+   + + R +++ +       SE AKS+ + +L 
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241

Query: 294 PDPKLRLTAK-----QVLEHPWLQN 313
            DPK RL  +     +V  HP+ +N
Sbjct: 242 KDPKQRLGCQEEGAGEVKRHPFFRN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 3e-28
 Identities = 74/288 (25%), Positives = 120/288 (41%), Gaps = 40/288 (13%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK--NSSIV 115
           E+G G +G  Y   D +T   +A K +        + +  +R E+A++K L    + +IV
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNIV 64

Query: 116 SLKEAC---EDDNA--VHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            L + C     D    + LV E  +        +    G         + R ++  V   
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDFL 123

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR 228
           H H ++HRDLKP+N L  +  +   +K  DFGL+  +      + +V + +Y APEVL +
Sbjct: 124 HSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ 180

Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR--GL---------------- 269
           + Y   +D+WS G I   L    P F   SE      I    GL                
Sbjct: 181 SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSS 240

Query: 270 ------IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                   FK    P + E    L+++ML  +P  R++A + L+HP+ 
Sbjct: 241 FPSYTPRSFK-SFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  110 bits (277), Expect = 3e-28
 Identities = 85/284 (29%), Positives = 143/284 (50%), Gaps = 27/284 (9%)

Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  +D  T + +A   I +  L+     + + 
Sbjct: 13  VSVGDPKK----KYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELII 65

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 66  NEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 123

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSP 218
             ++ ++  H + VIHRD+K +N L      +  +K  DFG      P + + S +VG+P
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180

Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGT 233

Query: 278 PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P +    K        + + L+ D + R +AK++L+H +L+ AK
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 3e-28
 Identities = 85/273 (31%), Positives = 136/273 (49%), Gaps = 26/273 (9%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           ++ Y + + +G G +G  Y   D  T EL+A K I   KL    D + +++E++++K   
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKEC- 57

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLC 168
           ++ +IV+   +    + + +VME C GG L D   V RG  +E   A V R  ++ +   
Sbjct: 58  RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMAPEVL 226
           H+ G IHRD+K  N L     E+  +K  DFG+S  +     +R S I G+PY+MAPEV 
Sbjct: 118 HETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVA 173

Query: 227 ----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
               K  Y  + DIW+ G+    L    PP +   +    +A+   LI     P P + +
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMF---DLHPMRALF--LISKSNFPPPKLKD 228

Query: 283 SAK------SLVRQMLEPDPKLRLTAKQVLEHP 309
             K        +++ L  DPK R TA ++L+HP
Sbjct: 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  112 bits (280), Expect = 5e-28
 Identities = 92/273 (33%), Positives = 137/273 (50%), Gaps = 20/273 (7%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V + +GRG FG   L   + TR++ A K +SK ++    D      E  IM     + 
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  +   H  G
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 162

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGE-RFSEIVGSPYYMAPEVLKRN- 229
            IHRD+KP+N L     ++  LK  DFG  +   K G  R    VG+P Y++PEVLK   
Sbjct: 163 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVSES 283
               YG E D WS GV LY +L G  PF+A+S  G    I+  +  + F  D   ++S+ 
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKE 277

Query: 284 AKSLVRQMLEPDPKLRLTAKQVLE---HPWLQN 313
           AK+L+   L  D ++RL    V E   H + +N
Sbjct: 278 AKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 309

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  109 bits (274), Expect = 6e-28
 Identities = 76/268 (28%), Positives = 122/268 (45%), Gaps = 25/268 (9%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSI---SKRKLRTAVDIDDVRREVAIMKHLPKNSSIV 115
           LG+G +G  Y  +  +  +L+A K +   +   L    + + ++ EV ++K L K+ +IV
Sbjct: 8   LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIV 65

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIH 175
                C DDN + + ME   GG +   +   G   E      T+ I++ V   H + V+H
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125

Query: 176 RDLKPENFLFANKKENSPLKAIDFG-------LSIFFKPGERFSEIVGSPYYMAPEVLKR 228
           RD+K  N +      N  +K IDFG       + +          + G+PY+MAPEV+  
Sbjct: 126 RDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182

Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV----SES 283
           + YG + DIWS G  ++ +  G PP  A  ++  A       I   R   P +    S +
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPP-LASMDRLAAMF----YIGAHRGLMPRLPDSFSAA 237

Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           A   V   L  D   R +A Q+L H +L
Sbjct: 238 AIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  110 bits (275), Expect = 2e-27
 Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 17/264 (6%)

Query: 57  RELGRGEFGVTYLCIDRDTR-ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIV 115
           R LG G FG   L   ++     +A K   K K+     +D V  E  I+ ++  +   V
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCV 94

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIH 175
           +L  + +D++ ++LV+E   GGE F  +     +           IV + +      +++
Sbjct: 95  NLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-KRNYGPEI 234
           RDLKPEN L     ++  +K  DFG +       R   + G+P Y+APE+L    +G   
Sbjct: 155 RDLKPENLLL---DKDGFIKMTDFGFAKVVD--TRTYTLCGTPEYIAPEILLNVGHGKAA 209

Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D W+ G+ +Y +L G PPF+A     + Q IL G+I F +     +  + K L++++L  
Sbjct: 210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLMKKLLSH 265

Query: 295 D-----PKLRLTAKQVLEHPWLQN 313
           D       L+  A+ V EHPW  N
Sbjct: 266 DLTKRYGNLKKGAQNVKEHPWFGN 289

Length = 340

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  107 bits (270), Expect = 2e-27
 Identities = 67/267 (25%), Positives = 113/267 (42%), Gaps = 30/267 (11%)

Query: 56  DRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            ++LG G FG  Y           +  +A K++ +    +   I++  RE  IM+ L  +
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKL-DH 60

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC-- 168
            ++V L   C ++  +++VME  EGG+L   +                 ++   +Q+   
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLS------LSDLLSFALQIARG 114

Query: 169 ----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG-SPY-YMA 222
                    IHRDL   N L         +K  DFGLS      + + +  G  P  +MA
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYRKRGGKLPIRWMA 171

Query: 223 PEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           PE LK   +  + D+WS GV+L+ I   G  P+   S + V + +  G   ++    PN 
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG---YRLPQPPNC 228

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLE 307
                 L+ Q    DP+ R T  +++E
Sbjct: 229 PPELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  107 bits (270), Expect = 3e-27
 Identities = 76/277 (27%), Positives = 127/277 (45%), Gaps = 36/277 (12%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA-IM 105
           E ++   L+D     G+FG   +   + T++L   K I K K   A++       V  +M
Sbjct: 17  EIVKKLKLID-----GKFGKVSVLKHKPTQKLFVQKII-KAKNFNAIEPM-----VHQLM 65

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           K    N + + L  +        L+M+  + G+LFD +   G  +E     + R +VE +
Sbjct: 66  KD---NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY------ 219
              HKH +IH D+K EN L+   K+   +   D+GL           +I+G+P       
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDR--IYLCDYGL----------CKIIGTPSCYDGTL 170

Query: 220 -YMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y +PE +   NY    D W+ GV+ Y LL G  PF  + ++ +    L      K    
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI 230

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTA-KQVLEHPWLQN 313
            NVS++A   V+ ML+ +   RLT   ++++HP+L+ 
Sbjct: 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267

Length = 267

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  108 bits (272), Expect = 3e-27
 Identities = 79/258 (30%), Positives = 130/258 (50%), Gaps = 16/258 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 61

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRD 177
            + +  + +  VME   GGELF  +     ++E  A      IV  +   H +  V++RD
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121

Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           LK EN +     ++  +K  DFGL     K G       G+P Y+APEVL+ N YG  +D
Sbjct: 122 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ D
Sbjct: 179 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLKKD 234

Query: 296 PKLRL-----TAKQVLEH 308
           PK RL      AK++++H
Sbjct: 235 PKQRLGGGPDDAKEIMQH 252

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  107 bits (270), Expect = 3e-27
 Identities = 84/290 (28%), Positives = 131/290 (45%), Gaps = 50/290 (17%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD------VRREVAIMKHLPKN 111
           ++G G +G  +   +R+T E++A K       R  +D DD        RE+ ++K L K+
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALK-------RVRLDDDDEGVPSSALREICLLKEL-KH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            +IV L +    D  + LV E C+    + FD     G        +    +++ +  CH
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-- 226
            H V+HRDLKP+N L  NK  N  LK  DFGL+  F  P   +S  V + +Y  P+VL  
Sbjct: 117 SHNVLHRDLKPQNLLI-NK--NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173

Query: 227 KRNYGPEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE--- 282
            + Y   ID+WSAG I   L   G P F         + I R L     + WP VS+   
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233

Query: 283 ----------------------SAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                                 + + L++ +L  +P  R++A++ L+HP+
Sbjct: 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  107 bits (268), Expect = 4e-27
 Identities = 79/264 (29%), Positives = 127/264 (48%), Gaps = 18/264 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSIS--KRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           LG+G FG  YLC D DT   LA K +        T+ ++  +  E+ ++K+L ++  IV 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQ 68

Query: 117 LKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
                 D  +  + + ME   GG + D++ A G  TE      TR I+E +   H + ++
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128

Query: 175 HRDLKPENFLFANKKENSPLKAIDFG----LSIFFKPGERFSEIVGSPYYMAPEVLK-RN 229
           HRD+K  N L   +     +K  DFG    L      G     + G+PY+M+PEV+    
Sbjct: 129 HRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKSLV 288
           YG + D+WS G  +  +L   PP WAE E     AI +          P+ +SE A+  +
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTNPQLPSHISEHARDFL 242

Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQ 312
             +   + + R +A+++L HP+ Q
Sbjct: 243 GCIF-VEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  107 bits (270), Expect = 4e-27
 Identities = 82/283 (28%), Positives = 129/283 (45%), Gaps = 32/283 (11%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKHLPKNSSIV 115
             LG G  G    C  ++T  + A K+I+        D+   + RE+ I K   K+  IV
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTD---PNPDLQKQILRELEINKSC-KSPYIV 62

Query: 116 SLKEAC--EDDNAVHLVMELCEGGEL---FDRIVARGHYT-ERAAAAVTRTIVEVVQLCH 169
               A   E  +++ + ME CEGG L   + ++  RG    E+    +  ++++ +   H
Sbjct: 63  KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEV 225
              +IHRD+KP N L   K +   +K  DFG+S     GE  + +     G+ +YMAPE 
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQ---VKLCDFGVS-----GELVNSLAGTFTGTSFYMAPER 174

Query: 226 LK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI------DFKRDPWP 278
           ++ + Y    D+WS G+ L  +     PF  E E  +    L   I      + K +P  
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 279 NV--SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
            +  SE  K  ++Q LE DP  R T   +LEHPW++   K   
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  107 bits (267), Expect = 9e-27
 Identities = 81/281 (28%), Positives = 146/281 (51%), Gaps = 24/281 (8%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +  ++ +   +A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDY-QHQNVVEM 83

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
            ++      + ++ME  +GG L D IV++    E   A V  ++++ +   H  GVIHRD
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142

Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           +K ++ L      +  +K  DFG  +   K   +   +VG+PY+MAPEV+ R  YG E+D
Sbjct: 143 IKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK------SLVR 289
           IWS G+++  ++ G PP++++S     QA+ R     +  P P +  + K        + 
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSP---VQAMKR----LRDSPPPKLKNAHKISPVLRDFLE 252

Query: 290 QMLEPDPKLRLTAKQVLEHPW-LQNAKKAPNVPLGDVVRSR 329
           +ML  +P+ R TA+++L+HP+ LQ       VPL    R R
Sbjct: 253 RMLTREPQERATAQELLDHPFLLQTGLPECLVPLIQQYRKR 293

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  106 bits (266), Expect = 1e-26
 Identities = 79/268 (29%), Positives = 128/268 (47%), Gaps = 30/268 (11%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G +G+ Y   D  T+  +A K I +R  R    +  +  E+A+  +L K+ +IV   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIALHSYL-KHRNIVQYL 71

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTRTIVEVVQLCHKHGVIH 175
            +  ++    + ME   GG L   + ++       E+     T+ I+E ++  H + ++H
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-------VGSPYYMAPEVLK- 227
           RD+K +N L      +  +K  DFG S      +R + I        G+  YMAPEV+  
Sbjct: 132 RDIKGDNVLV--NTYSGVVKISDFGTS------KRLAGINPCTETFTGTLQYMAPEVIDK 183

Query: 228 --RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSES 283
             R YG   DIWS G  +  +  G PPF    E G  QA +  +  FK  P    ++S  
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFI---ELGEPQAAMFKVGMFKIHPEIPESLSAE 240

Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           AK+ + +  EPDP  R +A  +L+ P+L
Sbjct: 241 AKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  106 bits (268), Expect = 1e-26
 Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 46/286 (16%)

Query: 62  GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC 121
           G +GV Y   D+ T E++A K +   K +    I  + RE+ I+  L ++ +IV++KE  
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLKL-QHPNIVTVKEVV 73

Query: 122 --EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV----EVVQLCHKHGVIH 175
              + + +++VME  E  +L   +       +    +  + ++      V   H + ++H
Sbjct: 74  VGSNLDKIYMVMEYVE-HDLKSLM---ETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH 129

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVL--KRNYGP 232
           RDLK  N L  N+     LK  DFGL+  +  P + ++++V + +Y APE+L   + Y  
Sbjct: 130 RDLKTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186

Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR-------------------GLIDFK 273
            ID+WS G I   LL   P F  +SE      I +                       F 
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFT 246

Query: 274 RDPW---------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
           + P+          ++S++   L+ ++L  DP  R++A+  L+HP+
Sbjct: 247 KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  106 bits (265), Expect = 1e-26
 Identities = 80/261 (30%), Positives = 129/261 (49%), Gaps = 20/261 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSI--SKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           LG+G FG  YLC D DT   LA K +        T+ +++ +  E+ ++K+L  +  IV 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQ 68

Query: 117 LKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
                 D  +  + + ME   GG + D++ + G  TE      TR I+E V   H + ++
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIV 128

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFK----PGERFSEIVGSPYYMAPEVLK-RN 229
           HRD+K  N L   +     +K  DFG S   +     G     + G+PY+M+PEV+    
Sbjct: 129 HRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAKSL 287
           YG + DIWS G  +  +L   PP WAE E   A A +  +     +P   P+VS+  +  
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPVLPPHVSDHCRDF 241

Query: 288 VRQMLEPDPKLRLTAKQVLEH 308
           ++++   + KLR +A ++L H
Sbjct: 242 LKRIF-VEAKLRPSADELLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  106 bits (267), Expect = 1e-26
 Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 43/288 (14%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKNSS 113
           ++G G +GV Y   ++ T +++A K     K+R   + + V     RE++++K L ++ +
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKEL-QHPN 60

Query: 114 IVSLKEACEDDNAVHLVMEL--CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
           IV L++    ++ ++L+ E    +  +  D +    +       +    I++ +  CH  
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL--KR 228
            V+HRDLKP+N L  NK     +K  DFGL+  F  P   ++  V + +Y APEVL    
Sbjct: 121 RVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP 177

Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP---------- 278
            Y   +DIWS G I   +    P F  +SE      I R L     D WP          
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237

Query: 279 ---------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                          N+ E    L+ +ML  DP  R++AK+ L HP+ 
Sbjct: 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  106 bits (265), Expect = 2e-26
 Identities = 86/286 (30%), Positives = 146/286 (51%), Gaps = 29/286 (10%)

Query: 38  ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           + V  G P+E + D ++   ++G G  G+  +  ++ T + +A K +  RK +     + 
Sbjct: 13  LVVSPGDPREYL-DSFI---KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---EL 65

Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           +  EV IM+    + ++V +  +    + + +VME  EGG L D IV      E   A V
Sbjct: 66  LFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATV 123

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVG 216
             +++  +   H  GVIHRD+K ++ L  +   +  +K  DFG  +   K   +   +VG
Sbjct: 124 CLSVLRALSYLHNQGVIHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVG 180

Query: 217 SPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
           +PY+MAPEV+ R  YG E+DIWS G+++  ++ G PP++ E      QA+ R      RD
Sbjct: 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRR-----IRD 232

Query: 276 PWP-------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             P        VS   +  +  ML  +P  R TA+++L+HP+L+ A
Sbjct: 233 NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  106 bits (267), Expect = 2e-26
 Identities = 89/296 (30%), Positives = 136/296 (45%), Gaps = 45/296 (15%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I +RY+  + +G G FG+     D+ T + +A K I K    T V      RE+ ++KHL
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYRELKLLKHL 66

Query: 109 PKNSSIVSLKE----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
            ++ +I+SL +      ED   ++ V EL   G    R++      ++        I+  
Sbjct: 67  -RHENIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRG 120

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           ++  H  GV+HRDLKP N L     EN  LK  DFGL+    P  + +  V + YY APE
Sbjct: 121 LKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPE 175

Query: 225 VLK--RNYGPEIDIWSAGVILYILLCGVPPFWAE----------------SEQGVAQAIL 266
           ++   + Y  E+DIWSAG I   +L G P F  +                 +  +     
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235

Query: 267 RGLIDF-----KRDPWP------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              + F     KR+P P      N   SA  L+ +ML  DP+ R++A + L HP+L
Sbjct: 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  106 bits (266), Expect = 2e-26
 Identities = 86/300 (28%), Positives = 141/300 (47%), Gaps = 31/300 (10%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R LG+G FG   L   +++  L A K + K  +    D++    E  I+  L +N   ++
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILS-LARNHPFLT 59

Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIH 175
               C +  + +  VME   GG+L   I     + E  A      I   +   H  G+I+
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119

Query: 176 RDLKPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLKRN-YG 231
           RDLK +N L  ++      K  DFG+    IF   G+  S   G+P Y+APE+L+   YG
Sbjct: 120 RDLKLDNVLLDHEGH---CKLADFGMCKEGIF--NGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM 291
           P +D W+ GV+LY +LCG  PF AE+E  + +AIL   + +    W  +S+ A  +++  
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TW--LSQDAVDILKAF 230

Query: 292 LEPDPKLRLTA------KQVLEHP------WLQNAKKAPNVPLGDVVRSRLKQFSMMNRF 339
           +  +P +RL +      + +L HP      W +  ++    P     R R+K    ++ F
Sbjct: 231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPF----RPRIKSREDVSNF 286

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  107 bits (268), Expect = 3e-26
 Identities = 85/321 (26%), Positives = 130/321 (40%), Gaps = 61/321 (19%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + +G G FG   L    DT  L A K++ K  +        V+ E  I+     N  +V 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEWVVK 65

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L  + +D + ++ VM+   GG++   ++  G + E  A      +   ++  HK G IHR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFK--------------------PGERFSEI-- 214
           D+KP+N L      +  +K  DFGL   F+                    P E +SEI  
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 215 ----------------------VGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVP 251
                                 VG+P Y+APEVL R  Y    D WS GVILY +L G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 252 PFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL---TAKQVLEH 308
           PF A++       ++             +S  A  L+ + L    + RL    A ++  H
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAH 301

Query: 309 PWLQNA--------KKAPNVP 321
           P+ +          +KAP +P
Sbjct: 302 PFFKGIDFASLIRRQKAPYIP 322

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  106 bits (265), Expect = 3e-26
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 21/263 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ + +  A K + K  +    ++     E  ++K+  ++  + SLK
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK 61

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +  + +  VME   GGELF  +     ++E         IV  +   H   +++RDL
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPG----ERFSEIVGSPYYMAPEVLKRN-YGPE 233
           K EN +     ++  +K  DFGL    K G           G+P Y+APEVL+ N YG  
Sbjct: 122 KLENLML---DKDGHIKITDFGLC---KEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
           +D W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L 
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLI 231

Query: 294 PDPKLRL-----TAKQVLEHPWL 311
            DP  RL      AK+++ H + 
Sbjct: 232 KDPNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 4e-26
 Identities = 84/301 (27%), Positives = 132/301 (43%), Gaps = 72/301 (23%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKNSSI 114
           +G G +GV Y   D+ T E++A K     K+R   + + V     RE++++K L  + +I
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKEL-NHPNI 60

Query: 115 VSLKEACEDDNAVHLV-----------MELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           V L +    +N ++LV           M+      L   ++    Y           +++
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ----------LLQ 110

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMA 222
            +  CH H V+HRDLKP+N L  +++    LK  DFGL+  F  P   ++  V + +Y A
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLI-DREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRA 167

Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------------------QGV 261
           PE+L   R Y   +DIWS G I   ++   P F  +SE                    GV
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227

Query: 262 AQAILRGLIDFK-------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                  L D+K       R       PN+ E    L+ +ML  DP  R++AK  L+HP+
Sbjct: 228 TS-----LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Query: 311 L 311
            
Sbjct: 283 F 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  104 bits (261), Expect = 4e-26
 Identities = 74/273 (27%), Positives = 144/273 (52%), Gaps = 30/273 (10%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           +Y+  +++G G FG   L   ++  +    K I+  K+    + ++ R+EVA++ ++ K+
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNM-KH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC-- 168
            +IV  +E+ E++  +++VM+ CEGG+L+ +I A+     R        I++  VQ+C  
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-----RGVLFPEDQILDWFVQICLA 113

Query: 169 ----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAP 223
               H   ++HRD+K +N +F  K  +  +K  DFG++ +     E     +G+PYY++P
Sbjct: 114 LKHVHDRKILHRDIKSQN-IFLTK--DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170

Query: 224 EVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-- 280
           E+ + R Y  + DIW+ G +LY +      F A + + +   I+RG        +P V  
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-------SYPPVSS 223

Query: 281 --SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             S   ++LV Q+ + +P+ R +   +LE  ++
Sbjct: 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  104 bits (261), Expect = 5e-26
 Identities = 68/267 (25%), Positives = 110/267 (41%), Gaps = 29/267 (10%)

Query: 56  DRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            ++LG G FG  Y              +A K++ +    +   I++  RE  IM+ L  +
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA--SEQQIEEFLREARIMRKL-DH 60

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC-- 168
            +IV L   C ++  + +VME   GG+L D +                 ++   +Q+   
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELS-----LSDLLSFALQIARG 115

Query: 169 ----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG-SPY-YMA 222
                    IHRDL   N L         +K  DFGLS      + +    G  P  +MA
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYKVKGGKLPIRWMA 172

Query: 223 PEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           PE LK   +  + D+WS GV+L+ I   G  P+   S   V + + +G   ++    PN 
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG---YRLPKPPNC 229

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLE 307
                 L+ Q    DP+ R T  +++E
Sbjct: 230 PPELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  105 bits (264), Expect = 5e-26
 Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 16/263 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T E+ A K + K  +    D+D    E  I+    K+  + +L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + +  VME   GG+L  +I     + E  +      +   +   H+HGVI+RDL
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDI 236
           K +N L          K  DFG+       G   +   G+P Y+APE+L+   YGP +D 
Sbjct: 123 KLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W+ GV++Y ++ G PPF A++E  + ++IL    D     W  +S+ A S+++  +  +P
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVW--LSKEAVSILKAFMTKNP 235

Query: 297 KLRL-------TAKQVLEHPWLQ 312
             RL           + +HP+ +
Sbjct: 236 NKRLGCVASQGGEDAIKQHPFFK 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  106 bits (265), Expect = 5e-26
 Identities = 86/273 (31%), Positives = 139/273 (50%), Gaps = 20/273 (7%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V + +GRG FG   L   + ++++ A K +SK ++    D      E  IM     + 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  +   H  G
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVLKRN- 229
           +IHRD+KP+N L     ++  LK  DFG  +        R    VG+P Y++PEVLK   
Sbjct: 163 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVSES 283
               YG E D WS GV L+ +L G  PF+A+S  G    I+  +  ++F  D    +S+ 
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED--VEISKH 277

Query: 284 AKSLVRQMLEPDPKLRL---TAKQVLEHPWLQN 313
           AK+L+   L  D ++RL     +++ +HP+ +N
Sbjct: 278 AKNLICAFLT-DREVRLGRNGVEEIKQHPFFKN 309

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  105 bits (264), Expect = 6e-26
 Identities = 74/263 (28%), Positives = 122/263 (46%), Gaps = 18/263 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T EL A K + K  +    D++    E  ++    K   +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + ++ VME   GG+L   I   G + E  A      I   +   H  G+I+RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 179 KPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEI 234
           K +N +         +K  DFG+   +IF   G+      G+P Y+APE +  + YG  +
Sbjct: 128 KLDNVML---DAEGHIKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D W+ GV+LY +L G PPF  E E  + Q+I+   + + +    ++S+ A S+ + +L  
Sbjct: 183 DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLLTK 238

Query: 295 DPKLRLTA-----KQVLEHPWLQ 312
            P  RL       + + EH + +
Sbjct: 239 HPAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  104 bits (260), Expect = 7e-26
 Identities = 81/262 (30%), Positives = 130/262 (49%), Gaps = 14/262 (5%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IV 115
           R LG+G FG    C  R T ++ ACK + K++++          E  I++ +  NS  +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV--NSRFVV 63

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGV 173
           SL  A E  +A+ LV+ L  GG+L   I   G   + E  A      I   ++  H+  +
Sbjct: 64  SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGP 232
           ++RDLKPEN L     ++  ++  D GL++    G+     VG+  YMAPEV+K   Y  
Sbjct: 124 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180

Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML 292
             D W+ G +LY ++ G  PF    ++   + + R + + + +     S  A+SL + +L
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240

Query: 293 EPDPKLRL-----TAKQVLEHP 309
             DPK RL      A++V EHP
Sbjct: 241 CKDPKERLGCQGGGAREVKEHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (257), Expect = 1e-25
 Identities = 79/261 (30%), Positives = 126/261 (48%), Gaps = 18/261 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSI--SKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           LGRG FG  YLC D DT   LA K +        T+ +++ +  E+ ++K+L ++  IV 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQ 68

Query: 117 LKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
                 D  +  + + +E   GG + D++ A G  TE      TR I++ V   H + ++
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS----IFFKPGERFSEIVGSPYYMAPEVLK-RN 229
           HRD+K  N L   +     +K  DFG S         G     + G+PY+M+PEV+    
Sbjct: 129 HRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLV 288
           YG + D+WS    +  +L   PP WAE E     AI +      +   P  VS++ +  +
Sbjct: 186 YGRKADVWSVACTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTKPMLPDGVSDACRDFL 242

Query: 289 RQMLEPDPKLRLTAKQVLEHP 309
           +Q+   + K R TA+ +L HP
Sbjct: 243 KQIFVEE-KRRPTAEFLLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  102 bits (257), Expect = 3e-25
 Identities = 87/301 (28%), Positives = 136/301 (45%), Gaps = 49/301 (16%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMK 106
           D Y    ++G G +G  Y   D++T +L+A K     K R  +D + +     RE+++++
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK-----KTRLEMDEEGIPPTALREISLLQ 55

Query: 107 HLPKNSSIVSL--KEACEDDNA---VHLVME-LCEGGELFDRIVARGHYTERAAAAVTRT 160
            L ++  IV L   E  E+ N    ++LV E L    + F     RG      A  +   
Sbjct: 56  MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 161 IVEVVQ---LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVG 216
           + ++++    CHKHGV+HRDLKP+N L    K+   LK  D GL   F  P + ++  + 
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLV--DKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 217 SPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL----- 269
           + +Y APEVL    +Y   +DIWS G I   +    P F  +SE      I + L     
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233

Query: 270 --------------------IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
                                D  R   P++S     L+++ML  DP  R++AK  L HP
Sbjct: 234 QVWPGVSKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292

Query: 310 W 310
           +
Sbjct: 293 Y 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 3e-25
 Identities = 83/267 (31%), Positives = 133/267 (49%), Gaps = 14/267 (5%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IV 115
           R LG+G FG    C  R T ++ ACK + K++++          E  I++ +  NS  +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV--NSRFVV 63

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGV 173
           SL  A E  +A+ LV+ L  GG+L   I   G+  + E  A      I   ++  H+  +
Sbjct: 64  SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGP 232
           ++RDLKPEN L  +      ++  D GL++    GE     VG+  YMAPEV+K   Y  
Sbjct: 124 VYRDLKPENILLDDYGH---IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180

Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML 292
             D W  G ++Y ++ G  PF    E+   + + R + + + +     SE+A+S+ RQ+L
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240

Query: 293 EPDPKLRL-----TAKQVLEHPWLQNA 314
             DP  RL      A++V  HP+ + A
Sbjct: 241 TKDPGFRLGCRGEGAEEVKAHPFFRTA 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  103 bits (258), Expect = 3e-25
 Identities = 79/269 (29%), Positives = 133/269 (49%), Gaps = 27/269 (10%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS----I 114
           LGRG FG   L   + T EL A K++ K  +    +++ +  E  I      NS     +
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIF--ETANSERHPFL 64

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V+L    + ++ V  VME   GG+L   I     ++E  A      +V  +Q  H++ ++
Sbjct: 65  VNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIV 123

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFK----PGERFSEIVGSPYYMAPEVL-KRN 229
           +RDLK +N L   +     +K  DFGL    K     G+R S   G+P ++APEVL + +
Sbjct: 124 YRDLKLDNLLLDTEGF---VKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETS 177

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W  GV++Y +L G  PF  + E+ V  +I+   + + R     +S  A S++R
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIMR 233

Query: 290 QMLEPDPKLRL-----TAKQVLEHPWLQN 313
           ++L  +P+ RL      A+ V + P+ ++
Sbjct: 234 RLLRRNPERRLGSGEKDAEDVKKQPFFRD 262

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 3e-25
 Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 37/284 (13%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
             + +   +G G +G  Y    + T +L+A K +   +       ++++ E  I++    
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKYSN 61

Query: 111 NSSIVS------LKEACEDDNAVHLVMELCEGG---ELFDRIVARGH-YTERAAAAVTRT 160
           + +I +       K    +D+ + LVMELC GG   +L   +  +G    E   A + R 
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPY 219
            +  +   H++ VIHRD+K +N L     +N+ +K +DFG+S        R +  +G+PY
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Query: 220 YMAPEVLKRNYGPE------IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK 273
           +MAPEV+  +  P+       D+WS G+    L  G PP             +R L    
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-------CDMHPMRALFKIP 231

Query: 274 RDPWPNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWL 311
           R+P P +             + + L  + + R   +++LEHP++
Sbjct: 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  102 bits (255), Expect = 4e-25
 Identities = 80/271 (29%), Positives = 130/271 (47%), Gaps = 24/271 (8%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R LG+G FG    C  R T ++ ACK + K++++          E  I++ +  +  +VS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVS 64

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLC------ 168
           L  A E  +A+ LV+ +  GG+L   I   G+  + E+      R I    +LC      
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ------RAIFYAAELCCGLEDL 118

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
            +  +++RDLKPEN L  ++     ++  D GL++    GE     VG+  YMAPEV+  
Sbjct: 119 QRERIVYRDLKPENILLDDRGH---IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN 175

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
             Y    D W  G ++Y ++ G  PF    E+   + + R + + + +     SE AKS+
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI 235

Query: 288 VRQMLEPDPKLRL-----TAKQVLEHPWLQN 313
            R +L  +PK RL      A  V +HP  +N
Sbjct: 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  102 bits (255), Expect = 4e-25
 Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 42/286 (14%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKNSS 113
           ++G G +GV Y   ++ T E++A K     K+R   + + V     RE++++K L  + +
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 60

Query: 114 IVSLKEACEDDNAVHLVME-LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           IV L +    +N ++LV E L +  + F               +    +++ +  CH H 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRN 229
           V+HRDLKP+N L         +K  DFGL+  F  P   ++  V + +Y APE+L   + 
Sbjct: 121 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR--------------GLIDFKRD 275
           Y   +DIWS G I   ++     F  +SE      I R               L D+K  
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237

Query: 276 --PW---------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
              W         P + E  + L+ QML  DP  R++AK  L HP+
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  101 bits (253), Expect = 5e-25
 Identities = 77/273 (28%), Positives = 130/273 (47%), Gaps = 26/273 (9%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTR---ELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           RY++ + LG+G FG  YL  D+       L   K I   +L     +    +E  ++  L
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV-QANQEAQLLSKL 59

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER-AAAAVTRTIVEV--- 164
             + +IV    +  + +A  ++ E CEG +L  ++    H  +  +   V    +++   
Sbjct: 60  -DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIVGSPYYMAP 223
           V   H+  ++HRDLK +N       +N+ LK  DFG+S       +  +   G+PYYM+P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174

Query: 224 EVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-- 280
           E LK + Y  + DIWS G ILY + C    F  ++   V   I+ G       P P++  
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-------PTPSLPE 227

Query: 281 --SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             S    S+++ ML  DP LR +A ++L +P++
Sbjct: 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  101 bits (253), Expect = 5e-25
 Identities = 71/263 (26%), Positives = 126/263 (47%), Gaps = 12/263 (4%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + +  ++G+G FGV +  + +  + + A K I   K+    + ++   E  ++  L  +S
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKL-DSS 59

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGH-YTERAAAAVTRTIVEVVQLCHK 170
            I+   E+  D   +++VME  E G+L   +   RG    E         I+  +   H 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEVLK-R 228
             ++HRD+K  N LF +  +N  +K  D G++        F+  IVG+PYY++PE+ + +
Sbjct: 120 KKILHRDIKSLN-LFLDAYDN--VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            Y  + D+W+ GV+LY    G  PF A ++  +   I+RG+  F        S+    L+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV--FPPVSQM-YSQQLAQLI 233

Query: 289 RQMLEPDPKLRLTAKQVLEHPWL 311
            Q L  D + R    Q+L +P L
Sbjct: 234 DQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  102 bits (255), Expect = 5e-25
 Identities = 85/304 (27%), Positives = 138/304 (45%), Gaps = 47/304 (15%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D+Y    ++G G +GV Y   DR T E +A K I   +    V    +R E++++K + +
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEM-Q 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV------ 164
           + +IV L++    +  ++LV E  +       +  + H       A    +++       
Sbjct: 60  HGNIVRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQIL 112

Query: 165 --VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYM 221
             +  CH H V+HRDLKP+N L  +++ N+ LK  DFGL+  F  P   F+  V + +Y 
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLI-DRRTNA-LKLADFGLARAFGIPVRTFTHEVVTLWYR 170

Query: 222 APEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           APE+L   R+Y   +DIWS G I   ++   P F  +SE      I R L     + WP 
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230

Query: 280 VSE-------------------------SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           V+                          +   L+ +ML  DP  R+TA+  LEH + ++ 
Sbjct: 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290

Query: 315 KKAP 318
             AP
Sbjct: 291 GDAP 294

Length = 294

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  101 bits (254), Expect = 1e-24
 Identities = 80/257 (31%), Positives = 125/257 (48%), Gaps = 10/257 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T E  A K++ K  +    D++    E  ++    ++  +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +    +  VME   GG+L   I + G + E  A      I+  +Q  HK G+I+RDL
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLK-RNYGPEIDI 236
           K +N L     ++  +K  DFG+      GE + S   G+P Y+APE+LK + Y   +D 
Sbjct: 123 KLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS GV+LY +L G  PF  E E  +  +IL     F R  W  +S+ AK  + ++ E DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLFERDP 235

Query: 297 KLRLTAK-QVLEHPWLQ 312
             RL     + +HP+ +
Sbjct: 236 TKRLGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  101 bits (252), Expect = 2e-24
 Identities = 69/247 (27%), Positives = 117/247 (47%), Gaps = 9/247 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG   L   +   +  A K + K+ +    +   +  E  ++    K+  +V L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +  + ++ V++   GGELF  +     + E  A      I   +   H   +++RDL
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           KPEN L  ++     +   DFGL     +     S   G+P Y+APEVL K+ Y   +D 
Sbjct: 123 KPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  G +LY +L G+PPF++ +   +   IL   +  K    PN++ SA+ L+  +L+ D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 235

Query: 297 KLRLTAK 303
             RL AK
Sbjct: 236 TKRLGAK 242

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  101 bits (253), Expect = 2e-24
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 44/296 (14%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           DRY     +G G +G      D  T   +A K +S R  ++A+      RE+ ++KH+  
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHM-D 72

Query: 111 NSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           + +++ L        + ED   V+LV  L  G +L + IV     ++     +   I+  
Sbjct: 73  HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRG 130

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           ++  H  G+IHRDLKP N +  N  E+  LK +DFGL+      +  +  V + +Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSN-IAVN--EDCELKILDFGLA--RHTDDEMTGYVATRWYRAPE 185

Query: 225 VL--KRNYGPEIDIWSAGVILYILL---------------------CGVPP--FWAESEQ 259
           ++    +Y   +DIWS G I+  LL                      G P      +   
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 260 GVAQAILRGLIDFKR----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             A+  ++ L    +    + +   +  A  L+ +ML  DP  R+TA + L HP+L
Sbjct: 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  100 bits (250), Expect = 2e-24
 Identities = 88/298 (29%), Positives = 132/298 (44%), Gaps = 43/298 (14%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK----HLPKNSS 113
           ELG+G +G  Y  + R T   +A K I        +++D+ +    IM+    H   +  
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIR-------LELDESKFNQIIMELDILHKAVSPY 60

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV-----QLC 168
           IV    A   + AV++ ME  + G L D++ A G  TE     V R I   V      L 
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPE 224
            +H +IHRD+KP N L     +   +K  DFG+S     G   + +    +G   YMAPE
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVS-----GNLVASLAKTNIGCQSYMAPE 171

Query: 225 VLKR-------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGV---AQAILRGLIDFKR 274
            +K         Y  + D+WS G+ +  +  G  P+  E+   +     AI+ G  D   
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG--DPPT 229

Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQ 332
            P    S+ A+  V + L   P  R T  Q+LEHPWL    K  +V + + V   LK+
Sbjct: 230 LP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV-KYKNADVDMAEWVTGALKR 285

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  100 bits (250), Expect = 3e-24
 Identities = 79/311 (25%), Positives = 145/311 (46%), Gaps = 28/311 (9%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K++ E  +   RE+G G FG  Y   D  T E++A K +S    ++     D+ +EV  +
Sbjct: 10  KDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVE 163
           + L ++ + +  K     ++   LVME C G   ++ +  V +    E   AA+    ++
Sbjct: 70  QQL-RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQ 126

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            +   H H  IHRD+K  N L     E   +K  DFG +    P   F   VG+PY+MAP
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAP 180

Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG----VAQAILRGLIDFKRD 275
           EV+    +  Y  ++D+WS G+    L    PP +  +       +AQ     L     +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL---SSN 237

Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR--LKQF 333
            W   S+  ++ V   L+  P+ R +++++L+H ++   ++ P V +  + R++  +++ 
Sbjct: 238 DW---SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR-ERPPTVIIDLIQRTKDAVREL 293

Query: 334 SMMNRFKRKAL 344
             +   K K +
Sbjct: 294 DNLQYRKMKKI 304

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 98.5 bits (245), Expect = 6e-24
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 13/265 (4%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY + +++G G FG  YL   +   E    K I   K+    + +  ++EV ++  + K+
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKM-KH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARG-HYTERAAAAVTRTIVEVVQLCH 169
            +IV+   + +++  + +VME C+GG+L  RI   RG  ++E    +    I   ++  H
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 170 KHGVIHRDLKPEN-FLFANKKENSPLKAIDFGLSIFFKPGERFSEI-VGSPYYMAPEVLK 227
              ++HRD+K +N FL  N       K  DFG++         +   VG+PYY++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGM---VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
            R Y  + DIWS G +LY L     PF   +   +   I +G         PN S   +S
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF---APISPNFSRDLRS 232

Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
           L+ Q+ +  P+ R +   +L+ P+L
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 99.9 bits (249), Expect = 6e-24
 Identities = 71/247 (28%), Positives = 117/247 (47%), Gaps = 9/247 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG   L   +   +  A K + K+ +    +   +  E  ++    K+  +V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +  + ++ V++   GGELF  +     + E  A      I   +   H   +I+RDL
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           KPEN L  ++     +   DFGL     +  +  S   G+P Y+APEVL K+ Y   +D 
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  G +LY +L G+PPF++     +   IL   +  K    PN+S SA+ L+  +L+ D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDR 235

Query: 297 KLRLTAK 303
             RL AK
Sbjct: 236 TKRLGAK 242

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 98.3 bits (245), Expect = 9e-24
 Identities = 73/262 (27%), Positives = 126/262 (48%), Gaps = 21/262 (8%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDT-RELLACKSIS-------KRKLRTAVDIDDVRREVAI 104
           Y V   LG G FG  Y    ++  + LLA K I+       K K      I D+  EV I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEG---GELFDRIVARG-HYTERAAAAVTRT 160
           +K   ++ +IV   +   +++ +++VM+L EG   GE F+ +  +   +TE     +   
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 161 IVEVVQLCHKHG-VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           +V  ++  HK   ++HRDL P N +     E+  +   DFGL+   +P  + + +VG+  
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-FKRDPW 277
           Y  PE++K   YG + D+W+ G ILY +    PPF++ +   +A  I+  + +      +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238

Query: 278 PNVSESAKSLVRQMLEPDPKLR 299
              SE    ++   L PD + R
Sbjct: 239 ---SEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 81/309 (26%), Positives = 130/309 (42%), Gaps = 56/309 (18%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK-----LRTAVDIDDVRRE 101
            ++  RY     +G G +G+      + T   +A K IS  +      RT        RE
Sbjct: 1   FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-------RE 53

Query: 102 VAIMKHLPKNSSIVSLK-----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA 156
           + I++   K+ +I+ +       + E  N V++V EL E  +L+ +++   H +      
Sbjct: 54  IKILRRF-KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQY 110

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS---- 212
               I+  ++  H   V+HRDLKP N L      N  LK  DFGL+    P    +    
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLT 167

Query: 213 EIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----------------- 253
           E V + +Y APE++   + Y   IDIWS G IL  +L   P F                 
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227

Query: 254 --WAESEQGV----AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAK 303
               E    +    A+  ++ L    + PW    PN    A  L+ +ML  +P  R+T +
Sbjct: 228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE 287

Query: 304 QVLEHPWLQ 312
           + L HP+L+
Sbjct: 288 EALAHPYLE 296

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 97.6 bits (243), Expect = 2e-23
 Identities = 68/277 (24%), Positives = 122/277 (44%), Gaps = 39/277 (14%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACK-------SISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           +G+G +G  YL ++  T E++A K          +   R    +  +R E+  +K L  +
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DH 67

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
            +IV        +  + + +E   GG +   +   G + E+     T  ++E +   H  
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV----------GSPYYM 221
           G++HRDLK +N L      +   K  DFG+S       + S+ +          GS ++M
Sbjct: 128 GILHRDLKADNLLV---DADGICKISDFGIS-------KKSDDIYDNDQNMSMQGSVFWM 177

Query: 222 APEVL---KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APEV+    + Y  ++DIWS G ++  +  G  P W++ E     A+ +        P P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEA--IAAMFKLGNKRSAPPIP 234

Query: 279 -----NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                N+S  A   +      +P  R TA+++L+HP+
Sbjct: 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 97.8 bits (243), Expect = 2e-23
 Identities = 80/273 (29%), Positives = 136/273 (49%), Gaps = 19/273 (6%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-IDDVRREVAIMKHL 108
           E+ +    ++G+G FG  +  ID  T++++A K I    L  A D I+D+++E+ ++   
Sbjct: 3   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID---LEEAEDEIEDIQQEITVLSQC 59

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
             +  +     +   D  + ++ME   GG   D ++  G   E   A + R I++ +   
Sbjct: 60  -DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYL 117

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLK 227
           H    IHRD+K  N L +   E+  +K  DFG++      + + +  VG+P++MAPEV+K
Sbjct: 118 HSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 174

Query: 228 RN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESA 284
           ++ Y  + DIWS G+    L  G PP    SE    + +   LI     P    N S+  
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP---HSELHPMKVLF--LIPKNNPPTLEGNYSKPL 229

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPW-LQNAKK 316
           K  V   L  +P  R TAK++L+H + ++ AKK
Sbjct: 230 KEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 97.6 bits (243), Expect = 2e-23
 Identities = 76/268 (28%), Positives = 127/268 (47%), Gaps = 27/268 (10%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG    C  R T +L ACK ++K++L+     +    E  I+  +  +  IVSL 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGH----------YTERAAAAVTRTIVEVVQLC 168
            A +    + LVM +  GG+L      R H          + E  A   T  I+  ++  
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDL------RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEVLK 227
           H+  +I+RDLKPEN L  N   +  ++  D GL++  K G+  ++   G+P +MAPE+L+
Sbjct: 114 HQRRIIYRDLKPENVLLDN---DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170

Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
              Y   +D ++ GV LY ++    PF A  E+   + + + +++         S ++KS
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKS 230

Query: 287 LVRQMLEPDPKLRL-----TAKQVLEHP 309
               +L  DP+ RL         +  HP
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCDGLRTHP 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 98.2 bits (244), Expect = 2e-23
 Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 24/274 (8%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   + T  + A K + K  +    DID V+ E  + +    +  +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 177 DLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L  ++     +K  D+G+     +PG+  S   G+P Y+APE+L+  +YG  +
Sbjct: 121 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 235 DIWSAGVILYILLCGVPPF---------WAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           D W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 233

Query: 286 SLVRQMLEPDPKLRLTA------KQVLEHPWLQN 313
           S+++  L  DPK RL          +  HP+ +N
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 70/253 (27%), Positives = 115/253 (45%), Gaps = 16/253 (6%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   +   ++ A K + K  +    DID V+ E  + +    N  +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    +  + + LV+E   GG+L   +  +    E  A      I   +   H+ G+I+R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 177 DLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L      +  +K  D+G+      PG+  S   G+P Y+APE+L+   YG  +
Sbjct: 121 DLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177

Query: 235 DIWSAGVILYILLCGVPPF-------WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           D W+ GV+++ ++ G  PF          +E  + Q IL   I   R     +S  A  +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHV 233

Query: 288 VRQMLEPDPKLRL 300
           ++  L  DPK RL
Sbjct: 234 LKGFLNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 97.0 bits (241), Expect = 3e-23
 Identities = 86/280 (30%), Positives = 133/280 (47%), Gaps = 33/280 (11%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P+E+ E   L+ R +G G +G  Y   + +T EL A K I   KL    D   V++E+ +
Sbjct: 7   PQEDFE---LIQR-IGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIM 59

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           MK   K+S+IV+   +    + + + ME C GG L D     G  +E   A V+R  ++ 
Sbjct: 60  MKDC-KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQG 118

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMA 222
           +   H  G +HRD+K  N L     +N  +K  DFG+S  I     +R S  +G+PY+MA
Sbjct: 119 LYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMA 174

Query: 223 PEVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW- 277
           PEV     K  Y    DIW+ G+    L    PP +           +R L    +  + 
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP-------MRALFLMTKSNFQ 227

Query: 278 -PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPW 310
            P + +  K        V+  L  +PK R TA+++L+HP+
Sbjct: 228 PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 96.2 bits (239), Expect = 4e-23
 Identities = 72/258 (27%), Positives = 126/258 (48%), Gaps = 20/258 (7%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + +++++GRG+F   Y       R+ +A K +   ++  A    D  +E+ ++K L  + 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHP 62

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC--- 168
           +++   ++  +DN +++V+EL + G+L   I    ++ ++      RT+ +  VQLC   
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIK---YFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 169 ---HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPE 224
              H   V+HRD+KP N           +K  D GL  FF      +  +VG+PYYM+PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 225 VLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQ--GVAQAILRGLIDFKRDPWPNVS 281
            +  N Y  + DIWS G +LY +     PF+ +      + Q I +   D+   P  + S
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ--CDYPPLPTEHYS 234

Query: 282 ESAKSLVRQMLEPDPKLR 299
           E  + LV   + PDP  R
Sbjct: 235 EKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 97.5 bits (243), Expect = 4e-23
 Identities = 82/274 (29%), Positives = 137/274 (50%), Gaps = 36/274 (13%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   +   ++T ++ A K ++K ++    +    R E  ++ +      I +L 
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN-GDRRWITNLH 67

Query: 119 EACEDDNAVHLVMELCEGGELF-------DRI---VARGHYTERAAAAVTRTIVEVVQLC 168
            A +D+N ++LVM+   GG+L        DR+   +AR +  E         +V  +   
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAE---------MVLAIDSV 118

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFSEIVGSPYYMAPEVL 226
           H+ G +HRD+KP+N L     +N  ++  DFG  L +      + +  VG+P Y++PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175

Query: 227 ------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWP 278
                 K  YGPE D WS GV +Y +L G  PF+AES       I+  +    F  D   
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-T 234

Query: 279 NVSESAKSLVRQML-EPDPKL-RLTAKQVLEHPW 310
           +VSE AK L+R+++  P+ +L R   +   +HP+
Sbjct: 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 96.5 bits (240), Expect = 5e-23
 Identities = 69/265 (26%), Positives = 123/265 (46%), Gaps = 21/265 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV----RREVAIMKHLPKNSSI 114
           LG G F   Y   D  T  L+A K ++  +  T+ + ++V    R+E+ +M  L  +  I
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVR-NTSSEQEEVVEALRKEIRLMARL-NHPHI 65

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           + +  A  +D+  +L +E   GG +   +   G + E      T  ++  +   H++ +I
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSI-----FFKPGERFSEIVGSPYYMAPEVLK-R 228
           HRD+K  N L  +  +   L+  DFG +          GE   +++G+  +MAPEVL+  
Sbjct: 126 HRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183

Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            YG   D+WS G ++  +    PP+ AE        I +  I       P++ E     +
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK--IASATTA-PSIPEHLSPGL 240

Query: 289 RQM----LEPDPKLRLTAKQVLEHP 309
           R +    LE  P+ R  ++++L+HP
Sbjct: 241 RDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 97.6 bits (244), Expect = 5e-23
 Identities = 93/319 (29%), Positives = 138/319 (43%), Gaps = 75/319 (23%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           ++I  +Y + ++LG+G +G+ +  IDR T+E++A K I     R A D     RE+  ++
Sbjct: 3   KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD-AFRNATDAQRTFREIMFLQ 61

Query: 107 HLPKNSSIVSLKEA--CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT-IVE 163
            L  + +IV L      E+D  ++LV E                Y E    AV R  I+E
Sbjct: 62  ELGDHPNIVKLLNVIKAENDKDIYLVFE----------------YMETDLHAVIRANILE 105

Query: 164 VV-------QL------CHKHGVIHRDLKPENFLFANKKENSP--LKAIDFGLSIFFKPG 208
            V       QL       H   VIHRDLKP N L      NS   +K  DFGL+      
Sbjct: 106 DVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL-----NSDCRVKLADFGLARSLSEL 160

Query: 209 ER------FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF------- 253
           E        ++ V + +Y APE+L     Y   +D+WS G IL  +L G P F       
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220

Query: 254 ---------WAESEQGVAQ-------AILRGLIDFKRDP----WPNVSESAKSLVRQMLE 293
                       S + +          +L  L    R P     P  S+ A  L++++L 
Sbjct: 221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLV 280

Query: 294 PDPKLRLTAKQVLEHPWLQ 312
            +P  RLTA++ LEHP++ 
Sbjct: 281 FNPNKRLTAEEALEHPYVA 299

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 97.0 bits (241), Expect = 6e-23
 Identities = 74/277 (26%), Positives = 128/277 (46%), Gaps = 15/277 (5%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K++ E+ ++   E+G G FG  Y   +  T E++A K +S    +T     D+ +EV  +
Sbjct: 16  KDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFL 75

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + L K+ + +  K     ++   LVME C G       V +    E   AA+T   ++ +
Sbjct: 76  QQL-KHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 134

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              H H +IHRD+K  N L     E   +K  DFG +    P   F   VG+PY+MAPEV
Sbjct: 135 AYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEV 188

Query: 226 L----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG-LIDFKRDPWPNV 280
           +    +  Y  ++D+WS G+    L    PP +  +       I +      + + W   
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW--- 245

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA 317
           ++S +  V   L+  P+ R  + ++L H +++  + A
Sbjct: 246 TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 97.8 bits (243), Expect = 8e-23
 Identities = 82/308 (26%), Positives = 129/308 (41%), Gaps = 55/308 (17%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + LG G FG   L    DT+ L A K++ K+ +     +  V+ E  I+     N  +V 
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWVVR 65

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L  + +D + ++ VM+   GG++   ++  G + E  A      +   V+  HK G IHR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFF------------------------------- 205
           D+KP+N L      +  +K  DFGL   F                               
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 206 -------KPGERFS----------EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILL 247
                  KP ER +           +VG+P Y+APEVL R  Y    D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 248 CGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE-PDPKL-RLTAKQV 305
            G PPF A++       ++         P   +S  A  L+ ++   P+ +L +  A ++
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEI 302

Query: 306 LEHPWLQN 313
             HP+ + 
Sbjct: 303 KAHPFFKT 310

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 95.9 bits (238), Expect = 9e-23
 Identities = 75/266 (28%), Positives = 131/266 (49%), Gaps = 23/266 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-IDDVRREVAIMKHLPKNSSIVSL 117
           +G+G FG  +  ID  T++++A K I    L  A D I+D+++E+ ++     +  +   
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEITVLSQC-DSPYVTKY 67

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +      + ++ME   GG   D + A G + E   A + + I++ +   H    IHRD
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRD 126

Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKRN-YGPEID 235
           +K  N L +   E   +K  DFG++      + + +  VG+P++MAPEV++++ Y  + D
Sbjct: 127 IKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV----SESAKSLVRQM 291
           IWS G+    L  G PP             +R L    ++  P +    S+  K  +   
Sbjct: 184 IWSLGITAIELAKGEPP-------NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC 236

Query: 292 LEPDPKLRLTAKQVLEHPWL-QNAKK 316
           L  DP  R TAK++L+H ++ +NAKK
Sbjct: 237 LNKDPSFRPTAKELLKHKFIVKNAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 95.9 bits (238), Expect = 2e-22
 Identities = 74/250 (29%), Positives = 124/250 (49%), Gaps = 26/250 (10%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   +   ++  ++ A K ++K ++    +    R E  ++ +   N  I +L 
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDNQWITTLH 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR----TIVEVVQLCHKHGVI 174
            A +D+N ++LVM+   GG+L   +     + +R    + R     +V  +   H+   +
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124

Query: 175 HRDLKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFSEIVGSPYYMAPEVL------ 226
           HRD+KP+N L      N  ++  DFG  L +      + S  VG+P Y++PE+L      
Sbjct: 125 HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181

Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP----NVSE 282
           K  YGPE D WS GV +Y +L G  PF+AES       I+     F+   +P    +VSE
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPAQVTDVSE 238

Query: 283 SAKSLVRQML 292
            AK L+R+++
Sbjct: 239 DAKDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 76/285 (26%), Positives = 128/285 (44%), Gaps = 35/285 (12%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K++ E  +   RE+G G FG  Y   D    E++A K +S    ++     D+ +EV  +
Sbjct: 10  KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + L ++ + +  +     ++   LVME C G       V +    E   AAVT   ++ +
Sbjct: 70  QKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              H H +IHRD+K  N L +   E   +K  DFG +    P   F   VG+PY+MAPEV
Sbjct: 129 AYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEV 182

Query: 226 L----KRNYGPEIDIWSAGVILYILLCGVPPFW-----------AESEQGVAQAILRGLI 270
           +    +  Y  ++D+WS G+    L    PP +           A++E    Q+      
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS------ 236

Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
                 W   SE  ++ V   L+  P+ R T++ +L+H ++   +
Sbjct: 237 ----GHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 94.8 bits (236), Expect = 2e-22
 Identities = 75/286 (26%), Positives = 133/286 (46%), Gaps = 43/286 (15%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKNSSI 114
           +G G +G+   C  ++T +++A K     K   + D   V+    RE+ ++K L ++ ++
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQL-RHENL 62

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V+L E       ++LV E  +   L D         E         I+  ++ CH H +I
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVLKRN--YG 231
           HRD+KPEN L +   ++  +K  DFG +     PGE +++ V + +Y APE+L  +  YG
Sbjct: 123 HRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID--------FKRDP------- 276
             +DIW+ G ++  +L G P F  +S+      I++ L +        F+++P       
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239

Query: 277 ------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                       +P +S     L +Q L  DP  R ++ Q+L H +
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 96.1 bits (239), Expect = 3e-22
 Identities = 85/311 (27%), Positives = 139/311 (44%), Gaps = 71/311 (22%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS--IVS 116
           +G+G FG   L   +DT ++ A K++ K ++     +  V+ E  +   L ++ S  +VS
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV---LAESDSPWVVS 65

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR----TIVEVVQLCHKHG 172
           L  + +D   ++L+ME   GG+L   ++    ++E     VTR      V  ++  HK G
Sbjct: 66  LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED----VTRFYMAECVLAIEAVHKLG 121

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFF------------------KPG--ERFS 212
            IHRD+KP+N L         +K  DFGLS  F                  K     R S
Sbjct: 122 FIHRDIKPDNILIDRGGH---IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178

Query: 213 EIV----------------------------GSPYYMAPEV-LKRNYGPEIDIWSAGVIL 243
             V                            G+P Y+APE+ L++ YG E D WS G I+
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238

Query: 244 YILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVSESAKSLVRQML-EPDPKL-R 299
           +  L G PPF +E+     + I+  R  + F  D   ++S  A+ L+R+++   + +L R
Sbjct: 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLITNAENRLGR 296

Query: 300 LTAKQVLEHPW 310
             A ++  HP+
Sbjct: 297 GGAHEIKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 89/317 (28%), Positives = 135/317 (42%), Gaps = 74/317 (23%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS---------KRKLRTAVDIDDVR 99
           +  RY     +G G +GV    ID  + + +A K I          KR LR         
Sbjct: 3   VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR--------- 53

Query: 100 REVAIMKHLPKNSSIVSLKE----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA 155
            E+ I++H  K+ +I+++++       D   V++VM+L E  +L   I +    TE    
Sbjct: 54  -ELKILRHF-KHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIR 110

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL--SIFFKPGE--RF 211
                ++  ++  H   VIHRDLKP N L     E+  L+  DFG+   +   P E   F
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYF 167

Query: 212 -SEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVI---------------------LYILL 247
            +E V + +Y APE+L     Y   ID+WS G I                     L + +
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227

Query: 248 CGVPPFWAESEQGVAQAI----LRGLI-DFKRD---PW----PNVSESAKSLVRQMLEPD 295
            G P       + V   I    +R  I +  R    PW    P  S  A  L+ QML+ D
Sbjct: 228 LGSPS------EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFD 281

Query: 296 PKLRLTAKQVLEHPWLQ 312
           P+ R+T +Q L+HP+L 
Sbjct: 282 PEERITVEQALQHPFLA 298

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 94.1 bits (234), Expect = 4e-22
 Identities = 80/285 (28%), Positives = 125/285 (43%), Gaps = 34/285 (11%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSI---SKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
            +LG G  G         T  ++A K +   +K  +R       + RE+ IM H  ++  
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK-----QILRELQIM-HECRSPY 64

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVE-VVQLCHKH 171
           IVS   A  ++N + + ME  + G L DRI  + G         +   +VE +  L + H
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVLK 227
            ++HRD+KP N L  ++ +   +K  DFG+S     GE  + I    VG+  YM+PE ++
Sbjct: 124 RIMHRDIKPSNILVNSRGQ---IKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQ 175

Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF---------KRDPW 277
              Y  + D+WS G+ +  L  G  PF   +     Q    G++D           R P 
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            +  E  +  V   L  DP  R T +Q+   P    A +A NV L
Sbjct: 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDL 280

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 94.4 bits (234), Expect = 5e-22
 Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 17/287 (5%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           KE+ E  +   RE+G G FG  Y   D  T E++A K +S    ++     D+ +EV  +
Sbjct: 20  KEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFL 79

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + +   +SI   K     ++   LVME C G       V +    E   AA+T   ++ +
Sbjct: 80  QRIKHPNSI-EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              H H +IHRD+K  N L     E   +K  DFG +    P   F   VG+PY+MAPEV
Sbjct: 139 AYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPANSF---VGTPYWMAPEV 192

Query: 226 L----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG-LIDFKRDPWPNV 280
           +    +  Y  ++D+WS G+    L    PP +  +       I +      + + W   
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW--- 249

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVR 327
           S+  ++ V   L+  P+ R T++++L+H ++   ++ P   L D+++
Sbjct: 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFV--LRERPETVLIDLIQ 294

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 93.9 bits (233), Expect = 6e-22
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 12/205 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G G +GV   C  ++T+E++A K     +    V  +   RE+ +++ L K  +IV LK
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVK-ETTLRELKMLRTL-KQENIVELK 66

Query: 119 EACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           EA      ++LV E  E    EL + +   G   E+  + + + +++ +  CHK+ ++HR
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQ-LIKAIHWCHKNDIVHR 124

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPE-VLKRNYGPE 233
           D+KPEN L ++   N  LK  DFG +     G    ++E V + +Y +PE +L   YG  
Sbjct: 125 DIKPENLLISH---NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 234 IDIWSAGVILYILLCGVPPFWAESE 258
           +D+WS G IL  L  G P F  ESE
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 94.3 bits (234), Expect = 7e-22
 Identities = 71/264 (26%), Positives = 124/264 (46%), Gaps = 19/264 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG   L   +   +  A K + K+ +    +   +  E  ++    K+  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +    ++ V++   GGELF  +     + E  A      I   +   H   +++RDL
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV----GSPYYMAPEVLKRN-YGPE 233
           KPEN L  ++     +   DFGL    K G   S+      G+P Y+APEV+++  Y   
Sbjct: 123 KPENILLDSQGH---VVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
           +D W  G +LY +L G+PPF+      +   IL   +  +    P  S +A S++ ++LE
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232

Query: 294 PDPKLRLTAK----QVLEHPWLQN 313
            D + RL AK    ++ EHP+ ++
Sbjct: 233 KDRQRRLGAKEDFLEIQEHPFFES 256

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 94.7 bits (235), Expect = 7e-22
 Identities = 79/294 (26%), Positives = 125/294 (42%), Gaps = 45/294 (15%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   L   +DT  + A K + K  +     +  +R E  I+      + +V + 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-ADGAWVVKMF 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D   ++L+ME   GG++   ++ +   +E A        V  +   H+ G IHRD+
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDI 127

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGER--------------FS------------ 212
           KP+N L   K     +K  DFGL    K   R              FS            
Sbjct: 128 KPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184

Query: 213 ----------EIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
                       VG+P Y+APEV ++  Y    D WS GVI+Y +L G PPF +E+ Q  
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE---HPWLQ 312
            + ++         P   +SE AK L+ +    D + R+ +  V E   HP+ +
Sbjct: 245 YRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 76/251 (30%), Positives = 120/251 (47%), Gaps = 18/251 (7%)

Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKLRTAVDIDDVR--REVAIMKHLPKNSS 113
           LG+G FG  +L       D  +L A K + K  L+     D VR   E  I+  +  +  
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR---DRVRTKMERDILAEV-NHPF 59

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           IV L  A + +  ++L+++   GG+LF R+     +TE         +   +   H  G+
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS-EIVGSPYYMAPEVL-KRNYG 231
           I+RDLKPEN L     E   +K  DFGLS      E+ +    G+  YMAPEV+ +R + 
Sbjct: 120 IYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM 291
              D WS GV+++ +L G  PF  +  +     IL+  +   +     +S  A+SL+R +
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRAL 232

Query: 292 LEPDPKLRLTA 302
            + +P  RL A
Sbjct: 233 FKRNPANRLGA 243

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 93.5 bits (232), Expect = 1e-21
 Identities = 69/244 (28%), Positives = 116/244 (47%), Gaps = 9/244 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T EL A K + K  +    D++    E  ++    K   +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + ++ VME   GG+L   I   G + E  A      I   +   H+ G+I+RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDI 236
           K +N +  ++     +K  DFG+       G       G+P Y+APE++  + YG  +D 
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W+ GV+LY +L G PPF  E E  + Q+I+   + + +    ++S+ A S+ + ++   P
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLMTKHP 240

Query: 297 KLRL 300
             RL
Sbjct: 241 SKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 73/268 (27%), Positives = 112/268 (41%), Gaps = 43/268 (16%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   L   +DT  + A K + K  +     +  +R E  I+     +  +V + 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVKMF 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D   ++L+ME   GG++   ++ +   TE          V  +   H+ G IHRD+
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDI 127

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGER---------------------------- 210
           KP+N L  +K     +K  DFGL    K   R                            
Sbjct: 128 KPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184

Query: 211 ---------FSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQG 260
                    FS  VG+P Y+APEV  +  Y    D WS GVI+Y +L G PPF +E+ Q 
Sbjct: 185 WKRNRRQLAFS-TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243

Query: 261 VAQAILRGLIDFKRDPWPNVSESAKSLV 288
             + ++         P   +SE AK L+
Sbjct: 244 TYKKVMNWKETLIFPPEVPISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 83/303 (27%), Positives = 138/303 (45%), Gaps = 49/303 (16%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD--IDDVR--REVAI 104
           ++ +Y+  + +GRG +G+     + +T E +A K I+      A D  ID  R  RE+ +
Sbjct: 3   VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-----AFDNRIDAKRTLREIKL 57

Query: 105 MKHLPKNSSIVSLKEAC-----EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           ++HL  + +++++K+       E  N V++V EL +  +L   I +    ++        
Sbjct: 58  LRHL-DHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLY 115

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSP 218
            ++  ++  H   V+HRDLKP N L      N  LK  DFGL+    + G+  +E V + 
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTR 172

Query: 219 YYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA------------------ESE 258
           +Y APE+L     Y   ID+WS G I   LL   P F                    E +
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232

Query: 259 QGV-----AQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
            G      A+  +R L    R      +P+ +  A  L+ +ML  DP  R+T ++ L HP
Sbjct: 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292

Query: 310 WLQ 312
           +L 
Sbjct: 293 YLA 295

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 92.4 bits (229), Expect = 1e-21
 Identities = 77/265 (29%), Positives = 127/265 (47%), Gaps = 22/265 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-IDDVRREVAIMKHLPKNSSIVSL 117
           +G+G FG  Y  ID  T+E++A K I    L  A D I+D+++E+ ++     +  I   
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIID---LEEAEDEIEDIQQEITVLSQC-DSPYITRY 67

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +      + ++ME   GG   D ++  G   E   A + R I++ +   H    IHRD
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRD 126

Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKRN-YGPEID 235
           +K  N L +   E   +K  DFG++      + + +  VG+P++MAPEV+K++ Y  + D
Sbjct: 127 IKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV----SESAKSLVRQM 291
           IWS G+    L  G PP             +R L    ++  P +    S+  K  V   
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHP-------MRVLFLIPKNSPPTLEGQYSKPFKEFVEAC 236

Query: 292 LEPDPKLRLTAKQVLEHPWLQNAKK 316
           L  DP+ R TAK++L+H ++    K
Sbjct: 237 LNKDPRFRPTAKELLKHKFITRYTK 261

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 82/310 (26%), Positives = 131/310 (42%), Gaps = 52/310 (16%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++  RY+  R LG G  G+ +  +D D  + +A K I    L     +    RE+ I++ 
Sbjct: 2   DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV---LTDPQSVKHALREIKIIRR 58

Query: 108 L-------------PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
           L             P  S +     +  + N+V++V E  E       ++ +G  +E  A
Sbjct: 59  LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHA 116

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---- 210
                 ++  ++  H   V+HRDLKP N +F N  E+  LK  DFGL+    P       
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPAN-VFINT-EDLVLKIGDFGLARIVDPHYSHKGY 174

Query: 211 FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG 268
            SE + + +Y +P +L    NY   ID+W+AG I   +L G P F    E    Q IL  
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234

Query: 269 --LIDFK------------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTA 302
             ++  +                        RD  P V+  A   + Q+L  +P  RLTA
Sbjct: 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294

Query: 303 KQVLEHPWLQ 312
           ++ L HP++ 
Sbjct: 295 EEALMHPYMS 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 92.0 bits (228), Expect = 2e-21
 Identities = 86/285 (30%), Positives = 136/285 (47%), Gaps = 34/285 (11%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G FG  Y   +++T  L A K I   + ++  +++D   E+ I+     +  IV L
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYMVEIEILATC-NHPYIVKL 74

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
             A   D  + +++E C GG + D I+    RG  TE     + R ++E +Q  H   +I
Sbjct: 75  LGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKII 132

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVL------K 227
           HRDLK  N L     +   +K  DFG+S    K  +R    +G+PY+MAPEV+       
Sbjct: 133 HRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK-- 285
             Y  + DIWS G+ L  +    PP    +   V   I       K +P P +S+ +K  
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA------KSEP-PTLSQPSKWS 242

Query: 286 ----SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVV 326
                 ++  L+  P+ R +A Q+LEHP++  +    N PL ++V
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFV--SSVTSNRPLRELV 285

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 92.3 bits (229), Expect = 3e-21
 Identities = 72/257 (28%), Positives = 120/257 (46%), Gaps = 10/257 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   +   E  A K++ K  +    D++    E  ++    +N  +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +    +  VME   GG+L   I  +G +    A      IV  +Q  H  G+I+RDL
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLK-RNYGPEIDI 236
           K +N +      +  +K  DFG+      G+ R S   G+P Y+APE+L+   Y   +D 
Sbjct: 123 KLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS GV+LY +L G  PF  + E  + ++I      + R  W  +++ +K ++ ++ E DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKLFERDP 235

Query: 297 KLRL-TAKQVLEHPWLQ 312
             RL     +  HP+ +
Sbjct: 236 TRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 92.2 bits (229), Expect = 4e-21
 Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 24/274 (8%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   + TR + A K I K  +    DID V+ E  + +    +  +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 177 DLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L         +K  D+G+     +PG+  S   G+P Y+APE+L+  +YG  +
Sbjct: 121 DLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 235 DIWSAGVILYILLCGVPPF---------WAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           D W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAS 233

Query: 286 SLVRQMLEPDPKLRLTAK------QVLEHPWLQN 313
           S+++  L  DPK RL          +  HP+ +N
Sbjct: 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 90.9 bits (225), Expect = 4e-21
 Identities = 70/256 (27%), Positives = 120/256 (46%), Gaps = 16/256 (6%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + +++++GRG+F   Y          +A K +    L  A    D  +E+ ++K L  + 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP 62

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC--- 168
           +++    +  +DN +++V+EL + G+L   I    H+ ++      +T+ +  VQLC   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 169 ---HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPE 224
              H   V+HRD+KP N           +K  D GL  FF      +  +VG+PYYM+PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 225 VLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES 283
            +  N Y  + DIWS G +LY +     PF+ +     +        D+   P  + SE 
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236

Query: 284 AKSLVRQMLEPDPKLR 299
            + LV   + PDP+ R
Sbjct: 237 LRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 91.3 bits (227), Expect = 6e-21
 Identities = 78/317 (24%), Positives = 134/317 (42%), Gaps = 58/317 (18%)

Query: 42  AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
              P  +   +Y    ++G+G FG  +    + T++++A K +     +    I  +R E
Sbjct: 3   YEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-E 61

Query: 102 VAIMKHLPKNSSIVSLKEAC--------EDDNAVHLVMELCE---GGELFDRIVARGHYT 150
           + I++ L K+ ++V+L E C            + +LV E CE    G L ++ V    +T
Sbjct: 62  IKILQLL-KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFT 117

Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE- 209
                 V + ++  +   H++ ++HRD+K  N L     ++  LK  DFGL+  F   + 
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKN 174

Query: 210 ----RFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ 263
               R++  V + +Y  PE+L  +R+YGP ID+W AG I+  +    P     +EQ    
Sbjct: 175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT 234

Query: 264 AI--LRGLIDFKRDPWPNV----------------------------SESAKSLVRQMLE 293
            I  L G I    + WP V                               A  L+ ++L 
Sbjct: 235 LISQLCGSIT--PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLV 292

Query: 294 PDPKLRLTAKQVLEHPW 310
            DP  R+ A   L H +
Sbjct: 293 LDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 90.8 bits (225), Expect = 7e-21
 Identities = 77/286 (26%), Positives = 136/286 (47%), Gaps = 30/286 (10%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N E+ + +  ELG G FG  Y   +++T  L A K I  +   +  +++D   E+ I+  
Sbjct: 2   NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILAS 58

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVV 165
              + +IV L +A   +N + +++E C GG + D ++       TE     V +  +E +
Sbjct: 59  C-DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEAL 116

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPE 224
              H++ +IHRDLK  N LF     +  +K  DFG+S    +  +R    +G+PY+MAPE
Sbjct: 117 NYLHENKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 173

Query: 225 VL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           V+       R Y  + D+WS G+ L  +    PP    +        +R L+   +   P
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPP 226

Query: 279 NVSESA------KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
            +++ +      K  +++ LE +   R T  Q+L+HP++      P
Sbjct: 227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKP 272

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 91.4 bits (227), Expect = 8e-21
 Identities = 81/323 (25%), Positives = 134/323 (41%), Gaps = 62/323 (19%)

Query: 46  KENIEDRYL-VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-----IDDV- 98
             +I +RY+     LG G +G      D  T +++A K +   ++   V      +    
Sbjct: 3   SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62

Query: 99  -----RREVAIMKHLPKNSSIVSLKEA-CEDDNAVHLVMELCEGGELFDRIVARGHYTER 152
                 RE+ IM  + K+ +I+ L +   E D  ++LVM++    +L   +  +   TE 
Sbjct: 63  IHFTTLRELKIMNEI-KHENIMGLVDVYVEGD-FINLVMDIMAS-DLKKVVDRKIRLTES 119

Query: 153 AAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS---------- 202
               +   I+  + + HK   +HRDL P N +F N K     K  DFGL+          
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPAN-IFINSK--GICKIADFGLARRYGYPPYSD 176

Query: 203 -----IFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA 255
                   +  E  +  V + +Y APE+L     Y   +D+WS G I   LL G P F  
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236

Query: 256 ESEQGVAQAI--LRGL-----------------------IDFKRDPWPNVSESAKSLVRQ 290
           E+E      I  L G                         D K   +PN S+ A  L++ 
Sbjct: 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQS 295

Query: 291 MLEPDPKLRLTAKQVLEHPWLQN 313
           +L+ +P  R++AK+ L+H + ++
Sbjct: 296 LLKLNPLERISAKEALKHEYFKS 318

Length = 335

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 90.8 bits (225), Expect = 9e-21
 Identities = 66/247 (26%), Positives = 112/247 (45%), Gaps = 9/247 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG   L   +      A K + K+ +    + + +  E  ++    K+  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +    ++ V++   GGELF  +     + E  A      +   +   H   +I+RDL
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           KPEN L  ++     +   DFGL     +P E  S   G+P Y+APEVL++  Y   +D 
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  G +LY +L G+PPF++     +   IL   +          + +A  L+  +L  D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ 235

Query: 297 KLRLTAK 303
           + RL AK
Sbjct: 236 RRRLGAK 242

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 90.8 bits (225), Expect = 1e-20
 Identities = 73/258 (28%), Positives = 127/258 (49%), Gaps = 26/258 (10%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D + + + +GRG FG   +   + T  + A K ++K ++    +    R E  ++ +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GD 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR----TIVEVVQ 166
              I +L  A +D+N ++LVM+   GG+L   +     + +R    + R     +V  + 
Sbjct: 60  CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLAIH 116

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEI-VGSPYYMAPE 224
             H+   +HRD+KP+N L      N  ++  DFG  +   + G   S + VG+P Y++PE
Sbjct: 117 SIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 225 VLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           +L+        YGPE D WS GV +Y +L G  PF+AES       I+     F+   +P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FP 230

Query: 279 ----NVSESAKSLVRQML 292
               +VSE AK L+++++
Sbjct: 231 SHITDVSEEAKDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 89.4 bits (221), Expect = 1e-20
 Identities = 74/273 (27%), Positives = 127/273 (46%), Gaps = 34/273 (12%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL- 117
           +G G +G  Y      T +L A K +      T  + +++++E+ ++K    + +I +  
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDV----TGDEEEEIKQEINMLKKYSHHRNIATYY 69

Query: 118 -----KEACEDDNAVHLVMELCEGGELFDRIVARGHYT--ERAAAAVTRTIVEVVQLCHK 170
                K     D+ + LVME C  G + D I      T  E   A + R I+  +   H+
Sbjct: 70  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVLKRN 229
           H VIHRD+K +N L     EN+ +K +DFG+S    +   R +  +G+PY+MAPEV+  +
Sbjct: 130 HKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 230 YGPEI------DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV--- 280
             P+       D+WS G+    +  G PP             +R L    R+P P +   
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL-------CDMHPMRALFLIPRNPAPRLKSK 239

Query: 281 --SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             S+  +S +   L  +   R T +Q+++HP++
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 89.2 bits (221), Expect = 2e-20
 Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 24/275 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IVSL 117
           LG+G FG       ++T ++ ACK + K++L+          E  I++ +  NS  IV+L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV--NSPFIVNL 58

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIV---ARGHYTERA---AAAVTRTIVEVVQLCHKH 171
             A E    + LVM L  GG+L   I     RG   ER    +A +T  I+ +    H  
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL----HSM 114

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN-Y 230
            +++RD+KPEN L     +    +  D GL++  K G+  ++  G+  YMAPE+LK   Y
Sbjct: 115 DIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY 171

Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESE----QGVAQAILRGLIDFKRDPWPNVSESAKS 286
              +D ++ G  +Y ++ G  PF    E    + + +  L   + F+     N +E +K 
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEESKD 228

Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           + R  L   P+ RL +++  + P      K  N P
Sbjct: 229 ICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 16/208 (7%)

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIVEVVQLCH 169
           IV   +  + D+ + L+ME   GG+L  +I  R      + E     +   IV  +   H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVL 226
              ++HRDLK  N           +K  DFG S  +         S   G+PYY+APE+ 
Sbjct: 187 SRKMMHRDLKSANIFLM---PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELW 243

Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESA 284
           +R  Y  + D+WS GVILY LL    PF   S++ + Q +L G    K DP+P  VS   
Sbjct: 244 ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG----KYDPFPCPVSSGM 299

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           K+L+  +L  +P LR T +Q+L   +L+
Sbjct: 300 KALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 80/317 (25%), Positives = 128/317 (40%), Gaps = 76/317 (23%)

Query: 60  GRGEFGVTYLCI--DRDTRELLACKSISKRKLR------TAVDIDDVRREVAIMKHLPKN 111
           GRG +G  Y     +    +  A K     K +      +A       RE+A+++ L K+
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC------REIALLREL-KH 61

Query: 112 SSIVSLKEACEDDNA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTRT-------IV 162
            ++VSL E   +     V+L+ +  E  +L+  I  + H   +  +            I+
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII--KFHRQAKRVSIPPSMVKSLLWQIL 118

Query: 163 EVVQLCHKHGVIHRDLKPEN-FLFANKKENSPLKAIDFGLS-IFFKPGERFSE---IVGS 217
             V   H + V+HRDLKP N  +     E   +K  D GL+ +F  P +  ++   +V +
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178

Query: 218 PYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA---------QAIL 266
            +Y APE+L   R+Y   IDIW+ G I   LL   P F     +            + I 
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238

Query: 267 RGL---------------------IDFKRDPWPNVS------------ESAKSLVRQMLE 293
             L                      DFK   +P+ S                 L+R++LE
Sbjct: 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE 298

Query: 294 PDPKLRLTAKQVLEHPW 310
            DP  R+TA++ LEHP+
Sbjct: 299 YDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 88.9 bits (220), Expect = 6e-20
 Identities = 67/246 (27%), Positives = 118/246 (47%), Gaps = 13/246 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T EL A K + K  +    D++    E  ++    K   +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + ++ VME   GG+L  +I   G + E  A      I   +   H  G+I+RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 179 KPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           K +N +  ++     +K  DFG+   +++   G       G+P Y+APE++  + YG  +
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKENMW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D W+ GV+LY +L G  PF  E E  + Q+I+   + + +    ++S+ A ++ + ++  
Sbjct: 183 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTK 238

Query: 295 DPKLRL 300
            P  RL
Sbjct: 239 HPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 88.6 bits (220), Expect = 6e-20
 Identities = 85/311 (27%), Positives = 135/311 (43%), Gaps = 67/311 (21%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTR----ELLACKSIS---------KRKLRTAVDIDDV 98
           RY + +ELG+G +G+  +C  R+      E +A K I+         KR LR        
Sbjct: 1   RYELIKELGQGAYGI--VCSARNAETSEEETVAIKKITNVFSKKILAKRALR-------- 50

Query: 99  RREVAIMKHLPKNSSIVSL--KEACEDD--NAVHLVMELCEGGELFDRIVARGHYTERAA 154
             E+ +++H   + +I  L   +       N ++L  EL E  +L   I +    T+   
Sbjct: 51  --ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHF 107

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-----E 209
            +    I+  ++  H   V+HRDLKP N L      +  LK  DFGL+  F         
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFSENPGENAG 164

Query: 210 RFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAE----------- 256
             +E V + +Y APE++   ++Y   ID+WS G IL  LL   P F  +           
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224

Query: 257 ----------SEQGV--AQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDPKLRL 300
                     S  G   AQ  +R L +  + P    +PN +  A  L+ ++L  DP  R+
Sbjct: 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI 284

Query: 301 TAKQVLEHPWL 311
           + ++ LEHP+L
Sbjct: 285 SVEEALEHPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 90.6 bits (224), Expect = 9e-20
 Identities = 87/299 (29%), Positives = 137/299 (45%), Gaps = 47/299 (15%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + Y V +++G G FG  +L   + T+E    K+IS R L+   +   +  EV +M+ L K
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER-EKSQLVIEVNVMREL-K 70

Query: 111 NSSIVS-----LKEACEDDNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTI 161
           + +IV      L +A   +  ++++ME C+ G+L   I       G   E A   +TR +
Sbjct: 71  HKNIVRYIDRFLNKA---NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127

Query: 162 VEVVQLCH--KHG-----VIHRDLKPENFLF-------------ANKKENSPLKAI-DFG 200
           +  +  CH  K G     V+HRDLKP+N                AN     P+  I DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 201 LSIFFKPGERFSEIVGSPYYMAPEVL---KRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
           LS            VG+PYY +PE+L    ++Y  + D+W+ G I+Y L  G  PF    
Sbjct: 188 LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF--HK 245

Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKS---LVRQMLEPDPKLRLTAKQVLEHPWLQN 313
               +Q I     + KR P   +   +K    L++ +L    K R +A Q L +  ++N
Sbjct: 246 ANNFSQLI----SELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300

Length = 1021

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 87.7 bits (217), Expect = 1e-19
 Identities = 68/257 (26%), Positives = 121/257 (47%), Gaps = 10/257 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG  +L   + T +  A K++ K  +    D++    E  ++    ++  +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +    +  VME   GG+L   I +   +    A      I+  +Q  H  G+++RDL
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K +N L      +  +K  DFG+      G+ +     G+P Y+APE+L  + Y   +D 
Sbjct: 123 KLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS GV+LY +L G  PF    E+ + Q+I      + R  W  ++  AK ++ ++   +P
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTREAKDILVKLFVREP 235

Query: 297 KLRLTAK-QVLEHPWLQ 312
           + RL  K  + +HP+ +
Sbjct: 236 ERRLGVKGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 68/250 (27%), Positives = 105/250 (42%), Gaps = 53/250 (21%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + LG G FG   L    DT  L A K++ K+ +     +  V+ E  I+     N  +V 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNEWVVK 65

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L  + +D + ++ VM+   GG++   ++    + E  A      +   ++  HK G IHR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFK--------------------P--------- 207
           D+KP+N L      +  +K  DFGL   F+                    P         
Sbjct: 126 DIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 208 ---GERFS----------------EIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILL 247
              G+R                   +VG+P Y+APEV L++ Y    D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 248 CGVPPFWAES 257
            G PPF A +
Sbjct: 243 VGQPPFLAPT 252

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 89/323 (27%), Positives = 137/323 (42%), Gaps = 49/323 (15%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY +   +G+G +GV    ID  T E +A K I+        D   + RE+ +++ L ++
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND-VFEHVSDATRILREIKLLRLL-RH 58

Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
             IV +K      +  +   +++V EL E  +L   I A    T          ++  ++
Sbjct: 59  PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALK 117

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFK--PGERF-SEIVGSPYYMA 222
             H   V HRDLKP+N L AN   +  LK  DFGL+ + F   P   F ++ V + +Y A
Sbjct: 118 YIHTANVFHRDLKPKNIL-ANA--DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 223 PEV---LKRNYGPEIDIWSAGVILYILLCGVPPF-------------------WAESEQG 260
           PE+       Y P IDIWS G I   +L G P F                     E+   
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 261 V----AQAILRGLIDFKRDP------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
           V    A+  L  +   K+ P      +PN    A  L+ ++L  DPK R TA++ L  P+
Sbjct: 235 VRNEKARRYLSSM--RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Query: 311 LQNAKKAPNVPLGDVVRSRLKQF 333
            +   K    P    +     +F
Sbjct: 293 FKGLAKVEREPSAQPITKLEFEF 315

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 85.0 bits (210), Expect = 5e-19
 Identities = 69/270 (25%), Positives = 127/270 (47%), Gaps = 25/270 (9%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSI-----SKRKLRTAVDIDDVRREVAIMKH 107
           Y   R +G+G +G   L   R   +    K +     S+R+ + A       +E  ++  
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA------EQEAQLLSQ 55

Query: 108 LPKNSSIVSLKEACE-DDNAVHLVMELCEGGELFDRIV-ARGHY-TERAAAAVTRTIVEV 164
           L K+ +IV+ +E+ E +D  +++VM  CEGG+L+ ++   +G    E         I   
Sbjct: 56  L-KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA 114

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAP 223
           +Q  H+  ++HRDLK +N         + +K  D G++ +     +  S ++G+PYYM+P
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171

Query: 224 EVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG-LIDFKRDPWPNVS 281
           E+   + Y  + D+W+ G  +Y +      F A+    +   I+ G L    +D  P + 
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELG 231

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           E    L+  ML   P+ R + K +L  P++
Sbjct: 232 E----LIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 85.0 bits (210), Expect = 7e-19
 Identities = 75/287 (26%), Positives = 122/287 (42%), Gaps = 38/287 (13%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK--NSSIV 115
           E+G G +G  Y   D  +   +A KS+  +     + +  VR EVA++K L    + +IV
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65

Query: 116 SLKEAC-----EDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            L + C     + +  V LV E  +       D++   G   E     + R  +  +   
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD-LMRQFLRGLDFL 124

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-LK 227
           H + ++HRDLKPEN L  +  +   +K  DFGL+  +      + +V + +Y APEV L+
Sbjct: 125 HANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---------- 277
             Y   +D+WS G I   +    P F   SE      I   +     D W          
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA 241

Query: 278 -------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                        P + ES   L+ +ML  +P  R++A + L+HP+ 
Sbjct: 242 FSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 84.5 bits (210), Expect = 7e-19
 Identities = 70/279 (25%), Positives = 114/279 (40%), Gaps = 51/279 (18%)

Query: 56  DRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            ++LG G FG  Y          T   +A K++  ++  +  + ++   E +IMK L  +
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKL-SH 60

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV-VQLC-- 168
            +IV L   C     +++V E   GG+L D +   G           + ++++ +Q+   
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE------KLTLKDLLQMALQIAKG 114

Query: 169 ----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY---- 220
                    +HRDL   N L         +K  DFGLS          +I    YY    
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLV---VKISDFGLSR---------DIYEDDYYRKRG 162

Query: 221 --------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI 270
                   MAPE LK   +  + D+WS GV+L+ I   G  P+   S + V + +  G  
Sbjct: 163 GGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG-- 220

Query: 271 DFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
              R P P N  +    L+ Q    DP+ R T  +++E 
Sbjct: 221 --YRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 74/314 (23%), Positives = 123/314 (39%), Gaps = 65/314 (20%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
             Y +  +LG G FG  Y      T  ++A K I     +    I  +R E+ I+K L K
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL-K 65

Query: 111 NSSIVSL--------KEACEDDNAVHLVM-----ELCEGGELFDRIVARGHYTERAAAAV 157
           + ++V L         ++     +V++V      +L   G L +  V     TE      
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSV---KLTESQIKCY 120

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-----KPG---- 208
              ++E +   H++ ++HRD+K  N L  N+     LK  DFGL+  +      P     
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGI---LKIADFGLARPYDGPPPNPKGGGG 177

Query: 209 ---ERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ 263
               +++ +V + +Y  PE+L  +R Y   +DIW  G +   +    P    +S+     
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237

Query: 264 AILR--------------------GLIDFKRDPWPNVSESAK-------SLVRQMLEPDP 296
            I +                    G+  F   P   + E           L+ ++L  DP
Sbjct: 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEERFGKLGPEGLDLLSKLLSLDP 296

Query: 297 KLRLTAKQVLEHPW 310
             RLTA   LEHP+
Sbjct: 297 YKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 78/302 (25%), Positives = 125/302 (41%), Gaps = 72/302 (23%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMKHLPKNSSI 114
           LG G +   Y    + T +L+A K I          TA+      RE +++K L K+++I
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI------REASLLKDL-KHANI 65

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV--QL----- 167
           V+L +       + LV E        D  + +  Y +     ++   V +   QL     
Sbjct: 66  VTLHDIIHTKKTLTLVFEYL------DTDLKQ--YMDDCGGGLSMHNVRLFLFQLLRGLA 117

Query: 168 -CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL----SIFFKPGERFSEIVGSPYYMA 222
            CH+  V+HRDLKP+N L + + E   LK  DFGL    S+   P + +S  V + +Y  
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSV---PSKTYSNEVVTLWYRP 171

Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES---EQGVAQAILRGLIDFKRDPW 277
           P+VL     Y   +D+W  G I Y +  G P F   +   +Q     I R L     + W
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFRVLGTPTEETW 229

Query: 278 PNVSE----------------------------SAKSLVRQMLEPDPKLRLTAKQVLEHP 309
           P VS                               + L  + L+ +PK R++A + ++HP
Sbjct: 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289

Query: 310 WL 311
           + 
Sbjct: 290 YF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 73/301 (24%), Positives = 131/301 (43%), Gaps = 53/301 (17%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV    + R +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLI-HLEIKPAIR-NQIIRELKVL-HECNSPYIVGF 64

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVE-VVQLCHKHGVIH 175
             A   D  + + ME  +GG L D+++ + G   E     ++  ++  +  L  KH ++H
Sbjct: 65  YGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVLKRN-Y 230
           RD+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+PE L+   Y
Sbjct: 124 RDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHY 175

Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR-----GLIDFKRDPWPNVSESAK 285
             + DIWS G+ L  +  G  P      + +     R        +  R    +  +S +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235

Query: 286 SL-VRQML-----EPDPKL-----------------------RLTAKQVLEHPWLQNAKK 316
            + + ++L     EP PKL                       R   K++ +HP+++ A+ 
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295

Query: 317 A 317
            
Sbjct: 296 E 296

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 82.4 bits (203), Expect = 6e-18
 Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 34/273 (12%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL- 117
           +G G +G  Y      T +L A K +      T  + ++++ E+ ++K    + +I +  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDV----TEDEEEEIKLEINMLKKYSHHRNIATYY 79

Query: 118 -----KEACEDDNAVHLVMELCEGGELFDRIV-ARGH-YTERAAAAVTRTIVEVVQLCHK 170
                K     D+ + LVME C  G + D +   +G+   E   A + R I+  +   H 
Sbjct: 80  GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA 139

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVLKRN 229
           H VIHRD+K +N L     EN+ +K +DFG+S    +   R +  +G+PY+MAPEV+  +
Sbjct: 140 HKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196

Query: 230 YGPEI------DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV--- 280
             P+       DIWS G+    +  G PP             +R L    R+P P +   
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL-------CDMHPMRALFLIPRNPPPKLKSK 249

Query: 281 --SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             S+     +   L  +   R + +Q+L+HP++
Sbjct: 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 81.0 bits (201), Expect = 1e-17
 Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 32/272 (11%)

Query: 57  RELGRGEFGVTYLCI--DRDTRELL-ACKSISKRKLRTAVDIDDVRREVAIMKHLP-KNS 112
           ++LG G FG  Y      +D +    A K++ +    +  +  D  +E  +MK L   N 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKLGHPN- 57

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC---- 168
            +V L   C ++  ++LV+E  EGG+L D +            +   ++ +++       
Sbjct: 58  -VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL-SLKDLLSFAIQIA 115

Query: 169 ------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSP-Y 219
                      +HRDL   N L         +K  DFGLS  ++     R       P  
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSRDVYDDDYYRKKTGGKLPIR 172

Query: 220 YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           +MAPE LK   +  + D+WS GV+L+ I   G  P+   S + V + + +G     R P 
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG----YRLPK 228

Query: 278 P-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
           P    +    L+    + DP+ R T  +++E 
Sbjct: 229 PEYCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 74/266 (27%), Positives = 122/266 (45%), Gaps = 18/266 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS---IV 115
           +GRG FG  Y C   DT ++ A K + K++++          E  IM  L        IV
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 60

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIH 175
            +  A    + +  +++L  GG+L   +   G ++E         I+  ++  H   V++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--YGPE 233
           RDLKP N L     E+  ++  D GL+  F   +  +  VG+  YMAPEVL++   Y   
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSS 176

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKSLVRQML 292
            D +S G +L+ LL G  PF     +     I R  +    +  P+  S   +SL+  +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVE-LPDSFSPELRSLLEGLL 234

Query: 293 EPDPKLRL-----TAKQVLEHPWLQN 313
           + D   RL      A++V EHP+ ++
Sbjct: 235 QRDVNRRLGCLGRGAQEVKEHPFFRS 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 74/268 (27%), Positives = 119/268 (44%), Gaps = 29/268 (10%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKNS 112
             +G G  G  Y  I R T  L A K I           D VR    RE+ I++ +  + 
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH------EDTVRRQICREIEILRDV-NHP 132

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           ++V   +  + +  + +++E  +GG L    +A     E+  A V R I+  +   H+  
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILSGIAYLHRRH 188

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRNY- 230
           ++HRD+KP N L  + K    +K  DFG+S I  +  +  +  VG+  YM+PE +  +  
Sbjct: 189 IVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLN 245

Query: 231 -----GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP--NVSES 283
                G   DIWS GV +     G  PF     QG   A L   I   + P      S  
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQG-DWASLMCAICMSQPPEAPATASRE 303

Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            +  +   L+ +P  R +A Q+L+HP++
Sbjct: 304 FRHFISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 81.1 bits (200), Expect = 3e-17
 Identities = 82/309 (26%), Positives = 140/309 (45%), Gaps = 47/309 (15%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY   +++G G +G     ID+ T E +A K +S R  ++ +      RE+ ++KH+
Sbjct: 13  LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKHM 71

Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTI 161
            ++ +++ L +      + ++    +LVM   +     D     GH  +E     +   +
Sbjct: 72  -QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQM 126

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           +  ++  H  G+IHRDLKP N L  N  E+  LK +DFGL+         +  V + +Y 
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGN-LAVN--EDCELKILDFGLA--RHADAEMTGYVVTRWYR 181

Query: 222 APEVLKR--NYGPEIDIWSAGVILYILLCGV-----------------------PPFWAE 256
           APEV+    +Y   +DIWS G I+  +L G                        P F  +
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241

Query: 257 SEQGVAQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            E   A++ ++ L  + R      +P  S  A  L+ +MLE D   RLTA + LEHP+  
Sbjct: 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301

Query: 313 NAKKAPNVP 321
           + + A    
Sbjct: 302 SFRDADEET 310

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 79.3 bits (195), Expect = 6e-17
 Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 29/279 (10%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           + + N +  Y + + +G G +G  Y   +  T EL A K I   KL    D   +++E+ 
Sbjct: 2   ILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIF 58

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           ++K   K+ +IV+   +      + + ME C GG L D     G  +E   A V R  ++
Sbjct: 59  MVKEC-KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ 117

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYM 221
            +   H  G +HRD+K  N L     +N  +K  DFG++  I     +R S  +G+PY+M
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKS-FIGTPYWM 173

Query: 222 APEV--LKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           APEV  +++N  Y    DIW+ G+    L    PP +           +R L    +  +
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP-------MRALFLMSKSNF 226

Query: 278 --PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEH 308
             P + +  K      + V+  L  +PK R TA+++L H
Sbjct: 227 QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 79.3 bits (196), Expect = 8e-17
 Identities = 76/278 (27%), Positives = 114/278 (41%), Gaps = 45/278 (16%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSI--------SKRKLRTAVDIDDVRREVAIMKHLP 109
           E+G G  G  Y    + T  ++A K +        +KR L    D+D     V +  H  
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILM---DLD-----VVLKSHDC 73

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQ- 166
               IV        D+ V + MEL       D+++ R  G   E     +T  IV+ +  
Sbjct: 74  PY--IVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHY 129

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
           L  KHGVIHRD+KP N L      +  +K  DFG+S      +  +   G   YMAPE +
Sbjct: 130 LKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERI 186

Query: 227 -----KRNYGPEIDIWSAGVILYILLCGVPPF-WAESEQGVAQAILRGLIDFKRDPWP-- 278
                   Y    D+WS G+ L  L  G  P+   ++E  V   IL       ++  P  
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL-------QEEPPSL 239

Query: 279 ----NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                 S    S V   L  D + R   +++L+HP+++
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 79.3 bits (195), Expect = 8e-17
 Identities = 73/285 (25%), Positives = 124/285 (43%), Gaps = 38/285 (13%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD-VRREVAIMKHLP 109
           D + +   +G+G +G  Y   ++    L A K      L    D+D+ +  E  I++ LP
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKI-----LDPISDVDEEIEAEYNILQSLP 76

Query: 110 KNSSIVSL-----KEACEDDNAVHLVMELCEGG---ELFDRIVARGHYTERAAAA-VTRT 160
            + ++V       K        + LV+ELC GG   EL   ++  G   + A  + +   
Sbjct: 77  NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPY 219
            +  +Q  H + +IHRD+K  N L   +     +K +DFG+S        R +  VG+P+
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPF 193

Query: 220 YMAPEVL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK 273
           +MAPEV+        +Y    D+WS G+    L  G PP +           ++ L    
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------VKTLFKIP 246

Query: 274 RDPWPNV------SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           R+P P +        S    + Q L  D + R +   +LEHP+++
Sbjct: 247 RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 80.7 bits (199), Expect = 9e-17
 Identities = 88/312 (28%), Positives = 140/312 (44%), Gaps = 44/312 (14%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTR-ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +Y + R LG G  G T LC  R +  E  A K +    + +  D +  + EV  + +   
Sbjct: 33  KYWISRVLGSGATG-TVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNC-D 89

Query: 111 NSSIVSLKE--ACEDDN------AVHLVMELCEGGELFDRIVARGH----YTERAAAAVT 158
             SIV   E  A +D         + LV++    G+L   I +R      + E  A  + 
Sbjct: 90  FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149

Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP------GERFS 212
             ++  V   H   +IHRD+K  N L  +   N  +K  DFG S  +        G  F 
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTF- 205

Query: 213 EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID 271
              G+PYY+APE+ +R  Y  + D++S GV+LY LL    PF  E+ + V    L G   
Sbjct: 206 --CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG--- 260

Query: 272 FKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEHP--------WLQNAKKAP--NV 320
            + DP P ++S   + +V  +L  DPK R ++ ++L  P         L+  +  P  + 
Sbjct: 261 -RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSG 319

Query: 321 PLGDVVRSRLKQ 332
           PL D +  +++Q
Sbjct: 320 PLRDTISRQIQQ 331

Length = 496

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 78.9 bits (194), Expect = 9e-17
 Identities = 73/295 (24%), Positives = 122/295 (41%), Gaps = 59/295 (20%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMKHLPKNSS 113
           +LG G +   +    + T  L+A K I          TA+      REV+++K+L K+++
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI------REVSLLKNL-KHAN 64

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV--------V 165
           IV+L +    +  + LV E  +             Y +     ++   V++        +
Sbjct: 65  IVTLHDIIHTERCLTLVFEYLDSD--------LKQYLDNCGNLMSMHNVKIFMFQLLRGL 116

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPE 224
             CHK  ++HRDLKP+N L   K E   LK  DFGL+     P + +S  V + +Y  P+
Sbjct: 117 SYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173

Query: 225 VL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           VL     Y   ID+W  G ILY +  G P F   + +     I R L     + WP ++ 
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233

Query: 283 SAK--------------------------SLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + +                           L+  +L  + K R++A+  L H + 
Sbjct: 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 74/302 (24%), Positives = 138/302 (45%), Gaps = 50/302 (16%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + DRY   +++G G +G     +DR T   +A K +  R  ++ +      RE+ ++KH+
Sbjct: 13  VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHM 71

Query: 109 PKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L        + +  +  +LVM     G    +++     +E     +   ++
Sbjct: 72  -KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG---SPY 219
           + ++  H  G+IHRDLKP N       E+  LK +DFGL+      +  SE+ G   + +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLA-----RQTDSEMTGYVVTRW 180

Query: 220 YMAPEVLKR--NYGPEIDIWSAGVILYILLCGVP-----------------------PFW 254
           Y APEV+    +Y   +DIWS G I+  +L G P                        F 
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240

Query: 255 AESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
            + +   A+  ++ L  F++  +    PN +  A +++ +ML  D + R+TA + L HP+
Sbjct: 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300

Query: 311 LQ 312
            +
Sbjct: 301 FE 302

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 67/246 (27%), Positives = 112/246 (45%), Gaps = 33/246 (13%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMK 106
           + Y+   +LG G +   +    + T  L+A K I          TA+      REV+++K
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI------REVSLLK 59

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV-- 164
            L K+++IV+L +    D ++ LV E        D+ + +  Y +     ++   V++  
Sbjct: 60  DL-KHANIVTLHDIVHTDKSLTLVFEY------LDKDLKQ--YMDDCGNIMSMHNVKIFL 110

Query: 165 ------VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGS 217
                 +  CH+  V+HRDLKP+N L   + E   LK  DFGL+     P + +S  V +
Sbjct: 111 YQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVT 167

Query: 218 PYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
            +Y  P+VL     Y  +ID+W  G I + +  G P F   + +     I R L     +
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227

Query: 276 PWPNVS 281
            WP +S
Sbjct: 228 TWPGIS 233

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 80/315 (25%), Positives = 129/315 (40%), Gaps = 52/315 (16%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 15  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 73

Query: 109 PKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L        + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 74  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 130

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 185

Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           PE++    +Y   +DIWS G I+  LL G   F         + ILR        P   +
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR----LVGTPGAEL 241

Query: 281 -----SESAKS--------------------------LVRQMLEPDPKLRLTAKQVLEHP 309
                SESA++                          L+ +ML  D   R+TA Q L H 
Sbjct: 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301

Query: 310 WLQNAKKAPNVPLGD 324
           +        + P+ D
Sbjct: 302 YFAQYHDPDDEPVAD 316

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 38/284 (13%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD-VRREVAIMKHLP 109
           D + +   +G+G +G  +  +++      A K      L    DID+ +  E  I+K L 
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKI-----LDPIHDIDEEIEAEYNILKALS 72

Query: 110 KNSSIVSL-----KEACEDDNAVHLVMELCEGGELFDRI---VARG-HYTERAAAAVTRT 160
            + ++V       K+  ++ + + LV+ELC GG + D +   + RG    E   A +   
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPY 219
            +  +Q  H +  IHRD+K  N L   +     +K +DFG+S        R +  VG+P+
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189

Query: 220 YMAPEV------LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK 273
           +MAPEV      L   Y    D+WS G+    L  G PP  A+         +R L    
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP------MRALFKIP 242

Query: 274 RDPWPNV------SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           R+P P +      S      +R+ L  D + R T   +L+H ++
Sbjct: 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 77/306 (25%), Positives = 136/306 (44%), Gaps = 65/306 (21%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMK 106
           + Y+   +LG G +   Y    + T  L+A K I          TA+      REV+++K
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI------REVSLLK 59

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV-- 164
            L K+++IV+L +    + ++ LV E        D+ + +  Y +    ++    V++  
Sbjct: 60  DL-KHANIVTLHDIIHTEKSLTLVFEY------LDKDLKQ--YLDDCGNSINMHNVKLFL 110

Query: 165 ------VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL----SIFFKPGERFSEI 214
                 +  CH+  V+HRDLKP+N L   + E   LK  DFGL    SI   P + +S  
Sbjct: 111 FQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSI---PTKTYSNE 164

Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF 272
           V + +Y  P++L    +Y  +ID+W  G I Y +  G P F   + +     I R L   
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP 224

Query: 273 KRDPWPNV--SESAKS------------------------LVRQMLEPDPKLRLTAKQVL 306
             + WP +  +E  KS                        L+ ++L+ + + R++A++ +
Sbjct: 225 TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284

Query: 307 EHPWLQ 312
           +HP+  
Sbjct: 285 KHPYFH 290

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 77.3 bits (190), Expect = 4e-16
 Identities = 85/300 (28%), Positives = 121/300 (40%), Gaps = 56/300 (18%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMKHL 108
           YL   +LG G +   Y  I R   +L+A K IS +       TA+      RE +++K L
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI------REASLLKGL 60

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            K+++IV L +       +  V E          I   G             ++  +   
Sbjct: 61  -KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGL----SIFFKPGERFSEIVGSPYYMAPE 224
           H   ++HRDLKP+N L +   E   LK  DFGL    SI   P + +S  V + +Y  P+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSI---PSQTYSSEVVTLWYRPPD 173

Query: 225 VL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES---EQGVAQAILRGLIDFKRDPWPN 279
           VL    +Y   +DIW AG I   +L G P F   S   EQ   + I   L     D WP 
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ--LEKIWTVLGVPTEDTWPG 231

Query: 280 VSE----------------------------SAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           VS+                             A+ L  QML   PK R++A+  L HP+ 
Sbjct: 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 76.6 bits (188), Expect = 6e-16
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 16/264 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS---IV 115
           +GRG FG  Y C   DT ++ A K + K++++     + +     IM  L        IV
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIH 175
            +  A    + +  +++L  GG+L   +   G ++E+        I+  ++  H   V++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--YGPE 233
           RDLKP N L     E+  ++  D GL+  F   +  +  VG+  YMAPEVL++   Y   
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
            D +S G +L+ LL G  PF     +     I R  +    +   + S   KSL+  +L+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235

Query: 294 PDPKLRL-----TAKQVLEHPWLQ 312
            D   RL      A++V EH + +
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.1 bits (190), Expect = 9e-16
 Identities = 85/297 (28%), Positives = 128/297 (43%), Gaps = 49/297 (16%)

Query: 56  DRELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIM---KHLPKN 111
           DR +G G FGV +   D RD + + A K +     +  V    V RE+ ++   KH    
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRV-ALKKMPN-VFQNLVSCKRVFRELKMLCFFKHDNVL 62

Query: 112 SSIVSLKEACEDD-NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           S++  L+    D    +++V EL +  +L   IV+    +          I+  ++  H 
Sbjct: 63  SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGSPYYMAPEVL-- 226
            G++HRD+KP N L  +   N  LK  DFGL+   +P E    ++ V + YY APE+L  
Sbjct: 122 AGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178

Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-----------------------QGVAQ 263
            R+Y   +DIWS G I   LL     F A+S                        +G   
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238

Query: 264 AILRGLIDFKRDPWPNV--------SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            ILRG     + P   V        +  A  L+ +ML  DP  R++A   L HP+L 
Sbjct: 239 HILRGP---HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 17/209 (8%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D   R+ +A K +S R  ++ +      RE+ ++KH+
Sbjct: 13  VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHM 71

Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     ++     +   ++
Sbjct: 72  -KHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLL 128

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H  G+IHRDLKP N       E+  L+ +DFGL+   +  +  +  V + +Y A
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLA--RQADDEMTGYVATRWYRA 183

Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCG 249
           PE++    +Y   +DIWS G I+  LL G
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 76.1 bits (187), Expect = 4e-15
 Identities = 43/108 (39%), Positives = 63/108 (58%), Gaps = 15/108 (13%)

Query: 208 GERFSEIVGSPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
           GER   I+G+P Y+APE+L  + +GP +D W+ GV L+  L G+PPF  E+ Q V Q IL
Sbjct: 537 GER---ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNIL 593

Query: 267 RGLIDFKRD-PWPN----VSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
                  RD PWP     +S +A++ +  +L  DP  R   K++ +HP
Sbjct: 594 ------NRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 73.8 bits (181), Expect = 5e-15
 Identities = 82/289 (28%), Positives = 122/289 (42%), Gaps = 49/289 (16%)

Query: 52  RYL-VDRELGRGEFG-VTYLCID---RDTRELLACKSISK---RKLRTAVDIDDVRREVA 103
           RYL   R LG G FG V+  C D     T E++A K++ +   ++  +       ++E+ 
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGW-----KKEIN 58

Query: 104 IMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           I+K L  + +IV  K  C +     + L+ME    G L D       Y  +    + + +
Sbjct: 59  ILKTL-YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLL 110

Query: 162 VEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFS 212
           +   Q+C      H    IHRDL   N L  N +    +K  DFGL+     G    R  
Sbjct: 111 LFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHEYYRVR 167

Query: 213 EIVGSP-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV-----PPFWAESEQGVAQAI 265
           E   SP ++ A E LK N +    D+WS GV LY LL        PP   E   G  Q  
Sbjct: 168 EDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ 227

Query: 266 LR--GLIDF----KRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +    LI+      R P P N  +    L++   E + K R T + ++ 
Sbjct: 228 MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 75.3 bits (185), Expect = 7e-15
 Identities = 50/154 (32%), Positives = 79/154 (51%), Gaps = 5/154 (3%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           IE+  +V + + RG FG  YL   ++  +L A K + K  +     +  V+ E   +  L
Sbjct: 3   IEEFVIV-KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-L 60

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            K+  IV L  + +  N V+LVME   GG++   +   G++ E  A      +   +   
Sbjct: 61  SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYL 120

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
           H+HG+IHRDLKP+N L +N+     +K  DFGLS
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGH---IKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 69/272 (25%), Positives = 108/272 (39%), Gaps = 44/272 (16%)

Query: 59  LGRGEFGVTY----LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           LG G FG  Y      I       +     + RK  T  +  +  +E  +M +   + +I
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR----TIVEVVQLC-- 168
           V L   C  +   +++MEL EGG+L         Y   A          T+ E++ +C  
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLL-------SYLRDARVERFGPPLLTLKELLDICLD 114

Query: 169 --------HKHGVIHRDLKPENFLFANKKENSP--LKAIDFGLS-------IFFKPGERF 211
                    +   IHRDL   N L + K  ++   +K  DFGL+        + K GE  
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 212 SEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL 269
             +     +MAPE L    +  + D+WS GV+++ IL  G  P+ A + Q V Q +  G 
Sbjct: 175 LPV----RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG- 229

Query: 270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT 301
              +     N  +    L+      DP  R T
Sbjct: 230 --GRLQKPENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 29/216 (13%)

Query: 50  EDRYLVD-RELGRGEFGVTYLC---IDRD-TRELLACKSISKRKLRTAVDIDDVRREVAI 104
           E R+L   ++LG G FG   LC      D T E +A KS+            D  RE+ I
Sbjct: 2   EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEI 59

Query: 105 MKHLPKNSSIVSLKEACEDD--NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++ L  + +IV  K  CE     ++ L+ME    G L  R   + H   R    + R ++
Sbjct: 60  LRTL-DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRH---RDQINLKRLLL 113

Query: 163 EVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSE 213
              Q+C           IHRDL   N L  ++     +K  DFGL+      +      E
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDL---VKISDFGLAKVLPEDKDYYYVKE 170

Query: 214 IVGSP-YYMAPEVLK-RNYGPEIDIWSAGVILYILL 247
              SP ++ APE L+   +    D+WS GV LY L 
Sbjct: 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 72.8 bits (178), Expect = 4e-14
 Identities = 73/252 (28%), Positives = 113/252 (44%), Gaps = 33/252 (13%)

Query: 22  SHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLAC 81
           SH++   E    +K     +   P ++    Y +   +G G FGV Y  I  DT E +A 
Sbjct: 41  SHNNNAGEDEDEEKMIDNDINRSPNKS----YKLGNIIGNGSFGVVYEAICIDTSEKVAI 96

Query: 82  KSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE----ACEDDNAVHLVMELCEGG 137
           K + +       D     RE+ IMK+L  + +I+ LK+     C   N  ++ + +    
Sbjct: 97  KKVLQ-------DPQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIFLNVVM-- 146

Query: 138 ELFDRIVAR--GHYTERAAAAVTRTIVEVV--QLC------HKHGVIHRDLKPENFLFAN 187
           E   + V +   HY  R   A+   +V++   QLC      H   + HRDLKP+N L   
Sbjct: 147 EFIPQTVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP 205

Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
                 LK  DFG +     G+R    + S +Y APE++    NY   ID+WS G I+  
Sbjct: 206 NTHT--LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAE 263

Query: 246 LLCGVPPFWAES 257
           ++ G P F  +S
Sbjct: 264 MILGYPIFSGQS 275

Length = 440

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 70.0 bits (171), Expect = 8e-14
 Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 15/192 (7%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           E+G G+FG+ +L    + R+ +A K+I +     A+  +D   E  +M  L     +V L
Sbjct: 11  EIGSGQFGLVWLGYWLEKRK-VAIKTIRE----GAMSEEDFIEEAQVMMKLSHP-KLVQL 64

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
              C + + + LV E  E G L D + A RG +++     +   + E +       VIHR
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLK-RNYGP 232
           DL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV     Y  
Sbjct: 125 DLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 233 EIDIWSAGVILY 244
           + D+WS GV+++
Sbjct: 181 KSDVWSFGVLMW 192

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 9e-14
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 16/220 (7%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +ELG G+FGV +L   R   + +A K I +     A+  DD   E  +M  L  + ++V 
Sbjct: 10  KELGSGQFGVVHLGKWRGKID-VAIKMIRE----GAMSEDDFIEEAKVMMKL-SHPNLVQ 63

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRTIVEVVQLCHKHGVIH 175
           L   C     + +V E    G L + +  R           +   + E ++    +G IH
Sbjct: 64  LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH 123

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN-YG 231
           RDL   N L     E++ +K  DFGL+ +    +  S   G+ +   +  PEV   + + 
Sbjct: 124 RDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFS 179

Query: 232 PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI 270
            + D+WS GV+++ +   G  P+   S   V +++  G  
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR 219

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 82/296 (27%), Positives = 129/296 (43%), Gaps = 57/296 (19%)

Query: 50  EDRYLVD-RELGRGEFGVTYLCI-----DRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           E R+L   R+LG G FG   LC      D  T E +A KS+          I D+++E+ 
Sbjct: 2   EKRFLKRIRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPES--GGNHIADLKKEIE 58

Query: 104 IMKHLPKNSSIVSLKEACEDD--NAVHLVMELCEGGELFDRIVARGHYTERAAAAVT--R 159
           I+++L  + +IV  K  C +D  N + L+ME    G L +       Y  R    +   +
Sbjct: 59  ILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-------YLPRNKNKINLKQ 110

Query: 160 TIVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
            +   VQ+C           +HRDL   N L  ++ +   +K  DFGL+   +  + +  
Sbjct: 111 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEYYT 167

Query: 214 I---VGSP-YYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESE---------- 258
           +   + SP ++ APE L +  +    D+WS GV LY LL      + +SE          
Sbjct: 168 VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT-----YCDSESSPMTLFLKM 222

Query: 259 ------QGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                 Q     ++R L + KR P P N  E    L+R+  E  P  R T + ++E
Sbjct: 223 IGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 69/287 (24%), Positives = 125/287 (43%), Gaps = 39/287 (13%)

Query: 58  ELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSI 114
           E+G G +G  +   D ++    +A K +  +     + +  +R EVA+++HL   ++ ++
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNV 66

Query: 115 VSLKEAC-----EDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           V L + C     + +  + LV E  +       D++   G  TE     + + ++  +  
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 125

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-L 226
            H H V+HRDLKP+N L  +  +   +K  DFGL+  +      + +V + +Y APEV L
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182

Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN------- 279
           + +Y   +D+WS G I   +    P F   S+      IL  +     + WP        
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 242

Query: 280 ----------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                           + E  K L+ + L  +P  R++A   L HP+
Sbjct: 243 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 77/298 (25%), Positives = 117/298 (39%), Gaps = 60/298 (20%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSI----------SKRKLRTAVDIDDVRRE 101
           RY + R +G+G  G  YL  D      +A K I           KR LR A       + 
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREA-------KI 55

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--------RIVARGHYTERA 153
            A + H      IV +   C D + V+  M   EG  L            +++    + +
Sbjct: 56  AADLIH----PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTS 111

Query: 154 AAAVTR---TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK---- 206
             A       I   ++  H  GV+HRDLKP+N L     E   +  +D+G +IF K    
Sbjct: 112 VGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE---VVILDWGAAIFKKLEEE 168

Query: 207 ---------PGERFSE------IVGSPYYMAPEVLKRNYGPE-IDIWSAGVILYILLCGV 250
                        +S       IVG+P YMAPE L      E  DI++ GVILY +L   
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228

Query: 251 PPFWAESEQGVAQAILRGLIDFKRD--PWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            P+  +  + ++    R +I    +  P+  +      +  + L  DP  R ++ Q L
Sbjct: 229 FPYRRKKGRKIS---YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 68.6 bits (167), Expect = 6e-13
 Identities = 82/305 (26%), Positives = 130/305 (42%), Gaps = 53/305 (17%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 75

Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      +++ E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 133

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 134 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189

Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++  + L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309

Query: 307 EHPWL 311
           +HP++
Sbjct: 310 QHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.5 bits (170), Expect = 8e-13
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 20/223 (8%)

Query: 99  RREVAIMKHLPKNSSIVSLKEACE-DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           RRE A+   L  + +IV+L ++ E     +  V E   G  L + + A G         +
Sbjct: 26  RRETALCARL-YHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRL 84

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG--------- 208
              +++ +   H  G++HRDLKP+N + +        K +DFG+     PG         
Sbjct: 85  MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDADVATL 143

Query: 209 ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR 267
            R +E++G+P Y APE L+     P  D+++ G+I    L G       S   VA+ + +
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS---VAEILYQ 200

Query: 268 GL--IDFKRDPWPNVSESAKSLVRQMLEPDPKLR-LTAKQVLE 307
            L  +D    PW         ++R+ L  DP+ R  +A  + E
Sbjct: 201 QLSPVDVSLPPWIA-GHPLGQVLRKALNKDPRQRAASAPALAE 242

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 67/326 (20%), Positives = 127/326 (38%), Gaps = 65/326 (19%)

Query: 54  LVDRELGRGEFGVT--YLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIMKHL 108
            +   +G+    +   +L   + T  L+A K I+   L +    +D++    E+   + L
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN---LDSCSK-EDLKLLQQEIITSRQL 56

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT----ERAAAAVTRTIVEV 164
            ++ +I+    +   D+ +++V  L   G   D +  + H+     E A A + + ++  
Sbjct: 57  -QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNA 113

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI---FFKPGERFSEIVGSP--- 218
           +   H  G IHR +K  + L +        K +  GL       K G+R   +   P   
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDG-----KVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168

Query: 219 ----YYMAPEVLKRN---YGPEIDIWSAGVILYILLCGVPPF------------------ 253
                +++PEVL++N   Y  + DI+S G+    L  G  PF                  
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVP 228

Query: 254 -------WAESEQGVAQAILRGLIDFKRDPWPNV-----SESAKSLVRQMLEPDPKLRLT 301
                  +   E  ++Q+         RD   +      SE     V   L+ DP+ R +
Sbjct: 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288

Query: 302 AKQVLEHPWLQNAKKAPNVPLGDVVR 327
           A Q+L H + +  K+     L D+++
Sbjct: 289 ASQLLNHSFFKQCKRRNTS-LLDLLK 313

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 77/306 (25%), Positives = 130/306 (42%), Gaps = 55/306 (17%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ ++K +  +
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCV-NH 79

Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      +++ E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIK 137

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 138 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193

Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPF--------WAESEQGVA----------QAIL 266
            L   Y   +DIWS G I+  L+ G   F        W +  + +           Q  +
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253

Query: 267 RGLIDFKRDPWPNVS---------------------ESAKSLVRQMLEPDPKLRLTAKQV 305
           R  ++  R  +P +S                       A+ L+ +ML  DP  R++  + 
Sbjct: 254 RNYVE-NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312

Query: 306 LEHPWL 311
           L HP++
Sbjct: 313 LRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 21/231 (9%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 12  ELGAGNGGVVFKVSHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 68

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L  KH ++HR
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 128

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVLK-RNYG 231
           D+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+PE L+  +Y 
Sbjct: 129 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYS 180

Query: 232 PEIDIWSAGVILYILLCG----VPPFWAESEQGVAQAILRGLIDFKRDPWP 278
            + DIWS G+ L  +  G     PP   E E      +     + +  P P
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82

Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196

Query: 226 -LKRNYGPEIDIWSAGVILYILLCG 249
            L   Y   +DIWS G I+  ++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 16/218 (7%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +ELG G+FGV +L   R   + +A K+I++     A+  +D   E  +M  L  +  +V 
Sbjct: 10  KELGSGQFGVVHLGKWRAQIK-VAIKAINE----GAMSEEDFIEEAKVMMKL-SHPKLVQ 63

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIH 175
           L   C     +++V E  E G L + +  R G  ++    ++ + + E ++   ++  IH
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN-YG 231
           RDL   N L +       +K  DFG++ +    E  S   G+ +   +  PEV   + Y 
Sbjct: 124 RDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNFSKYS 179

Query: 232 PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + D+WS GV+++ +   G  PF  +S   V + I RG
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG 217

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 84/313 (26%), Positives = 132/313 (42%), Gaps = 68/313 (21%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D  T + +A K +S R  +         RE+ +MK L  +
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLS-RPFQNVTHAKRAYRELVLMK-LVNH 74

Query: 112 SSIVSL------KEACEDDNAVHLVME-----LCEGGELFDRIVARGHYTERAAAAVTRT 160
            +I+ L      +++ E+   V+LVME     LC+       ++      ER +  + + 
Sbjct: 75  KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQ-------VIQMDLDHERMSYLLYQM 127

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGSP 218
           +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+     G  F  +  V + 
Sbjct: 128 LCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA--RTAGTSFMMTPYVVTR 181

Query: 219 YYMAPEV-LKRNYGPEIDIWSAGVIL---------------------YILLCGVPP--FW 254
           YY APEV L   Y   +DIWS G I+                      I   G P   F 
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241

Query: 255 AESEQGVAQAIL-----RGL-ID--FKRDPWPNVSES--------AKSLVRQMLEPDPKL 298
           +  +  V   +       G   +  F    +P  SES        A+ L+ +ML  DP+ 
Sbjct: 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301

Query: 299 RLTAKQVLEHPWL 311
           R++    L+HP++
Sbjct: 302 RISVDDALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 71/280 (25%), Positives = 119/280 (42%), Gaps = 39/280 (13%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSI-----SKRKLRTAVDIDDVRREVAIMKHLPKN 111
            ELGRG +GV        T  ++A K I     S+ + R  +D+D   R V      P  
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV----DCPY- 61

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARG-HYTERAAAAVTRTIVEVVQLC 168
              V+   A   +  V + ME+ +    + + ++  +G    E     +  +IV+ ++  
Sbjct: 62  --TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119

Query: 169 H-KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           H K  VIHRD+KP N L  N+     +K  DFG+S +       +   G   YMAPE + 
Sbjct: 120 HSKLSVIHRDVKPSNVL-INRNGQ--VKLCDFGISGYLVDSVAKTIDAGCKPYMAPERIN 176

Query: 227 ----KRNYGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFKRDPWPNV 280
               ++ Y  + D+WS G+ +  L  G  P+  W    Q + Q +         +P P +
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------EEPSPQL 228

Query: 281 SESAKSL-----VRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
                S      V + L+ + K R    ++L+HP+ +   
Sbjct: 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 64/260 (24%), Positives = 105/260 (40%), Gaps = 60/260 (23%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY-----LCIDRDTRELLACKSISKR---KLRTAVDI 95
           +P   +  R+L   ELG G FG  Y        +R +   +A K++ +    K++     
Sbjct: 2   IPLSAV--RFL--EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ----- 52

Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA 155
            + R+E  +M  L ++ +IV L   C  +    ++ E    G+L + +V    +++  A 
Sbjct: 53  QEFRQEAELMSDL-QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111

Query: 156 AVTRT----------------IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF 199
           +   T                I   ++    H  +HRDL   N L         +K  DF
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT---VKISDF 168

Query: 200 GLSIFFKPGERFSEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-I 245
           GLS          +I  + YY            M PE +L   +  E DIWS GV+L+ I
Sbjct: 169 GLS---------RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Query: 246 LLCGVPPFWAESEQGVAQAI 265
              G+ P++  S Q V + I
Sbjct: 220 FSYGLQPYYGFSNQEVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 72/267 (26%), Positives = 119/267 (44%), Gaps = 33/267 (12%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS--IVS 116
           LG G  G  Y      TR +LA K I    L   V++   ++ ++ ++ L K  S  I+ 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIP---LDITVELQ--KQIMSELEILYKCDSPYIIG 63

Query: 117 LKEACEDDNAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
              A   +N + +  E  +GG L  + +I    H   R A AV + +  +  L     ++
Sbjct: 64  FYGAFFVENRISICTEFMDGGSLDVYRKIPE--HVLGRIAVAVVKGLTYLWSL----KIL 117

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPE-VLKRN 229
           HRD+KP N L   + +   +K  DFG+S      +  + I    VG+  YMAPE +    
Sbjct: 118 HRDVKPSNMLVNTRGQ---VKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGEQ 169

Query: 230 YGPEIDIWSAGVILYILLCGVPPF-WAESEQG--VAQAILRGLIDFK--RDPWPNVSESA 284
           YG   D+WS G+    L  G  P+   +  QG  +   +L+ ++D      P    SE  
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              + Q +   PK R   + +++HP++
Sbjct: 230 VHFITQCMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 53/188 (28%), Positives = 92/188 (48%), Gaps = 21/188 (11%)

Query: 62  GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC 121
           G  G  + CID  T E +  K+  +    T         E  I++ +  + SI+ LK   
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKAGQRGGTAT---------EAHILRAI-NHPSIIQLKGTF 152

Query: 122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPE 181
             +    L++   +  +L+  + A+ +       A+ R+++  +Q  H++ +IHRD+K E
Sbjct: 153 TYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAE 211

Query: 182 NFLFANKKENSPLKAIDFGLSIFFKP----GERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           N +F N   +  L   DFG + F  P      ++    G+    APE+L R+ YGP +DI
Sbjct: 212 N-IFINHPGDVCLG--DFGAACF--PVDINANKYYGWAGTIATNAPELLARDPYGPAVDI 266

Query: 237 WSAGVILY 244
           WSAG++L+
Sbjct: 267 WSAGIVLF 274

Length = 391

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 67/274 (24%), Positives = 112/274 (40%), Gaps = 32/274 (11%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKNSSI 114
           E+GRG FG     + + +  ++A K I     R+ VD  + +R   ++ ++        I
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRI-----RSTVDEKEQKRLLMDLDVVMRSSDCPYI 65

Query: 115 VSLKEACEDDNAVHLVMELCEGG-ELFDRIV---ARGHYTERAAAAVTRTIVEVVQ-LCH 169
           V    A   +    + MEL +   + F + V    +    E     +    V+ +  L  
Sbjct: 66  VKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPE 224
           +  +IHRD+KP N L  ++  N  +K  DFG+S     G+    I      G   YMAPE
Sbjct: 126 ELKIIHRDVKPSNILL-DRNGN--IKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPE 177

Query: 225 VLKRN----YGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFKRDPWP 278
            +  +    Y    D+WS G+ LY +  G  P+  W      + Q +             
Sbjct: 178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237

Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             S S  + +   L  D   R   K++LEHP+++
Sbjct: 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 63.2 bits (153), Expect = 3e-11
 Identities = 71/316 (22%), Positives = 128/316 (40%), Gaps = 68/316 (21%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++GRG +G  Y    +D ++    +  + +++          RE+A+++ L K+ +++SL
Sbjct: 8   KVGRGTYGHVYKAKRKDGKD---DRDYALKQIEGTGISMSACREIALLREL-KHPNVISL 63

Query: 118 KEA--CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR--------TIVEVVQL 167
           ++      D  V L+ +  E          R     +    + R         I++ +  
Sbjct: 64  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 168 CHKHGVIHRDLKPENFLFANK-KENSPLKAIDFGLSIFF----KPGERFSEIVGSPYYMA 222
            H + V+HRDLKP N L   +  E   +K  D G +  F    KP      +V + +Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF--------------------------- 253
           PE+L   R+Y   IDIW+ G I   LL   P F                           
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243

Query: 254 -----WAESEQGVAQAILRGLIDFKRDPWPNVS-------------ESAKSLVRQMLEPD 295
                W + ++    + L  + DF+R+ + N S               A  L++++L  D
Sbjct: 244 PADKDWEDIKKMPEHSTL--MKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 301

Query: 296 PKLRLTAKQVLEHPWL 311
           P  R+T++Q ++ P+ 
Sbjct: 302 PIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 58/255 (22%), Positives = 112/255 (43%), Gaps = 19/255 (7%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           +LG G++G  Y  + +     +A K++ +  +     +++  +E A+MK + K+ ++V L
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEI-KHPNLVQL 67

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRTIVEVVQLCHKHGVIH 175
              C  +   +++ E    G L D +         A   +     I   ++   K   IH
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN-YG 231
           RDL   N L     EN  +K  DFGLS     G+ ++   G+ +   + APE L  N + 
Sbjct: 128 RDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 183

Query: 232 PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
            + D+W+ GV+L+ I   G+ P+       V + + +G   ++ +           L+R 
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG---YRMERPEGCPPKVYELMRA 240

Query: 291 MLEPDPKLRLTAKQV 305
             + +P  R +  ++
Sbjct: 241 CWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.8 bits (152), Expect = 4e-11
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 20/204 (9%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV      + +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 68

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +       E     V+  ++  +  L  KH ++HR
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 128

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVLK-RNYG 231
           D+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+PE L+  +Y 
Sbjct: 129 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYS 180

Query: 232 PEIDIWSAGVILYILLCG---VPP 252
            + DIWS G+ L  L  G   +PP
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 81/305 (26%), Positives = 132/305 (43%), Gaps = 61/305 (20%)

Query: 54  LVDRELGRGEFGVTYL------CIDRDTRELLACKSISKRKLRTAVD--IDDVRREVAIM 105
           ++ RELG G FG  +L      C ++D + L+A K+     L+ A D    D  RE  ++
Sbjct: 8   VLKRELGEGAFGKVFLAECYNLCPEQD-KILVAVKT-----LKDASDNARKDFHREAELL 61

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-------------HYTER 152
            +L ++  IV     C + + + +V E  + G+L   + A G               T+ 
Sbjct: 62  TNL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120

Query: 153 AAAAVTRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
               + + I   +V L  +H  +HRDL   N L     EN  +K  DFG+S         
Sbjct: 121 QMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVG---ENLLVKIGDFGMS--------- 167

Query: 212 SEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
            ++  + YY            M PE ++ R +  E D+WS GV+L+ I   G  P++  S
Sbjct: 168 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227

Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA 317
              V + I +G +  +    P   +    L+    + +P +RL  K++  H  LQN  KA
Sbjct: 228 NNEVIECITQGRVLQRPRTCP---KEVYDLMLGCWQREPHMRLNIKEI--HSLLQNLAKA 282

Query: 318 PNVPL 322
             V L
Sbjct: 283 SPVYL 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 61.6 bits (149), Expect = 8e-11
 Identities = 75/304 (24%), Positives = 121/304 (39%), Gaps = 56/304 (18%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMK 106
           D Y    +LG G +   Y    +   +L+A K I  ++      TA+      RE +++K
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI------REASLLK 58

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVME-----LCEGGELFDRIVARGHYTERAAAAVTRTI 161
            L K+++IV L +       + LV E     LC+     D+    G             +
Sbjct: 59  GL-KHANIVLLHDIIHTKETLTLVFEYVHTDLCQ---YMDK--HPGGLHPENVKLFLFQL 112

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYY 220
           +  +   H+  ++HRDLKP+N L ++  E   LK  DFGL+     P   +S  V + +Y
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWY 169

Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGLIDFKRDPW 277
             P+VL     Y   +D+W  G I   ++ GV  F    + Q   + I   L     D W
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229

Query: 278 PNVSE----------------------------SAKSLVRQMLEPDPKLRLTAKQVLEHP 309
           P V                               A+ L  ++L+  PK RL+A+  L H 
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289

Query: 310 WLQN 313
           +  +
Sbjct: 290 YFSD 293

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)

Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNID 191

Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251

Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 252 LKEG---HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 77/299 (25%), Positives = 117/299 (39%), Gaps = 66/299 (22%)

Query: 51  DRYLVDRELGRGEFG----VTYLCIDRDTREL-LACKSISKRKLRTAVDIDDVRREVAIM 105
           DR  + + LG G FG       + +D       +A K +      T  D+ D+  E+ +M
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD--ATEKDLSDLVSEMEMM 69

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           K + K+ +I++L   C  +  +++V+E    G L D + AR    E A+    R   E  
Sbjct: 70  KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE-- 127

Query: 166 QLCHKHGV------------------IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
            L  K  V                  IHRDL   N L     E+  +K  DFGL+     
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLA----- 179

Query: 208 GERFSEIVGSPYY------------MAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                +I    YY            MAPE L  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 180 ----RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235

Query: 254 WAESEQGVAQAILRGLIDFKR-----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                 G+    +  L    +     +   N ++    L+R      P  R T KQ++E
Sbjct: 236 -----PGIP---VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 74/301 (24%), Positives = 126/301 (41%), Gaps = 63/301 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYL--C---IDRDTRELLACKSISKRKLRTAVDIDDV 98
           V ++ I    ++ RELG G FG  +L  C      + +EL+A K++ +     A    D 
Sbjct: 2   VQRDTI----VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK--DF 55

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
            RE  ++ +  ++ +IV     C + +   +V E  E G+L      R H  + A     
Sbjct: 56  EREAELLTNF-QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNK--FLRSHGPDAAFLKSP 112

Query: 159 R------TIVEVVQ-----------LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL 201
                  T+ +++Q           L  +H V HRDL   N L      +  +K  DFG+
Sbjct: 113 DSPMGELTLSQLLQIAVQIASGMVYLASQHFV-HRDLATRNCLVG---YDLVVKIGDFGM 168

Query: 202 SIFFKPGERFSEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILL 247
           S          ++  + YY            M PE ++ R +  E D+WS GV+L+ I  
Sbjct: 169 S---------RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Query: 248 CGVPPFWAESEQGVAQAILRG-LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            G  P++  S + V + I +G L+   R     V +    ++    + DP+ R+  K + 
Sbjct: 220 YGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYD----IMLGCWKRDPQQRINIKDIH 275

Query: 307 E 307
           E
Sbjct: 276 E 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 64/261 (24%), Positives = 105/261 (40%), Gaps = 37/261 (14%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P+E       ++R+LG G FG  +  + ++   + A K +   K    +   D ++EV  
Sbjct: 4   PREEFT----LERKLGSGYFGEVWEGLWKNRVRV-AIKIL---KSDDLLKQQDFQKEVQA 55

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT---- 160
           +K L ++  ++SL   C     V+++ EL E G L         +       V       
Sbjct: 56  LKRL-RHKHLISLFAVCSVGEPVYIITELMEKGSLL-------AFLRSPEGQVLPVASLI 107

Query: 161 -----IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
                + E +    +   IHRDL   N L     E+   K  DFGL+   K     S   
Sbjct: 108 DMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKEDVYLSSDK 164

Query: 216 GSPY-YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDF 272
             PY + APE      +  + D+WS G++LY +   G  P+   +   V   I  G    
Sbjct: 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY--- 221

Query: 273 KRDPWPNVSESAKSLVRQMLE 293
            R P P  ++  + + + MLE
Sbjct: 222 -RMPCP--AKCPQEIYKIMLE 239

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 68/290 (23%), Positives = 112/290 (38%), Gaps = 43/290 (14%)

Query: 44  VPKENIEDRYLVDRELGRGEFGV----TYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           VP+++I    L+ R LG G FG      Y   D D  EL      +  +  +  D  D  
Sbjct: 3   VPRDSIT---LL-RALGHGAFGEVYEGLYRGRDGDAVEL-QVAVKTLPESCSEQDESDFL 57

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E  IM     + +IV L     +     +++EL  GG+L   +       ER ++   +
Sbjct: 58  MEALIMSKF-NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116

Query: 160 TIV----EVVQLCH---KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
            ++    +V + C    ++  IHRD+   N L   K      K  DFG++          
Sbjct: 117 DLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------R 167

Query: 213 EIVGSPYY------------MAPEV-LKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
           +I  + YY            M PE  L   +  + D+WS GV+L+ I   G  P+   + 
Sbjct: 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227

Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
           Q V + +  G    + DP          ++    +  P+ R     +LE 
Sbjct: 228 QEVMEFVTGG---GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 44/222 (19%)

Query: 50  EDRYLVD-RELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           E+R+L   ++LG+G FG   LC    +  +T E++A K   K +  TA  + D  RE+ I
Sbjct: 2   EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEI 58

Query: 105 MKHLPKNSSIVSLKEAC--EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +K L ++ +IV  K  C       + LVME    G L D +       +       + ++
Sbjct: 59  LKSL-QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDH-----RKLLL 112

Query: 163 EVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF----------K 206
              Q+C           +HRDL   N L  ++   + +K  DFGL+             +
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVLPQDKEYYKVRE 169

Query: 207 PGERFSEIVGSP-YYMAPEVLKRN-YGPEIDIWSAGVILYIL 246
           PGE       SP ++ APE L  + +    D+WS GV+LY L
Sbjct: 170 PGE-------SPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 76/259 (29%), Positives = 108/259 (41%), Gaps = 37/259 (14%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
            +GRG FG  +    R     +A KS   R+           +E  I+K    + +IV L
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQY-SHPNIVRL 58

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARG---------HYTERAAAAVTRTIVEVVQLC 168
              C     +++VMEL +GG+    +   G            E AAA +         L 
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGME-------YLE 111

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE--IVGSPY-YMAPEV 225
            KH  IHRDL   N L     E + LK  DFG+S   + G   S   +   P  + APE 
Sbjct: 112 SKH-CIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA 167

Query: 226 LKRNYG---PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NV 280
           L  NYG    E D+WS G++L+     G  P+   S Q   +AI +G+    R P P   
Sbjct: 168 L--NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV----RLPCPELC 221

Query: 281 SESAKSLVRQMLEPDPKLR 299
            ++   L+ +  E DP  R
Sbjct: 222 PDAVYRLMERCWEYDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 73/316 (23%), Positives = 127/316 (40%), Gaps = 68/316 (21%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++GRG +G  Y    +D ++    K  + +++          RE+A+++ L K+ ++++L
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDE---KEYALKQIEGTGISMSACREIALLREL-KHPNVIAL 63

Query: 118 KEA--CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV--------VQL 167
           ++      D  V L+ +  E          R     +    + R++V+         +  
Sbjct: 64  QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 168 CHKHGVIHRDLKPENFLFANK-KENSPLKAIDFGLSIFF----KPGERFSEIVGSPYYMA 222
            H + V+HRDLKP N L   +  E   +K  D G +  F    KP      +V + +Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF--------------------------- 253
           PE+L   R+Y   IDIW+ G I   LL   P F                           
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243

Query: 254 -----WAESEQGVAQAILRGLIDFKRDPWPNVS-----ESAKS--------LVRQMLEPD 295
                W +  +      L+   DF+R  + N S     E  K         L++++L  D
Sbjct: 244 PADKDWEDIRKMPEYPTLQK--DFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMD 301

Query: 296 PKLRLTAKQVLEHPWL 311
           P  R+T++Q L+ P+ 
Sbjct: 302 PTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 60.3 bits (146), Expect = 5e-10
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE- 213
            AV R ++  +   H  G+IHRD+K EN +  N  E+  L   DFG + F + G   +  
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFAR-GSWSTPF 318

Query: 214 ---IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY 244
              I G+    APEVL  + Y P +DIWSAG++++
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 56/201 (27%), Positives = 82/201 (40%), Gaps = 25/201 (12%)

Query: 58  ELGRGEFGVTYLCIDR-------DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +LG G FGV    + R            +A K +   KL     +DD  +E AIM  L  
Sbjct: 2   KLGDGSFGV----VRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSL-D 54

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTRTIVEVVQLC 168
           + +++ L         + +V EL   G L DR+   A GH+           I   ++  
Sbjct: 55  HENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPY-YMAPE 224
                IHRDL   N L A+  +   +K  DFGL       E      E +  P+ + APE
Sbjct: 114 ESKRFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170

Query: 225 VLK-RNYGPEIDIWSAGVILY 244
            L+ R +    D+W  GV L+
Sbjct: 171 SLRTRTFSHASDVWMFGVTLW 191

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 71/280 (25%), Positives = 106/280 (37%), Gaps = 52/280 (18%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV-----DIDDVRR----- 100
           +   + R +G G+FG  Y  +           S    K+  AV           R     
Sbjct: 6   EDITLGRCIGEGQFGDVYQGV---------YMSPENEKIAVAVKTCKNCTSPSVREKFLQ 56

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY--TERAAAAVT 158
           E  IM+    +  IV L     ++  V +VMEL   GEL         Y    + +  + 
Sbjct: 57  EAYIMRQF-DHPHIVKLIGVITEN-PVWIVMELAPLGEL-------RSYLQVNKYSLDLA 107

Query: 159 RTIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSP--LKAIDFGLSIFFKPGER 210
             I+   QL            +HRD+   N L +     SP  +K  DFGLS + +    
Sbjct: 108 SLILYSYQLSTALAYLESKRFVHRDIAARNVLVS-----SPDCVKLGDFGLSRYLEDESY 162

Query: 211 FSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAIL 266
           +    G  P  +MAPE +  R +    D+W  GV ++ IL+ GV PF       V   I 
Sbjct: 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE 222

Query: 267 RGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQV 305
            G    +R P P N   +  SL+ +    DP  R    ++
Sbjct: 223 NG----ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 69/261 (26%), Positives = 107/261 (40%), Gaps = 38/261 (14%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R+LG G+FG  +  +  +T  +    ++   K  T  D  D   E  IMK L ++  ++ 
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPV----AVKTLKPGTM-DPKDFLAEAQIMKKL-RHPKLIQ 65

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARG-------HYTERAA-AAVTRTIVEVVQLC 168
           L   C  +  +++V EL + G L + +              + AA  A     +E     
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE----- 120

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEV 225
                IHRDL   N L     EN+  K  DFGL+   K    +    G+ +   + APE 
Sbjct: 121 -AQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEA 175

Query: 226 LKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES 283
              N +  + D+WS G++L  I+  G  P+   +   V Q + +G     R P P     
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY----RMPCP--PGC 229

Query: 284 AKSLVRQMLE---PDPKLRLT 301
            K L   ML+    DP  R T
Sbjct: 230 PKELYDIMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 69/285 (24%), Positives = 120/285 (42%), Gaps = 36/285 (12%)

Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIM 105
           DR ++ + LG G FG         ID+   +     ++   K   T  D+ D+  E+ +M
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           K + K+ +I++L   C  +  +++++E    G L + + AR          +T+   E  
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-- 129

Query: 166 QLCHKHGV------------------IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
           QL  K  V                  IHRDL   N L     E++ +K  DFGL+     
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHD 186

Query: 208 GERFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVA 262
            + + +         +MAPE L  R Y  + D+WS G++++ I   G  P+     + + 
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246

Query: 263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           + +  G    + D   N +     L+R+     P  R T KQ++E
Sbjct: 247 KLLREG---HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 68/283 (24%), Positives = 121/283 (42%), Gaps = 32/283 (11%)

Query: 51  DRYLVDRELGRGEFGVTYLC--IDRDTRELLACKSISKRKLR---TAVDIDDVRREVAIM 105
           DR ++ + LG G FG   +   I  D  +      ++ + L+   T  D+ D+  E+ +M
Sbjct: 18  DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG------HYTERAAAAVTR 159
           K + K+ +I++L  AC  D  +++++E    G L + + AR        Y          
Sbjct: 78  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137

Query: 160 TIVEVVQLCHK----------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           +  ++V   ++             IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 138 SFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 194

Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254

Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 255 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 44/199 (22%)

Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
             A  + + I+E ++  H   +IHRD+K EN +F N  +   +   D G + F      F
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTEN-IFINDVDQVCIG--DLGAAQFPVVAPAF 213

Query: 212 SEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLC------GVPPFWAESEQGVAQA 264
             + G+    APEVL R+ Y  + DIWSAG++L+ +L         PP   E       +
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273

Query: 265 ILRGLI--------DFKRDP---------------------WP-----NVSESAKSLVRQ 290
            L  +I        +F RDP                     +P     N+    + LV +
Sbjct: 274 HLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHK 333

Query: 291 MLEPDPKLRLTAKQVLEHP 309
           ML  D  +R +A+++L +P
Sbjct: 334 MLTFDAAMRPSAEEILNYP 352

Length = 357

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 51/204 (25%), Positives = 80/204 (39%), Gaps = 31/204 (15%)

Query: 57  RELGRGEFGVTYLCI--DRDTREL-LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           +ELG G FG     +   +  +E+ +A K++ +  +       +  RE ++M  L  +  
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA--GKKEFLREASVMAQL-DHPC 57

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           IV L   C+ +  + LVMEL   G L   +  R          +   +   +        
Sbjct: 58  IVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK---RNY 230
           +HRDL   N L  N+ +    K  DFG+S             GS YY A    +   + Y
Sbjct: 117 VHRDLAARNVLLVNRHQ---AKISDFGMSRALGA--------GSDYYRATTAGRWPLKWY 165

Query: 231 GPEI----------DIWSAGVILY 244
            PE           D+WS GV L+
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLW 189

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 56.6 bits (137), Expect = 3e-09
 Identities = 62/254 (24%), Positives = 107/254 (42%), Gaps = 21/254 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+GEFG   L   R  +  +A K + K     A        E ++M  L ++ ++V L 
Sbjct: 14  IGKGEFGDVMLGDYRGQK--VAVKCL-KDDSTAA---QAFLAEASVMTTL-RHPNLVQLL 66

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
                 N +++V E    G L D + +RG    T          + E ++   +   +HR
Sbjct: 67  GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHR 126

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEI 234
           DL   N L +   E+   K  DFGL+   K   +  +    P  + APE L+   +  + 
Sbjct: 127 DLAARNVLVS---EDLVAKVSDFGLA---KEASQGQDSGKLPVKWTAPEALREKKFSTKS 180

Query: 235 DIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
           D+WS G++L+ I   G  P+     + V   + +G   ++ +           +++   E
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---YRMEAPEGCPPEVYKVMKDCWE 237

Query: 294 PDPKLRLTAKQVLE 307
            DP  R T KQ+ E
Sbjct: 238 LDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 59/228 (25%), Positives = 105/228 (46%), Gaps = 26/228 (11%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRD--TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +Y +   L  G  G  ++C       R+ +  K+++  K           RE+ I+K + 
Sbjct: 93  QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTI- 143

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            + +I++L  A    + V +VM   +  +LF  +   G      A  + R ++E +   H
Sbjct: 144 SHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLH 202

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-----IVGSPYYMAPE 224
             G+IHRD+K EN +F ++ EN+ L   DFG +   K              G+    +PE
Sbjct: 203 GRGIIHRDVKTEN-IFLDEPENAVLG--DFGAAC--KLDAHPDTPQCYGWSGTLETNSPE 257

Query: 225 VLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI 270
           +L  + Y  + DIWSAG++L+ + +  V  F  + +   +Q  LR +I
Sbjct: 258 LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ--LRSII 303

Length = 392

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 55.8 bits (134), Expect = 9e-09
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 36/284 (12%)

Query: 52  RYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLR---TAVDIDDVRREVAI 104
           R  + + LG G FG   +     ID+D        +++ + L+   T  D+ D+  E+ +
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPN--KPVTVAVKMLKDDATDKDLSDLVSEMEM 70

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GH 148
           MK + K+ +I++L  AC  D  +++++E    G L + + AR                  
Sbjct: 71  MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 149 YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
            T +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHNI 187

Query: 209 ERFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           + + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + +
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247

Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
            +  G    + D   N +     ++R+     P  R T KQ++E
Sbjct: 248 LLKEG---HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 36/234 (15%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD------IDDVRR----EVAI 104
           +++ +G GEFG   +C  R        K   KR++  A+        +  RR    E +I
Sbjct: 8   IEKVIGAGEFG--EVCSGR-------LKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASI 58

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +  G +T      + R I 
Sbjct: 59  MGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIA 116

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPL--KAIDFGLSIFFK--PGERFSEIVGS- 217
             ++     G +HRDL   N L      NS L  K  DFGLS   +  P   ++   G  
Sbjct: 117 SGMKYLSDMGYVHRDLAARNILV-----NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171

Query: 218 PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
           P  + APE +  R +    D+WS G++++ ++  G  P+W  S Q V +AI  G
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 14/219 (6%)

Query: 58  ELGRGEFGVTYLCI--DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIV 115
           ELG G FG     +   + + + +A K I K         D++ RE  +M+ L  N  IV
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQL-DNPYIV 59

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIH 175
            +   CE ++ + LVMEL E G L   +    H TE+    +   +   ++   +   +H
Sbjct: 60  RMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS---PY-YMAPEVLK-RNY 230
           RDL   N L   +      K  DFGLS      E + +       P  + APE +    +
Sbjct: 119 RDLAARNVLLVTQHY---AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 231 GPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
             + D+WS GV+++     G  P+       V Q I  G
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG 214

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 49/192 (25%), Positives = 86/192 (44%), Gaps = 22/192 (11%)

Query: 125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH------KHGVIHRDL 178
           N +++VMEL   G L + +  RG    RA  +V + +   + +           ++HRDL
Sbjct: 71  NGLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDI 236
              N L +   E+   K  DFGL+   + G    +    P  + APE LK   +  + D+
Sbjct: 127 AARNILVS---EDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDV 180

Query: 237 WSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           WS GV+L+ +   G  P+   S + V + + +G   ++ +P          L+    E +
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVYVLMTSCWETE 237

Query: 296 PKLRLTAKQVLE 307
           PK R +  ++ E
Sbjct: 238 PKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 63/253 (24%), Positives = 104/253 (41%), Gaps = 53/253 (20%)

Query: 54  LVDRELGRGEFGVTYL--CID---RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           ++ RELG G FG  +L  C +      + L+A K++    L       D +RE  ++ +L
Sbjct: 8   VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---KDFQREAELLTNL 64

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT-----------------E 151
            ++  IV     C D + + +V E  + G+L   + A G                     
Sbjct: 65  -QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123

Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
           +     ++    +V L  +H  +HRDL   N L      N  +K  DFG+S         
Sbjct: 124 QMLHIASQIASGMVYLASQH-FVHRDLATRNCLVGA---NLLVKIGDFGMS--------- 170

Query: 212 SEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
            ++  + YY            M PE ++ R +  E D+WS GVIL+ I   G  P++  S
Sbjct: 171 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230

Query: 258 EQGVAQAILRGLI 270
              V + I +G +
Sbjct: 231 NTEVIECITQGRV 243

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 75/307 (24%), Positives = 124/307 (40%), Gaps = 63/307 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRD-------TRELLACKSISKR-KLRTAVDI 95
           V +E I     + RELG+G FG+ Y    RD       TR  +A K++++   LR  ++ 
Sbjct: 3   VSREKIT----LLRELGQGSFGMVYEGNARDIIKGEAETR--VAVKTVNESASLRERIEF 56

Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA 155
            +   E ++MK    +  +V L           +VMEL   G+L   + +     E    
Sbjct: 57  LN---EASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112

Query: 156 AVTRTIVEVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
               T+ E++Q+           +    +HRDL   N + A    +  +K  DFG++   
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMT--- 166

Query: 206 KPGERFSEIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVP 251
                  +I  + YY            MAPE LK   +    D+WS GV+L+ I      
Sbjct: 167 ------RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 220

Query: 252 PFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE---- 307
           P+   S + V + ++ G      D   N  E    L+R   + +PK+R T  +++     
Sbjct: 221 PYQGLSNEQVLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Query: 308 --HPWLQ 312
             HP   
Sbjct: 278 DLHPSFP 284

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 61/278 (21%), Positives = 114/278 (41%), Gaps = 50/278 (17%)

Query: 59  LGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           LGRGEFG  +L       +     L+  K++ K K        + RRE+ + + L  + +
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKL-SHKN 69

Query: 114 IVSLKEACEDDNAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTRTIVEVV-QLCH- 169
           +V L   C +    ++++E  + G+L  F R         +     T+  V +  Q+   
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 170 -----KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY---- 220
                    +HRDL   N L ++++E   +K     LS          ++  S YY    
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLS---------KDVYNSEYYKLRN 177

Query: 221 -------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLID 271
                  +APE V + ++  + D+WS GV+++ +   G  PF+  S++ V   +  G ++
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE 237

Query: 272 FKRDPWPNVSESAKSLVRQMLE---PDPKLRLTAKQVL 306
                 P        L + M      +PK R +  +++
Sbjct: 238 -----LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 52.5 bits (126), Expect = 6e-08
 Identities = 63/242 (26%), Positives = 93/242 (38%), Gaps = 61/242 (25%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV------DIDDVRR----EVAIMK 106
            ++G+G FG  Y             K + K     AV         D++R    E  I+K
Sbjct: 1   EKIGKGNFGDVY-------------KGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILK 47

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
               + +IV L   C     +++VMEL  GG L         +  +    +  T+ +++Q
Sbjct: 48  QY-DHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT-------FLRKKKNRL--TVKKLLQ 97

Query: 167 LC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
           +                IHRDL   N L     EN+ LK  DFG+S   +  E     V 
Sbjct: 98  MSLDAAAGMEYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMS---REEEGGIYTVS 151

Query: 217 SPY------YMAPEVLKRNYG---PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAIL 266
                    + APE L  NYG    E D+WS G++L+     G  P+   S Q   + I 
Sbjct: 152 DGLKQIPIKWTAPEAL--NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE 209

Query: 267 RG 268
            G
Sbjct: 210 SG 211

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 35/233 (15%)

Query: 55  VDRELGRGEFGVTY---LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           +++ +G GEFG      L +       +A K++  +   +     D   E +IM     +
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQF-DH 64

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            +I+ L+        V ++ E  E G L  F R    G +T      + R I   ++   
Sbjct: 65  PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKYLS 123

Query: 170 KHGVIHRDLKPENFLFANKKENSPL--KAIDFGLSIFFKPGERFSEIVGSPY-------- 219
           +   +HRDL   N L      NS L  K  DFGLS       R  E   + Y        
Sbjct: 124 EMNYVHRDLAARNILV-----NSNLVCKVSDFGLS-------RRLEDSEATYTTKGGKIP 171

Query: 220 --YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
             + APE +  R +    D+WS G++++ ++  G  P+W  S Q V +A+  G
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 47/229 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYL-----CIDRDTRELLACKSISKRKLRTAVDIDDV 98
           +P+E I     + RELG+G FG+ Y       +  +    +A K++++    +  +  + 
Sbjct: 3   LPREKIT----LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEF 56

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
             E ++MK    +  +V L           +VMEL   G+L   + +R    E       
Sbjct: 57  LNEASVMKEFNCHH-VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115

Query: 159 RTIVEVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
            T+ + +Q+                +HRDL   N + A   E+  +K  DFG++      
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMT------ 166

Query: 209 ERFSEIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY 244
               +I  + YY            MAPE LK   +  + D+WS GV+L+
Sbjct: 167 ---RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 16/219 (7%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +ELG G+FGV      R   + +A K I +  +      D+   E  +M  L  +  +V 
Sbjct: 10  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE----DEFIEEAKVMMKL-SHEKLVQ 63

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA-AAVTRTIVEVVQLCHKHGVIH 175
           L   C     +++V E    G L + +   G   + +    + + + E +        IH
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKR-NYG 231
           RDL   N L     +   +K  DFGLS +    E  S  VGS +   +  PEVL    + 
Sbjct: 124 RDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLYSKFS 179

Query: 232 PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL 269
            + D+W+ GV+++ +   G  P+   +     + + +GL
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL 218

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 59/271 (21%), Positives = 114/271 (42%), Gaps = 24/271 (8%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N+++  L+ + +G+GEFG   L   R  +  + C       ++          E ++M  
Sbjct: 4   NMKELKLL-QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQ 55

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRTIVEVV 165
           L  ++ +  L    E+   +++V E    G L D + +RG         +  +  + E +
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-YMAPE 224
           +    +  +HRDL   N L +   E++  K  DFGL+   K      +    P  + APE
Sbjct: 116 EYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPE 169

Query: 225 VLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
            L+ + +  + D+WS G++L+ I   G  P+     + V   + +G   +K D       
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPP 226

Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
               +++Q    D   R +  Q+ E   L++
Sbjct: 227 VVYDVMKQCWHLDAATRPSFLQLRE--QLEH 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 28/223 (12%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG  +    +D +  +A K+  K  L   + I  +  E  I+K    + +IV L 
Sbjct: 3   LGKGNFGEVFKGTLKD-KTPVAVKT-CKEDLPQELKIKFLS-EARILKQY-DHPNIVKLI 58

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV---VQLCHKHGVIH 175
             C     +++VMEL  GG+    +  R    E     + +  ++    +        IH
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLS------IFFKPGERFSEIVGSPYYMAPEVLKRN 229
           RDL   N L     EN+ LK  DFG+S      I+   G +   I     + APE L  N
Sbjct: 117 RDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPI----KWTAPEAL--N 167

Query: 230 YG---PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
           YG    E D+WS G++L+     GV P+   + Q   + + +G
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 36/244 (14%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKS---------ISKRKLRTAVDI---DDV 98
            +  +  +LG G+FG  +LC      E L   +         ++ + LR  V     +D 
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA--- 155
            +E+ IM  L KN +I+ L   C  D+ + ++ E  E G+L   +  R   +    A   
Sbjct: 65  LKEIKIMSRL-KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123

Query: 156 -AVTRT--------IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
            +V+          I   ++       +HRDL   N L  N   +  +K  DFG+S    
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN---HYTIKIADFGMSRNLY 180

Query: 207 PGERFSEIVGSPY----YMAPE-VLKRNYGPEIDIWSAGVILY--ILLCGVPPFWAESEQ 259
            G+ +  I G       +MA E +L   +    D+W+ GV L+    LC   P+   S++
Sbjct: 181 SGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239

Query: 260 GVAQ 263
            V +
Sbjct: 240 QVIE 243

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 18/164 (10%)

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVT 158
           E+ IM HL  + +IV+L  AC     + ++ E C  G+L +  R       T     + +
Sbjct: 88  ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147

Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL-------SIFFKPGERF 211
             + + +        IHRDL   N L  + K    +K  DFGL       S +   G   
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLARDIMNDSNYVVKGNAR 204

Query: 212 SEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPF 253
             +     +MAPE +    Y  E D+WS G++L+ I   G  P+
Sbjct: 205 LPV----KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 57/234 (24%), Positives = 108/234 (46%), Gaps = 25/234 (10%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E+I+    + ++LG G+FG  ++    ++ ++ A K++        + +     E  
Sbjct: 3   IPRESIK----LVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKP----GTMSVQAFLEEAN 53

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTI 161
           +MK L ++  +V L      +  ++++ E    G L D + +   G          +  I
Sbjct: 54  LMKTL-QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI 112

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L +   E+   K  DFGL+   +  E ++   G+ +  
Sbjct: 113 AEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPI 168

Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + APE +  N+G    + D+WS G++LY I+  G  P+   S   V  A+ RG
Sbjct: 169 KWTAPEAI--NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 60/250 (24%), Positives = 106/250 (42%), Gaps = 45/250 (18%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACK---SISK-RKLRTAVDI----------DD 97
             L   +LG G+FG  +LC   + ++L   +   ++ K R L  AV I          +D
Sbjct: 6   HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND 65

Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA- 156
             +EV I+  L K+ +I+ L   C D++ + ++ E  E G+L ++ ++  H  ++     
Sbjct: 66  FLKEVKILSRL-KDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGN 123

Query: 157 -------------------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI 197
                              V   I   ++       +HRDL   N L     EN  +K  
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG---ENLTIKIA 180

Query: 198 DFGLSIFFKPGERF---SEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILY--ILLCGVP 251
           DFG+S     G+ +      V    +MA E +L   +    D+W+ GV L+  ++LC   
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240

Query: 252 PFWAESEQGV 261
           P+   +++ V
Sbjct: 241 PYGELTDEQV 250

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 49.1 bits (117), Expect = 9e-07
 Identities = 63/244 (25%), Positives = 103/244 (42%), Gaps = 50/244 (20%)

Query: 96  DDVRREVAIMKHLPKNS---------------SIVSLKEACEDDNAVHLVMELCEGGELF 140
           D   ++  I+K L K+S               ++V L +    +++V LV++  EGG+L+
Sbjct: 14  DTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73

Query: 141 DRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG 200
             I    +  E         +V  +   H+ G++ RDL P N L  ++            
Sbjct: 74  SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--------IQ 125

Query: 201 LSIFFKPGERFSEIVGS-------PYYMAPEVLKRNYGPE-IDIWSAGVILYILLCGVPP 252
           L+ F     R+SE+  S         Y APEV   +   E  D WS G IL+ LL G   
Sbjct: 126 LTYF----SRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKT- 180

Query: 253 FWAESE-QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTA-----KQVL 306
              E    G+       + ++       VSE A+SL++Q+L+ +P  RL A     + + 
Sbjct: 181 -LVECHPSGINTHTTLNIPEW-------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIK 232

Query: 307 EHPW 310
            HP+
Sbjct: 233 SHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 72/285 (25%), Positives = 127/285 (44%), Gaps = 39/285 (13%)

Query: 59  LGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           +G G FG V    I +D  ++ A   + K +  +  D  D   E+ ++  L  + +I++L
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 118 KEACEDDNAVHLVMELCEGGELFD-----RIV------ARGHYTERAAAAVTRTIVEV-- 164
             ACE+   +++ +E    G L D     R++      A+ H T  A+   ++ +++   
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT--ASTLTSQQLLQFAS 126

Query: 165 -----VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGS 217
                +Q   +   IHRDL   N L     EN   K  DFGLS     GE     + +G 
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS----RGEEVYVKKTMGR 179

Query: 218 -PY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFK 273
            P  +MA E L  + Y  + D+WS GV+L+ I+  G  P+   +   + + + +G   ++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YR 236

Query: 274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV-LEHPWLQNAKKA 317
            +   N  +    L+RQ     P  R    Q+ ++   +  A+KA
Sbjct: 237 MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 49/212 (23%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAIMKH 107
           ELG G FG    C+ +   ++       K+++  A+ +          D++ RE  IM  
Sbjct: 2   ELGSGNFG----CVKKGVYKM------RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQ 51

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  N  IV +   CE + A+ LVME+  GG L   +  +             T+  VV+L
Sbjct: 52  L-DNPYIVRMIGVCEAE-ALMLVMEMASGGPLNKFLSGKKD---------EITVSNVVEL 100

Query: 168 CHK----------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIV 215
            H+             +HRDL   N L  N+      K  DFGLS      + +  +   
Sbjct: 101 MHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY---AKISDFGLSKALGADDSYYKARSA 157

Query: 216 GS-PY-YMAPE-VLKRNYGPEIDIWSAGVILY 244
           G  P  + APE +  R +    D+WS G+ ++
Sbjct: 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMW 189

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 47/283 (16%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISKR-KLRTAVDI 95
           V +E I     + RELG+G FG+ Y  I +       +TR  +A K++++   +R  ++ 
Sbjct: 3   VAREKIT----MSRELGQGSFGMVYEGIAKGVVKDEPETR--VAIKTVNEAASMRERIEF 56

Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA 155
            +   E ++MK       +V L           ++MEL   G+L   + +     E    
Sbjct: 57  LN---EASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 112

Query: 156 AVTRTIVEVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--- 202
               ++ +++Q+           + +  +HRDL   N + A   E+  +K  DFG++   
Sbjct: 113 QAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDI 169

Query: 203 ----IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAE 256
                + K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   
Sbjct: 170 YETDYYRKGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225

Query: 257 SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           S + V + ++ G +  K D  P++      L+R   + +PK+R
Sbjct: 226 SNEQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMR 265

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 73/305 (23%), Positives = 124/305 (40%), Gaps = 59/305 (19%)

Query: 51  DRYLVDRELGRGEFGVTYLC--------IDRDTRELLACKS---ISKRKLRTAVDID--- 96
            R     +LG G+FG  +LC        +D+D    ++      ++ + LR   + +   
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64

Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA 156
           D  +E+ IM  L K+ +I+ L   C   + + ++ E  E G+L ++ ++R H  + AA  
Sbjct: 65  DFLKEIKIMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSR-HEPQEAAEK 121

Query: 157 VTRTIVEVVQLCHKHGVI-------------HRDLKPENFLFANKKENSPLKAIDFGLSI 203
                +    L      I             HRDL   N L     +N  +K  DFG+S 
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADFGMSR 178

Query: 204 FFKPGERFSEIVGSPY----YMAPE-VLKRNYGPEIDIWSAGVILY--ILLCGVPPFWAE 256
               G+ +  I G       +M+ E +L   +    D+W+ GV L+  + LC   P+   
Sbjct: 179 NLYSGD-YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237

Query: 257 SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA 314
           S++ V +               N  E  +   RQ+  P P L      K +L   W +NA
Sbjct: 238 SDEQVIE---------------NTGEFFRDQGRQVYLPKPALCPDSLYKLMLS-CWRRNA 281

Query: 315 KKAPN 319
           K+ P+
Sbjct: 282 KERPS 286

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 72/268 (26%), Positives = 121/268 (45%), Gaps = 30/268 (11%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E+++    ++R+LG G+FG  ++     T ++ A K++        +  +   +E  
Sbjct: 3   IPRESLK----LERKLGAGQFGEVWMGTWNGTTKV-AVKTLKP----GTMSPEAFLQEAQ 53

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRTI 161
           IMK L ++  +V L   C ++  +++V E    G L D + +      R    V     I
Sbjct: 54  IMKKL-RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI 112

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +        IHRDL   N L     EN   K  DFGL+   +  E ++   G+ +  
Sbjct: 113 AEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDE-YTAREGAKFPI 168

Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE    NYG    + D+WS G++L  I+  G  P+   + + V + + RG     R
Sbjct: 169 KWTAPEAA--NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY----R 222

Query: 275 DPWP-NVSESAKSLVRQMLEPDPKLRLT 301
            P P N  E    L+ Q  + DP+ R T
Sbjct: 223 MPRPPNCPEELYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 27/266 (10%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E++     +D +LG+G FG  ++     T ++ A K++    +     +     E  
Sbjct: 3   IPRESLR----LDVKLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQ----EAQ 53

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV-ARGHYTERAAAA-VTRTI 161
           IMK L ++  +V L  A   +  +++V E    G L D +    G Y +      +   I
Sbjct: 54  IMKKL-RHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQI 111

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            + +    +   IHRDL+  N L     +N   K  DFGL+   +  E ++   G+ +  
Sbjct: 112 ADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNE-YTARQGAKFPI 167

Query: 220 -YMAPE-VLKRNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDP 276
            + APE  L   +  + D+WS G++L  L+  G  P+     + V + + RG     R P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY----RMP 223

Query: 277 WPN-VSESAKSLVRQMLEPDPKLRLT 301
            P    ES   L++   + DP  R T
Sbjct: 224 CPQGCPESLHELMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 66/252 (26%), Positives = 106/252 (42%), Gaps = 46/252 (18%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY------LCIDRDTRELLACKSISKRKLRTAVDID- 96
            P+ NIE  Y+  R++G+G FG  +      L        ++A K +   K   + D+  
Sbjct: 2   YPRNNIE--YV--RDIGQGAFGRVFQARAPGLLPYEP-FTMVAVKML---KEEASADMQA 53

Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA 156
           D +RE A+M     + +IV L   C     + L+ E    G+L + +  R    + + + 
Sbjct: 54  DFQREAALMAEF-DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH 112

Query: 157 VTRT----------IVEVVQLCHKHGV------------IHRDLKPENFLFANKKENSPL 194
            T +          +    QLC    V            +HRDL   N L     EN  +
Sbjct: 113 STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVV 169

Query: 195 KAIDFGLS--IFFKPGERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCG 249
           K  DFGLS  I+     + SE    P  +M PE +    Y  E D+W+ GV+L+ I   G
Sbjct: 170 KIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 229

Query: 250 VPPFWAESEQGV 261
           + P++  + + V
Sbjct: 230 MQPYYGMAHEEV 241

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 53/241 (21%), Positives = 99/241 (41%), Gaps = 46/241 (19%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI---DDVRREVAIMKHLPKNSSI 114
           ELG   FG  Y      T      ++++ + L+   +    ++ + E A+M+   ++ +I
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE-AMMRSRLQHPNI 70

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI---VEVVQLCH-- 169
           V L      +  + ++   C   +L + +V R  +++  +    +T+   +E     H  
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 170 -----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSP 218
                       H V+H+DL   N L  +K     +K  D GL         F E+  + 
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGL---------FREVYAAD 178

Query: 219 YY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
           YY            M+PE ++   +  + DIWS GV+L+ +   G+ P+   S Q V + 
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238

Query: 265 I 265
           I
Sbjct: 239 I 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 65/246 (26%), Positives = 97/246 (39%), Gaps = 52/246 (21%)

Query: 58  ELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           ELG G FG  +L      +    + L+A K++ +       D    +RE  ++  L ++ 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF---QREAELLTVL-QHQ 67

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGEL--FDR-------------IVARGHYTERAAAAV 157
            IV     C +   + +V E    G+L  F R              VA G  T     A+
Sbjct: 68  HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 158 TRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
              I   +V L   H  +HRDL   N L     +   +K  DFG+S          +I  
Sbjct: 128 ASQIASGMVYLASLH-FVHRDLATRNCLVG---QGLVVKIGDFGMS---------RDIYS 174

Query: 217 SPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVA 262
           + YY            M PE +L R +  E DIWS GV+L+ I   G  P++  S     
Sbjct: 175 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234

Query: 263 QAILRG 268
           + I +G
Sbjct: 235 ECITQG 240

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 55/235 (23%), Positives = 110/235 (46%), Gaps = 28/235 (11%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI-DRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           +P+E+++    ++++LG G+FG  ++   ++ T+  +A K++    +     +     E 
Sbjct: 3   IPRESLK----LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLA----EA 52

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRT 160
            +MK L ++  +V L  A      ++++ E    G L D + +     +     +  +  
Sbjct: 53  NVMKTL-QHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 110

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY- 219
           I E +    +   IHRDL+  N L +    +   K  DFGL+   +  E ++   G+ + 
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE-YTAREGAKFP 166

Query: 220 --YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
             + APE +  N+G    + D+WS G++L  I+  G  P+   S   V +A+ RG
Sbjct: 167 IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 54/243 (22%), Positives = 97/243 (39%), Gaps = 50/243 (20%)

Query: 58  ELGRGEFGVTY----LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           ELG   FG  Y         D  +L+A K++  + +       + ++E ++M  L  + +
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAEL-HHPN 68

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA----------------- 156
           IV L      +  V ++ E    G+L + ++ R  +++   ++                 
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
           +   I   ++    H  +H+DL   N L     E   +K  D GLS          EI  
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLS---------REIYS 176

Query: 217 SPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVA 262
           + YY            M PE ++   +  + DIWS GV+L+ I   G+ P++  S Q V 
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236

Query: 263 QAI 265
           + +
Sbjct: 237 EMV 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 46.5 bits (110), Expect = 7e-06
 Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 35/279 (12%)

Query: 57  RELGRGEFGV---TYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK--HLPKN 111
           R LG+GEFG      L  +  + + +A K + K  + ++ DI++  RE A MK    P  
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFDHPNV 63

Query: 112 SSI--VSLKEACEDDNAVHLV-MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
             +  VSL+   +    + +V +   + G+L   ++      E     +   +  ++ + 
Sbjct: 64  IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123

Query: 169 ------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY--- 219
                      IHRDL   N +     EN  +   DFGLS     G+ + +   S     
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA-ILRGLIDFKR-- 274
           ++A E L  N Y    D+W+ GV ++ I+  G  P+      GV  + I   LI   R  
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYLIKGNRLK 235

Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPW 310
            P P+  E    L+ Q   P+PK R +    +  LE  W
Sbjct: 236 QP-PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 46.6 bits (110), Expect = 8e-06
 Identities = 66/272 (24%), Positives = 113/272 (41%), Gaps = 38/272 (13%)

Query: 59  LGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           +G G FG V    I +D   + A     K +  +  D  D   E+ ++  L  + +I++L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 118 KEACEDDNAVHLVMELCEGGELFD-----RIV------ARGHYTERAAAAVTRTIVEV-- 164
             ACE    ++L +E    G L D     R++      A  + T  A+   ++ ++    
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST--ASTLSSQQLLHFAA 119

Query: 165 -----VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGS 217
                +    +   IHRDL   N L     EN   K  DFGLS     G+     + +G 
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS----RGQEVYVKKTMGR 172

Query: 218 --PYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFK 273
               +MA E L  + Y    D+WS GV+L+ I+  G  P+   +   + + + +G   ++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YR 229

Query: 274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
            +   N  +    L+RQ     P  R +  Q+
Sbjct: 230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 71/277 (25%), Positives = 114/277 (41%), Gaps = 46/277 (16%)

Query: 59  LGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKNSSI 114
           +G G FG V    I +D   + A    + ++++     DD R    E+ ++  L  + +I
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDA----AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRT--IVEVVQLCH-- 169
           ++L  ACE    ++L +E    G L D +  +R   T+ A A    T   +   QL H  
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 170 -----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSP 218
                      +   IHRDL   N L     EN   K  DFGLS       R  E+    
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-------RGQEVYVKK 180

Query: 219 Y-------YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL 269
                   +MA E L  + Y    D+WS GV+L+ I+  G  P+   +   + + + +G 
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 239

Query: 270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
             ++ +   N  +    L+RQ     P  R +  Q+L
Sbjct: 240 --YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 34/118 (28%), Positives = 50/118 (42%), Gaps = 19/118 (16%)

Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
           R+ RT       RRE  I+    +    V +    + DN + +VME  EG  L D     
Sbjct: 42  RRERT-------RREARILAKAREAGVPVPIVYDVDPDNGL-IVMEYIEGELLKD----- 88

Query: 147 GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF 204
               E A   + R +  +V   HK G++H DL   N + +  +    +  IDFGL  F
Sbjct: 89  --ALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEF 140

Length = 204

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 33/238 (13%)

Query: 59  LGRGEFGVTYLCI---DRDTREL-LACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSS 113
           LG G FG  +  I   + D+ ++ +A K+I  R  R T  +I D    +  + H    + 
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH----AY 70

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC----- 168
           IV L   C    ++ LV +L   G L D +  R H   R +    R +   VQ+      
Sbjct: 71  IVRLLGICPG-ASLQLVTQLSPLGSLLDHV--RQH---RDSLDPQRLLNWCVQIAKGMYY 124

Query: 169 -HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
             +H ++HR+L   N L    K +S ++  DFG++    P ++   +SE      +MA E
Sbjct: 125 LEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 225 -VLKRNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
            +L   Y  + D+WS GV ++ ++  G  P+       V   + +G    +R   P +
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG----ERLAQPQI 235

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 44.1 bits (104), Expect = 4e-05
 Identities = 72/268 (26%), Positives = 119/268 (44%), Gaps = 31/268 (11%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV + LG G+FG  ++       ++ A KS+ +     ++  +    E  
Sbjct: 3   VPRETLK---LVKK-LGAGQFGEVWMGYYNGHTKV-AIKSLKQ----GSMSPEAFLAEAN 53

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGH-YTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +    G   T      +   I
Sbjct: 54  LMKQL-QHPRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQI 111

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L +   E    K  DFGL+   +  E ++   G+ +  
Sbjct: 112 AEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE-YTAREGAKFPI 167

Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG     R
Sbjct: 168 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY----R 221

Query: 275 DPWP-NVSESAKSLVRQMLEPDPKLRLT 301
            P P N  E    L+R   +  P+ R T
Sbjct: 222 MPRPDNCPEELYELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 62/285 (21%), Positives = 118/285 (41%), Gaps = 43/285 (15%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR---TAVDIDDVRREVAIMKHLPKN 111
           + + LG GEFG          +      +++ + L+   ++ ++ D+  E  ++K +  +
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NH 62

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIVAR------GHYTERAAAAVTRTIVE 163
             ++ L  AC  D  + L++E  + G L  F R   +      G    R ++ +      
Sbjct: 63  PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 164 VV----------QLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
            +          Q+        +  ++HRDL   N L A  ++   +K  DFGLS     
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK---MKISDFGLSRDVYE 179

Query: 208 GERF---SEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVA 262
            + +   S+      +MA E L  + Y  + D+WS GV+L+ I+  G  P+      G+A
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-----PGIA 234

Query: 263 QAILRGLID--FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
              L  L+   ++ +   N SE   +L+    + +P  R T   +
Sbjct: 235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.4 bits (100), Expect = 6e-05
 Identities = 29/122 (23%), Positives = 49/122 (40%), Gaps = 14/122 (11%)

Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIV-SLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           +   +     D  REVAI++ L +    V  +  + E D   +L+ME  EG  L      
Sbjct: 27  KINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL------ 80

Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKH---GVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
               +E     +   + E++   H+     + H DL P N L  + K    L  ID+  +
Sbjct: 81  -DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI---LGIIDWEYA 136

Query: 203 IF 204
            +
Sbjct: 137 GY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 44.3 bits (104), Expect = 7e-05
 Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 5/73 (6%)

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
            V R ++  ++  H+ G++HRD+KPEN L      +  +K IDFG ++    G  F+ + 
Sbjct: 313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFNPLY 369

Query: 216 G--SPYYMAPEVL 226
           G   P Y  PE L
Sbjct: 370 GMLDPRYSPPEEL 382

Length = 507

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 16/143 (11%)

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGE-RFSEIVGSPYYMAPE-VLKRN 229
           IHRDL   N L +   EN+ +K  DFGL+  I+  P   R  +      +MAPE +  R 
Sbjct: 201 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257

Query: 230 YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
           Y  + D+WS GV+L+ I   G  P+       + +   R L +  R   P+ +     + 
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPYPGVK---IDEEFCRRLKEGTRMRAPDYTTP--EMY 312

Query: 289 RQMLE---PDPKLRLTAKQVLEH 308
           + ML+    +P  R T  +++EH
Sbjct: 313 QTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 31/102 (30%), Positives = 45/102 (44%), Gaps = 13/102 (12%)

Query: 218 PYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF---- 272
           PY+MAPEV++  +Y  + DI+S G+ LY  L    P    +E+    AIL  L++     
Sbjct: 68  PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP---YNEERELSAILEILLNGMPAD 124

Query: 273 ---KRDPWPNVSE--SAKSLVRQMLEPDPKLRLTAKQVLEHP 309
               R     VS   S +  +R      P+ R  A   L H 
Sbjct: 125 DPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 39/266 (14%)

Query: 57  RELGRGEFGVTY--LCIDRDTREL-LACKSISKRKLRTAVDIDDVR---REVAIMKHLPK 110
           R +G+G FG  Y    ID D +++  A KS+++       D+++V    +E  IMK    
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR-----ITDLEEVEQFLKEGIIMKDF-S 54

Query: 111 NSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           + +++SL   C   + +  +V+   + G+L + I      +E     V   I   +Q+  
Sbjct: 55  HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAK 109

Query: 170 ------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY-- 219
                     +HRDL   N +     E+  +K  DFGL+  I+ K         G+    
Sbjct: 110 GMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166

Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDP 276
            +MA E L+ + +  + D+WS GV+L+ L+  G PP+       +   +L+G    +R  
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG----RRLL 222

Query: 277 WPN-VSESAKSLVRQMLEPDPKLRLT 301
            P    +    ++     P P++R T
Sbjct: 223 QPEYCPDPLYEVMLSCWHPKPEMRPT 248

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 62/298 (20%), Positives = 118/298 (39%), Gaps = 72/298 (24%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKNSS 113
           +E+G G FG   L    +         +  ++LR +  + +  +   E    + L ++S+
Sbjct: 1   KEIGNGWFGKVIL---GEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSN 56

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLC---- 168
           ++     C +     LVME C  G+L      +G+  + R A  +T     + ++     
Sbjct: 57  LLQCLGQCTEVTPYLLVMEFCPLGDL------KGYLRSCRKAELMTPDPTTLQRMACEIA 110

Query: 169 ------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSEIV 215
                 HK+  IH DL   N L      +  +K  D+GLS        +  P + +  + 
Sbjct: 111 LGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL- 166

Query: 216 GSPYYMAPEVLKRNYG--------PEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAIL 266
               ++APE++   +G         E ++WS GV ++ L   G  P+   S++ V    +
Sbjct: 167 ---RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV 223

Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAK----QVLEHPWLQNAKKAPNV 320
           R                     +Q+  P P+L+L       +V++  WLQ  ++ P+ 
Sbjct: 224 RE--------------------QQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQR-PSA 260

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 8/85 (9%)

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPE-VLKRN 229
           IHRDL   N L +   EN+ +K  DFGL+  I+  P          P  +MAPE +  + 
Sbjct: 195 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251

Query: 230 YGPEIDIWSAGVILY-ILLCGVPPF 253
           Y  + D+WS GV+L+ I   G  P+
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 8/85 (9%)

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPE-VLKRN 229
           IHRDL   N L +   EN+ +K  DFGL+  I+  P          P  +MAPE +  + 
Sbjct: 196 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV 252

Query: 230 YGPEIDIWSAGVILY-ILLCGVPPF 253
           Y  + D+WS GV+L+ I   G  P+
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 64/271 (23%), Positives = 118/271 (43%), Gaps = 37/271 (13%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E+++    + ++LG G+FG  ++       ++ A K++    +     ++    E  
Sbjct: 3   IPRESLQ----LIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQ 53

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-------RIVARGHYTERAAAA 156
           IMK L ++  +V L  A   +  +++V E    G L D       R +   +  + AA  
Sbjct: 54  IMKKL-RHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA-- 109

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
               +   +    +   IHRDL+  N L  +       K  DFGL+   +  E ++   G
Sbjct: 110 ---QVAAGMAYIERMNYIHRDLRSANILVGD---GLVCKIADFGLARLIEDNE-YTARQG 162

Query: 217 SPY---YMAPE-VLKRNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLID 271
           + +   + APE  L   +  + D+WS G++L  L+  G  P+   + + V + + RG   
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-- 220

Query: 272 FKRDPWPNVSE-SAKSLVRQMLEPDPKLRLT 301
             R P P     S   L+ Q  + DP+ R T
Sbjct: 221 --RMPCPQDCPISLHELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 61/246 (24%), Positives = 100/246 (40%), Gaps = 46/246 (18%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI------DDVRR----EVAI 104
           ++R LG G FG   LC     R  L  K  SKR+L  A+        D  RR    E   
Sbjct: 9   IERILGTGRFG--ELC-----RGCL--KLPSKRELPVAIHTLRAGCSDKQRRGFLAEALT 59

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           +     +S+IV L+      N + +V E    G L D  + +  G         +   + 
Sbjct: 60  LGQF-DHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLA 117

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER------FSEIVG 216
             ++   + G +H+ L     L      NS L     G    F+  +       ++ + G
Sbjct: 118 SGMKYLSEMGYVHKGLAAHKVLV-----NSDLVCKISG----FRRLQEDKSEAIYTTMSG 168

Query: 217 -SP-YYMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDF 272
            SP  + APE ++  ++    D+WS G++++ ++  G  P+W  S Q V +A+  G    
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF--- 225

Query: 273 KRDPWP 278
            R P P
Sbjct: 226 -RLPAP 230

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 40.3 bits (95), Expect = 6e-04
 Identities = 37/118 (31%), Positives = 51/118 (43%), Gaps = 16/118 (13%)

Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
           R+ RT       RRE  IM    K    V      + +N + +VME  EG  L D I + 
Sbjct: 42  RRERT-------RREARIMSRARKAGVNVPAVYFVDPENFI-IVMEYIEGEPLKDLINSN 93

Query: 147 GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF 204
           G         ++R I  +V   H  G+IH DL   N + +  K    +  IDFGL+ F
Sbjct: 94  G----MEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGK----IYLIDFGLAEF 143

Length = 211

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.2 bits (96), Expect = 6e-04
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSE- 213
           A+ + ++  V+  H   +IHRD+K EN +F N      L   DFG ++ F K  E F   
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYG 327

Query: 214 IVGSPYYMAPEVLKRNYGPEI-DIWSAGVIL 243
            VG+    +PE+L  +   EI DIWS G+IL
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLIL 358

Length = 501

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 31/112 (27%), Positives = 48/112 (42%), Gaps = 27/112 (24%)

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EI 214
           + R I+  +   H  G++HRD+KP+N +F+    +   K ID G +   + G  +   E 
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS--FKIIDLGAAADLRVGINYIPKEF 317

Query: 215 VGSPYYMAPE----------------------VL-KRNYGPEIDIWSAGVIL 243
           +  P Y APE                      VL + N     DI+SAG+I 
Sbjct: 318 LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369

Length = 566

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 69/311 (22%), Positives = 111/311 (35%), Gaps = 73/311 (23%)

Query: 54  LVDRELGRGEFGVTYLC-----------IDRDTRELLACKSISKRKLRTAVDI---DDVR 99
               +LG G+FG  +LC              +     A   ++ + LR        +D  
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           +EV I+  L  + +I  L   C  D  + ++ME  E G+L         + ++  A  + 
Sbjct: 68  KEVKILSRL-SDPNIARLLGVCTVDPPLCMIMEYMENGDL-------NQFLQKHVAETSG 119

Query: 160 TIVEVVQL---CHKH---------------GVIHRDLKPENFLFANKKENSPLKAIDFGL 201
                  L      +                 +HRDL   N L      N  +K  DFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK---NYTIKIADFGM 176

Query: 202 SIFFKPGERFSEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-IL- 246
           S           +  S YY            MA E VL   +  + D+W+ GV L+ IL 
Sbjct: 177 S---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Query: 247 LCGVPPFWAESEQGVAQAILRGLIDFKR----DPWPNVSESAKSLVRQMLEPDPKLRLTA 302
           LC   P+   ++Q V +       D  R       PN  +    L+ +    D + R T 
Sbjct: 228 LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF 287

Query: 303 KQVLEHPWLQN 313
           +++  H +LQ 
Sbjct: 288 REI--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 38.7 bits (91), Expect = 0.002
 Identities = 33/116 (28%), Positives = 45/116 (38%), Gaps = 19/116 (16%)

Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
           R+ RT       R E  ++    K      +    + DN   +VME  EG  L D     
Sbjct: 40  RRERT-------RNEARLLSRARKAGVNTPVVYDVDPDNKT-IVMEYIEGKPLKD----- 86

Query: 147 GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
               E     + R I  +V   HK G++H DL   N +  + K    L  IDFGL 
Sbjct: 87  --VIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDK----LYLIDFGLG 136

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 38.2 bits (89), Expect = 0.003
 Identities = 26/81 (32%), Positives = 38/81 (46%), Gaps = 7/81 (8%)

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPE-VL 226
             ++HRDL   N L    K    +K  DFGL+      E+     G      +MA E +L
Sbjct: 128 KRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 227 KRNYGPEIDIWSAGVILYILL 247
            R Y  + D+WS GV ++ L+
Sbjct: 185 HRIYTHKSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 8/86 (9%)

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPE-VLKR 228
           ++HRDL   N L    +    +K  DFGL+      E+     G      +MA E +L R
Sbjct: 130 LVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186

Query: 229 NYGPEIDIWSAGVILYILLC-GVPPF 253
            Y  + D+WS GV ++ L+  G  P+
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	347
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.97
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
PRK10345	210	hypothetical protein; Provisional	99.85
smart00090	237	RIO RIO-like kinase.	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.55
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.54
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.49
KOG3087	229	consensus Serine/threonine protein kinase [General	99.49
KOG1243	690	consensus Protein kinase [General function predict	99.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.45
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.39
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.3
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.21
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.19
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.18
COG4248	637	Uncharacterized protein with protein kinase and he	99.08
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.03
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.02
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.9
PRK09902	216	hypothetical protein; Provisional	98.89
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.87
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.73
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.71
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.69
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.66
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.58
PF01636	239	APH: Phosphotransferase enzyme family This family	98.56
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.53
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.52
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.36
PLN02876	822	acyl-CoA dehydrogenase	98.34
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.25
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.19
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.17
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.12
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.04
KOG2270	520	consensus Serine/threonine protein kinase involved	98.02
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.93
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.91
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.86
PLN02236	344	choline kinase	97.73
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.7
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.69
PRK05231	319	homoserine kinase; Provisional	97.64
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.64
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.61
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.57
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.56
PLN02756	418	S-methyl-5-thioribose kinase	97.54
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.39
PTZ00384	383	choline kinase; Provisional	97.26
PRK12396	409	5-methylribose kinase; Reviewed	97.21
PRK10593	297	hypothetical protein; Provisional	97.16
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.94
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.92
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.86
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.68
PTZ00296	442	choline kinase; Provisional	96.61
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.32
PRK11768	325	serine/threonine protein kinase; Provisional	96.23
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.09
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.87
PRK06148	1013	hypothetical protein; Provisional	95.55
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.07
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.68

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-60  Score=413.84  Aligned_cols=274  Identities=37%  Similarity=0.664  Sum_probs=250.4

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc----hhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT----AVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      .+...+.+.|.+.+.||+|+||.|-+|..+.+|+.||||++++.....    ......+.+|+++|++| +||+|+++++
T Consensus       165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d  243 (475)
T KOG0615|consen  165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKD  243 (475)
T ss_pred             CccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEee
Confidence            345557889999999999999999999999999999999999876544    22445578999999999 9999999999


Q ss_pred             EEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       120 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                      +++..+..||||||++||+|.+.+-.++.+.+..-+.+++||+.|+.|||+.||+||||||+|||+..+.++..+||+||
T Consensus       244 ~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  244 FFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             eeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999999999999999988999999999999999999999999999999999999988778889999999


Q ss_pred             ccccccCCCCcccccccCcccccccccccc----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccccccC
Q 019040          200 GLSIFFKPGERFSEIVGSPYYMAPEVLKRN----YGPEIDIWSAGVILYILLCGVPPFWAESEQG-VAQAILRGLIDFKR  274 (347)
Q Consensus       200 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  274 (347)
                      |+|.......-..+.+|||.|.|||++.+.    +..+.|+|||||++|-+++|.+||.+..... ..+++.++...+.+
T Consensus       324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p  403 (475)
T KOG0615|consen  324 GLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP  403 (475)
T ss_pred             chhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence            999998877778889999999999998632    4458999999999999999999998877665 89999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCC
Q 019040          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (347)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  318 (347)
                      ..|..++++..+||+.||..||++|||+.++|+||||+..+...
T Consensus       404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  404 LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS  447 (475)
T ss_pred             hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence            99999999999999999999999999999999999999886433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-56  Score=407.62  Aligned_cols=259  Identities=36%  Similarity=0.588  Sum_probs=242.8

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .+|...+.||+|||+.||.+++..+|..||+|++.+..+......+.+.+||++++.| +||||++++++|++.+.+|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEE
Confidence            6899999999999999999999999999999999998888888889999999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-C
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-E  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~  209 (347)
                      +|+|+.++|.++++..+.+++..++.+++||+.||.|||+++|+|||||..|+|+   +++..|||+|||+|+..... +
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc
Confidence            9999999999999988999999999999999999999999999999999999999   78889999999999988755 5


Q ss_pred             cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ...+.+|||.|.|||++. ..++..+||||+||+||.|++|++||...+-++.+..|......+|.    .++.+..+||
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI  249 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI  249 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence            667789999999999986 45999999999999999999999999999999999999888776655    7899999999


Q ss_pred             HHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      .++|++||.+|||+.++|.|+||.+-..+
T Consensus       250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p  278 (592)
T KOG0575|consen  250 RKLLRPNPSERPSLDEVLDHPFFKSGFTP  278 (592)
T ss_pred             HHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence            99999999999999999999999555433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-56  Score=384.63  Aligned_cols=258  Identities=27%  Similarity=0.380  Sum_probs=226.5

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC-eE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-AV  127 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~-~~  127 (347)
                      ..++.+.++.||.|+.|+||+++++.+++.+|+|++..+.  ..+..+++.+|+++++.. ++|+|+.+|+.|..++ ..
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceE
Confidence            3457788999999999999999999999999999995432  445668899999999999 9999999999999998 59


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .|+||||++|+|.++++..+.+++..+..++.+++.||.|||+ ++||||||||+|||+   +..|.|||||||.+....
T Consensus       154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILV  230 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhh
Confidence            9999999999999999998899999999999999999999996 999999999999999   667889999999999876


Q ss_pred             CCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhccccccCCCCCC-
Q 019040          207 PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE-----SEQGVAQAILRGLIDFKRDPWPN-  279 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~-  279 (347)
                      +. ...+.+||..|||||.+.+ .|+.++||||||++++|+.+|+.||...     ..-+.+..|..+   .++..... 
T Consensus       231 nS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~---ppP~lP~~~  306 (364)
T KOG0581|consen  231 NS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE---PPPRLPEGE  306 (364)
T ss_pred             hh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC---CCCCCCccc
Confidence            65 5567899999999999886 5999999999999999999999999774     233444444443   33333333 


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      +++++++||..||++||.+|||+.|+++|||+++...
T Consensus       307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  307 FSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            8999999999999999999999999999999999863

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-54  Score=374.14  Aligned_cols=258  Identities=33%  Similarity=0.616  Sum_probs=238.4

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+.|++++.||.|+||+||+++.+.+++.||+|++++..+....+.+...+|..+|..+ +||+|+.++..|++...+|+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEE
Confidence            57899999999999999999999999999999999998888888889999999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc-CCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~-~~~  208 (347)
                      |+||+.||.|.-.|.+.+.|++..+.-++..|+.||.|||++||||||+||+|||+   +..|+++|+|||++... ..+
T Consensus       103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCC
Confidence            99999999999999999999999999999999999999999999999999999999   88999999999999854 444


Q ss_pred             CcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          209 ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      ....+.+||+.|||||++. ..|+..+|+||||+++|+|++|.+||.+.+.....+.+.++....++.   -++.+.+++
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---~ls~~ardl  256 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---YLSEEARDL  256 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---cCCHHHHHH
Confidence            5566789999999999876 559999999999999999999999999999999999998887443332   478999999


Q ss_pred             HHHhccCCCCCCC----CHHHHhcCcccccC
Q 019040          288 VRQMLEPDPKLRL----TAKQVLEHPWLQNA  314 (347)
Q Consensus       288 i~~~l~~dp~~Rp----s~~~ll~h~~~~~~  314 (347)
                      |+++|+.||.+|.    ++.++-+||||+..
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence            9999999999996    68899999999765

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-56  Score=363.17  Aligned_cols=296  Identities=39%  Similarity=0.734  Sum_probs=270.3

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ..+.+.|++-+.||+|.|+.|+++.+..+|+.+|+|++....+... ..+.+.+|+++.+.| +||||+++.+.+.....
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~   84 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL-QHPNIVRLHDSIQEESF   84 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhc-CCCcEeehhhhhcccce
Confidence            4567889999999999999999999999999999999987766555 678899999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .|+|+|++.|++|..-+-.+.-+++..+-..++||++||.|+|.+||||||+||.|+++-+++...-+||+|||+|....
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            99999999999998877776668999999999999999999999999999999999999988888899999999999988


Q ss_pred             CCCcccccccCcccccccccccc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          207 PGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      .+.......|||.|+|||+++.. |+.++|||+-|++||-|+.|.+||++.+....++.|..+...++.+.|+.++++.+
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak  244 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK  244 (355)
T ss_pred             CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence            77777888999999999998755 99999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhhhhHHhhHHHHhhh
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKAL  344 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (347)
                      +||++||..||.+|+|+.++|+|||+++.....+..-.-.+++-++.|--.+-||...|
T Consensus       245 ~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavL  303 (355)
T KOG0033|consen  245 SLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAIL  303 (355)
T ss_pred             HHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHH
Confidence            99999999999999999999999999998766665555666777777777777776643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-54  Score=385.87  Aligned_cols=260  Identities=31%  Similarity=0.566  Sum_probs=241.3

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      -.++|..++.||.|+|++|++|+++.+++.||||++.+..+......+.+..|-.+|.+|.+||.|++++.+|+++..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            35789999999999999999999999999999999999888888888889999999999999999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +|+||+++|+|.+++++.+.|++...+.++.+|+.||+|||++|||||||||+|||+   +.+++++|+|||.|..+.+.
T Consensus       151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChh
Confidence            999999999999999999999999999999999999999999999999999999999   88999999999999876433


Q ss_pred             Ccc--------------cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc
Q 019040          209 ERF--------------SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (347)
Q Consensus       209 ~~~--------------~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  273 (347)
                      ...              ...+||..|.+||++. +..++.+|||+|||++|+|+.|.+||.+.++--.++.|+.....++
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp  307 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP  307 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence            211              3478999999999987 4588899999999999999999999999999999999999888776


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .    +.++.+.+||+++|..||++|+|+.+|.+||||....
T Consensus       308 ~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  308 E----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             C----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence            5    7789999999999999999999999999999998753

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.2e-54  Score=362.23  Aligned_cols=262  Identities=29%  Similarity=0.535  Sum_probs=226.9

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|+.+..+|+|+||.||+++++.||+.||||.+..+ .......+-..+||++|++| +|+|++.++.+|......++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEE
Confidence            5789999999999999999999999999999998543 33344456678999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC-CCC
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~-~~~  209 (347)
                      +|||+..-|.+.-.....++...+..+++|++.|+.|+|++++|||||||+||||   ..++.+||||||+|+... ++.
T Consensus        80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pgd  156 (396)
T KOG0593|consen   80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPGD  156 (396)
T ss_pred             eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCcc
Confidence            9999885554444444669999999999999999999999999999999999999   788899999999999887 667


Q ss_pred             cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC------------
Q 019040          210 RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD------------  275 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------  275 (347)
                      ..+.++.|.+|+|||.+.+  +|+.+.|||++||++.||++|.+.|++..+-+.+-.|......+.+.            
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            7788899999999998875  49999999999999999999999999998888777776655433211            


Q ss_pred             ---------------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          276 ---------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       276 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                     ..+.++.-+.+|++.||+.||++|++.+++|.|+||+...+.
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence                           123566778899999999999999999999999999776644

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-52  Score=376.52  Aligned_cols=296  Identities=57%  Similarity=0.984  Sum_probs=269.7

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ....+...|.+.+.||.|.||.||+++.+.+|+.+|+|++.+...........+.+|+++|+++..|||++.+++.+++.
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            45667789999999999999999999999999999999999888777767789999999999996699999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC-CCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE-NSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~-~~~~~l~Dfg~a~  203 (347)
                      +.+++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.||+|||+||+|+|+....+ ++.++++|||++.
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999999999999887 4999999999999999999999999999999999999986544 5689999999999


Q ss_pred             ccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ...........+||+.|+|||++. ..|+...||||+|+++|.|++|..||++.+.......+..+...+..+.|+.++.
T Consensus       188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            988766778889999999999988 6799999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhhhhHHhhHHHH
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKR  341 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (347)
                      .+.++|..||..||.+|+|+.++|+|||++......+......+....+++...+.++.
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKK  326 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHH
Confidence            99999999999999999999999999999998777766666666666666655444443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-53  Score=352.73  Aligned_cols=257  Identities=29%  Similarity=0.560  Sum_probs=240.3

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...++|++++.||.|+||+|.+++.+.+|..+|+|++.+..+-.....+...+|..+|+.+ .||+++++++.+.+.+.+
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~l  119 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSNL  119 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCeE
Confidence            4457899999999999999999999999999999999998887777888899999999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |+||||++||.|..++++.++|++..++-++.||+.||+|||+++|++||+||+|||+   +.+|.+||+|||+|.....
T Consensus       120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecC
Confidence            9999999999999999999999999999999999999999999999999999999999   8899999999999998654


Q ss_pred             CCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      .  ..+.+|||.|+|||++. ..+..++|+|+||+++|||+.|.+||...++..+.+.|..+...+|.    -.++++++
T Consensus       197 r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kd  270 (355)
T KOG0616|consen  197 R--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKD  270 (355)
T ss_pred             c--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHH
Confidence            4  55679999999999876 55999999999999999999999999999999999999999988876    66899999


Q ss_pred             HHHHhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          287 LVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       287 li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      ||..+|+.|-.+|.     ...++.+||||+..
T Consensus       271 Ll~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  271 LLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             HHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence            99999999999994     56799999999865

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-53  Score=373.86  Aligned_cols=269  Identities=34%  Similarity=0.527  Sum_probs=233.9

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ...+.+||.+++.||.|.||.||+|+.+.+|..||||.+++.- ..- +.-.-.||++.|++|+.||||+++.+++.+.+
T Consensus         5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~-ee~~nLREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            4456789999999999999999999999999999999986543 222 22345679999999966999999999999887


Q ss_pred             -eEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          126 -AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       126 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                       .+|+|||||+. +|+++++.++ .|+++.++.|+.||+.||+|+|.+|++|||+||+||||   .....+||+|||+|+
T Consensus        83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---SGNDVIKIADFGLAR  158 (538)
T ss_pred             ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe---cccceeEeccccccc
Confidence             99999999965 9999998774 59999999999999999999999999999999999999   446679999999999


Q ss_pred             ccCCCCcccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC----
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW----  277 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  277 (347)
                      ........+.++.|.+|+|||++.  +.|+.+.|||++||+++|+.+-++.|.+.++-+.+..|..-+.......|    
T Consensus       159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            999889999999999999999875  45999999999999999999999999999988888777665543322222    


Q ss_pred             ----------------------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCC
Q 019040          278 ----------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV  320 (347)
Q Consensus       278 ----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  320 (347)
                                            +..+.++.++|.+||.+||++|||+.++|+||||+........
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~~  303 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGSS  303 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccccccc
Confidence                                  3477899999999999999999999999999999887655433

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-52  Score=361.90  Aligned_cols=264  Identities=36%  Similarity=0.615  Sum_probs=237.1

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|.+.+.||.|+||+||+|+++.++..||||.+.+... .....+.+..||.+|+.+ +||||+.+++++..++.+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~   85 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIY   85 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEE
Confidence            34789999999999999999999999999999999987654 445567789999999999 8999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCC---CCEEEEeecccccc
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN---SPLKAIDFGLSIFF  205 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~---~~~~l~Dfg~a~~~  205 (347)
                      +|||||+||+|.++++..+.+++.+++.++.||+.||++||+++||||||||.|||+.....+   ..+||.|||+|+..
T Consensus        86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            999999999999999999999999999999999999999999999999999999999764233   57999999999999


Q ss_pred             CCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          206 KPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      .++....+.+|+|.|||||++. .+|+.|+|+||+|+++|++++|..||...+..+.+..+.++....+. ....++...
T Consensus       166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~-~~~~~s~~~  244 (429)
T KOG0595|consen  166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV-LPAELSNPL  244 (429)
T ss_pred             CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc-hhhhccCch
Confidence            9888888899999999999985 67999999999999999999999999999999888877666544332 223556667


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .+++...++.+|.+|.+..+-+.|+++....
T Consensus       245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  245 RELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            7999999999999999999999999998776

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-51  Score=371.11  Aligned_cols=261  Identities=39%  Similarity=0.681  Sum_probs=232.9

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc--hhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT--AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ....++|.+.+.||.|+||+|+.|.+..++..||+|++.+.....  ......+.+|+.+++.+..||||++++.++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            345679999999999999999999999999999999887653321  134567789999999995599999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCC-CCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN-SPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~-~~~~l~Dfg~a~  203 (347)
                      ..+|+||||+.||+|.+++.+.+++.+..+..+++||+.|++|||++||+||||||+|||+   +.+ +.+||+|||++.
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSA  169 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEecccccc
Confidence            9999999999999999999998899999999999999999999999999999999999999   455 889999999999


Q ss_pred             cc-CCCCcccccccCcccccccccccc--C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          204 FF-KPGERFSEIVGSPYYMAPEVLKRN--Y-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       204 ~~-~~~~~~~~~~~~~~y~aPE~~~~~--~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      .. .........+|++.|+|||++.+.  | +.++||||+|++||.|++|..||...+.......+..+...++.    .
T Consensus       170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----~  245 (370)
T KOG0583|consen  170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----Y  245 (370)
T ss_pred             ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----C
Confidence            87 455666778999999999998753  4 57899999999999999999999998888888888887666654    4


Q ss_pred             C-CHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          280 V-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       280 ~-~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      + +.++.+|+.+||.+||.+|+|+.++++||||+..
T Consensus       246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  246 LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence            4 9999999999999999999999999999999983

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.9e-51  Score=367.58  Aligned_cols=262  Identities=32%  Similarity=0.522  Sum_probs=238.3

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      -.++|+++..||+|+||.||+|+.+.||..+|+|++.++.......+..+..|-.+|... ..+.|++++..|++...+|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeE
Confidence            457899999999999999999999999999999999999888888899999999999996 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      |||||++||++..+|.+.+.+++..++.++.+++.|++.||..|+|||||||+|+||   +..|++||+|||++......
T Consensus       218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhh
Confidence            999999999999999999999999999999999999999999999999999999999   89999999999998642110


Q ss_pred             ----------------------C-c-----c--------------------cccccCccccccccccc-cCCCchhHHHH
Q 019040          209 ----------------------E-R-----F--------------------SEIVGSPYYMAPEVLKR-NYGPEIDIWSA  239 (347)
Q Consensus       209 ----------------------~-~-----~--------------------~~~~~~~~y~aPE~~~~-~~~~~~Di~sl  239 (347)
                                            . .     .                    ...+|||.|+|||++.+ .|+..+|+|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                  0 0     0                    12469999999999764 59999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCcccccCc
Q 019040          240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPWLQNAK  315 (347)
Q Consensus       240 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~  315 (347)
                      ||+||||+.|.+||.+.++.+..+.|.+-...+..+.-..++++.+|||.+||. ||++|..   +.+|.+||||+...
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence            999999999999999999999999999888666665556788999999999999 9999995   88999999998764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.2e-50  Score=335.07  Aligned_cols=259  Identities=32%  Similarity=0.541  Sum_probs=230.8

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .+|..++.||+|.||.||+|++.++|+.||||.+.........+ ....+||+.|+.+ +|+||+.++++|...+.+.+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQEL-KHPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHc-cCcchhhhhhhccCCCceEEE
Confidence            57899999999999999999999999999999998765544433 3567799999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      +||++. +|...++... .++...+..++.+++.||+|||++.|+||||||+|+|+   +.+|.+||+|||+++...++.
T Consensus        80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCC
Confidence            999966 9999987764 48999999999999999999999999999999999999   788899999999999887665


Q ss_pred             cc-cccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCC--------
Q 019040          210 RF-SEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP--------  278 (347)
Q Consensus       210 ~~-~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------  278 (347)
                      .. ...+-|.+|+|||.+-+  .|+...||||.||++.||+.|.+.|.+.++-+.+..+.+......+..|+        
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            43 34478999999998753  49999999999999999999999999999999999998888776666664        


Q ss_pred             ----------------CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          279 ----------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       279 ----------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                      ..+++..+|+..||..||.+|+++.|+|+|+||..+.
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                            3567788999999999999999999999999999865

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.9e-52  Score=344.13  Aligned_cols=264  Identities=34%  Similarity=0.662  Sum_probs=241.8

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc-----hhcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-----AVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      ..+-+.|.-.+.||.|..++|.++..+.+|+.+|+|++.......     ..-.+.-.+|+.+|+++.+||+|+.+.++|
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            344567888899999999999999999999999999986432211     112334567999999999999999999999


Q ss_pred             eeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       122 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                      +.+..+++|+|.++.|.|.+++...-.+++...+++++|+++++.|||.++|||||+||+|||+   +++..++|+|||+
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGF  169 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGF  169 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccce
Confidence            9999999999999999999999988889999999999999999999999999999999999999   7888999999999


Q ss_pred             ccccCCCCcccccccCcccccccccc-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLK-------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR  274 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  274 (347)
                      ++.+.++......+|||+|+|||.+.       .+|+...|+|+.|++||.|+.|.+||+.....-+++.|+.+...+..
T Consensus       170 a~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s  249 (411)
T KOG0599|consen  170 ACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS  249 (411)
T ss_pred             eeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence            99999999999999999999999874       24788899999999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                      +.|.+++.+.++||.+||+.||.+|+|++++|.||||.+
T Consensus       250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            999999999999999999999999999999999999943

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-50  Score=371.81  Aligned_cols=261  Identities=35%  Similarity=0.631  Sum_probs=242.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      +-|++++-||.|+.|.|-+|++..||+.+|||++.+...........+.+||-+|+.+ .|||++.+|++|++..++|+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEE
Confidence            5689999999999999999999999999999999887655566677899999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      .||++||.|.+++...+++++..+.++++||+.|+.|||..+|+|||+||+|+|+   +..+.+||+|||+|..-.++.-
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCcc
Confidence            9999999999999999999999999999999999999999999999999999999   5666699999999999888888


Q ss_pred             ccccccCcccccccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ..+.+|+|.|++||++.+.  .+.++||||-|++||.|++|.+||.+.+....+..+.++....|    ..++.++.+||
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLL  243 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLL  243 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHH
Confidence            8899999999999998754  67899999999999999999999999999999999999987766    48899999999


Q ss_pred             HHhccCCCCCCCCHHHHhcCcccccCcCCCC
Q 019040          289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                      .+||..||.+|+|..+|++|||+......+.
T Consensus       244 r~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~  274 (786)
T KOG0588|consen  244 RRMLDVDPSTRITTEEILKHPFLSGYTSLPS  274 (786)
T ss_pred             HHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence            9999999999999999999999988765433

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-50  Score=360.11  Aligned_cols=259  Identities=28%  Similarity=0.496  Sum_probs=229.2

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--Ce
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NA  126 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~~  126 (347)
                      ..+.|+.++.||+|.||.||+|++..+|+.||+|.+..+..... ......+||.+|++| +||||+++.+...+.  ..
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhc-CCCcccceeeEEEecCCce
Confidence            35679999999999999999999999999999999987654333 345678899999999 999999999998876  78


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      +|+|+|||+. +|..++... -+|++.++..+++||+.||+|||++||+|||||.+||||   +++|.+||+|||+|+.+
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeec
Confidence            9999999977 888888764 369999999999999999999999999999999999999   88999999999999966


Q ss_pred             CCCC--cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCC---
Q 019040          206 KPGE--RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP---  278 (347)
Q Consensus       206 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  278 (347)
                      ....  ..+..+-|.+|+|||.+.+  .|+.+.|+||.||+|.||+.|++.|.+.+.-+.+..|.+.........|+   
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            5443  4677789999999998765  49999999999999999999999999999999999998877665555553   


Q ss_pred             ----------------------CCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          279 ----------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       279 ----------------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                                            .++....+|+..||..||.+|.|+.++|+|+||..
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                                  36778889999999999999999999999999933

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-50  Score=371.69  Aligned_cols=258  Identities=29%  Similarity=0.512  Sum_probs=239.0

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      -.++|.+++.||.|+||+|++|..+.+++.+|||++++..+....+++..+.|-+++..+++||++..++..|+..+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            35789999999999999999999999999999999999999899999999999999999988999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC-C
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-P  207 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~-~  207 (347)
                      +||||+.||++.. +.....|++..+.-++..++.||.|||++||||||+|.+|||+   +.+|.+||+|||+++..- .
T Consensus       446 fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  446 FVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCCC
Confidence            9999999999543 3344579999999999999999999999999999999999999   889999999999998754 5


Q ss_pred             CCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      +...++.+|||.|+|||++.+ .|+.+.|+||||++||||+.|..||.+.+.+++...|......+|.    .++.+..+
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~  597 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIA  597 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHH
Confidence            567788999999999999875 4999999999999999999999999999999999999999877765    88999999


Q ss_pred             HHHHhccCCCCCCCCH-----HHHhcCcccccC
Q 019040          287 LVRQMLEPDPKLRLTA-----KQVLEHPWLQNA  314 (347)
Q Consensus       287 li~~~l~~dp~~Rps~-----~~ll~h~~~~~~  314 (347)
                      +|+++|+.+|++|..+     .+|.+||||+..
T Consensus       598 il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             HHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence            9999999999999964     789999999765

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-49  Score=347.99  Aligned_cols=267  Identities=30%  Similarity=0.443  Sum_probs=232.7

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .+..-.+.|++...||.|..++||+|+...++..||||++..+.....  .+.+.+|++.+..+ +||||+.++..|..+
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~-~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLI-DHPNIVTYHCSFVVD   96 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhc-CCCCcceEEEEEEec
Confidence            344445789999999999999999999999999999999988876554  78999999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 NAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      ..+|+||.+|.+|++.++++..  ..+++..+..++++++.||.|||.+|.||||||+.||||   +.+|.|+|+|||.+
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvs  173 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVS  173 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceee
Confidence            9999999999999999999875  349999999999999999999999999999999999999   78899999999977


Q ss_pred             cccCCC-Cc----ccccccCcccccccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc-
Q 019040          203 IFFKPG-ER----FSEIVGSPYYMAPEVLK---RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-  273 (347)
Q Consensus       203 ~~~~~~-~~----~~~~~~~~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-  273 (347)
                      ..+... ..    .....||++|||||++.   .+|+.|+||||||++.+||.+|..||....+..++..-+++..... 
T Consensus       174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence            654332 21    14558999999999964   4599999999999999999999999999998877766666554321 


Q ss_pred             -----CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          274 -----RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       274 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                           .+.....+..++.+|..||+.||.+|||+.++|+|+||++.+..
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence                 12223577889999999999999999999999999999998755

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-50  Score=364.11  Aligned_cols=259  Identities=31%  Similarity=0.518  Sum_probs=227.4

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      +....|.....||+|+.|.||.|+...+++.||||.+...   .....+-+.+|+.+++.+ +|+||+.+++.|-..+.+
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~---~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deL  345 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR---KQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDEL  345 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEec---cCCchhhhHHHHHHHHhc-cchHHHHHHHHhccccee
Confidence            3446788999999999999999999999999999999765   344557799999999999 999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |+||||++||+|.+.+... .+++.++..+++.++.||.|||.+||+|||||.+|||+   ..++.+||+|||++..+..
T Consensus       346 WVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeecccc
Confidence            9999999999999988665 59999999999999999999999999999999999999   6778899999999998766


Q ss_pred             CC-cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          208 GE-RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       208 ~~-~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      .. .....+|||.|||||+.. ..|+++.||||||++++||+-|++||...++-..+..| ..........+..+++.++
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-a~ng~P~lk~~~klS~~~k  500 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPKLKNPEKLSPELK  500 (550)
T ss_pred             ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-hhcCCCCcCCccccCHHHH
Confidence            65 556789999999999886 56999999999999999999999999876655444333 3333444455568999999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +||.+||+.|+++|+++.+||+||||+.+.
T Consensus       501 dFL~~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  501 DFLDRCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             HHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence            999999999999999999999999996664

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=349.60  Aligned_cols=258  Identities=32%  Similarity=0.514  Sum_probs=215.2

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC--eE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN--AV  127 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~--~~  127 (347)
                      ..++...+.||.|+||+||++.+..+|...|||.+....   ....+.+.+|+.+|.+| +||+|++++|......  .+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeee
Confidence            346888999999999999999999999999999987652   11267799999999999 6999999999854444  69


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC-CCCEEEEeecccccc
Q 019040          128 HLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE-NSPLKAIDFGLSIFF  205 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~-~~~~~l~Dfg~a~~~  205 (347)
                      +++|||+++|+|.+++.+.+ .++++.++.+.+||+.||.|||++||||+||||+|||+   +. ++.+||+|||.+...
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCcccccc
Confidence            99999999999999999876 79999999999999999999999999999999999999   45 678999999998876


Q ss_pred             CC----CCcccccccCcccccccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccccccCCCCC
Q 019040          206 KP----GERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAE-SEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       206 ~~----~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ..    ........||+.|||||++...  ...++|||||||++.||+||..||... ......-.+....  ..+....
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip~  246 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIPD  246 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCCc
Confidence            53    1223457899999999998743  334999999999999999999999773 3222222222222  1223445


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      .++.+.++||.+|+..||++|||+.++|+|||++....
T Consensus       247 ~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  247 SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            78999999999999999999999999999999988765

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-49  Score=351.67  Aligned_cols=255  Identities=28%  Similarity=0.521  Sum_probs=224.9

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||.||+|.++.+++.||+|++.............+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEE
Confidence            4789999999999999999999999999999998765443444556788999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      |||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC--
Confidence            9999999999999888889999999999999999999999999999999999999   66788999999998865432  


Q ss_pred             ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+......++.    .++..+.++|+
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~  230 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIK  230 (291)
T ss_pred             cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHHH
Confidence            233568999999998764 4889999999999999999999999998888777777766544432    56889999999


Q ss_pred             HhccCCCCCCCC-----HHHHhcCcccccCc
Q 019040          290 QMLEPDPKLRLT-----AKQVLEHPWLQNAK  315 (347)
Q Consensus       290 ~~l~~dp~~Rps-----~~~ll~h~~~~~~~  315 (347)
                      +||+.||.+||+     +.++++||||+...
T Consensus       231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  261 (291)
T cd05612         231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVD  261 (291)
T ss_pred             HHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence            999999999995     99999999998653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-49  Score=343.86  Aligned_cols=260  Identities=31%  Similarity=0.542  Sum_probs=236.5

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+.|++++.||.|.-|+||+|..+.++..+|+|++.++.+.......+.+.|-+||+.+ +||.++.+|..++.+...|+
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEE
Confidence            46799999999999999999999999999999999998888777888899999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          130 VMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      +||||+||+|....+++  +.|++..++.++..++.||+|||-.|||+||+||+||||   .++|+|.|+||.++.....
T Consensus       155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCC
Confidence            99999999999998876  349999999999999999999999999999999999999   8899999999997653210


Q ss_pred             ---------------------------------C-C-----------------------cccccccCcccccccccccc-
Q 019040          208 ---------------------------------G-E-----------------------RFSEIVGSPYYMAPEVLKRN-  229 (347)
Q Consensus       208 ---------------------------------~-~-----------------------~~~~~~~~~~y~aPE~~~~~-  229 (347)
                                                       . .                       .....+||-.|.|||++.+. 
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 0                       01224689999999999864 


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCC----HHHH
Q 019040          230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT----AKQV  305 (347)
Q Consensus       230 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~l  305 (347)
                      .+.+.|+|+||+++|||+.|..||.+.+.++.+.+++.....++...  .++.+++|||+++|.+||++|..    +.+|
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            99999999999999999999999999999999999999988887664  78899999999999999999998    9999


Q ss_pred             hcCcccccCc
Q 019040          306 LEHPWLQNAK  315 (347)
Q Consensus       306 l~h~~~~~~~  315 (347)
                      .+||||+..+
T Consensus       390 K~HpFF~gVn  399 (459)
T KOG0610|consen  390 KRHPFFEGVN  399 (459)
T ss_pred             hcCccccCCC
Confidence            9999999876

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=342.73  Aligned_cols=268  Identities=33%  Similarity=0.511  Sum_probs=231.2

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee----
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----  123 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~----  123 (347)
                      .+..+|..++.||.|++|.|+.|.++.+|+.||||.+. +.+......++..+|+++++.+ +|+||+.+.+++..    
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~-~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL-NPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhh-hhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeeccccccc
Confidence            34567777899999999999999999999999999984 4466777888999999999999 79999999999865    


Q ss_pred             -CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          124 -DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       124 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                       -+.+|+|+|++ +.+|...++.+..+++..+..+++||+.||+|+|+.|++|||+||+|+|+   +.+..+||+|||+|
T Consensus        97 ~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen   97 KFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLA  172 (359)
T ss_pred             ccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccce
Confidence             36799999999 55999999888779999999999999999999999999999999999999   66777999999999


Q ss_pred             cccCC---CCcccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc----
Q 019040          203 IFFKP---GERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK----  273 (347)
Q Consensus       203 ~~~~~---~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----  273 (347)
                      +....   ....+.++.|.+|+|||++.  ..|+.+.||||.||++.||++|++.|.+.+.-+.+..+..-.+...    
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            98764   33446778999999999865  4599999999999999999999999999887776666655443221    


Q ss_pred             -------------------CC----CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCC
Q 019040          274 -------------------RD----PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP  321 (347)
Q Consensus       274 -------------------~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~  321 (347)
                                         ..    .++..++...+|+.+||++||.+|+|++++|+||||...-.+..++
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence                               11    1357889999999999999999999999999999999887665444

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-50  Score=336.61  Aligned_cols=249  Identities=29%  Similarity=0.504  Sum_probs=214.6

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeee-EEeeC-
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE-ACEDD-  124 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~-~~~~~-  124 (347)
                      ......|+|++.||.|+||.||++.+..+|..+|.|.+.-.... ....+.+..|+.+|++| +||||+++++ .+..+ 
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md-~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD-AKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc-HHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccc
Confidence            33456799999999999999999999999999999999855443 34567788999999999 9999999998 34444 


Q ss_pred             CeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--cEeeCCCCCcEEeecCCCCCCEEE
Q 019040          125 NAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHK--HG--VIHRDLKPENFLFANKKENSPLKA  196 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~--~~--ivH~Dikp~NIli~~~~~~~~~~l  196 (347)
                      ..++|+||+|++|+|...++.    .+.+++..+|+++.|++.||.++|+  ..  |+||||||.|||+   +.+|.+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKL  169 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKL  169 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceee
Confidence            459999999999999998865    2459999999999999999999999  45  9999999999999   78899999


Q ss_pred             EeeccccccCCCCcc-cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC
Q 019040          197 IDFGLSIFFKPGERF-SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR  274 (347)
Q Consensus       197 ~Dfg~a~~~~~~~~~-~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  274 (347)
                      +|||+++........ ...+|||.||+||.+. ..|+.++||||+||++|||+.-..||.+.+-...-..|.++..  ++
T Consensus       170 GDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~--~~  247 (375)
T KOG0591|consen  170 GDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY--PP  247 (375)
T ss_pred             ccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC--CC
Confidence            999999987766543 4578999999999887 5599999999999999999999999999988888888888733  22


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCH
Q 019040          275 DPWPNVSESAKSLVRQMLEPDPKLRLTA  302 (347)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~Rps~  302 (347)
                      -+-.-++.++..||..|+..||..||+.
T Consensus       248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  248 LPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            2224678899999999999999999985

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-49  Score=345.70  Aligned_cols=297  Identities=33%  Similarity=0.554  Sum_probs=259.3

Q ss_pred             ccccchhhcccCCCchhhhhhccCCCCC--ceeeecCCCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEecc
Q 019040            9 AAVAREDVKSNYSSHDHARKEAGANKKQ--PITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK   86 (347)
Q Consensus         9 ~~~~~~~~~s~~~s~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~   86 (347)
                      .+.+.+.+....-.+.............  ...+....+.-.+..+|++.+.||.|.||+|-+|.+...|+.||||.+.+
T Consensus         9 ~~~r~d~~~~a~~~~rp~~~g~i~~~~P~k~~gvkrhhhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrK   88 (668)
T KOG0611|consen    9 DQAREDQCIDACVTHRPTCSGYIYGTHPLKMSGVKRHHHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRK   88 (668)
T ss_pred             hcccCCCCCccccccchhhhhhhcCCCCcccccccccCcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhh
Confidence            4444444455544444443333222221  33333445666778899999999999999999999999999999999999


Q ss_pred             ccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 019040           87 RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ  166 (347)
Q Consensus        87 ~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~  166 (347)
                      +.+....++-.+.+||+|+..| +||||+.+|.+|++.+...|||||..+|.|++|+.+++.+++...+.+++||..|+.
T Consensus        89 dkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVh  167 (668)
T KOG0611|consen   89 DKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVH  167 (668)
T ss_pred             hhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999 999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccccCcccccccccccc--CCCchhHHHHHHHHH
Q 019040          167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILY  244 (347)
Q Consensus       167 ~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~  244 (347)
                      |+|.++++|||+|.+|||+   +.++.+||.|||++..+....-..+++|+|-|.+||++++.  -++..|-||||++||
T Consensus       168 YCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLY  244 (668)
T KOG0611|consen  168 YCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLY  244 (668)
T ss_pred             HHhhccceecccchhheee---cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHH
Confidence            9999999999999999999   78888999999999988877778889999999999998765  457899999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          245 ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       245 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      .|+.|..||.+.+-.....+|.++...-+     .-|.+..-||+.||-.||++|.|..++..|.|++=-
T Consensus       245 tLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-----~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwg  309 (668)
T KOG0611|consen  245 TLVYGTMPFDGRDHKRLVRQISRGAYREP-----ETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWG  309 (668)
T ss_pred             HHhhcccccCCchHHHHHHHhhcccccCC-----CCCchHHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence            99999999999999999999998865443     457889999999999999999999999999998643

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-48  Score=355.88  Aligned_cols=255  Identities=30%  Similarity=0.556  Sum_probs=226.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++.+.||.|+||.||+|+++.+++.||+|++.............+.+|+.+++.+ +||||+++++++...+..++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEE
Confidence            47899999999999999999999999999999999766544445567789999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||||+++++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.......
T Consensus        96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCCc
Confidence            99999999999999888889999999999999999999999999999999999999   677889999999998654322


Q ss_pred             cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                        ....|++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+..+...++    ..++..+.+||
T Consensus       173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li  246 (329)
T PTZ00263        173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARDLV  246 (329)
T ss_pred             --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----CCCCHHHHHHH
Confidence              33578999999998764 488999999999999999999999998887777777766644332    25789999999


Q ss_pred             HHhccCCCCCCCC-----HHHHhcCcccccC
Q 019040          289 RQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       289 ~~~l~~dp~~Rps-----~~~ll~h~~~~~~  314 (347)
                      .+||+.||.+||+     +.++++||||+..
T Consensus       247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            9999999999997     7999999999874

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.2e-49  Score=334.85  Aligned_cols=260  Identities=27%  Similarity=0.449  Sum_probs=227.0

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--CeE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAV  127 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~~~  127 (347)
                      -+.|+.+..|++|+||.||+|+|+.+++.||+|.++-+.....--+ .-.+||.+|.++ +||||+.+-.+....  +.+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~-~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKA-RHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhc-CCCCeeeeEEEEecccccee
Confidence            3679999999999999999999999999999999986653333333 345699999999 899999999887644  679


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      |+|||||+. +|...+..-+ +|...+++.++.|++.|++|||.+.|+|||+||+|+|+   ...|.+||+|||+|+.+.
T Consensus       153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhhc
Confidence            999999976 9999997764 79999999999999999999999999999999999999   788999999999999887


Q ss_pred             CC-CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCC----
Q 019040          207 PG-ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN----  279 (347)
Q Consensus       207 ~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----  279 (347)
                      .+ ...+..+-|.+|+|||.+.+  .|+.+.|+||+||++.||+++.+.|.+....+.+..|.+.........|++    
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            65 44677789999999998764  399999999999999999999999999999999999987776544444421    


Q ss_pred             ------------------------CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          280 ------------------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       280 ------------------------~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                              +++.-.+|++.+|..||.+|.|+.++|+|+||....
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence                                    447778999999999999999999999999999854

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.8e-50  Score=360.16  Aligned_cols=256  Identities=32%  Similarity=0.569  Sum_probs=231.5

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|-+.+.||+|+||+||+|+.+.+.+.||+|.+.+.. +...++..+.+|+++++.+ +||||+.++++|+...++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEE
Confidence            57899999999999999999999999999999998764 3445678899999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      .||+.| +|..++...+.++++.+..++.++..||.|||+.+|+|+|+||.|||+   +..+.+|+||||+|+....+..
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence            999977 999999999999999999999999999999999999999999999999   8889999999999998776654


Q ss_pred             -ccccccCcccccccccccc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          211 -FSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       211 -~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                       .....|||.|||||...+. |+..+|+|||||++||++.|.+||....--.....|..+...+    ....+..+.+|+
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~----p~~~S~~f~nfl  231 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP----PSTASSSFVNFL  231 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC----cccccHHHHHHH
Confidence             3556799999999998754 9999999999999999999999998777666666666654433    348899999999


Q ss_pred             HHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          289 RQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      ..+|.+||.+|++..+++.|||.+....
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhhhhh
Confidence            9999999999999999999999987763

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.9e-48  Score=346.34  Aligned_cols=258  Identities=29%  Similarity=0.476  Sum_probs=218.7

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      |++.+.||.|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.+ +|++++.+++.+...+..++|+|
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEE
Confidence            78899999999999999999999999999998765544444445678899999999 99999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          133 LCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       133 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      |+++++|...+...  ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCe
Confidence            99999998887653  358999999999999999999999999999999999999   6678899999999987654444


Q ss_pred             ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .....|++.|+|||++.+ .++.++||||||+++|+|++|..||...........+..............++.++.+||+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            455678999999998864 5899999999999999999999999876654333333332222223333468899999999


Q ss_pred             HhccCCCCCCCC-----HHHHhcCcccccC
Q 019040          290 QMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       290 ~~l~~dp~~Rps-----~~~ll~h~~~~~~  314 (347)
                      +||+.||++||+     +.++++||||+..
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            999999999997     8999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-49  Score=324.96  Aligned_cols=256  Identities=30%  Similarity=0.567  Sum_probs=237.3

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++++.||.|.||.||+|+.+.++-.||+|++.++.+.......++.+|+++...| +||||+++|+++.++...|+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccceeEE
Confidence            47899999999999999999999999999999999999887777788999999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          130 VMELCEGGELFDRIV--ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       130 v~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      ++||...|+|...|.  ...++++...+.+++|++.||.|+|.++++||||||+|+|+   +..+.+||+|||.+.... 
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-
Confidence            999999999999998  45679999999999999999999999999999999999999   667779999999999866 


Q ss_pred             CCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      .......+||..|.+||+..+ .++...|+|++|++.||++.|.+||......+.++.|.+....++    +.++.+..+
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~d  251 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAAD  251 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHH
Confidence            445567899999999999875 499999999999999999999999999998889999988877666    488999999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +|.+||..+|.+|.+..+++.|||+...
T Consensus       252 lI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  252 LISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHHhccCccccccHHHHhhhHHHHhc
Confidence            9999999999999999999999999764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.7e-48  Score=352.51  Aligned_cols=250  Identities=31%  Similarity=0.554  Sum_probs=219.4

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            3689999999999999999999999999765544445566788899999999 999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-CCcccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~~~~~~~~  215 (347)
                      ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++..... ........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   6778899999999875322 22334457


Q ss_pred             cCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccC
Q 019040          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (347)
Q Consensus       216 ~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (347)
                      ||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+......++    ..++.++.++|.+||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            9999999998864 589999999999999999999999988887777776665544333    36799999999999999


Q ss_pred             CCCCCC-----CHHHHhcCcccccC
Q 019040          295 DPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       295 dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      ||++||     ++.++++||||...
T Consensus       233 dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         233 DPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-48  Score=352.86  Aligned_cols=258  Identities=31%  Similarity=0.506  Sum_probs=225.4

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||.||+|++..+++.||+|++.+...........+.+|+.++..+ +|+||+++++++...+..|+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEE
Confidence            4799999999999999999999999999999999766544444566788999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      |||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.....  .
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~  154 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--Y  154 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--c
Confidence            9999999999999888889999999999999999999999999999999999999   6778899999999976543  2


Q ss_pred             ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC----CCCCHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW----PNVSESAK  285 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  285 (347)
                      .....|++.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+.........+..    ..++.++.
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~  234 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW  234 (333)
T ss_pred             cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence            344578999999998764 5899999999999999999999999988887776666544322222222    25689999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ++|.+||..+|++||++.++++||||.+.
T Consensus       235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         235 DLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            99999999999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=346.13  Aligned_cols=266  Identities=33%  Similarity=0.604  Sum_probs=227.4

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccch-----------hcHHHHHHHHHHHHhCCCCC
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA-----------VDIDDVRREVAIMKHLPKNS  112 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~ei~~l~~l~~h~  112 (347)
                      ......-++|++++.||.|.||.|-+|++..+++.||||++.+......           ..++...+||.+++++ +|+
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~  168 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHP  168 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCc
Confidence            3444556899999999999999999999999999999999987543221           2356899999999999 999


Q ss_pred             ceeEeeeEEee--CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC
Q 019040          113 SIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE  190 (347)
Q Consensus       113 ~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~  190 (347)
                      ||++++.+..+  .+.+|||+|||..|.+.+.-....-+++.+++.+++.+..||+|||..|||||||||+|+|+   ++
T Consensus       169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~  245 (576)
T KOG0585|consen  169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SS  245 (576)
T ss_pred             CeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cC
Confidence            99999999875  47899999999988774432222228999999999999999999999999999999999999   67


Q ss_pred             CCCEEEEeeccccccCCC------CcccccccCccccccccccc---c--CCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 019040          191 NSPLKAIDFGLSIFFKPG------ERFSEIVGSPYYMAPEVLKR---N--YGPEIDIWSAGVILYILLCGVPPFWAESEQ  259 (347)
Q Consensus       191 ~~~~~l~Dfg~a~~~~~~------~~~~~~~~~~~y~aPE~~~~---~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  259 (347)
                      +|++||+|||.+.....+      ......+|||.|+|||.+.+   .  .+.+.||||+|++||.|+.|..||.+....
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            799999999998866322      12344689999999998754   2  456899999999999999999999999999


Q ss_pred             HHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +....|.+....++...  .+..++++||.+||.+||++|++..++..|||.-.-.
T Consensus       326 ~l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  326 ELFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             HHHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            99999999888776543  6889999999999999999999999999999997664

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.1e-47  Score=353.93  Aligned_cols=259  Identities=27%  Similarity=0.450  Sum_probs=220.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||+||+|.++.+++.||+|++.+...........+.+|+.++..+ +|++|+++++.+.+.+.+|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEE
Confidence            4789999999999999999999999999999999765544445566788999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      |||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||+   +.++.++|+|||++........
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   6678899999999875422110


Q ss_pred             ------------------------------------ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCC
Q 019040          211 ------------------------------------FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPF  253 (347)
Q Consensus       211 ------------------------------------~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf  253 (347)
                                                          .....||+.|+|||++. ..++.++||||||+++|+|++|..||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                                12346899999999876 45899999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCC---CCCCHHHHhcCcccccC
Q 019040          254 WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPK---LRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~---~Rps~~~ll~h~~~~~~  314 (347)
                      .+.+.......+.........+....+++++.++|.+|+. +|.   .||++.++++||||+..
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            9888887777776643333223333578999999999775 344   46899999999999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-48  Score=355.22  Aligned_cols=259  Identities=30%  Similarity=0.518  Sum_probs=223.9

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||+||+|++..+++.||+|++.............+.+|+.++..+ +|+||+++++.+.+.+..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEE
Confidence            4799999999999999999999999999999999765544445566788999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      |||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++........
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceecccccc
Confidence            9999999999999888889999999999999999999999999999999999999   6788899999999865422110


Q ss_pred             ---------------------------------------ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCC
Q 019040          211 ---------------------------------------FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGV  250 (347)
Q Consensus       211 ---------------------------------------~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~  250 (347)
                                                             .....||+.|+|||++. ..++.++||||||+++|+|++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                   01235899999999876 45899999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCcccccC
Q 019040          251 PPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPWLQNA  314 (347)
Q Consensus       251 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~  314 (347)
                      .||...+.......+.........+....+++++.++|.+|+. +|.+|++   +.++++||||+..
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999888877777776544433333334678999999999997 8999998   9999999999765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-48  Score=357.52  Aligned_cols=259  Identities=35%  Similarity=0.586  Sum_probs=227.4

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|.+.+.||.|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +|++++++++.+.+.+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEE
Confidence            4799999999999999999999999999999999876554445567788999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      |||+++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++....... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCc
Confidence            9999999999999888889999999999999999999999999999999999999   677889999999987654332 


Q ss_pred             -----------------------------cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 019040          210 -----------------------------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ  259 (347)
Q Consensus       210 -----------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  259 (347)
                                                   ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                         1234568999999998764 5899999999999999999999999998877


Q ss_pred             HHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCC-HHHHhcCcccccC
Q 019040          260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT-AKQVLEHPWLQNA  314 (347)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll~h~~~~~~  314 (347)
                      .....+.........+....+++++.++|..||. ||.+||+ +.++++||||+..
T Consensus       237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            7777776633333333344579999999999998 9999999 9999999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-47  Score=349.58  Aligned_cols=257  Identities=29%  Similarity=0.515  Sum_probs=226.1

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCC-ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTR-ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ...++|.+.+.||.|+||.||+|.++.++ ..||+|++.............+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESY  105 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCE
Confidence            34568999999999999999999977655 68999998766554455567788999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .++||||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.++|+|||++....
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecC
Confidence            99999999999999999888889999999999999999999999999999999999999   677889999999997654


Q ss_pred             CCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          207 PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      ..  .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+......++    ..+++.+.
T Consensus       183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  256 (340)
T PTZ00426        183 TR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCK  256 (340)
T ss_pred             CC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence            32  234578999999998764 488999999999999999999999999888777777777654443    36789999


Q ss_pred             HHHHHhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          286 SLVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       286 ~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      ++|++||+.||.+|+     ++.++++||||++.
T Consensus       257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999999995     89999999999875

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-47  Score=345.53  Aligned_cols=248  Identities=31%  Similarity=0.556  Sum_probs=217.9

Q ss_pred             ecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCc
Q 019040           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (347)
Q Consensus        59 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  138 (347)
                      ||.|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++.+...+..++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            69999999999999999999999999765544455567788999999999 99999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-CcccccccC
Q 019040          139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIVGS  217 (347)
Q Consensus       139 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~~~~~~~~~  217 (347)
                      |.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...... .......||
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCC
Confidence            99999888889999999999999999999999999999999999999   67788999999998754322 223345789


Q ss_pred             ccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCC
Q 019040          218 PYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP  296 (347)
Q Consensus       218 ~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  296 (347)
                      +.|+|||.+.+ .++.++||||||+++|+|++|..||...........+......++    ..+++.+.++|.+||..||
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp  232 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP  232 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCH
Confidence            99999998764 489999999999999999999999998888777777766544332    4678999999999999999


Q ss_pred             CCCC---CHHHHhcCcccccC
Q 019040          297 KLRL---TAKQVLEHPWLQNA  314 (347)
Q Consensus       297 ~~Rp---s~~~ll~h~~~~~~  314 (347)
                      .+||   ++.++++||||.+.
T Consensus       233 ~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         233 TRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHcCCCCCHHHHHcCCCcCCC
Confidence            9997   58999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.8e-47  Score=345.23  Aligned_cols=256  Identities=28%  Similarity=0.473  Sum_probs=223.3

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|++++.||.|+||.||+|.++.+++.||+|++.+...........+..|+.++..+.+|++++.+++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            48899999999999999999999999999999987654445556778889999999966677999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-CCc
Q 019040          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GER  210 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~~~  210 (347)
                      ||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++..... ...
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   6678899999999865322 222


Q ss_pred             ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+......++    ..++.++.++|.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  233 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK  233 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            334578999999998764 488999999999999999999999999888888877776554433    367899999999


Q ss_pred             HhccCCCCCCCCH-----HHHhcCcccccC
Q 019040          290 QMLEPDPKLRLTA-----KQVLEHPWLQNA  314 (347)
Q Consensus       290 ~~l~~dp~~Rps~-----~~ll~h~~~~~~  314 (347)
                      +||+.||.+|++.     .++++||||+..
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         234 GLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999986     899999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.6e-47  Score=346.11  Aligned_cols=251  Identities=31%  Similarity=0.551  Sum_probs=219.4

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|+||.||+|.++.+|+.||+|++.............+.+|+.+++.+ +|||++++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence            4689999999999999999999999999766544445566788899999999 999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-Ccccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~~~~~~~  215 (347)
                      ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++...... .......
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   67788999999998753222 2233457


Q ss_pred             cCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccC
Q 019040          216 GSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (347)
Q Consensus       216 ~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (347)
                      |++.|+|||.+. +.++.++||||||+++|+|++|..||...+.......+......++    ..+++++.++|.+||..
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            899999999876 4589999999999999999999999998888777777665544433    36789999999999999


Q ss_pred             CCCCCC-----CHHHHhcCcccccCc
Q 019040          295 DPKLRL-----TAKQVLEHPWLQNAK  315 (347)
Q Consensus       295 dp~~Rp-----s~~~ll~h~~~~~~~  315 (347)
                      ||++|+     ++.++++|+||....
T Consensus       233 dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         233 DPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             CHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            999998     899999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.5e-47  Score=352.12  Aligned_cols=259  Identities=28%  Similarity=0.468  Sum_probs=219.9

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      .|.+++.||.|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+ +|++|+++++.+.+.+.+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEE
Confidence            689999999999999999999999999999999776555555667899999999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC--
Q 019040          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--  209 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~--  209 (347)
                      ||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.++|+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   667889999999875321000  


Q ss_pred             ----------------------------------------------cccccccCcccccccccc-ccCCCchhHHHHHHH
Q 019040          210 ----------------------------------------------RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVI  242 (347)
Q Consensus       210 ----------------------------------------------~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~  242 (347)
                                                                    ......||+.|+|||++. ..++.++||||||++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                          001346899999999876 448999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhcc--CCCCCCCCHHHHhcCcccccC
Q 019040          243 LYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE--PDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       243 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~--~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +|+|++|..||...+.......+.........+....+++++.+||.+|+.  .+|..|+++.++++||||...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            999999999998887766555555433333333444689999999999654  555569999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.7e-47  Score=345.47  Aligned_cols=251  Identities=30%  Similarity=0.533  Sum_probs=219.2

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|+||+||+|+++.+++.||+|++.+...........+..|+.++..+.+||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999999999999999997655444445667788999998876899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-CCcccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~~~~~~~~  215 (347)
                      ++|..++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++..... ........
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   6778899999999875322 22334457


Q ss_pred             cCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccC
Q 019040          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (347)
Q Consensus       216 ~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (347)
                      ||+.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+.......+    ..++.++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~  233 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTK  233 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccc
Confidence            8999999998764 488999999999999999999999999888888777766544332    35789999999999999


Q ss_pred             CCCCCCCH------HHHhcCcccccC
Q 019040          295 DPKLRLTA------KQVLEHPWLQNA  314 (347)
Q Consensus       295 dp~~Rps~------~~ll~h~~~~~~  314 (347)
                      ||.+||++      .++++||||+..
T Consensus       234 dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            99999998      899999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.3e-47  Score=338.21  Aligned_cols=254  Identities=27%  Similarity=0.442  Sum_probs=212.8

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||.||+|.++.+++.||+|++.....  ......+.+|+.+++.+ +|+||+++++++...+..++|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEE
Confidence            579999999999999999999999999999999865432  22234677899999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      +||+++ +|.+++.... .++...+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++.......
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC
Confidence            999976 8988887654 47899999999999999999999999999999999999   667889999999987643322


Q ss_pred             -cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC-----------
Q 019040          210 -RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD-----------  275 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------  275 (347)
                       ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+..+....+..........           
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence             2234568899999998753  48899999999999999999999998888776665554332211110           


Q ss_pred             ---------------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          276 ---------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       276 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                                     ..+.++.++.+||.+||+.||.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                           112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.9e-47  Score=345.56  Aligned_cols=250  Identities=29%  Similarity=0.536  Sum_probs=218.0

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            3689999999999999999999999999766544455567788999999999 999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-Ccccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~~~~~~~  215 (347)
                      ++|...+.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++...... .......
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccccccc
Confidence            9999999888789999999999999999999999999999999999999   67788999999998753222 2233457


Q ss_pred             cCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccC
Q 019040          216 GSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (347)
Q Consensus       216 ~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (347)
                      ||+.|+|||.+. ..++.++||||||+++|+|++|..||...+.......+......++    ..++.++.++|.+||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIK  232 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCC
Confidence            899999999876 4589999999999999999999999988877766666655443332    36789999999999999


Q ss_pred             CCCCCC-----CHHHHhcCcccccC
Q 019040          295 DPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       295 dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      ||++|+     ++.++++||||...
T Consensus       233 dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999997     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.2e-47  Score=353.77  Aligned_cols=259  Identities=29%  Similarity=0.484  Sum_probs=221.4

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||.|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+ +|++|+++++.+.+.+.+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEE
Confidence            4799999999999999999999999999999999765444444567788999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC--
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG--  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~--  208 (347)
                      |||+++++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.++|+|||++......  
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCcccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   67788999999997522100  


Q ss_pred             ------------------------------------------CcccccccCccccccccccc-cCCCchhHHHHHHHHHH
Q 019040          209 ------------------------------------------ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYI  245 (347)
Q Consensus       209 ------------------------------------------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~  245 (347)
                                                                .......||+.|+|||++.+ .++.++||||||+++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                      00112468999999998764 48999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCC---CHHHHhcCcccccC
Q 019040          246 LLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL---TAKQVLEHPWLQNA  314 (347)
Q Consensus       246 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~  314 (347)
                      |++|..||......+....+.........+....++.++.++|.+|+ .+|.+|+   ++.++++||||+..
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            99999999988877666655544333334444578999999999977 5999999   99999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.7e-47  Score=352.94  Aligned_cols=259  Identities=30%  Similarity=0.512  Sum_probs=222.0

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .+|.+++.||.|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+ +|++|+++++.+.+.+..++|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEE
Confidence            3689999999999999999999999999999999765444445567789999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC--
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG--  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~--  208 (347)
                      |||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.++|+|||++......  
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCcccccccc
Confidence            9999999999999888789999999999999999999999999999999999999   67888999999987532100  


Q ss_pred             ----------------------------------------------CcccccccCcccccccccc-ccCCCchhHHHHHH
Q 019040          209 ----------------------------------------------ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGV  241 (347)
Q Consensus       209 ----------------------------------------------~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~  241 (347)
                                                                    .......||+.|+|||++. ..++.++||||||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                          0011246899999999876 45999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCcccccC
Q 019040          242 ILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPWLQNA  314 (347)
Q Consensus       242 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~  314 (347)
                      ++|+|++|..||...+.......+.........+....+++++.++|.+|+ .+|.+|++   +.++++||||+..
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            999999999999988877666666554444444444578999999999987 49999997   9999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-47  Score=352.91  Aligned_cols=259  Identities=28%  Similarity=0.486  Sum_probs=219.4

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|.+++.||.|+||.||+|.++.+++.||+|++.+...........+.+|+++++.+ +||||+++++++.+.+..|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEE
Confidence            4799999999999999999999999999999998765444444567788999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      |||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||+   +.++.++|+|||++........
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeecccccccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   6778899999999863211000


Q ss_pred             ------------------------------------------------ccccccCcccccccccc-ccCCCchhHHHHHH
Q 019040          211 ------------------------------------------------FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGV  241 (347)
Q Consensus       211 ------------------------------------------------~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~  241 (347)
                                                                      .....||+.|+|||++. ..++.++||||||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                                                            01246899999999876 45899999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCC---CCHHHHhcCcccccC
Q 019040          242 ILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR---LTAKQVLEHPWLQNA  314 (347)
Q Consensus       242 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~~ll~h~~~~~~  314 (347)
                      ++|+|++|..||...........+.........+....++.++.++|.+||. +|.+|   +++.++++||||+..
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999999999998888777666665533333323333578999999999998 66665   599999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.5e-47  Score=349.39  Aligned_cols=261  Identities=32%  Similarity=0.493  Sum_probs=225.7

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++.+.||.|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEE
Confidence            347899999999999999999999999999999999765444444556688899999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||||++|++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.++|+|||++......
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCC
Confidence            999999999999988654 68899999999999999999999999999999999999   67888999999998765433


Q ss_pred             C--cccccccCccccccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          209 E--RFSEIVGSPYYMAPEVLKR-----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       209 ~--~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      .  ......||+.|+|||++.+     .++.++||||||+++|+|++|..||...........+.........+....++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS  275 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence            2  1234579999999998742     37889999999999999999999999988877777776654444434444689


Q ss_pred             HHHHHHHHHhccCCCCC--CCCHHHHhcCcccccC
Q 019040          282 ESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA  314 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~  314 (347)
                      .++.++|..||+.+|++  |+++.++++||||++.
T Consensus       276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            99999999999999998  9999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-49  Score=346.90  Aligned_cols=275  Identities=28%  Similarity=0.469  Sum_probs=233.4

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      ...|...+.||+|+||.||+|.+..+++.||+|++..+.  ....++.+++|+.++.++ +++||.++|+.+..+..+++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHH
Confidence            456888899999999999999999999999999998765  344578899999999999 88999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      +|||+.||++.+.++....+.+..+..+++.++.||.|||..+.+|||||+.|||+   ...+.+||+|||.+.......
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~---s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL---SESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE---eccCcEEEEecceeeeeechh
Confidence            99999999999999888778999999999999999999999999999999999999   556889999999998765443


Q ss_pred             c-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          210 R-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       210 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      . ....+|||.|||||++.. .|+.++||||||++.+||.+|.+|+....+..++..|-+.   .++..-...++.+++|
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~---~PP~L~~~~S~~~kEF  242 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS---APPRLDGDFSPPFKEF  242 (467)
T ss_pred             hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC---CCCccccccCHHHHHH
Confidence            3 266799999999999875 5999999999999999999999999888875433332221   2222223678889999


Q ss_pred             HHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhhhhHHh
Q 019040          288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMM  336 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (347)
                      |..||..||+.||||.++|+|+|++++.  .+..|. ..+...++|+..
T Consensus       243 V~~CL~k~P~~RpsA~~LLKh~FIk~a~--k~s~L~-~~i~r~~~~~~~  288 (467)
T KOG0201|consen  243 VEACLDKNPEFRPSAKELLKHKFIKRAK--KTSELK-ELIDRYKRWRVK  288 (467)
T ss_pred             HHHHhhcCcccCcCHHHHhhhHHHHhcC--CchHHH-HHHHHHHHHhhc
Confidence            9999999999999999999999999942  333333 344566677653

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-47  Score=341.08  Aligned_cols=250  Identities=28%  Similarity=0.409  Sum_probs=213.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC-eEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-AVH  128 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~-~~~  128 (347)
                      .....+.+.||.|+||+||+|.++.+.. ||+|++......... ...+.+|+.++.++ +||||+.++|++.... .++
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~-~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDES-RKAFRREASLLSRL-RHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHH-HHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCceE
Confidence            4456677779999999999999964433 999999765544443 77899999999999 9999999999999887 799


Q ss_pred             EEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-cEeeCCCCCcEEeecCCCCC-CEEEEeeccccc
Q 019040          129 LVMELCEGGELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHG-VIHRDLKPENFLFANKKENS-PLKAIDFGLSIF  204 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dikp~NIli~~~~~~~-~~~l~Dfg~a~~  204 (347)
                      +||||+++|+|.+++..  ...++...+..++.+|+.|+.|||+++ ||||||||.|||+   +.+. ++||+|||+++.
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCcccee
Confidence            99999999999999988  567999999999999999999999999 9999999999999   5665 899999999987


Q ss_pred             cCCC-CcccccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          205 FKPG-ERFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       205 ~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      .... .......||+.|||||++.+   .++.++||||||+++|||+||..||...........+.........  ...+
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~--p~~~  271 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI--PKEC  271 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--CccC
Confidence            6544 33344689999999999984   3999999999999999999999999999886655555544333222  2348


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ++.+..+|..||..||++||++.+++.
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            999999999999999999999998853

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.1e-48  Score=334.09  Aligned_cols=275  Identities=29%  Similarity=0.431  Sum_probs=229.4

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--C
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--N  125 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~  125 (347)
                      ...-.|.-.+.+|.|+||.||+|...++++.||||..-.+.-       .-.+|+++++.+ .||||+++..+|...  +
T Consensus        21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l-~HpNIV~L~~~f~~~~~~   92 (364)
T KOG0658|consen   21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKL-DHPNIVRLLYFFSSSTES   92 (364)
T ss_pred             ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhc-CCcCeeeEEEEEEecCCC
Confidence            344578999999999999999999999999999998754431       122499999999 999999999887643  2


Q ss_pred             ---eEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          126 ---AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       126 ---~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                         +..+|+||++. +|.+.++.    +..++...++.+++||+.||.|||+.||+||||||.|+|++  .+.+.+||||
T Consensus        93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicD  169 (364)
T KOG0658|consen   93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICD  169 (364)
T ss_pred             chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEecc
Confidence               45689999965 99998875    45689999999999999999999999999999999999996  5678999999


Q ss_pred             eccccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc---
Q 019040          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK---  273 (347)
Q Consensus       199 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---  273 (347)
                      ||.|.....+.....+.+|..|+|||.+.+  .|+.+.||||.||+|.||+-|.+.|.+.+..+.+..+.+-.....   
T Consensus       170 FGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  170 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             CCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999999998988889999999999998764  499999999999999999999999999998888888765543221   


Q ss_pred             -----------------CCC-----CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhh
Q 019040          274 -----------------RDP-----WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLK  331 (347)
Q Consensus       274 -----------------~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~  331 (347)
                                       ...     ....+++..+|+.++|+.+|++|.++.+++.||||+.+..+.......-..+.+.
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf  329 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLF  329 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCcc
Confidence                             111     1357899999999999999999999999999999999987733322222334444


Q ss_pred             hh
Q 019040          332 QF  333 (347)
Q Consensus       332 ~~  333 (347)
                      .|
T Consensus       330 ~f  331 (364)
T KOG0658|consen  330 NF  331 (364)
T ss_pred             Cc
Confidence            44

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-46  Score=341.77  Aligned_cols=256  Identities=27%  Similarity=0.453  Sum_probs=223.5

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|++.+.||.|+||.||+|+++.+++.||+|++.+..............|..++..+.+|++++.+++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            48899999999999999999999999999999987654444455667778888888877999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-CCc
Q 019040          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GER  210 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~~~  210 (347)
                      ||+++++|..++.....+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.++|+|||++..... ...
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   6778899999999875432 223


Q ss_pred             ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+......++    ..++.++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  233 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICK  233 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHHHH
Confidence            344578999999998764 589999999999999999999999999888888877776654433    367899999999


Q ss_pred             HhccCCCCCCCC-----HHHHhcCcccccC
Q 019040          290 QMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       290 ~~l~~dp~~Rps-----~~~ll~h~~~~~~  314 (347)
                      +||+.||++|++     ..++++||||+..
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             HHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999998     4899999999764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-46  Score=335.68  Aligned_cols=256  Identities=29%  Similarity=0.463  Sum_probs=211.3

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||.||+|+++.+++.||+|++..... .......+.+|+.+++.+ +|+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEE
Confidence            479999999999999999999999999999999865432 233456788899999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      |||++++.+..+......+++..+..++.|++.||.|||+.||+|+||||+||++   +.++.++|+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccccc
Confidence            9999887665554444569999999999999999999999999999999999999   677889999999998754322 


Q ss_pred             -cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc--------------
Q 019040          210 -RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK--------------  273 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  273 (347)
                       ......+++.|+|||++. ..++.++||||||+++|+|++|..||...+.......+.......+              
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence             223456899999999875 4588999999999999999999999988766544433322111100              


Q ss_pred             -----C---------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          274 -----R---------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       274 -----~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                           .         .....++.++.+||.+||+.||++|||+.++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                 0         0011367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.5e-47  Score=342.50  Aligned_cols=251  Identities=28%  Similarity=0.510  Sum_probs=219.8

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|+||.||+|+++.+++.||+|++.+...........+..|..++..+.+||+|+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36899999999999999999999999998765544555667788999998877899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-Ccccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~~~~~~~  215 (347)
                      ++|...+.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...... .......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccc
Confidence            9999999888889999999999999999999999999999999999999   67788999999998754322 2233456


Q ss_pred             cCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccC
Q 019040          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (347)
Q Consensus       216 ~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (347)
                      |++.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+......++    ..++.++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFMTK  233 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcc
Confidence            8999999998764 589999999999999999999999999988888887776654333    25789999999999999


Q ss_pred             CCCCCC-------CHHHHhcCcccccC
Q 019040          295 DPKLRL-------TAKQVLEHPWLQNA  314 (347)
Q Consensus       295 dp~~Rp-------s~~~ll~h~~~~~~  314 (347)
                      ||++||       ++.++++||||...
T Consensus       234 dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence            999999       89999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-48  Score=323.85  Aligned_cols=273  Identities=38%  Similarity=0.689  Sum_probs=245.3

Q ss_pred             CCCCcccceeeee-eecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           45 PKENIEDRYLVDR-ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        45 ~~~~~~~~y~i~~-~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      ....+.++|.+-. .||.|-.|.|..+.++.+++.+|+|++..+        ....+|++..-..+.|+||+.++++|++
T Consensus        55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            4445667787764 589999999999999999999999998532        4567799999888899999999999875


Q ss_pred             C----CeEEEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          124 D----NAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       124 ~----~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                      .    ..+.+|||.++||.|...+..++.  |.+..+..|++||+.|+.|||+.+|.||||||+|+|+.....+..+||+
T Consensus       127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence            4    678899999999999999988755  9999999999999999999999999999999999999988888999999


Q ss_pred             eeccccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccccc
Q 019040          198 DFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDF  272 (347)
Q Consensus       198 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~  272 (347)
                      |||+|..........+.+.||.|.|||+++ ..|+...|+||+|++||.|++|.+||.+..    ...+...|..+...|
T Consensus       207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            999999877666677778999999999998 459999999999999999999999997653    457788899999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHH
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDV  325 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~  325 (347)
                      +.+.|..++++.+++|+.+|..+|.+|.|..+++.|||+.....-+..++.+.
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~  339 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTS  339 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhh
Confidence            99999999999999999999999999999999999999999988888887543

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.1e-47  Score=345.92  Aligned_cols=259  Identities=29%  Similarity=0.436  Sum_probs=223.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|.+.+.||.|+||+||+|.++.+++.||+|++.............+.+|+.+++.+ +|++++++++.+.+.+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEE
Confidence            4799999999999999999999999999999999866544445567788999999998 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence            9999999999999876 679999999999999999999999999999999999999   677889999999998654433


Q ss_pred             cc--cccccCcccccccccc-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          210 RF--SEIVGSPYYMAPEVLK-------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       210 ~~--~~~~~~~~y~aPE~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      ..  ....+|+.|+|||++.       ..++.++||||||+++|+|++|..||...........+.........+....+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV  236 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence            22  2346899999999874       23778999999999999999999999888877777766554332222333468


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +.++.+||..||+ +|.+|||+.++++||||+..
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            8999999999998 99999999999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-46  Score=334.33  Aligned_cols=259  Identities=31%  Similarity=0.501  Sum_probs=219.9

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      .|++.+.||.|+||.||++.+..+++.||+|++.............+.+|+.+++.+ +|++++++++.+...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence            488999999999999999999999999999998765444444455678899999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       132 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||+++++|.+.+...  ..+++..+..++.|++.||.|||+.|++|+||+|+||++   ++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence            999999999888654  358999999999999999999999999999999999999   677889999999998765444


Q ss_pred             cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ......|++.|+|||.+. ..++.++||||+|+++|++++|..||.+.........+..............++..+.++|
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            444457899999999876 4488999999999999999999999988766544434433333223333346889999999


Q ss_pred             HHhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          289 RQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       289 ~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      .+||+.||++||     ++.++++||||+..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            999999999999     89999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.5e-46  Score=340.42  Aligned_cols=251  Identities=31%  Similarity=0.532  Sum_probs=219.2

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|+||+||+|.++.+++.||+|++.+...........+.+|+.++..+.+||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999999999999998765444555677888999999887899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-CCcccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~~~~~~~~  215 (347)
                      ++|...+.....+++..+..++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||++..... ........
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   6678899999999865322 22233456


Q ss_pred             cCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccC
Q 019040          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (347)
Q Consensus       216 ~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (347)
                      +++.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+......++    ..++..+.++|.+||+.
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTK  233 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccC
Confidence            8999999998764 589999999999999999999999998887777777665544332    36789999999999999


Q ss_pred             CCCCCCCH-----HHHhcCcccccC
Q 019040          295 DPKLRLTA-----KQVLEHPWLQNA  314 (347)
Q Consensus       295 dp~~Rps~-----~~ll~h~~~~~~  314 (347)
                      ||++||++     .++++||||+..
T Consensus       234 dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999     999999999875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.7e-46  Score=339.60  Aligned_cols=251  Identities=31%  Similarity=0.512  Sum_probs=215.9

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|+||.||+|.+..+++.||+|++.............+..|..++..+.+||||+++++++...+..++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999999999999999997655444444556667777887666899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-Ccccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~~~~~~~  215 (347)
                      ++|..++.....+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++...... .......
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   67788999999998754322 2234457


Q ss_pred             cCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccC
Q 019040          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (347)
Q Consensus       216 ~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (347)
                      ||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+.......+......++    ..++.++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFER  233 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            8999999998764 489999999999999999999999999888777777765443322    36789999999999999


Q ss_pred             CCCCCCCHH-HHhcCcccccC
Q 019040          295 DPKLRLTAK-QVLEHPWLQNA  314 (347)
Q Consensus       295 dp~~Rps~~-~ll~h~~~~~~  314 (347)
                      ||++||++. ++++||||+..
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         234 DPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             CHHHcCCChHHHHcCcccCCC
Confidence            999999865 88899999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.9e-47  Score=347.36  Aligned_cols=259  Identities=29%  Similarity=0.492  Sum_probs=221.3

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      +.|++.+.||.|+||+||+|.++.+++.||+|++.............+.+|+.++..+ +|++++++++.+.+.+.+++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence            4689999999999999999999999999999999765544455567888999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      |||++|++|.+++.+...+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   677889999999986432110 


Q ss_pred             -----------------------------------cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCC
Q 019040          210 -----------------------------------RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPF  253 (347)
Q Consensus       210 -----------------------------------~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf  253 (347)
                                                         ......||+.|+|||++. ..++.++||||||+++|+|++|..||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                               011346899999999876 45899999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCC---CHHHHhcCcccccC
Q 019040          254 WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL---TAKQVLEHPWLQNA  314 (347)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~  314 (347)
                      ...+.......+.........+....++.++.++|.+++. ||.+|+   ++.++++||||+..
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            9888877777666533222222223478999999999875 999998   48999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.6e-46  Score=341.73  Aligned_cols=251  Identities=29%  Similarity=0.513  Sum_probs=213.0

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|+||.||+|.++.+++.||+|++.++..........+.+|..++..+.+||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999999999999999998765555556677889999999997899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC-CCCcccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~-~~~~~~~~~  215 (347)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.... .........
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   667889999999987532 223334467


Q ss_pred             cCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES---------EQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       216 ~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      ||+.|+|||++.+ .++.++||||||+++|+|++|..||....         .....+.+.......    ...++..+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----p~~~~~~~~  233 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI----PRSLSVKAS  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC----CCCCCHHHH
Confidence            8999999998764 48899999999999999999999995321         112333333332222    236789999


Q ss_pred             HHHHHhccCCCCCCCC------HHHHhcCcccccC
Q 019040          286 SLVRQMLEPDPKLRLT------AKQVLEHPWLQNA  314 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps------~~~ll~h~~~~~~  314 (347)
                      ++|.+||+.||.+|++      +.++++||||+..
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999999997      7899999999763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.2e-46  Score=336.02  Aligned_cols=259  Identities=25%  Similarity=0.381  Sum_probs=209.3

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++.+.||.|+||.||+|.++.+++.||+|++.....  ......+.+|+.+++.+ +|+|++++++++.+....++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEE
Confidence            4789999999999999999999999999999999865432  22234577899999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++......
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCC
Confidence            999996 5787877664 458999999999999999999999999999999999999   67788999999998754322


Q ss_pred             -CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccc------------
Q 019040          209 -ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDF------------  272 (347)
Q Consensus       209 -~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~------------  272 (347)
                       .......+++.|+|||++.+  .++.++||||||+++|+|++|..||.+.... .....+.......            
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence             22234568899999998753  4888999999999999999999999775432 2232222111100            


Q ss_pred             --cCCCC--------------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          273 --KRDPW--------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       273 --~~~~~--------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                        ....+              ...+.++.+||.+||+.||.+|||+.++++||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence              00000              12456789999999999999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.7e-46  Score=346.42  Aligned_cols=261  Identities=31%  Similarity=0.475  Sum_probs=223.3

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++.+.||.|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++.+.+++..|
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEE
Confidence            357899999999999999999999999999999999765444444456688899999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecccC
Confidence            999999999999988654 68999999999999999999999999999999999999   67788999999999865432


Q ss_pred             Cc--ccccccCccccccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          209 ER--FSEIVGSPYYMAPEVLKR-----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       209 ~~--~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ..  .....||+.|+|||++.+     .++.++||||||+++|+|++|..||...+.......+.........+....++
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  275 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS  275 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence            22  234579999999998753     27889999999999999999999999888877777776654433333334678


Q ss_pred             HHHHHHHHHhccCCCCC--CCCHHHHhcCcccccC
Q 019040          282 ESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA  314 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~  314 (347)
                      ..+.++|..||+.++.+  |+++.++++||||+..
T Consensus       276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            99999999999866554  8999999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.2e-46  Score=340.24  Aligned_cols=254  Identities=30%  Similarity=0.504  Sum_probs=217.6

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC--CCCceeEeeeEEeeCCeEEEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~--~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      |++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++..+.  +||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            688999999999999999999999999999997654444445567777777665332  799999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-CC
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~~  209 (347)
                      |||+++++|...+.. ..+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++..... ..
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCCC
Confidence            999999999887754 469999999999999999999999999999999999999   6778899999999875332 22


Q ss_pred             cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+.......+......++    ..++..+.++|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li  232 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISIM  232 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHH
Confidence            2344678999999998764 488999999999999999999999998888877777766544332    36789999999


Q ss_pred             HHhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          289 RQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       289 ~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      .+||+.||++||     ++.++++||||++.
T Consensus       233 ~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         233 RRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            999999999999     79999999999875

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2e-46  Score=339.20  Aligned_cols=251  Identities=27%  Similarity=0.469  Sum_probs=215.7

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|+||.||+|.++.+|+.||+|++.+..............|..++..+.+|++++++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46899999999999999999999999997654433344566777888888766899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-CCcccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~~~~~~~~  215 (347)
                      ++|..++.....+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++..... ........
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccC
Confidence            9999999888789999999999999999999999999999999999999   6678899999999875322 22234457


Q ss_pred             cCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccC
Q 019040          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (347)
Q Consensus       216 ~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (347)
                      ||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+......++    ..++.++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFER  233 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHccC
Confidence            8999999998864 589999999999999999999999998888777776655443332    25789999999999999


Q ss_pred             CCCCCCCH-HHHhcCcccccC
Q 019040          295 DPKLRLTA-KQVLEHPWLQNA  314 (347)
Q Consensus       295 dp~~Rps~-~~ll~h~~~~~~  314 (347)
                      ||++||++ .++++||||+..
T Consensus       234 dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         234 DPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             CHHHcCCChHHHHcCCCcCCC
Confidence            99999998 588899999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-46  Score=324.05  Aligned_cols=264  Identities=29%  Similarity=0.475  Sum_probs=227.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCc-eeEeeeEEeeCC---
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IVSLKEACEDDN---  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~-i~~~~~~~~~~~---  125 (347)
                      ...|..++.||+|+||+||+|+.+.+|+.||+|.+..+...+ -......+|+.+++.| +|+| |+.+++++...+   
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-G~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-GVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-CCCchhhHHHHHHHHh-CCCcceEEEEeeeeeccccc
Confidence            456888899999999999999999999999999997664321 2335577899999999 8888 999999998877   


Q ss_pred             ---eEEEEEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          126 ---AVHLVMELCEGGELFDRIVARG----HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       126 ---~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                         ..++|+||++. +|..++....    .++...++.+++||+.||+|||++||+||||||.||+|   ++.|.+||+|
T Consensus        88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaD  163 (323)
T KOG0594|consen   88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLAD  163 (323)
T ss_pred             ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeec
Confidence               89999999965 9999998765    47888999999999999999999999999999999999   6689999999


Q ss_pred             eccccccC-CCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC
Q 019040          199 FGLSIFFK-PGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD  275 (347)
Q Consensus       199 fg~a~~~~-~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  275 (347)
                      ||+|+... +.....+.++|.+|+|||++.+  .|+...||||+||+++||+++...|.+..+.+.+..|.+........
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            99999766 3344677789999999998764  49999999999999999999999999999988888887776555444


Q ss_pred             CCC--------------------------CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCC
Q 019040          276 PWP--------------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       276 ~~~--------------------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                      .|+                          ..+.+..+++.+||+.+|..|.|+..+|+||||+......+
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~  313 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS  313 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence            443                          23357889999999999999999999999999999865443

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.4e-47  Score=343.11  Aligned_cols=250  Identities=30%  Similarity=0.554  Sum_probs=217.7

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|+||.||+|.+..+++.||+|++.+...........+.+|++++..+ +|+||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999999999999999999876544445566778899999999 999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-CCccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEI  214 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~~~~~~~  214 (347)
                      ++|..++.....+++..+..++.||+.||.|||+ .||+||||||+|||+   +.++.++|+|||++..... .......
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccc
Confidence            9999999888889999999999999999999997 799999999999999   6778899999999875322 2233345


Q ss_pred             ccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhcc
Q 019040          215 VGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (347)
Q Consensus       215 ~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (347)
                      .||+.|+|||++. ..++.++||||||+++|+|++|..||...+.......+......++    ..+++++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~  232 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLK  232 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhh
Confidence            7999999999876 4589999999999999999999999988887776666655544333    3678999999999999


Q ss_pred             CCCCCCC-----CHHHHhcCcccccC
Q 019040          294 PDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       294 ~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      .||++|+     ++.++++||||...
T Consensus       233 ~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            9999997     99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.5e-46  Score=342.51  Aligned_cols=256  Identities=30%  Similarity=0.550  Sum_probs=214.1

Q ss_pred             ceeeeeeecccCCeEEEEEEEC---CCCceeEEeEecccccc-chhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      +|++.+.||.|+||.||+|++.   .+++.||+|++.+.... .......+.+|+.+++.+.+|++|+.+++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4889999999999999999874   47899999998764332 2334566888999999997799999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      ++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccc
Confidence            9999999999999999888889999999999999999999999999999999999999   6678899999999876433


Q ss_pred             CC--cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccccccCCCCCC
Q 019040          208 GE--RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQ----GVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       208 ~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ..  ......||+.|+|||.+.+  .++.++||||||+++|+|++|..||......    .....+...    .......
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~  233 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC----DPPFPSF  233 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC----CCCCCCC
Confidence            22  2234578999999998764  3788999999999999999999999654322    222333322    2223346


Q ss_pred             CCHHHHHHHHHhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          280 VSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      ++..+.++|.+||+.||++||     ++.++++||||+..
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            889999999999999999999     88899999999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-46  Score=340.83  Aligned_cols=262  Identities=30%  Similarity=0.451  Sum_probs=213.2

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC-----Ce
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD-----NA  126 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~-----~~  126 (347)
                      +|++.+.||.|+||.||+|+++.+++.||+|.+.... ........+.+|+.+++.+ +||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCce
Confidence            6899999999999999999999999999999986432 2233445788999999999 999999999987543     35


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .|+|+||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++....
T Consensus        79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccc
Confidence            899999995 5899999888789999999999999999999999999999999999999   678889999999987543


Q ss_pred             CCC----cccccccCcccccccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------
Q 019040          207 PGE----RFSEIVGSPYYMAPEVLK---RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI---------  270 (347)
Q Consensus       207 ~~~----~~~~~~~~~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------  270 (347)
                      ...    ......+++.|+|||++.   ..++.++||||||+++|+|++|..||.+.+.......+.....         
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            221    123457899999999875   3588999999999999999999999987665433322211100         


Q ss_pred             ------------------cccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCC
Q 019040          271 ------------------DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       271 ------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                                        ......++.+++++.++|.+||+.||++|||+.++++||||+.......
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~  301 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVER  301 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcccc
Confidence                              0001122457888999999999999999999999999999988765443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.1e-46  Score=337.58  Aligned_cols=256  Identities=27%  Similarity=0.473  Sum_probs=222.8

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      .|++.+.||.|+||+||+|.++.+|+.||+|++.+...........+..|..++..+.+|++++++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            47889999999999999999999999999999976654444455678889999998867888999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-c
Q 019040          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-R  210 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-~  210 (347)
                      ||+++++|..++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++....... .
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCcc
Confidence            999999999999888889999999999999999999999999999999999999   677889999999987543222 2


Q ss_pred             ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......++    ..++.++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  233 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK  233 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Confidence            334568999999998764 489999999999999999999999999888877777776554433    367899999999


Q ss_pred             HhccCCCCCCCC-----HHHHhcCcccccC
Q 019040          290 QMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       290 ~~l~~dp~~Rps-----~~~ll~h~~~~~~  314 (347)
                      +||+.+|.+|++     ..++++||||+..
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            999999999997     5799999999875

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-45  Score=336.23  Aligned_cols=259  Identities=23%  Similarity=0.355  Sum_probs=217.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++.+.||.|+||.||+|.+..++..||+|++..+.  .......+.+|+++++.+ +|+||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEE
Confidence            578999999999999999999999999999999986542  223456789999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+||++   +.++.++|+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence            999999999999998888899999999999999999999986 69999999999999   66788999999998765432


Q ss_pred             CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-----------------
Q 019040          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI-----------------  270 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------------  270 (347)
                       ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||...+..+....+.....                 
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence             2234578999999998764 489999999999999999999999977665443322211100                 


Q ss_pred             -------------------------cc--cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          271 -------------------------DF--KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       271 -------------------------~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                               ..  +......+++++.+||.+||+.||++|||+.++++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                     00  0001124678999999999999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.2e-46  Score=335.92  Aligned_cols=252  Identities=26%  Similarity=0.457  Sum_probs=215.7

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||+|+||+||+|.+..+++.||+|++................|..++..+.+||+|+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999999999999999997654333344556677888888766999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-Ccccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~~~~~~~  215 (347)
                      ++|..++.....+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++...... .......
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeec
Confidence            9999999887789999999999999999999999999999999999999   66778999999998753222 2234457


Q ss_pred             cCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccC
Q 019040          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (347)
Q Consensus       216 ~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (347)
                      ||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.....+.+......++    ..++.++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR  233 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence            8999999998764 589999999999999999999999998888777776655433222    25789999999999999


Q ss_pred             CCCCCCCHH-HHhcCcccccCc
Q 019040          295 DPKLRLTAK-QVLEHPWLQNAK  315 (347)
Q Consensus       295 dp~~Rps~~-~ll~h~~~~~~~  315 (347)
                      ||++||++. ++++||||+...
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         234 EPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             CHhhcCCChHHHHcCcccCCCC
Confidence            999999997 899999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.8e-46  Score=338.53  Aligned_cols=251  Identities=28%  Similarity=0.492  Sum_probs=212.0

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++..+.+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46899999999999999999999999998765555556677888999998887899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-CCcccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~~~~~~~~  215 (347)
                      ++|..++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..... ........
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   6778899999999875322 22334457


Q ss_pred             cCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE---------SEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       216 ~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      ||+.|+|||++.+ .++.++||||||+++|+|++|..||...         ......+.+......+    ...++..+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~----p~~~~~~~~  233 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI----PRSLSVKAA  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCC----CCCCCHHHH
Confidence            8999999998764 4889999999999999999999999531         1112233333332222    236789999


Q ss_pred             HHHHHhccCCCCCCCC------HHHHhcCcccccC
Q 019040          286 SLVRQMLEPDPKLRLT------AKQVLEHPWLQNA  314 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps------~~~ll~h~~~~~~  314 (347)
                      ++|.+||+.||++||+      +.++++||||+..
T Consensus       234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999999998      5799999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.3e-46  Score=346.76  Aligned_cols=261  Identities=31%  Similarity=0.444  Sum_probs=218.5

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCC-----CCceeEeeeE
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK-----NSSIVSLKEA  120 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~-----h~~i~~~~~~  120 (347)
                      .+.+.-+|.|++.||+|+||.|.+|.|..+++.||||+++...    .-..+...|+.+|..|++     .-|+++++++
T Consensus       181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~  256 (586)
T KOG0667|consen  181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY  256 (586)
T ss_pred             cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence            3344558999999999999999999999999999999996542    223456669999999952     3569999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      +...++.|||+|++ +.+|.++++.++  .++...++.++.||+.||..||+.||||+||||+|||+..... ..|||+|
T Consensus       257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r-~~vKVID  334 (586)
T KOG0667|consen  257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR-SRIKVID  334 (586)
T ss_pred             cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc-CceeEEe
Confidence            99999999999999 569999998874  4899999999999999999999999999999999999976433 3899999


Q ss_pred             eccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCC-
Q 019040          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP-  276 (347)
Q Consensus       199 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  276 (347)
                      ||.|+.....  .-.++.+..|+|||++.+ .|+.+.|||||||+++||++|.+.|.+.+..+.+..|.+.....+... 
T Consensus       335 FGSSc~~~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  335 FGSSCFESQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             cccccccCCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9999875433  236788999999998764 599999999999999999999999999998888877755442111000 


Q ss_pred             ----------------------------------------------CC------------CCCHHHHHHHHHhccCCCCC
Q 019040          277 ----------------------------------------------WP------------NVSESAKSLVRQMLEPDPKL  298 (347)
Q Consensus       277 ----------------------------------------------~~------------~~~~~~~~li~~~l~~dp~~  298 (347)
                                                                    .+            .....+.++|++||..||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence                                                          00            13356789999999999999


Q ss_pred             CCCHHHHhcCcccccC
Q 019040          299 RLTAKQVLEHPWLQNA  314 (347)
Q Consensus       299 Rps~~~ll~h~~~~~~  314 (347)
                      |+|+.++|+||||...
T Consensus       493 R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  493 RITPAQALNHPFLTGT  508 (586)
T ss_pred             cCCHHHHhcCcccccc
Confidence            9999999999999843

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-45  Score=341.69  Aligned_cols=255  Identities=24%  Similarity=0.404  Sum_probs=208.2

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|.+++.||.|+||.||+|.+..+++.||+|....         ..+.+|+++++.+ +||||+++++++......+
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAI-NHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeE
Confidence            34689999999999999999999999999999997532         3467899999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +++|++. ++|..++.....++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++......
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCcccccccc
Confidence            9999995 5898998887789999999999999999999999999999999999999   66788999999998653222


Q ss_pred             --CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhccccc------
Q 019040          209 --ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES-------EQGVAQAILRGLIDF------  272 (347)
Q Consensus       209 --~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~------  272 (347)
                        .......||+.|+|||++.+ .++.++||||||+++|+|++|..||....       ....+..+.......      
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence              22234579999999998764 58999999999999999999998875432       111222221111100      


Q ss_pred             ----------------------cCCCC---CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          273 ----------------------KRDPW---PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       273 ----------------------~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                            ..+.|   ..++.++.+||.+||+.||.+|||+.++|+||||+....+
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence                                  00011   1356789999999999999999999999999999986544

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9e-46  Score=341.77  Aligned_cols=262  Identities=32%  Similarity=0.479  Sum_probs=223.8

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++.+.||.|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++.+...+..+
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEE
Confidence            347999999999999999999999999999999998764444444456688899999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++......
T Consensus       120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcC
Confidence            999999999999988654 58999999999999999999999999999999999999   66788999999999865432


Q ss_pred             C--cccccccCccccccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          209 E--RFSEIVGSPYYMAPEVLKR-----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       209 ~--~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      .  ......||+.|+|||++.+     .++.++||||||+++|+|++|..||...+.......+.........+....++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  275 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence            2  1234579999999998753     27889999999999999999999999988877777777655444444445789


Q ss_pred             HHHHHHHHHhccCCCCC--CCCHHHHhcCcccccCc
Q 019040          282 ESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~~  315 (347)
                      ..+.++|..||..++.+  |+++.++++|+||++.+
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            99999999999855544  78999999999998743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.5e-46  Score=329.58  Aligned_cols=252  Identities=29%  Similarity=0.492  Sum_probs=209.5

Q ss_pred             ecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCc
Q 019040           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (347)
Q Consensus        59 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  138 (347)
                      ||.|+||+||+|.++.+++.||+|.+.............+..|+.+++.+ +|++++++.+++...+..++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            69999999999999999999999998765544444456778899999999 99999999999999999999999999999


Q ss_pred             hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc-ccc
Q 019040          139 LFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSE  213 (347)
Q Consensus       139 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~-~~~  213 (347)
                      |...+..    ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++........ ...
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccc
Confidence            9887743    2458999999999999999999999999999999999999   6678899999999876544322 234


Q ss_pred             cccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhc
Q 019040          214 IVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML  292 (347)
Q Consensus       214 ~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  292 (347)
                      ..|++.|+|||.+. ..++.++||||||+++|+|++|..||...........+.......+......++.++.+++.+||
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            57899999999876 45889999999999999999999999765433222222222222222333468899999999999


Q ss_pred             cCCCCCCC-----CHHHHhcCcccccC
Q 019040          293 EPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       293 ~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      +.||++||     ++.++++||||+..
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            99999999     88999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.4e-46  Score=335.89  Aligned_cols=251  Identities=32%  Similarity=0.555  Sum_probs=215.9

Q ss_pred             eeeecccCCeEEEEEEEC---CCCceeEEeEeccccc-cchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           56 DRELGRGEFGVTYLCIDR---DTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~-~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      ++.||.|+||.||+|++.   .+++.||+|++.+... ........+.+|+.+++.+ +||||+++++.+..++..|+||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEE
Confidence            367999999999999874   4788999999876543 2223445678899999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-Cc
Q 019040          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ER  210 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~~  210 (347)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...... ..
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCc
Confidence            999999999999888889999999999999999999999999999999999999   67788999999998753322 22


Q ss_pred             ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .....|++.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+.......+    +.+++++.++|.
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~  232 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLK  232 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            334578999999998764 488999999999999999999999998888777777766644332    367899999999


Q ss_pred             HhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          290 QMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       290 ~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      +||+.||++||     ++.++++||||+..
T Consensus       233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.8e-46  Score=337.32  Aligned_cols=250  Identities=28%  Similarity=0.509  Sum_probs=213.7

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHH-HHHhCCCCCceeEeeeEEeeCCeEEEEEEecC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA-IMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~-~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (347)
                      +.||.|+||+||+|.++.+|+.||+|++.+...........+..|.. +++.+ +||||+++++.+...+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            36899999999999999999999999997654444444455556655 45677 99999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-Cccccc
Q 019040          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEI  214 (347)
Q Consensus       136 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~~~~~~  214 (347)
                      +++|..++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++...... ......
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccc
Confidence            99999999888889999999999999999999999999999999999999   67788999999998753222 223345


Q ss_pred             ccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhcc
Q 019040          215 VGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (347)
Q Consensus       215 ~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (347)
                      .||+.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+.......    .+.++..+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~  232 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL----KPNISVSARHLLEGLLQ  232 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHHhh
Confidence            78999999998764 48899999999999999999999999888877777776654333    23679999999999999


Q ss_pred             CCCCCCCCH----HHHhcCcccccC
Q 019040          294 PDPKLRLTA----KQVLEHPWLQNA  314 (347)
Q Consensus       294 ~dp~~Rps~----~~ll~h~~~~~~  314 (347)
                      .||.+||++    .++++||||...
T Consensus       233 ~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         233 KDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             cCHHhCCCCCCCHHHHHcCCCcCCC
Confidence            999999987    699999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.9e-45  Score=328.87  Aligned_cols=256  Identities=25%  Similarity=0.418  Sum_probs=208.5

Q ss_pred             cceeeeeeecccCCeEEEEEEECC-CCceeEEeEeccccccchhcHHHHHHHHHHHHhCC--CCCceeEeeeEEe-----
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRD-TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACE-----  122 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~--~h~~i~~~~~~~~-----  122 (347)
                      ++|++.+.||.|+||.||+|.+.. +++.||+|.+....... .....+.+|+.+++.+.  .||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999864 46889999886543222 22345566777777663  5999999999875     


Q ss_pred             eCCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          123 DDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       123 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                      .....++|+||++ ++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg  155 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG  155 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEcccc
Confidence            3456899999996 4898888764  348999999999999999999999999999999999999   667889999999


Q ss_pred             cccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC----
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD----  275 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  275 (347)
                      ++.............+++.|+|||.+. ..++.++||||||+++|+|++|..||.+....+....+..........    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            998765444445567899999999875 458899999999999999999999999888777766665432211111    


Q ss_pred             -------------------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          276 -------------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       276 -------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                                         ..+.++..+.++|.+||+.||++|||+.++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                               113567888999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.3e-45  Score=338.92  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=211.8

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+.|++++.||.|+||.||+|++..+++.||+|++....  .......+.+|+++++.+ +|+||+++++++...+..++
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEE
Confidence            467899999999999999999999999999999985432  233356788999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |+||+++++|...    ...++..+..++.||+.||.|||+.||+||||||+|||+   ++++.++|+|||++.......
T Consensus       150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceeccccc
Confidence            9999999988542    245778888999999999999999999999999999999   677889999999987654322


Q ss_pred             -cccccccCccccccccccc------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          210 -RFSEIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                       ......|+..|+|||.+..      ..+.++||||||+++|+|++|..||......+....+..............++.
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR  302 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence             2234578999999998742      245689999999999999999999974433322222222212222333347889


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                      ++.+||..||+.||++|||+.++++||||.+.+...+
T Consensus       303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~~~  339 (353)
T PLN00034        303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQG  339 (353)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccccCCcccc
Confidence            9999999999999999999999999999999865543

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.7e-45  Score=334.70  Aligned_cols=251  Identities=28%  Similarity=0.478  Sum_probs=212.8

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+.+|++|+.+++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765555556677889999999997899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC-CCCcccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~-~~~~~~~~~  215 (347)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.... .........
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceeccc
Confidence            9999999888889999999999999999999999999999999999999   667889999999987532 223334567


Q ss_pred             cCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          216 GSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAES-------EQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       216 ~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      ||+.|+|||++. ..++.++||||||+++|+|++|..||....       .....+.+......    ....++..+.++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~l  233 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----IPRFLSVKASHV  233 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----CCCCCCHHHHHH
Confidence            999999999876 458999999999999999999999995321       12233333332222    223678999999


Q ss_pred             HHHhccCCCCCCCC------HHHHhcCcccccC
Q 019040          288 VRQMLEPDPKLRLT------AKQVLEHPWLQNA  314 (347)
Q Consensus       288 i~~~l~~dp~~Rps------~~~ll~h~~~~~~  314 (347)
                      |.+||+.||.+|++      +.++++||||+..
T Consensus       234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            99999999999998      5799999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.6e-45  Score=327.30  Aligned_cols=259  Identities=30%  Similarity=0.490  Sum_probs=214.8

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      .|++.+.||.|+||.||+|.+..+++.||+|.+.............+.+|+.+++.+ +|++++.+++.+...+..++|+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEE
Confidence            378889999999999999999999999999998765444444455677899999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       132 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.||+|+||||+||++   +.++.++|+|||++.......
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence            999999999888654  358999999999999999999999999999999999999   667789999999987655444


Q ss_pred             cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ......|+..|+|||++. ..++.++||||||+++|+|++|..||..........................+++++.+|+
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC  236 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence            434457899999999876 4489999999999999999999999976543211111111111111222346789999999


Q ss_pred             HHhccCCCCCCCC-----HHHHhcCcccccC
Q 019040          289 RQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       289 ~~~l~~dp~~Rps-----~~~ll~h~~~~~~  314 (347)
                      ..||+.||++|||     +.++++||||+..
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            9999999999999     9999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-45  Score=347.19  Aligned_cols=257  Identities=26%  Similarity=0.392  Sum_probs=209.2

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~----  124 (347)
                      ..++|++.+.||.|+||.||+|.+..+++.||||.+....       ....+|+.+++.+ +|+||+++++++...    
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNL-NHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhc-CCCCCcceeeeEeeccccc
Confidence            4568999999999999999999999999999999875331       2345699999999 999999998876432    


Q ss_pred             ----CeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEE
Q 019040          125 ----NAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (347)
Q Consensus       125 ----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l  196 (347)
                          ..+++||||+++ +|.+++..    ...++...++.++.||+.||.|||++||+||||||+|||++  ..++.+||
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL  212 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKL  212 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceee
Confidence                357799999975 77676643    35689999999999999999999999999999999999994  23457999


Q ss_pred             EeeccccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc--
Q 019040          197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF--  272 (347)
Q Consensus       197 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--  272 (347)
                      +|||++.............+|+.|+|||++.+  .++.++||||||+++|+|++|.+||.+....+.+..+.......  
T Consensus       213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99999987665555555678999999998753  48999999999999999999999998887766555554322110  


Q ss_pred             ---------------cCC--------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          273 ---------------KRD--------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       273 ---------------~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                                     +..        .....+.++.+||.+||+.||.+|||+.++|+||||+....
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                           000        01246789999999999999999999999999999987653

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-45  Score=332.85  Aligned_cols=260  Identities=29%  Similarity=0.494  Sum_probs=218.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||.||+|++..+++.||+|++.+...........+.+|+.++..+ +|++|+.+++.+.+++..|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence            4799999999999999999999999999999999765444444566788899999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |||+++++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence            999999999999976 3568999999999999999999999999999999999999   677889999999987654332


Q ss_pred             c--ccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc-CCCCCCC
Q 019040          210 R--FSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-RDPWPNV  280 (347)
Q Consensus       210 ~--~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  280 (347)
                      .  .....||+.|+|||++.      ..++.++||||||+++|+|++|..||......+....+......+. +.....+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  236 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV  236 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence            2  12246899999999875      2378899999999999999999999988877666666654332222 1223457


Q ss_pred             CHHHHHHHHHhccCCCCC--CCCHHHHhcCcccccC
Q 019040          281 SESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA  314 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~  314 (347)
                      +..+.++|.+||..++++  |+++.++++||||...
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            999999999998765544  8899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.9e-45  Score=324.99  Aligned_cols=260  Identities=30%  Similarity=0.496  Sum_probs=220.8

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      .|+..+.||.|+||+||+|.+..+++.||+|.+.............+.+|+++++.+ +|++++.+++.+..++..++++
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEE
Confidence            377889999999999999999999999999998765544444456678899999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       132 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||+++++|.+.+...  ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence            999999998888653  358999999999999999999999999999999999999   566789999999987654443


Q ss_pred             cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+..............++.++.+|+
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            334457899999999875 4589999999999999999999999988766544444444333333333456889999999


Q ss_pred             HHhccCCCCCCCC-----HHHHhcCcccccCc
Q 019040          289 RQMLEPDPKLRLT-----AKQVLEHPWLQNAK  315 (347)
Q Consensus       289 ~~~l~~dp~~Rps-----~~~ll~h~~~~~~~  315 (347)
                      ..||+.||++||+     +.++++|+||+...
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            9999999999999     88999999998874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-46  Score=338.46  Aligned_cols=250  Identities=31%  Similarity=0.556  Sum_probs=214.3

Q ss_pred             ecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC--CCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        59 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~--~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      ||.|+||+||+|.++.+++.||+|++.+..............|..++..+.  +||+|+.+++.+...+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999999999999999997654444444455666777776654  799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-Ccccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~~~~~~~  215 (347)
                      ++|..++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++...... .......
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            9999999888889999999999999999999999999999999999999   66788999999998754322 2234457


Q ss_pred             cCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhcc
Q 019040          216 GSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (347)
Q Consensus       216 ~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (347)
                      ||+.|+|||.+.+  .++.++||||||+++|+|++|..||...+.......+..+...++.   ..+++++.++|.+||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~  234 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN  234 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence            9999999998753  3789999999999999999999999998887777777665544432   2578999999999999


Q ss_pred             CCCCCCC----CHHHHhcCcccccC
Q 019040          294 PDPKLRL----TAKQVLEHPWLQNA  314 (347)
Q Consensus       294 ~dp~~Rp----s~~~ll~h~~~~~~  314 (347)
                      .||++||    ++.++++||||+..
T Consensus       235 ~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         235 RNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CCHHHCCCCCCCHHHHhcCccccCC
Confidence            9999998    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-45  Score=324.14  Aligned_cols=254  Identities=35%  Similarity=0.659  Sum_probs=213.4

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      |++++.||+|+||+||+|.+..+++.||+|++......... .....+|+.+++.+ +|+||+++++++...+..++++|
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccc-ccccccccccccccccccccccc
Confidence            78999999999999999999999999999999765433222 22345599999999 99999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc-CCCCcc
Q 019040          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERF  211 (347)
Q Consensus       133 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~-~~~~~~  211 (347)
                      ++++++|.+++.....++...+..++.||+.||.+||++|++|+||||+||++   ++++.++|+|||.+... ......
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEB
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            99999999999877789999999999999999999999999999999999999   67788999999998753 333444


Q ss_pred             cccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccccccCCCCCCCCHHHHH
Q 019040          212 SEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQG---VAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       212 ~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      ....+++.|+|||.+.  ..++.++||||||+++++|++|..||.......   ....................+..+.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            5567899999999976  459999999999999999999999998874333   33333322222222222233489999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcCccc
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      +|..||+.||++|||+.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.9e-45  Score=328.69  Aligned_cols=260  Identities=26%  Similarity=0.444  Sum_probs=215.4

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|.+.+.||.|+||.||+|+++.+++.||+|.+.....  ......+.+|+.+++.+ +|+|++++++++..++..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEE
Confidence            679999999999999999999999999999999865432  22234577899999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |||+++ +|.+++.... .++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.......
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCc
Confidence            999975 8888886654 48899999999999999999999999999999999999   667889999999987643322


Q ss_pred             -cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc--------------
Q 019040          210 -RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF--------------  272 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------  272 (347)
                       ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||...+..+....+.+.....              
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence             2233467899999998753  48899999999999999999999998877665555443322110              


Q ss_pred             -----cC-------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          273 -----KR-------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       273 -----~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                           +.       ...+.++.++.++|.+||+.||.+|||+.++++||||+.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  295 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR  295 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence                 00       1113578899999999999999999999999999999987644

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.6e-45  Score=336.89  Aligned_cols=260  Identities=26%  Similarity=0.391  Sum_probs=210.4

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC---
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~---  124 (347)
                      .+.++|++.+.||.|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCc
Confidence            46689999999999999999999999999999999986542 2334456788899999999 999999999988654   


Q ss_pred             ---CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          125 ---NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       125 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                         ...|+||||+++ +|...+..  .++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~  169 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  169 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCC
Confidence               357999999965 66666543  47889999999999999999999999999999999999   6778899999999


Q ss_pred             ccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----------
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI----------  270 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------  270 (347)
                      +.............+|+.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+.......+.....          
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            976544444455678999999998764 589999999999999999999999987765443332222111          


Q ss_pred             ------------cccCC----------------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          271 ------------DFKRD----------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       271 ------------~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                  ..+..                .....++.+.+||.+||+.||++|||+.++|+||||+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence                        00000                0012457789999999999999999999999999997533

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-45  Score=334.40  Aligned_cols=250  Identities=27%  Similarity=0.509  Sum_probs=213.1

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHH-HHhCCCCCceeEeeeEEeeCCeEEEEEEecC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI-MKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~-l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (347)
                      +.||.|+||+||+|.++.+|+.||+|++.+...........+..|..+ ++.+ +||||+++++.+...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence            368999999999999999999999999976544333344556666654 5667 99999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-CCccccc
Q 019040          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEI  214 (347)
Q Consensus       136 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~~~~~~~  214 (347)
                      +++|...+.....+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.++|+|||++..... .......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999   6778899999999875322 2223445


Q ss_pred             ccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhcc
Q 019040          215 VGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (347)
Q Consensus       215 ~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (347)
                      .|++.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+.......+    +..+..+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~  232 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE  232 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence            78999999998764 488999999999999999999999998888777777766543332    3678999999999999


Q ss_pred             CCCCCCCCH----HHHhcCcccccC
Q 019040          294 PDPKLRLTA----KQVLEHPWLQNA  314 (347)
Q Consensus       294 ~dp~~Rps~----~~ll~h~~~~~~  314 (347)
                      .+|.+||++    .++++||||+..
T Consensus       233 ~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         233 KDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             cCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            999999976    599999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-46  Score=331.47  Aligned_cols=277  Identities=36%  Similarity=0.604  Sum_probs=249.2

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ...+.+-|.+.+.||+|.|+.|-+|++.-+|..||||++.+.++... ....+.+|++.++.. +||||+++|.+.....
T Consensus        13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLV-QHpNiVRLYEViDTQT   90 (864)
T KOG4717|consen   13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLV-QHPNIVRLYEVIDTQT   90 (864)
T ss_pred             ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHh-cCcCeeeeeehhcccc
Confidence            44567889999999999999999999999999999999988776554 346688899999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      .+|+|+|+=++|+|++|+.+. ..+++....+++.||+.|+.|+|...+||||+||+||.+.  ..-|.|||.|||++-.
T Consensus        91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNk  168 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNK  168 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeecccccc
Confidence            999999999999999999765 4699999999999999999999999999999999999886  5678899999999999


Q ss_pred             cCCCCcccccccCcccccccccccc-CC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          205 FKPGERFSEIVGSPYYMAPEVLKRN-YG-PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       205 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      +.+++.....+|+..|.|||++.+. |+ ++.||||||++||.|++|.+||...++.+.+..|+......|.    .++.
T Consensus       169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~  244 (864)
T KOG4717|consen  169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSK  244 (864)
T ss_pred             CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhH
Confidence            9999999999999999999998765 54 6899999999999999999999999988888888887665543    6789


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHh
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRL  330 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~  330 (347)
                      ++++||..||+.||.+|.+.++|..|+|++.....+...++.+...++
T Consensus       245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPLvsr~~L  292 (864)
T KOG4717|consen  245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPLVSRHHL  292 (864)
T ss_pred             HHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCceeehhhC
Confidence            999999999999999999999999999999998887776666555444

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.7e-45  Score=322.27  Aligned_cols=249  Identities=27%  Similarity=0.453  Sum_probs=207.2

Q ss_pred             ecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCc
Q 019040           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (347)
Q Consensus        59 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  138 (347)
                      ||.|+||.||++.++.+|+.||+|.+.............+..|+++++.+ +||||+++++.+......++||||++|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            69999999999999999999999998765444433445566799999999 99999999999999999999999999999


Q ss_pred             hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCccccccc
Q 019040          139 LFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG  216 (347)
Q Consensus       139 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~  216 (347)
                      |...+....  .++...+..++.||+.||.|||+.|++||||||+||++   +.++.++|+|||++.............+
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCC
Confidence            988886543  48889999999999999999999999999999999999   6678899999999887655444444578


Q ss_pred             Ccccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccccccCCCCCCCCHHHHHHHHHh
Q 019040          217 SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ----GVAQAILRGLIDFKRDPWPNVSESAKSLVRQM  291 (347)
Q Consensus       217 ~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  291 (347)
                      ++.|+|||++. ..++.++||||||+++|+|++|..||......    ...........   ......++.++.++|.+|
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~  233 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV---KFEHQNFTEESKDICRLF  233 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc---ccccccCCHHHHHHHHHH
Confidence            99999999876 44899999999999999999999999765432    22222222211   112236789999999999


Q ss_pred             ccCCCCCCCCH----HHHhcCcccccC
Q 019040          292 LEPDPKLRLTA----KQVLEHPWLQNA  314 (347)
Q Consensus       292 l~~dp~~Rps~----~~ll~h~~~~~~  314 (347)
                      |+.||++||++    .+++.|+||+..
T Consensus       234 L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             hccCHhhCCCCccchhhhhcChhhcCC
Confidence            99999999999    678899999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.9e-45  Score=331.64  Aligned_cols=250  Identities=27%  Similarity=0.476  Sum_probs=211.5

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHH-HHHhCCCCCceeEeeeEEeeCCeEEEEEEecC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA-IMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~-~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (347)
                      +.||.|+||.||+|++..+++.||+|++.+...........+.+|.. +++.+ +|+||+++++.+.+.+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence            36899999999999999999999999997654433334455556654 56777 99999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-Cccccc
Q 019040          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEI  214 (347)
Q Consensus       136 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~~~~~~  214 (347)
                      +++|...+.....+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++...... ......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccc
Confidence            99999988887789999999999999999999999999999999999999   67788999999998753222 223345


Q ss_pred             ccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhcc
Q 019040          215 VGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (347)
Q Consensus       215 ~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (347)
                      .|++.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+.......    ....+.++.++|..||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~  232 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQL----PGGKTVAACDLLVGLLH  232 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHcc
Confidence            78999999998764 48899999999999999999999999888777766666543332    23678899999999999


Q ss_pred             CCCCCCCCH----HHHhcCcccccC
Q 019040          294 PDPKLRLTA----KQVLEHPWLQNA  314 (347)
Q Consensus       294 ~dp~~Rps~----~~ll~h~~~~~~  314 (347)
                      .||.+||++    .++++|+||...
T Consensus       233 ~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         233 KDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             CCHhhcCCCCCCHHHHhCCCCcCCC
Confidence            999999975    599999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.9e-44  Score=322.50  Aligned_cols=255  Identities=31%  Similarity=0.592  Sum_probs=224.4

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|++|.||+|.+..+++.||+|++.............+.+|+++++.+ +||||+++++++...+..++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEE
Confidence            4799999999999999999999999999999998766554455567889999999999 799999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      +||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||++   +.++.++|+|||++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--
Confidence            9999999999999888889999999999999999999999999999999999999   66788999999998876544  


Q ss_pred             ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .....+++.|+|||.+. ..++.++||||||+++++|++|..||.........+.+..+...++    ...+..+.++|.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~  230 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIR  230 (290)
T ss_pred             CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHHHHHH
Confidence            33446889999999875 4488899999999999999999999988876666666655433322    356899999999


Q ss_pred             HhccCCCCCCC-----CHHHHhcCcccccCc
Q 019040          290 QMLEPDPKLRL-----TAKQVLEHPWLQNAK  315 (347)
Q Consensus       290 ~~l~~dp~~Rp-----s~~~ll~h~~~~~~~  315 (347)
                      +||+.||.+|+     ++.++++||||+...
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            99999999999     999999999998765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=332.61  Aligned_cols=250  Identities=26%  Similarity=0.380  Sum_probs=214.1

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ++..-...+..++.||.|.||.||.|.++.+. .||+|.+.....    ..+.+.+|++++++| +|++|+++++++..+
T Consensus       200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m----~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~  273 (468)
T KOG0197|consen  200 PWEIPREELKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSM----SPEAFLREAQIMKKL-RHEKLVKLYGVCTKQ  273 (468)
T ss_pred             CeeecHHHHHHHHHhcCCccceEEEEEEcCCC-cccceEEecccc----ChhHHHHHHHHHHhC-cccCeEEEEEEEecC
Confidence            34444556788899999999999999996543 599999864322    335688999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 NAVHLVMELCEGGELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      ..++|||||++.|+|.++|+.  ...+....+..++.|||.|++||+++++|||||...||||   +++..+||+|||+|
T Consensus       274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLA  350 (468)
T ss_pred             CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccc
Confidence            999999999999999999987  4569999999999999999999999999999999999999   78889999999999


Q ss_pred             cccCCCCccc--ccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          203 IFFKPGERFS--EIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       203 ~~~~~~~~~~--~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      +.........  .-.-...|+|||.+. +.++.++||||||++|||++| |+.|+...+..++++.+.++.-   .+.++
T Consensus       351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR---lp~P~  427 (468)
T KOG0197|consen  351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR---LPRPE  427 (468)
T ss_pred             cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc---CCCCC
Confidence            9544333221  122355699999986 679999999999999999999 9999999999999999988853   33445


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVL  306 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll  306 (347)
                      .+|+.+.++|..||+.+|++|||+..+.
T Consensus       428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  428 GCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             CCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            8999999999999999999999999764

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.2e-44  Score=323.34  Aligned_cols=255  Identities=28%  Similarity=0.446  Sum_probs=206.9

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC--CCCceeEeeeEEee-----C
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACED-----D  124 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~--~h~~i~~~~~~~~~-----~  124 (347)
                      +|++.+.||.|+||+||+|.++.+++.||+|.+....... .....+.+|+.+++.+.  +|+||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            5899999999999999999999999999999986543222 12234556777776653  69999999998764     3


Q ss_pred             CeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 NAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      ...++++||+++ +|.+++...  ..+++..+..++.|++.||.|||+.||+|+||||+||++   +.++.++|+|||++
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcc
Confidence            568999999975 888888764  348999999999999999999999999999999999999   67788999999999


Q ss_pred             cccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc--------
Q 019040          203 IFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK--------  273 (347)
Q Consensus       203 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  273 (347)
                      .............++..|+|||++. ..++.++||||||+++|+|++|..||...........+........        
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            8765444444557899999999875 4589999999999999999999999988776655555433211000        


Q ss_pred             ---------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          274 ---------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       274 ---------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                                     ....+.++..+.++|.+||+.||++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                           01123577889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.4e-44  Score=329.37  Aligned_cols=260  Identities=23%  Similarity=0.352  Sum_probs=214.4

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++.+.||.|+||.||+|.+..++..+|+|++....  .......+.+|+++++.+ +|+||+++++++...+..+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEE
Confidence            3578999999999999999999999999999999886542  223346788999999999 8999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+. +++|+||||+||++   +.++.++|+|||++.....
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhh
Confidence            9999999999999998887899999999999999999999985 79999999999999   5677899999999875432


Q ss_pred             CCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------------
Q 019040          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--------------------  266 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--------------------  266 (347)
                      . ......++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+.                    
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         157 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             h-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence            2 2234568999999998864 48899999999999999999999997655433321110                    


Q ss_pred             --------------------hccccccCCC--CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          267 --------------------RGLIDFKRDP--WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       267 --------------------~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                          ........+.  ....+.++.+||.+||+.||++|||+.++++||||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                                0000000000  013578899999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-44  Score=330.25  Aligned_cols=260  Identities=28%  Similarity=0.474  Sum_probs=220.0

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||.||+++++.+++.+|+|++.+...........+.+|+.++..+ +|++++.+++.+.+.+..++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEE
Confidence            4799999999999999999999999999999998764443444455688899999998 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |||+++++|.+++.+. ..+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++.......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence            9999999999999774 568999999999999999999999999999999999999   677889999999987543322


Q ss_pred             c--ccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc-CCCCCCC
Q 019040          210 R--FSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-RDPWPNV  280 (347)
Q Consensus       210 ~--~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  280 (347)
                      .  .....||+.|+|||++.      ..++.++||||||+++|+|++|..||...+.......+........ +..+..+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV  236 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence            2  22347899999999874      3478899999999999999999999998887777777765543332 2223468


Q ss_pred             CHHHHHHHHHhccCCCCC--CCCHHHHhcCcccccC
Q 019040          281 SESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA  314 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~  314 (347)
                      +.++.++|.+||..++++  |+++.++++||||...
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            999999999999765555  7899999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.9e-44  Score=342.94  Aligned_cols=259  Identities=22%  Similarity=0.332  Sum_probs=204.4

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC-----CCCceeEeeeEEeeC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-----KNSSIVSLKEACEDD  124 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~-----~h~~i~~~~~~~~~~  124 (347)
                      .++|++++.||.|+||+||+|.+..+++.||||++....    ........|+.+++.+.     +|.+++.+++++...
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            578999999999999999999999999999999985321    12234556777777662     344588888888765


Q ss_pred             -CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCC------------
Q 019040          125 -NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKE------------  190 (347)
Q Consensus       125 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~------------  190 (347)
                       +++++|++++ |++|.+++.+...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.            
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence             5788999988 77899999888889999999999999999999998 59999999999999964321            


Q ss_pred             -CCCEEEEeeccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 019040          191 -NSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG  268 (347)
Q Consensus       191 -~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  268 (347)
                       ...+||+|||.+....  .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+....+...
T Consensus       283 ~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~  360 (467)
T PTZ00284        283 DPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT  360 (467)
T ss_pred             CCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence             2359999999876432  22345679999999998764 5999999999999999999999999887766555544333


Q ss_pred             cccccCCC------------------------------------C--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcc
Q 019040          269 LIDFKRDP------------------------------------W--PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (347)
Q Consensus       269 ~~~~~~~~------------------------------------~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  310 (347)
                      ...++...                                    +  ...++.+.+||.+||+.||.+|||+.++|+|||
T Consensus       361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  440 (467)
T PTZ00284        361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY  440 (467)
T ss_pred             cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence            22111000                                    0  001356779999999999999999999999999


Q ss_pred             cccCc
Q 019040          311 LQNAK  315 (347)
Q Consensus       311 ~~~~~  315 (347)
                      |++..
T Consensus       441 ~~~~~  445 (467)
T PTZ00284        441 VLKYY  445 (467)
T ss_pred             ccccC
Confidence            98864

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.5e-45  Score=330.35  Aligned_cols=260  Identities=28%  Similarity=0.468  Sum_probs=220.2

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||.||+++++.+++.||+|++.+...........+.+|+.++..+ +|++|+.+++.+...+..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence            4799999999999999999999999999999998765444444556688899999998 999999999999999999999


Q ss_pred             EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence            999999999999987 4578999999999999999999999999999999999999   677889999999987654332


Q ss_pred             cc--cccccCccccccccccc------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc-CCCCCCC
Q 019040          210 RF--SEIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-RDPWPNV  280 (347)
Q Consensus       210 ~~--~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  280 (347)
                      ..  ....|++.|+|||++.+      .++.++||||||+++|+|++|..||...+.......+......++ +..+..+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV  236 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence            21  23468999999998753      478899999999999999999999988887777766665433332 2223467


Q ss_pred             CHHHHHHHHHhccCCCCC--CCCHHHHhcCcccccC
Q 019040          281 SESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA  314 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~  314 (347)
                      +.++.++|.+||..++.+  |+++.++++|+||+..
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            899999999999876655  5799999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-45  Score=332.80  Aligned_cols=250  Identities=30%  Similarity=0.495  Sum_probs=215.3

Q ss_pred             eeeecccCCeEEEEEEEC---CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           56 DRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      ++.||.|+||.||++.+.   .+|+.||+|++...... ......+.+|+++++++ +||||+++++.+...+..|+|+|
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEc
Confidence            357999999999999863   57899999999765432 22345577899999999 99999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-Ccc
Q 019040          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERF  211 (347)
Q Consensus       133 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~~~  211 (347)
                      |+++++|.+++.+...+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++...... ...
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCce
Confidence            99999999999887789999999999999999999999999999999999999   66788999999998765433 223


Q ss_pred             cccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHH
Q 019040          212 SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ  290 (347)
Q Consensus       212 ~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  290 (347)
                      ....|++.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+.......+    ..+++++.++|..
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~  231 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRA  231 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence            34578999999998764 488999999999999999999999998888777777766554332    3678999999999


Q ss_pred             hccCCCCCCCC-----HHHHhcCcccccC
Q 019040          291 MLEPDPKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       291 ~l~~dp~~Rps-----~~~ll~h~~~~~~  314 (347)
                      ||+.||++||+     ..+++.||||+..
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            99999999999     7889999999764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.9e-45  Score=330.97  Aligned_cols=250  Identities=28%  Similarity=0.508  Sum_probs=211.6

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHH-HHHhCCCCCceeEeeeEEeeCCeEEEEEEecC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA-IMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~-~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (347)
                      +.||.|+||+||+|++..+++.||+|++.+...........+..|.. +++.+ +|+||+++++.+...+..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            36899999999999999999999999997654333333344555544 46677 99999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-CCccccc
Q 019040          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEI  214 (347)
Q Consensus       136 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~~~~~~~  214 (347)
                      +++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..... .......
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccc
Confidence            99999999888789999999999999999999999999999999999999   6678899999999875432 2223445


Q ss_pred             ccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhcc
Q 019040          215 VGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (347)
Q Consensus       215 ~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (347)
                      .||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+......    ..+.++..+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~~~l~  232 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ----LKPNITNSARHLLEGLLQ  232 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC----CCCCCCHHHHHHHHHHcc
Confidence            79999999998764 4889999999999999999999999988887777776654333    234789999999999999


Q ss_pred             CCCCCCCCHH----HHhcCcccccC
Q 019040          294 PDPKLRLTAK----QVLEHPWLQNA  314 (347)
Q Consensus       294 ~dp~~Rps~~----~ll~h~~~~~~  314 (347)
                      .||.+||++.    ++++|+||...
T Consensus       233 ~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         233 KDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             cCHHHCCCCCCCHHHHhcCcccCCC
Confidence            9999999876    89999999654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.4e-44  Score=323.54  Aligned_cols=263  Identities=25%  Similarity=0.427  Sum_probs=216.8

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|.+.+.||.|+||.||+|.++.+++.||+|.+.....  ......+.+|+.+++.+ +|+||+++++++...+..++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEE
Confidence            3679999999999999999999999999999999865432  22234577899999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      |+||+++ +|.+++... ..++...+..++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||++......
T Consensus        82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIP  157 (301)
T ss_pred             EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCC
Confidence            9999975 888888764 458999999999999999999999999999999999999   66778999999998764332


Q ss_pred             C-cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC-----------
Q 019040          209 E-RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----------  274 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  274 (347)
                      . ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||...+..+....+.........           
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence            2 2233467889999998753  4788999999999999999999999888776555444332211100           


Q ss_pred             ---------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCC
Q 019040          275 ---------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       275 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                                     ...+.+++.+.+||.+||+.||.+|||+.++++||||+.+.+..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~  297 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIH  297 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhh
Confidence                           011357889999999999999999999999999999998876543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-45  Score=332.48  Aligned_cols=258  Identities=33%  Similarity=0.516  Sum_probs=232.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe-EE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA-VH  128 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~-~~  128 (347)
                      .++|..++.+|.|+||.+++++++.+++.|++|.+.......... ....+|+.+++++ .||||+.+.+.|..++. .+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhc-cCCCeeeeccchhcCCceEE
Confidence            367999999999999999999999999999999998766544433 4678899999999 99999999999999888 99


Q ss_pred             EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          129 LVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      |+|+||+||+|.+.+++.+  .|+++.+..|+.||+.|+.|||+++|+|||||+.|||+   ..+..|+|+|||+|+...
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhhhcC
Confidence            9999999999999998765  49999999999999999999999999999999999999   667779999999999988


Q ss_pred             CCC-cccccccCcccccccccccc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          207 PGE-RFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       207 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      +.. .....+|||.|++||.+.+. |..++|||||||++|||++-+.+|.+.+-......+.+.....   .....+.++
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P---lp~~ys~el  234 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP---LPSMYSSEL  234 (426)
T ss_pred             CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC---CCccccHHH
Confidence            776 56778999999999999764 9999999999999999999999999999999999998887332   224789999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +.+|+.||..+|..||++.++|.+|.+...-
T Consensus       235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  235 RSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            9999999999999999999999999987543

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.2e-44  Score=331.19  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=211.8

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC---
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~---  124 (347)
                      .+.++|++.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+ +|+|++.+++++...   
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhc-CCCCccccceeecccccc
Confidence            45689999999999999999999999999999999986432 2333456778899999999 999999999887543   


Q ss_pred             ---CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          125 ---NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       125 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                         ..+|+||||+++ +|...+..  .++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||+
T Consensus        99 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~  172 (364)
T cd07875          99 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  172 (364)
T ss_pred             cccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCC
Confidence               467999999965 77777754  47889999999999999999999999999999999999   6678899999999


Q ss_pred             ccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc-------
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-------  273 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------  273 (347)
                      +.............+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+........       
T Consensus       173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            987654444455678999999998764 489999999999999999999999988877665555443221100       


Q ss_pred             -------------------------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          274 -------------------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       274 -------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                                                     .......+..+.+||.+||+.||++|||+.++|+||||+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                                           0000123467899999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-44  Score=314.05  Aligned_cols=255  Identities=29%  Similarity=0.471  Sum_probs=216.0

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEecccccc--chhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      +.|.+.+.||.|++|.||.|.+..+++.|++|.+......  .......+.+|+.+++.+ +|+||+++++++......+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEE
Confidence            5689999999999999999999999999999998654322  122346788999999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +++||+++++|.+.+.....++...+..++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||++......
T Consensus        81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecccc
Confidence            999999999999999888789999999999999999999999999999999999999   66778999999998765332


Q ss_pred             Ccc----cccccCcccccccccccc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          209 ERF----SEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       209 ~~~----~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      ...    ....++..|+|||.+.+. ++.++||||||+++|++++|..||..................  ......++..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  235 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PQLPSHVSPD  235 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--CCCCccCCHH
Confidence            211    234577889999988644 889999999999999999999999777665544444333222  2223467899


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      +.++|.+||..+|++|||+.++++|+||
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         236 ARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.2e-44  Score=333.21  Aligned_cols=257  Identities=29%  Similarity=0.428  Sum_probs=213.0

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC-----e
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-----A  126 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~-----~  126 (347)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+... .........+.+|+.+++.+ +|+||+++++++...+     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccce
Confidence            478899999999999999999999999999988543 22233456788999999999 9999999999998776     8


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .|+|+||+. ++|.+.+.....++...+..++.||+.||.|||+.||+||||||+|||+   +.++.++|+|||++....
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecc
Confidence            899999996 5888888877789999999999999999999999999999999999999   677889999999987643


Q ss_pred             CCC--cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-----------
Q 019040          207 PGE--RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-----------  271 (347)
Q Consensus       207 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  271 (347)
                      ...  ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+.......+......           
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            322  2233467889999998764  3789999999999999999999999888766555544332110           


Q ss_pred             -----------ccC------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          272 -----------FKR------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       272 -----------~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                                 .++      ......++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                       000      1113467889999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.7e-44  Score=329.67  Aligned_cols=260  Identities=26%  Similarity=0.377  Sum_probs=211.1

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC---
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~---  124 (347)
                      .+.++|++.+.||.|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+ +|+||+++++++...   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccc
Confidence            45689999999999999999999999999999999986532 2333456778899999999 999999999987643   


Q ss_pred             ---CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          125 ---NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       125 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                         ...+++|||+++ +|.+.+..  .++...+..++.|++.||.|||++||+||||||+|||+   +.++.++|+|||+
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~  165 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  165 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcc
Confidence               357999999976 67666644  48889999999999999999999999999999999999   6678899999999


Q ss_pred             ccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc--------
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF--------  272 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------  272 (347)
                      +.............+|+.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+.......+.......        
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            987655444455678999999998764 48999999999999999999999998876554433332211100        


Q ss_pred             --------------c----------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          273 --------------K----------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       273 --------------~----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                    .                .......+.++.++|.+||+.||++|||+.++|+||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence                          0                000112456789999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.9e-44  Score=338.66  Aligned_cols=255  Identities=28%  Similarity=0.433  Sum_probs=218.0

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCC-CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ...|.+.+.||.|++|.||+|.+..+ +..||+|.+...   .......+.+|+.+++.+ +||||+++++++...+..|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEE
Confidence            45699999999999999999998877 788999876433   233345678899999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          129 LVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +||||+++++|.+++..    ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~  218 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQ  218 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCcee
Confidence            99999999999988754    3458999999999999999999999999999999999999   6678899999999986


Q ss_pred             cCCCCc---ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          205 FKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       205 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      ......   .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+....   ....+
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~  295 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCPV  295 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCccC
Confidence            543321   234568999999998764 48999999999999999999999998888777777766554321   12367


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +.++.++|..||+.||++||++.+++.|+|++..
T Consensus       296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            8999999999999999999999999999999764

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-44  Score=315.73  Aligned_cols=271  Identities=28%  Similarity=0.484  Sum_probs=225.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|++|.||+|.+..+++.|++|.+....  .......+.+|+++++.+ +|+|++++++.+..+...++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEE
Confidence            47899999999999999999999999999999986543  233446788999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-C
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-E  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~  209 (347)
                      +||+++++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||++   ++++.++|+|||.+...... .
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc
Confidence            9999999999998765 78999999999999999999999999999999999999   66788999999999876543 2


Q ss_pred             cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+.........  ...++.++.++|
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  231 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFV  231 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHH
Confidence            2334568889999998764 4899999999999999999999999877765555444443221111  112788999999


Q ss_pred             HHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhhhh
Q 019040          289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQF  333 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~  333 (347)
                      .+||..+|++|||+.++++||||++....   ...+......|+|
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~---~~~~~~~~~~~~~  273 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAKKT---SYLTLLIERIKKW  273 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCCcc---cHHHHHHHHHHhc
Confidence            99999999999999999999999887633   4445554444444

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.9e-44  Score=339.07  Aligned_cols=259  Identities=28%  Similarity=0.450  Sum_probs=218.8

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC--
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN--  125 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~--  125 (347)
                      ...++|++.+.||.|+||+||+|++..+++.||+|++..... .......+.+|+.++..+ .|+++++++..+...+  
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcC-CCCcEEEeecceeccccc
Confidence            345799999999999999999999999999999999876543 234456788899999999 9999999887765332  


Q ss_pred             ------eEEEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEE
Q 019040          126 ------AVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (347)
Q Consensus       126 ------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~  195 (347)
                            .+++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.++
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEE
Confidence                  478999999999999988653    358999999999999999999999999999999999999   5678899


Q ss_pred             EEeeccccccCCC---CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 019040          196 AIDFGLSIFFKPG---ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID  271 (347)
Q Consensus       196 l~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  271 (347)
                      |+|||++......   .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+..+...
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~  263 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD  263 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            9999998765332   12234578999999999864 4899999999999999999999999988877777666654432


Q ss_pred             ccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                         +..+.+++++.++|..||+.||++||++.++++|||++..
T Consensus       264 ---~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        264 ---PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence               2234788999999999999999999999999999998754

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-45  Score=334.68  Aligned_cols=260  Identities=22%  Similarity=0.425  Sum_probs=227.3

Q ss_pred             ccce-eeeeeecccCCeEEEEEEECCCCceeEEeEeccccc-cchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC--
Q 019040           50 EDRY-LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN--  125 (347)
Q Consensus        50 ~~~y-~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~--  125 (347)
                      .+|| +....||.|+|-+||+|.|..+|..||.-.++.+.+ +......++..|+.+|+.| +|+||+++|.+|.+..  
T Consensus        38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~  116 (632)
T KOG0584|consen   38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNK  116 (632)
T ss_pred             CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCc
Confidence            3555 566789999999999999999999999877765443 4455578999999999999 9999999999998765  


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      ...+|.|++.+|+|..|+++.+..+...++.|++||+.||.|||++.  |+|||||.+||||+  +..|.|||+|+|+|+
T Consensus       117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAt  194 (632)
T KOG0584|consen  117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLAT  194 (632)
T ss_pred             eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHH
Confidence            48899999999999999999999999999999999999999999996  99999999999997  788999999999999


Q ss_pred             ccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ......... .+|||.|||||++...|+...||||||++|+||+|+..||.. .++..++..+..++........  -++
T Consensus       195 l~r~s~aks-vIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV--~dP  271 (632)
T KOG0584|consen  195 LLRKSHAKS-VIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV--KDP  271 (632)
T ss_pred             Hhhccccce-eccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc--CCH
Confidence            876554433 799999999999999999999999999999999999999965 4566788888888754433322  268


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      ++++||.+||.. .++|||+.++|+||||..-..
T Consensus       272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  272 EVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             HHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence            899999999999 999999999999999988643

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-44  Score=328.93  Aligned_cols=261  Identities=25%  Similarity=0.444  Sum_probs=211.9

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC---
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~---  124 (347)
                      .+.++|++.+.||.|+||+||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +|+||+++++++...   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccc
Confidence            345789999999999999999999999999999999865321 223345677899999999 999999999887533   


Q ss_pred             ---CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          125 ---NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       125 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                         ...+++++++ +++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||+
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~  164 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGL  164 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCcc
Confidence               4578999998 778987765 4479999999999999999999999999999999999999   6778899999999


Q ss_pred             ccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc--------
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID--------  271 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------  271 (347)
                      +.....  ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||...+.......+......        
T Consensus       165 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         165 ARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             ceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            986543  2344578999999998764  4889999999999999999999999877655444443221110        


Q ss_pred             ---------------ccC----CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          272 ---------------FKR----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       272 ---------------~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                     .+.    ..+...++.+.+||.+||+.||++|||+.++++||||.....+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence                           000    0112456778999999999999999999999999999887544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=320.01  Aligned_cols=259  Identities=29%  Similarity=0.519  Sum_probs=221.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|++|+||+|.+..+++.||+|.+.............+.+|+++++.+ +|++|+++++.+...+..++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEE
Confidence            4799999999999999999999999999999999876555444567789999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          131 MELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence            9999999999998764  458999999999999999999999999999999999999   56788999999988654322


Q ss_pred             Cc------------------------------ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 019040          209 ER------------------------------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES  257 (347)
Q Consensus       209 ~~------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~  257 (347)
                      ..                              .....|+..|+|||++.+ .++.++||||||+++|+|++|..||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            11                              112367888999998764 48899999999999999999999998888


Q ss_pred             HHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCC----HHHHhcCcccccCc
Q 019040          258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT----AKQVLEHPWLQNAK  315 (347)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~  315 (347)
                      .......+......++..  ..++..+.++|.+||..||++|||    +.++++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         237 RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             hHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            776666665444333222  237899999999999999999999    99999999998764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.1e-43  Score=314.70  Aligned_cols=256  Identities=30%  Similarity=0.570  Sum_probs=212.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|++|.||+|.++.+++.||+|++..... .......+.+|+.+++.+ .|+|++++++.+......++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEE
Confidence            479999999999999999999999999999999865432 222335678899999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      +||+++++|..++.....+++..+..++.||+.+|.|||+.|++|+||+|+||++   +.++.++|+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence            9999998887777666679999999999999999999999999999999999999   567789999999998765433 


Q ss_pred             cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc----------------
Q 019040          210 RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID----------------  271 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------------  271 (347)
                      ......++..|+|||.+.+  .++.++||||||+++++|++|..||.+....+....+......                
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            2234467888999998753  3788999999999999999999999877765544433221110                


Q ss_pred             ---ccC--------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          272 ---FKR--------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       272 ---~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                         .+.        ..++.++..+.+||.+||+.+|++||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence               000        0123568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-43  Score=349.75  Aligned_cols=268  Identities=29%  Similarity=0.483  Sum_probs=219.7

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .+.+...++|.+++.||.|+||+||+|.+..++..||+|++...... ......+..|+.+++.| +||||+++++++..
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~d   83 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMREL-KHKNIVRYIDRFLN   83 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEe
Confidence            34556678999999999999999999999999999999998754332 23456788999999999 99999999998854


Q ss_pred             --CCeEEEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc-------CcEeeCCCCCcEEeecC--
Q 019040          124 --DNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKH-------GVIHRDLKPENFLFANK--  188 (347)
Q Consensus       124 --~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-------~ivH~Dikp~NIli~~~--  188 (347)
                        .+.+|+||||+++++|.+++...    ..+++..++.|+.||+.||.|||+.       +|||+||||+|||+...  
T Consensus        84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence              46799999999999999998653    4699999999999999999999985       49999999999999632  


Q ss_pred             ------------CCCCCEEEEeeccccccCCCCcccccccCcccccccccc---ccCCCchhHHHHHHHHHHHHhCCCCC
Q 019040          189 ------------KENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK---RNYGPEIDIWSAGVILYILLCGVPPF  253 (347)
Q Consensus       189 ------------~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~pf  253 (347)
                                  +....++|+|||++.............||+.|+|||++.   ..++.++||||||++||+|++|..||
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                        123458999999998765444444567999999999874   23889999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          254 WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      ........+.......   +.......+.++.+||..||+.+|.+||++.++|.|+||+....
T Consensus       244 ~~~~~~~qli~~lk~~---p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        244 HKANNFSQLISELKRG---PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             CcCCcHHHHHHHHhcC---CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            7665543333332222   22223467899999999999999999999999999999986643

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-45  Score=308.72  Aligned_cols=264  Identities=37%  Similarity=0.615  Sum_probs=232.3

Q ss_pred             cccceee-eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           49 IEDRYLV-DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        49 ~~~~y~i-~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      +.+-|.+ .+.||+|+++.|--+....+|.+||||++.+.   ......++.+|++++.+.++|+||+.++++|+++...
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F  151 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF  151 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence            4444554 35689999999999999999999999999765   3445678999999999999999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |+|+|.+.||+|...+.+...|++..+.++.+.|+.||.+||.+||.|||+||+|||....+.-.-||||||.+......
T Consensus       152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~  231 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL  231 (463)
T ss_pred             EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence            99999999999999999999999999999999999999999999999999999999998766666799999998765432


Q ss_pred             CC--------cccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---------------H
Q 019040          208 GE--------RFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAES---------------E  258 (347)
Q Consensus       208 ~~--------~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---------------~  258 (347)
                      ..        ...+.+|+..|||||+..      ..|+.+.|.||||+++|.|++|.+||.+.-               .
T Consensus       232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ  311 (463)
T KOG0607|consen  232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ  311 (463)
T ss_pred             CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence            22        223457888999999753      248899999999999999999999995542               3


Q ss_pred             HHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +..+..|..+...||...|..++.+..++|..+|..|+.+|.++.+.++|||++...
T Consensus       312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~  368 (463)
T KOG0607|consen  312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA  368 (463)
T ss_pred             HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence            467889999999999999999999999999999999999999999999999998764

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-43  Score=328.76  Aligned_cols=256  Identities=23%  Similarity=0.375  Sum_probs=207.5

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEEC--CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      ...+..+|.+++.||.|+||.||+|...  .+++.|++|.+...        ....+|+.+++.+ +|+||+++++++..
T Consensus        87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l-~h~~iv~~~~~~~~  157 (392)
T PHA03207         87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTI-SHRAIINLIHAYRW  157 (392)
T ss_pred             chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhc-CCCCccceeeeEee
Confidence            3445678999999999999999999764  35678999987532        2345799999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      .+..+++||++. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.
T Consensus       158 ~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~  233 (392)
T PHA03207        158 KSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAAC  233 (392)
T ss_pred             CCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCcccc
Confidence            999999999995 5888888777789999999999999999999999999999999999999   677889999999987


Q ss_pred             ccCCCCc---ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcccccc---
Q 019040          204 FFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ---GVAQAILRGLIDFK---  273 (347)
Q Consensus       204 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~---  273 (347)
                      .......   .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....   ..+..+.+.....+   
T Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence            6543322   234578999999998864 5899999999999999999999999765432   22222222111000   


Q ss_pred             --------------------CC-CC------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          274 --------------------RD-PW------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       274 --------------------~~-~~------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                                          .. .+      ...+.++.++|.+||+.||++|||+.++|.||||++.
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                                00 00      1346788999999999999999999999999999875

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-43  Score=324.78  Aligned_cols=251  Identities=23%  Similarity=0.355  Sum_probs=200.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      ..+|++++.||.|+||.||+|.+..++..||+|+....         ....|+.+++.+ +|+||+++++++...+..++
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEE
Confidence            35799999999999999999999999999999985432         234589999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      |+|++. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++......
T Consensus       135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccC
Confidence            999995 4888888654 568999999999999999999999999999999999999   67788999999998754433


Q ss_pred             CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCC-CHH---------HHHHHHHhcccc----cc
Q 019040          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE-SEQ---------GVAQAILRGLID----FK  273 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~---------~~~~~~~~~~~~----~~  273 (347)
                      .......||+.|+|||++.+ .++.++||||||+++|+|+++..++... ...         ..+..+......    ++
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            33345678999999998764 5899999999999999999865444222 110         111111111100    00


Q ss_pred             --------------------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          274 --------------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       274 --------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                                                ......++.++.++|.+||+.||.+|||+.++|+||||++.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence                                      00011456777889999999999999999999999999863

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=310.09  Aligned_cols=253  Identities=31%  Similarity=0.482  Sum_probs=214.0

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|++|.||+|.+..+++.||+|++.+...........+..|..++....+|+|++++++.+...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999999999999999987554333333344555665555444899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCccccccc
Q 019040          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG  216 (347)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~  216 (347)
                      ++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++.....   .....+
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCC
Confidence            9999999888889999999999999999999999999999999999999   5677899999998876433   233467


Q ss_pred             Cccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCC
Q 019040          217 SPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD  295 (347)
Q Consensus       217 ~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  295 (347)
                      +..|+|||.+.+ .++.++||||||+++|++++|..||...+.......+......++......+++.+.++|.+||+.+
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            889999998764 3789999999999999999999999888887777776665555554444578999999999999999


Q ss_pred             CCCCCC---HHHHhcCcccccCc
Q 019040          296 PKLRLT---AKQVLEHPWLQNAK  315 (347)
Q Consensus       296 p~~Rps---~~~ll~h~~~~~~~  315 (347)
                      |++||+   +.++++||||++..
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhcCC
Confidence            999995   57999999998764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.6e-44  Score=312.70  Aligned_cols=252  Identities=29%  Similarity=0.481  Sum_probs=218.6

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|++.+.||.|+||.||+|.+..+++.|++|++.+.........+.+.+|+++++++ +|||++++++.+......++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEE
Confidence            589999999999999999999999999999999876554545677899999999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcc
Q 019040          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF  211 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~  211 (347)
                      ||+.|++|..++.....+++..+..++.||+.||.|||+.|++|+||+|+||++   ++++.++|+|||.+.........
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCccc
Confidence            999999999999887789999999999999999999999999999999999999   66778999999998876554444


Q ss_pred             cccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          212 SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE---QGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       212 ~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      ....++..|+|||.+.+ .++.++|+||||+++|+|++|..||.....   .........    .........+.++.++
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  232 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET----ADVLYPATWSTEAIDA  232 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc----ccccCcccCcHHHHHH
Confidence            45578889999998764 489999999999999999999999987764   222222221    2222334678999999


Q ss_pred             HHHhccCCCCCCCCH--HHHhcCccc
Q 019040          288 VRQMLEPDPKLRLTA--KQVLEHPWL  311 (347)
Q Consensus       288 i~~~l~~dp~~Rps~--~~ll~h~~~  311 (347)
                      |.+||..||.+||++  .++++||||
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHccCChhHcCCccHHHHhcCCCC
Confidence            999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5e-43  Score=315.57  Aligned_cols=259  Identities=28%  Similarity=0.481  Sum_probs=220.4

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|.+.+.||.|+||.||+|.+..+++.|++|.+.............+.+|+.+++.+ +|+||+++++.+...+..++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEE
Confidence            4689999999999999999999999999999998765443344556788999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      +||++|++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||.+....... 
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCcc
Confidence            9999999999999888889999999999999999999999999999999999999   677889999999876321100 


Q ss_pred             ---------------cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc
Q 019040          210 ---------------RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (347)
Q Consensus       210 ---------------~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  273 (347)
                                     ......++..|+|||.+. ..++.++|+||||+++|++++|..||.+.................+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  236 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence                           001235678899999875 4589999999999999999999999998887777776665543333


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCcccccC
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPWLQNA  314 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~  314 (347)
                      ... ..++.++.++|.+||+.+|++||+   +.++++||||...
T Consensus       237 ~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         237 EGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             Ccc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            322 267899999999999999999998   7999999999664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-45  Score=309.49  Aligned_cols=258  Identities=30%  Similarity=0.561  Sum_probs=238.7

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      --++|..++.||.|.||+|-+++.+.+++.||+|+++++-+-.......-..|-++|+.. +||++..+.-.++..+.++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEE
Confidence            357899999999999999999999999999999999998877777778888899999999 9999999998999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc-CC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KP  207 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~-~~  207 (347)
                      +||||..||.|.-.+.+...+++...+.+...|+.||.|||+++||+||+|.+|.++   +.+|++||.|||++..- ..
T Consensus       245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhcccc
Confidence            999999999999999888889999999999999999999999999999999999999   88999999999999853 44


Q ss_pred             CCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      +......+|||.|+|||++. ..|+...|+|.+|++||||++|++||...+-+.....|..+...++.    .++++...
T Consensus       322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAkt  397 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKT  397 (516)
T ss_pred             cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHH
Confidence            55667889999999999987 66999999999999999999999999999999999999888888776    78999999


Q ss_pred             HHHHhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          287 LVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       287 li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      |+..+|.+||.+|.     .+.++.+|+||...
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v  430 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV  430 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence            99999999999998     48899999999764

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.2e-43  Score=309.75  Aligned_cols=250  Identities=32%  Similarity=0.564  Sum_probs=215.5

Q ss_pred             ecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCc
Q 019040           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (347)
Q Consensus        59 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  138 (347)
                      ||.|++|.||+|.+..+++.+++|++.+.........+.+.+|+.+++.+ +|+|++++++.+.+++..++++||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            68999999999999999999999999766554445567899999999999 99999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccccCc
Q 019040          139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSP  218 (347)
Q Consensus       139 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~  218 (347)
                      |.+++.+...++...+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||++.............+++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCc
Confidence            99999887789999999999999999999999999999999999999   567789999999998765543334456888


Q ss_pred             ccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCC
Q 019040          219 YYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAES--EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD  295 (347)
Q Consensus       219 ~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  295 (347)
                      .|++||.+. ..++.++|+||||+++|++++|..||....  .......+.........  ....++++.++|.+||+.+
T Consensus       157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCC--CcccCHHHHHHHHHHccCC
Confidence            999999875 458899999999999999999999998776  55555555532222221  2245899999999999999


Q ss_pred             CCCCCC-----HHHHhcCcccccC
Q 019040          296 PKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       296 p~~Rps-----~~~ll~h~~~~~~  314 (347)
                      |++||+     +.++++||||+..
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhhhCC
Confidence            999999     9999999999875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.9e-43  Score=306.33  Aligned_cols=252  Identities=25%  Similarity=0.444  Sum_probs=216.6

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      .|.+.+.||.|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.+ +|+|++++++.+...+..++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEE
Confidence            478899999999999999999999999999998654333 33456788999999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       132 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||+++++|.+++...  ..++...++.++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++.......
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCcc
Confidence            999999999999774  468999999999999999999999999999999999999   567789999999987654432


Q ss_pred             c-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          210 R-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       210 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      . .....+++.|+|||++.+ .++.++|+||||+++++|++|..||...+.......+.......   ....++..+.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  232 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP---VSQMYSQQLAQL  232 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC---CccccCHHHHHH
Confidence            2 233467889999998764 48899999999999999999999998888766666665543222   112678999999


Q ss_pred             HHHhccCCCCCCCCHHHHhcCccc
Q 019040          288 VRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      |.+||+.+|++||++.++++|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-45  Score=331.63  Aligned_cols=274  Identities=22%  Similarity=0.366  Sum_probs=224.3

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      ..++...+...+...||+|+||+||+|+|-++   ||||++.-+.... +..+.|++|+.++++- +|-||+-+.|++..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~-~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTP-EQLQAFKNEVAVLKKT-RHENILLFMGACMN  459 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCH-HHHHHHHHHHHHHhhc-chhhheeeehhhcC
Confidence            45666677889999999999999999999665   9999997665444 3788999999999998 99999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      ... .||..||+|.+|+.++.-. .+|...+++.|++||++|+.|||.++|||+|+|.+|||+   .++++|||+|||++
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLA  535 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccce
Confidence            887 8999999999999999664 459999999999999999999999999999999999999   67789999999998


Q ss_pred             ccc---CCCCcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC
Q 019040          203 IFF---KPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD  275 (347)
Q Consensus       203 ~~~---~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  275 (347)
                      ..-   ..........|...|||||+++    ..|+..+||||||+++|||++|..||.....+.++..+-++.......
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s  615 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS  615 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence            742   2233444556888999999986    348999999999999999999999999777776666666664333221


Q ss_pred             -CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc-CcccccCcCCCCCCChHHH
Q 019040          276 -PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE-HPWLQNAKKAPNVPLGDVV  326 (347)
Q Consensus       276 -~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~-h~~~~~~~~~~~~~~~~~~  326 (347)
                       ....+++++.+|+..||..++++||.+.+||. -.-+.......+.+.+.|+
T Consensus       616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~  668 (678)
T KOG0193|consen  616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEPV  668 (678)
T ss_pred             hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCccc
Confidence             22467889999999999999999999999987 3333332333344444443

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.6e-43  Score=309.02  Aligned_cols=253  Identities=28%  Similarity=0.490  Sum_probs=213.2

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc------hhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT------AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      +|.+...||.|++|.||+|.+..+++.||+|.+.......      ....+.+.+|+.+++.+ +|++++++++++...+
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Confidence            4778899999999999999999999999999886543221      12345688899999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ..++++||+++++|.+++.....++...+..++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||.+...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKL  156 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCccc
Confidence            999999999999999999888789999999999999999999999999999999999999   67788999999998765


Q ss_pred             CCCC-------cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC
Q 019040          206 KPGE-------RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       206 ~~~~-------~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  277 (347)
                      ....       ......++..|+|||.+. +.++.++|+||||+++|+|++|..||...+.......+...   ..+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~  233 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN---ASPEIP  233 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc---CCCcCC
Confidence            4221       112235788899999876 44888999999999999999999999877655444443332   122223


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ..++..+.++|.+||++||++||++.++++||||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            4678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.9e-43  Score=316.06  Aligned_cols=257  Identities=25%  Similarity=0.394  Sum_probs=213.0

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||.||+|.+..++..+++|.+....  .......+.+|+++++.+ +||||+++++.+..++.++++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEE
Confidence            46999999999999999999999999999999886432  223345688899999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      +||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||++   +.++.++|+|||++...... 
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCccccccc-
Confidence            9999999999999888889999999999999999999998 599999999999999   56778999999998754322 


Q ss_pred             cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc---------------
Q 019040          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK---------------  273 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  273 (347)
                      ......+++.|+|||.+.+ .++.++|+||||+++++|++|..||...+.......+........               
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            2234578899999998764 488899999999999999999999976654433322221111000               


Q ss_pred             -------------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          274 -------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       274 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                                         ......++.++.++|.+||..+|++|||+.++++||||.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                               00111367889999999999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.5e-43  Score=313.11  Aligned_cols=253  Identities=31%  Similarity=0.524  Sum_probs=212.1

Q ss_pred             ecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCc
Q 019040           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (347)
Q Consensus        59 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  138 (347)
                      ||.|+||+||+|.+..+|+.|++|++.............+.+|+.+++.+ +||+++++++.+...+..++|+||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            68999999999999999999999998765444444455677899999999 89999999999999999999999999999


Q ss_pred             hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCccccccc
Q 019040          139 LFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG  216 (347)
Q Consensus       139 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~  216 (347)
                      |.+++....  .+++..+..++.|++.||.|||++|++|+||+|+||++   ++++.++|+|||.+.............+
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccC
Confidence            999997765  68999999999999999999999999999999999999   6678899999999876554433344567


Q ss_pred             Ccccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCC
Q 019040          217 SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD  295 (347)
Q Consensus       217 ~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  295 (347)
                      +..|+|||.+. +.++.++||||||+++++|++|..||...........+.......+.......++++.++|.+||+.|
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            88999999875 44889999999999999999999999776543222333333333333333467899999999999999


Q ss_pred             CCCCC-----CHHHHhcCcccccCc
Q 019040          296 PKLRL-----TAKQVLEHPWLQNAK  315 (347)
Q Consensus       296 p~~Rp-----s~~~ll~h~~~~~~~  315 (347)
                      |++||     ++.++++||||.+..
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhcCC
Confidence            99999     888999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=327.70  Aligned_cols=260  Identities=32%  Similarity=0.598  Sum_probs=234.9

Q ss_pred             cceee--eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           51 DRYLV--DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        51 ~~y~i--~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      .-|+|  .+.||.|.||+||-|+++.+|+.||||++.+..+..... ..+.+|+.||+.+ +||.|+.+...++..+.+|
T Consensus       562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l-~HPGiV~le~M~ET~ervF  639 (888)
T KOG4236|consen  562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNL-HHPGIVNLECMFETPERVF  639 (888)
T ss_pred             HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhc-CCCCeeEEEEeecCCceEE
Confidence            34554  467999999999999999999999999998877655543 7899999999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          129 LVMELCEGGELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +|||.+.| ++.+.+..  .+.+++...+.++.||+.||+|||-+||+|+|+||+|||+.+.+..-.+||||||+|++++
T Consensus       640 VVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg  718 (888)
T KOG4236|consen  640 VVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG  718 (888)
T ss_pred             EEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence            99999955 77676654  4669999999999999999999999999999999999999887777789999999999998


Q ss_pred             CCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          207 PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      ...-....+|||.|+|||++++ .|...-|+||.|+++|--++|..||..  ++++..+|.+...-+++.+|..++.+..
T Consensus       719 EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~Ai  796 (888)
T KOG4236|consen  719 EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAI  796 (888)
T ss_pred             hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHH
Confidence            7766677899999999999874 599999999999999999999999954  4467788899999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +||+.+|+..-.+|.|..+.|.|||+++.+
T Consensus       797 dlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  797 DLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            999999999999999999999999999886

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.7e-43  Score=321.81  Aligned_cols=252  Identities=24%  Similarity=0.348  Sum_probs=201.2

Q ss_pred             CcccceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      ...++|++.+.||.|+||.||+|.+.     .++..||+|++....  .......+.+|+.++..+.+||||+++++++.
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            34578999999999999999999753     345679999986432  22344678899999999988999999999877


Q ss_pred             eC-CeEEEEEEecCCCchHHHHHhc-------------------------------------------------------
Q 019040          123 DD-NAVHLVMELCEGGELFDRIVAR-------------------------------------------------------  146 (347)
Q Consensus       123 ~~-~~~~lv~e~~~~~~L~~~l~~~-------------------------------------------------------  146 (347)
                      .. +.++++|||+++++|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            54 4688999999999999998653                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc---cccccc
Q 019040          147 -------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVG  216 (347)
Q Consensus       147 -------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~  216 (347)
                             ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++........   .....+
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCC
Confidence                   136778889999999999999999999999999999999   5677899999999976432221   122345


Q ss_pred             Ccccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHhccccccCCCCCCCCHHHHHHHHHhcc
Q 019040          217 SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGV-AQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (347)
Q Consensus       217 ~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (347)
                      ++.|+|||++. ..++.++||||||+++|+|++ |..||........ ...+..+..   ......+++++.+++.+||+
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~  315 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR---MRAPENATPEIYRIMLACWQ  315 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC---CCCCCCCCHHHHHHHHHHcc
Confidence            67899999875 458999999999999999997 9999987654333 333333221   11224678999999999999


Q ss_pred             CCCCCCCCHHHHhc
Q 019040          294 PDPKLRLTAKQVLE  307 (347)
Q Consensus       294 ~dp~~Rps~~~ll~  307 (347)
                      .||++|||+.++++
T Consensus       316 ~dp~~RPs~~el~~  329 (338)
T cd05102         316 GDPKERPTFSALVE  329 (338)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.5e-43  Score=308.27  Aligned_cols=255  Identities=29%  Similarity=0.466  Sum_probs=215.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|++|+||+|.+..++..+++|++..+....  ....+.+|+.+++.+ +|++++++++.+...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEE
Confidence            47999999999999999999999999999999986543322  567899999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          131 MELCEGGELFDRIVAR---GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      +|++++++|.+++...   ..+++..+..++.|++.||.+||+.|++|+||+|+||++   ++++.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhcc
Confidence            9999999999999764   358999999999999999999999999999999999999   5677899999999876554


Q ss_pred             CCcc-----cccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCC--CC
Q 019040          208 GERF-----SEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP--WP  278 (347)
Q Consensus       208 ~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~  278 (347)
                      ....     ....++..|+|||.+..  .++.++|+||||+++++|++|..||...+...................  +.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence            3222     23467889999998753  488999999999999999999999987776655555444422211111  23


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      .+++.+.+++.+||..||++||++.++++||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            678999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8.1e-43  Score=305.91  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=217.3

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|++.+.||.|++|.||+|.+..+++.+|+|.+....... .....+.+|+++++.+ +|++++++++.+...+..++|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEE
Confidence            5899999999999999999999999999999987654332 3457788999999999 8999999999999999999999


Q ss_pred             EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       132 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||+++++|.+++...  ..+++..+..++.+++.+|.|||++|++|+||+|+||+++  +++..++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCc
Confidence            999999999999764  3489999999999999999999999999999999999995  234568999999998766554


Q ss_pred             cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ......++..|+|||.+.+ .++.++||||||+++++|++|..||...+.......+......   .....++.++.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li  233 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---PISDRYSPDLRQLI  233 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC---CCCCCcCHHHHHHH
Confidence            4445678889999998764 4888999999999999999999999887776666555443322   12235789999999


Q ss_pred             HHhccCCCCCCCCHHHHhcCccc
Q 019040          289 RQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ..||+.+|++|||+.++++||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.2e-42  Score=311.16  Aligned_cols=261  Identities=28%  Similarity=0.446  Sum_probs=217.6

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..+.|++++.||.|+||.||+|.+..+++.+++|.+...   .......+.+|+.+++.+ +|+|++++++.+..++..+
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEE
Confidence            356799999999999999999999999999999998643   334456788899999999 8999999999999999999


Q ss_pred             EEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          129 LVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      +||||+++++|..++.+ ...+++..+..++.|++.+|.|||+.|++|+||+|+||++   +.++.++|+|||.+.....
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccc
Confidence            99999999999887765 3568999999999999999999999999999999999999   5677899999998875432


Q ss_pred             C-CcccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          208 G-ERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       208 ~-~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      . .......+++.|+|||.+.      ..++.++||||||+++|+|++|..||...+.......+...... .......+
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  241 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKW  241 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCccc
Confidence            2 2223456788999999873      23678999999999999999999999877765555444333221 11122357


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      +.++.++|.+||..+|++||++.++++||||......
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            7899999999999999999999999999999877543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.2e-42  Score=311.73  Aligned_cols=262  Identities=29%  Similarity=0.484  Sum_probs=218.9

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .......+|++.+.||.|++|.||+|.+..+++.|++|.+.....   .....+.+|+.+++.+ .|+|++++++.+...
T Consensus        14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~   89 (296)
T cd06654          14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVG   89 (296)
T ss_pred             ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEEeC
Confidence            344556799999999999999999999999999999999865432   2346688899999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ...++|+||+++++|.+++... .++...+..++.|++.||.|||+.||+|+||+|+||++   +.++.++|+|||.+..
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~  165 (296)
T cd06654          90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ  165 (296)
T ss_pred             CEEEEeecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchh
Confidence            9999999999999999988653 68999999999999999999999999999999999999   6677899999999876


Q ss_pred             cCCCCc-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          205 FKPGER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       205 ~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ...... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||................ .........++.
T Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  244 (296)
T cd06654         166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSA  244 (296)
T ss_pred             ccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCCCCccccCH
Confidence            543322 233468889999998764 48899999999999999999999998777654433332221 111122346788


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .+.++|.+||..+|++||++.++++||||....
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             HHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence            999999999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.4e-43  Score=309.76  Aligned_cols=255  Identities=29%  Similarity=0.453  Sum_probs=212.9

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|.+.+.||.|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.+ +|||++++++.+...+..+
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEE
Confidence            3468999999999999999999999999999999986442   22345678899999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +++||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||.+......
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCc
Confidence            999999999999999888889999999999999999999999999999999999999   66778999999998754322


Q ss_pred             C-cccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC-CCCCCCCH
Q 019040          209 E-RFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-DPWPNVSE  282 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  282 (347)
                      . ......++..|+|||.+.    +.++.++|+||||+++|+|++|..||...................+. .....++.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence            1 223457889999999863    34888999999999999999999999766554433333322221111 11124678


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~  310 (347)
                      .+.++|.+||+.+|++|||+.++++|||
T Consensus       240 ~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         240 SFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.4e-43  Score=310.82  Aligned_cols=254  Identities=29%  Similarity=0.454  Sum_probs=207.6

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|.+.+.||.|++|.||+|++..+++.||+|.+..... .......+.+|+.+++.+ +|+|++++++++..++..++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEE
Confidence            48899999999999999999999999999999865432 222346688899999999 8999999999999999999999


Q ss_pred             EecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          132 ELCEGGELFDRIVAR---GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       132 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ||++ ++|.+++...   ..+++..++.++.||+.||.|||+.|++|+||+|+||++   +.++.++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCC
Confidence            9997 4888887653   458999999999999999999999999999999999999   67788999999998754332


Q ss_pred             C-cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc------------
Q 019040          209 E-RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK------------  273 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------  273 (347)
                      . ......+++.|+|||.+.+  .++.++||||||+++++|++|..||.+.........+........            
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            2 1233456889999998753  378899999999999999999999987665443333222111000            


Q ss_pred             -------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          274 -------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       274 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                                   ......+++++.++|.+||+.||++|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                         01123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6e-43  Score=313.88  Aligned_cols=266  Identities=30%  Similarity=0.486  Sum_probs=219.8

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ......++|.+.+.||.|++|.||+|.+..+++.||+|.+.....   .....+.+|+.+++.+ +|+|++++++.+..+
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~   88 (297)
T cd06656          13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVG   88 (297)
T ss_pred             ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence            344556899999999999999999999999999999999865432   2345688899999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +..++|+||+++++|.+++.+. .++...+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++..
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~  164 (297)
T cd06656          89 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ  164 (297)
T ss_pred             CEEEEeecccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceE
Confidence            9999999999999999988654 68899999999999999999999999999999999999   6678899999999876


Q ss_pred             cCCCCc-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          205 FKPGER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       205 ~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ...... .....+++.|+|||.+.+ .++.++|+||||+++|++++|..||...+.......+... ..........++.
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  243 (297)
T cd06656         165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPELQNPERLSA  243 (297)
T ss_pred             ccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCCCCCCccccCH
Confidence            543322 233468889999998764 4889999999999999999999999776653332222211 1111122346788


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                      .+.++|.+||..+|++||++.++++||||+.......
T Consensus       244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence            8999999999999999999999999999998864433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.3e-43  Score=311.52  Aligned_cols=260  Identities=28%  Similarity=0.391  Sum_probs=216.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||.|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.+ +|+|++++++.+...+..++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEE
Confidence            46899999999999999999999999999999885431  233346788999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          131 MELCEGGELFDRIVAR---GHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +||+++++|..++...   ..+++..+..++.||+.||.|||+ .|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCccccc
Confidence            9999999998888763   368999999999999999999997 599999999999999   557789999999987653


Q ss_pred             CCCcccccccCccccccccccc-------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          207 PGERFSEIVGSPYYMAPEVLKR-------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ... .....+++.|+|||.+.+       .++.++|+||||+++|+|++|..||...........+.......+....+.
T Consensus       155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         155 ASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             CCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence            322 233467889999998742       257899999999999999999999977665544444333222223333446


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      ++.++.++|.+||+.+|++||++.++++||||......
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            89999999999999999999999999999999888754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.4e-43  Score=308.71  Aligned_cols=254  Identities=27%  Similarity=0.444  Sum_probs=210.8

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~----  124 (347)
                      ..++|++.+.||.|+||.||+|.+..+++.||+|++....    .....+.+|+.++..+.+|+|++++++.+...    
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            4578999999999999999999999999999999986432    23456888999999987799999999998753    


Q ss_pred             --CeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          125 --NAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       125 --~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                        ...++++||+++++|.+++...  ..+++..+..++.|++.||.|||++||+|+||+|+||++   ++++.++|+|||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg  156 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFG  156 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCC
Confidence              4689999999999999998764  358999999999999999999999999999999999999   667789999999


Q ss_pred             cccccCCC-CcccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc
Q 019040          201 LSIFFKPG-ERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (347)
Q Consensus       201 ~a~~~~~~-~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  273 (347)
                      ++...... .......+++.|+|||++.      ..++.++||||||+++|+|++|..||...........+....  ..
T Consensus       157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~  234 (272)
T cd06637         157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--AP  234 (272)
T ss_pred             CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CC
Confidence            98765332 1223456889999999874      247889999999999999999999997766554444333221  11


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ......++.++.+||.+||..+|.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            22223678999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.6e-42  Score=310.85  Aligned_cols=257  Identities=32%  Similarity=0.524  Sum_probs=217.9

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      ..+|++.+.||.|++|.||+|.+..+++.|++|.+....   ......+.+|+.+++.+ +|+|++++++.+...+..++
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l   93 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFV   93 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEE
Confidence            467999999999999999999999999999999986432   22346788899999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |+||+++++|..++... .+++..+..++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||++.......
T Consensus        94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          94 VMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             EEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccccc
Confidence            99999999999888654 68999999999999999999999999999999999999   667889999999987654332


Q ss_pred             c-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          210 R-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       210 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      . .....++..|+|||.+.+ .++.++||||||+++|++++|..||...+.......+.... .........++..+.++
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  248 (296)
T cd06655         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSPIFRDF  248 (296)
T ss_pred             ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CcccCCcccCCHHHHHH
Confidence            2 233468889999998764 48899999999999999999999998877655444443321 11222334688999999


Q ss_pred             HHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          288 VRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      |.+||..||++||++.++++||||+...
T Consensus       249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         249 LNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            9999999999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.1e-42  Score=303.51  Aligned_cols=252  Identities=25%  Similarity=0.472  Sum_probs=212.3

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee-CCeEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-DNAVHLV  130 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~-~~~~~lv  130 (347)
                      .|++.+.||.|++|.||+|.++.+++.||+|.+..... .....+.+.+|+++++.+ +|++++++++.+.. .+..+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEE
Confidence            48999999999999999999999999999999865432 223456788899999999 89999999988764 4578999


Q ss_pred             EEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          131 MELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||+++++|.+++...  ..+++.+++.++.+++.+|.+||+.|++|+||+|+||++   +.++.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEeccc
Confidence            9999999999998763  348999999999999999999999999999999999999   66788999999998765332


Q ss_pred             C-cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          209 E-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      . ......+++.|+|||.+.+ .++.++||||||++++++++|..||...+.......+..+...   ......++.+.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  232 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP---PMPKDYSPELGE  232 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHHHHH
Confidence            2 2233467889999998764 4888999999999999999999999877766655555444321   222467899999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcCccc
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      +|.+||+.||++||++.++++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.7e-43  Score=313.18  Aligned_cols=263  Identities=29%  Similarity=0.464  Sum_probs=215.9

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEecccccc--chhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      +|.+.+.||.|++|.||+|.+..+++.|++|.+......  .......+..|+++++.+ +|+|++++++++.+.+..++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEE
Confidence            588899999999999999999999999999998765433  122234577899999999 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      |+||+ +++|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||++......
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCC
Confidence            99999 889999998765 79999999999999999999999999999999999999   56788999999999876443


Q ss_pred             C-cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC-----------
Q 019040          209 E-RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----------  274 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  274 (347)
                      . ......+++.|+|||.+.+  .++.++||||||+++++|++|..+|......+....+.........           
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            2 2233456788999998743  4788999999999999999998888776655544444332111000           


Q ss_pred             -------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCC
Q 019040          275 -------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       275 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                                   ..+...+..+.++|.+||.+||++|||+.++++|+||++...+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~  293 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP  293 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence                         011245788999999999999999999999999999999875543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.6e-43  Score=313.08  Aligned_cols=254  Identities=28%  Similarity=0.511  Sum_probs=205.7

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|++.+.||.|++|.||+|+++.+|+.|++|.+..... .......+.+|+.+++.+ +|+|++++++++.+.+..++++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEE
Confidence            58899999999999999999999999999999865432 222335677899999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          132 ELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       132 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      ||+++ +|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||++   +.++.++|+|||.+....... 
T Consensus        79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC
Confidence            99965 88887765 4568999999999999999999999999999999999999   567789999999987654332 


Q ss_pred             cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcccc--------------c
Q 019040          210 RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGLID--------------F  272 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~--------------~  272 (347)
                      ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||. +.+.......+......              .
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            2233467889999998754  37899999999999999999988854 33433333333221110              0


Q ss_pred             ---c--------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          273 ---K--------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       273 ---~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                         +        ....+.++.++.++|.+||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence               0        00113577899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-43  Score=310.47  Aligned_cols=257  Identities=32%  Similarity=0.484  Sum_probs=217.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++.+.||.|++|.||+|.+..++..+|+|++...   .......+.+|+.+++.+ +|+|++++++.+...+..++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEE
Confidence            46799999999999999999999989999999998543   333456788899999999 79999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||++   +.++.++|+|||.+......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccc
Confidence            99999999999998764 468999999999999999999999999999999999999   66788999999988654322


Q ss_pred             C-cccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          209 E-RFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      . ......+++.|+|||.+.      ..++.++|+||||+++|+|++|..||...........+....... ......++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  235 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT-LDQPSKWS  235 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCC-cCCcccCC
Confidence            2 223446888999999863      236789999999999999999999998877666555554432211 11223678


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      .++.++|..||+.+|++||++.++++||||.+.
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            899999999999999999999999999999887

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.5e-43  Score=311.68  Aligned_cols=256  Identities=27%  Similarity=0.473  Sum_probs=211.8

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|++|.||+|.++.+++.||+|.+....... ...+.+.+|+++++.+ +|+|++++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEE
Confidence            47999999999999999999999999999999986543322 3345688899999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      +||+++++|..+......++...+..++.||+.||.|||+.|++|+||+|+||++   ++++.++|+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence            9999998888777666679999999999999999999999999999999999999   667889999999987654332 


Q ss_pred             cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc---------------
Q 019040          210 RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF---------------  272 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------  272 (347)
                      ......++..|+|||++.+  .++.++||||||+++++|++|..||......+....+......+               
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            2234567889999998753  37789999999999999999999997766544333332211110               


Q ss_pred             ----c--------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          273 ----K--------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       273 ----~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                          +        ...++.++..+.+++.+||+.+|++||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                0        01123678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-42  Score=310.09  Aligned_cols=255  Identities=30%  Similarity=0.520  Sum_probs=212.9

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|++.+.||.|++|.||+|.+..+|..|++|++...... ......+.+|+.+++.+ +|+|++++++++...+..++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEe
Confidence            589999999999999999999999999999998654322 23356788999999999 8999999999999999999999


Q ss_pred             EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          132 ELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       132 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      ||+ +++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||++   +.++.++|+|||.+....... 
T Consensus        79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC
Confidence            999 99999998654 468999999999999999999999999999999999999   567889999999988765433 


Q ss_pred             -cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC------------
Q 019040          210 -RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR------------  274 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------  274 (347)
                       ......++..|+|||.+.+  .++.++||||||+++++|++|.++|.+.........+.........            
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence             1334568889999998753  3688999999999999999998888777765555444332211000            


Q ss_pred             --------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 019040          275 --------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (347)
Q Consensus       275 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  312 (347)
                                    ...+..+.++.++|.+||+.+|++|||+.++++||||-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                          11135678999999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1e-42  Score=309.52  Aligned_cols=252  Identities=25%  Similarity=0.354  Sum_probs=208.3

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|++|.||+|.+..+++.||+|++..+.  .......+.+|+++++++ +|||++++++.+...+..+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEE
Confidence            36889999999999999999999999999999986542  223345688999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      +||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+||++   +.++.++|+|||++...... .
T Consensus        78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~  149 (279)
T cd06619          78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-I  149 (279)
T ss_pred             EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-c
Confidence            999999988544    257889999999999999999999999999999999999   66788999999998765433 2


Q ss_pred             ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccccccCCCCCCCCH
Q 019040          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-------GVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .....++..|+|||.+.+ .++.++|+||||+++|+|++|..||......       .....+....  .+.......+.
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  227 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFSE  227 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCCH
Confidence            334578999999998764 4899999999999999999999999653321       1112222111  11112235788


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ++.++|.+||+.+|.+||++.++++||||+...
T Consensus       228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         228 KFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            999999999999999999999999999998774

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.3e-42  Score=307.72  Aligned_cols=257  Identities=28%  Similarity=0.463  Sum_probs=215.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      +-|++.+.||.|+||.||+|.+..++..+++|.+...   .......+.+|+++++.+ +|+|++++++.+...+..+++
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEE
Confidence            3478899999999999999999999999999998543   233456788899999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-
Q 019040          131 MELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-  208 (347)
                      +||+++++|..++.. ...+++..+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccc
Confidence            999999999888765 4568999999999999999999999999999999999999   66778999999998654322 


Q ss_pred             CcccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          209 ERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .......+++.|+|||++.      ..++.++||||||+++|+|++|..||...+.......+....... ......++.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  236 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSS  236 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCH
Confidence            1223456889999999873      237789999999999999999999998877666555554432221 112235788


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .+.++|.+||+.||++||++.++++||||+...
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence            999999999999999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.5e-43  Score=307.93  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=211.0

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++.+.||.|+||.||+|++..+++.||+|++....   ......+.+|+.+++.+ +|+|++++++.+...+..+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEE
Confidence            3568999999999999999999999999999999986432   22345688899999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +|+||+++++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||++   +.++.++|+|||++......
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeeccc
Confidence            999999999999999887789999999999999999999999999999999999999   66778999999998865432


Q ss_pred             C-cccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc-CCCCCCCCH
Q 019040          209 E-RFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-RDPWPNVSE  282 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  282 (347)
                      . ......+++.|+|||.+.    ..++.++||||||+++++|++|..||...........+.......+ ......++.
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS  239 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence            2 223346888999999863    3377899999999999999999999966554332222222211111 111235688


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~  310 (347)
                      .+.++|.+||+.+|++|||+.++++|+|
T Consensus       240 ~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         240 TFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.9e-43  Score=316.31  Aligned_cols=249  Identities=26%  Similarity=0.423  Sum_probs=192.7

Q ss_pred             eeeecccCCeEEEEEEEC--CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee--CCeEEEEE
Q 019040           56 DRELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DNAVHLVM  131 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~  131 (347)
                      .+.||.|+||+||+|+++  .+++.||+|.+....     ....+.+|+.+++.+ +||||+++++.+..  +..+++++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEE
Confidence            457999999999999976  467889999885432     124567899999999 99999999998854  46789999


Q ss_pred             EecCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC-CCCCCEEEEeecc
Q 019040          132 ELCEGGELFDRIVAR---------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK-KENSPLKAIDFGL  201 (347)
Q Consensus       132 e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~-~~~~~~~l~Dfg~  201 (347)
                      ||+.+ +|.+++...         ..+++..++.++.||+.||.|||+.||+||||||+|||+..+ +..+.+||+|||+
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            99954 888877532         248899999999999999999999999999999999999643 4567899999999


Q ss_pred             ccccCCCC----cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHH
Q 019040          202 SIFFKPGE----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQ---------GVAQAIL  266 (347)
Q Consensus       202 a~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~~  266 (347)
                      +.......    ......+|+.|+|||++.+  .++.++||||||+++|+|++|..||......         .....+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            97654322    2234578999999998754  4889999999999999999999999654321         1111111


Q ss_pred             hccccc---------------------c-------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          267 RGLIDF---------------------K-------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       267 ~~~~~~---------------------~-------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ......                     .             .......+..+.+||.+||+.||.+|||+.++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            110000                     0             00001235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.3e-42  Score=309.56  Aligned_cols=258  Identities=29%  Similarity=0.450  Sum_probs=208.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe----
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA----  126 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~----  126 (347)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+.+|+|++++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            479999999999999999999999999999999865432 222345678899999999778999999999887665    


Q ss_pred             -EEEEEEecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          127 -VHLVMELCEGGELFDRIVAR-----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       127 -~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                       .|+++||+++ +|.+++...     ..+++..++.++.||+.||.|||+.||+|+||+|+||+++  ..++.++|+|||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg  156 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLG  156 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecc
Confidence             8999999976 888887653     3479999999999999999999999999999999999994  226789999999


Q ss_pred             cccccCCC-CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC---
Q 019040          201 LSIFFKPG-ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR---  274 (347)
Q Consensus       201 ~a~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---  274 (347)
                      .+...... .......+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+.......+.........   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            98754322 22233356888999998753  3789999999999999999999999887766555444332211000   


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 019040          275 ---------------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (347)
Q Consensus       275 ---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  312 (347)
                                           ...+.++..+.++|.+||..||.+||++.+++.||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                 01135788999999999999999999999999999996

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.5e-42  Score=308.13  Aligned_cols=272  Identities=26%  Similarity=0.443  Sum_probs=224.2

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      ...|+..+.||.|+||.||+|.+..++..||+|++....  .......+.+|+.+++.+ .|++++++++.+.+++..++
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEE
Confidence            356888999999999999999999999999999986542  223456788999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |+||+++++|.+++.. .++++..+..++.|++.||.+||+.+++|+||+|+||++   +.++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCc
Confidence            9999999999998865 468999999999999999999999999999999999999   567789999999987654332


Q ss_pred             c-ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          210 R-FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       210 ~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      . .....++..|+|||.+. ..++.++|+||||+++|+|++|..||...........+....   ++.....++..+.++
T Consensus       156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l  232 (277)
T cd06640         156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEF  232 (277)
T ss_pred             cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC---CCCCchhhhHHHHHH
Confidence            2 22345788899999875 448899999999999999999999998777665544432221   222333578899999


Q ss_pred             HHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhhhh
Q 019040          288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQF  333 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~  333 (347)
                      |.+||..+|++||++.++++|+||.+....  ...-+.+..++++|
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~--~~~~~~~~~~~~~~  276 (277)
T cd06640         233 IDACLNKDPSFRPTAKELLKHKFIVKNAKK--TSYLTELIDRFKRW  276 (277)
T ss_pred             HHHHcccCcccCcCHHHHHhChHhhhcchh--hhHHHHHHHHHHhc
Confidence            999999999999999999999999777433  34445555555555

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.8e-43  Score=317.00  Aligned_cols=256  Identities=20%  Similarity=0.286  Sum_probs=204.8

Q ss_pred             eeeeeccc--CCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           55 VDRELGRG--EFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        55 i~~~lg~G--~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      +++.||.|  +|++||++.++.+|+.||+|.+..+... ......+.+|+.+++.+ +||||+++++++..++..++|+|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEe
Confidence            56789999  7899999999999999999998654322 33456788899999999 99999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          133 LCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       133 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      |+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.++++||+.+........
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhccccccc
Confidence            99999999998653  458999999999999999999999999999999999999   5667899999986543221100


Q ss_pred             --------ccccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc------
Q 019040          211 --------FSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK------  273 (347)
Q Consensus       211 --------~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  273 (347)
                              .....++..|+|||++.+   .++.++||||||+++|+|++|..||....................      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                    112246677999998753   488999999999999999999999976655443333222111000      


Q ss_pred             ------------------------------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          274 ------------------------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       274 ------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                                          .+....+++.+.++|.+||+.||++|||+.++++||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                                000113567899999999999999999999999999998765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.7e-42  Score=304.72  Aligned_cols=255  Identities=28%  Similarity=0.467  Sum_probs=209.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEecccccc--chhcHHHHHHHHHHHHhCCCCCceeEeeeEEee--CCe
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DNA  126 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~--~~~  126 (347)
                      ..|++.+.||.|+||.||+|.+..++..|++|.+......  .......+.+|+.+++.+ +|+|++++++.+..  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence            4789999999999999999999999999999988654322  223456788999999999 89999999998875  367


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .++++||+++++|.+++.....++...+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++....
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccc
Confidence            88999999999999999887789999999999999999999999999999999999999   567789999999987543


Q ss_pred             CCC----cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          207 PGE----RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       207 ~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ...    ......++..|+|||.+.+ .++.++||||||+++|++++|..||...........+.....  .+.....++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT--NPQLPSHIS  235 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC--CCCCchhcC
Confidence            211    1123457889999998764 488999999999999999999999987765444433322211  122223567


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  312 (347)
                      +.+.++| .||..+|++||++.++++||||+
T Consensus       236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         236 EHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            8888998 67778999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.8e-42  Score=308.56  Aligned_cols=242  Identities=19%  Similarity=0.210  Sum_probs=206.3

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee----CCeEEEEEE
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----DNAVHLVME  132 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~----~~~~~lv~e  132 (347)
                      ..||.|+++.||+|.+  +|+.||+|.+...........+.+.+|+.++.++ +||||+++++++.+    ....++|+|
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence            5689999999999988  6889999999765444444457788999999999 99999999999876    457899999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcc
Q 019040          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF  211 (347)
Q Consensus       133 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~  211 (347)
                      |+++++|.+++.+...++......++.+++.||.|||+. +++||||||+||++   ++++.+||+|||++.......  
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence            999999999998888899999999999999999999985 99999999999999   677889999999987643322  


Q ss_pred             cccccCcccccccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          212 SEIVGSPYYMAPEVLK---RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       212 ~~~~~~~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ....++..|+|||.+.   ..++.++||||||+++|+|++|..||...+..+....+.......+.  ...+++.+.++|
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~l~~li  255 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL--PLDCPLEIKCIV  255 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--CCcCcHHHHHHH
Confidence            2346788999999875   35899999999999999999999999988877777766554333222  236789999999


Q ss_pred             HHhccCCCCCCCCHHHHhcC
Q 019040          289 RQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+||+.||++|||+.++++.
T Consensus       256 ~~cl~~dp~~Rps~~ell~~  275 (283)
T PHA02988        256 EACTSHDSIKRPNIKEILYN  275 (283)
T ss_pred             HHHhcCCcccCcCHHHHHHH
Confidence            99999999999999999753

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=330.25  Aligned_cols=258  Identities=29%  Similarity=0.467  Sum_probs=223.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+-|.|+..||.|+||+||+|..+.++...|.|++...   ....+..+.-||.||..+ .||+|+++++.|..++.+||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEE
Confidence            45689999999999999999999999998999988533   556678888999999999 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC-C
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-P  207 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~-~  207 (347)
                      ++|+|.||-...++.+- ..+.+.++.-+++|+++||.|||+.+|||||+|..|||+   .-+|.++|.|||.+.... .
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccchhH
Confidence            99999999998888775 459999999999999999999999999999999999999   677889999999875432 2


Q ss_pred             CCcccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          208 GERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ......++|||+|||||+..      ..|++++||||||++|.+|.-+.+|....++..++-.+.......- -....-+
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTL-lqPS~Ws  262 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-LQPSHWS  262 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcc-cCcchhh
Confidence            33446689999999999763      3499999999999999999999999999999888877765543211 1112346


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ..+.|++.+||.+||..||++.++|+|||+.+..
T Consensus       263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             hHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            7899999999999999999999999999999874

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.9e-42  Score=301.12  Aligned_cols=252  Identities=31%  Similarity=0.503  Sum_probs=217.5

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|++.+.||.|+||.||.+++..+++.+++|.+...... ......+.+|+.+++++ +|+|++++++++.+.+..++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEE
Confidence            589999999999999999999999999999998654322 23456788999999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       132 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||+++++|.+++...  ..++...+..++.|++.+|.|||+.|++|+||+|+||++   ++++.++|+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEccccc
Confidence            999999999999765  458999999999999999999999999999999999999   567789999999987654333


Q ss_pred             -cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          210 -RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                       ......+++.|+|||.+.+ .++.++||||||+++++|++|..||......+....+..+....   ....++.++.++
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  232 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP---VVSVYSSELISL  232 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---CccccCHHHHHH
Confidence             2234568899999998764 48889999999999999999999998887777666665543322   124678999999


Q ss_pred             HHHhccCCCCCCCCHHHHhcCccc
Q 019040          288 VRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      |.+||..+|++||++.++++|+|+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.1e-42  Score=302.39  Aligned_cols=252  Identities=26%  Similarity=0.525  Sum_probs=216.1

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|++.+.||.|+||.||++.+..+++.|++|.+...... ......+.+|+.+++.+ +|+|++++++++...+..++|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEE
Confidence            589999999999999999999999999999998654332 23446788999999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          132 ELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||+++++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++.......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcch
Confidence            9999999999987643  47899999999999999999999999999999999999   567789999999987654332


Q ss_pred             c-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          210 R-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       210 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      . .....+++.|+|||.+.+ .++.++|+||||++++++++|..||...+..+....+..+...   .....++.++.++
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l  232 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP---PVSSHYSYDLRNL  232 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC---CCcccCCHHHHHH
Confidence            2 123457888999998764 4888999999999999999999999888877776666554332   2224678999999


Q ss_pred             HHHhccCCCCCCCCHHHHhcCccc
Q 019040          288 VRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      |.+||+.+|++||++.++++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.9e-42  Score=302.96  Aligned_cols=255  Identities=28%  Similarity=0.466  Sum_probs=213.8

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|.+.+.||.|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.+ +|++|+++++.....+.+++++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEE
Confidence            689999999999999999999999999999998765433 34567899999999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcc
Q 019040          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF  211 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~  211 (347)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||++   ++++.++|+|||.+.........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence            999999999999887778999999999999999999999999999999999999   56788999999998876433221


Q ss_pred             -----cccccCccccccccccc-c---CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          212 -----SEIVGSPYYMAPEVLKR-N---YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       212 -----~~~~~~~~y~aPE~~~~-~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                           ....+++.|+|||++.+ .   ++.++||||||++++++++|..||.....................+....++.
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP  235 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence                 13467889999998753 2   78899999999999999999999976643322222222222222233335689


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      .+.++|..||+.+|++||++.+++.|||+
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         236 EGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3e-42  Score=304.09  Aligned_cols=254  Identities=28%  Similarity=0.457  Sum_probs=211.0

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccc---cchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL---RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      +|.+.+.||.|+||.||+|.+ .+++.+|+|.+.....   ........+.+|+++++.+ +|+|++++.+++.+.+..+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEE
Confidence            478899999999999999987 4788899998864321   1223346688999999999 8999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +++||+++++|.+++.+...+++..+..++.|++.||.|||+.||+|+||+|+||++   +.++.++|+|||++......
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhhc
Confidence            999999999999999887789999999999999999999999999999999999999   66788999999988754211


Q ss_pred             -------CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          209 -------ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       209 -------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                             .......++..|+|||.+.+ .++.++||||||++++++++|..||...+.......+..... ..+.....+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  234 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG-LMPRLPDSF  234 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC-CCCCCCCCC
Confidence                   11223468889999998764 488999999999999999999999987665443333332211 122233468


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      +.++.++|.+||+.+|++||++.++++||||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=327.24  Aligned_cols=270  Identities=27%  Similarity=0.463  Sum_probs=232.2

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      -.++....|.-++.||.|+||.||.|++..+.+.||||.+..+.......-.++.+|+.+|+++ .|||++.+.++|-.+
T Consensus        20 ~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre   98 (948)
T KOG0577|consen   20 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLRE   98 (948)
T ss_pred             ccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeecc
Confidence            3445556788899999999999999999999999999999988877778888999999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      ...|+|||||-| +-.+++.-. +++.+..+..|+.+.+.||.|||+.+.||||||..|||+   .+.|.|||+|||.|.
T Consensus        99 ~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAs  174 (948)
T KOG0577|consen   99 HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSAS  174 (948)
T ss_pred             chHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchh
Confidence            999999999955 777777543 579999999999999999999999999999999999999   788999999999998


Q ss_pred             ccCCCCcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-ccccCCCCC
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL-IDFKRDPWP  278 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~  278 (347)
                      ...+.   ..++|||.|||||++.    |.|+-++||||||++-.+|.-.++|...++....+-.|-... +.....   
T Consensus       175 i~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~---  248 (948)
T KOG0577|consen  175 IMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSN---  248 (948)
T ss_pred             hcCch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCc---
Confidence            75543   5578999999999874    679999999999999999999999999998886665554432 223323   


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHH
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVV  326 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~  326 (347)
                      .-+..+++||..||++-|.+|||..++|.|+|..+-. ++.+.+....
T Consensus       249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R-p~tvi~dLIq  295 (948)
T KOG0577|consen  249 EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER-PPTVIMDLIQ  295 (948)
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC-CchHHHHHHH
Confidence            3467899999999999999999999999999997763 4455554433

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.8e-42  Score=307.97  Aligned_cols=253  Identities=28%  Similarity=0.432  Sum_probs=203.2

Q ss_pred             eecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhC--CCCCceeEeeeEEeeCCeEEEEEEecC
Q 019040           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL--PKNSSIVSLKEACEDDNAVHLVMELCE  135 (347)
Q Consensus        58 ~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l--~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (347)
                      .||+|+||.||+|.+..+++.+|+|.+.+.............+|..+++.+  ..|++++.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            389999999999999999999999998765443333233344454443333  279999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccc
Q 019040          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV  215 (347)
Q Consensus       136 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~  215 (347)
                      +++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||++....... .....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcC
Confidence            99999999888889999999999999999999999999999999999999   677789999999987554332 23346


Q ss_pred             cCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhcc
Q 019040          216 GSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (347)
Q Consensus       216 ~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (347)
                      +++.|+|||.+.  ..++.++||||+|+++++|++|..||......... .+..............++.++.++|.+||.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence            899999999875  34789999999999999999999999765432211 111111222223334688999999999999


Q ss_pred             CCCCCCC-----CHHHHhcCcccccCc
Q 019040          294 PDPKLRL-----TAKQVLEHPWLQNAK  315 (347)
Q Consensus       294 ~dp~~Rp-----s~~~ll~h~~~~~~~  315 (347)
                      .||++||     ++.++++||||+...
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            9999999     699999999998854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.3e-42  Score=302.97  Aligned_cols=252  Identities=27%  Similarity=0.461  Sum_probs=212.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++.+.||.|++|.||+|.+..+++.+++|.+....     ..+.+.+|+++++.+ +|+|++++++.+......++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEE
Confidence            367999999999999999999999889999999986432     157899999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ++||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++......
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccC
Confidence            99999999999998764 468999999999999999999999999999999999999   66778999999998876544


Q ss_pred             C-cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          209 E-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      . ......++..|+|||.+.+ .++.++||||||+++++|++|..||...........+..... ........++.++.+
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  231 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP-PTLSDPEKWSPEFND  231 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCC-CCCCchhhcCHHHHH
Confidence            3 2233457889999998764 488899999999999999999999987665543333222111 111112356789999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcCccc
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      +|..||+.||++|||+.++++||||
T Consensus       232 ~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         232 FVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.9e-42  Score=303.66  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=218.1

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|++|.||+|.+..+++.|++|.+......  .....+.+|+..+..+ +|++++++++.+...+..+++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEE
Confidence            4689999999999999999999999999999998654322  4457799999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      +||+++++|.+++.....+++..+..++.|++.||.+||+ .|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCC
Confidence            9999999999999887889999999999999999999999 999999999999999   667889999999988765443


Q ss_pred             cc-cccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccccccCCCCCC-CCHH
Q 019040          210 RF-SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES---EQGVAQAILRGLIDFKRDPWPN-VSES  283 (347)
Q Consensus       210 ~~-~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~-~~~~  283 (347)
                      .. ....++..|+|||.+.+ .++.++|+||||+++|++++|..||....   .......+.....   ...... ++..
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  231 (264)
T cd06623         155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP---PSLPAEEFSPE  231 (264)
T ss_pred             CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC---CCCCcccCCHH
Confidence            32 24567889999998764 48889999999999999999999997774   3334444433221   111223 7899


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +.++|..||.++|++||++.++++||||+...
T Consensus       232 l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         232 FRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            99999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.3e-42  Score=305.34  Aligned_cols=249  Identities=27%  Similarity=0.445  Sum_probs=202.0

Q ss_pred             cceeeeeee--cccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           51 DRYLVDREL--GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        51 ~~y~i~~~l--g~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ++|.+.+.+  |.|+||.||++.++.++..+|+|++........        |+.....+.+|+|++++++.+...+..+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            466676666  999999999999999999999999865432211        3333333447999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC-CEEEEeeccccccCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS-PLKAIDFGLSIFFKP  207 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~-~~~l~Dfg~a~~~~~  207 (347)
                      +||||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++ .++|+|||.+.....
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCC
Confidence            9999999999999998887899999999999999999999999999999999999994   444 799999999876543


Q ss_pred             CCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      .   ....++..|+|||.+.+ .++.++||||||+++++|++|..||.......................+...+..+.+
T Consensus       163 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T PHA03390        163 P---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND  239 (267)
T ss_pred             C---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence            2   23467889999998864 5889999999999999999999999765443321111111112223334468999999


Q ss_pred             HHHHhccCCCCCCCC-HHHHhcCccccc
Q 019040          287 LVRQMLEPDPKLRLT-AKQVLEHPWLQN  313 (347)
Q Consensus       287 li~~~l~~dp~~Rps-~~~ll~h~~~~~  313 (347)
                      +|.+||+.+|.+||+ +.++|+||||++
T Consensus       240 li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        240 FVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHhccChhhCCchHHHHhcCCcccC
Confidence            999999999999996 599999999974

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-42  Score=302.02  Aligned_cols=254  Identities=29%  Similarity=0.463  Sum_probs=214.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++.+.||.|++|.||+|.+..+++.+++|++....   ......+.+|+.+++.+ +|+|++++++.+...+.+++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEE
Confidence            368999999999999999999999999999999986543   22457889999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ++||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++   ++++.++|+|||.+......
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhh
Confidence            99999999999998776 679999999999999999999999999999999999999   66788999999998765433


Q ss_pred             C-cccccccCcccccccccc-c---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc-CCCCCCCCH
Q 019040          209 E-RFSEIVGSPYYMAPEVLK-R---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-RDPWPNVSE  282 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~-~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  282 (347)
                      . ......++..|+|||.+. .   .++.++|+||||+++++|++|..||...........+........ .......+.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP  234 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence            2 223456788899999875 3   578899999999999999999999988776554444433321111 111224578


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~  310 (347)
                      ++.++|.+||..+|.+|||+.+++.|+|
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         235 VFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-42  Score=305.78  Aligned_cols=258  Identities=24%  Similarity=0.441  Sum_probs=211.0

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc---hhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      +|+..+.||.|++|.||+|.+..+++.||+|++.......   ......+.+|+++++.+ +|+|++++++++.+.+..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEE
Confidence            4788899999999999999999999999999986433211   22356789999999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +|+||+++++|.+++.+...+++..+..++.||+.||.+||++|++|+||+|+||+++.  ....++|+|||.+......
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccccccc
Confidence            99999999999999988888999999999999999999999999999999999999942  2235999999998765432


Q ss_pred             Cc-----ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-ccccCCCCCCCC
Q 019040          209 ER-----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL-IDFKRDPWPNVS  281 (347)
Q Consensus       209 ~~-----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  281 (347)
                      ..     .....++..|+|||.+.+ .++.++|+||||++++++++|..||...........+.... ..........++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            11     123457889999998764 48899999999999999999999996554332222222111 111222233678


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  312 (347)
                      +++.+++.+||..+|++||++.++++||||+
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            9999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.9e-43  Score=307.64  Aligned_cols=254  Identities=28%  Similarity=0.413  Sum_probs=212.1

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|++|.||+|.++.+++.+++|.+.....  ......+.+|+++++.+ +|+|++++++.+...+.++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEE
Confidence            468889999999999999999999999999999865432  24456788999999999 799999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||++   ++++.++|+|||.+......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHH
Confidence            9999999999999876 678999999999999999999999 999999999999999   56788999999998765332


Q ss_pred             CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhccccccCCCCC-CCC
Q 019040          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES-----EQGVAQAILRGLIDFKRDPWP-NVS  281 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~-~~~  281 (347)
                      ... ...++..|+|||.+.+ .++.++||||||++++++++|..||....     .....+.+....   .+.... .++
T Consensus       155 ~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  230 (265)
T cd06605         155 LAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRLPSGKFS  230 (265)
T ss_pred             Hhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC---CCCCChhhcC
Confidence            221 2568889999998764 48899999999999999999999996652     122222222221   111111 278


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      .++.++|.+||..||++|||+.+++.||||++.
T Consensus       231 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            899999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.8e-42  Score=307.48  Aligned_cols=261  Identities=30%  Similarity=0.474  Sum_probs=212.5

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|++|.||+|.++.+++.||+|.+...... ......+.+|+++++.+ +|+|++++++++...+..++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEE
Confidence            5799999999999999999999999999999998654322 22345688899999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          131 MELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||+++ +|.+.+.....  +++..++.++.||+.||.|||++|++|+||+|+||+++.  .++.++|+|||++......
T Consensus        80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIP  156 (294)
T ss_pred             Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEcccccccccCCC
Confidence            999964 88888766533  578889999999999999999999999999999999952  3456999999998764332


Q ss_pred             C-cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC----------
Q 019040          209 E-RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD----------  275 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------  275 (347)
                      . ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||...+..+....+..........          
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            2 2233467889999998753  37889999999999999999999998877665555443321111000          


Q ss_pred             ---------------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          276 ---------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       276 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                                     ..+.++.++.++|.+||+.+|++||++.++++||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence                           12356888999999999999999999999999999998754

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.9e-42  Score=310.30  Aligned_cols=262  Identities=28%  Similarity=0.421  Sum_probs=214.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--CeE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAV  127 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~~~  127 (347)
                      .++|++.+.||.|+||.||+|.+..+|+.||+|.+....... .......+|+.+++.+ +|++++++++++...  +..
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeE
Confidence            468999999999999999999999999999999986543222 1223456799999999 999999999998755  568


Q ss_pred             EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      ++|+||+.+ +|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecC
Confidence            999999965 888888764 568999999999999999999999999999999999999   667889999999988765


Q ss_pred             CCC-cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCC-------
Q 019040          207 PGE-RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP-------  276 (347)
Q Consensus       207 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------  276 (347)
                      ... ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||...+.......+...........       
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            432 2223345788999998753  478999999999999999999999998887776666654321110000       


Q ss_pred             -------------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          277 -------------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       277 -------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                         ....++.+.++|.+||+.||++|||+.++++||||++...+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence                               12357888999999999999999999999999999877644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.5e-42  Score=304.13  Aligned_cols=256  Identities=25%  Similarity=0.430  Sum_probs=211.6

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEecccccc-------chhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-------TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+......       .....+.+.+|+.+++.+ +|++++++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence            588899999999999999999999999999987532211       111235678899999999 899999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +..++|+||+++++|.+++.....++...+..++.||+.||.+||+.|++|+||+|+||++   +.++.++|+|||++..
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~~  157 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKK  157 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecccccc
Confidence            9999999999999999999888889999999999999999999999999999999999999   6678899999999876


Q ss_pred             cCCCC---cccccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--ccccCCC
Q 019040          205 FKPGE---RFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL--IDFKRDP  276 (347)
Q Consensus       205 ~~~~~---~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~  276 (347)
                      .....   ......++..|+|||.+..   .++.++|+||||++++++++|..||...........+....  ..++...
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            43221   1223457889999998753   37889999999999999999999997665544333332221  1222223


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ...++..+.++|.+||.++|++|||+.++++||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            34678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.8e-42  Score=301.62  Aligned_cols=252  Identities=30%  Similarity=0.511  Sum_probs=214.9

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee--CCeEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DNAVHL  129 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~--~~~~~l  129 (347)
                      +|++.+.||.|++|.||+|.+..+++.+|+|++..... .....+.+.+|+++++.+ +|+|++++++.+..  ....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEE
Confidence            58899999999999999999999999999999865433 233456788999999999 99999999987753  467899


Q ss_pred             EEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH-----HcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          130 VMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCH-----KHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH-----~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                      ++||+++++|.+++...    ..+++..++.++.||+.||.+||     +.+++|+||+|+||++   +.++.++|+|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccc
Confidence            99999999999998663    56899999999999999999999     8899999999999999   567889999999


Q ss_pred             cccccCCCCc-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          201 LSIFFKPGER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       201 ~a~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ++........ .....+++.|+|||.+.+ .++.++|+||||+++++|++|..||...+.....+.+......   ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  232 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR---RIPY  232 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC---CCcc
Confidence            9987654443 344578999999998764 4888999999999999999999999888776666666554332   1223


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ..+..+.+++.+||..+|++||++.++++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            678999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.2e-42  Score=301.01  Aligned_cols=254  Identities=29%  Similarity=0.468  Sum_probs=215.5

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccc--cchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL--RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      +|+..+.||.|++|.||+|.+..++..|++|.+.....  ........+.+|+.+++.+ +|++++++++++.....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEE
Confidence            57788999999999999999998999999999865332  2233456789999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ++||+++++|.+++.....+++..+..++.||+.||.+||+.|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceeccccc
Confidence            99999999999999887778999999999999999999999999999999999999   667889999999988755444


Q ss_pred             cccccccCcccccccccc-cc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLK-RN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~-~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      ......++..|++||.+. .. ++.++|+||||+++|++++|..||...........+....  ........++.++.++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l  234 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--ELPPIPDHLSDEAKDF  234 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--cCCCcCCCcCHHHHHH
Confidence            344556888999999875 34 8899999999999999999999997776544443333311  1122234678999999


Q ss_pred             HHHhccCCCCCCCCHHHHhcCccc
Q 019040          288 VRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      +.+||+.+|++||++.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-43  Score=320.53  Aligned_cols=262  Identities=37%  Similarity=0.597  Sum_probs=238.0

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ....+.|.+...||.|.|++|.+|++..++..||+|++.+...... ....+.+|+++++.| +||||++++.+.+....
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSL-NHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhc-CCcceeeeeeeeeecce
Confidence            3445789999999999999999999999999999999987765444 344589999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +|+||||+.++.+.+++.+.+...+..+..++.|+..|++|||+++|+|||||++|||+   +.+..+||+|||++....
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFD  206 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeec
Confidence            99999999999999999999998889999999999999999999999999999999999   777889999999999998


Q ss_pred             CCCcccccccCcccccccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          207 PGERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      .+......+|++.|.|||++.+.  -++..|+||+|+++|.|+.|.+||.+.+-.......+.+....+.    -++.++
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dc  282 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDC  282 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechh
Confidence            88888899999999999998753  678999999999999999999999999888777777777666554    567889


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      .++|+++|.++|.+|++..++.+|.|.......
T Consensus       283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            999999999999999999999999999877654

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.5e-42  Score=308.19  Aligned_cols=259  Identities=27%  Similarity=0.454  Sum_probs=216.3

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      .....+|.+.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +|||++++.+++...+.
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~   89 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHT   89 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCe
Confidence            44456799999999999999999999999999999998655444444556788999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .++|+||++| ++.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++...
T Consensus        90 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          90 AWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLV  165 (307)
T ss_pred             EEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceec
Confidence            9999999975 77676654 4568999999999999999999999999999999999999   66788999999998764


Q ss_pred             CCCCcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          206 KPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ...   ....+++.|+|||.+.    +.++.++||||||+++|+|++|..||...+.......+.....  +.......+
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  240 (307)
T cd06607         166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDWS  240 (307)
T ss_pred             CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCchhhC
Confidence            332   2346788999999863    3488899999999999999999999988776554444433211  111112467


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ..+.++|.+||..+|++||++.+++.||||....
T Consensus       241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            8899999999999999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8e-42  Score=301.43  Aligned_cols=255  Identities=29%  Similarity=0.491  Sum_probs=210.3

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccc--cchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--Ce
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL--RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NA  126 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~~  126 (347)
                      .+|++.+.||.|+||.||.|.+..++..|++|.+.....  ........+.+|+.+++.+ +|++++++++.+.+.  ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence            579999999999999999999999999999998854321  1223456788999999999 999999999988763  57


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +++++||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccccc
Confidence            88999999999999999887778999999999999999999999999999999999999   667889999999987543


Q ss_pred             CC----CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          207 PG----ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       207 ~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ..    .......++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+.....  .......++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPVLPPHVS  235 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC--CCCCchhhC
Confidence            21    11223468889999998754 488999999999999999999999987655544443332211  122223567


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  312 (347)
                      ..+.++|..|+. +|++||++.++++|||+.
T Consensus       236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            889999999995 899999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2e-42  Score=309.80  Aligned_cols=255  Identities=29%  Similarity=0.460  Sum_probs=210.4

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--CeEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAVH  128 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~~~~  128 (347)
                      ++|++.+.||.|++|.||+|.++.+++.+++|.+...... ......+.+|+.++..+ +|||++++++++...  +..+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence            5799999999999999999999999999999998754332 22334567899999999 899999999998877  8999


Q ss_pred             EEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          129 LVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      +|+||+++ +|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||.+.....
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence            99999975 8988887654 48999999999999999999999999999999999999   6678899999999887654


Q ss_pred             C-CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc------------
Q 019040          208 G-ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF------------  272 (347)
Q Consensus       208 ~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  272 (347)
                      . .......+++.|+|||.+.+  .++.++|+||||+++++|++|..||...........+.......            
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            3 23334467888999998753  36889999999999999999999998877665555443321100            


Q ss_pred             --------------cCCCCCC--CCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          273 --------------KRDPWPN--VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       273 --------------~~~~~~~--~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                                    ....++.  +++.+.++|++||+.+|++|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                          0011122  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.1e-42  Score=305.83  Aligned_cols=252  Identities=29%  Similarity=0.483  Sum_probs=206.3

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--CeEEEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAVHLV  130 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~~~~lv  130 (347)
                      |++.+.||.|+||.||+|.+..+++.||+|.+..... .. ......+|+.++.++.+|+|++++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            6788999999999999999999999999999865421 11 2223457899999986699999999999987  899999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      +||+++ +|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||++   +. +.++|+|||.+.......
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---KD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---cC-CCeEEEecccccccccCC
Confidence            999975 888888764 468999999999999999999999999999999999999   44 889999999998765444


Q ss_pred             cccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc---------------
Q 019040          210 RFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF---------------  272 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------  272 (347)
                      ......++..|+|||.+.  +.++.++||||||+++|+|++|..||...+..+....+.......               
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            444456888999999753  347889999999999999999999998877655444443221110               


Q ss_pred             ---cC-------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          273 ---KR-------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       273 ---~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                         +.       ...+.++.++.++|.+||+++|++||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence               00       0012568999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.3e-41  Score=304.33  Aligned_cols=256  Identities=25%  Similarity=0.409  Sum_probs=210.5

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~----  124 (347)
                      ..++|.+.+.||.|+||.||+|.++.+++.+|+|++....    .....+.+|+.+++.+.+|+|++++++++...    
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~   95 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV   95 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence            4578999999999999999999999999999999985431    12356778999999987899999999998653    


Q ss_pred             -CeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          125 -NAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       125 -~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                       +..++|+||+++++|.+++..    ...+++..++.++.|++.||.+||+.|++|+||+|+||++   +.++.++|+||
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~df  172 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDF  172 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEeec
Confidence             468999999999999998753    3468999999999999999999999999999999999999   66778999999


Q ss_pred             ccccccCCCC-cccccccCccccccccccc------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc
Q 019040          200 GLSIFFKPGE-RFSEIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF  272 (347)
Q Consensus       200 g~a~~~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  272 (347)
                      |++....... ......++..|+|||.+..      .++.++||||||+++|+|++|..||...........+.+.....
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~  252 (291)
T cd06639         173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT  252 (291)
T ss_pred             ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence            9987654332 2233467889999998742      26789999999999999999999998777655554443332111


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  312 (347)
                       .......+..+.++|.+||+.+|++||++.++++||||+
T Consensus       253 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 -LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             -CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence             111235678899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-42  Score=305.02  Aligned_cols=258  Identities=29%  Similarity=0.495  Sum_probs=214.0

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC--CCCceeEeeeEEeeCCeEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~--~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .|++.+.||.|+||.||+|.+..+++.|++|.+....  .......+.+|+.+++.+.  .|++++++++++..+...++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            5788999999999999999999999999999986432  2334567889999999994  39999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ++||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCc
Confidence            99999999999988654 78999999999999999999999999999999999999   567889999999988765433


Q ss_pred             c-ccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          210 R-FSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       210 ~-~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      . .....++..|+|||.+.+  .++.++|+||||+++|+|++|..||...........+...  ..+.......+.++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  233 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLRE  233 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHH
Confidence            2 233468889999998753  3788999999999999999999999877655443332222  1111111237889999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      ++..||..||++||++.++++|+||++....
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~  264 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAHSKT  264 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence            9999999999999999999999999886533

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-42  Score=323.99  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=201.5

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      ...|.+.+.||.|+||.||+|.+..+++.||+|....         ..+.+|+++++.+ +|+||+++++++...+..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEE
Confidence            4579999999999999999999999999999996421         2356799999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ++|++. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++......
T Consensus       238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccc
Confidence            999995 5888888664 469999999999999999999999999999999999999   66778999999998765332


Q ss_pred             Cc---ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccc---cc-
Q 019040          209 ER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES--------EQGVAQAILRGLI---DF-  272 (347)
Q Consensus       209 ~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~---~~-  272 (347)
                      ..   .....||+.|+|||++.+ .++.++||||||+++|+|++|..++....        .....+.+.....   .+ 
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            21   123468999999998764 48999999999999999999876543321        1222222222111   00 


Q ss_pred             -----------------------cCCCCC---CCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          273 -----------------------KRDPWP---NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       273 -----------------------~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                                             ....|.   .++.++.+||.+||+.||.+|||+.++|+||||+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                   011111   35568899999999999999999999999999975

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.9e-42  Score=305.56  Aligned_cols=254  Identities=27%  Similarity=0.427  Sum_probs=209.4

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe------
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE------  122 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~------  122 (347)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+..|+.+++.+.+|+|++++++++.      
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            4478999999999999999999999999999999985432    234567889999999978999999999884      


Q ss_pred             eCCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          123 DDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       123 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                      ..+..+++|||+++++|.+++...  ..+++..+..++.||+.||.|||+.||+|+||+|+||++   ++++.++|+|||
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg  166 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFG  166 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCc
Confidence            346889999999999999988764  347888899999999999999999999999999999999   667789999999


Q ss_pred             cccccCCC-CcccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc
Q 019040          201 LSIFFKPG-ERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (347)
Q Consensus       201 ~a~~~~~~-~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  273 (347)
                      ++...... .......+++.|+|||.+.      ..++.++||||||+++|+|++|..||...........+.....  +
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~  244 (282)
T cd06636         167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--P  244 (282)
T ss_pred             chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--C
Confidence            98754322 1223456889999999864      2477899999999999999999999977665444433333211  1


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ......++.++.++|.+||+.||.+||++.++++||||
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            11223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.4e-42  Score=306.76  Aligned_cols=254  Identities=31%  Similarity=0.566  Sum_probs=219.8

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|.+.+.||.|++|.||+|.+..+++.|++|++.............+.+|+.+++.+..|+|++++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999997755544455577889999999994499999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      ||++++++|.+++.....++...++.++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||++........
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCccc
Confidence            9999999999999888889999999999999999999999999999999999999   6678899999999876543221


Q ss_pred             ---------------------ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 019040          211 ---------------------FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG  268 (347)
Q Consensus       211 ---------------------~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  268 (347)
                                           .....++..|+|||... ..++.++|+||||++++++++|..||.........+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                                 12235688899999865 44888999999999999999999999888766665555543


Q ss_pred             cccccCCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCccc
Q 019040          269 LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTA----KQVLEHPWL  311 (347)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~h~~~  311 (347)
                      ...++    ..+++.+.++|.+||+.+|++||++    .++++||||
T Consensus       238 ~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 EYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            33322    3668999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-42  Score=306.02  Aligned_cols=256  Identities=31%  Similarity=0.505  Sum_probs=211.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|++|.||+|.++.+++.|++|++..... .......+.+|+++++.+ +|+|++++++.+...+..+++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEE
Confidence            479999999999999999999999999999999865322 233456788999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      +||++++.+..+......++...+..++.||+.||.|||+.|++|+||+|+||++   ++++.++|+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCcc
Confidence            9999887676666555679999999999999999999999999999999999999   668889999999988765443 


Q ss_pred             -cccccccCcccccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC------------
Q 019040          210 -RFSEIVGSPYYMAPEVLK-R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR------------  274 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------  274 (347)
                       ......++..|+|||++. . .++.++||||||+++|+|++|..||......+....+.......++            
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence             233456788999999875 4 5788999999999999999999999876655444333221111000            


Q ss_pred             ----------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          275 ----------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       275 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                                      .....++.++.++|++||..+|++|||+.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                            0011348889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.1e-43  Score=310.63  Aligned_cols=257  Identities=29%  Similarity=0.461  Sum_probs=215.2

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+.|.+.+.||.|+||.||+|.+..+++.||+|.+.....  ......+.+|+.+++.+ +|+|++++++.+...+..++
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEE
Confidence            3568888999999999999999999999999999864432  23456789999999999 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |+||+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||++   ++++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcc
Confidence            9999999999988854 468999999999999999999999999999999999999   567789999999987654332


Q ss_pred             c-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          210 R-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       210 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      . .....++..|+|||.+.+ .++.++|+||||+++++|++|..||...........+....   .......++..+.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l  232 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQYSKPFKEF  232 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC---CCCCCcccCHHHHHH
Confidence            1 223457888999998764 48889999999999999999999997766555444433322   112223578899999


Q ss_pred             HHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      |.+||+.+|++||++.++++||||.+...
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         233 VEACLNKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             HHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence            99999999999999999999999987653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.4e-42  Score=315.67  Aligned_cols=258  Identities=27%  Similarity=0.402  Sum_probs=209.8

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC---
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~---  124 (347)
                      .+.++|++.+.||.|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.+++.+ +|+|++++++++...   
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCc
Confidence            46789999999999999999999999999999999986432 2233445677899999999 999999999987643   


Q ss_pred             ---CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          125 ---NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       125 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                         ...|+|+||+++ +|.+.+...  ++...+..++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||.
T Consensus        91 ~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~  164 (353)
T cd07850          91 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  164 (353)
T ss_pred             cccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCcc
Confidence               357999999965 888877654  8999999999999999999999999999999999999   6678899999999


Q ss_pred             ccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc-------
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-------  273 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------  273 (347)
                      +.............+++.|+|||.+. ..++.++||||||+++++|++|..||...+.......+.......+       
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            98765443334456888999999876 4589999999999999999999999987765544444332111100       


Q ss_pred             ---------------CC-----------------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          274 ---------------RD-----------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       274 ---------------~~-----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                                     ..                 .....++.+.++|.+||+.||++|||+.++|+||||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                           00                 01124567899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-42  Score=313.88  Aligned_cols=265  Identities=29%  Similarity=0.467  Sum_probs=211.3

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~----  124 (347)
                      +.++|.+.+.||.|++|.||+|.+..+|+.||+|.+....  .......+.+|+.+++.+ +|+|++++++++...    
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFES   79 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccc
Confidence            5679999999999999999999999999999999985321  223345678899999999 899999999886644    


Q ss_pred             -CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 -NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                       ...++++||+++ +|.+.+.. ..+++..++.++.|++.||.+||+.||+||||||+||++   +.++.++|+|||++.
T Consensus        80 ~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~  154 (336)
T cd07849          80 FNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLAR  154 (336)
T ss_pred             cceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECccccee
Confidence             358999999965 88777744 479999999999999999999999999999999999999   677889999999987


Q ss_pred             ccCCCCc----ccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc------
Q 019040          204 FFKPGER----FSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID------  271 (347)
Q Consensus       204 ~~~~~~~----~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------  271 (347)
                      .......    .....+++.|+|||.+.  ..++.++||||||+++|+|++|..||.+.+.......+......      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            6543221    12346788999999764  34889999999999999999999999776554333322211100      


Q ss_pred             -----------------ccCC----CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCC
Q 019040          272 -----------------FKRD----PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP  321 (347)
Q Consensus       272 -----------------~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~  321 (347)
                                       .+..    ..+..+.++.++|.+||+.+|++|||+.++++||||+.......++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~  305 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEP  305 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcc
Confidence                             0000    1134678899999999999999999999999999999887553333

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.1e-42  Score=305.82  Aligned_cols=263  Identities=26%  Similarity=0.352  Sum_probs=217.3

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||+|++|+||+|.+..+++.||+|++....  .......+.+|+++++.+ +|+|++++++.+...+.+++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEE
Confidence            67999999999999999999999999999999886432  233456789999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      +||+++++|.+++...+.++...+..++.+++.+|.|||+ .|++|+||+|+||++   ++++.++|+|||++.......
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhhc
Confidence            9999999999999887789999999999999999999997 599999999999999   667889999999886543221


Q ss_pred             cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhccccccCCCC
Q 019040          210 RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-----------GVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~  277 (347)
                       .....++..|+|||++. +.++.++||||||++++++++|..||......           .....+.....  +....
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  235 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--PRLPS  235 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--CCCCc
Confidence             23346889999999875 55889999999999999999999999765542           12222222111  11111


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCC
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL  322 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~  322 (347)
                      ..++.++.+++.+||+.||++|||+.++++|+||.+........+
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~~~~~  280 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDL  280 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccccCCc
Confidence            237889999999999999999999999999999988765554443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=326.33  Aligned_cols=258  Identities=30%  Similarity=0.489  Sum_probs=218.2

Q ss_pred             eecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCC
Q 019040           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGG  137 (347)
Q Consensus        58 ~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~  137 (347)
                      .||.|.||+||.|+|..+...+|||.+...   ......-+..||...++| +|.||++++|.+..+++.-|.||.++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            589999999999999999999999998643   333446688899999999 9999999999999999999999999999


Q ss_pred             chHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-cccc
Q 019040          138 ELFDRIVAR-GHY--TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSE  213 (347)
Q Consensus       138 ~L~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-~~~~  213 (347)
                      +|.+++... +++  .+.++..+.+||++||.|||++.|||||||-+||||+  .-.|.+||+|||-+.....-. ...+
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccc
Confidence            999999765 666  8889999999999999999999999999999999996  667889999999988765443 3456


Q ss_pred             cccCcccccccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHH
Q 019040          214 IVGSPYYMAPEVLK---RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ  290 (347)
Q Consensus       214 ~~~~~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  290 (347)
                      ..||..|||||++.   .+|+.++|||||||++.||.||++||....... .....-+....-++....++.+.+.+|.+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-AAMFkVGmyKvHP~iPeelsaeak~Filr  814 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-AAMFKVGMYKVHPPIPEELSAEAKNFILR  814 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-HhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence            78999999999986   349999999999999999999999997665432 12222333333344445788899999999


Q ss_pred             hccCCCCCCCCHHHHhcCcccccCcCCCCCCC
Q 019040          291 MLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL  322 (347)
Q Consensus       291 ~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~  322 (347)
                      |+.+||.+||++.++|+.||++...+.+...+
T Consensus       815 cFepd~~~R~sA~~LL~DpFlq~~~kk~r~~l  846 (1226)
T KOG4279|consen  815 CFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKL  846 (1226)
T ss_pred             HcCCCcccCccHHHhccCcccccCCCCCCCCC
Confidence            99999999999999999999998855544444

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.1e-42  Score=305.17  Aligned_cols=254  Identities=30%  Similarity=0.460  Sum_probs=208.1

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|++.+.||.|++|.||+|.++.+++.|++|.+..... .......+.+|+++++++ +|+|++++++++.+.+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEe
Confidence            48899999999999999999999999999998865432 222345788899999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       132 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||+. ++|.+++...  ..++...+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++.......
T Consensus        79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCc
Confidence            9996 5888888653  458999999999999999999999999999999999999   667889999999987654332


Q ss_pred             -cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC------------
Q 019040          210 -RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR------------  274 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------  274 (347)
                       ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||...........+.........            
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             2233456788999998753  2688999999999999999999999877655444333322111000            


Q ss_pred             -------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          275 -------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       275 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                                   ...+.++.++.++|.+||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                         0113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.5e-42  Score=309.10  Aligned_cols=266  Identities=27%  Similarity=0.491  Sum_probs=220.5

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      +.....+.|.....||.|+||.||++.+..++..||||.+...   .......+.+|+.+++.+ +|+|++++++.+...
T Consensus        16 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~   91 (292)
T cd06658          16 SPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVG   91 (292)
T ss_pred             ccCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecC
Confidence            3444556677778899999999999999999999999987543   233456688999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +..++++||+++++|.+++.. ..++...+..++.||+.||.|||+.||+||||+|+||++   ++++.++|+|||++..
T Consensus        92 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~  167 (292)
T cd06658          92 DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQ  167 (292)
T ss_pred             CeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhh
Confidence            999999999999999887754 468999999999999999999999999999999999999   6677899999999875


Q ss_pred             cCCCC-cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          205 FKPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       205 ~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ..... ......++..|+|||.+.+ .++.++||||||++++++++|..||...........+...... .......++.
T Consensus       168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  246 (292)
T cd06658         168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-RVKDSHKVSS  246 (292)
T ss_pred             cccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-ccccccccCH
Confidence            43222 2233468889999998764 5889999999999999999999999887776655554443221 1122235788


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                      .+.++|.+||..||++|||+.++++||||+....+..
T Consensus       247 ~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~  283 (292)
T cd06658         247 VLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC  283 (292)
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence            9999999999999999999999999999998875543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=304.76  Aligned_cols=255  Identities=27%  Similarity=0.443  Sum_probs=204.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++.+.||.|++|.||+|.++.+++.||+|.+......  .....+.+|+++++.+ +|+||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEE
Confidence            36899999999999999999999999999999998654321  1223467899999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      |+||+++ +|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||++   +.++.++|+|||.+......
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVP  156 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCC
Confidence            9999975 899888765 458999999999999999999999999999999999999   66778999999998754322


Q ss_pred             C-cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccccccC----------
Q 019040          209 E-RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDFKR----------  274 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~----------  274 (347)
                      . ......++..|+|||.+.+  .++.++||||||+++|+|++|..||.... ..+....+.+.......          
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence            1 1222346788999998753  37889999999999999999999997665 22222222211110000          


Q ss_pred             ----------------CCCCCCC--HHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          275 ----------------DPWPNVS--ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       275 ----------------~~~~~~~--~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                                      ...+.++  .++.++|.+||+.+|.+|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                            0011233  788899999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.1e-42  Score=302.56  Aligned_cols=250  Identities=34%  Similarity=0.574  Sum_probs=215.7

Q ss_pred             ecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCc
Q 019040           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (347)
Q Consensus        59 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  138 (347)
                      ||.|+||.||+|.+..+++.+++|++.............+.+|+++++.+ +|+|++++++.+...+..++++||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence            68999999999999999999999998766554455667899999999999 89999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC---------
Q 019040          139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---------  209 (347)
Q Consensus       139 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~---------  209 (347)
                      |.+++.....+++..+..++.||+.||.+||+.|++|+||+|+||++   +.++.++|+|||++.......         
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccc
Confidence            99999887789999999999999999999999999999999999999   667789999999987644331         


Q ss_pred             cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ......++..|++||... ..++.++||||||++++++++|..||...........+..+...++.  ...++..+.+++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i  234 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--DVEVSDEAIDLI  234 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc--cccCCHHHHHHH
Confidence            123346788899999875 34888999999999999999999999888887777776664433322  123589999999


Q ss_pred             HHhccCCCCCCCCH---HHHhcCcccccC
Q 019040          289 RQMLEPDPKLRLTA---KQVLEHPWLQNA  314 (347)
Q Consensus       289 ~~~l~~dp~~Rps~---~~ll~h~~~~~~  314 (347)
                      .+||+.+|++|||+   .++++||||++.
T Consensus       235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            99999999999999   999999999854

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-41  Score=302.54  Aligned_cols=258  Identities=30%  Similarity=0.512  Sum_probs=217.3

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      ...|...+.||.|++|.||+|.+..+++.+++|.+...   .....+.+.+|+.+++.+ +|++++++++++...+..++
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~   93 (285)
T cd06648          18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWV   93 (285)
T ss_pred             hHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEE
Confidence            34566678999999999999999999999999987533   223345688999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ++||+++++|.+++.. ..++...+..++.|++.||.+||+.|++||||+|+||++   +.++.++|+|||.+.......
T Consensus        94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          94 VMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             EEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCC
Confidence            9999999999998877 578999999999999999999999999999999999999   667889999999876543322


Q ss_pred             -cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          210 -RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                       ......+++.|+|||.+.+ .++.++||||||+++++|++|..||...+.......+........ .....++..+.++
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l  248 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL-KNLHKVSPRLRSF  248 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC-cccccCCHHHHHH
Confidence             1233468889999998764 488999999999999999999999988776666665555432221 1223478999999


Q ss_pred             HHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      |.+||+.+|++||++.++++||||++...
T Consensus       249 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         249 LDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHHHcccChhhCcCHHHHccCcccccCCC
Confidence            99999999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=311.82  Aligned_cols=262  Identities=32%  Similarity=0.510  Sum_probs=231.8

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+.|+.-+.||.|+||.||-+..+.||+-||+|.+.+..+..........+|-.+|.++ +.++|+.+--.|++.+.+++
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEE
Confidence            46688999999999999999999999999999999887776666677788899999999 88999999989999999999


Q ss_pred             EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          130 VMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |+..|.||+|.-.+.+.+  .|++..+..++.+|+.||++||+.+||+||+||+|||+   |+.|+++|+|+|+|+.+..
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecCC
Confidence            999999999988787655  59999999999999999999999999999999999999   8899999999999999999


Q ss_pred             CCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      ++.....+||.+|||||++.+ .|+.+.|+|||||++|+|+.|..||...........+.+....-+.+.....++++++
T Consensus       340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks  419 (591)
T KOG0986|consen  340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS  419 (591)
T ss_pred             CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence            988888899999999999874 4999999999999999999999999776655444344444433344444588999999


Q ss_pred             HHHHhccCCCCCCCC-----HHHHhcCcccccCc
Q 019040          287 LVRQMLEPDPKLRLT-----AKQVLEHPWLQNAK  315 (347)
Q Consensus       287 li~~~l~~dp~~Rps-----~~~ll~h~~~~~~~  315 (347)
                      +.+.+|+.||++|..     +.++.+||||++..
T Consensus       420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln  453 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN  453 (591)
T ss_pred             HHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence            999999999999985     56999999999863

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-41  Score=303.88  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=207.7

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe----
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE----  122 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~----  122 (347)
                      ....++|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+.+|+|++++++++.    
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            345679999999999999999999999999999999875421    122457789999999967999999999873    


Q ss_pred             -eCCeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          123 -DDNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       123 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                       .++..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+++|+||+|+||++   +.++.++|+
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~kl~  166 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGVKLV  166 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCEEEc
Confidence             45679999999999999988753    2458889999999999999999999999999999999999   566779999


Q ss_pred             eeccccccCCCC-cccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 019040          198 DFGLSIFFKPGE-RFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI  270 (347)
Q Consensus       198 Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  270 (347)
                      |||++....... ......+++.|+|||++.      ..++.++||||||+++|+|++|..||...........+.....
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  246 (286)
T cd06638         167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP  246 (286)
T ss_pred             cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence            999987654322 223346889999999874      2378899999999999999999999987765443333222211


Q ss_pred             cccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                       .........+.++.++|.+||+.||++|||+.++++|+||
T Consensus       247 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         247 -PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             -CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence             1111112457889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.8e-42  Score=301.06  Aligned_cols=252  Identities=27%  Similarity=0.480  Sum_probs=208.8

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||.||+|+++.+++.||+|.+.............+.+|+.+++.+ +|||++++++.+...+..+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEE
Confidence            5799999999999999999999999999999988654444445556788999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          131 MELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +||+++++|.+++..    ...+++..+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence            999999999888753    2348999999999999999999999999999999999999   567789999999987654


Q ss_pred             CCCc-ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccccccCCCCCCCCH
Q 019040          207 PGER-FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESE--QGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       207 ~~~~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .... .....+++.|+|||.+. ..++.++|+||||+++|+|++|..||.....  ......+...  ..++......+.
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEHYSE  235 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhhcCH
Confidence            3322 22346788999999875 4588999999999999999999999966543  2333333222  122222336788


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+.++|.+||+.+|++||++.++++.
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            99999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-42  Score=302.53  Aligned_cols=254  Identities=27%  Similarity=0.447  Sum_probs=210.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC----
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN----  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~----  125 (347)
                      .++|++.+.||.|++|.||+|.++.+++.+++|++....    ...+.+.+|+.+++.+..|+|++++++++....    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            479999999999999999999999999999999986442    234678899999999977999999999986544    


Q ss_pred             --eEEEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          126 --AVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       126 --~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                        .+++++||+++++|.+++...    ..+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCC
Confidence              589999999999999988652    468999999999999999999999999999999999999   56788999999


Q ss_pred             ccccccCCCC-cccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc
Q 019040          200 GLSIFFKPGE-RFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF  272 (347)
Q Consensus       200 g~a~~~~~~~-~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  272 (347)
                      |.+....... ......++..|+|||.+.      ..++.++||||||++++++++|..||...........+.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  237 (275)
T cd06608         158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT  237 (275)
T ss_pred             ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence            9987543322 223346888999999863      236788999999999999999999998766555555544432211


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                       .......++++.++|.+||..||++|||+.++++|||+
T Consensus       238 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 -LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             -CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence             11112367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.2e-42  Score=313.23  Aligned_cols=263  Identities=28%  Similarity=0.459  Sum_probs=213.9

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~----  124 (347)
                      +.++|.+.+.||.|+||+||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +|+|++++++++...    
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCccchHHheecccccc
Confidence            45789999999999999999999999999999999865322 223345677899999999 999999999987644    


Q ss_pred             -CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 -NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                       ...++++||+. ++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++.
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~  156 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR  156 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccc
Confidence             35899999995 5899998887789999999999999999999999999999999999999   567789999999988


Q ss_pred             ccCCC-CcccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc---------
Q 019040          204 FFKPG-ERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID---------  271 (347)
Q Consensus       204 ~~~~~-~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  271 (347)
                      ..... .......++..|+|||.+.  ..++.++||||||+++|+|++|..||.+.+.......+......         
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            65433 2223446788999999875  34889999999999999999999999776543333222211100         


Q ss_pred             --------------cc----CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          272 --------------FK----RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       272 --------------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                    ..    ....+.++.++.++|.+||+.+|++|||+.++++||||+.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                          00    01124678899999999999999999999999999999887644

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-41  Score=303.32  Aligned_cols=257  Identities=24%  Similarity=0.313  Sum_probs=205.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||.||+|.++.+|+.||+|.+......  .....+..|+..+.+..+|+|++++++.+..++..+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            4789999999999999999999999999999998654221  12345556766544444999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          131 MELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      +||++ ++|.+++...    ..+++..++.++.||+.||.|||++ +++||||||+||++   +.++.++|+|||.+...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYL  154 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeeccccccc
Confidence            99996 5887777542    3589999999999999999999997 99999999999999   66788999999998865


Q ss_pred             CCCCcccccccCccccccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccccccCCCCCC
Q 019040          206 KPGERFSEIVGSPYYMAPEVLKR-----NYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ..........++..|+|||.+.+     .++.++|+||||+++|+|++|..||..... ............  +......
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  232 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLPAEK  232 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCCccc
Confidence            44333333567889999998742     368899999999999999999999965332 222223322211  1111125


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ++.++.++|.+||..+|++||++.++++||||++..
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            789999999999999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-41  Score=300.54  Aligned_cols=249  Identities=18%  Similarity=0.267  Sum_probs=207.7

Q ss_pred             ccceeeeeeecccCCeEEEEEEEC---CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      .++|++.+.||.|+||.||+|.++   ..+..||+|.+....  .......+.+|+.++..+ +|||++++++++...+.
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCC
Confidence            467999999999999999999875   446789999986532  223346788999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .++||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||++   +.++.++++|||.+...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED  157 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence            99999999999999998774 468999999999999999999999999999999999999   66788999999987654


Q ss_pred             CCCCccc--ccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          206 KPGERFS--EIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       206 ~~~~~~~--~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      .......  ...++..|+|||.+. ..++.++||||||+++|++++ |..||...........+.....   .+....++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~  234 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR---LPAPRNCP  234 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC---CCCCCCCC
Confidence            3222111  123456899999875 558999999999999999775 9999998888777776655432   22335789


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         235 NLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-43  Score=289.29  Aligned_cols=262  Identities=24%  Similarity=0.323  Sum_probs=222.5

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+..+++..||.|+.|.||+++.+.+|..+|||.+.+..  +.++.+++...+.+......+|+|++.+|+|..+..+++
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I  168 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI  168 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence            355678889999999999999999999999999997654  556677888888888776569999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      -||.+ +.-+..+++.- +++++..+-.+...++.||.||.++ ||+|||+||+|||+   ++.|.+||||||.+.....
T Consensus       169 cMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  169 CMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeec
Confidence            99999 44566666553 5699999999999999999999876 89999999999999   7889999999999998887


Q ss_pred             CCcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccccccCCCCCCCCH
Q 019040          208 GERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ....+...|-+.|||||.+.    ..|+.++||||||++++||.||..||.+.+. -+++..+.+... ...+.-.+.++
T Consensus       245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~~~gFSp  323 (391)
T KOG0983|consen  245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPGHMGFSP  323 (391)
T ss_pred             ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCcccCcCH
Confidence            77777778999999999885    3489999999999999999999999988543 366666666443 22222235899


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  318 (347)
                      ++.+|+..||++|+.+||...++|+|||++.....+
T Consensus       324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~  359 (391)
T KOG0983|consen  324 DFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE  359 (391)
T ss_pred             HHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence            999999999999999999999999999999876544

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.6e-42  Score=306.11  Aligned_cols=259  Identities=22%  Similarity=0.320  Sum_probs=207.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|...+.||.|+||.||++.+..+++.||+|.+......  .....+.+|+.++.++..|+|++++++++..++..+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            3567788999999999999999999999999998754322  34567889999999995699999999999999999999


Q ss_pred             EEecCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          131 MELCEGGELFDRIV-----ARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       131 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +||+.+ ++.++..     ....+++..+..++.|++.||+|||+. |++||||||+||++   +.++.++|+|||++..
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~  157 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQ  157 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHH
Confidence            999854 5544332     235689999999999999999999975 99999999999999   5677899999999876


Q ss_pred             cCCCCcccccccCccccccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcc-ccccCCCCC
Q 019040          205 FKPGERFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGL-IDFKRDPWP  278 (347)
Q Consensus       205 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~-~~~~~~~~~  278 (347)
                      ...........++..|+|||.+.+    .++.++||||||+++|+|++|..||...... .....+.... .........
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd06616         158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER  237 (288)
T ss_pred             hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence            544433344568889999998753    4889999999999999999999999665421 1112222211 112222223


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .++.++.+||.+||+.+|++|||+.++++||||+...
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            5789999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.7e-41  Score=305.95  Aligned_cols=261  Identities=26%  Similarity=0.454  Sum_probs=207.1

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      +....-++|.+.+.||.|+||.||+|.+..+++.||+|.+...... ......+.+|+++++.+ +||+++++++++...
T Consensus         6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   83 (310)
T cd07865           6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLL-KHENVVNLIEICRTK   83 (310)
T ss_pred             cccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhC-CCCCccceEEEEecc
Confidence            3444557899999999999999999999999999999988644322 22233566799999999 999999999987654


Q ss_pred             C--------eEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEE
Q 019040          125 N--------AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (347)
Q Consensus       125 ~--------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~  195 (347)
                      .        ..++|+||+.+ +|.+.+.... .+++..+..++.||+.||.|||+.|++|+||+|+||++   +.++.++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~k  159 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILK  159 (310)
T ss_pred             cccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEE
Confidence            3        45999999965 8888776653 68999999999999999999999999999999999999   6778899


Q ss_pred             EEeeccccccCCCCc-----ccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 019040          196 AIDFGLSIFFKPGER-----FSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG  268 (347)
Q Consensus       196 l~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  268 (347)
                      |+|||++........     .....++..|+|||.+.+  .++.++||||||+++|+|++|..||...+.......+...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~  239 (310)
T cd07865         160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL  239 (310)
T ss_pred             ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            999999876543221     123457788999998753  3788999999999999999999999887765544443332


Q ss_pred             cccccCCCC----------------------------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          269 LIDFKRDPW----------------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       269 ~~~~~~~~~----------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ....+...+                            ...+..+.++|.+||..||.+|||+.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            211111110                            0135677899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.3e-42  Score=304.17  Aligned_cols=249  Identities=23%  Similarity=0.340  Sum_probs=209.9

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCC-----ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTR-----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ++|++.+.||.|+||.||+|.+...+     ..|++|.+....  .......+.+|+.++..+ +|++++++++++...+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCC
Confidence            57899999999999999999987655     679999886432  233346688999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC
Q 019040          126 AVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~  189 (347)
                      ..++++||+++++|.+++...                ..++...+..++.|++.||.|||++|++|+||||+||++   +
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence            999999999999999999764                347888999999999999999999999999999999999   5


Q ss_pred             CCCCEEEEeeccccccCCCC---cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 019040          190 ENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQA  264 (347)
Q Consensus       190 ~~~~~~l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  264 (347)
                      +++.++|+|||++.......   ......+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+....+....
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            67789999999987643222   122345678899999865 558999999999999999998 9999998888777776


Q ss_pred             HHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +......   .....++.++.+++.+||+.||++||++.+++++
T Consensus       239 i~~~~~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSRQLL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcC---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6654332   2234789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.1e-41  Score=308.25  Aligned_cols=248  Identities=26%  Similarity=0.427  Sum_probs=190.9

Q ss_pred             eeecccCCeEEEEEEECC--CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe--eCCeEEEEEE
Q 019040           57 RELGRGEFGVTYLCIDRD--TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE--DDNAVHLVME  132 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~--~~~~~~lv~e  132 (347)
                      ..||.|+||.||+|.++.  ++..||+|.+....     ....+.+|+.+++.+ +|||++++++++.  .+...++++|
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEe
Confidence            579999999999999754  56789999885432     224577899999999 9999999999885  3567899999


Q ss_pred             ecCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC-CCCCCEEEEeeccc
Q 019040          133 LCEGGELFDRIVAR---------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK-KENSPLKAIDFGLS  202 (347)
Q Consensus       133 ~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~-~~~~~~~l~Dfg~a  202 (347)
                      |+.+ +|.+++...         ..+++..++.++.||+.||.|||+.||+||||||+||++..+ +.++.++|+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            9965 787777431         247889999999999999999999999999999999999643 45678999999999


Q ss_pred             cccCCCC----cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHh
Q 019040          203 IFFKPGE----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQ---------GVAQAILR  267 (347)
Q Consensus       203 ~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~~~  267 (347)
                      .......    ......+|+.|+|||.+.+  .++.++||||||+++|+|++|..||......         .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            8654332    1234568899999998753  4889999999999999999999999654321         11111111


Q ss_pred             cccccc----------------------------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          268 GLIDFK----------------------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       268 ~~~~~~----------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ......                                  .......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000000                                  00001235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.7e-41  Score=305.42  Aligned_cols=251  Identities=23%  Similarity=0.322  Sum_probs=202.3

Q ss_pred             ccceeeeeeecccCCeEEEEEEECC----------------CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCc
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRD----------------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS  113 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~  113 (347)
                      .++|++.+.||.|+||.||+|.+..                ++..||+|++....  .......+.+|+.++..+ +|+|
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRL-KDPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhc-CCCC
Confidence            4689999999999999999998642                34579999986432  233456788999999999 9999


Q ss_pred             eeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcE
Q 019040          114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-------------------HYTERAAAAVTRTIVEVVQLCHKHGVI  174 (347)
Q Consensus       114 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~iv  174 (347)
                      |+++++++.+.+..++|+||+++++|.+++....                   .++...+..++.||+.||.|||+.||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999886532                   356778899999999999999999999


Q ss_pred             eeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh--
Q 019040          175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC--  248 (347)
Q Consensus       175 H~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~--  248 (347)
                      |+||||+|||+   +.++.++|+|||++........   .....++..|+|||.+. +.++.++||||||+++|+|++  
T Consensus       161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            99999999999   6678899999999876543321   12234577899999865 558999999999999999986  


Q ss_pred             CCCCCCCCCHHHHHHHHHhcc----ccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 019040          249 GVPPFWAESEQGVAQAILRGL----IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL  306 (347)
Q Consensus       249 g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  306 (347)
                      +..||................    ........+.++..+.++|.+||+.||++|||+.++.
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            567888777665554443211    1111122346789999999999999999999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.7e-42  Score=313.13  Aligned_cols=268  Identities=29%  Similarity=0.445  Sum_probs=217.1

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe----eC
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE----DD  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~----~~  124 (347)
                      +.++|.+.+.||.|++|.||+|.++.+++.||+|++..... .......+.+|+.+++.+ +|+||+++++++.    ..
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCC
Confidence            45789999999999999999999999999999999875422 223456778899999999 8999999998875    34


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ...++|+||+. ++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||++..
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~  156 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARG  156 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEeccccccee
Confidence            57899999995 5899988777779999999999999999999999999999999999999   6778899999999876


Q ss_pred             cCCCCc-----ccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc------
Q 019040          205 FKPGER-----FSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID------  271 (347)
Q Consensus       205 ~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------  271 (347)
                      ......     .....++..|+|||.+.+  .++.++||||||+++|+|++|..||...+.......+......      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            533221     123468889999998753  4889999999999999999999999777654433322221110      


Q ss_pred             -----------------ccCC----CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCC
Q 019040          272 -----------------FKRD----PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL  322 (347)
Q Consensus       272 -----------------~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~  322 (347)
                                       ....    ..+..+.++.++|.+||+.+|++|||+.+++.||||++...+.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~  308 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT  308 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc
Confidence                             0011    11357899999999999999999999999999999998876655433

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-42  Score=328.73  Aligned_cols=265  Identities=21%  Similarity=0.300  Sum_probs=196.3

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCc-eeEEe--------------EeccccccchhcHHHHHHHHHHHHhCCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRE-LLACK--------------SISKRKLRTAVDIDDVRREVAIMKHLPK  110 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~-~vavK--------------~~~~~~~~~~~~~~~~~~ei~~l~~l~~  110 (347)
                      ...+.++|++++.||+|+||+||+|..+.... ..+.|              .+.+...........+.+|+.+++.+ +
T Consensus       143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~  221 (501)
T PHA03210        143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-N  221 (501)
T ss_pred             chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-C
Confidence            34556899999999999999999997653322 22222              11111111222345688999999999 9


Q ss_pred             CCceeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEe
Q 019040          111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-----HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF  185 (347)
Q Consensus       111 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli  185 (347)
                      |+||+++++++...+..|++++++. ++|.+++....     ......+..++.||+.||.|||++||+||||||+|||+
T Consensus       222 HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl  300 (501)
T PHA03210        222 HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL  300 (501)
T ss_pred             CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            9999999999999999999999995 47777775431     23456778899999999999999999999999999999


Q ss_pred             ecCCCCCCEEEEeeccccccCCCCc--ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCC-CCC--HH
Q 019040          186 ANKKENSPLKAIDFGLSIFFKPGER--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFW-AES--EQ  259 (347)
Q Consensus       186 ~~~~~~~~~~l~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~-~~~--~~  259 (347)
                         +.++.+||+|||++........  .....||+.|+|||++.+ .++.++||||||+++|+|++|..++. ...  ..
T Consensus       301 ---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        301 ---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             ---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence               6678899999999987644322  224579999999998764 48999999999999999999875443 221  11


Q ss_pred             HHHHHHHhccc----cccC------------------C------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          260 GVAQAILRGLI----DFKR------------------D------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       260 ~~~~~~~~~~~----~~~~------------------~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ..+..+.....    .++.                  .      ....++.++.++|.+||+.||++|||+.++|+||||
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            22222221110    0000                  0      001356778889999999999999999999999999


Q ss_pred             ccCc
Q 019040          312 QNAK  315 (347)
Q Consensus       312 ~~~~  315 (347)
                      ....
T Consensus       458 ~~~~  461 (501)
T PHA03210        458 SAEE  461 (501)
T ss_pred             hcCC
Confidence            7753

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.7e-41  Score=295.17  Aligned_cols=253  Identities=32%  Similarity=0.542  Sum_probs=215.0

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--CeEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAVHL  129 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~~~~l  129 (347)
                      +|.+.+.||.|++|.||+|.+..+++.|++|++...... ....+.+.+|+.+++++ +|++++++++.+...  +.+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEE
Confidence            478899999999999999999999999999998654322 34567899999999999 899999999999988  89999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ++||+++++|.+++.....+++..++.++.|++.+|.|||+.|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEeccccc
Confidence            99999999999999887789999999999999999999999999999999999999   567889999999998766554


Q ss_pred             c---ccccccCcccccccccccc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccccCCCCCCCCHHH
Q 019040          210 R---FSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       210 ~---~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      .   .....++..|+|||.+... .+.++||||||++++++++|..||...... .....+..  ...........+..+
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  233 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--SGEPPEIPEHLSEEA  233 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--cCCCcCCCcccCHHH
Confidence            3   3445788899999987644 889999999999999999999999776622 22222221  111122233568999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      .++|.+||+.+|++||++.++++||||
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         234 KDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.4e-42  Score=315.91  Aligned_cols=252  Identities=20%  Similarity=0.320  Sum_probs=202.9

Q ss_pred             ccceeeeeeecccCCeEEEEEEE-----CCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCID-----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .++|++.+.||.|+||.||+|++     ..++..||+|++....  .......+.+|+.++..+.+||||+++++++...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            46899999999999999999975     3456789999986432  2233467889999999997899999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC---------------------------------------------------------
Q 019040          125 NAVHLVMELCEGGELFDRIVARG---------------------------------------------------------  147 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  147 (347)
                      +..++||||+++++|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999986532                                                         


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          148 ------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       148 ------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                                        .++...+..++.||+.||.|||+.||+||||||+|||+   +.++.++|+|||++.......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcc
Confidence                              36778889999999999999999999999999999999   556789999999987654322


Q ss_pred             cc---cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          210 RF---SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       210 ~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      ..   ....++..|+|||.+. ..++.++||||||+++|+|++ |..||..................  .......+.++
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  346 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR--MLSPECAPSEM  346 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc--CCCCCCCCHHH
Confidence            11   1223456799999876 458999999999999999997 88999776544333333222211  11223568899


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcC
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .++|..||+.||++|||+.++++.
T Consensus       347 ~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=301.74  Aligned_cols=253  Identities=29%  Similarity=0.501  Sum_probs=210.5

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--CeEEEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAVHLV  130 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~~~~lv  130 (347)
                      |++.+.||.|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.+ +|+|++++++++...  +..++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEE
Confidence            678999999999999999999999999999997653 2233345688899999999 899999999999988  899999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      +||+++ +|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||++   ++++.++|+|||.+.......
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCC
Confidence            999975 888888765 569999999999999999999999999999999999999   677889999999988765443


Q ss_pred             --cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC--------
Q 019040          210 --RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--------  277 (347)
Q Consensus       210 --~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------  277 (347)
                        ......++..|+|||.+.+  .++.++||||||+++++|++|..||...+.......+...........+        
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence              1233456788999997653  4789999999999999999999999888776655555432211111111        


Q ss_pred             ------------------CC-CCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          278 ------------------PN-VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       278 ------------------~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                                        .. ++.++.++|.+||..+|.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                              12 37889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.5e-41  Score=304.82  Aligned_cols=260  Identities=26%  Similarity=0.486  Sum_probs=216.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .-|.....||.|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.+ +|||++++++.+..++..+++
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEE
Confidence            34555667999999999999999999999999986432   22346688899999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      +||+++++|..++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||++....... 
T Consensus        97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659          97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccccc
Confidence            999999999887754 468999999999999999999999999999999999999   677889999999987543322 


Q ss_pred             cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ......++..|+|||.+.+ .++.++||||||+++++|++|..||...........+.... ......+...+..+.++|
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i  251 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFL  251 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCccccCCCCHHHHHHH
Confidence            2234568899999998764 58899999999999999999999998777666555544332 112222346788999999


Q ss_pred             HHhccCCCCCCCCHHHHhcCcccccCcCCCC
Q 019040          289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                      .+||+.+|++||++.++++||||.+..-+++
T Consensus       252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~  282 (297)
T cd06659         252 ERMLTREPQERATAQELLDHPFLLQTGLPEC  282 (297)
T ss_pred             HHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence            9999999999999999999999998875444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-45  Score=305.58  Aligned_cols=252  Identities=27%  Similarity=0.463  Sum_probs=216.3

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .-|.+++.||+|+||.||+|.++++|+.+|||.+..     ..++..+.+||.++++. +.++++++||.|-....+|+|
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEee
Confidence            348999999999999999999999999999998863     34678899999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-  208 (347)
                      ||||..|+..++++-+ +++++..+..+++..+.||+|||...-+|||||..|||+   +.+|..||.|||.|..+..- 
T Consensus       107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhH
Confidence            9999989999999765 569999999999999999999999999999999999999   78899999999998765432 


Q ss_pred             CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC---CCCCHHH
Q 019040          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---PNVSESA  284 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  284 (347)
                      -..+..+|||-|||||++.. .|...+||||||++..||..|++||..--+...+-.+    ...+++.+   ..-++++
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----PT~PPPTF~KPE~WS~~F  259 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----PTKPPPTFKKPEEWSSEF  259 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----cCCCCCCCCChHhhhhHH
Confidence            13356789999999999874 5999999999999999999999999665543211111    11122221   2356788


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .++|+.||.++|++|.|+.++++|||+++++
T Consensus       260 ~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  260 NDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             HHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            9999999999999999999999999999885

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.2e-41  Score=301.46  Aligned_cols=253  Identities=30%  Similarity=0.522  Sum_probs=208.2

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|++.+.||.|++|.||+|++..++..||+|++.....  ......+.+|+.+++.+ +|+|++++++.+...+..++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEE
Confidence            58999999999999999999999999999999875432  22345677899999999 8999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          132 ELCEGGELFDRIVARG---HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ||+++ +|.+++....   .+++..+..++.|++.||.|||+.|++|+||+|+||++   ++++.++|+|||.+......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCC
Confidence            99975 8888886543   58999999999999999999999999999999999999   66778999999998754332


Q ss_pred             C-cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc------------
Q 019040          209 E-RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK------------  273 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------  273 (347)
                      . ......++..|++||.+.+  .++.++||||||+++|++++|..||...+..+....+........            
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            2 2233457888999998753  378899999999999999999999988776655444432211000            


Q ss_pred             --C-----------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          274 --R-----------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       274 --~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                        .           ...+.++..+.++|.+||+.||.+||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence              0           0012457888999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=288.73  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=205.4

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC-----
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD-----  124 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~-----  124 (347)
                      ++||+|.+.||.|||+-||+++...+++.||+|.+....   ..+++...+|+...+++ +|||+++++++...+     
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCc
Confidence            579999999999999999999999999999999997653   45678899999999999 899999998886543     


Q ss_pred             CeEEEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--cEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          125 NAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      ...|++++|+..|+|.+.+...    ..+++..+..|+.+|+.||++||+..  ++||||||.|||+   .+.+.++|.|
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~vl~D  172 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL---SDSGLPVLMD  172 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe---cCCCceEEEe
Confidence            4599999999999999998653    35899999999999999999999999  9999999999999   5578899999


Q ss_pred             eccccccCCC----------CcccccccCccccccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HH
Q 019040          199 FGLSIFFKPG----------ERFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESEQG--VA  262 (347)
Q Consensus       199 fg~a~~~~~~----------~~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~  262 (347)
                      ||.++...-.          +......+|..|+|||.+.-    ..+.++|||||||++|.|+.|..||.......  ..
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            9988754211          11123458999999998852    37889999999999999999999994322211  11


Q ss_pred             HHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      -.+..+...++...  .+++.+.++|+.||+.||.+||++.+++.+
T Consensus       253 LAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  253 LAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            12233334444433  489999999999999999999999999876

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-41  Score=314.98  Aligned_cols=255  Identities=20%  Similarity=0.293  Sum_probs=205.2

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCC-----ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTR-----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      ....++|++.+.||.|+||.||+|++...+     ..||+|.+....  .......+.+|+.+++.+.+|+||+++++.+
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            344568999999999999999999875443     579999986543  2223467889999999997899999999999


Q ss_pred             eeCCeEEEEEEecCCCchHHHHHhc-------------------------------------------------------
Q 019040          122 EDDNAVHLVMELCEGGELFDRIVAR-------------------------------------------------------  146 (347)
Q Consensus       122 ~~~~~~~lv~e~~~~~~L~~~l~~~-------------------------------------------------------  146 (347)
                      ...+..++||||+++++|.+++...                                                       
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            9999999999999999999988542                                                       


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcc
Q 019040          147 ---------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF  211 (347)
Q Consensus       147 ---------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~  211 (347)
                                     ..++...+..++.||+.||.|||++||+||||||+||++   ++++.++|+|||++.........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcce
Confidence                           136778899999999999999999999999999999999   56778999999998765433221


Q ss_pred             ---cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          212 ---SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       212 ---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                         ....++..|+|||++. ..++.++||||||+++|+|++ |..||...................  .....+++++.+
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~  346 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM--SRPDFAPPEIYS  346 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc--cCCCCCCHHHHH
Confidence               1223456799999875 459999999999999999997 999998766544443443332221  122356899999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcC
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +|..||+.||++|||+.++++.
T Consensus       347 li~~cl~~dp~~RPs~~~l~~~  368 (374)
T cd05106         347 IMKMCWNLEPTERPTFSQISQL  368 (374)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999754

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8e-42  Score=311.09  Aligned_cols=265  Identities=32%  Similarity=0.490  Sum_probs=221.9

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC-----e
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-----A  126 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~-----~  126 (347)
                      +|++.+.||.|++|.||+|++..+++.|++|.+.... ......+.+.+|+.+++.+ +|+|++++++++...+     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccc
Confidence            6899999999999999999999999999999986432 2234456788999999999 8999999999988775     7


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .|+++||+. ++|.+++.....+++..+..++.||+.||.+||+.||+|+||||.||++   +.++.++|+|||.+....
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVD  154 (330)
T ss_pred             eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeec
Confidence            899999996 4898988877789999999999999999999999999999999999999   566889999999998765


Q ss_pred             CCC----cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC-----
Q 019040          207 PGE----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD-----  275 (347)
Q Consensus       207 ~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  275 (347)
                      ...    ......++..|+|||.+.+  .++.++|+||||+++++|++|..||...+.......+..........     
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            543    2344567889999998753  48889999999999999999999998888776665555433221111     


Q ss_pred             ----------------------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCC
Q 019040          276 ----------------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL  322 (347)
Q Consensus       276 ----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~  322 (347)
                                            ..+.++.++.++|.+||+.+|++||++.++++||||+.....+...+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~  303 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPV  303 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCC
Confidence                                  01246788999999999999999999999999999998876655444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.5e-41  Score=300.77  Aligned_cols=254  Identities=29%  Similarity=0.436  Sum_probs=202.5

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|.+.+.||.|+||.||+|.+..+++.|++|++.....  ......+.+|+.+++.+ +|+|++++++++...+..++|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEE
Confidence            689999999999999999999999999999999865432  22234567899999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-  208 (347)
                      +||+. ++|.+.+... ..++...+..++.|++.||.|||+.||+|+||||+||++   +.++.++|+|||++...... 
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCC
Confidence            99996 5777766553 457888899999999999999999999999999999999   66778999999998754322 


Q ss_pred             CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccc--------------c
Q 019040          209 ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLI--------------D  271 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~--------------~  271 (347)
                      .......+++.|+|||.+.+  .++.++||||||+++++|++|..||...... +.+..+.....              .
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            12233457889999998753  4788999999999999999999999765532 22222111000              0


Q ss_pred             ccCCC------------CC--CCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          272 FKRDP------------WP--NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       272 ~~~~~------------~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      +....            +.  ..+.++.+++.+|+..||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            00000            00  135788999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.7e-41  Score=308.28  Aligned_cols=265  Identities=28%  Similarity=0.436  Sum_probs=214.9

Q ss_pred             Ccccceee-eeeecccCCeEEEEEEECCCCceeEEeEeccccccchh-----------cHHHHHHHHHHHHhCCCCCcee
Q 019040           48 NIEDRYLV-DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV-----------DIDDVRREVAIMKHLPKNSSIV  115 (347)
Q Consensus        48 ~~~~~y~i-~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~ei~~l~~l~~h~~i~  115 (347)
                      .+.++|.. .+.||.|+||+||+|.++.+++.||+|++.........           ....+.+|+++++.+ +|+|++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv   83 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIM   83 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCccee
Confidence            34578875 56799999999999999999999999998654322110           112477899999999 999999


Q ss_pred             EeeeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEE
Q 019040          116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (347)
Q Consensus       116 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~  195 (347)
                      ++++++...+..++++||++ ++|.+++.....++...+..++.|++.||.+||+.|++|+||+|+||++   +.++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~~k  159 (335)
T PTZ00024         84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICK  159 (335)
T ss_pred             eeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCCEE
Confidence            99999999999999999996 5899999887789999999999999999999999999999999999999   6677899


Q ss_pred             EEeeccccccCCC---------------CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 019040          196 AIDFGLSIFFKPG---------------ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESE  258 (347)
Q Consensus       196 l~Dfg~a~~~~~~---------------~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  258 (347)
                      |+|||.+......               .......+++.|+|||.+.+  .++.++||||||+++++|++|..||...+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999998765411               11122346788999998754  378899999999999999999999988887


Q ss_pred             HHHHHHHHhccccccCC------------------------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          259 QGVAQAILRGLIDFKRD------------------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       259 ~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      .+....+..........                        .....+..+.++|.+||+.+|++|||+.+++.||||+..
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            66555544322111111                        012457889999999999999999999999999999877


Q ss_pred             cCC
Q 019040          315 KKA  317 (347)
Q Consensus       315 ~~~  317 (347)
                      ...
T Consensus       320 ~~~  322 (335)
T PTZ00024        320 PLP  322 (335)
T ss_pred             CCC
Confidence            543

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.5e-41  Score=298.79  Aligned_cols=258  Identities=28%  Similarity=0.429  Sum_probs=207.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--CeEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAVH  128 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~~~~  128 (347)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+....  .......+.+|+++++.+ +|+||+++++++...  +.++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEE
Confidence            47899999999999999999999999999999986542  223456789999999999 899999999988653  4789


Q ss_pred             EEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          129 LVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +++||+++++|.+++..    ...++...+..++.||+.||.|||+.|++|+||+|+||++   +.++.++|+|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeecccccc
Confidence            99999999999887754    2458899999999999999999999999999999999999   5667799999999876


Q ss_pred             cCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhccccccCCCC-
Q 019040          205 FKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAES-----EQGVAQAILRGLIDFKRDPW-  277 (347)
Q Consensus       205 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~-  277 (347)
                      ...... ....++..|+|||.+. ..++.++||||||+++|+|++|..||....     ..+....+............ 
T Consensus       155 ~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         155 LVNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             cccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            443222 2345788899999876 458999999999999999999999997652     22333333221111111000 


Q ss_pred             --CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          278 --PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       278 --~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                        ...++.+.++|..||..+|++|||+.++++||||++..
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence              13467899999999999999999999999999997664

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.1e-41  Score=298.90  Aligned_cols=256  Identities=28%  Similarity=0.471  Sum_probs=215.0

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      +-|++.+.||.|+||.||+|.+..++..||+|++.....  ......+.+|+.++..+ +|+|++++++.+..++..++|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEE
Confidence            457888999999999999999999999999998754322  23346788999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      +||+++++|.+++.. ..++...+..++.|++.++.+||+.|++|+||+|+||++   +.++.++|+|||++....... 
T Consensus        81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh
Confidence            999999999988864 468999999999999999999999999999999999999   667789999999987554322 


Q ss_pred             cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ......++..|+|||.+.+ .++.++|+||||++++++++|..||...........+....   .......++.++.++|
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~i  233 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFV  233 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC---CCCCCcccCHHHHHHH
Confidence            1233467888999998764 48889999999999999999999998777655555443321   1122236789999999


Q ss_pred             HHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          289 RQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      .+||+.+|++||++.++++||||++...
T Consensus       234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         234 EACLNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             HHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence            9999999999999999999999998743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2e-41  Score=303.43  Aligned_cols=257  Identities=30%  Similarity=0.505  Sum_probs=214.0

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|.+.+.||.|+||.||+|.+..++..|++|.+....   ....+.+.+|+.+++.+ +|||++++++.+...+..++
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~l   93 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWV   93 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEE
Confidence            479999999999999999999999899999999985432   22346688899999999 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |+||+++++|.+++.+. .++...+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++.......
T Consensus        94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccccc
Confidence            99999999999988654 57889999999999999999999999999999999999   567789999999887544332


Q ss_pred             c-ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          210 R-FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       210 ~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      . .....+++.|++||.+. +.++.++|+||||+++|++++|..||...+.......+.... .........++..+.++
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l  248 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF  248 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHHHH
Confidence            2 23346888899999875 458899999999999999999999997766543332222111 11111223567889999


Q ss_pred             HHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          288 VRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      |.+||..+|++||++.++++|+||+...
T Consensus       249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         249 LNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            9999999999999999999999998875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.8e-41  Score=305.16  Aligned_cols=250  Identities=23%  Similarity=0.307  Sum_probs=203.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCce--eEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTREL--LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ++|++.+.||.|+||.||+|.++.++..  +++|.+...  ........+.+|+.++.++.+|+|++++++++...+..+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            5789999999999999999999877754  466665422  233345678889999999978999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC
Q 019040          129 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                      +++||+++++|.+++....                .++...+..++.||+.||.|||++|++||||||+||++   +.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCC
Confidence            9999999999999997542                47889999999999999999999999999999999999   6677


Q ss_pred             CEEEEeeccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 019040          193 PLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLI  270 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  270 (347)
                      .++|+|||++.............++..|+|||.+.+ .++.++||||||+++++|++ |..||...+..+....+...  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--  239 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG--  239 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC--
Confidence            899999999864322111111233567999998764 48899999999999999998 99999887776655554332  


Q ss_pred             cccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                       ........+++++.++|.+||+.+|++||++.+++++
T Consensus       240 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         240 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             1222233578999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.7e-41  Score=294.00  Aligned_cols=252  Identities=29%  Similarity=0.524  Sum_probs=216.9

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|.+.+.||.|++|.||+|.+..++..|++|++..... .......+.+|+++++.+ +|+|++++.+.+......++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEE
Confidence            58899999999999999999999999999999865432 234556788999999999 8999999999999999999999


Q ss_pred             EecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          132 ELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       132 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      ||+++++|.+.+...    ..++...+..++.+++.||.+||+.|++|+||+|+||++   +.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeeccc
Confidence            999999999999774    569999999999999999999999999999999999999   5677899999999887544


Q ss_pred             CC-cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          208 GE-RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       208 ~~-~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      .. ......+++.|+|||.+. ..++.++|+||+|+++++|++|..||...................   ....++..+.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSSELR  232 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCHHHH
Confidence            43 223346888999999865 448889999999999999999999998877766666665543222   2236789999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      +++.+||..+|++|||+.++|+||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.2e-41  Score=295.90  Aligned_cols=253  Identities=28%  Similarity=0.528  Sum_probs=212.9

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|.+.+.||.|+||.||+|.++.++..+|+|.+....... ...+.+.+|+.+++.+ +|+|++++++.+...+..++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEE
Confidence            5889999999999999999999999999999987643322 3446788999999999 8999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          132 ELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+.+++|+||+|+||+++.  ++..++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhccCCc
Confidence            9999999999987643  4789999999999999999999999999999999999942  22357999999987654433


Q ss_pred             cc-cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          210 RF-SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       210 ~~-~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      .. ....+++.|+|||.+. ..++.++|+||||++++++++|..||...+.......+.....   ....+..+.++.++
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  233 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF---APISPNFSRDLRSL  233 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC---CCCCCCCCHHHHHH
Confidence            22 2345788999999875 4488999999999999999999999987776655555444322   22234678899999


Q ss_pred             HHHhccCCCCCCCCHHHHhcCccc
Q 019040          288 VRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      |.+||..+|++|||+.++++||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-41  Score=300.47  Aligned_cols=253  Identities=30%  Similarity=0.473  Sum_probs=208.2

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      |++.+.||.|++|.||+|.++.+|..||+|++...... ......+.+|+.+++.+ +|++++++++++.+.+..++++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEe
Confidence            67889999999999999999999999999998754322 22335678899999999 89999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          133 LCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       133 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      |++ ++|.+++....  .+++..+..++.|++.||.|||+.+++|+||+|+||++   +.++.++|+|||.+....... 
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCcc
Confidence            995 58999987765  68999999999999999999999999999999999999   557889999999987543322 


Q ss_pred             cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc----------------
Q 019040          210 RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID----------------  271 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------------  271 (347)
                      ......++..|+|||.+.+  .++.++||||||+++|+|++|..||...+.......+.+....                
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            2223356888999998753  3788999999999999999999999877665444333322110                


Q ss_pred             ---------ccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          272 ---------FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       272 ---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                               ......+.++..+.++|.+||+++|.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                     0011124577899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.9e-41  Score=294.69  Aligned_cols=248  Identities=31%  Similarity=0.510  Sum_probs=211.1

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+....  .....+.+.+|+.+++.+ +|+|++++++.+..++.+++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEE
Confidence            5889999999999999999999999999999986432  223456788899999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       132 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||+++++|.+++...  ..+++..+..++.||+.||.+||+.|++|+||+|+||++   ++++.++|+|||.+.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccc
Confidence            999999999988653  348999999999999999999999999999999999999   667789999999987654332


Q ss_pred             c-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          210 R-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       210 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      . .....+++.|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+..+....   ....++..+.++
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  231 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP---LPSHYSYELRSL  231 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC---CCcccCHHHHHH
Confidence            2 234568889999998764 48899999999999999999999998877766666555443221   223578899999


Q ss_pred             HHHhccCCCCCCCCHHHHhcC
Q 019040          288 VRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h  308 (347)
                      |.+||+.||++|||+.+++.-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4e-41  Score=299.18  Aligned_cols=249  Identities=28%  Similarity=0.453  Sum_probs=201.9

Q ss_pred             eecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHH---HHHHhCCCCCceeEeeeEEeeCCeEEEEEEec
Q 019040           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV---AIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (347)
Q Consensus        58 ~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei---~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (347)
                      .||.|+||.||+|.+..+++.||+|.+................|.   ..++.. .|++++.+++.+...+..++|+||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEEecC
Confidence            379999999999999999999999998765433222222233343   334444 7999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCccccc
Q 019040          135 EGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI  214 (347)
Q Consensus       135 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~  214 (347)
                      .|++|..++.....+++..+..++.|++.||.|||+.+++|+||+|+||++   +.++.++|+|||++....... ....
T Consensus        80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~-~~~~  155 (278)
T cd05606          80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHAS  155 (278)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-CcCc
Confidence            999999999887789999999999999999999999999999999999999   667789999999987543322 2334


Q ss_pred             ccCcccccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          215 VGSPYYMAPEVLK-R-NYGPEIDIWSAGVILYILLCGVPPFWAESE---QGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       215 ~~~~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .|+..|+|||.+. + .++.++||||+|+++|+|++|..||.....   ........    .........++.++.+++.
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~s~~~~~li~  231 (278)
T cd05606         156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----TMAVELPDSFSPELRSLLE  231 (278)
T ss_pred             CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh----ccCCCCCCcCCHHHHHHHH
Confidence            7899999999875 3 488999999999999999999999977632   22222221    1122233357899999999


Q ss_pred             HhccCCCCCCC-----CHHHHhcCcccccCc
Q 019040          290 QMLEPDPKLRL-----TAKQVLEHPWLQNAK  315 (347)
Q Consensus       290 ~~l~~dp~~Rp-----s~~~ll~h~~~~~~~  315 (347)
                      +||..+|.+||     ++.++++||||+...
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             HHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            99999999999     999999999998864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-41  Score=292.45  Aligned_cols=252  Identities=31%  Similarity=0.554  Sum_probs=216.4

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|.+.+.||.|++|.||+|.+..+++.|++|.+...... ......+.+|++++..+ +|++++++++++.+.+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEE
Confidence            588999999999999999999999999999999765432 24557899999999999 8999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc-
Q 019040          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-  210 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~-  210 (347)
                      ||+++++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||++   +.++.++|+|||.+........ 
T Consensus        79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCCCccc
Confidence            999999999999888889999999999999999999999999999999999999   5578899999999987654433 


Q ss_pred             ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .....++..|+|||...+ .++.++||||||++++++++|..||................   .......++..+.++|.
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~  232 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD---HPPLPEGISPELKDFLM  232 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC---CCCCCCCCCHHHHHHHH
Confidence            233467889999998753 47889999999999999999999998776544444433221   22223467899999999


Q ss_pred             HhccCCCCCCCCHHHHhcCccc
Q 019040          290 QMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       290 ~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      +||..+|++|||+.+++.||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.7e-41  Score=291.65  Aligned_cols=251  Identities=29%  Similarity=0.489  Sum_probs=212.9

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      .|.+.+.||.|++|.||+|.+..+++.+++|++.....   .....+.+|+.+++.+ .|++++.+++++...+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEE
Confidence            47889999999999999999999999999999865432   3457789999999999 7999999999999999999999


Q ss_pred             EecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          132 ELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       132 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      ||+++++|.+++... ..++...+..++.|++.+|.+||+.|++||||+|+||++   ++++.++|+|||.+........
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc
Confidence            999999999998776 578999999999999999999999999999999999999   5678899999999987655443


Q ss_pred             ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .....++..|+|||.+. ..++.++|+||||+++++|++|..||...+.............. .......++..+.++|.
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~  232 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPP-GLRNPEKWSDEFKDFLK  232 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCC-CcCcccccCHHHHHHHH
Confidence            34457888999999876 44888999999999999999999999877555444443332111 11111234889999999


Q ss_pred             HhccCCCCCCCCHHHHhcCcc
Q 019040          290 QMLEPDPKLRLTAKQVLEHPW  310 (347)
Q Consensus       290 ~~l~~dp~~Rps~~~ll~h~~  310 (347)
                      +||+.||++|||+.++++|||
T Consensus       233 ~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHccCChhhCCCHHHHhcCCC
Confidence            999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=294.48  Aligned_cols=245  Identities=35%  Similarity=0.621  Sum_probs=213.7

Q ss_pred             ecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCc
Q 019040           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (347)
Q Consensus        59 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  138 (347)
                      ||.|++|.||++.+..+++.+++|++.............+.+|+.+++.+ +|++++++++.+..++..++++||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            68999999999999989999999999876655555677899999999999 89999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-CcccccccC
Q 019040          139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIVGS  217 (347)
Q Consensus       139 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~~~~~~~~~  217 (347)
                      |.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||.+...... .......++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCC
Confidence            99999888789999999999999999999999999999999999999   56778999999998876443 223445678


Q ss_pred             ccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCC
Q 019040          218 PYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP  296 (347)
Q Consensus       218 ~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  296 (347)
                      ..|+|||...+ .++.++|+||||+++|++++|..||...+.......+......    .....+..+.++|++||..||
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~i~~~l~~~p  232 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR----FPEFLSPEARDLISGLLQKDP  232 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC----CCCCCCHHHHHHHHHHhcCCH
Confidence            89999998764 4788999999999999999999999887766666666553222    223568999999999999999


Q ss_pred             CCCCCH---HHHhcCccc
Q 019040          297 KLRLTA---KQVLEHPWL  311 (347)
Q Consensus       297 ~~Rps~---~~ll~h~~~  311 (347)
                      ++||++   .++++||||
T Consensus       233 ~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         233 TKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hhCCCcccHHHHHhCCCC
Confidence            999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-42  Score=326.75  Aligned_cols=250  Identities=33%  Similarity=0.472  Sum_probs=210.4

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeee-EEee-----
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE-ACED-----  123 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~-~~~~-----  123 (347)
                      ..+++|.+.|.+|||+.||+|.+...|..||+|.+...   +......+.+||.+++.|.+|+||+.+++ ....     
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            46789999999999999999999988899999998654   56677889999999999988999999999 3221     


Q ss_pred             -CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC--cEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          124 -DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       124 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                       .-.++|+||||.|+.|.+++..+  ..|++.++.+|++++++|+.+||...  |||||||-+||||   ..++..||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCD  189 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCD  189 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCc
Confidence             13577999999999999999753  45999999999999999999999998  9999999999999   6788899999


Q ss_pred             eccccccCCCCcc----------cccccCcccccccccc---c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 019040          199 FGLSIFFKPGERF----------SEIVGSPYYMAPEVLK---R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA  264 (347)
Q Consensus       199 fg~a~~~~~~~~~----------~~~~~~~~y~aPE~~~---~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  264 (347)
                      ||.++........          -....|+.|+|||++.   + ..+.|+|||+|||+||-|+....||.....    ..
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----la  265 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LA  265 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----ee
Confidence            9998754333211          1124799999999874   2 388999999999999999999999966633    25


Q ss_pred             HHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      |+.+...+|..  +.++..+.+||+.||+.||++||++-|++++-+.
T Consensus       266 Ilng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  266 ILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             EEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence            56666665553  5889999999999999999999999999877443

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=316.99  Aligned_cols=238  Identities=25%  Similarity=0.415  Sum_probs=207.3

Q ss_pred             eeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEe
Q 019040           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL  133 (347)
Q Consensus        54 ~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  133 (347)
                      .-++-||.|+.|.||+|+.  .++.||||.+..-          -..+|+-|++| +|+||+.+.|+|.....++|||||
T Consensus       127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkL-kH~NII~FkGVCtqsPcyCIiMEf  193 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKL-KHPNIITFKGVCTQSPCYCIIMEF  193 (904)
T ss_pred             hhhhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhc-cCcceeeEeeeecCCceeEEeeec
Confidence            4466799999999999976  5788999987421          12388899999 999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccc
Q 019040          134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE  213 (347)
Q Consensus       134 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~  213 (347)
                      |+.|-|...|+..+.+....+..|..+|+.|+.|||.+.|||||+|.-||||   ..+..|||+|||-+.........-.
T Consensus       194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI---s~~d~VKIsDFGTS~e~~~~STkMS  270 (904)
T KOG4721|consen  194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI---SYDDVVKISDFGTSKELSDKSTKMS  270 (904)
T ss_pred             cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe---eccceEEeccccchHhhhhhhhhhh
Confidence            9999999999999999999999999999999999999999999999999999   5566799999999988766655556


Q ss_pred             cccCcccccccccccc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhc
Q 019040          214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML  292 (347)
Q Consensus       214 ~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  292 (347)
                      +.||..|||||++++. .+.+.||||||++||||+||+.||...+...++.-+-...+..+  ....+|+.+.=||++||
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp--vPstcP~GfklL~Kqcw  348 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP--VPSTCPDGFKLLLKQCW  348 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc--CcccCchHHHHHHHHHH
Confidence            7899999999999866 78899999999999999999999988777655444433333333  33589999999999999


Q ss_pred             cCCCCCCCCHHHHhcCc
Q 019040          293 EPDPKLRLTAKQVLEHP  309 (347)
Q Consensus       293 ~~dp~~Rps~~~ll~h~  309 (347)
                      +-.|..|||+.++|.|-
T Consensus       349 ~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  349 NSKPRNRPSFRQILLHL  365 (904)
T ss_pred             hcCCCCCccHHHHHHHH
Confidence            99999999999999994

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.9e-41  Score=308.82  Aligned_cols=259  Identities=31%  Similarity=0.478  Sum_probs=208.6

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~----  124 (347)
                      +.++|.+.+.||.|+||.||+|.++.+++.||+|.+....   ....+.+.+|+++++.+ +|+|++++++.+...    
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhc-CCCcchhhHhhhccccccc
Confidence            4689999999999999999999999999999999986543   23456788899999999 999999998776543    


Q ss_pred             ----------CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCE
Q 019040          125 ----------NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (347)
Q Consensus       125 ----------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~  194 (347)
                                ...++++||++ ++|.+++.. ..+++..++.++.||+.||.|||+.|++|+||||+||+++  .++..+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~  154 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVL  154 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceE
Confidence                      36889999996 488887754 4689999999999999999999999999999999999995  245578


Q ss_pred             EEEeeccccccCCCCc----ccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 019040          195 KAIDFGLSIFFKPGER----FSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG  268 (347)
Q Consensus       195 ~l~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  268 (347)
                      +|+|||.+........    .....++..|+|||.+.  ..++.++||||||+++|+|++|..||...........+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999876432211    12235788899999764  34888999999999999999999999877665544443322


Q ss_pred             cccc---------------------cC-----CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          269 LIDF---------------------KR-----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       269 ~~~~---------------------~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ....                     ..     ...+.++.++.++|.+||+.||.+|||+.++++||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  307 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS  307 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence            1100                     00     01235778899999999999999999999999999998654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=305.85  Aligned_cols=258  Identities=29%  Similarity=0.462  Sum_probs=204.0

Q ss_pred             ceeeeeeecccCCeEEEEEEECC--CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--CeE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRD--TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAV  127 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~~~  127 (347)
                      +|++.+.||.|++|.||+|.+..  +++.||+|.+.............+.+|+.+++.+ +|||++++++++...  +..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence            58899999999999999999988  8999999999764433333446678899999999 999999999999988  889


Q ss_pred             EEEEEecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeec-CCCCCCEEEEeecc
Q 019040          128 HLVMELCEGGELFDRIVAR-----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN-KKENSPLKAIDFGL  201 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~-~~~~~~~~l~Dfg~  201 (347)
                      ++|+||+++ +|.+.+...     ..+++..++.++.||+.||.|||+.||+|+||+|+||+++. ++.++.++|+|||+
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999999965 777766432     25889999999999999999999999999999999999953 22278899999999


Q ss_pred             ccccCCCCc----ccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHH
Q 019040          202 SIFFKPGER----FSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQG---------VAQAIL  266 (347)
Q Consensus       202 a~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~  266 (347)
                      +........    .....++..|+|||.+.+  .++.++||||||+++++|++|..||.......         ....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            886543322    223467888999997653  47899999999999999999999997654322         111111


Q ss_pred             hccc---------------------cccCCCC------------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          267 RGLI---------------------DFKRDPW------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       267 ~~~~---------------------~~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ....                     .......            ...+.++.++|.+||+.||++|||+.++++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            1000                     0000111            1456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.5e-41  Score=295.37  Aligned_cols=250  Identities=29%  Similarity=0.482  Sum_probs=202.7

Q ss_pred             eeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEec
Q 019040           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (347)
                      ....||+|+||.||+|.+..++..|++|.+...   .......+.+|+.+++.+ +|+||+++++++..++..++++||+
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecC
Confidence            345799999999999999999999999987643   233456788999999999 9999999999999999999999999


Q ss_pred             CCCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc-
Q 019040          135 EGGELFDRIVAR-GHY--TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-  210 (347)
Q Consensus       135 ~~~~L~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~-  210 (347)
                      ++++|.+++... ..+  +...+..++.||+.||.|||++||+|+||+|+||+++  ...+.++|+|||.+........ 
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCc
Confidence            999999999764 345  7888899999999999999999999999999999994  2356799999999876533222 


Q ss_pred             ccccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      .....+++.|+|||.+.+   .++.++||||||+++|+|++|..||............. ............+++++.++
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l  244 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFKIHPEIPESLSAEAKNF  244 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhhccCCCCCcccCHHHHHH
Confidence            233457889999998753   37889999999999999999999997654322111111 11111122233678899999


Q ss_pred             HHHhccCCCCCCCCHHHHhcCccc
Q 019040          288 VRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      +.+||+.+|++|||+.++++||||
T Consensus       245 i~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         245 ILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.6e-41  Score=298.06  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=209.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECC-----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .++|.+.+.||.|++|.||+|.+..     ++..|++|.+....  .......+.+|+.+++.+ +|+||+++++++...
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKF-NHQNIVRLIGVSFER   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC
Confidence            4679999999999999999999987     67889999875432  233345688899999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          125 NAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                      +..++++||+++++|.+++....       .+++..+..++.||+.||.|||++|++|+||+|+||+++.++....++|+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999997653       47889999999999999999999999999999999999755555679999


Q ss_pred             eeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccc
Q 019040          198 DFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDF  272 (347)
Q Consensus       198 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  272 (347)
                      |||++........   ......+..|+|||++. ..++.++||||||+++|+|++ |..||...+.......+....   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---  238 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG---  238 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---
Confidence            9999886532211   11223356799999875 459999999999999999997 999998887776655554332   


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .......++..+.+++.+||+.+|++|||+.++++|
T Consensus       239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            122234678999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.1e-41  Score=300.86  Aligned_cols=261  Identities=30%  Similarity=0.534  Sum_probs=212.9

Q ss_pred             ceeeeeeecccCCeEEEEEEEC---CCCceeEEeEecccccc-chhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .|++.+.||.|+||.||+|.+.   .+|..||+|++...... .....+.+.+|+.++..+.+|++|+.+++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999885   47889999998654322 2223466788999999997799999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      ++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceeccc
Confidence            9999999999999999888889999999999999999999999999999999999999   5678899999999876543


Q ss_pred             CCc--ccccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          208 GER--FSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       208 ~~~--~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ...  .....++..|+|||.+..   .++.++||||||+++|+|++|..||...........+.........+....++.
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  237 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence            221  223468889999998753   367899999999999999999999965433222222222221112222236789


Q ss_pred             HHHHHHHHhccCCCCCCC-----CHHHHhcCcccccCc
Q 019040          283 SAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQNAK  315 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~  315 (347)
                      .+.+++.+||+.||++||     ++.++++||||+...
T Consensus       238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            999999999999999997     899999999998874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.4e-41  Score=294.66  Aligned_cols=249  Identities=21%  Similarity=0.359  Sum_probs=210.5

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ....|.+.+.||.|++|.||+|.++.+++.|++|.+..+    ......+.+|+.+++.+ +|++++++++++..++..+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcE
Confidence            345689999999999999999999999999999998643    22356788999999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          129 LVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +++||+++++|.+++....  .++...+..++.|++.+|.|||++|++|+||||+||++   ++++.++|+|||++....
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT  155 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccc
Confidence            9999999999999987643  48899999999999999999999999999999999999   667889999999988754


Q ss_pred             CCCcc--cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          207 PGERF--SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       207 ~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .....  ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+.+..+....+....   .......++.
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (263)
T cd05052         156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---RMERPEGCPP  232 (263)
T ss_pred             cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---CCCCCCCCCH
Confidence            43221  1123456799999875 458899999999999999998 999998887776666665442   2233347889


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ++.++|.+||..||++|||+.++++.
T Consensus       233 ~~~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         233 KVYELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHHH
Confidence            99999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.9e-41  Score=330.93  Aligned_cols=253  Identities=28%  Similarity=0.393  Sum_probs=205.5

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++..+.........++.+|+++++.+ +|||++++++++.+.+..+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEE
Confidence            6899999999999999999999999999999998755433444456789999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          131 MELCEGGELFDRIVAR-----------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                      |||++|++|.+++...           ...+...+..++.||+.||.|||+.||+||||||+||++   +.++.++|+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence            9999999999988642           234566788999999999999999999999999999999   67788999999


Q ss_pred             ccccccCCCC-------------------cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 019040          200 GLSIFFKPGE-------------------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ  259 (347)
Q Consensus       200 g~a~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  259 (347)
                      |++.......                   ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9997652110                   0112468999999998764 4899999999999999999999999776544


Q ss_pred             HHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ......... ..........+++.+.+++.+||+.||++||+..+.+.+
T Consensus       238 ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            332221111 011112234688999999999999999999987766644

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.1e-40  Score=301.39  Aligned_cols=259  Identities=27%  Similarity=0.457  Sum_probs=216.1

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ....+.|...+.||.|++|+||+|++..+++.|++|.+.............+.+|+++++.+ +|+|++++++++.+...
T Consensus        17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   95 (313)
T cd06633          17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHT   95 (313)
T ss_pred             CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCE
Confidence            44455678888899999999999999999999999998765444445556788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .|+|+||+.+ ++.+.+.. ...++...+..++.||+.+|.|||+.|++|+||+|+||++   +.++.++|+|||++...
T Consensus        96 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~  171 (313)
T cd06633          96 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKS  171 (313)
T ss_pred             EEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCccc
Confidence            9999999965 77777755 3468999999999999999999999999999999999999   56778999999988653


Q ss_pred             CCCCcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          206 KPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ..   .....++..|+|||.+.    +.++.++||||||+++|+|++|..||...+.......+.....  +.......+
T Consensus       172 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  246 (313)
T cd06633         172 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWT  246 (313)
T ss_pred             CC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccC
Confidence            22   23456888999999873    3488899999999999999999999988776555554443322  222223567


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ..+.++|.+||+.+|.+||++.+++.||||+...
T Consensus       247 ~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         247 DSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            8899999999999999999999999999999743

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.6e-42  Score=326.39  Aligned_cols=246  Identities=26%  Similarity=0.449  Sum_probs=214.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECC-----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .+....+.||+|+||+||+|....     +...||||.++...  ......+|++|++++..| +||||++++|++..++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAEL-QHPNIVRLLGVCREGD  562 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCC
Confidence            456788899999999999998653     34679999986543  344567899999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC----------C----CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCC
Q 019040          126 AVHLVMELCEGGELFDRIVARG----------H----YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~----------~----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~  191 (347)
                      .+++|+||++.|+|.++|....          .    ++..+...|+.||+.|+.||-++.+||||+-..|+||   .++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccc
Confidence            9999999999999999996532          2    7788999999999999999999999999999999999   788


Q ss_pred             CCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 019040          192 SPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAIL  266 (347)
Q Consensus       192 ~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~  266 (347)
                      ..|||+|||+++..-..+.   ........+|||||.+. ++++.++||||+|++|||+++ |..||.+...+++++.+.
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            8999999999986533322   22345678999999764 889999999999999999998 999999999999999999


Q ss_pred             hccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 019040          267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV  305 (347)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  305 (347)
                      ++.. ++.  ...+|.++++||..||+.+|.+||++++|
T Consensus       720 ~g~l-L~~--Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  720 AGQL-LSC--PENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             cCCc-ccC--CCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            8876 333  35899999999999999999999999998

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-42  Score=309.30  Aligned_cols=257  Identities=26%  Similarity=0.440  Sum_probs=205.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      ...|++++.||.||.+.||+++.-. .+.||+|.+... ......+.-+.+||..|.+|.+|.+|+.++++-..++.+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            4569999999999999999998743 455666655433 23455678899999999999999999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      |||+=+ .+|..+|++... .+...++.+..||+.|+.++|..||||.|+||.|+|++    .|.+||+|||.|..+...
T Consensus       438 vmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  438 VMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             Eeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccCcc
Confidence            999974 499999987754 45468888999999999999999999999999999995    678999999999877655


Q ss_pred             Cc---ccccccCccccccccccc------------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccc
Q 019040          209 ER---FSEIVGSPYYMAPEVLKR------------NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDF  272 (347)
Q Consensus       209 ~~---~~~~~~~~~y~aPE~~~~------------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~  272 (347)
                      ..   ....+||+.||+||.+..            ..++++|||||||+||+|+.|+.||...... .-+..|.......
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I  592 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI  592 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence            43   245689999999998731            1567899999999999999999999554422 2223333332222


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ..+..+. +.++.++++.||+.||++|||..++|+|||++-.
T Consensus       593 efp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  593 EFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             cccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            2222212 2348999999999999999999999999999875

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.9e-41  Score=297.27  Aligned_cols=251  Identities=26%  Similarity=0.477  Sum_probs=207.9

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|.+.+.||.|++|.||+|.++.+++.+++|.+.............+.+|+.+++.+ +|+|++++++.+...+..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEE
Confidence            4788999999999999999999999999999988765444444557788999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          131 MELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +||+++++|.+++..    ...+++..++.++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence            999999999998864    3458999999999999999999999999999999999999   567789999999887654


Q ss_pred             CCCc-ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccccccCCCCCCCCH
Q 019040          207 PGER-FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ--GVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       207 ~~~~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .... .....++..|+|||.+. ..++.++|+||||+++|+|++|..||......  .....+...  ..+.......+.
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE  235 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccH
Confidence            3322 22346888999999875 44888999999999999999999999765432  222222221  222223346788


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .+.++|.+||+.||++|||+.++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.2e-41  Score=297.33  Aligned_cols=253  Identities=22%  Similarity=0.352  Sum_probs=207.0

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECC-----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      +...++|++.+.||.|++|.||+|.++.     ++..||+|.+....  .......+.+|+.+++.+ +|+|++++++++
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~   78 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVV   78 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE
Confidence            3456889999999999999999998753     35679999875432  222345688999999999 999999999999


Q ss_pred             eeCCeEEEEEEecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCC
Q 019040          122 EDDNAVHLVMELCEGGELFDRIVARG----------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (347)
Q Consensus       122 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~  191 (347)
                      ......++|+||+++++|.+++....          .++...+..++.|++.||.|||+.|++|+||||+||++   +++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~  155 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AED  155 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCC
Confidence            99999999999999999999986532          24677889999999999999999999999999999999   567


Q ss_pred             CCEEEEeeccccccCCCCcc---cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 019040          192 SPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAIL  266 (347)
Q Consensus       192 ~~~~l~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~  266 (347)
                      +.++|+|||++.........   ....+++.|+|||.+. +.++.++||||||+++|+|++ |..||...........+.
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            88999999998754332211   1224567899999876 458999999999999999998 789998888777666655


Q ss_pred             hccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .....   .....++..+.+++.+||+.+|++|||+.+++++
T Consensus       236 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         236 EGGLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            54322   2224678999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.3e-40  Score=301.47  Aligned_cols=261  Identities=28%  Similarity=0.452  Sum_probs=218.2

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ........|...+.||.|+||.||+|.+..++..||+|.+.............+.+|+++++.+ +|+|++++++++..+
T Consensus        19 ~~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   97 (317)
T cd06635          19 FKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLRE   97 (317)
T ss_pred             cCCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeC
Confidence            4445556689999999999999999999999999999998765444444556788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      +..++|+||+.| +|.+.+.. ...+++..+..++.||+.||.|||+.|++|+||+|+||++   +.++.++|+|||++.
T Consensus        98 ~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~  173 (317)
T cd06635          98 HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSAS  173 (317)
T ss_pred             CeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCcc
Confidence            999999999976 77777654 4568999999999999999999999999999999999999   667889999999887


Q ss_pred             ccCCCCcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      .....   ....+++.|+|||.+.    +.++.++||||||+++|+|++|..||...........+......  ......
T Consensus       174 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  248 (317)
T cd06635         174 IASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--TLQSNE  248 (317)
T ss_pred             ccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC--CCCCcc
Confidence            54332   3346888999999863    34888999999999999999999999887766555555443321  122235


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .++.+.++|.+||+.+|.+||++.++++|+|+....
T Consensus       249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            788899999999999999999999999999996654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-43  Score=335.60  Aligned_cols=261  Identities=30%  Similarity=0.479  Sum_probs=231.8

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|.|++.||.|+||.|.+++.+.+++.||+|++++.......+...|..|-.++... +.+=|+.++-.|+++.++|+
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEE
Confidence            46899999999999999999999999999999999987766666778888899999887 77888999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-  208 (347)
                      ||||++||+|..++.+..++++..++.++..|..||..||+.|+|||||||+|||+   +..|++||.|||.+-.+... 
T Consensus       153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCCC
Confidence            99999999999999888889999999999999999999999999999999999999   88999999999998877633 


Q ss_pred             Cc-ccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          209 ER-FSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       209 ~~-~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      .. ...-+|||.|.+||++.      +.|++..|+||+|+++|||+.|..||....--+.+-.|++-...+..+....++
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS  309 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS  309 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence            32 24458999999999883      349999999999999999999999999999888888888774444443445799


Q ss_pred             HHHHHHHHHhccCCCCCCCC---HHHHhcCcccccCc
Q 019040          282 ESAKSLVRQMLEPDPKLRLT---AKQVLEHPWLQNAK  315 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~  315 (347)
                      .+..+||.+++.. |+.|..   +.++..||||....
T Consensus       310 eeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  310 EEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             HHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCC
Confidence            9999999999886 777887   99999999998764

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.7e-41  Score=298.75  Aligned_cols=249  Identities=24%  Similarity=0.398  Sum_probs=209.2

Q ss_pred             ccceeeeeeecccCCeEEEEEEECC-----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .++|.+.+.||.|+||.||+|.+..     +++.||+|.+....  .......+.+|+++++.+ +|+|++++++++...
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNF-QHENIVKFYGVCTEG   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhc-CCCCchheeeEEecC
Confidence            3568999999999999999998753     46789999986432  222456889999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC
Q 019040          125 NAVHLVMELCEGGELFDRIVARG--------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE  190 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~  190 (347)
                      ...+++|||+++++|.+++...+              .+++..+..++.||+.||.+||++|++|+||||+||++   +.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~  157 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GY  157 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cC
Confidence            99999999999999999997542              37888899999999999999999999999999999999   66


Q ss_pred             CCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 019040          191 NSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAI  265 (347)
Q Consensus       191 ~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  265 (347)
                      ++.++|+|||++........   .....+++.|+|||++. ..++.++||||||+++|+|++ |..||...........+
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI  237 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            78899999999875432221   12234567899999876 458999999999999999998 99999888887777777


Q ss_pred             HhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          266 LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ..+.....   ...++..+.+++.+||+.||++||++.++++
T Consensus       238 ~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            65543322   2468899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.1e-41  Score=300.05  Aligned_cols=250  Identities=23%  Similarity=0.292  Sum_probs=205.0

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCc--eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRE--LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ++|++.+.||.|+||.||+|.++.++.  .+++|.+...  ........+.+|+.++.++.+|||++++++++...+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            579999999999999999999887765  4688876522  223335678889999999977999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC
Q 019040          129 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                      +++||+++++|.+++....                .++...+..++.||+.||+|||++|++|+||||+||++   +.++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCC
Confidence            9999999999999997642                37888999999999999999999999999999999999   5677


Q ss_pred             CEEEEeeccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 019040          193 PLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLI  270 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  270 (347)
                      .++|+|||++..............+..|+|||.+.. .++.++||||||+++|+|++ |..||...........+..+..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            899999999864322211111223456999998764 48999999999999999997 9999988887776666654422


Q ss_pred             cccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                         ......++..+.++|.+||..+|.+|||+.++++.
T Consensus       237 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         237 ---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               22223688999999999999999999999999755

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-41  Score=309.08  Aligned_cols=266  Identities=27%  Similarity=0.475  Sum_probs=217.3

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe-
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA-  126 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~-  126 (347)
                      .+.++|++.+.||.|++|.||+|++..+++.||+|++.... ........+.+|+.+++.+ .|+|++++.+++...+. 
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSL   89 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccc
Confidence            45688999999999999999999999999999999886432 2223345677899999999 99999999888766544 


Q ss_pred             -----EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          127 -----VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       127 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                           .++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||++   +.++.++|+|||+
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~  164 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGL  164 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEccccc
Confidence                 89999999 6699888865 468999999999999999999999999999999999999   6678899999999


Q ss_pred             ccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc------
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK------  273 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  273 (347)
                      +......  .....++..|+|||.+.+  .++.++||||||+++|++++|..||...........+.......+      
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence            9865432  334567888999998753  478899999999999999999999988776655555443221100      


Q ss_pred             -----------------C----CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCC
Q 019040          274 -----------------R----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL  322 (347)
Q Consensus       274 -----------------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~  322 (347)
                                       .    ......+..+.++|.+||..+|++|||+.++++||||++........+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~  312 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV  312 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc
Confidence                             0    001245889999999999999999999999999999998876644443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=291.91  Aligned_cols=254  Identities=29%  Similarity=0.480  Sum_probs=211.2

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEecccc--ccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--Ce
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK--LRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NA  126 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~~  126 (347)
                      .+|++.+.||.|++|.||+|.+..++..|++|.+....  .........+.+|+.+++.+ +|++++++++.+.+.  +.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence            57999999999999999999999999999999875322  12233456789999999999 999999999998764  56


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +++++||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++....
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence            88999999999999999887778999999999999999999999999999999999999   567789999999987643


Q ss_pred             CC----CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          207 PG----ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       207 ~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ..    .......++..|+|||.+.+ .++.++|+||||++++++++|..||...........+....  .....+..++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~p~~~~  235 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP--TKPMLPDGVS  235 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC--CCCCCCcccC
Confidence            21    11223468889999998764 48899999999999999999999998776555444433221  1222345788


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      +.+.++|.+||+ +|..||++.+++.|||.
T Consensus       236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            999999999999 47999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-40  Score=305.18  Aligned_cols=279  Identities=27%  Similarity=0.438  Sum_probs=220.4

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC-
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-  125 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~-  125 (347)
                      ..+.++|++.+.||.|++|.||+|.+..++..||+|.+.... ........+.+|+.+++.+ +|+||+++++++.... 
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCcc
Confidence            346789999999999999999999999999999999986432 2223345688899999999 9999999999887553 


Q ss_pred             -----eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          126 -----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       126 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                           ..++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||++   +.++.++|+|||
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~dfg  163 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFG  163 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecc
Confidence                 468999999 7789877754 478999999999999999999999999999999999999   567789999999


Q ss_pred             cccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc------
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF------  272 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------  272 (347)
                      ++......  .....+++.|+|||.+.+  .++.++|+||||++++++++|..||...+.......+.......      
T Consensus       164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         164 LARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             cccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            98765432  233467889999998753  48889999999999999999999998776554444333211110      


Q ss_pred             -----------------c----CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCC-------CChH
Q 019040          273 -----------------K----RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV-------PLGD  324 (347)
Q Consensus       273 -----------------~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~-------~~~~  324 (347)
                                       .    ...++.++..+.++|.+||+.||++|||+.++++||||+.....+..       ...+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  321 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYDDSFD  321 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCccccHH
Confidence                             0    01123578889999999999999999999999999999887544322       2234


Q ss_pred             HHHHHhhhhH
Q 019040          325 VVRSRLKQFS  334 (347)
Q Consensus       325 ~~~~~~~~~~  334 (347)
                      .....+.||+
T Consensus       322 ~~~~~~~~~~  331 (343)
T cd07880         322 EVDQSLEEWK  331 (343)
T ss_pred             hhccchHHHH
Confidence            4444555554

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-40  Score=296.89  Aligned_cols=260  Identities=31%  Similarity=0.507  Sum_probs=219.3

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...+.|++...||.|++|.||+|.+..++..|++|++.....    ....+.+|+++++.+ +|+|++++++.+...+..
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDC-KHPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEE
Confidence            455779999999999999999999998899999999864322    456788899999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      ++++||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhc
Confidence            99999999999999998876 79999999999999999999999999999999999999   667789999999887654


Q ss_pred             CCC-cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          207 PGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       207 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      ... ......+++.|++||.+.+ .++.++|+||||+++|+|++|..||...........+...... .......++..+
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  246 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEF  246 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHHH
Confidence            332 1233457888999998764 4889999999999999999999999877665544444332211 112223478999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      .++|..||+.+|.+||++.++++|+||++.-.
T Consensus       247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             HHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence            99999999999999999999999999998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.1e-40  Score=292.13  Aligned_cols=251  Identities=31%  Similarity=0.474  Sum_probs=214.7

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +|++.+.||.|++|.||++++..+++.+++|.+...... ......+.+|+++++.+ +|+|++++.+++......++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEe
Confidence            588999999999999999999999999999998654332 33456778899999999 7999999999999999999999


Q ss_pred             EecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          132 ELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       132 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      ||+++++|.+++..    ...+++..++.++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL---VANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---ecCCcEEEeeccchhhhcc
Confidence            99999999998866    3458999999999999999999999999999999999999   4577899999999887654


Q ss_pred             CCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      . ......+++.|+|||.+.+ .++.++|+||||++++++++|..||...+.......+......   ......+.++.+
T Consensus       156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  231 (256)
T cd08530         156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP---PIPPIYSQDLQN  231 (256)
T ss_pred             C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---CCchhhCHHHHH
Confidence            4 2333467889999998764 4888999999999999999999999888876665555443322   122367899999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcCccc
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ++.+||+.+|++||++.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2e-40  Score=292.48  Aligned_cols=251  Identities=26%  Similarity=0.481  Sum_probs=208.0

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|++|.||+|.+..+|+.|++|.+.............+.+|+++++.+ +|++++++++.+...+..+++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEE
Confidence            5799999999999999999999999999999998754444444567889999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          131 MELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +||+++++|..++...    ..++...+..++.+++.||.+||+.|++|+||+|+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence            9999999999988642    348999999999999999999999999999999999999   667889999999987654


Q ss_pred             CCCc-ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccccccCCCCCCCCH
Q 019040          207 PGER-FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESE--QGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       207 ~~~~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .... .....+++.|+|||.+. ..++.++|+||||+++|+|++|..||.....  ......+....  .+.......+.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPLPADHYSE  235 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--CCCCChhhcCH
Confidence            3321 22346788899999876 4488999999999999999999999965432  22333333222  11222236788


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .+.++|.+||..+|++|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.8e-40  Score=296.45  Aligned_cols=259  Identities=24%  Similarity=0.343  Sum_probs=209.2

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECC-----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      +...++|++.+.||.|+||.||+|.++.     .+..||+|.+....  .......+.+|+.+++.+ +|++++++++++
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   78 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGF-TCHHVVRLLGVV   78 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE
Confidence            3456899999999999999999997652     35579999875432  222334578899999999 899999999999


Q ss_pred             eeCCeEEEEEEecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCC
Q 019040          122 EDDNAVHLVMELCEGGELFDRIVARG----------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (347)
Q Consensus       122 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~  191 (347)
                      ...+..+++|||+++++|.+++....          .++...+..++.|++.||.|||++||+|+||||+||++   +.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~  155 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHD  155 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCC
Confidence            99999999999999999999997532          24567788999999999999999999999999999999   567


Q ss_pred             CCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 019040          192 SPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAIL  266 (347)
Q Consensus       192 ~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~  266 (347)
                      +.++|+|||++........   .....++..|+|||.+. +.++.++||||||+++|+|++ |..||......+....+.
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            8899999999875432221   11123466799999876 458999999999999999998 788998887777666555


Q ss_pred             hccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc------CcccccC
Q 019040          267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE------HPWLQNA  314 (347)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~  314 (347)
                      .+...   .....++..+.+++.+||+.||++|||+.++++      ||||+..
T Consensus       236 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         236 DGGYL---DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             cCCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            43221   122356899999999999999999999999987      8888754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-41  Score=296.98  Aligned_cols=245  Identities=28%  Similarity=0.456  Sum_probs=200.7

Q ss_pred             eeeeeecccCCeEEEEEEEC----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           54 LVDRELGRGEFGVTYLCIDR----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        54 ~i~~~lg~G~~g~V~~a~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+.+.||.|+||.||+|.+.    ..+..|+||.+...  ......+.+.+|++.++++ +||||+++++++...+..++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence            46788999999999999988    44678999998432  2333468899999999999 99999999999998888999


Q ss_pred             EEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          130 VMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |+||+++++|.+++...  ..++...+..++.||+.||.|||+++++|+||+++||++   +.++.+||+|||++.....
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence            99999999999999887  669999999999999999999999999999999999999   5677899999999987632


Q ss_pred             CCc---ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          208 GER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       208 ~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ...   .........|+|||.+.. .++.++||||||+++||+++ |..||...+.......+.+.....   ....++.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCPK  232 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSBH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce---eccchhH
Confidence            221   123356778999999864 48999999999999999999 789999888887777775554322   2346899


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .+.++|..||..+|++|||+.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-40  Score=296.71  Aligned_cols=253  Identities=25%  Similarity=0.412  Sum_probs=209.2

Q ss_pred             cceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ++|.+.+.||.|+||.||++.+.     .++..+|+|.+...   .......+.+|+.+++.+ +|++++++++++...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Confidence            57999999999999999999863     34567899987543   233456789999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC
Q 019040          126 AVHLVMELCEGGELFDRIVARG-------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                      ..++++||+++++|.+++....             .+++..+..++.|++.||.|||++|++||||||+||++   ++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCC
Confidence            9999999999999999997543             38999999999999999999999999999999999999   6778


Q ss_pred             CEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 019040          193 PLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILR  267 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~  267 (347)
                      .++|+|||++........   .....++..|+|||.+. ..++.++||||||+++++|++ |..||...........+..
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            899999999876533221   12233567899999876 458999999999999999998 9999988887777777666


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +....   ....++.++.+++.+||+.||.+|||+.++++.  |++..
T Consensus       238 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~--l~~~~  280 (288)
T cd05093         238 GRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSL--LQNLA  280 (288)
T ss_pred             CCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH--HHHHH
Confidence            54221   223578999999999999999999999999443  55443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=299.28  Aligned_cols=265  Identities=28%  Similarity=0.446  Sum_probs=214.2

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCC-CC----ceeEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK-NS----SIVSLK  118 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~-h~----~i~~~~  118 (347)
                      ..++.+.++|.++..+|+|.||.|..+.|..++..||+|+++.-...    .+...-|+++++++.. .|    -++.+.
T Consensus        82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY----reAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY----REAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH----hhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            45667789999999999999999999999999999999998643211    1223448999999832 22    267788


Q ss_pred             eEEeeCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC-------
Q 019040          119 EACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK-------  189 (347)
Q Consensus       119 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~-------  189 (347)
                      +++...++.+||+|.+ |.++.+++.+++  +++..+++.+++|++.++.+||+.+++|.|+||+|||+.+.+       
T Consensus       158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEecc
Confidence            8899999999999999 779999998863  599999999999999999999999999999999999996421       


Q ss_pred             ----------CCCCEEEEeeccccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 019040          190 ----------ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESE  258 (347)
Q Consensus       190 ----------~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  258 (347)
                                .+..|+|+|||.|+....  .....+.|..|+|||++. -.|+.++||||+||+|+|+++|...|...+.
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen  314 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN  314 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence                      244689999999987443  336678899999999876 5799999999999999999999999988887


Q ss_pred             HHHHHHHHhccccccCC----------------CCC--------------------------CCCHHHHHHHHHhccCCC
Q 019040          259 QGVAQAILRGLIDFKRD----------------PWP--------------------------NVSESAKSLVRQMLEPDP  296 (347)
Q Consensus       259 ~~~~~~~~~~~~~~~~~----------------~~~--------------------------~~~~~~~~li~~~l~~dp  296 (347)
                      .+.+..+.+-+..+|..                .|+                          ..-..+.+||+.||..||
T Consensus       315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            77554443333322210                010                          011356799999999999


Q ss_pred             CCCCCHHHHhcCcccccCc
Q 019040          297 KLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       297 ~~Rps~~~ll~h~~~~~~~  315 (347)
                      .+|+|+.++|.||||+...
T Consensus       395 ~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  395 ARRITLREALSHPFFARLT  413 (415)
T ss_pred             cccccHHHHhcCHHhhcCC
Confidence            9999999999999999864

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=291.88  Aligned_cols=243  Identities=25%  Similarity=0.395  Sum_probs=209.0

Q ss_pred             eeecccCCeEEEEEEECCC---CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEe
Q 019040           57 RELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL  133 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  133 (347)
                      +.||.|+||.||+|.+...   +..|++|.+.......  ....+.+|+.++..+ +|++++++++++......++++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEe
Confidence            4689999999999999866   8899999987543222  467899999999999 699999999999999999999999


Q ss_pred             cCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          134 CEGGELFDRIVAR---------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       134 ~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +++++|.+++...         ..+++..++.++.|++.||.+||++|++|+||+|+||++   +.++.++|+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence            9999999999875         679999999999999999999999999999999999999   6678899999999987


Q ss_pred             cCCCC---cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          205 FKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       205 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      .....   ......++..|+|||.+.. .++.++||||||+++++|++ |..||...........+....   .......
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~  231 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY---RLPKPEY  231 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCcc
Confidence            65432   2233457888999998764 58899999999999999998 699999888777777776532   2222346


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ++.++.+++.+||..+|++|||+.+++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            78999999999999999999999999876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.3e-40  Score=297.95  Aligned_cols=257  Identities=30%  Similarity=0.518  Sum_probs=214.9

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      .|.-...||.|+||.||+|.++.+++.||+|.+...   .......+.+|+.+++.+ +|+|++++++.+...+..++++
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   96 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVM   96 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEE
Confidence            344457899999999999999999999999987532   223456788999999999 8999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-c
Q 019040          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-R  210 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-~  210 (347)
                      ||+++++|.+++.. ..+++..+..++.|++.+|.|||+.|++||||+|+||++   +.++.++|+|||++....... .
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~  172 (292)
T cd06657          97 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPR  172 (292)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceeccccccc
Confidence            99999999887644 468999999999999999999999999999999999999   667789999999887654322 2


Q ss_pred             ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .....+++.|+|||.+. ..++.++|+||+|+++|+|++|..||...........+...... .......++..+.+++.
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~  251 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-KLKNLHKVSPSLKGFLD  251 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc-ccCCcccCCHHHHHHHH
Confidence            23346788999999876 44889999999999999999999999887766555555433221 11223467899999999


Q ss_pred             HhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          290 QMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       290 ~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      +||+.+|.+||++.++++||||.+...+
T Consensus       252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         252 RLLVRDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             HHHhCCcccCcCHHHHhcChHHhccCCC
Confidence            9999999999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=295.40  Aligned_cols=254  Identities=28%  Similarity=0.458  Sum_probs=206.9

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC--CCCceeEeeeEEeeCCe----
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACEDDNA----  126 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~--~h~~i~~~~~~~~~~~~----  126 (347)
                      |++.+.||.|++|.||+|.++.+++.||+|++..... .......+.+|+.+++.+.  .|++++++++++...+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            6789999999999999999998899999999864432 2222345667888777763  59999999999988776    


Q ss_pred             -EEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          127 -VHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       127 -~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                       .++++||+.+ +|.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||.+.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcce
Confidence             9999999975 8888887643  48999999999999999999999999999999999999   566889999999988


Q ss_pred             ccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-----c----
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF-----K----  273 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----~----  273 (347)
                      ............++..|+|||.+. ..++.++|+||||+++|+|++|..||......+....+.......     +    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            765444444456788899999876 448899999999999999999999998887766665554422110     0    


Q ss_pred             --------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          274 --------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       274 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                                    ....+.++..+.++|.+||+.||++||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                          00012356778899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.4e-40  Score=299.06  Aligned_cols=259  Identities=31%  Similarity=0.511  Sum_probs=210.5

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC-
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-  125 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~-  125 (347)
                      +...++|++.+.||.|++|.||+|.++.+++.||+|.+..... .......+.+|+++++.+ +|||++++++++.+.. 
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcch
Confidence            3456789999999999999999999999999999999865432 222335677899999999 8999999999887654 


Q ss_pred             ---------eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEE
Q 019040          126 ---------AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (347)
Q Consensus       126 ---------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~  195 (347)
                               ..++++||+++ ++...+... ..++...+..++.||+.||.|||+.||+|+||+|+||++   ++++.++
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~k  156 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIK  156 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEE
Confidence                     79999999976 777777654 468999999999999999999999999999999999999   6778899


Q ss_pred             EEeeccccccCCCC--cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 019040          196 AIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID  271 (347)
Q Consensus       196 l~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  271 (347)
                      |+|||.+.......  ......++..|+|||.+.+  .++.++||||||+++++|++|..||...........+......
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999987654332  1222346778999998753  3788999999999999999999999877765555444432211


Q ss_pred             ccC--------------------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          272 FKR--------------------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       272 ~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ...                          ..+..++..+.++|..||+.+|++||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            100                          1123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-40  Score=304.57  Aligned_cols=265  Identities=30%  Similarity=0.497  Sum_probs=214.4

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--  124 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--  124 (347)
                      ..+.++|.+.+.||.|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.+.+|+||+++++++...  
T Consensus         3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            346689999999999999999999999999999999885432 22233456778999999998899999999988653  


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ...++|+||+++ +|..++... .+++..+..++.||+.||.|||+.||+|+||+|+||++   +.++.++|+|||.+..
T Consensus        82 ~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~  156 (337)
T cd07852          82 KDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARS  156 (337)
T ss_pred             ceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhc
Confidence            468999999975 998888765 78888999999999999999999999999999999999   6788899999999876


Q ss_pred             cCCCC------cccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-----
Q 019040          205 FKPGE------RFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-----  271 (347)
Q Consensus       205 ~~~~~------~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----  271 (347)
                      .....      ......++..|+|||.+.  ..++.++||||||+++|+|++|..||...........+......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            54322      223346888999999864  34788999999999999999999999776655443333222110     


Q ss_pred             ----------------------ccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          272 ----------------------FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       272 ----------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                            ......+.++.++.++|.+||+.||++|||+.++++||||++....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence                                  0011123478899999999999999999999999999999888654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=296.78  Aligned_cols=253  Identities=34%  Similarity=0.526  Sum_probs=210.2

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      |.+.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+++++.+ +|++++++++++..++..++|+|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEe
Confidence            67788999999999999999999999999998654322 23456788899999999 89999999999999999999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-c
Q 019040          133 LCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-R  210 (347)
Q Consensus       133 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-~  210 (347)
                      |+++ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||.+....... .
T Consensus        79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccc
Confidence            9976 888888664 578999999999999999999999999999999999999   567889999999987765443 2


Q ss_pred             ccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC--------------
Q 019040          211 FSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR--------------  274 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------  274 (347)
                      .....++..|+|||.+.+  .++.++|+||||+++|++++|..||...+..+....+.........              
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            333567888999998753  5889999999999999999999999877765554444332211100              


Q ss_pred             ------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          275 ------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       275 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                                  ...+.++.++.++|.+||++||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                        1122467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.1e-40  Score=289.86  Aligned_cols=245  Identities=25%  Similarity=0.398  Sum_probs=205.9

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||.||+|.++. +..+|+|.+....    .....+.+|+.+++.+ +|||++++++++...+..+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA----MSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC----ccHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEE
Confidence            578999999999999999998864 4579999875432    2245788899999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCc
Confidence            9999999999998754 458999999999999999999999999999999999999   667789999999987654332


Q ss_pred             cc--cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          210 RF--SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       210 ~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      ..  ....++..|+|||.+. ..++.++||||||+++|++++ |..||...+..+....+..+....   .....+..+.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~  231 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY---RPKLASMTVY  231 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCHHHH
Confidence            22  1223456799999876 458899999999999999999 899998888777777776653221   2235678899


Q ss_pred             HHHHHhccCCCCCCCCHHHHhc
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      +++.+||+.+|++|||+.++++
T Consensus       232 ~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         232 EVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.9e-40  Score=296.29  Aligned_cols=261  Identities=25%  Similarity=0.329  Sum_probs=210.0

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .-.+.|++.+.||.|++|.||+|.+..+++.||+|.+.....  ......+.+|+.++.....|+|++++++++......
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            344789999999999999999999998899999999865432  223345666887777775699999999999999999


Q ss_pred             EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          128 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ++++||+.+ +|...+.. ...+++..+..++.||+.||.|||+ .||+||||+|+||++   ++++.++|+|||.+...
T Consensus        90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRL  165 (296)
T ss_pred             EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhc
Confidence            999999854 77776655 3468999999999999999999997 599999999999999   66788999999998765


Q ss_pred             CCCCcccccccCccccccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccccCCCCCC
Q 019040          206 KPGERFSEIVGSPYYMAPEVLKR-----NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ..........++..|+|||.+.+     .++.++||||||+++|+|++|..||...... +....+....... .+....
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~  244 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS-LPPNEG  244 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC-CCCCCC
Confidence            54433344457888999998753     2788999999999999999999999764332 3333333332111 111224


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ++.++.++|.+||+.||++||++.++++||||+...
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            789999999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=292.08  Aligned_cols=250  Identities=23%  Similarity=0.353  Sum_probs=208.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCC---CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      .++|.+.+.||.|+||+||+|.++.+   ...||+|.+....  .......+.+|+.+++.+ +|+|++++++.+...+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCc
Confidence            36799999999999999999998754   4579999876432  233456788899999999 89999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .++++||+++++|.+++... ..++...+..++.|++.||.|||+.||+|+||+|+||++   ++++.++|+|||++...
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhcc
Confidence            99999999999999998764 468999999999999999999999999999999999999   66788999999999876


Q ss_pred             CCCCc-c--cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          206 KPGER-F--SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       206 ~~~~~-~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      ..... .  ....++..|+|||.+. ..++.++||||||+++|++++ |..||...........+.....   .+....+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~  233 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR---LPPPMDC  233 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCC
Confidence            42211 1  1123456799999876 458999999999999999997 9999988877766666654422   1223467


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +..+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         234 PSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            8999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.3e-40  Score=296.73  Aligned_cols=252  Identities=22%  Similarity=0.293  Sum_probs=207.4

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCC----------------ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCc
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTR----------------ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS  113 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~  113 (347)
                      .++|++++.||.|+||.||+|.+...+                ..||+|.+....  .......+.+|+++++.+ +|+|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~   80 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRL-SDPN   80 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhc-CCCC
Confidence            368999999999999999999887544                457999886543  223456788999999999 9999


Q ss_pred             eeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCc
Q 019040          114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-----------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN  182 (347)
Q Consensus       114 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~N  182 (347)
                      ++++++++..++..++++|++++++|.+++....           .++...++.++.|++.||.|||+.|++|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999997765           68999999999999999999999999999999999


Q ss_pred             EEeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh--CCCCCCCC
Q 019040          183 FLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC--GVPPFWAE  256 (347)
Q Consensus       183 Ili~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~--g~~pf~~~  256 (347)
                      |++   +.++.++|+|||++........   .....+++.|+|||.+. +.++.++||||||+++|+|++  +..||...
T Consensus       161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         161 CLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             eee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            999   5668899999999876533321   12334577899999876 468999999999999999998  77899877


Q ss_pred             CHHHHHHHHHhcc----ccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          257 SEQGVAQAILRGL----IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       257 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .............    ..........++.++.+++..||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            7766665554331    11111222356799999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.1e-40  Score=289.96  Aligned_cols=246  Identities=22%  Similarity=0.340  Sum_probs=206.3

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|.+.+.||.|++|.||.|.+.. +..+|+|.+.....    ..+.+.+|+.+++.+ +||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEE
Confidence            578999999999999999998754 44599998764322    235688999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |||+.+++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCc
Confidence            9999999999998764 358999999999999999999999999999999999999   567789999999987654332


Q ss_pred             cc--cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          210 RF--SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       210 ~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      ..  ....++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+........   ....+..+.
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---PHLASEKVY  231 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC---CCCCCHHHH
Confidence            21  1223456799999886 458899999999999999998 9999988887777666666543322   235689999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcC
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +++..||+.+|++||++.+++++
T Consensus       232 ~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         232 AIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999999865

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=295.39  Aligned_cols=253  Identities=34%  Similarity=0.525  Sum_probs=208.8

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      |.+.+.||.|++|+||+|.+..+++.|++|.+......  .......+|+..+..+.+|++++++++.+..++..++|+|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            67889999999999999999999999999998644221  2223456799999999449999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          133 LCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       133 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      |+ +++|.+.+....  .++...+..++.|++.+|.|||++|++|+||+|+||++   +.++.++|+|||.+........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC
Confidence            99 779999887765  68999999999999999999999999999999999999   6678899999999987655444


Q ss_pred             ccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC--------------
Q 019040          211 FSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR--------------  274 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------  274 (347)
                      .....++..|+|||.+.  ..++.++|+||||+++++|++|..||......+....+.........              
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            45567888999999874  34789999999999999999999999777665544433322111100              


Q ss_pred             ------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          275 ------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       275 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                                  ...+..+.++.++|.+||+.+|++|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                        0012346889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.2e-40  Score=290.49  Aligned_cols=247  Identities=21%  Similarity=0.354  Sum_probs=207.5

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      -.++|++.+.||.|++|.||+|.+. ++..||+|.+....    ...+.+.+|+.+++.+ +|+|++++++.+...+..+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcE
Confidence            3578999999999999999999875 55679999875432    2346788999999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          129 LVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +++||+++++|.+++...  ..++...+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIE  154 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecC
Confidence            999999999999998653  458889999999999999999999999999999999999   667889999999998654


Q ss_pred             CCCcc--cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          207 PGERF--SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       207 ~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .....  ....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+....   ..+....++.
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY---RMPRMENCPD  231 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCH
Confidence            33211  2234566799999875 458889999999999999998 999998887777666665542   2233346889


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ++.+++.+||..+|++||++.++++
T Consensus       232 ~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         232 ELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.7e-40  Score=289.48  Aligned_cols=242  Identities=26%  Similarity=0.372  Sum_probs=200.1

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|+||.||+|.++.+++.||+|.+....  .......+.+|+++++.+ +|+|++++++++...+..++|+||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccC
Confidence            36899999999999999999999999875332  233446788999999999 999999999999999999999999999


Q ss_pred             CchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCccc---
Q 019040          137 GELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS---  212 (347)
Q Consensus       137 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~---  212 (347)
                      ++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||.+..........   
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccccCC
Confidence            99999987653 58999999999999999999999999999999999999   567789999999987644321111   


Q ss_pred             ccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHH
Q 019040          213 EIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ  290 (347)
Q Consensus       213 ~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  290 (347)
                      ....+..|+|||.+. +.++.++||||||+++|++++ |..||...........+....   +......++..+.+++.+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~  231 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV---RLPCPELCPDAVYRLMER  231 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC---CCCCcccCCHHHHHHHHH
Confidence            112245699999875 458899999999999999997 899998777665555554432   222234678999999999


Q ss_pred             hccCCCCCCCCHHHHhc
Q 019040          291 MLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       291 ~l~~dp~~Rps~~~ll~  307 (347)
                      ||+.+|++|||+.++++
T Consensus       232 ~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         232 CWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999964

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.7e-40  Score=300.50  Aligned_cols=249  Identities=21%  Similarity=0.302  Sum_probs=203.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCce----eEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTREL----LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ..+|++.+.||+|+||.||+|.+..++..    ||+|++....  .......+.+|+.+++.+ +|+||+++++++... 
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-
Confidence            45799999999999999999998766654    8999875322  233456788899999999 999999999998765 


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..+++++|+++++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~  158 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKL  158 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEcccccccc
Confidence            467899999999999999875 358899999999999999999999999999999999999   6677899999999987


Q ss_pred             cCCCCcc---cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          205 FKPGERF---SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       205 ~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      .......   ....++..|+|||.+. ..++.++||||||+++|++++ |..||.+.........+... ...+  ..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~  235 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLP--QPPI  235 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC-CCCC--CCCC
Confidence            6433321   1123456799999876 458999999999999999987 99999877765544433332 2222  2346


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ++.++.+++..||..+|++||++.+++.+
T Consensus       236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         236 CTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            78899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-40  Score=307.63  Aligned_cols=254  Identities=20%  Similarity=0.289  Sum_probs=203.3

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCC-----CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDT-----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      .-.++|.+++.||.|+||.||+|.+...     +..||+|++....  .....+.+.+|+.+++.+..||||+++++++.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            3357899999999999999999987533     3469999986432  23334678999999999955999999999999


Q ss_pred             eCCeEEEEEEecCCCchHHHHHhc--------------------------------------------------------
Q 019040          123 DDNAVHLVMELCEGGELFDRIVAR--------------------------------------------------------  146 (347)
Q Consensus       123 ~~~~~~lv~e~~~~~~L~~~l~~~--------------------------------------------------------  146 (347)
                      ..+..|+||||+++++|.+++..+                                                        
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            999999999999999999888542                                                        


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEee
Q 019040          147 ----------------------------------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFA  186 (347)
Q Consensus       147 ----------------------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~  186 (347)
                                                              ..++...+..++.||+.||.|||+.||+|+||||+||++ 
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill-  270 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL-  270 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE-
Confidence                                                    136677788999999999999999999999999999999 


Q ss_pred             cCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 019040          187 NKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGV  261 (347)
Q Consensus       187 ~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  261 (347)
                        +.++.++|+|||++........   .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||........
T Consensus       271 --~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         271 --AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             --eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence              5677899999999876533221   12234677899999875 458999999999999999997 9999977654433


Q ss_pred             HHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .........  .......++.++.+++.+||+.||++||++.++.+.
T Consensus       349 ~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  393 (400)
T cd05105         349 FYNKIKSGY--RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI  393 (400)
T ss_pred             HHHHHhcCC--CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence            333222222  222234678999999999999999999999998663

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-40  Score=304.19  Aligned_cols=255  Identities=23%  Similarity=0.333  Sum_probs=202.0

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECC-----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      ....++|++.+.||.|+||.||+|.+..     +++.||+|.+....  .......+.+|+.++..+.+|+||+++++++
T Consensus         3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            3445789999999999999999997543     45789999886432  2233466788999999997899999999987


Q ss_pred             ee-CCeEEEEEEecCCCchHHHHHhc------------------------------------------------------
Q 019040          122 ED-DNAVHLVMELCEGGELFDRIVAR------------------------------------------------------  146 (347)
Q Consensus       122 ~~-~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------------------  146 (347)
                      .. +...++++||+++++|.+++...                                                      
T Consensus        81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            64 46788999999999999988542                                                      


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc---cccccc
Q 019040          147 -------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVG  216 (347)
Q Consensus       147 -------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~  216 (347)
                             ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++........   .....+
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~  237 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARL  237 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcchhhccCCCC
Confidence                   257888999999999999999999999999999999999   5567899999999986533221   122345


Q ss_pred             Ccccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccC
Q 019040          217 SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (347)
Q Consensus       217 ~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (347)
                      +..|+|||++. ..++.++||||||+++++|++ |..||.+....+............  ......+.++.+++.+||+.
T Consensus       238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~cl~~  315 (337)
T cd05054         238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM--RAPEYATPEIYSIMLDCWHN  315 (337)
T ss_pred             CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC--CCCccCCHHHHHHHHHHccC
Confidence            67899999875 559999999999999999998 999997755433332222221111  11235688999999999999


Q ss_pred             CCCCCCCHHHHhcC
Q 019040          295 DPKLRLTAKQVLEH  308 (347)
Q Consensus       295 dp~~Rps~~~ll~h  308 (347)
                      +|++||++.++++|
T Consensus       316 ~p~~RPs~~ell~~  329 (337)
T cd05054         316 NPEDRPTFSELVEI  329 (337)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=309.75  Aligned_cols=258  Identities=22%  Similarity=0.308  Sum_probs=219.2

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCc---e-eEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE---L-LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~---~-vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      .+++.-.++-.+.+.||+|+||.||+|..+..+.   . ||+|....+.......+..+.+|.++++++ +||||+++||
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yG  228 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYG  228 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEE
Confidence            4455566777888999999999999998875432   3 899988765555677788999999999999 9999999999


Q ss_pred             EEeeCCeEEEEEEecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          120 ACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       120 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      +......+++|||+|+||+|.++|++... ++......++.+.+.||+|||+++++||||-..|+|+   ..+..+||+|
T Consensus       229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISD  305 (474)
T KOG0194|consen  229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISD  305 (474)
T ss_pred             EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCc
Confidence            99999999999999999999999999864 9999999999999999999999999999999999999   5666789999


Q ss_pred             eccccccCCCCccc-ccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCC
Q 019040          199 FGLSIFFKPGERFS-EIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRD  275 (347)
Q Consensus       199 fg~a~~~~~~~~~~-~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  275 (347)
                      ||+++......... ...-...|+|||.+. +.++.++||||||+++||+++ |..||.+....+....+.......+.+
T Consensus       306 FGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~  385 (474)
T KOG0194|consen  306 FGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP  385 (474)
T ss_pred             cccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC
Confidence            99988654222111 113457899999987 459999999999999999999 788999999999998885544333332


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                        ...|.++..++.+||..+|++||++.++.+
T Consensus       386 --~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  386 --SKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             --CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence              377899999999999999999999998843

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.6e-40  Score=293.77  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=205.6

Q ss_pred             cceeeeeeecccCCeEEEEEEEC----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDR----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      +.|++.+.||+|+||+||+|.+.    .++..|++|.+....  .......+.+|+.+++.+ +|+|++++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCc
Confidence            56899999999999999999863    455789999886432  233456788999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC
Q 019040          127 VHLVMELCEGGELFDRIVAR-----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~  189 (347)
                      .+++|||+++++|.+++...                 ..++...+..++.||+.||.|||++|++|+||||+||++   +
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence            99999999999999998532                 236788899999999999999999999999999999999   5


Q ss_pred             CCCCEEEEeeccccccCCCC---cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 019040          190 ENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQA  264 (347)
Q Consensus       190 ~~~~~~l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  264 (347)
                      .++.++|+|||++.......   ......++..|+|||.+. +.++.++||||||+++|+|++ |..||.+.........
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            67789999999997653322   122334567799999875 458999999999999999998 9999988776665555


Q ss_pred             HHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +.....   ......++..+.+++..||+.||.+||++.+++++
T Consensus       239 ~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQL---LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            544322   22334688999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-40  Score=292.47  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=208.0

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCC-----CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDT-----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      ...++|.+.+.||.|+||.||+|.++..     +..||+|.+....  .......+.+|+.+++.+ +|+|++++++++.
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~   79 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVS   79 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEc
Confidence            3467899999999999999999998743     3789999975432  223345688899999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC
Q 019040          123 DDNAVHLVMELCEGGELFDRIVARG----------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       123 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                      .....++++||+++++|.+++....          .+++..+..++.||+.||.|||+.|++|+||+|+||++   +.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCC
Confidence            9999999999999999999986532          35778899999999999999999999999999999999   6678


Q ss_pred             CEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 019040          193 PLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILR  267 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~  267 (347)
                      .++|+|||++........   .....++..|+|||.+. +.++.++||||||+++|++++ |..||...+.......+..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence            899999999876543321   12234677899999875 458999999999999999998 9999988887776666653


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ...   ......++.++.++|.+||+.+|++|||+.++++.
T Consensus       237 ~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         237 GGH---LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             CCC---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            321   12223568999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.8e-40  Score=300.29  Aligned_cols=261  Identities=30%  Similarity=0.440  Sum_probs=209.3

Q ss_pred             ceeeeeeecccCCeEEEEEEECCC--CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee----CC
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDT--RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----DN  125 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~----~~  125 (347)
                      +|.+.+.||.|+||.||+|.+..+  +..||+|.+.... ........+.+|+.+++.+.+|+||+++++....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            588999999999999999999888  8899999986432 2223345678899999999779999999986532    25


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ..+++++++. ++|.+.+.....+++..+..++.||+.||.|||+.|++|+||||+||++   +.++.++|+|||.+...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGF  155 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceec
Confidence            6788899985 5899999887789999999999999999999999999999999999999   66788999999998765


Q ss_pred             CCCC-----cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-------
Q 019040          206 KPGE-----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-------  271 (347)
Q Consensus       206 ~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------  271 (347)
                      ....     ......+++.|+|||.+.+  .++.++||||||++++++++|..||...........+......       
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4321     1233468899999997653  4889999999999999999999999876654444333221110       


Q ss_pred             ----------------cc----CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          272 ----------------FK----RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       272 ----------------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                      .+    ....+..+..+.+++.+||+.||.+|||+.++++||||+....+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence                            00    01123467899999999999999999999999999999866543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.5e-40  Score=298.38  Aligned_cols=257  Identities=28%  Similarity=0.444  Sum_probs=214.3

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ....|...+.||.|++|.||+|+++.++..+++|.+.............+.+|+++++.+ +|++++++++++......+
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeE
Confidence            445688899999999999999999999999999998654333444456788899999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          129 LVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      +|+||+.+ ++.+.+.. ...++...+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++.....
T Consensus        92 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          92 LVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecC
Confidence            99999964 77777754 3458999999999999999999999999999999999999   5678899999999876543


Q ss_pred             CCcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          208 GERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      .   ....+++.|+|||.+.    +.++.++||||||+++|+|++|..||...+.......+......  .......+..
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  242 (308)
T cd06634         168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHWSEY  242 (308)
T ss_pred             c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC--CcCcccccHH
Confidence            2   2346788999999863    34788999999999999999999999877665544444433221  1122367888


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +.++|.+||+.+|++||++.++++|||+....
T Consensus       243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            99999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.8e-40  Score=292.05  Aligned_cols=248  Identities=23%  Similarity=0.368  Sum_probs=209.6

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ...+|.+.+.||.|+||.||+|.+.. +..+++|++....   ......+.+|+.+++.+ +|+|++++++++...+..+
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeE
Confidence            34679999999999999999999987 8889999986543   22345688899999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          129 LVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +++||+++++|.+++...  ..++...+..++.||+.||.|||+.|++|+||+|+||++   ++++.++|+|||.+....
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcC
Confidence            999999999999999764  358999999999999999999999999999999999999   667789999999987654


Q ss_pred             CCCc-ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          207 PGER-FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       207 ~~~~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      .... .....++..|+|||.+. ..++.++||||||+++++|++ |..||......+....+....   ..+....++..
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY---RMPCPAKCPQE  232 (261)
T ss_pred             CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC---cCCCCCCCCHH
Confidence            3221 11223566799999875 458899999999999999998 899998888777776666432   22223478899


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhc
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      +.++|.+||+.||++|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         233 IYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-40  Score=302.91  Aligned_cols=259  Identities=29%  Similarity=0.487  Sum_probs=209.4

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~----  124 (347)
                      +.++|.+.+.||.|++|.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.+ +|+||+++++++...    
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~   90 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGD   90 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhc-CCCCccchhheecccccCC
Confidence            45789999999999999999999999999999999865322 222345678899999999 999999999988654    


Q ss_pred             --CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 --NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                        ..+++++||+.. +|..+.  ...++...+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++
T Consensus        91 ~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~  164 (342)
T cd07879          91 EFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLA  164 (342)
T ss_pred             CCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCC
Confidence              346899999954 776654  2368999999999999999999999999999999999999   66788999999998


Q ss_pred             cccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----------
Q 019040          203 IFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI----------  270 (347)
Q Consensus       203 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------  270 (347)
                      .....  ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+.......+.....          
T Consensus       165 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         165 RHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             cCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            76432  2234567889999998754  488899999999999999999999988775554444332110          


Q ss_pred             -------------cccCC----CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          271 -------------DFKRD----PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       271 -------------~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                   ..+..    .++..+.++.++|.+||+.||++||++.+++.||||+.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                         00000    123567889999999999999999999999999999988754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.6e-41  Score=303.76  Aligned_cols=255  Identities=18%  Similarity=0.266  Sum_probs=202.3

Q ss_pred             eeeccc--CCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEec
Q 019040           57 RELGRG--EFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (347)
Q Consensus        57 ~~lg~G--~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (347)
                      ..||.|  +||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.+ +|+||+++++++...+..++++||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecc
Confidence            456666  9999999999999999999998654322 23457889999999999 8999999999999999999999999


Q ss_pred             CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcc-
Q 019040          135 EGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF-  211 (347)
Q Consensus       135 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~-  211 (347)
                      .+++|.+++...  ..+++..+..++.||+.||.|||++|++||||||+||++   +.++.++++||+.+......... 
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccc
Confidence            999999988764  348999999999999999999999999999999999999   56678999999855332111100 


Q ss_pred             -------cccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc---------
Q 019040          212 -------SEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF---------  272 (347)
Q Consensus       212 -------~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------  272 (347)
                             ....++..|+|||++.+   .++.++||||||+++++|++|..||...................         
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                   11124567999998754   37889999999999999999999998776554443332221100         


Q ss_pred             ----------------------------------cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          273 ----------------------------------KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       273 ----------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                                                        ..+....++..+.+||.+||+.||++|||+.++++||||+...+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                              00011235678899999999999999999999999999988764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.7e-40  Score=298.25  Aligned_cols=257  Identities=25%  Similarity=0.392  Sum_probs=205.4

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~----  124 (347)
                      ..++|++.+.||.|++|.||+|.++.+++.+++|.+........ ....+.+|+++++.+ +|+|++++++.+...    
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKL-KHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhc-CCCCccchhhheecccccc
Confidence            35899999999999999999999999999999999865432221 224567899999999 999999999887543    


Q ss_pred             ----CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          125 ----NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       125 ----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                          ..+++++||+.+ +|...+... ..+++..+..++.||+.||.|||+.||+|+||+|+||++   ++++.++|+||
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~df  159 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADF  159 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcC
Confidence                357999999965 677766543 469999999999999999999999999999999999999   67788999999


Q ss_pred             ccccccCCCCc------------ccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 019040          200 GLSIFFKPGER------------FSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI  265 (347)
Q Consensus       200 g~a~~~~~~~~------------~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  265 (347)
                      |++........            .....+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+.......+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99876433221            122356788999998653  4788999999999999999999999887776555554


Q ss_pred             HhccccccC--------------------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          266 LRGLIDFKR--------------------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       266 ~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      .........                          ..+....+.+.++|.+||+.||.+|||+.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            332211110                          0012345788899999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-40  Score=288.32  Aligned_cols=247  Identities=22%  Similarity=0.305  Sum_probs=206.5

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++.+.||.|++|.||+|.+. +++.||+|.+.....    ....+.+|+.+++.+ +|+|++++++++...+..+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHC-CCCCccceeEEEecCCCee
Confidence            3467999999999999999999975 456799999864322    245688899999999 8999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          129 LVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +++||+++++|.+++....  .++...+..++.|++.||.+||+.|++|+||||+||++   +.++.++|+|||++....
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIK  154 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEcc
Confidence            9999999999999997654  68999999999999999999999999999999999999   667789999999988754


Q ss_pred             CCCcc--cccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          207 PGERF--SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       207 ~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .....  .....+..|+|||.+.+ .++.++||||||+++++|++ |..||.+.+.......+.....   ......++.
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (261)
T cd05068         155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR---MPCPPGCPK  231 (261)
T ss_pred             CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCH
Confidence            32211  11122457999998764 58899999999999999999 9999988887776666654422   122246789


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         232 ELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHHH
Confidence            9999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=299.01  Aligned_cols=275  Identities=28%  Similarity=0.476  Sum_probs=244.7

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      ..+|..+..||.|+||+|.+|..+.+.+.||||+++++-+-...+.+.-..|-++|....+.|.++.++..++.-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            46789999999999999999999999999999999998877777777778899999988889999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC-CC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~-~~  208 (347)
                      ||||+.||+|.=.++.-+++.++.+..++..|+.||-+||++||++||+|.+||++   +.+|++||.|||++.... .+
T Consensus       428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccCC
Confidence            99999999999999988999999999999999999999999999999999999999   788999999999998643 34


Q ss_pred             CcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          209 ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      ....+.+|||.|+|||++. ..|+.+.|+||+|++||||+.|.+||.+.+..+..+.|......++.    .++.+..++
T Consensus       505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~i  580 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVAI  580 (683)
T ss_pred             cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHHH
Confidence            4556789999999999876 56999999999999999999999999999999999999998877765    679999999


Q ss_pred             HHHhccCCCCCCCCH-----HHHhcCcccccCc--CCCCCCChHHHHHHhh
Q 019040          288 VRQMLEPDPKLRLTA-----KQVLEHPWLQNAK--KAPNVPLGDVVRSRLK  331 (347)
Q Consensus       288 i~~~l~~dp~~Rps~-----~~ll~h~~~~~~~--~~~~~~~~~~~~~~~~  331 (347)
                      .+.+|.+.|.+|...     .++-+||||+...  ..++..++-|..+++|
T Consensus       581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k  631 (683)
T KOG0696|consen  581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIK  631 (683)
T ss_pred             HHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccc
Confidence            999999999999864     5899999998764  2344445555555553

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6e-40  Score=298.37  Aligned_cols=263  Identities=32%  Similarity=0.485  Sum_probs=212.9

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee-CCeE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-DNAV  127 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~-~~~~  127 (347)
                      +.++|++.+.||.|+||.||+|.++.+++.||+|.+.+... .......+.+|+.+++.+ +|||++++.+++.. .+..
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLEDI   85 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCcE
Confidence            56889999999999999999999999999999998865422 223446688899999999 99999999998865 5678


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      ++++||+ +++|.+++.. ..++...+..++.||+.||.|||+.|++|+||+|+||++   +.++.++|+|||.+.....
T Consensus        86 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP  160 (328)
T ss_pred             EEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCC
Confidence            9999999 5688877754 468888899999999999999999999999999999999   6678899999999875432


Q ss_pred             CCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc--------------
Q 019040          208 GERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID--------------  271 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------  271 (347)
                        ......+++.|+|||.+.+  .++.++||||||++++++++|..||...........+.+....              
T Consensus       161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd07856         161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT  238 (328)
T ss_pred             --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence              2233467888999998653  4889999999999999999999999877654332222211100              


Q ss_pred             ------c----c---CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCC
Q 019040          272 ------F----K---RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV  320 (347)
Q Consensus       272 ------~----~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  320 (347)
                            .    +   ....+.++..+.++|.+||+.+|++||++.+++.||||+..+.+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~  300 (328)
T cd07856         239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE  300 (328)
T ss_pred             HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence                  0    0   01123578899999999999999999999999999999988766444

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=287.27  Aligned_cols=262  Identities=27%  Similarity=0.468  Sum_probs=231.3

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      +..-.+.|++++.||.|+|++|.+++.+.+.+.||+|+++++-+...++++-++.|-.+..+.++||+++-+...++.+.
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            33446789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .+++|.||++||+|.-.++++.+++++.++.+...|+.||.|||++||++||+|.+|||+   +..|++||+|+|++...
T Consensus       325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~  401 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcC
Confidence            999999999999999999999999999999999999999999999999999999999999   78899999999999754


Q ss_pred             -CCCCcccccccCcccccccccccc-CCCchhHHHHHHHHHHHHhCCCCCCC-------CCHH-HHHHHHHhccccccCC
Q 019040          206 -KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWA-------ESEQ-GVAQAILRGLIDFKRD  275 (347)
Q Consensus       206 -~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~-------~~~~-~~~~~~~~~~~~~~~~  275 (347)
                       .++...++.+|||.|.|||++++. |+.+.|+|+||++|+||+.|+.||..       .+.+ ...+-++......++ 
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr-  480 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR-  480 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc-
Confidence             455667888999999999999865 99999999999999999999999932       2223 344444444444433 


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCC------HHHHhcCcccccC
Q 019040          276 PWPNVSESAKSLVRQMLEPDPKLRLT------AKQVLEHPWLQNA  314 (347)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~h~~~~~~  314 (347)
                         .++-....+++..|.+||.+|..      ..++.+|+||+..
T Consensus       481 ---slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i  522 (593)
T KOG0695|consen  481 ---SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI  522 (593)
T ss_pred             ---eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence               45667778999999999999984      6799999999743

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.7e-40  Score=295.25  Aligned_cols=256  Identities=32%  Similarity=0.537  Sum_probs=209.5

Q ss_pred             ceeeeeeecccCCeEEEEEEEC---CCCceeEEeEecccccc-chhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      +|++.+.||.|++|.||+|.+.   .++..||+|++.+.... .......+.+|+.++..+.+|++++++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999864   46788999998754322 2233456888999999997799999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      ++|+||+++++|.+++.....+++..+..++.|++.+|.|||+.|++|+||+|.||++   +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECcccccccc
Confidence            9999999999999999877789999999999999999999999999999999999999   5677899999999876543


Q ss_pred             CCc--ccccccCcccccccccccc---CCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccccccCCCCC
Q 019040          208 GER--FSEIVGSPYYMAPEVLKRN---YGPEIDIWSAGVILYILLCGVPPFWAESEQ----GVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       208 ~~~--~~~~~~~~~y~aPE~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~  278 (347)
                      ...  .....++..|+|||.+.+.   .+.++||||||+++++|++|..||......    ...+.+....    .....
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~  233 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK----PPFPK  233 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC----CCCCc
Confidence            322  1234578899999987532   678999999999999999999999644322    2222222222    22234


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCC---HHHHhcCcccccC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPWLQNA  314 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~  314 (347)
                      .++..+.++|.+||+.||++|||   +.++|+||||+..
T Consensus       234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            57899999999999999999998   5677999999876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=310.34  Aligned_cols=277  Identities=26%  Similarity=0.470  Sum_probs=248.2

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .+++++..||.|+||.|=++..+.....+|+|++++..+-.....+.+..|-+++... +.++|+++|.+|.++.++|++
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchhhhhh
Confidence            5677888999999999999988877777999999988877777778899999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      ||-|-||.|...+...+.|...+.+.++..+++|++|||++|||+||+||+|.++   +.+|=+||.|||+|.....+..
T Consensus       499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   7888999999999999999999


Q ss_pred             ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      ..+.+|||.|.|||++. ...+.+.|.||||+++|||++|.+||.+.++...+..|++++..+..+  ..++....+||+
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik  653 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIK  653 (732)
T ss_pred             eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHH
Confidence            99999999999999865 569999999999999999999999999999999999999998655433  378899999999


Q ss_pred             HhccCCCCCCCC-----HHHHhcCcccccCc--CCCCCCChHHHHHHhhhh
Q 019040          290 QMLEPDPKLRLT-----AKQVLEHPWLQNAK--KAPNVPLGDVVRSRLKQF  333 (347)
Q Consensus       290 ~~l~~dp~~Rps-----~~~ll~h~~~~~~~--~~~~~~~~~~~~~~~~~~  333 (347)
                      +++..+|.+|..     ..+|.+|.||..+.  ..-...|..|..+.++.|
T Consensus       654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~p  704 (732)
T KOG0614|consen  654 KLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANP  704 (732)
T ss_pred             HHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCc
Confidence            999999999996     88999999998764  222334455555555554

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.8e-40  Score=294.33  Aligned_cols=256  Identities=21%  Similarity=0.316  Sum_probs=207.9

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      +....++|.+.+.||.|+||.||+|.+.     .++..||+|.+....  .....+.+.+|+.+++++.+|+||+++++.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            4455678999999999999999999863     345679999876442  223346788999999999779999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      +...+..++++||+++++|.+++.....  ++..++..++.|++.||.|||+.|++|+||||+||++   +.++.++|+|
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~d  184 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICD  184 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECC
Confidence            9999999999999999999999976432  8999999999999999999999999999999999999   5677899999


Q ss_pred             eccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccc
Q 019040          199 FGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK  273 (347)
Q Consensus       199 fg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  273 (347)
                      ||.+........   .....++..|+|||.+. +.++.++||||||+++|++++ |..||.................  .
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~--~  262 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY--R  262 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC--c
Confidence            999876543321   11234567899999876 458999999999999999998 9999987766544433333221  1


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .......+..+.+++.+||..+|++|||+.++++.
T Consensus       263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~  297 (302)
T cd05055         263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL  297 (302)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            12223568999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=294.24  Aligned_cols=253  Identities=30%  Similarity=0.520  Sum_probs=209.8

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      |++.+.||.|++|.||+|++..+++.|++|++.... ........+.+|+.+++.+ +|++++++++++...+..++++|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEec
Confidence            567889999999999999999999999999987653 2233345677899999999 89999999999999999999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-c
Q 019040          133 LCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-R  210 (347)
Q Consensus       133 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-~  210 (347)
                      |+++ +|.+++... ..+++..+..++.|++.||.+||+.||+||||+|+||++   ++++.++|+|||.+....... .
T Consensus        79 ~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          79 YCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             CcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccc
Confidence            9974 899999876 579999999999999999999999999999999999999   667889999999987654332 2


Q ss_pred             ccccccCcccccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc---------------
Q 019040          211 FSEIVGSPYYMAPEVLK-R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK---------------  273 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  273 (347)
                      ......+..|+|||.+. . .++.++||||||++++++++|..||...........+........               
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            23345677899999874 3 588899999999999999999999988776555444432211000               


Q ss_pred             ----------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          274 ----------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       274 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                                ...++..+..+.++|..||..+|++||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                      01123457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.8e-40  Score=322.52  Aligned_cols=149  Identities=30%  Similarity=0.496  Sum_probs=137.4

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|.+++.||.|+||.||+|.+..+++.||+|++.............+.+|+.++..+ +|++|+++++++...+..|+|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEE
Confidence            6899999999999999999999999999999999765555555567789999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      |||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence            9999999999999887789999999999999999999999999999999999999   567889999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.4e-40  Score=295.62  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=206.9

Q ss_pred             cccceeeeeeecccCCeEEEEEEECC-------CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRD-------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      ..++|.+.+.||+|+||.||+|.+..       +...+|+|.+..+.  .......+.+|+.+++.+.+|++++++++++
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34789999999999999999998753       23569999986542  2334567888999999997899999999999


Q ss_pred             eeCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEe
Q 019040          122 EDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF  185 (347)
Q Consensus       122 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli  185 (347)
                      ...+..++|+||+++++|.+++....                .++...+..++.|++.||.|||+.|++|+||||+||++
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  173 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  173 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence            99999999999999999999997642                37888999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEEeeccccccCCCCc---ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 019040          186 ANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQG  260 (347)
Q Consensus       186 ~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~  260 (347)
                         +.++.++|+|||.+........   .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||......+
T Consensus       174 ---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         174 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             ---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence               5677899999999876543211   111234567999998764 48899999999999999998 889998877766


Q ss_pred             HHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          261 VAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ....+....   .......++.++.+++.+||..+|++|||+.+++++
T Consensus       251 ~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         251 LFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHcCC---CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            665554432   222334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.7e-40  Score=294.45  Aligned_cols=249  Identities=20%  Similarity=0.310  Sum_probs=206.9

Q ss_pred             cceeeeeeecccCCeEEEEEEECCC-----CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDT-----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .+|++.+.||.|+||.||+|.+..+     ++.||+|++....  .......+.+|+.++..+ +|+||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~   81 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCC
Confidence            4688999999999999999987543     5789999986432  222346688899999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC
Q 019040          126 AVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~  189 (347)
                      ..++++||+++++|.+++...                ..++...+..++.|++.||.|||++||+||||||+||++   +
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---F  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---c
Confidence            999999999999999998532                247888899999999999999999999999999999999   5


Q ss_pred             CCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 019040          190 ENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQA  264 (347)
Q Consensus       190 ~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  264 (347)
                      +++.++|+|||++........   .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+....+....
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            677899999999876533221   12334577899999875 558999999999999999998 8889988887777777


Q ss_pred             HHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +.......   ....++..+.+++..||+.+|.+||++.+++..
T Consensus       239 i~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            66654322   224789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-41  Score=262.74  Aligned_cols=258  Identities=29%  Similarity=0.535  Sum_probs=224.2

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .+|...+.||+|.+|+||+|+++.+++.||+|.+..+.... .......+||-+++.+ +|.||++++++...++.+.+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkel-khknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEe
Confidence            35777889999999999999999999999999997654322 2345678899999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      +|||+. +|..++... +.+..+.++.++.|++.||.++|++++.|||+||.|.+|   +.+|.+|+.|||+++..+-+-
T Consensus        80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCce
Confidence            999955 999998875 458999999999999999999999999999999999999   788999999999998765443


Q ss_pred             -cccccccCcccccccccccc--CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC-------
Q 019040          210 -RFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP-------  278 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------  278 (347)
                       -.+..+-|.+|++|.++.+.  |+.+.|+||.||++.|+.. |++.|.+.+..+.+..+.+.........|+       
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence             34556789999999987654  9999999999999999887 889999999999999998877666555553       


Q ss_pred             ------------------CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          279 ------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       279 ------------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                                        .++..-+++++.+|.-+|.+|+++..+++||||.+.
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                              244566799999999999999999999999999875

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.3e-40  Score=293.40  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=207.8

Q ss_pred             cceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .+|.+.+.||.|+||.||+|.+.     .++..+++|.+...   .......+.+|+.+++.+ +|+|++++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNL-QHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCC
Confidence            56899999999999999999864     34566888887533   223346688999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC
Q 019040          126 AVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~  189 (347)
                      ..++||||+++++|.+++....                .++...++.++.||+.||.|||++||+||||||+||++   +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---G  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---c
Confidence            9999999999999999997542                37889999999999999999999999999999999999   6


Q ss_pred             CCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 019040          190 ENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQA  264 (347)
Q Consensus       190 ~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  264 (347)
                      .++.++|+|||++........   .....++..|+|||.+. ..++.++||||||+++|+|++ |..||...........
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            678899999999876543221   12334677899999876 458899999999999999998 9999988887776666


Q ss_pred             HHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +..+....   .....+..+.+++.+||+.+|++|||+.++++.  +++.
T Consensus       238 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~--l~~~  282 (291)
T cd05094         238 ITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI--LHAL  282 (291)
T ss_pred             HhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHHH--HHHH
Confidence            65543322   223568899999999999999999999999654  4444

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.6e-40  Score=288.12  Aligned_cols=246  Identities=23%  Similarity=0.330  Sum_probs=202.8

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++.+.||.|++|.||+|.+..++ .||+|.+.....    ....+.+|+++++.+ +|++++++++.+.. +..+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~   76 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIY   76 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhC-CCCCcceEEEEECC-CCcE
Confidence            4578999999999999999999987664 599999864322    235688899999999 89999999988754 5678


Q ss_pred             EEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          129 LVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +++||+++++|.+++...  ..++...+..++.|++.||.|||+.|++|+||+|+||++   ++++.++|+|||.+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIE  153 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeecc
Confidence            999999999999999763  347899999999999999999999999999999999999   567789999999997654


Q ss_pred             CCCcc--cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          207 PGERF--SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       207 ~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .....  ....++..|+|||... ..++.++||||||+++|++++ |..||...........+....   .......++.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~  230 (262)
T cd05071         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPECPE  230 (262)
T ss_pred             ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC---CCCCccccCH
Confidence            33221  1234566799999875 458999999999999999999 889998887776666554432   1122346889


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .+.+++.+||+.+|++||++.++++
T Consensus       231 ~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         231 SLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHH
Confidence            9999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-40  Score=300.77  Aligned_cols=260  Identities=27%  Similarity=0.455  Sum_probs=209.4

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~----  124 (347)
                      +.++|.+.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+ +|+||+++++++...    
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~   92 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLE   92 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeeccccc
Confidence            4588999999999999999999999999999999986532 1222345678899999999 999999999987643    


Q ss_pred             --CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 --NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                        +..+++++++ +++|.+.+.. ..+++..+..++.|++.||.|||+.||+|+||||+||++   +.++.++|+|||++
T Consensus        93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~  167 (345)
T cd07877          93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA  167 (345)
T ss_pred             ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEeccccc
Confidence              3477888887 7799877754 468999999999999999999999999999999999999   66788999999998


Q ss_pred             cccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----------
Q 019040          203 IFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI----------  270 (347)
Q Consensus       203 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------  270 (347)
                      .....  ......++..|+|||.+.+  .++.++||||||+++++|++|..||...........+.....          
T Consensus       168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T cd07877         168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  245 (345)
T ss_pred             ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            76432  2334567889999998654  478899999999999999999999977665544433322111          


Q ss_pred             -------------cccC----CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          271 -------------DFKR----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       271 -------------~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                   ..+.    ..+...+..+.++|.+||+.||.+||++.++++||||++...+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence                         0000    0112457889999999999999999999999999999976544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.4e-40  Score=295.28  Aligned_cols=252  Identities=26%  Similarity=0.380  Sum_probs=208.9

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCC-----ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTR-----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      ..++|++.+.||.|+||.||+|.+...+     ..+|+|.+....  .......+.+|+.+++.+.+|+|++++++++..
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            3478999999999999999999886443     679999886432  223446688999999999789999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeec
Q 019040          124 DNAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN  187 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~  187 (347)
                      ++..++++||+++++|..++...                ..++...+..++.|++.||.|||+.||+|+||||+||++  
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~--  165 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--  165 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE--
Confidence            99999999999999999998642                357889999999999999999999999999999999999  


Q ss_pred             CCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 019040          188 KKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVA  262 (347)
Q Consensus       188 ~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~  262 (347)
                       +.++.++|+|||++........   .....++..|+|||.+. ..++.++||||||+++|++++ |..||.........
T Consensus       166 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         166 -TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             -cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence             6678899999999986543321   11123456799999865 458999999999999999997 99999888877766


Q ss_pred             HHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ..+.....   ......++..+.+++.+||..||++|||+.+++++
T Consensus       245 ~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         245 KLLKEGYR---MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHcCCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            66655432   12233678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.9e-40  Score=287.45  Aligned_cols=242  Identities=24%  Similarity=0.337  Sum_probs=200.0

Q ss_pred             eecccCCeEEEEEEE--CCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecC
Q 019040           58 ELGRGEFGVTYLCID--RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (347)
Q Consensus        58 ~lg~G~~g~V~~a~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (347)
                      .||.|+||.||+|.+  +.++..+|+|++.... ......+.+.+|+.+++.+ +|+|++++++++.. +..++|+||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQL-DNPYIVRMIGICEA-ESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCcEEEEecCC
Confidence            589999999999965  4567889999986432 2233456788999999999 99999999998754 56789999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcc----
Q 019040          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF----  211 (347)
Q Consensus       136 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~----  211 (347)
                      +++|.+++.....+++..+..++.|++.||.+||++|++|+||||.||++   +.++.++|+|||.+.........    
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeec
Confidence            99999999887789999999999999999999999999999999999999   56778999999998765433221    


Q ss_pred             cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          212 SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       212 ~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      ....++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+..+..   .+....++.++.++|.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l~~li~  232 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER---MECPQRCPPEMYDLMK  232 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHHHHHHH
Confidence            1123357899999876 458889999999999999998 9999988877776666655432   2223468999999999


Q ss_pred             HhccCCCCCCCCHHHHhcC
Q 019040          290 QMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       290 ~~l~~dp~~Rps~~~ll~h  308 (347)
                      .||+.||++||++.++.+.
T Consensus       233 ~~~~~~p~~Rp~~~~i~~~  251 (257)
T cd05116         233 LCWTYGVDERPGFAVVELR  251 (257)
T ss_pred             HHhccCchhCcCHHHHHHH
Confidence            9999999999999998643

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=286.68  Aligned_cols=241  Identities=22%  Similarity=0.328  Sum_probs=200.2

Q ss_pred             eeecccCCeEEEEEEECCCC---ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEe
Q 019040           57 RELGRGEFGVTYLCIDRDTR---ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL  133 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  133 (347)
                      +.||+|+||.||+|++..++   ..+|+|.+..+...  ...+.+.+|+++++.+ .|+|++++++++. .+..++++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQL-DHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-CCceEEEEEe
Confidence            46899999999999887655   78999998755433  3456788999999999 9999999999876 4568999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCccc-
Q 019040          134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS-  212 (347)
Q Consensus       134 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~-  212 (347)
                      +++++|.+++.....+++..+..++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||.+.......... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcccc
Confidence            9999999999887789999999999999999999999999999999999999   667889999999987654332211 


Q ss_pred             ---ccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          213 ---EIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       213 ---~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                         ...++..|+|||.+. ..++.++||||||+++|++++ |..||...+..+....+.....   ......++..+.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l  230 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER---LPRPEECPQEIYSI  230 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc---CCCCCCCCHHHHHH
Confidence               112345799999876 458999999999999999997 9999988877666665544422   22334678999999


Q ss_pred             HHHhccCCCCCCCCHHHHhc
Q 019040          288 VRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~  307 (347)
                      |.+||..+|++||++.++++
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999965

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-39  Score=290.20  Aligned_cols=249  Identities=21%  Similarity=0.287  Sum_probs=203.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCc----eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRE----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .++|++.+.||.|+||+||+|.+..++.    .||+|++....  .......+.+|+.++..+ +|+|++++++++... 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGV-GSPYVCRLLGICLTS-   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcCC-
Confidence            4679999999999999999999877776    47899875432  233346788899999999 999999999988754 


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..+++++|+++++|.+++... ..++...+..++.||+.||.|||++||+|+||||+||++   .+++.++|+|||++..
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~  158 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARL  158 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceee
Confidence            567899999999999999774 458999999999999999999999999999999999999   5677899999999886


Q ss_pred             cCCCCcc---cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          205 FKPGERF---SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       205 ~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      .......   ....+++.|+|||.+. ..++.++||||||+++|++++ |..||...........+.... .  .+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~  235 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-R--LPQPPI  235 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-c--CCCCcc
Confidence            5433221   1123466799999875 458999999999999999998 899998777666555444432 1  122346


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ++.++.+++..||..||++||++.+++..
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~~  264 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVDE  264 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78999999999999999999999999843

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-40  Score=287.04  Aligned_cols=246  Identities=24%  Similarity=0.370  Sum_probs=204.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .+|++.+.||.|++|.||+|.++ ++..+|+|++.....    ....+.+|+.+++.+ +|+|++++++++...+..++|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEE
Confidence            46889999999999999999886 456799998754322    235678899999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      +||+++++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccc
Confidence            9999999999999764 458999999999999999999999999999999999999   667889999999987654332


Q ss_pred             ccc--ccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          210 RFS--EIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       210 ~~~--~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      ...  ...++..|+|||.+. ..++.++||||||+++|++++ |..||...+..+....+.....   ......++.++.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  231 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR---LYRPKLAPTEVY  231 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc---CCCCCCCCHHHH
Confidence            211  112345799999876 458899999999999999998 8999988777766666554422   222236799999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcC
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +++.+||..+|++|||+.++++.
T Consensus       232 ~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         232 TIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-40  Score=289.05  Aligned_cols=244  Identities=23%  Similarity=0.308  Sum_probs=198.2

Q ss_pred             eeecccCCeEEEEEEECCCCc--eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEec
Q 019040           57 RELGRGEFGVTYLCIDRDTRE--LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (347)
                      +.||.|+||.||+|.++.++.  .+++|.+....  .......+.+|++++..+.+|||++++++++...+..+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            358999999999999988775  46788775321  23344678889999999988999999999999999999999999


Q ss_pred             CCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          135 EGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       135 ~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      ++++|.+++....                .++...+..++.|++.||.|||++|++|+||||+||++   +.++.++|+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECC
Confidence            9999999997642                37889999999999999999999999999999999999   6778899999


Q ss_pred             eccccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCC
Q 019040          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDP  276 (347)
Q Consensus       199 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  276 (347)
                      ||++..............+..|+|||++. ..++.++||||||+++++|++ |..||...+.......+....   ....
T Consensus       156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---~~~~  232 (270)
T cd05047         156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLEK  232 (270)
T ss_pred             CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC---CCCC
Confidence            99986432111111122356799999875 458899999999999999997 999998877766666554432   2222


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ...++.++.+++.+||..+|.+|||+.++++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS  264 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            33678999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-40  Score=289.35  Aligned_cols=248  Identities=21%  Similarity=0.300  Sum_probs=202.9

Q ss_pred             eeeeeeecccCCeEEEEEEECCC---CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe---
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA---  126 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~---  126 (347)
                      |.+.+.||.|+||.||+|.+..+   +..||+|.+..... .......+.+|+..++.+ +|+|++++++.+.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCcccc
Confidence            56889999999999999987654   47899999865422 233456789999999999 99999999998765543   


Q ss_pred             ---EEEEEEecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          127 ---VHLVMELCEGGELFDRIVAR------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       127 ---~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                         .++++||+++++|..++...      ..++...+..++.|++.||.|||+.|++|+||||+||++   ++++.++|+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence               79999999999999888543      258999999999999999999999999999999999999   667889999


Q ss_pred             eeccccccCCCCcc---cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccc
Q 019040          198 DFGLSIFFKPGERF---SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDF  272 (347)
Q Consensus       198 Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  272 (347)
                      |||.+.........   .....+..|+|||.+. ..++.++||||||+++|+|++ |..||.+.........+...... 
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  234 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL-  234 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            99998765433211   1123456799999876 448999999999999999999 89999888777766666554322 


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                        .....++..+.+++.+||+.||++|||+.+++++
T Consensus       235 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         235 --KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             --CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              2234678999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-39  Score=293.16  Aligned_cols=254  Identities=26%  Similarity=0.373  Sum_probs=209.1

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEEC-------CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      ....++|.+.+.||.|+||.||+|++.       .++..||+|.+....  .......+.+|+.+++.+.+|+||+++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            344678999999999999999999753       234579999886432  23445678999999999978999999999


Q ss_pred             EEeeCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcE
Q 019040          120 ACEDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (347)
Q Consensus       120 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NI  183 (347)
                      .+...+..++++||+++++|.+++....                .++...+..++.||+.||.|||++|++|+||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            9999999999999999999999997642                367788999999999999999999999999999999


Q ss_pred             EeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 019040          184 LFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESE  258 (347)
Q Consensus       184 li~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  258 (347)
                      ++   +.++.++|+|||.+........   .....+++.|+|||.+. ..++.++||||||+++|++++ |..||.....
T Consensus       169 li---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         169 LV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             EE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            99   5677899999999876543221   12224567899999876 448999999999999999998 8899988887


Q ss_pred             HHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+....+......   .....++..+.+++.+||+.+|++|||+.++++.
T Consensus       246 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         246 EELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            7776666544321   2224678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=285.03  Aligned_cols=244  Identities=24%  Similarity=0.366  Sum_probs=207.4

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+.|++.+.||.|++|.||+|...  |+.||+|.+.....    ..+.+.+|+.+++.+ +|+|++++++++...+..++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEE
Confidence            467899999999999999999874  78899999865432    457789999999999 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          130 VMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |+||+++++|.+++....  .+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEccccccccccc
Confidence            999999999999998765  68999999999999999999999999999999999999   6678899999999987633


Q ss_pred             CCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      ...  ....+..|+|||.+. +.++.++||||||++++++++ |..||...........+....   .......+++.+.
T Consensus       155 ~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  229 (256)
T cd05039         155 GQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY---RMEAPEGCPPEVY  229 (256)
T ss_pred             ccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC---CCCCccCCCHHHH
Confidence            222  223456799999875 558889999999999999997 999998887776665554432   2222346789999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcC
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ++|.+||..+|++|||+.++++.
T Consensus       230 ~li~~~l~~~p~~Rp~~~~l~~~  252 (256)
T cd05039         230 KVMKDCWELDPAKRPTFKQLREQ  252 (256)
T ss_pred             HHHHHHhccChhhCcCHHHHHHH
Confidence            99999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.5e-39  Score=294.08  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=206.0

Q ss_pred             cccceeeeeeecccCCeEEEEEEECC-------CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRD-------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      ..++|.+.+.||.|+||.||+|++..       ....+|+|.+....  .......+.+|+.+++.+.+|+||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            34789999999999999999998642       34568999876432  2334567888999999996799999999999


Q ss_pred             eeCCeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEe
Q 019040          122 EDDNAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF  185 (347)
Q Consensus       122 ~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli  185 (347)
                      ...+..++++||+++++|.+++...                ..++...+..++.||+.||.|||++|++|+||||+||++
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            9999999999999999999999763                237888899999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 019040          186 ANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQG  260 (347)
Q Consensus       186 ~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~  260 (347)
                         +.++.++|+|||++........   .....++..|+|||.+. +.++.++||||||+++|++++ |..||.......
T Consensus       168 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         168 ---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             ---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence               5677899999999976543221   11112345799999876 448899999999999999998 899998887776


Q ss_pred             HHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          261 VAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ....+.....   ......++.++.+++.+||..+|++|||+.++++.
T Consensus       245 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         245 LFKLLREGHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             HHHHHHcCCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            6666554321   12234678899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.2e-39  Score=291.54  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=203.3

Q ss_pred             ceeeeeeecccCCeEEEEEEECC-----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      +|++.+.||.|+||.||+|.+..     ....+++|.+....  .......+.+|+.+++.+ +||||+++++.+...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCC
Confidence            47889999999999999998753     23568888876432  223456788999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCc
Q 019040          127 VHLVMELCEGGELFDRIVAR------------------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN  182 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~N  182 (347)
                      .++++||+++++|.+++...                        ..++...+..++.|++.||.|||+.|++||||+|+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            99999999999999988642                        236788899999999999999999999999999999


Q ss_pred             EEeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 019040          183 FLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAES  257 (347)
Q Consensus       183 Ili~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  257 (347)
                      |++   ++++.++|+|||++........   .....++..|+|||.+. ..++.++||||||+++++|++ |..||.+..
T Consensus       158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999   5677899999999876433221   12224566899999865 448899999999999999998 999998887


Q ss_pred             HHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .......+....   .......++.++.+++..||+.+|++||++.++++.
T Consensus       235 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~  282 (290)
T cd05045         235 PERLFNLLKTGY---RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE  282 (290)
T ss_pred             HHHHHHHHhCCC---CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence            776665554432   122234678999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.9e-40  Score=290.52  Aligned_cols=247  Identities=23%  Similarity=0.376  Sum_probs=205.2

Q ss_pred             cceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .+|.+.+.||.|+||.||+|...     .++..+++|.+...   .......+.+|+++++.+ +|+||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVL-QHQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCC
Confidence            57889999999999999999753     35667899987543   233456789999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC
Q 019040          126 AVHLVMELCEGGELFDRIVARG---------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE  190 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~  190 (347)
                      ..++++||+++++|.+++....               .++...+..++.||+.||.|||+.|++|+||||+||++   ++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cC
Confidence            9999999999999999987642               37889999999999999999999999999999999999   56


Q ss_pred             CCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 019040          191 NSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAI  265 (347)
Q Consensus       191 ~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  265 (347)
                      ++.++|+|||++........   .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||......+....+
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            78899999999875432221   12223567899999876 458999999999999999998 99999887777766666


Q ss_pred             HhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          266 LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ......   .....+++.+.++|.+||+.||++||++.++++
T Consensus       238 ~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            554322   222467899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.5e-39  Score=287.51  Aligned_cols=249  Identities=23%  Similarity=0.381  Sum_probs=206.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCc---eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      +.|++.+.||.|+||.||+|.++.+++   .|++|.+....  .......+.+|+.+++.+ +|||++++++++..+...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCce
Confidence            468999999999999999999887665   59999986432  233456789999999999 999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      ++++||+++++|.+++... +.++...+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence            9999999999999998764 458999999999999999999999999999999999999   567789999999987553


Q ss_pred             CCCcccc---cc---cCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          207 PGERFSE---IV---GSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       207 ~~~~~~~---~~---~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      .......   ..   .+..|+|||.+. ..++.++||||||+++|++++ |..||...........+...   ...+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~  234 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD---YRLPPPM  234 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---CcCCCcc
Confidence            3221111   11   134799999876 458999999999999999886 99999888877766666433   2223335


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .++..+.+++..||..+|++||++.++++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-39  Score=289.73  Aligned_cols=249  Identities=25%  Similarity=0.377  Sum_probs=196.1

Q ss_pred             ccce-eeeeeecccCCeEEEEEEE----CCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           50 EDRY-LVDRELGRGEFGVTYLCID----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        50 ~~~y-~i~~~lg~G~~g~V~~a~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .+|| .+.+.||.|+||+||++..    ..++..||+|.+....  .......+.+|+++++.+ +|+|++++++++...
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   78 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQ   78 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence            4566 8999999999999988753    3567889999986442  223346788899999999 999999999987653


Q ss_pred             --CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 --NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                        ...+++|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||++   +.++.++|+|||++
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~  154 (283)
T cd05080          79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLA  154 (283)
T ss_pred             CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeecccc
Confidence              4689999999999999998764 59999999999999999999999999999999999999   56778999999998


Q ss_pred             cccCCCCcc----cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--H------------HH
Q 019040          203 IFFKPGERF----SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQG--V------------AQ  263 (347)
Q Consensus       203 ~~~~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~------------~~  263 (347)
                      .........    ....++..|+|||.+. ..++.++||||||+++++|++|..||.......  .            ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence            765433221    1223456799999876 458899999999999999999999985543210  0            00


Q ss_pred             HHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .......  ..+....++..+.+++.+||+.+|++|||+.++++
T Consensus       235 ~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         235 ELLERGM--RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhcCC--CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000001  11112357899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-39  Score=288.15  Aligned_cols=248  Identities=20%  Similarity=0.283  Sum_probs=201.1

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCc--eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC------
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRE--LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD------  124 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~------  124 (347)
                      +.+.+.||.|+||.||+|.+..++.  .+|+|.+.... ........+.+|+.+++.+ +|+||+++++.+...      
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCC
Confidence            3567889999999999999887765  58999876432 2344467788999999999 999999999876432      


Q ss_pred             CeEEEEEEecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          125 NAVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      ...++++||+++++|.+++...      ..++...+..++.||+.||.|||++||+|+||||+||++   +.++.++|+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECC
Confidence            3578999999999999887432      237899999999999999999999999999999999999   6778899999


Q ss_pred             eccccccCCCCc---ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccc
Q 019040          199 FGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK  273 (347)
Q Consensus       199 fg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  273 (347)
                      ||++........   .....+++.|++||.+.+ .++.++||||||+++|+|++ |..||...........+..+..   
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---  232 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR---  232 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---
Confidence            999887543321   112235677999998764 48999999999999999999 8899988777666666555432   


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ....+.++..+.++|.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            12234678999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.7e-39  Score=286.98  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=206.7

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCC---ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTR---ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      .++|++.+.||.|+||.||+|.++.++   ..+|+|.+....  .......+.+|+.+++.+ +|||++++++++..++.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCc
Confidence            367999999999999999999986544   368999875432  223456789999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .++|+||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||||+||++   +.++.++|+|||.+...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCccccc
Confidence            99999999999999999765 458999999999999999999999999999999999999   56778999999998765


Q ss_pred             CCCCcc----cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          206 KPGERF----SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       206 ~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ......    ....++..|+|||.+. +.++.++|+||||++++++++ |..||......+....+....   ..+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~  233 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY---RLPAPMD  233 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC---cCCCCCC
Confidence            433211    1122346799999876 458999999999999999886 999998887766666665542   2222346


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ++..+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         234 CPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            7899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-39  Score=284.41  Aligned_cols=248  Identities=24%  Similarity=0.362  Sum_probs=208.1

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...++|.+.+.||.|++|.||+|.+. +++.|++|.+....    .....+.+|+.+++.+ +|++++++++++......
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCce
Confidence            45678999999999999999999976 45779999886433    2346788999999999 899999999999998999


Q ss_pred             EEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          128 HLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ++++||+++++|.+++....  .++...+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||.+...
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLI  153 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceec
Confidence            99999999999999997653  58999999999999999999999999999999999999   66788999999998765


Q ss_pred             CCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          206 KPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       206 ~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      .....  ......+..|+|||.+. ..++.++||||||++++++++ |..||.+.........+.....   .......+
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (261)
T cd05034         154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR---MPRPPNCP  230 (261)
T ss_pred             cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence            43211  11223456799999876 458899999999999999998 9999988887777776655432   22223568


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .++.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         231 EELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHH
Confidence            99999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.1e-40  Score=287.76  Aligned_cols=252  Identities=28%  Similarity=0.505  Sum_probs=207.2

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEecccccc--chhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      +|.+.+.||.|+||.||++.+...+..+++|+.......  .......+.+|+.+++.+ +|||++++++.+.+....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEE
Confidence            689999999999999999999888777777776543221  122334567799999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          130 VMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ++||+++++|.+.+..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++    ++.++|+|||.+...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence            9999999999988854    34589999999999999999999999999999999999994    245999999998765


Q ss_pred             CCCCc-ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          206 KPGER-FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       206 ~~~~~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      ..... .....+++.|+|||.+. ..++.++|+||||+++++|++|..||...........+.....   +.....++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT---PSLPETYSRQ  232 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC---CCCcchhcHH
Confidence            43322 23346788999999875 3488899999999999999999999977666555555443322   1122367889


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      +.++|.+||..+|++||++.++++||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.5e-39  Score=283.82  Aligned_cols=246  Identities=23%  Similarity=0.328  Sum_probs=202.6

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++.+.||.|++|.||+|.+..++ .+++|.+....    .....+.+|+.+++.+ +|++++++++++. .+..+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT----MMPEAFLQEAQIMKKL-RHDKLVPLYAVVS-EEPIY   76 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC----ccHHHHHHHHHHHHhC-CCCCeeeEEEEEc-CCCcE
Confidence            3467999999999999999999986654 58999875432    2235688899999999 9999999998875 45688


Q ss_pred             EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          129 LVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      ++|||+.+++|.+++....  .++...+..++.|++.||.|||+.|++|+||+|+||++   ++++.++|+|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEcc
Confidence            9999999999999997643  37889999999999999999999999999999999999   677889999999997653


Q ss_pred             CCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          207 PGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       207 ~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ....  .....++..|+|||... ..++.++||||||+++|+|++ |..||......+....+....   ........+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~  230 (260)
T cd05069         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY---RMPCPQGCPE  230 (260)
T ss_pred             CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCcccCH
Confidence            3221  12234567799999875 458899999999999999999 999998888777666665542   1222346789


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .+.+++.+||.+||++||++.++++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         231 SLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.3e-39  Score=284.93  Aligned_cols=246  Identities=22%  Similarity=0.313  Sum_probs=203.1

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...++|++.+.||.|++|.||+|.+. ++..+|+|.+.....    ..+.+.+|+.+++.+ +|++++++++++.. +..
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~   75 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKL-RHDKLVQLYAVVSE-EPI   75 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhc-CCCceEEEEeEECC-CCc
Confidence            44578999999999999999999876 556699998865332    235688999999999 99999999998754 567


Q ss_pred             EEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          128 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      +++|||+++++|.+++...  ..++...+..++.|++.||.|||+.|++|+||+|+||++   ++++.++|+|||.+...
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~  152 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLI  152 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeec
Confidence            8999999999999998764  348999999999999999999999999999999999999   56778999999999765


Q ss_pred             CCCCcc--cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          206 KPGERF--SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       206 ~~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ......  ....++..|+|||.+. ..++.++||||||+++|++++ |..||...+..+....+....   ..+.....+
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~  229 (260)
T cd05070         153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY---RMPCPQDCP  229 (260)
T ss_pred             cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCcCC
Confidence            432211  1223456799999865 458899999999999999999 899998887777666665432   222234678


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHh
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVL  306 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll  306 (347)
                      ..+.+++.+||..+|++|||+.+++
T Consensus       230 ~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         230 ISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.9e-39  Score=284.57  Aligned_cols=246  Identities=27%  Similarity=0.406  Sum_probs=208.6

Q ss_pred             eeeeeeecccCCeEEEEEEECCCC----ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTR----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      +.+.+.||.|+||.||+|.+...+    ..||+|.+....  .......+.+|+.+++.+ +|++++++++++.+.+..+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeE
Confidence            357789999999999999998766    889999986442  222457889999999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          129 LVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +++||+++++|.+++.....  +++..+..++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecc
Confidence            99999999999999976544  8999999999999999999999999999999999999   667789999999998765


Q ss_pred             CCCccc--ccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          207 PGERFS--EIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       207 ~~~~~~--~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ......  ...+++.|+|||.+. ..++.++||||||+++++|++ |..||...+.....+.+.......   ....++.
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  231 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP---KPENCPP  231 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CCCcCCH
Confidence            442221  123678899999875 458999999999999999998 889998877777777666554322   2235899


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ++.+++.+||..+|++|||+.++++
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      232 EIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=291.57  Aligned_cols=252  Identities=23%  Similarity=0.323  Sum_probs=202.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCC--------------ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCcee
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTR--------------ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIV  115 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~--------------~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~  115 (347)
                      .++|++.+.||+|+||.||+|.+..++              ..||+|.+....  .......+.+|+++++.+ +|+|++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~   80 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRL-KNPNII   80 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCcC
Confidence            468999999999999999999875432              358999986432  233446788999999999 999999


Q ss_pred             EeeeEEeeCCeEEEEEEecCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcE
Q 019040          116 SLKEACEDDNAVHLVMELCEGGELFDRIVARG------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (347)
Q Consensus       116 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NI  183 (347)
                      ++++++...+..++||||+++++|.+++....            .++...+..++.|++.||.|||+.|++|+||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999986532            267788999999999999999999999999999999


Q ss_pred             EeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh--CCCCCCCCC
Q 019040          184 LFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC--GVPPFWAES  257 (347)
Q Consensus       184 li~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~  257 (347)
                      ++   ++++.++|+|||++........   .....++..|+|||.+. +.++.++||||||+++++|++  +..||....
T Consensus       161 ll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         161 LV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             EE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            99   5677899999999876433221   12234467899999865 558999999999999999988  678888777


Q ss_pred             HHHHHHHHHhcc----ccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          258 EQGVAQAILRGL----IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       258 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .......+....    ........+.++..+.+++.+||+.+|++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            666555443211    11111223357899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.6e-39  Score=290.31  Aligned_cols=249  Identities=22%  Similarity=0.337  Sum_probs=205.8

Q ss_pred             ccceeeeeeecccCCeEEEEEEECC-----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .++|++.+.||.|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.+ .|++++++++++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DHPNIVKLLGVCAVG   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC
Confidence            4679999999999999999998753     67889999886432  223346788999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCc
Q 019040          125 NAVHLVMELCEGGELFDRIVARG----------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN  182 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~N  182 (347)
                      ...++++||+++++|.+++....                      .++...++.++.||+.||.|||++|++||||+|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997532                      36778889999999999999999999999999999


Q ss_pred             EEeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 019040          183 FLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAES  257 (347)
Q Consensus       183 Ili~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  257 (347)
                      |++   +.++.++|+|||++........   ......+..|+|||.+. ..++.++||||||+++|+|++ |..||.+..
T Consensus       161 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         161 CLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             eEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999   6678899999999875432211   12234466799999865 458999999999999999997 888998887


Q ss_pred             HHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ..+....+......   .....++..+.++|.+||+.+|++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         238 HEEVIYYVRDGNVL---SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            77766666544321   122367899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.8e-39  Score=284.78  Aligned_cols=250  Identities=22%  Similarity=0.348  Sum_probs=207.3

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCc---eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      .++|+..+.||.|++|.||+|.++.++.   .+++|.+....  .......+.+|+++++.+ +|+|++++.+++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCC
Confidence            4678999999999999999999876654   68999875432  223346788999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .+++|||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL  157 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence            99999999999999999764 468999999999999999999999999999999999999   56778999999998765


Q ss_pred             CCCCcc----cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          206 KPGERF----SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       206 ~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ......    .....+..|+|||.+. ..++.++||||||+++|++++ |..||...+.......+....   ..+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~  234 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMD  234 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---CCCCCCC
Confidence            432211    1112345699999876 458899999999999999987 999998888777776665542   2223346


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ++.++.+++.+||+.+|++||++.++++.
T Consensus       235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~~  263 (268)
T cd05063         235 CPSAVYQLMLQCWQQDRARRPRFVDIVNL  263 (268)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            78999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=303.28  Aligned_cols=249  Identities=34%  Similarity=0.529  Sum_probs=212.2

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .+...|.+...+|.|+|+.|-.+.+..+++..++|++.+..       ....+|+.++...++|+|++++.+++.+..+.
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~  391 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI  391 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCcee
Confidence            45678999999999999999999999999999999997652       22345787888888999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |+|||.+.|+-+.+.+.....+. ..+..|+++|+.|+.|||++|+||||+||+|||+.  ++.++++|+|||.+.....
T Consensus       392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCch
Confidence            99999999998888887765555 77888999999999999999999999999999995  4678899999999987654


Q ss_pred             CCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccccCCCCCCCCHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      .  .....-|..|.|||++.. .|+.++||||||++||+|++|..||...... +....+..+...      ..++...+
T Consensus       469 ~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AK  540 (612)
T KOG0603|consen  469 S--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAK  540 (612)
T ss_pred             h--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHH
Confidence            4  334467888999999874 4999999999999999999999999877766 333333222211      48899999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +||+.||+.||.+||++.+++.||||-..
T Consensus       541 dLl~~LL~~dP~~Rl~~~~i~~h~w~~~~  569 (612)
T KOG0603|consen  541 DLLQQLLQVDPALRLGADEIGAHPWFLSH  569 (612)
T ss_pred             HHHHHhccCChhhCcChhhhccCcchhcC
Confidence            99999999999999999999999999333

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.4e-39  Score=295.29  Aligned_cols=255  Identities=25%  Similarity=0.370  Sum_probs=208.1

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCC-------CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEee
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDT-------RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK  118 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~  118 (347)
                      ++....+|.+.+.||.|+||.||+|.+...       +..||+|.+....  .......+.+|+++++++.+|+||++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            334456899999999999999999986532       2368999876432  2334567889999999997799999999


Q ss_pred             eEEeeCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCc
Q 019040          119 EACEDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN  182 (347)
Q Consensus       119 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~N  182 (347)
                      +++...+..++++||+++++|.+++....                .++...+..++.||+.||.|||++|++|+||||+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  164 (334)
T cd05100          85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN  164 (334)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence            99999999999999999999999987532                36778889999999999999999999999999999


Q ss_pred             EEeecCCCCCCEEEEeeccccccCCCCcc---cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 019040          183 FLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAES  257 (347)
Q Consensus       183 Ili~~~~~~~~~~l~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  257 (347)
                      |++   +.++.++|+|||++.........   ....++..|+|||.+. ..++.++||||||+++|+|++ |..||...+
T Consensus       165 ill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  241 (334)
T cd05100         165 VLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  241 (334)
T ss_pred             EEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            999   56778999999998765432211   1123346799999876 458899999999999999998 889998888


Q ss_pred             HHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .......+.....   ......++..+.+++.+||+.+|++|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         242 VEELFKLLKEGHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            7777666654422   22234678899999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.5e-39  Score=286.90  Aligned_cols=249  Identities=22%  Similarity=0.322  Sum_probs=200.9

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCce----eEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTREL----LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .++|++.+.||.|+||.||+|.+..++..    +++|.+...  ........+..|+..++.+ .|+||+++++++.. .
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~-~   81 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG-A   81 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC-C
Confidence            35789999999999999999999877764    666665322  1223345677888899999 99999999998754 4


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..++++||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||++   +.++.++|+|||.+..
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADL  158 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCcccee
Confidence            577899999999999999764 468999999999999999999999999999999999999   6678899999999976


Q ss_pred             cCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          205 FKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       205 ~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ......   .....++..|+|||.+. +.++.++||||||+++|++++ |..||.+.........+..+...   .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  235 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL---AQPQI  235 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC---CCCCC
Confidence            533221   12334667899999875 558999999999999999998 99999888766555544433221   12235


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ++.++.+++..||..||++|||+.++++.
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         236 CTIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            67899999999999999999999999774

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.7e-39  Score=283.62  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=205.1

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...+.|++++.||.|+||.||+|.++ +++.||+|.+....    .....+.+|+.+++.+ +|+|++++++++. .+..
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~   75 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----MSPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPI   75 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----CcHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCc
Confidence            45678999999999999999999865 56779999886432    2346788999999999 8999999998874 4578


Q ss_pred             EEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          128 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ++++||+++++|.+++...  ..++...+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||.+...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLI  152 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeec
Confidence            9999999999999988654  358889999999999999999999999999999999999   66788999999998765


Q ss_pred             CCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          206 KPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       206 ~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      .....  .....++..|+|||.+. ..++.++||||||++++++++ |..||.+.+.......+....   ..+.....+
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~  229 (260)
T cd05067         153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY---RMPRPDNCP  229 (260)
T ss_pred             CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC---CCCCCCCCC
Confidence            42221  12234567899999876 458899999999999999998 999998888777666655442   222334678


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .++.++|.+||..+|++||++.++++
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         230 EELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHH
Confidence            99999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4e-39  Score=283.06  Aligned_cols=241  Identities=24%  Similarity=0.344  Sum_probs=196.9

Q ss_pred             eecccCCeEEEEEEEC--CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecC
Q 019040           58 ELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (347)
Q Consensus        58 ~lg~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (347)
                      .||.|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++.+ +|+|++++++++.. +..++|+||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~-~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA-EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence            4899999999999875  445679999886442  233456788999999999 99999999998764 57889999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcc---
Q 019040          136 GGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---  211 (347)
Q Consensus       136 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~---  211 (347)
                      +++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||++   +.++.++|+|||.+.........   
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccceec
Confidence            99999998753 468999999999999999999999999999999999999   56778999999998754333211   


Q ss_pred             -cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          212 -SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       212 -~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                       ....++..|+|||.+. ..++.++||||||+++|++++ |..||...........+..+..   ......+++++.++|
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li  231 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR---LDCPAECPPEMYALM  231 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC---CCCCCCCCHHHHHHH
Confidence             1112356799999876 458899999999999999996 9999988887776666655432   222246789999999


Q ss_pred             HHhccCCCCCCCCHHHHhcC
Q 019040          289 RQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ..||..+|++||++.++++.
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999653

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.9e-39  Score=286.57  Aligned_cols=250  Identities=21%  Similarity=0.364  Sum_probs=208.4

Q ss_pred             cceeeeeeecccCCeEEEEEEECC-----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ++|++.+.||.|+||.||+|+.+.     +.+.|++|.+....  .......+.+|+++++.+ +|+|++++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCC
Confidence            679999999999999999999764     34679999875432  222456789999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEE
Q 019040          126 AVHLVMELCEGGELFDRIVARG---------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l  196 (347)
                      ..++++||+++++|.+++....         .++...+..++.|++.||.|||+.||+|+||||+||++   +.++.++|
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence            9999999999999999997765         68999999999999999999999999999999999999   56778999


Q ss_pred             EeeccccccCCCC--cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccc
Q 019040          197 IDFGLSIFFKPGE--RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDF  272 (347)
Q Consensus       197 ~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  272 (347)
                      +|||++.......  ......++..|+|||.+. ..++.++||||||++++++++ |..||...........+......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            9999986543221  122335677799999875 458889999999999999998 888998777776666665544433


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +.  ...++..+.+++.+||+.+|++|||+.+++..
T Consensus       239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            32  24688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-39  Score=297.14  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=199.1

Q ss_pred             cccceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      -.++|++.+.||.|+||.||+|.+.     .+++.||+|.+....  .......+.+|+.++..+.+|+||+++++++..
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            3578999999999999999999853     467889999986432  223346788899999999789999999998765


Q ss_pred             C-CeEEEEEEecCCCchHHHHHhcC-------------------------------------------------------
Q 019040          124 D-NAVHLVMELCEGGELFDRIVARG-------------------------------------------------------  147 (347)
Q Consensus       124 ~-~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------------------------  147 (347)
                      . ...++++||+++++|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 56889999999999999886431                                                       


Q ss_pred             ------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc---cc
Q 019040          148 ------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FS  212 (347)
Q Consensus       148 ------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~---~~  212 (347)
                                  .++...+..++.||+.||.|||++||+||||||.||++   +.++.++|+|||++........   ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcC
Confidence                        25677788899999999999999999999999999999   5677899999999876432211   11


Q ss_pred             ccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          213 EIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGV-AQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       213 ~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      ...++..|+|||.+. ..++.++||||||+++|++++ |..||........ ...+..+. ...  .....++++.+++.
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~  316 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-RMR--APDYTTPEMYQTML  316 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC-CCC--CCCCCCHHHHHHHH
Confidence            223456799999875 458999999999999999997 8999976544322 22222222 111  12246789999999


Q ss_pred             HhccCCCCCCCCHHHHhcC
Q 019040          290 QMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       290 ~~l~~dp~~Rps~~~ll~h  308 (347)
                      .||+.||++|||+.++++|
T Consensus       317 ~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         317 DCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHccCChhhCcCHHHHHHH
Confidence            9999999999999999987

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=292.81  Aligned_cols=275  Identities=26%  Similarity=0.450  Sum_probs=217.2

Q ss_pred             CCCCCcc-cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCC-------CCcee
Q 019040           44 VPKENIE-DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK-------NSSIV  115 (347)
Q Consensus        44 ~~~~~~~-~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~-------h~~i~  115 (347)
                      ..++.+. +||-+.+.||.|.|++||+|.|..+.++||+|+.+.....    .+....||++|++++.       ...|+
T Consensus        70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY----tEaAlDEIklL~~v~~~Dp~~~~~~~VV  145 (590)
T KOG1290|consen   70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY----TEAALDEIKLLQQVREGDPNDPGKKCVV  145 (590)
T ss_pred             eccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH----HHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence            3466676 8999999999999999999999999999999998654322    2445669999998843       34699


Q ss_pred             EeeeEEee----CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecC
Q 019040          116 SLKEACED----DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANK  188 (347)
Q Consensus       116 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~  188 (347)
                      ++++.|..    +.+++||+|++ |.+|..++...  +.++...++.|++||+.||.|||.. ||||.||||+|||+...
T Consensus       146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence            99999874    57999999999 88999999775  4599999999999999999999965 99999999999998332


Q ss_pred             C-------------------------------------------------------------------------------
Q 019040          189 K-------------------------------------------------------------------------------  189 (347)
Q Consensus       189 ~-------------------------------------------------------------------------------  189 (347)
                      +                                                                               
T Consensus       225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n  304 (590)
T KOG1290|consen  225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN  304 (590)
T ss_pred             ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence            1                                                                               


Q ss_pred             --------------------------------------------------------------------------------
Q 019040          190 --------------------------------------------------------------------------------  189 (347)
Q Consensus       190 --------------------------------------------------------------------------------  189 (347)
                                                                                                      
T Consensus       305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~  384 (590)
T KOG1290|consen  305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI  384 (590)
T ss_pred             cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence                                                                                            


Q ss_pred             ----CCCCEEEEeeccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCC------CH
Q 019040          190 ----ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE------SE  258 (347)
Q Consensus       190 ----~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~------~~  258 (347)
                          .+..|||.|||.|++.  .+..+..+.|..|+|||++.+ .|++.+||||++|+++||+||...|...      .+
T Consensus       385 ~~~~~di~vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD  462 (590)
T KOG1290|consen  385 PLPECDIRVKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD  462 (590)
T ss_pred             CCCccceeEEEeeccchhhh--hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc
Confidence                0113688888888874  334455678999999998764 5999999999999999999999988433      34


Q ss_pred             HHHHHHHHhccccccC-------------------------CCCC-------------CCCHHHHHHHHHhccCCCCCCC
Q 019040          259 QGVAQAILRGLIDFKR-------------------------DPWP-------------NVSESAKSLVRQMLEPDPKLRL  300 (347)
Q Consensus       259 ~~~~~~~~~~~~~~~~-------------------------~~~~-------------~~~~~~~~li~~~l~~dp~~Rp  300 (347)
                      ++.+..|+..+...|+                         .+|+             ....++.+||.-||+++|.+||
T Consensus       463 EDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~  542 (590)
T KOG1290|consen  463 EDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP  542 (590)
T ss_pred             HHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence            5666667665543332                         1121             1235677999999999999999


Q ss_pred             CHHHHhcCcccccCcCCCCCCChHHH
Q 019040          301 TAKQVLEHPWLQNAKKAPNVPLGDVV  326 (347)
Q Consensus       301 s~~~ll~h~~~~~~~~~~~~~~~~~~  326 (347)
                      ||.++|+||||+....+ ...++.+.
T Consensus       543 tA~~cl~hPwLn~~~~~-~~~~~~~~  567 (590)
T KOG1290|consen  543 TAAQCLKHPWLNPVAGP-PPSDSPQN  567 (590)
T ss_pred             cHHHHhcCccccCCCCC-ccccCCcc
Confidence            99999999999988776 44444433

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.3e-39  Score=282.60  Aligned_cols=241  Identities=23%  Similarity=0.349  Sum_probs=201.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEE-eeCCeEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC-EDDNAVHL  129 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~-~~~~~~~l  129 (347)
                      .+|.+.+.||.|++|.||+|...  +..|++|.+...     ...+.+.+|+.+++.+ +|++++++++++ ...+..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEE
Confidence            57899999999999999999764  777999987532     2345788999999999 999999999875 45567899


Q ss_pred             EEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          130 VMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      ++||+++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||++   ++++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccc
Confidence            999999999999997653  37889999999999999999999999999999999999   6778899999999876433


Q ss_pred             CCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      ..  .....+..|+|||++.+ .++.++||||||+++|+|++ |..||...........+..+..   ......++..+.
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  229 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVY  229 (256)
T ss_pred             cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHH
Confidence            22  22234567999998764 48889999999999999997 9999988777666666655422   223347899999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhc
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      +++.+||+.+|++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=296.13  Aligned_cols=251  Identities=24%  Similarity=0.343  Sum_probs=198.0

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC-eEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-AVH  128 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~-~~~  128 (347)
                      .++|.-...||+|+||.||+|.... +..||||.+.......   ..+|.+|+.++.++ +|||+++++|+|.+.+ ..+
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~~~~  148 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRL-RHPNLVKLLGYCLEGGEHRL  148 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcC-CCcCcccEEEEEecCCceEE
Confidence            4688888999999999999998854 4889999776543221   35599999999999 7999999999999998 599


Q ss_pred             EEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---cEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          129 LVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHG---VIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      +|+||++.|+|.+.+....  .+++....+|+..++.||+|||+..   |||||||++|||+   |++..+||+|||+|.
T Consensus       149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~  225 (361)
T KOG1187|consen  149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAK  225 (361)
T ss_pred             EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcc
Confidence            9999999999999998765  7899999999999999999999864   9999999999999   788999999999997


Q ss_pred             ccCC-CCccccc-ccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHH----HHHHhcc-ccc
Q 019040          204 FFKP-GERFSEI-VGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAES---EQGVA----QAILRGL-IDF  272 (347)
Q Consensus       204 ~~~~-~~~~~~~-~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~----~~~~~~~-~~~  272 (347)
                      .... ....... .||.+|+|||+.. +..+.++||||||++|+|+++|+.+.....   .....    ..+.+.. ..+
T Consensus       226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei  305 (361)
T KOG1187|consen  226 LGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI  305 (361)
T ss_pred             cCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence            6544 3322333 7999999999986 679999999999999999999998775432   11111    1222211 111


Q ss_pred             cCCCC--CCCC-----HHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          273 KRDPW--PNVS-----ESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       273 ~~~~~--~~~~-----~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .-+..  ...+     ..+..+...|++.+|.+||++.++++.
T Consensus       306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence            11111  1222     234578889999999999999997543

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4e-39  Score=282.82  Aligned_cols=242  Identities=24%  Similarity=0.321  Sum_probs=202.0

Q ss_pred             eeecccCCeEEEEEEECC-CC--ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEe
Q 019040           57 RELGRGEFGVTYLCIDRD-TR--ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL  133 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  133 (347)
                      +.||.|++|.||+|.+.. .+  ..||+|.+......  ...+.+.+|+.+++++ +|+|++++++.+.. ...++++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEe
Confidence            368999999999999865 33  36899998765433  4567899999999999 99999999999988 899999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc-
Q 019040          134 CEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-  210 (347)
Q Consensus       134 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~-  210 (347)
                      +++++|.+.+....  .++...++.++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++........ 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence            99999999997764  58999999999999999999999999999999999999   5668899999999887644221 


Q ss_pred             ---ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          211 ---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       211 ---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                         .....++..|+|||.+.. .++.++||||||+++++|++ |..||...+..+....+........  .....+..+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  231 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY  231 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence               112346778999998764 58999999999999999998 9999988877776666654322222  2236789999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhc
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      +++.+||..+|++|||+.++++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.4e-39  Score=292.69  Aligned_cols=248  Identities=22%  Similarity=0.319  Sum_probs=197.1

Q ss_pred             CCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCchHHH
Q 019040           63 EFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDR  142 (347)
Q Consensus        63 ~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  142 (347)
                      +++.||.++...+++.||+|++.... ........+.+|+.+++.+ +|+||+++++++...+..++++||+++++|.++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~   89 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL   89 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence            44566777777799999999987542 2334567899999999999 899999999999999999999999999999999


Q ss_pred             HHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc--------cc
Q 019040          143 IVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--------FS  212 (347)
Q Consensus       143 l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~--------~~  212 (347)
                      +...  ..+++..+..++.|++.||.|||+.||+|+||+|+||++   +.++.++|+|||.+........        ..
T Consensus        90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~  166 (314)
T cd08216          90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK  166 (314)
T ss_pred             HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeeccccccccccccccc
Confidence            8764  458999999999999999999999999999999999999   5667899999998865432211        12


Q ss_pred             ccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-------c---------
Q 019040          213 EIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF-------K---------  273 (347)
Q Consensus       213 ~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------~---------  273 (347)
                      ...++..|+|||.+..   .++.++|+||||+++++|++|..||..............+....       +         
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
T cd08216         167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS  246 (314)
T ss_pred             cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcc
Confidence            2356778999998753   38889999999999999999999998766544332222111000       0         


Q ss_pred             --------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          274 --------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       274 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                    ......++.++.+++..||..||++|||+.++|+||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                          000012346788999999999999999999999999998775

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.7e-40  Score=280.52  Aligned_cols=266  Identities=29%  Similarity=0.457  Sum_probs=210.6

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCC----ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee-
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTR----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-  123 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~-  123 (347)
                      ....|++...||+|.+|.||+|..+.++    +.+|+|.+..+....... ...-+|+.+++.+ +|+|++.+..++-. 
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl-~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLREL-KHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHh-cCCcchhHHHHHhcc
Confidence            3467999999999999999999665443    378999987654333322 3466799999999 99999999988876 


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC-CCCCCEEEE
Q 019040          124 DNAVHLVMELCEGGELFDRIVAR-----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK-KENSPLKAI  197 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~-~~~~~~~l~  197 (347)
                      +..+++++||.+. +|..+++-.     +.++..++..++.||+.|+.|||++-|+|||+||.||++..+ .+.|.|||+
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence            8899999999976 898888542     358999999999999999999999999999999999999632 345899999


Q ss_pred             eeccccccCCCCc----ccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHH
Q 019040          198 DFGLSIFFKPGER----FSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQ---------GVA  262 (347)
Q Consensus       198 Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------~~~  262 (347)
                      |||+++...++-.    ....+-|.+|+|||.+.+  .|+.+.|||+.||++.||++-.+.|.+....         +.+
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            9999998765432    245678999999998764  4999999999999999999998888665332         233


Q ss_pred             HHHHhccccccCCCCC---------------------------------CCCHHHHHHHHHhccCCCCCCCCHHHHhcCc
Q 019040          263 QAILRGLIDFKRDPWP---------------------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHP  309 (347)
Q Consensus       263 ~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  309 (347)
                      ..|..-........|+                                 .-++...+|+.+||+.||-+|+|+.++|+|+
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            4444433332222222                                 1233467999999999999999999999999


Q ss_pred             ccccCcCC
Q 019040          310 WLQNAKKA  317 (347)
Q Consensus       310 ~~~~~~~~  317 (347)
                      ||..-..+
T Consensus       339 yF~~d~lp  346 (438)
T KOG0666|consen  339 YFTEDPLP  346 (438)
T ss_pred             ccccCCCC
Confidence            99877533

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.7e-39  Score=299.45  Aligned_cols=256  Identities=21%  Similarity=0.309  Sum_probs=204.7

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      +....++|.+.+.||.|+||.||+|++.     .++..||+|++....  .......+.+|+.++..+..|+||+++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            4444567899999999999999999964     345689999996542  222345688999999999559999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhcC-----------------------------------------------------
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVARG-----------------------------------------------------  147 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------------------------------------  147 (347)
                      +...+..++|+||+++++|.+++...+                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999986532                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCc
Q 019040          148 ---------------------------------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN  182 (347)
Q Consensus       148 ---------------------------------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~N  182 (347)
                                                                   .++...+..++.||+.||.|||+.|++|+||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         24566778899999999999999999999999999


Q ss_pred             EEeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 019040          183 FLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAES  257 (347)
Q Consensus       183 Ili~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  257 (347)
                      ||+   ++++.++|+|||++........   .....+++.|+|||.+. ..++.++||||||+++++|++ |..||....
T Consensus       270 iLl---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         270 VLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             EEE---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999   5677899999999876432221   12235678899999876 448899999999999999998 889997766


Q ss_pred             HHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ..+..........  .......++.++.+++.+||..+|.+||++.++++.
T Consensus       347 ~~~~~~~~~~~~~--~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         347 MNEQFYNAIKRGY--RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             chHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5544433333221  122234678999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.6e-39  Score=288.52  Aligned_cols=252  Identities=21%  Similarity=0.304  Sum_probs=201.0

Q ss_pred             ccceeeeeeecccCCeEEEEEEECC----------------CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCc
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRD----------------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS  113 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~  113 (347)
                      .++|++.+.||.|+||.||+|.+..                ++..+|+|++....  .......+.+|+.+++.+ +|+|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l-~~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRL-KDPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCC
Confidence            4679999999999999999986542                34568999886432  233456788999999999 9999


Q ss_pred             eeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCc
Q 019040          114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-----------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN  182 (347)
Q Consensus       114 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~N  182 (347)
                      ++++++++...+..++++||+++++|.+++....           .++...+..++.||+.||.|||+.|++|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999987642           25677899999999999999999999999999999


Q ss_pred             EEeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh--CCCCCCCC
Q 019040          183 FLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC--GVPPFWAE  256 (347)
Q Consensus       183 Ili~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~--g~~pf~~~  256 (347)
                      |++   +.++.++|+|||++........   .....++..|++||... +.++.++||||||+++|+|++  |..||...
T Consensus       161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            999   5677899999999876533221   11223457799999754 569999999999999999998  77899777


Q ss_pred             CHHHHHHHHHhc----cccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          257 SEQGVAQAILRG----LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       257 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      +...........    ......+....+++.+.+++..||+.||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            666554433221    111111222467899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.4e-39  Score=285.21  Aligned_cols=249  Identities=21%  Similarity=0.298  Sum_probs=205.2

Q ss_pred             ccceeeeeeecccCCeEEEEEEECC----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee-C
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRD----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-D  124 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~-~  124 (347)
                      .++|.+.+.||.|+||.||+|.+..    ++..|++|.+...  ........+.+|+.+++.+ +|+|++++++++.. .
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence            4789999999999999999999876    3577999987532  2344467788999999999 99999999998765 5


Q ss_pred             CeEEEEEEecCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEE
Q 019040          125 NAVHLVMELCEGGELFDRIVAR--------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l  196 (347)
                      ...+++++|+++++|.+++...        ..++...+..++.|++.||.|||+.|++|+||+|+||++   ++++.++|
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence            7788999999999999998663        348899999999999999999999999999999999999   56788999


Q ss_pred             EeeccccccCCCCcc---cccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccc
Q 019040          197 IDFGLSIFFKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLID  271 (347)
Q Consensus       197 ~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  271 (347)
                      +|||++.........   ....++..|+|||.+.+ .++.++||||||+++|++++ |..||...+.......+..+.  
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--  236 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY--  236 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC--
Confidence            999999765433211   12345667999998764 48899999999999999998 999998877766555554432  


Q ss_pred             ccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                       .......+++++.+++.+||..+|++|||+.++++
T Consensus       237 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 -RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             22223467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=319.10  Aligned_cols=248  Identities=27%  Similarity=0.436  Sum_probs=213.8

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCc-----eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRE-----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ..-...+.||.|+||.||.|.......     .||+|.+.+  .....++..|.+|..+++.+ +||||++++|++-+..
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCC
Confidence            456788999999999999998764332     377777654  44666788999999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          126 AVHLVMELCEGGELFDRIVAR-------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      ..+|++|||+||+|..+|++.       ..++...+..++.+|+.|+.||+++++|||||...|+|+   +....+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEcc
Confidence            999999999999999999886       248999999999999999999999999999999999999   6668999999


Q ss_pred             eccccccCCCCcc---cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccc
Q 019040          199 FGLSIFFKPGERF---SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK  273 (347)
Q Consensus       199 fg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  273 (347)
                      ||+|+.+-.....   ..-.....|||||.+. +.++.++||||||+++||+++ |..||...+..++.....++-   +
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---R  922 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---R  922 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---c
Confidence            9999954333221   1124457899999987 669999999999999999999 899999999988888666664   4


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .+....+|+.+.++|..||+.+|++||++..|++
T Consensus       923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            4455689999999999999999999999999986

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-39  Score=284.09  Aligned_cols=248  Identities=22%  Similarity=0.289  Sum_probs=205.9

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCc----eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRE----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .++|++.+.||.|+||.||+|.++.+|.    .+|+|......  .......+.+|+.+++.+ +|+|++++++++.. .
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~   81 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASV-DHPHVVRLLGICLS-S   81 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-C
Confidence            4689999999999999999999877665    58888876543  233456788999999999 99999999999887 7


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..++++||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||.+..
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~  158 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKL  158 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccccc
Confidence            889999999999999999775 458999999999999999999999999999999999999   5677899999999986


Q ss_pred             cCCCCccc---ccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          205 FKPGERFS---EIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       205 ~~~~~~~~---~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ........   ...++..|+|||.+. ..++.++|+||||++++++++ |..||......+....+......   .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  235 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL---PQPPI  235 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC---CCCCC
Confidence            54332211   112356799999875 458899999999999999998 99999888877777666554221   22235


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .+.++.+++.+||..+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         236 CTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            6789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-42  Score=333.09  Aligned_cols=259  Identities=28%  Similarity=0.456  Sum_probs=220.9

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      +.-+++....||.|.||.||-|.+..+|...|+|.+.-.... ....+.+.+|..++..+ +|||++.++|+-.+.+.++
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhc-cCccccccCceeecHHHHH
Confidence            344677788999999999999999999999999998654433 45567789999999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      |.||||+||+|.+.+...+..++.....+..|++.|+.|||+.|||||||||+|||+   +.+|.+|++|||.|....++
T Consensus      1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCc
Confidence            999999999999999888778888888899999999999999999999999999999   77889999999999877654


Q ss_pred             C-----cccccccCccccccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          209 E-----RFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       209 ~-----~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      .     .....+||+.|||||++.+    +...++|||||||++.||+||+.||...+.+..+--....-..  +..+..
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~--Pq~P~~ 1465 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK--PQIPER 1465 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC--CCCchh
Confidence            3     2356789999999999853    3667999999999999999999999888876544332222111  112235


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ++++-.+||.+||..||..|.++.|+++|.|=+.-
T Consensus      1466 ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             hhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            89999999999999999999999999999886544

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.3e-38  Score=279.43  Aligned_cols=246  Identities=26%  Similarity=0.424  Sum_probs=205.9

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .+|++.+.||.|+||.||+|.+. .+..+++|.+.....    ....+.+|+++++.+ .|++++++++++......+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEE
Confidence            57899999999999999999886 467799998864322    235688899999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      +||+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCc
Confidence            9999999999998764 458999999999999999999999999999999999999   567789999999987654322


Q ss_pred             c--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          210 R--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       210 ~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      .  .....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+..+.....   ....+.++.
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---PRLASQSVY  231 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC---CCCCCHHHH
Confidence            1  11223456899999876 558899999999999999998 9999988877777777655432222   124689999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcC
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +++.+||+.+|++|||+.+++++
T Consensus       232 ~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         232 ELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHcccChhhCCCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.4e-38  Score=278.20  Aligned_cols=242  Identities=22%  Similarity=0.342  Sum_probs=199.3

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|+||.||+|... ++..+|+|.+....  .......+.+|+.+++.+ +|+|++++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCC
Confidence            36899999999999865 67889999876432  222345688899999999 999999999999999999999999999


Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcc--cc
Q 019040          137 GELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SE  213 (347)
Q Consensus       137 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~--~~  213 (347)
                      ++|.+++... ..+++..+..++.+++.+|.|||+.|++|+||+|+||++   +.++.++|+|||++.........  ..
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccccCCC
Confidence            9999988764 357899999999999999999999999999999999999   66778999999998754332211  11


Q ss_pred             cccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHh
Q 019040          214 IVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM  291 (347)
Q Consensus       214 ~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  291 (347)
                      ..++..|+|||++. +.++.++||||||+++|++++ |..||...........+....   .......++..+.+++.+|
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~  230 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY---RMSCPQKCPDDVYKVMQRC  230 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHHHHHHHHHH
Confidence            23356799999876 458899999999999999998 999998887766655554432   2222346789999999999


Q ss_pred             ccCCCCCCCCHHHHhcC
Q 019040          292 LEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       292 l~~dp~~Rps~~~ll~h  308 (347)
                      |+.+|++||++.++++.
T Consensus       231 l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         231 WDYKPENRPKFSELQKE  247 (250)
T ss_pred             cccCcccCCCHHHHHHH
Confidence            99999999999999753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-38  Score=282.06  Aligned_cols=252  Identities=29%  Similarity=0.500  Sum_probs=208.7

Q ss_pred             ceeeeeeecccCCeEEEEEEECC-CCceeEEeEeccccc-------cchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRD-TRELLACKSISKRKL-------RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .|++.+.||.|+||.||+|.+.. +++.+|+|.+.....       ........+.+|+.++....+|+|++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37889999999999999999987 678899998864321       2233455677888888764499999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          124 DNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      .+..++++||+++++|.+++..    ...+++..++.++.|++.+|.+||+ .|++|+||+|+||++   +.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence            9999999999999999988743    3458999999999999999999996 789999999999999   6678899999


Q ss_pred             eccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC
Q 019040          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       199 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  277 (347)
                      ||.+.............++..|++||.+.+ .++.++|+||||+++|+|++|..||...........+........  ..
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~  235 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL--PE  235 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--Cc
Confidence            999987655444445678889999998764 488999999999999999999999988777666665554433211  11


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ..++..+.++|.+||+.||++||++.++.++
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            2578999999999999999999999999765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=278.24  Aligned_cols=242  Identities=25%  Similarity=0.347  Sum_probs=200.1

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  136 (347)
                      +.||.|++|.||+|.+.. ++.|++|.+......  .....+.+|+++++.+ .|++++++++++...+..++++||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            468999999999999987 899999988654322  3456788999999999 999999999999999999999999999


Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcc---c
Q 019040          137 GELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---S  212 (347)
Q Consensus       137 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~---~  212 (347)
                      ++|.+++... ..++...+..++.+++.+|.|||++|++|+||+|+||++   +.++.++|+|||++.........   .
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccc
Confidence            9999998664 458899999999999999999999999999999999999   66778999999998765422111   1


Q ss_pred             ccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHH
Q 019040          213 EIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ  290 (347)
Q Consensus       213 ~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  290 (347)
                      ....+..|+|||.+. +.++.++|+||||+++++|++ |..||...........+....   .......++.++.+++.+
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~  230 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY---RMPAPQLCPEEIYRLMLQ  230 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC---CCCCCccCCHHHHHHHHH
Confidence            122355699999875 458999999999999999998 889998877665555554331   122234678999999999


Q ss_pred             hccCCCCCCCCHHHHhcC
Q 019040          291 MLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       291 ~l~~dp~~Rps~~~ll~h  308 (347)
                      ||..+|++||++.++++.
T Consensus       231 ~l~~~p~~Rp~~~ell~~  248 (251)
T cd05041         231 CWAYDPENRPSFSEIYNE  248 (251)
T ss_pred             HhccChhhCcCHHHHHHH
Confidence            999999999999999753

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.1e-38  Score=278.84  Aligned_cols=248  Identities=21%  Similarity=0.353  Sum_probs=204.3

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      +...++|++.+.||.|+||.||+|.+. .+..+++|.+...    ....+.+.+|+.+++.+ +|++++++++.+.. ..
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~   74 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EP   74 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CC
Confidence            345678999999999999999999865 4456999987543    22346788899999999 89999999999887 77


Q ss_pred             EEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      .++++||+++++|.+++...  ..++...+..++.|++.||.|||+.|++|+||+|+||++   +..+.++|+|||.+..
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~  151 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARV  151 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceee
Confidence            89999999999999999764  347888899999999999999999999999999999999   6678899999999876


Q ss_pred             cCCCCcc--cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          205 FKPGERF--SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       205 ~~~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      .......  ....++..|+|||++. +.++.++|+||||++++++++ |..||...+.......+....   ..+.....
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~  228 (260)
T cd05073         152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---RMPRPENC  228 (260)
T ss_pred             ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---CCCCcccC
Confidence            5432211  1223456799999876 458889999999999999998 999998887776666655442   22233467


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      +.++.+++.+||+.+|++||++.++++
T Consensus       229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         229 PEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.4e-38  Score=281.52  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=203.8

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCC---CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      .++|.+.+.||.|+||.||+|.+...   ...|++|......  .....+.+.+|+.+++.+ +|+|++++++++.+. .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~-~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQF-DHPHIVKLIGVITEN-P   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCchhceeEEEcCC-C
Confidence            45689999999999999999987644   3468899875432  133456788999999999 899999999988764 5


Q ss_pred             EEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .++|+||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeec
Confidence            779999999999999997754 58999999999999999999999999999999999999   56678999999998765


Q ss_pred             CCCCcc--cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          206 KPGERF--SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       206 ~~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ......  ....++..|+|||.+. ..++.++||||||++++++++ |..||......+....+..+...   .....++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~  234 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCP  234 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCC
Confidence            433211  1123346799999875 458899999999999999886 99999888877666665554322   2234788


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ..+.++|.+|+..+|++|||+.+++..
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-41  Score=277.29  Aligned_cols=266  Identities=28%  Similarity=0.499  Sum_probs=224.3

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .|.-...+.|+-...||+|.||.||+|+.+.+|+.||+|.+.-+......-+ ...+|+.+|..| +|+|++.++..+..
T Consensus        10 ~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpi-talreikiL~~l-kHenv~nliEic~t   87 (376)
T KOG0669|consen   10 EPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPI-TALREIKILQLL-KHENVVNLIEICRT   87 (376)
T ss_pred             CCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcH-HHHHHHHHHHHh-cchhHHHHHHHHhh
Confidence            4455556789999999999999999999999999999987755443333333 356699999999 99999999887753


Q ss_pred             --------CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCE
Q 019040          124 --------DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (347)
Q Consensus       124 --------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~  194 (347)
                              ...+|+|+.+|+. +|..++... -+++..++..++.+++.||.|+|...|+|||+|+.||||   +.++.+
T Consensus        88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgil  163 (376)
T KOG0669|consen   88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGIL  163 (376)
T ss_pred             ccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceE
Confidence                    2458999999976 888888665 469999999999999999999999999999999999999   788999


Q ss_pred             EEEeeccccccCCCC-----cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 019040          195 KAIDFGLSIFFKPGE-----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR  267 (347)
Q Consensus       195 ~l~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  267 (347)
                      +|.|||+++......     .....+-|.+|++||.+.+  .|+++.|||..||+|.+|+++.+.|.+.+....+..|..
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~  243 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ  243 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence            999999996543332     2344567999999998764  499999999999999999999999999999999998888


Q ss_pred             ccccccCCCCCCC-------------------------------CHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          268 GLIDFKRDPWPNV-------------------------------SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       268 ~~~~~~~~~~~~~-------------------------------~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ...+...+.|+++                               +++..+|+.++|..||.+|+++.++++|.||.+-.
T Consensus       244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence            8877777777531                               23667999999999999999999999999998764

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.5e-39  Score=285.08  Aligned_cols=248  Identities=26%  Similarity=0.411  Sum_probs=197.3

Q ss_pred             ceeeeeeecccCCeEEEEEEE----CCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--C
Q 019040           52 RYLVDRELGRGEFGVTYLCID----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--N  125 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~  125 (347)
                      -|++++.||+|+||.||+|+.    +.++..||+|.+....  .......+.+|+++++.+ +|+|++++.+++...  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCC
Confidence            468999999999999999984    4568889999986432  233456789999999999 999999999998775  6


Q ss_pred             eEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..++++||++|++|.+++.+.. .++...+..++.||+.||.|||++|++||||||+||++   +.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~  158 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKA  158 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCccccc
Confidence            7899999999999999987653 58999999999999999999999999999999999999   5677899999999886


Q ss_pred             cCCCCcc----cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHHH
Q 019040          205 FKPGERF----SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESE---------------QGVAQA  264 (347)
Q Consensus       205 ~~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------------~~~~~~  264 (347)
                      .......    ....++..|+|||.+. ..++.++||||||+++|+++++..|+.....               ......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            5433221    2234566799999875 4588999999999999999997765422110               111111


Q ss_pred             HHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +...   ...+.+..++..+.+|+.+||+.+|++|||+.+++++
T Consensus       239 ~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         239 LEEG---KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHcC---ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            1111   1122334688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.1e-38  Score=277.93  Aligned_cols=241  Identities=25%  Similarity=0.385  Sum_probs=201.2

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++.+.||.|+||.||++..  +++.||+|.+....     ....+.+|+.+++.+ +|+|++++++.+... ..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEE
Confidence            5799999999999999999964  77889999885431     235688899999999 999999999998765 47899


Q ss_pred             EEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          131 MELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||+++++|.+++....  .++...+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||.+......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceecccc
Confidence            99999999999997653  47899999999999999999999999999999999999   56778999999998764322


Q ss_pred             CcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          209 ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                        ......+..|+|||.+. +.++.++|+||||+++++|++ |..||...........+....   .......++..+.+
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  228 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---RMEPPEGCPADVYV  228 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---CCCCCCcCCHHHHH
Confidence              12223456799999876 458899999999999999997 999998888777666665542   22233467899999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcC
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ++.+||+.+|++||++.++++.
T Consensus       229 li~~~l~~~p~~Rp~~~~l~~~  250 (254)
T cd05083         229 LMTSCWETEPKKRPSFHKLREK  250 (254)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.4e-38  Score=281.07  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=195.7

Q ss_pred             cceeeeeeecccCCeEEEEEE----ECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee--C
Q 019040           51 DRYLVDRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--D  124 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~--~  124 (347)
                      .+|++.+.||.|+||.||+|.    +..++..||+|.+...   .......+.+|+++++.+ +|+|++++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCC
Confidence            478999999999999999997    4467889999998643   233456788999999999 99999999987643  3


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      ...++|+||+++++|.+++... ..++...+..++.|++.||.|||++|++|+||||+||++   +.++.++|+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~  156 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK  156 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccc
Confidence            5789999999999999999765 458999999999999999999999999999999999999   667789999999998


Q ss_pred             ccCCCCcc----cccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---------------HHH
Q 019040          204 FFKPGERF----SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQG---------------VAQ  263 (347)
Q Consensus       204 ~~~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------------~~~  263 (347)
                      ........    ....++..|+|||.+.+ .++.++||||||+++++|++|..++.......               ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            65433221    11123445999998764 48899999999999999999877653332110               001


Q ss_pred             HHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .......  ..+....++.++.++|.+||..+|++|||+.++++.
T Consensus       237 ~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         237 ELLKNNG--RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             HHHhcCC--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            1111111  112234678999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1e-38  Score=277.17  Aligned_cols=228  Identities=25%  Similarity=0.351  Sum_probs=187.4

Q ss_pred             cCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCchHH
Q 019040           62 GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD  141 (347)
Q Consensus        62 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  141 (347)
                      |.+|.||++.++.+++.||+|.+....        ...+|...+... .|||++++++++...+..++++||+++++|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999999999999999986542        122344444555 79999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccccCcccc
Q 019040          142 RIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM  221 (347)
Q Consensus       142 ~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~  221 (347)
                      ++.....+++..+..++.|++.||.|||++|++|+||||+||++   +.++.++++|||.+......  .....++..|+
T Consensus        75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcCcccc
Confidence            99887789999999999999999999999999999999999999   66778999999987654332  22335567799


Q ss_pred             cccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 019040          222 APEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL  300 (347)
Q Consensus       222 aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  300 (347)
                      |||.+. ..++.++|+||+|+++|++++|..||.......      ......  .....+++.+.++|.+||+.||++||
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~  221 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTL--NIPEWVSEEARSLLQQLLQFNPTERL  221 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------cccccc--CCcccCCHHHHHHHHHHccCCHHHhc
Confidence            999876 458899999999999999999998875433210      000111  11235788999999999999999999


Q ss_pred             CH-----HHHhcCccc
Q 019040          301 TA-----KQVLEHPWL  311 (347)
Q Consensus       301 s~-----~~ll~h~~~  311 (347)
                      ++     .++++||||
T Consensus       222 ~~~~~~~~~~~~h~~~  237 (237)
T cd05576         222 GAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCCccchHHHHcCCCC
Confidence            85     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.7e-38  Score=278.63  Aligned_cols=245  Identities=21%  Similarity=0.298  Sum_probs=192.0

Q ss_pred             eeecccCCeEEEEEEECC--CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEec
Q 019040           57 RELGRGEFGVTYLCIDRD--TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (347)
                      +.||.|+||.||+|....  ....+++|.+....  .......+.+|+.+++.+ +|+||+++++.+...+..++||||+
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeC
Confidence            358999999999996543  34568888765332  233345688899999999 9999999999999999999999999


Q ss_pred             CCCchHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          135 EGGELFDRIVARGH-----YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       135 ~~~~L~~~l~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ++++|.+++.....     .+...+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccch
Confidence            99999999976432     4677888999999999999999999999999999999   667889999999986533221


Q ss_pred             c---ccccccCcccccccccc--------ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-ccccCC-
Q 019040          210 R---FSEIVGSPYYMAPEVLK--------RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGL-IDFKRD-  275 (347)
Q Consensus       210 ~---~~~~~~~~~y~aPE~~~--------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~-  275 (347)
                      .   .....++..|+|||++.        ..++.++||||||+++|+|++ |..||......+......... ...+.+ 
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ  234 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence            1   12234567799999863        236789999999999999999 788998877666555544332 222222 


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ....++..+.+++..|+ .||++|||+.++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~  266 (269)
T cd05042         235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL  266 (269)
T ss_pred             ccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence            22367888899999998 599999999999753

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.2e-39  Score=281.56  Aligned_cols=240  Identities=18%  Similarity=0.279  Sum_probs=191.3

Q ss_pred             eeecccCCeEEEEEEECCCCc-------eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           57 RELGRGEFGVTYLCIDRDTRE-------LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      +.||.|+||.||+|.++..+.       .+++|.+...   .....+.+.+|+.+++.+ .|||++++++++...+..++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEE
Confidence            368999999999999865543       3888877533   223345678899999999 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC-----CCCEEEEeecccc
Q 019040          130 VMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE-----NSPLKAIDFGLSI  203 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~-----~~~~~l~Dfg~a~  203 (347)
                      ||||+++++|.+++.... .++...+..++.||+.||.|||++||+|+||||+||+++.++.     ...++++|||.+.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999999997654 4899999999999999999999999999999999999964322     1237999999987


Q ss_pred             ccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCG-VPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      .....   ....++..|+|||.+.+  .++.++||||||+++|+|++| ..||.......... ........+    ...
T Consensus       157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~----~~~  228 (258)
T cd05078         157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLP----APK  228 (258)
T ss_pred             ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCC----CCC
Confidence            65432   23457888999998864  478899999999999999998 46666555443332 222222222    245


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +.++.++|.+||+.||++|||+.++++.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         229 WTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            6889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-38  Score=278.23  Aligned_cols=240  Identities=19%  Similarity=0.224  Sum_probs=189.1

Q ss_pred             eeecccCCeEEEEEEECCC------------CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           57 RELGRGEFGVTYLCIDRDT------------RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      +.||.|+||.||+|+....            ...|++|++....   ......+.+|+.++..+ +||||+++++++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQV-SHKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence            3689999999999985422            2358888865432   23345678899999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC----CCCEEEEee
Q 019040          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE----NSPLKAIDF  199 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~----~~~~~l~Df  199 (347)
                      ...++++||+++++|..++... ..++...+..++.||+.||.|||++||+|+||||+||+++.+..    ...++++||
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999999998888654 45899999999999999999999999999999999999954221    123899999


Q ss_pred             ccccccCCCCcccccccCcccccccccc--ccCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhccccccCCC
Q 019040          200 GLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAILRGLIDFKRDP  276 (347)
Q Consensus       200 g~a~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  276 (347)
                      |.+......   ....++..|+|||.+.  ..++.++||||||+++|+|+ +|..||......+... .......    .
T Consensus       157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~----~  228 (262)
T cd05077         157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCM----L  228 (262)
T ss_pred             CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCcc----C
Confidence            988654322   2345788899999875  44889999999999999997 5888887665443332 2222111    1


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ....+.++.++|.+||+.||++||++.+|+++
T Consensus       229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            12346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.7e-38  Score=277.49  Aligned_cols=244  Identities=21%  Similarity=0.283  Sum_probs=191.3

Q ss_pred             eeecccCCeEEEEEEEC--CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEec
Q 019040           57 RELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (347)
                      +.||.|+||.||+|.+.  .++..+++|.+....  .......+.+|+.+++.+ +|+|++++++.+.+....++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECC
Confidence            36899999999999865  345678999875442  223345788899999999 9999999999999999999999999


Q ss_pred             CCCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          135 EGGELFDRIVARG-----HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       135 ~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ++++|.+++....     ..+...+..++.|++.||.|||++|++|+||||+||++   +.++.++|+|||.+.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcc
Confidence            9999999986532     35667788999999999999999999999999999999   567889999999986543221


Q ss_pred             c---ccccccCccccccccccc--------cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cccccCCC
Q 019040          210 R---FSEIVGSPYYMAPEVLKR--------NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG-LIDFKRDP  276 (347)
Q Consensus       210 ~---~~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~  276 (347)
                      .   .....++..|+|||++.+        .++.++||||||+++|+|++ |..||......+........ ....+.+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            1   122356778999998742        25789999999999999996 99999877766544333222 22222221


Q ss_pred             -CCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          277 -WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       277 -~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                       ....++.+.+++..|+ .+|++|||+.+++.
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence             1246788999999998 68999999999963

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.4e-40  Score=297.58  Aligned_cols=261  Identities=26%  Similarity=0.395  Sum_probs=220.0

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCC-----CCceeEeee
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK-----NSSIVSLKE  119 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~-----h~~i~~~~~  119 (347)
                      .++.+.++|.+....|.|-||+|.+|.|...|+.||||++..+..-    -+.-++|+++|++|..     ..+++.++.
T Consensus       426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            4566788999999999999999999999999999999999654321    1334569999999932     457899999


Q ss_pred             EEeeCCeEEEEEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEE
Q 019040          120 ACEDDNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (347)
Q Consensus       120 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l  196 (347)
                      +|...+++|||+|.+ ..+|.+.|++.+.   +....+..++.|++.||..|-.+||+|.||||.|||++  .....+||
T Consensus       502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKL  578 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKL  578 (752)
T ss_pred             HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeee
Confidence            999999999999999 5699999988653   88899999999999999999999999999999999996  45567999


Q ss_pred             EeeccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC
Q 019040          197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD  275 (347)
Q Consensus       197 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  275 (347)
                      ||||.|.....+. ...+.-+.-|+|||++.+ .|+...|+||.||+||||+||...|++.+...++...+.....++..
T Consensus       579 CDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K  657 (752)
T KOG0670|consen  579 CDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK  657 (752)
T ss_pred             ccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence            9999998876544 345566778999998765 59999999999999999999999999999999988887766555432


Q ss_pred             CC-------------------------------------------------CCC-------CHHHHHHHHHhccCCCCCC
Q 019040          276 PW-------------------------------------------------PNV-------SESAKSLVRQMLEPDPKLR  299 (347)
Q Consensus       276 ~~-------------------------------------------------~~~-------~~~~~~li~~~l~~dp~~R  299 (347)
                      .+                                                 +.+       -..+.+||..||..||++|
T Consensus       658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR  737 (752)
T KOG0670|consen  658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR  737 (752)
T ss_pred             HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence            11                                                 011       1466799999999999999


Q ss_pred             CCHHHHhcCccccc
Q 019040          300 LTAKQVLEHPWLQN  313 (347)
Q Consensus       300 ps~~~ll~h~~~~~  313 (347)
                      .|..++|+||||..
T Consensus       738 it~nqAL~HpFi~~  751 (752)
T KOG0670|consen  738 ITVNQALKHPFITE  751 (752)
T ss_pred             CCHHHHhcCCcccC
Confidence            99999999999964

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.4e-38  Score=279.78  Aligned_cols=245  Identities=26%  Similarity=0.364  Sum_probs=198.2

Q ss_pred             eeecccCCeEEEEEEECCCC------ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           57 RELGRGEFGVTYLCIDRDTR------ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      +.||.|+||.||+|+++..+      +.+++|.+....  .......+.+|+.+++.+ +|+||+++++++...+..+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEE
Confidence            35899999999999986544      679999875432  123356788899999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC--CCCCEEEEeecc
Q 019040          131 MELCEGGELFDRIVAR-------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK--ENSPLKAIDFGL  201 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~--~~~~~~l~Dfg~  201 (347)
                      +||+++++|.+++...       ..++...+..++.|++.||.|||+.+++|+||+|+||+++.++  ....++|+|||+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999999652       2378889999999999999999999999999999999996433  223799999999


Q ss_pred             ccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCC
Q 019040          202 SIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDP  276 (347)
Q Consensus       202 a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  276 (347)
                      +........   .....++..|+|||.+. +.++.++||||||+++|+|++ |..||...+.......+....   ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~  234 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG---RLQK  234 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC---ccCC
Confidence            876533221   12234567899999876 458999999999999999998 999998777666555544332   1122


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ...++..+.++|.+||..+|++||++.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3467899999999999999999999999865

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.1e-38  Score=276.56  Aligned_cols=243  Identities=22%  Similarity=0.356  Sum_probs=192.4

Q ss_pred             eeecccCCeEEEEEEECC---CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe-eCCeEEEEEE
Q 019040           57 RELGRGEFGVTYLCIDRD---TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-DDNAVHLVME  132 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~-~~~~~~lv~e  132 (347)
                      +.||.|+||.||+|.+..   .+..+|+|.+...  ........+.+|+.+++.+ +|||++++++++. .++..++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEe
Confidence            368999999999998753   3457999987432  2233456788899999999 9999999999765 4566889999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC--
Q 019040          133 LCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--  209 (347)
Q Consensus       133 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~--  209 (347)
                      |+.+++|.+++... ...+...+..++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||++.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence            99999999999764 346778888999999999999999999999999999999   567789999999987543221  


Q ss_pred             ---cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          210 ---RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       210 ---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                         ......++..|+|||.+. ..++.++||||||+++|+|++ |.+||...+.......+.....   ......++..+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  231 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR---LLQPEYCPDPL  231 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC---CCCCCcCCHHH
Confidence               111234567899999875 458899999999999999999 5677777666555555444321   11123568899


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcC
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+++..||..+|++||++.++++.
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.8e-38  Score=277.60  Aligned_cols=237  Identities=19%  Similarity=0.215  Sum_probs=189.4

Q ss_pred             eeecccCCeEEEEEEECCCC----------ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           57 RELGRGEFGVTYLCIDRDTR----------ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      +.||.|+||.||+|.+..++          ..+++|.+....    .....+.+|+.+++.+ +|+|++++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQL-SHKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcC-CCcchhheeeEEec-CC
Confidence            46899999999999998776          347777765332    1156788999999999 89999999999888 77


Q ss_pred             EEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC----CCCCEEEEeecc
Q 019040          127 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----ENSPLKAIDFGL  201 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~----~~~~~~l~Dfg~  201 (347)
                      .++|+||+++++|.+++.... .++...+..++.||+.||.|||+.||+|+||||+||+++.+.    ....++|+|||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            899999999999999998765 689999999999999999999999999999999999995432    112699999999


Q ss_pred             ccccCCCCcccccccCccccccccccc---cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCC
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  277 (347)
                      +.....   .....++..|+|||++.+   .++.++||||||+++|++++ |..||...+.......... ....+.   
T Consensus       155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~~---  227 (259)
T cd05037         155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLPM---  227 (259)
T ss_pred             cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCCC---
Confidence            886543   223356778999998753   48899999999999999999 5788877654333332221 111111   


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                       .....+.++|.+||..+|++|||+.++++
T Consensus       228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         228 -PDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence             22378999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.6e-38  Score=281.77  Aligned_cols=255  Identities=13%  Similarity=0.142  Sum_probs=188.1

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCC---CceeEEeEeccccccchhc--------HHHHHHHHHHHHhCCCCCcee
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVD--------IDDVRREVAIMKHLPKNSSIV  115 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~--------~~~~~~ei~~l~~l~~h~~i~  115 (347)
                      +...++|++.+.||+|+||+||+|.+..+   +..+++|+...........        ......+...+..+ .|++++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~   86 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIP   86 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCC
Confidence            34457999999999999999999999877   6677887654322111000        01122233445556 799999


Q ss_pred             EeeeEEeeCC----eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCC
Q 019040          116 SLKEACEDDN----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (347)
Q Consensus       116 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~  191 (347)
                      .+++.+....    ..+++++++. .++.+.+......++..+..++.|++.||.|||++||+||||||+|||+   +.+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~  162 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGN  162 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCC
Confidence            9998765543    4567788773 4777777665557888999999999999999999999999999999999   567


Q ss_pred             CCEEEEeeccccccCCCC--------cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HH
Q 019040          192 SPLKAIDFGLSIFFKPGE--------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GV  261 (347)
Q Consensus       192 ~~~~l~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~  261 (347)
                      +.++|+|||+|.......        ......||+.|+|||.+.+ .++.++||||||+++++|++|..||...... ..
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            789999999987653221        1122368999999998764 4899999999999999999999999877332 21


Q ss_pred             HHHHH----hccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          262 AQAIL----RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       262 ~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .....    ..... .....+.+++.+.+++..|+..+|++||++.++++
T Consensus       243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        243 IHAAKCDFIKRLHE-GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHhHHHHHHHhhh-hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11111    11111 11123466899999999999999999999999875

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.9e-38  Score=282.83  Aligned_cols=249  Identities=22%  Similarity=0.300  Sum_probs=200.9

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCc----eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRE----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .++|++.+.||.|+||.||+|.+..++.    .+|+|.+....  .......+.+|+.+++.+ +|+|++++++++... 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-
Confidence            4578899999999999999999987776    46888775432  222334688899999999 999999999998754 


Q ss_pred             eEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..++++||+++++|.+++.... .++...+..++.|++.||.|||++||+|+||||+||++   +.++.++|+|||++..
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARL  158 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEcccccccc
Confidence            4678999999999999987653 58999999999999999999999999999999999999   5667899999999986


Q ss_pred             cCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          205 FKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       205 ~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ......   .....++..|+|||.+. ..++.++||||||+++|++++ |..||.+.........+... ...  ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~--~~~~~  235 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG-ERL--PQPPI  235 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCC--CCCCC
Confidence            543222   12234567899999876 458899999999999999997 89999877655544444332 222  22246


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ++.++.+++..||..+|++||++.++++.
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         236 CTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.8e-39  Score=313.97  Aligned_cols=256  Identities=28%  Similarity=0.424  Sum_probs=203.7

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee-----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-----  123 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~-----  123 (347)
                      ....|+.++.||+||||.||+++++-+|++||||.+....  ....-..+.+|+..+.+| +||||++++..|.+     
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCcc
Confidence            4567899999999999999999999999999999997654  344456799999999999 99999998855411     


Q ss_pred             --------------------------------------------------------------------------------
Q 019040          124 --------------------------------------------------------------------------------  123 (347)
Q Consensus       124 --------------------------------------------------------------------------------  123 (347)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------C--------CeEEEEEEecCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHH
Q 019040          124 --------------------------D--------NAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLC  168 (347)
Q Consensus       124 --------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~i~~qi~~~l~~l  168 (347)
                                                +        ..+||-||||+..++.+++..+... .....|+++++|++||.|+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence                                      0        2368889999987777777666443 4778999999999999999


Q ss_pred             HHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC------------------CC-CcccccccCcccccccccc--
Q 019040          169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK------------------PG-ERFSEIVGSPYYMAPEVLK--  227 (347)
Q Consensus       169 H~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~------------------~~-~~~~~~~~~~~y~aPE~~~--  227 (347)
                      |+.|||||||||.|||+   +....|||+|||+|+...                  .+ ...+..+||.-|+|||++.  
T Consensus       714 H~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99999999999999999   577779999999998721                  00 1234568999999999985  


Q ss_pred             c--cCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 019040          228 R--NYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQ  304 (347)
Q Consensus       228 ~--~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  304 (347)
                      .  .|+.++|+||||++++||+.   ||.. +.....+..+..+....+...+..--+.-..+|+.|++.||++|||+.+
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence            2  58999999999999999994   4533 2333455555544444432223333455578999999999999999999


Q ss_pred             HhcCccccc
Q 019040          305 VLEHPWLQN  313 (347)
Q Consensus       305 ll~h~~~~~  313 (347)
                      +|++.||-.
T Consensus       868 LL~s~llpp  876 (1351)
T KOG1035|consen  868 LLNSELLPP  876 (1351)
T ss_pred             HhhccCCCc
Confidence            999999986

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.6e-38  Score=280.60  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=200.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECC----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee--C
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRD----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--D  124 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~--~  124 (347)
                      ..|++.+.||.|+||.||+|.+..    ++..+|+|++......  .....+.+|+++++.+ .|+|++++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTL-DHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhC-CCCChheEEeeeecCCC
Confidence            467888999999999999998653    4788999998754322  3457799999999999 99999999999877  5


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      ...++++||+++++|.+++.... .++...+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||.+.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~  157 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK  157 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence            68999999999999999997764 58999999999999999999999999999999999999   567889999999998


Q ss_pred             ccCCCCcc----cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHH
Q 019040          204 FFKPGERF----SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQG--------------VAQA  264 (347)
Q Consensus       204 ~~~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~  264 (347)
                      ........    ....++..|++||.+. ..++.++||||||+++++|++|..||.......              ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            76533221    1223455699999875 458899999999999999999999986543221              1111


Q ss_pred             HHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .......  .+....++.++.+++.+||..+|++|||+.++++.
T Consensus       238 ~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05038         238 LLKEGER--LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI  279 (284)
T ss_pred             HHHcCCc--CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            1111111  12224678899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.3e-38  Score=279.12  Aligned_cols=239  Identities=17%  Similarity=0.195  Sum_probs=189.2

Q ss_pred             eecccCCeEEEEEEECCC------------------------CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCc
Q 019040           58 ELGRGEFGVTYLCIDRDT------------------------RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS  113 (347)
Q Consensus        58 ~lg~G~~g~V~~a~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~  113 (347)
                      .||+|+||.||+|....+                        ...|++|++....   ......+.+|+.+++.+ +|+|
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l-~h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQV-SHIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcC-CCCC
Confidence            689999999999975321                        2358888875432   22335677889999999 9999


Q ss_pred             eeEeeeEEeeCCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC---
Q 019040          114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK---  189 (347)
Q Consensus       114 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~---  189 (347)
                      |+++++++...+..++||||+++++|..++.. .+.++...+..++.||+.||.|||++||+||||||+||+++...   
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999988865 45689999999999999999999999999999999999996421   


Q ss_pred             -CCCCEEEEeeccccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHH
Q 019040          190 -ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAI  265 (347)
Q Consensus       190 -~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~  265 (347)
                       ....++++|||.+......   ....++..|+|||.+.+  .++.++||||||+++|+++ +|..||...........+
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  234 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY  234 (274)
T ss_pred             CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence             2234899999987653322   22357788999998753  4889999999999999985 689999877655443322


Q ss_pred             HhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          266 LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      . .....+    ...+..+.++|.+||+.+|++|||+.+++++
T Consensus       235 ~-~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         235 E-KKHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             H-hccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            2 211111    2346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.5e-39  Score=264.00  Aligned_cols=258  Identities=28%  Similarity=0.528  Sum_probs=213.8

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--Ce
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NA  126 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--~~  126 (347)
                      -.++|++.+.+|.|.++.||.|....+++.++||+++      ....+.+.+|+.+|+.|.++|||++++++..+.  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK------PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec------hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            4578999999999999999999999999999999985      334578999999999998899999999998764  66


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      ..+|+||+...+...+.   ..++...+..++.+++.||.|+|+.||+|||+||.||+|+  .+...++|+|+|+|....
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcC
Confidence            88999999887665443   2478888999999999999999999999999999999996  455569999999999999


Q ss_pred             CCCcccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcc--------------
Q 019040          207 PGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAE-SEQGVAQAILRGL--------------  269 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~--------------  269 (347)
                      ++...+-.+.+..|.-||.+.  ..|+.+-|+|||||++..|++.+.||... +..+.+..+-+-+              
T Consensus       185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence            998888888888999999876  45999999999999999999998887443 3334333331111              


Q ss_pred             ----------ccccCCCCC---------CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          270 ----------IDFKRDPWP---------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       270 ----------~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                .......|.         -++++..+|+.++|..|.++|+|+.+++.||||....+.
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence                      011112221         356899999999999999999999999999999876544

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.5e-38  Score=277.17  Aligned_cols=248  Identities=21%  Similarity=0.338  Sum_probs=198.9

Q ss_pred             eeeeeeecccCCeEEEEEEECC---CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC----
Q 019040           53 YLVDRELGRGEFGVTYLCIDRD---TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN----  125 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~----  125 (347)
                      |.+.+.||+|+||.||+|.++.   +++.||+|++..+. ......+.+.+|+++++.+ +|||++++++++...+    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCc
Confidence            6778899999999999998653   57889999986543 2333467788999999999 8999999999876532    


Q ss_pred             --eEEEEEEecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          126 --AVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       126 --~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                        ..+++++|+.+++|..++...      ..++...+..++.|++.||.|||++||+|+||||+||++   +.++.++|+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence              347888999999998887532      147888999999999999999999999999999999999   667889999


Q ss_pred             eeccccccCCCCc---ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccc
Q 019040          198 DFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDF  272 (347)
Q Consensus       198 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  272 (347)
                      |||++........   .....+++.|++||.+.. .++.++||||||+++|+|++ |..||...+.......+.....  
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--  233 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR--  233 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc--
Confidence            9999886543221   122234567999998764 48889999999999999999 8899987776665555544321  


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                       .......+..+.+++.+||+.+|++|||+.+++++
T Consensus       234 -~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         234 -LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             11223678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-40  Score=271.91  Aligned_cols=262  Identities=21%  Similarity=0.277  Sum_probs=215.2

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++.+-+..||.|+||+|++..++.+|+.+|||.+.....  ..+..++..|.....+-.++|+|+++||..-.++..|+-
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC  141 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC  141 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence            344567789999999999999999999999999976553  344577888999888888999999999999999999999


Q ss_pred             EEecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          131 MELCEGGELFDRIVA-----RGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ||+|+- +|..+.+.     ...++++-+..+.-.+..||.||-.. +||||||||+|||+   +..|.+||||||.+..
T Consensus       142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQ  217 (361)
T ss_pred             HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHh
Confidence            999954 77554432     34689999999999999999999865 89999999999999   7788899999999887


Q ss_pred             cCCCCcccccccCcccccccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccccC--CCCC
Q 019040          205 FKPGERFSEIVGSPYYMAPEVLK---RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKR--DPWP  278 (347)
Q Consensus       205 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~--~~~~  278 (347)
                      +...-..+...|-..|+|||.+.   ..|+.++||||||++|+|+.||..|+...+.. +.+.++..+....-.  ..+-
T Consensus       218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~  297 (361)
T KOG1006|consen  218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV  297 (361)
T ss_pred             HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence            66555555567888999999885   34999999999999999999999999776652 444444444432211  1122


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  318 (347)
                      ..+..+..+|..||.+|-++||...+++++||++......
T Consensus       298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~  337 (361)
T KOG1006|consen  298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEG  337 (361)
T ss_pred             ccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcC
Confidence            4788999999999999999999999999999998876543

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-38  Score=291.06  Aligned_cols=259  Identities=31%  Similarity=0.512  Sum_probs=220.5

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .-|-.++.||-|+||.|.++....+...||.|.+.+..+........++.|-.||... ..+-|+++|-.|++.+.+|+|
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEE
Confidence            4588899999999999999999999999999999888777777788899999999999 889999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC----
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK----  206 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~----  206 (347)
                      |+|++||++..+|-+.+-|.+..++.++..+..|+++.|..|+|||||||+||||   |.+|+|||+|||+++...    
T Consensus       708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceeccc
Confidence            9999999999999999899999999999999999999999999999999999999   889999999999987421    


Q ss_pred             -----CCCc----------------------------------ccccccCcccccccccc-ccCCCchhHHHHHHHHHHH
Q 019040          207 -----PGER----------------------------------FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYIL  246 (347)
Q Consensus       207 -----~~~~----------------------------------~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l  246 (347)
                           .+..                                  ....+||+.|+|||++. ..|+...|+||.|++||+|
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                 0000                                  01246999999999976 5699999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCC---CHHHHhcCcccccC
Q 019040          247 LCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL---TAKQVLEHPWLQNA  314 (347)
Q Consensus       247 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~  314 (347)
                      +.|..||...++.+.-..+.+=........+.+++.++.++|.+++.- ++.|.   .+.++..||||+..
T Consensus       865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~s-ad~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCS-ADSRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcC-hhhhhcccchhhhhcCcccccc
Confidence            999999988776654433333222233344568999999999987764 67777   46789999999865

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=303.75  Aligned_cols=261  Identities=23%  Similarity=0.352  Sum_probs=223.2

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCC---ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTR---ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      +..+.-.+...|.+.||.|.||.|++|+.+..+   ..||||.++.-.  .......|..|..|+-++ .||||+++.|+
T Consensus       622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQF-dHPNIIrLEGV  698 (996)
T KOG0196|consen  622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIRLEGV  698 (996)
T ss_pred             hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccC-CCCcEEEEEEE
Confidence            444555667789999999999999999998766   469999985432  334457799999999999 99999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                      ......+.||.|||+.|+|..+|+.+ +.|...++..+++.|+.|++||-+.|+|||||...|||+   +.+..+|++||
T Consensus       699 VTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDF  775 (996)
T KOG0196|consen  699 VTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDF  775 (996)
T ss_pred             EecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccc
Confidence            99999999999999999999999886 569999999999999999999999999999999999999   77888999999


Q ss_pred             ccccccCCCCcc--cccc--cCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccc
Q 019040          200 GLSIFFKPGERF--SEIV--GSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK  273 (347)
Q Consensus       200 g~a~~~~~~~~~--~~~~--~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  273 (347)
                      |+++...+....  +..-  -..+|+|||.+. .+++.++||||+|++|||.++ |+-||+....++++..+.++.   +
T Consensus       776 GLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy---R  852 (996)
T KOG0196|consen  776 GLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY---R  852 (996)
T ss_pred             cceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc---C
Confidence            999876544321  1111  246799999986 779999999999999999665 999999999999999998874   3


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .++..++|..+.+|+..||++|-++||.+.||+.+  |.+..
T Consensus       853 LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~--lDklI  892 (996)
T KOG0196|consen  853 LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST--LDKLI  892 (996)
T ss_pred             CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH--HHHHh
Confidence            44445899999999999999999999999999876  54444

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.8e-37  Score=267.64  Aligned_cols=242  Identities=43%  Similarity=0.740  Sum_probs=205.7

Q ss_pred             CCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCchHHH
Q 019040           63 EFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDR  142 (347)
Q Consensus        63 ~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  142 (347)
                      +||.||+|.+..+++.+++|++........  .+.+.+|++.++.+ +|++++++++.+......++++|++++++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            589999999999999999999875433221  57899999999999 999999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccccCccccc
Q 019040          143 IVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA  222 (347)
Q Consensus       143 l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~a  222 (347)
                      +.....++...+..++.+++.++.+||+.|++|+||+|.||++   +.++.++|+|||.+.............++..|++
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            9887668999999999999999999999999999999999999   5568899999999987765544455678889999


Q ss_pred             ccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 019040          223 PEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL  300 (347)
Q Consensus       223 PE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  300 (347)
                      ||... ..++.++||||||++++++++|..||.. .........+......... ....++.++.+++.+||..+|++||
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-ccccCCHHHHHHHHHHccCCchhcc
Confidence            99875 4588899999999999999999999987 4444444444443332221 1112889999999999999999999


Q ss_pred             CHHHHhcCccc
Q 019040          301 TAKQVLEHPWL  311 (347)
Q Consensus       301 s~~~ll~h~~~  311 (347)
                      ++.++++||||
T Consensus       234 ~~~~~~~~~~~  244 (244)
T smart00220      234 TAEEALQHPFF  244 (244)
T ss_pred             CHHHHhhCCCC
Confidence            99999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.1e-37  Score=271.32  Aligned_cols=244  Identities=19%  Similarity=0.267  Sum_probs=190.0

Q ss_pred             eeecccCCeEEEEEEECCCC--ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEec
Q 019040           57 RELGRGEFGVTYLCIDRDTR--ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (347)
                      +.||.|+||.||+|.+...+  ..+++|.+....  .......+.+|+.+++.+ +|||++++++.+......+++|||+
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecC
Confidence            36899999999999764332  345666654432  223456789999999999 9999999999999999999999999


Q ss_pred             CCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          135 EGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       135 ~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      ++++|.+++.+.    ...+...+..++.||+.||.|||+.+++|+||||+||++   +.++.++|+|||++....... 
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchh
Confidence            999999998764    235667788999999999999999999999999999999   667889999999876432211 


Q ss_pred             --cccccccCccccccccccc--------cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc-ccc-CCC
Q 019040          210 --RFSEIVGSPYYMAPEVLKR--------NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLI-DFK-RDP  276 (347)
Q Consensus       210 --~~~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~-~~~-~~~  276 (347)
                        ......++..|+|||++..        .++.++||||||+++|+|++ |..||......+....+..... ... +..
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL  234 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence              1123457888999998632        25678999999999999997 5778877776665555443322 211 222


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ....++.+.+++..|| .+|++||++.++++
T Consensus       235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            2357888999999999 67999999999964

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-38  Score=285.93  Aligned_cols=264  Identities=22%  Similarity=0.357  Sum_probs=222.8

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .........||.|.||.||.|.|+.-.-.||||.++.+.    -.+..|.+|..+++.+ +|||+++++++|..+..+||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYI  340 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYI  340 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEE
Confidence            344566778999999999999999999999999986443    3457899999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          130 VMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |.|||..|+|.+||++++.  ++.-.+..++.||..|++||..+++||||+-..|+|+   .++..||+.|||+++.+..
T Consensus       341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcC
Confidence            9999999999999998755  6777788899999999999999999999999999999   7889999999999998764


Q ss_pred             CCcccccc---cCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          208 GERFSEIV---GSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       208 ~~~~~~~~---~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ... ....   -...|.|||.+. +.++.++|||+||++|||+.| |..||.+-+...++..+.++.   +-....+||+
T Consensus       418 DTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy---RM~~PeGCPp  493 (1157)
T KOG4278|consen  418 DTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY---RMDGPEGCPP  493 (1157)
T ss_pred             Cce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc---cccCCCCCCH
Confidence            432 2222   355699999876 779999999999999999998 889999999888877776653   3344568999


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHH
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR  329 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~  329 (347)
                      ....|++.||+++|.+||++.++  |.-|....  ....++++|...
T Consensus       494 kVYeLMraCW~WsPsDRPsFaei--HqafEtmf--~~sSisdEV~ke  536 (1157)
T KOG4278|consen  494 KVYELMRACWNWSPSDRPSFAEI--HQAFETMF--SSSSISDEVQKE  536 (1157)
T ss_pred             HHHHHHHHHhcCCcccCccHHHH--HHHHHHHh--ccccccHHHHHH
Confidence            99999999999999999999998  54455542  334555555433

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-38  Score=286.32  Aligned_cols=245  Identities=25%  Similarity=0.393  Sum_probs=204.6

Q ss_pred             ceeeeeeecccCCeEEEEEEECCC--Cc--eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDT--RE--LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .....+.||.|.||.||.|.....  |+  -||||..+.+.  ...+.+.|..|..+++.+ +||||++++|++.+. ..
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~-P~  465 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ-PM  465 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc-ce
Confidence            345567799999999999986532  33  47778765433  444578899999999999 999999999999765 78


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      |||||+++-|.|..+++.++ .++...+..++.||+.||.|||+.++|||||-..|||+.+.   .-|||+|||+++...
T Consensus       466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp---~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP---QCVKLADFGLSRYLE  542 (974)
T ss_pred             eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc---ceeeecccchhhhcc
Confidence            99999999999999998764 48999999999999999999999999999999999999654   349999999999876


Q ss_pred             CCCcccccc--cCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          207 PGERFSEIV--GSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       207 ~~~~~~~~~--~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .........  ....|||||.++ ..++.++|||-||++|||+++ |..||.+....+++-.+.++.   +.+..+.+|+
T Consensus       543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe---RlP~P~nCPp  619 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE---RLPCPPNCPP  619 (974)
T ss_pred             ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC---CCCCCCCCCh
Confidence            655443323  355699999886 679999999999999999776 999999998887776666653   3344468999


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHh
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVL  306 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll  306 (347)
                      .+..|+.+||+.+|.+||++.++.
T Consensus       620 ~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  620 ALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHHHHHHHhccCcccCCcHHHHH
Confidence            999999999999999999988774

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=292.40  Aligned_cols=260  Identities=23%  Similarity=0.302  Sum_probs=220.7

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCC---CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      .++..+.+.||+|+||.|++|.|+..   ...||||++......  ...++|.+|+.++.+| .|++++++||+..+ ..
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L-~H~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKL-QHPHLIRLYGVVLD-QP  184 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhc-cCcceeEEeeeecc-ch
Confidence            45677889999999999999999853   346899998655433  2678999999999999 99999999999988 67


Q ss_pred             EEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..+|+|+++.|+|.+.|.+.  ..|....+-.++.||+.|+.||.++++||||+-..|+|+   .....|||+|||+.+.
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll---asprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL---ASPRTVKICDFGLMRA  261 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee---cccceeeeecccceec
Confidence            88999999999999999873  348888999999999999999999999999999999999   5566799999999998


Q ss_pred             cCCCCcccc----cccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          205 FKPGERFSE----IVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       205 ~~~~~~~~~----~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      +..++..-.    ..-...|+|||.++ ..++.++|||++|+++|||++ |+.||.+...-.+++.+..+..   .+...
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er---LpRPk  338 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER---LPRPK  338 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc---CCCCC
Confidence            876654322    22345699999987 679999999999999999998 8899999999888888874432   23334


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                      .++++++++++.||+.+|.+||++..|.+.-++..++...-
T Consensus       339 ~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~a  379 (1039)
T KOG0199|consen  339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVA  379 (1039)
T ss_pred             CChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCcee
Confidence            78999999999999999999999999998888877765433

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-39  Score=281.84  Aligned_cols=267  Identities=30%  Similarity=0.443  Sum_probs=221.7

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc----hhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT----AVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .+.++|.++..||.|+|+.||+|.|...+++||||+-..+..=.    ..-.+...+|..|.+.| .||.|+++|+++..
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSL  538 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeee
Confidence            46789999999999999999999999999999999865443211    11234566799999999 99999999999975


Q ss_pred             C-CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          124 D-NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       124 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                      + +.+|-|+|||+|.+|.-+|+..+.+++..++.|+-||..||.||.+..  |||-|+||.|||+......|.+||+|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            4 678889999999999999999888999999999999999999999874  9999999999999988888999999999


Q ss_pred             cccccCCCCc--------ccccccCcccccccccc-c----cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH--
Q 019040          201 LSIFFKPGER--------FSEIVGSPYYMAPEVLK-R----NYGPEIDIWSAGVILYILLCGVPPFWAESEQG-VAQA--  264 (347)
Q Consensus       201 ~a~~~~~~~~--------~~~~~~~~~y~aPE~~~-~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~--  264 (347)
                      ++.++.....        .+...||.+|++||.+. +    ..+.+.||||.|+++|..+.|+.||....... +++.  
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            9998754422        23457999999999763 2    37789999999999999999999997665442 2221  


Q ss_pred             H-HhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          265 I-LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       265 ~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      | ......|++.  +.++++..+||++||+..-++|....++..||+|......
T Consensus       699 IlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rr  750 (775)
T KOG1151|consen  699 ILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRR  750 (775)
T ss_pred             hhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhh
Confidence            1 2222344433  4789999999999999999999999999999999875544

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=281.13  Aligned_cols=256  Identities=22%  Similarity=0.341  Sum_probs=213.7

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+...+++.||+|-||.|.++.... +..||+|.+....  .......|.+||++|.+| +||||+.++++|..++.+++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHH
Confidence            4567899999999999999998643 6889999986543  344467899999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          130 VMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |+||++.|+|..++.+...  .......+++.||+.|++||.+.++|||||.+.|+|+   +.++++||+|||+++..-.
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCccccccccc
Confidence            9999999999999988733  3455667899999999999999999999999999999   8889999999999996644


Q ss_pred             CCcc---cccccCccccccccc-cccCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhcccccc----CCCC
Q 019040          208 GERF---SEIVGSPYYMAPEVL-KRNYGPEIDIWSAGVILYILLC--GVPPFWAESEQGVAQAILRGLIDFK----RDPW  277 (347)
Q Consensus       208 ~~~~---~~~~~~~~y~aPE~~-~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~  277 (347)
                      +...   ...+...+|||+|.+ .++++.++|+|+||++|||+++  ...||....++.+.++.-.......    ....
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P  769 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP  769 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence            4332   234567899999975 5889999999999999998665  7889999988877776644433222    2333


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +-+|..+.++|.+||..|-.+||+++++  |.+|++.
T Consensus       770 ~~cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq~~  804 (807)
T KOG1094|consen  770 PACPQGLYELMLRCWRRESEQRPSFEQL--HLFLQED  804 (807)
T ss_pred             CcCcHHHHHHHHHHhchhhhcCCCHHHH--HHHHHHh
Confidence            5789999999999999999999999999  6566543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.3e-37  Score=295.93  Aligned_cols=258  Identities=21%  Similarity=0.300  Sum_probs=176.1

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCC----CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDT----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA----  120 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~----  120 (347)
                      ..++|.+.+.||+|+||.||+|.+..+    +..||+|.+.....     .+....+  .+... .+.++..+...    
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~-~~~~~~~~~~~~~~~  201 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRA-CPNSCADFVYGFLEP  201 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhh-chhhHHHHHHhhhcc
Confidence            457899999999999999999999988    89999998753211     1111111  11111 12222111111    


Q ss_pred             --EeeCCeEEEEEEecCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCcEeeCC
Q 019040          121 --CEDDNAVHLVMELCEGGELFDRIVARGH--------------------YTERAAAAVTRTIVEVVQLCHKHGVIHRDL  178 (347)
Q Consensus       121 --~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~~l~~lH~~~ivH~Di  178 (347)
                        .......++|+||+++++|.+++.....                    .....+..++.||+.||.|||++||+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              2456789999999999999998865421                    123446689999999999999999999999


Q ss_pred             CCCcEEeecCCCCCCEEEEeeccccccCCCC--cccccccCcccccccccc-c----------------------cCCCc
Q 019040          179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVLK-R----------------------NYGPE  233 (347)
Q Consensus       179 kp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~-~----------------------~~~~~  233 (347)
                      ||+|||++  ++++.+||+|||++.......  ......+++.|+|||.+. .                      .++.+
T Consensus       282 KP~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        282 KPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             CHHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999995  245789999999997543322  224457899999999652 1                      12345


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----------cccC-------CCCCCCCHHHHHHHHHhccCCC
Q 019040          234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI----------DFKR-------DPWPNVSESAKSLVRQMLEPDP  296 (347)
Q Consensus       234 ~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------~~~~-------~~~~~~~~~~~~li~~~l~~dp  296 (347)
                      +|||||||++|+|+++..++.... ......+.....          ....       ..........++||.+||+.||
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            699999999999999776643221 111111111000          0000       0011223456699999999999


Q ss_pred             CCCCCHHHHhcCcccccCcCC
Q 019040          297 KLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       297 ~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      .+|||+.++|+||||+.....
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCcc
Confidence            999999999999999886544

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-38  Score=290.60  Aligned_cols=204  Identities=30%  Similarity=0.498  Sum_probs=178.9

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC------
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD------  124 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~------  124 (347)
                      .-+.-.+.||.|+||.||+|+++.+|+.||||.+....  .....+..-+|++++++| +|+||++++++-+..      
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCccc
Confidence            34566778999999999999999999999999987654  444567888999999999 799999999886544      


Q ss_pred             CeEEEEEEecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC-CCCCEEEEeec
Q 019040          125 NAVHLVMELCEGGELFDRIVAR---GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFG  200 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~-~~~~~~l~Dfg  200 (347)
                      ....++||||.||+|...+.+-   ..+++..+..++..+..||.|||++||+||||||.||++.... .....||+|||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            4678999999999999999653   4599999999999999999999999999999999999997533 33457999999


Q ss_pred             cccccCCCCcccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAES  257 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  257 (347)
                      .|+...++.......||+.|.+||++.  +.|+...|.||||+++|+.+||..||....
T Consensus       170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            999999998889999999999999986  558999999999999999999999995443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=284.96  Aligned_cols=270  Identities=26%  Similarity=0.427  Sum_probs=220.7

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe-----eC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-----DD  124 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~-----~~  124 (347)
                      .+.|+|.+.||.|.+|.||+++.+.+++..|+|+.....    ..-+.+..|.++++.+..|||++.+++++.     .+
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            356899999999999999999999999999999986432    222457779999999999999999999986     35


Q ss_pred             CeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 NAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      +.+|||||||.||+..++++..  ..+.+..+..|++.++.||.+||.+.++|||||-.|||+   ..++.|||+|||.+
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVS  170 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeeeee
Confidence            7899999999999999999764  458999999999999999999999999999999999999   78889999999998


Q ss_pred             cccCCC-CcccccccCccccccccccc------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC
Q 019040          203 IFFKPG-ERFSEIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD  275 (347)
Q Consensus       203 ~~~~~~-~~~~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  275 (347)
                      ...... ....+.+|||.|||||++..      .|+..+|+||||++..||.-|.+|+..+-+...+-.|-+.. .....
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PPkLk  249 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPKLK  249 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-Ccccc
Confidence            776433 33456789999999999852      37778999999999999999999998777654333222211 11111


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhhhh
Q 019040          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQF  333 (347)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~  333 (347)
                      .+..-+..+.++|..||.+|..+||+..++|+|||+....      +..++..-++.-
T Consensus       250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~------~e~qir~~ik~~  301 (953)
T KOG0587|consen  250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP------NERQVRIQIKDH  301 (953)
T ss_pred             chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc------cHHHHHHHHHHH
Confidence            1234467889999999999999999999999999999443      666665555443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=264.31  Aligned_cols=257  Identities=26%  Similarity=0.423  Sum_probs=214.2

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--  124 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--  124 (347)
                      .+...||.-++.+|.|+- .|.-|.|.-.++.|++|..... .......++..+|...+..+ .|+|+++++.++.-.  
T Consensus        13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~   89 (369)
T KOG0665|consen   13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKT   89 (369)
T ss_pred             eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhh-cccceeeeeeccCcccc
Confidence            345678999999999998 8899999999999999998765 55666778899999999999 999999999988533  


Q ss_pred             ----CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          125 ----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       125 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                          ...|+|||+++. +|...+..  .+...++..+..|++.|++|||+.||+|||+||+||++   ..+..+||.|||
T Consensus        90 l~~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg  163 (369)
T KOG0665|consen   90 LEEFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFG  163 (369)
T ss_pred             HHHHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccch
Confidence                568999999955 88888873  47889999999999999999999999999999999999   677889999999


Q ss_pred             cccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc------
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK------  273 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  273 (347)
                      +|......-..+.++.+..|+|||++. ..+....||||+||++.||++|...|.+.+.-+...++........      
T Consensus       164 ~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  164 LARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             hhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            999876665667788999999999865 4499999999999999999999999988765554444433321110      


Q ss_pred             -------------------------CCCC-------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 019040          274 -------------------------RDPW-------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (347)
Q Consensus       274 -------------------------~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  312 (347)
                                               ...|       ..-...+++++.+||..||++|.|+.++|.|||++
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                     0001       01235568999999999999999999999999997

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4e-35  Score=275.98  Aligned_cols=259  Identities=20%  Similarity=0.287  Sum_probs=184.7

Q ss_pred             cccceeeeeeecccCCeEEEEEEEC----------------CCCceeEEeEeccccccch-----------hcHHHHHHH
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDR----------------DTRELLACKSISKRKLRTA-----------VDIDDVRRE  101 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~----------------~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e  101 (347)
                      -.++|.+.+.||+|+||+||+|.+.                ..++.||||.+........           ...+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3578999999999999999999753                2346799999854321100           011223446


Q ss_pred             HHHHHhCCCCCc-----eeEeeeEEee--------CCeEEEEEEecCCCchHHHHHhcC---------------------
Q 019040          102 VAIMKHLPKNSS-----IVSLKEACED--------DNAVHLVMELCEGGELFDRIVARG---------------------  147 (347)
Q Consensus       102 i~~l~~l~~h~~-----i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~---------------------  147 (347)
                      +.++.++ +|++     ++.+++++..        .+..++|+||+++++|.+++....                     
T Consensus       223 ~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        223 AYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777777 4443     3556666542        356899999999999999886421                     


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccc--cccCccccc
Q 019040          148 ---HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE--IVGSPYYMA  222 (347)
Q Consensus       148 ---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~--~~~~~~y~a  222 (347)
                         .++...+..++.|++.+|.|||+.+|+||||||+||++   +.++.++|+|||++...........  -.+++.|+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence               13456788899999999999999999999999999999   5667899999999876543322222  234789999


Q ss_pred             ccccccc---------------------CC--CchhHHHHHHHHHHHHhCCC-CCCCCCHHH-----------HHHHHHh
Q 019040          223 PEVLKRN---------------------YG--PEIDIWSAGVILYILLCGVP-PFWAESEQG-----------VAQAILR  267 (347)
Q Consensus       223 PE~~~~~---------------------~~--~~~Di~slG~~l~~l~~g~~-pf~~~~~~~-----------~~~~~~~  267 (347)
                      ||.+...                     ++  ...||||+|+++++|+++.. ||.......           ....+..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            9976421                     11  24699999999999999875 664321110           0111111


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHhccCCC---CCCCCHHHHhcCccccc
Q 019040          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDP---KLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rps~~~ll~h~~~~~  313 (347)
                      ..  .....+...++..++|+.+||..+|   .+|+|+.++|+||||..
T Consensus       459 ~~--~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        459 QK--YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cC--CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            12  2223455788999999999999766   68999999999999964

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-38  Score=260.70  Aligned_cols=258  Identities=26%  Similarity=0.423  Sum_probs=213.7

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC-----Ce
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD-----NA  126 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~-----~~  126 (347)
                      +.+-.+.||.|+||.||.+.|..+|+.|++|.+. +-+.+....+++-+|++++..+ +|.|++..++...-.     +.
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~p-nvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMP-NVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcc-hHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHH
Confidence            4556788999999999999999999999999874 3455666778899999999999 999999998887644     34


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .|++.|++.. +|+.++..-..++...++-+++||+.||+|||+.||.||||||.|.|+   +.+..+||||||+++...
T Consensus       132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccc
Confidence            6788888855 898888887889999999999999999999999999999999999999   678889999999998765


Q ss_pred             CCC--cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC-------
Q 019040          207 PGE--RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD-------  275 (347)
Q Consensus       207 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------  275 (347)
                      ..+  .....+-|..|+|||++.+  .|+.+.||||.||++.|++..+..|....+-+.++.|...+.....+       
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            443  2344567889999999864  49999999999999999999999998888777776665544321110       


Q ss_pred             --------------C---------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          276 --------------P---------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       276 --------------~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                    .         ......+...++.+++.+||+.|.+..+++.|+++....
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence                          0         012334567899999999999999999999999987654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=284.68  Aligned_cols=253  Identities=28%  Similarity=0.424  Sum_probs=198.9

Q ss_pred             eeeeeeecccCCe-EEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           53 YLVDRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        53 y~i~~~lg~G~~g-~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      |.-.+.+|.|+.| .||+|..  .|+.||||.+-.+      -.+...+|+..|+.-..||||+++++.-.+.++.||..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            3445567899887 6899976  7889999998433      33567889999999999999999999999999999999


Q ss_pred             EecCCCchHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC--CCCCEEEEeecccccc
Q 019040          132 ELCEGGELFDRIVARG-H---YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK--ENSPLKAIDFGLSIFF  205 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~-~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~--~~~~~~l~Dfg~a~~~  205 (347)
                      |.|. .+|.+++.... .   ......+.++.|++.||.+||+.+|||||+||-||||...+  ...+++|+|||++..+
T Consensus       583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            9995 59999997741 1   12244678899999999999999999999999999998643  3457899999999988


Q ss_pred             CCCCc----ccccccCcccccccccccc-CCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          206 KPGER----FSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCG-VPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       206 ~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ..++.    .....||.+|+|||++... -+.+.|||||||++|+.++| .+||...-..  ..+|..+......-.. .
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~-~  738 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEP-L  738 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeecc-C
Confidence            66543    3556899999999998754 56689999999999998875 8999655432  2344444433221111 1


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      ...+..+||.+|++++|..||++.++|.||||=+....
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekr  776 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKR  776 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHH
Confidence            11278999999999999999999999999999655433

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=277.37  Aligned_cols=253  Identities=23%  Similarity=0.353  Sum_probs=207.8

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECC-------CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRD-------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      +...++..+.+.||.|.||.|++|....       ....||||........  .+.+.+..|+++++.+.+|+|++.+++
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            3334445677799999999999997541       1456899988654322  567889999999999999999999999


Q ss_pred             EEeeCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcE
Q 019040          120 ACEDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (347)
Q Consensus       120 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NI  183 (347)
                      .+...+..++|.||+..|+|.++++.++                .++...+..++.||+.|++||++..+||||+-..||
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV  449 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV  449 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence            9999999999999999999999998876                388889999999999999999999999999999999


Q ss_pred             EeecCCCCCCEEEEeeccccccCCCCcccc--cc--cCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 019040          184 LFANKKENSPLKAIDFGLSIFFKPGERFSE--IV--GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAES  257 (347)
Q Consensus       184 li~~~~~~~~~~l~Dfg~a~~~~~~~~~~~--~~--~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  257 (347)
                      |+   ..+..+||+|||+|+..........  -.  ....|||||.+.. .++.++||||+|++|||+++ |..|+.+..
T Consensus       450 Li---~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  450 LI---TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             Ee---cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99   6778899999999986544333221  12  2445999998874 59999999999999999998 889998855


Q ss_pred             -HHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          258 -EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       258 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                       ..+..+.+..+..   ......+++++.++++.||+.+|++||++.++.+
T Consensus       527 ~~~~l~~~l~~G~r---~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  527 PTEELLEFLKEGNR---MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             cHHHHHHHHhcCCC---CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence             5555554544432   2333477999999999999999999999999854

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=5.3e-35  Score=256.71  Aligned_cols=262  Identities=29%  Similarity=0.485  Sum_probs=206.4

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECC---CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRD---TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      ...+.+.|.++..||.|.|++||+|++..   .+++||+|.+...     ....++.+|+++|..+.++.||+++.+.+.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhc
Confidence            33456789999999999999999999987   7889999988643     234679999999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          123 DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       123 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      .++++.+|+||++.....++...   ++...+..+++.++.||.++|.+|||||||||+|+|.+  ...+...|+|||+|
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLA  180 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhH
Confidence            99999999999999888777755   57889999999999999999999999999999999997  45667899999998


Q ss_pred             cccC-----------------C--CC--------------------------cccccccCccccccccccc--cCCCchh
Q 019040          203 IFFK-----------------P--GE--------------------------RFSEIVGSPYYMAPEVLKR--NYGPEID  235 (347)
Q Consensus       203 ~~~~-----------------~--~~--------------------------~~~~~~~~~~y~aPE~~~~--~~~~~~D  235 (347)
                      ....                 +  +.                          ..-...||++|+|||++.+  .-+++.|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7210                 0  00                          0012469999999998763  4788999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH--------------Hhcc-------------------cc----------
Q 019040          236 IWSAGVILYILLCGVPPFWAESEQ-GVAQAI--------------LRGL-------------------ID----------  271 (347)
Q Consensus       236 i~slG~~l~~l~~g~~pf~~~~~~-~~~~~~--------------~~~~-------------------~~----------  271 (347)
                      |||.|++++.++++..||...... +.+..+              ..+.                   ..          
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            999999999999999998433211 111000              0000                   00          


Q ss_pred             ---ccCCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          272 ---FKRDPW-PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       272 ---~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                         .....+ ...+..+.+++.+||..||.+|+|++++|+||||....+.
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~  390 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT  390 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence               001111 1244588999999999999999999999999999966543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.2e-34  Score=294.73  Aligned_cols=244  Identities=22%  Similarity=0.278  Sum_probs=184.5

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ..+.....||.|+||.||+|+++.++..||+|.+.....       ....|++.++++ +||||+++++++.+.+..++|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKL-QHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhC-CCCCcceEEEEEEcCCCCEEE
Confidence            346667789999999999999999999999998854321       112468889999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH---KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |||+++++|.+++..   +++..+..++.|++.||.|||   +.+|+||||||+||++   +.++..++. ||.......
T Consensus       762 ~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        762 HEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-ecccccccc
Confidence            999999999999853   788999999999999999999   6699999999999999   455556654 555433221


Q ss_pred             CCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcc--------cc--ccC
Q 019040          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ--GVAQAILRGL--------ID--FKR  274 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~--------~~--~~~  274 (347)
                      .   ....+++.|+|||++.+ .++.++||||||+++|||++|+.||......  ..........        ..  ...
T Consensus       835 ~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 D---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             C---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence            1   22367899999998764 5999999999999999999999998543211  1111110000        00  000


Q ss_pred             --CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          275 --DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       275 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                        ........++.+++.+||+.||++|||+.++++.  ++..
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~  951 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT--LESA  951 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH--HHHh
Confidence              0000122356789999999999999999999876  4444

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=249.36  Aligned_cols=252  Identities=23%  Similarity=0.360  Sum_probs=194.4

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhC-CCCCceeEeeeEEe
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL-PKNSSIVSLKEACE  122 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l-~~h~~i~~~~~~~~  122 (347)
                      .-..++..+..+.+.||+|.||.||+|.+  .|+.||||++...      +.+...+|.++++.. -+|+||+.+++.-.
T Consensus       204 LVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~  275 (513)
T KOG2052|consen  204 LVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADN  275 (513)
T ss_pred             HhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence            34567788999999999999999999998  5778999999533      346677788877742 38999999987754


Q ss_pred             eC----CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEeeCCCCCcEEeecCCC
Q 019040          123 DD----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH--------GVIHRDLKPENFLFANKKE  190 (347)
Q Consensus       123 ~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~Dikp~NIli~~~~~  190 (347)
                      .+    .++|+|.+|-+.|||.++|.+ ..++.+...+++..++.||.+||..        .|.|||||..||||   ..
T Consensus       276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kk  351 (513)
T KOG2052|consen  276 KDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KK  351 (513)
T ss_pred             cCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---cc
Confidence            33    579999999999999999988 4799999999999999999999953        39999999999999   78


Q ss_pred             CCCEEEEeeccccccCCCC-----cccccccCccccccccccccCC-------CchhHHHHHHHHHHHHhC---------
Q 019040          191 NSPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYMAPEVLKRNYG-------PEIDIWSAGVILYILLCG---------  249 (347)
Q Consensus       191 ~~~~~l~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~-------~~~Di~slG~~l~~l~~g---------  249 (347)
                      ++++.|+|+|+|.......     ..+..+||.+|||||++.....       ..+||||||+++||+...         
T Consensus       352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee  431 (513)
T KOG2052|consen  352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE  431 (513)
T ss_pred             CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence            8999999999998765542     2355689999999999864322       259999999999998863         


Q ss_pred             -CCCCCCCCHH-----HHHHHHHhccc-cccCCCCCCCC--HHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          250 -VPPFWAESEQ-----GVAQAILRGLI-DFKRDPWPNVS--ESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       250 -~~pf~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~--~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                       .+||.+..+.     ++..-+.-... ...+..|...+  ..+..+|+.||..+|.-|.|+.-+.+
T Consensus       432 y~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  432 YQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             hcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence             4677554432     22221111111 12233343322  45568999999999999999887743

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=225.51  Aligned_cols=213  Identities=23%  Similarity=0.340  Sum_probs=177.2

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+....+..||.|++|.|-+.++..+|...|+|.+...-  +....+++.+|+.+..+...+|+++.++|.+..+..+|+
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            344556778999999999999999999999999986432  344557788899988887789999999999999999999


Q ss_pred             EEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          130 VMELCEGGELFDRIV----ARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       130 v~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      .||.++. +|..+.+    .....++..+-+++..+..||.|||++ .++|||+||+|||+   +.+|++|+||||.+..
T Consensus       123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGY  198 (282)
T ss_pred             eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEccccccee
Confidence            9999954 7766543    346699999999999999999999987 89999999999999   7889999999999987


Q ss_pred             cCCCCcccccccCcccccccccc-----ccCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhc
Q 019040          205 FKPGERFSEIVGSPYYMAPEVLK-----RNYGPEIDIWSAGVILYILLCGVPPFWAE-SEQGVAQAILRG  268 (347)
Q Consensus       205 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~  268 (347)
                      +.+.-..+...|-..|+|||.+.     ..|+.++||||||++++||.+++.||... ++-+.+.++...
T Consensus       199 L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  199 LVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             ehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            76554444456778899999875     24899999999999999999999999554 344555555544

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-33  Score=247.83  Aligned_cols=241  Identities=24%  Similarity=0.357  Sum_probs=187.5

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC-CCCceeEeeeEEeeCC----
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-KNSSIVSLKEACEDDN----  125 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~-~h~~i~~~~~~~~~~~----  125 (347)
                      ...++.+.||+|.||.||+|..  +++.||||++.      ..+.+.+.+|-.+++... .|+||+.+++.-+...    
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            4567888999999999999976  66999999995      344567888888877552 6999999998876655    


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CcEeeCCCCCcEEeecCCCCCCEEE
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH---------GVIHRDLKPENFLFANKKENSPLKA  196 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------~ivH~Dikp~NIli~~~~~~~~~~l  196 (347)
                      .+++|++|.+.|+|.++|+.+ ..+.....+++..|++||+|||+.         .|+|||||..||||   .+++++.|
T Consensus       282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccI  357 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCI  357 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEe
Confidence            899999999999999999776 689999999999999999999963         49999999999999   78899999


Q ss_pred             EeeccccccCCCCc---ccccccCcccccccccccc--CC-----CchhHHHHHHHHHHHHhCCCC------------CC
Q 019040          197 IDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKRN--YG-----PEIDIWSAGVILYILLCGVPP------------FW  254 (347)
Q Consensus       197 ~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~-----~~~Di~slG~~l~~l~~g~~p------------f~  254 (347)
                      +|||+|....+...   .-..+||.+|||||++.+.  +.     .+.||||+|++|||+++....            |.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            99999998765543   2346899999999999754  22     258999999999999985432            21


Q ss_pred             -----CCCHHHHHHHHHhccccc-cCCCCC--CCCHHHHHHHHHhccCCCCCCCCHH
Q 019040          255 -----AESEQGVAQAILRGLIDF-KRDPWP--NVSESAKSLVRQMLEPDPKLRLTAK  303 (347)
Q Consensus       255 -----~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~  303 (347)
                           ....+++...+.+..... .+..|.  .-..-+++.+..||..||+.|.|+.
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence                 111223333333322211 112222  2335678999999999999999987

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-34  Score=257.00  Aligned_cols=199  Identities=31%  Similarity=0.525  Sum_probs=176.6

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHH-----HHHHHHHHHHhCC--CCCceeEeeeEEeeC
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDID-----DVRREVAIMKHLP--KNSSIVSLKEACEDD  124 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~ei~~l~~l~--~h~~i~~~~~~~~~~  124 (347)
                      .|..++.+|.|+||.|++|.++++...|+||.+.++.+..+..++     .+--||+||..+.  .|+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            489999999999999999999999999999999988765443322     3566999999993  299999999999999


Q ss_pred             CeEEEEEEec-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELC-EGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      +.+|+++|-- +|.+|.+++.....+++.....|++|++.|+++||+.||||||||-+||.+   +.+|-+||+|||.+.
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsaa  718 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSAA  718 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccchh
Confidence            9999999954 577999999988889999999999999999999999999999999999999   788889999999987


Q ss_pred             ccCCCCcccccccCcccccccccccc--CCCchhHHHHHHHHHHHHhCCCCCC
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFW  254 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~  254 (347)
                      .... .+.....||..|.|||++++.  .+.+-|||+||++||.++..+.||.
T Consensus       719 ~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  719 YTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            6543 355667899999999999854  6788999999999999999999985

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-33  Score=261.17  Aligned_cols=245  Identities=24%  Similarity=0.324  Sum_probs=205.9

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCc----eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRE----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      .+..+.||+|+||+||+|.+--.|+    +||+|++....  ....-..+.+|+-++.++ +|||++++++++..+. +-
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HH
Confidence            4556789999999999999875554    57888875443  333456788999999999 9999999999998887 77


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          129 LVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      ||++|+++|+|.++++.. .++-......|..||+.|+.|||.++++||||-..||||   ..-..+||.|||+++....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCc
Confidence            899999999999999875 458889999999999999999999999999999999999   5666799999999998765


Q ss_pred             CCcc-ccc--ccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          208 GERF-SEI--VGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       208 ~~~~-~~~--~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .... ...  .-.+.|+|-|.+. ..++.++||||+|+++||++| |..|+.+...+++-..+..+.-   .+..+.++.
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR---LsqPpiCti  927 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER---LSQPPICTI  927 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc---CCCCCCccH
Confidence            4332 211  2345699999876 559999999999999999888 9999999998888877776653   444568899


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      +++.++.+||..|++.||+++++.+
T Consensus       928 DVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHHHHHH
Confidence            9999999999999999999998854

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=2.6e-31  Score=224.81  Aligned_cols=210  Identities=44%  Similarity=0.715  Sum_probs=183.8

Q ss_pred             ecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCc
Q 019040           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (347)
Q Consensus        59 lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  138 (347)
                      ||.|++|.||++.+..+++.+++|++.......  ....+.+|++.++.+ .|++++++++++......++++|++++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999998889999999987543221  356799999999999 88999999999999999999999999899


Q ss_pred             hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC-CCCEEEEeeccccccCCCC-cccccc
Q 019040          139 LFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE-NSPLKAIDFGLSIFFKPGE-RFSEIV  215 (347)
Q Consensus       139 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~-~~~~~l~Dfg~a~~~~~~~-~~~~~~  215 (347)
                      |.+++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++   . ++.++|+|||.+....... ......
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcchhhccc
Confidence            99998776 4689999999999999999999999999999999999994   4 6789999999988654432 123345


Q ss_pred             cCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhcc
Q 019040          216 GSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (347)
Q Consensus       216 ~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (347)
                      +...|++||....  .++.+.|+|++|++++++                                   ..+.+++..|++
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence            7888999998764  688899999999999998                                   568899999999


Q ss_pred             CCCCCCCCHHHHhcCc
Q 019040          294 PDPKLRLTAKQVLEHP  309 (347)
Q Consensus       294 ~dp~~Rps~~~ll~h~  309 (347)
                      .+|++||++.++++|+
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=233.60  Aligned_cols=264  Identities=25%  Similarity=0.373  Sum_probs=207.8

Q ss_pred             CCCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE-E
Q 019040           43 GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA-C  121 (347)
Q Consensus        43 ~~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~-~  121 (347)
                      ..+.-.+.+.|.|.+.||+|.||.+-+|.++.++..+++|.+.+.    ....+.+.+|...--.|+.|.||+.-|++ |
T Consensus        16 el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF   91 (378)
T KOG1345|consen   16 ELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAF   91 (378)
T ss_pred             cccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence            356667889999999999999999999999999999999999754    44567899999888888889999887765 7


Q ss_pred             eeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       122 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                      +..+.+++++||++.|+|.+-+... .+-+.....++.|++.|+.|||++++||||||.+||||-. .+..+|||||||.
T Consensus        92 qt~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~-~df~rvKlcDFG~  169 (378)
T KOG1345|consen   92 QTSDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD-ADFYRVKLCDFGL  169 (378)
T ss_pred             hcCceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec-CCccEEEeeeccc
Confidence            7888999999999999998877553 5788899999999999999999999999999999999975 3445899999999


Q ss_pred             ccccCCCCcccccccCcccccccccc----cc--CCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcccc
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLK----RN--YGPEIDIWSAGVILYILLCGVPPFWAESE----QGVAQAILRGLID  271 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~----~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~  271 (347)
                      .+..+.-  ....--+..|.+||.+.    +.  ..+.+|+|.||++++..++|..||.....    -....+.......
T Consensus       170 t~k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~  247 (378)
T KOG1345|consen  170 TRKVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP  247 (378)
T ss_pred             ccccCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc
Confidence            8764322  22223345689999763    22  56789999999999999999999953221    1222233333333


Q ss_pred             ccCCCCCCCCHHHHHHHHHhccCCCCCC---CCHHHHhcCcccccC
Q 019040          272 FKRDPWPNVSESAKSLVRQMLEPDPKLR---LTAKQVLEHPWLQNA  314 (347)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~~ll~h~~~~~~  314 (347)
                      .-+..+...++.+..++++-|.++|++|   -+++......|....
T Consensus       248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence            3334445678889999999999999999   666666666776543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=259.71  Aligned_cols=260  Identities=27%  Similarity=0.455  Sum_probs=221.3

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      +..++|++++.+|.|.+|.||+|+|+.+++..|+|+++.+.   ..+..-+++|+-+++.. +|+||+.+++.+...+..
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecC-CCcChHHHHhhhhhhcCc
Confidence            45678999999999999999999999999999999998663   44556788899999999 999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |+.||||.|++|.+...-.+++++.++..+.+..+.+|+|||+.|-+|||||-.||++   .+.+.+|+.|||.+..+..
T Consensus        88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchhhhhh
Confidence            9999999999999988888899999999999999999999999999999999999999   6778899999998876543


Q ss_pred             C-CcccccccCccccccccc----cccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc-CCCCCCCC
Q 019040          208 G-ERFSEIVGSPYYMAPEVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-RDPWPNVS  281 (347)
Q Consensus       208 ~-~~~~~~~~~~~y~aPE~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  281 (347)
                      . -+.....||+.|||||+-    .+.|...+|||++|++..|+---..|....-+...+..+.+.....+ ......-+
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws  244 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS  244 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence            2 233557899999999974    35699999999999999999887777666666555555544433322 22223456


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +.+.+|++.+|..+|++||++..+|.|||....
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            788999999999999999999999999998665

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=3e-31  Score=230.80  Aligned_cols=249  Identities=19%  Similarity=0.251  Sum_probs=205.2

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCC-----ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe-e
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTR-----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-D  123 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~-~  123 (347)
                      ..|++....+.+|.||.||.|.+.+.+     +.|.+|.++...  ..-....+..|.-.+..+ .|||+..+.++.. +
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIED  359 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcC-cCCCccceeEEEeec
Confidence            456888888999999999999887543     456677664332  344566788899999999 8999999998865 4


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEE
Q 019040          124 DNAVHLVMELCEGGELFDRIVAR--------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~  195 (347)
                      ....++++.+..-++|..++..+        ..++..++..++.|++.|++|||+.|+||.||-..|++|   ++..++|
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVk  436 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVK  436 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEE
Confidence            57788889999888999999732        136677788999999999999999999999999999999   6778999


Q ss_pred             EEeeccccccCCCCcc---cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 019040          196 AIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLI  270 (347)
Q Consensus       196 l~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  270 (347)
                      |+|=.+++...+.+..   ........||+||.+. ..|+.++|+||||++||||+| |..|+-.-++.++..-+..+.-
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR  516 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR  516 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence            9999999877655432   2234566799999986 459999999999999999998 8999999999998888877753


Q ss_pred             cccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      -.   ..-++|+++..++.-||+.+|++||+..|+..
T Consensus       517 la---QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  517 LA---QPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ec---CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            32   23389999999999999999999999999853

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.9e-30  Score=220.56  Aligned_cols=211  Identities=41%  Similarity=0.707  Sum_probs=180.0

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      |.+.+.||.|++|.||+|.+..+++.+++|.+......  .....+.+|++.++.+ +|++++++++.+...+..++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEe
Confidence            56788999999999999999988999999998765332  2457888999999999 89999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC--
Q 019040          133 LCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--  209 (347)
Q Consensus       133 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~--  209 (347)
                      ++++++|.+++..... ++...+..++.+++.++.+||+.+++|+||+|.||++   +.++.++|+|||.+.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc
Confidence            9999999999988766 8999999999999999999999999999999999999   556889999999988765443  


Q ss_pred             cccccccCccccccccc-c-ccCCCchhHHHHHHHHHHHHhCCCCCCC-CC-HHHHHHHHHhcc
Q 019040          210 RFSEIVGSPYYMAPEVL-K-RNYGPEIDIWSAGVILYILLCGVPPFWA-ES-EQGVAQAILRGL  269 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~-~-~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~-~~~~~~~~~~~~  269 (347)
                      ......++..|++||.+ . ..++.++|+|+||++++++++|+.||.. .+ ...+.+.+..+.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            33445678889999987 3 3477899999999999999999999977 33 335555555543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-29  Score=207.25  Aligned_cols=255  Identities=20%  Similarity=0.237  Sum_probs=208.3

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .+.....++|++++.||.|+||.+|+|....+|..||||+-....     .-.++..|..+.+.|+.-..++.+..+..+
T Consensus         8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e   82 (341)
T KOG1163|consen    8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTE   82 (341)
T ss_pred             hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccc
Confidence            344556789999999999999999999999999999999975432     224577799999999888899999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      ..+-.+||++. |.+|.+++.-+ ..++..++..++-|++.-++|+|.++++||||||+|+|..-......+.++|||+|
T Consensus        83 ~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   83 KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence            99999999999 89999998765 46999999999999999999999999999999999999987667778999999999


Q ss_pred             cccCCCC--------cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhccc
Q 019040          203 IFFKPGE--------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA---ILRGLI  270 (347)
Q Consensus       203 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~  270 (347)
                      ...-+..        ......||.+|++-....+ .-+...|+-|+|.+|.++-.|.+||.+..+....+.   |.+-..
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~  241 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM  241 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence            8764332        2244679999999776654 478899999999999999999999988876544333   333322


Q ss_pred             ccc-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 019040          271 DFK-RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQ  304 (347)
Q Consensus       271 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  304 (347)
                      +.+ ...|.+.|.++.-.+..|=..--++-|...-
T Consensus       242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y  276 (341)
T KOG1163|consen  242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY  276 (341)
T ss_pred             CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence            222 2345688999999999997777777777543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=6.4e-29  Score=212.32  Aligned_cols=249  Identities=20%  Similarity=0.270  Sum_probs=200.0

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      +.-.|++.+.||+|+||.++.|++.-++++||||.-..     ..+..++..|....+.|...++|+.+|-+...+.+-.
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            34579999999999999999999999999999998653     3345778899999999999999999999989999999


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC--CCCCCEEEEeecccccc
Q 019040          129 LVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK--KENSPLKAIDFGLSIFF  205 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~--~~~~~~~l~Dfg~a~~~  205 (347)
                      +|+|++ |.+|.+++.-+ ..|+..++..++.||+.-++++|++++|.|||||+|+||...  .+...|.|+|||+|..+
T Consensus       101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999999 89999999776 459999999999999999999999999999999999999742  23446899999999987


Q ss_pred             CCCCcc--------cccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccccc-
Q 019040          206 KPGERF--------SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQG---VAQAILRGLIDF-  272 (347)
Q Consensus       206 ~~~~~~--------~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~-  272 (347)
                      .++...        ....||.+||+-....+ .-++..|+.|||.++++++.|.+||.+.....   -.+.|-...... 
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~  259 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP  259 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence            655432        34579999999876554 48889999999999999999999998876543   333332222111 


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHH
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAK  303 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  303 (347)
                      ....+.++|.++...++..=..+-.+-|...
T Consensus       260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd  290 (449)
T KOG1165|consen  260 IEVLCEGFPEEFATYLRYVRRLDFFETPDYD  290 (449)
T ss_pred             HHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence            1223446777777777666666666666543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=3.5e-30  Score=259.43  Aligned_cols=197  Identities=19%  Similarity=0.262  Sum_probs=142.8

Q ss_pred             CceeEeeeEE-------eeCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcE
Q 019040          112 SSIVSLKEAC-------EDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (347)
Q Consensus       112 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NI  183 (347)
                      +||..+++++       .....+++++|++ +++|.+++... ..++...+..++.||+.||.|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            4555555554       2234567778888 55999999753 4589999999999999999999999999999999999


Q ss_pred             EeecC----------------CCCCCEEEEeeccccccCCCC-----------------cccccccCcccccccccc-cc
Q 019040          184 LFANK----------------KENSPLKAIDFGLSIFFKPGE-----------------RFSEIVGSPYYMAPEVLK-RN  229 (347)
Q Consensus       184 li~~~----------------~~~~~~~l~Dfg~a~~~~~~~-----------------~~~~~~~~~~y~aPE~~~-~~  229 (347)
                      |+...                +.++.+|++|||++.......                 ......+|+.|+|||++. ..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            99431                234567778888775421100                 001135788999999876 45


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCc
Q 019040          230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP  309 (347)
Q Consensus       230 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  309 (347)
                      ++.++|||||||+||||++|..|+....  .....+.....  ++ ..........+++..||+++|.+||++.++++||
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PP-QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Ch-hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            9999999999999999999988864322  12222222111  11 1112245567899999999999999999999999


Q ss_pred             ccccC
Q 019040          310 WLQNA  314 (347)
Q Consensus       310 ~~~~~  314 (347)
                      ||...
T Consensus       267 ~~~~~  271 (793)
T PLN00181        267 FINEP  271 (793)
T ss_pred             hhhhh
Confidence            99864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=7.8e-28  Score=217.80  Aligned_cols=253  Identities=23%  Similarity=0.280  Sum_probs=197.2

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCC-ceeEEeEeccccccchhcHHHHHHHHHHHHhCC---CCCceeEeeeEE-eeCCe
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTR-ELLACKSISKRKLRTAVDIDDVRREVAIMKHLP---KNSSIVSLKEAC-EDDNA  126 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~---~h~~i~~~~~~~-~~~~~  126 (347)
                      +|.+.+.||.|+||.||.|.+..++ ..+|+|+.........   ..+..|..++..+.   ..++++.+++.. .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999998775 6799998765432221   15677888888885   246889999888 57889


Q ss_pred             EEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC--CCCCEEEEeeccc
Q 019040          127 VHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK--ENSPLKAIDFGLS  202 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~--~~~~~~l~Dfg~a  202 (347)
                      .|+||+.+ |.+|.++....  +.++..++..++.|++.+|++||+.|++||||||.|+++....  +...++|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999999 88999988655  4699999999999999999999999999999999999997432  2257999999999


Q ss_pred             c--ccCCCC--------c-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 019040          203 I--FFKPGE--------R-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI  270 (347)
Q Consensus       203 ~--~~~~~~--------~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  270 (347)
                      +  ......        . .....||..|+++.+..+ ..+++.|+|||+.++.++..|..||...........+.....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8  321111        1 123459999999998765 489999999999999999999999977664333333332222


Q ss_pred             cccCC-CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          271 DFKRD-PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       271 ~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ..... .....+..+.++...+-..+..++|....+.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            22222 233566788888888888999999998888655

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.7e-27  Score=197.03  Aligned_cols=162  Identities=27%  Similarity=0.325  Sum_probs=126.7

Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccc
Q 019040          137 GELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV  215 (347)
Q Consensus       137 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~  215 (347)
                      |+|.+++... ..+++..++.++.||+.||.|||+.+      ||+||++   +.++.+++  ||.+.......    ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence            5889999874 45999999999999999999999999      9999999   67778888  99987654322    26


Q ss_pred             cCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccccC---CCCCCCCH--HHHHHH
Q 019040          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKR---DPWPNVSE--SAKSLV  288 (347)
Q Consensus       216 ~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~--~~~~li  288 (347)
                      |++.|+|||++.+ .++.++||||||+++|+|++|..||...... .....+.........   .....++.  .+.++|
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            8899999998864 5899999999999999999999999665432 233333332221111   01112333  689999


Q ss_pred             HHhccCCCCCCCCHHHHhcCccccc
Q 019040          289 RQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                      ..||..+|.+||++.++++|+|+..
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHHH
Confidence            9999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=1.2e-24  Score=196.37  Aligned_cols=259  Identities=36%  Similarity=0.568  Sum_probs=207.9

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.............+.+|+.+++.+..+++++.+.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999987   77999998776544433567899999999999444489999999988888899999


Q ss_pred             ecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC-CEEEEeeccccccCCC
Q 019040          133 LCEGGELFDRIVARG---HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS-PLKAIDFGLSIFFKPG  208 (347)
Q Consensus       133 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~-~~~l~Dfg~a~~~~~~  208 (347)
                      ++.++++.+++....   .++......++.|++.++.++|+.|++|||+||+||++   +... .++++|||.+......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCcceecCCC
Confidence            999999997776664   68999999999999999999999999999999999999   4555 6999999998754433


Q ss_pred             C-------cccccccCccccccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcccc-c
Q 019040          209 E-------RFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESE----QGVAQAILRGLID-F  272 (347)
Q Consensus       209 ~-------~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~-~  272 (347)
                      .       ......++..|++||.+.+    ..+...|+|++|++++++++|..||.....    ......+...... .
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence            2       2355689999999998764    588899999999999999999999877763    3444444443322 1


Q ss_pred             cCCCCCCC----CHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          273 KRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       273 ~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      ........    ...+.+++..++..+|..|.+..+...+++.......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~  284 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK  284 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccc
Confidence            21111111    2578999999999999999999999998776655433

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=5.4e-26  Score=205.80  Aligned_cols=171  Identities=20%  Similarity=0.246  Sum_probs=132.3

Q ss_pred             cCCCCCCcccceeeeeeecccCCeEEEEEEECC-CCceeEEeEeccccc--cchhcHHHHHHHHHHHHhCCCCCceeE-e
Q 019040           42 AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRD-TRELLACKSISKRKL--RTAVDIDDVRREVAIMKHLPKNSSIVS-L  117 (347)
Q Consensus        42 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~ei~~l~~l~~h~~i~~-~  117 (347)
                      ++.+...+.++|.+.+.||+|+||+||+|.++. +++.||||+......  ........+.+|+++++.+ +|++++. +
T Consensus         9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l   87 (365)
T PRK09188          9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQL   87 (365)
T ss_pred             cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEE
Confidence            456667788999999999999999999999876 677789998653211  1223456799999999999 7888774 4


Q ss_pred             eeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCC-CCCcEEeecCCCCCCEEE
Q 019040          118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL-KPENFLFANKKENSPLKA  196 (347)
Q Consensus       118 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Di-kp~NIli~~~~~~~~~~l  196 (347)
                      ++    .+..|+||||++|++|.. +.   ...   ...++.|++.+|.|||+.||+|||| ||+|||+   +.++.++|
T Consensus        88 ~~----~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikL  153 (365)
T PRK09188         88 LA----TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAV  153 (365)
T ss_pred             EE----cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEE
Confidence            43    245799999999999962 21   111   1467899999999999999999999 9999999   55678999


Q ss_pred             EeeccccccCCCC---------cccccccCcccccccccc
Q 019040          197 IDFGLSIFFKPGE---------RFSEIVGSPYYMAPEVLK  227 (347)
Q Consensus       197 ~Dfg~a~~~~~~~---------~~~~~~~~~~y~aPE~~~  227 (347)
                      +|||+|.......         ......++..|.|||.+.
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            9999998654332         113456788899999885

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.7e-27  Score=227.64  Aligned_cols=260  Identities=27%  Similarity=0.455  Sum_probs=197.9

Q ss_pred             cce-eeeeeecccCCeEEEEEEECCCCceeEEeEeccc--c-ccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           51 DRY-LVDRELGRGEFGVTYLCIDRDTRELLACKSISKR--K-LRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        51 ~~y-~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~-~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ..| .-...+|.|++|.|+.+........++.|.+...  . .........+..|.-+-..+ .|++++..+....+...
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDG  395 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhccc
Confidence            334 4567789999998888888777766666655321  1 11111122256677777788 89998877777766655


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      ..-.||||++ +|..++.....+....+-.++.|++.|+.|+|+.||.|||+|++|+++   ..++.+||+|||.+....
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFR  471 (601)
T ss_pred             chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeec
Confidence            5566999999 999999887789999999999999999999999999999999999999   677899999999887654


Q ss_pred             CCC-----cccccccCccccccccccc-cCCC-chhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhc----cccccC
Q 019040          207 PGE-----RFSEIVGSPYYMAPEVLKR-NYGP-EIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRG----LIDFKR  274 (347)
Q Consensus       207 ~~~-----~~~~~~~~~~y~aPE~~~~-~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~----~~~~~~  274 (347)
                      .+.     ......|+..|+|||.+.+ .|.+ ..||||.|++++.|++|+.||......+.. ......    ....+.
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~  551 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN  551 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence            332     2345689999999999864 4665 699999999999999999999655443221 111111    111122


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ..+..++.+.+.+|.+||++||.+|.|+.+|++.+||+...
T Consensus       552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            23346888999999999999999999999999999999764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=5.9e-25  Score=190.99  Aligned_cols=234  Identities=24%  Similarity=0.357  Sum_probs=156.3

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCC---------CCceeEeeeEEe
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK---------NSSIVSLKEACE  122 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~---------h~~i~~~~~~~~  122 (347)
                      .....+.||.|+++.||.++|.++|+.+|+|++...........+.+.+|.-....+.+         |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45778899999999999999999999999999976664445567777777765555422         212333333322


Q ss_pred             e---------C---C-----eEEEEEEecCCCchHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHHcCcEeeCC
Q 019040          123 D---------D---N-----AVHLVMELCEGGELFDRIVA---RGH----YTERAAAAVTRTIVEVVQLCHKHGVIHRDL  178 (347)
Q Consensus       123 ~---------~---~-----~~~lv~e~~~~~~L~~~l~~---~~~----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Di  178 (347)
                      .         .   +     ..+++|+-+ .++|.+++.-   ...    +.......+..|++..+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            1         1   1     236677777 4488776532   222    223334556689999999999999999999


Q ss_pred             CCCcEEeecCCCCCCEEEEeeccccccCCCCcccccccCccccccccccc---------cCCCchhHHHHHHHHHHHHhC
Q 019040          179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR---------NYGPEIDIWSAGVILYILLCG  249 (347)
Q Consensus       179 kp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~Di~slG~~l~~l~~g  249 (347)
                      +|+|+++   +.+|.++|+||+.....+.....  ...+..|.+||....         .++.+.|.|+||+++|.|+|+
T Consensus       172 ~~~nfll---~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLL---DQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE----TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEE---cCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999   77899999999988765433222  345577999997532         278899999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCC
Q 019040          250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR  299 (347)
Q Consensus       250 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  299 (347)
                      ..||..........        .....|..+|+.+++||..+|+.+|.+|
T Consensus       247 ~lPf~~~~~~~~~~--------~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPE--------WDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSG--------GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCcccccc--------ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            99997665432111        1233455889999999999999999988

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=1.7e-24  Score=182.81  Aligned_cols=176  Identities=19%  Similarity=0.192  Sum_probs=134.3

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHH------HHHHHHHHHhCCCCCceeEeeeE
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD------VRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      ..+.++|++.+.+|.|+||.||++.+  ++..+|+|++.............      +.+|+..+.++ .|++++.+.++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~  103 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDF  103 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEe
Confidence            44688999999999999999999755  46679999997554433333333      67899999999 99999999888


Q ss_pred             EeeC--------CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC
Q 019040          121 CEDD--------NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       121 ~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                      +...        +..+++|||++|.+|.+..    .+++    ....+++.++..+|+.|++|||++|+||++   +.++
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili---~~~g  172 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIV---SKNG  172 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEE---eCCC
Confidence            6533        3588999999999997763    2333    346699999999999999999999999999   4455


Q ss_pred             CEEEEeeccccccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHH
Q 019040          193 PLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILL  247 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~  247 (347)
                       ++|+|||.............      |    ++...+..++|+||||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~d~------~----vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAKDR------I----DLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhHHH------H----HHHhHhcccccccceeEeehHHH
Confidence             99999998865432221110      0    11234668999999999987654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=6.6e-26  Score=209.16  Aligned_cols=241  Identities=29%  Similarity=0.467  Sum_probs=202.7

Q ss_pred             ecccCCeEEEEEEEC---CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecC
Q 019040           59 LGRGEFGVTYLCIDR---DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (347)
Q Consensus        59 lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (347)
                      +|.|++|.|+++...   ..|..+++|+..+......... .-..|-.++.....||+++.+...++.+...++++++..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            689999999987543   4577899999876554443333 455577888888679999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccc
Q 019040          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV  215 (347)
Q Consensus       136 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~  215 (347)
                      |+.|...+.+...+.+.....+...++.+++++|+.||+|+|+|++||++   +.+|.+++.|||+++.....+..   +
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~---c  154 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---C  154 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc---c
Confidence            99998888777778888999999999999999999999999999999999   78899999999999876544332   8


Q ss_pred             cCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCC
Q 019040          216 GSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD  295 (347)
Q Consensus       216 ~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  295 (347)
                      ||..|||||+++ ......|.||+|+++++|++|..||..    +....|.......+.    .+...+.+++..++..+
T Consensus       155 gt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r~  225 (612)
T KOG0603|consen  155 GTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKRN  225 (612)
T ss_pred             cchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhhC
Confidence            899999999988 577899999999999999999999977    555566555444433    66788899999999999


Q ss_pred             CCCCCCH-----HHHhcCcccccCc
Q 019040          296 PKLRLTA-----KQVLEHPWLQNAK  315 (347)
Q Consensus       296 p~~Rps~-----~~ll~h~~~~~~~  315 (347)
                      |..|...     .++++|+||+...
T Consensus       226 p~nrLg~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  226 PENRLGAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             HHHHhccCcchhHHHhccchheeee
Confidence            9999864     6999999997654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=3.7e-24  Score=178.48  Aligned_cols=144  Identities=17%  Similarity=0.171  Sum_probs=111.1

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhc-----------------------HHHHHHHHHHHHhCCCCC
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-----------------------IDDVRREVAIMKHLPKNS  112 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~-----------------------~~~~~~ei~~l~~l~~h~  112 (347)
                      ...||+|++|.||+|.+. +|+.||+|++..........                       .....+|++.+..+ .++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence            567999999999999997 89999999997543211110                       12234599999999 666


Q ss_pred             ceeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCcEeeCCCCCcEEeecCCCC
Q 019040          113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-HKHGVIHRDLKPENFLFANKKEN  191 (347)
Q Consensus       113 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~ivH~Dikp~NIli~~~~~~  191 (347)
                      ++........ .. .++||||++|+++.........++...+..++.|++.+|.++ |+.||+||||||+||+++    +
T Consensus        80 ~v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~  153 (190)
T cd05147          80 GIPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----D  153 (190)
T ss_pred             CCCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----C
Confidence            6644433322 22 379999999877765544556799999999999999999999 799999999999999994    3


Q ss_pred             CCEEEEeeccccccCC
Q 019040          192 SPLKAIDFGLSIFFKP  207 (347)
Q Consensus       192 ~~~~l~Dfg~a~~~~~  207 (347)
                      +.++|+|||+|.....
T Consensus       154 ~~v~LiDFG~a~~~~~  169 (190)
T cd05147         154 GKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CcEEEEEccccccCCC
Confidence            6799999999976443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.91  E-value=2.9e-24  Score=207.79  Aligned_cols=224  Identities=29%  Similarity=0.500  Sum_probs=178.3

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ....+.|..++.|..|++|.||..+++.+.+.+|+|+-+.+-         +.+-  ++... ..|.++           
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l---------ilRn--ilt~a-~npfvv-----------  135 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL---------ILRN--ILTFA-GNPFVV-----------  135 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhcccccch---------hhhc--ccccc-CCccee-----------
Confidence            344578999999999999999999999999999996542211         1111  23333 444444           


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                                ++-...++.-++++...        +.+++|||+.||+|+|+||+|.+|   ..-|++|++|||++....
T Consensus       136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             ----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhh
Confidence                      34444455545555444        789999999999999999999999   678899999999876432


Q ss_pred             CCC----------------cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 019040          207 PGE----------------RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL  269 (347)
Q Consensus       207 ~~~----------------~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  269 (347)
                      ...                .....+|||.|+|||++. ..|+...|+|++|+++|+++-|..||.+.++++.+..+....
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~  274 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD  274 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence            111                012357999999999875 569999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCHHHHHHHHHhccCCCCCCC---CHHHHhcCcccccCc
Q 019040          270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRL---TAKQVLEHPWLQNAK  315 (347)
Q Consensus       270 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~~  315 (347)
                      ..++.. ...++++..++|.++|+.+|.+|.   .+.++.+|+||+.+.
T Consensus       275 i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD  322 (1205)
T KOG0606|consen  275 IEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD  322 (1205)
T ss_pred             cccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence            888887 457899999999999999999998   466888999998874

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.4e-22  Score=169.47  Aligned_cols=145  Identities=18%  Similarity=0.160  Sum_probs=112.0

Q ss_pred             eeeeecccCCeEEEEEEECCCCceeEEeEeccccccchh-----------------------cHHHHHHHHHHHHhCCCC
Q 019040           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV-----------------------DIDDVRREVAIMKHLPKN  111 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~ei~~l~~l~~h  111 (347)
                      +.+.||+|++|.||+|.+. +|+.||||++.........                       ......+|...+..+ .+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~   78 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YE   78 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-Hh
Confidence            4578999999999999987 8999999998764211000                       012346789999999 77


Q ss_pred             CceeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCC
Q 019040          112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKE  190 (347)
Q Consensus       112 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~  190 (347)
                      +++.....+....  .++||||++|+++.........++......++.|++.++.++|+ .||+||||||+||+++    
T Consensus        79 ~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~----  152 (190)
T cd05145          79 AGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH----  152 (190)
T ss_pred             CCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----
Confidence            7764443333322  47999999887654443344568888999999999999999999 9999999999999994    


Q ss_pred             CCCEEEEeeccccccCC
Q 019040          191 NSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       191 ~~~~~l~Dfg~a~~~~~  207 (347)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            57799999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=7.5e-23  Score=179.19  Aligned_cols=191  Identities=28%  Similarity=0.402  Sum_probs=141.4

Q ss_pred             CCCCceeEeeeEEee---------------------------CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHH
Q 019040          109 PKNSSIVSLKEACED---------------------------DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI  161 (347)
Q Consensus       109 ~~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi  161 (347)
                      ..||||+.+.+.|.+                           ...+|+||.-++. +|++++..+ ..+.....-++.|+
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHH
Confidence            469999999877633                           3468999998855 999998765 56788888999999


Q ss_pred             HHHHHHHHHcCcEeeCCCCCcEEeecCC-CCCCEEEEeeccccccCCC-------CcccccccCccccccccccccCC--
Q 019040          162 VEVVQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFGLSIFFKPG-------ERFSEIVGSPYYMAPEVLKRNYG--  231 (347)
Q Consensus       162 ~~~l~~lH~~~ivH~Dikp~NIli~~~~-~~~~~~l~Dfg~a~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~--  231 (347)
                      ++|+.|||..||.|||+|.+|||+.-++ .--.++|.|||++-.....       ......-|+...||||+...-++  
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            9999999999999999999999997543 3335799999976532210       01112346777999998753222  


Q ss_pred             -----CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHH
Q 019040          232 -----PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAK  303 (347)
Q Consensus       232 -----~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  303 (347)
                           .++|.|+.|.+.||+++...||......... .-.......+. ..+.+|+.+++++..+|+.||++|+++.
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-~r~Yqe~qLPa-lp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-TRTYQESQLPA-LPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchheec-hhhhhhhhCCC-CcccCChHHHHHHHHHhcCCccccCCcc
Confidence                 3799999999999999999999874332111 11111111221 2247899999999999999999999965

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=4.2e-22  Score=164.84  Aligned_cols=189  Identities=22%  Similarity=0.287  Sum_probs=139.8

Q ss_pred             eeeeeecccCCeEEEEEEECCCCceeEEeEecccccc-chhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        54 ~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      .+...|+.|+||+||.+..  .+..++.+.+.....- .......+.+|++++++|.++++++.++++    +..+++|+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4577899999999998755  6677776666443221 111223578999999999777889999886    34689999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCC-CCCcEEeecCCCCCCEEEEeeccccccCCCCcc
Q 019040          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL-KPENFLFANKKENSPLKAIDFGLSIFFKPGERF  211 (347)
Q Consensus       133 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Di-kp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~  211 (347)
                      |+.|.+|......       ....++.|++.+|.++|+.||+|||| ||+||++   +.++.++|+|||++.........
T Consensus        79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcchH
Confidence            9999888654321       12357889999999999999999999 7999999   56678999999999865433321


Q ss_pred             cc--------------cccCcccccccccc--ccCC-CchhHHHHHHHHHHHHhCCCCCCCCCH
Q 019040          212 SE--------------IVGSPYYMAPEVLK--RNYG-PEIDIWSAGVILYILLCGVPPFWAESE  258 (347)
Q Consensus       212 ~~--------------~~~~~~y~aPE~~~--~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~  258 (347)
                      ..              ...++.+++|+...  ...+ ...++++.|.-+|.++|+..++++...
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            00              12466677776432  2333 578999999999999999999877654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.1e-23  Score=204.04  Aligned_cols=239  Identities=24%  Similarity=0.325  Sum_probs=176.1

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEecccc-ccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK-LRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .|...+.||.+.|=+|.+|++.+ |. |+||++-+.. ........+...|++ .... ++||++++..+.......|+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHHHH
Confidence            67889999999999999998853 44 9999986543 222223334444555 3344 899999999888888889999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      -+|+.. +|++.+..+..+..-+.+-|+.|++.||..+|..||+|||||.+||||.   .-.=+.|+||...+..--+. 
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCCC
Confidence            999955 9999998776678888889999999999999999999999999999994   43447889998665432111 


Q ss_pred             ---cccccc----cCccccccccccc-----------c-CCCchhHHHHHHHHHHHHh-CCCCCCCCCH-------HHHH
Q 019040          210 ---RFSEIV----GSPYYMAPEVLKR-----------N-YGPEIDIWSAGVILYILLC-GVPPFWAESE-------QGVA  262 (347)
Q Consensus       210 ---~~~~~~----~~~~y~aPE~~~~-----------~-~~~~~Di~slG~~l~~l~~-g~~pf~~~~~-------~~~~  262 (347)
                         ...-+.    .-..|.|||.+..           . .+++.||||+||+++||++ |.+||....-       ....
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~  255 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP  255 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence               111112    2346999997631           1 5678999999999999998 6888821100       1111


Q ss_pred             HHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +.+++.+          -+..++.+|..|++.||++|.|+.+.|+.
T Consensus       256 e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  256 EQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1222221          13468999999999999999999999976

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=2.9e-22  Score=197.15  Aligned_cols=197  Identities=24%  Similarity=0.358  Sum_probs=160.2

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      ...|.|.+.||.|+||+||+|.... |+.||+|+-.....=.-.-..+++..++ ...   -+.|+.+...+.-.+.-++
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~---~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQM---LPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhh---hcchHHHHHHHccCCccee
Confidence            5679999999999999999999876 9999999976443222222333333333 222   2556666666777788889


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeec----CCCCCCEEEEeecccccc
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN----KKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~----~~~~~~~~l~Dfg~a~~~  205 (347)
                      |+||.+.|+|.+++...+.+++..+..+..||+..++.||..+||||||||+|+++..    +.+...++|+|||.+..+
T Consensus       772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            9999999999999998888999999999999999999999999999999999999953    234557999999998754


Q ss_pred             ---CCCCcccccccCcccccccccccc-CCCchhHHHHHHHHHHHHhCCC
Q 019040          206 ---KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVP  251 (347)
Q Consensus       206 ---~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~  251 (347)
                         .++.......+|..|-.+|+..|. |++..|.|.|+.+++.|++|..
T Consensus       852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence               344566777899999999998765 9999999999999999999965

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-21  Score=163.21  Aligned_cols=240  Identities=17%  Similarity=0.221  Sum_probs=185.6

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      ...+...|.....|..|+|++..+  .+++|++........ ....|..|.-.++-+ .||||+.+++.+.....+.+|.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~r-isrdfneefp~lrif-shpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTAR-ISRDFNEEFPALRIF-SHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchh-hcchhhhhCcceeee-cCCchhhhhhhccCCCCceEee
Confidence            345667788899999999999644  477787764433222 224577788888888 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC--cEeeCCCCCcEEeecCCCCCCEEE--Eeecccccc
Q 019040          132 ELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKA--IDFGLSIFF  205 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~NIli~~~~~~~~~~l--~Dfg~a~~~  205 (347)
                      .|++.++|+..+.+...  ....++.+++..|+.|+.|||+..  |.---+....|+|   +++.+.+|  .|--++...
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfqe  343 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQE  343 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeeec
Confidence            99999999999988755  677889999999999999999985  4445678888999   55555555  444443321


Q ss_pred             CCCCcccccccCcccccccccccc----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          206 KPGERFSEIVGSPYYMAPEVLKRN----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                            ....-.|.|++||.+...    .-.++|+|||++++||+.|.+.||....+.+.--.+--+  ..+....++++
T Consensus       344 ------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale--glrv~ippgis  415 (448)
T KOG0195|consen  344 ------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE--GLRVHIPPGIS  415 (448)
T ss_pred             ------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc--cccccCCCCcc
Confidence                  223457889999988643    235799999999999999999999888877654444222  22334445899


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHh
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVL  306 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll  306 (347)
                      ..+..|++-|...||.+||.+..++
T Consensus       416 ~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  416 RHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHHHHhcCCCCcCCCcceeh
Confidence            9999999999999999999988763

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=1.5e-20  Score=158.21  Aligned_cols=138  Identities=20%  Similarity=0.216  Sum_probs=108.4

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC----CCCceeEeeeEEeeCC---eEE
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP----KNSSIVSLKEACEDDN---AVH  128 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~----~h~~i~~~~~~~~~~~---~~~  128 (347)
                      .+.||+|++|.||.  ++.++.. +||++....   ....+.+.+|+.+++.+.    .||||++++++++++.   .++
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            56799999999995  7777665 699886542   223467899999999994    3799999999999874   434


Q ss_pred             -EEEEe--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCcEeeCCCCCcEEeecCC-CCCCEEEEeeccc
Q 019040          129 -LVMEL--CEGGELFDRIVARGHYTERAAAAVTRTIVEVV-QLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFGLS  202 (347)
Q Consensus       129 -lv~e~--~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l-~~lH~~~ivH~Dikp~NIli~~~~-~~~~~~l~Dfg~a  202 (347)
                       +|+||  +.+++|.+++.+. .+++.  ..++.|++.++ +|||+.+|+||||||+||+++..+ .+..++|+||+-+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence             78999  5578999999764 46655  35678888777 999999999999999999997533 3458999995444

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=1.6e-20  Score=161.85  Aligned_cols=146  Identities=18%  Similarity=0.135  Sum_probs=113.2

Q ss_pred             ceeeeeeecccCCeEEEEEE-ECCCCceeEEeEeccccccch---------------------hcHHHHHHHHHHHHhCC
Q 019040           52 RYLVDRELGRGEFGVTYLCI-DRDTRELLACKSISKRKLRTA---------------------VDIDDVRREVAIMKHLP  109 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~-~~~~~~~vavK~~~~~~~~~~---------------------~~~~~~~~ei~~l~~l~  109 (347)
                      -|.+.+.||.|++|.||+|. +..+|+.||+|++........                     .....+.+|+..+..+ 
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-  107 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-  107 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            48899999999999999999 667899999999875431100                     0113467899999999 


Q ss_pred             CCC--ceeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-cEeeCCCCCcEEee
Q 019040          110 KNS--SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG-VIHRDLKPENFLFA  186 (347)
Q Consensus       110 ~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dikp~NIli~  186 (347)
                      .+.  .++.++..   . ..++||||++|.+|.........+....+..++.||+.++.+||+.| ++|+||||+||+++
T Consensus       108 ~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      108 YEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             HhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            442  24444432   2 34799999999888665544445666777899999999999999999 99999999999994


Q ss_pred             cCCCCCCEEEEeeccccccC
Q 019040          187 NKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       187 ~~~~~~~~~l~Dfg~a~~~~  206 (347)
                          ++.++|+|||.+....
T Consensus       184 ----~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 ----DGKVVIIDVSQSVELD  199 (237)
T ss_pred             ----CCCEEEEEChhhhccC
Confidence                5679999999987644

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=1.3e-20  Score=171.22  Aligned_cols=175  Identities=30%  Similarity=0.462  Sum_probs=134.4

Q ss_pred             CeEEEEEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          125 NAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                      .++||.|++|...+|.+++....   ..+......+..|+..+++|   +|.+|+|+||.||+.   ..+..++|+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhhhhhhhhh
Confidence            46889999999999999997553   36778889999999999999   999999999999999   5556799999999


Q ss_pred             ccccCCCC-------cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccc
Q 019040          202 SIFFKPGE-------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDF  272 (347)
Q Consensus       202 a~~~~~~~-------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  272 (347)
                      ........       ......||..||+||.+.+ .|+.++|||+||++++|++. -...|.   .......+..+  .+
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g--~i  477 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDG--II  477 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcC--CC
Confidence            88765544       4456789999999999875 59999999999999999997 222221   11122222222  23


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ++..+.+. +.-..|+..++.+.|.+||++...--|.|.
T Consensus       478 p~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  478 PPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            33333333 344689999999999999977776666665

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=8.7e-19  Score=149.20  Aligned_cols=137  Identities=27%  Similarity=0.350  Sum_probs=112.4

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccch-----hcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA-----VDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +.||+|++|.||+|.+  .|..+++|+.........     .....+.+|+.++..+ .+++++....++...+..+++|
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEE
Confidence            5789999999999987  667799997654322211     1234678899999999 7888877766777777889999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ||++|.+|.+.+.....    ....++.+++.+|.++|+.|++|+|++|.||+++    ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence            99999999998865422    7789999999999999999999999999999994    56799999999875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=2e-18  Score=145.55  Aligned_cols=133  Identities=24%  Similarity=0.326  Sum_probs=105.3

Q ss_pred             eecccCCeEEEEEEECCCCceeEEeEeccccccc-----hhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-----AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        58 ~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      .||+|++|.||+|.+  ++..+++|.........     .....++.+|++++..+ .++++.....++...+..+++||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEE
Confidence            379999999999985  56789999865432221     11246678899999999 66665544445556667789999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       133 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      |++|++|.+.+.....       .++.+++.+|.+||+.|++|+|++|.||+++    ++.++++|||.+..
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcC
Confidence            9999999887755321       8899999999999999999999999999994    57799999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.5e-18  Score=146.16  Aligned_cols=140  Identities=24%  Similarity=0.274  Sum_probs=106.9

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccch-------------------hcHHHHHHHHHHHHhCCCCC-
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA-------------------VDIDDVRREVAIMKHLPKNS-  112 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~ei~~l~~l~~h~-  112 (347)
                      |.+.+.||.|+||.||+|.+. +|+.||||++........                   .......+|+.++..+ .++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence            788899999999999999875 799999998754321000                   0112366788888888 555 


Q ss_pred             -ceeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCC
Q 019040          113 -SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (347)
Q Consensus       113 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~  191 (347)
                       .++..++    ....+++|||++|++|.....      ......++.+++.++.++|+.|++|+||+|+||++   +++
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~~  161 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DDD  161 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cCC
Confidence             3444433    234589999999998865432      13456788999999999999999999999999999   567


Q ss_pred             CCEEEEeeccccccCC
Q 019040          192 SPLKAIDFGLSIFFKP  207 (347)
Q Consensus       192 ~~~~l~Dfg~a~~~~~  207 (347)
                      +.++|+|||.+.....
T Consensus       162 ~~~~liDfg~~~~~~~  177 (198)
T cd05144         162 EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcEEEEECCccccCCC
Confidence            8899999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=1.8e-18  Score=159.86  Aligned_cols=198  Identities=23%  Similarity=0.317  Sum_probs=155.1

Q ss_pred             HhCCCCCceeEeeeEEeeCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCc-EeeCCCCCcE
Q 019040          106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGV-IHRDLKPENF  183 (347)
Q Consensus       106 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i-vH~Dikp~NI  183 (347)
                      +.+ .|.|+.+++|.+.++...++|.+||..|+|.+.+... ..++.--...+++.|+.||.|+|+--| .||.++..|+
T Consensus         2 ~~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             ccc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            456 8999999999999999999999999999999999874 457777788899999999999998866 9999999999


Q ss_pred             EeecCCCCCCEEEEeeccccccCCC---CcccccccCcccccccccccc--------CCCchhHHHHHHHHHHHHhCCCC
Q 019040          184 LFANKKENSPLKAIDFGLSIFFKPG---ERFSEIVGSPYYMAPEVLKRN--------YGPEIDIWSAGVILYILLCGVPP  252 (347)
Q Consensus       184 li~~~~~~~~~~l~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~--------~~~~~Di~slG~~l~~l~~g~~p  252 (347)
                      ++   +....+||+|||+.......   ..........-|.|||.++..        .+.+.||||+|++++|+++...|
T Consensus        81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99   77888999999998765321   111112244569999988642        46679999999999999999999


Q ss_pred             CCCCC----HHHHHHHHHh-ccccccCCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          253 FWAES----EQGVAQAILR-GLIDFKRDPW--PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       253 f~~~~----~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      |....    ..+....+.. +...+.+..+  ...++++..+++.||..+|.+||++.++-.
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            96632    2244444444 2222222222  145668999999999999999999999843

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=1.3e-17  Score=160.97  Aligned_cols=141  Identities=22%  Similarity=0.308  Sum_probs=111.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccc-----cchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ...|...+.||+|+||.||+|.+...+  +++|+......     ........+.+|+++++.+ +|++++....+....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~  408 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeC
Confidence            345567889999999999999875443  44443322111     1112345688999999999 888888877777777


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ...++||||++|++|.+++.        ....++.+++.+|.+||+.|++||||||+||+++    ++.++|+|||++..
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFGla~~  476 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFGLGKY  476 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCccccc
Confidence            77889999999999998875        3467899999999999999999999999999992    45799999999876


Q ss_pred             c
Q 019040          205 F  205 (347)
Q Consensus       205 ~  205 (347)
                      .
T Consensus       477 ~  477 (535)
T PRK09605        477 S  477 (535)
T ss_pred             C
Confidence            3

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=6.1e-20  Score=176.98  Aligned_cols=260  Identities=28%  Similarity=0.498  Sum_probs=207.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCC-CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ...|.+.+.||.|+++.|-.+....+ ...+|.|.+.... ........+..|..+.+.+.+|.|++.+++.....+..+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            35688888899999999998877543 3446666665433 233344566778999999966999999999999999999


Q ss_pred             EEEEecCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCcEeeCCCCCcEEeecCCCCC-CEEEEeeccccc
Q 019040          129 LVMELCEGGELFDRI-VARG-HYTERAAAAVTRTIVEVVQLCH-KHGVIHRDLKPENFLFANKKENS-PLKAIDFGLSIF  204 (347)
Q Consensus       129 lv~e~~~~~~L~~~l-~~~~-~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dikp~NIli~~~~~~~-~~~l~Dfg~a~~  204 (347)
                      ++.+|.+|+++.+.+ .... ..+......++.|+..++.|+| ..++.|+||+|+|.++   +..+ .+++.|||+|..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLATA  174 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhcc
Confidence            999999999998888 4443 5777888999999999999999 9999999999999999   5555 899999999987


Q ss_pred             cCC-CC---ccccccc-Cccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccccccCCC
Q 019040          205 FKP-GE---RFSEIVG-SPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRGLIDFKRDP  276 (347)
Q Consensus       205 ~~~-~~---~~~~~~~-~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~  276 (347)
                      ... ..   ......| ++.|.|||...+  ......|+||.|+++..+++|..||......... .........+....
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP  254 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence            655 21   2234567 999999998765  4678899999999999999999998655443311 11122222333456


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                      |..++....+++.+++..+|+.|.+..++-.++|+..
T Consensus       255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccCChhhhhcccccccCCchhccccccccccccccc
Confidence            6788999999999999999999999999999999988

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=1.1e-17  Score=139.67  Aligned_cols=141  Identities=20%  Similarity=0.241  Sum_probs=98.2

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHH---------------------HHHHHHHHHHhCCCC-Cc
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDID---------------------DVRREVAIMKHLPKN-SS  113 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~ei~~l~~l~~h-~~  113 (347)
                      .+.||+|+||+||+|.+. +++.||||++............                     ....|...+..+..+ -.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            567999999999999986 7899999998654321111111                     113566666666222 22


Q ss_pred             eeEeeeEEeeCCeEEEEEEecCCCchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCCC
Q 019040          114 IVSLKEACEDDNAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKEN  191 (347)
Q Consensus       114 i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~~  191 (347)
                      ++++++.    ...++++||++++++.. .+... ... ..+..++.+++.++.++|. .||+|+||+|+||+++    +
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----~  150 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----D  150 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----C
Confidence            4444432    23589999999843321 11111 111 6678899999999999999 9999999999999994    6


Q ss_pred             CCEEEEeeccccccCC
Q 019040          192 SPLKAIDFGLSIFFKP  207 (347)
Q Consensus       192 ~~~~l~Dfg~a~~~~~  207 (347)
                      +.++|+|||.+.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            7899999999976443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=1.6e-17  Score=153.80  Aligned_cols=256  Identities=21%  Similarity=0.269  Sum_probs=203.5

Q ss_pred             cccceeeeeeecc--cCCeEEEEEEE--CCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           49 IEDRYLVDRELGR--GEFGVTYLCID--RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~--G~~g~V~~a~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      +...+.+...+|.  |.+|.||.+..  ..++..+|+|.-+. .........+=.+|+...+.+..|.+.++.+..+...
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCcccccC
Confidence            3566888999999  99999999988  88899999987432 2222233334455888888888899999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHcCcEeeCCCCCcEEeecCCCC-CCEEEEe
Q 019040          125 NAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVE----VVQLCHKHGVIHRDLKPENFLFANKKEN-SPLKAID  198 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~----~l~~lH~~~ivH~Dikp~NIli~~~~~~-~~~~l~D  198 (347)
                      +..|+-+|++ +.+|..+...... ++...++..+.++..    ||.++|+.+++|-|+||.||+.   ..+ ..++++|
T Consensus       191 ~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~---~~~~~s~~~~d  266 (524)
T KOG0601|consen  191 GILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT---TSDWTSCKLTD  266 (524)
T ss_pred             Ccceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheec---ccccceeecCC
Confidence            9999999999 5688887766544 899999999999999    9999999999999999999999   555 7899999


Q ss_pred             eccccccCCCCcc------cccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc
Q 019040          199 FGLSIFFKPGERF------SEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF  272 (347)
Q Consensus       199 fg~a~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  272 (347)
                      ||+...+....-.      ....+...|++||...+-++..+|+|+||.++.+..++..++...... ....+...  ..
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~--~i  343 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQG--YI  343 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC-Cccccccc--cC
Confidence            9998877655422      112577889999999999999999999999999998887655333111 11111111  14


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  312 (347)
                      +.+.+...+.++...+..|++.+|-.|+++..+++|+++.
T Consensus       344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~  383 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH  383 (524)
T ss_pred             chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence            4555667778888899999999999999999999999986

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=4.2e-16  Score=134.69  Aligned_cols=138  Identities=19%  Similarity=0.238  Sum_probs=102.9

Q ss_pred             eeec-ccCCeEEEEEEECCCCceeEEeEeccccc----------cchhcHHHHHHHHHHHHhCCCCCce--eEeeeEEee
Q 019040           57 RELG-RGEFGVTYLCIDRDTRELLACKSISKRKL----------RTAVDIDDVRREVAIMKHLPKNSSI--VSLKEACED  123 (347)
Q Consensus        57 ~~lg-~G~~g~V~~a~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~ei~~l~~l~~h~~i--~~~~~~~~~  123 (347)
                      ..|| .|+.|+||.+..  .+..+++|.+.....          ........+.+|+.++..| .++++  +..+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence            4576 888899999876  367799998854221          1123346788899999999 76664  666665433


Q ss_pred             C-Ce---EEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          124 D-NA---VHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       124 ~-~~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      . ..   .++|+|+++| .+|.+++... .++..    .+.+|+.+|.+||+.||+|+||||.|||+   +.++.++|+|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv---~~~~~v~LID  185 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL---DPDGKFWLID  185 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE---cCCCCEEEEE
Confidence            2 22   3599999997 6888877553 45544    35789999999999999999999999999   4456799999


Q ss_pred             ecccccc
Q 019040          199 FGLSIFF  205 (347)
Q Consensus       199 fg~a~~~  205 (347)
                      ||.+...
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9998763

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=4.1e-16  Score=124.96  Aligned_cols=133  Identities=26%  Similarity=0.312  Sum_probs=109.9

Q ss_pred             eeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCC-CceeEeeeEEeeCCeEEEEEEe
Q 019040           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL  133 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h-~~i~~~~~~~~~~~~~~lv~e~  133 (347)
                      +++.||.|.++.||++.+..  ..+++|.......     ...+.+|+.+++.+.++ ..+++++.+....+..++++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            46789999999999998854  6799998754321     45788899999999444 6889998888888899999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH---GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       134 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ++|..+..+       +......++.+++.++..||..   +++|+|++|+||+++   ..+.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence            998777543       5566778899999999999985   799999999999994   467799999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=1.8e-17  Score=142.40  Aligned_cols=240  Identities=18%  Similarity=0.195  Sum_probs=162.8

Q ss_pred             CeEEEEEEECCCCceeEEeEeccccccchh-cHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC-----eEEEEEEecCCC
Q 019040           64 FGVTYLCIDRDTRELLACKSISKRKLRTAV-DIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-----AVHLVMELCEGG  137 (347)
Q Consensus        64 ~g~V~~a~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~  137 (347)
                      .-.||++.+.+.|.+|+...+......+.. .......=...+-++ -|.|+++++.+|.+.+     ...++.||+..+
T Consensus        79 id~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssg  157 (458)
T KOG1266|consen   79 IDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSG  157 (458)
T ss_pred             hHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccch
Confidence            446888888888888876655432211111 111122222233344 6888999999887654     478999999999


Q ss_pred             chHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--cEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC---
Q 019040          138 ELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG---  208 (347)
Q Consensus       138 ~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~---  208 (347)
                      ++..+|++.    ..+....+.+|+.||+.||.|||+..  |+|+++..+.|++   ..++.+|++---.......-   
T Consensus       158 s~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~  234 (458)
T KOG1266|consen  158 SLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNST  234 (458)
T ss_pred             hHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecccCccccchhhhhh
Confidence            999999764    34888999999999999999999995  9999999999999   67888887543222111000   


Q ss_pred             --CcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          209 --ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPF-WAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       209 --~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                        .......+-++|.+||.-. ..-+-++|||++|++.++|..+...- .+...-..-..+.+.+....       +..-
T Consensus       235 ~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lq  307 (458)
T KOG1266|consen  235 REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQ  307 (458)
T ss_pred             hHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------Cccc
Confidence              0111224577899999765 34667899999999999999887642 22221122222222222111       1223


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ++++.+|+...|+.||+++.++-||.+=..
T Consensus       308 r~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  308 RGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             cCcCcccccCCCCCCcchhhhhcCceeeec
Confidence            578999999999999999999999987443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.58  E-value=6.3e-16  Score=150.62  Aligned_cols=261  Identities=26%  Similarity=0.400  Sum_probs=204.3

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+.+.+.+.+..|+++.++.+.-..+|...++|+..........+.+.+..+-.++-.- .+|.++...-.+......++
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcch
Confidence            45678888999999999999988888877777776554433333333333343333333 45666655444556678899


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC--
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP--  207 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~--  207 (347)
                      +++|+.+++|...+......+.+..+.....+..++++||+..+.|+|++|.|.++   ..++..++.|||.......  
T Consensus       882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCcccccccccccc
Confidence            99999999999999888777878888888999999999999999999999999999   7788899999973221100  


Q ss_pred             --------C----------------------CcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 019040          208 --------G----------------------ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAE  256 (347)
Q Consensus       208 --------~----------------------~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~  256 (347)
                              .                      .......+|+.|.+||... ......+|+|++|+++++.++|..||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                    0                      0012246899999999865 45889999999999999999999999999


Q ss_pred             CHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHH---HHhcCcccccCc
Q 019040          257 SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAK---QVLEHPWLQNAK  315 (347)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~---~ll~h~~~~~~~  315 (347)
                      ..+.+.+++.+....++.-. ...+....+++..++..+|.+|..+.   +.-.|+||+...
T Consensus      1039 tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             chhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            99999988888776665433 35678899999999999999999988   889999998765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=4.1e-14  Score=132.64  Aligned_cols=145  Identities=19%  Similarity=0.225  Sum_probs=98.9

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccch-h----------------------c--------------HHHH
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA-V----------------------D--------------IDDV   98 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-~----------------------~--------------~~~~   98 (347)
                      .+.||.|++|.||+|+.+ +|+.||||+........- .                      .              .-++
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            467999999999999875 789999999854310000 0                      0              0123


Q ss_pred             HHHHHHHHhC----CCCCceeEeeeEEeeCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHcC
Q 019040           99 RREVAIMKHL----PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVE-VVQLCHKHG  172 (347)
Q Consensus        99 ~~ei~~l~~l----~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~-~l~~lH~~~  172 (347)
                      .+|...+..+    .+++++....-++...+..+++|||++|.+|.+..... ....   ...++.+++. .+..+|..|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence            4455444444    23455443333344455678999999999998876432 1222   3445666655 478899999


Q ss_pred             cEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       173 ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      ++|+|++|.||++   ..++.++++|||++.....
T Consensus       278 ~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       278 FFHADLHPGNIFV---LKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ceeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence            9999999999999   6678899999999877643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.55  E-value=7.9e-14  Score=115.48  Aligned_cols=144  Identities=13%  Similarity=0.123  Sum_probs=102.7

Q ss_pred             eeeecccCCeEEEEEEECC------CCceeEEeEeccccc--cc-----------------hhcHHHHH----HHHHHHH
Q 019040           56 DRELGRGEFGVTYLCIDRD------TRELLACKSISKRKL--RT-----------------AVDIDDVR----REVAIMK  106 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~------~~~~vavK~~~~~~~--~~-----------------~~~~~~~~----~ei~~l~  106 (347)
                      ...||.|.-+.||.|....      .+..+|+|++.....  ..                 ......+.    +|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998653      357899999864221  00                 01122333    7999999


Q ss_pred             hCCCC-CceeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCcEeeCCCCCcEE
Q 019040          107 HLPKN-SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-HKHGVIHRDLKPENFL  184 (347)
Q Consensus       107 ~l~~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~ivH~Dikp~NIl  184 (347)
                      ++... -+++.++.+    ...++||||+.+..+.....+...++...+..+..+++.++..| |..||+|||+++.||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            88332 356666654    45678999997654432222223456667778899999999998 8999999999999999


Q ss_pred             eecCCCCCCEEEEeeccccccCC
Q 019040          185 FANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       185 i~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      +.    ++.++|+|||.+.....
T Consensus       158 ~~----~~~v~iIDF~qav~~~h  176 (197)
T cd05146         158 WH----DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EE----CCcEEEEECCCceeCCC
Confidence            94    35699999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.54  E-value=3.9e-14  Score=134.42  Aligned_cols=152  Identities=22%  Similarity=0.268  Sum_probs=95.2

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc---------------------------h----hcH
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---------------------------A----VDI   95 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---------------------------~----~~~   95 (347)
                      +.+-..|+. +.||.|++|.||+|+.+.+|+.||||+........                           .    +-.
T Consensus       116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~  194 (537)
T PRK04750        116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE  194 (537)
T ss_pred             HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence            333455776 78999999999999998889999999986431000                           0    001


Q ss_pred             H------HHHHHHHHHHhCC---CCCceeEeee-EEeeCCeEEEEEEecCCCchHHHH--HhcC----CCCHHHHHHHHH
Q 019040           96 D------DVRREVAIMKHLP---KNSSIVSLKE-ACEDDNAVHLVMELCEGGELFDRI--VARG----HYTERAAAAVTR  159 (347)
Q Consensus        96 ~------~~~~ei~~l~~l~---~h~~i~~~~~-~~~~~~~~~lv~e~~~~~~L~~~l--~~~~----~~~~~~~~~i~~  159 (347)
                      .      ++.+|...+.++.   .+...+.+-. ++.-.+..++||||++|.++.+..  ...+    .+....+..++.
T Consensus       195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence            1      2333444444431   1222222222 233356778999999999997642  2222    133333444444


Q ss_pred             HHHHHHHHHHHcCcEeeCCCCCcEEeecC-CCCCCEEEEeeccccccC
Q 019040          160 TIVEVVQLCHKHGVIHRDLKPENFLFANK-KENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       160 qi~~~l~~lH~~~ivH~Dikp~NIli~~~-~~~~~~~l~Dfg~a~~~~  206 (347)
                      |+       ...|++|+|+||.||+++.+ ...+.++++|||.+....
T Consensus       275 Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        275 QV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            44       46899999999999999532 123389999999987654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.49  E-value=1.6e-13  Score=112.53  Aligned_cols=129  Identities=19%  Similarity=0.157  Sum_probs=95.3

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecC
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (347)
                      ++.++.|.++.||++...  +..|++|+......    ....+.+|+.+++.+.+...+++++....  +..++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            457889999999999874  77899998754321    12245778999988844444556655433  34579999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCc-----EeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGV-----IHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       136 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i-----vH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      |.++...        ......++.+++.+|..||..++     +|||++|+||+++    ++.++++|||.+..
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence            9887542        01123467899999999999985     9999999999994    45699999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.49  E-value=4.4e-13  Score=107.00  Aligned_cols=148  Identities=20%  Similarity=0.210  Sum_probs=111.5

Q ss_pred             eeeeecccCCeEEEEEEECCCCceeEEeEe-----ccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           55 VDRELGRGEFGVTYLCIDRDTRELLACKSI-----SKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~~~~vavK~~-----~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+..+.+|+-+.|+++.+  .|+..+||.=     ....+...-...+..+|++.+.++ .--.|....-++.+...-.+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeE
Confidence            577889999999999977  5666666542     222233333456788899999988 44455444445666666678


Q ss_pred             EEEecCC-CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          130 VMELCEG-GELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       130 v~e~~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      +|||++| .++.+++...-  .........+++.|-..+.-||..+|+|||+.++||++.+++....+.++|||++...
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9999987 47778876642  2344444789999999999999999999999999999998777778899999998754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.46  E-value=1e-12  Score=123.50  Aligned_cols=183  Identities=15%  Similarity=0.163  Sum_probs=136.7

Q ss_pred             eeeeeeecccCCeEEE-EEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           53 YLVDRELGRGEFGVTY-LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~-~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      |.+ ...+.++.+ +| .|..+.++.+|.|.++..+..   .......+.++.++.+ +||+|+++++.++.++..|+|+
T Consensus        15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvT   88 (690)
T KOG1243|consen   15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVT   88 (690)
T ss_pred             ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEe
Confidence            444 333444444 55 477788899999998876543   4456788899999999 9999999999999999999999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      |-+.  .|..++++..   ...+..-+.||+.||.+|| +++++|++|...-|+|   +..|.+||++|.++........
T Consensus        89 ErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~  160 (690)
T KOG1243|consen   89 ERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNA  160 (690)
T ss_pred             eccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCc
Confidence            9883  6777776653   5666777899999999998 5689999999999999   7888899999998865432221


Q ss_pred             -ccccccCccccccccccccCCCchhHHHHHHHHHHHHhCC
Q 019040          211 -FSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGV  250 (347)
Q Consensus       211 -~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~  250 (347)
                       ......--.|..|+.+... +...|.|-||+++++++.|.
T Consensus       161 ~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  161 PAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCcc
Confidence             1111122235555544211 13479999999999999993

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=1e-13  Score=128.76  Aligned_cols=255  Identities=21%  Similarity=0.206  Sum_probs=184.1

Q ss_pred             CcccceeeeeeecccCCeEEEEEEEC-CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDR-DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ....+|..+..||.|.|+.|+..... .++..|++|...........++ .-..|+.+...+..|.+++.....|.....
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            34567889999999999999987655 7788899998765443333332 233477777777788888888888887778


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .|+-.|||+++++.....-...+.+...+++..|++.++.++|+..++|.|++|+||++..++  +-.+++|||.++...
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLA  418 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccccc
Confidence            889999999988766664444578888999999999999999999999999999999995322  667899999886522


Q ss_pred             CCCcccccccCcccc-cccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          207 PGERFSEIVGSPYYM-APEVLK-R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~-aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      -...  ......++. ..|.+. . .+..+.|++|||..+.+.+++...-+...   ....+..+.    .+..+.....
T Consensus       419 ~~~~--~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~----~p~~~~~~~~  489 (524)
T KOG0601|consen  419 FSSG--VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGD----TPNLPGLKLQ  489 (524)
T ss_pred             eecc--cccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeeccc----ccCCCchHHh
Confidence            1111  112333444 255444 2 37789999999999999999865322211   111222221    1111244477


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +..+.+.+..+++..||.+.++..|+-|...
T Consensus       490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  490 LQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             hhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence            8889999999999999999999888766543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=3.7e-12  Score=102.17  Aligned_cols=134  Identities=23%  Similarity=0.303  Sum_probs=99.4

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccc-----cchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      ..+++|+-+.+|.+.+  -|..+++|.=.....     ...-...+-.+|..++..+ ....|+..+-+..+.+...|+|
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEE
Confidence            3578899999999966  344466665322222     2222344577799999988 5556666666666777788999


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ||++|..|.+.+...       ...+++.+-..+.-||..||+|||+.++||++.    .+.+.++|||++..
T Consensus        79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCcccc
Confidence            999998888888665       245667777777889999999999999999994    33499999999875

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.30  E-value=1.6e-10  Score=105.80  Aligned_cols=211  Identities=16%  Similarity=0.178  Sum_probs=156.2

Q ss_pred             CeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe----eCCeEEEEEEecCC-Cc
Q 019040           64 FGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE----DDNAVHLVMELCEG-GE  138 (347)
Q Consensus        64 ~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~  138 (347)
                      -.+.|++....+|..|++|+++-......   .....-+++++++ .|.|++++.+++.    .+..+++|++|+++ ++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            36899999999999999999854332222   1233467889999 9999999998887    34678999999985 47


Q ss_pred             hHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          139 LFDRIVAR---------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       139 L~~~l~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      |.++....               .+.++..+|.++.|+..||.++|+.|+..+-+.|.+|++   ..+.+++|+..|...
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEeccccee
Confidence            87765322               236789999999999999999999999999999999999   455579998888776


Q ss_pred             ccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHH-HHHHHhccccccCCCCCCCC
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPP-FWAESEQGV-AQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  281 (347)
                      .......             |-+  .--.+.|.--||.+++.|.||..- +........ +..+.           ..++
T Consensus       442 vl~~d~~-------------~~l--e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS  495 (655)
T KOG3741|consen  442 VLQEDPT-------------EPL--ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTYS  495 (655)
T ss_pred             eecCCCC-------------cch--hHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhhh
Confidence            5543320             001  012467899999999999999543 212222211 22221           2668


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+++++|..+...++++ -+..+++.|
T Consensus       496 ~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  496 TDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            89999999999999998 788888766

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=5.1e-11  Score=101.92  Aligned_cols=143  Identities=24%  Similarity=0.401  Sum_probs=102.0

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCC-CceeEeeeEEeeC---CeEEEEEE
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN-SSIVSLKEACEDD---NAVHLVME  132 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h-~~i~~~~~~~~~~---~~~~lv~e  132 (347)
                      +.|+.|..+.||++.... |..+++|+.......  .....+.+|.++++.+..+ ..+++++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            568999999999998743 578999997543221  1345688899999999432 3456677666553   36789999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 019040          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK------------------------------------------  170 (347)
Q Consensus       133 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~------------------------------------------  170 (347)
                      |++|.++...+.. ..++......++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999887664421 245666666667777777777663                                          


Q ss_pred             --------------cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          171 --------------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       171 --------------~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                                    ..++|+|+++.||+++.+ .++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence                          246999999999999531 145689999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=1.4e-11  Score=116.39  Aligned_cols=152  Identities=19%  Similarity=0.359  Sum_probs=110.9

Q ss_pred             HHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcc-----c-----ccccCccccccccccc
Q 019040          160 TIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF-----S-----EIVGSPYYMAPEVLKR  228 (347)
Q Consensus       160 qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~-----~-----~~~~~~~y~aPE~~~~  228 (347)
                      +..+|+.++|.. ++||++|.|.+|.+   +..+.+||+.|+++.....+...     .     -......|.|||++..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            334999999965 89999999999999   78888999999998876552211     1     1134667999998764


Q ss_pred             -cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccc-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 019040          229 -NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK-RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV  305 (347)
Q Consensus       229 -~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  305 (347)
                       ..+.++|+||||+++|.+.. |...+...... ............. .-.-..+|+++.+=|.+++..++.-||++..+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l  262 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL  262 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence             47889999999999999884 55444333221 1111211111111 11114789999999999999999999999999


Q ss_pred             hcCcccccCc
Q 019040          306 LEHPWLQNAK  315 (347)
Q Consensus       306 l~h~~~~~~~  315 (347)
                      +..+||.+..
T Consensus       263 ~~~~ff~D~~  272 (700)
T KOG2137|consen  263 LSIPFFSDPG  272 (700)
T ss_pred             hcccccCCch
Confidence            9999998764

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.19  E-value=7.2e-10  Score=97.00  Aligned_cols=137  Identities=16%  Similarity=0.103  Sum_probs=94.1

Q ss_pred             eEEEEEEECCCCceeEEeEecccccc----c----hhcHHHHHHHHHHHHhCCCCCce--eEeeeEEee-----CCeEEE
Q 019040           65 GVTYLCIDRDTRELLACKSISKRKLR----T----AVDIDDVRREVAIMKHLPKNSSI--VSLKEACED-----DNAVHL  129 (347)
Q Consensus        65 g~V~~a~~~~~~~~vavK~~~~~~~~----~----~~~~~~~~~ei~~l~~l~~h~~i--~~~~~~~~~-----~~~~~l  129 (347)
                      ..|+++..  .|+.|.||........    .    ........+|...+..| ...+|  +.+..+.+.     ...-++
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCCccceeEE
Confidence            34556544  5667888876322210    0    01112367788888777 33333  233334432     235789


Q ss_pred             EEEecCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC----CCCCCEEEEeeccc
Q 019040          130 VMELCEGG-ELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK----KENSPLKAIDFGLS  202 (347)
Q Consensus       130 v~e~~~~~-~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~----~~~~~~~l~Dfg~a  202 (347)
                      |+|++++. +|.+++..  ....+......++.+++..+..||..||+|+|++++|||++.+    +++..+.|+||+.+
T Consensus       113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            99999886 89888864  2345667788999999999999999999999999999999642    34568999999988


Q ss_pred             cc
Q 019040          203 IF  204 (347)
Q Consensus       203 ~~  204 (347)
                      ..
T Consensus       193 ~~  194 (268)
T PRK15123        193 QI  194 (268)
T ss_pred             cc
Confidence            54

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.18  E-value=2.1e-10  Score=94.76  Aligned_cols=130  Identities=22%  Similarity=0.241  Sum_probs=81.8

Q ss_pred             EEEEEEECCCCceeEEeEecccccc-----------------------chhcHHHHHHHHHHHHhCCCCC-ceeEeeeEE
Q 019040           66 VTYLCIDRDTRELLACKSISKRKLR-----------------------TAVDIDDVRREVAIMKHLPKNS-SIVSLKEAC  121 (347)
Q Consensus        66 ~V~~a~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~ei~~l~~l~~h~-~i~~~~~~~  121 (347)
                      .||.|... +|..+|+|+.......                       .........+|.+.|..+.... +++.++.+.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38889874 5678999997542110                       0112345778999999994432 577776442


Q ss_pred             eeCCeEEEEEEecC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          122 EDDNAVHLVMELCE--GGELFDRIVARGHYTERAAAAVTRTIVEVVQL-CHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       122 ~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~-lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                          ..++||||++  |..+.. +... .++......++.+++..+.. +|..||+|||+++.||++.   ++ .+.|+|
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~---~~-~~~iID  149 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD---DG-KVYIID  149 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE---TT-CEEE--
T ss_pred             ----CCEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee---cc-eEEEEe
Confidence                2359999998  655644 3332 12244566777888885555 5799999999999999995   32 799999


Q ss_pred             eccccccC
Q 019040          199 FGLSIFFK  206 (347)
Q Consensus       199 fg~a~~~~  206 (347)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.08  E-value=3.1e-09  Score=95.40  Aligned_cols=238  Identities=18%  Similarity=0.169  Sum_probs=154.9

Q ss_pred             eeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE------EeeC-Ce
Q 019040           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA------CEDD-NA  126 (347)
Q Consensus        54 ~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~------~~~~-~~  126 (347)
                      ...+.||+|+-+.+|-.-.-.   .-+.|++..-.....      .+-+..|.....||-+-.-+.|      ..+. ..
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecchhh---chhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            456779999999999663322   245688765432111      1123334444455544331111      1122 23


Q ss_pred             EEEEEEecCCC-chHHHHH---h---cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          127 VHLVMELCEGG-ELFDRIV---A---RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       127 ~~lv~e~~~~~-~L~~~l~---~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                      ..++|..+.|. .+..++.   +   ........+.+.++.++.+...||+.|.+-||+.++|+|+   .+++.+.|.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEcc
Confidence            67888888775 2333321   1   1236778899999999999999999999999999999999   67788999986


Q ss_pred             ccccccCCCCcccccccCcccccccccc-c-----cCCCchhHHHHHHHHHHHHhC-CCCCCCCCHH-----HHHHHHHh
Q 019040          200 GLSIFFKPGERFSEIVGSPYYMAPEVLK-R-----NYGPEIDIWSAGVILYILLCG-VPPFWAESEQ-----GVAQAILR  267 (347)
Q Consensus       200 g~a~~~~~~~~~~~~~~~~~y~aPE~~~-~-----~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~-----~~~~~~~~  267 (347)
                      .......++....-.+|.+.|++||.-. +     .-+...|-|.||+++++++.| ++||.+-...     .....|-.
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            6554445555555568999999999754 2     255679999999999998886 9999653210     01111111


Q ss_pred             cc---------c---cccCCCCCCCCHHHHHHHHHhccC--CCCCCCCHH
Q 019040          268 GL---------I---DFKRDPWPNVSESAKSLVRQMLEP--DPKLRLTAK  303 (347)
Q Consensus       268 ~~---------~---~~~~~~~~~~~~~~~~li~~~l~~--dp~~Rps~~  303 (347)
                      +.         .   .....+|.-+++++..++.+|+..  ++.-|||++
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            11         1   111234457899999999999874  356799976

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=3.9e-09  Score=89.27  Aligned_cols=111  Identities=19%  Similarity=0.248  Sum_probs=85.5

Q ss_pred             cHHHHHHHHHHHHhCCCCCc--eeEeeeEEeeC----CeEEEEEEecCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 019040           94 DIDDVRREVAIMKHLPKNSS--IVSLKEACEDD----NAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTRTIVEVVQ  166 (347)
Q Consensus        94 ~~~~~~~ei~~l~~l~~h~~--i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~  166 (347)
                      ......+|...+..| ....  ++.++.+....    ...++|+|++++. +|.+++......+......++.+++..+.
T Consensus        54 ~~~ra~~E~~~~~~L-~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   54 RRSRAKREWRNLQRL-REAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIA  132 (206)
T ss_pred             cchHHHHHHHHHHHH-HHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHH
Confidence            345677788877766 3222  34455555442    2458999999874 89998887555777888999999999999


Q ss_pred             HHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       167 ~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      -||..||+|+|+++.|||++.++....+.++||+.+...
T Consensus       133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999999999976555568999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.02  E-value=2.2e-09  Score=91.50  Aligned_cols=141  Identities=23%  Similarity=0.284  Sum_probs=102.6

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccc--ccc----------c-------hhcHHHHHHHHHHHHhCCCC-C
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKR--KLR----------T-------AVDIDDVRREVAIMKHLPKN-S  112 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~----------~-------~~~~~~~~~ei~~l~~l~~h-~  112 (347)
                      +.+...||.|.-|.||.|.+. .|..+|+|.=..-  .+.          .       ........+|.++|..|... -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            467789999999999999986 6778999973210  000          0       11234577899999999322 2


Q ss_pred             ceeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC
Q 019040          113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       113 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                      .+++.+++    +...+|||+++|..|...-     +..+....++..|+.-+.-+-..|+||||+++-||++   +++|
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~dg  239 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TEDG  239 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecCC
Confidence            56666544    4556999999997664322     2355566677777777777779999999999999999   6788


Q ss_pred             CEEEEeeccccccC
Q 019040          193 PLKAIDFGLSIFFK  206 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~  206 (347)
                      .++++||-.+....
T Consensus       240 ~~~vIDwPQ~v~~~  253 (304)
T COG0478         240 DIVVIDWPQAVPIS  253 (304)
T ss_pred             CEEEEeCcccccCC
Confidence            89999998876544

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.90  E-value=1.5e-08  Score=95.96  Aligned_cols=146  Identities=18%  Similarity=0.205  Sum_probs=97.5

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccc---------------------------hh----------cHHHHH
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---------------------------AV----------DIDDVR   99 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---------------------------~~----------~~~~~~   99 (347)
                      ..|+.++-|.||+|+.+. |+.||||+....-...                           ..          ..-++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            679999999999999865 9999999974321000                           00          011233


Q ss_pred             HHHHHHHhC----CCCCceeEeeeEEeeCCeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcE
Q 019040          100 REVAIMKHL----PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVI  174 (347)
Q Consensus       100 ~ei~~l~~l----~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  174 (347)
                      +|...+.++    .+.+.+.-..-+++-.+.-.++|||++|..+.+.... ....+...+...+.++.  +..+-..|++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff  287 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF  287 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence            444444443    3345555555566667788899999999988887422 23455444443333322  2334458999


Q ss_pred             eeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       175 H~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      |+|.+|.||++   ..++.+.+.|||......+.
T Consensus       288 HaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         288 HADPHPGNILV---RSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ccCCCccceEE---ecCCcEEEEcCcceecCCHH
Confidence            99999999999   66788999999998876544

>PRK09902 hypothetical protein; Provisional

Probab=98.89  E-value=5.3e-08  Score=81.11  Aligned_cols=140  Identities=16%  Similarity=0.147  Sum_probs=99.0

Q ss_pred             cccCCeEEEEEEECCCCceeEEeEeccc---cccchhcHHHHHHHHHHHHhCCCCCc--eeEeeeEEe-e----CCeEEE
Q 019040           60 GRGEFGVTYLCIDRDTRELLACKSISKR---KLRTAVDIDDVRREVAIMKHLPKNSS--IVSLKEACE-D----DNAVHL  129 (347)
Q Consensus        60 g~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~ei~~l~~l~~h~~--i~~~~~~~~-~----~~~~~l  129 (347)
                      |.||.|.|+....  .|+.+-+|.....   ..........+.+|+..+..| ...+  ++.+. ++. .    .-.-+|
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L-~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKEL-ERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHH-HHcCCCCCccc-eeeeeccCCceEEEE
Confidence            5688999999865  3446888876411   111133457789999988888 3222  44444 222 1    134678


Q ss_pred             EEEecCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          130 VMELCEG-GELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       130 v~e~~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      |+|-++| .+|.+++.+.  .+.+......+..+++.++.-||+.|+.|+|+.+.||+++.++ ...+.++||.-+..
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence            9997754 4888887663  3457777889999999999999999999999999999995322 23599999987654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.87  E-value=5.6e-08  Score=81.26  Aligned_cols=143  Identities=21%  Similarity=0.214  Sum_probs=90.2

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHH------HHHHHHHHHHhCC--CCCceeEeee
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDID------DVRREVAIMKHLP--KNSSIVSLKE  119 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~------~~~~ei~~l~~l~--~h~~i~~~~~  119 (347)
                      .+.++|.+.+.+.......|.+..  -+|+.+++|..............      ...+++..+..+.  +......++-
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            356788988988887777666664  46788999987543221111111      1222333333331  2222222222


Q ss_pred             -----EEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCE
Q 019040          120 -----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (347)
Q Consensus       120 -----~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~  194 (347)
                           .+.-....+++|||++|..|.+...    +++    .+...+.+++.-||+.|++|||.+|+|+++.    ++.+
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~i  173 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNGI  173 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCcE
Confidence                 2223356678999999988865431    222    3556677889999999999999999999994    3449


Q ss_pred             EEEeeccccc
Q 019040          195 KAIDFGLSIF  204 (347)
Q Consensus       195 ~l~Dfg~a~~  204 (347)
                      +++||+....
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999986543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.73  E-value=2.6e-07  Score=79.25  Aligned_cols=73  Identities=19%  Similarity=0.208  Sum_probs=54.3

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCc-eeEeeeEEeeCCeEEEEEEecC
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IVSLKEACEDDNAVHLVMELCE  135 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~-i~~~~~~~~~~~~~~lv~e~~~  135 (347)
                      ..||.|..+.||+.    .+..+++|......     ....+.+|.++++.+....- +++++.+....+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            56899999999984    24457889875321     33457889999998843333 6788888888888899999999


Q ss_pred             CCc
Q 019040          136 GGE  138 (347)
Q Consensus       136 ~~~  138 (347)
                      |.+
T Consensus        78 G~~   80 (226)
T TIGR02172        78 GKR   80 (226)
T ss_pred             Ccc
Confidence            863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.71  E-value=2e-07  Score=78.88  Aligned_cols=144  Identities=18%  Similarity=0.151  Sum_probs=93.8

Q ss_pred             eeeeecccCCeEEEEEEECCCCceeEEeEeccccccchh----------------c-----HHHHHHHHHHHHhCCC-CC
Q 019040           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV----------------D-----IDDVRREVAIMKHLPK-NS  112 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~----------------~-----~~~~~~ei~~l~~l~~-h~  112 (347)
                      +...|+.|.-+.||+|.. .++..+|+|++.........                .     ..-..+|..-|+++.. .=
T Consensus        52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            344677888889999975 46888999998654322111                1     1123457777766611 22


Q ss_pred             ceeEeeeEEeeCCeEEEEEEecCCCchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCC
Q 019040          113 SIVSLKEACEDDNAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKE  190 (347)
Q Consensus       113 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~  190 (347)
                      .+++.+.+.    ...+|||++....... .|+. -.+.......+..+++..+.-|-. .|+||+|++.-|||+.    
T Consensus       131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~----  201 (268)
T COG1718         131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH----  201 (268)
T ss_pred             CCCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----
Confidence            344444443    3458999995421110 1111 123333577788888888888877 8999999999999993    


Q ss_pred             CCCEEEEeeccccccCCC
Q 019040          191 NSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       191 ~~~~~l~Dfg~a~~~~~~  208 (347)
                      ++.+.|+|||.|.....+
T Consensus       202 ~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         202 DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             CCeEEEEECccccccCCC
Confidence            567999999999876543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.69  E-value=3.5e-07  Score=91.74  Aligned_cols=212  Identities=17%  Similarity=0.176  Sum_probs=149.3

Q ss_pred             cHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE----EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019040           94 DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH----LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH  169 (347)
Q Consensus        94 ~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH  169 (347)
                      .+....-|+..+..+ .|+|+..++.+........    +..+++...++...+..-...+..+.+.+..++..||.++|
T Consensus       225 ~i~~~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  225 EIQTTEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            344455577788888 8999999988876553333    44578888899998988888999999999999999999999


Q ss_pred             HcCcEeeCCCCCcEEeecCCCCCCEEEE--eeccccccCCCCcccccccCcccccccccccc---CCCchhHHHHHHHHH
Q 019040          170 KHGVIHRDLKPENFLFANKKENSPLKAI--DFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN---YGPEIDIWSAGVILY  244 (347)
Q Consensus       170 ~~~ivH~Dikp~NIli~~~~~~~~~~l~--Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~Di~slG~~l~  244 (347)
                      +....|.-+..+-..-...+..+.+.++  ||+.+..............+..+-++|.....   .....|+|++|.+..
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            9865555554442222212445556666  88888776665554445566677888876533   334579999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCC
Q 019040          245 ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       245 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                      .+..|..+-.-   ......++..          .......+.+.+|+.-++++|+++.+++.|+|.+.......
T Consensus       384 ~~~~~~~i~~~---~~~~~~~l~~----------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~  445 (1351)
T KOG1035|consen  384 QLSQGEDISEK---SAVPVSLLDV----------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES  445 (1351)
T ss_pred             hhhhcCccccc---ccchhhhhcc----------ccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence            98887543211   0111111111          12226788999999999999999999999999987765544

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=2e-07  Score=88.24  Aligned_cols=146  Identities=17%  Similarity=0.168  Sum_probs=92.1

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccch-----------------------------hcHHHHHHHHHHHH
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA-----------------------------VDIDDVRREVAIMK  106 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----------------------------~~~~~~~~ei~~l~  106 (347)
                      .+.||..+.|.||+|+.+. |+.||||+-+.. +...                             +-.+.+..|+..+.
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~  243 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK  243 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence            4679999999999999876 999999996432 1110                             01112222322222


Q ss_pred             hCC---------CCCc------eeEeeeEEeeCCeEEEEEEecCCCchHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019040          107 HLP---------KNSS------IVSLKEACEDDNAVHLVMELCEGGELFDR--IVARGHYTERAAAAVTRTIVEVVQLCH  169 (347)
Q Consensus       107 ~l~---------~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~i~~qi~~~l~~lH  169 (347)
                      ...         .|-+      |++++  +.......++|||++|..+.+.  +.+. .++...+..-+.+...  +-+=
T Consensus       244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~--~qIf  318 (538)
T KOG1235|consen  244 EAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL--EQIF  318 (538)
T ss_pred             HHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH--HHHH
Confidence            220         2233      45553  4445677899999999866554  3333 4555544443333322  2233


Q ss_pred             HcCcEeeCCCCCcEEeecC-CCCCCEEEEeeccccccCCC
Q 019040          170 KHGVIHRDLKPENFLFANK-KENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       170 ~~~ivH~Dikp~NIli~~~-~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ..|++|+|-+|.||++.++ ..+..+.+-|||+.......
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            5689999999999999743 35678999999998776543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.58  E-value=7e-07  Score=77.64  Aligned_cols=76  Identities=14%  Similarity=0.128  Sum_probs=55.1

Q ss_pred             ecccCC-eEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCC
Q 019040           59 LGRGEF-GVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGG  137 (347)
Q Consensus        59 lg~G~~-g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~  137 (347)
                      |..|.. +.||+....  +..+++|+.....      ...+.+|+.+++.+..+-.+++++++....+..++||++++|.
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            444555 789999653  3668888875332      2356779999988865666788888887777789999999997


Q ss_pred             chHHH
Q 019040          138 ELFDR  142 (347)
Q Consensus       138 ~L~~~  142 (347)
                      ++...
T Consensus        78 ~l~~~   82 (244)
T cd05150          78 PAAAL   82 (244)
T ss_pred             cHhHh
Confidence            76643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.56  E-value=1.1e-06  Score=75.64  Aligned_cols=79  Identities=23%  Similarity=0.214  Sum_probs=55.8

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCC-ceeEeeeEE---eeCCeEEEEE
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-SIVSLKEAC---EDDNAVHLVM  131 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~-~i~~~~~~~---~~~~~~~lv~  131 (347)
                      ++.++.|..+.||++....  ..+++|.....     .....+.+|..+++.+..+. .++.++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            4678999999999998755  47999986432     34466778888888874332 366666543   2335689999


Q ss_pred             EecCCCchHH
Q 019040          132 ELCEGGELFD  141 (347)
Q Consensus       132 e~~~~~~L~~  141 (347)
                      ++++|.++..
T Consensus        75 ~~i~g~~~~~   84 (239)
T PF01636_consen   75 EYIPGRPLDD   84 (239)
T ss_dssp             EEESSEEHHH
T ss_pred             EEeccccccc
Confidence            9999987777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.53  E-value=8.1e-07  Score=71.23  Aligned_cols=132  Identities=21%  Similarity=0.241  Sum_probs=93.7

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      .-++.+.|+.|.+|.||++.+  .|..+|+|+-..+     .....+..|.+++..+.....-+.++.+..+.    +.|
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~m   91 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRM   91 (201)
T ss_pred             hhhhhhhhhcccccEEEEeec--cCceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhh
Confidence            346778899999999999988  4568999986533     34567889999999996666667776654433    459


Q ss_pred             EecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCC--CcEEeecCCCCCCEEEEeecccccc
Q 019040          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP--ENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       132 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp--~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ||++|.+|.+.....   ...    -...++.+---|-..||-|+.|.-  .||++    .+..+.|+||..|+.-
T Consensus        92 e~i~G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~k  156 (201)
T COG2112          92 EYIDGRPLGKLEIGG---DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhcCcchhhhhhcc---cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhhc
Confidence            999998887655332   222    333444555556778999999863  45665    2336999999999853

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.52  E-value=4.2e-06  Score=69.79  Aligned_cols=135  Identities=24%  Similarity=0.285  Sum_probs=98.1

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEecccc-------------ccchhcHHHHHHHHHHHHhCC-----CCCceeEe
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRK-------------LRTAVDIDDVRREVAIMKHLP-----KNSSIVSL  117 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~~~ei~~l~~l~-----~h~~i~~~  117 (347)
                      ...||.|+.-.||.-  + .+...+||+.....             ...........+|+.....+.     .+.+|+++
T Consensus         6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            346899999988875  2 34448899987654             011123456777887777772     27789999


Q ss_pred             eeEEeeCCeEEEEEEecCC------CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCC
Q 019040          118 KEACEDDNAVHLVMELCEG------GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (347)
Q Consensus       118 ~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~  191 (347)
                      +|+.+++....+|+|.+..      .+|.+++.+. .++.    .+...+-+-..+|-+.+|+.+|++|.||++...++.
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999997632      4788888554 4554    444455566778889999999999999999876555


Q ss_pred             C-CEEEEe
Q 019040          192 S-PLKAID  198 (347)
Q Consensus       192 ~-~~~l~D  198 (347)
                      . .++|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence            5 677877

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.36  E-value=3e-08  Score=93.42  Aligned_cols=247  Identities=16%  Similarity=0.147  Sum_probs=166.5

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCc-eeEeeeEEeeCCeEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IVSLKEACEDDNAVHLV  130 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~-i~~~~~~~~~~~~~~lv  130 (347)
                      .+.....++.|+++++++.+...+...+ .+++...        ....-++++|.++ +||| .+..++.++.+...++.
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i~  312 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWIP  312 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHc-cCCCCcccccccCCcccccchh
Confidence            3555667889999999999887665544 6665432        2344588899999 8888 77777777888899999


Q ss_pred             EEecCCC-chHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          131 MELCEGG-ELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       131 ~e~~~~~-~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ++++.++ +-.... ...-.+.+-+...+.+.-..+++++|+.-=+|+|    ||+.    .++..+..||+....+...
T Consensus       313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCcc
Confidence            9999876 221111 0111233344455666667889999988778888    8886    3466899999988877665


Q ss_pred             CcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC---CCCCCCCHHH
Q 019040          209 ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR---DPWPNVSESA  284 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  284 (347)
                      .......+++.++|||+.. +.+....|.|++|.-..++.-|.+|-...  ......+-.+...+..   ..|.  +..-
T Consensus       385 ~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~--~~~~  460 (829)
T KOG0576|consen  385 MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWS--PVFH  460 (829)
T ss_pred             cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcC--cccc
Confidence            5556678999999999765 56889999999998666777676654331  1111111111000000   1111  1111


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCC
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV  320 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  320 (347)
                      .++...|+...|..|+....++.|.+|+.-....+.
T Consensus       461 ~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~~  496 (829)
T KOG0576|consen  461 RDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIHC  496 (829)
T ss_pred             cCCcccccCCCCCCCcchhhHHHHHHhccCccccee
Confidence            257788999999999999999999999887766554

>PLN02876 acyl-CoA dehydrogenase

Probab=98.34  E-value=8.7e-06  Score=82.98  Aligned_cols=81  Identities=20%  Similarity=0.298  Sum_probs=56.7

Q ss_pred             eeeecccCCeEEEEEEECCCC--ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCce--eEeeeEEeeC---CeEE
Q 019040           56 DRELGRGEFGVTYLCIDRDTR--ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI--VSLKEACEDD---NAVH  128 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i--~~~~~~~~~~---~~~~  128 (347)
                      ++.++.|.++.+|+......+  ..+++|+......  ......+.+|..+++.+..|.++  ++++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~--~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL--LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc--CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            677899999999998765432  3577777543321  11234688999999999445554  7777776654   5688


Q ss_pred             EEEEecCCCc
Q 019040          129 LVMELCEGGE  138 (347)
Q Consensus       129 lv~e~~~~~~  138 (347)
                      +||||++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.25  E-value=6.8e-06  Score=71.04  Aligned_cols=74  Identities=15%  Similarity=0.057  Sum_probs=46.3

Q ss_pred             eeecccCCe-EEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCC--ceeEeeeEEeeC---CeEEEE
Q 019040           57 RELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS--SIVSLKEACEDD---NAVHLV  130 (347)
Q Consensus        57 ~~lg~G~~g-~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~--~i~~~~~~~~~~---~~~~lv  130 (347)
                      +.|+.|+.. .||+..     ..+++|+....     .....+.+|.+++..+..+-  .++.++......   ...+++
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            457766665 588762     24778875432     12357888999999884331  345554443332   245889


Q ss_pred             EEecCCCchH
Q 019040          131 MELCEGGELF  140 (347)
Q Consensus       131 ~e~~~~~~L~  140 (347)
                      |++++|.++.
T Consensus        73 ~~~i~G~~l~   82 (235)
T cd05155          73 YRWLEGETAT   82 (235)
T ss_pred             EEeecCCCCC
Confidence            9999996653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.19  E-value=4.8e-05  Score=63.11  Aligned_cols=130  Identities=18%  Similarity=0.177  Sum_probs=91.2

Q ss_pred             ccceeeeeeecccCC-eEEEEEEECCCCceeEEeEeccccc----------cc-h-------hcHHHHHHHHHHHHhCC-
Q 019040           50 EDRYLVDRELGRGEF-GVTYLCIDRDTRELLACKSISKRKL----------RT-A-------VDIDDVRREVAIMKHLP-  109 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~-g~V~~a~~~~~~~~vavK~~~~~~~----------~~-~-------~~~~~~~~ei~~l~~l~-  109 (347)
                      ...++.++.||.|.- |.||++..  +|+.||+|++..-..          .. .       ...+.+..|.+...+|. 
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            378999999999999 99999976  678999999322111          00 0       12345777888777773 


Q ss_pred             -CCCce--eEeeeEEeeC------------------CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 019040          110 -KNSSI--VSLKEACEDD------------------NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC  168 (347)
Q Consensus       110 -~h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~l  168 (347)
                       ++..+  ++.+|+..-.                  ....||-||.+...         .++    ..-+.+|..-+..+
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~  180 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKIL  180 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHH
Confidence             23344  8888886322                  12457778776543         122    34456777788999


Q ss_pred             HHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       169 H~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      |..||+-+|+++.|..=        -+|+|||.+
T Consensus       181 ~k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             HHCCeeeccCccccccC--------CEEEecccC
Confidence            99999999999999873        389999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.17  E-value=3.2e-05  Score=66.77  Aligned_cols=76  Identities=20%  Similarity=0.247  Sum_probs=49.5

Q ss_pred             eeeecccCCeEEEEEEECC-CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEec
Q 019040           56 DRELGRGEFGVTYLCIDRD-TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (347)
                      ++.|..|-...+|++.... .++.|++|+..... ..   .-...+|+.+++.+..+...+++++...  +  .+++||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-EL---IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cc---eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence            4567788888999997543 35678899765321 11   1223468888888854555566655433  2  3799999


Q ss_pred             CCCch
Q 019040          135 EGGEL  139 (347)
Q Consensus       135 ~~~~L  139 (347)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.12  E-value=0.00011  Score=67.86  Aligned_cols=80  Identities=19%  Similarity=0.224  Sum_probs=55.1

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccc--cc--hhcHHHHHHHHHHHHhCCCC--CceeEeeeEEeeCCeEEE
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKL--RT--AVDIDDVRREVAIMKHLPKN--SSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~--~~~~~~~~~ei~~l~~l~~h--~~i~~~~~~~~~~~~~~l  129 (347)
                      .+.||.|.+..||++.+...++.++||.......  ..  ....++...|.+.|+.+...  ..+++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4679999999999999864445899998531110  01  12456677788888876432  457778766  4456789


Q ss_pred             EEEecCCC
Q 019040          130 VMELCEGG  137 (347)
Q Consensus       130 v~e~~~~~  137 (347)
                      ||||+++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999764

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.04  E-value=3.5e-05  Score=67.46  Aligned_cols=135  Identities=16%  Similarity=0.078  Sum_probs=76.9

Q ss_pred             eecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCC
Q 019040           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGG  137 (347)
Q Consensus        58 ~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~  137 (347)
                      .+..|-.+.+|+..  .++..+++|..........   -...+|..+++.+..+.-.++++....    .++|+||++|.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALG---VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCccccccc---CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence            35567778899886  3566788887643321110   124678888888854434455554432    36899999986


Q ss_pred             chHH--------------HHHh---cC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------cCcEeeCC
Q 019040          138 ELFD--------------RIVA---RG----HYTE-RAAAAVTRTI---------VEVVQLCHK--------HGVIHRDL  178 (347)
Q Consensus       138 ~L~~--------------~l~~---~~----~~~~-~~~~~i~~qi---------~~~l~~lH~--------~~ivH~Di  178 (347)
                      .+..              .+.+   ..    +++. ..+..+..++         ...+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            6432              1111   10    1111 1112221111         111222221        24899999


Q ss_pred             CCCcEEeecCCCCCCEEEEeecccccc
Q 019040          179 KPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       179 kp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .|.||+++   +++ +.|+||+.+...
T Consensus       154 ~~~Nil~~---~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       154 HAYNLVVT---PQG-LKLIDWEYASDG  176 (256)
T ss_pred             CcCcEEEe---CCC-CEEEeccccCcC
Confidence            99999994   333 789999988753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.02  E-value=5.5e-05  Score=67.76  Aligned_cols=147  Identities=18%  Similarity=0.175  Sum_probs=102.4

Q ss_pred             eeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchh------------------c-----HHHHHHHHHHHHhCCC
Q 019040           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV------------------D-----IDDVRREVAIMKHLPK  110 (347)
Q Consensus        54 ~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~------------------~-----~~~~~~ei~~l~~l~~  110 (347)
                      .|-..|..|.-+.||.|.. .+|..+|||+++.+.+....                  .     ..-..+|++-|.++ +
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~  224 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-N  224 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-H
Confidence            5666788899999999976 56788999999765431111                  0     12245688888888 5


Q ss_pred             CCceeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCcEeeCCCCCcEEeecCC
Q 019040          111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-HKHGVIHRDLKPENFLFANKK  189 (347)
Q Consensus       111 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~ivH~Dikp~NIli~~~~  189 (347)
                      ...|+..--+. .. ...|||+++.......-..+...++...+..+..+++..+.-| |.+++||.||+--|+|+    
T Consensus       225 ~aGIP~PePIl-Lk-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----  298 (520)
T KOG2270|consen  225 NAGIPCPEPIL-LK-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----  298 (520)
T ss_pred             hcCCCCCCcee-ee-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----
Confidence            55554432222 22 2458999995433333333444678788888888888888777 46799999999999999    


Q ss_pred             CCCCEEEEeeccccccCCC
Q 019040          190 ENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       190 ~~~~~~l~Dfg~a~~~~~~  208 (347)
                      .+|.++|+|.+.+.....+
T Consensus       299 hdG~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  299 HDGKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             ECCEEEEEEccccccCCCh
Confidence            4678999999988765544

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.93  E-value=0.00011  Score=65.80  Aligned_cols=138  Identities=17%  Similarity=0.202  Sum_probs=80.6

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCC-ceeEeeeE------EeeCCeEE
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-SIVSLKEA------CEDDNAVH  128 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~-~i~~~~~~------~~~~~~~~  128 (347)
                      .+.+..|....+|+...  ++..+++|+...      .....+..|+.++..|..+. .+++++..      ....+..+
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            55677787789999864  334688898753      12345667888777773221 24444432      23345678


Q ss_pred             EEEEecCCCchHH-----------HHHh---c-CCCCH--------HHHH------------HHHHHHHHHHHHHHH---
Q 019040          129 LVMELCEGGELFD-----------RIVA---R-GHYTE--------RAAA------------AVTRTIVEVVQLCHK---  170 (347)
Q Consensus       129 lv~e~~~~~~L~~-----------~l~~---~-~~~~~--------~~~~------------~i~~qi~~~l~~lH~---  170 (347)
                      +++++++|..+..           .+.+   . ..+..        .-..            .....+..++.++..   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999999866421           1100   0 00000        0000            011112334444443   


Q ss_pred             ----cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          171 ----HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       171 ----~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                          .+++|+|+.|.||++   ++++.+.|+||+.+..
T Consensus       171 ~~~~~~l~HgD~~~~Nil~---~~~~~~~iIDfe~a~~  205 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLF---DGDELSGVIDFYFACT  205 (296)
T ss_pred             hcCCCcCCccCcCcccEEE---eCCceEEEeehhhhcC
Confidence                479999999999999   4455568999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.91  E-value=5.3e-05  Score=62.90  Aligned_cols=99  Identities=18%  Similarity=0.252  Sum_probs=78.7

Q ss_pred             HHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCchHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHH---cCc
Q 019040          100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD---RIVARGHYTERAAAAVTRTIVEVVQLCHK---HGV  173 (347)
Q Consensus       100 ~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~---~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i  173 (347)
                      .|.-+++.++..+++++++|++..    +++.||...+++..   .+......++....+++.++++.+.+|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            488889999776799999999833    57899997665532   12222346889999999999999999997   358


Q ss_pred             EeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       174 vH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .-.|++++|+-+   .+++.+|++|...+...
T Consensus        84 ~lcDv~~~nfgv---~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGV---NDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEE---eCCCcEEEEechhcchh
Confidence            899999999999   56788999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.86  E-value=0.00015  Score=65.22  Aligned_cols=77  Identities=13%  Similarity=0.076  Sum_probs=49.8

Q ss_pred             eeeecccCCeEEEEEEECC------CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           56 DRELGRGEFGVTYLCIDRD------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      ++.+..|-...+|++....      .++.+++|+.....    .......+|..++..+......++++.....    .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence            3456667777899887543      25779999975432    1123456788888888544445666665542    35


Q ss_pred             EEEecCCCchH
Q 019040          130 VMELCEGGELF  140 (347)
Q Consensus       130 v~e~~~~~~L~  140 (347)
                      |++|++|.++.
T Consensus        75 v~e~i~G~~l~   85 (302)
T cd05156          75 IEEFIPSRTLT   85 (302)
T ss_pred             hhheeCCCcCC
Confidence            89999887654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=97.73  E-value=0.00047  Score=63.10  Aligned_cols=139  Identities=12%  Similarity=0.092  Sum_probs=82.6

Q ss_pred             eeeecccCCeEEEEEEECC----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEE
Q 019040           56 DRELGRGEFGVTYLCIDRD----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      +..+..|-...+|++....    .++.|++|+.....   ...++ ..+|..+++.+.....-+++++.+..+    .|.
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~  112 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE  112 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence            4456568888999987543    24679999875432   22222 366888888885555566777766433    579


Q ss_pred             EecCCCchHHH--------------HHh---cC----C-C-CHHHHHHHHHHH-----------------HHHHHHH---
Q 019040          132 ELCEGGELFDR--------------IVA---RG----H-Y-TERAAAAVTRTI-----------------VEVVQLC---  168 (347)
Q Consensus       132 e~~~~~~L~~~--------------l~~---~~----~-~-~~~~~~~i~~qi-----------------~~~l~~l---  168 (347)
                      +|+++.++...              +.+   ..    . + ....+..+..++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99987665421              110   00    0 1 112222332221                 1111112   


Q ss_pred             -H----HcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          169 -H----KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       169 -H----~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                       .    ...++|+|+++.||+++  +.++.+.|+||..+..
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~  231 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYASY  231 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhccc
Confidence             1    22589999999999995  2346799999998864

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.70  E-value=3.5e-05  Score=67.88  Aligned_cols=140  Identities=21%  Similarity=0.257  Sum_probs=95.4

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEecccc--ccchh-----------------cHHHHHHHHHHHHhCCCCCc
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK--LRTAV-----------------DIDDVRREVAIMKHLPKNSS  113 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~-----------------~~~~~~~ei~~l~~l~~h~~  113 (347)
                      +.++..||-|.-+.||.+-+. .|.+.++|+=..-.  ++...                 ..-...+|...++.|..|.+
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            567889999999999999874 57778888632110  10000                 01224568888888833322


Q ss_pred             -eeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC
Q 019040          114 -IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       114 -i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                       +++.+++    +..++|||+++|..|...-.      ......+...++..+--|-..|+||||+.--||++   .++.
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd~  239 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDDD  239 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEE---ecCC
Confidence             4444433    35568999999988854331      12234556667777778889999999999999999   5677


Q ss_pred             CEEEEeeccccccC
Q 019040          193 PLKAIDFGLSIFFK  206 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~  206 (347)
                      .++++||-......
T Consensus       240 ~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  240 KIVVIDFPQMVSTS  253 (465)
T ss_pred             CEEEeechHhhccC
Confidence            89999998665543

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.69  E-value=0.00056  Score=61.61  Aligned_cols=140  Identities=20%  Similarity=0.233  Sum_probs=78.8

Q ss_pred             eeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCC-ceeEeeeEE------eeCCeE
Q 019040           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-SIVSLKEAC------EDDNAV  127 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~-~i~~~~~~~------~~~~~~  127 (347)
                      ..+.++.|....+|++.. .++ .+++|+.....     ..+.+..|++++..|..+. .+++++...      ...+..
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~   98 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP   98 (307)
T ss_pred             eccccCCccccceEEEEe-CCC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence            356677787789998864 334 57788764321     1234556677777662211 144544421      234667


Q ss_pred             EEEEEecCCCchH-----------HHH---Hh-cCCC--------CHHHHH---------------HHHHHHHHHHHHHH
Q 019040          128 HLVMELCEGGELF-----------DRI---VA-RGHY--------TERAAA---------------AVTRTIVEVVQLCH  169 (347)
Q Consensus       128 ~lv~e~~~~~~L~-----------~~l---~~-~~~~--------~~~~~~---------------~i~~qi~~~l~~lH  169 (347)
                      +++++|++|..+.           ..+   .. ...+        ......               .....+...++++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            8999999885431           111   10 0001        001000               00111233455553


Q ss_pred             H-------cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          170 K-------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       170 ~-------~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      .       .+++|+|+++.||+++   .++...|+||+.+..
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFACT  217 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEE---CCceEEEeecccccC
Confidence            2       5899999999999994   445568999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.64  E-value=0.0021  Score=58.22  Aligned_cols=75  Identities=12%  Similarity=0.113  Sum_probs=43.3

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCC-CceeEeeeE------EeeCCeEE
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN-SSIVSLKEA------CEDDNAVH  128 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h-~~i~~~~~~------~~~~~~~~  128 (347)
                      .+.++.|....+|+.... +| .+++|++. .  .   ....+..|+.+++.|..+ -.+++++..      ....+..+
T Consensus        27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~-~--~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~   98 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFE-R--L---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA   98 (319)
T ss_pred             cchhccccccceEEEEeC-CC-cEEEEEec-c--C---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence            345677777899998653 33 58889874 1  1   123344455555555211 114444421      23356688


Q ss_pred             EEEEecCCCc
Q 019040          129 LVMELCEGGE  138 (347)
Q Consensus       129 lv~e~~~~~~  138 (347)
                      ++++|++|..
T Consensus        99 ~l~~~l~G~~  108 (319)
T PRK05231         99 AIVTFLEGKW  108 (319)
T ss_pred             EEEEecCCCC
Confidence            9999999864

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.64  E-value=0.00088  Score=60.82  Aligned_cols=84  Identities=14%  Similarity=0.120  Sum_probs=53.5

Q ss_pred             eecccCCeEEEEEEECCCCceeEEeEecccc----ccchhcHHHHHHHHHHHHhCCCC-C-ceeEeeeEEeeCCeEEEEE
Q 019040           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRK----LRTAVDIDDVRREVAIMKHLPKN-S-SIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        58 ~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~ei~~l~~l~~h-~-~i~~~~~~~~~~~~~~lv~  131 (347)
                      .||.|....||++.+...++.|+||-....-    ..-....++..-|...|+..... | .+++++  +.+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence            5799999999999986444679998754211    11133455666788888776332 2 466664  34455566899


Q ss_pred             EecCC-CchHHHH
Q 019040          132 ELCEG-GELFDRI  143 (347)
Q Consensus       132 e~~~~-~~L~~~l  143 (347)
                      |+++. ..|...+
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            99854 3444444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.61  E-value=0.0011  Score=59.26  Aligned_cols=148  Identities=18%  Similarity=0.254  Sum_probs=84.5

Q ss_pred             eeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCC-CCceeEeeeEEeeCC--eEEEE
Q 019040           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK-NSSIVSLKEACEDDN--AVHLV  130 (347)
Q Consensus        54 ~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~-h~~i~~~~~~~~~~~--~~~lv  130 (347)
                      .+++.+..|.-..+|...+.  ++.++++ ... ............+|..+++.+.. .-.++..++.+.++.  ..|.|
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence            44555555555566766554  7778887 321 12223344667789999988833 233455556665554  77999


Q ss_pred             EEecCCCch------------------HHHHHhc--------------CCCCHHHHHHHHHHH--------------HHH
Q 019040          131 MELCEGGEL------------------FDRIVAR--------------GHYTERAAAAVTRTI--------------VEV  164 (347)
Q Consensus       131 ~e~~~~~~L------------------~~~l~~~--------------~~~~~~~~~~i~~qi--------------~~~  164 (347)
                      |+|++|..+                  .++|..-              +.+....+..+..+.              ...
T Consensus       104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            999988322                  1111110              001111222222222              112


Q ss_pred             HHHHHHc--------CcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          165 VQLCHKH--------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       165 l~~lH~~--------~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ..+++.+        .++|||+++.|+++.   ....+-++||+.+..-.+.
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~---~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIID---PGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEe---CCCeeEEEeccccccCCcH
Confidence            3334332        489999999999995   4444899999999865443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.57  E-value=0.0011  Score=60.36  Aligned_cols=76  Identities=11%  Similarity=0.112  Sum_probs=47.6

Q ss_pred             eeeecccCCeEEEEEEECCC---CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           56 DRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      ++.|..|-...+|+......   +..|++|+.....   .. .-...+|..+++.+..+..-+++++++..  .  +|.+
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~--G--~i~~   90 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DY-VIDRERELQAIKYLSAAGFGAKLLGVFGN--G--MIQS   90 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---Ce-EechHHHHHHHHHHHhcCCCCceeEEeCC--c--Eeeh
Confidence            44455577788998875432   2378899875432   11 12235688888888555555667666532  2  5899


Q ss_pred             ecCCCch
Q 019040          133 LCEGGEL  139 (347)
Q Consensus       133 ~~~~~~L  139 (347)
                      |++|.+|
T Consensus        91 fi~g~~l   97 (330)
T PLN02421         91 FINARTL   97 (330)
T ss_pred             hhcCCCC
Confidence            9987655

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.56  E-value=0.00037  Score=65.12  Aligned_cols=165  Identities=18%  Similarity=0.188  Sum_probs=104.4

Q ss_pred             HHHHHHHHHHHhCCCCCceeEeeeEEeeC-CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcE
Q 019040           96 DDVRREVAIMKHLPKNSSIVSLKEACEDD-NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI  174 (347)
Q Consensus        96 ~~~~~ei~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  174 (347)
                      ..+.-..++++.+ .|+++..++++-... ....+|+|++ +.+|.+++.... +-.....                  +
T Consensus        27 ~~ilgr~~~lktl-~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~   85 (725)
T KOG1093|consen   27 IQILGRFQYLKSL-QHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------A   85 (725)
T ss_pred             HHHhhhhHHHHhh-cCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------c
Confidence            4566788899999 999999998887644 4578889999 679999887764 2111111                  2


Q ss_pred             eeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCC
Q 019040          175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFW  254 (347)
Q Consensus       175 H~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  254 (347)
                      |+-+ +-||          ++.+| -+++.   .              |-.    ..+++||||+|.++.++.-|...+.
T Consensus        86 ~~~~-~~~~----------~~~td-~~~t~---~--------------~~~----~~pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   86 HGVL-HLNI----------IYITD-HFLTK---Y--------------PSP----IGPKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             cccc-eehh----------hhccc-ccccc---C--------------CCC----CCcchhhhhHHHHHHHHHHhhHHHH
Confidence            2211 1122          22233 11110   0              000    1249999999999999999987765


Q ss_pred             CCCHHHHHHHHHhccccccC--------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          255 AESEQGVAQAILRGLIDFKR--------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ....-+....+..-....-.        ...-.++....++.+.|+...|..||...++.+++-|...
T Consensus       133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            55444433333222110000        0001467778899999999999999999999999988665

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.54  E-value=0.0016  Score=60.13  Aligned_cols=85  Identities=11%  Similarity=0.090  Sum_probs=55.8

Q ss_pred             eeeeecccCCeEEEEEEECCCCceeEEeEeccccccch----hcHHHHHHHHHHHHhCCC--CCceeEeeeEEeeCCeEE
Q 019040           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA----VDIDDVRREVAIMKHLPK--NSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~ei~~l~~l~~--h~~i~~~~~~~~~~~~~~  128 (347)
                      ..+.||.|....||+..+.  +..++||..........    ....+...|...|+.+..  ...+++++.++.  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            3677899999999999873  45688998652211111    234555667777776632  257888887776  4466


Q ss_pred             EEEEecCC--CchHHHH
Q 019040          129 LVMELCEG--GELFDRI  143 (347)
Q Consensus       129 lv~e~~~~--~~L~~~l  143 (347)
                      ++||++++  ..+.+.+
T Consensus       112 lvME~L~~~~~ilr~~L  128 (418)
T PLN02756        112 IGMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEEeecCCcceehhhhh
Confidence            78999976  3454444

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.39  E-value=0.0019  Score=57.15  Aligned_cols=30  Identities=27%  Similarity=0.440  Sum_probs=24.3

Q ss_pred             CcEeeCCCCCcEEeecCCCCCC-EEEEeeccccc
Q 019040          172 GVIHRDLKPENFLFANKKENSP-LKAIDFGLSIF  204 (347)
Q Consensus       172 ~ivH~Dikp~NIli~~~~~~~~-~~l~Dfg~a~~  204 (347)
                      .++|||++|.||+++   +++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~---~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILID---EDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEe---CCCCEEEEECcHhccc
Confidence            489999999999995   3244 57999998875

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PTZ00384 choline kinase; Provisional

Probab=97.26  E-value=0.0029  Score=58.53  Aligned_cols=79  Identities=18%  Similarity=0.102  Sum_probs=50.3

Q ss_pred             eeeeeecccCCeEEEEEEECCCC-ce-----eEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           54 LVDRELGRGEFGVTYLCIDRDTR-EL-----LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        54 ~i~~~lg~G~~g~V~~a~~~~~~-~~-----vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...+.|..|-...+|++...... ..     |.++....    .....-.-.+|+.+++.+..+..-+++++.+..    
T Consensus        53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----  124 (383)
T PTZ00384         53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----  124 (383)
T ss_pred             EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence            34455666888899999754332 22     44444311    111112245689999999777778888888754    


Q ss_pred             EEEEEecCCCchH
Q 019040          128 HLVMELCEGGELF  140 (347)
Q Consensus       128 ~lv~e~~~~~~L~  140 (347)
                      +++.||++|.+|.
T Consensus       125 g~l~efIeGr~l~  137 (383)
T PTZ00384        125 FTIQEWVEGNTMG  137 (383)
T ss_pred             EEEEEEeccccCC
Confidence            4899999987653

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.21  E-value=0.0036  Score=57.66  Aligned_cols=86  Identities=14%  Similarity=0.152  Sum_probs=55.5

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEecccc-c--cchhcHHHHHHHHHHHHhCCC--CCceeEeeeEEeeCCeEEEE
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRK-L--RTAVDIDDVRREVAIMKHLPK--NSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~--~~~~~~~~~~~ei~~l~~l~~--h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .+.||.|...-||++.+...++.|+||-....- .  .-.-..++..-|.+.|+.+..  ...+++++  +.+.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHH
Confidence            677899999999999985445679998653211 1  113345667778888887633  23577775  4445556688


Q ss_pred             EEecCC-CchHHHH
Q 019040          131 MELCEG-GELFDRI  143 (347)
Q Consensus       131 ~e~~~~-~~L~~~l  143 (347)
                      ||+++. ..|.+.|
T Consensus       112 MEdL~~~~ilR~~L  125 (409)
T PRK12396        112 MEDLSDHTILRTAL  125 (409)
T ss_pred             HHhCcccHHHHHHH
Confidence            998854 2344444

>PRK10593 hypothetical protein; Provisional

Probab=97.16  E-value=0.0041  Score=55.66  Aligned_cols=105  Identities=10%  Similarity=0.017  Sum_probs=71.5

Q ss_pred             eeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCC--CceeEeeeEEee---CCeEE
Q 019040           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN--SSIVSLKEACED---DNAVH  128 (347)
Q Consensus        54 ~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h--~~i~~~~~~~~~---~~~~~  128 (347)
                      .-.+.||.|..+.||..... ++ .+++|..+.     ......+.+|...++.+...  -.++++++++..   .+..+
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~   89 (297)
T PRK10593         17 SRVECISEQPYAALWALYDS-QG-NPMPLMARS-----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV   89 (297)
T ss_pred             heeeecCCccceeEEEEEcC-CC-CEEEEEecc-----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence            44667999999999998653 23 477787432     11225688899999988554  368888887754   36789


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK  170 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~  170 (347)
                      +|||+++|.++.+.     .........++.+++.+|..||.
T Consensus        90 LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~  126 (297)
T PRK10593         90 LLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHR  126 (297)
T ss_pred             EEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhC
Confidence            99999999877541     12233345556666677777775

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.94  E-value=0.0025  Score=56.55  Aligned_cols=76  Identities=18%  Similarity=0.129  Sum_probs=48.1

Q ss_pred             eeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC--CCCceeEeeeEEeeCCeEEEEE
Q 019040           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACEDDNAVHLVM  131 (347)
Q Consensus        54 ~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~--~h~~i~~~~~~~~~~~~~~lv~  131 (347)
                      .-.+.++.|..+.+|+..  .+++.+.+|+-...      ....+..|..-|+.|.  ..-.+++++.+....+..++|+
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            445678889999999986  57788999987521      2245677888777772  3556888999888887889999


Q ss_pred             EecCCC
Q 019040          132 ELCEGG  137 (347)
Q Consensus       132 e~~~~~  137 (347)
                      ||++.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            999765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.92  E-value=0.0021  Score=54.45  Aligned_cols=31  Identities=32%  Similarity=0.563  Sum_probs=20.5

Q ss_pred             CcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       172 ~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      -++|+|+.+.||+++  +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEET--SSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEec--cCCCeEEEecHHHHhh
Confidence            479999999999993  4567799999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.86  E-value=0.0042  Score=56.76  Aligned_cols=61  Identities=20%  Similarity=0.189  Sum_probs=44.0

Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCcEeeCCCCCcEEeec
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRDLKPENFLFAN  187 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dikp~NIli~~  187 (347)
                      ...++-+|..|.++..+++.. ..++.....++.-..+|+.-+- -.+++|.|++|.||++..
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            344666788888998888665 3455566666666666655544 458999999999999964

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.68  E-value=0.00047  Score=71.99  Aligned_cols=149  Identities=17%  Similarity=0.096  Sum_probs=103.4

Q ss_pred             HHHHHHhCCCCCceeEeeeEEe--eCCeEEEEEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC--
Q 019040          101 EVAIMKHLPKNSSIVSLKEACE--DDNAVHLVMELCEGGELFDRIVARG----HYTERAAAAVTRTIVEVVQLCHKHG--  172 (347)
Q Consensus       101 ei~~l~~l~~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--  172 (347)
                      |..-++.+ .|+++.....-..  .+...+..++++.+|.+.+.+.+.-    ......+.....+...+..-+|+..  
T Consensus      1279 e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1279 ERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            33344445 6777665544443  2356778899999999999886642    2333334444444466667767542  


Q ss_pred             ---cEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-cccccccCccccccccccc-cCCCchhHHHHHHHHHHHH
Q 019040          173 ---VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILL  247 (347)
Q Consensus       173 ---ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~  247 (347)
                         -+|+++++.|.+|   ..+..++++++|+.++..+.. -.....+++.|+.|+.... .++.++|+|..|+.+|...
T Consensus      1358 g~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             Cccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence               6899999999999   566779999999998433332 2244567888888887653 4777799999999999988


Q ss_pred             hCCCCC
Q 019040          248 CGVPPF  253 (347)
Q Consensus       248 ~g~~pf  253 (347)
                      -|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            887776

>PTZ00296 choline kinase; Provisional

Probab=96.61  E-value=0.029  Score=53.07  Aligned_cols=77  Identities=13%  Similarity=0.036  Sum_probs=48.3

Q ss_pred             eeeeecccCCeEEEEEEECCC--------CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           55 VDRELGRGEFGVTYLCIDRDT--------RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      -++.|..|-.-.+|++.....        ++.|++|+.....   ..-+ ...+|..+++.+..+.--+++++.+.    
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----  180 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS----  180 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence            455666677788999875422        4678999875421   1111 34558888887744444556666553    


Q ss_pred             EEEEEEecCCCch
Q 019040          127 VHLVMELCEGGEL  139 (347)
Q Consensus       127 ~~lv~e~~~~~~L  139 (347)
                      -+.|.+|++|.+|
T Consensus       181 gg~I~efi~g~~l  193 (442)
T PTZ00296        181 GGRIEEWLYGDPL  193 (442)
T ss_pred             CCEEEEeeCCccC
Confidence            2357999988644

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.32  E-value=0.086  Score=47.48  Aligned_cols=30  Identities=27%  Similarity=0.412  Sum_probs=26.5

Q ss_pred             CcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       172 ~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +++|||+.+.||++   +.++.+.++||..++.
T Consensus       197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence            79999999999999   5666799999998875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.23  E-value=0.17  Score=45.99  Aligned_cols=70  Identities=13%  Similarity=0.065  Sum_probs=40.6

Q ss_pred             CeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCC--CCceeEe--ee--EEeeCCeEEEEEEecCCC
Q 019040           64 FGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK--NSSIVSL--KE--ACEDDNAVHLVMELCEGG  137 (347)
Q Consensus        64 ~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~--h~~i~~~--~~--~~~~~~~~~lv~e~~~~~  137 (347)
                      -..||+... .++..+++|+.....    .....+..|+..+..|..  .|-+.++  -+  ....++..+.++++++|.
T Consensus        38 eN~vy~v~~-~~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~  112 (325)
T PRK11768         38 ENRVYQFGD-EDGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR  112 (325)
T ss_pred             cceEEEEec-CCCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence            457898865 345679999874221    123556667777776632  2211111  11  123356788899999875


Q ss_pred             c
Q 019040          138 E  138 (347)
Q Consensus       138 ~  138 (347)
                      .
T Consensus       113 ~  113 (325)
T PRK11768        113 A  113 (325)
T ss_pred             C
Confidence            3

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.09  E-value=0.04  Score=46.67  Aligned_cols=76  Identities=14%  Similarity=0.180  Sum_probs=51.3

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC--CCCceeEeeeEEeeCCeEEEEEEec
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACEDDNAVHLVMELC  134 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~--~h~~i~~~~~~~~~~~~~~lv~e~~  134 (347)
                      +.+..|..-..|...+  ....+.+|+-..+      ....+..|+.-|+.+.  +.-.+++++.+....++.|+|+||+
T Consensus        22 ~~v~gG~inea~~v~d--g~~~~FvK~n~~~------~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L   93 (286)
T COG3001          22 EEVSGGDINEAWRLRD--GTDPFFVKCNQRE------QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL   93 (286)
T ss_pred             cccCCccccceeEeec--CCcceEEEecchh------hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence            3455555566666644  3456888876433      3345666777776662  2345888888899999999999999


Q ss_pred             CCCchH
Q 019040          135 EGGELF  140 (347)
Q Consensus       135 ~~~~L~  140 (347)
                      +.+.+.
T Consensus        94 ~~~~~d   99 (286)
T COG3001          94 PTGPLD   99 (286)
T ss_pred             cCCCCC
Confidence            875543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.87  E-value=0.05  Score=49.32  Aligned_cols=102  Identities=16%  Similarity=0.183  Sum_probs=66.8

Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      .+.|+++++- |+++.. +   ..-..+++..++.+.+..+.-+..+ ..-|||+...||+|   + +|.|-|+||.+++
T Consensus       299 ~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfklsR  369 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKLSR  369 (488)
T ss_pred             eEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeeeee
Confidence            4566666665 555532 2   1235567778888877777777655 68999999999999   5 7889999999998


Q ss_pred             ccCCCCcccccccCccccccccccccCCCchhHHHH
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA  239 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~sl  239 (347)
                      .......    +....+--|-.+.|.-+...|||-+
T Consensus       370 l~~~q~~----isy~rldhp~lF~G~dd~QFeIYrl  401 (488)
T COG5072         370 LSYSQGI----ISYNRLDHPDLFNGVDDYQFEIYRL  401 (488)
T ss_pred             cccCCce----eeccccCchhhhcCccceeeeHHHH
Confidence            4322221    1122233344455555677788865

>PRK06148 hypothetical protein; Provisional

Probab=95.55  E-value=0.13  Score=53.88  Aligned_cols=34  Identities=29%  Similarity=0.368  Sum_probs=25.6

Q ss_pred             cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       171 ~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      .++||+|+.+.||+++.+......-|+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999996432222345999998865

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.07  E-value=0.16  Score=42.99  Aligned_cols=149  Identities=13%  Similarity=0.104  Sum_probs=85.0

Q ss_pred             cCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCCchHH
Q 019040           62 GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD  141 (347)
Q Consensus        62 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  141 (347)
                      |+.++.-.++-+- |- ..+|.+......-  ....+.++.++++++   -.|+++..-  +.-.+.+|.|.|-....  
T Consensus        73 ~gNsTl~~~kt~i-G~-L~lKKi~slp~~~--~~~~y~nky~v~Arm---hGilrL~ND--n~~~yGvIlE~Cy~~~i--  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GP-LFLKKIRSLPCCI--NDALYFNKYRVFARM---HGILRLKND--NNYKYGVILERCYKIKI--  141 (308)
T ss_pred             CCceEEEEecccc-ch-hhhhhccCCCccc--chhhhhhhhhHHHHh---hheeEeecC--CCceeEEEEeeccCccc--
Confidence            4555555554433 33 4555554333321  224467788888877   457776522  34457789998843211  


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccccCcc
Q 019040          142 RIVARGHYTERAAAAVTRTIVEVVQLCHKH--GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY  219 (347)
Q Consensus       142 ~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~  219 (347)
                                 ....+...=+.+|.-.|+.  +.+|||-.|+||+.   +..|-+||.|-+....   ..  ..+. ...
T Consensus       142 -----------~~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~---D~~G~lKlVDP~~Ll~---~~--V~~v-N~~  201 (308)
T PF07387_consen  142 -----------NFSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMC---DKFGYLKLVDPVCLLE---NQ--VNMV-NIE  201 (308)
T ss_pred             -----------chhHHHHHhHHHHHHhhccCCCeecCCCChhheee---cCCCCEEecChhhhhh---he--eeEE-eee
Confidence                       0011222224567778844  69999999999999   7889999999765321   10  0011 111


Q ss_pred             ccccccccccCCCchhHHHHHHHHHHHHh
Q 019040          220 YMAPEVLKRNYGPEIDIWSAGVILYILLC  248 (347)
Q Consensus       220 y~aPE~~~~~~~~~~Di~slG~~l~~l~~  248 (347)
                      |.       ..+.++++-+|-.-++++..
T Consensus       202 Y~-------~lT~~aE~~~fv~s~l~~v~  223 (308)
T PF07387_consen  202 YE-------SLTQEAEVKVFVKSCLKLVE  223 (308)
T ss_pred             cc-------ccChHHHHHHHHHHHHHHHH
Confidence            21       25666777666555555554

The function of this family is unknown.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.68  E-value=0.074  Score=47.81  Aligned_cols=30  Identities=27%  Similarity=0.500  Sum_probs=24.9

Q ss_pred             cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       171 ~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      .+++|||+++.||+++   . +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEe---C-CcEEEEECccccc
Confidence            4789999999999994   3 4589999997653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	347
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-63
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-63
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-60
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-60
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-60
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-59
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-59
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-58
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-58
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-57
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-57
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-57
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-57
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-56
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-55
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-55
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-55
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-55
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-55
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-54
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-54
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-54
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-54
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-53
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-53
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-53
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-53
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-52
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-52
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-51
3soa_A	444	Full-Length Human Camkii Length = 444		7e-51
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-49
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-46
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-46
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-46
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-46
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-46
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-45
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-45
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-45
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-45
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-45
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-45
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-45
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-45
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-45
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-45
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-45
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-45
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-45
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-44
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-44
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-44
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-43
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-43
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-43
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-43
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-43
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-43
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-43
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-43
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-43
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-43
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-43
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-43
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-43
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-43
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-43
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-43
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-43
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-43
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-43
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-43
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-43
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-43
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-43
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-43
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-43
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-42
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-42
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-42
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-42
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-42
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-42
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-41
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		9e-41
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-40
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-40
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-40
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-39
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-38
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-38
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-38
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-38
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-38
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		8e-38
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-37
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-37
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-37
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-37
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-37
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-37
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-37
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-37
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-37
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-37
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-37
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-36
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-36
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-36
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		7e-36
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-36
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-36
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-36
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-35
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-35
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-35
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-35
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-35
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-35
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-35
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-35
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-35
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-35
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-35
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-35
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-35
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-35
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-35
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-35
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-35
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-35
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-35
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-34
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-34
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-34
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-34
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-34
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-34
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-34
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-34
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-34
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-34
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-34
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-34
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-34
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-34
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-34
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-34
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-34
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-34
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-33
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-33
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-33
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-33
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-32
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-32
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-32
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-31
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-31
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-30
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-30
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-30
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-29
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-29
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-29
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-28
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-28
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-28
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-28
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-28
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-28
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-28
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-27
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-27
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-27
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-27
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-27
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-27
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-27
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-27
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-27
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-27
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-27
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-27
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-27
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-27
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-27
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-27
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-27
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-27
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-26
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-26
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-26
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-26
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-26
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-26
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-26
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-26
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-26
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-26
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-26
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-26
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-26
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-26
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-26
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-26
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-26
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-26
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-26
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-26
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-26
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-26
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-26
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-26
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-26
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-26
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		9e-26
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-25
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-25
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-25
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-25
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-25
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-25
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-25
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-25
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-25
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-25
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-25
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-25
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-25
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-25
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-25
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-25
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-25
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-25
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-25
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-25
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-25
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-25
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-25
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-25
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-25
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-25
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-25
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-25
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-25
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-25
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-25
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-25
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-25
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-25
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-25
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-25
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-25
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-25
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-25
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-25
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-25
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-25
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-25
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-25
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-25
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-25
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-25
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-25
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-25
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-25
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-25
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-25
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-25
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-25
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-25
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-25
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-25
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-25
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-25
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-25
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-25
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-25
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-25
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-25
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-25
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-25
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-25
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-25
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-25
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-25
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-25
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-25
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-24
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-24
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-24
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-24
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-24
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-24
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-24
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-24
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-24
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-24
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-24
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-24
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-24
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-24
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-24
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-24
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-24
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-24
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-24
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-24
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-24
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-24
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-24
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-24
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-24
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-24
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-24
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-24
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-24
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-24
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-24
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-24
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-24
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-24
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-23
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-23
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-23
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-23
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-23
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-23
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-23
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-23
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-23
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-23
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-23
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-23
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-22
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-22
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-22
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-22
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-22
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-22
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-21
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-21
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-21
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-21
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-21
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-21
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-21
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-21
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-21
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-21
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-21
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-21
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-21
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-21
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-21
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-21
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-21
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-21
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-21
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-21
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-21
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-21
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-21
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-21
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-21
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-21
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-21
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-21
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-21
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-21
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-21
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-21
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-21
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-21
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-21
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-21
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-21
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-21
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-21
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-21
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-21
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-21
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-21
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-21
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-21
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-20
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-20
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-20
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-20
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-20
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-20
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-20
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-20
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-20
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-20
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-20
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-20
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-19
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-19
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-19
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-19
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-19
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-19
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-19
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-19
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-19
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-19
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-19
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-19
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-19
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-19
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-19
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-19
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-19
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-18
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-18
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-18
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-18
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-18
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-18
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-18
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-18
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-18
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-18
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-17
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-17
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-17
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-17
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-17
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-17
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-17
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-17
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-17
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-17
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-17
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-17
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-16
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-16
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-16
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-16
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-16
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-16
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-16
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-16
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-16
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-16
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-16
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-16
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-16
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-16
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-16
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-16
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-16
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-16
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-16
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-16
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-16
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-16
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-16
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-16
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-16
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-16
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-16
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-16
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-16
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-16
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-16
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-16
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-16
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-16
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-16
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-16
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-16
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-16
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-15
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-15
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-15
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-15
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-15
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-15
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-15
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-15
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-15
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-15
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-15
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-15
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-15
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-15
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-15
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-15
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-15
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-15
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-15
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-15
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-15
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-15
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-15
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-15
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-15
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-15
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-15
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-15
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-15
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-15
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-15
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-15
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-15
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-15
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-15
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-15
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-15
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-15
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-15
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-15
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-15
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-15
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-15
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-15
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-15
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-15
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		6e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-15
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-14
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-14
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-14
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-14
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-14
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-14
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-14
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-14
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-14
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-14
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-14
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-14
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-14
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-14
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-14
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-13
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-13
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-13
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-13
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		4e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-13
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-12
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-12
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-12
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-12
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-12
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-11
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		7e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-10
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		3e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-10
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-09
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-08
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-08
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		9e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-08
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-07
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		3e-07
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		3e-07
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		3e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-07
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		4e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-07
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		9e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-06
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-06
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-06
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-06
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-06
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-06
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-06
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-05
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		2e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-05
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-05
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-04
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-04

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  238 bits (607), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 120/272 (44%), Positives = 167/272 (61%), Gaps = 4/272 (1%)
Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
             G  K +I   Y ++  +GRG +G   + + + TR   A K I K  +    D+D  ++
Sbjct: 16  FQGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQ 72
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E+ IMK L  + +I+ L E  ED+  ++LVMELC GGELF+R+V +  + E  AA + + 
Sbjct: 73  EIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD 131
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           ++  V  CHK  V HRDLKPENFLF     +SPLK IDFGL+  FKPG+     VG+PYY
Sbjct: 132 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYY 191
Query: 221 MAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           ++P+VL+  YGPE D WSAGV++Y+LLCG PPF A ++  V   I  G   F    W NV
Sbjct: 192 VSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNV 251
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           S  A+SL+R++L   PK R+T+ Q LEH W +
Sbjct: 252 SPQAESLIRRLLTKSPKQRITSLQALEHEWFE 283

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  238 bits (606), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 120/270 (44%), Positives = 167/270 (61%), Gaps = 4/270 (1%)
Query: 43  GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           G  K +I   Y ++  +GRG +G   + + + TR   A K I K  +    D+D  ++E+
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEI 57
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            IMK L  + +I+ L E  ED+  ++LVMELC GGELF+R+V +  + E  AA + + ++
Sbjct: 58  EIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             V  CHK  V HRDLKPENFLF     +SPLK IDFGL+  FKPG+     VG+PYY++
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 223 PEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           P+VL+  YGPE D WSAGV++Y+LLCG PPF A ++  V   I  G   F    W NVS 
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSP 236
Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            A+SL+R++L   PK R+T+ Q LEH W +
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFE 266

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  230 bits (586), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 117/297 (39%), Positives = 178/297 (59%), Gaps = 4/297 (1%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           DRY   R LG+G FG   LC D+ T +  A K ISKR+++   D + + REV ++K L  
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 108
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED    +LV E+  GGELFD I++R  ++E  AA + R ++  +   HK
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 168
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           + ++HRDLKPEN L  +K +++ ++ IDFGLS  F+  ++  + +G+ YY+APEVL   Y
Sbjct: 169 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 228
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WS GVILYILL G PPF   +E  + + + +G   F+   W  VSESAK L+R+
Sbjct: 229 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 288
Query: 291 MLEPDPKLRLTAKQVLEHPWLQNAKK---APNVPLGDVVRSRLKQFSMMNRFKRKAL 344
           ML   P +R++A+  L+H W+Q   K   + +VP  D     ++QF    +  + AL
Sbjct: 289 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAAL 345

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  229 bits (585), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 117/297 (39%), Positives = 178/297 (59%), Gaps = 4/297 (1%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           DRY   R LG+G FG   LC D+ T +  A K ISKR+++   D + + REV ++K L  
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 107
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED    +LV E+  GGELFD I++R  ++E  AA + R ++  +   HK
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 167
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           + ++HRDLKPEN L  +K +++ ++ IDFGLS  F+  ++  + +G+ YY+APEVL   Y
Sbjct: 168 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 227
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WS GVILYILL G PPF   +E  + + + +G   F+   W  VSESAK L+R+
Sbjct: 228 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 287
Query: 291 MLEPDPKLRLTAKQVLEHPWLQNAKK---APNVPLGDVVRSRLKQFSMMNRFKRKAL 344
           ML   P +R++A+  L+H W+Q   K   + +VP  D     ++QF    +  + AL
Sbjct: 288 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAAL 344

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  229 bits (584), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 117/297 (39%), Positives = 178/297 (59%), Gaps = 4/297 (1%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           DRY   R LG+G FG   LC D+ T +  A K ISKR+++   D + + REV ++K L  
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 84
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED    +LV E+  GGELFD I++R  ++E  AA + R ++  +   HK
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           + ++HRDLKPEN L  +K +++ ++ IDFGLS  F+  ++  + +G+ YY+APEVL   Y
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 204
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WS GVILYILL G PPF   +E  + + + +G   F+   W  VSESAK L+R+
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 291 MLEPDPKLRLTAKQVLEHPWLQNAKK---APNVPLGDVVRSRLKQFSMMNRFKRKAL 344
           ML   P +R++A+  L+H W+Q   K   + +VP  D     ++QF    +  + AL
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAAL 321

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  224 bits (571), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 115/298 (38%), Positives = 176/298 (59%), Gaps = 6/298 (2%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +RY +   LG+G FG    C DR T++  A K I+K   +   D   + REV ++K L  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD- 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED ++ ++V EL  GGELFD I+ R  ++E  AA + + +   +   HK
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           H ++HRDLKPEN L  +K+++  +K IDFGLS  F+   +  + +G+ YY+APEVL+  Y
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WSAGVILYILL G PPF+ ++E  + + +  G   F    W  +S+ AK L+R+
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 291 MLEPDPKLRLTAKQVLEHPWLQN-AKKAPNV---PLGDVVRSRLKQFSMMNRFKRKAL 344
           ML   P LR+TA Q LEHPW+Q  + + P +   P  +   + ++QF    +  + AL
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAAL 317

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  224 bits (571), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 110/266 (41%), Positives = 165/266 (62%), Gaps = 1/266 (0%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           DRY   R LG+G FG   LC D+ T +  A K ISKR+++   D + + REV ++K L  
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 90
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED    +LV E+  GGELFD I++R  ++E  AA + R ++  +   HK
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 150
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           + ++HRDLKPEN L  +K +++ ++ IDFGLS  F+  ++  + +G+ YY+APEVL   Y
Sbjct: 151 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 210
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WS GVILYILL G PPF   +E  + + + +G   F+   W  VSESAK L+R+
Sbjct: 211 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 270
Query: 291 MLEPDPKLRLTAKQVLEHPWLQNAKK 316
           ML   P +R++A+  L+H W+Q   K
Sbjct: 271 MLTYVPSMRISARDALDHEWIQTYTK 296

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  223 bits (569), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 116/297 (39%), Positives = 175/297 (58%), Gaps = 4/297 (1%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           DRY   R LG+G FG   LC D+ T +  A K ISKR+++   D + + REV ++K L  
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 84
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I  L E  ED    +LV E+  GGELFD I++R  ++E  AA + R ++  +   HK
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHK 144
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           + ++HRDLKPEN L  +K +++ ++ IDFGLS  F+  ++  + +G+ YY+APEVL   Y
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTY 204
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WS GVILYILL G PPF   +E  + + + +G   F+   W  VSESAK L+R+
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 291 MLEPDPKLRLTAKQVLEHPWLQNAKK---APNVPLGDVVRSRLKQFSMMNRFKRKAL 344
            L   P  R++A+  L+H W+Q   K   + +VP  D     ++QF    +  + AL
Sbjct: 265 XLTYVPSXRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAAL 321

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  220 bits (561), Expect = 8e-58,   Method: Compositional matrix adjust.
 Identities = 127/332 (38%), Positives = 185/332 (55%), Gaps = 10/332 (3%)
Query: 11  VAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLC 70
           +  E++     S   A    G     P   + G  ++ + D + V+ ELGRG   + Y C
Sbjct: 13  LGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRC 72
Query: 71  IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV 130
             + T++  A K + K      VD   VR E+ ++  L  + +I+ LKE  E    + LV
Sbjct: 73  KQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEISLV 126
Query: 131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE 190
           +EL  GGELFDRIV +G+Y+ER AA   + I+E V   H++G++HRDLKPEN L+A    
Sbjct: 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAP 186
Query: 191 NSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCG 249
           ++PLK  DFGLS   +       + G+P Y APE+L+   YGPE+D+WS G+I YILLCG
Sbjct: 187 DAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
Query: 250 VPPFWAE-SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
             PF+ E  +Q + + IL     F    W  VS +AK LVR+++  DPK RLT  Q L+H
Sbjct: 247 FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306
Query: 309 PWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFK 340
           PW+    KA N    D  + +L++F+   + K
Sbjct: 307 PWVTG--KAANFVHMDTAQKKLQEFNARRKLK 336

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  219 bits (559), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 161/262 (61%), Gaps = 2/262 (0%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +RY +   LG+G FG    C DR T++  A K I+K   +   D   + REV ++K L  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD- 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED ++ ++V EL  GGELFD I+ R  ++E  AA + + +   +   HK
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           H ++HRDLKPEN L  +K+++  +K IDFGLS  F+   +  + +G+ YY+APEVL+  Y
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WSAGVILYILL G PPF+ ++E  + + +  G   F    W  +S+ AK L+R+
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 291 MLEPDPKLRLTAKQVLEHPWLQ 312
           ML   P LR+TA Q LEHPW+Q
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQ 281

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  219 bits (559), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 161/262 (61%), Gaps = 2/262 (0%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +RY +   LG+G FG    C DR T++  A K I+K   +   D   + REV ++K L  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD- 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED ++ ++V EL  GGELFD I+ R  ++E  AA + + +   +   HK
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           H ++HRDLKPEN L  +K+++  +K IDFGLS  F+   +  + +G+ YY+APEVL+  Y
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WSAGVILYILL G PPF+ ++E  + + +  G   F    W  +S+ AK L+R+
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 291 MLEPDPKLRLTAKQVLEHPWLQ 312
           ML   P LR+TA Q LEHPW+Q
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQ 281

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  218 bits (555), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 107/265 (40%), Positives = 161/265 (60%), Gaps = 1/265 (0%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           + + DRY   ++LG G +G   LC D+ T    A K I K  + T  +   +  EVA++K
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            L  + +I+ L E  ED    +LVME+  GGELFD I+ R  ++E  AA + + ++    
Sbjct: 77  QLD-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT 135
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             HKH ++HRDLKPEN L  +K  ++ +K +DFGLS  F+ G +  E +G+ YY+APEVL
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 195
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
           ++ Y  + D+WS GVILYILLCG PPF  +++Q + + + +G   F    W  VS+ AK 
Sbjct: 196 RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQ 255
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
           LV+ ML  +P  R++A++ L HPW+
Sbjct: 256 LVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  218 bits (555), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 107/263 (40%), Positives = 160/263 (60%), Gaps = 1/263 (0%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + DRY   ++LG G +G   LC D+ T    A K I K  + T  +   +  EVA++K L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
             + +I+ L E  ED    +LVME+  GGELFD I+ R  ++E  AA + + ++      
Sbjct: 62  D-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 120
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR 228
           HKH ++HRDLKPEN L  +K  ++ +K +DFGLS  F+ G +  E +G+ YY+APEVL++
Sbjct: 121 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK 180
Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            Y  + D+WS GVILYILLCG PPF  +++Q + + + +G   F    W  VS+ AK LV
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 240
Query: 289 RQMLEPDPKLRLTAKQVLEHPWL 311
           + ML  +P  R++A++ L HPW+
Sbjct: 241 KLMLTYEPSKRISAEEALNHPWI 263

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  216 bits (551), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 113/303 (37%), Positives = 183/303 (60%), Gaps = 6/303 (1%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K ++ + Y   ++LG G +G   LC D+ T    A K I K  + T+ +   +  EVA++
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEEVAVL 90
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           K L  + +I+ L +  ED    +LVME  +GGELFD I+ R  + E  AA + + ++  V
Sbjct: 91  K-LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGV 149
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              HKH ++HRDLKPEN L  +K++++ +K +DFGLS  F+  ++  E +G+ YY+APEV
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV 209
Query: 226 LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           L++ Y  + D+WS GVIL+ILL G PPF  +++Q + + + +G   F    W NVSE AK
Sbjct: 210 LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN--AKKAPNVPLGDVVRS--RLKQFSMMNRFKR 341
            L++QML+ D + R++A+Q LEHPW++   +KK   + L  +  +   +++F    +  +
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQ 329
Query: 342 KAL 344
            AL
Sbjct: 330 AAL 332

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  213 bits (542), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 109/266 (40%), Positives = 163/266 (61%), Gaps = 4/266 (1%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E+I D Y     LG G F    L  D+ T++L+A K I+K+ L        +  E+A++ 
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAVL- 70
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           H  K+ +IV+L +  E    ++L+M+L  GGELFDRIV +G YTER A+ +   +++ V+
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  G++HRDLKPEN L+ +  E+S +   DFGLS    PG   S   G+P Y+APEVL
Sbjct: 131 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 190
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            ++ Y   +D WS GVI YILLCG PPF+ E++  + + IL+   +F    W ++S+SAK
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
             +R ++E DP+ R T +Q L+HPW+
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  212 bits (540), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 109/266 (40%), Positives = 162/266 (60%), Gaps = 4/266 (1%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E+I D Y     LG G F    L  D+ T++L+A K I+K  L        +  E+A++ 
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAVL- 70
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           H  K+ +IV+L +  E    ++L+M+L  GGELFDRIV +G YTER A+ +   +++ V+
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  G++HRDLKPEN L+ +  E+S +   DFGLS    PG   S   G+P Y+APEVL
Sbjct: 131 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 190
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            ++ Y   +D WS GVI YILLCG PPF+ E++  + + IL+   +F    W ++S+SAK
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
             +R ++E DP+ R T +Q L+HPW+
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  212 bits (540), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 109/266 (40%), Positives = 162/266 (60%), Gaps = 4/266 (1%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E+I D Y     LG G F    L  D+ T++L+A K I+K  L        +  E+A++ 
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAVL- 70
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           H  K+ +IV+L +  E    ++L+M+L  GGELFDRIV +G YTER A+ +   +++ V+
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  G++HRDLKPEN L+ +  E+S +   DFGLS    PG   S   G+P Y+APEVL
Sbjct: 131 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 190
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            ++ Y   +D WS GVI YILLCG PPF+ E++  + + IL+   +F    W ++S+SAK
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
             +R ++E DP+ R T +Q L+HPW+
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  211 bits (538), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 109/266 (40%), Positives = 162/266 (60%), Gaps = 4/266 (1%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E+I D Y     LG G F    L  D+ T++L+A K I+K  L        +  E+A++ 
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAVL- 70
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           H  K+ +IV+L +  E    ++L+M+L  GGELFDRIV +G YTER A+ +   +++ V+
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  G++HRDLKPEN L+ +  E+S +   DFGLS    PG   S   G+P Y+APEVL
Sbjct: 131 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 190
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            ++ Y   +D WS GVI YILLCG PPF+ E++  + + IL+   +F    W ++S+SAK
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
             +R ++E DP+ R T +Q L+HPW+
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  211 bits (536), Expect = 7e-55,   Method: Compositional matrix adjust.
 Identities = 105/266 (39%), Positives = 162/266 (60%), Gaps = 4/266 (1%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E+I+  +     LG G F    L  ++ T +L A K I K+ L+       +  E+A+++
Sbjct: 18  EDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKES--SIENEIAVLR 75
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            + K+ +IV+L++  E  N ++LVM+L  GGELFDRIV +G YTE+ A+ + R +++ V 
Sbjct: 76  KI-KHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVY 134
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H+ G++HRDLKPEN L+ ++ E S +   DFGLS     G+  S   G+P Y+APEVL
Sbjct: 135 YLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVL 194
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            ++ Y   +D WS GVI YILLCG PPF+ E++  + + IL+   +F    W ++S+SAK
Sbjct: 195 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAK 254
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
             +R ++E DP  R T +Q   HPW+
Sbjct: 255 DFIRNLMEKDPNKRYTCEQAARHPWI 280

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  210 bits (534), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 116/294 (39%), Positives = 173/294 (58%), Gaps = 5/294 (1%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
             D Y V  ELG+G F V   C+ + T    A K I+ +KL +A D   + RE  I + L
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL 85
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +IV L ++ ++++  +LV +L  GGELF+ IVAR  Y+E  A+   + I+E +  C
Sbjct: 86  -QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR 228
           H +G++HR+LKPEN L A+K + + +K  DFGL+I     E +    G+P Y++PEVLK+
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 204
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           + Y   +DIW+ GVILYILL G PPFW E +  +   I  G  D+    W  V+  AKSL
Sbjct: 205 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKK-APNVPLGDVVRSRLKQFSMMNRFK 340
           +  ML  +PK R+TA Q L+ PW+ N ++ A  +   D V   LK+F+   + K
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDC-LKKFNARRKLK 317

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  207 bits (528), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 109/266 (40%), Positives = 160/266 (60%), Gaps = 3/266 (1%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
             D Y V  ELG+G F V   C+ + T    A K I+ +KL +A D   + RE  I + L
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL 62
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +IV L ++ ++++  +LV +L  GGELF+ IVAR  Y+E  A+   + I+E +  C
Sbjct: 63  -QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR 228
           H +G++HR+LKPEN L A+K + + +K  DFGL+I     E +    G+P Y++PEVLK+
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           + Y   +DIW+ GVILYILL G PPFW E +  +   I  G  D+    W  V+  AKSL
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQN 313
           +  ML  +PK R+TA Q L+ PW+ N
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICN 267

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  207 bits (528), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 109/269 (40%), Positives = 162/269 (60%), Gaps = 3/269 (1%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
             D Y V  ELG+G F V   C+ + T    A K I+ +KL +A D   + RE  I + L
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL 62
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +IV L ++ ++++  +LV +L  GGELF+ IVAR  Y+E  A+   + I+E +  C
Sbjct: 63  -QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR 228
           H +G++HR+LKPEN L A+K + + +K  DFGL+I     E +    G+P Y++PEVLK+
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           + Y   +DIW+ GVILYILL G PPFW E +  +   I  G  D+    W  V+  AKSL
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           +  ML  +PK R+TA Q L+ PW+ N ++
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRER 270

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  207 bits (527), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 109/269 (40%), Positives = 162/269 (60%), Gaps = 3/269 (1%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
             D Y V  ELG+G F V   C+ + T    A K I+ +KL +A D   + RE  I + L
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL 61
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +IV L ++ ++++  +LV +L  GGELF+ IVAR  Y+E  A+   + I+E +  C
Sbjct: 62  -QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR 228
           H +G++HR+LKPEN L A+K + + +K  DFGL+I     E +    G+P Y++PEVLK+
Sbjct: 121 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 180
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           + Y   +DIW+ GVILYILL G PPFW E +  +   I  G  D+    W  V+  AKSL
Sbjct: 181 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 240
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           +  ML  +PK R+TA Q L+ PW+ N ++
Sbjct: 241 IDSMLTVNPKKRITADQALKVPWICNRER 269

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  206 bits (525), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 109/265 (41%), Positives = 158/265 (59%), Gaps = 6/265 (2%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           NI   ++    LG G F   +L   R T +L A K I K     A     +  E+A++K 
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKK 62
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           + K+ +IV+L++  E     +LVM+L  GGELFDRI+ RG YTE+ A+ V + ++  V+ 
Sbjct: 63  I-KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
            H++G++HRDLKPEN L+   +ENS +   DFGLS   + G   S   G+P Y+APEVL 
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLA 180
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
           ++ Y   +D WS GVI YILLCG PPF+ E+E  + + I  G  +F+   W ++SESAK 
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
            +  +LE DP  R T ++ L HPW+
Sbjct: 241 FICHLLEKDPNERYTCEKALSHPWI 265

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  206 bits (524), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 117/296 (39%), Positives = 177/296 (59%), Gaps = 6/296 (2%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ D Y +  ++G+G F V   C+   T    A K I+ +KL +A D   + RE  I + 
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKL-SARDHQKLEREARICR- 58
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L K+S+IV L ++  ++   +LV +L  GGELF+ IVAR +Y+E  A+   + I+E V  
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSPYYMAPEVL 226
           CH+ GV+HRDLKPEN L A+K + + +K  DFGL+I  +  ++ +    G+P Y++PEVL
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           ++  YG  +DIW+ GVILYILL G PPFW E +  + Q I  G  DF    W  V+  AK
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL-QNAKKAPNVPLGDVVRSRLKQFSMMNRFK 340
           +L+ QML  +P  R+TA + L+HPW+ Q +  A  +   + V   LK+F+   + K
Sbjct: 239 NLINQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVEC-LKKFNARRKLK 293

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  204 bits (519), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 108/266 (40%), Positives = 164/266 (61%), Gaps = 4/266 (1%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ D Y +  ELG+G F V   C+   T +  A K I+ +KL +A D   + RE  I + 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL-SARDHQKLEREARICR- 58
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L K+ +IV L ++  ++   +LV +L  GGELF+ IVAR +Y+E  A+   + I+E V  
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSPYYMAPEVL 226
           CH +G++HRDLKPEN L A+K + + +K  DFGL+I  +  ++ +    G+P Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           +++ YG  +D+W+ GVILYILL G PPFW E +  + Q I  G  DF    W  V+  AK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
            L+ +ML  +P  R+TA + L+HPW+
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWI 264

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  203 bits (517), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 111/264 (42%), Positives = 162/264 (61%), Gaps = 6/264 (2%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D Y +  ELG+G F V   C+ +   +  A K I+ +KL +A D   + RE  I + L K
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKL-SARDHQKLEREARICR-LLK 88
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +IV L ++  ++   +LV +L  GGELF+ IVAR +Y+E  A+     I+E V   H+
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGSPYYMAPEVLKR 228
           H ++HRDLKPEN L A+K + + +K  DFGL+I  + GE+  +    G+P Y++PEVL++
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ-GEQQAWFGFAGTPGYLSPEVLRK 207
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           + YG  +DIW+ GVILYILL G PPFW E +  + Q I  G  DF    W  V+  AK+L
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 267
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWL 311
           + QML  +P  R+TA Q L+HPW+
Sbjct: 268 INQMLTINPAKRITADQALKHPWV 291

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  203 bits (516), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 108/266 (40%), Positives = 164/266 (61%), Gaps = 4/266 (1%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ D Y +  ELG+G F V   C+   T +  A K I+ +KL +A D   + RE  I + 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL-SARDHQKLEREARICR- 58
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L K+ +IV L ++  ++   +LV +L  GGELF+ IVAR +Y+E  A+   + I+E V  
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSPYYMAPEVL 226
           CH +G++HRDLKPEN L A+K + + +K  DFGL+I  +  ++ +    G+P Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           +++ YG  +D+W+ GVILYILL G PPFW E +  + Q I  G  DF    W  V+  AK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
            L+ +ML  +P  R+TA + L+HPW+
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWI 264

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  201 bits (510), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 104/286 (36%), Positives = 160/286 (55%), Gaps = 13/286 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD----------V 98
           I + Y   R+LG G +G   LC +++     A K I K +       DD          +
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
             E++++K L  + +I+ L +  ED    +LV E  EGGELF++I+ R  + E  AA + 
Sbjct: 94  YNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSP 218
           + I+  +   HKH ++HRD+KPEN L  NK     +K +DFGLS FF    +  + +G+ 
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 219 YYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           YY+APEVLK+ Y  + D+WS GVI+YILLCG PPF  +++Q + + + +G   F  + W 
Sbjct: 213 YYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK 272
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD 324
           N+S+ AK L++ ML  D   R TA++ L   W++  K A N+   D
Sbjct: 273 NISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK--KYANNINKSD 316

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  199 bits (506), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 113/301 (37%), Positives = 172/301 (57%), Gaps = 6/301 (1%)
Query: 43  GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           G      +  Y +  ELG+G F V   C+     +  A K I+ +KL +A D   + RE 
Sbjct: 14  GTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKL-SARDHQKLEREA 72
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            I + L K+ +IV L ++  ++   +L+ +L  GGELF+ IVAR +Y+E  A+   + I+
Sbjct: 73  RICR-LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL 131
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGSPYY 220
           E V  CH+ GV+HRDLKPEN L A+K + + +K  DFGL+I  + GE+  +    G+P Y
Sbjct: 132 EAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGY 190
Query: 221 MAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           ++PEVL+++ YG  +D+W+ GVILYILL G PPFW E +  + Q I  G  DF    W  
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 250
Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRF 339
           V+  AK L+ +ML  +P  R+TA + L+HPW+ +     +          LK+F+   + 
Sbjct: 251 VTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKL 310
Query: 340 K 340
           K
Sbjct: 311 K 311

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  197 bits (501), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 113/309 (36%), Positives = 175/309 (56%), Gaps = 6/309 (1%)
Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           +A +      + Y +  ELG+G F V   C+     +  A   I+ +KL +A D   + R
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLER 59
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  I + L K+ +IV L ++  ++   +L+ +L  GGELF+ IVAR +Y+E  A+   + 
Sbjct: 60  EARICR-LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ 118
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGSP 218
           I+E V  CH+ GV+HR+LKPEN L A+K + + +K  DFGL+I  + GE+  +    G+P
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTP 177
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y++PEVL+++ YG  +D+W+ GVILYILL G PPFW E +  + Q I  G  DF    W
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMN 337
             V+  AK L+ +ML  +P  R+TA + L+HPW+ +     +          LK+F+   
Sbjct: 238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARR 297
Query: 338 RFKRKALRV 346
           + K   L V
Sbjct: 298 KLKGAILTV 306

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 112/305 (36%), Positives = 176/305 (57%), Gaps = 12/305 (3%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA--VDIDDVRREVAIMK 106
            ED Y +   +G+G F V   CI+R+T +  A K +   K  ++  +  +D++RE +I  
Sbjct: 22  FEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC- 80
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIV 162
           H+ K+  IV L E    D  +++V E  +G +L   IV R      Y+E  A+   R I+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYM 221
           E ++ CH + +IHRD+KPEN L A+K+ ++P+K  DFG++I   + G      VG+P++M
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APEV+KR  YG  +D+W  GVIL+ILL G  PF+   E+ + + I++G        W ++
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI 259
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK-APNVPLGDVVRSRLKQFSMMNRF 339
           SESAK LVR+ML  DP  R+T  + L HPWL+   + A  + L + V  +L++F+   + 
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVE-QLRKFNARRKL 318
Query: 340 KRKAL 344
           K   L
Sbjct: 319 KGAVL 323

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 102/279 (36%), Positives = 157/279 (56%), Gaps = 10/279 (3%)
Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL---RTAVDIDD 97
           ++   +E++ED Y +  ELG G+F +   C  + T +  A K I KR+L   R  V  ++
Sbjct: 2   MSTFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE 61
Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           + REV I++ + ++ +I++L +  E+   V L++EL  GGELFD +  +   TE  A   
Sbjct: 62  IEREVNILREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF 120
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVG 216
            + I++ V   H   + H DLKPEN +  +K   +P +K IDFG++   + G  F  I G
Sbjct: 121 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG 180
Query: 217 SPYYMAPEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK 273
           +P ++APE++  NY P   E D+WS GVI YILL G  PF  E++Q     I     DF 
Sbjct: 181 TPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 238
Query: 274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            + + N SE AK  +R++L  DPK R+   Q LEH W++
Sbjct: 239 EEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 109/305 (35%), Positives = 173/305 (56%), Gaps = 12/305 (3%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA--VDIDDVRREVAIMK 106
            ED Y +   +G+G F V   CI+R+T +  A K +   K  ++  +  +D++RE +I  
Sbjct: 24  FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC- 82
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIV 162
           H+ K+  IV L E    D  +++V E  +G +L   IV R      Y+E  A+   R I+
Sbjct: 83  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 142
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYM 221
           E ++ CH + +IHRD+KP   L A+K+ ++P+K   FG++I   + G      VG+P++M
Sbjct: 143 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 202
Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APEV+KR  YG  +D+W  GVIL+ILL G  PF+   E+ + + I++G        W ++
Sbjct: 203 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI 261
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK-APNVPLGDVVRSRLKQFSMMNRF 339
           SESAK LVR+ML  DP  R+T  + L HPWL+   + A  + L + V  +L++F+   + 
Sbjct: 262 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVE-QLRKFNARRKL 320
Query: 340 KRKAL 344
           K   L
Sbjct: 321 KGAVL 325

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 102/275 (37%), Positives = 155/275 (56%), Gaps = 10/275 (3%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL---RTAVDIDDVRREVAIM 105
           +ED Y +  ELG G+F +   C  + T +  A K I KR+L   R  V  +++ REV I+
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + + ++ +I++L +  E+   V L++EL  GGELFD +  +   TE  A    + I++ V
Sbjct: 63  REI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
              H   + H DLKPEN +  +K   +P +K IDFG++   + G  F  I G+P ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 225 VLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           ++  NY P   E D+WS GVI YILL G  PF  E++Q     I     DF  + + N S
Sbjct: 182 IV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           E AK  +R++L  DPK R+T  Q LEH W++  ++
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 109/305 (35%), Positives = 173/305 (56%), Gaps = 12/305 (3%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA--VDIDDVRREVAIMK 106
            ED Y +   +G+G F V   CI+R+T +  A K +   K  ++  +  +D++RE +I  
Sbjct: 22  FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC- 80
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIV 162
           H+ K+  IV L E    D  +++V E  +G +L   IV R      Y+E  A+   R I+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYM 221
           E ++ CH + +IHRD+KP   L A+K+ ++P+K   FG++I   + G      VG+P++M
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APEV+KR  YG  +D+W  GVIL+ILL G  PF+   E+ + + I++G        W ++
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI 259
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK-APNVPLGDVVRSRLKQFSMMNRF 339
           SESAK LVR+ML  DP  R+T  + L HPWL+   + A  + L + V  +L++F+   + 
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVE-QLRKFNARRKL 318
Query: 340 KRKAL 344
           K   L
Sbjct: 319 KGAVL 323

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  180 bits (457), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 154/275 (56%), Gaps = 10/275 (3%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL---RTAVDIDDVRREVAIM 105
           +ED Y +  ELG G+F +   C  + T +  A K I KR+L   R  V  +++ REV I+
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + + ++ +I++L +  E+   V L++EL  GGELFD +  +   TE  A    + I++ V
Sbjct: 84  REI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 142
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
              H   + H DLKPEN +  +K   +P +K IDFG++   + G  F  I G+P ++APE
Sbjct: 143 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 202
Query: 225 VLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           ++  NY P   E D+WS GVI YILL G  PF  E++Q     I     DF  + + N S
Sbjct: 203 IV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 260
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           E AK  +R++L  DPK R+   Q LEH W++  ++
Sbjct: 261 ELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRR 295

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 166/298 (55%), Gaps = 12/298 (4%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL--QNAKKAPNVPLGDVVRSRLKQFS 334
           N S  AK  +R++L  DPK R+T +  L+HPW+  ++ ++A +     V   + K+F+
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFA 300

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 65  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 184 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 65  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 184 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 102/271 (37%), Positives = 156/271 (57%), Gaps = 8/271 (2%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            I+D ++  R+LG G FG  +L  +R +      K+I+K   R+ V ++ +  E+ ++K 
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD--RSQVPMEQIEAEIEVLKS 76
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV---ARGH-YTERAAAAVTRTIVE 163
           L  + +I+ + E  ED + +++VME CEGGEL +RIV   ARG   +E   A + + ++ 
Sbjct: 77  L-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            +   H   V+H+DLKPEN LF +   +SP+K IDFGL+  FK  E  +   G+  YMAP
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 224 EVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES 283
           EV KR+   + DIWSAGV++Y LL G  PF   S + V Q       ++  +  P ++  
Sbjct: 196 EVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LTPQ 254
Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           A  L++QML  DP+ R +A QVL H W + A
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 154/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L+ EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 154/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 91/266 (34%), Positives = 150/266 (56%), Gaps = 15/266 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-IDDVR----REVAIMKHLPKNSS 113
           +GRG   V   C+ R T    A K +     R + + +++VR    RE  I++ +  +  
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           I++L ++ E  + + LV +L   GELFD +  +   +E+   ++ R+++E V   H + +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK------ 227
           +HRDLKPEN L     +N  ++  DFG S   +PGE+  E+ G+P Y+APE+LK      
Sbjct: 222 VHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278
Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
              YG E+D+W+ GVIL+ LL G PPFW   +  + + I+ G   F    W + S + K 
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           L+ ++L+ DP+ RLTA+Q L+HP+ +
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 106/313 (33%), Positives = 159/313 (50%), Gaps = 25/313 (7%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D  L D+ LG G F +   C+ + + +  A K ISKR         + ++E+  +K    
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA------NTQKEITALKLCEG 64
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +IV L E   D     LVMEL  GGELF+RI  + H++E  A+ + R +V  V   H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSPYYMAPEVLKRN 229
            GV+HRDLKPEN LF ++ +N  +K IDFG +    P  +       + +Y APE+L +N
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAE-------SEQGVAQAILRGLIDFKRDPWPNVS 281
            Y    D+WS GVILY +L G  PF +        S   + + I +G   F+ + W NVS
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL---------GDVVRSRLK- 331
           + AK L++ +L  DP  RL    +  + WLQ+  +  + PL         G  V + +K 
Sbjct: 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKA 304
Query: 332 QFSMMNRFKRKAL 344
            F   N++KR+  
Sbjct: 305 TFHAFNKYKREGF 317

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 101/285 (35%), Positives = 147/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 65
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 66  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +E   +PYY+A
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVA 185
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 245
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 246 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 152/287 (52%), Gaps = 12/287 (4%)
Query: 37  PITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RT 91
           P+     V  + + D Y++ + LG G  G   L  +R T + +A K ISKRK      R 
Sbjct: 2   PLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE 61
Query: 92  AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTE 151
           A    +V  E+ I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E
Sbjct: 62  ADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKE 119
Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
                    ++  VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S         
Sbjct: 120 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 179
Query: 212 SEIVGSPYYMAPEVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAIL 266
             + G+P Y+APEVL       Y   +D WS GVIL+I L G PPF     Q  +   I 
Sbjct: 180 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 239
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            G  +F  + W  VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 240 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 102/275 (37%), Positives = 148/275 (53%), Gaps = 12/275 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVA 103
           + D Y++ + LG G  G   L  +R T + +A K ISKRK      R A    +V  E+ 
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         ++ 
Sbjct: 68  ILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWP 278
           EVL       Y   +D WS GVIL+I L G PPF     Q  +   I  G  +F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 102/275 (37%), Positives = 148/275 (53%), Gaps = 12/275 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVA 103
           + D Y++ + LG G  G   L  +R T + +A K ISKRK      R A    +V  E+ 
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         ++ 
Sbjct: 68  ILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWP 278
           EVL       Y   +D WS GVIL+I L G PPF     Q  +   I  G  +F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 102/275 (37%), Positives = 148/275 (53%), Gaps = 12/275 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVA 103
           + D Y++ + LG G  G   L  +R T + +A K ISKRK      R A    +V  E+ 
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         ++ 
Sbjct: 68  ILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWP 278
           EVL       Y   +D WS GVIL+I L G PPF     Q  +   I  G  +F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 102/275 (37%), Positives = 148/275 (53%), Gaps = 12/275 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVA 103
           + D Y++ + LG G  G   L  +R T + +A K ISKRK      R A    +V  E+ 
Sbjct: 7   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 66
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         ++ 
Sbjct: 67  ILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+AP
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 184
Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWP 278
           EVL       Y   +D WS GVIL+I L G PPF     Q  +   I  G  +F  + W 
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 244
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 245 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 117
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 118 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 177
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 178 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 237
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 238 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 297
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 298 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 342

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 111
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 336

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 67
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 187
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 188 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 247
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 248 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 72
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 73  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 132
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 133 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 192
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 193 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 252
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 253 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 297

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 81
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 82  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 141
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 142 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 201
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 202 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 261
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 262 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 306

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 65
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 66  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 185
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 245
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 246 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 66
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 67  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 126
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 127 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 186
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 187 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 246
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 247 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 291

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 71
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 72  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 131
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 132 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 191
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 192 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 251
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 252 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 296

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 148/275 (53%), Gaps = 12/275 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVA 103
           + D Y++ + LG G  G   L  +R T + +A + ISKRK      R A    +V  E+ 
Sbjct: 147 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 206
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         ++ 
Sbjct: 207 ILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 264
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+AP
Sbjct: 265 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 324
Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWP 278
           EVL       Y   +D WS GVIL+I L G PPF     Q  +   I  G  +F  + W 
Sbjct: 325 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 384
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 385 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 419

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 154/273 (56%), Gaps = 10/273 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R +   V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  ++ +++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQVLHHN-VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     I     DF  + + 
Sbjct: 186 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + SE AK  +R++L  + + RLT ++ L HPW+
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 73
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 74  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 133
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 134 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 193
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 194 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 253
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 254 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 298

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 67
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 187
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 188 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 247
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 248 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  171 bits (432), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 147/291 (50%), Gaps = 25/291 (8%)
Query: 46  KENIEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           K  + D Y + ++ LG G  G    C  R T +        K  L+   D    R+EV  
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQ--------KCALKLLYDSPKARQEVDH 74
Query: 105 MKHLPKNSSIVSLKEACED----DNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVT 158
                    IV + +  E+       + ++ME  EGGELF RI  RG   +TER AA + 
Sbjct: 75  HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVG 216
           R I   +Q  H H + HRD+KPEN L+ +K++++ LK  DFG   F K   +        
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG---FAKETTQNALQTPCY 191
Query: 217 SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR----GLID 271
           +PYY+APEVL    Y    D+WS GVI+YILLCG PPF++ + Q ++  + R    G   
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           F    W  VSE AK L+R +L+ DP  RLT  Q + HPW+  +   P  PL
Sbjct: 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 147/291 (50%), Gaps = 25/291 (8%)
Query: 46  KENIEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           K  + D Y + ++ LG G  G    C  R T +  A        L+   D    R+EV  
Sbjct: 4   KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCA--------LKLLYDSPKARQEVDH 55
Query: 105 MKHLPKNSSIVSLKEACED----DNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVT 158
                    IV + +  E+       + ++ME  EGGELF RI  RG   +TER AA + 
Sbjct: 56  HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 115
Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVG 216
           R I   +Q  H H + HRD+KPEN L+ +K++++ LK  DFG   F K   +        
Sbjct: 116 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG---FAKETTQNALQTPCY 172
Query: 217 SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR----GLID 271
           +PYY+APEVL    Y    D+WS GVI+YILLCG PPF++ + Q ++  + R    G   
Sbjct: 173 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 232
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           F    W  VSE AK L+R +L+ DP  RLT  Q + HPW+  +   P  PL
Sbjct: 233 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 283

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 154/273 (56%), Gaps = 10/273 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R +   V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  ++ +++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQVLHHN-VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     I     DF  + + 
Sbjct: 186 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + SE AK  +R++L  + + RLT ++ L HPW+
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 148/275 (53%), Gaps = 12/275 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVA 103
           + D Y++ + LG G  G   L  +R T + +A + ISKRK      R A    +V  E+ 
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         ++ 
Sbjct: 193 ILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 250
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+AP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWP 278
           EVL       Y   +D WS GVIL+I L G PPF     Q  +   I  G  +F  + W 
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 153/273 (56%), Gaps = 10/273 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R +   V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + ++++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     I     DF  + + 
Sbjct: 186 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             SE AK  +R++L  + + RLT ++ L HPW+
Sbjct: 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 154/273 (56%), Gaps = 10/273 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R +   V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + ++++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     I     DF  + + 
Sbjct: 186 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + SE AK  +R++L  + + RLT ++ L HPW+
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 153/273 (56%), Gaps = 10/273 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R +   V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + ++++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     I     DF  + + 
Sbjct: 186 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             SE AK  +R++L  + + RLT ++ L HPW+
Sbjct: 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 104/283 (36%), Positives = 149/283 (52%), Gaps = 19/283 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
             D Y+V   +G G +     C+ + T    A K I K K        D   E+ I+   
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRY 77
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I++LK+  +D   V+LV EL  GGEL D+I+ +  ++ER A+ V  TI + V+  
Sbjct: 78  GQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYL 137
Query: 169 HKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYY----MAP 223
           H  GV+HRDLKP N L+ ++  N   L+  DFG   F K     + ++ +P Y    +AP
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFG---FAKQLRAENGLLMTPCYTANFVAP 194
Query: 224 EVLKRN-YGPEIDIWSAGVILYILLCGVPPFW---AESEQGVAQAILRGLIDFKRDPWPN 279
           EVLKR  Y    DIWS G++LY +L G  PF    +++ + +   I  G        W  
Sbjct: 195 EVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNT 254
Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           VSE+AK LV +ML  DP  RLTAKQVL+HPW+    K P   L
Sbjct: 255 VSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQL 297

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 104/283 (36%), Positives = 149/283 (52%), Gaps = 19/283 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
             D Y+V   +G G +     C+ + T    A K I K K        D   E+ I+   
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRY 77
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I++LK+  +D   V+LV EL  GGEL D+I+ +  ++ER A+ V  TI + V+  
Sbjct: 78  GQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYL 137
Query: 169 HKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYY----MAP 223
           H  GV+HRDLKP N L+ ++  N   L+  DFG   F K     + ++ +P Y    +AP
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFG---FAKQLRAENGLLMTPCYTANFVAP 194
Query: 224 EVLKRN-YGPEIDIWSAGVILYILLCGVPPFW---AESEQGVAQAILRGLIDFKRDPWPN 279
           EVLKR  Y    DIWS G++LY +L G  PF    +++ + +   I  G        W  
Sbjct: 195 EVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNT 254
Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           VSE+AK LV +ML  DP  RLTAKQVL+HPW+    K P   L
Sbjct: 255 VSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQL 297

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 96/273 (35%), Positives = 153/273 (56%), Gaps = 10/273 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R +   V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + +I++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     I     DF  + + 
Sbjct: 186 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             SE AK  +R++L  + + RLT ++ L HPW+
Sbjct: 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 147/268 (54%), Gaps = 16/268 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACK--SISKRKLRTAVDIDDVR----REVAIMKHLPKNS 112
           LGRG   V   CI + T +  A K   ++     +A ++ ++R    +EV I++ +  + 
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +I+ LK+  E +    LV +L + GELFD +  +   +E+    + R ++EV+   HK  
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 131
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--- 229
           ++HRDLKPEN L     ++  +K  DFG S    PGE+  E+ G+P Y+APE+++ +   
Sbjct: 132 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 188
Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
               YG E+D+WS GVI+Y LL G PPFW   +  + + I+ G   F    W + S++ K
Sbjct: 189 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 248
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            LV + L   P+ R TA++ L HP+ Q 
Sbjct: 249 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  167 bits (423), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 147/268 (54%), Gaps = 16/268 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACK--SISKRKLRTAVDIDDVR----REVAIMKHLPKNS 112
           LGRG   V   CI + T +  A K   ++     +A ++ ++R    +EV I++ +  + 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +I+ LK+  E +    LV +L + GELFD +  +   +E+    + R ++EV+   HK  
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--- 229
           ++HRDLKPEN L     ++  +K  DFG S    PGE+  E+ G+P Y+APE+++ +   
Sbjct: 145 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 201
Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
               YG E+D+WS GVI+Y LL G PPFW   +  + + I+ G   F    W + S++ K
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            LV + L   P+ R TA++ L HP+ Q 
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 90/268 (33%), Positives = 146/268 (54%), Gaps = 16/268 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACK--SISKRKLRTAVDIDDVR----REVAIMKHLPKNS 112
           LGRG   V   CI + T +  A K   ++     +A ++ ++R    +EV I++ +  + 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +I+ LK+  E +    LV +L + GELFD +  +   +E+    + R ++EV+   HK  
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--- 229
           ++HRDLKPEN L     ++  +K  DFG S    PGE+   + G+P Y+APE+++ +   
Sbjct: 145 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMND 201
Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
               YG E+D+WS GVI+Y LL G PPFW   +  + + I+ G   F    W + S++ K
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            LV + L   P+ R TA++ L HP+ Q 
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  164 bits (414), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 99/285 (34%), Positives = 140/285 (49%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQ--------DCPKARREVELHWRA 111
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +V E  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIG 171
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D WS GVI YILLCG PPF++        G    I  G  +F    W
Sbjct: 232 PEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEW 291
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R T  +   HPW+  + K P  PL
Sbjct: 292 SEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTPL 336

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 95/279 (34%), Positives = 150/279 (53%), Gaps = 11/279 (3%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           QP+ V  G    ++ D Y +  ELG G FGV + C+++ T  +   K I+       +D 
Sbjct: 40  QPVEVKQG----SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDK 92
Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAA 154
             V+ E++IM  L  +  +++L +A ED   + L++E   GGELFDRI A  +  +E   
Sbjct: 93  YTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV 151
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
               R   E ++  H+H ++H D+KPEN +   KK +S +K IDFGL+    P E     
Sbjct: 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVT 210
Query: 215 VGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK 273
             +  + APE++ R   G   D+W+ GV+ Y+LL G+ PF  E +    Q + R   +F 
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270
Query: 274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            D + +VS  AK  ++ +L+ +P+ RLT    LEHPWL+
Sbjct: 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 150/281 (53%), Gaps = 19/281 (6%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D Y V  ++G G + V   CI + T    A K I K K        D   E+ I+    +
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQ 74
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I++LK+  +D   V++V EL +GGEL D+I+ +  ++ER A+AV  TI + V+  H 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 171 HGVIHRDLKPENFLFANKKEN-SPLKAIDFGLSIFFKPGERFSEIVGSPYY----MAPEV 225
            GV+HRDLKP N L+ ++  N   ++  DFG   F K     + ++ +P Y    +APEV
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFG---FAKQLRAENGLLMTPCYTANFVAPEV 191
Query: 226 LKRN-YGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRGLIDFKRDPWPNVS 281
           L+R  Y    DIWS GV+LY +L G  PF     ++ + +   I  G        W +VS
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           ++AK LV +ML  DP  RLTA  VL HPW+ +  + P   L
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQL 292

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  160 bits (405), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 148/259 (57%), Gaps = 7/259 (2%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG  + C +  T   LA K I  R ++   D ++V+ E+++M  L  +++++ L 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQL-DHANLIQLY 152
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
           +A E  N + LVME  +GGELFDRI+   +  TE       + I E ++  H+  ++H D
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY-GPEIDI 236
           LKPEN L  N+ +   +K IDFGL+  +KP E+     G+P ++APEV+  ++     D+
Sbjct: 213 LKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS GVI Y+LL G+ PF  +++      IL    D + + + ++SE AK  + ++L  + 
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 297 KLRLTAKQVLEHPWLQNAK 315
             R++A + L+HPWL + K
Sbjct: 332 SWRISASEALKHPWLSDHK 350

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 148/281 (52%), Gaps = 19/281 (6%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D Y V  ++G G + V   CI + T    A K I K K        D   E+ I+    +
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK-------RDPTEEIEILLRYGQ 74
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I++LK+  +D   V++V EL +GGEL D+I+ +  ++ER A+AV  TI + V+  H 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 171 HGVIHRDLKPENFLFANKKEN-SPLKAIDFGLSIFFKPGERFSEIVGSPYY----MAPEV 225
            GV+HRDLKP N L+ ++  N   ++  DFG   F K     + ++ +P Y    +APEV
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFG---FAKQLRAENGLLXTPCYTANFVAPEV 191
Query: 226 LKRN-YGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRGLIDFKRDPWPNVS 281
           L+R  Y    DIWS GV+LY  L G  PF     ++ + +   I  G        W +VS
Sbjct: 192 LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           ++AK LV + L  DP  RLTA  VL HPW+ +  + P   L
Sbjct: 252 DTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQLPQYQL 292

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 89/270 (32%), Positives = 141/270 (52%), Gaps = 7/270 (2%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +  +++ D Y +  ELG G FGV +   +R T    A K +         D + VR+E+ 
Sbjct: 44  IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQ 100
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTRTIV 162
            M  L ++ ++V+L +A EDDN + ++ E   GGELF+++       +E  A    R + 
Sbjct: 101 TMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 159
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           + +   H++  +H DLKPEN +F  K+ N  LK IDFGL+    P +      G+  + A
Sbjct: 160 KGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAA 218
Query: 223 PEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           PEV + +  G   D+WS GV+ YILL G+ PF  E++    + +     +     +  +S
Sbjct: 219 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 278
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           E  K  +R++L  DP  R+T  Q LEHPWL
Sbjct: 279 EDGKDFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 148/265 (55%), Gaps = 8/265 (3%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y++  +LGRGEFG+ + C++  +++    K +  +      D   V++E++I+ ++ +
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISIL-NIAR 59
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCH 169
           + +I+ L E+ E    + ++ E   G ++F+RI  +     ER   +    + E +Q  H
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN 229
            H + H D++PEN ++  ++ +S +K I+FG +   KPG+ F  +  +P Y APEV + +
Sbjct: 120 SHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 230 Y-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
                 D+WS G ++Y+LL G+ PF AE+ Q + + I+     F  + +  +S  A   V
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQN 313
            ++L  + K R+TA + L+HPWL+ 
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 89/270 (32%), Positives = 141/270 (52%), Gaps = 7/270 (2%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +  +++ D Y +  ELG G FGV +   +R T    A K +         D + VR+E+ 
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQ 206
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTRTIV 162
            M  L ++ ++V+L +A EDDN + ++ E   GGELF+++       +E  A    R + 
Sbjct: 207 TMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           + +   H++  +H DLKPEN +F  K+ N  LK IDFGL+    P +      G+  + A
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAA 324
Query: 223 PEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           PEV + +  G   D+WS GV+ YILL G+ PF  E++    + +     +     +  +S
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 384
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           E  K  +R++L  DP  R+T  Q LEHPWL
Sbjct: 385 EDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 142/263 (53%), Gaps = 10/263 (3%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y++   LG G FG   +     T   +A K ++++K+R+   +  +RRE+  +K L ++ 
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRHP 76
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            I+ L +     + + +VME   GGELFD I   G   E+ +  + + I+  V  CH+H 
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY- 230
           V+HRDLKPEN L  +   N+  K  DFGLS     GE      GSP Y APEV+  R Y 
Sbjct: 137 VVHRDLKPENVLL-DAHMNA--KIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYA 193
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+DIWS+GVILY LLCG  PF  +    + + I  G+  F    + N   S  SL++ 
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQYLN--PSVISLLKH 249
Query: 291 MLEPDPKLRLTAKQVLEHPWLQN 313
           ML+ DP  R T K + EH W + 
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQ 272

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 136/284 (47%), Gaps = 38/284 (13%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 67
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG                     A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------A 167
Query: 223 PEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPWP 278
            E     Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W 
Sbjct: 168 KETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 146/261 (55%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A + I K +L ++  +  + REV IMK L  + 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSS-SLQKLFREVRIMKVL-NHP 73
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +  E  GSP Y APE+   K+  
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD 190
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKK 246
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 138/264 (52%), Gaps = 10/264 (3%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y++   LG G FG   +   + T   +A K ++++K+R+   +  ++RE+  +K L ++
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRH 70
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +         +VME   GGELFD I   G   E  A  + + I+  V  CH+H
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY 230
            V+HRDLKPEN L  +   N+  K  DFGLS     GE   +  GSP Y APEV+  R Y
Sbjct: 131 MVVHRDLKPENVLL-DAHMNA--KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187
Query: 231 -GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
            GPE+DIWS GVILY LLCG  PF  E    + + I  G+          ++ S  +L+ 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSVATLLM 243
Query: 290 QMLEPDPKLRLTAKQVLEHPWLQN 313
            ML+ DP  R T K + EH W + 
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 145/261 (55%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A K I K +L ++  +  + REV IMK L  + 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVL-NHP 73
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     GSP Y APE+   K+  
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKK 246
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 150/276 (54%), Gaps = 11/276 (3%)
Query: 39  TVLAGVPKENIE-DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           T LA +PK     D + + R LG+G+FG  YL  ++  + ++A K + K +L        
Sbjct: 2   TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 61
Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           +RRE+ I  HL ++ +I+ +     D   ++L++E    GEL+  +   G + E+ +A  
Sbjct: 62  LRREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF 120
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS 217
              + + +  CH+  VIHRD+KPEN L   K E   LK  DFG S+   P  R   + G+
Sbjct: 121 MEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRXMCGT 176
Query: 218 PYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP 276
             Y+ PE+++ + +  ++D+W AGV+ Y  L G+PPF + S     + I+   +D K  P
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPP 234
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           +  +S+ +K L+ ++L   P  RL  K V+EHPW++
Sbjct: 235 F--LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 268

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 145/261 (55%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A K I K +L ++  +  + REV IMK L  + 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVL-NHP 73
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     GSP Y APE+   K+  
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKK 246
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 137/264 (51%), Gaps = 10/264 (3%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y++   LG G FG   +   + T   +A K ++++K+R+   +  ++RE+  +K L ++
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRH 70
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +         +VME   GGELFD I   G   E  A  + + I+  V  CH+H
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY 230
            V+HRDLKPEN L  +   N+  K  DFGLS     GE      GSP Y APEV+  R Y
Sbjct: 131 MVVHRDLKPENVLL-DAHMNA--KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 231 -GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
            GPE+DIWS GVILY LLCG  PF  E    + + I  G+          ++ S  +L+ 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSVATLLM 243
Query: 290 QMLEPDPKLRLTAKQVLEHPWLQN 313
            ML+ DP  R T K + EH W + 
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 150/276 (54%), Gaps = 11/276 (3%)
Query: 39  TVLAGVPKENIE-DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           T LA +PK     D + + R LG+G+FG  YL  ++  + ++A K + K +L        
Sbjct: 1   TALAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           +RRE+ I  HL ++ +I+ +     D   ++L++E    GEL+  +   G + E+ +A  
Sbjct: 61  LRREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF 119
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS 217
              + + +  CH+  VIHRD+KPEN L   K E   LK  DFG S+   P  R   + G+
Sbjct: 120 MEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRXMCGT 175
Query: 218 PYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP 276
             Y+ PE+++ + +  ++D+W AGV+ Y  L G+PPF + S     + I+   +D K  P
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPP 233
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           +  +S+ +K L+ ++L   P  RL  K V+EHPW++
Sbjct: 234 F--LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 96/262 (36%), Positives = 145/262 (55%), Gaps = 11/262 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A K I K +L ++  +  + REV IMK L  + 
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVL-NHP 66
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     GSP Y APE+   K+  
Sbjct: 127 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 183
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKK 239
Query: 291 MLEPDPKLRLTAKQVLEHPWLQ 312
            L  +P  R T +Q+++  W+ 
Sbjct: 240 FLILNPSKRGTLEQIMKDRWMN 261

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 145/261 (55%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A + I K +L ++  +  + REV IMK L  + 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSS-SLQKLFREVRIMKVL-NHP 73
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     GSP Y APE+   K+  
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKK 246
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 145/261 (55%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A K I K +L ++  +  + REV IMK L  + 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVL-NHP 73
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     G+P Y APE+   K+  
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKK 246
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 13/274 (4%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +ED + + R LG+G+FG  YL  +R ++ +LA K + K +L  A     +RREV I  H
Sbjct: 10  TLED-FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH 68
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  
Sbjct: 69  L-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSY 127
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK 227
           CH   VIHRD+KPEN L  +   N  LK  DFG S+   P  R + + G+  Y+ PE+++
Sbjct: 128 CHSKRVIHRDIKPENLLLGS---NGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIE 183
Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAK 285
            R +  ++D+WS GV+ Y  L G+PPF A + Q   + I R  ++F    +P+ V+E A+
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISR--VEFT---FPDFVTEGAR 238
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
            L+ ++L+ +   RLT  +VLEHPW++     P+
Sbjct: 239 DLISRLLKHNASQRLTLAEVLEHPWIKANSSKPS 272

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 149/274 (54%), Gaps = 13/274 (4%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +ED + + R LG+G+FG  YL  +R ++ +LA K + K +L  A     +RREV I  H
Sbjct: 10  TLED-FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH 68
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  
Sbjct: 69  L-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSY 127
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK 227
           CH   VIHRD+KPEN L  +   N  LK  DFG S+   P  R   + G+  Y+ PE+++
Sbjct: 128 CHSKRVIHRDIKPENLLLGS---NGELKIADFGWSV-HAPSSRRDTLCGTLDYLPPEMIE 183
Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAK 285
            R +  ++D+WS GV+ Y  L G+PPF A + Q   + I R  ++F    +P+ V+E A+
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISR--VEFT---FPDFVTEGAR 238
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
            L+ ++L+ +   RLT  +VLEHPW++     P+
Sbjct: 239 DLISRLLKHNASQRLTLAEVLEHPWIKANSSKPS 272

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 95/280 (33%), Positives = 146/280 (52%), Gaps = 24/280 (8%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y++   LG G FG   L     T++ +A K IS++ L+ +     V RE++ +K L ++ 
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK-LLRHP 69
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            I+ L +       + +V+E   GGELFD IV +   TE       + I+  ++ CH+H 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLKPEN L     +N  +K  DFGLS     G       GSP Y APEV+  K   
Sbjct: 129 IVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI---LRGLIDFKRDPWPNVSESAKSL 287
           GPE+D+WS G++LY++L G  PF  E    + + +   +  + DF       +S  A+SL
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF-------LSPGAQSL 238
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVR 327
           +R+M+  DP  R+T +++   PW        NV L D +R
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWF-------NVNLPDYLR 271

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 155/313 (49%), Gaps = 52/313 (16%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMK 106
           ++ +Y +   +G+G +GV  + I+  TR + A K ++K K+R     D++ ++ EV +MK
Sbjct: 24  LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI--------------VARGHYT-- 150
            L  + +I  L E  ED+  + LVMELC GG L D++              V +      
Sbjct: 84  KL-HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 151 ------------------------ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFA 186
                                   E+  + + R I   +   H  G+ HRD+KPENFLF+
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS 202
Query: 187 NKKENSPLKAIDFGLSI-FFK--PGERFSEIV--GSPYYMAPEVLK---RNYGPEIDIWS 238
             K +  +K +DFGLS  F+K   GE +      G+PY++APEVL     +YGP+ D WS
Sbjct: 203 TNK-SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 239 AGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKL 298
           AGV+L++LL G  PF   ++      +L   + F+   +  +S  A+ L+  +L  +   
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321
Query: 299 RLTAKQVLEHPWL 311
           R  A + L+HPW+
Sbjct: 322 RFDAMRALQHPWI 334

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 98/295 (33%), Positives = 138/295 (46%), Gaps = 33/295 (11%)
Query: 49  IEDRYLVDREL-GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            ED Y +  EL G G +      +     +  A K I K+   +      V REV  +  
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSR---SRVFREVETLYQ 66
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              N +I+ L E  EDD   +LV E  +GG +   I  + H+ ER A+ V R +   +  
Sbjct: 67  CQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDF 126
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV--------GSPY 219
            H  G+ HRDLKPEN L  + ++ SP+K  DF L    K     + I         GS  
Sbjct: 127 LHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 220 YMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPF---------WAESE------ 258
           YMAPEV++        Y    D+WS GV+LYI+L G PPF         W   E      
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 246
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
             + ++I  G  +F    W ++S  AK L+ ++L  D K RL+A QVL+HPW+Q 
Sbjct: 247 NKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  147 bits (371), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 142/261 (54%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T   +A K I K +L     +  + REV IMK L  + 
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHP 71
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++L+ME   GGE+FD +VA G   E+ A +  R IV  VQ CH+  
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     GSP Y APE+   K+  
Sbjct: 132 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKR 244
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 245 FLVLNPIKRGTLEQIMKDRWI 265

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 151/274 (55%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 12  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    GE++  +     + E+  A     +   +  C
Sbjct: 71  -RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC 129
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 185
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 240
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 91/278 (32%), Positives = 152/278 (54%), Gaps = 13/278 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I
Sbjct: 2   PRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
             HL ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   
Sbjct: 62  QSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           +  CH   VIHRD+KPEN L  +  E   LK  DFG S+   P  R +E+ G+  Y+ PE
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTELCGTLDYLPPE 176
Query: 225 VLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSE 282
           +++ R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTE 231
Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
            A+ L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 12  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    GE++  +     + E+  A     +   +  C
Sbjct: 71  -RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC 129
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R   + G+  Y+ PE+++ 
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLXGTLDYLPPEMIEG 185
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 240
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 142/261 (54%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T   +A K I K +L     +  + REV IMK L  + 
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHP 74
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++L+ME   GGE+FD +VA G   E+ A +  R IV  VQ CH+  
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     G+P Y APE+   K+  
Sbjct: 135 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKR 247
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWI 268

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 149/273 (54%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  +++++ +LA K + K +L  A     +RREV I  HL
Sbjct: 7   LED-FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 66  -RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 125 HSKKVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEG 180
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISR--VEFT---FPDFVTEGARD 235
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 151/274 (55%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 12  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 71  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R +++ G+  Y+ PE+++ 
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEG 185
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 240
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 151/274 (55%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 7   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 66  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R +++ G+  Y+ PE+++ 
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 235
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 151/274 (55%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 7   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 66  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R +++ G+  Y+ PE+++ 
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 235
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 151/274 (55%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 8   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 67  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R +++ G+  Y+ PE+++ 
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 236
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 90/278 (32%), Positives = 151/278 (54%), Gaps = 13/278 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I
Sbjct: 2   PRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
             HL ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   
Sbjct: 62  QSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           +  CH   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPE 176
Query: 225 VLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSE 282
           +++ R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTE 231
Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
            A+ L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 33  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 92  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 206
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 261
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 262 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 295

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 91/275 (33%), Positives = 145/275 (52%), Gaps = 16/275 (5%)
Query: 45  PKENIED-----RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           PK ++ D      Y + + LG G FG   L     T + +A K I+K+ L  +     + 
Sbjct: 2   PKSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE 61
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           RE++ ++ L ++  I+ L +  +  + + +V+E   G ELFD IV R   +E+ A    +
Sbjct: 62  REISYLR-LLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQ 119
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            I+  V+ CH+H ++HRDLKPEN L     E+  +K  DFGLS     G       GSP 
Sbjct: 120 QIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPN 176
Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y APEV+  K   GPE+D+WS GVILY++LC   PF  ES   + + I  G+    +   
Sbjct: 177 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK--- 233
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +S  A  L+++ML  +P  R++  ++++  W +
Sbjct: 234 -FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 33  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 92  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R  ++ G+  Y+ PE+++ 
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDDLCGTLDYLPPEMIEG 206
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 261
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 262 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 295

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 24  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 83  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 141
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 142 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 197
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 198 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 252
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 253 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 286

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  144 bits (363), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 91/275 (33%), Positives = 145/275 (52%), Gaps = 16/275 (5%)
Query: 45  PKENIED-----RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           PK ++ D      Y + + LG G FG   L     T + +A K I+K+ L  +     + 
Sbjct: 3   PKSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE 62
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           RE++ ++ L ++  I+ L +  +  + + +V+E   G ELFD IV R   +E+ A    +
Sbjct: 63  REISYLR-LLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQ 120
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            I+  V+ CH+H ++HRDLKPEN L     E+  +K  DFGLS     G       GSP 
Sbjct: 121 QIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPN 177
Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y APEV+  K   GPE+D+WS GVILY++LC   PF  ES   + + I  G+    +   
Sbjct: 178 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK--- 234
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +S  A  L+++ML  +P  R++  ++++  W +
Sbjct: 235 -FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 268

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 12  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 71  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 185
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 240
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 10  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 69  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 238
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 10  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 69  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEG 183
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 238
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 148/273 (54%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 7   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 66  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTXLCGTLDYLPPEMIEG 180
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 235
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 148/273 (54%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 6   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 65  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 123
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 124 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 179
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 180 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 234
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 235 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 267

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 12  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 71  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE ++ 
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEXIEG 185
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 186 RXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 240
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 241 LISRLLKHNPSQRPXLREVLEHPWITANSSKPSN 274

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 148/273 (54%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 11  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 70  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 128
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 129 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 184
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 239
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 240 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 272

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 148/273 (54%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 10  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 69  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R  ++ G+  Y+ PE+++ 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDDLCGTLDYLPPEMIEG 183
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 238
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 271

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 9   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 68  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 126
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R   + G+  Y+ PE+++ 
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEG 182
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 237
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 238 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 148/273 (54%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 7   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 66  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEG 180
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 235
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/282 (34%), Positives = 134/282 (47%), Gaps = 37/282 (13%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T   +A K I K +L     +  + REV IMK L  + 
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQL-NPTSLQKLFREVRIMKIL-NHP 74
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY 134
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     GSP Y APE+   K+  
Sbjct: 135 IVHRDLKAENLLLDG---DMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYD 191
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG---------------------- 268
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG                      
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKLLVL 251
Query: 269 -------LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAK 303
                  L    +D W NV    + L +   EPDP    T +
Sbjct: 252 NPIKRGSLEQIMKDRWMNVGHEEEEL-KPYTEPDPDFNDTKR 292

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 140/262 (53%), Gaps = 11/262 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + LG G FG   L     T + +A K I+K+ L  +     + RE++ ++ L ++ 
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LLRHP 68
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            I+ L +  +  + + +V+E   G ELFD IV R   +E+ A    + I+  V+ CH+H 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 127
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLKPEN L     E+  +K  DFGLS     G       GSP Y APEV+  K   
Sbjct: 128 IVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 184
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY++LC   PF  ES   + + I  G+    +     +S  A  L+++
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKR 240
Query: 291 MLEPDPKLRLTAKQVLEHPWLQ 312
           ML  +P  R++  ++++  W +
Sbjct: 241 MLIVNPLNRISIHEIMQDDWFK 262

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 140/262 (53%), Gaps = 11/262 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + LG G FG   L     T + +A K I+K+ L  +     + RE++ ++ L ++ 
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LLRHP 64
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            I+ L +  +  + + +V+E   G ELFD IV R   +E+ A    + I+  V+ CH+H 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 123
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLKPEN L     E+  +K  DFGLS     G       GSP Y APEV+  K   
Sbjct: 124 IVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 180
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY++LC   PF  ES   + + I  G+    +     +S  A  L+++
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKR 236
Query: 291 MLEPDPKLRLTAKQVLEHPWLQ 312
           ML  +P  R++  ++++  W +
Sbjct: 237 MLIVNPLNRISIHEIMQDDWFK 258

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 93/260 (35%), Positives = 140/260 (53%), Gaps = 11/260 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A K I K +L ++  +  + REV I K L  + 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIXKVL-NHP 73
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LV E   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     G+P Y APE+   K+  
Sbjct: 134 IVHRDLKAENLLL---DADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+   S   ++L+++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YXSTDCENLLKK 246
Query: 291 MLEPDPKLRLTAKQVLEHPW 310
            L  +P  R T +Q+ +  W
Sbjct: 247 FLILNPSKRGTLEQIXKDRW 266

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 8   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 67  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R   + G+  Y+ PE+++ 
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDTLCGTLDYLPPEMIEG 181
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 236
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 147/273 (53%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 7   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 66  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R   + G+  Y+ PE+++ 
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEG 180
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 235
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 8   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 67  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S    P  R + + G+  Y+ PE+++ 
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSC-HAPSSRRTTLSGTLDYLPPEMIEG 181
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 236
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 143/272 (52%), Gaps = 9/272 (3%)
Query: 47  ENIEDRY-LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           EN  + Y L  +ELGRG+F V   CI + T +  A K + KR+ R      ++  E+A++
Sbjct: 24  ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVL 82
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVE 163
           +       +++L E  E+ + + L++E   GGE+F   +       +E     + + I+E
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            V   H++ ++H DLKP+N L ++      +K +DFG+S          EI+G+P Y+AP
Sbjct: 143 GVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
Query: 224 EVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           E+L  NY P     D+W+ G+I Y+LL    PF  E  Q     I +  +D+  + + +V
Sbjct: 203 EIL--NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           S+ A   ++ +L  +P+ R TA+  L H WLQ
Sbjct: 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 9   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 68  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 126
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  +FG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGE---LKIANFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 182
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 237
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 238 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 146/265 (55%), Gaps = 13/265 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 10  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 69  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 238
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
           L+ ++L+ +P  R   ++VLEHPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 10  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 69  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  +FG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE---LKIANFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 238
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 145/265 (54%), Gaps = 13/265 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 10  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 69  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R   + G+  Y+ PE+++ 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEG 183
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 238
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
           L+ ++L+ +P  R   ++VLEHPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 145/265 (54%), Gaps = 13/265 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++  + +LA K + K +L  A     +RREV I  HL
Sbjct: 4   LED-FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 63  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 121
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 122 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 177
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 178 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 232
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
           L+ ++L+ +P  R   ++VLEHPW+
Sbjct: 233 LISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 102/305 (33%), Positives = 145/305 (47%), Gaps = 37/305 (12%)
Query: 49  IEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLACKSISKR--KLRTAVDIDDVRREVAIM 105
            ED Y +  + LG G       CI+  T +  A K I K+   +R+ V      REV ++
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-----FREVEML 64
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
                + +++ L E  E+++  +LV E   GG +   I  R H+ E  A+ V + +   +
Sbjct: 65  YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL 124
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI--------VGS 217
              H  G+ HRDLKPEN L  +  + SP+K  DFGL    K     S I         GS
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 218 PYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPF---------WAESEQGVA 262
             YMAPEV++        Y    D+WS GVILYILL G PPF         W   E   A
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 263 ------QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                 ++I  G  +F    W ++S +AK L+ ++L  D K RL+A QVL+HPW+Q    
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304
Query: 317 APNVP 321
              +P
Sbjct: 305 ENTLP 309

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 141/275 (51%), Gaps = 12/275 (4%)
Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           LA    E IED + V   LG+G F   Y      T   +A K I K+ +  A  +  V+ 
Sbjct: 2   LATCIGEKIED-FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTR 159
           EV I   L K+ SI+ L    ED N V+LV+E+C  GE+   +  R   ++E  A     
Sbjct: 61  EVKIHCQL-KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSP 218
            I+  +   H HG++HRDL   N L      N  +K  DFGL+   K P E+   + G+P
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHYTLCGTP 176
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y++PE+  R+ +G E D+WS G + Y LL G PPF  ++ +     ++  L D++   +
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSF 234
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +S  AK L+ Q+L  +P  RL+   VL+HP++ 
Sbjct: 235 --LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 95/272 (34%), Positives = 139/272 (51%), Gaps = 10/272 (3%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY+  R LG+G F   Y   D DT+E+ A K + K  L      + +  E+AI K L  N
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DN 101
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             +V      EDD+ V++V+E+C    L +    R   TE  A    R  ++ VQ  H +
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRN 229
            VIHRDLK  N LF N  ++  +K  DFGL+   +  GER  ++ G+P Y+APEVL K+ 
Sbjct: 162 RVIHRDLKLGN-LFLN--DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           +  E+DIWS G ILY LL G PPF     +     I +      R    +++  A +L+R
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIR 274
Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           +ML  DP LR +  ++L   +  +      +P
Sbjct: 275 RMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 95/272 (34%), Positives = 139/272 (51%), Gaps = 10/272 (3%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY+  R LG+G F   Y   D DT+E+ A K + K  L      + +  E+AI K L  N
Sbjct: 27  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DN 85
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             +V      EDD+ V++V+E+C    L +    R   TE  A    R  ++ VQ  H +
Sbjct: 86  PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 145
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRN 229
            VIHRDLK  N LF N  ++  +K  DFGL+   +  GER  ++ G+P Y+APEVL K+ 
Sbjct: 146 RVIHRDLKLGN-LFLN--DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           +  E+DIWS G ILY LL G PPF     +     I +      R    +++  A +L+R
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIR 258
Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           +ML  DP LR +  ++L   +  +      +P
Sbjct: 259 RMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 290

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 101/305 (33%), Positives = 144/305 (47%), Gaps = 37/305 (12%)
Query: 49  IEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLACKSISKR--KLRTAVDIDDVRREVAIM 105
            ED Y +  + LG G       CI+  T +  A K I K+   +R+ V      REV ++
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-----FREVEML 64
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
                + +++ L E  E+++  +LV E   GG +   I  R H+ E  A+ V + +   +
Sbjct: 65  YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL 124
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI--------VGS 217
              H  G+ HRDLKPEN L  +  + SP+K  DF L    K     S I         GS
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 218 PYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPF---------WAESEQGVA 262
             YMAPEV++        Y    D+WS GVILYILL G PPF         W   E   A
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 263 ------QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                 ++I  G  +F    W ++S +AK L+ ++L  D K RL+A QVL+HPW+Q    
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304
Query: 317 APNVP 321
              +P
Sbjct: 305 ENTLP 309

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 95/272 (34%), Positives = 138/272 (50%), Gaps = 10/272 (3%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY+  R LG+G F   Y   D DT+E+ A K + K  L      + +  E+AI K L  N
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DN 101
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             +V      EDD+ V++V+E+C    L +    R   TE  A    R  ++ VQ  H +
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRN 229
            VIHRDLK  N LF N  ++  +K  DFGL+   +  GER   + G+P Y+APEVL K+ 
Sbjct: 162 RVIHRDLKLGN-LFLN--DDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           +  E+DIWS G ILY LL G PPF     +     I +      R    +++  A +L+R
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIR 274
Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           +ML  DP LR +  ++L   +  +      +P
Sbjct: 275 RMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 95/272 (34%), Positives = 138/272 (50%), Gaps = 10/272 (3%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY+  R LG+G F   Y   D DT+E+ A K + K  L      + +  E+AI K L  N
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DN 101
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             +V      EDD+ V++V+E+C    L +    R   TE  A    R  ++ VQ  H +
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRN 229
            VIHRDLK  N LF N  ++  +K  DFGL+   +  GER   + G+P Y+APEVL K+ 
Sbjct: 162 RVIHRDLKLGN-LFLN--DDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           +  E+DIWS G ILY LL G PPF     +     I +      R    +++  A +L+R
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIR 274
Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           +ML  DP LR +  ++L   +  +      +P
Sbjct: 275 RMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 144/277 (51%), Gaps = 16/277 (5%)
Query: 42  AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           A +P  +  DRY + +++G G FGV  L  D+ + EL+A K I + +    +D ++V+RE
Sbjct: 9   ADLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE---KID-ENVKRE 64
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           +   + L ++ +IV  KE       + +VME   GGELF+RI   G ++E  A    + +
Sbjct: 65  IINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 123
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSP---LKAIDFGLSIFFKPGERFSEIVGSP 218
           +  V  CH   V HRDLK EN L     + SP   LK  DFG S       +    VG+P
Sbjct: 124 ISGVSYCHAMQVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 179
Query: 219 YYMAPEV-LKRNY-GPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGL-IDFKR 274
            Y+APEV LK+ Y G   D+WS GV LY++L G  PF   E  +   + I R L + +  
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAI 239
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             + ++S   + L+ ++   DP  R++  ++  H W 
Sbjct: 240 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/275 (33%), Positives = 141/275 (51%), Gaps = 16/275 (5%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P  +  DRY + +++G G FGV  L  D+ + EL+A K I + +   A    +V+RE+ 
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAA----NVKREII 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             + L ++ +IV  KE       + +VME   GGELF+RI   G ++E  A    + ++ 
Sbjct: 68  NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSP---LKAIDFGLSIFFKPGERFSEIVGSPYY 220
            V  CH   V HRDLK EN L     + SP   LK  DFG S       +    VG+P Y
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 182
Query: 221 MAPEV-LKRNY-GPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGL-IDFKRDP 276
           +APEV LK+ Y G   D+WS GV LY++L G  PF   E  +   + I R L + +    
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 242
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + ++S   + L+ ++   DP  R++  ++  H W 
Sbjct: 243 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 91/275 (33%), Positives = 143/275 (52%), Gaps = 16/275 (5%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P  +  DRY + +++G G FGV  L  D+ + EL+A K I + +    +D ++V+RE+ 
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE---KID-ENVKREII 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             + L ++ +IV  KE       + +VME   GGELF+RI   G ++E  A    + ++ 
Sbjct: 68  NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSP---LKAIDFGLSIFFKPGERFSEIVGSPYY 220
            V  CH   V HRDLK EN L     + SP   LK   FG S       +  + VG+P Y
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLL----DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAY 182
Query: 221 MAPEV-LKRNY-GPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGL-IDFKRDP 276
           +APEV LK+ Y G   D+WS GV LY++L G  PF   E  +   + I R L + +    
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 242
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + ++S   + L+ ++   DP  R++  ++  H W 
Sbjct: 243 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/275 (33%), Positives = 142/275 (51%), Gaps = 16/275 (5%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P  +  DRY + +++G G FGV  L  D+ + EL+A K I + +    +D ++V+RE+ 
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE---KID-ENVKREII 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             + L ++ +IV  KE       + +VME   GGELF+RI   G ++E  A    + ++ 
Sbjct: 68  NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSP---LKAIDFGLSIFFKPGERFSEIVGSPYY 220
            V  CH   V HRDLK EN L     + SP   LK   FG S       +    VG+P Y
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLL----DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAY 182
Query: 221 MAPEV-LKRNY-GPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGL-IDFKRDP 276
           +APEV LK+ Y G   D+WS GV LY++L G  PF   E  +   + I R L + +    
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 242
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + ++S   + L+ ++   DP  R++  ++  H W 
Sbjct: 243 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 92/294 (31%), Positives = 146/294 (49%), Gaps = 27/294 (9%)
Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNSSI 114
           LG G +G  +L       DT +L A K + K  + + A   +  R E  +++H+ ++  +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V+L  A + +  +HL+++   GGELF  +  R  +TE         IV  ++  HK G+I
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII 181
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFF--KPGERFSEIVGSPYYMAPEVLK---RN 229
           +RD+K EN L  +   N  +   DFGLS  F     ER  +  G+  YMAP++++     
Sbjct: 182 YRDIKLENILLDS---NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKSLV 288
           +   +D WS GV++Y LL G  PF  + E+     I R ++     P+P  +S  AK L+
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALAKDLI 297
Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN-------AKKAPNVPLGDVVRSRL 330
           +++L  DPK RL      A ++ EH + Q        AKK P  P   V+R  L
Sbjct: 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP-APFKPVIRDEL 350

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/275 (33%), Positives = 141/275 (51%), Gaps = 16/275 (5%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P  +  DRY + +++G G FGV  L  D+   EL+A K I + +    +D ++V+RE+ 
Sbjct: 12  LPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGE---KID-ENVKREII 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             + L ++ +IV  KE       + +VME   GGELF+RI   G ++E  A    + ++ 
Sbjct: 68  NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSP---LKAIDFGLSIFFKPGERFSEIVGSPYY 220
            V   H   V HRDLK EN L     + SP   LK  DFG S       +    VG+P Y
Sbjct: 127 GVSYAHAMQVAHRDLKLENTLL----DGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAY 182
Query: 221 MAPEV-LKRNY-GPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGL-IDFKRDP 276
           +APEV LK+ Y G   D+WS GV LY++L G  PF   E  +   + I R L + +    
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 242
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + ++S   + L+ ++   DP  R++  ++  H W 
Sbjct: 243 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 141/276 (51%), Gaps = 18/276 (6%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P  +  DRY   +++G G FGV  L  D+ T+EL+A K I +     A+D ++V+RE+ 
Sbjct: 13  MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG---AAID-ENVQREII 68
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             + L ++ +IV  KE       + ++ME   GGEL++RI   G ++E  A    + ++ 
Sbjct: 69  NHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS 127
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSP---LKAIDFGLSIFFKPGERFSEIVGSPYY 220
            V  CH   + HRDLK EN L     + SP   LK  DFG S       +    VG+P Y
Sbjct: 128 GVSYCHSMQICHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 183
Query: 221 MAPEVLKRN-YGPEI-DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           +APEVL R  Y  +I D+WS GV LY++L G  PF    E    +  ++ ++  K    P
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS-IP 242
Query: 279 N---VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           +   +S     L+ ++   DP  R++  ++  H W 
Sbjct: 243 DDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 143/293 (48%), Gaps = 35/293 (11%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV + C +RDT +++A K   + +    +      RE+ ++K L K+ ++V+L
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQL-KHPNLVNL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
            E       +HLV E C+   L +    +    E    ++T   ++ V  CHKH  IHRD
Sbjct: 68  LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRD 127
Query: 178 LKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEI 234
           +KPEN L     ++S +K  DFG + +   P + + + V + +Y +PE+L     YGP +
Sbjct: 128 VKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPV 184
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF------------------KRDP 276
           D+W+ G +   LL GVP +  +S+      I + L D                     DP
Sbjct: 185 DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDP 244
Query: 277 ---------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV 320
                    +PN+S  A  L++  L  DP  RLT +Q+L HP+ +N ++  ++
Sbjct: 245 EDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 12/264 (4%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D + + R LG+G+FG  YL  ++ +  ++A K + K ++        +RRE+ I  HL  
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHL-H 81
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L     D   ++L++E    GEL+  +     + E+  A +   + + +  CH 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RN 229
             VIHRD+KPEN           LK  DFG S+   P  R   + G+  Y+ PE+++ R 
Sbjct: 142 KKVIHRDIKPEN---LLLGLKGELKIADFGWSV-HAPSLRRKTMCGTLDYLPPEMIEGRM 197
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLV 288
           +  ++D+W  GV+ Y LL G PPF + S     + I++  +D K   +P +V   A+ L+
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVK--VDLK---FPASVPTGAQDLI 252
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQ 312
            ++L  +P  RL   QV  HPW++
Sbjct: 253 SKLLRHNPSERLPLAQVSAHPWVR 276

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 146/275 (53%), Gaps = 12/275 (4%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   R + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 91
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 150
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 151 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 207
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  +      VS S K  + ++L  D
Sbjct: 208 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 266
Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   A  VPL    R+R
Sbjct: 267 PAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 301

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 146/275 (53%), Gaps = 12/275 (4%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   R + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 93
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 152
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 153 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 209
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  +      VS S K  + ++L  D
Sbjct: 210 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 268
Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   A  VPL    R+R
Sbjct: 269 PAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 303

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 146/275 (53%), Gaps = 12/275 (4%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   R + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 86
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 145
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 146 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 202
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  +      VS S K  + ++L  D
Sbjct: 203 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 261
Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   A  VPL    R+R
Sbjct: 262 PAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 296

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 146/275 (53%), Gaps = 12/275 (4%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   R + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 82
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 141
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 142 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 198
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  +      VS S K  + ++L  D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 257
Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   A  VPL    R+R
Sbjct: 258 PAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 292

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 146/275 (53%), Gaps = 12/275 (4%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   R + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 136
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 195
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 196 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 252
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  +      VS S K  + ++L  D
Sbjct: 253 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 311
Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   A  VPL    R+R
Sbjct: 312 PAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 346

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 146/275 (53%), Gaps = 12/275 (4%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   R + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 213
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 272
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 273 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 329
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  +      VS S K  + ++L  D
Sbjct: 330 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 388
Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   A  VPL    R+R
Sbjct: 389 PAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 423

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 10/266 (3%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  +  +V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 83
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H++ VIHRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K  N LF N  E+  +K  DFGL+   +  GER   + G+P Y+APEVL K+ +  E+D+
Sbjct: 144 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS G I+Y LL G PPF     +     I +      +    +++  A SL+++ML+ DP
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 256
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPL 322
             R T  ++L   +  +      +P+
Sbjct: 257 TARPTINELLNDEFFTSGYIPARLPI 282

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 10/266 (3%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  +  +V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 83
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H++ VIHRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K  N LF N  E+  +K  DFGL+   +  GER   + G+P Y+APEVL K+ +  E+D+
Sbjct: 144 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS G I+Y LL G PPF     +     I +      +    +++  A SL+++ML+ DP
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 256
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPL 322
             R T  ++L   +  +      +P+
Sbjct: 257 TARPTINELLNDEFFTSGYIPARLPI 282

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 144/295 (48%), Gaps = 29/295 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNVPLGDVVRS 328
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V  G V  S
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSES 286

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 144/295 (48%), Gaps = 29/295 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNVPLGDVVRS 328
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V  G V  S
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSES 285

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 10/266 (3%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  +  +V   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 87
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H++ VIHRDL
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 147
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K  N LF N  E+  +K  DFGL+   +  GER   + G+P Y+APEVL K+ +  E+D+
Sbjct: 148 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 204
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS G I+Y LL G PPF     +     I +      +    +++  A SL+++ML+ DP
Sbjct: 205 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 260
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPL 322
             R T  ++L   +  +      +P+
Sbjct: 261 TARPTINELLNDEFFTSGYIPARLPI 286

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 144/295 (48%), Gaps = 29/295 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNVPLGDVVRS 328
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V  G V  S
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSES 286

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 144/295 (48%), Gaps = 29/295 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNVPLGDVVRS 328
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V  G V  S
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSES 286

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 144/295 (48%), Gaps = 29/295 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNVPLGDVVRS 328
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V  G V  S
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSES 286

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 10/266 (3%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  +  +V   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 105
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H++ VIHRDL
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 165
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K  N LF N  E+  +K  DFGL+   +  GER   + G+P Y+APEVL K+ +  E+D+
Sbjct: 166 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 222
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS G I+Y LL G PPF     +     I +      +    +++  A SL+++ML+ DP
Sbjct: 223 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 278
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPL 322
             R T  ++L   +  +      +P+
Sbjct: 279 TARPTINELLNDEFFTSGYIPARLPI 304

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 138/269 (51%), Gaps = 16/269 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  +  +V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 81
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H++ VIHRDL
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K  N LF N  E+  +K  DFGL+   +  GER   + G+P Y+APEVL K+ +  E+D+
Sbjct: 142 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP---NVSESAKSLVRQMLE 293
           WS G I+Y LL G PPF       + +  LR     K++ +    +++  A SL+++ML+
Sbjct: 199 WSIGCIMYTLLVGKPPFETSC---LKETYLR----IKKNEYSIPKHINPVAASLIQKMLQ 251
Query: 294 PDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            DP  R T  ++L   +  +      +P+
Sbjct: 252 TDPTARPTINELLNDEFFTSGYIPARLPI 280

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 10/266 (3%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  +  +V   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 107
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H++ VIHRDL
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K  N LF N  E+  +K  DFGL+   +  GER   + G+P Y+APEVL K+ +  E+D+
Sbjct: 168 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS G I+Y LL G PPF     +     I +      +    +++  A SL+++ML+ DP
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 280
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPL 322
             R T  ++L   +  +      +P+
Sbjct: 281 TARPTINELLNDEFFTSGYIPARLPI 306

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 277

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 74
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 75  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 134
Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 135 KLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 191
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 192 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 247
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 248 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 280

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 277

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 277

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 277

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 76
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 77  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 136
Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 137 KLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 193
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 194 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 249
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 250 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 282

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 277

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 138/291 (47%), Gaps = 37/291 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD---------------- 94
           ++Y +  E+G+G +GV  L  + +     A K +SK+KL                     
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 95  -------IDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM--ELCEGGELFDRIVA 145
                  I+ V +E+AI+K L  + ++V L E  +D N  HL M  EL   G + + +  
Sbjct: 73  CIQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPT 130
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
               +E  A    + +++ ++  H   +IHRD+KP N L     E+  +K  DFG+S  F
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEF 187
Query: 206 KPGERF-SEIVGSPYYMAPEVLKRN----YGPEIDIWSAGVILYILLCGVPPFWAESEQG 260
           K  +   S  VG+P +MAPE L        G  +D+W+ GV LY  + G  PF  E    
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 261 VAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           +   I    ++F   P  +++E  K L+ +ML+ +P+ R+   ++  HPW+
Sbjct: 248 LHSKIKSQALEFPDQP--DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 141/287 (49%), Gaps = 29/287 (10%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 277

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 147/305 (48%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 4   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 62
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 63  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 122
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 123 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 181
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 182 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+RG + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 239 DIPFEHDEE------IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 289 WMQDV 293

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 147/305 (48%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 19  SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 77
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 78  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 137
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 138 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 196
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 197 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+RG + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 254 DIPFEHDEE------IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 303
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 304 WMQDV 308

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 142/287 (49%), Gaps = 29/287 (10%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P+   S+     +      D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYS------DWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 277

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 141/287 (49%), Gaps = 29/287 (10%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 277

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 138/282 (48%), Gaps = 19/282 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 4   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 59
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 60  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 119 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           +LKR   +   +D+WS G++L  +L G  P W +      +           +PW  +  
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
           +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 235 APLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 276

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 147/305 (48%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 24  SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 82
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 83  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 142
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 143 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 201
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 202 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+RG + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 259 DIPFEHDEE------IIRGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHP 308
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 309 WMQDV 313

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 141/287 (49%), Gaps = 29/287 (10%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEIXINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 277

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 141/287 (49%), Gaps = 29/287 (10%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEIXINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 277

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 147/305 (48%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 19  SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 77
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 78  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 137
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 138 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 196
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 197 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+RG + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 254 DIPFEHDEE------IIRGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHP 303
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 304 WMQDV 308

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 142/293 (48%), Gaps = 22/293 (7%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL 89
           A  N      +  G  KE +E +Y V   LG G FG  Y  I       +A K + K ++
Sbjct: 2   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 61
Query: 90  RTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIV 144
               ++ +  R   EV ++K +    S ++ L +  E  ++  L++E  E   +LFD I 
Sbjct: 62  SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT 121
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSI 203
            RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG   
Sbjct: 122 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGA 178
Query: 204 FFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG  PF  + E   
Sbjct: 179 LLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 234
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
              I+RG + F++     VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 235 ---IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 142/293 (48%), Gaps = 22/293 (7%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL 89
           A  N      +  G  KE +E +Y V   LG G FG  Y  I       +A K + K ++
Sbjct: 22  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 81
Query: 90  RTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIV 144
               ++ +  R   EV ++K +    S ++ L +  E  ++  L++E  E   +LFD I 
Sbjct: 82  SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT 141
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSI 203
            RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG   
Sbjct: 142 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGA 198
Query: 204 FFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG  PF  + E   
Sbjct: 199 LLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 254
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
              I+RG + F++     VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 255 ---IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 142/293 (48%), Gaps = 22/293 (7%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL 89
           A  N      +  G  KE +E +Y V   LG G FG  Y  I       +A K + K ++
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 62
Query: 90  RTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIV 144
               ++ +  R   EV ++K +    S ++ L +  E  ++  L++E  E   +LFD I 
Sbjct: 63  SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT 122
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSI 203
            RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG   
Sbjct: 123 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGA 179
Query: 204 FFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG  PF  + E   
Sbjct: 180 LLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 235
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
              I+RG + F++     VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 236 ---IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 142/293 (48%), Gaps = 22/293 (7%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL 89
           A  N      +  G  KE +E +Y V   LG G FG  Y  I       +A K + K ++
Sbjct: 2   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 61
Query: 90  RTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIV 144
               ++ +  R   EV ++K +    S ++ L +  E  ++  L++E  E   +LFD I 
Sbjct: 62  SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT 121
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSI 203
            RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG   
Sbjct: 122 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGA 178
Query: 204 FFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG  PF  + E   
Sbjct: 179 LLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 234
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
              I+RG + F++     VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 235 ---IIRGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 142/293 (48%), Gaps = 22/293 (7%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL 89
           A  N      +  G  KE +E +Y V   LG G FG  Y  I       +A K + K ++
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 62
Query: 90  RTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIV 144
               ++ +  R   EV ++K +    S ++ L +  E  ++  L++E  E   +LFD I 
Sbjct: 63  SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT 122
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSI 203
            RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG   
Sbjct: 123 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGA 179
Query: 204 FFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG  PF  + E   
Sbjct: 180 LLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 235
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
              I+RG + F++     VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 236 ---IIRGQVFFRQ----RVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDV 281

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 142/293 (48%), Gaps = 22/293 (7%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL 89
           A  N      +  G  KE +E +Y V   LG G FG  Y  I       +A K + K ++
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 62
Query: 90  RTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIV 144
               ++ +  R   EV ++K +    S ++ L +  E  ++  L++E  E   +LFD I 
Sbjct: 63  SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT 122
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSI 203
            RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG   
Sbjct: 123 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGA 179
Query: 204 FFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG  PF  + E   
Sbjct: 180 LLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 235
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
              I+RG + F++     VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 236 ---IIRGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
             +  +  +L+ ++L  +P  R+T   + +  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
             +  +  +L+ ++L  +P  R+T   + +  W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
             +  +  +L+ ++L  +P  R+T   + +  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEIXINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
             +  +  +L+ ++L  +P  R+T   + +  W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 134/274 (48%), Gaps = 15/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           +LKR   +   +D+WS G++L  +L G  P W +      +           +PW  +  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           +  +L+ ++L  +P  R+T   + +  W     K
Sbjct: 236 APLALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
             +  +  +L+ ++L  +P  R+T   + +  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
             +  +  +L+ ++L  +P  R+T   + +  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
             +  +  +L+ ++L  +P  R+T   + +  W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 3   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 62
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 63  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQ 122
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 178
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 229
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 230 -RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  114 bits (284), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 4   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 63
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 123
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 179
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 231 -RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 150/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWESPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   ++T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN +     +   +K  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLMI---DQQGYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 140/287 (48%), Gaps = 29/287 (10%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G  G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAAGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 277

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 150/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWESPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   ++T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIXNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 4   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 63
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 123
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 179
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 231 -RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 144/284 (50%), Gaps = 27/284 (9%)
Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  +D  T + +A   I +  L+     + + 
Sbjct: 13  VSVGDPKK----KYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELII 65
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 66  NEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 123
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSP 218
             ++ ++  H + VIHRD+K +N L      +  +K  DFG      P + + SE+VG+P
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSEMVGTP 180
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGT 233
Query: 278 PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P +    K        + + L+ D + R +AK++L+H +L+ AK
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 3   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 62
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 63  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 122
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 178
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 229
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 230 -RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 4   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 63
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 123
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 179
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 231 -RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 150/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGXEQESVK-----------EFLAKAKEDFLKKWESPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   ++T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 150/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 21  MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWESPAQNTAHLDQFERIKT 69
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   ++T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 128
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 129 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 189 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 243
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 244 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 299
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 300 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 337

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 4   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 62
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 63  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 122
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 123 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 181
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 182 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 239 DIPFEHDEE------IIGGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 289 WMQDV 293

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 136/286 (47%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+    +I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN +     +   +K  DFGL+   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIKVTDFGLAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 5   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 63
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 64  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 123
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 124 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 182
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 183 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 240 DIPFEHDEE------IIGGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 290 WMQDV 294

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 26  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 85
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 86  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 145
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 146 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 201
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 202 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 252
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 253 -RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 288

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 4   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 62
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 63  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 122
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 123 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 181
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 182 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 239 DIPFEHDEE------IIGGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 289 WMQDV 293

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 91/338 (26%), Positives = 149/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   R 
Sbjct: 1   MGNAAAAKKGXEQESVK-----------EFLAKAKEDFLKKWESPAQNTAHLDQFERIRT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   ++T    A K + K+K+     I+    E  I + +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++V+E   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   +K  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L   ++T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 150/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWESPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   ++T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 2   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 61
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 62  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 121
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 122 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 177
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 178 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 228
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 229 -RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 264

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 5   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 63
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 64  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 123
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 124 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 182
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 183 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 240 DIPFEHDEE------IIGGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 290 WMQDV 294

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 5   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 63
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 64  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 123
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 124 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 182
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 183 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 240 DIPFEHDEE------IIGGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 290 WMQDV 294

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 148/338 (43%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--E 58
           MGN   +     +E VK           E  A  K+        P +N       DR   
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   +++    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 4   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 62
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 63  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 122
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 123 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 181
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 182 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 239 DIPFEHDEE------IIGGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 289 WMQDV 293

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L   ++T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 138/284 (48%), Gaps = 22/284 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD-----VRREVAIMK 106
           +Y     LG G FG  +  +D++  + +  K I K K+     I+D     V  E+AI+ 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTRTIVEVV 165
            + ++++I+ + +  E+     LVME    G +LF  I       E  A+ + R +V  V
Sbjct: 85  RV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
                  +IHRD+K EN + A   E+  +K IDFG + + + G+ F    G+  Y APEV
Sbjct: 144 GYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 226 LKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES 283
           L  N   GPE+++WS GV LY L+    PF  E E+ V  AI          P   VS+ 
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPF-CELEETVEAAI---------HPPYLVSKE 250
Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVR 327
             SLV  +L+P P+ R T ++++  PW+       +    +V R
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFR 294

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L   ++T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 5   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 63
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 64  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 123
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 124 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 182
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 183 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 240 DIPFEHDEE------IIGGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 290 WMQDV 294

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 143/284 (50%), Gaps = 27/284 (9%)
Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  +D  T + +A   I +  L+     + + 
Sbjct: 13  VSVGDPKK----KYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELII 65
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 66  NEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 123
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSP 218
             ++ ++  H + VIHRD+K +N L      +  +K  DFG      P + + S +VG+P
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTP 180
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGT 233
Query: 278 PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P +    K        + + LE D + R +AK++L+H +L+ AK
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 135/273 (49%), Gaps = 25/273 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I   
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINAM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
             +  +  +L+ ++L  +P  R+T   + +  W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 139/277 (50%), Gaps = 20/277 (7%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V + +GRG FG   L   + TR++ A K +SK ++    D      E  IM     + 
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 134
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  +   H  G
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGE-RFSEIVGSPYYMAPEVLKRN- 229
            IHRD+KP+N L     ++  LK  DFG  +   K G  R    VG+P Y++PEVLK   
Sbjct: 194 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVSES 283
               YG E D WS GV LY +L G  PF+A+S  G    I+  +  + F  D   ++S+ 
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKE 308
Query: 284 AKSLVRQMLEPDPKLRLTAKQVLE---HPWLQNAKKA 317
           AK+L+   L  D ++RL    V E   H + +N + A
Sbjct: 309 AKNLICAFL-TDREVRLGRNGVEEIKRHLFFKNDQWA 344

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 144/320 (45%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 144/320 (45%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 139/277 (50%), Gaps = 20/277 (7%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V + +GRG FG   L   + TR++ A K +SK ++    D      E  IM     + 
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 129
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  +   H  G
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGE-RFSEIVGSPYYMAPEVLKRN- 229
            IHRD+KP+N L     ++  LK  DFG  +   K G  R    VG+P Y++PEVLK   
Sbjct: 189 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVSES 283
               YG E D WS GV LY +L G  PF+A+S  G    I+  +  + F  D   ++S+ 
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKE 303
Query: 284 AKSLVRQMLEPDPKLRLTAKQVLE---HPWLQNAKKA 317
           AK+L+   L  D ++RL    V E   H + +N + A
Sbjct: 304 AKNLICAFL-TDREVRLGRNGVEEIKRHLFFKNDQWA 339

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 144/320 (45%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 139/277 (50%), Gaps = 20/277 (7%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V + +GRG FG   L   + TR++ A K +SK ++    D      E  IM     + 
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 134
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  +   H  G
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGE-RFSEIVGSPYYMAPEVLKRN- 229
            IHRD+KP+N L     ++  LK  DFG  +   K G  R    VG+P Y++PEVLK   
Sbjct: 194 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVSES 283
               YG E D WS GV LY +L G  PF+A+S  G    I+  +  + F  D   ++S+ 
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKE 308
Query: 284 AKSLVRQMLEPDPKLRLTAKQVLE---HPWLQNAKKA 317
           AK+L+   L  D ++RL    V E   H + +N + A
Sbjct: 309 AKNLICAFL-TDREVRLGRNGVEEIKRHLFFKNDQWA 344

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 141/311 (45%), Gaps = 27/311 (8%)
Query: 28  KEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSIS 85
           KE  A  K+        P +N       DR   LG G FG   L   +++    A K + 
Sbjct: 3   KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 62
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE+F  +  
Sbjct: 63  KQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 121
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
            G ++E  A      IV   +  H   +I+RDLKPEN L     E   ++  DFG +   
Sbjct: 122 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DEQGYIQVTDFGFAKRV 178
Query: 206 KPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
           K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+    + + 
Sbjct: 179 KG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 236
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL-------- 311
           I+ G + F      + S   K L+R +L+ D       L+     +  H W         
Sbjct: 237 IVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 292
Query: 312 -QNAKKAPNVP 321
            Q   +AP +P
Sbjct: 293 YQRKVEAPFIP 303

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 144/320 (45%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 144/320 (45%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKAFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 150/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--E 58
           MGN   +     +E VK           E  A  K+        P +N       DR   
Sbjct: 21  MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKT 69
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   +++    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 128
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K G  ++ + G+P Y+APE +L + Y   +D W
Sbjct: 189 KPENLLI---DQQGYIQVTDFGFAKRVK-GATWT-LCGTPEYLAPEIILSKGYNKAVDWW 243
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 244 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 299
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 300 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 337

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 147/338 (43%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--E 58
           MGN   +     +E VK           E  A  K+        P +N       DR   
Sbjct: 21  MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKT 69
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   +++    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 128
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H   +I+RDL
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 189 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 243
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 244 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 299
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 300 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 337

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 136/286 (47%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+    +I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN +     +   ++  DFGL+   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIQVTDFGLAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 142/318 (44%), Gaps = 27/318 (8%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
            A K + K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
           +F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++  D
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTD 184
Query: 199 FGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
           FG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+ 
Sbjct: 185 FGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWL- 311
              + + I+ G + F      + S   K L+R +L+ D   R          +  H W  
Sbjct: 243 PIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLPNGVNDIKNHKWFA 298
Query: 312 --------QNAKKAPNVP 321
                   Q   +AP +P
Sbjct: 299 TTDWIAIYQRKVEAPFIP 316

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L   ++T    A K + K+K+     I+    E  I++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 92
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 153 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 207
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 263
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 309

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 129/258 (50%), Gaps = 16/258 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 214
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRD 177
            + +  + +  VME   GGELF  +     ++E  A      IV  +   H +  V++RD
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           LK EN +     ++  +K  DFGL     K G       G+P Y+APEVL+ N YG  +D
Sbjct: 275 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 331
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W  GV++Y ++CG  PF+ +  + + + IL   I F R   P     AKSL+  +L+ D
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLKKD 387
Query: 296 PKLRL-----TAKQVLEH 308
           PK RL      AK++++H
Sbjct: 388 PKQRLGGGSEDAKEIMQH 405

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 16/261 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 75
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRD 177
            + +  + +  VME   GGELF  +     ++E  A      IV  +   H +  V++RD
Sbjct: 76  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 135
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           LK EN +     ++  +K  DFGL     K G       G+P Y+APEVL+ N YG  +D
Sbjct: 136 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 192
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W  GV++Y ++CG  PF+ +  + + + IL   I F R   P     AKSL+  +L+ D
Sbjct: 193 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE----AKSLLSGLLKKD 248
Query: 296 PKLRL-----TAKQVLEHPWL 311
           PK RL      AK++++H + 
Sbjct: 249 PKQRLGGGSEDAKEIMQHRFF 269

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 143/284 (50%), Gaps = 27/284 (9%)
Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  +D  T + +A   I +  L+     + + 
Sbjct: 13  VSVGDPKK----KYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELII 65
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 66  NEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 123
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSP 218
             ++ ++  H + VIHRD+K +N L      +  +K  DFG      P + + S +VG+P
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGT 233
Query: 278 PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P +    K        + + L+ D + R +AK++L+H +L+ AK
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 16/261 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 74
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRD 177
            + +  + +  VME   GGELF  +     ++E  A      IV  +   H +  V++RD
Sbjct: 75  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 134
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           LK EN +     ++  +K  DFGL     K G       G+P Y+APEVL+ N YG  +D
Sbjct: 135 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 191
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W  GV++Y ++CG  PF+ +  + + + IL   I F R   P     AKSL+  +L+ D
Sbjct: 192 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE----AKSLLSGLLKKD 247
Query: 296 PKLRL-----TAKQVLEHPWL 311
           PK RL      AK++++H + 
Sbjct: 248 PKQRLGGGSEDAKEIMQHRFF 268

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 143/284 (50%), Gaps = 27/284 (9%)
Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  +D  T + +A   I +  L+     + + 
Sbjct: 14  VSVGDPKK----KYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELII 66
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 67  NEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 124
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSP 218
             ++ ++  H + VIHRD+K +N L      +  +K  DFG      P + + S +VG+P
Sbjct: 125 ECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTP 181
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGT 234
Query: 278 PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P +    K        + + LE D + R +AK++++H +L+ AK
Sbjct: 235 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAK 278

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 141/311 (45%), Gaps = 27/311 (8%)
Query: 28  KEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSIS 85
           KE  A  K+        P +N       DR   LG G FG   L   +++    A K + 
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE+F  +  
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
            G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++  DFG +   
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191
Query: 206 KPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
           K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+    + + 
Sbjct: 192 KG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL-------- 311
           I+ G + F      + S   K L+R +L+ D       L+     +  H W         
Sbjct: 250 IVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305
Query: 312 -QNAKKAPNVP 321
            Q   +AP +P
Sbjct: 306 YQRKVEAPFIP 316

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 129/258 (50%), Gaps = 16/258 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 217
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRD 177
            + +  + +  VME   GGELF  +     ++E  A      IV  +   H +  V++RD
Sbjct: 218 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 277
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           LK EN +     ++  +K  DFGL     K G       G+P Y+APEVL+ N YG  +D
Sbjct: 278 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 334
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W  GV++Y ++CG  PF+ +  + + + IL   I F R   P     AKSL+  +L+ D
Sbjct: 335 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLKKD 390
Query: 296 PKLRL-----TAKQVLEH 308
           PK RL      AK++++H
Sbjct: 391 PKQRLGGGSEDAKEIMQH 408

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 149/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWENPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L    +T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWTLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN +     +   +K  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 142/318 (44%), Gaps = 27/318 (8%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
            A K + K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
           +F  +   G + E  A      IV   +  H   +I+RDLKPEN L     +   ++  D
Sbjct: 128 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTD 184
Query: 199 FGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
           FG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+ 
Sbjct: 185 FGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL- 311
              + + I+ G + F      + S   K L+R +L+ D       L+     +  H W  
Sbjct: 243 PIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 312 --------QNAKKAPNVP 321
                   Q   +AP +P
Sbjct: 299 TTDWIAIYQRKVEAPFIP 316

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 16/261 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 76
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRD 177
            + +  + +  VME   GGELF  +     ++E  A      IV  +   H +  V++RD
Sbjct: 77  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 136
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           LK EN +     ++  +K  DFGL     K G       G+P Y+APEVL+ N YG  +D
Sbjct: 137 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 193
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W  GV++Y ++CG  PF+ +  + + + IL   I F R   P     AKSL+  +L+ D
Sbjct: 194 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE----AKSLLSGLLKKD 249
Query: 296 PKLRL-----TAKQVLEHPWL 311
           PK RL      AK++++H + 
Sbjct: 250 PKQRLGGGSEDAKEIMQHRFF 270

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 144/286 (50%), Gaps = 27/286 (9%)
Query: 38  ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           I V  G PK+    +Y    ++G+G  G  Y  +D  T + +A   I +  L+     + 
Sbjct: 12  IIVSVGDPKK----KYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKEL 64
Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           +  E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV
Sbjct: 65  IINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAV 122
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVG 216
            R  ++ ++  H + VIHR++K +N L      +  +K  DFG      P + + S +VG
Sbjct: 123 CRECLQALEFLHSNQVIHRNIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVG 179
Query: 217 SPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
           +PY+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATN 232
Query: 276 PWPNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
             P +    K        + + LE D + R +AK++++H +L+ AK
Sbjct: 233 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAK 278

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 141/311 (45%), Gaps = 27/311 (8%)
Query: 28  KEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSIS 85
           KE  A  K+        P +N       DR   LG G FG   L   +++    A K + 
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE+F  +  
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
            G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++  DFG +   
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191
Query: 206 KPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
           K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+    + + 
Sbjct: 192 KG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEK 249
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL-------- 311
           I+ G + F      + S   K L+R +L+ D       L+     +  H W         
Sbjct: 250 IVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305
Query: 312 -QNAKKAPNVP 321
            Q   +AP +P
Sbjct: 306 YQRKVEAPFIP 316

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 149/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWENPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L    +T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 142/318 (44%), Gaps = 27/318 (8%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
            A K + K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
           +F  +   G + E  A      IV   +  H   +I+RDLKPEN L     +   ++  D
Sbjct: 128 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTD 184
Query: 199 FGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
           FG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+ 
Sbjct: 185 FGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL- 311
              + + I+ G + F      + S   K L+R +L+ D       L+     +  H W  
Sbjct: 243 PIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 312 --------QNAKKAPNVP 321
                   Q   +AP +P
Sbjct: 299 TTDWIAIYQRKVEAPFIP 316

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 130/271 (47%), Gaps = 17/271 (6%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D +   R LG+G FG   L   ++T +L A K + K  +    D++    E  I+  L +
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS-LAR 81
Query: 111 NSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           N   ++    C +  + +  VME   GG+L   I     + E  A      I+  +   H
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKR 228
             G+I+RDLK +N L  ++      K  DFG+       G   +   G+P Y+APE+L+ 
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGH---CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE 198
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
             YGP +D W+ GV+LY +LCG  PF AE+E  + +AIL   + +    W  + E A  +
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LHEDATGI 254
Query: 288 VRQMLEPDPKLRLTA------KQVLEHPWLQ 312
           ++  +  +P +RL +        +L HP+ +
Sbjct: 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L   ++T    A K + K+K+     I+    E  I++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 92
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H 
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 153 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 207
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 263
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 309

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 140/311 (45%), Gaps = 27/311 (8%)
Query: 28  KEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSIS 85
           KE  A  K+        P +N       DR   LG G FG   L   +++    A K + 
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE+F  +  
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
            G + E  A      IV   +  H   +I+RDLKPEN L     +   ++  DFG +   
Sbjct: 135 IGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191
Query: 206 KPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
           K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+    + + 
Sbjct: 192 KG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL-------- 311
           I+ G + F      + S   K L+R +L+ D       L+     +  H W         
Sbjct: 250 IVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305
Query: 312 -QNAKKAPNVP 321
            Q   +AP +P
Sbjct: 306 YQRKVEAPFIP 316

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 89/338 (26%), Positives = 148/338 (43%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGXEQESVK-----------EFLAKAKEDFLKKWENPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L    +T    A K + K+K+     I+    E  I++ +     +  L+
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN +     +   +K  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLMI---DQQGYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + +G G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   +K  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 129/277 (46%), Gaps = 23/277 (8%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKR---KLRTAVDIDDVRRE 101
           PK +++D + + R LG G FG  +L   R      A K + K    +L+     +D R  
Sbjct: 1   PKYSLQD-FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM 59
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           ++I+ H      I+ +    +D   + ++M+  EGGELF  +     +    A      +
Sbjct: 60  LSIVTH----PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
              ++  H   +I+RDLKPEN L     +N  +K  DFG + +  P   +  + G+P Y+
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV-PDVTYX-LCGTPDYI 170
Query: 222 APEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APEV+  + Y   ID WS G+++Y +L G  PF+  +     + IL   + F     P  
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFF 226
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQ-----VLEHPWLQ 312
           +E  K L+ +++  D   RL   Q     V  HPW +
Sbjct: 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 136/274 (49%), Gaps = 22/274 (8%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIM 105
           +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 106 KHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVE 163
           K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    ++E
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 164 VVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
            V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  Y  
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSP 177
Query: 223 PEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++     V
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RV 227
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           S   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 228 SXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN +     +   +K  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 140/311 (45%), Gaps = 27/311 (8%)
Query: 28  KEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSIS 85
           KE  A  K+        P +N       DR   LG G FG   L   +++    A K + 
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE+F  +  
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
            G + E  A      IV   +  H   +I+RDLKPEN L     +   ++  DFG +   
Sbjct: 135 IGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191
Query: 206 KPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
           K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+    + + 
Sbjct: 192 KG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL-------- 311
           I+ G + F      + S   K L+R +L+ D       L+     +  H W         
Sbjct: 250 IVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305
Query: 312 -QNAKKAPNVP 321
            Q   +AP +P
Sbjct: 306 YQRKVEAPFIP 316

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 140/311 (45%), Gaps = 27/311 (8%)
Query: 28  KEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSIS 85
           KE  A  K+        P +N       DR   LG G FG   L   +++    A K + 
Sbjct: 11  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 70
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE+F  +  
Sbjct: 71  KQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 129
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
            G + E  A      IV   +  H   +I+RDLKPEN L     +   ++  DFG +   
Sbjct: 130 IGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 186
Query: 206 KPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
           K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+    + + 
Sbjct: 187 KG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 244
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL-------- 311
           I+ G + F      + S   K L+R +L+ D       L+     +  H W         
Sbjct: 245 IVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 300
Query: 312 -QNAKKAPNVP 321
            Q   +AP +P
Sbjct: 301 YQRKVEAPFIP 311

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 148/338 (43%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWENPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L    +T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 89/338 (26%), Positives = 148/338 (43%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWENPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L    +T    A K + K+K+     I+    E  I++ +     +  L+
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN +     +   +K  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLMI---DQQGYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 144/320 (45%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN +     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLII---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+APE ++ + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 85
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 146 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWTLCGTPEYLAPEIILSKG 200
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 201 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 256
Query: 290 QMLEPDPKLRL-----TAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D   R          +  H W          Q   +AP +P
Sbjct: 257 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 302

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN +     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 136/274 (49%), Gaps = 22/274 (8%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIM 105
           +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 106 KHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVE 163
           K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    ++E
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 164 VVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
            V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  Y  
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSP 177
Query: 223 PEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++     V
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RV 227
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           S   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 143/320 (44%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+AP  +L + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 125/265 (47%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F  T L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 96
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 157 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 213
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 269
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/338 (26%), Positives = 147/338 (43%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWENPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L    +T    A K + K+K+     I+    E  I++ +     +  L+
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN +     +   +K  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLMI---DQQGYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + +G G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GG++F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   +K  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 141/279 (50%), Gaps = 15/279 (5%)
Query: 38  ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           + V  G P+E + +      ++G G  G+  +  ++ T + +A K +  RK +     + 
Sbjct: 36  LVVSPGDPREYLANFI----KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---EL 88
Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           +  EV IM+    + ++V +  +    + + +VME  EGG L D IV      E   A V
Sbjct: 89  LFNEVVIMRDY-HHDNVVDMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATV 146
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVG 216
             +++  +   H  GVIHRD+K ++ L  +   +  +K  DFG  +   K   +   +VG
Sbjct: 147 CLSVLRALSYLHNQGVIHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKXLVG 203
Query: 217 SPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
           +PY+MAPEV+ R  YG E+DIWS G+++  ++ G PP++ E      + I   L    +D
Sbjct: 204 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKD 263
Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
               VS   +  +  ML  +P  R TA+++L HP+L+ A
Sbjct: 264 -LHKVSSVLRGFLDLMLVREPSQRATAQELLGHPFLKLA 301

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + +G G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GG++F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   +K  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/224 (34%), Positives = 122/224 (54%), Gaps = 20/224 (8%)
Query: 101 EVAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVA----RGHYTERAA 154
           EV +++ L K+ +IV   +   D  +  +++VME CEGG+L   I      R +  E   
Sbjct: 55  EVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 155 AAVTRTIVEVVQLCHK-----HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
             V   +   ++ CH+     H V+HRDLKP N +F + K+N  +K  DFGL+      E
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDE 170
Query: 210 RFS-EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR 267
            F+ E VG+PYYM+PE + R +Y  + DIWS G +LY L   +PPF A S++ +A  I  
Sbjct: 171 DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           G   F+R P+   S+    ++ +ML      R + +++LE+P +
Sbjct: 231 G--KFRRIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 150/289 (51%), Gaps = 26/289 (8%)
Query: 52  RYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           R L+D   ++G G  G+  L  ++ +   +A K +  RK +     + +  EV IM+   
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDY- 99
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           ++ ++V + ++      + ++ME  +GG L D IV++    E   A V   +++ +   H
Sbjct: 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLH 158
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR 228
             GVIHRD+K ++ L      +  +K  DFG  +   K   +   +VG+PY+MAPEV+ R
Sbjct: 159 AQGVIHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISR 215
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK-- 285
           + Y  E+DIWS G+++  ++ G PP++++S     QA+ R     +  P P +  S K  
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKR----LRDSPPPKLKNSHKVS 268
Query: 286 ----SLVRQMLEPDPKLRLTAKQVLEHPW-LQNAKKAPNVPLGDVVRSR 329
                 + +ML  DP+ R TA+++L+HP+ LQ       VPL  + R +
Sbjct: 269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLYRKQ 317

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 142/318 (44%), Gaps = 27/318 (8%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
            A K + K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
           +F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++  D
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTD 184
Query: 199 FGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
           FG +   K   R   + G+P  +APE +L + Y   +D W+ GV++Y +  G PPF+A+ 
Sbjct: 185 FGFAKRVKG--RTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL- 311
              + + I+ G + F      + S   K L+R +L+ D       L+     +  H W  
Sbjct: 243 PIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 312 --------QNAKKAPNVP 321
                   Q   +AP +P
Sbjct: 299 TTDWIAIYQRKVEAPFIP 316

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 12/265 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + +   + LG G F    L  +  T    A K + KR +     +  V RE  +
Sbjct: 3   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 62
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           M  L  +   V L    +DD  ++  +   + GEL   I   G + E      T  IV  
Sbjct: 63  MSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 121
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYM 221
           ++  H  G+IHRDLKPEN L     E+  ++  DFG +    P     R +  VG+  Y+
Sbjct: 122 LEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 222 APEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           +PE+L +++     D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P  
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK- 237
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQV 305
              A+ LV ++L  D   RL  +++
Sbjct: 238 ---ARDLVEKLLVLDATKRLGCEEM 259

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 12/265 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + +   + LG G F    L  +  T    A K + KR +     +  V RE  +
Sbjct: 2   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           M  L  +   V L    +DD  ++  +   + GEL   I   G + E      T  IV  
Sbjct: 62  MSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYM 221
           ++  H  G+IHRDLKPEN L     E+  ++  DFG +    P     R +  VG+  Y+
Sbjct: 121 LEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 222 APEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           +PE+L +++     D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P  
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK- 236
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQV 305
              A+ LV ++L  D   RL  +++
Sbjct: 237 ---ARDLVEKLLVLDATKRLGCEEM 258

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 99
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 159
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 160 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 216
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 217 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 272
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 273 DATKRLGCEEMEGYGPLKAHPFFES 297

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 12/265 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + +   + LG G F    L  +  T    A K + KR +     +  V RE  +
Sbjct: 4   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 63
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           M  L  +   V L    +DD  ++  +   + GEL   I   G + E      T  IV  
Sbjct: 64  MSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 122
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYM 221
           ++  H  G+IHRDLKPEN L     E+  ++  DFG +    P     R +  VG+  Y+
Sbjct: 123 LEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 222 APEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           +PE+L +++     D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P  
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK- 238
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQV 305
              A+ LV ++L  D   RL  +++
Sbjct: 239 ---ARDLVEKLLVLDATKRLGCEEM 260

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 98
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 159 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 215
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 271
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 12/265 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + +   + LG G F    L  +  T    A K + KR +     +  V RE  +
Sbjct: 1   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 60
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           M  L  +   V L    +DD  ++  +   + GEL   I   G + E      T  IV  
Sbjct: 61  MSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 119
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYM 221
           ++  H  G+IHRDLKPEN L     E+  ++  DFG +    P     R +  VG+  Y+
Sbjct: 120 LEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 222 APEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           +PE+L +++     D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P  
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK- 235
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQV 305
              A+ LV ++L  D   RL  +++
Sbjct: 236 ---ARDLVEKLLVLDATKRLGCEEM 257

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 12/251 (4%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 98
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 159 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 215
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 271
Query: 295 DPKLRLTAKQV 305
           D   RL  +++
Sbjct: 272 DATKRLGCEEM 282

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 96
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 157 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 213
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 269
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 96
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 157 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSS 213
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 269
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 12/251 (4%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 99
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 159
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 160 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 216
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 217 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 272
Query: 295 DPKLRLTAKQV 305
           D   RL  +++
Sbjct: 273 DATKRLGCEEM 283

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 12/251 (4%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 80
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 81  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 140
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 141 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 197
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 198 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 253
Query: 295 DPKLRLTAKQV 305
           D   RL  +++
Sbjct: 254 DATKRLGCEEM 264

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 12/251 (4%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 98
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 159 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 215
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 271
Query: 295 DPKLRLTAKQV 305
           D   RL  +++
Sbjct: 272 DATKRLGCEEM 282

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 12/251 (4%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 95
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 155
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 156 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 212
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 213 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 268
Query: 295 DPKLRLTAKQV 305
           D   RL  +++
Sbjct: 269 DATKRLGCEEM 279

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 96
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 157 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 213
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 269
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 12/251 (4%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 95
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 155
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 156 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 212
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 213 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 268
Query: 295 DPKLRLTAKQV 305
           D   RL  +++
Sbjct: 269 DATKRLGCEEM 279

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 103
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 163
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 164 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 220
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 221 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 276
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 277 DATKRLGCEEMEGYGPLKAHPFFES 301

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 22/274 (8%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIM 105
           +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 106 KHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVE 163
           K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    ++E
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 164 VVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
            V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  Y  
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSP 177
Query: 223 PEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           PE ++  R +G    +WS G++LY ++CG  PF  + E      I+ G + F++     V
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ----RV 227
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           S   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 137/273 (50%), Gaps = 20/273 (7%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V + +GRG FG   L   + ++++ A K +SK ++    D      E  IM     + 
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 135
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  +   H  G
Sbjct: 136 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 194
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGSPYYMAPEVLKRN- 229
           +IHRD+KP+N L     ++  LK  DFG  +             VG+P Y++PEVLK   
Sbjct: 195 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVSES 283
               YG E D WS GV L+ +L G  PF+A+S  G    I+  +  + F  D    +S+ 
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPED--AEISKH 309
Query: 284 AKSLVRQMLEPDPKLRL---TAKQVLEHPWLQN 313
           AK+L+   L  D ++RL     +++ +HP+ +N
Sbjct: 310 AKNLICAFL-TDREVRLGRNGVEEIKQHPFFKN 341

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 131/292 (44%), Gaps = 38/292 (13%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y    ++G G +GV Y     +  E  A K I   K    +    +R E++I+K L K
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKEL-K 58
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
           +S+IV L +       + LV E  +    +L D  V  G      A +    ++  +  C
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL- 226
           H   V+HRDLKP+N L   + E   LK  DFGL+  F  P  +++  V + +Y AP+VL 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLM 173
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---- 281
             + Y   IDIWS G I   ++ G P F   SE      I R L       WPNV+    
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 282 ---------------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                                ES   L+ +ML+ DP  R+TAKQ LEH + +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 131/292 (44%), Gaps = 38/292 (13%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y    ++G G +GV Y     +  E  A K I   K    +    +R E++I+K L K
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKEL-K 58
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
           +S+IV L +       + LV E  +    +L D  V  G      A +    ++  +  C
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL- 226
           H   V+HRDLKP+N L   + E   LK  DFGL+  F  P  +++  V + +Y AP+VL 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLM 173
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---- 281
             + Y   IDIWS G I   ++ G P F   SE      I R L       WPNV+    
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 282 ---------------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                                ES   L+ +ML+ DP  R+TAKQ LEH + +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 101
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 102 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 161
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 162 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 218
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 219 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPK----ARDLVEKLLVL 274
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 275 DATKRLGCEEMEGYGPLKAHPFFES 299

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 131/292 (44%), Gaps = 38/292 (13%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y    ++G G +GV Y     +  E  A K I   K    +    +R E++I+K L K
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKEL-K 58
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
           +S+IV L +       + LV E  +    +L D  V  G      A +    ++  +  C
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL- 226
           H   V+HRDLKP+N L   + E   LK  DFGL+  F  P  +++  + + +Y AP+VL 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---- 281
             + Y   IDIWS G I   ++ G P F   SE      I R L       WPNV+    
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 282 ---------------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                                ES   L+ +ML+ DP  R+TAKQ LEH + +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 123/262 (46%), Gaps = 13/262 (4%)
Query: 45  PKENIEDRYLVDRE----LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           P  N++   L D      LG+G FG   L   + T EL A K + K  +    D++    
Sbjct: 9   PSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMV 68
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  ++  L K   +  L    +  + ++ VME   GG+L   I   G + E  A      
Sbjct: 69  EKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 128
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPY 219
           I   +   HK G+I+RDLK +N +  ++     +K  DFG+       G    E  G+P 
Sbjct: 129 ISIGLFFLHKRGIIYRDLKLDNVMLDSEGH---IKIADFGMCKEHMMDGVTTREFCGTPD 185
Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           Y+APE++    YG  +D W+ GV+LY +L G PPF  E E  + Q+I+   + + +    
Sbjct: 186 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK---- 241
Query: 279 NVSESAKSLVRQMLEPDPKLRL 300
           ++S+ A S+ + ++   P  RL
Sbjct: 242 SLSKEAVSICKGLMTKHPAKRL 263

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 133/309 (43%), Gaps = 34/309 (11%)
Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           ++  P     DRY    +LG G +G  Y  ID  T E +A K I        V    +R 
Sbjct: 24  VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR- 82
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           EV+++K L ++ +I+ LK     ++ +HL+ E  E  +L   +      + R   +    
Sbjct: 83  EVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF--ANKKENSPLKAIDFGLS-IFFKPGERFSEIVGS 217
           ++  V  CH    +HRDLKP+N L   ++  E   LK  DFGL+  F  P  +F+  + +
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIIT 200
Query: 218 PYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
            +Y  PE+L   R+Y   +DIWS   I   +L   P F  +SE      I   L      
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260
Query: 276 PWPNVSE-----------SAKSLVR---------------QMLEPDPKLRLTAKQVLEHP 309
            WP V+              K+L R                MLE DP  R++AK  LEHP
Sbjct: 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320
Query: 310 WLQNAKKAP 318
           +  +    P
Sbjct: 321 YFSHNDFDP 329

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 57  RELGRGEFGVTYLC---IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNS 112
           R LG+G +G  +        +T ++ A K + K  + R A D    + E  I++ + K+ 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHP 81
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            IV L  A +    ++L++E   GGELF ++   G + E  A      I   +   H+ G
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLKRN 229
           +I+RDLKPEN +  ++     +K  DFGL   SI    G       G+  YMAPE+L R+
Sbjct: 142 IIYRDLKPENIMLNHQGH---VKLTDFGLCKESI--HDGTVTHXFCGTIEYMAPEILMRS 196
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +   +D WS G ++Y +L G PPF  E+ +     IL+  ++      P +++ A+ L+
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARDLL 252
Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN 313
           +++L+ +   RL      A +V  HP+ ++
Sbjct: 253 KKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 57  RELGRGEFGVTYLC---IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNS 112
           R LG+G +G  +        +T ++ A K + K  + R A D    + E  I++ + K+ 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHP 81
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            IV L  A +    ++L++E   GGELF ++   G + E  A      I   +   H+ G
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLKRN 229
           +I+RDLKPEN +  ++     +K  DFGL   SI    G       G+  YMAPE+L R+
Sbjct: 142 IIYRDLKPENIMLNHQGH---VKLTDFGLCKESI--HDGTVTHTFCGTIEYMAPEILMRS 196
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +   +D WS G ++Y +L G PPF  E+ +     IL+  ++      P +++ A+ L+
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARDLL 252
Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN 313
           +++L+ +   RL      A +V  HP+ ++
Sbjct: 253 KKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 123/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 98
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 159 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSS 215
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  +   I++   DF    +P     A+ LV ++L  
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK----ARDLVEKLLVL 271
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 123/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 98
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + G L   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 159 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSS 215
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 271
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/224 (33%), Positives = 121/224 (54%), Gaps = 20/224 (8%)
Query: 101 EVAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVA----RGHYTERAA 154
           EV +++ L K+ +IV   +   D  +  +++VME CEGG+L   I      R +  E   
Sbjct: 55  EVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 155 AAVTRTIVEVVQLCHK-----HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
             V   +   ++ CH+     H V+HRDLKP N +F + K+N  +K  DFGL+       
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDT 170
Query: 210 RFSE-IVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR 267
            F++  VG+PYYM+PE + R +Y  + DIWS G +LY L   +PPF A S++ +A  I  
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           G   F+R P+   S+    ++ +ML      R + +++LE+P +
Sbjct: 231 G--KFRRIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/224 (33%), Positives = 121/224 (54%), Gaps = 20/224 (8%)
Query: 101 EVAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVA----RGHYTERAA 154
           EV +++ L K+ +IV   +   D  +  +++VME CEGG+L   I      R +  E   
Sbjct: 55  EVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 155 AAVTRTIVEVVQLCHK-----HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
             V   +   ++ CH+     H V+HRDLKP N +F + K+N  +K  DFGL+       
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDT 170
Query: 210 RFSE-IVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR 267
            F++  VG+PYYM+PE + R +Y  + DIWS G +LY L   +PPF A S++ +A  I  
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           G   F+R P+   S+    ++ +ML      R + +++LE+P +
Sbjct: 231 G--KFRRIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 123/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 98
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 159 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 215
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  +   I++   DF    +P     A+ LV ++L  
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK----ARDLVEKLLVL 271
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 137/291 (47%), Gaps = 36/291 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK--HL 108
           D Y +   +G G   V         +E +A K I+  K +T+  +D++ +E+  M   H 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHH 72
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFD---RIVARGHYT-----ERAAAAVTRT 160
           P   +IVS   +    + + LVM+L  GG + D    IVA+G +      E   A + R 
Sbjct: 73  P---NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS------EI 214
           ++E ++  HK+G IHRD+K  N L     E+  ++  DFG+S F   G   +        
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 215 VGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR----- 267
           VG+P +MAPEV++  R Y  + DIWS G+    L  G  P+       V    L+     
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 268 ---GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
              G+ D  ++      +S + ++   L+ DP+ R TA ++L H + Q AK
Sbjct: 247 LETGVQD--KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 136/289 (47%), Gaps = 32/289 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D Y +   +G G   V         +E +A K I+  K +T+  +D++ +E+  M     
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQC-H 66
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFD---RIVARGHYT-----ERAAAAVTRTIV 162
           + +IVS   +    + + LVM+L  GG + D    IVA+G +      E   A + R ++
Sbjct: 67  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS------EIVG 216
           E ++  HK+G IHRD+K  N L     E+  ++  DFG+S F   G   +        VG
Sbjct: 127 EGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 217 SPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------- 267
           +P +MAPEV++  R Y  + DIWS G+    L  G  P+       V    L+       
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 243
Query: 268 -GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
            G+ D  ++      +S + ++   L+ DP+ R TA ++L H + Q AK
Sbjct: 244 TGVQD--KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 290

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 100/378 (26%), Positives = 161/378 (42%), Gaps = 93/378 (24%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           +Y + ++LG+G +G+ +  IDR T E++A K I     + + D     RE+ I+  L  +
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-AFQNSTDAQRTFREIMILTELSGH 68
Query: 112 SSIVSLKEACEDDNA--VHLVMELCEGGELFDRIVARGHYTERA-AAAVTRTIVEVVQLC 168
            +IV+L      DN   V+LV +  E        V R +  E      V   +++V++  
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMETDL---HAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---------------KPGERF-- 211
           H  G++HRD+KP N L         +K  DFGLS  F               +  E F  
Sbjct: 126 HSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 212 -----SEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
                ++ V + +Y APE+L     Y   ID+WS G IL  +LCG P F   S     + 
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 265 ILRGLIDF-------------------------------KRD---PWPNV---------- 280
           I+ G+IDF                               KRD    W N+          
Sbjct: 243 II-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPW---LQNAKKAPN------VPLGDVVRSRLK 331
           +E A  L+ ++L+ +P  R++A   L+HP+     N  + PN      +P+ D V+  + 
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSID 361
Query: 332 Q-----FSMMNRFKRKAL 344
                 +S ++R KR+ +
Sbjct: 362 DYRNLVYSEISRRKRELI 379

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G  G  Y  I      
Sbjct: 19  SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGSGSVYSGIRVSDNL 77
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 78  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 137
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 138 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 196
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 197 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+RG + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 254 DIPFEHDEE------IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 303
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 304 WMQDV 308

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 143/274 (52%), Gaps = 30/274 (10%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y+  +++G G FG   L    +       K I+  ++ ++ + ++ RREVA++ ++ K
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-K 81
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC- 168
           + +IV  +E+ E++ ++++VM+ CEGG+LF RI A     ++        I++  VQ+C 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA-----QKGVLFQEDQILDWFVQICL 136
Query: 169 -----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMA 222
                H   ++HRD+K +N       ++  ++  DFG++ +     E     +G+PYY++
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 223 PEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV- 280
           PE+ + + Y  + DIW+ G +LY L      F A S + +   I+ G        +P V 
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-------SFPPVS 246
Query: 281 ---SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              S   +SLV Q+ + +P+ R +   +LE  ++
Sbjct: 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 116/247 (46%), Gaps = 9/247 (3%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG   L   +      A K + K+ +    +   +  E  ++    K+  +V L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +  + ++ V++   GGELF  +     + E  A      I   +   H   +++RDL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165
Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           KPEN L  ++     +   DFGL     +     S   G+P Y+APEVL K+ Y   +D 
Sbjct: 166 KPENILLDSQGH---IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  G +LY +L G+PPF++ +   +   IL   +  K    PN++ SA+ L+  +L+ D 
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 278
Query: 297 KLRLTAK 303
             RL AK
Sbjct: 279 TKRLGAK 285

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 122/253 (48%), Gaps = 22/253 (8%)
Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKN 111
           LG+G FG  +L       D R+L A K + K  L+     D VR    R++ +  + P  
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---DRVRTKMERDILVEVNHP-- 86
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             IV L  A + +  ++L+++   GG+LF R+     +TE         +   +   H  
Sbjct: 87  -FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS-EIVGSPYYMAPEVL-KRN 229
           G+I+RDLKPEN L     E   +K  DFGLS      E+ +    G+  YMAPEV+ +R 
Sbjct: 146 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           +    D WS GV+++ +L G  PF  +  +     IL+  +   +     +S  A+SL+R
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLR 258
Query: 290 QMLEPDPKLRLTA 302
            + + +P  RL A
Sbjct: 259 MLFKRNPANRLGA 271

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 68
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 69  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 127 HRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 122/253 (48%), Gaps = 22/253 (8%)
Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKN 111
           LG+G FG  +L       D R+L A K + K  L+     D VR    R++ +  + P  
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---DRVRTKMERDILVEVNHP-- 86
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             IV L  A + +  ++L+++   GG+LF R+     +TE         +   +   H  
Sbjct: 87  -FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS-EIVGSPYYMAPEVL-KRN 229
           G+I+RDLKPEN L     E   +K  DFGLS      E+ +    G+  YMAPEV+ +R 
Sbjct: 146 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           +    D WS GV+++ +L G  PF  +  +     IL+  +   +     +S  A+SL+R
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLR 258
Query: 290 QMLEPDPKLRLTA 302
            + + +P  RL A
Sbjct: 259 MLFKRNPANRLGA 271

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 70  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 128 HRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 74
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 75  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 132
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 133 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 189
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 249
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 250 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 299

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 128/269 (47%), Gaps = 22/269 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G +G+ Y   D   +  +A K I +R  R +     +  E+A+ KHL K+ +IV   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHL-KHKNIVQYL 85
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHY-----TERAAAAVTRTIVEVVQLCHKHGV 173
            +  ++  + + ME   GG L    + R  +      E+     T+ I+E ++  H + +
Sbjct: 86  GSFSENGFIKIFMEQVPGGSL--SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEVLK---RN 229
           +HRD+K +N L      +  LK  DFG S         +E   G+  YMAPE++    R 
Sbjct: 144 VHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAKSL 287
           YG   DIWS G  +  +  G PPF+   E G  QA +  +  FK  P    ++S  AK+ 
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFY---ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           + +  EPDP  R  A  +L   +L+ + K
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFLKVSSK 287

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 122/253 (48%), Gaps = 22/253 (8%)
Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKN 111
           LG+G FG  +L       D R+L A K + K  L+     D VR    R++ +  + P  
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---DRVRTKMERDILVEVNHP-- 87
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             IV L  A + +  ++L+++   GG+LF R+     +TE         +   +   H  
Sbjct: 88  -FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 146
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS-EIVGSPYYMAPEVL-KRN 229
           G+I+RDLKPEN L     E   +K  DFGLS      E+ +    G+  YMAPEV+ +R 
Sbjct: 147 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 203
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           +    D WS GV+++ +L G  PF  +  +     IL+  +   +     +S  A+SL+R
Sbjct: 204 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLR 259
Query: 290 QMLEPDPKLRLTA 302
            + + +P  RL A
Sbjct: 260 MLFKRNPANRLGA 272

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 24/275 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   + T  + A K + K  +    DID V+ E  + +    +  +V 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+R
Sbjct: 71  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 130
Query: 177 DLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L  ++     +K  D+G+     +PG+  S   G+P Y+APE+L+  +YG  +
Sbjct: 131 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 187
Query: 235 DIWSAGVILYILLCGVPPF---------WAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           D W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A 
Sbjct: 188 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 243
Query: 286 SLVRQMLEPDPKLRLTAK------QVLEHPWLQNA 314
           S+++  L  DPK RL          +  HP+ +N 
Sbjct: 244 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 278

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 68
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 69  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 127 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 183
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 24/275 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   + T  + A K + K  +    DID V+ E  + +    +  +V 
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+R
Sbjct: 86  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 145
Query: 177 DLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L  ++     +K  D+G+     +PG+  S   G+P Y+APE+L+  +YG  +
Sbjct: 146 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 202
Query: 235 DIWSAGVILYILLCGVPPF---------WAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           D W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A 
Sbjct: 203 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SMSVKAA 258
Query: 286 SLVRQMLEPDPKLRLTA------KQVLEHPWLQNA 314
           S+++  L  DPK RL          +  HP+ +N 
Sbjct: 259 SVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNV 293

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 130/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +L D + A    T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKDFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 71
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 72  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 129
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 130 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 186
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 246
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 247 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 296

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 24/275 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   + T  + A K + K  +    DID V+ E  + +    +  +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+R
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 177 DLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L  ++     +K  D+G+     +PG+  S   G+P Y+APE+L+  +YG  +
Sbjct: 135 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 191
Query: 235 DIWSAGVILYILLCGVPPF---------WAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           D W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A 
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 247
Query: 286 SLVRQMLEPDPKLRLTAK------QVLEHPWLQNA 314
           S+++  L  DPK RL          +  HP+ +N 
Sbjct: 248 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 66
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 67  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 125 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 127/290 (43%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E         + +     T      +   + +++Q    CH H V+
Sbjct: 71  LDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 129 HRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 66
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 67  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 125 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 74
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 75  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 132
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 133 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 189
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 249
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 250 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 299

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 127/290 (43%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 68
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E         + +     T      +   + +++Q    CH H V+
Sbjct: 69  LDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 127 HRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 131/271 (48%), Gaps = 16/271 (5%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D + + R +G+G FG   +    DT+++ A K ++K+K     ++ +V +E+ IM+ L +
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-E 73
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  +V+L  + +D+  + +V++L  GG+L   +    H+ E         +V  +     
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-- 228
             +IHRD+KP+N L     E+  +   DF ++       + + + G+  YMAPE+     
Sbjct: 134 QRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 229 --NYGPEIDIWSAGVILYILLCGVPPFW---AESEQGVAQAILRGLIDFKRDPWPNVSES 283
              Y   +D WS GV  Y LL G  P+    + S + +       ++ +    W   S+ 
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP-SAW---SQE 246
Query: 284 AKSLVRQMLEPDPKLRLTA-KQVLEHPWLQN 313
             SL++++LEP+P  R +    V   P++ +
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 70  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 128 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 132/300 (44%), Gaps = 60/300 (20%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR-REVAIMKHLPKNSSIVS 116
           +LG G +   Y  +++ T   +A K +   KL +         RE+++MK L K+ +IV 
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKEL-KHENIVR 67
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR------------TIVEV 164
           L +    +N + LV E  +          + +   R      R             +++ 
Sbjct: 68  LYDVIHTENKLTLVFEFMDND-------LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAP 223
           +  CH++ ++HRDLKP+N L   + +   LK  DFGL+  F  P   FS  V + +Y AP
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177
Query: 224 EVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           +VL   R Y   IDIWS G IL  ++ G P F   +++   + I   +       WP+V+
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237
Query: 282 ESAKSL----------VRQMLEP--------------------DPKLRLTAKQVLEHPWL 311
           +  K            +RQ+L+P                    +P +RL+AKQ L HPW 
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 68
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 69  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 127 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 71  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 129 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 71  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 129 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 70  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 128 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 68
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 69  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 127 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 126/265 (47%), Gaps = 22/265 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G +G+ Y   D   +  +A K I +R  R +     +  E+A+ KHL K+ +IV   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHL-KHKNIVQYL 71
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHY-----TERAAAAVTRTIVEVVQLCHKHGV 173
            +  ++  + + ME   GG L    + R  +      E+     T+ I+E ++  H + +
Sbjct: 72  GSFSENGFIKIFMEQVPGGSL--SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEVLK---RN 229
           +HRD+K +N L      +  LK  DFG S         +E   G+  YMAPE++    R 
Sbjct: 130 VHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 187
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAKSL 287
           YG   DIWS G  +  +  G PPF+   E G  QA +  +  FK  P    ++S  AK+ 
Sbjct: 188 YGKAADIWSLGCTIIEMATGKPPFY---ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 244
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQ 312
           + +  EPDP  R  A  +L   +L+
Sbjct: 245 ILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 71
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 72  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 129
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 130 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 246
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 247 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 296

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 24/275 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   + T  + A + + K  +    DID V+ E  + +    +  +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 177 DLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L  ++     +K  D+G+     +PG+  S   G+P Y+APE+L+  +YG  +
Sbjct: 178 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 234
Query: 235 DIWSAGVILYILLCGVPPF---------WAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           D W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A 
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 290
Query: 286 SLVRQMLEPDPKLRLTAK------QVLEHPWLQNA 314
           S+++  L  DPK RL          +  HP+ +N 
Sbjct: 291 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 66
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 67  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 125 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 66
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 67  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 125 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 130/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +L D + A    T      +   + +++Q    CH H V+
Sbjct: 71  LDVIHTENKLYLVFEFL-SMDLKDFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 129 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 130/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +L D + A    T      +   + +++Q    CH H V+
Sbjct: 70  LDVIHTENKLYLVFEFL-SMDLKDFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 128 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 130/286 (45%), Gaps = 24/286 (8%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRREV 102
           +E  E  Y +   LG+G FG  +       R  +A K I + ++     + D      EV
Sbjct: 26  REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 103 AIMKHLPKNSS---IVSLKEACEDDNAVHLVME-LCEGGELFDRIVARGHYTERAAAAVT 158
           A++  +        ++ L +  E      LV+E      +LFD I  +G   E  +    
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSP 218
             +V  +Q CH  GV+HRD+K EN L   ++  +  K IDFG        E +++  G+ 
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSGALLH-DEPYTDFDGTR 202
Query: 219 YYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP 276
            Y  PE + R+  +     +WS G++LY ++CG  PF  + E      IL   + F    
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPA-- 254
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             +VS    +L+R+ L P P  R + +++L  PW+Q    A +VPL
Sbjct: 255 --HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT--PAEDVPL 296

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E  +  +   + +     T      +   + +++Q    CH H V+
Sbjct: 71  LDVIHTENKLYLVFEHVD--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 129 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 127/290 (43%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +     +     T      +   + +++Q    CH H V+
Sbjct: 71  LDVIHTENKLYLVFEFLH--QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 129 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A   I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A   I        V    +R E++++K L  + +IV L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 66
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 67  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 125 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 129/288 (44%), Gaps = 34/288 (11%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 66
Query: 118 KEACEDDNAVHLVME-LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
            +    +N ++LV E + +  + F    A          +    +++ +  CH H V+HR
Sbjct: 67  LDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 177 DLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYGPE 233
           DLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y   
Sbjct: 127 DLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS------------ 281
           +DIWS G I   ++     F  +SE      I R L       WP V+            
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 282 -------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                        E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 38/287 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                          E  +SL+ QML  DP  R++AK  L HP+ Q+
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 121/258 (46%), Gaps = 15/258 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I +RY +  +LG G     YL  D      +A K+I          +    REV     L
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
             + +IVS+ +  E+D+  +LVME  EG  L + I + G  +   A   T  I++ ++  
Sbjct: 69  -SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVL 226
           H   ++HRD+KP+N L  +   N  LK  DFG++         + + ++G+  Y +PE  
Sbjct: 128 HDMRIVHRDIKPQNILIDS---NKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 227 KRNYGPE-IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           K     E  DI+S G++LY +L G PPF  E+   +A       I   +D  PNV+   +
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-------IKHIQDSVPNVTTDVR 237
Query: 286 SLVRQMLEPDPKLRLTAK 303
             + Q L  +  LR T K
Sbjct: 238 KDIPQSL-SNVILRATEK 254

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 20/268 (7%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R LG+G FG    C  R T ++ ACK + K++++          E  I++ +  +  +VS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 248
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC------HK 170
           L  A E  +A+ LV+ L  GG+L   I   G    +A     R +    ++C      H+
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMG----QAGFPEARAVFYAAEICCGLEDLHR 304
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
             +++RDLKPEN L     ++  ++  D GL++    G+     VG+  YMAPEV+K   
Sbjct: 305 ERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y    D W+ G +LY ++ G  PF    ++   + + R + +   +     S  A+SL  
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 290 QMLEPDPKLRL-----TAKQVLEHPWLQ 312
           Q+L  DP  RL     +A++V EHP  +
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPLFK 449

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 140/291 (48%), Gaps = 30/291 (10%)
Query: 34  KKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV 93
           ++QP+T       +N   +Y   R LG+G FG    C  R T ++ ACK + K++++   
Sbjct: 177 ERQPVT-------KNTFRQY---RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 226
Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA 153
                  E  I++ +  +  +VSL  A E  +A+ LV+ L  GG+L   I   G    +A
Sbjct: 227 GEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG----QA 281
Query: 154 AAAVTRTIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
                R +    ++C      H+  +++RDLKPEN L     ++  ++  D GL++    
Sbjct: 282 GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPE 338
Query: 208 GERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
           G+     VG+  YMAPEV+K   Y    D W+ G +LY ++ G  PF    ++   + + 
Sbjct: 339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQ 312
           R + +   +     S  A+SL  Q+L  DP  RL     +A++V EHP  +
Sbjct: 399 RLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 127/284 (44%), Gaps = 35/284 (12%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G G +G+   C ++DT  ++A K   +      V      RE+ ++K L ++ ++V+L 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQL-RHENLVNLL 90
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
           E C+     +LV E  +   L D  +       +        I+  +  CH H +IHRD+
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150
Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN--YGPEID 235
           KPEN L +   ++  +K  DFG +     PGE + + V + +Y APE+L  +  YG  +D
Sbjct: 151 KPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVD 207
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID--------FKRDP----------- 276
           +W+ G ++  +  G P F  +S+      I+  L +        F ++P           
Sbjct: 208 VWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIK 267
Query: 277 --------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                   +P +SE    L ++ L  DP  R    ++L H + Q
Sbjct: 268 EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           E+ + V  +LG G +G  Y  I ++T +++A K +         D+ ++ +E++IM+   
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-----VESDLQEIIKEISIMQQC- 81
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLC 168
            +  +V    +   +  + +VME C  G + D I  R    TE   A + ++ ++ ++  
Sbjct: 82  DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK 227
           H    IHRD+K  N L   +      K  DFG++        + + ++G+P++MAPEV++
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHA---KLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQ 198
Query: 228 R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV------ 280
              Y    DIWS G+    +  G PP+            +R +     +P P        
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPY-------ADIHPMRAIFMIPTNPPPTFRKPELW 251
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           S++    V+Q L   P+ R TA Q+L+HP++++AK
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 145/309 (46%), Gaps = 21/309 (6%)
Query: 29  EAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK 88
           E   NK++P   +    K  IED + + + LG+G FG  +L   + T +  A K++ K  
Sbjct: 1   EPELNKERPSLQI----KLKIED-FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV 55
Query: 89  LRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH 148
           +    D++    E  ++    ++  +  +    +    +  VME   GG+L   I +   
Sbjct: 56  VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK 115
Query: 149 YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
           +    A      I+  +Q  H  G+++RDLK +N L     ++  +K  DFG+      G
Sbjct: 116 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLG 172
Query: 209 E-RFSEIVGSPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
           + + +E  G+P Y+APE+L  + Y   +D WS GV+LY +L G  PF  + E+ +  +I 
Sbjct: 173 DAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 232
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAK-QVLEHP------WLQNAKKAPN 319
                + R  W  + + AK L+ ++   +P+ RL  +  + +HP      W +  +K  +
Sbjct: 233 MDNPFYPR--W--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEID 288
Query: 320 VPLGDVVRS 328
            P    V+S
Sbjct: 289 PPFRPKVKS 297

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 50/293 (17%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD------VRREVAIMKHLPKN 111
           ++G G +G  +   +R+T E++A K       R  +D DD        RE+ ++K L K+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALK-------RVRLDDDDEGVPSSALREICLLKEL-KH 60
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            +IV L +    D  + LV E C+    + FD     G        +    +++ +  CH
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL-- 226
              V+HRDLKP+N L      N  LK  DFGL+  F  P   +S  V + +Y  P+VL  
Sbjct: 119 SRNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGLIDFKRDPWPNVSE--- 282
            + Y   ID+WSAG I   L     P +  ++     + I R L     + WP++++   
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 283 ----------------------SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                                 + + L++ +L+ +P  R++A++ L+HP+  +
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 89/337 (26%), Positives = 142/337 (42%), Gaps = 64/337 (18%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK-----LRTAVDIDDVRREV 102
           NI   + +   LG G +GV      + T E++A K I         LRT        RE+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------REI 60
Query: 103 AIMKHLPKNSSIVSL-----KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
            I+KH  K+ +I+++      ++ E+ N V+++ EL +      R+++    ++      
Sbjct: 61  KILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYF 117
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK---------PG 208
               +  V++ H   VIHRDLKP N L      N  LK  DFGL+              G
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 209 ER--FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES------- 257
           ++   +E V + +Y APEV+     Y   +D+WS G IL  L    P F           
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 258 -----------------EQGVAQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDP 296
                            E   A+  ++ L  +   P    +P V+     L+++ML  DP
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQF 333
             R+TAK+ LEHP+LQ      + P G+ +     +F
Sbjct: 295 AKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF 331

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 120/244 (49%), Gaps = 14/244 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   +   ++  ++ A K ++K ++    +    R E  ++ +   +  I +L 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITTLH 140
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
            A +DDN ++LVM+   GG+L   +        E  A      +V  +   H+   +HRD
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200
Query: 178 LKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFSEIVGSPYYMAPEVL------KRN 229
           +KP+N L      N  ++  DFG  L +      + S  VG+P Y++PE+L      K  
Sbjct: 201 IKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW-PNVSESAKSLV 288
           YGPE D WS GV +Y +L G  PF+AES       I+     F+      +VSE+AK L+
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLI 317
Query: 289 RQML 292
           R+++
Sbjct: 318 RRLI 321

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 50/293 (17%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD------VRREVAIMKHLPKN 111
           ++G G +G  +   +R+T E++A K       R  +D DD        RE+ ++K L K+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALK-------RVRLDDDDEGVPSSALREICLLKEL-KH 60
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            +IV L +    D  + LV E C+    + FD     G        +    +++ +  CH
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL-- 226
              V+HRDLKP+N L      N  LK  +FGL+  F  P   +S  V + +Y  P+VL  
Sbjct: 119 SRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 227 KRNYGPEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE--- 282
            + Y   ID+WSAG I   L   G P F         + I R L     + WP++++   
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 283 ----------------------SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                                 + + L++ +L+ +P  R++A++ L+HP+  +
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 89/337 (26%), Positives = 142/337 (42%), Gaps = 64/337 (18%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK-----LRTAVDIDDVRREV 102
           NI   + +   LG G +GV      + T E++A K I         LRT        RE+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------REI 60
Query: 103 AIMKHLPKNSSIVSL-----KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
            I+KH  K+ +I+++      ++ E+ N V+++ EL +      R+++    ++      
Sbjct: 61  KILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYF 117
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK---------PG 208
               +  V++ H   VIHRDLKP N L      N  LK  DFGL+              G
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 209 ER--FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES------- 257
           ++   +E V + +Y APEV+     Y   +D+WS G IL  L    P F           
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 258 -----------------EQGVAQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDP 296
                            E   A+  ++ L  +   P    +P V+     L+++ML  DP
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQF 333
             R+TAK+ LEHP+LQ      + P G+ +     +F
Sbjct: 295 AKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF 331

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 138/292 (47%), Gaps = 17/292 (5%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K  IED +++ + LG+G FG  +L   + T +  A K++ K  +    D++    E  ++
Sbjct: 13  KLKIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
               ++  +  +    +    +  VME   GG+L   I +   +    A      I+  +
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPE 224
           Q  H  G+++RDLK +N L     ++  +K  DFG+      G+ + +   G+P Y+APE
Sbjct: 132 QFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPE 188
Query: 225 VL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES 283
           +L  + Y   +D WS GV+LY +L G  PF  + E+ +  +I      + R  W  + + 
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W--LEKE 244
Query: 284 AKSLVRQMLEPDPKLRLTAK-QVLEHP------WLQNAKKAPNVPLGDVVRS 328
           AK L+ ++   +P+ RL  +  + +HP      W +  +K  + P    V+S
Sbjct: 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKS 296

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 90/337 (26%), Positives = 142/337 (42%), Gaps = 64/337 (18%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK-----LRTAVDIDDVRREV 102
           NI   + +   LG G +GV      + T E++A K I         LRT        RE+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------REI 60
Query: 103 AIMKHLPKNSSIVSL-----KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
            I+KH  K+ +I+++      ++ E+ N V+++ EL +      R+++    ++      
Sbjct: 61  KILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYF 117
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF--------KPGE 209
               +  V++ H   VIHRDLKP N L      N  LK  DFGL+           +P  
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 210 RFS---EIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES------- 257
           + S   E V + +Y APEV+     Y   +D+WS G IL  L    P F           
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 258 -----------------EQGVAQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDP 296
                            E   A+  ++ L  +   P    +P V+     L+++ML  DP
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQF 333
             R+TAK+ LEHP+LQ      + P G+ +     +F
Sbjct: 295 AKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF 331

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 134/282 (47%), Gaps = 21/282 (7%)
Query: 28  KEAGANKKQPIT--VLAGVPKENIEDRYLVDRELGRGEFGVTYLC--IDR-DTRELLACK 82
           K+ G  K+  IT  V AG  K +     L+ + LG+G FG  +L   + R D+  L A K
Sbjct: 4   KDEGVLKEISITHHVKAGSEKADPSHFELL-KVLGQGSFGKVFLVRKVTRPDSGHLYAMK 62
Query: 83  SISKR--KLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF 140
            + K   K+R  V     R  +A + H      +V L  A + +  ++L+++   GG+LF
Sbjct: 63  VLKKATLKVRDRVRTKMERDILADVNH----PFVVKLHYAFQTEGKLYLILDFLRGGDLF 118
Query: 141 DRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG 200
            R+     +TE         +   +   H  G+I+RDLKPEN L     E   +K  DFG
Sbjct: 119 TRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFG 175
Query: 201 LSIFFKPGERFS-EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE 258
           LS      E+ +    G+  YMAPEV+ R  +    D WS GV+++ +L G  PF  +  
Sbjct: 176 LSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDR 235
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           +     IL+  +   +     +S  A+SL+R + + +P  RL
Sbjct: 236 KETMTLILKAKLGMPQ----FLSTEAQSLLRALFKRNPANRL 273

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 22/282 (7%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N ED + +  ELG G FG  Y   +++T  L A K I  +   +  +++D   E+ I+  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 90
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVV 165
              + +IV L +A   +N + +++E C GG + D ++       TE     V +  ++ +
Sbjct: 91  C-DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDAL 148
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPE 224
              H + +IHRDLK  N LF     +  +K  DFG+S    +  +R    +G+PY+MAPE
Sbjct: 149 NYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 205
Query: 225 VL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP-- 276
           V+       R Y  + D+WS G+ L  +    PP    +   V   I +        P  
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 265
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
           W   S + K  +++ LE +   R T  Q+L+HP++      P
Sbjct: 266 W---SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 304

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 22/282 (7%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N ED + +  ELG G FG  Y   +++T  L A K I  +   +  +++D   E+ I+  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 90
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVV 165
              + +IV L +A   +N + +++E C GG + D ++       TE     V +  ++ +
Sbjct: 91  C-DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDAL 148
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPE 224
              H + +IHRDLK  N LF     +  +K  DFG+S    +  +R    +G+PY+MAPE
Sbjct: 149 NYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPE 205
Query: 225 VL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP-- 276
           V+       R Y  + D+WS G+ L  +    PP    +   V   I +        P  
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 265
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
           W   S + K  +++ LE +   R T  Q+L+HP++      P
Sbjct: 266 W---SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 304

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 34/275 (12%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL- 117
           +G G +G  Y      T +L A K +      T  + +++++E+ ++K    + +I +  
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDV----TGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 118 -----KEACEDDNAVHLVMELCEGGELFDRIVARGHYT--ERAAAAVTRTIVEVVQLCHK 170
                K     D+ + LVME C  G + D I      T  E   A + R I+  +   H+
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 147
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVLKRN 229
           H VIHRD+K +N L     EN+ +K +DFG+S    +   R +  +G+PY+MAPEV+  +
Sbjct: 148 HKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 230 YGPEI------DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV--- 280
             P+       D+WS G+    +  G PP             +R L    R+P P +   
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPL-------CDMHPMRALFLIPRNPAPRLKSK 257
Query: 281 --SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
             S+  +S +   L  +   R   +Q+++HP++++
Sbjct: 258 KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 22/282 (7%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N ED + +  ELG G FG  Y   +++T  L A K I  +   +  +++D   E+ I+  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 90
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVV 165
              + +IV L +A   +N + +++E C GG + D ++       TE     V +  ++ +
Sbjct: 91  C-DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDAL 148
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPE 224
              H + +IHRDLK  N LF     +  +K  DFG+S    +  +R    +G+PY+MAPE
Sbjct: 149 NYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPE 205
Query: 225 VL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP-- 276
           V+       R Y  + D+WS G+ L  +    PP    +   V   I +        P  
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 265
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
           W   S + K  +++ LE +   R T  Q+L+HP++      P
Sbjct: 266 W---SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 304

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 123/261 (47%), Gaps = 16/261 (6%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N    + +++++GRG+F   Y          +A K +    L  A    D  +E+ ++K 
Sbjct: 29  NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQ 166
           L  + +++    +  +DN +++V+EL + G+L  R++   H+ ++      RT+ +  VQ
Sbjct: 89  L-NHPNVIKYYASFIEDNELNIVLELADAGDL-SRMIK--HFKKQKRLIPERTVWKYFVQ 144
Query: 167 LC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPY 219
           LC      H   V+HRD+KP N           +K  D GL  FF      +  +VG+PY
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 201
Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           YM+PE +  N Y  + DIWS G +LY +     PF+ +     +        D+   P  
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 261
Query: 279 NVSESAKSLVRQMLEPDPKLR 299
           + SE  + LV   + PDP+ R
Sbjct: 262 HYSEELRQLVNMCINPDPEKR 282

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 16/278 (5%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           RE+G G FG  Y   D    E++A K +S    ++     D+ +EV  ++ L ++ + + 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 118
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
            +     ++   LVME C G       V +    E   AAVT   ++ +   H H +IHR
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL----KRNYGP 232
           D+K  N L +   E   +K  DFG +    P   F   VG+PY+MAPEV+    +  Y  
Sbjct: 179 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 232
Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-FKRDPWPNVSESAKSLVRQM 291
           ++D+WS G+    L    PP +  +       I +      +   W   SE  ++ V   
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 289
Query: 292 LEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR 329
           L+  P+ R T++ +L+H ++   ++ P V +  + R++
Sbjct: 290 LQKIPQDRPTSEVLLKHRFVLR-ERPPTVIMDLIQRTK 326

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 16/278 (5%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           RE+G G FG  Y   D    E++A K +S    ++     D+ +EV  ++ L ++ + + 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 79
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
            +     ++   LVME C G       V +    E   AAVT   ++ +   H H +IHR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL----KRNYGP 232
           D+K  N L +   E   +K  DFG +    P   F   VG+PY+MAPEV+    +  Y  
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193
Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPWPNVSESAKSLVRQM 291
           ++D+WS G+    L    PP +  +       I +      +   W   SE  ++ V   
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250
Query: 292 LEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR 329
           L+  P+ R T++ +L+H ++   ++ P V +  + R++
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLR-ERPPTVIMDLIQRTK 287

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 141/288 (48%), Gaps = 22/288 (7%)
Query: 40  VLAGVP-----KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD 94
           V +G+P     K + E+ +    ++G+G FG  +  ID  T++++A K I   +    ++
Sbjct: 6   VQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE 65
Query: 95  IDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
              +++E+ ++     +  +     +   D  + ++ME   GG   D ++  G   E   
Sbjct: 66  D--IQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQI 121
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSE 213
           A + R I++ +   H    IHRD+K  N L +   E+  +K  DFG++      + + + 
Sbjct: 122 ATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNX 178
Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF 272
            VG+P++MAPEV+K++ Y  + DIWS G+    L  G PP    SE    + +   LI  
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP---HSELHPMKVLF--LIPK 233
Query: 273 KRDPW--PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW-LQNAKKA 317
              P    N S+  K  V   L  +P  R TAK++L+H + L+NAKK 
Sbjct: 234 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 94/346 (27%), Positives = 142/346 (41%), Gaps = 77/346 (22%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI--SKRKLRTAVDIDDVRRE 101
           VP +++  RY V + +G+G FG      D    + +A K +   KR  R A +      E
Sbjct: 90  VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE------E 143
Query: 102 VAIMKHLPKNS-----SIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAA 154
           + I++HL K       +++ + E     N + +  EL      EL  +   +G ++    
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLV 202
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
                +I++ +   HK+ +IH DLKPEN L   ++  S +K IDFG S +    +R    
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSSCY--EHQRVYTX 259
Query: 215 VGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVP--PFWAESEQGVAQAILRGLID 271
           + S +Y APEV L   YG  ID+WS G IL  LL G P  P   E +Q      L G+  
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319
Query: 272 FK-------------------------------------------RDP-----WPNVSES 283
            K                                           R P     W N  + 
Sbjct: 320 QKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 284 AKS-----LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD 324
                    ++Q LE DP +R+T  Q L HPWL+  ++ P  P G+
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR--RRLPKPPTGE 423

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 115
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 175 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 286
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 115/246 (46%), Gaps = 13/246 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T EL A K + K  +    D++    E  ++    K   +  L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + ++ VME   GG+L   I   G + E  A      I   +      G+I+RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 179 KPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEI 234
           K +N +  ++     +K  DFG+   +I+   G       G+P Y+APE++    YG  +
Sbjct: 148 KLDNVMLDSEGH---IKIADFGMCKENIW--DGVTTKXFCGTPDYIAPEIIAYQPYGKSV 202
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D W+ GV+LY +L G  PF  E E  + Q+I+   + + +    ++S+ A ++ + ++  
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTK 258
Query: 295 DPKLRL 300
            P  RL
Sbjct: 259 HPGKRL 264

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 13/246 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T EL A K + K  +    D++    E  ++    K   +  L 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + ++ VME   GG+L   I   G + E  A      I   +      G+I+RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 179 KPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           K +N +  ++     +K  DFG+   +I+   G       G+P Y+APE++  + YG  +
Sbjct: 469 KLDNVMLDSEGH---IKIADFGMCKENIW--DGVTTKXFCGTPDYIAPEIIAYQPYGKSV 523
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D W+ GV+LY +L G  PF  E E  + Q+I+   + + +    ++S+ A ++ + ++  
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTK 579
Query: 295 DPKLRL 300
            P  RL
Sbjct: 580 HPGKRL 585

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 115
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 175 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 286
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 68
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 69  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 128 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 239
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 115
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 175 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 286
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 140/305 (45%), Gaps = 49/305 (16%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y + R+LGRG++   +  I+    E +  K +        V  + ++RE+ I+++L 
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK------PVKKNKIKREIKILENLR 89
Query: 110 KNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +I++L +  +D       LV E     + F ++      T+         I++ +  
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF------K 273
             + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+      +
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 274 RDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            DP  N                      VS  A   + ++L  D + RLTA++ +EHP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 312 QNAKK 316
               K
Sbjct: 325 YTVVK 329

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 129/258 (50%), Gaps = 12/258 (4%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           ED +L  R LGRG FG  + C  + T +L ACK ++K++L+          E  I+  + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV- 242
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIVEVV 165
            +  IVSL  A E    + LVM +  GG++   I         + E  A   T  IV  +
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPE 224
           +  H+  +I+RDLKPEN L     ++  ++  D GL++  K G+  ++   G+P +MAPE
Sbjct: 303 EHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359
Query: 225 -VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSE 282
            +L   Y   +D ++ GV LY ++    PF A  E+ V    L+  +  +   +P+  S 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSP 418
Query: 283 SAKSLVRQMLEPDPKLRL 300
           ++K     +L+ DP+ RL
Sbjct: 419 ASKDFCEALLQKDPEKRL 436

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 129/258 (50%), Gaps = 12/258 (4%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           ED +L  R LGRG FG  + C  + T +L ACK ++K++L+          E  I+  + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV- 242
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIVEVV 165
            +  IVSL  A E    + LVM +  GG++   I         + E  A   T  IV  +
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPE 224
           +  H+  +I+RDLKPEN L     ++  ++  D GL++  K G+  ++   G+P +MAPE
Sbjct: 303 EHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359
Query: 225 -VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSE 282
            +L   Y   +D ++ GV LY ++    PF A  E+ V    L+  +  +   +P+  S 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSP 418
Query: 283 SAKSLVRQMLEPDPKLRL 300
           ++K     +L+ DP+ RL
Sbjct: 419 ASKDFCEALLQKDPEKRL 436

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 129/258 (50%), Gaps = 12/258 (4%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           ED +L  R LGRG FG  + C  + T +L ACK ++K++L+          E  I+  + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV- 242
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIVEVV 165
            +  IVSL  A E    + LVM +  GG++   I         + E  A   T  IV  +
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPE 224
           +  H+  +I+RDLKPEN L     ++  ++  D GL++  K G+  ++   G+P +MAPE
Sbjct: 303 EHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359
Query: 225 -VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSE 282
            +L   Y   +D ++ GV LY ++    PF A  E+ V    L+  +  +   +P+  S 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSP 418
Query: 283 SAKSLVRQMLEPDPKLRL 300
           ++K     +L+ DP+ RL
Sbjct: 419 ASKDFCEALLQKDPEKRL 436

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 94/346 (27%), Positives = 142/346 (41%), Gaps = 77/346 (22%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI--SKRKLRTAVDIDDVRRE 101
           VP +++  RY V + +G+G FG      D    + +A K +   KR  R A +      E
Sbjct: 90  VPHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE------E 143
Query: 102 VAIMKHLPKNS-----SIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAA 154
           + I++HL K       +++ + E     N + +  EL      EL  +   +G ++    
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLV 202
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
                +I++ +   HK+ +IH DLKPEN L   ++  S +K IDFG S +    +R    
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSSCY--EHQRVYXX 259
Query: 215 VGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVP--PFWAESEQGVAQAILRGLID 271
           + S +Y APEV L   YG  ID+WS G IL  LL G P  P   E +Q      L G+  
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPX 319
Query: 272 FK-------------------------------------------RDP-----WPNVSES 283
            K                                           R P     W N  + 
Sbjct: 320 QKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 284 AKS-----LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD 324
                    ++Q LE DP +R+T  Q L HPWL+  ++ P  P G+
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR--RRLPKPPTGE 423

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 87
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 147 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKD 202
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 258
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 129/258 (50%), Gaps = 12/258 (4%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           ED +L  R LGRG FG  + C  + T +L ACK ++K++L+          E  I+  + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV- 242
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIVEVV 165
            +  IVSL  A E    + LVM +  GG++   I         + E  A   T  IV  +
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPE 224
           +  H+  +I+RDLKPEN L     ++  ++  D GL++  K G+  ++   G+P +MAPE
Sbjct: 303 EHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359
Query: 225 -VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSE 282
            +L   Y   +D ++ GV LY ++    PF A  E+ V    L+  +  +   +P+  S 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSP 418
Query: 283 SAKSLVRQMLEPDPKLRL 300
           ++K     +L+ DP+ RL
Sbjct: 419 ASKDFCEALLQKDPEKRL 436

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 14  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 71
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 72  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 130
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 131 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 186
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 187 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 242
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 243 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 87
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 147 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 258
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 134/273 (49%), Gaps = 17/273 (6%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           E+ +    ++G+G FG  +  ID  T++++A K I   +    ++   +++E+ ++    
Sbjct: 6   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED--IQQEITVLSQC- 62
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            +  +     +   D  + ++ME   GG   D ++  G   E   A + R I++ +   H
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLH 121
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKR 228
               IHRD+K  N L +   E+  +K  DFG++      + + +  VG+P++MAPEV+K+
Sbjct: 122 SEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 178
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAK 285
           + Y  + DIWS G+    L  G PP    SE    + +   LI     P    N S+  K
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPP---HSELHPMKVLF--LIPKNNPPTLEGNYSKPLK 233
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPW-LQNAKKA 317
             V   L  +P  R TAK++L+H + L+NAKK 
Sbjct: 234 EFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 266

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 134/273 (49%), Gaps = 17/273 (6%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           E+ +    ++G+G FG  +  ID  T++++A K I   +    ++   +++E+ ++    
Sbjct: 26  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED--IQQEITVLSQC- 82
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            +  +     +   D  + ++ME   GG   D ++  G   E   A + R I++ +   H
Sbjct: 83  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLH 141
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKR 228
               IHRD+K  N L +   E+  +K  DFG++      + + +  VG+P++MAPEV+K+
Sbjct: 142 SEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAK 285
           + Y  + DIWS G+    L  G PP    SE    + +   LI     P    N S+  K
Sbjct: 199 SAYDSKADIWSLGITAIELARGEPP---HSELHPMKVLF--LIPKNNPPTLEGNYSKPLK 253
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPW-LQNAKKA 317
             V   L  +P  R TAK++L+H + L+NAKK 
Sbjct: 254 EFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 286

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 134/273 (49%), Gaps = 17/273 (6%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           E+ +    ++G+G FG  +  ID  T++++A K I   +    ++   +++E+ ++    
Sbjct: 6   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED--IQQEITVLSQC- 62
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            +  +     +   D  + ++ME   GG   D ++  G   E   A + R I++ +   H
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLH 121
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKR 228
               IHRD+K  N L +   E+  +K  DFG++      + + +  VG+P++MAPEV+K+
Sbjct: 122 SEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAK 285
           + Y  + DIWS G+    L  G PP    SE    + +   LI     P    N S+  K
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPP---HSELHPMKVLF--LIPKNNPPTLEGNYSKPLK 233
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPW-LQNAKKA 317
             V   L  +P  R TAK++L+H + L+NAKK 
Sbjct: 234 EFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 266

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 10  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 67
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 68  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 126
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 127 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 182
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 183 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 238
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 239 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 133/270 (49%), Gaps = 21/270 (7%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           +P T L    + + ED  ++ + +GRG FG   +   ++T  + A K ++K ++    + 
Sbjct: 60  KPFTQLVKEMQLHREDFEII-KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAET 118
Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAA 154
              R E  ++ +      I +L  A +D+N ++LVM+   GG+L   +        E  A
Sbjct: 119 ACFREERDVLVN-GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMA 177
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFS 212
                 +V  +   H+   +HRD+KP+N L      N  ++  DFG  L +      + S
Sbjct: 178 RFYIGEMVLAIDSIHQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSS 234
Query: 213 EIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
             VG+P Y++PE+L+        YGPE D WS GV +Y +L G  PF+AES   + +   
Sbjct: 235 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYG 291
Query: 267 RGLIDFKRDPWP----NVSESAKSLVRQML 292
           + +   +R  +P    +VSE AK L+++++
Sbjct: 292 KIMNHEERFQFPSHVTDVSEEAKDLIQRLI 321

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 133/270 (49%), Gaps = 21/270 (7%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           +P T L    + + ED  ++ + +GRG FG   +   ++T  + A K ++K ++    + 
Sbjct: 76  KPFTQLVKEMQLHREDFEII-KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAET 134
Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAA 154
              R E  ++ +      I +L  A +D+N ++LVM+   GG+L   +        E  A
Sbjct: 135 ACFREERDVLVN-GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMA 193
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFS 212
                 +V  +   H+   +HRD+KP+N L      N  ++  DFG  L +      + S
Sbjct: 194 RFYIGEMVLAIDSIHQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSS 250
Query: 213 EIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
             VG+P Y++PE+L+        YGPE D WS GV +Y +L G  PF+AES   + +   
Sbjct: 251 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYG 307
Query: 267 RGLIDFKRDPWP----NVSESAKSLVRQML 292
           + +   +R  +P    +VSE AK L+++++
Sbjct: 308 KIMNHEERFQFPSHVTDVSEEAKDLIQRLI 337

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 91/334 (27%), Positives = 136/334 (40%), Gaps = 75/334 (22%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI--SKRKLRTAVDIDDVRRE 101
           VP +++  RY V + +G+G FG      D    + +A K +   KR  R A +      E
Sbjct: 90  VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE------E 143
Query: 102 VAIMKHLPKNS-----SIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAA 154
           + I++HL K       +++ + E     N + +  EL      EL  +   +G ++    
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLV 202
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
                +I++ +   HK+ +IH DLKPEN L   ++  S +K IDFG S +    +R    
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSSCY--EHQRVYTX 259
Query: 215 VGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVP--PFWAESEQGVAQAILRGLID 271
           + S +Y APEV L   YG  ID+WS G IL  LL G P  P   E +Q      L G+  
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319
Query: 272 FK-------------------------------------------RDP-----WPNVSES 283
            K                                           R P     W N  + 
Sbjct: 320 QKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 284 AKS-----LVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                    ++Q LE DP +R+T  Q L HPWL+
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 130/298 (43%), Gaps = 39/298 (13%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           + + ++Y    ++G G +GV Y   D   R ++A K I        +    +R E++++K
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIR-EISLLK 74
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEV 164
            L  + +IVSL +    +  + LV E  E    ++ D    +    +         ++  
Sbjct: 75  EL-HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRG 131
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAP 223
           V  CH+H ++HRDLKP+N L  +   +  LK  DFGL+  F  P   ++  V + +Y AP
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
Query: 224 EVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--------------- 266
           +VL   + Y   +DIWS G I   ++ G P F   ++      I                
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 267 -------RGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                  R    F++ PW    P   +    L+  ML  DP  R++A+  + HP+ ++
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 130/298 (43%), Gaps = 39/298 (13%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           + + ++Y    ++G G +GV Y   D   R ++A K I        +    +R E++++K
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIR-EISLLK 74
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEV 164
            L  + +IVSL +    +  + LV E  E    ++ D    +    +         ++  
Sbjct: 75  EL-HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRG 131
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAP 223
           V  CH+H ++HRDLKP+N L  +   +  LK  DFGL+  F  P   ++  V + +Y AP
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
Query: 224 EVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--------------- 266
           +VL   + Y   +DIWS G I   ++ G P F   ++      I                
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 267 -------RGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                  R    F++ PW    P   +    L+  ML  DP  R++A+  + HP+ ++
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 150/315 (47%), Gaps = 36/315 (11%)
Query: 37  PITVLAGVPKENI---EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV 93
           P+ V     + NI   E+ +     +G+G FG  +  ID  T++++A K I   +    +
Sbjct: 6   PVAVQVPGMQNNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI 65
Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA 153
           +   +++E+ ++     +S +     +    + + ++ME   GG   D + A G + E  
Sbjct: 66  ED--IQQEITVLSQC-DSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQ 121
Query: 154 AAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFS 212
            A + + I++ +   H    IHRD+K  N L +   E   +K  DFG++      + + +
Sbjct: 122 IATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN 178
Query: 213 EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID 271
             VG+P++MAPEV++++ Y  + DIWS G+    L  G PP             +R L  
Sbjct: 179 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP-------NSDMHPMRVLFL 231
Query: 272 FKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL-QNAKKAPNVPLGDVV 326
             ++  P +    ++S K  +   L  DP  R TAK++L+H ++ +N+KK          
Sbjct: 232 IPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNSKKT--------- 282
Query: 327 RSRLKQFSMMNRFKR 341
            S L +  +++RFKR
Sbjct: 283 -SYLTE--LIDRFKR 294

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 132/271 (48%), Gaps = 30/271 (11%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G FG  Y   +++T  L A K I   + ++  +++D   E+ I+     +  IV L
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATC-DHPYIVKL 81
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
             A   D  + +++E C GG + D I+    RG  TE     V R ++E +   H   +I
Sbjct: 82  LGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRII 139
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVL------K 227
           HRDLK  N L   + +   ++  DFG+S    K  ++    +G+PY+MAPEV+       
Sbjct: 140 HRDLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
             Y  + DIWS G+ L  +    PP     E    + +L+     K DP   ++ S  S+
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPP---HHELNPMRVLLKIA---KSDPPTLLTPSKWSV 250
Query: 288 -----VRQMLEPDPKLRLTAKQVLEHPWLQN 313
                ++  L+ +P+ R +A Q+LEHP++ +
Sbjct: 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 127/268 (47%), Gaps = 21/268 (7%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +DR +G+G FG  Y  ID  T+E++A K I   +    ++   +++E+ ++     +  I
Sbjct: 24  LDR-IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIED--IQQEITVLSQC-DSPYI 79
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
                +      + ++ME   GG   D ++  G   E   A + R I++ +   H    I
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKI 138
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKRN-YGP 232
           HRD+K  N L +   E   +K  DFG++      + + +  VG+P++MAPEV+K++ Y  
Sbjct: 139 HRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDF 195
Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV----SESAKSLV 288
           + DIWS G+    L  G PP             +R L    ++  P +    S+  K  V
Sbjct: 196 KADIWSLGITAIELAKGEPP-------NSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFV 248
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
              L  DP+ R TAK++L+H ++    K
Sbjct: 249 EACLNKDPRFRPTAKELLKHKFITRYTK 276

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 132/271 (48%), Gaps = 30/271 (11%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G FG  Y   +++T  L A K I   + ++  +++D   E+ I+     +  IV L
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATC-DHPYIVKL 73
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
             A   D  + +++E C GG + D I+    RG  TE     V R ++E +   H   +I
Sbjct: 74  LGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRII 131
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVL------K 227
           HRDLK  N L   + +   ++  DFG+S    K  ++    +G+PY+MAPEV+       
Sbjct: 132 HRDLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
             Y  + DIWS G+ L  +    PP     E    + +L+     K DP   ++ S  S+
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPP---HHELNPMRVLLKIA---KSDPPTLLTPSKWSV 242
Query: 288 -----VRQMLEPDPKLRLTAKQVLEHPWLQN 313
                ++  L+ +P+ R +A Q+LEHP++ +
Sbjct: 243 EFRDFLKIALDKNPETRPSAAQLLEHPFVSS 273

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 138/282 (48%), Gaps = 20/282 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDID-DVRREVAIMKHLPK 110
           +YL+   LG G +G     +D +T    A K + K+KLR   + + +V++E+ +++ L +
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64
Query: 111 NSSIVSLKEAC--EDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           + +++ L +    E+   +++VME C  G  E+ D +  +     +A     + +++ ++
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ-LIDGLE 123
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP---GERFSEIVGSPYYMAP 223
             H  G++H+D+KP N L         LK    G++    P    +      GSP +  P
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTT---GGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 224 EV---LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           E+   L    G ++DIWSAGV LY +  G+ PF  ++   + + I +G      D  P +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           S+    L++ MLE +P  R + +Q+ +H W +        P+
Sbjct: 241 SD----LLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD--VRREVAIMKHLPKNSSIVS 116
           LG G+F   Y   D++T +++A K I       A D  +    RE+ +++ L  + +I+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIG 76
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHY--TERAAAAVTRTIVEVVQLCHKHGVI 174
           L +A    + + LV +  E     + I+       T     A     ++ ++  H+H ++
Sbjct: 77  LLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 134
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRNYG 231
           HRDLKP N L     EN  LK  DFGL+  F  P   +   V + +Y APE+L   R YG
Sbjct: 135 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV----------- 280
             +D+W+ G IL  LL  VP    +S+      I   L     + WP++           
Sbjct: 192 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 251
Query: 281 -------------SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                         +    L++ +   +P  R+TA Q L+  +  N
Sbjct: 252 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 97/344 (28%), Positives = 141/344 (40%), Gaps = 53/344 (15%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ E
Sbjct: 21  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80
Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMEL 133
           L+A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L
Sbjct: 81  LVAIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFAN 187
               E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L   
Sbjct: 133 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-- 189
Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
             + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  
Sbjct: 190 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 249
Query: 246 LLCGVPPFWAESEQGVAQAI---------LRGLI-------------DFKRDPW-----P 278
           LL G P F  +S  GV Q +          R  I               K  PW     P
Sbjct: 250 LLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 350

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 97/344 (28%), Positives = 141/344 (40%), Gaps = 53/344 (15%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ E
Sbjct: 21  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80
Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMEL 133
           L+A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L
Sbjct: 81  LVAIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFAN 187
               E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L   
Sbjct: 133 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-- 189
Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
             + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  
Sbjct: 190 DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 249
Query: 246 LLCGVPPFWAESEQGVAQAI---------LRGLI-------------DFKRDPW-----P 278
           LL G P F  +S  GV Q +          R  I               K  PW     P
Sbjct: 250 LLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 350

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 97/344 (28%), Positives = 141/344 (40%), Gaps = 53/344 (15%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ E
Sbjct: 15  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 74
Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMEL 133
           L+A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L
Sbjct: 75  LVAIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 126
Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFAN 187
               E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L   
Sbjct: 127 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-- 183
Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
             + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  
Sbjct: 184 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 243
Query: 246 LLCGVPPFWAESEQGVAQAI---------LRGLI-------------DFKRDPW-----P 278
           LL G P F  +S  GV Q +          R  I               K  PW     P
Sbjct: 244 LLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 301
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 302 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 344

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 97/344 (28%), Positives = 144/344 (41%), Gaps = 53/344 (15%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ E
Sbjct: 66  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 125
Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMEL 133
           L+A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L
Sbjct: 126 LVAIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 177
Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFAN 187
               E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L   
Sbjct: 178 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-- 234
Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
             + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  
Sbjct: 235 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 294
Query: 246 LLCGVPPFWAESEQGVAQAI-------------LRGL----IDF-----KRDPW-----P 278
           LL G P F  +S  GV Q +             +R +     +F     K  PW     P
Sbjct: 295 LLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 352
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 353 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 395

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 97/344 (28%), Positives = 141/344 (40%), Gaps = 53/344 (15%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ E
Sbjct: 23  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 82
Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMEL 133
           L+A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L
Sbjct: 83  LVAIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 134
Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFAN 187
               E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L   
Sbjct: 135 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-- 191
Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
             + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  
Sbjct: 192 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 251
Query: 246 LLCGVPPFWAESEQGVAQAI---------LRGLI-------------DFKRDPW-----P 278
           LL G P F  +S  GV Q +          R  I               K  PW     P
Sbjct: 252 LLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 309
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 310 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 352

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 97/344 (28%), Positives = 141/344 (40%), Gaps = 53/344 (15%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ E
Sbjct: 25  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 84
Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMEL 133
           L+A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L
Sbjct: 85  LVAIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 136
Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFAN 187
               E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L   
Sbjct: 137 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-- 193
Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
             + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  
Sbjct: 194 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 253
Query: 246 LLCGVPPFWAESEQGVAQAI---------LRGLI-------------DFKRDPW-----P 278
           LL G P F  +S  GV Q +          R  I               K  PW     P
Sbjct: 254 LLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 311
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 312 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 354

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 116/271 (42%), Gaps = 13/271 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P+   +  +     LG G +G  +    ++   L A K  S    R   D      EV  
Sbjct: 51  PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGS 109
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVE 163
            + + ++   V L++A E+   ++L  ELC G  L     A G    E       R  + 
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            +   H  G++H D+KP N     +      K  DFGL +            G P YMAP
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGR---CKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225
Query: 224 EVLKRNYGPEIDIWSAGVILYILLCGVP-PFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           E+L+ +YG   D++S G+ +  + C +  P   E  Q + Q  L    +F       +S 
Sbjct: 226 ELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP--PEFT----AGLSS 279
Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
             +S++  MLEPDPKLR TA+ +L  P L+ 
Sbjct: 280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 94/333 (28%), Positives = 138/333 (41%), Gaps = 53/333 (15%)
Query: 31  GANKKQPITVLAGVPKENI----EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK 86
           GA     +T +   P +      E  Y   + +G G FGV Y     D+ EL+A K + +
Sbjct: 1   GAMSLSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 60
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDR 142
            K           RE+ IM+ L  + +IV L+     + E  + V+L + L    E   R
Sbjct: 61  DKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR 112
Query: 143 IVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKA 196
            VAR +   +    V    + + QL       H  G+ HRD+KP+N L     + + LK 
Sbjct: 113 -VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKL 169
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFW 254
            DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL G P F 
Sbjct: 170 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 229
Query: 255 AESEQGVAQAILRGL---------------IDF-----KRDPW-----PNVSESAKSLVR 289
            +S       I++ L                +F     K  PW     P     A +L  
Sbjct: 230 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS 289
Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 290 RLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 321

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 94/340 (27%), Positives = 140/340 (41%), Gaps = 49/340 (14%)
Query: 20  YSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELL 79
           + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ EL+
Sbjct: 1   FGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELV 60
Query: 80  ACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCE 135
           A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L  
Sbjct: 61  AIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 112
Query: 136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKK 189
             E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L     
Sbjct: 113 VPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DP 169
Query: 190 ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILL 247
           + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL
Sbjct: 170 DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229
Query: 248 CGVPPFWAESEQGVAQAILRGL---------------IDF-----KRDPW-----PNVSE 282
            G P F  +S       I++ L                +F     K  PW     P    
Sbjct: 230 LGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 289
Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 290 EAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 328

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 92/334 (27%), Positives = 136/334 (40%), Gaps = 49/334 (14%)
Query: 26  ARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS 85
           +R + G+     +      P    E  Y   + +G G FGV Y     D+ EL+A K + 
Sbjct: 14  SRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFD 141
           + K           RE+ IM+ L  + +IV L+     + E  + V+L + L    E   
Sbjct: 74  QDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 125
Query: 142 RIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLK 195
           R VAR +   +    V    + + QL       H  G+ HRD+KP+N L     + + LK
Sbjct: 126 R-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLK 182
Query: 196 AIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF 253
             DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL G P F
Sbjct: 183 LCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242
Query: 254 WAESEQGVAQAILRGL--------------------IDFKRDPW-----PNVSESAKSLV 288
             +S       I++ L                       K  PW     P     A +L 
Sbjct: 243 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 302
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 303 SRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 335

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 92/334 (27%), Positives = 136/334 (40%), Gaps = 49/334 (14%)
Query: 26  ARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS 85
           +R + G+     +      P    E  Y   + +G G FGV Y     D+ EL+A K + 
Sbjct: 8   SRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFD 141
           + K           RE+ IM+ L  + +IV L+     + E  + V+L + L    E   
Sbjct: 68  QDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 119
Query: 142 RIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLK 195
           R VAR +   +    V    + + QL       H  G+ HRD+KP+N L     + + LK
Sbjct: 120 R-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLK 176
Query: 196 AIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF 253
             DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL G P F
Sbjct: 177 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236
Query: 254 WAESEQGVAQAILRGL--------------------IDFKRDPW-----PNVSESAKSLV 288
             +S       I++ L                       K  PW     P     A +L 
Sbjct: 237 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 296
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 297 SRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 329

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 92/334 (27%), Positives = 136/334 (40%), Gaps = 49/334 (14%)
Query: 26  ARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS 85
           +R + G+     +      P    E  Y   + +G G FGV Y     D+ EL+A K + 
Sbjct: 3   SRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFD 141
           + K           RE+ IM+ L  + +IV L+     + E  + V+L + L    E   
Sbjct: 63  QDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 114
Query: 142 RIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLK 195
           R VAR +   +    V    + + QL       H  G+ HRD+KP+N L     + + LK
Sbjct: 115 R-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLK 171
Query: 196 AIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF 253
             DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL G P F
Sbjct: 172 LCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231
Query: 254 WAESEQGVAQAILRGL--------------------IDFKRDPW-----PNVSESAKSLV 288
             +S       I++ L                       K  PW     P     A +L 
Sbjct: 232 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 291
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 292 SRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 324

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 92/334 (27%), Positives = 136/334 (40%), Gaps = 49/334 (14%)
Query: 26  ARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS 85
           +R + G+     +      P    E  Y   + +G G FGV Y     D+ EL+A K + 
Sbjct: 7   SRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFD 141
           + K           RE+ IM+ L  + +IV L+     + E  + V+L + L    E   
Sbjct: 67  QDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 118
Query: 142 RIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLK 195
           R VAR +   +    V    + + QL       H  G+ HRD+KP+N L     + + LK
Sbjct: 119 R-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLK 175
Query: 196 AIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF 253
             DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL G P F
Sbjct: 176 LCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235
Query: 254 WAESEQGVAQAILRGL--------------------IDFKRDPW-----PNVSESAKSLV 288
             +S       I++ L                       K  PW     P     A +L 
Sbjct: 236 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 295
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 296 SRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 328

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 92/317 (29%), Positives = 132/317 (41%), Gaps = 53/317 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI------- 265
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S  GV Q +       
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLG 240
Query: 266 ------LR---------GLIDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQV 305
                 +R              K  PW     P     A +L  ++LE  P  RLT  + 
Sbjct: 241 TPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
Query: 306 LEHPWLQNAKKAPNVPL 322
             H +    +  PNV L
Sbjct: 301 CAHSFFDELRD-PNVKL 316

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 95/332 (28%), Positives = 137/332 (41%), Gaps = 52/332 (15%)
Query: 31  GANKKQPITVLAGV---PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKR 87
           GA   +  TV+A     P    E  Y   + +G G FGV Y     D+ EL+A K + + 
Sbjct: 1   GAMGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD 60
Query: 88  KLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRI 143
           K           RE+ IM+ L  + +IV L+     + E  + V+L + L    E   R 
Sbjct: 61  KRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR- 111
Query: 144 VARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAI 197
           VAR +   +    V    + + QL       H  G+ HRD+KP+N L     + + LK  
Sbjct: 112 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLC 169
Query: 198 DFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA 255
           DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL G P F  
Sbjct: 170 DFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 229
Query: 256 ESEQGVAQAILRGL--------------------IDFKRDPW-----PNVSESAKSLVRQ 290
           +S       I++ L                       K  PW     P     A +L  +
Sbjct: 230 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 289
Query: 291 MLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           +LE  P  RLT  +   H +    +  PNV L
Sbjct: 290 LLEYTPTARLTPLEACAHSFFDELRD-PNVKL 320

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 130/315 (41%), Gaps = 49/315 (15%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL--- 269
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S       I++ L   
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 270 -----------------IDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                               K  PW     P     A +L  ++LE  P  RLT  +   
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 308 HPWLQNAKKAPNVPL 322
           H +    +  PNV L
Sbjct: 303 HSFFDELRD-PNVKL 316

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 131/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 100
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V+LV  L  G +L+ +++   H +          I+  ++
Sbjct: 101 ENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLY-KLLKTQHLSNDHICYFLYQILRGLK 158
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 159 YIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 276 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 336 YYDPSDEPIAE 346

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 130/315 (41%), Gaps = 49/315 (15%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL--- 269
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S       I++ L   
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 270 -----------------IDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                               K  PW     P     A +L  ++LE  P  RLT  +   
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 308 HPWLQNAKKAPNVPL 322
           H +    +  PNV L
Sbjct: 303 HSFFDELRD-PNVKL 316

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 91/315 (28%), Positives = 132/315 (41%), Gaps = 49/315 (15%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL--- 269
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S       I++ L   
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 270 ------------IDF-----KRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                        +F     K  PW     P     A +L  ++LE  P  RLT  +   
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 308 HPWLQNAKKAPNVPL 322
           H +    +  PNV L
Sbjct: 303 HSFFDELRD-PNVKL 316

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 130/315 (41%), Gaps = 49/315 (15%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL--- 269
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S       I++ L   
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 270 -----------------IDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                               K  PW     P     A +L  ++LE  P  RLT  +   
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 308 HPWLQNAKKAPNVPL 322
           H +    +  PNV L
Sbjct: 303 HSFFDELRD-PNVKL 316

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 130/315 (41%), Gaps = 49/315 (15%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL--- 269
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S       I++ L   
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 270 -----------------IDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                               K  PW     P     A +L  ++LE  P  RLT  +   
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 308 HPWLQNAKKAPNVPL 322
           H +    +  PNV L
Sbjct: 303 HSFFDELRD-PNVKL 316

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG     I +DT E +A K    R+  +  + +    E+ IMK L  + ++VS +
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKL-NHPNVVSAR 79
Query: 119 EACED------DNAVHLVMELCEGGEL---FDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           E  +       ++   L ME CEGG+L    ++        E     +   I   ++  H
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-KR 228
           ++ +IHRDLKPEN +     +    K ID G +     GE  +E VG+  Y+APE+L ++
Sbjct: 140 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK 199
Query: 229 NYGPEIDIWSAGVILYILLCGVPPF 253
            Y   +D WS G + +  + G  PF
Sbjct: 200 KYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 130/315 (41%), Gaps = 49/315 (15%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 15  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQI 67
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 68  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 125
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 126 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSX 183
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL--- 269
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S       I++ L   
Sbjct: 184 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 243
Query: 270 -----------------IDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                               K  PW     P     A +L  ++LE  P  RLT  +   
Sbjct: 244 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 303
Query: 308 HPWLQNAKKAPNVPL 322
           H +    +  PNV L
Sbjct: 304 HSFFDELRD-PNVKL 317

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG     I +DT E +A K    R+  +  + +    E+ IMK L  + ++VS +
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKL-NHPNVVSAR 78
Query: 119 EACED------DNAVHLVMELCEGGEL---FDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           E  +       ++   L ME CEGG+L    ++        E     +   I   ++  H
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-KR 228
           ++ +IHRDLKPEN +     +    K ID G +     GE  +E VG+  Y+APE+L ++
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK 198
Query: 229 NYGPEIDIWSAGVILYILLCGVPPF 253
            Y   +D WS G + +  + G  PF
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 80
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 138
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 316 YYDPSDEPIAE 326

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 80
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 138
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 316 YYDPSDEPIAE 326

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 84
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 142
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 320 YYDPSDEPIAE 330

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 80
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 138
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 316 YYDPSDEPIAE 326

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQ--RTLREIKILLRF-RH 84
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 142
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 320 YYDPSDEPIAE 330

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+S LK +DFGL       +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLC--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 123/270 (45%), Gaps = 14/270 (5%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + V R +GRG FG  Y C   DT ++ A K + K++++          E  ++  +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 113 S--IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              IV +  A    + +  +++L  GG+L   +   G ++E         I+  ++  H 
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
             V++RDLKP N L     E+  ++  D GL+  F   +  +  VG+  YMAPEVL++  
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            Y    D +S G +L+ LL G  PF     +     I R  +    +   + S   +SL+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN 313
             +L+ D   RL      A++V E P+ ++
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 130/285 (45%), Gaps = 38/285 (13%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D + + + +GRG F    +   + T ++ A K ++K  +    ++   R E  ++ +  +
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR----TIVEVVQ 166
              I  L  A +D+N ++LVME   GG+L   +   G   ER  A + R     IV  + 
Sbjct: 121 RW-ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAID 176
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV--GSPYYMAPE 224
             H+ G +HRD+KP+N L         ++  DFG  +  +       +V  G+P Y++PE
Sbjct: 177 SVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
Query: 225 VLK--------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR-------GL 269
           +L+         +YGPE D W+ GV  Y +  G  PF+A+S       I+         L
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293
Query: 270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRL---TAKQVLEHPWL 311
           +D        V E A+  ++++L P P+ RL    A     HP+ 
Sbjct: 294 VD------EGVPEEARDFIQRLLCP-PETRLGRGGAGDFRTHPFF 331

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 133/308 (43%), Gaps = 54/308 (17%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----DDVRREVA 103
           ++ D Y +   +G G +GV         R  L  + ++ +K+  A D+        RE+ 
Sbjct: 51  DVGDEYEIIETIGNGAYGVV-----SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK 105
Query: 104 IMKHLPKNSSIVSLKEACE------DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           I+KH  K+ +I+++K+         +  +V++V++L E  +L   I +    T       
Sbjct: 106 ILKHF-KHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYF 163
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGER---FS 212
              ++  ++  H   VIHRDLKP N L     EN  LK  DFG++  +   P E     +
Sbjct: 164 LYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMT 220
Query: 213 EIVGSPYYMAPEVLK--RNYGPEIDIWSAGVI---------------------LYILLCG 249
           E V + +Y APE++     Y   ID+WS G I                     L +++ G
Sbjct: 221 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280
Query: 250 VPPFWAESEQGV--AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAK 303
            P        G    +A ++ L   +  PW    P     A SL+ +ML  +P  R++A 
Sbjct: 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 340
Query: 304 QVLEHPWL 311
             L HP+L
Sbjct: 341 AALRHPFL 348

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 123/270 (45%), Gaps = 14/270 (5%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + V R +GRG FG  Y C   DT ++ A K + K++++          E  ++  +    
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 113 S--IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              IV +  A    + +  +++L  GG+L   +   G ++E         I+  ++  H 
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 309
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
             V++RDLKP N L     E+  ++  D GL+  F   +  +  VG+  YMAPEVL++  
Sbjct: 310 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 365
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            Y    D +S G +L+ LL G  PF     +     I R  +    +   + S   +SL+
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRSLL 424
Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN 313
             +L+ D   RL      A++V E P+ ++
Sbjct: 425 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 454

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 127/309 (41%), Gaps = 52/309 (16%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++  RY+  + LG G  G+ +  +D D  + +A K I    L     +    RE+ I++ 
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKIIRR 64
Query: 108 L-------------PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
           L             P  S +     +  + N+V++V E  E       ++ +G   E  A
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEEHA 122
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE----R 210
                 ++  ++  H   V+HRDLKP N LF N  E+  LK  DFGL+    P       
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINT-EDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 211 FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG 268
            SE + + +Y +P +L    NY   ID+W+AG I   +L G   F    E    Q IL  
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240
Query: 269 L----------------IDFKRDP----------WPNVSESAKSLVRQMLEPDPKLRLTA 302
           +                +  + D            P +S  A   + Q+L   P  RLTA
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300
Query: 303 KQVLEHPWL 311
           ++ L HP++
Sbjct: 301 EEALSHPYM 309

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 91/317 (28%), Positives = 131/317 (41%), Gaps = 53/317 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L        R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI------- 265
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S  GV Q +       
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLG 240
Query: 266 ------LR---------GLIDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQV 305
                 +R              K  PW     P     A +L  ++LE  P  RLT  + 
Sbjct: 241 TPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
Query: 306 LEHPWLQNAKKAPNVPL 322
             H +    +  PNV L
Sbjct: 301 CAHSFFDELRD-PNVKL 316

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 125/259 (48%), Gaps = 27/259 (10%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +G G +G      D   R+ +A K +S R  ++ +      RE+ ++KHL K+ +++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHL-KHENVIG 91
Query: 117 LKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           L +      + ED + V+LV  L   G   + IV     ++     +   ++  ++  H 
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-- 228
            G+IHRDLKP N       E+S L+ +DFGL+   +  E  +  V + +Y APE++    
Sbjct: 150 AGIIHRDLKPSNVAV---NEDSELRILDFGLA--RQADEEMTGYVATRWYRAPEIMLNWM 204
Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-----SES 283
           +Y   +DIWS G I+  LL G   F       + Q  L+ +++    P P V     SE 
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALF--PGSDYIDQ--LKRIMEVVGTPSPEVLAKISSEH 260
Query: 284 AKSLVRQMLEPDPKLRLTA 302
           A++ + Q L P P+  L++
Sbjct: 261 ARTYI-QSLPPMPQKDLSS 278

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 84
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 85  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+S LK +DFGL+      +  +  V + +Y A
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLA--RHTDDEMTGYVATRWYRA 196
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 317 YHDPDDEPVAD 327

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 133/308 (43%), Gaps = 54/308 (17%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----DDVRREVA 103
           ++ D Y +   +G G +GV         R  L  + ++ +K+  A D+        RE+ 
Sbjct: 52  DVGDEYEIIETIGNGAYGVV-----SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK 106
Query: 104 IMKHLPKNSSIVSLKEACE------DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           I+KH  K+ +I+++K+         +  +V++V++L E  +L   I +    T       
Sbjct: 107 ILKHF-KHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYF 164
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGER---FS 212
              ++  ++  H   VIHRDLKP N L     EN  LK  DFG++  +   P E     +
Sbjct: 165 LYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMT 221
Query: 213 EIVGSPYYMAPEVLK--RNYGPEIDIWSAGVI---------------------LYILLCG 249
           E V + +Y APE++     Y   ID+WS G I                     L +++ G
Sbjct: 222 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 281
Query: 250 VPPFWAESEQGV--AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAK 303
            P        G    +A ++ L   +  PW    P     A SL+ +ML  +P  R++A 
Sbjct: 282 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 341
Query: 304 QVLEHPWL 311
             L HP+L
Sbjct: 342 AALRHPFL 349

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 123/270 (45%), Gaps = 14/270 (5%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + V R +GRG FG  Y C   DT ++ A K + K++++          E  ++  +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 113 S--IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              IV +  A    + +  +++L  GG+L   +   G ++E         I+  ++  H 
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
             V++RDLKP N L     E+  ++  D GL+  F   +  +  VG+  YMAPEVL++  
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            Y    D +S G +L+ LL G  PF     +     I R  +    +   + S   +SL+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN 313
             +L+ D   RL      A++V E P+ ++
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 123/270 (45%), Gaps = 14/270 (5%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + V R +GRG FG  Y C   DT ++ A K + K++++          E  ++  +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 113 S--IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              IV +  A    + +  +++L  GG+L   +   G ++E         I+  ++  H 
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
             V++RDLKP N L     E+  ++  D GL+  F   +  +  VG+  YMAPEVL++  
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            Y    D +S G +L+ LL G  PF     +     I R  +    +   + S   +SL+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN 313
             +L+ D   RL      A++V E P+ ++
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 82
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 140
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 318 YYDPSDEPIAE 328

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 80
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 81  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+S LK +DFGL+      +  +  V + +Y A
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLA--RHTDDEMTGYVATRWYRA 192
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 313 YHDPDDEPVAD 323

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 100
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 101 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 158
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 159 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 276 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 336 YYDPSDEPIAE 346

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 88
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 89  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 146
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 147 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 263
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 264 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 323
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 324 YYDPSDEPIAE 334

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 80
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 138
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 316 YYDPSDEPIAE 326

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 80
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 138
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 316 YYDPSDEPIAE 326

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 78
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 79  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 136
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 137 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 253
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 254 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 314 YYDPSDEPIAE 324

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 130/311 (41%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLAF-RH 82
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 140
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L       S LK  DFGL+    P        +E V + +Y A
Sbjct: 141 YIHSANVLHRDLKPSNLLL---NTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----------------WAESEQGV--- 261
           PE++   + Y   IDIWS G IL  +L   P F                 + S++ +   
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCG 257
Query: 262 ----AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
               A+  L  L    + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L  
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 318 YYDPSDEPIAE 328

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 85
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 86  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 143
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 144 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 261 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 321 YYDPSDEPIAE 331

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 86
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 87  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 144
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 145 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 261
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 262 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 321
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 322 YYDPSDEPIAE 332

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 77
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 78  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 135
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 136 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 252
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 253 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 312
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 313 YYDPSDEPIAE 323

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 84
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 142
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 320 YYDPSDEPIAE 330

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 110/239 (46%), Gaps = 40/239 (16%)
Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
             G+   ++ D Y++   +GRG +G  YL  D++T + +A K ++ R     +D   + R
Sbjct: 16  FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILR 74
Query: 101 EVAIMKHLPKNSSIVSLKEACEDD-----NAVHLVMELCEGG--ELFDRIVARGHYTERA 153
           E+ I+  L K+  I+ L +    D     + +++V+E+ +    +LF   +     TE  
Sbjct: 75  EITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI---FLTEEH 130
Query: 154 AAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-------- 205
              +   ++      H+ G+IHRDLKP N L     ++  +K  DFGL+           
Sbjct: 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNI 187
Query: 206 --------KPG-------ERFSEIVGSPYYMAPE--VLKRNYGPEIDIWSAGVILYILL 247
                   +PG       ++ +  V + +Y APE  +L+ NY   IDIWS G I   LL
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 122/300 (40%), Gaps = 38/300 (12%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-- 109
           RY    E+G G +G  Y   D  +   +A KS+        + I  VR EVA+++ L   
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAF 63
Query: 110 KNSSIVSLKEACEDDNA-----VHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIV 162
           ++ ++V L + C          V LV E  +       D+    G   E     + R  +
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFL 122
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             +   H + ++HRDLKPEN L  +      +K  DFGL+  +      + +V + +Y A
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALAPVVVTLWYRA 179
Query: 223 PEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---- 277
           PEV L+  Y   +D+WS G I   +    P F   SE      I   +     D W    
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 239
Query: 278 -------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
                              P + ES   L+ +ML  +P  R++A + L+H +L   +  P
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 74
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 75  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQIL 131
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 186
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 307 YHDPDDEPVAD 317

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/337 (24%), Positives = 138/337 (40%), Gaps = 49/337 (14%)
Query: 23  HDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           H H+++     +++    +  VP     +RY     +G G +G      D  T   +A K
Sbjct: 5   HHHSQERPTFYRQELNKTIWEVP-----ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK 59
Query: 83  SISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE------ACEDDNAVHLVMELCEG 136
            +S R  ++ +      RE+ ++KH+ K+ +++ L +      + E+ N V+LV  L   
Sbjct: 60  KLS-RPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-- 115
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           G   + IV     T+     +   I+  ++  H   +IHRDLKP N       E+  LK 
Sbjct: 116 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKI 172
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFW 254
           +DFGL+      +  +  V + +Y APE++    +Y   +DIWS G I+  LL G   F 
Sbjct: 173 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 230
Query: 255 AESEQGVAQAILR-----------------------GLIDFKRDPWPNVSESAK----SL 287
                   + ILR                        L    +  + NV   A      L
Sbjct: 231 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDL 290
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD 324
           + +ML  D   R+TA Q L H +        + P+ D
Sbjct: 291 LEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD 327

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 88/323 (27%), Positives = 130/323 (40%), Gaps = 69/323 (21%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMK- 106
           DR+ V+R  G+G FG   L  ++ T   +A K +          I D R   RE+ IM+ 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----------IQDPRFRNRELQIMQD 72
Query: 107 ----HLPK----NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
               H P      S   +L E    D  +++VME     +   R   R +Y  + A    
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHR-CCRNYYRRQVAPPPI 129
Query: 159 RTIVEVVQLCHKHG--------VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
              V + QL    G        V HRD+KP N L    + +  LK  DFG +    P E 
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEP 187
Query: 211 FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR- 267
               + S YY APE++   ++Y   +DIWS G I   ++ G P F  ++  G    I+R 
Sbjct: 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247
Query: 268 -------------------GLIDFKRDPWPNV--------SESAKSLVRQMLEPDPKLRL 300
                               L + K  PW NV        ++ A  L+  +L+  P+ R+
Sbjct: 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307
Query: 301 TAKQVLEHPWLQN----AKKAPN 319
              + L HP+       A K PN
Sbjct: 308 KPYEALCHPYFDELHDPATKLPN 330

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMAGFVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 74
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 75  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 131
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMAGFVATRWYRA 186
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 307 YHDPDDEPVAD 317

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 98
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 99  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 210
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 330
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 331 YHDPDDEPVAD 341

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 121/300 (40%), Gaps = 38/300 (12%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-- 109
           RY    E+G G +G  Y   D  +   +A KS+        + I  VR EVA+++ L   
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAF 63
Query: 110 KNSSIVSLKEACEDDNA-----VHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIV 162
           ++ ++V L + C          V LV E  +       D+    G   E     + R  +
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFL 122
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             +   H + ++HRDLKPEN L  +      +K  DFGL+  +        +V + +Y A
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALDPVVVTLWYRA 179
Query: 223 PEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---- 277
           PEV L+  Y   +D+WS G I   +    P F   SE      I   +     D W    
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 239
Query: 278 -------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
                              P + ES   L+ +ML  +P  R++A + L+H +L   +  P
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMAGFVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/321 (25%), Positives = 142/321 (44%), Gaps = 49/321 (15%)
Query: 42  AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           A VP    +D Y + R+LGRG++   +  I+    E +  K +   K +         RE
Sbjct: 29  AHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIK------RE 82
Query: 102 VAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           V I+++L   ++I+ L +  +D       LV E     + F ++      T+        
Sbjct: 83  VKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMY 139
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            +++ +  CH  G++HRD+KP N +  ++++   L+ ID+GL+ F+ P + ++  V S Y
Sbjct: 140 ELLKALDYCHSKGIMHRDVKPHNVMIDHQQKK--LRLIDWGLAEFYHPAQEYNVRVASRY 197
Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG------ 268
           +  PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G      
Sbjct: 198 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYG 257
Query: 269 ----------------LIDFKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAK 303
                           L    R  W N         VS  A  L+ ++L  D + RLTAK
Sbjct: 258 YLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAK 317
Query: 304 QVLEHPWLQNAKKAPNVPLGD 324
           + +EHP+     K  + P  D
Sbjct: 318 EAMEHPYFYPVVKEQSQPSAD 338

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 39  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 97
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 98  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 154
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 155 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 209
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 269
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 270 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 329
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 330 YHDPDDEPVAD 340

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 132/295 (44%), Gaps = 45/295 (15%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y+    +G G +G     ID+ + E +A K +S R  ++ +      RE+ ++KH+ ++ 
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHM-QHE 101
Query: 113 SIVSLKEACEDDNAV------HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           +++ L +     +++      +LVM   +      +I+    ++E     +   +++ ++
Sbjct: 102 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLK 158
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  GV+HRDLKP N       E+  LK +DFGL+         +  V + +Y APEV+
Sbjct: 159 YIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVI 213
Query: 227 KR--NYGPEIDIWSAGVILYILLCG---------------------VP--PFWAESEQGV 261
               +Y   +DIWS G I+  +L G                     VP   F  +     
Sbjct: 214 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273
Query: 262 AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           A++ ++ L    R  +    P  S  A  L+ +MLE D   RLTA Q L HP+ +
Sbjct: 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 84
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 142
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS----EIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P    +    E V + +Y A
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 320 YYDPSDEPIAE 330

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 85
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 86  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 143
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS----EIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P    +    E V + +Y A
Sbjct: 144 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 261 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 321 YYDPSDEPIAE 331

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 129/311 (41%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 78
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 79  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 136
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 137 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI-----------LRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +        I           L  +
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCI 253
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 254 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 314 YYDPSDEPIAE 324

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 112/241 (46%), Gaps = 26/241 (10%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G+G FG  +    R T + +A K +     +    I  +R E+ I++ L K+ ++V+L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLL-KHENVVNL 82
Query: 118 KEACEDD--------NAVHLVMELCE---GGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            E C            +++LV + CE    G L + +V    +T      V + ++  + 
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLY 139
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYM 221
             H++ ++HRD+K  N L      +  LK  DFGL+  F   +     R+   V + +Y 
Sbjct: 140 YIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 222 APEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
            PE+L  +R+YGP ID+W AG I+  +    P     +EQ     I +       + WPN
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 280 V 280
           V
Sbjct: 257 V 257

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 74
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 75  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 186
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 307 YHDPDDEPVAD 317

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 125/259 (48%), Gaps = 27/259 (10%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +G G +G      D   R+ +A K +S R  ++ +      RE+ ++KHL K+ +++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHL-KHENVIG 91
Query: 117 LKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           L +      + ED + V+LV  L   G   + IV     ++     +   ++  ++  H 
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-- 228
            G+IHRDLKP N       E+S L+ +DFGL+   +  E  +  V + +Y APE++    
Sbjct: 150 AGIIHRDLKPSNVAV---NEDSELRILDFGLA--RQADEEMTGYVATRWYRAPEIMLNWM 204
Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-----SES 283
           +Y   +DIWS G I+  LL G   F       + Q  L+ +++    P P V     SE 
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALF--PGSDYIDQ--LKRIMEVVGTPSPEVLAKISSEH 260
Query: 284 AKSLVRQMLEPDPKLRLTA 302
           A++ + Q L P P+  L++
Sbjct: 261 ARTYI-QSLPPMPQKDLSS 278

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 85
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 86  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTADEMTGYVATRWYRA 197
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 318 YHDPDDEPVAD 328

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A + IS  + +T        RE+ I+    ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQ--RTLREIKILLRF-RH 84
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 142
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 320 YYDPSDEPIAE 330

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 84
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKCQHLSNDHICYFLYQILRGLK 142
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 320 YYDPSDEPIAE 330

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 130/293 (44%), Gaps = 39/293 (13%)
Query: 58  ELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSI 114
           E+G G +G  +   D ++    +A K +  +     + +  +R EVA+++HL   ++ ++
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNV 76
Query: 115 VSLKEAC-----EDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           V L + C     + +  + LV E  +       D++   G  TE     + + ++  +  
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 135
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-L 226
            H H V+HRDLKP+N L  +  +   +K  DFGL+  +      + +V + +Y APEV L
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-------- 278
           + +Y   +D+WS G I   +    P F   S+      IL  +     + WP        
Sbjct: 193 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 252
Query: 279 ---------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          ++ E  K L+ + L  +P  R++A   L HP+ Q+ ++
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 25  VPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 83
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 84  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 140
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLA--RHTDDEMTGYVATRWYRA 195
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 316 YHDPDDEPVAD 326

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 85
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 86  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTADEMTGYVATRWYRA 197
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 318 YHDPDDEPVAD 328

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/337 (24%), Positives = 138/337 (40%), Gaps = 49/337 (14%)
Query: 23  HDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           H H+++     +++    +  VP     +RY     +G G +G      D  T   +A K
Sbjct: 5   HHHSQERPTFYRQELNKTIWEVP-----ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 59
Query: 83  SISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE------ACEDDNAVHLVMELCEG 136
            +S R  ++ +      RE+ ++KH+ K+ +++ L +      + E+ N V+LV  L   
Sbjct: 60  KLS-RPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-- 115
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           G   + IV     T+     +   I+  ++  H   +IHRDLKP N       E+  LK 
Sbjct: 116 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKI 172
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFW 254
           +DFGL+      +  +  V + +Y APE++    +Y   +DIWS G I+  LL G   F 
Sbjct: 173 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 230
Query: 255 AESEQGVAQAILR-----------------------GLIDFKRDPWPNVSESAK----SL 287
                   + ILR                        L    +  + NV   A      L
Sbjct: 231 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 290
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD 324
           + +ML  D   R+TA Q L H +        + P+ D
Sbjct: 291 LEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD 327

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 85
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 86  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTADEMTGYVATRWYRA 197
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 318 YHDPDDEPVAD 328

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 39  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 97
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 98  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 154
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 155 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 209
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 269
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 270 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 329
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 330 YHDPDDEPVAD 340

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 30  VPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 88
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 89  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 145
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 146 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 200
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 260
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 261 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 320
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 321 YHDPDDEPVAD 331

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 121/300 (40%), Gaps = 38/300 (12%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-- 109
           RY    E+G G +G  Y   D  +   +A KS+        + I  VR EVA+++ L   
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAF 63
Query: 110 KNSSIVSLKEACEDDNA-----VHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIV 162
           ++ ++V L + C          V LV E  +       D+    G   E     + R  +
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFL 122
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             +   H + ++HRDLKPEN L  +      +K  DFGL+  +        +V + +Y A
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALFPVVVTLWYRA 179
Query: 223 PEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---- 277
           PEV L+  Y   +D+WS G I   +    P F   SE      I   +     D W    
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 239
Query: 278 -------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
                              P + ES   L+ +ML  +P  R++A + L+H +L   +  P
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E   DRY +D  +G+G FG      DR  +E +A K I  +K      ++  + EV +++
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLE 105
Query: 107 HLPKNSS-----IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
            + K+ +     IV LK      N + LV E+     L+D  + R       +  +TR  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYD--LLRNTNFRGVSLNLTRKF 162
Query: 162 VEVVQLCH--------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
            +  Q+C         +  +IH DLKPEN L  N K  S +K +DFG S   + G+R  +
Sbjct: 163 AQ--QMCTALLFLATPELSIIHCDLKPENILLCNPKR-SAIKIVDFGSSC--QLGQRIYQ 217
Query: 214 IVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE 258
            + S +Y +PEV L   Y   ID+WS G IL  +  G P F   +E
Sbjct: 218 XIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 31  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 89
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 90  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 146
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 147 RGLKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLA--RHTDDEMTGYVATRWYRA 201
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 261
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 321
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 322 YHDPDDEPVAD 332

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 112/241 (46%), Gaps = 26/241 (10%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G+G FG  +    R T + +A K +     +    I  +R E+ I++ L K+ ++V+L
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLL-KHENVVNL 81
Query: 118 KEACEDD--------NAVHLVMELCE---GGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            E C            +++LV + CE    G L + +V    +T      V + ++  + 
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLY 138
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYM 221
             H++ ++HRD+K  N L      +  LK  DFGL+  F   +     R+   V + +Y 
Sbjct: 139 YIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 195
Query: 222 APEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
            PE+L  +R+YGP ID+W AG I+  +    P     +EQ     I +       + WPN
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255
Query: 280 V 280
           V
Sbjct: 256 V 256

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 131/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLAF-RH 82
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 140
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----WAESEQGV-------AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F    + +    +       +Q  L  +
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L  
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 318 YYDPSDEPIAE 328

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 98
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 99  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 210
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 271 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 330
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 331 YHDPDDEPVAD 341

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 130/293 (44%), Gaps = 39/293 (13%)
Query: 58  ELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSI 114
           E+G G +G  +   D ++    +A K +  +     + +  +R EVA+++HL   ++ ++
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNV 76
Query: 115 VSLKEAC-----EDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           V L + C     + +  + LV E  +       D++   G  TE     + + ++  +  
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 135
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-L 226
            H H V+HRDLKP+N L  +  +   +K  DFGL+  +      + +V + +Y APEV L
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-------- 278
           + +Y   +D+WS G I   +    P F   S+      IL  +     + WP        
Sbjct: 193 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 252
Query: 279 ---------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          ++ E  K L+ + L  +P  R++A   L HP+ Q+ ++
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 83
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 84  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 140
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLA--RHTDDEMTGYVATRWYRA 195
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 316 YHDPDDEPVAD 326

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 84
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 85  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 196
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 317 YHDPDDEPVAD 327

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 112/241 (46%), Gaps = 26/241 (10%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G+G FG  +    R T + +A K +     +    I  +R E+ I++ L K+ ++V+L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLL-KHENVVNL 82
Query: 118 KEACEDD--------NAVHLVMELCE---GGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            E C            +++LV + CE    G L + +V    +T      V + ++  + 
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLY 139
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYM 221
             H++ ++HRD+K  N L      +  LK  DFGL+  F   +     R+   V + +Y 
Sbjct: 140 YIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 222 APEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
            PE+L  +R+YGP ID+W AG I+  +    P     +EQ     I +       + WPN
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 280 V 280
           V
Sbjct: 257 V 257

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 90
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 91  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 202
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 323 YHDPDDEPVAD 333

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 90
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 91  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 202
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 323 YHDPDDEPVAD 333

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 18  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 76
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 77  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 133
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 134 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 188
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 248
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 249 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 308
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 309 YHDPDDEPVAD 319

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 134/295 (45%), Gaps = 45/295 (15%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y+    +G G +G     ID+ + E +A K +S R  ++ +      RE+ ++KH+ ++ 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHM-QHE 83
Query: 113 SIVSLKEACEDDNAV------HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           +++ L +     +++      +LVM   +      +I+    ++E     +   +++ ++
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQMLKGLK 140
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  GV+HRDLKP N L  N  E+  LK +DFGL+         +  V + +Y APEV+
Sbjct: 141 YIHSAGVVHRDLKPGN-LAVN--EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVI 195
Query: 227 KR--NYGPEIDIWSAGVILYILLCG---------------------VP--PFWAESEQGV 261
               +Y   +DIWS G I+  +L G                     VP   F  +     
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255
Query: 262 AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           A++ ++ L    R  +    P  S  A  L+ +MLE D   RLTA Q L HP+ +
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 31  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 89
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 90  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 146
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 147 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 201
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 261
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 321
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 322 YHDPDDEPVAD 332

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 80
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 81  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 192
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 313 YHDPDDEPVAD 323

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E   DRY +D  +G+G FG      DR  +E +A K I  +K      ++  + EV +++
Sbjct: 31  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLE 86
Query: 107 HLPKNSS-----IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
            + K+ +     IV LK      N + LV E+     L+D  + R       +  +TR  
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYD--LLRNTNFRGVSLNLTRKF 143
Query: 162 VEVVQLCH--------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
            +  Q+C         +  +IH DLKPEN L  N K  S +K +DFG S   + G+R  +
Sbjct: 144 AQ--QMCTALLFLATPELSIIHCDLKPENILLCNPKR-SAIKIVDFGSSC--QLGQRIYQ 198
Query: 214 IVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE 258
            + S +Y +PEV L   Y   ID+WS G IL  +  G P F   +E
Sbjct: 199 XIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 244

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 74
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 75  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 131
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 186
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 307 YHDPDDEPVAD 317

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 17  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 75
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 76  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 132
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 133 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 187
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 307
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 308 YHDPDDEPVAD 318

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 43  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 101
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 102 -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 158
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 159 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 213
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 273
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 274 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 333
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 334 YHDPDDEPVAD 344

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 83
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 84  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 195
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 316 YHDPDDEPVAD 326

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 80
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 81  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 192
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 313 YHDPDDEPVAD 323

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 19  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 77
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 78  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 134
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 135 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 189
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 249
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 250 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 309
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 310 YHDPDDEPVAD 320

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 83
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 84  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 195
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 316 YHDPDDEPVAD 326

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 85
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 86  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 197
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 318 YHDPDDEPVAD 328

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGXVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 123/268 (45%), Gaps = 27/268 (10%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           ++ DRY +   LG G     +L  D RD R++ A K +     R        RRE     
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDV-AVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 107 HLPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            L  + +IV++ +  E +       ++VME  +G  L D +   G  T + A  V     
Sbjct: 68  AL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSE---IVGSP 218
           + +   H++G+IHRD+KP N + +     + +K +DFG++      G   ++   ++G+ 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R       DP 
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVR------EDPI 237
Query: 278 P------NVSESAKSLVRQMLEPDPKLR 299
           P       +S    ++V + L  +P+ R
Sbjct: 238 PPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 80
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 81  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 192
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 313 YHDPDDEPVAD 323

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 17  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 75
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 76  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 132
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 133 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 187
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 307
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 308 YHDPDDEPVAD 318

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +SK   ++ +      RE+ ++KH+
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSK-PFQSIIHAKRTYRELRLLKHM 90
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 91  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 202
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 323 YHDPDDEPVAD 333

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 127/311 (40%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 98
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 99  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +     V + +Y A
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMXGXVATRWYRA 210
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 330
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 331 YHDPDDEPVAD 341

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 112/241 (46%), Gaps = 26/241 (10%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G+G FG  +    R T + +A K +     +    I  +R E+ I++ L K+ ++V+L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLL-KHENVVNL 82
Query: 118 KEACEDDNA--------VHLVMELCE---GGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            E C    +        ++LV + CE    G L + +V    +T      V + ++  + 
Sbjct: 83  IEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLY 139
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYM 221
             H++ ++HRD+K  N L      +  LK  DFGL+  F   +     R+   V + +Y 
Sbjct: 140 YIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 222 APEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
            PE+L  +R+YGP ID+W AG I+  +    P     +EQ     I +       + WPN
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 280 V 280
           V
Sbjct: 257 V 257

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 27/268 (10%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           ++ DRY +   LG G     +L  D RD R++ A K +     R        RRE     
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDV-AVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 107 HLPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            L  + +IV++ +  E +       ++VME  +G  L D +   G  T + A  V     
Sbjct: 68  AL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSE---IVGSP 218
           + +   H++G+IHRD+KP N L +     + +K +DFG++      G    +   ++G+ 
Sbjct: 127 QALNFSHQNGIIHRDVKPANILIS---ATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R       DP 
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPI 237
Query: 278 P------NVSESAKSLVRQMLEPDPKLR 299
           P       +S    ++V + L  +P+ R
Sbjct: 238 PPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 127/311 (40%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 43  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 101
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 102 -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 158
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +     V + +Y A
Sbjct: 159 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMXGYVATRWYRA 213
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 273
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 274 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 333
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 334 YHDPDDEPVAD 344

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 38/200 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKKAPNVPLGD 324
            +EHP+     K  + P  D
Sbjct: 318 AMEHPYFYPVVKEQSQPCAD 337

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 139/305 (45%), Gaps = 49/305 (16%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y + R+LGRG++   +  I+    E +A K +   K +         RE+ I+++L 
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIK------REIKILENLR 89
Query: 110 KNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +I++L +  +D       LV E     + F ++      T+         I++ +  
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N L  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 147 CHSMGIMHRDVKPHNVLIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF------K 273
             + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+      +
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 274 RDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            DP  N                      VS  A   + ++L  D + RLTA++ +EHP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 312 QNAKK 316
               K
Sbjct: 325 YTVVK 329

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 123/268 (45%), Gaps = 27/268 (10%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           ++ DRY +   LG G     +L  D RD R++ A K +     R        RRE     
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDV-AVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 107 HLPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            L  + +IV++ +  E +       ++VME  +G  L D +   G  T + A  V     
Sbjct: 68  AL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSE---IVGSP 218
           + +   H++G+IHRD+KP N + +     + +K +DFG++      G   ++   ++G+ 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R       DP 
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPI 237
Query: 278 P------NVSESAKSLVRQMLEPDPKLR 299
           P       +S    ++V + L  +P+ R
Sbjct: 238 PPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 131/296 (44%), Gaps = 47/296 (15%)
Query: 52  RYLVDRE----LGRGEFGVTYLCIDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIMK 106
           RY  D E    LG+G FG          R  L  +  + +K+R T   +  +  EV ++ 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVV-----KARNALDSRYYAIKKIRHTEEKLSTILSEVMLLA 57
Query: 107 HLP------------KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
            L             +  + V    A +  + + + ME CE G L+D I +     +R  
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 155 A-AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK------- 206
              + R I+E +   H  G+IHRDLKP N +F ++  N  +K  DFGL+           
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMN-IFIDESRN--VKIGDFGLAKNVHRSLDILK 174
Query: 207 ------PG--ERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAE 256
                 PG  +  +  +G+  Y+A EVL    +Y  +ID++S G+I + ++    PF   
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231
Query: 257 SEQGVAQAILRGL-IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            E+      LR + I+F  D   N  +  K ++R +++ DP  R  A+ +L   WL
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 39/289 (13%)
Query: 58  ELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSI 114
           E+G G +G  +   D ++    +A K +  +     + +  +R EVA+++HL   ++ ++
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNV 76
Query: 115 VSLKEAC-----EDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           V L + C     + +  + LV E  +       D++   G  TE     + + ++  +  
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 135
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-L 226
            H H V+HRDLKP+N L  +  +   +K  DFGL+  +      + +V + +Y APEV L
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-------- 278
           + +Y   +D+WS G I   +    P F   S+      IL  +     + WP        
Sbjct: 193 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 252
Query: 279 ---------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                          ++ E  K L+ + L  +P  R++A   L HP+ Q
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E   DRY +D  +G+G FG      DR  +E +A K I  +K      ++  + EV +++
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLE 105
Query: 107 HLPKNSS-----IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
            + K+ +     IV LK      N + LV E+     L+D  + R       +  +TR  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYD--LLRNTNFRGVSLNLTRKF 162
Query: 162 VEVVQLCH--------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
            +  Q+C         +  +IH DLKPEN L  N K  + +K +DFG S   + G+R  +
Sbjct: 163 AQ--QMCTALLFLATPELSIIHCDLKPENILLCNPKRXA-IKIVDFGSSC--QLGQRIYQ 217
Query: 214 IVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE 258
            + S +Y +PEV L   Y   ID+WS G IL  +  G P F   +E
Sbjct: 218 XIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 27/259 (10%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +G G +G      D   R+ +A K +S R  ++ +      RE+ ++KHL K+ +++ 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHL-KHENVIG 83
Query: 117 LKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           L +      + ED + V+LV  L   G   + IV     ++     +   ++  ++  H 
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-- 228
            G+IHRDLKP N       E+  L+ +DFGL+   +  E  +  V + +Y APE++    
Sbjct: 142 AGIIHRDLKPSNVAV---NEDCELRILDFGLA--RQADEEMTGYVATRWYRAPEIMLNWM 196
Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-----SES 283
           +Y   +DIWS G I+  LL G   F       + Q  L+ +++    P P V     SE 
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALF--PGSDYIDQ--LKRIMEVVGTPSPEVLAKISSEH 252
Query: 284 AKSLVRQMLEPDPKLRLTA 302
           A++ + Q L P P+  L++
Sbjct: 253 ARTYI-QSLPPMPQKDLSS 270

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +D+GL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDYGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 123/303 (40%), Gaps = 41/303 (13%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSI---SKRKLRTAVDIDDVRREVAIMKHL 108
           RY    E+G G +G  Y   D  +   +A KS+   +       + I  VR EVA+++ L
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRL 68
Query: 109 P--KNSSIVSLKEACEDDNA-----VHLVMELCEGG--ELFDRIVARGHYTERAAAAVTR 159
              ++ ++V L + C          V LV E  +       D+    G   E     + R
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMR 127
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
             +  +   H + ++HRDLKPEN L  +      +K  DFGL+  +      + +V + +
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 220 YMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW- 277
           Y APEV L+  Y   +D+WS G I   +    P F   SE      I   +     D W 
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244
Query: 278 ----------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
                                 P + ES   L+ +ML  +P  R++A + L+H +L   +
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304
Query: 316 KAP 318
             P
Sbjct: 305 GNP 307

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 138/308 (44%), Gaps = 49/308 (15%)
Query: 42  AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           A VP    +D Y + R+LGRG++   +  I+    E +  K +   K +         RE
Sbjct: 34  AHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIK------RE 87
Query: 102 VAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           V I+++L   ++I+ L +  +D       LV E     + F ++      T+        
Sbjct: 88  VKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMY 144
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            +++ +  CH  G++HRD+KP N +  ++++   L+ ID+GL+ F+ P + ++  V S Y
Sbjct: 145 ELLKALDYCHSKGIMHRDVKPHNVMIDHQQKK--LRLIDWGLAEFYHPAQEYNVRVASRY 202
Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG------ 268
           +  PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G      
Sbjct: 203 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYG 262
Query: 269 ----------------LIDFKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAK 303
                           L    R  W N         VS  A  L+ ++L  D + RLTAK
Sbjct: 263 YLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAK 322
Query: 304 QVLEHPWL 311
           + +EHP+ 
Sbjct: 323 EAMEHPYF 330

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 131/279 (46%), Gaps = 25/279 (8%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D +    ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HEC 61
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC 168
            +  IV    A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPE 224
            KH ++HRD+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+PE
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPE 173
Query: 225 VLK-RNYGPEIDIWSAGVILYILLCG---VPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
            L+  +Y  + DIWS G+ L  +  G   +PP  A+ +     AI   L     +P P +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKL 233
Query: 281 SESAKSL-----VRQMLEPDPKLRLTAKQVLEHPWLQNA 314
                SL     V + L  +P  R   KQ++ H +++ +
Sbjct: 234 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 272

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 119/267 (44%), Gaps = 25/267 (9%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ DRY +   LG G     +L  D      +A K +     R        RRE      
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 108 LPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           L  + +IV++ +  E +       ++VME  +G  L D +   G  T + A  V     +
Sbjct: 69  L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSE---IVGSPY 219
            +   H++G+IHRD+KP N + +     + +K +DFG++      G   ++   ++G+  
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R       DP P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPIP 238
Query: 279 ------NVSESAKSLVRQMLEPDPKLR 299
                  +S    ++V + L  +P+ R
Sbjct: 239 PSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DF L+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFYLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 49/305 (16%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y + R+LGRG++   +  I+    E +  K +   K +         RE+ I+++L 
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------REIKILENLR 89
Query: 110 KNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +I++L +  +D       LV E     + F ++  R   T+         I++ +  
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--RQTLTDYDIRFYMYEILKALDY 146
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF------K 273
             + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+      +
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 274 RDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            DP  N                      VS  A   + ++L  D + RLTA++ +EHP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 312 QNAKK 316
               K
Sbjct: 325 YTVVK 329

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 119/267 (44%), Gaps = 25/267 (9%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ DRY +   LG G     +L  D      +A K +     R        RRE      
Sbjct: 26  HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 85
Query: 108 LPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           L  + +IV++ +  E +       ++VME  +G  L D +   G  T + A  V     +
Sbjct: 86  L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 144
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSE---IVGSPY 219
            +   H++G+IHRD+KP N + +     + +K +DFG++      G   ++   ++G+  
Sbjct: 145 ALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R       DP P
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPIP 255
Query: 279 ------NVSESAKSLVRQMLEPDPKLR 299
                  +S    ++V + L  +P+ R
Sbjct: 256 PSARHEGLSADLDAVVLKALAKNPENR 282

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 133/315 (42%), Gaps = 56/315 (17%)
Query: 52  RYLVDRE----LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           RYL D E    LGRG FGV +   ++      A K I  R     +  + V REV  +  
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAK 59
Query: 108 LPKNSSIVSLKEACEDDNA------------VHLVMELCEGGELFDRIVARGHYTERAAA 155
           L ++  IV    A  + N             +++ M+LC    L D +  R    ER  +
Sbjct: 60  L-EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 156 A---VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--- 209
               +   I E V+  H  G++HRDLKP N  F     +  +K  DFGL       E   
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEEEQ 175
Query: 210 ----------RFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE 258
                     R +  VG+  YM+PE +  N Y  ++DI+S G+IL+ LL    PF  + E
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME 232
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKS----LVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           +      +R L D +   +P +          +V+ ML P P  R  A  ++E+   ++ 
Sbjct: 233 R------VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286
Query: 315 KKAPNVPLGDVVRSR 329
               + P   V+R R
Sbjct: 287 ----DFPGKTVLRQR 297

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 196
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 317 AMEHPYFYTVVK 328

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 196
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 317 AMEHPYFYTVVK 328

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 31  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLX 84
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 85  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 141
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 142 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 200 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 259
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 260 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 319
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 320 QQVRAAEN 327

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 138 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 195
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 316 AMEHPYFYTVVK 327

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 127/311 (40%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK + FGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILGFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 51  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLX 104
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 105 GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 161
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 162 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 219
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 220 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIE 279
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 280 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 339
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 340 QQVRAAEN 347

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 30  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLX 83
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 84  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 140
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 141 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 319 QQVRAAEN 326

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 145 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 202
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 203 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 262
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 263 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 322
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 323 AMEHPYFYTVVK 334

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 30  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLX 83
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 84  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 140
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 141 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 319 QQVRAAEN 326

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 30  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLX 83
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 84  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 140
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 141 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 319 QQVRAAEN 326

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 128/308 (41%), Gaps = 44/308 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  +   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 49  VPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS-RPFQSIIHAKRTYRELRLLKHM 107
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 108 -KHENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 164
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 165 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 219
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         Q I+R             
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRM 279
Query: 268 -------GLIDFKRDPWPNVSES-------AKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                   +    + P  N ++        A  L+ +ML  D   R+TA + L HP+   
Sbjct: 280 PSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQ 339
Query: 314 AKKAPNVP 321
                + P
Sbjct: 340 YHDPDDEP 347

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 31  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLC 84
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 85  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 141
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 142 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 200 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 259
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 260 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 319
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 320 QQVRAAEN 327

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 32  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLC 85
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 86  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 142
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 143 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 200
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 201 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 260
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 261 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 320
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 321 QQVRAAEN 328

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 30  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLM 83
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 84  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 140
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 141 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 319 QQVRAAEN 326

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 89/316 (28%), Positives = 133/316 (42%), Gaps = 57/316 (18%)
Query: 38  ITVLA--GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           I VLA  G   E  E  Y   + +G G FGV +     ++ E+   K +  ++ +     
Sbjct: 25  IKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN---- 80
Query: 96  DDVRREVAIMKHLPKNSSIVSLKEAC------EDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ IM+ + K+ ++V LK         +D+  ++LV+E     E   R  A  HY
Sbjct: 81  ----RELQIMR-IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP--ETVYR--ASRHY 131
Query: 150 TERAAAAVTRTI-VEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
            +         I + + QL       H  G+ HRD+KP+N L      +  LK IDFG +
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSA 189
Query: 203 IFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG 260
                GE     + S YY APE++    NY   IDIWS G ++  L+ G P F  ES   
Sbjct: 190 KILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249
Query: 261 VAQAILRGLIDFKRD--------------------PW-----PNVSESAKSLVRQMLEPD 295
               I++ L    R+                    P+     P     A  L+ ++LE  
Sbjct: 250 QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYT 309
Query: 296 PKLRLTAKQVLEHPWL 311
           P  RLTA + L HP+ 
Sbjct: 310 PSARLTAIEALCHPFF 325

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 118/267 (44%), Gaps = 25/267 (9%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ DRY +   LG G     +L  D      +A K +     R        RRE      
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 108 LPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           L  + +IV++    E +       ++VME  +G  L D +   G  T + A  V     +
Sbjct: 69  L-NHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSE---IVGSPY 219
            +   H++G+IHRD+KP N + +     + +K +DFG++      G   ++   ++G+  
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R       DP P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPIP 238
Query: 279 ------NVSESAKSLVRQMLEPDPKLR 299
                  +S    ++V + L  +P+ R
Sbjct: 239 PSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 30  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLC 83
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 84  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 140
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 141 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 319 QQVRAAEN 326

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 137/299 (45%), Gaps = 32/299 (10%)
Query: 27  RKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK 86
           R EA   +KQ +  L        +D +    ELG G  GV +    + +  ++A K I  
Sbjct: 8   RLEAFLTQKQKVGELK-------DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-H 59
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
            +++ A+  + + RE+ ++ H   +  IV    A   D  + + ME  +GG L   +   
Sbjct: 60  LEIKPAIR-NQIIRELQVL-HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 117
Query: 147 GHYTERAAAAVTRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
           G   E+    V+  +++ +  L  KH ++HRD+KP N L  ++ E   +K  DFG+S   
Sbjct: 118 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS--- 171
Query: 206 KPGERFSEI----VGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQG 260
             G+    +    VG+  YM+PE L+  +Y  + DIWS G+ L  +  G  P  + S   
Sbjct: 172 --GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSG-- 227
Query: 261 VAQAILRGLIDFKRDPWPNVSESAKSL-----VRQMLEPDPKLRLTAKQVLEHPWLQNA 314
            + AI   L     +P P +     SL     V + L  +P  R   KQ++ H +++ +
Sbjct: 228 -SMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 285

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 127/311 (40%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +D GL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDAGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 125/263 (47%), Gaps = 28/263 (10%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V+  +GRG FGV  +C  +   + +A K I     R A  ++   R+++ + H     +I
Sbjct: 12  VEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIVE--LRQLSRVNH----PNI 63
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARG-----HYTERAAAAVTRTIVEVVQLCH 169
           V L  AC   N V LVME  EGG L++  V  G     +YT   A +      + V   H
Sbjct: 64  VKLYGACL--NPVCLVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 170 K---HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
                 +IHRDLKP N L       + LK  DFG +   +     +   GS  +MAPEV 
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVF 175
Query: 227 K-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW-PNVSESA 284
           +  NY  + D++S G+IL+ ++    PF  +   G A  I+  + +  R P   N+ +  
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 285 KSLVRQMLEPDPKLRLTAKQVLE 307
           +SL+ +    DP  R + +++++
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 125/263 (47%), Gaps = 28/263 (10%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V+  +GRG FGV  +C  +   + +A K I     R A  ++   R+++ + H     +I
Sbjct: 13  VEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIVE--LRQLSRVNH----PNI 64
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARG-----HYTERAAAAVTRTIVEVVQLCH 169
           V L  AC   N V LVME  EGG L++  V  G     +YT   A +      + V   H
Sbjct: 65  VKLYGACL--NPVCLVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 170 K---HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
                 +IHRDLKP N L       + LK  DFG +   +     +   GS  +MAPEV 
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVF 176
Query: 227 K-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW-PNVSESA 284
           +  NY  + D++S G+IL+ ++    PF  +   G A  I+  + +  R P   N+ +  
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 234
Query: 285 KSLVRQMLEPDPKLRLTAKQVLE 307
           +SL+ +    DP  R + +++++
Sbjct: 235 ESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 127/311 (40%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +D GL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDGGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMK-VVNH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +V + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K ++ LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCG 249
            L   Y   +DIWS GVI+  ++ G
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 127/311 (40%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +D GL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDRGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNVSESAK----SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV   A      L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 131/301 (43%), Gaps = 57/301 (18%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMK 106
           + Y+   +LG G +   Y    + T  L+A K I          TA+      REV+++K
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI------REVSLLK 55
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRI--VARGHYTERAAAAVTRTIV 162
            L K+++IV+L +    + ++ LV E  +    +  D    +   H  +     + R + 
Sbjct: 56  DL-KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL----SIFFKPGERFSEIVGSP 218
                CH+  V+HRDLKP+N L   + E   LK  DFGL    SI   P + +   V + 
Sbjct: 115 ----YCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSI---PTKTYDNEVVTL 164
Query: 219 YYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP 276
           +Y  P++L    +Y  +ID+W  G I Y +  G P F   + +     I R L     + 
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET 224
Query: 277 WPNV--SESAKS------------------------LVRQMLEPDPKLRLTAKQVLEHPW 310
           WP +  +E  K+                        L+ ++L+ + + R++A+  ++HP+
Sbjct: 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 311 L 311
Sbjct: 285 F 285

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 132/301 (43%), Gaps = 50/301 (16%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL- 117
           +G G +G     +D  T   +A K +  R  ++ +      RE+ ++KH+ ++ +++ L 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHM-RHENVIGLL 90
Query: 118 -----KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
                 E  +D    +LVM     G    +++      E     +   +++ ++  H  G
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG---SPYYMAPEVLKR- 228
           +IHRDLKP N       E+  LK +DFGL+      +  SE+ G   + +Y APEV+   
Sbjct: 149 IIHRDLKPGNLAV---NEDCELKILDFGLA-----RQADSEMXGXVVTRWYRAPEVILNW 200
Query: 229 -NYGPEIDIWSAGVILYILLCG---------------------VPP--FWAESEQGVAQA 264
             Y   +DIWS G I+  ++ G                      PP  F    +   A+ 
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260
Query: 265 ILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV 320
            ++GL + ++  +     N S  A +L+ +ML  D + R+TA + L HP+ ++     + 
Sbjct: 261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 320
Query: 321 P 321
           P
Sbjct: 321 P 321

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 130/296 (43%), Gaps = 47/296 (15%)
Query: 52  RYLVDRE----LGRGEFGVTYLCIDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIMK 106
           RY  D E    LG+G FG          R  L  +  + +K+R T   +  +  EV ++ 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVV-----KARNALDSRYYAIKKIRHTEEKLSTILSEVMLLA 57
Query: 107 HLP------------KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
            L             +  + V    A +  + + + ME CE   L+D I +     +R  
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE 117
Query: 155 A-AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK------- 206
              + R I+E +   H  G+IHRDLKP N +F ++  N  +K  DFGL+           
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMN-IFIDESRN--VKIGDFGLAKNVHRSLDILK 174
Query: 207 ------PG--ERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAE 256
                 PG  +  +  +G+  Y+A EVL    +Y  +ID++S G+I + ++    PF   
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231
Query: 257 SEQGVAQAILRGL-IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            E+      LR + I+F  D   N  +  K ++R +++ DP  R  A+ +L   WL
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 87/362 (24%), Positives = 149/362 (41%), Gaps = 68/362 (18%)
Query: 43  GVPKE---------NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV 93
           GVP E         ++  RY   + +G G +G+     D   +  +A K IS  + +T  
Sbjct: 26  GVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYC 85
Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGH 148
                 RE+ I+    ++ +++ +++       E    V++V +L E  +L+ +++    
Sbjct: 86  Q--RTLREIQILLRF-RHENVIGIRDILRASTLEAMRDVYIVQDLMET-DLY-KLLKSQQ 140
Query: 149 YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
            +          I+  ++  H   V+HRDLKP N L     +   LK  DFGL+    P 
Sbjct: 141 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCD---LKICDFGLARIADPE 197
Query: 209 ER----FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF--------- 253
                  +E V + +Y APE++   + Y   IDIWS G IL  +L   P F         
Sbjct: 198 HDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 257
Query: 254 -------WAESEQGV-------AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPD 295
                   + S++ +       A+  L+ L    +  W    P     A  L+ +ML  +
Sbjct: 258 NHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFN 317
Query: 296 PKLRLTAKQVLEHPWLQNAKKAPNVP-----------LGDVVRSRLKQ--FSMMNRFKRK 342
           P  R+T ++ L HP+L+      + P           L D+ + RLK+  F    RF+  
Sbjct: 318 PNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQPG 377
Query: 343 AL 344
            L
Sbjct: 378 VL 379

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMK-VVNH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +V + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K ++ LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCG 249
            L   Y   +DIWS GVI+  ++ G
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 128/275 (46%), Gaps = 27/275 (9%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D +    ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H  
Sbjct: 8   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HEC 64
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC 168
            +  IV    A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
            KH ++HRD+KP N L  ++ E   +K  DFG+S      E  +E VG+  YM+PE L+ 
Sbjct: 125 EKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DEMANEFVGTRSYMSPERLQG 180
Query: 228 RNYGPEIDIWSAGVILYILLCG---VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            +Y  + DIWS G+ L  +  G    PP           AI   L     +P P +  + 
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYPRPPM----------AIFELLDYIVNEPPPKLPSAV 230
Query: 285 KSL-----VRQMLEPDPKLRLTAKQVLEHPWLQNA 314
            SL     V + L  +P  R   KQ++ H +++ +
Sbjct: 231 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 265

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/330 (25%), Positives = 123/330 (37%), Gaps = 70/330 (21%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK- 110
           RY +   LG G FG    CID           I K   R     +  R E+ +++HL   
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC---EAARSEIQVLEHLNTT 71
Query: 111 --NSSI--VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA--AVTRTIVEV 164
             NS+   V + E  E    + +V EL  G   +D I   G    R      +   I + 
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKE----------------NSPLKAIDFGLSIFFKPG 208
           V   H + + H DLKPEN LF                     N  +K +DFG + +    
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DD 188
Query: 209 ERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL---YILLCGVPPFWAESEQGVAQA 264
           E  S +V + +Y APEV L   +    D+WS G IL   Y+     P   ++    + + 
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 265 IL-------------RGLIDFKRDPWPNVSESAK------------------------SL 287
           IL             R      R  W   S + +                         L
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKA 317
           +++MLE DP  R+T ++ L+HP+    KK+
Sbjct: 309 IQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 135/306 (44%), Gaps = 49/306 (16%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 30  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLC 83
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 84  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 140
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 141 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 312 QNAKKA 317
           Q  + A
Sbjct: 319 QQVRAA 324

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/359 (23%), Positives = 145/359 (40%), Gaps = 100/359 (27%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + D Y +   +GRG +G  YL  D++  + +A K ++ R     +D   + RE+ I+  L
Sbjct: 26  VPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVN-RMFEDLIDCKRILREITILNRL 84
Query: 109 PKNSSIVSLKEAC--ED---DNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTI 161
            K+  I+ L +    ED    + +++V+E+ +    +LF   +     TE+    +   +
Sbjct: 85  -KSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPI---FLTEQHVKTILYNL 140
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS------------------- 202
           +   +  H+ G+IHRDLKP N L     ++  +K  DFGL+                   
Sbjct: 141 LLGEKFIHESGIIHRDLKPANCLL---NQDCSVKICDFGLARTINSDKDIHIVNDLEEKE 197
Query: 203 IFFKPG-------ERFSEIVGSPYYMAPE--VLKRNYGPEIDIWSAGVILYILL------ 247
              +PG       ++ +  V + +Y APE  +L+ NY   IDIWS G I   LL      
Sbjct: 198 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSH 257
Query: 248 -------------------------------------------CGVPP---FWAESEQGV 261
                                                       G PP       ++Q V
Sbjct: 258 INNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEV 317
Query: 262 AQAI----LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
            + I     R  ID  +  + ++S+    L+  ML  + + R+T  + L HP+L++ +K
Sbjct: 318 IKYIKLFPTRDGIDLSK-KYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRK 375

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           E R  V R L  G F   Y   D  + RE    + +S  + +    I    +EV  MK L
Sbjct: 27  ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII----QEVCFMKKL 82
Query: 109 PKNSSIVSL-------KEACEDDNAVHLVM-ELCEGG--ELFDRIVARGHYTERAAAAVT 158
             + +IV         KE  +   A  L++ ELC+G   E   ++ +RG  +      + 
Sbjct: 83  SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142
Query: 159 RTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFS-- 212
                 VQ  H+    +IHRDLK EN L +N+     +K  DFG   +I   P   +S  
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ---GTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 213 -------EIV--GSPYYMAPEV--LKRNY--GPEIDIWSAGVILYILLCGVPPFWAESEQ 259
                  EI    +P Y  PE+  L  N+  G + DIW+ G ILY+L     PF    E 
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----ED 255
Query: 260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           G    I+ G   +   P         SL+R ML+ +P+ RL+  +V+    LQ    A N
Sbjct: 256 GAKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ--LQEIAAARN 311
Query: 320 V 320
           V
Sbjct: 312 V 312

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 16/224 (7%)
Query: 95  IDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
           I++VR+E  +   L K+ +I++L+  C  +  + LVME   GG L +R+++         
Sbjct: 50  IENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDIL 107
Query: 155 AAVTRTIVEVVQLCHKHGV---IHRDLKPENFLFANKKENSP-----LKAIDFGLSIFFK 206
                 I   +   H   +   IHRDLK  N L   K EN       LK  DFGL+  + 
Sbjct: 108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167
Query: 207 PGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI 265
              + S   G+  +MAPEV++ + +    D+WS GV+L+ LL G  PF       VA  +
Sbjct: 168 RTTKMSA-AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV 226
Query: 266 LRGLIDFKRDPWPNVS-ESAKSLVRQMLEPDPKLRLTAKQVLEH 308
               +     P P+   E    L+     PDP  R +   +L+ 
Sbjct: 227 AMNKLAL---PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 16/230 (6%)
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           REV +++   ++ +++      +D    ++ +ELC         V +  +       +T 
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA--TLQEYVEQKDFAHLGLEPITL 123
Query: 160 TIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAI--DFGLSIFFKPG----ERF 211
                  L H H   ++HRDLKP N L +    +  +KA+  DFGL      G     R 
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 212 SEIVGSPYYMAPEVL----KRNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAIL 266
           S + G+  ++APE+L    K N    +DI+SAG + Y ++  G  PF  +S Q  A  +L
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-GKSLQRQANILL 242
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                    P  +    A+ L+ +M+  DP+ R +AK VL+HP+  + +K
Sbjct: 243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 67
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 68  KRAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELD 124
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 125 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSF 180
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 241 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 300
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 301 MLVIDPAKRISVDDALQHPYI 321

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 67
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 68  KRAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELD 124
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 125 HERMSYLLYQMLXGIKHL-HSAGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSF 180
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 241 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 300
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 301 MLVIDPAKRISVDDALQHPYI 321

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 47  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 105
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 106 KRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELD 162
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 163 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSF 218
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 338
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 339 MLVIDPAKRISVDDALQHPYI 359

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 67
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 68  KRAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELD 124
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 125 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSF 180
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 241 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 300
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 301 MLVIDPAKRISVDDALQHPYI 321

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 83/330 (25%), Positives = 122/330 (36%), Gaps = 70/330 (21%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK- 110
           RY +   LG G FG    CID           I K   R     +  R E+ +++HL   
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC---EAARSEIQVLEHLNTT 71
Query: 111 --NSSI--VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA--AVTRTIVEV 164
             NS+   V + E  E    + +V EL  G   +D I   G    R      +   I + 
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKE----------------NSPLKAIDFGLSIFFKPG 208
           V   H + + H DLKPEN LF                     N  +K +DFG + +    
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DD 188
Query: 209 ERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL---YILLCGVPPFWAESEQGVAQA 264
           E  S +V   +Y APEV L   +    D+WS G IL   Y+     P   ++    + + 
Sbjct: 189 EHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 265 IL-------------RGLIDFKRDPWPNVSESAK------------------------SL 287
           IL             R      R  W   S + +                         L
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKA 317
           +++MLE DP  R+T ++ L+HP+    KK+
Sbjct: 309 IQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 67
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 68  KRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELD 124
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 125 HERMSYLLYQMLXGIKHL-HSAGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSF 180
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 241 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 300
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 301 MLVIDPAKRISVDDALQHPYI 321

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 60
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 61  KRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELD 117
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 118 HERMSYLLYQMLXGIKHL-HSAGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSF 173
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 293
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 294 MLVIDPAKRISVDDALQHPYI 314

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 47  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 105
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 106 KRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELD 162
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 163 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSF 218
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 338
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 339 MLVIDPAKRISVDDALQHPYI 359

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMK-VVNH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +V + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K ++ LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCG 249
            L   Y   +DIWS G I+  ++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 10  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 68
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 69  KRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELD 125
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 126 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSF 181
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 242 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 301
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 302 MLVIDPAKRISVDDALQHPYI 322

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 131/306 (42%), Gaps = 55/306 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ ++K +  +
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPF--------WAESEQGVA----------QAIL 266
            L   Y   +DIWS G I+  L+ G   F        W +  + +           Q  +
Sbjct: 197 ILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 256
Query: 267 RGLIDFKRDPWPNV------------SES---------AKSLVRQMLEPDPKLRLTAKQV 305
           R  ++  R  +P +            SES         A+ L+ +ML  DP  R++  + 
Sbjct: 257 RNYVE-NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 315
Query: 306 LEHPWL 311
           L HP++
Sbjct: 316 LRHPYI 321

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 10  QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 68
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 69  KRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELD 125
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 126 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSF 181
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 242 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 301
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 302 MLVIDPAKRISVDDALQHPYI 322

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 67
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 68  KRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELD 124
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 125 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSF 180
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 241 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 300
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 301 MLVIDPAKRISVDDALQHPYI 321

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 67
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 68  KRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELD 124
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 125 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSF 180
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 241 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 300
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 301 MLVIDPAKRISVDDALQHPYI 321

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 131/306 (42%), Gaps = 55/306 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ ++K +  +
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCV-NH 80
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIK 138
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 139 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEV 194
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPF--------WAES-EQ---------GVAQAIL 266
            L   Y   +DIWS G I+  L+ G   F        W +  EQ            Q  +
Sbjct: 195 ILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 254
Query: 267 RGLIDFKRDPWPNV------------SES---------AKSLVRQMLEPDPKLRLTAKQV 305
           R  ++  R  +P +            SES         A+ L+ +ML  DP  R++  + 
Sbjct: 255 RNYVE-NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 313
Query: 306 LEHPWL 311
           L HP++
Sbjct: 314 LRHPYI 319

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 3   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 61
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 62  KRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELD 118
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 119 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSF 174
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 175 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 235 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 294
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 295 MLVIDPAKRISVDDALQHPYI 315

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 8   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 66
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 67  KRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELD 123
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 124 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSF 179
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 180 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 239
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 240 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 299
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 300 MLVIDPAKRISVDDALQHPYI 320

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 3   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 61
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 62  KRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELD 118
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 119 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSF 174
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 175 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 235 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 294
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 295 MLVIDPAKRISVDDALQHPYI 315

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           +L+   LG+G     +    + T +L A K  +       VD+    RE  ++K L  + 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKL-NHK 67
Query: 113 SIVSLKEACEDDNAVH--LVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQL 167
           +IV L    E+    H  L+ME C  G L+  +    +     E     V R +V  +  
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 168 CHKHGVIHRDLKPENFL-FANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             ++G++HR++KP N +    +   S  K  DFG +   +  E+F  + G+  Y+ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMY 187
Query: 227 KR---------NYGPEIDIWSAGVILYILLCGVPPF 253
           +R          YG  +D+WS GV  Y    G  PF
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 60
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 61  KRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELD 117
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 118 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSF 173
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 293
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 294 MLVIDPAKRISVDDALQHPYI 314

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           +L+   LG+G     +    + T +L A K  +       VD+    RE  ++K L  + 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKL-NHK 67
Query: 113 SIVSLKEACEDDNAVH--LVMELCEGGELFDRIV----ARGHYTERAAAAVTRTIVEVVQ 166
           +IV L    E+    H  L+ME C  G L+  +     A G   E     V R +V  + 
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMN 126
Query: 167 LCHKHGVIHRDLKPENFL-FANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              ++G++HR++KP N +    +   S  K  DFG +   +  E+F  + G+  Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 226 LKR---------NYGPEIDIWSAGVILYILLCGVPPF 253
            +R          YG  +D+WS GV  Y    G  PF
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 111/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMK-VVNH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K ++ LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPSPEFMKKL 252
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 253 QPTVRTYVENRPK 265

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 44/287 (15%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G GEFG  + C+ R    + A K  SK+ L  +VD  +  REV     L ++S +V  
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGV 173
             A  +D+ + +  E C GG L D I        ++ E     +   +   ++  H   +
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFG-------LSIFFKPGE-----RFSEIV---GSP 218
           +H D+KP N   +  + + P  A + G         + FK G+     R S      G  
Sbjct: 135 VHMDIKPSNIFIS--RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS 192
Query: 219 YYMAPEVLKRNYG--PEIDIWSAGVILYILLCGVPPF------WAESEQGVAQAILRGLI 270
            ++A EVL+ NY   P+ DI++  + + +   G  P       W E  QG    I     
Sbjct: 193 RFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRI----- 246
Query: 271 DFKRDPWPNV-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                  P V S+    L++ M+ PDP+ R +A  +++H  L +A +
Sbjct: 247 -------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 286

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 44/287 (15%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G GEFG  + C+ R    + A K  SK+ L  +VD  +  REV     L ++S +V  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGV 173
             A  +D+ + +  E C GG L D I        ++ E     +   +   ++  H   +
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 136
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFG-------LSIFFKPGE-----RFSEIV---GSP 218
           +H D+KP N   +  + + P  A + G         + FK G+     R S      G  
Sbjct: 137 VHMDIKPSNIFIS--RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS 194
Query: 219 YYMAPEVLKRNYG--PEIDIWSAGVILYILLCGVPPF------WAESEQGVAQAILRGLI 270
            ++A EVL+ NY   P+ DI++  + + +   G  P       W E  QG    I     
Sbjct: 195 RFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRI----- 248
Query: 271 DFKRDPWPNV-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                  P V S+    L++ M+ PDP+ R +A  +++H  L +A +
Sbjct: 249 -------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 44/287 (15%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G GEFG  + C+ R    + A K  SK+ L  +VD  +  REV     L ++S +V  
Sbjct: 14  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 72
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGV 173
             A  +D+ + +  E C GG L D I        ++ E     +   +   ++  H   +
Sbjct: 73  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 132
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFG-------LSIFFKPGE-----RFSEIV---GSP 218
           +H D+KP N   +  + + P  A + G         + FK G+     R S      G  
Sbjct: 133 VHMDIKPSNIFIS--RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS 190
Query: 219 YYMAPEVLKRNYG--PEIDIWSAGVILYILLCGVPPF------WAESEQGVAQAILRGLI 270
            ++A EVL+ NY   P+ DI++  + + +   G  P       W E  QG    I     
Sbjct: 191 RFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPLPRNGDQWHEIRQGRLPRI----- 244
Query: 271 DFKRDPWPNV-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                  P V S+    L++ M+ PDP+ R +A  +++H  L +A +
Sbjct: 245 -------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 284

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            +           +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 44/287 (15%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G GEFG  + C+ R    + A K  SK+ L  +VD  +  REV     L ++S +V  
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGV 173
             A  +D+ + +  E C GG L D I        ++ E     +   +   ++  H   +
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFG-------LSIFFKPGE-----RFSEIV---GSP 218
           +H D+KP N   +  + + P  A + G         + FK G+     R S      G  
Sbjct: 135 VHMDIKPSNIFIS--RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS 192
Query: 219 YYMAPEVLKRNYG--PEIDIWSAGVILYILLCGVPPF------WAESEQGVAQAILRGLI 270
            ++A EVL+ NY   P+ DI++  + + +   G  P       W E  QG    I     
Sbjct: 193 RFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRI----- 246
Query: 271 DFKRDPWPNV-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                  P V S+    L++ M+ PDP+ R +A  +++H  L +A +
Sbjct: 247 -------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 286

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 111/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K ++ LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPSPEFMKKL 252
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 253 QPTVRTYVENRPK 265

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 47/296 (15%)
Query: 52  RYLVDRE----LGRGEFGVTYLCIDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIMK 106
           RY  D E    LG+G FG          R  L  +  + +K+R T   +  +  EV ++ 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVV-----KARNALDSRYYAIKKIRHTEEKLSTILSEVXLLA 57
Query: 107 HLP------------KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
            L             +  + V    A +  + + +  E CE   L+D I +     +R  
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE 117
Query: 155 A-AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK------- 206
              + R I+E +   H  G+IHR+LKP N +F ++  N  +K  DFGL+           
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRNLKPXN-IFIDESRN--VKIGDFGLAKNVHRSLDILK 174
Query: 207 ------PG--ERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAE 256
                 PG  +  +  +G+  Y+A EVL    +Y  +ID +S G+I +     + PF   
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFF---EXIYPFSTG 231
Query: 257 SEQGVAQAILRGL-IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            E+      LR + I+F  D   N  +  K ++R +++ DP  R  A+ +L   WL
Sbjct: 232 XERVNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I+ L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 112/235 (47%), Gaps = 27/235 (11%)
Query: 27  RKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK 86
           R EA   +KQ +  L        +D +    ELG G  GV +    + +  ++A K I  
Sbjct: 51  RLEAFLTQKQKVGELK-------DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-H 102
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
            +++ A+  + + RE+ ++ H   +  IV    A   D  + + ME  +GG L   +   
Sbjct: 103 LEIKPAIR-NQIIRELQVL-HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 160
Query: 147 GHYTERAAAAVTRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
           G   E+    V+  +++ +  L  KH ++HRD+KP N L  ++ E   +K  DFG+S   
Sbjct: 161 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS--- 214
Query: 206 KPGERFSEI----VGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCG---VPP 252
             G+    +    VG+  YM+PE L+  +Y  + DIWS G+ L  +  G   +PP
Sbjct: 215 --GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPSPEFMKKL 252
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 253 QPTVRTYVENRPK 265

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 200
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 260
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 261 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 203
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 263
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 264 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVT---ENNVMKIADFGLARDINNID 198
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 258
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 259 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 257
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 318 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/343 (23%), Positives = 135/343 (39%), Gaps = 70/343 (20%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTR----ELLACKSISKRKLRTAVDIDDVRREVAI 104
           +++RY +   LG G FG    C+D         L   K++ K K    ++I+ + +   I
Sbjct: 31  LQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEK---I 87
Query: 105 MKHLPKNSSI-VSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTI 161
            +  P N ++ V + +  +    + +  EL  G   FD +    +  Y       +   +
Sbjct: 88  NEKDPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQL 146
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKK----------------ENSPLKAIDFGLSIFF 205
            + V+  H + + H DLKPEN LF N                  +++ ++ +DFG + F 
Sbjct: 147 CQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF- 205
Query: 206 KPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ---GV 261
              E  S IV + +Y APEV L+  +    D+WS G I++    G   F     +    +
Sbjct: 206 -DHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAM 264
Query: 262 AQAIL------------------RGLIDFKRDPWPN--VSESAK---------------- 285
            + IL                  RG +D+  +      V E+ K                
Sbjct: 265 MERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQL 324
Query: 286 -SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVR 327
             L+  MLE +P  RLT  + L+HP+    +  P   L D  R
Sbjct: 325 FDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSR 367

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ ++  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMRIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 112/235 (47%), Gaps = 27/235 (11%)
Query: 27  RKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK 86
           R EA   +KQ +  L        +D +    ELG G  GV +    + +  ++A K I  
Sbjct: 16  RLEAFLTQKQKVGELK-------DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-H 67
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
            +++ A+  + + RE+ ++ H   +  IV    A   D  + + ME  +GG L   +   
Sbjct: 68  LEIKPAIR-NQIIRELQVL-HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 125
Query: 147 GHYTERAAAAVTRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
           G   E+    V+  +++ +  L  KH ++HRD+KP N L  ++ E   +K  DFG+S   
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS--- 179
Query: 206 KPGERFSEI----VGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCG---VPP 252
             G+    +    VG+  YM+PE L+  +Y  + DIWS G+ L  +  G   +PP
Sbjct: 180 --GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 30  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 87
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 145
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 146 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 201
Query: 226 -LKRNYGPEIDIWSAGVILYILLC 248
            L   Y   +D+WS G I+  ++C
Sbjct: 202 ILGMGYKENVDLWSVGCIMGEMVC 225

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
              +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 57  RELGRGEFGVTYLCIDRDT----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
            ++G G FGV Y     +T    ++L A   I+  +L+   D     +E+ +M    ++ 
Sbjct: 37  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD-----QEIKVMAKC-QHE 90
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCH 169
           ++V L     D + + LV      G L DR+         +      + +     +   H
Sbjct: 91  NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF------SEIVGSPYYMAP 223
           ++  IHRD+K  N L     E    K  DFGL+   +  E+F      S IVG+  YMAP
Sbjct: 151 ENHHIHRDIKSANILL---DEAFTAKISDFGLA---RASEKFAQTVMXSRIVGTTAYMAP 204
Query: 224 EVLKRNYGPEIDIWSAGVILYILLCGVP 251
           E L+    P+ DI+S GV+L  ++ G+P
Sbjct: 205 EALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 76
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 134
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 135 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 226 -LKRNYGPEIDIWSAGVILYILLC 248
            L   Y   +D+WS G I+  ++C
Sbjct: 191 ILGMGYKENVDLWSVGCIMGEMVC 214

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 57  RELGRGEFGVTYLCIDRDT----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
            ++G G FGV Y     +T    ++L A   I+  +L+   D     +E+ +M    ++ 
Sbjct: 31  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD-----QEIKVMAKC-QHE 84
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCH 169
           ++V L     D + + LV      G L DR+         +      + +     +   H
Sbjct: 85  NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 144
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE------IVGSPYYMAP 223
           ++  IHRD+K  N L     E    K  DFGL+   +  E+F++      IVG+  YMAP
Sbjct: 145 ENHHIHRDIKSANILL---DEAFTAKISDFGLA---RASEKFAQXVMXXRIVGTTAYMAP 198
Query: 224 EVLKRNYGPEIDIWSAGVILYILLCGVP 251
           E L+    P+ DI+S GV+L  ++ G+P
Sbjct: 199 EALRGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 83
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 142 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPCPEFMKKL 253
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 254 QPTVRTYVENRPK 266

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPCPEFMKKL 252
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 253 QPTVRTYVENRPK 265

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 57  RELGRGEFGVTYLCIDRDT----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
            ++G G FGV Y     +T    ++L A   I+  +L+   D     +E+ +M    ++ 
Sbjct: 37  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD-----QEIKVMAKC-QHE 90
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCH 169
           ++V L     D + + LV      G L DR+         +      + +     +   H
Sbjct: 91  NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE------IVGSPYYMAP 223
           ++  IHRD+K  N L     E    K  DFGL+   +  E+F++      IVG+  YMAP
Sbjct: 151 ENHHIHRDIKSANILL---DEAFTAKISDFGLA---RASEKFAQTVMXXRIVGTTAYMAP 204
Query: 224 EVLKRNYGPEIDIWSAGVILYILLCGVP 251
           E L+    P+ DI+S GV+L  ++ G+P
Sbjct: 205 EALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
              +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           + +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 141 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 197
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 257
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 258 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 297

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D +    ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HEC 61
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC 168
            +  IV    A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPE 224
            KH ++HRD+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+PE
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPE 173
Query: 225 VLK-RNYGPEIDIWSAGVILYILLCG---VPP 252
            L+  +Y  + DIWS G+ L  +  G   +PP
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           + +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 204
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 265 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D +    ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HEC 61
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC 168
            +  IV    A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPE 224
            KH ++HRD+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+PE
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPE 173
Query: 225 VLK-RNYGPEIDIWSAGVILYILLCG---VPP 252
            L+  +Y  + DIWS G+ L  +  G   +PP
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           + +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 189
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 250 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           + +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 140 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 196
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 256
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 257 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++     G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPSPEFMKKL 252
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 253 QPTVRTYVENRPK 265

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           + +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 204
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 265 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           + +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 137 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 193
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 253
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 254 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 20/192 (10%)
Query: 127 VHLVMELCEGGELFDRIVAR-GHYTERAAA-AVTRTIVEVVQLCHKHGVIHRDLKPENFL 184
           + + ME C+ G L   I  R G   ++  A  +   I + V   H   +IHRDLKP N  
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIF 168
Query: 185 FANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVIL 243
             + K+   +K  DFGL    K   + +   G+  YM+PE +  ++YG E+D+++ G+IL
Sbjct: 169 LVDTKQ---VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 225
Query: 244 YILL--CG----VPPFWAESEQGV--------AQAILRGLIDFKRDPWPNVSESAKSLVR 289
             LL  C        F+ +   G+         + +L+ L+  K +  PN SE  ++L  
Sbjct: 226 AELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 285
Query: 290 QMLEPDPKLRLT 301
               P+   R T
Sbjct: 286 WKKSPEKNERHT 297

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+            V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLC 248
            L   Y   +DIWS G I+  ++C
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVC 220

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           + +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 204
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 265 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 56  DRELGRGEFGVTYLCIDRDTRELLACKSI----SKRKLRTAVDIDDVRREVAIMKHLPKN 111
           ++++G+G FG+ +       + ++A KS+    S+ +        + +REV IM +L  +
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NH 82
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV---VQLC 168
            +IV L       N   +VME    G+L+ R++ + H  + +     R ++++   ++  
Sbjct: 83  PNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK--LRLMLDIALGIEYM 138
Query: 169 HKHG--VIHRDLKPENFLFANKKENSPL--KAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
                 ++HRDL+  N    +  EN+P+  K  DFGLS   +     S ++G+  +MAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPE 196
Query: 225 VL---KRNYGPEIDIWSAGVILYILLCGVPPF 253
            +   + +Y  + D +S  +ILY +L G  PF
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L  KH ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVLK-RNYG 231
           D+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+PE L+  +Y 
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 232 PEIDIWSAGVILYILLCG---VPP 252
            + DIWS G+ L  +  G   +PP
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L  KH ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVLK-RNYG 231
           D+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+PE L+  +Y 
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 232 PEIDIWSAGVILYILLCG---VPP 252
            + DIWS G+ L  +  G   +PP
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++     G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 27  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 84
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 142
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+            V + YY APEV
Sbjct: 143 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEV 198
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 199 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPCPEFMKKL 254
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 255 QPTVRTYVENRPK 267

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           + +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 245
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 306 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 133/311 (42%), Gaps = 53/311 (17%)
Query: 50  EDRYLVD----RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI---------- 95
           +D+Y+ D    R L +G+F    LC ++D +   A K   K  L    D           
Sbjct: 26  KDKYINDYRIIRTLNQGKFNKIILC-EKDNK-FYALKKYEKSLLEKKRDFTKSNNDKISI 83
Query: 96  ----DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--FDR--IVARG 147
               DD + E+ I+  + KN   ++ +    + + V+++ E  E   +  FD    V   
Sbjct: 84  KSKYDDFKNELQIITDI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 148 HYTERAAAAVTRTIVEVV-----QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
           +YT      V + I++ V      + ++  + HRD+KP N L     +N  +K  DFG S
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGES 199
Query: 203 IFFKPGERFSEIVGSPYYMAPEVL--KRNY-GPEIDIWSAGVILYILLCGVPPFWAE-SE 258
            +    ++     G+  +M PE    + +Y G ++DIWS G+ LY++   V PF  + S 
Sbjct: 200 EYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
Query: 259 QGVAQAILRGLIDFKRD------PWPN---------VSESAKSLVRQMLEPDPKLRLTAK 303
             +   I    I++  D      P  N         +S      ++  L  +P  R+T++
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318
Query: 304 QVLEHPWLQNA 314
             L+H WL + 
Sbjct: 319 DALKHEWLADT 329

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPCPEFMKKL 252
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 253 QPTVRTYVENRPK 265

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+            V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLC 248
            L   Y   +D+WS G I+  ++C
Sbjct: 197 ILGMGYKENVDLWSVGCIMGEMVC 220

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           + +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 204
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
              +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 265 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LGRG FG  +   D+ T    A K          V ++  R E  +      +  IV L 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKK---------VRLEVFRAEELMACAGLTSPRIVPLY 132
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A  +   V++ MEL EGG L   +  +G   E  A       +E ++  H   ++H D+
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV------GSPYYMAPE-VLKRNYG 231
           K +N L ++   ++ L   DFG ++  +P     +++      G+  +MAPE VL R+  
Sbjct: 193 KADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCD 250
Query: 232 PEIDIWSAGVILYILLCGVPPF 253
            ++D+WS+  ++  +L G  P+
Sbjct: 251 AKVDVWSSCCMMLHMLNGCHPW 272

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 130/287 (45%), Gaps = 35/287 (12%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG       R+T E++  K + +    T        +EV +M+ L ++ +++   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCL-EHPNVLKFI 73
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
                D  ++ + E  +GG L   I +    Y      +  + I   +   H   +IHRD
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133
Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFF--------------KPG--ERFSEIVGSPYYM 221
           L   N L    +EN  +   DFGL+                 KP   +R++ +VG+PY+M
Sbjct: 134 LNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT-VVGNPYWM 189
Query: 222 APEVLK-RNYGPEIDIWSAGVILYILLCGV--PPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  R+Y  ++D++S G++L  ++  V   P +          + RG +D  R   P
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLD--RYCPP 246
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK--APNVPLG 323
           N   S   +  +  + DP+ R +  + LEH WL+  +   A ++PLG
Sbjct: 247 NCPPSFFPITVRCCDLDPEKRPSFVK-LEH-WLETLRMHLAGHLPLG 291

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 56  DRELGRGEFGVTYLCIDRDTRELLACKSI----SKRKLRTAVDIDDVRREVAIMKHLPKN 111
           ++++G+G FG+ +       + ++A KS+    S+ +        + +REV IM +L  +
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NH 82
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV---VQLC 168
            +IV L       N   +VME    G+L+ R++ + H  + +     R ++++   ++  
Sbjct: 83  PNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK--LRLMLDIALGIEYM 138
Query: 169 HKHG--VIHRDLKPENFLFANKKENSPL--KAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
                 ++HRDL+  N    +  EN+P+  K  DFG S   +     S ++G+  +MAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGLLGNFQWMAPE 196
Query: 225 VL---KRNYGPEIDIWSAGVILYILLCGVPPF 253
            +   + +Y  + D +S  +ILY +L G  PF
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 29/184 (15%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           +   V   H  G+ HRD+KP+N L  N K+N+ LK  DFG +    P E     + S +Y
Sbjct: 150 LFRAVGFIHSLGICHRDIKPQN-LLVNSKDNT-LKLCDFGSAKKLIPSEPSVAXICSRFY 207
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES--EQGVAQAILRG-------- 268
            APE++     Y P ID+WS G +   L+ G P F  E+  +Q V    + G        
Sbjct: 208 RAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMI 267
Query: 269 ----------LIDFKRDPW----PNVSES-AKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                         K   W    P  + S A  L+ Q+L  +P LR+   + + HP+  +
Sbjct: 268 RMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327
Query: 314 AKKA 317
            + +
Sbjct: 328 LRNS 331

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 136/311 (43%), Gaps = 47/311 (15%)
Query: 39  TVLAGVPKENIEDRYLVDRELGRGEFGVTYL------CIDRDTRELLACKSISKRKLRTA 92
           T +  + + NI    ++ RELG G FG  +L      C ++D + L+A K+     L+ A
Sbjct: 5   TFVQHIKRHNI----VLKRELGEGAFGKVFLAECYNLCPEQD-KILVAVKT-----LKDA 54
Query: 93  VDI--DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--- 147
            D    D  RE  ++ +L ++  IV     C + + + +V E  + G+L   + A G   
Sbjct: 55  SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDA 113
Query: 148 ----------HYTERAAAAVTRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
                       T+     + + I   +V L  +H  +HRDL   N L     EN  +K 
Sbjct: 114 VLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVG---ENLLVKI 169
Query: 197 IDFGLS--IFFKPGERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVP 251
            DFG+S  ++     R       P  +M PE ++ R +  E D+WS GV+L+ I   G  
Sbjct: 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229
Query: 252 PFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           P++  S   V + I +G +  +    P   +    L+    + +P +R   K +  H  L
Sbjct: 230 PWYQLSNNEVIECITQGRVLQRPRTCP---QEVYELMLGCWQREPHMRKNIKGI--HTLL 284
Query: 312 QNAKKAPNVPL 322
           QN  KA  V L
Sbjct: 285 QNLAKASPVYL 295

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 20/225 (8%)
Query: 57  RELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +E+G G+FG+ +L   +++D    +A K+I +  +      DD   E  +M  L  +  +
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDK---VAIKTIKEGSMSE----DDFIEEAEVMMKL-SHPKL 84
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           V L   C +   + LV E  E G L D +   RG +       +   + E +    +  V
Sbjct: 85  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 144
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN- 229
           IHRDL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV   + 
Sbjct: 145 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 200
Query: 230 YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK 273
           Y  + D+WS GV+++ +   G  P+   S   V + I  G   +K
Sbjct: 201 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 245

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 20/193 (10%)
Query: 127 VHLVMELCEGGELFDRIVAR-GHYTERAAA-AVTRTIVEVVQLCHKHGVIHRDLKPENFL 184
           + + ME C+ G L   I  R G   ++  A  +   I + V   H   +I+RDLKP N  
Sbjct: 95  LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154
Query: 185 FANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVIL 243
             + K+   +K  DFGL    K   +     G+  YM+PE +  ++YG E+D+++ G+IL
Sbjct: 155 LVDTKQ---VKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 211
Query: 244 YILL--CG----VPPFWAESEQGV--------AQAILRGLIDFKRDPWPNVSESAKSLVR 289
             LL  C        F+ +   G+         + +L+ L+  K +  PN SE  ++L  
Sbjct: 212 AELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
Query: 290 QMLEPDPKLRLTA 302
               P+   R TA
Sbjct: 272 WKKSPEKNERHTA 284

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LGRG FG  +   D+ T    A K          V ++  R E  +      +  IV L 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKK---------VRLEVFRAEELMACAGLTSPRIVPLY 151
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A  +   V++ MEL EGG L   +  +G   E  A       +E ++  H   ++H D+
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 211
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKP---GERF---SEIVGSPYYMAPE-VLKRNYG 231
           K +N L ++   ++ L   DFG ++  +P   G+       I G+  +MAPE VL R+  
Sbjct: 212 KADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCD 269
Query: 232 PEIDIWSAGVILYILLCGVPPF 253
            ++D+WS+  ++  +L G  P+
Sbjct: 270 AKVDVWSSCCMMLHMLNGCHPW 291

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 56  DRELGRGEFGVTYLCIDRDTRELLACKSI----SKRKLRTAVDIDDVRREVAIMKHLPKN 111
           ++++G+G FG+ +       + ++A KS+    S+ +        + +REV IM +L  +
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NH 82
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV---VQLC 168
            +IV L       N   +VME    G+L+ R++ + H  + +     R ++++   ++  
Sbjct: 83  PNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK--LRLMLDIALGIEYM 138
Query: 169 HKHG--VIHRDLKPENFLFANKKENSPL--KAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
                 ++HRDL+  N    +  EN+P+  K  DF LS   +     S ++G+  +MAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNFQWMAPE 196
Query: 225 VL---KRNYGPEIDIWSAGVILYILLCGVPPF 253
            +   + +Y  + D +S  +ILY +L G  PF
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 57  RELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +E+G G+FG+ +L   +++D    +A K+I +     A+  +D   E  +M  L  +  +
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDK---VAIKTIRE----GAMSEEDFIEEAEVMMKL-SHPKL 64
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           V L   C +   + LV E  E G L D +   RG +       +   + E +    +  V
Sbjct: 65  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASV 124
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN- 229
           IHRDL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV   + 
Sbjct: 125 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 180
Query: 230 YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK 273
           Y  + D+WS GV+++ +   G  P+   S   V + I  G   +K
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 225

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 129 LVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN 187
           +V + CEG  L+  + A    +  +    + R     +   H   +IHRDLK  N     
Sbjct: 84  IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-- 141
Query: 188 KKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVLKRN----YGPEIDIWSAG 240
             E++ +K  DFGL+     +    +F ++ GS  +MAPEV++      Y  + D+++ G
Sbjct: 142 -HEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 200
Query: 241 VILYILLCGVPPF 253
           ++LY L+ G  P+
Sbjct: 201 IVLYELMTGQLPY 213

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I DRY +   +G G +G      D+  + ++A K I  R     +D   + RE+AI+  L
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRILREIAILNRL 109
Query: 109 PKNSSI----VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVE 163
             +  +    + + +  E  + +++V+E+ +    F ++     Y TE     +   ++ 
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS------------IFFKPGERF 211
            V+  H  G++HRDLKP N L     ++  +K  DFGL+            +   P E  
Sbjct: 168 GVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 212 SEIVGSP----------------YYMAPE--VLKRNYGPEIDIWSAGVILYILL 247
             +V  P                +Y APE  +L+ NY   ID+WS G I   LL
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 57  RELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +E+G G+FG+ +L   +++D    +A K+I +     A+  +D   E  +M  L  +  +
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDK---VAIKTIRE----GAMSEEDFIEEAEVMMKL-SHPKL 67
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           V L   C +   + LV E  E G L D +   RG +       +   + E +    +  V
Sbjct: 68  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 127
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN- 229
           IHRDL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV   + 
Sbjct: 128 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 183
Query: 230 YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK 273
           Y  + D+WS GV+++ +   G  P+   S   V + I  G   +K
Sbjct: 184 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 228

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV      R +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 79
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +       E     V+  ++  +  L  KH ++HR
Sbjct: 80  YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 139
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVLK-RNYG 231
           D+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YMAPE L+  +Y 
Sbjct: 140 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMAPERLQGTHYS 191
Query: 232 PEIDIWSAGVILYILLCG---VPP 252
            + DIWS G+ L  L  G   +PP
Sbjct: 192 VQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 39/275 (14%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSI-----SKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           ELGRG +GV        + +++A K I     S+ + R  +D+D   R V          
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC-------P 110
Query: 113 SIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYT-ERAAAAVTRTIVEVVQLCH 169
             V+   A   +  V + MEL +    + + +++ +G    E     +  +IV+ ++  H
Sbjct: 111 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 170
Query: 170 -KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-- 226
            K  VIHRD+KP N L     +   +K  DFG+S +       +   G   YMAPE +  
Sbjct: 171 SKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINP 227
Query: 227 ---KRNYGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFKRDPWPNV- 280
              ++ Y  + DIWS G+ +  L     P+  W    Q + Q +         +P P + 
Sbjct: 228 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV--------EEPSPQLP 279
Query: 281 ----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               S        Q L+ + K R T  ++++HP+ 
Sbjct: 280 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 57  RELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +E+G G+FG+ +L   +++D    +A K+I +     A+  +D   E  +M  L  +  +
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDK---VAIKTIRE----GAMSEEDFIEEAEVMMKL-SHPKL 64
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           V L   C +   + LV E  E G L D +   RG +       +   + E +    +  V
Sbjct: 65  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 124
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN- 229
           IHRDL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV   + 
Sbjct: 125 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 180
Query: 230 YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK 273
           Y  + D+WS GV+++ +   G  P+   S   V + I  G   +K
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 225

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 57  RELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +E+G G+FG+ +L   +++D    +A K+I +     A+  +D   E  +M  L  +  +
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDK---VAIKTIRE----GAMSEEDFIEEAEVMMKL-SHPKL 62
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           V L   C +   + LV E  E G L D +   RG +       +   + E +    +  V
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN- 229
           IHRDL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV   + 
Sbjct: 123 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 230 YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK 273
           Y  + D+WS GV+++ +   G  P+   S   V + I  G   +K
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 52  RYLVD-RELGRGEFG-VTYLCID---RDTRELLACKSI---SKRKLRTAVDIDDVRREVA 103
           RYL   R+LG G FG V+  C D     T E++A K++   +  + R+       ++E+ 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW-----KQEID 85
Query: 104 IMKHLPKNSSIVSLKEACEDDNA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           I++ L  +  I+  K  CED  A  + LVME    G L D       Y  R +  + + +
Sbjct: 86  ILRTL-YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD-------YLPRHSIGLAQLL 137
Query: 162 VEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFS 212
           +   Q+C      H    IHRDL   N L  N +    +K  DFGL+     G    R  
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL---VKIGDFGLAKAVPEGHEXYRVR 194
Query: 213 EIVGSP-YYMAPEVLKR-NYGPEIDIWSAGVILYILL 247
           E   SP ++ APE LK   +    D+WS GV LY LL
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 57  RELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +E+G G+FG+ +L   +++D    +A K+I +     A+  +D   E  +M  L  +  +
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDK---VAIKTIRE----GAMSEEDFIEEAEVMMKL-SHPKL 65
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           V L   C +   + LV E  E G L D +   RG +       +   + E +    +  V
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN- 229
           IHRDL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV   + 
Sbjct: 126 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 181
Query: 230 YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK 273
           Y  + D+WS GV+++ +   G  P+   S   V + I  G   +K
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 226

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 129 LVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN 187
           +V + CEG  L+  + A    +  +    + R     +   H   +IHRDLK  N     
Sbjct: 96  IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-- 153
Query: 188 KKENSPLKAIDFGLSI---FFKPGERFSEIVGSPYYMAPEVLKRN----YGPEIDIWSAG 240
             E++ +K  DFGL+     +    +F ++ GS  +MAPEV++      Y  + D+++ G
Sbjct: 154 -HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 241 VILYILLCGVPPF 253
           ++LY L+ G  P+
Sbjct: 213 IVLYELMTGQLPY 225

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 127 VHLVMELCEGGELFDRIVARGHYTERAAAA---VTRTIVEVVQLCHKHGVIHRDLKPENF 183
           +++ M+LC    L D +  R    +R       +   I E V+  H  G++HRDLKP N 
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI 195
Query: 184 LFANKKENSPLKAIDFGLSIFFKPGERFSEI-------------VGSPYYMAPEVLK-RN 229
            F     +  +K  DFGL       E    +             VG+  YM+PE +   N
Sbjct: 196 FFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNN 252
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE----SAK 285
           Y  ++DI+S G+IL+ LL     F  + E+      +R + D +   +P +         
Sbjct: 253 YSHKVDIFSLGLILFELLYS---FSTQMER------VRIITDVRNLKFPLLFTQKYPQEH 303
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            +V+ ML P P  R  A  ++E+   +N
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 129 LVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN 187
           +V + CEG  L+  +  +   +  +    + R     +   H   +IHRDLK  N     
Sbjct: 96  IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-- 153
Query: 188 KKENSPLKAIDFGLSI---FFKPGERFSEIVGSPYYMAPEVLKRN----YGPEIDIWSAG 240
             E++ +K  DFGL+     +    +F ++ GS  +MAPEV++      Y  + D+++ G
Sbjct: 154 -HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 241 VILYILLCGVPPF 253
           ++LY L+ G  P+
Sbjct: 213 IVLYELMTGQLPY 225

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 54  LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           ++   +G G FG  Y         +   K +      T       R EVA+++     + 
Sbjct: 39  MLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDP----TPEQFQAFRNEVAVLRKTRHVNI 94
Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           ++ +    +D+ A+  V + CEG  L+  + V    +       + R   + +   H   
Sbjct: 95  LLFMGYMTKDNLAI--VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN 152
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVLKRN 229
           +IHRD+K  N       E   +K  DFGL+     +   ++  +  GS  +MAPEV++  
Sbjct: 153 IIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 230 ----YGPEIDIWSAGVILYILLCGVPPF 253
               +  + D++S G++LY L+ G  P+
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 66
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D + A     +       T  
Sbjct: 67  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQ 125
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 126 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 14  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  + +   A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 70  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 127
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 128 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 64/133 (48%), Gaps = 11/133 (8%)
Query: 129 LVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN 187
           +V + CEG  L+  + +    +       + R   + +   H   +IHRDLK  N     
Sbjct: 107 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-- 164
Query: 188 KKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL----KRNYGPEIDIWSAG 240
             E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    K  Y  + D+++ G
Sbjct: 165 -HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 223
Query: 241 VILYILLCGVPPF 253
           ++LY L+ G  P+
Sbjct: 224 IVLYELMTGQLPY 236

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 64/133 (48%), Gaps = 11/133 (8%)
Query: 129 LVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN 187
           +V + CEG  L+  + +    +       + R   + +   H   +IHRDLK  N     
Sbjct: 108 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-- 165
Query: 188 KKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL----KRNYGPEIDIWSAG 240
             E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    K  Y  + D+++ G
Sbjct: 166 -HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 224
Query: 241 VILYILLCGVPPF 253
           ++LY L+ G  P+
Sbjct: 225 IVLYELMTGQLPY 237

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 17  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  + +   A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 73  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 131 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 17  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  + +   A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 73  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 131 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 12  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  + +   A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 68  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 126 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 78/334 (23%), Positives = 140/334 (41%), Gaps = 79/334 (23%)
Query: 46  KENIEDRYLVDR-ELGRGEFGVTYLCIDRDTREL--LACKSISKRKLRTAVDIDDVRREV 102
           +E +ED +  +  ++GRG +G  Y    +D ++    A K I    +  +       RE+
Sbjct: 15  RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-----CREI 69
Query: 103 AIMKHLPKNSSIVSLKEA--CEDDNAVHLVMELCEGGELFDRIVARGHYTERA------- 153
           A+++ L K+ +++SL++      D  V L+ +  E  +L+   + + H   +A       
Sbjct: 70  ALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWH--IIKFHRASKANKKPVQL 125
Query: 154 ----AAAVTRTIVEVVQLCHKHGVIHRDLKPENFL-FANKKENSPLKAIDFGLSIFF--- 205
                 ++   I++ +   H + V+HRDLKP N L      E   +K  D G +  F   
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 206 -KPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF--------- 253
            KP      +V + +Y APE+L   R+Y   IDIW+ G I   LL   P F         
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245
Query: 254 -----------------------WAESEQGVAQAILRGLIDFKRDPWPNVS--------- 281
                                  W + ++    + L  + DF+R+ + N S         
Sbjct: 246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTL--MKDFRRNTYTNCSLIKYMEKHK 303
Query: 282 ----ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                 A  L++++L  DP  R+T++Q ++ P+ 
Sbjct: 304 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 109/265 (41%), Gaps = 26/265 (9%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDT--RELLACKSISKRKLRTAVDIDDVRREV 102
           P + +  +Y V   +  G  G  YL +DR+   R ++    +              R+ +
Sbjct: 74  PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 103 AIMKHLPKNSSIVSLKEACE--DDNAVHLVMELCEGGELFDRIVARGHYTERAAA-AVTR 159
           A + H P    I +  E  +   D   ++VME   GG+   R  ++G     A A A   
Sbjct: 134 AEVVH-PSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKR--SKGQKLPVAEAIAYLL 189
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            I+  +   H  G+++ DLKPEN +   ++    LK ID G          F  + G+P 
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAVSRIN---SFGYLYGTPG 242
Query: 220 YMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           + APE+++       DI++ G  L  L   +P        G+ +           DP   
Sbjct: 243 FQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------DDPVLK 292
Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQ 304
             +S   L+R+ ++PDP+ R T  +
Sbjct: 293 TYDSYGRLLRRAIDPDPRQRFTTAE 317

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 116/275 (42%), Gaps = 39/275 (14%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSI-----SKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           ELGRG +GV        + +++A K I     S+ + R  +D+D   R V          
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC-------P 66
Query: 113 SIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYT-ERAAAAVTRTIVEVVQLCH 169
             V+   A   +  V + MEL +    + + +++ +G    E     +  +IV+ ++  H
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 170 -KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-- 226
            K  VIHRD+KP N L     +   +K  DFG+S +           G   YMAPE +  
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183
Query: 227 ---KRNYGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFKRDPWPNV- 280
              ++ Y  + DIWS G+ +  L     P+  W    Q + Q +         +P P + 
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV--------EEPSPQLP 235
Query: 281 ----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               S        Q L+ + K R T  ++++HP+ 
Sbjct: 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 109/270 (40%), Gaps = 57/270 (21%)
Query: 40  VLAGVPKE---------NIEDRYLVDRELGRGEFGVTYLC---IDRDTRELLACKSI--S 85
           +LAGV K+          + + + ++ ++G G F   YL    +     E +A K +  +
Sbjct: 1   MLAGVKKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT 60
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
              +R A        E+  +       +++ +K     ++ V + M   E     D + +
Sbjct: 61  SHPIRIAA-------ELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS 113
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL---- 201
                 R        + + ++  H+ G++HRD+KP NFL+  + +   L  +DFGL    
Sbjct: 114 LSFQEVRE---YMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYAL--VDFGLAQGT 168
Query: 202 -------------------------SIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEI 234
                                    SI     ++ +   G+P + APEVL +  N    I
Sbjct: 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAI 228
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQA 264
           D+WSAGVI   LL G  PF+  S+   A A
Sbjct: 229 DMWSAGVIFLSLLSGRYPFYKASDDLTALA 258

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 43  GVPKENIEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDD 97
           G      E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 57
Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA 155
             RE+ I+K L ++ +IV  K  C       + L+ME    G L D +       +    
Sbjct: 58  FEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 116
Query: 156 -AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-------FFK- 206
              T  I + ++       IHRDL   N L  N+     +K  DFGL+        FFK 
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEFFKV 173
Query: 207 --PGERFSEIVGSP-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
             PGE       SP ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 174 KEPGE-------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 12  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  +     A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 68  LFMGYSTAPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 126 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LGRG FG  +   D+ T    A K          V ++  R E  +      +  IV L 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKK---------VRLEVFRVEELVACAGLSSPRIVPLY 130
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A  +   V++ MEL EGG L   I   G   E  A       +E ++  H   ++H D+
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKP---GERF---SEIVGSPYYMAPE-VLKRNYG 231
           K +N L ++    + L   DFG ++  +P   G+       I G+  +MAPE V+ +   
Sbjct: 191 KADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 232 PEIDIWSAGVILYILLCGVPPF 253
            ++DIWS+  ++  +L G  P+
Sbjct: 249 AKVDIWSSCCMMLHMLNGCHPW 270

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 60  GRGEFGVTYLCIDRDT----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIV 115
           G G FGV Y     +T    ++L A   I+  +L+   D     +E+ +     ++ ++V
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD-----QEIKVXAKC-QHENLV 84
Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHKHG 172
            L     D + + LV      G L DR+         +      + +     +   H++ 
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENH 144
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF------SEIVGSPYYMAPEVL 226
            IHRD+K  N L     E    K  DFGL+   +  E+F      S IVG+  Y APE L
Sbjct: 145 HIHRDIKSANILL---DEAFTAKISDFGLA---RASEKFAQXVXXSRIVGTTAYXAPEAL 198
Query: 227 KRNYGPEIDIWSAGVILYILLCGVP 251
           +    P+ DI+S GV+L  ++ G+P
Sbjct: 199 RGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 111/261 (42%), Gaps = 40/261 (15%)
Query: 90  RTAVDIDDVR-REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH 148
           R  +D  D+   E+ ++     + +++    +   D  +++ +ELC    L D + ++  
Sbjct: 64  RMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNV 122
Query: 149 YTERAA-------AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------EN 191
             E           ++ R I   V   H   +IHRDLKP+N L +             EN
Sbjct: 123 SDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 182
Query: 192 SPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYMAPEVL----KRNYGPEIDIWSAGVI 242
             +   DFGL      G+       +   G+  + APE+L    KR     IDI+S G +
Sbjct: 183 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV 242
Query: 243 LYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE-----SAKSLVRQMLEPDP 296
            Y +L  G  PF  +  +     I+RG+  F  D    + +      A  L+ QM++ DP
Sbjct: 243 FYYILSKGKHPFGDKYSR--ESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDP 298
Query: 297 KLRLTAKQVLEHP--WLQNAK 315
             R TA +VL HP  W ++ K
Sbjct: 299 LKRPTAMKVLRHPLFWPKSKK 319

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 111/261 (42%), Gaps = 40/261 (15%)
Query: 90  RTAVDIDDVR-REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH 148
           R  +D  D+   E+ ++     + +++    +   D  +++ +ELC    L D + ++  
Sbjct: 64  RMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNV 122
Query: 149 YTERAA-------AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------EN 191
             E           ++ R I   V   H   +IHRDLKP+N L +             EN
Sbjct: 123 SDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 182
Query: 192 SPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYMAPEVL----KRNYGPEIDIWSAGVI 242
             +   DFGL      G+       +   G+  + APE+L    KR     IDI+S G +
Sbjct: 183 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV 242
Query: 243 LYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE-----SAKSLVRQMLEPDP 296
            Y +L  G  PF  +  +     I+RG+  F  D    + +      A  L+ QM++ DP
Sbjct: 243 FYYILSKGKHPFGDKYSR--ESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDP 298
Query: 297 KLRLTAKQVLEHP--WLQNAK 315
             R TA +VL HP  W ++ K
Sbjct: 299 LKRPTAMKVLRHPLFWPKSKK 319

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 64/133 (48%), Gaps = 11/133 (8%)
Query: 129 LVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN 187
           +V + CEG  L+  + +    +       + R   + +   H   +IHRDLK  N     
Sbjct: 108 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-- 165
Query: 188 KKENSPLKAIDFGLSI---FFKPGERFSEIVGSPYYMAPEVL----KRNYGPEIDIWSAG 240
             E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    K  Y  + D+++ G
Sbjct: 166 -HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 224
Query: 241 VILYILLCGVPPF 253
           ++LY L+ G  P+
Sbjct: 225 IVLYELMTGQLPY 237

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 64/133 (48%), Gaps = 11/133 (8%)
Query: 129 LVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN 187
           +V + CEG  L+  + +    +       + R   + +   H   +IHRDLK  N     
Sbjct: 100 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-- 157
Query: 188 KKENSPLKAIDFGLSI---FFKPGERFSEIVGSPYYMAPEVL----KRNYGPEIDIWSAG 240
             E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    K  Y  + D+++ G
Sbjct: 158 -HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 216
Query: 241 VILYILLCGVPPF 253
           ++LY L+ G  P+
Sbjct: 217 IVLYELMTGQLPY 229

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 12  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  + +   A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 68  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSI---FFKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 126 IHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 115/277 (41%), Gaps = 42/277 (15%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISK-----RKLRTAVDIDDVRREVAIMKHLPKNS 112
           E+G G  G  +    R T  ++A K + +        R  +D+D     V +  H     
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD-----VVLKSH--DCP 84
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQ-LCH 169
            IV        +  V + MEL   G   +++  R  G   ER    +T  IV+ +  L  
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--- 226
           KHGVIHRD+KP N L     E   +K  DFG+S      +      G   YMAPE +   
Sbjct: 143 KHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 227 ---KRNYGPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILR-------GLIDFKRD 275
              K +Y    D+WS G+ L  L  G  P+   +++  V   +L+       G + F  D
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259
Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                    +S V+  L  D + R    ++LEH +++
Sbjct: 260 --------FQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 20/221 (9%)
Query: 43  GVPKENIEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDD 97
           G      E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 57
Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA 155
             RE+ I+K L ++ +IV  K  C       + L+ME    G L D +       +    
Sbjct: 58  FEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 116
Query: 156 -AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERF 211
              T  I + ++       IHRDL   N L  N+     +K  DFGL+      K   + 
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKV 173
Query: 212 SEIVGSP-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
            E   SP ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   R+LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 10  FEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 66
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L + +       +       T  
Sbjct: 67  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQ 125
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 126 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 94
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 95  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 210
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG  +   D+ T    A K          V ++  R E  +      +  IV L 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKK---------VRLEVFRVEELVACAGLSSPRIVPLY 132
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A  +   V++ MEL EGG L   I   G   E  A       +E ++  H   ++H D+
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKP---GERF---SEIVGSPYYMAPE-VLKRNYG 231
           K +N L ++    + L   DFG ++  +P   G+       I G+  +MAPE V+ +   
Sbjct: 193 KADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 232 PEIDIWSAGVILYILLCGVPPF 253
            ++DIWS+  ++  +L G  P+
Sbjct: 251 AKVDIWSSCCMMLHMLNGCHPW 272

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 63
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 64  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 179
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 81
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 82  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 140
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 141 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 232

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG  +   D+ T    A K          V ++  R E  +      +  IV L 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKK---------VRLEVFRVEELVACAGLSSPRIVPLY 116
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A  +   V++ MEL EGG L   I   G   E  A       +E ++  H   ++H D+
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKP---GERF---SEIVGSPYYMAPE-VLKRNYG 231
           K +N L ++    + L   DFG ++  +P   G+       I G+  +MAPE V+ +   
Sbjct: 177 KADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 232 PEIDIWSAGVILYILLCGVPPF 253
            ++DIWS+  ++  +L G  P+
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPW 256

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 11  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 67
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 68  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 126
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 127 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 183
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 184 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 218

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 14  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 70
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 71  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 129
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 130 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 186
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 187 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 221

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 12  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 68
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 69  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 127
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 128 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 184
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 185 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 219

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 81
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 82  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 140
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 141 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 232

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 61
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 62  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 120
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 121 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 177
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 178 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 6   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 62
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 63  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 121
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 122 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 178
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 179 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 213

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 66
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 67  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 125
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 126 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 13  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 69
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 70  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 128
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 129 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 185
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 186 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 220

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 111/265 (41%), Gaps = 44/265 (16%)
Query: 90  RTAVDIDDVR-REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH 148
           R  +D  D+   E+ ++     + +++    +   D  +++ +ELC    L D + ++  
Sbjct: 46  RMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNV 104
Query: 149 YTERAA-------AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------EN 191
             E           ++ R I   V   H   +IHRDLKP+N L +             EN
Sbjct: 105 SDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
Query: 192 SPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYMAPEVL--------KRNYGPEIDIWS 238
             +   DFGL      G+       +   G+  + APE+L        KR     IDI+S
Sbjct: 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 239 AGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE-----SAKSLVRQML 292
            G + Y +L  G  PF  +  +     I+RG+  F  D    + +      A  L+ QM+
Sbjct: 225 MGCVFYYILSKGKHPFGDKYSR--ESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMI 280
Query: 293 EPDPKLRLTAKQVLEHP--WLQNAK 315
           + DP  R TA +VL HP  W ++ K
Sbjct: 281 DHDPLKRPTAMKVLRHPLFWPKSKK 305

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 111/265 (41%), Gaps = 44/265 (16%)
Query: 90  RTAVDIDDVR-REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH 148
           R  +D  D+   E+ ++     + +++    +   D  +++ +ELC    L D + ++  
Sbjct: 46  RMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNV 104
Query: 149 YTERAA-------AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------EN 191
             E           ++ R I   V   H   +IHRDLKP+N L +             EN
Sbjct: 105 SDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
Query: 192 SPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYMAPEVL--------KRNYGPEIDIWS 238
             +   DFGL      G+       +   G+  + APE+L        KR     IDI+S
Sbjct: 165 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 239 AGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE-----SAKSLVRQML 292
            G + Y +L  G  PF  +  +     I+RG+  F  D    + +      A  L+ QM+
Sbjct: 225 MGCVFYYILSKGKHPFGDKYSR--ESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMI 280
Query: 293 EPDPKLRLTAKQVLEHP--WLQNAK 315
           + DP  R TA +VL HP  W ++ K
Sbjct: 281 DHDPLKRPTAMKVLRHPLFWPKSKK 305

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 112/274 (40%), Gaps = 25/274 (9%)
Query: 52  RYL-VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           R+L  D E+GRG F   Y  +D +T   +A   +  RKL T  +    + E   +K L +
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEXLKGL-Q 83
Query: 111 NSSIVSLKEACEDD----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           + +IV   ++ E        + LV EL   G L   +        +   +  R I++ +Q
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQ 143
Query: 167 LCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
             H     +IHRDLK +N           +K  D GL+   K       ++G+P + APE
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATL-KRASFAKAVIGTPEFXAPE 200
Query: 225 VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI------DFKRDPWP 278
             +  Y   +D+++ G           P+   SE   A  I R +        F +   P
Sbjct: 201 XYEEKYDESVDVYAFGXCXLEXATSEYPY---SECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            V E  +  +RQ    +   R + K +L H + Q
Sbjct: 258 EVKEIIEGCIRQ----NKDERYSIKDLLNHAFFQ 287

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 135/311 (43%), Gaps = 54/311 (17%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVD-RELGRGEFGVTYLC----IDRDTRELLACKSISK 86
            ++K+P T    V   + E R+L   R+LG G FG   LC       +T E +A KS+  
Sbjct: 4   VSEKKPAT---EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAVHLVMELCEGGELFDRIV 144
                   I D+++E+ I+++L  + +IV  K  C +D  N + L+ME    G L + + 
Sbjct: 61  ES--GGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP 117
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAID 198
                  +    + + +   VQ+C           +HRDL   N L  ++ +   +K  D
Sbjct: 118 KN-----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGD 169
Query: 199 FGLSIFFKPGERFSEIV---GSP-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPF 253
           FGL+   +  +    +     SP ++ APE L ++ +    D+WS GV L+ LL      
Sbjct: 170 FGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT----- 224
Query: 254 WAESE----------------QGVAQAILRGLIDFKRDPW-PNVSESAKSLVRQMLEPDP 296
           + +S+                Q     ++  L + KR P  PN  +    L+R+  E  P
Sbjct: 225 YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQP 284
Query: 297 KLRLTAKQVLE 307
             R + + ++E
Sbjct: 285 SNRTSFQNLIE 295

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/329 (22%), Positives = 129/329 (39%), Gaps = 74/329 (22%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV------------DIDDVR 99
           RY++ R+LG G F   +L  D      +A K +   K+ T              D D+ +
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA-----A 154
            +     H+ K     + K      N VH+VM     GE    ++ +  Y  R       
Sbjct: 80  EDSMGANHILKLLDHFNHKGP----NGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYV 133
Query: 155 AAVTRTIVEVVQLCHKH-GVIHRDLKPENFLF--ANKKEN-SPLKAIDFGLSIFFKPGER 210
             +++ ++  +   H+  G+IH D+KPEN L    +  EN   +K  D G + ++   E 
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EH 191
Query: 211 FSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPF-------WAESEQGVA 262
           ++  + +  Y +PEV L   +G   DIWS   +++ L+ G   F       + + +  +A
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 263 QAI--------------------------LRGLIDFKRDPWPNV-----------SESAK 285
           Q I                          LR +   K  P  +V           ++   
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             +  ML+ DP+ R  A  ++ HPWL++ 
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/329 (22%), Positives = 129/329 (39%), Gaps = 74/329 (22%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV------------DIDDVR 99
           RY++ R+LG G F   +L  D      +A K +   K+ T              D D+ +
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA-----A 154
            +     H+ K     + K      N VH+VM     GE    ++ +  Y  R       
Sbjct: 80  EDSMGANHILKLLDHFNHKGP----NGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYV 133
Query: 155 AAVTRTIVEVVQLCHKH-GVIHRDLKPENFLF--ANKKEN-SPLKAIDFGLSIFFKPGER 210
             +++ ++  +   H+  G+IH D+KPEN L    +  EN   +K  D G + ++   E 
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EH 191
Query: 211 FSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPF-------WAESEQGVA 262
           ++  + +  Y +PEV L   +G   DIWS   +++ L+ G   F       + + +  +A
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 263 QAI--------------------------LRGLIDFKRDPWPNV-----------SESAK 285
           Q I                          LR +   K  P  +V           ++   
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             +  ML+ DP+ R  A  ++ HPWL++ 
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 128/295 (43%), Gaps = 51/295 (17%)
Query: 48  NIEDRYLVD-RELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           + E R+L   R+LG G FG   LC       +T E +A KS+          I D+++E+
Sbjct: 5   HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEI 62
Query: 103 AIMKHLPKNSSIVSLKEACEDD--NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
            I+++L  + +IV  K  C +D  N + L+ME    G L + +        +    + + 
Sbjct: 63  EILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-----KNKINLKQQ 116
Query: 161 IVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
           +   VQ+C           +HRDL   N L  ++ +   +K  DFGL+   +  +    +
Sbjct: 117 LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEXXTV 173
Query: 215 V---GSP-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE----------- 258
                SP ++ APE L ++ +    D+WS GV L+ LL      + +S+           
Sbjct: 174 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-----YCDSDSSPMALFLKMI 228
Query: 259 -----QGVAQAILRGLIDFKRDPW-PNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                Q     ++  L + KR P  PN  +    L+R+  E  P  R + + ++E
Sbjct: 229 GPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 8   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 64
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 65  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 123
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG---S 217
           I + ++       IHR+L   N L  N+     +K  DFGL+      + + ++     S
Sbjct: 124 ICKGMEYLGTKRYIHRNLATRNILVENENR---VKIGDFGLTKVLPQDKEYYKVKEPGES 180
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 181 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 215

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 112/264 (42%), Gaps = 47/264 (17%)
Query: 33  NKKQPITVLAGV------PKE----NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           + +QP+T  +GV      PK+    N ED  ++  ++GRG FG  +    R    L+A K
Sbjct: 87  STQQPLTKKSGVVLHRAVPKDKWVLNHED-LVLGEQIGRGNFGEVFSGRLRADNTLVAVK 145
Query: 83  SISKRKLRTAVDID---DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL 139
           S      R  +  D      +E  I+K    + +IV L   C     +++VMEL +GG+ 
Sbjct: 146 SC-----RETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199
Query: 140 FDRIVARGHYTERAAAAVTRTIVEVV-------QLCHKHGVIHRDLKPENFLFANKKENS 192
              +   G      A    +T++++V       +       IHRDL   N L     E +
Sbjct: 200 LTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKN 250
Query: 193 PLKAIDFGLS------IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY- 244
            LK  DFG+S      ++   G      V    + APE L    Y  E D+WS G++L+ 
Sbjct: 251 VLKISDFGMSREEADGVYAASGGLRQVPVK---WTAPEALNYGRYSSESDVWSFGILLWE 307
Query: 245 ILLCGVPPFWAESEQGVAQAILRG 268
               G  P+   S Q   + + +G
Sbjct: 308 TFSLGASPYPNLSNQQTREFVEKG 331

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +  ++G G FG  +      +   +A K + ++    A  +++  REVAIMK L ++ +I
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFH-AERVNEFLREVAIMKRL-RHPNI 96
Query: 115 VSLKEACEDDNAVHLVMELCEGGELF---DRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
           V    A      + +V E    G L+    +  AR    ER   ++   + + +   H  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 172 G--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV-GSPYYMAPEVLKR 228
              ++HRDLK  N L   K     +K  DFGLS         S+   G+P +MAPEVL+ 
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 229 NYGPE-IDIWSAGVILYIL 246
               E  D++S GVIL+ L
Sbjct: 214 EPSNEKSDVYSFGVILWEL 232

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 116/279 (41%), Gaps = 43/279 (15%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS---I 114
           E+GRG +G     + + + +++A K     ++R+ VD  + ++ +  +  + ++S    I
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVK-----RIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT------ERAAAAVTRTIVEVV-QL 167
           V    A   +    + MEL      FD+     +        E     +T   V+ +  L
Sbjct: 84  VQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
                +IHRD+KP N L      +  +K  DFG+S         +   G   YMAPE + 
Sbjct: 142 KENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198
Query: 227 ----KRNYGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFKRDPWPNV 280
               ++ Y    D+WS G+ LY L  G  P+  W      + Q +       K DP P +
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-------KGDP-PQL 250
Query: 281 SESAK--------SLVRQMLEPDPKLRLTAKQVLEHPWL 311
           S S +        + V   L  D   R   K++L+HP++
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 112/261 (42%), Gaps = 41/261 (15%)
Query: 33  NKKQPITVLAGV------PKE----NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           + +QP+T  +GV      PK+    N ED  ++  ++GRG FG  +    R    L+A K
Sbjct: 87  STQQPLTKKSGVVLHRAVPKDKWVLNHED-LVLGEQIGRGNFGEVFSGRLRADNTLVAVK 145
Query: 83  SISKRKLRTAVDID---DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL 139
           S      R  +  D      +E  I+K    + +IV L   C     +++VMEL +GG+ 
Sbjct: 146 SC-----RETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199
Query: 140 FDRIVARGHYTERAAAAVTRTIVEVV-------QLCHKHGVIHRDLKPENFLFANKKENS 192
              +   G      A    +T++++V       +       IHRDL   N L     E +
Sbjct: 200 LTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKN 250
Query: 193 PLKAIDFGLSIFFKPGERFSE--IVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILL 247
            LK  DFG+S     G   +   +   P  + APE L    Y  E D+WS G++L+    
Sbjct: 251 VLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
Query: 248 CGVPPFWAESEQGVAQAILRG 268
            G  P+   S Q   + + +G
Sbjct: 311 LGASPYPNLSNQQTREFVEKG 331

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 30/252 (11%)
Query: 42  AGVPKENIEDRYLV-DRELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDV 98
           +G+  ++I+ R +V  RELG G FG  +L  C +    +     ++   K  T     D 
Sbjct: 5   SGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF 64
Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF--------DRIV------ 144
           +RE  ++ +L ++  IV     C D + + +V E  + G+L         D ++      
Sbjct: 65  QREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 145 --ARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL 201
             A+G         +   I   +V L  +H  +HRDL   N L      N  +K  DFG+
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQH-FVHRDLATRNCLVG---ANLLVKIGDFGM 179
Query: 202 S--IFFKPGERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAE 256
           S  ++     R       P  +M PE ++ R +  E D+WS GVIL+ I   G  P++  
Sbjct: 180 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239
Query: 257 SEQGVAQAILRG 268
           S   V + I +G
Sbjct: 240 SNTEVIECITQG 251

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +  ++G G FG  +      +   +A K + ++    A  +++  REVAIMK L ++ +I
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFH-AERVNEFLREVAIMKRL-RHPNI 96
Query: 115 VSLKEACEDDNAVHLVMELCEGGELF---DRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
           V    A      + +V E    G L+    +  AR    ER   ++   + + +   H  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 172 G--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE--IVGSPYYMAPEVLK 227
              ++HR+LK  N L   K     +K  DFGLS   K     S     G+P +MAPEVL+
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYT---VKVCDFGLS-RLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 228 RNYGPE-IDIWSAGVILYIL 246
                E  D++S GVIL+ L
Sbjct: 213 DEPSNEKSDVYSFGVILWEL 232

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGAVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 37  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 88  MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 145
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 146 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 202
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 254

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGFVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 20  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 71  MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 128
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 129 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 237

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 47  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 97
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 98  MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 155
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 156 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 212
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 213 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 264

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 20  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 71  MGQF-DHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 128
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 129 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 237

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 16/256 (6%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +R  + R +G G+FG  +  I           +I   K  T+  + +   + A+      
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCH 169
           +  IV L      +N V ++MELC  GEL   +  R +  + A+  +    +   +    
Sbjct: 72  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 130
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK 227
               +HRD+   N L ++   N  +K  DFGLS + +    +    G  P  +MAPE + 
Sbjct: 131 SKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 187
Query: 228 -RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSES 283
            R +    D+W  GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +
Sbjct: 188 FRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPT 242
Query: 284 AKSLVRQMLEPDPKLR 299
             SL+ +    DP  R
Sbjct: 243 LYSLMTKCWAYDPSRR 258

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 16/256 (6%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +R  + R +G G+FG  +  I           +I   K  T+  + +   + A+      
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCH 169
           +  IV L      +N V ++MELC  GEL   +  R +  + A+  +    +   +    
Sbjct: 73  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 131
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK 227
               +HRD+   N L ++   N  +K  DFGLS + +    +    G  P  +MAPE + 
Sbjct: 132 SKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 188
Query: 228 -RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSES 283
            R +    D+W  GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +
Sbjct: 189 FRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPT 243
Query: 284 AKSLVRQMLEPDPKLR 299
             SL+ +    DP  R
Sbjct: 244 LYSLMTKCWAYDPSRR 259

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 16/256 (6%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +R  + R +G G+FG  +  I           +I   K  T+  + +   + A+      
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCH 169
           +  IV L      +N V ++MELC  GEL   +  R +  + A+  +    +   +    
Sbjct: 75  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK 227
               +HRD+   N L ++   N  +K  DFGLS + +    +    G  P  +MAPE + 
Sbjct: 134 SKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190
Query: 228 -RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSES 283
            R +    D+W  GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPT 245
Query: 284 AKSLVRQMLEPDPKLR 299
             SL+ +    DP  R
Sbjct: 246 LYSLMTKCWAYDPSRR 261

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 16/256 (6%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +R  + R +G G+FG  +  I           +I   K  T+  + +   + A+      
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCH 169
           +  IV L      +N V ++MELC  GEL   +  R +  + A+  +    +   +    
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK 227
               +HRD+   N L ++   N  +K  DFGLS + +    +    G  P  +MAPE + 
Sbjct: 126 SKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 228 -RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSES 283
            R +    D+W  GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPT 237
Query: 284 AKSLVRQMLEPDPKLR 299
             SL+ +    DP  R
Sbjct: 238 LYSLMTKCWAYDPSRR 253

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 16/256 (6%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +R  + R +G G+FG  +  I           +I   K  T+  + +   + A+      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCH 169
           +  IV L      +N V ++MELC  GEL   +  R +  + A+  +    +   +    
Sbjct: 70  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK 227
               +HRD+   N L ++   N  +K  DFGLS + +    +    G  P  +MAPE + 
Sbjct: 129 SKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 228 -RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSES 283
            R +    D+W  GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPT 240
Query: 284 AKSLVRQMLEPDPKLR 299
             SL+ +    DP  R
Sbjct: 241 LYSLMTKCWAYDPSRR 256

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R +  + A+  +    +   +        +HRD+   N
Sbjct: 82  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 141
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L ++   N  +K  DFGLS + +    +    G  P  +MAPE +  R +    D+W  
Sbjct: 142 VLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 198
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 199 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 253
Query: 297 KLR 299
             R
Sbjct: 254 SRR 256

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 16/256 (6%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +R  + R +G G+FG  +  I           +I   K  T+  + +   + A+      
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCH 169
           +  IV L      +N V ++MELC  GEL   +  R +  + A+  +    +   +    
Sbjct: 98  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK 227
               +HRD+   N L ++   N  +K  DFGLS + +    +    G  P  +MAPE + 
Sbjct: 157 SKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 213
Query: 228 -RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSES 283
            R +    D+W  GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +
Sbjct: 214 FRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPT 268
Query: 284 AKSLVRQMLEPDPKLR 299
             SL+ +    DP  R
Sbjct: 269 LYSLMTKCWAYDPSRR 284

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGL+   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGL    +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDID-DVRREV 102
            E+R+L    +LG+G FG   LC    +  +T  L+A K +      +  D   D +RE+
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREI 62
Query: 103 AIMKHLPKNSSIVSLKEACEDD--NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
            I+K L  +  IV  +         ++ LVME    G L D +        RA    +R 
Sbjct: 63  QILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-----QRHRARLDASRL 116
Query: 161 IVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
           ++   Q+C           +HRDL   N L  ++     +K  DFGL+    P ++   +
Sbjct: 117 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLL-PLDKDYYV 172
Query: 215 VGSP-----YYMAPEVLKRN-YGPEIDIWSAGVILYILL 247
           V  P     ++ APE L  N +  + D+WS GV+LY L 
Sbjct: 173 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDID-DVRREV 102
            E+R+L    +LG+G FG   LC    +  +T  L+A K +      +  D   D +RE+
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREI 63
Query: 103 AIMKHLPKNSSIVSLKEACEDD--NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
            I+K L  +  IV  +         ++ LVME    G L D +        RA    +R 
Sbjct: 64  QILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-----QRHRARLDASRL 117
Query: 161 IVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
           ++   Q+C           +HRDL   N L  ++     +K  DFGL+    P ++   +
Sbjct: 118 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLL-PLDKDYYV 173
Query: 215 VGSP-----YYMAPEVLKRN-YGPEIDIWSAGVILYILL 247
           V  P     ++ APE L  N +  + D+WS GV+LY L 
Sbjct: 174 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDID-DVRREV 102
            E+R+L    +LG+G FG   LC    +  +T  L+A K +      +  D   D +RE+
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREI 75
Query: 103 AIMKHLPKNSSIVSLKEACEDD--NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
            I+K L  +  IV  +         ++ LVME    G L D +        RA    +R 
Sbjct: 76  QILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-----RHRARLDASRL 129
Query: 161 IVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
           ++   Q+C           +HRDL   N L  ++     +K  DFGL+    P ++   +
Sbjct: 130 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLL-PLDKDYYV 185
Query: 215 VGSP-----YYMAPEVLKRN-YGPEIDIWSAGVILYILL 247
           V  P     ++ APE L  N +  + D+WS GV+LY L 
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R    + A+  +    +   +        +HRD+   N
Sbjct: 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 521
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L ++   N  +K  DFGLS + +    +    G  P  +MAPE +  R +    D+W  
Sbjct: 522 VLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 578
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 579 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 633
Query: 297 KLR 299
             R
Sbjct: 634 SRR 636

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDID-DVRREV 102
            E+R+L    +LG+G FG   LC    +  +T  L+A K +      +  D   D +RE+
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREI 59
Query: 103 AIMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
            I+K L  +  IV  +          + LVME    G L D +        RA    +R 
Sbjct: 60  QILKAL-HSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL-----QRHRARLDASRL 113
Query: 161 IVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
           ++   Q+C           +HRDL   N L  ++     +K  DFGL+    P ++   +
Sbjct: 114 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLL-PLDKDXXV 169
Query: 215 VGSP-----YYMAPEVLKRN-YGPEIDIWSAGVILYILL 247
           V  P     ++ APE L  N +  + D+WS GV+LY L 
Sbjct: 170 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 73/329 (22%), Positives = 120/329 (36%), Gaps = 74/329 (22%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRD-TRELLACKSISK-RKLRTAVDIDDVRREVAIMK 106
           +++RY +   LG G FG    C+D    +  +A K I    K R A      R E+ ++K
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLK 71
Query: 107 HLPKNSS-----IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTR 159
            + +         V + +       + +  EL  G   F+ +       Y       +  
Sbjct: 72  KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 130
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKK----------------ENSPLKAIDFGLSI 203
            +   ++  H++ + H DLKPEN LF N +                +N+ ++  DFG + 
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 204 FFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE---- 258
           F    E  + IV + +Y  PEV L+  +    D+WS G IL+    G   F         
Sbjct: 191 F--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
Query: 259 ---QGVAQAILRGLIDFKRDP---------WPNVSESAK--------------------- 285
              + +   I   +I   R           W   S   +                     
Sbjct: 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 308
Query: 286 ---SLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L+R+MLE DP  R+T  + L HP+ 
Sbjct: 309 QLFDLMRRMLEFDPAQRITLAEALLHPFF 337

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 360 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 419
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 420 EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 477
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 478 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKW 534
Query: 218 -PYYMAPEVLK-RNYGPEIDIWSAGVILY 244
              + APE +    +  + D+WS GV+++
Sbjct: 535 PVKWYAPECINYYKFSSKSDVWSFGVLMW 563

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 76/329 (23%), Positives = 121/329 (36%), Gaps = 74/329 (22%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRD-TRELLACKSISK-RKLRTAVDIDDVRREVAIMK 106
           +++RY +   LG G FG    C+D    +  +A K I    K R A      R E+ ++K
Sbjct: 49  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLK 103
Query: 107 HLPKNSS-----IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTR 159
            + +         V + +       + +  EL  G   F+ +       Y       +  
Sbjct: 104 KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 162
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKK----------------ENSPLKAIDFGLSI 203
            +   ++  H++ + H DLKPEN LF N +                +N+ ++  DFG + 
Sbjct: 163 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 222
Query: 204 FFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAES--EQG 260
           F    E  + IV + +Y  PEV L+  +    D+WS G IL+    G   F      E  
Sbjct: 223 F--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 280
Query: 261 VAQAILRGLI---------------------DFKRDPWPNVSESAK-------------- 285
           V    + G I                     D        V E+ K              
Sbjct: 281 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 340
Query: 286 ---SLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L+R+MLE DP  R+T  + L HP+ 
Sbjct: 341 QLFDLMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + +++E C+ G L   +                + +   T
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 203
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/329 (22%), Positives = 120/329 (36%), Gaps = 74/329 (22%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRD-TRELLACKSISK-RKLRTAVDIDDVRREVAIMK 106
           +++RY +   LG G FG    C+D    +  +A K I    K R A      R E+ ++K
Sbjct: 26  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLK 80
Query: 107 HLPKNSS-----IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTR 159
            + +         V + +       + +  EL  G   F+ +       Y       +  
Sbjct: 81  KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 139
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKK----------------ENSPLKAIDFGLSI 203
            +   ++  H++ + H DLKPEN LF N +                +N+ ++  DFG + 
Sbjct: 140 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 199
Query: 204 FFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE---- 258
           F    E  + IV + +Y  PEV L+  +    D+WS G IL+    G   F         
Sbjct: 200 F--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 257
Query: 259 ---QGVAQAILRGLIDFKRDP---------WPNVSESAK--------------------- 285
              + +   I   +I   R           W   S   +                     
Sbjct: 258 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 317
Query: 286 ---SLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L+R+MLE DP  R+T  + L HP+ 
Sbjct: 318 QLFDLMRRMLEFDPAQRITLAEALLHPFF 346

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 361 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 420
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 421 EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 478
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 479 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKW 535
Query: 218 -PYYMAPEVLK-RNYGPEIDIWSAGVILY 244
              + APE +    +  + D+WS GV+++
Sbjct: 536 PVKWYAPECINYYKFSSKSDVWSFGVLMW 564

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIV 162
           +  + ++V+L  AC      + +++E C+ G L   + ++ +    Y E         + 
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLT 148
Query: 163 EVVQLCHKHGV------------IHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
               +C+   V            IHRDL   N L +   E + +K  DFGL+  I+  P 
Sbjct: 149 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 205
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 206 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 253

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 123
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + +++E C+ G L   +                + +   T
Sbjct: 124 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 183
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P 
Sbjct: 184 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 240
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 241 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + +++E C+ G L   +                + +   T
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 203
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + ++ E C+ G L   +                + +   T
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 194
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 49/280 (17%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR------EVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 23  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 80  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
                   +    +HRDL   N + A+   +  +K  DFG++          +I  + YY
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMT---------RDIYETAYY 186
Query: 221 ------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAIL 266
                       MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 246
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            G    + D   N  E    L+R   + +PK+R T  +++
Sbjct: 247 DGGYLDQPD---NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + ++ E C+ G L   +                + +   T
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 194
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 128/335 (38%), Gaps = 78/335 (23%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS--KRKLRTAVDIDDVRREVAIMK 106
           + + +LV R++G G FG   LC   D ++  A K +   K+  R+A    D+ +++    
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDD 92
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
               N      K    D    H+ +     G     I+ R +Y       +    +E+++
Sbjct: 93  INNNNIVKYHGKFMYYD----HMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILK 148
Query: 167 LCH---KHGVIHRDLKPENFLFAN----------------------KKENSPLKAIDFGL 201
             +   K  + H DLKPEN L  +                      + +++ +K IDFG 
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 202 SIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEI--DIWSAGVILYILLCGVPPFWAESE- 258
           + F    +    I+ +  Y APEV+  N G ++  D+WS G +L  L  G   F      
Sbjct: 209 ATF--KSDYHGSIINTRQYRAPEVI-LNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 259 ------QGVAQAILRGLI--------------DFKRDPWPNVSESAKSL----------- 287
                 + + Q I + ++              D  +  WP  + S  S+           
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325
Query: 288 ----------VRQMLEPDPKLRLTAKQVLEHPWLQ 312
                     +  +L+ DP LR +  ++L+H +L+
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 16  PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 75
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 76  EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 133
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 134 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKW 190
Query: 218 -PYYMAPEVLK-RNYGPEIDIWSAGVILY 244
              + APE +    +  + D+WS GV+++
Sbjct: 191 PVKWYAPECINYYKFSSKSDVWSFGVLMW 219

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 49/280 (17%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR------EVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 22  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 78
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 79  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
                   +    +HRDL   N + A+   +  +K  DFG++          +I  + YY
Sbjct: 138 IADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMT---------RDIYETDYY 185
Query: 221 ------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAIL 266
                       MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++
Sbjct: 186 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 245
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            G    + D   N  E    L+R   + +PK+R T  +++
Sbjct: 246 DGGYLDQPD---NCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 31/232 (13%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+ N++      + LG G FG           +  A   ++ + L++    D+   +  E
Sbjct: 44  PRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER-AAAAVTRT 160
           + IM HL ++ +IV+L  AC     V ++ E C  G+L + +  +    E   A A+  +
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 161 IVEVVQLCH-------------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
            +    L H                 IHRD+   N L  N       K  DFGL+     
Sbjct: 160 TLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN---GHVAKIGDFGLARDIMN 216
Query: 208 GERFSEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
              +  + G+      +MAPE +    Y  + D+WS G++L+ I   G+ P+
Sbjct: 217 DSNYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 49/280 (17%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR------EVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 23  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 80  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
                   +    +HRDL   N + A+   +  +K  DFG++          +I  + YY
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMT---------RDIYETDYY 186
Query: 221 ------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAIL 266
                       MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 246
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            G    + D   N  E    L+R   + +PK+R T  +++
Sbjct: 247 DGGYLDQPD---NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 82/196 (41%), Gaps = 42/196 (21%)
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           R  A+++   ++ ++V L      D  + ++   C  G+L + +V R  +++  +    R
Sbjct: 77  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 136
Query: 160 TI---VEVVQLCH-------------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI 203
           T+   +E     H              H V+H+DL   N L  +K     +K  D GL  
Sbjct: 137 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGL-- 191
Query: 204 FFKPGERFSEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCG 249
                  F E+  + YY            MAPE ++   +  + DIWS GV+L+ +   G
Sbjct: 192 -------FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYG 244
Query: 250 VPPFWAESEQGVAQAI 265
           + P+   S Q V + I
Sbjct: 245 LQPYCGYSNQDVVEMI 260

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 109/256 (42%), Gaps = 16/256 (6%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +R  + R +G G+FG  +  I           +I   K  T+  + +   + A+      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCH 169
           +  IV L      +N V ++MELC  GEL   +  R    + A+  +    +   +    
Sbjct: 70  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK 227
               +HRD+   N L ++   N  +K  DFGLS + +         G  P  +MAPE + 
Sbjct: 129 SKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESIN 185
Query: 228 -RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSES 283
            R +    D+W  GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPT 240
Query: 284 AKSLVRQMLEPDPKLR 299
             SL+ +    DP  R
Sbjct: 241 LYSLMTKCWAYDPSRR 256

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 2   PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 61
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 62  EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKW 176
Query: 218 -PYYMAPEVLK-RNYGPEIDIWSAGVILY 244
              + APE +    +  + D+WS GV+++
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMW 205

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 81/196 (41%), Gaps = 42/196 (21%)
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           R  A+++   ++ ++V L      D  + ++   C  G+L + +V R  +++  +    R
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 160 T----------------IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI 203
           T                I   ++    H V+H+DL   N L  +K     +K  D GL  
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGL-- 174
Query: 204 FFKPGERFSEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCG 249
                  F E+  + YY            MAPE ++   +  + DIWS GV+L+ +   G
Sbjct: 175 -------FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYG 227
Query: 250 VPPFWAESEQGVAQAI 265
           + P+   S Q V + I
Sbjct: 228 LQPYCGYSNQDVVEMI 243

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 18  PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 77
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 78  EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKW 192
Query: 218 -PYYMAPEVLK-RNYGPEIDIWSAGVILY 244
              + APE +    +  + D+WS GV+++
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMW 221

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 18  PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 77
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 78  EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKW 192
Query: 218 -PYYMAPEVLK-RNYGPEIDIWSAGVILY 244
              + APE +    +  + D+WS GV+++
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMW 221

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 8   PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 67
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 68  EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 125
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 218 -PYYMAPEVLK-RNYGPEIDIWSAGVILY 244
              + APE +    +  + D+WS GV+++
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMW 211

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 95/232 (40%), Gaps = 31/232 (13%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+ N++      + LG G FG           +  A   ++ + L++    D+   +  E
Sbjct: 44  PRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI--------------VARG 147
           + IM HL ++ +IV+L  AC     V ++ E C  G+L + +              +A  
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 148 HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
             + R     +  + + +        IHRD+   N L  N       K  DFGL+     
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN---GHVAKIGDFGLARDIMN 216
Query: 208 GERFSEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
              +  + G+      +MAPE +    Y  + D+WS G++L+ I   G+ P+
Sbjct: 217 DSNYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 33/179 (18%)
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           + + H+ GV+HRDL P N L A   +N+ +   DF L+         +  V   +Y APE
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTADANKTHYVTHRWYRAPE 203
Query: 225 VLK--RNYGPEIDIWSAGVILYIL-----LCGVPPFWAESEQGV---------------- 261
           ++   + +   +D+WSAG ++  +     L     F+ +  + V                
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS 263
Query: 262 --AQAILR-GLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
             A+  LR  L +     W    P     A  L+ +MLE +P+ R++ +Q L HP+ ++
Sbjct: 264 PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 83/192 (43%), Gaps = 17/192 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + +G+GEFG   L   R  +  + C       ++          E ++M  L  ++ +  
Sbjct: 27  QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRTIVEVVQLCHKHGVI 174
           L    E+   +++V E    G L D + +RG         +  +  + E ++    +  +
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-YMAPEVLK-RNYGP 232
           HRDL   N L +   E++  K  DFGL+   K      +    P  + APE L+ + +  
Sbjct: 140 HRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 233 EIDIWSAGVILY 244
           + D+WS G++L+
Sbjct: 194 KSDVWSFGILLW 205

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 33/179 (18%)
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           + + H+ GV+HRDL P N L A   +N+ +   DF L+         +  V   +Y APE
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTADANKTHYVTHRWYRAPE 203
Query: 225 VLK--RNYGPEIDIWSAGVILYIL-----LCGVPPFWAESEQGV---------------- 261
           ++   + +   +D+WSAG ++  +     L     F+ +  + V                
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS 263
Query: 262 --AQAILR-GLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
             A+  LR  L +     W    P     A  L+ +MLE +P+ R++ +Q L HP+ ++
Sbjct: 264 PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + +++E C+ G L   +                + +   T
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I   P 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPD 194
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 83/192 (43%), Gaps = 17/192 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + +G+GEFG   L   R  +  + C       ++          E ++M  L  ++ +  
Sbjct: 12  QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRTIVEVVQLCHKHGVI 174
           L    E+   +++V E    G L D + +RG         +  +  + E ++    +  +
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 124
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-YMAPEVLK-RNYGP 232
           HRDL   N L +   E++  K  DFGL+   K      +    P  + APE L+ + +  
Sbjct: 125 HRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 233 EIDIWSAGVILY 244
           + D+WS G++L+
Sbjct: 179 KSDVWSFGILLW 190

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V R +G G FGV +   +    + +A K   +R      D   +R E    K L   +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCT 66
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKH 171
            I ++    ++     LV++L  G  L D +   G  ++ +  A   + ++  VQ  H+ 
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 172 GVIHRDLKPENFLFA--NKKENSPLKAIDFGLSIFFK--------PGERFSEIVGSPYYM 221
            +++RD+KP+NFL    N K  + +  +DFG+  F++        P      + G+  YM
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
Query: 222 APEV-LKRNYGPEIDIWSAGVILYILLCGVPPF 253
           +    L R      D+ + G +    L G  P+
Sbjct: 186 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V R +G G FGV +   +    + +A K   +R      D   +R E    K L   +
Sbjct: 11  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCT 65
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKH 171
            I ++    ++     LV++L  G  L D +   G  ++ +  A   + ++  VQ  H+ 
Sbjct: 66  GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 124
Query: 172 GVIHRDLKPENFLFA--NKKENSPLKAIDFGLSIFFK--------PGERFSEIVGSPYYM 221
            +++RD+KP+NFL    N K  + +  +DFG+  F++        P      + G+  YM
Sbjct: 125 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 184
Query: 222 APEV-LKRNYGPEIDIWSAGVILYILLCGVPPF 253
           +    L R      D+ + G +    L G  P+
Sbjct: 185 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 217

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY + R++G G FG  YL  D    E +A K    +     + I     E  I K +
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-----ESKIYKMM 61
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQL 167
                I +++    + +   +VMEL  G  L D        ++ +    +   ++  ++ 
Sbjct: 62  QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
            H    IHRD+KP+NFL    K+ + +  IDFGL+
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 115/273 (42%), Gaps = 35/273 (12%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKNSSI 114
           ELGRG +GV         R + + +  + +++R  V+  + +R   ++ I          
Sbjct: 41  ELGRGAYGVV-----EKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFT 95
Query: 115 VSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYT-ERAAAAVTRTIVEVVQLCH-K 170
           V+   A   +  V +  EL +    + + +++ +G    E     +  +IV+ ++  H K
Sbjct: 96  VTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 155
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-----KPGERFSEIVGSPYYMAPEV 225
             VIHRD+KP N L     +   +K  DFG+S +      K  +   +   +P  + PE+
Sbjct: 156 LSVIHRDVKPSNVLINALGQ---VKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPEL 212
Query: 226 LKRNYGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFKRDPWPNV--- 280
            ++ Y  + DIWS G+    L     P+  W    Q + Q +         +P P +   
Sbjct: 213 NQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVV--------EEPSPQLPAD 264
Query: 281 --SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             S        Q L+ + K R T  ++ +HP+ 
Sbjct: 265 KFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 27/227 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI---------------VARGHYTE 151
           +  + ++V+L  AC      + +++E C+ G L   +               + +   T 
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTL 147
Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGE 209
                 +  + + ++       IHRDL   N L +   E + +K  DFGL+  I   P  
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPDX 204
Query: 210 RFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                   P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY + R++G G FG  YL  D    E +A K    +     + I     E  I K +
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-----ESKIYKMM 59
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQL 167
                I +++    + +   +VMEL  G  L D        ++ +    +   ++  ++ 
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
            H    IHRD+KP+NFL    K+ + +  IDFGL+
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + +++E C+ G L   +                + +   T
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I   P 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPD 203
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 83/192 (43%), Gaps = 17/192 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + +G+GEFG   L   R  +  + C       ++          E ++M  L  ++ +  
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRTIVEVVQLCHKHGVI 174
           L    E+   +++V E    G L D + +RG         +  +  + E ++    +  +
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-YMAPEVLK-RNYGP 232
           HRDL   N L +   E++  K  DFGL+   K      +    P  + APE L+ + +  
Sbjct: 312 HRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 233 EIDIWSAGVILY 244
           + D+WS G++L+
Sbjct: 366 KSDVWSFGILLW 377

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + ++ E C+ G L   +                + +   T
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I   P 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPD 194
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 113/284 (39%), Gaps = 43/284 (15%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G +G  +  +     E +A K  S R  ++     ++   V +++H      I S  
Sbjct: 16  VGKGRYGEVWRGLWHG--ESVAVKIFSSRDEQSWFRETEIYNTV-LLRHDNILGFIASDM 72
Query: 119 EACEDDNAVHLVMELCEGGELFD---RIVARGHYTER----AAAAVTRTIVEVVQLCHKH 171
            +      + L+    E G L+D   R     H   R    AA  +    VE+     K 
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKP 132
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPEVL 226
            + HRD K  N L    K N      D GL++    G  + +I     VG+  YMAPEVL
Sbjct: 133 AIAHRDFKSRNVLV---KSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 227 KRNYGPE-------IDIWSAGVILY-----ILLCGV-----PPFWAESEQGVAQAILRGL 269
                 +        DIW+ G++L+      ++ G+     PPF+       +   ++ +
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFEDMKKV 249
Query: 270 --IDFKRDPWPN------VSESAKSLVRQMLEPDPKLRLTAKQV 305
             +D +    PN      V      ++R+   P+P  RLTA ++
Sbjct: 250 VCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRI 293

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 108/256 (42%), Gaps = 16/256 (6%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +R  + R +G G+FG  +  I           +I   K  T+  + +   + A+      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCH 169
           +  IV L      +N V ++MELC  GEL   +  R    + A+  +    +   +    
Sbjct: 70  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK 227
               +HRD+   N L +       +K  DFGLS + +    +    G  P  +MAPE + 
Sbjct: 129 SKRFVHRDIAARNVLVS---ATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 228 -RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSES 283
            R +    D+W  GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPT 240
Query: 284 AKSLVRQMLEPDPKLR 299
             SL+ +    DP  R
Sbjct: 241 LYSLMTKCWAYDPSRR 256

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 82/183 (44%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R    + A+  +    +   +        +HRD+   N
Sbjct: 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 521
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L +       +K  DFGLS + +    +    G  P  +MAPE +  R +    D+W  
Sbjct: 522 VLVS---ATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 578
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 579 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 633
Query: 297 KLR 299
             R
Sbjct: 634 SRR 636

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 2   PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 61
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 62  EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSPY 219
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E  +       +
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENXYKAQTHGKW 176
Query: 220 ---YMAPEVLK-RNYGPEIDIWSAGVILY 244
              + APE +    +  + D+WS GV+++
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMW 205

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 118/267 (44%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +     ++  D    E  
Sbjct: 20  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEAN 70
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 71  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 128
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E ++   G+ +  
Sbjct: 129 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNE-YTAREGAKFPI 184
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 185 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 242
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 243 D---NCPEELYQLMRLCWKERPEDRPT 266

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 109/234 (46%), Gaps = 25/234 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E+I+   LV R LG G+FG  ++    ++ ++ A K++    +     ++    E  
Sbjct: 10  IPRESIK---LVKR-LGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE----EAN 60
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTI 161
           +MK L ++  +V L      +  ++++ E    G L D + +   G          +  I
Sbjct: 61  LMKTL-QHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI 119
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L +   E+   K  DFGL+   +  E ++   G+ +  
Sbjct: 120 AEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPI 175
Query: 220 -YMAPEVLKRNYG---PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + APE +  N+G    + D+WS G++LY I+  G  P+   +   V  A+ +G
Sbjct: 176 KWTAPEAI--NFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQG 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 119/275 (43%), Gaps = 39/275 (14%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR------EVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 20  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 76
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 77  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSE 213
                   +    +HRDL   N + A+   +  +K  DFG++          K G+    
Sbjct: 136 IADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLID 271
           +     +MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++ G   
Sbjct: 193 V----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 248
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            + D   N  E    L+R   + +PK+R T  +++
Sbjct: 249 DQPD---NCPERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 119/275 (43%), Gaps = 39/275 (14%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR------EVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 23  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 80  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSE 213
                   +    +HRDL   N + A+   +  +K  DFG++          K G+    
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLID 271
           +     +MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++ G   
Sbjct: 196 V----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            + D   N  E    L+R   + +PK+R T  +++
Sbjct: 252 DQPD---NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +  +      D    E  
Sbjct: 16  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 66
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 67  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 124
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E ++   G+ +  
Sbjct: 125 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNE-YTAREGAKFPI 180
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 181 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 238
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 239 D---NCPEELYQLMRLCWKERPEDRPT 262

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 65/143 (45%), Gaps = 9/143 (6%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY V R+LG G F   +LC D   +  +A K +   +  T   +D+++    + +  P +
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSD 91
Query: 112 SSIVSLKEACED-----DNAVHLVMELCEGGELFDRIVARGHYTE---RAAAAVTRTIVE 163
            +   + +  +D      N +H+ M     G    + + + +Y     R   ++ R +++
Sbjct: 92  PNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQ 151
Query: 164 VVQLCH-KHGVIHRDLKPENFLF 185
            +   H K  +IH D+KPEN L 
Sbjct: 152 GLDYLHSKCKIIHTDIKPENILM 174

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +  +      D    E  
Sbjct: 15  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 65
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 66  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 123
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E ++   G+ +  
Sbjct: 124 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNE-YTAREGAKFPI 179
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 180 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 237
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 238 D---NCPEELYQLMRLCWKERPEDRPT 261

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 8/147 (5%)
Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           +V + +  E D  +++   L  G +L   +  +G      A A+ R I   +   H  G 
Sbjct: 96  VVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---VGSPYYMAPEVLKRNY 230
            HRD+KPEN L +    +     +DFG++      E+ +++   VG+ YY APE    ++
Sbjct: 156 THRDVKPENILVS---ADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYXAPERFSESH 211
Query: 231 GP-EIDIWSAGVILYILLCGVPPFWAE 256
                DI++   +LY  L G PP+  +
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQGD 238

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +    ++++ + L+      + R    E+ I+ H
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI------------VARGHYTERAA 154
           +  + ++V+L  AC      + +++E C+ G L   +            + +   T    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFS 212
              +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P     
Sbjct: 147 IXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 213 EIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +    ++++ + L+      + R    E+ I+ H
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI------------VARGHYTERAA 154
           +  + ++V+L  AC      + +++E C+ G L   +            + +   T    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFS 212
              +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P     
Sbjct: 147 ICYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRK 203
Query: 213 EIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +  +      D    E  
Sbjct: 10  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 60
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 61  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E ++   G+ +  
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNE-YTAREGAKFPI 174
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 175 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 233 D---NCPEELYQLMRLCWKERPEDRPT 256

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 58  ELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           ELG G FG  +L      +    + L+A K++   K  +     D +RE  ++  L ++ 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTML-QHQ 80
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA----------------AA 156
            IV     C +   + +V E    G+L   + + G   +  A                A 
Sbjct: 81  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEI 214
            ++    +V L   H  +HRDL   N L     +   +K  DFG+S  I+     R    
Sbjct: 141 ASQVAAGMVYLAGLH-FVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYRVGGR 196
Query: 215 VGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL-I 270
              P  +M PE +L R +  E D+WS GV+L+ I   G  P++  S       I +G  +
Sbjct: 197 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 256
Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           +  R   P V     +++R   + +P+ R + K V  H  LQ   +AP V L
Sbjct: 257 ERPRACPPEVY----AIMRGCWQREPQQRHSIKDV--HARLQALAQAPPVYL 302

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 58  ELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           ELG G FG  +L      +    + L+A K++   K  +     D +RE  ++  L ++ 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTML-QHQ 103
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA----------------AA 156
            IV     C +   + +V E    G+L   + + G   +  A                A 
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEI 214
            ++    +V L   H  +HRDL   N L     +   +K  DFG+S  I+     R    
Sbjct: 164 ASQVAAGMVYLAGLH-FVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYRVGGR 219
Query: 215 VGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL-I 270
              P  +M PE +L R +  E D+WS GV+L+ I   G  P++  S       I +G  +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 279
Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           +  R   P V     +++R   + +P+ R + K V  H  LQ   +AP V L
Sbjct: 280 ERPRACPPEV----YAIMRGCWQREPQQRHSIKDV--HARLQALAQAPPVYL 325

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 58  ELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           ELG G FG  +L      +    + L+A K++   K  +     D +RE  ++  L ++ 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTML-QHQ 74
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA----------------AA 156
            IV     C +   + +V E    G+L   + + G   +  A                A 
Sbjct: 75  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEI 214
            ++    +V L   H  +HRDL   N L     +   +K  DFG+S  I+     R    
Sbjct: 135 ASQVAAGMVYLAGLH-FVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYRVGGR 190
Query: 215 VGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL-I 270
              P  +M PE +L R +  E D+WS GV+L+ I   G  P++  S       I +G  +
Sbjct: 191 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 250
Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           +  R   P V     +++R   + +P+ R + K V  H  LQ   +AP V L
Sbjct: 251 ERPRACPPEVY----AIMRGCWQREPQQRHSIKDV--HARLQALAQAPPVYL 296

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + ++Y + R++G G FG  YL  +  + E +A K    +     + I     E    K +
Sbjct: 7   VGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHI-----ESKFYKMM 61
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQL 167
                I S+K    + +   +VMEL  G  L D        ++ +    +   ++  ++ 
Sbjct: 62  QGGVGIPSIKWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
            H    IHRD+KP+NFL    K+ + +  IDFGL+
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +  +      D    E  
Sbjct: 5   VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 55
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 56  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 113
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E ++   G+ +  
Sbjct: 114 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNE-YTAREGAKFPI 169
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 170 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 227
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 228 D---NCPEELYQLMRLCWKERPEDRPT 251

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +     ++  D    E  
Sbjct: 18  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEAN 68
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 69  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 126
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 127 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNEXTAR-EGAKFPI 182
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 183 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 240
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 241 D---NCPEELYQLMRLCWKERPEDRPT 264

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +     ++  D    E  
Sbjct: 16  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEAN 66
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 67  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 124
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 125 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNEXTAR-EGAKFPI 180
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 181 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 238
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 239 D---NCPEELYQLMRLCWKERPEDRPT 262

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +ELG G+FGV  L   +   + +A K I +  +      D+  +E   M  L  +  +V 
Sbjct: 14  KELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSE----DEFFQEAQTMMKL-SHPKLVK 67
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA-AAVTRTIVEVVQLCHKHGVIH 175
               C  +  +++V E    G L + + + G   E +    +   + E +     H  IH
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127
Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKR-NYG 231
           RDL   N L      +  +K  DFG++ +    +  S  VG+ +   + APEV     Y 
Sbjct: 128 RDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYVSS-VGTKFPVKWSAPEVFHYFKYS 183
Query: 232 PEIDIWSAGVILY-ILLCGVPPF 253
            + D+W+ G++++ +   G  P+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPY 206

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 11/197 (5%)
Query: 54  LVDRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           L D+ELG G FG V                 I K +       D++  E  +M+ L  N 
Sbjct: 8   LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP 66
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            IV +   CE ++ + LVME+ E G L   +    H  ++    +   +   ++   +  
Sbjct: 67  YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 125
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS--PYYMAPEVLK- 227
            +HRDL   N L   +      K  DFGLS   +  E +  ++  G     + APE +  
Sbjct: 126 FVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 182
Query: 228 RNYGPEIDIWSAGVILY 244
             +  + D+WS GV+++
Sbjct: 183 YKFSSKSDVWSFGVLMW 199

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +  +      D    E  
Sbjct: 19  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 69
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 70  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 127
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 128 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNEXTAR-EGAKFPI 183
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 184 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 241
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 242 D---NCPEELYQLMRLCWKERPEDRPT 265

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 11/197 (5%)
Query: 54  LVDRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           L D+ELG G FG V                 I K +       D++  E  +M+ L  N 
Sbjct: 10  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP 68
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            IV +   CE ++ + LVME+ E G L   +    H  ++    +   +   ++   +  
Sbjct: 69  YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS--PYYMAPEVLK- 227
            +HRDL   N L   +      K  DFGLS   +  E +  ++  G     + APE +  
Sbjct: 128 FVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 228 RNYGPEIDIWSAGVILY 244
             +  + D+WS GV+++
Sbjct: 185 YKFSSKSDVWSFGVLMW 201

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +  +      D    E  
Sbjct: 10  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 60
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 61  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNEXTAR-EGAKFPI 174
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 175 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 233 D---NCPEELYQLMRLCWKERPEDRPT 256

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/280 (22%), Positives = 118/280 (42%), Gaps = 49/280 (17%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR------REVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 24  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 80
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 81  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
                   +    +HR+L   N + A+   +  +K  DFG++          +I  + YY
Sbjct: 140 IADGMAYLNAKKFVHRNLAARNCMVAH---DFTVKIGDFGMT---------RDIYETDYY 187
Query: 221 ------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAIL 266
                       MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++
Sbjct: 188 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 247
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            G    + D   N  E    L+R   + +P +R T  +++
Sbjct: 248 DGGYLDQPD---NCPERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +  +      D    E  
Sbjct: 12  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 62
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 63  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 120
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 121 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNEXTAR-EGAKFPI 176
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 177 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 234
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 235 D---NCPEELYQLMRLCWKERPEDRPT 258

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 76/180 (42%), Gaps = 13/180 (7%)
Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIVARGHYTERAA 154
           D   E +IM     + +I+ L+          +V E  E G L  F R    G +T    
Sbjct: 96  DFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQL 153
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFS 212
             + R +   ++     G +HRDL   N L      N   K  DFGLS   +  P   ++
Sbjct: 154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 213 EIVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
              G  P  + APE +  R +    D+WS GV+++ +L  G  P+W  + + V  ++  G
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/280 (22%), Positives = 118/280 (42%), Gaps = 49/280 (17%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR------REVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 23  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 80  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
                   +    +HR+L   N + A+   +  +K  DFG++          +I  + YY
Sbjct: 139 IADGMAYLNAKKFVHRNLAARNCMVAH---DFTVKIGDFGMT---------RDIYETDYY 186
Query: 221 ------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAIL 266
                       MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 246
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            G    + D   N  E    L+R   + +P +R T  +++
Sbjct: 247 DGGYLDQPD---NCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +  +      D    E  
Sbjct: 11  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 61
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 62  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 119
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 120 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNEXTAR-EGAKFPI 175
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 176 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 233
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 234 D---NCPEELYQLMRLCWKERPEDRPT 257

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +  +      D    E  
Sbjct: 10  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 60
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 61  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNEXTAR-EGAKFPI 174
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 175 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 233 D---NCPEELYQLMRLCWKERPEDRPT 256

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 27/228 (11%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+ N++      + LG G FG           +  A   ++ + L++    D+   +  E
Sbjct: 44  PRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----------YTE 151
           + IM HL ++ +IV+L  AC     V ++ E C  G+L + +  +               
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 159
Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
           R     +  + + +        IHRD+   N L  N       K  DFGL+        +
Sbjct: 160 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN---GHVAKIGDFGLARDIMNDSNY 216
Query: 212 SEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
             + G+      +MAPE +    Y  + D+WS G++L+ I   G+ P+
Sbjct: 217 I-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 27/228 (11%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+ N++      + LG G FG           +  A   ++ + L++    D+   +  E
Sbjct: 36  PRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 91
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----------YTE 151
           + IM HL ++ +IV+L  AC     V ++ E C  G+L + +  +               
Sbjct: 92  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 151
Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
           R     +  + + +        IHRD+   N L  N       K  DFGL+        +
Sbjct: 152 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN---GHVAKIGDFGLARDIMNDSNY 208
Query: 212 SEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
             + G+      +MAPE +    Y  + D+WS G++L+ I   G+ P+
Sbjct: 209 I-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 118/275 (42%), Gaps = 39/275 (14%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR------EVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 23  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 80  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSE 213
                   +    +HRDL   N + A+   +  +K  DFG++          K G+    
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLID 271
           +     +MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++ G   
Sbjct: 196 V----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            + D   N  E    L+R   + +P +R T  +++
Sbjct: 252 DQPD---NCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 9/144 (6%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY V R+LG G F   +L  D   ++ +A K +   +  T   +D++R   ++    P +
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 81
Query: 112 SSIVSLKEACEDD-----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +   + +  +D      N  H+ M     G    + + + +Y       V + I +V+Q
Sbjct: 82  PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 141
Query: 167 ----LCHKHGVIHRDLKPENFLFA 186
               L  K  +IH D+KPEN L +
Sbjct: 142 GLDYLHTKCRIIHTDIKPENILLS 165

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 9/144 (6%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY V R+LG G F   +L  D   ++ +A K +   +  T   +D++R   ++    P +
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 112 SSIVSLKEACEDD-----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +   + +  +D      N  H+ M     G    + + + +Y       V + I +V+Q
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 167 ----LCHKHGVIHRDLKPENFLFA 186
               L  K  +IH D+KPEN L +
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLS 181

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 40/241 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+EN+E      + LG G FG           +      ++ + L+   D  +   +  E
Sbjct: 43  PRENLE----FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 98
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRT 160
           + +M  L  + +IV+L  AC     ++L+ E C  G+L + + + R  ++E       + 
Sbjct: 99  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 161 IVEVVQ----------LCHKHGV------------IHRDLKPENFLFANKKENSPLKAID 198
            +E  +          LC  + V            +HRDL   N L  + K    +K  D
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK---VVKICD 215
Query: 199 FGLSIFFKPGERFSEIVGSP----YYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPP 252
           FGL+        +  + G+      +MAPE L    Y  + D+WS G++L+ I   GV P
Sbjct: 216 FGLARDIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
Query: 253 F 253
           +
Sbjct: 275 Y 275

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 109/276 (39%), Gaps = 44/276 (15%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDID--DVRREVAIMKHLPKNSSIVS 116
           +G G FG       R  ++ L   +  KR    A   D  D   E+ ++  L  + +I++
Sbjct: 33  IGEGNFGQVLKA--RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER----AAAAVTRTIVEVVQLCH--- 169
           L  ACE    ++L +E    G L D  + +    E     A A  T + +   QL H   
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 170 ----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
                     +   IHRDL   N L     EN   K  DFGLS       R  E+     
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-------RGQEVYVKKT 199
Query: 220 -------YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI 270
                  +MA E L  + Y    D+WS GV+L+ I+  G  P+   +   + + + +G  
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 257
Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ +   N  +    L+RQ     P  R +  Q+L
Sbjct: 258 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 96/234 (41%), Gaps = 33/234 (14%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+ N++      + LG G FG           +  A   ++ + L++    D+   +  E
Sbjct: 44  PRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-----------GHYT 150
           + IM HL ++ +IV+L  AC     V ++ E C  G+L + +  +            H  
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNP 159
Query: 151 ERAAAA-----VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
           E   ++      +  + + +        IHRD+   N L  N       K  DFGL+   
Sbjct: 160 EEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN---GHVAKIGDFGLARDI 216
Query: 206 KPGERFSEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                +  + G+      +MAPE +    Y  + D+WS G++L+ I   G+ P+
Sbjct: 217 MNDSNYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 16/90 (17%)
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAI--DFGLSIFFKPGERFSEI---VGSPYYMAP 223
           HK  + HRD K +N L       S L A+  DFGL++ F+PG+   +    VG+  YMAP
Sbjct: 140 HKPSIAHRDFKSKNVLL-----KSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 224 EVL------KRNYGPEIDIWSAGVILYILL 247
           EVL      +R+    ID+++ G++L+ L+
Sbjct: 195 EVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 26/226 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +    ++++ + L+      + R    E+ I+ H
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI--------------VARGHYTER 152
           +  + ++V+L  AC      + +++E C+ G L   +              + +   T  
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLE 148
Query: 153 AAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGER 210
                +  + + ++       IHRDL   N L +   E + +K  DFGL+  I   P   
Sbjct: 149 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPDXV 205
Query: 211 FSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                  P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 125/288 (43%), Gaps = 53/288 (18%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 16  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 70
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 71  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 129
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 130 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 177
Query: 213 EIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
           +I  + YY            M+PE LK   +    D+WS GV+L+ I      P+   S 
Sbjct: 178 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 237
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
           + V + ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 238 EQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 282

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 109/276 (39%), Gaps = 44/276 (15%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDID--DVRREVAIMKHLPKNSSIVS 116
           +G G FG       R  ++ L   +  KR    A   D  D   E+ ++  L  + +I++
Sbjct: 23  IGEGNFGQVLKA--RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER----AAAAVTRTIVEVVQLCH--- 169
           L  ACE    ++L +E    G L D  + +    E     A A  T + +   QL H   
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 170 ----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
                     +   IHRDL   N L     EN   K  DFGLS       R  E+     
Sbjct: 140 DVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-------RGQEVYVKKT 189
Query: 220 -------YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI 270
                  +MA E L  + Y    D+WS GV+L+ I+  G  P+   +   + + + +G  
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 247
Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ +   N  +    L+RQ     P  R +  Q+L
Sbjct: 248 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 125/288 (43%), Gaps = 53/288 (18%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 47  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 101
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 102 SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 160
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 161 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 208
Query: 213 EIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
           +I  + YY            M+PE LK   +    D+WS GV+L+ I      P+   S 
Sbjct: 209 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 268
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
           + V + ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 269 EQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 313

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 125/288 (43%), Gaps = 53/288 (18%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 12  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 67  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 126 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 173
Query: 213 EIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
           +I  + YY            M+PE LK   +    D+WS GV+L+ I      P+   S 
Sbjct: 174 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 233
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
           + V + ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 234 EQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 278

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 125/288 (43%), Gaps = 53/288 (18%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 18  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 72
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 73  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 132 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 179
Query: 213 EIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
           +I  + YY            M+PE LK   +    D+WS GV+L+ I      P+   S 
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 239
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
           + V + ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 240 EQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 284

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 125/288 (43%), Gaps = 53/288 (18%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 18  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 72
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 73  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 132 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 179
Query: 213 EIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
           +I  + YY            M+PE LK   +    D+WS GV+L+ I      P+   S 
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 239
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
           + V + ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 240 EQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 284

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 125/288 (43%), Gaps = 53/288 (18%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 19  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 73
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 74  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 133 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 180
Query: 213 EIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
           +I  + YY            M+PE LK   +    D+WS GV+L+ I      P+   S 
Sbjct: 181 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 240
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
           + V + ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 241 EQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 285

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 124/288 (43%), Gaps = 53/288 (18%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++      E 
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEF---LNEA 79
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 80  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 138
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 186
Query: 213 EIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
           +I  + YY            M+PE LK   +    D+WS GV+L+ I      P+   S 
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
           + V + ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 247 EQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 291

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 48/87 (55%), Gaps = 12/87 (13%)
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---VGSPYYMAPEV 225
           HK  + HRD+K +N L  N   N      DFGL++ F+ G+   +    VG+  YMAPEV
Sbjct: 148 HKPAISHRDIKSKNVLLKN---NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204
Query: 226 L------KRNYGPEIDIWSAGVILYIL 246
           L      +R+    ID+++ G++L+ L
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 109/265 (41%), Gaps = 49/265 (18%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N + ++L+    G G FG  Y  + RD       K   KR+   +    +          
Sbjct: 40  NFDHKFLI----GHGVFGKVYKGVLRD-----GAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
             ++  +VSL   C++ N + L+ +  E G L      + H        ++ +  + +++
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNL------KRHLYGSDLPTMSMSWEQRLEI 144
Query: 168 C----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE---- 213
           C          H   +IHRD+K  N L     EN   K  DFG+S   K G    +    
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGIS---KKGTELGQTHLX 198
Query: 214 --IVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI 270
             + G+  Y+ PE  +K     + D++S GV+L+ +LC        +   + Q++ R ++
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC--------ARSAIVQSLPREMV 250
Query: 271 DFKRDPWPNVSESAKSLVRQMLEPD 295
           +     W   S +   L  Q+++P+
Sbjct: 251 NLAE--WAVESHNNGQL-EQIVDPN 272

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 13/180 (7%)
Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIVARGHYTERAA 154
           D   E +IM     + +I+ L+          +V E  E G L  F R    G +T    
Sbjct: 96  DFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQL 153
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFS 212
             + R +   ++     G +HRDL   N L      N   K  DFGLS   +  P    +
Sbjct: 154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAXT 210
Query: 213 EIVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
              G  P  + APE +  R +    D+WS GV+++ +L  G  P+W  + + V  ++  G
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 102/267 (38%), Gaps = 58/267 (21%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDID---DVRRE 101
           P+ NIE  Y+  R++G G FG  +               ++ + L+     D   D +RE
Sbjct: 45  PRNNIE--YV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 100
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT----------E 151
            A+M     N +IV L   C     + L+ E    G+L + + +   +T           
Sbjct: 101 AALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 152 RAAAA--------------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI 197
           RA  +              + R +   +    +   +HRDL   N L     EN  +K  
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIA 216
Query: 198 DFGLSIFFKPGERFSEIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY 244
           DFGLS           I  + YY            M PE +  N Y  E D+W+ GV+L+
Sbjct: 217 DFGLS---------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267
Query: 245 -ILLCGVPPFWAESEQGVAQAILRGLI 270
            I   G+ P++  + + V   +  G I
Sbjct: 268 EIFSYGLQPYYGMAHEEVIYYVRDGNI 294

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 109/265 (41%), Gaps = 49/265 (18%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N + ++L+    G G FG  Y  + RD       K   KR+   +    +          
Sbjct: 40  NFDHKFLI----GHGVFGKVYKGVLRD-----GAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
             ++  +VSL   C++ N + L+ +  E G L      + H        ++ +  + +++
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNL------KRHLYGSDLPTMSMSWEQRLEI 144
Query: 168 C----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE---- 213
           C          H   +IHRD+K  N L     EN   K  DFG+S   K G    +    
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGIS---KKGTELDQTHLX 198
Query: 214 --IVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI 270
             + G+  Y+ PE  +K     + D++S GV+L+ +LC        +   + Q++ R ++
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC--------ARSAIVQSLPREMV 250
Query: 271 DFKRDPWPNVSESAKSLVRQMLEPD 295
           +     W   S +   L  Q+++P+
Sbjct: 251 NLAE--WAVESHNNGQL-EQIVDPN 272

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 112/235 (47%), Gaps = 28/235 (11%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI-DRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           +P+E+++    ++++LG G+FG  ++   ++ T+  +A K++       ++ ++    E 
Sbjct: 12  IPRESLK----LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKP----GSMSVEAFLAEA 61
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRT 160
            +MK L ++  +V L  A      ++++ E    G L D + +     +     +  +  
Sbjct: 62  NVMKTL-QHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 119
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY- 219
           I E +    +   IHRDL+  N L +    +   K  DFGL+   +  E ++   G+ + 
Sbjct: 120 IAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE-YTAREGAKFP 175
Query: 220 --YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
             + APE +  N+G    + D+WS G++L  I+  G  P+   S   V +A+ RG
Sbjct: 176 IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 228

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 40/241 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+ N++      + LG G FG           +  A   ++ + L++    D+   +  E
Sbjct: 29  PRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 84
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-----------VARGHYT 150
           + IM HL ++ +IV+L  AC     V ++ E C  G+L + +           +A G   
Sbjct: 85  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDP 144
Query: 151 E------------RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
           E            R     +  + + +        IHRD+   N L  N       K  D
Sbjct: 145 EGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN---GHVAKIGD 201
Query: 199 FGLSIFFKPGERFSEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPP 252
           FGL+        +  + G+      +MAPE +    Y  + D+WS G++L+ I   G+ P
Sbjct: 202 FGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 260
Query: 253 F 253
           +
Sbjct: 261 Y 261

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 112/235 (47%), Gaps = 28/235 (11%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI-DRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           +P+E+++    ++++LG G+FG  ++   ++ T+  +A K++       ++ ++    E 
Sbjct: 185 IPRESLK----LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKP----GSMSVEAFLAEA 234
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRT 160
            +MK L ++  +V L  A      ++++ E    G L D + +     +     +  +  
Sbjct: 235 NVMKTL-QHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY- 219
           I E +    +   IHRDL+  N L +    +   K  DFGL+   +  E ++   G+ + 
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE-YTAREGAKFP 348
Query: 220 --YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
             + APE +  N+G    + D+WS G++L  I+  G  P+   S   V +A+ RG
Sbjct: 349 IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 124/288 (43%), Gaps = 53/288 (18%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 12  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 67  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
           +++Q+           + +  +HRDL   N   A   E+  +K  DFG++          
Sbjct: 126 KMIQMAGEIADGMAYLNANKFVHRDLAARNCXVA---EDFTVKIGDFGMT---------R 173
Query: 213 EIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
           +I  + YY            M+PE LK   +    D+WS GV+L+ I      P+   S 
Sbjct: 174 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 233
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
           + V + ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 234 EQVLRFVMEGGLLDKPDNCPDM---LLELMRMCWQYNPKMRPSFLEII 278

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 113/278 (40%), Gaps = 48/278 (17%)
Query: 59  LGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKNSSI 114
           +G G FG V    I +D   + A    + ++++     DD R    E+ ++  L  + +I
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDA----AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER----AAAAVTRTIVEVVQLCH- 169
           ++L  ACE    ++L +E    G L D  + +    E     A A  T + +   QL H 
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHF 144
Query: 170 ------------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS 217
                       +   IHR+L   N L     EN   K  DFGLS       R  E+   
Sbjct: 145 AADVARGMDYLSQKQFIHRNLAARNILVG---ENYVAKIADFGLS-------RGQEVYVK 194
Query: 218 PY-------YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
                    +MA E L  + Y    D+WS GV+L+ I+  G  P+   +   + + + +G
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 254
Query: 269 LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
              ++ +   N  +    L+RQ     P  R +  Q+L
Sbjct: 255 ---YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 39/228 (17%)
Query: 43  GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           G     I    ++   +G+G FG  +    R   E +A K  S R+ R+     ++ + V
Sbjct: 1   GAMGSTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTV 58
Query: 103 AIMKHLPKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
            +     ++ +I+    A   DN     + LV +  E G LFD +     YT      + 
Sbjct: 59  ML-----RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIK 110
Query: 159 RTIVEVVQLCHKH----------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
             +     L H H           + HRDLK +N L    K+N      D GL++     
Sbjct: 111 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSA 167
Query: 209 ERFSEI-----VGSPYYMAPEVLKRNYG-------PEIDIWSAGVILY 244
               +I     VG+  YMAPEVL  +            DI++ G++ +
Sbjct: 168 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 215

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 93/232 (40%), Gaps = 42/232 (18%)
Query: 42  AGVP---KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV 98
           +G+P   +  I    ++   +G+G FG  +    R   E +A K  S R+ R+     ++
Sbjct: 17  SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEI 74
Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAA 154
            + V +     ++ +I+    A   DN     + LV +  E G LFD +     YT    
Sbjct: 75  YQTVML-----RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVE 126
Query: 155 AAVTRTIVEVVQLCHKH----------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF 204
             +   +     L H H           + HRDLK +N L    K+N      D GL++ 
Sbjct: 127 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVR 183
Query: 205 FKPGERFSEI-----VGSPYYMAPEVLKRNYG-------PEIDIWSAGVILY 244
                   +I     VG+  YMAPEVL  +            DI++ G++ +
Sbjct: 184 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 235

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 93/232 (40%), Gaps = 42/232 (18%)
Query: 42  AGVP---KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV 98
           +G+P   +  I    ++   +G+G FG  +    R   E +A K  S R+ R+     ++
Sbjct: 30  SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEI 87
Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAA 154
            + V +     ++ +I+    A   DN     + LV +  E G LFD +     YT    
Sbjct: 88  YQTVML-----RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVE 139
Query: 155 AAVTRTIVEVVQLCHKH----------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF 204
             +   +     L H H           + HRDLK +N L    K+N      D GL++ 
Sbjct: 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVR 196
Query: 205 FKPGERFSEI-----VGSPYYMAPEVLKRNYG-------PEIDIWSAGVILY 244
                   +I     VG+  YMAPEVL  +            DI++ G++ +
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 100
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 160
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K  +      G+     +MA E L+ +
Sbjct: 161 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 218 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 258

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 126/304 (41%), Gaps = 37/304 (12%)
Query: 46  KENIED------RYLVDRELGRGEFGVT--YLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           KE +ED      ++ + R LG+GEFG          D   +     + K  +  + DI++
Sbjct: 12  KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE 71
Query: 98  VRREVAIMKHL--PKNSSI--VSLKEACEDDNAVHLV-MELCEGGELFDRIVAR---GHY 149
             RE A MK    P  + +  VSL+   +    + +V +   + G+L   ++A     + 
Sbjct: 72  FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 150 TERAAAAVTRTIVEV---VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
                  + R +V++   ++       IHRDL   N + A   E+  +   DFGLS    
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIY 188
Query: 207 PGERFSEIVGSPY---YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGV 261
            G+ + +   S     ++A E L  N Y    D+W+ GV ++ I+  G  P+       +
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPK-------LRLTAKQVLEHPWLQNA 314
              ++ G  +  + P P   E    L+ Q    DPK       LR+  + +L H  + + 
Sbjct: 249 YNYLIGG--NRLKQP-PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305
Query: 315 KKAP 318
            + P
Sbjct: 306 SQDP 309

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 128/314 (40%), Gaps = 29/314 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+    + A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 8   DYNPNYSFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 63
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+  L  + +IV             +++EL  GG+
Sbjct: 64  VAVKTLPE--VCSEQDELDFLMEALIISKL-NHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 139 LFDRI-VARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN 191
           L   +   R   ++ ++ A      V R I    Q   ++  IHRD+   N L       
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 180
Query: 192 SPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-IL 246
              K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I 
Sbjct: 181 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240
Query: 247 LCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
             G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +L
Sbjct: 241 SLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 297
Query: 307 EHPWLQNAKKAPNV 320
           E   ++   + P+V
Sbjct: 298 ER--IEYCTQDPDV 309

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 95
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 155
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K  +      G+     +MA E L+ +
Sbjct: 156 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 253

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 93
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 153
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K  +      G+     +MA E L+ +
Sbjct: 154 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 251

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 71/155 (45%), Gaps = 7/155 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +++ + R++G G FG  YL  +  T E +A K +   K +       +  E  I + L
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHP----QLLYESKIYRIL 59
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQL 167
              + I +++    + +   LVM+L  G  L D         + +    +   ++  V+ 
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
            H    +HRD+KP+NFL    +  + +  IDFGL+
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 95
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 155
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K  +      G+     +MA E L+ +
Sbjct: 156 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 253

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 115/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+ G  ++    +    +A KS+ +  +      D    E  
Sbjct: 10  VPRETLK---LVER-LGAGQAGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 60
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 61  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDAEXTAR-EGAKFPI 174
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 175 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 233 D---NCPEELYQLMRLCWKERPEDRPT 256

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 96
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 156
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K  +      G+     +MA E L+ +
Sbjct: 157 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 214 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 254

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 154
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 214
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K  +      G+     +MA E L+ +
Sbjct: 215 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 43/283 (15%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 10  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 64
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 65  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFF 205
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 124 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIXETDXXR 180
Query: 206 KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   S + V +
Sbjct: 181 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 236
Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 237 FVMEGGLLDKPDNCPDM---LLELMRMCWQYNPKMRPSFLEII 276

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 111/268 (41%), Gaps = 26/268 (9%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            YL  ++LG G F    L          A K I   + +   D ++ +RE A M  L  +
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQRE-ADMHRLFNH 85
Query: 112 SSIVSLKEAC-EDDNAVH---LVMELCEGGELFD---RIVARGHY-TERAAAAVTRTIVE 163
            +I+ L   C  +  A H   L++   + G L++   R+  +G++ TE     +   I  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG------- 216
            ++  H  G  HRDLKP N L  ++ +   +       +     G R +  +        
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 217 SPYYMAPEVLKRNYGPEI----DIWSAGVILYILLCGVPPFWAESEQGVAQAI-LRGLID 271
           +  Y APE+        I    D+WS G +LY ++ G  P+    ++G + A+ ++  + 
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLR 299
             +   P  S +   L+  M+  DP  R
Sbjct: 266 IPQS--PRHSSALWQLLNSMMTVDPHQR 291

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/288 (21%), Positives = 124/288 (43%), Gaps = 53/288 (18%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 15  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 69
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +              ++ 
Sbjct: 70  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 128
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 129 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 176
Query: 213 EIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
           +I  + YY            M+PE LK   +    D+WS GV+L+ I      P+   S 
Sbjct: 177 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 236
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
           + V + ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 237 EQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 281

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 43/283 (15%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 19  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 73
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 74  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFF 205
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 133 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIXETDXXR 189
Query: 206 KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   S + V +
Sbjct: 190 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 246 FVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 285

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/288 (21%), Positives = 123/288 (42%), Gaps = 53/288 (18%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++      E 
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEF---LNEA 79
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +              ++ 
Sbjct: 80  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 186
Query: 213 EIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
           +I  + YY            M+PE LK   +    D+WS GV+L+ I      P+   S 
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
           + V + ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 247 EQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 291

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 124/306 (40%), Gaps = 29/306 (9%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL-LACKSISK 86
           A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L +A K++ +
Sbjct: 15  AGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 70
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VA 145
             + +  D  D   E  I+     + +IV             ++MEL  GG+L   +   
Sbjct: 71  --VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET 127
Query: 146 RGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF 199
           R   ++ ++ A      V R I    Q   ++  IHRD+   N L          K  DF
Sbjct: 128 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187
Query: 200 GLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFW 254
           G++  I+     R       P  +M PE      +  + D WS GV+L+ I   G  P+ 
Sbjct: 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247
Query: 255 AESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +LE   ++  
Sbjct: 248 SKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEYC 302
Query: 315 KKAPNV 320
            + P+V
Sbjct: 303 TQDPDV 308

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 112/268 (41%), Gaps = 37/268 (13%)
Query: 56  DRELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           DR +G+G FGV Y    ID+  +  + C   S  ++     ++   RE  +M+ L   + 
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQ-AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +  +      +   H+++     G+L   I + + + T +   +    +   ++   +  
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY------------ 220
            +HRDL   N +     E+  +K  DFGL+          +I+   YY            
Sbjct: 145 FVHRDLAARNCML---DESFTVKVADFGLA---------RDILDREYYSVQQHRHARLPV 192
Query: 221 --MAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDP 276
              A E L+   +  + D+WS GV+L+ LL  G PP+       +   + +G    +R P
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG----RRLP 248
Query: 277 WPNVS-ESAKSLVRQMLEPDPKLRLTAK 303
            P    +S   +++Q  E DP +R T +
Sbjct: 249 QPEYCPDSLYQVMQQCWEADPAVRPTFR 276

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 124/306 (40%), Gaps = 29/306 (9%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL-LACKSISK 86
           A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L +A K++ +
Sbjct: 30  AGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 85
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VA 145
             + +  D  D   E  I+     + +IV             ++MEL  GG+L   +   
Sbjct: 86  --VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET 142
Query: 146 RGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF 199
           R   ++ ++ A      V R I    Q   ++  IHRD+   N L          K  DF
Sbjct: 143 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 202
Query: 200 GLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFW 254
           G++  I+     R       P  +M PE      +  + D WS GV+L+ I   G  P+ 
Sbjct: 203 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 262
Query: 255 AESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +LE   ++  
Sbjct: 263 SKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEYC 317
Query: 315 KKAPNV 320
            + P+V
Sbjct: 318 TQDPDV 323

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 39/217 (17%)
Query: 54  LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           ++   +G+G FG  +    R   E +A K  S R+ R+     ++ + V +     ++ +
Sbjct: 9   VLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVML-----RHEN 61
Query: 114 IVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           I+    A   DN     + LV +  E G LFD +     YT      +   +     L H
Sbjct: 62  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAH 118
Query: 170 KH----------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----- 214
            H           + HRDLK +N L    K+N      D GL++         +I     
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHR 175
Query: 215 VGSPYYMAPEVLKRNYG-------PEIDIWSAGVILY 244
           VG+  YMAPEVL  +            DI++ G++ +
Sbjct: 176 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 212

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 39/217 (17%)
Query: 54  LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           ++   +G+G FG  +    R   E +A K  S R+ R+     ++ + V +     ++ +
Sbjct: 7   VLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVML-----RHEN 59
Query: 114 IVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           I+    A   DN     + LV +  E G LFD +     YT      +   +     L H
Sbjct: 60  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAH 116
Query: 170 KH----------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----- 214
            H           + HRDLK +N L    K+N      D GL++         +I     
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHR 173
Query: 215 VGSPYYMAPEVLKRNYG-------PEIDIWSAGVILY 244
           VG+  YMAPEVL  +            DI++ G++ +
Sbjct: 174 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 210

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI-DRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           +P+E+++    ++++LG G+FG  ++   ++ T+  +A K++       ++ ++    E 
Sbjct: 179 IPRESLK----LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKP----GSMSVEAFLAEA 228
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRT 160
            +MK L ++  +V L  A      ++++ E    G L D + +     +     +  +  
Sbjct: 229 NVMKTL-QHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 286
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I E +    +   IHRDL+  N L +    +   K  DFGL+   + G +F        +
Sbjct: 287 IAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLA---RVGAKF-----PIKW 335
Query: 221 MAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            APE +  N+G    + D+WS G++L  I+  G  P+   S   V +A+ RG
Sbjct: 336 TAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 385

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 39/217 (17%)
Query: 54  LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           ++   +G+G FG  +    R   E +A K  S R+ R+     ++ + V +     ++ +
Sbjct: 6   VLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVML-----RHEN 58
Query: 114 IVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           I+    A   DN     + LV +  E G LFD +     YT      +   +     L H
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAH 115
Query: 170 KH----------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----- 214
            H           + HRDLK +N L    K+N      D GL++         +I     
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 215 VGSPYYMAPEVLKRNYG-------PEIDIWSAGVILY 244
           VG+  YMAPEVL  +            DI++ G++ +
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 125/306 (40%), Gaps = 29/306 (9%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL-LACKSISK 86
           A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L +A K++ +
Sbjct: 30  AGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 85
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VA 145
             + +  D  D   E  I+  L  + +IV             +++EL  GG+L   +   
Sbjct: 86  --VCSEQDELDFLMEALIISKL-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET 142
Query: 146 RGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF 199
           R   ++ ++ A      V R I    Q   ++  IHRD+   N L          K  DF
Sbjct: 143 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 202
Query: 200 GLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFW 254
           G++  I+     R       P  +M PE      +  + D WS GV+L+ I   G  P+ 
Sbjct: 203 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 262
Query: 255 AESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +LE   ++  
Sbjct: 263 SKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEYC 317
Query: 315 KKAPNV 320
            + P+V
Sbjct: 318 TQDPDV 323

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 29/314 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+    + A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 8   DYNPNYSFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 63
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 64  VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 139 LFDRI-VARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN 191
           L   +   R   ++ ++ A      V R I    Q   ++  IHRD+   N L       
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 180
Query: 192 SPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-IL 246
              K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I 
Sbjct: 181 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240
Query: 247 LCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
             G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +L
Sbjct: 241 SLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 297
Query: 307 EHPWLQNAKKAPNV 320
           E   ++   + P+V
Sbjct: 298 ER--IEYCTQDPDV 309

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 29/314 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+    + A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 14  DYNPNYSFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 69
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 70  VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 126
Query: 139 LFDRI-VARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN 191
           L   +   R   ++ ++ A      V R I    Q   ++  IHRD+   N L       
Sbjct: 127 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 186
Query: 192 SPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-IL 246
              K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I 
Sbjct: 187 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 246
Query: 247 LCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
             G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +L
Sbjct: 247 SLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 303
Query: 307 EHPWLQNAKKAPNV 320
           E   ++   + P+V
Sbjct: 304 ER--IEYCTQDPDV 315

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 94
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 154
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K         G+     +MA E L+ +
Sbjct: 155 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 252

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 96
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 156
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  +  K  +      G+     +MA E L+ +
Sbjct: 157 HRDLAARNCML---DEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 214 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 254

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 29/314 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+    + A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 8   DYNPNYSFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 63
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 64  VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 139 LFDRI-VARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN 191
           L   +   R   ++ ++ A      V R I    Q   ++  IHRD+   N L       
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 180
Query: 192 SPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-IL 246
              K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I 
Sbjct: 181 RVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240
Query: 247 LCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
             G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +L
Sbjct: 241 SLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 297
Query: 307 EHPWLQNAKKAPNV 320
           E   ++   + P+V
Sbjct: 298 ER--IEYCTQDPDV 309

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 95
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 155
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 156 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 253

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 87
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 147
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 148 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 205 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 245

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 114
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 174
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 175 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 231
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 232 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 272

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 113
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 173
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 174 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 230
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 231 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 271

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 92
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 152
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 153 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 94
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 154
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 155 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 252

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 124/306 (40%), Gaps = 29/306 (9%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL-LACKSISK 86
           A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L +A K++ +
Sbjct: 30  AGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 85
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VA 145
             + +  D  D   E  I+     + +IV             +++EL  GG+L   +   
Sbjct: 86  --VYSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET 142
Query: 146 RGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF 199
           R   ++ ++ A      V R I    Q   ++  IHRD+   N L          K  DF
Sbjct: 143 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 202
Query: 200 GLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFW 254
           G++  I+     R       P  +M PE      +  + D WS GV+L+ I   G  P+ 
Sbjct: 203 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 262
Query: 255 AESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +LE   ++  
Sbjct: 263 SKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEYC 317
Query: 315 KKAPNV 320
            + P+V
Sbjct: 318 TQDPDV 323

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 95
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 155
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 156 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 253

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 103/246 (41%), Gaps = 46/246 (18%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR---TAVDIDDVRRE 101
           P++N+    ++ + LG GEFG          +      +++ + L+   +  ++ D+  E
Sbjct: 21  PRKNL----VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSE 76
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF-----DRIVARG--------- 147
             ++K +  +  ++ L  AC  D  + L++E  + G L       R V  G         
Sbjct: 77  FNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 148 -----HYTERAAA-----AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI 197
                H  ERA       +    I + +Q   +  ++HRDL   N L A   E   +K  
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKIS 192
Query: 198 DFGLSIFFKPGERF---SEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLC----- 248
           DFGLS      + +   S+      +MA E L  + Y  + D+WS GV+L+ ++      
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 249 --GVPP 252
             G+PP
Sbjct: 253 YPGIPP 258

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 90
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 150
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 151 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 29/314 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+    + A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 34  DYNPNYSFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 89
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 90  VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 146
Query: 139 LFDRI-VARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN 191
           L   +   R   ++ ++ A      V R I    Q   ++  IHRD+   N L       
Sbjct: 147 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 206
Query: 192 SPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-IL 246
              K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I 
Sbjct: 207 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 266
Query: 247 LCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
             G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +L
Sbjct: 267 SLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 323
Query: 307 EHPWLQNAKKAPNV 320
           E   ++   + P+V
Sbjct: 324 ER--IEYCTQDPDV 335

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +++G+G +G  ++   R   E +A K     +  +     ++ + V +M+H      I +
Sbjct: 43  KQIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEASWFRETEIYQTV-LMRHENILGFIAA 99
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH----- 171
             +       ++L+ +  E G L+D + +    T  A + +      V  LCH H     
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 172 -----GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYM 221
                 + HRDLK +N L    K+N      D GL++ F       +I     VG+  YM
Sbjct: 157 TQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 222 APEV----LKRNYGPEI---DIWSAGVILY 244
            PEV    L RN+       D++S G+IL+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILW 243

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 102/246 (41%), Gaps = 46/246 (18%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR---TAVDIDDVRRE 101
           P++N+    ++ + LG GEFG          +      +++ + L+   +  ++ D+  E
Sbjct: 21  PRKNL----VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSE 76
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF-----DRIVARG--------- 147
             ++K +  +  ++ L  AC  D  + L++E  + G L       R V  G         
Sbjct: 77  FNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 148 -----HYTERAAA-----AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI 197
                H  ERA       +    I + +Q   +  ++HRDL   N L A   E   +K  
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVA---EGRKMKIS 192
Query: 198 DFGLS-IFFKPGERFSEIVG--SPYYMAPEVLKRN-YGPEIDIWSAGVILYILLC----- 248
           DFGLS   ++         G     +MA E L  + Y  + D+WS GV+L+ ++      
Sbjct: 193 DFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 249 --GVPP 252
             G+PP
Sbjct: 253 YPGIPP 258

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 124/306 (40%), Gaps = 29/306 (9%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL-LACKSISK 86
           A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L +A K++ +
Sbjct: 7   AGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 62
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VA 145
             + +  D  D   E  I+     + +IV             +++EL  GG+L   +   
Sbjct: 63  --VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET 119
Query: 146 RGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF 199
           R   ++ ++ A      V R I    Q   ++  IHRD+   N L          K  DF
Sbjct: 120 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 179
Query: 200 GLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFW 254
           G++  I+     R       P  +M PE      +  + D WS GV+L+ I   G  P+ 
Sbjct: 180 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 239
Query: 255 AESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +LE   ++  
Sbjct: 240 SKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEYC 294
Query: 315 KKAPNV 320
            + P+V
Sbjct: 295 TQDPDV 300

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 93
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 153
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 154 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 210
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 251

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 126/314 (40%), Gaps = 29/314 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+      A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 24  DYNPNYCFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 79
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 80  VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 136
Query: 139 LFDRI-VARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN 191
           L   +   R   ++ ++ A      V R I    Q   ++  IHRD+   N L       
Sbjct: 137 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 196
Query: 192 SPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-IL 246
              K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I 
Sbjct: 197 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 256
Query: 247 LCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
             G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +L
Sbjct: 257 SLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 313
Query: 307 EHPWLQNAKKAPNV 320
           E   ++   + P+V
Sbjct: 314 ER--IEYCTQDPDV 325

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/259 (21%), Positives = 105/259 (40%), Gaps = 62/259 (23%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTY------------LCIDRDTRELLACKSISKRKLRT 91
           +P E +E    +   +G+G FG  Y            + I+RD  + L            
Sbjct: 30  IPFEQLE----IGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKA---------- 75
Query: 92  AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-----RIVAR 146
                  +REV   +   ++ ++V    AC     + ++  LC+G  L+      +IV  
Sbjct: 76  ------FKREVMAYRQ-TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD 128
Query: 147 GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL---SI 203
            + T + A    + IV+ +   H  G++H+DLK +N  + N K    +   DFGL   S 
Sbjct: 129 VNKTRQIA----QEIVKGMGYLHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISG 180
Query: 204 FFKPGERFSEI---VGSPYYMAPEVLKR----------NYGPEIDIWSAGVILYILLCGV 250
             + G R  ++    G   ++APE++++           +    D+++ G I Y L    
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 251 PPFWAESEQGVAQAILRGL 269
            PF  +  + +   +  G+
Sbjct: 241 WPFKTQPAEAIIWQMGTGM 259

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 124/306 (40%), Gaps = 29/306 (9%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL-LACKSISK 86
           A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L +A K++ +
Sbjct: 15  AGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 70
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VA 145
             + +  D  D   E  I+     + +IV             +++EL  GG+L   +   
Sbjct: 71  --VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET 127
Query: 146 RGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF 199
           R   ++ ++ A      V R I    Q   ++  IHRD+   N L          K  DF
Sbjct: 128 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187
Query: 200 GLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFW 254
           G++  I+     R       P  +M PE      +  + D WS GV+L+ I   G  P+ 
Sbjct: 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247
Query: 255 AESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +LE   ++  
Sbjct: 248 SKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEYC 302
Query: 315 KKAPNV 320
            + P+V
Sbjct: 303 TQDPDV 308

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 22/225 (9%)
Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCI---DRDTRELLAC-KSISKRKLRTAVD- 94
           VLA + KE  E R L  + LG G FG  +  +   + ++ ++  C K I  +  R +   
Sbjct: 23  VLARIFKET-ELRKL--KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA 79
Query: 95  IDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERA 153
           + D    +  + H    + IV L   C   +++ LV +    G L D +   RG    + 
Sbjct: 80  VTDHMLAIGSLDH----AHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQL 134
Query: 154 AAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--- 210
                  I + +    +HG++HR+L   N L    K  S ++  DFG++    P ++   
Sbjct: 135 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLL 191
Query: 211 FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPF 253
           +SE      +MA E +    Y  + D+WS GV ++ L+  G  P+
Sbjct: 192 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 236

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 22/227 (9%)
Query: 38  ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCI---DRDTRELLAC-KSISKRKLRTAV 93
           + VLA + KE  E R L  + LG G FG  +  +   + ++ ++  C K I  +  R + 
Sbjct: 3   MKVLARIFKET-ELRKL--KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 59
Query: 94  D-IDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTE 151
             + D    +  + H    + IV L   C   +++ LV +    G L D +   RG    
Sbjct: 60  QAVTDHMLAIGSLDH----AHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP 114
Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER- 210
           +        I + +    +HG++HR+L   N L    K  S ++  DFG++    P ++ 
Sbjct: 115 QLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQ 171
Query: 211 --FSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLC-GVPPF 253
             +SE      +MA E +    Y  + D+WS GV ++ L+  G  P+
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 126/314 (40%), Gaps = 29/314 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+      A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 48  DYNPNYCFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 103
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 104 VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 160
Query: 139 LFDRI-VARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN 191
           L   +   R   ++ ++ A      V R I    Q   ++  IHRD+   N L       
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220
Query: 192 SPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-IL 246
              K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I 
Sbjct: 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
Query: 247 LCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
             G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +L
Sbjct: 281 SLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 337
Query: 307 EHPWLQNAKKAPNV 320
           E   ++   + P+V
Sbjct: 338 ER--IEYCTQDPDV 349

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 105/250 (42%), Gaps = 54/250 (21%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR---TAVDIDDVRRE 101
           P++N+    ++ + LG GEFG          +      +++ + L+   +  ++ D+  E
Sbjct: 21  PRKNL----VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSE 76
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF-----DRIVARG--------- 147
             ++K +  +  ++ L  AC  D  + L++E  + G L       R V  G         
Sbjct: 77  FNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 148 -----HYTERAAA-----AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI 197
                H  ERA       +    I + +Q   +  ++HRDL   N L A   E   +K  
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKIS 192
Query: 198 DFGLS--IFFKPGERFSEIVGSP-----YYMAPEVLKRN-YGPEIDIWSAGVILYILLC- 248
           DFGLS  ++    E  S +  S       +MA E L  + Y  + D+WS GV+L+ ++  
Sbjct: 193 DFGLSRDVY----EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 249 ------GVPP 252
                 G+PP
Sbjct: 249 GGNPYPGIPP 258

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 126/314 (40%), Gaps = 29/314 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+      A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 25  DYNPNYCFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 80
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 81  VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 137
Query: 139 LFDRI-VARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN 191
           L   +   R   ++ ++ A      V R I    Q   ++  IHRD+   N L       
Sbjct: 138 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 197
Query: 192 SPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-IL 246
              K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I 
Sbjct: 198 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 257
Query: 247 LCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
             G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +L
Sbjct: 258 SLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 314
Query: 307 EHPWLQNAKKAPNV 320
           E   ++   + P+V
Sbjct: 315 ER--IEYCTQDPDV 326

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 48/218 (22%)
Query: 129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ-LCHKH----------GVIHRD 177
           L+    E G L+D +      T     +  R ++ +   L H H           + HRD
Sbjct: 112 LITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRD 167
Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPEVLKRNYGP 232
           LK +N L    K+N      D GL++         ++     VG+  YMAPEVL      
Sbjct: 168 LKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 224
Query: 233 E-------IDIWSAGVILY-----ILLCGV-----PPFWAESEQGVAQAILRGL--IDFK 273
           +       +DIW+ G++L+     ++  G+     PPF+       +   +R +  +D +
Sbjct: 225 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 284
Query: 274 RDPWPN------VSESAKSLVRQMLEPDPKLRLTAKQV 305
           R   PN         S   L+++    +P  RLTA ++
Sbjct: 285 RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 322

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 48/218 (22%)
Query: 129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ-LCHKH----------GVIHRD 177
           L+    E G L+D +      T     +  R ++ +   L H H           + HRD
Sbjct: 83  LITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRD 138
Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPEVLKRNYGP 232
           LK +N L    K+N      D GL++         ++     VG+  YMAPEVL      
Sbjct: 139 LKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 233 E-------IDIWSAGVILY-----ILLCGV-----PPFWAESEQGVAQAILRGL--IDFK 273
           +       +DIW+ G++L+     ++  G+     PPF+       +   +R +  +D +
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 274 RDPWPN------VSESAKSLVRQMLEPDPKLRLTAKQV 305
           R   PN         S   L+++    +P  RLTA ++
Sbjct: 256 RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 48/218 (22%)
Query: 129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ-LCHKH----------GVIHRD 177
           L+    E G L+D +      T     +  R ++ +   L H H           + HRD
Sbjct: 83  LITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRD 138
Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPEVLKRNYGP 232
           LK +N L    K+N      D GL++         ++     VG+  YMAPEVL      
Sbjct: 139 LKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 233 E-------IDIWSAGVILY-----ILLCGV-----PPFWAESEQGVAQAILRGL--IDFK 273
           +       +DIW+ G++L+     ++  G+     PPF+       +   +R +  +D +
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 274 RDPWPN------VSESAKSLVRQMLEPDPKLRLTAKQV 305
           R   PN         S   L+++    +P  RLTA ++
Sbjct: 256 RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 91/232 (39%), Gaps = 35/232 (15%)
Query: 51  DRYLVDRELGRGEFG-----VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +R    + LG G FG       Y  I  D    +A K +      T  + + +  E+ ++
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 103
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAV------ 157
            +L  + +IV+L  AC       ++ E C  G+L + +  +       + + A+      
Sbjct: 104 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 163
Query: 158 ----------TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
                     +  + + +        IHRDL   N L  + +     K  DFGL+   K 
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARHIKN 220
Query: 208 GERFSEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILYILLC-GVPPF 253
              +  + G+      +MAPE +    Y  E D+WS G+ L+ L   G  P+
Sbjct: 221 DSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 271

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 35/232 (15%)
Query: 51  DRYLVDRELGRGEFG-----VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +R    + LG G FG       Y  I  D    +A K +      T  + + +  E+ ++
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 96
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIVARGHYTERAAAAV------ 157
            +L  + +IV+L  AC       ++ E C  G+L  F R         + + A+      
Sbjct: 97  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 156
Query: 158 ----------TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
                     +  + + +        IHRDL   N L  + +     K  DFGL+   K 
Sbjct: 157 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKN 213
Query: 208 GERFSEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILYILLC-GVPPF 253
              +  + G+      +MAPE +    Y  E D+WS G+ L+ L   G  P+
Sbjct: 214 DSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 264

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 91/228 (39%), Gaps = 28/228 (12%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTREL-------LACK 82
           AG    Q +T L G      +D  L+++ LG G FGV    + R   +        +A K
Sbjct: 3   AGEGPLQSLTCLIGE-----KDLRLLEK-LGDGSFGV----VRRGEWDAPSGKTVSVAVK 52
Query: 83  SISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDR 142
            +    L     +DD  REV  M  L  + +++ L         + +V EL   G L DR
Sbjct: 53  CLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDR 110
Query: 143 IVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL 201
           +   +GH+     +     + E +        IHRDL   N L A +     +K  DFGL
Sbjct: 111 LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR---DLVKIGDFGL 167
Query: 202 SIFFKPGER---FSEIVGSPY-YMAPEVLK-RNYGPEIDIWSAGVILY 244
                  +      E    P+ + APE LK R +    D W  GV L+
Sbjct: 168 MRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 215

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 91/232 (39%), Gaps = 35/232 (15%)
Query: 51  DRYLVDRELGRGEFG-----VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +R    + LG G FG       Y  I  D    +A K +      T  + + +  E+ ++
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 98
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAV------ 157
            +L  + +IV+L  AC       ++ E C  G+L + +  +       + + A+      
Sbjct: 99  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 158
Query: 158 ----------TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
                     +  + + +        IHRDL   N L  + +     K  DFGL+   K 
Sbjct: 159 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKN 215
Query: 208 GERFSEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILYILLC-GVPPF 253
              +  + G+      +MAPE +    Y  E D+WS G+ L+ L   G  P+
Sbjct: 216 DSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 266

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 91/228 (39%), Gaps = 28/228 (12%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTREL-------LACK 82
           AG    Q +T L G      +D  L+++ LG G FGV    + R   +        +A K
Sbjct: 3   AGEGPLQSLTCLIGE-----KDLRLLEK-LGDGSFGV----VRRGEWDAPSGKTVSVAVK 52
Query: 83  SISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDR 142
            +    L     +DD  REV  M  L  + +++ L         + +V EL   G L DR
Sbjct: 53  CLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDR 110
Query: 143 IVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL 201
           +   +GH+     +     + E +        IHRDL   N L A +     +K  DFGL
Sbjct: 111 LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR---DLVKIGDFGL 167
Query: 202 SIFFKPGER---FSEIVGSPY-YMAPEVLK-RNYGPEIDIWSAGVILY 244
                  +      E    P+ + APE LK R +    D W  GV L+
Sbjct: 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 215

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 91/232 (39%), Gaps = 35/232 (15%)
Query: 51  DRYLVDRELGRGEFG-----VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +R    + LG G FG       Y  I  D    +A K +      T  + + +  E+ ++
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 103
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAV------ 157
            +L  + +IV+L  AC       ++ E C  G+L + +  +       + + A+      
Sbjct: 104 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 163
Query: 158 ----------TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
                     +  + + +        IHRDL   N L  + +     K  DFGL+   K 
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKN 220
Query: 208 GERFSEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILYILLC-GVPPF 253
              +  + G+      +MAPE +    Y  E D+WS G+ L+ L   G  P+
Sbjct: 221 DSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 271

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 91/232 (39%), Gaps = 35/232 (15%)
Query: 51  DRYLVDRELGRGEFG-----VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +R    + LG G FG       Y  I  D    +A K +      T  + + +  E+ ++
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAV------ 157
            +L  + +IV+L  AC       ++ E C  G+L + +  +       + + A+      
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 158 ----------TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
                     +  + + +        IHRDL   N L  + +     K  DFGL+   K 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKN 197
Query: 208 GERFSEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILYILLC-GVPPF 253
              +  + G+      +MAPE +    Y  E D+WS G+ L+ L   G  P+
Sbjct: 198 DSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 106/238 (44%), Gaps = 34/238 (14%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYL-CIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           +P+E+++   L+ R LG G+FG  ++   + +T+  +A K++    +      +    E 
Sbjct: 6   IPRESLQ---LIKR-LGNGQFGEVWMGTWNGNTK--VAIKTLKPGTMSP----ESFLEEA 55
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-------RIVARGHYTERAAA 155
            IMK L K+  +V L  A   +  +++V E    G L D       R +   +  + AA 
Sbjct: 56  QIMKKL-KHDKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAA- 112
Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
                +   +    +   IHRDL+  N L  N       K  DFGL+   +  E  +   
Sbjct: 113 ----QVAAGMAYIERMNYIHRDLRSANILVGN---GLICKIADFGLARLIEDNEXTAR-Q 164
Query: 216 GSPY---YMAPE-VLKRNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
           G+ +   + APE  L   +  + D+WS G++L  L+  G  P+   + + V + + RG
Sbjct: 165 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 222

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 8/85 (9%)
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGE-RFSEIVGSPYYMAPE-VLKRN 229
           IHRDL   N L +   EN+ +K  DFGL+  I+  P   R  +      +MAPE +  + 
Sbjct: 221 IHRDLAARNILLS---ENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKI 277
Query: 230 YGPEIDIWSAGVILY-ILLCGVPPF 253
           Y  + D+WS GV+L+ I   G  P+
Sbjct: 278 YSTKSDVWSYGVLLWEIFSLGGSPY 302

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 79/200 (39%), Gaps = 22/200 (11%)
Query: 58  ELGRGEFGVTYLCIDRDTREL-------LACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +LG G FGV    + R   +        +A K +    L     +DD  REV  M  L  
Sbjct: 19  KLGDGSFGV----VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-D 73
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCH 169
           + +++ L         + +V EL   G L DR+   +GH+     +     + E +    
Sbjct: 74  HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPY-YMAPEV 225
               IHRDL   N L A +     +K  DFGL       +      E    P+ + APE 
Sbjct: 133 SKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 226 LK-RNYGPEIDIWSAGVILY 244
           LK R +    D W  GV L+
Sbjct: 190 LKTRTFSHASDTWMFGVTLW 209

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	347
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	0.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	0.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	0.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-179
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-177
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-177
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-175
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-175
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-174
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-173
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-172
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-172
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-170
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-170
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-170
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-169
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-168
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-167
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-166
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-166
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-166
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-165
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-163
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-162
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-158
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-158
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-157
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-156
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-156
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-153
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-149
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-148
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-148
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-104
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-100
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-96
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-92
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-90
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-89
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-89
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-88
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-87
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-87
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-87
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-86
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-85
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-85
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-83
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-83
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-83
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-83
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-83
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-82
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-82
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-82
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-81
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-81
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-81
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-81
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-81
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-80
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-79
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-76
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-75
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-75
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-73
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-69
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-69
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-68
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-65
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-64
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-64
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-63
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-61
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-55
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-54
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-54
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-53
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-51
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-51
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-51
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-50
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-49
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-49
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-49
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-49
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-49
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-48
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-48
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-48
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-48
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-48
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-47
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-47
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-47
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-47
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-47
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-47
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-46
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-46
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-46
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-45
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-45
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-45
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-45
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-45
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-45
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-45
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-45
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-44
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-44
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-44
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-44
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-44
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-44
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-44
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-43
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-42
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-42
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-42
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-41
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-40
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-39
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-38
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-38
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-38
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-37
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-37
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-37
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-37
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-37
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-37
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-36
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-36
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-36
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-35
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-35
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-34
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-34
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-34
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-33
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-33
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-33
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-33
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-33
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-32
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-32
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-32
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-31
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-30
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-29
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-29
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-28
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-28
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-28
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-27
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-27
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-27
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-27
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-26
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-25
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-24
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-24
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-23
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-21
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-20
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-18
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-18
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-17
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-16
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-16
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-16
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	9e-16
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-16
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-15
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-15
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-15
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-15
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-15
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-15
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-15
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-15
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-15
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-15
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	5e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-14
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-14
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-14
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-14
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-07
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-06
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-05
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	4e-05
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	5e-04

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  512 bits (1320), Expect = 0.0
 Identities = 116/323 (35%), Positives = 175/323 (54%), Gaps = 3/323 (0%)

Query: 25  HARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI 84
           H     G  +    +           D Y V  ELG+G F V   C+ + T    A K I
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62

Query: 85  SKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV 144
           + +KL +A D   + RE  I + L ++ +IV L ++ ++++  +LV +L  GGELF+ IV
Sbjct: 63  NTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120

Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF 204
           AR  Y+E  A+   + I+E +  CH +G++HR+LKPEN L A+K + + +K  DFGL+I 
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180

Query: 205 FKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ 263
               E +    G+P Y++PEVLK++ Y   +DIW+ GVILYILL G PPFW E +  +  
Sbjct: 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 240

Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLG 323
            I  G  D+    W  V+  AKSL+  ML  +PK R+TA Q L+ PW+ N ++  +    
Sbjct: 241 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHR 300

Query: 324 DVVRSRLKQFSMMNRFKRKALRV 346
                 LK+F+   + K   L  
Sbjct: 301 QDTVDCLKKFNARRKLKGAILTT 323

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  509 bits (1313), Expect = 0.0
 Identities = 111/308 (36%), Positives = 173/308 (56%), Gaps = 4/308 (1%)

Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           +A +      + Y +  ELG+G F V   C+     +  A   I+ +KL +A D   + R
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLER 59

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  I + L K+ +IV L ++  ++   +L+ +L  GGELF+ IVAR +Y+E  A+   + 
Sbjct: 60  EARICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ 118

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPY 219
           I+E V  CH+ GV+HR+LKPEN L A+K + + +K  DFGL+I  +   + +    G+P 
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178

Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           Y++PEVL+++ YG  +D+W+ GVILYILL G PPFW E +  + Q I  G  DF    W 
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD 238

Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNR 338
            V+  AK L+ +ML  +P  R+TA + L+HPW+ +     +          LK+F+   +
Sbjct: 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRK 298

Query: 339 FKRKALRV 346
            K   L V
Sbjct: 299 LKGAILTV 306

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  510 bits (1315), Expect = 0.0
 Identities = 114/305 (37%), Positives = 175/305 (57%), Gaps = 6/305 (1%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +    +RY +   LG+G FG    C DR T++  A K I+K   +   D   + REV ++
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELL 75

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           K L  + +I+ L E  ED ++ ++V EL  GGELFD I+ R  ++E  AA + + +   +
Sbjct: 76  KKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              HKH ++HRDLKPEN L  +K+++  +K IDFGLS  F+   +  + +G+ YY+APEV
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194

Query: 226 LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           L+  Y  + D+WSAGVILYILL G PPF+ ++E  + + +  G   F    W  +S+ AK
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN----AKKAPNVPLGDVVRSRLKQFSMMNRFKR 341
            L+R+ML   P LR+TA Q LEHPW+Q          ++P  +   + ++QF    +  +
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQ 314

Query: 342 KALRV 346
            AL  
Sbjct: 315 AALLY 319

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  505 bits (1303), Expect = e-179
 Identities = 117/305 (38%), Positives = 178/305 (58%), Gaps = 4/305 (1%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
                 DRY   R LG+G FG   LC D+ T +  A K ISKR+++   D + + REV +
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           +K L  + +I+ L E  ED    +LV E+  GGELFD I++R  ++E  AA + R ++  
Sbjct: 80  LKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           +   HK+ ++HRDLKPEN L  +K +++ ++ IDFGLS  F+  ++  + +G+ YY+APE
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198

Query: 225 VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
           VL   Y  + D+WS GVILYILL G PPF   +E  + + + +G   F+   W  VSESA
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK---APNVPLGDVVRSRLKQFSMMNRFKR 341
           K L+R+ML   P +R++A+  L+H W+Q   K   + +VP  D     ++QF    +  +
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQ 318

Query: 342 KALRV 346
            AL  
Sbjct: 319 AALLY 323

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  501 bits (1292), Expect = e-177
 Identities = 104/342 (30%), Positives = 172/342 (50%), Gaps = 21/342 (6%)

Query: 25  HARKEAGANKKQPITVLAGVP-------KENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           H    +   +      +A  P       +  I + Y   R+LG G +G   LC +++   
Sbjct: 3   HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHS 62

Query: 78  LLACKSISKRKLRTAV----------DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV 127
             A K I K +                 +++  E++++K L  + +I+ L +  ED    
Sbjct: 63  EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYF 121

Query: 128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN 187
           +LV E  EGGELF++I+ R  + E  AA + + I+  +   HKH ++HRD+KPEN L  N
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLEN 181

Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILL 247
           K     +K +DFGLS FF    +  + +G+ YY+APEVLK+ Y  + D+WS GVI+YILL
Sbjct: 182 KNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILL 241

Query: 248 CGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           CG PPF  +++Q + + + +G   F  + W N+S+ AK L++ ML  D   R TA++ L 
Sbjct: 242 CGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301

Query: 308 HPWLQNAKK---APNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
             W++         +        S +++F    +  + A+  
Sbjct: 302 SRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILF 343

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  495 bits (1276), Expect = e-177
 Identities = 128/342 (37%), Positives = 186/342 (54%), Gaps = 10/342 (2%)

Query: 7   SPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGV 66
           S   +  E++     S   A    G     P   + G  ++ + D + V+ ELGRG   +
Sbjct: 9   SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSI 68

Query: 67  TYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA 126
            Y C  + T++  A K + K       D   VR E+ ++  L  + +I+ LKE  E    
Sbjct: 69  VYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTE 122

Query: 127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFA 186
           + LV+EL  GGELFDRIV +G+Y+ER AA   + I+E V   H++G++HRDLKPEN L+A
Sbjct: 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182

Query: 187 NKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYI 245
               ++PLK  DFGLS   +       + G+P Y APE+L+   YGPE+D+WS G+I YI
Sbjct: 183 TPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYI 242

Query: 246 LLCGVPPFWAE-SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQ 304
           LLCG  PF+ E  +Q + + IL     F    W  VS +AK LVR+++  DPK RLT  Q
Sbjct: 243 LLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQ 302

Query: 305 VLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
            L+HPW+    KA N    D  + +L++F+   + K     V
Sbjct: 303 ALQHPWVTG--KAANFVHMDTAQKKLQEFNARRKLKAAVKAV 342

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  494 bits (1274), Expect = e-175
 Identities = 111/306 (36%), Positives = 177/306 (57%), Gaps = 6/306 (1%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
            K ++ + Y   ++LG G +G   LC D+ T    A K I K  + T+     +  EVA+
Sbjct: 31  KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAV 89

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           +K L  + +I+ L +  ED    +LVME  +GGELFD I+ R  + E  AA + + ++  
Sbjct: 90  LKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           V   HKH ++HRDLKPEN L  +K++++ +K +DFGLS  F+  ++  E +G+ YY+APE
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE 208

Query: 225 VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
           VL++ Y  + D+WS GVIL+ILL G PPF  +++Q + + + +G   F    W NVSE A
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP----NVPLGDVVRSRLKQFSMMNRFK 340
           K L++QML+ D + R++A+Q LEHPW++           +P        +++F    +  
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLA 328

Query: 341 RKALRV 346
           + AL  
Sbjct: 329 QAALLY 334

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  488 bits (1258), Expect = e-175
 Identities = 105/307 (34%), Positives = 165/307 (53%), Gaps = 10/307 (3%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL--RTAVDIDDVRREVAIM 105
             ED Y +   +G+G F V   CI+R+T +  A K +   K      +  +D++RE +I 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTI 161
             L K+  IV L E    D  +++V E  +G +L   IV R      Y+E  A+   R I
Sbjct: 81  HML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYY 220
           +E ++ CH + +IHRD+KP   L A+K+ ++P+K   FG++I   + G      VG+P++
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 221 MAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           MAPEV+KR  YG  +D+W  GVIL+ILL G  PF+   ++ + + I++G        W +
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH 258

Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRF 339
           +SESAK LVR+ML  DP  R+T  + L HPWL+   +            +L++F+   + 
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKL 318

Query: 340 KRKALRV 346
           K   L  
Sbjct: 319 KGAVLAA 325

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  482 bits (1244), Expect = e-174
 Identities = 121/280 (43%), Positives = 169/280 (60%), Gaps = 4/280 (1%)

Query: 43  GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           G  K +I   Y ++  +GRG +G   + + + TR   A K I K  +    D+D  ++E+
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEI 57

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            IMK L  + +I+ L E  ED+  ++LVMELC GGELF+R+V +  + E  AA + + ++
Sbjct: 58  EIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             V  CHK  V HRDLKPENFLF     +SPLK IDFGL+  FKPG+     VG+PYY++
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176

Query: 223 PEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           P+VL+  YGPE D WSAGV++Y+LLCG PPF A ++  V   I  G   F    W NVS 
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236

Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            A+SL+R++L   PK R+T+ Q LEH W +    +    L
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  484 bits (1247), Expect = e-173
 Identities = 88/326 (26%), Positives = 155/326 (47%), Gaps = 8/326 (2%)

Query: 23  HDHARKEAGANKKQPITVLAGVPKENIEDRY-LVDRELGRGEFGVTYLCIDRDTRELLAC 81
           H H    +G +       L     EN  + Y L  +ELGRG+F V   CI + T +  A 
Sbjct: 2   HHHHHHSSGVDLGT--ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAA 59

Query: 82  KSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD 141
           K + KR+        ++  E+A+++       +++L E  E+ + + L++E   GGE+F 
Sbjct: 60  KFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFS 118

Query: 142 RIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF 199
             +       +E     + + I+E V   H++ ++H DLKP+N L ++      +K +DF
Sbjct: 119 LCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178

Query: 200 GLSIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE 258
           G+S          EI+G+P Y+APE+L  +      D+W+ G+I Y+LL    PF  E  
Sbjct: 179 GMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238

Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
           Q     I +  +D+  + + +VS+ A   ++ +L  +P+ R TA+  L H WLQ      
Sbjct: 239 QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298

Query: 319 NV-PLGDVVRSRLKQFSMMNRFKRKA 343
              P      S+ +  S+ +   + +
Sbjct: 299 LFHPEETSSSSQTQDHSVRSSEDKTS 324

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  479 bits (1236), Expect = e-172
 Identities = 112/282 (39%), Positives = 165/282 (58%), Gaps = 4/282 (1%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
               D Y V  ELG+G F V   C+ + T    A K I+ +KL +A D   + RE  I +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR 60

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            L ++ +IV L ++ ++++  +LV +L  GGELF+ IVAR  Y+E  A+   + I+E + 
Sbjct: 61  KL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
            CH +G++HR+LKPEN L A+K + + +K  DFGL+I     E +    G+P Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179

Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           K++ Y   +DIW+ GVILYILL G PPFW E +  +   I  G  D+    W  V+  AK
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN-AKKAPNVPLGDVV 326
           SL+  ML  +PK R+TA Q L+ PW+ N  + A  +   D V
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  480 bits (1237), Expect = e-172
 Identities = 105/306 (34%), Positives = 160/306 (52%), Gaps = 13/306 (4%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL---RTAVDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+    R  V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APE++     G E D+WS GVI YILL G  PF  +++Q     +     +F+ + + N 
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFK 340
           S  AK  +R++L  DPK R+T +  L+HPW++               SR      M +FK
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ-------ALSRKASAVNMEKFK 297

Query: 341 RKALRV 346
           + A R 
Sbjct: 298 KFAARK 303

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  475 bits (1224), Expect = e-170
 Identities = 112/292 (38%), Positives = 165/292 (56%), Gaps = 11/292 (3%)

Query: 22  SHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLAC 81
            H H       N            +    +RY +   LG+G FG    C DR T++  A 
Sbjct: 2   HHHHHHSSGRENLYF---------QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAV 52

Query: 82  KSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD 141
           K I+K   +   D   + REV ++K L  + +I+ L E  ED ++ ++V EL  GGELFD
Sbjct: 53  KVINKASAKNK-DTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110

Query: 142 RIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL 201
            I+ R  ++E  AA + + +   +   HKH ++HRDLKPEN L  +K+++  +K IDFGL
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170

Query: 202 SIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
           S  F+   +  + +G+ YY+APEVL+  Y  + D+WSAGVILYILL G PPF+ ++E  +
Sbjct: 171 STCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230

Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            + +  G   F    W  +S+ AK L+R+ML   P LR+TA Q LEHPW+Q 
Sbjct: 231 LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  474 bits (1222), Expect = e-170
 Identities = 82/302 (27%), Positives = 156/302 (51%), Gaps = 12/302 (3%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           + + ++Y++  +LGRGEFG+ + C++  +++    K +  +      D   V++E++I+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVV 165
              ++ +I+ L E+ E    + ++ E   G ++F+RI        ER   +    + E +
Sbjct: 57  IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
           Q  H H + H D++PEN ++  +  +S +K I+FG +   KPG+ F  +  +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 226 LKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            + +      D+WS G ++Y+LL G+ PF AE+ Q + + I+     F  + +  +S  A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKAL 344
              V ++L  + K R+TA + L+HPWL+   +  +      V   LK     +   +K L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVST----KVIRTLKHRRYYHTLIKKDL 290

Query: 345 RV 346
            +
Sbjct: 291 NM 292

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  473 bits (1220), Expect = e-169
 Identities = 104/323 (32%), Positives = 158/323 (48%), Gaps = 28/323 (8%)

Query: 46  KENIEDRY---LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
                  Y   L D+ LG G F +   C+ + + +  A K ISKR         + ++E+
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEI 56

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
             +K    + +IV L E   D     LVMEL  GGELF+RI  + H++E  A+ + R +V
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV 116

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIVGSPYYM 221
             V   H  GV+HRDLKPEN LF ++ +N  +K IDFG +    P  +       + +Y 
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQ-------GVAQAILRGLIDFK 273
           APE+L +N Y    D+WS GVILY +L G  PF +            + + I +G   F+
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236

Query: 274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDV-------- 325
            + W NVS+ AK L++ +L  DP  RL    +  + WLQ+  +  + PL           
Sbjct: 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGA 296

Query: 326 -VRSRLK-QFSMMNRFKRKALRV 346
            V + +K  F   N++KR+   +
Sbjct: 297 AVHTCVKATFHAFNKYKREGFCL 319

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  470 bits (1212), Expect = e-168
 Identities = 96/308 (31%), Positives = 162/308 (52%), Gaps = 9/308 (2%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R     V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + ++++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APE++     G E D+WS GVI YILL G  PF  +++Q     I     DF  + + + 
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD--VVRSRLKQFSMMNR 338
           SE AK  +R++L  + + RLT ++ L HPW+        +   +  V     ++  +  R
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRR 305

Query: 339 FKRKALRV 346
           +K  +  +
Sbjct: 306 WK-LSFSI 312

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  467 bits (1204), Expect = e-167
 Identities = 103/323 (31%), Positives = 156/323 (48%), Gaps = 19/323 (5%)

Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
             I            D Y V  ++G G + V   CI + T    A K I K K       
Sbjct: 7   HSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------ 60

Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA 155
            D   E+ I+    ++ +I++LK+  +D   V++V EL +GGEL D+I+ +  ++ER A+
Sbjct: 61  -DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS 119

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN-SPLKAIDFGLSIFFKPGER-FSE 213
           AV  TI + V+  H  GV+HRDLKP N L+ ++  N   ++  DFG +   +        
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179

Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRGL 269
              +  ++APEVL+R  Y    DIWS GV+LY +L G  PF     ++ + +   I  G 
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239

Query: 270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR 329
                  W +VS++AK LV +ML  DP  RLTA  VL HPW+ +  + P   L       
Sbjct: 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPH 299

Query: 330 LKQ------FSMMNRFKRKALRV 346
           L +      +S +NR +   L  
Sbjct: 300 LVKGAMAATYSALNRNQSPVLEP 322

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  463 bits (1194), Expect = e-166
 Identities = 100/280 (35%), Positives = 152/280 (54%), Gaps = 6/280 (2%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL---RTAVDIDDVRREVAI 104
            +ED Y +  ELG G+F +   C  + T +  A K I KR+L   R  V  +++ REV I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           ++ + ++ +I++L +  E+   V L++EL  GGELFD +  +   TE  A    + I++ 
Sbjct: 62  LREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120

Query: 165 VQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
           V   H   + H DLKPEN +  +K   N  +K IDFG++   + G  F  I G+P ++AP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180

Query: 224 EVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           E++     G E D+WS GVI YILL G  PF  E++Q     I     DF  + + N SE
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240

Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            AK  +R++L  DPK R+T  Q LEH W++  ++      
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  463 bits (1194), Expect = e-166
 Identities = 98/273 (35%), Positives = 155/273 (56%), Gaps = 8/273 (2%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +  I+D ++  R+LG G FG  +L  +R +      K+I+K + +  V ++ +  E+ ++
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVL 74

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTI 161
           K L  + +I+ + E  ED + +++VME CEGGEL +RIV+        +E   A + + +
Sbjct: 75  KSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           +  +   H   V+H+DLKPEN LF +   +SP+K IDFGL+  FK  E  +   G+  YM
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYM 193

Query: 222 APEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           APEV KR+   + DIWSAGV++Y LL G  PF   S + V Q       ++  +  P ++
Sbjct: 194 APEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LT 252

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             A  L++QML  DP+ R +A QVL H W + A
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  466 bits (1200), Expect = e-166
 Identities = 99/308 (32%), Positives = 161/308 (52%), Gaps = 8/308 (2%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R     V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + +I++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQV-LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APE++     G E D+WS GVI YILL G  PF  +++Q     I     DF  + +   
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRS--RLKQFSMMNR 338
           SE AK  +R++L  + + RLT ++ L HPW+        +   + V +    K+  +  R
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRR 305

Query: 339 FKRKALRV 346
           +K     V
Sbjct: 306 WKLSFSIV 313

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  464 bits (1197), Expect = e-165
 Identities = 96/326 (29%), Positives = 161/326 (49%), Gaps = 19/326 (5%)

Query: 3   NCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPK----ENIEDRYLVDRE 58
              R   + +   +      +D   K       Q +     +P     +    +Y     
Sbjct: 42  RSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDV 101

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-----IDDVRREVAIMKHLPKNSS 113
           +GRG   V   C+ R T    A K +     R + +      +  RRE  I++ +  +  
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           I++L ++ E  + + LV +L   GELFD +  +   +E+   ++ R+++E V   H + +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK------ 227
           +HRDLKPEN L     +N  ++  DFG S   +PGE+  E+ G+P Y+APE+LK      
Sbjct: 222 VHRDLKPENILLD---DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278

Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
              YG E+D+W+ GVIL+ LL G PPFW   +  + + I+ G   F    W + S + K 
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338

Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           L+ ++L+ DP+ RLTA+Q L+HP+ +
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPFFE 364

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  461 bits (1188), Expect = e-163
 Identities = 100/351 (28%), Positives = 156/351 (44%), Gaps = 19/351 (5%)

Query: 7   SPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGV 66
           +P          +  +           +    + L       I+D  +  + LG G  G 
Sbjct: 18  APPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGK 77

Query: 67  TYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--- 123
                ++ T+E  A K +              RREV +     +   IV + +  E+   
Sbjct: 78  VLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYA 129

Query: 124 -DNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
               + +VME  +GGELF RI  RG   +TER A+ + ++I E +Q  H   + HRD+KP
Sbjct: 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 189

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSA 239
           EN L+ +K+ N+ LK  DFG +         +    +PYY+APEVL    Y    D+WS 
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249

Query: 240 GVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           GVI+YILLCG PPF++        G+   I  G  +F    W  VSE  K L+R +L+ +
Sbjct: 250 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 309

Query: 296 PKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           P  R+T  + + HPW+  + K P  PL      +  +    +  +     +
Sbjct: 310 PTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSAL 360

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  455 bits (1172), Expect = e-162
 Identities = 93/289 (32%), Positives = 147/289 (50%), Gaps = 16/289 (5%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVR---- 99
                + Y     LGRG   V   CI + T +  A K I        +A ++ ++R    
Sbjct: 12  THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL 71

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           +EV I++ +  + +I+ LK+  E +    LV +L + GELFD +  +   +E+    + R
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            ++EV+   HK  ++HRDLKPEN L     ++  +K  DFG S    PGE+  E+ G+P 
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTPS 188

Query: 220 YMAPEVLK-------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF 272
           Y+APE+++         YG E+D+WS GVI+Y LL G PPFW   +  + + I+ G   F
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248

Query: 273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
               W + S++ K LV + L   P+ R TA++ L HP+ Q         
Sbjct: 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  445 bits (1146), Expect = e-158
 Identities = 99/307 (32%), Positives = 141/307 (45%), Gaps = 35/307 (11%)

Query: 46  KENIEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
               ED Y +  + LG G       CI+  T +  A K I K+          V REV +
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEM 63

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           +     + +++ L E  E+++  +LV E   GG +   I  R H+ E  A+ V + +   
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI--------VG 216
           +   H  G+ HRDLKPEN L  +  + SP+K  DF L    K     S I         G
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183

Query: 217 SPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAE-------------- 256
           S  YMAPEV++        Y    D+WS GVILYILL G PPF                 
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243

Query: 257 -SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
             +  + ++I  G  +F    W ++S +AK L+ ++L  D K RL+A QVL+HPW+Q   
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG-- 301

Query: 316 KAPNVPL 322
            AP   L
Sbjct: 302 CAPENTL 308

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  444 bits (1143), Expect = e-158
 Identities = 102/310 (32%), Positives = 154/310 (49%), Gaps = 18/310 (5%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRRE 101
           + + D Y++ + LG G  G   L  +R T + +A K ISKRK      R A    +V  E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           + I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         +
Sbjct: 66  IEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           +  VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183

Query: 222 APEVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDFKRDP 276
           APEVL       Y   +D WS GVIL+I L G PPF     +  +   I  G  +F  + 
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243

Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMM 336
           W  VSE A  LV+++L  DPK R T ++ L HPWLQ+                L + +  
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ------DLLSEENES 297

Query: 337 NRFKRKALRV 346
               +   + 
Sbjct: 298 TALPQVLAQP 307

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  444 bits (1144), Expect = e-157
 Identities = 95/322 (29%), Positives = 158/322 (49%), Gaps = 7/322 (2%)

Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKS 83
           +   K      K+ +     V + ++ D Y +  ELG G FGV + C+++ T  +   K 
Sbjct: 24  NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF 83

Query: 84  ISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI 143
           I+       +D   V+ E++IM  L  +  +++L +A ED   + L++E   GGELFDRI
Sbjct: 84  INTPYP---LDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 139

Query: 144 VARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
            A  +  +E       R   E ++  H+H ++H D+KPEN +   K + S +K IDFGL+
Sbjct: 140 AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLA 198

Query: 203 IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
               P E       +  + APE++ R   G   D+W+ GV+ Y+LL G+ PF  E +   
Sbjct: 199 TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 258

Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
            Q + R   +F  D + +VS  AK  ++ +L+ +P+ RLT    LEHPWL+         
Sbjct: 259 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318

Query: 322 LGDVVRSRLKQFSMMNRFKRKA 343
           +     ++++Q          A
Sbjct: 319 IPSSRYNKIRQKIKEKYADWPA 340

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  441 bits (1136), Expect = e-156
 Identities = 110/339 (32%), Positives = 158/339 (46%), Gaps = 26/339 (7%)

Query: 22  SHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLA 80
           +H H    +G    + +       K  + D Y + ++ LG G  G    C  R T +  A
Sbjct: 2   AHHHHHHSSGL---EVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCA 58

Query: 81  CKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----DNAVHLVMELCEG 136
            K +              R+EV           IV + +  E+       + ++ME  EG
Sbjct: 59  LKLLYDSP--------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110

Query: 137 GELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL 194
           GELF RI  RG   +TER AA + R I   +Q  H H + HRD+KPEN L+ +K++++ L
Sbjct: 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170

Query: 195 KAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  DFG +              +PYY+APEVL    Y    D+WS GVI+YILLCG PPF
Sbjct: 171 KLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

Query: 254 WAESEQ----GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
           ++ + Q    G+ + I  G   F    W  VSE AK L+R +L+ DP  RLT  Q + HP
Sbjct: 230 YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289

Query: 310 WLQNAKKAPNVPLG--DVVRSRLKQFSMMNRFKRKALRV 346
           W+  +   P  PL    V++     +  +      AL  
Sbjct: 290 WINQSMVVPQTPLHTARVLQEDKDHWDEVKEEMTSALAT 328

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  450 bits (1158), Expect = e-156
 Identities = 96/340 (28%), Positives = 155/340 (45%), Gaps = 9/340 (2%)

Query: 6   RSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFG 65
                   + V+   +   +         KQ       +  +++ D Y +  ELG G FG
Sbjct: 112 GYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFG 171

Query: 66  VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN 125
           V +   +R T    A K +         D + VR+E+  M  L ++ ++V+L +A EDDN
Sbjct: 172 VVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVL-RHPTLVNLHDAFEDDN 227

Query: 126 AVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFL 184
            + ++ E   GGELF+++       +E  A    R + + +   H++  +H DLKPEN +
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM 287

Query: 185 FANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVIL 243
           F  K+ N  LK IDFGL+    P +      G+  + APEV + +  G   D+WS GV+ 
Sbjct: 288 FTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

Query: 244 YILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAK 303
           YILL G+ PF  E++    + +     +     +  +SE  K  +R++L  DP  R+T  
Sbjct: 347 YILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIH 406

Query: 304 QVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKA 343
           Q LEHPWL             +  SR  +     + K  A
Sbjct: 407 QALEHPWLTPGNAPGRD--SQIPSSRYTKIRDSIKTKYDA 444

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  434 bits (1118), Expect = e-153
 Identities = 101/361 (27%), Positives = 174/361 (48%), Gaps = 30/361 (8%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLA-------------GVPKE 47
           M N     +     + K  +S+ D   +    +K+     +                 + 
Sbjct: 24  MKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQG 83

Query: 48  NIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
            +   Y V +   LG G FG  + C +  T   LA K I  R ++   D ++V+ E+++M
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVM 140

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEV 164
             L  +++++ L +A E  N + LVME  +GGELFDRI+   +  TE       + I E 
Sbjct: 141 NQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           ++  H+  ++H DLKPEN L  N+ +   +K IDFGL+  +KP E+     G+P ++APE
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258

Query: 225 VLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES 283
           V+  +      D+WS GVI Y+LL G+ PF  +++      IL    D + + + ++SE 
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318

Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMN--RFKR 341
           AK  + ++L  +   R++A + L+HPWL + K          + ++ K+    +   F  
Sbjct: 319 AKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSR------LSAQKKKNRGSDAQDFVT 372

Query: 342 K 342
           K
Sbjct: 373 K 373

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  421 bits (1085), Expect = e-149
 Identities = 93/312 (29%), Positives = 138/312 (44%), Gaps = 39/312 (12%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
               I+D  +  + LG G  G      ++ T+E  A K +              RREV +
Sbjct: 12  KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVEL 63

Query: 105 MKHLPKNSSIVSLKEACED----DNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVT 158
                +   IV + +  E+       + +VME  +GGELF RI  RG   +TER A+ + 
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123

Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSP 218
           ++I E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG                  
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------- 166

Query: 219 YYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKR 274
              A E     Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F  
Sbjct: 167 ---AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223

Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFS 334
             W  VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL      +  +  
Sbjct: 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE- 282

Query: 335 MMNRFKRKALRV 346
                K +    
Sbjct: 283 RWEDVKEEMTSA 294

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  424 bits (1092), Expect = e-148
 Identities = 100/278 (35%), Positives = 149/278 (53%), Gaps = 12/278 (4%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRR 100
            + + D Y++ + LG G  G   L  +R T + +A + ISKRK      R A    +V  
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E+ I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         
Sbjct: 190 EIEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           ++  VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 307

Query: 221 MAPEVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDFKRD 275
           +APEVL       Y   +D WS GVIL+I L G PPF     +  +   I  G  +F  +
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367

Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            W  VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  420 bits (1080), Expect = e-148
 Identities = 97/349 (27%), Positives = 161/349 (46%), Gaps = 57/349 (16%)

Query: 23  HDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           H H    +G   ++ +    G     ++ +Y +   +G+G +GV  + I+  TR + A K
Sbjct: 2   HHHHHHSSG---RENLYFQ-GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57

Query: 83  SISKRKLR--TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF 140
            ++K K+R     D++ ++ EV +MK L  + +I  L E  ED+  + LVMELC GG L 
Sbjct: 58  IMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMELCHGGHLL 116

Query: 141 DRIVARGH----------------------------------------YTERAAAAVTRT 160
           D++                                               E+  + + R 
Sbjct: 117 DKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-----GERFSEIV 215
           I   +   H  G+ HRD+KPENFLF+   ++  +K +DFGLS  F           +   
Sbjct: 177 IFSALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235

Query: 216 GSPYYMAPEVLK---RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF 272
           G+PY++APEVL     +YGP+ D WSAGV+L++LL G  PF   ++      +L   + F
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF 295

Query: 273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL-QNAKKAPNV 320
           +   +  +S  A+ L+  +L  +   R  A + L+HPW+ Q + K   +
Sbjct: 296 ENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  312 bits (800), Expect = e-104
 Identities = 76/340 (22%), Positives = 133/340 (39%), Gaps = 50/340 (14%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           ++++++  + ++ LG G  G             +A K +           D    E+ ++
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLL 62

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY-------TERAAAAVT 158
                + +++    +   D  +++ +ELC    L D + ++           E    ++ 
Sbjct: 63  TESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------ENSPLKAIDFGLSIFFKPG 208
           R I   V   H   +IHRDLKP+N L +             EN  +   DFGL      G
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 209 E-----RFSEIVGSPYYMAPEVL--------KRNYGPEIDIWSAGVILYILLC-GVPPFW 254
           +       +   G+  + APE+L        KR     IDI+S G + Y +L  G  PF 
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241

Query: 255 AESEQGVAQAILRG---LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            +  +     I+RG   L + K     ++   A  L+ QM++ DP  R TA +VL HP  
Sbjct: 242 DKYSR--ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

Query: 312 QNAKKAPNVPLGDV-----VRSRLKQFSMMNRFKRKALRV 346
               K     L  V     + +R    +++ +F   +  V
Sbjct: 300 WPKSKKLEFLL-KVSDRLEIENRDPPSALLMKFDAGSDFV 338

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  302 bits (776), Expect = e-100
 Identities = 65/279 (23%), Positives = 119/279 (42%), Gaps = 21/279 (7%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +  +     LG G  G T +         +A K I               REV +++   
Sbjct: 23  KISFCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESD 75

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLC 168
           ++ +++      +D    ++ +ELC    L + +  +   +       + +     +   
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAI--DFGLSIFFKPGE----RFSEIVGSPYYMA 222
           H   ++HRDLKP N L +    +  +KA+  DFGL      G     R S + G+  ++A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 223 PEVL----KRNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           PE+L    K N    +DI+SAG + Y ++  G  PF    ++     +    +D    P 
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-LHPE 253

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
            +    A+ L+ +M+  DP+ R +AK VL+HP+  + +K
Sbjct: 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  287 bits (736), Expect = 4e-96
 Identities = 66/315 (20%), Positives = 117/315 (37%), Gaps = 43/315 (13%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +      +L+   LG+G     +    + T +L A K  +         +D   RE  ++
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61

Query: 106 KHLPKNSSIVSLKEACEDDNAVH--LVMELCEGGELFDRIVARGH---YTERAAAAVTRT 160
           K L  + +IV L    E+    H  L+ME C  G L+  +    +     E     V R 
Sbjct: 62  KKL-NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 161 IVEVVQLCHKHGVIHRDLKPENFL-FANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           +V  +    ++G++HR++KP N +    +   S  K  DFG +   +  E+F  + G+  
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query: 220 YMAPEVLKR---------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR--- 267
           Y+ P++ +R          YG  +D+WS GV  Y    G  PF         + ++    
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 268 ----------------GLIDFKRD--PWPNVSESAKSLV----RQMLEPDPKLRLTAKQV 305
                           G ID+  D     ++S   + L+      +LE D +      Q 
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 306 LEHPWLQNAKKAPNV 320
                    +   + 
Sbjct: 301 FAETSDILHRGNSHH 315

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  279 bits (714), Expect = 8e-92
 Identities = 67/315 (21%), Positives = 118/315 (37%), Gaps = 43/315 (13%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +      +L+   LG+G     +    + T +L A K  +         +D   RE  ++
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61

Query: 106 KHLPKNSSIVSLKEACEDDNAVH--LVMELCEGGELFDRIVARGH---YTERAAAAVTRT 160
           K L  + +IV L    E+    H  L+ME C  G L+  +    +     E     V R 
Sbjct: 62  KKL-NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 161 IVEVVQLCHKHGVIHRDLKPENFL-FANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           +V  +    ++G++HR++KP N +    +   S  K  DFG +   +  E+F  + G+  
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query: 220 YMAPEVLKRN---------YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR--- 267
           Y+ P++ +R          YG  +D+WS GV  Y    G  PF         + ++    
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 268 ----------------GLIDFKRD--PWPNVSESAKSLV----RQMLEPDPKLRLTAKQV 305
                           G ID+  D     ++S   + L+      +LE D +      Q 
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 306 LEHPWLQNAKKAPNV 320
                    +   +V
Sbjct: 301 FAETSDILHRMVIHV 315

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  273 bits (699), Expect = 1e-90
 Identities = 71/308 (23%), Positives = 133/308 (43%), Gaps = 28/308 (9%)

Query: 23  HDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           H H    +G +          +  +     Y + +++G G     +  ++ + +++ A K
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSVKGR--IYSILKQIGSGGSSKVFQVLN-EKKQIYAIK 58

Query: 83  SISKRKLRTAVDIDDVRREVAIMKHLP-KNSSIVSLKEACEDDNAVHLVMELCEGGELFD 141
            ++  +      +D  R E+A +  L   +  I+ L +    D  +++VME C   +L  
Sbjct: 59  YVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNS 116

Query: 142 RIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL 201
            +  +         +  + ++E V   H+HG++H DLKP NFL  +      LK IDFG+
Sbjct: 117 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGI 172

Query: 202 SIFFKPGERFSE---IVGSPYYMAPEVLKRN------------YGPEIDIWSAGVILYIL 246
           +   +P          VG+  YM PE +K                P+ D+WS G ILY +
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232

Query: 247 LCGVPPFWAESEQGVA-QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
             G  PF     Q     AI+    + + +      +  + +++  L+ DPK R++  ++
Sbjct: 233 TYGKTPFQQIINQISKLHAIIDP--NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

Query: 306 LEHPWLQN 313
           L HP++Q 
Sbjct: 291 LAHPYVQI 298

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  269 bits (691), Expect = 1e-89
 Identities = 67/299 (22%), Positives = 115/299 (38%), Gaps = 41/299 (13%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
               +     LG+G FG      +       A K I   +      +  +  EV ++  L
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASL 59

Query: 109 PKNSSIVSLKEACEDDNAVH-------------LVMELCEGGELFDRIVARGHYTERAAA 155
             +  +V    A  +                  + ME CE G L+D I +     +R   
Sbjct: 60  -NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 156 A-VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS------------ 202
             + R I+E +   H  G+IHRDLKP N       E+  +K  DFGL+            
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 203 ---IFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
                    +  +  +G+  Y+A EVL    +Y  +ID++S G+I + ++   P      
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGME 233

Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
              + + +    I+F  D   N  +  K ++R +++ DP  R  A+ +L   WL    +
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  270 bits (693), Expect = 2e-89
 Identities = 72/315 (22%), Positives = 132/315 (41%), Gaps = 32/315 (10%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-K 110
            Y + +++G G     +  ++   +++ A K ++  +      +D  R E+A +  L   
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 67

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+
Sbjct: 68  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE---IVGSPYYMAPEVLK 227
           HG++H DLKP NFL  +      LK IDFG++   +P          VG+  YM PE +K
Sbjct: 127 HGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 228 R------------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRGLIDFKR 274
                           P+ D+WS G ILY +  G  PF     Q     AI+    + + 
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHEI 240

Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRS------ 328
           +      +  + +++  L+ DPK R++  ++L HP++Q      N               
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 300

Query: 329 RLKQFSMMNRFKRKA 343
           +L   +  N   + A
Sbjct: 301 QLVGLNSPNSILKAA 315

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  265 bits (680), Expect = 5e-88
 Identities = 86/273 (31%), Positives = 133/273 (48%), Gaps = 10/273 (3%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
            RY+  R LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-A 73

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  +V      ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H+
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVLKRN 229
           + VIHRDLK  N    N+     +K  DFGL+   +  GER   + G+P Y+APEVL + 
Sbjct: 134 NRVIHRDLKLGNLFL-NEDLE--VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190

Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +  E+D+WS G I+Y LL G PPF     +     I +   ++       ++  A SL+
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLI 246

Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           ++ML+ DP  R T  ++L   +  +      +P
Sbjct: 247 QKMLQTDPTARPTINELLNDEFFTSGYIPARLP 279

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  268 bits (686), Expect = 1e-87
 Identities = 75/362 (20%), Positives = 143/362 (39%), Gaps = 32/362 (8%)

Query: 5   CRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEF 64
                +  +E   + +        + G +     +  A          Y + +++G G  
Sbjct: 10  LVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGS 69

Query: 65  GVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-KNSSIVSLKEACED 123
              +  ++ + +++ A K ++  +      +D  R E+A +  L   +  I+ L +    
Sbjct: 70  SKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127

Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF 183
           D  +++VME C   +L   +  +         +  + ++E V   H+HG++H DLKP NF
Sbjct: 128 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 186

Query: 184 LFANKKENSPLKAIDFGLSIFFKPGERFSE---IVGSPYYMAPEVLKR------------ 228
           L  +      LK IDFG++   +P          VG+  YM PE +K             
Sbjct: 187 LIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242

Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRGLIDFKRDPWPNVSESAKSL 287
              P+ D+WS G ILY +  G  PF     Q     AI+    + + +      +  + +
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHEIEFPDIPEKDLQDV 300

Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRS------RLKQFSMMNRFKR 341
           ++  L+ DPK R++  ++L HP++Q      N               +L   +  N   +
Sbjct: 301 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILK 360

Query: 342 KA 343
            A
Sbjct: 361 AA 362

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  265 bits (680), Expect = 2e-87
 Identities = 88/294 (29%), Positives = 135/294 (45%), Gaps = 10/294 (3%)

Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLA 80
                A   A A       +   +       RY+  R LG+G F   +   D DT+E+ A
Sbjct: 11  GVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFA 70

Query: 81  CKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF 140
            K + K  L      + +  E++I + L  +  +V      ED++ V +V+ELC    L 
Sbjct: 71  GKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCRRRSLL 129

Query: 141 DRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG 200
           +    R   TE  A    R IV   Q  H++ VIHRDLK  N    N+     +K  DFG
Sbjct: 130 ELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL-NEDLE--VKIGDFG 186

Query: 201 LSIFFK-PGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE 258
           L+   +  GER   + G+P Y+APEVL +  +  E+D+WS G I+Y LL G PPF     
Sbjct: 187 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 246

Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           +     I +   ++       ++  A SL+++ML+ DP  R T  ++L   +  
Sbjct: 247 KETYLRIKKN--EYSIPKH--INPVAASLIQKMLQTDPTARPTINELLNDEFFT 296

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  263 bits (675), Expect = 9e-87
 Identities = 91/272 (33%), Positives = 145/272 (53%), Gaps = 11/272 (4%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y + + +G+G F    L     T   +A K I K +L     +  + REV IMK L  +
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKIL-NH 73

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
            +IV L E  E +  ++L+ME   GGE+FD +VA G   E+ A +  R IV  VQ CH+ 
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY 230
            ++HRDLK EN L      +  +K  DFG S  F  G +     G+P Y APE+ + + Y
Sbjct: 134 RIVHRDLKAENLLLD---ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190

Query: 231 -GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
            GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG   ++   +  +S   ++L++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFY--MSTDCENLLK 246

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           + L  +P  R T +Q+++  W+    +   + 
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELK 278

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  263 bits (672), Expect = 6e-86
 Identities = 53/341 (15%), Positives = 100/341 (29%), Gaps = 46/341 (13%)

Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLA 80
           ++   A       +    TV + + +   E +  +   L  G+  V +L  D +  E  A
Sbjct: 34  AAMVEAVTATVWPQNAETTVDSLLSQG--ERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91

Query: 81  CKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-----------------------SIVSL 117
            K  +     +  +++ +         L   S                           L
Sbjct: 92  LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151

Query: 118 KEACEDDNAVH--LVMELCEG------GELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
               +D    +  L+M             L    V RG     A   +T  ++ +     
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN 229
             G++H    P+N        +  L   D      +K G R         Y   E L  +
Sbjct: 212 SKGLVHGHFTPDNLFI---MPDGRLMLGDVSAL--WKVGTRGPASSVPVTYAPREFLNAS 266

Query: 230 ---YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW-----PNVS 281
              +   ++ W  G+ +Y + C   PF   +           L     D         + 
Sbjct: 267 TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP 326

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           +  K+L+ + L  D + RL   + +E P     +   +  L
Sbjct: 327 DFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSL 367

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  258 bits (662), Expect = 1e-85
 Identities = 92/286 (32%), Positives = 141/286 (49%), Gaps = 12/286 (4%)

Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           LA    E IED + V   LG+G F   Y      T   +A K I K+ +  A  +  V+ 
Sbjct: 2   LATCIGEKIED-FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTR 159
           EV I   L K+ SI+ L    ED N V+LV+E+C  GE+   +  R   ++E  A     
Sbjct: 61  EVKIHCQL-KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSP 218
            I+  +   H HG++HRDL   N L         +K  DFGL+   K P E+   + G+P
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTP 176

Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y++PE+  R+ +G E D+WS G + Y LL G PPF  ++ +     ++    D++   +
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSF 234

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLG 323
             +S  AK L+ Q+L  +P  RL+   VL+HP++       +   G
Sbjct: 235 --LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  261 bits (669), Expect = 2e-85
 Identities = 53/363 (14%), Positives = 112/363 (30%), Gaps = 62/363 (17%)

Query: 6   RSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFG 65
           R P A  R   +   S+ D     +  N  QP  V + + +       +    LG+ +  
Sbjct: 30  RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGER--PRTLVRGTVLGQEDPY 87

Query: 66  VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS------------ 113
                 D++T E          +   +  I  ++ EV  ++ L    +            
Sbjct: 88  AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147

Query: 114 ------------IVSLKEACEDDNA--VHLVMELCE------GGELFDRIVARGHYTERA 153
                       ++ ++    D        +    +      G  L             A
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207

Query: 154 AAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
              +T  ++ ++   H +G++H  L+P + +     +   +    F              
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHL---VRDGARVV 261

Query: 214 IVGSPYYMAPEVLKRN------------YGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
              S  +  PE+  R                  D W+ G+++Y + C   P   ++  G 
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG 321

Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK--APN 319
           ++ I R           N+ +  ++L+   L    + RL   Q +E P  +  +   +  
Sbjct: 322 SEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAA 373

Query: 320 VPL 322
           +PL
Sbjct: 374 LPL 376

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  254 bits (650), Expect = 1e-83
 Identities = 97/272 (35%), Positives = 137/272 (50%), Gaps = 10/272 (3%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y++   LG G FG   +   + T   +A K ++++K+R+   +  ++RE+  +K   ++
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RH 70

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +         +VME   GGELFD I   G   E  A  + + I+  V  CH+H
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-KRNY 230
            V+HRDLKPEN L      +   K  DFGLS     GE      GSP Y APEV+  R Y
Sbjct: 131 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187

Query: 231 -GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
            GPE+DIWS GVILY LLCG  PF  E    + + I  G   F    +  ++ S  +L+ 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLM 243

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
            ML+ DP  R T K + EH W +    +   P
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQDLPSYLFP 275

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  254 bits (652), Expect = 2e-83
 Identities = 91/312 (29%), Positives = 141/312 (45%), Gaps = 34/312 (10%)

Query: 21  SSHDHARKEAGA----------NKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLC 70
           SSH H    +G           N      +  G  KE +E +Y V   LG G FG  Y  
Sbjct: 3   SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62

Query: 71  IDRDTRELLACKSISKRKLRTAVDIDD---VRREVAIMK---HLPKNSSIVSLKEACEDD 124
           I       +A K + K ++    ++ +   V  EV ++K          ++ L +  E  
Sbjct: 63  IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG--VIRLLDWFERP 120

Query: 125 NAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF 183
           ++  L++E  E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN 
Sbjct: 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 180

Query: 184 LFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY-GPEIDIWSAGV 241
           L    +    LK IDFG     K    +++  G+  Y  PE ++   Y G    +WS G+
Sbjct: 181 LIDLNRGE--LKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237

Query: 242 ILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT 301
           +LY ++CG  PF  + E      I+RG + F+      VS   + L+R  L   P  R T
Sbjct: 238 LLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPT 287

Query: 302 AKQVLEHPWLQN 313
            +++  HPW+Q+
Sbjct: 288 FEEIQNHPWMQD 299

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  252 bits (646), Expect = 5e-83
 Identities = 91/293 (31%), Positives = 154/293 (52%), Gaps = 11/293 (3%)

Query: 39  TVLAGVPKENIE-DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           T LA +PK     D + + R LG+G+FG  YL  ++  + ++A K + K +L        
Sbjct: 1   TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60

Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           +RRE+ I  HL ++ +I+ +     D   ++L++E    GEL+  +   G + E+ +A  
Sbjct: 61  LRREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF 119

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS 217
              + + +  CH+  VIHRD+KPEN L   K E   LK  DFG S+   P  R   + G+
Sbjct: 120 MEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRTMCGT 175

Query: 218 PYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP 276
             Y+ PE++  + +  ++D+W AGV+ Y  L G+PPF + S     + I+    D K  P
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPP 233

Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR 329
           +  +S+ +K L+ ++L   P  RL  K V+EHPW++   +    P+    +S+
Sbjct: 234 F--LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  252 bits (645), Expect = 5e-83
 Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 10/269 (3%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL +
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 67

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  CH 
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
             VIHRD+KPEN L         LK  DFG S+   P  R +++ G+  Y+ PE+++   
Sbjct: 128 KRVIHRDIKPENLLLG---SAGELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRM 183

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           +  ++D+WS GV+ Y  L G PPF A + Q   + I R   +F    +  V+E A+ L+ 
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDF--VTEGARDLIS 239

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
           ++L+ +P  R   ++VLEHPW+      P
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKP 268

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  253 bits (649), Expect = 7e-83
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 22/290 (7%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD-----VRR 100
           +     +Y     LG G FG  +  +D++  + +  K I K K+     I+D     V  
Sbjct: 19  EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL-CEGGELFDRIVARGHYTERAAAAVTR 159
           E+AI+  + ++++I+ + +  E+     LVME    G +LF  I       E  A+ + R
Sbjct: 79  EIAILSRV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            +V  V       +IHRD+K EN + A   E+  +K IDFG + + + G+ F    G+  
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTIE 194

Query: 220 YMAPEVLKRN-Y-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y APEVL  N Y GPE+++WS GV LY L+    PF    E       +           
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEA--AIHPPYL 246

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVR 327
             VS+   SLV  +L+P P+ R T ++++  PW+       +    +V R
Sbjct: 247 --VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFR 294

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  262 bits (671), Expect = 2e-82
 Identities = 75/310 (24%), Positives = 123/310 (39%), Gaps = 33/310 (10%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
                  + +   LG G FG     I +DT E +A K   +    +  + +    E+ IM
Sbjct: 9   PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIM 66

Query: 106 KHLPKNSSIVSLKEACEDDNAVH------LVMELCEGGELFDRIVARGH---YTERAAAA 156
           K L  + ++VS +E  +    +       L ME CEGG+L   +    +     E     
Sbjct: 67  KKL-NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
           +   I   ++  H++ +IHRDLKPEN +     +    K ID G +     GE  +E VG
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185

Query: 217 SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR-------- 267
           +  Y+APE+L+ + Y   +D WS G + +  + G  PF    +       +R        
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245

Query: 268 ------GLIDFKRD-PWPN-----VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
                 G + F    P PN     ++   +  ++ ML    + R T  Q       Q   
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305

Query: 316 KAPNVPLGDV 325
              ++ L  V
Sbjct: 306 SILSLKLLSV 315

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  251 bits (643), Expect = 3e-82
 Identities = 79/320 (24%), Positives = 128/320 (40%), Gaps = 22/320 (6%)

Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLA 80
           S      +   A    P     G  +E  E  Y +   LG+G FG  +       R  +A
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA 60

Query: 81  CKSISKRKLRTAVDIDD---VRREVAIMKHLPKNSS---IVSLKEACEDDNAVHLVMEL- 133
            K I + ++     + D      EVA++  +        ++ L +  E      LV+E  
Sbjct: 61  IKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERP 120

Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSP 193
               +LFD I  +G   E  +      +V  +Q CH  GV+HRD+K EN L   ++    
Sbjct: 121 LPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC-- 178

Query: 194 LKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY-GPEIDIWSAGVILYILLCGVP 251
            K IDFG          +++  G+  Y  PE +    Y      +WS G++LY ++CG  
Sbjct: 179 AKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237

Query: 252 PFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           PF  + E      IL    +        VS    +L+R+ L P P  R + +++L  PW+
Sbjct: 238 PFERDQE------ILEA--ELHFPAH--VSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

Query: 312 QNAKKAPNVPLGDVVRSRLK 331
           Q   +   +       + L 
Sbjct: 288 QTPAEDVPLNPSKGGPAPLA 307

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  252 bits (645), Expect = 8e-82
 Identities = 87/292 (29%), Positives = 136/292 (46%), Gaps = 16/292 (5%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P  +  DRY   +++G G FGV  L  D+ T+EL+A K I +         ++V+RE+ 
Sbjct: 13  MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREII 68

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             + L ++ +IV  KE       + ++ME   GGEL++RI   G ++E  A    + ++ 
Sbjct: 69  NHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS 127

Query: 164 VVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
            V  CH   + HRDLK EN L   +      LK  DFG S       +    VG+P Y+A
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIA 185

Query: 223 PEVL-KRNY-GPEIDIWSAGVILYILLCGVPPFWAESE----QGVAQAILRGLIDFKRDP 276
           PEVL ++ Y G   D+WS GV LY++L G  PF    E    +   Q IL     +    
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV--KYSIPD 243

Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRS 328
              +S     L+ ++   DP  R++  ++  H W      A  +   +    
Sbjct: 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQ 295

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  247 bits (634), Expect = 2e-81
 Identities = 73/268 (27%), Positives = 126/268 (47%), Gaps = 14/268 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + + + + LG G +G   L ++R T E +A K +  ++     +  ++++E+ I K L  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKML-N 63

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + ++V       + N  +L +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---VGSPYYMAPEVL- 226
            G+ HRD+KPEN L     E   LK  DFGL+  F+   R   +    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 227 KRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRGLIDFKRDPWPNVSESA 284
           +R +    +D+WS G++L  +L G  P+   S+                 +PW  +  + 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAP 238

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            +L+ ++L  +P  R+T   + +  W  
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYN 266

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  249 bits (638), Expect = 4e-81
 Identities = 91/281 (32%), Positives = 144/281 (51%), Gaps = 11/281 (3%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y++   LG G FG   L     T++ +A K IS++ L+ +     V RE++ +K L ++
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RH 68

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +       + +V+E   GGELFD IV +   TE       + I+  ++ CH+H
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY 230
            ++HRDLKPEN L     +N  +K  DFGLS     G       GSP Y APEV+  + Y
Sbjct: 128 KIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184

Query: 231 -GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
            GPE+D+WS G++LY++L G  PF  E    + + +      +    +  +S  A+SL+R
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIR 240

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           +M+  DP  R+T +++   PW          P+ +V  S  
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYA 281

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  253 bits (647), Expect = 8e-81
 Identities = 97/272 (35%), Positives = 140/272 (51%), Gaps = 10/272 (3%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y++   LG G FG   +     T   +A K ++++K+R+   +  +RRE+  +K   ++
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RH 75

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +     + + +VME   GGELFD I   G   E+ +  + + I+  V  CH+H
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-KRNY 230
            V+HRDLKPEN L      +   K  DFGLS     GE      GSP Y APEV+  R Y
Sbjct: 136 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 192

Query: 231 -GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
            GPE+DIWS+GVILY LLCG  PF  +    + + I  G   F    +  ++ S  SL++
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLK 248

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
            ML+ DP  R T K + EH W +        P
Sbjct: 249 HMLQVDPMKRATIKDIREHEWFKQDLPKYLFP 280

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  247 bits (634), Expect = 9e-81
 Identities = 73/268 (27%), Positives = 126/268 (47%), Gaps = 14/268 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + + + + LG G +G   L ++R T E +A K +  ++     +  ++++E+ I K L  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKML-N 63

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + ++V       + N  +L +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---VGSPYYMAPEVL- 226
            G+ HRD+KPEN L     E   LK  DFGL+  F+   R   +    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 227 KRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRGLIDFKRDPWPNVSESA 284
           +R +    +D+WS G++L  +L G  P+   S+                 +PW  +  + 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAP 238

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            +L+ ++L  +P  R+T   + +  W  
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYN 266

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  246 bits (630), Expect = 2e-80
 Identities = 82/291 (28%), Positives = 138/291 (47%), Gaps = 37/291 (12%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD----------------- 94
           +Y +  E+G+G +GV  L  + +     A K +SK+KL                      
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 95  ------IDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL--VMELCEGGELFDRIVAR 146
                 I+ V +E+AI+K L  + ++V L E  +D N  HL  V EL   G + + +   
Sbjct: 74  IQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTL 131

Query: 147 GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
              +E  A    + +++ ++  H   +IHRD+KP N L     E+  +K  DFG+S  FK
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVSNEFK 188

Query: 207 PGERF-SEIVGSPYYMAPEVL---KRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             +   S  VG+P +MAPE L   ++ + G  +D+W+ GV LY  + G  PF  E    +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248

Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
              I       +    P+++E  K L+ +ML+ +P+ R+   ++  HPW+ 
Sbjct: 249 HSKIKSQ--ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  243 bits (622), Expect = 5e-79
 Identities = 74/270 (27%), Positives = 113/270 (41%), Gaps = 13/270 (4%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P+   +  +     LG G +G  +    ++   L A K  S    R   D      EV  
Sbjct: 51  PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGS 109

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVE 163
            + + ++   V L++A E+   ++L  ELC G  L     A G    E       R  + 
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            +   H  G++H D+KP N            K  DFGL +            G P YMAP
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225

Query: 224 EVLKRNYGPEIDIWSAGVILYILLCGVP-PFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           E+L+ +YG   D++S G+ +  + C +  P   E  Q + Q  L             +S 
Sbjct: 226 ELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSS 279

Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +S++  MLEPDPKLR TA+ +L  P L+
Sbjct: 280 ELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  236 bits (603), Expect = 1e-76
 Identities = 79/278 (28%), Positives = 131/278 (47%), Gaps = 25/278 (8%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + Y V   +G G +G       +   ++L  K +    + T  +   +  EV +++ L K
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-K 63

Query: 111 NSSIVSLKEA--CEDDNAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTRTIVEV 164
           + +IV   +      +  +++VME CEGG+L   I      R +  E     V   +   
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 165 VQLCHK-----HGVIHRDLKPEN-FLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGS 217
           ++ CH+     H V+HRDLKP N FL   +     +K  DFGL+        F++  VG+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQN----VKLGDFGLARILNHDTSFAKTFVGT 179

Query: 218 PYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP 276
           PYYM+PE +   +Y  + DIWS G +LY L   +PPF A S++ +A  I  G    K   
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----KFRR 235

Query: 277 WPNV-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            P   S+    ++ +ML      R + +++LE+P +  
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  234 bits (600), Expect = 3e-75
 Identities = 78/301 (25%), Positives = 146/301 (48%), Gaps = 16/301 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y+  +++G G FG   L    +       K I+  ++ ++ + ++ RREVA++ ++ K
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-K 81

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLC 168
           + +IV  +E+ E++ ++++VM+ CEGG+LF RI A+    + E         I   ++  
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 169 HKHGVIHRDLKPEN-FLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEVL 226
           H   ++HRD+K +N FL  +      ++  DFG++         +   +G+PYY++PE+ 
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT----VQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197

Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESA 284
           +   Y  + DIW+ G +LY L      F A S + +   I+ G       P   + S   
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG----SFPPVSLHYSYDL 253

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKAL 344
           +SLV Q+ + +P+ R +   +LE  ++    +    P        LK FS        A 
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAK 313

Query: 345 R 345
           R
Sbjct: 314 R 314

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  234 bits (599), Expect = 4e-75
 Identities = 65/360 (18%), Positives = 125/360 (34%), Gaps = 59/360 (16%)

Query: 16  VKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDT 75
           +K   S++ +        K++   +          + Y + R L +G+F    LC     
Sbjct: 6   MKDILSNYSNLIYLNKYVKEKDKYI----------NDYRIIRTLNQGKFNKIILC--EKD 53

Query: 76  RELLACKSISKRKLRTAVDI--------------DDVRREVAIMKHLPKNSSIVSLKEAC 121
            +  A K   K  L    D               DD + E+ I+  + KN   ++ +   
Sbjct: 54  NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLTCEGII 112

Query: 122 EDDNAVHLVMELCEGGELFDRIVARGH--------YTERAAAAVTRTIVEVVQLCHKH-G 172
            + + V+++ E  E   +                    +    + ++++      H    
Sbjct: 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN 172

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--- 229
           + HRD+KP N L         +K  DFG S +    ++     G+  +M PE        
Sbjct: 173 ICHRDVKPSNILMDKNGR---VKLSDFGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSY 228

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAE-SEQGVAQAILRGLIDF---------------K 273
            G ++DIWS G+ LY++   V PF  + S   +   I    I++                
Sbjct: 229 NGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKS 288

Query: 274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQF 333
                 +S      ++  L  +P  R+T++  L+H WL +            +  + K+ 
Sbjct: 289 TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKRKKL 348

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  227 bits (582), Expect = 4e-73
 Identities = 69/282 (24%), Positives = 131/282 (46%), Gaps = 20/282 (7%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD-VRREVAIMKHLPK 110
           +YL+   LG G +G     +D +T    A K + K+KLR   + +  V++E+ +++ L +
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64

Query: 111 NSSIVSLKE--ACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           + +++ L +    E+   +++VME C  G  E+ D +     +    A      +++ ++
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLE 123

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS---IFFKPGERFSEIVGSPYYMAP 223
             H  G++H+D+KP N L         LK    G++     F   +      GSP +  P
Sbjct: 124 YLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 224 EVL--KRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           E+      + G ++DIWSAGV LY +  G+ PF  ++   + + I +G   +        
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD--C 236

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                 L++ MLE +P  R + +Q+ +H W +        P+
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  217 bits (556), Expect = 4e-69
 Identities = 76/310 (24%), Positives = 132/310 (42%), Gaps = 16/310 (5%)

Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLA 80
                  +     + QP   L      N    + +++++GRG+F   Y          +A
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVA 61

Query: 81  CKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF 140
            K +    L  A    D  +E+ ++K L  + +++    +  +DN +++V+EL + G+L 
Sbjct: 62  LKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLS 120

Query: 141 DRIVARG----HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN-FLFANKKENSPLK 195
             I           ER        +   ++  H   V+HRD+KP N F+ A       +K
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV----VK 176

Query: 196 AIDFGLSIFFKPGERFSE-IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPF 253
             D GL  FF      +  +VG+PYYM+PE +  N Y  + DIWS G +LY +     PF
Sbjct: 177 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

Query: 254 WAESE--QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + +      + + I +   D+   P  + SE  + LV   + PDP+ R     V +    
Sbjct: 237 YGDKMNLYSLCKKIEQC--DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294

Query: 312 QNAKKAPNVP 321
            +A  A ++ 
Sbjct: 295 MHACTASSLE 304

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  216 bits (552), Expect = 7e-69
 Identities = 60/294 (20%), Positives = 107/294 (36%), Gaps = 38/294 (12%)

Query: 42  AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           A    +     +     +G G FG  +    R   +    K +           +   RE
Sbjct: 2   AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAERE 54

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNA----------------VHLVMELCEGGELFDRIVA 145
           V  +  L  + +IV      +  +                 + + ME C+ G L   I  
Sbjct: 55  VKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113

Query: 146 R--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI 203
           R      +  A  +   I + V   H   +I+RDLKP N    + K+   +K  DFGL  
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVT 170

Query: 204 FFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA 262
             K   + +   G+  YM+PE +  ++YG E+D+++ G+IL  LL               
Sbjct: 171 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFF 228

Query: 263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
             +  G+I           +  K+L++++L   P+ R    ++L    +     
Sbjct: 229 TDLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  216 bits (551), Expect = 2e-68
 Identities = 64/300 (21%), Positives = 105/300 (35%), Gaps = 37/300 (12%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            YL  ++LG G F    L          A K I   + +   D ++ +RE  + +    +
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQREADMHRLF-NH 85

Query: 112 SSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVE 163
            +I+ L   C  +        L++   + G L++ I          TE     +   I  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE---------- 213
            ++  H  G  HRDLKP N L  ++ +      +D G           S           
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 214 IVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQG--VAQAILR 267
              +  Y APE+             D+WS G +LY ++ G  P+    ++G  VA A+  
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262

Query: 268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW-LQNAKKAPNVPLGDVV 326
                     P  S +   L+  M+  DP  R     +L     LQ    AP      ++
Sbjct: 263 Q---LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP--APGQHTTQIL 317

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  208 bits (531), Expect = 1e-65
 Identities = 67/295 (22%), Positives = 119/295 (40%), Gaps = 34/295 (11%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
            K      +    ++G GEFG  + C+ R    + A K  SK+ L  +VD  +  REV  
Sbjct: 5   MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYA 63

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRT 160
              L ++S +V    A  +D+ + +  E C GG L D I        ++ E     +   
Sbjct: 64  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123

Query: 161 IVEVVQLCHKHGVIHRDLKPEN-FLFANKKENSPLKAI---------------DFGLSIF 204
           +   ++  H   ++H D+KP N F+      N+  +                 D G    
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182

Query: 205 FKPGERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVA 262
            +      E  G   ++A EVL+ N  + P+ DI++  + +       P      +    
Sbjct: 183 -RISSPQVE-EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--- 237

Query: 263 QAILRGLIDFKRDPWPNV-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
             I +G    +    P V S+    L++ M+ PDP+ R +A  +++H  L +A +
Sbjct: 238 HEIRQG----RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  206 bits (527), Expect = 2e-64
 Identities = 74/299 (24%), Positives = 110/299 (36%), Gaps = 41/299 (13%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           R  V R L  G F   Y   D  +    A K +   +         + +EV  MK L  +
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEVCFMKKLSGH 85

Query: 112 SSIVSLKEACEDDNA--------VHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTI 161
            +IV    A                L+ ELC+G   E   ++ +RG  +      +    
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 162 VEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS------- 212
              VQ  H+    +IHRDLK EN L +       +K  DFG +        +S       
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 213 ------EIVGSPYYMAPEVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA 262
                     +P Y  PE++        G + DIW+ G ILY+L     PF    E G  
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAK 258

Query: 263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
             I+ G   +   P         SL+R ML+ +P+ RL+  +V+       A +  N  
Sbjct: 259 LRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  204 bits (520), Expect = 6e-64
 Identities = 79/310 (25%), Positives = 121/310 (39%), Gaps = 44/310 (14%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
             +   + LGRG FGV +   ++      A K I  R     +  + V REV  +  L +
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKL-E 61

Query: 111 NSSIVSLKEACEDDNA------------VHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
           +  IV    A  + N             +++ M+LC    L D +  R    ER  +   
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 159 RT---IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS------------- 202
                I E V+  H  G++HRDLKP N  F        +K  DFGL              
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVL 178

Query: 203 IFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
                  R +  VG+  YM+PE +   +Y  ++DI+S G+IL+ LL    PF  + E+  
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235

Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
               +R L  F              +V+ ML P P  R  A  ++E+   ++        
Sbjct: 236 TLTDVRNLK-FPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTV 293

Query: 322 LGDVVRSRLK 331
           L    R R +
Sbjct: 294 L----RQRSR 299

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  206 bits (524), Expect = 2e-63
 Identities = 52/351 (14%), Positives = 104/351 (29%), Gaps = 59/351 (16%)

Query: 6   RSPAAVAREDVKSNYSSHDHARKEAGANKKQPITV---LAGVPKENIEDRYLVDRELGRG 62
           R P A  R   +   S+ D     +  N  QP  V   L   P+       +    LG+ 
Sbjct: 35  RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPR-----TLVRGTVLGQE 89

Query: 63  EFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP------------- 109
           +        D++T E          +   +  I  ++ EV  ++ L              
Sbjct: 90  DPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149

Query: 110 --------KNSSIVSLKEACEDDN-----AVHLVMELCEG------GELFDRIVARGHYT 150
                   K+     +     D+      +   +    +         L           
Sbjct: 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 209

Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
             A   +T  ++ ++   H +G++H  L+P + +     +   +    F   +       
Sbjct: 210 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFEHLVRDGASAV 266

Query: 211 FS--EIVGSPYYMAPEVL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA 262
                    P   A  +L              D W+ G+ +Y + C   P   ++  G +
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326

Query: 263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           + I R           N+ +  ++L+   L    + RL   Q +E P  + 
Sbjct: 327 EWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  199 bits (506), Expect = 4e-61
 Identities = 54/293 (18%), Positives = 92/293 (31%), Gaps = 39/293 (13%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRRE 101
           +       V   LG G F   Y     D      ++    K           +     + 
Sbjct: 61  QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQL 117

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA-----AAA 156
           +  +K        +    A    N   LV EL   G L + I    +  E+        +
Sbjct: 118 MERLKPS-MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANK--------KENSPLKAIDFGLSI---FF 205
               ++ +++  H   +IH D+KP+NF+  N           ++ L  ID G SI    F
Sbjct: 177 FAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236

Query: 206 KPGERFSEIVGSPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQ 263
             G  F+    +  +   E+L  + +  +ID +     +Y +L G       E  +   +
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296

Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP---WLQN 313
            + R L     D W             ML       L +  +L        Q 
Sbjct: 297 GLFRRL--PHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  182 bits (464), Expect = 2e-55
 Identities = 83/298 (27%), Positives = 124/298 (41%), Gaps = 25/298 (8%)

Query: 26  ARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS 85
           A    GA   Q         K+  ED +   + LG G F    L  +  T    A K + 
Sbjct: 6   AEPRPGAGSLQHAQPPPQPRKKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKILE 64

Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           KR +     +  V RE  +M  L  +   V L    +DD  ++  +   + GEL   I  
Sbjct: 65  KRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK 123

Query: 146 RGHYTERAA---AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
            G + E       A    IV  ++  H  G+IHRDLKPEN L     E+  ++  DFG +
Sbjct: 124 IGSFDETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTA 177

Query: 203 ---IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE 258
                     R +  VG+  Y++PE+L         D+W+ G I+Y L+ G+PPF A +E
Sbjct: 178 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT------AKQVLEHPW 310
             + Q I++   DF           A+ LV ++L  D   RL          +  HP+
Sbjct: 238 YLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  179 bits (456), Expect = 2e-54
 Identities = 66/270 (24%), Positives = 117/270 (43%), Gaps = 15/270 (5%)

Query: 52  RYL-VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           R+L  D E+GRG F   Y  +D +T   +A   +  RKL T  +    + E  ++K L +
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-Q 83

Query: 111 NSSIV----SLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           + +IV    S +   +    + LV EL   G L   +        +   +  R I++ +Q
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143

Query: 167 LCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
             H     +IHRDLK +N           +K  D GL+   +     + ++G+P +MAPE
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPE 200

Query: 225 VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-SES 283
           + +  Y   +D+++ G+ +  +     P ++E  Q  AQ   R     K   +  V    
Sbjct: 201 MYEEKYDESVDVYAFGMCMLEMATSEYP-YSE-CQNAAQIYRRVTSGVKPASFDKVAIPE 258

Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            K ++   +  +   R + K +L H + Q 
Sbjct: 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  177 bits (452), Expect = 8e-54
 Identities = 71/268 (26%), Positives = 122/268 (45%), Gaps = 20/268 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G +G+ Y   D   +  +A K I     R +     +  E+A+ KHL K+ +IV   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHL-KHKNIVQYL 85

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTRTIVEVVQLCHKHGVIH 175
            +  ++  + + ME   GG L   + ++       E+     T+ I+E ++  H + ++H
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN---YG 231
           RD+K +N L      +  LK  DFG S              G+  YMAPE++ +    YG
Sbjct: 146 RDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP---NVSESAKSLV 288
              DIWS G  +  +  G PP + E  +  A A+ +  +   +       ++S  AK+ +
Sbjct: 204 KAADIWSLGCTIIEMATGKPP-FYELGEPQA-AMFK--VGMFKVHPEIPESMSAEAKAFI 259

Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
            +  EPDP  R  A  +L   +L+ + K
Sbjct: 260 LKCFEPDPDKRACANDLLVDEFLKVSSK 287

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  176 bits (448), Expect = 8e-53
 Identities = 64/304 (21%), Positives = 111/304 (36%), Gaps = 28/304 (9%)

Query: 26  ARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS 85
                G    + +  +    +E +         +GRG FG  +   D+ T    A K + 
Sbjct: 34  TEDNEGVLLTEKLKPVDYEYREEVHW-MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR 92

Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
               R          E+     L  +  IV L  A  +   V++ MEL EGG L   I  
Sbjct: 93  LEVFR--------VEELVACAGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ 143

Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--- 202
            G   E  A       +E ++  H   ++H D+K +N L ++    S     DFG +   
Sbjct: 144 MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD--GSRAALCDFGHALCL 201

Query: 203 ---IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE 258
                 K       I G+  +MAPEV+       ++DIWS+  ++  +L G  P W +  
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP-WTQYF 260

Query: 259 QGVAQAILRGLIDFKRDPWP----NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           +      L+  I  +  P      + +      +++ L  +P  R +A ++         
Sbjct: 261 R--GPLCLK--IASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316

Query: 315 KKAP 318
           +   
Sbjct: 317 EVGG 320

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  172 bits (439), Expect = 3e-51
 Identities = 77/315 (24%), Positives = 137/315 (43%), Gaps = 25/315 (7%)

Query: 2   GNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGR 61
           GN   +     +E VK   +       +      Q            ++  +   + LG 
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQN--------TAQLDQ-FDRIKTLGT 51

Query: 62  GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC 121
           G FG   L   +++    A K + K+K+     I+    E  I++ +     +V L+ + 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSF 110

Query: 122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPE 181
           +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDLKPE
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170

Query: 182 NFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAG 240
           N L     +   ++  DFG +   +   R   + G+P  +APE++    Y   +D W+ G
Sbjct: 171 NLLID---QQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALG 225

Query: 241 VILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           V++Y +  G PPF+A+    + + I+ G + F   P  + S   K L+R +L+ D   R 
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDLLRNLLQVDLTKRF 281

Query: 301 -----TAKQVLEHPW 310
                    +  H W
Sbjct: 282 GNLKNGVNDIKNHKW 296

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  171 bits (435), Expect = 4e-51
 Identities = 84/307 (27%), Positives = 142/307 (46%), Gaps = 47/307 (15%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMK 106
           ++Y    ++G G +GV + C +RDT +++A K     K   + D   ++    RE+ ++K
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLK 57

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEV 164
            L K+ ++V+L E       +HLV E C+       DR   +    E    ++T   ++ 
Sbjct: 58  QL-KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQA 114

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAP 223
           V  CHKH  IHRD+KPEN L         +K  DFG + +   P + + + V + +Y +P
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171

Query: 224 EVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR-------------- 267
           E+L     YGP +D+W+ G +   LL GVP +  +S+      I +              
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231

Query: 268 GLIDFK-------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
               F                 +PN+S  A  L++  L  DP  RLT +Q+L HP+ +N 
Sbjct: 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291

Query: 315 KKAPNVP 321
           ++  ++ 
Sbjct: 292 REIEDLA 298

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  173 bits (440), Expect = 4e-51
 Identities = 67/271 (24%), Positives = 126/271 (46%), Gaps = 28/271 (10%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +G+G FG   +    DT+++ A K ++K+K     ++ +V +E+ IM+ L ++  +V+
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVN 79

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA---AAVTRTIVEVV---QLCHK 170
           L  + +D+  + +V++L  GG+L   +    H+ E              E+V        
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC------ELVMALDYLQN 133

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
             +IHRD+KP+N L     E+  +   DF ++       + + + G+  YMAPE+     
Sbjct: 134 QRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190

Query: 230 ---YGPEIDIWSAGVILYILLCGVPPFW---AESEQGVAQAILRGLIDFKRDPWPNVSES 283
              Y   +D WS GV  Y LL G  P+    + S + +       ++ +        S+ 
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQE 246

Query: 284 AKSLVRQMLEPDPKLRL-TAKQVLEHPWLQN 313
             SL++++LEP+P  R      V   P++ +
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  172 bits (438), Expect = 2e-50
 Identities = 82/262 (31%), Positives = 125/262 (47%), Gaps = 16/262 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   L   + TR++ A K +SK ++    D      E  IM     +  +V L 
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLF 135

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +DD  +++VME   GG+L   +++     E+ A   T  +V  +   H  G IHRD+
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 194

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGSPYYMAPEVLKR-----NYG 231
           KP+N L     ++  LK  DFG  +             VG+P Y++PEVLK       YG
Sbjct: 195 KPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 251

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM 291
            E D WS GV LY +L G  PF+A+S  G    I+            ++S+ AK+L+   
Sbjct: 252 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAF 311

Query: 292 LEPDPKLRLT---AKQVLEHPW 310
           L  D ++RL     +++  H +
Sbjct: 312 LT-DREVRLGRNGVEEIKRHLF 332

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  167 bits (426), Expect = 1e-49
 Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 23/275 (8%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           PK +++D  ++ R LG G FG  +L   R      A K + K  +     ++    E  +
Sbjct: 1   PKYSLQDFQIL-RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM 59

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA---AAVTRTI 161
           +  +  +  I+ +    +D   + ++M+  EGGELF  +     +    A   AA    +
Sbjct: 60  LSIV-THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---EV 115

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
              ++  H   +I+RDLKPEN L     +N  +K  DFG +      +    + G+P Y+
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAK--YVPDVTYTLCGTPDYI 170

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APEV+    Y   ID WS G+++Y +L G  PF+  +     + IL   + F     P  
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFF 226

Query: 281 SESAKSLVRQMLEPDPKLRL-----TAKQVLEHPW 310
           +E  K L+ +++  D   RL       + V  HPW
Sbjct: 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  167 bits (426), Expect = 1e-49
 Identities = 79/315 (25%), Positives = 148/315 (46%), Gaps = 26/315 (8%)

Query: 12  AREDVKSNYSSHDHARKEAGANKKQPITVL-AGVPKENIEDRYLVDRELGRGEFGVTYLC 70
                  +  + +   +      +Q    L   V + +         ++G G  G+  L 
Sbjct: 5   HHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLA 64

Query: 71  IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV 130
            ++ +   +A K +    LR     + +  EV IM+   ++ ++V + ++      + ++
Sbjct: 65  REKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVL 120

Query: 131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE 190
           ME  +GG L D IV++    E   A V   +++ +   H  GVIHRD+K ++ L      
Sbjct: 121 MEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT---L 176

Query: 191 NSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILL 247
           +  +K  DFG    I     +R S +VG+PY+MAPEV+ R+ Y  E+DIWS G+++  ++
Sbjct: 177 DGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235

Query: 248 CGVPPFWAESEQGVAQAILRGLIDFKRDPWP------NVSESAKSLVRQMLEPDPKLRLT 301
            G PP++++S        ++ +   +  P P       VS   +  + +ML  DP+ R T
Sbjct: 236 DGEPPYFSDSP-------VQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288

Query: 302 AKQVLEHPWLQNAKK 316
           A+++L+HP+L     
Sbjct: 289 AQELLDHPFLLQTGL 303

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  166 bits (422), Expect = 2e-49
 Identities = 82/282 (29%), Positives = 143/282 (50%), Gaps = 25/282 (8%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           V   + + +Y    ++G+G  G  Y  +D  T + +A + +    L+     + +  E+ 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEIL 69

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R  ++
Sbjct: 70  VMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQ 127

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYM 221
            ++  H + VIHRD+K +N L      +  +K  DFG    I  +  +R + +VG+PY+M
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWM 183

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-- 278
           APEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  P  
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGTPEL 236

Query: 279 ----NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                +S   +  + + LE D + R +AK++L+H +L+ AK 
Sbjct: 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  169 bits (430), Expect = 3e-49
 Identities = 80/291 (27%), Positives = 136/291 (46%), Gaps = 19/291 (6%)

Query: 33  NKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA 92
              +P T      + + ED  ++ + +GRG FG   +   ++  ++ A K ++K ++   
Sbjct: 57  EWAKPFTSKVKQMRLHREDFEIL-KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115

Query: 93  VDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV-ARGHYTE 151
            +    R E  ++ +   +  I +L  A +DDN ++LVM+   GG+L   +        E
Sbjct: 116 AETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE 174

Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-- 209
             A      +V  +   H+   +HRD+KP+N L      N  ++  DFG  +        
Sbjct: 175 EMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTV 231

Query: 210 RFSEIVGSPYYMAPEVL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ 263
           + S  VG+P Y++PE+L      K  YGPE D WS GV +Y +L G  PF+AES      
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 291

Query: 264 AILRGLIDFKRDPW-PNVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPW 310
            I+     F+      +VSE+AK L+R+++      RL     +   +HP+
Sbjct: 292 KIMNHKERFQFPTQVTDVSENAKDLIRRLICSREH-RLGQNGIEDFKKHPF 341

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  166 bits (422), Expect = 4e-49
 Identities = 69/338 (20%), Positives = 112/338 (33%), Gaps = 85/338 (25%)

Query: 52  RYLVD----RELGRGEFGVTYLCIDRDTRELLACKSI-------SKRKLRTAVDIDDVRR 100
           RYL D    + +GRG FGV +   ++      A K I       ++ K+   V       
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 101 EVAIMKHLP-----------------------------------------------KNSS 113
              I+++                                                    +
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR---TIVEVVQLCHK 170
            V   +       +++ M+LC    L D +  R    +R           I E V+  H 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------------IFFKPGERFSEIVGS 217
            G++HRDLKP N  F        +K  DFGL                       +  VG+
Sbjct: 183 KGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 218 PYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-VAQAILRGLIDFKRD 275
             YM+PE +   NY  ++DI+S G+IL+ LL     F  + E+  +   +          
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFP---L 293

Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            +         +V+ ML P P  R  A  ++E+   +N
Sbjct: 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  165 bits (419), Expect = 2e-48
 Identities = 70/304 (23%), Positives = 124/304 (40%), Gaps = 57/304 (18%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMK 106
           ++Y     +G G +G+   C ++DT  ++A K     K   + D   V+    RE+ ++K
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLK 79

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEV 164
            L ++ ++V+L E C+     +LV E  +    +  +          +        I+  
Sbjct: 80  QL-RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIING 136

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAP 223
           +  CH H +IHRD+KPEN L +       +K  DFG +     PGE + + V + +Y AP
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193

Query: 224 EVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------------------QGVA 262
           E+L     YG  +D+W+ G ++  +  G P F  +S+                   +   
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253

Query: 263 QAILRGLIDFK-------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
           +        F                 +P +SE    L ++ L  DP  R    ++L H 
Sbjct: 254 K-----NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308

Query: 310 WLQN 313
           + Q 
Sbjct: 309 FFQM 312

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  165 bits (420), Expect = 2e-48
 Identities = 74/263 (28%), Positives = 120/263 (45%), Gaps = 15/263 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   ++T +L A K + K  +    D++    E  I+     +  +  L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + +  VME   GG+L   I     + E  A      I+  +   H  G+I+RDL
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDL 150

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K +N L          K  DFG+       G   +   G+P Y+APE+L+   YGP +D 
Sbjct: 151 KLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDW 207

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W+ GV+LY +LCG  PF AE+E  + +AIL   + +       + E A  +++  +  +P
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGILKSFMTKNP 263

Query: 297 KLRL------TAKQVLEHPWLQN 313
            +RL          +L HP+ + 
Sbjct: 264 TMRLGSLTQGGEHAILRHPFFKE 286

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  164 bits (417), Expect = 4e-48
 Identities = 64/258 (24%), Positives = 118/258 (45%), Gaps = 10/258 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG  +L   + T +  A K++ K  +    D++    E  ++    ++  +  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +    +  VME   GG+L   I +   +    A      I+  +Q  H  G+++RDL
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K +N L     ++  +K  DFG+         + +   G+P Y+APE+L    Y   +D 
Sbjct: 145 KLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS GV+LY +L G  PF  + E+ +  +I      + R     + + AK L+ ++   +P
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVREP 257

Query: 297 KLRLTAKQ-VLEHPWLQN 313
           + RL  +  + +HP  + 
Sbjct: 258 EKRLGVRGDIRQHPLFRE 275

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  168 bits (428), Expect = 8e-48
 Identities = 77/260 (29%), Positives = 128/260 (49%), Gaps = 12/260 (4%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG    C  R T ++ ACK + K++++          E  I++ +  +  +VSL 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLA 250

Query: 119 EACEDDNAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
            A E  +A+ LV+ L  GG+L   I  + +  + E  A      I   ++  H+  +++R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           DLKPEN L     ++  ++  D GL++    G+     VG+  YMAPEV+K   Y    D
Sbjct: 311 DLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W+ G +LY ++ G  PF    ++   + + R + +   +     S  A+SL  Q+L  D
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427

Query: 296 PKLRL-----TAKQVLEHPW 310
           P  RL     +A++V EHP 
Sbjct: 428 PAERLGCRGGSAREVKEHPL 447

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  165 bits (420), Expect = 8e-48
 Identities = 75/293 (25%), Positives = 127/293 (43%), Gaps = 21/293 (7%)

Query: 33  NKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA 92
              +PI V     +   +D  ++ + +GRG F    +   + T ++ A K ++K  +   
Sbjct: 44  QWAEPIVVRLKEVRLQRDDFEIL-KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102

Query: 93  VDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-HYTE 151
            ++   R E  ++ +      I  L  A +D+N ++LVME   GG+L   +   G     
Sbjct: 103 GEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA 161

Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-- 209
             A      IV  +   H+ G +HRD+KP+N L         ++  DFG  +  +     
Sbjct: 162 EMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTV 218

Query: 210 RFSEIVGSPYYMAPEVLKR--------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
           R    VG+P Y++PE+L+         +YGPE D W+ GV  Y +  G  PF+A+S    
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278

Query: 262 AQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPW 310
              I+              V E A+  ++++L   P+ RL    A     HP+
Sbjct: 279 YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  169 bits (430), Expect = 1e-47
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 20/266 (7%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS--I 114
           R +GRG FG  Y C   DT ++ A K + K++++          E  ++  +       I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V +  A    + +  +++L  GG+L   +   G ++E         I+  ++  H   V+
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--YGP 232
           +RDLKP N L     E+  ++  D GL+  F   ++    VG+  YMAPEVL++   Y  
Sbjct: 315 YRDLKPANILL---DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDS 370

Query: 233 EIDIWSAGVILYILLCGVPPFWAESE---QGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
             D +S G +L+ LL G  PF          + +  L   ++       + S   +SL+ 
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLE 426

Query: 290 QMLEPDPKLRL-----TAKQVLEHPW 310
            +L+ D   RL      A++V E P+
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPF 452

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  162 bits (413), Expect = 2e-47
 Identities = 71/290 (24%), Positives = 122/290 (42%), Gaps = 17/290 (5%)

Query: 32  ANKKQPITVLAGVPKENIED-RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR 90
            N            +  + D  +L    LG+G FG   L   + T EL A K + K  + 
Sbjct: 2   TNTVSKFDNNGNRDRMKLTDFNFL--MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI 59

Query: 91  TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT 150
              D++    E  ++    K   +  L    +  + ++ VME   GG+L   I   G + 
Sbjct: 60  QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK 119

Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGE 209
           E  A      I   +      G+I+RDLK +N +         +K  DFG+       G 
Sbjct: 120 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGV 176

Query: 210 RFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG 268
                 G+P Y+APE++    YG  +D W+ GV+LY +L G  PF  E E  + Q+I+  
Sbjct: 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236

Query: 269 LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQN 313
            + + +    ++S+ A ++ + ++   P  RL       + + EH + + 
Sbjct: 237 NVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  168 bits (427), Expect = 3e-47
 Identities = 74/308 (24%), Positives = 129/308 (41%), Gaps = 17/308 (5%)

Query: 14  EDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIED-RYLVDRELGRGEFGVTYLCID 72
           +  ++       A +E  AN            +  + D  +L    LG+G FG   L   
Sbjct: 305 KFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFL--MVLGKGSFGKVMLSER 362

Query: 73  RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME 132
           + T EL A K + K  +    D++    E  ++    K   +  L    +  + ++ VME
Sbjct: 363 KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422

Query: 133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS 192
              GG+L   I   G + E  A      I   +      G+I+RDLK +N +        
Sbjct: 423 YVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEG 479

Query: 193 PLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
            +K  DFG+       G       G+P Y+APE++    YG  +D W+ GV+LY +L G 
Sbjct: 480 HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

Query: 251 PPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL-----TAKQV 305
            PF  E E  + Q+I+   + + +    ++S+ A ++ + ++   P  RL       + +
Sbjct: 540 APFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDI 595

Query: 306 LEHPWLQN 313
            EH + + 
Sbjct: 596 KEHAFFRY 603

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  161 bits (410), Expect = 4e-47
 Identities = 81/262 (30%), Positives = 131/262 (50%), Gaps = 15/262 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALK 71

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244

Query: 297 KLRL-----TAKQVLEHPWLQN 313
           K RL      AK+V+EH +  +
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLS 266

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  160 bits (407), Expect = 9e-47
 Identities = 75/268 (27%), Positives = 125/268 (46%), Gaps = 29/268 (10%)

Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKLRTAVDIDDV------RREVAIMKHLP 109
           LG+G +G  +        +T ++ A K + K  +    +  D       R  +  +KH P
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI--VRNAKDTAHTKAERNILEEVKH-P 81

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
               IV L  A +    ++L++E   GGELF ++   G + E  A      I   +   H
Sbjct: 82  ---FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKR 228
           + G+I+RDLKPEN +         +K  DFGL       G       G+  YMAPE+L R
Sbjct: 139 QKGIIYRDLKPENIMLN---HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR 195

Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           + +   +D WS G ++Y +L G PPF  E+ +     IL+  ++      P +++ A+ L
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARDL 251

Query: 288 VRQMLEPDPKLRL-----TAKQVLEHPW 310
           ++++L+ +   RL      A +V  HP+
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  158 bits (403), Expect = 6e-46
 Identities = 72/272 (26%), Positives = 123/272 (45%), Gaps = 24/272 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG +    L   + T  + A K + K  +    DID V+ E  + +    +  +V L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+RDL
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 136

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K +N L         +K  D+G+     +PG+  S   G+P Y+APE+L+   YG  +D 
Sbjct: 137 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193

Query: 237 WSAGVILYILLCGVPPFW---------AESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A S+
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASV 249

Query: 288 VRQMLEPDPKLRL------TAKQVLEHPWLQN 313
           ++  L  DPK RL          +  HP+ +N
Sbjct: 250 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  158 bits (401), Expect = 6e-46
 Identities = 76/267 (28%), Positives = 120/267 (44%), Gaps = 29/267 (10%)

Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKLRTAVDIDDV-----RREVAIMKHLPK 110
           LG+G FG  +L       D R+L A K + K  L      D V     R  +  + H P 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDILVEVNH-P- 86

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              IV L  A + +  ++L+++   GG+LF R+     +TE         +   +   H 
Sbjct: 87  --FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN 229
            G+I+RDLKPEN L     E   +K  DFGLS       ++     G+  YMAPEV+ R 
Sbjct: 145 LGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201

Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +    D WS GV+++ +L G  PF  +  +     IL+  +         +S  A+SL+
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLL 257

Query: 289 RQMLEPDPKLRL-----TAKQVLEHPW 310
           R + + +P  RL       +++  H +
Sbjct: 258 RMLFKRNPANRLGAGPDGVEEIKRHSF 284

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  157 bits (400), Expect = 9e-46
 Identities = 88/333 (26%), Positives = 134/333 (40%), Gaps = 44/333 (13%)

Query: 22  SHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLAC 81
            H H        +      ++  P     DRY    +LG G +G  Y  ID  T E +A 
Sbjct: 5   HHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAI 64

Query: 82  KSISKRKLR-----TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
           K I           TA+      REV+++K L ++ +I+ LK     ++ +HL+ E  E 
Sbjct: 65  KRIRLEHEEEGVPGTAI------REVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYAEN 117

Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSP--L 194
            +L   +      + R   +    ++  V  CH    +HRDLKP+N L +    +    L
Sbjct: 118 -DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176

Query: 195 KAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVP 251
           K  DFGL+  F  P  +F+  + + +Y  PE+L   R+Y   +DIWS   I   +L   P
Sbjct: 177 KIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236

Query: 252 PFWAESEQGVAQAILRGL--------------------------IDFKRDPWPNVSESAK 285
            F  +SE      I   L                             KR     + +   
Sbjct: 237 LFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGL 296

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
            L+  MLE DP  R++AK  LEHP+  +    P
Sbjct: 297 DLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  155 bits (395), Expect = 2e-45
 Identities = 85/301 (28%), Positives = 128/301 (42%), Gaps = 54/301 (17%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL--------RTAVDIDDVRREV 102
           ++Y    ++G G +GV Y   +    E  A K I   +L         T +      RE+
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI---RLEKEDEGIPSTTI------REI 51

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRT 160
           +I+K L K+S+IV L +       + LV E  +    +L D     G      A +    
Sbjct: 52  SILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQ 108

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPY 219
           ++  +  CH   V+HRDLKP+N L   + E   LK  DFGL+  F  P  +++  + + +
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLW 165

Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR---------- 267
           Y AP+VL   + Y   IDIWS G I   ++ G P F   SE      I R          
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225

Query: 268 ----GLIDFK-----------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                L  +                  + ES   L+ +ML+ DP  R+TAKQ LEH + +
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

Query: 313 N 313
            
Sbjct: 286 E 286

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  157 bits (398), Expect = 5e-45
 Identities = 67/261 (25%), Positives = 115/261 (44%), Gaps = 13/261 (4%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG   L   +      A K + K+ +    +   +  E  ++    K+  +V L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +  + ++ V++   GGELF  +     + E  A      I   +   H   +++RDL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           KPEN L         +   DFGL     +     S   G+P Y+APEVL +  Y   +D 
Sbjct: 166 KPENILLD---SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  G +LY +L G+PPF++ +   +   IL   +  K    PN++ SA+ L+  +L+ D 
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 278

Query: 297 KLRL----TAKQVLEHPWLQN 313
             RL       ++  H +   
Sbjct: 279 TKRLGAKDDFMEIKSHVFFSL 299

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  155 bits (393), Expect = 6e-45
 Identities = 72/285 (25%), Positives = 125/285 (43%), Gaps = 28/285 (9%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
             +  + + +  ELG G FG  Y   +++T  L A K I     ++  +++D   E+ I+
Sbjct: 14  DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEIL 70

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEV 164
                +  IV L  A   D  + +++E C GG +   ++      TE     V R ++E 
Sbjct: 71  ATC-DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIVGSPYYMAP 223
           +   H   +IHRDLK  N L         ++  DFG+S       ++    +G+PY+MAP
Sbjct: 130 LNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186

Query: 224 EVL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           EV+         Y  + DIWS G+ L  +    PP    +        +R L+   +   
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSDP 239

Query: 278 P------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           P        S   +  ++  L+ +P+ R +A Q+LEHP++ +   
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  157 bits (399), Expect = 6e-45
 Identities = 71/272 (26%), Positives = 123/272 (45%), Gaps = 24/272 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG +    L   + T  + A + + K  +    DID V+ E  + +    +  +V L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+RDL
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 179

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K +N L         +K  D+G+     +PG+  S   G+P Y+APE+L+   YG  +D 
Sbjct: 180 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 236

Query: 237 WSAGVILYILLCGVPPFW---------AESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A S+
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASV 292

Query: 288 VRQMLEPDPKLRL------TAKQVLEHPWLQN 313
           ++  L  DPK RL          +  HP+ +N
Sbjct: 293 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  156 bits (396), Expect = 6e-45
 Identities = 79/349 (22%), Positives = 147/349 (42%), Gaps = 25/349 (7%)

Query: 6   RSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFG 65
                +   +      + D       A   +   V     K++ E  +   RE+G G FG
Sbjct: 9   HHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFG 68

Query: 66  VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN 125
             Y   D    E++A K +S    ++     D+ +EV  ++ L ++ + +  +     ++
Sbjct: 69  AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREH 127

Query: 126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF 185
              LVME C G       V +    E   AAVT   ++ +   H H +IHRD+K  N L 
Sbjct: 128 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 187

Query: 186 ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL----KRNYGPEIDIWSAGV 241
           +   E   +K  DFG +    P   F   VG+PY+MAPEV+    +  Y  ++D+WS G+
Sbjct: 188 S---EPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241

Query: 242 ILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-----NVSESAKSLVRQMLEPDP 296
               L    PP +  +        +  L    ++  P     + SE  ++ V   L+  P
Sbjct: 242 TCIELAERKPPLFNMN-------AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 294

Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALR 345
           + R T++ +L+H ++   +  P   + D+++        ++  + + ++
Sbjct: 295 QDRPTSEVLLKHRFVLRER--PPTVIMDLIQRTKDAVRELDNLQYRKMK 341

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  158 bits (402), Expect = 6e-45
 Identities = 80/292 (27%), Positives = 142/292 (48%), Gaps = 19/292 (6%)

Query: 28  KEAGANKKQPITVLAGVPKENIED-RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK 86
            +    ++  +++     +  + +  YL  + LG+G FG   L  ++ T    A K + K
Sbjct: 126 SDNSGAEEMEVSLAKPKHRVTMNEFEYL--KLLGKGTFGKVILVKEKATGRYYAMKILKK 183

Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
             +    ++     E  ++++  ++  + +LK + +  + +  VME   GGELF  +   
Sbjct: 184 EVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE 242

Query: 147 GHYTERAAAAVTRTIVEVVQLCH-KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IF 204
             ++E  A      IV  +   H +  V++RDLK EN +     ++  +K  DFGL    
Sbjct: 243 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEG 299

Query: 205 FKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ 263
            K G       G+P Y+APEVL+ N YG  +D W  GV++Y ++CG  PF+ +  + + +
Sbjct: 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPW 310
            IL   I F R     +   AKSL+  +L+ DPK RL      AK++++H +
Sbjct: 360 LILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  154 bits (392), Expect = 7e-45
 Identities = 78/302 (25%), Positives = 134/302 (44%), Gaps = 54/302 (17%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL--------RTAVDIDDVRREV 102
            +Y    ++G G +G  +   +R+T E++A K +   +L         +A+      RE+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSAL------REI 52

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRT 160
            ++K L K+ +IV L +    D  + LV E C+    + FD     G        +    
Sbjct: 53  CLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQ 109

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPY 219
           +++ +  CH   V+HRDLKP+N L     E   LK  +FGL+  F  P   +S  V + +
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLW 166

Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILR--------- 267
           Y  P+VL   + Y   ID+WSAG I   +   G P F         + I R         
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226

Query: 268 -----GLIDFKRDP-----------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                 L D+K  P            P ++ + + L++ +L+ +P  R++A++ L+HP+ 
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

Query: 312 QN 313
            +
Sbjct: 287 SD 288

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  155 bits (393), Expect = 7e-45
 Identities = 73/283 (25%), Positives = 134/283 (47%), Gaps = 27/283 (9%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
              +  E+ + V  +LG G +G  Y  I ++T +++A K +         D+ ++ +E++
Sbjct: 22  SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEIS 76

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIV 162
           IM+    +  +V    +   +  + +VME C  G + D I  R    TE   A + ++ +
Sbjct: 77  IMQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL 135

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYY 220
           + ++  H    IHRD+K  N L          K  DFG++  +     +R + ++G+P++
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFW 191

Query: 221 MAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP- 278
           MAPEV++   Y    DIWS G+    +  G PP+            +R +     +P P 
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-------PMRAIFMIPTNPPPT 244

Query: 279 -----NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                  S++    V+Q L   P+ R TA Q+L+HP++++AK 
Sbjct: 245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  154 bits (392), Expect = 1e-44
 Identities = 69/301 (22%), Positives = 127/301 (42%), Gaps = 53/301 (17%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-------RTAVDIDDVRREVA 103
           + Y+   +LG G +   Y    + T  L+A K I   +L        TA+      REV+
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAI------REVS 52

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTI 161
           ++K L K+++IV+L +    + ++ LV E  +    +  D                   +
Sbjct: 53  LLKDL-KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQL 109

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYY 220
           +  +  CH+  V+HRDLKP+N L   + E   LK  DFGL+     P + +   V + +Y
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLWY 166

Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL--------- 269
             P++L    +Y  +ID+W  G I Y +  G P F   + +     I R L         
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 270 ----------IDFKRDP-------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                      ++ +          P +      L+ ++L+ + + R++A+  ++HP+  
Sbjct: 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

Query: 313 N 313
           +
Sbjct: 287 S 287

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  154 bits (391), Expect = 1e-44
 Identities = 75/317 (23%), Positives = 128/317 (40%), Gaps = 58/317 (18%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-------RTAVDIDDVRREVA 103
            ++    +LG G +   Y  +++ T   +A K +   KL        TA+      RE++
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAI------REIS 55

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGG-----ELFDRIVARGHYTERAAAAVT 158
           +MK L K+ +IV L +    +N + LV E  +       +                    
Sbjct: 56  LMKEL-KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGS 217
             +++ +  CH++ ++HRDLKP+N L   + +   LK  DFGL+  F  P   FS  V +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVT 171

Query: 218 PYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL------ 269
            +Y AP+VL   R Y   IDIWS G IL  ++ G P F   +++   + I   +      
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231

Query: 270 ------------------------IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
                                      +      +  +    +  +L+ +P +RL+AKQ 
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291

Query: 306 LEHPWLQNAKKAPNVPL 322
           L HPW        ++  
Sbjct: 292 LHHPWFAEYYHHASMGG 308

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  153 bits (389), Expect = 2e-44
 Identities = 77/282 (27%), Positives = 135/282 (47%), Gaps = 22/282 (7%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K + E+ +    ++G+G FG  +  ID  T++++A K I   +     +I+D+++E+ ++
Sbjct: 17  KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVL 74

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
                +  +     +   D  + ++ME   GG   D ++  G   E   A + R I++ +
Sbjct: 75  SQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGL 132

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMAP 223
              H    IHRD+K  N L +   E+  +K  DFG++  +     +R +  VG+P++MAP
Sbjct: 133 DYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAP 188

Query: 224 EVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP---- 278
           EV+K++ Y  + DIWS G+    L  G PP        V   I       K +P P    
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP------KNNP-PTLEG 241

Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV 320
           N S+  K  V   L  +P  R TAK++L+H ++    K  + 
Sbjct: 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  159 bits (403), Expect = 2e-44
 Identities = 74/267 (27%), Positives = 122/267 (45%), Gaps = 23/267 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LGRG FG  + C  + T +L ACK ++K++L+          E  I+  +  +  IVSL 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLA 251

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIVEVVQLCHKHGVI 174
            A E    + LVM +  GG++   I         + E  A   T  IV  ++  H+  +I
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGP 232
           +RDLKPEN L     ++  ++  D GL++       +     G+P +MAPE+L    Y  
Sbjct: 312 YRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368

Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQG----VAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +D ++ GV LY ++    PF A  E+     + Q +L   + +        S ++K   
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD----KFSPASKDFC 424

Query: 289 RQMLEPDPKLRL-----TAKQVLEHPW 310
             +L+ DP+ RL     +   +  HP 
Sbjct: 425 EALLQKDPEKRLGFRDGSCDGLRTHPL 451

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  153 bits (389), Expect = 3e-44
 Identities = 74/309 (23%), Positives = 127/309 (41%), Gaps = 49/309 (15%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-----TAVDIDDV 98
           +  + + ++Y    ++G G +GV Y   D     ++A K I           TA+     
Sbjct: 14  LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAI----- 67

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAA 156
            RE++++K L  + +IVSL +    +  + LV E  E    ++ D    +    +     
Sbjct: 68  -REISLLKEL-HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKI 123

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIV 215
               ++  V  CH+H ++HRDLKP+N L  +      LK  DFGL+  F  P   ++  V
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEV 180

Query: 216 GSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------ 267
            + +Y AP+VL   + Y   +DIWS G I   ++ G P F   ++      I        
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240

Query: 268 --------GLIDFK------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                    L  +K                P   +    L+  ML  DP  R++A+  + 
Sbjct: 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300

Query: 308 HPWLQNAKK 316
           HP+ ++   
Sbjct: 301 HPYFKDLDP 309

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  155 bits (394), Expect = 5e-44
 Identities = 83/343 (24%), Positives = 129/343 (37%), Gaps = 58/343 (16%)

Query: 12  AREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCI 71
                 S + S   +R + G+     +      P    E  Y   + +G G FGV Y   
Sbjct: 15  KPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAK 74

Query: 72  DRDTRELLACKSI---SKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA------CE 122
             D+ EL+A K +    + K R          E+ IM+ L  + +IV L+         +
Sbjct: 75  LCDSGELVAIKKVLQDKRFKNR----------ELQIMRKL-DHCNIVRLRYFFYSSGEKK 123

Query: 123 DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHR 176
           D+  ++LV++      ++          +       +  +   QL       H  G+ HR
Sbjct: 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM--YQLFRSLAYIHSFGICHR 180

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEI 234
           D+KP+N L  +  + + LK  DFG +     GE     + S YY APE++    +Y   I
Sbjct: 181 DIKPQNLL-LD-PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSI 238

Query: 235 DIWSAGVILYILLCGVPPFWAESE--QGV------------------AQAILRGLIDFKR 274
           D+WSAG +L  LL G P F  +S   Q V                             K 
Sbjct: 239 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA 298

Query: 275 DPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            PW     P     A +L  ++LE  P  RLT  +   H +  
Sbjct: 299 HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  152 bits (385), Expect = 7e-44
 Identities = 78/297 (26%), Positives = 130/297 (43%), Gaps = 28/297 (9%)

Query: 42  AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           + +P     D Y +   +G G   V         +E +A K I+  K +T   +D++ +E
Sbjct: 6   SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKE 63

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--------RIVARGHYTERA 153
           +  M     + +IVS   +    + + LVM+L  GG + D             G   E  
Sbjct: 64  IQAMSQC-HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122

Query: 154 AAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
            A + R ++E ++  HK+G IHRD+K  N L     E+  ++  DFG+S F   G   + 
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITR 179

Query: 214 ------IVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI 265
                  VG+P +MAPEV+++   Y  + DIWS G+    L  G  P+       V    
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239

Query: 266 LRG------LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           L+            ++      +S + ++   L+ DP+ R TA ++L H + Q AK 
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  152 bits (386), Expect = 2e-43
 Identities = 80/270 (29%), Positives = 134/270 (49%), Gaps = 25/270 (9%)

Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNSSI 114
           LG G +G  +L       DT +L A K + K  + + A   +  R E  +++H+ ++  +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V+L  A + +  +HL+++   GGELF  +  R  +TE         IV  ++  HK G+I
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII 181

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMAPEVLKRN--- 229
           +RD+K EN L      N  +   DFGLS        ER  +  G+  YMAP++++     
Sbjct: 182 YRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQG----VAQAILRGLIDFKRDPWPNVSESAK 285
           +   +D WS GV++Y LL G  PF  + E+     +++ IL+    +       +S  AK
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----QEMSALAK 294

Query: 286 SLVRQMLEPDPKLRL-----TAKQVLEHPW 310
            L++++L  DPK RL      A ++ EH +
Sbjct: 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  150 bits (381), Expect = 1e-42
 Identities = 72/297 (24%), Positives = 125/297 (42%), Gaps = 43/297 (14%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI---SKRKLRTAVDIDDVRREVAIMKH 107
            RY     LG G+F   Y   D++T +++A K I    + + +  ++   +R E+ +++ 
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQE 68

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVV 165
           L  + +I+ L +A    + + LV +  E     +          T     A     ++ +
Sbjct: 69  L-SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGL 125

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPE 224
           +  H+H ++HRDLKP N L         LK  DFGL+  F  P   ++  V + +Y APE
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 182

Query: 225 VL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-------------------GVAQ 263
           +L   R YG  +D+W+ G IL  LL  VP    +S+                     +  
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242

Query: 264 AILRGLIDFKRDP-------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
             L   + FK  P       +    +    L++ +   +P  R+TA Q L+  +  N
Sbjct: 243 --LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  150 bits (382), Expect = 1e-42
 Identities = 80/322 (24%), Positives = 128/322 (39%), Gaps = 59/322 (18%)

Query: 33  NKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI---SKRKL 89
           NK   +    G   E  E  Y   + +G G FGV +     ++ E+ A K +    + K 
Sbjct: 22  NKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKN 80

Query: 90  RTAVDIDDVRREVAIMKHLPKNSSIVSLKEA------CEDDNAVHLVMELCEGGELFDRI 143
           R          E+ IM+ + K+ ++V LK         +D+  ++LV+E      ++   
Sbjct: 81  R----------ELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS 128

Query: 144 VARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAI 197
                  +     + +  +   QL       H  G+ HRD+KP+N L  +   +  LK I
Sbjct: 129 RHYAKLKQTMPMLLIKLYM--YQLLRSLAYIHSIGICHRDIKPQNLL-LD-PPSGVLKLI 184

Query: 198 DFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA 255
           DFG +     GE     + S YY APE++    NY   IDIWS G ++  L+ G P F  
Sbjct: 185 DFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244

Query: 256 ESE-------------------QGV-AQAILRGLIDFKRDPW-----PNVSESAKSLVRQ 290
           ES                    + +    +       +  P+     P     A  L+ +
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISR 304

Query: 291 MLEPDPKLRLTAKQVLEHPWLQ 312
           +LE  P  RLTA + L HP+  
Sbjct: 305 LLEYTPSARLTAIEALCHPFFD 326

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  148 bits (376), Expect = 3e-42
 Identities = 72/296 (24%), Positives = 131/296 (44%), Gaps = 36/296 (12%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
             +    + +   +G G +G  Y      T +L A K +    +    + +++++E+ ++
Sbjct: 19  LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGD-EEEEIKQEINML 74

Query: 106 KHLPKNSSIVSLKEA------CEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAV 157
           K    + +I +   A         D+ + LVME C  G + D  +        E   A +
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIV 215
            R I+  +   H+H VIHRD+K +N L     EN+ +K +DFG+S  +    G R +  +
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNT-FI 190

Query: 216 GSPYYMAPEVLKRN------YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL 269
           G+PY+MAPEV+  +      Y  + D+WS G+    +  G PP             +R L
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRAL 243

Query: 270 IDFKRDPWP-----NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV 320
               R+P P       S+  +S +   L  +   R   +Q+++HP++++      V
Sbjct: 244 FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQV 299

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  144 bits (365), Expect = 7e-41
 Identities = 75/312 (24%), Positives = 121/312 (38%), Gaps = 57/312 (18%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----------RTAVDIDDVR 99
            RY    E+G G +G  Y   D  +   +A KS+   ++            + V      
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTV------ 59

Query: 100 REVAIMKHLPKNS--SIVSLKEAC-----EDDNAVHLVMELCEG--GELFDRIVARGHYT 150
           REVA+++ L      ++V L + C     + +  V LV E  +       D+    G   
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LP 118

Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
                 + R  +  +   H + ++HRDLKPEN L  +      +K  DFGL+  +     
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMA 175

Query: 211 FSEIVGSPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR-- 267
            + +V + +Y APEVL +  Y   +D+WS G I   +    P F   SE      I    
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235

Query: 268 ------------GLIDFKRDPW---------PNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
                        L      P          P + ES   L+ +ML  +P  R++A + L
Sbjct: 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295

Query: 307 EHPWLQNAKKAP 318
           +H +L   +  P
Sbjct: 296 QHSYLHKDEGNP 307

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  142 bits (360), Expect = 7e-40
 Identities = 67/307 (21%), Positives = 123/307 (40%), Gaps = 49/307 (15%)

Query: 51  DRYLVDRELGRGEFGVTYLCID-RDTRELLACKSISKRKLR-----TAVDIDDVRREVAI 104
            +Y    E+G G +G  +   D ++    +A K +  +        + +      REVA+
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI------REVAV 64

Query: 105 MKHLPKNS--SIVSLKEAC-----EDDNAVHLVMELCEG--GELFDRIVARGHYTERAAA 155
           ++HL      ++V L + C     + +  + LV E  +       D++            
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIK 123

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
            +   ++  +   H H V+HRDLKP+N L  +  +   +K  DFGL+  +      + +V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVV 180

Query: 216 GSPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL----- 269
            + +Y APEVL + +Y   +D+WS G I   +    P F   S+      IL  +     
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240

Query: 270 --------------IDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                               P      ++ E  K L+ + L  +P  R++A   L HP+ 
Sbjct: 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

Query: 312 QNAKKAP 318
           Q+ ++  
Sbjct: 301 QDLERCK 307

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  140 bits (354), Expect = 4e-39
 Identities = 67/295 (22%), Positives = 115/295 (38%), Gaps = 25/295 (8%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +      E+G G  G  +    R T  ++A K +  R+     +   +  ++ ++     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKSHD 82

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCH 169
              IV        +  V + MEL        +   +G   ER    +T  IV+ +  L  
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPE 224
           KHGVIHRD+KP N L   + +   +K  DFG+S     G    +       G   YMAPE
Sbjct: 143 KHGVIHRDVKPSNILLDERGQ---IKLCDFGIS-----GRLVDDKAKDRSAGCAAYMAPE 194

Query: 225 VLKRN------YGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPW 277
            +         Y    D+WS G+ L  L  G  P+   +++  V   +L+          
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH- 253

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQ 332
              S   +S V+  L  D + R    ++LEH +++  +    V +    +  + +
Sbjct: 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET-LEVDVASWFKDVMAK 307

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  140 bits (354), Expect = 2e-38
 Identities = 56/337 (16%), Positives = 114/337 (33%), Gaps = 62/337 (18%)

Query: 50  EDRYLVDRELGRGE--FGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
              Y +   +G+G        L   + T E +  + I+         +  ++ E+ + K 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE-MVTFLQGELHVSKL 82

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTRTIVEVV 165
              + +IV  +     DN + +V      G   D           E A A + + +++ +
Sbjct: 83  F-NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGER-------FSEIVGS 217
              H  G +HR +K  + L +    +  +       ++     G+R           V  
Sbjct: 142 DYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 218 PYYMAPEVLKRN---YGPEIDIWSAGVILYILLCGVPPF--------------------- 253
             +++PEVL++N   Y  + DI+S G+    L  G  PF                     
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258

Query: 254 ---------------WAESEQGVAQAILRGLIDFKRDPWPNV------SESAKSLVRQML 292
                           + +  G++ ++            P+       S      V Q L
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318

Query: 293 EPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR 329
           + +P  R +A  +L H + +  K+  +  L +++R  
Sbjct: 319 QRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPV 355

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  138 bits (350), Expect = 2e-38
 Identities = 65/283 (22%), Positives = 109/283 (38%), Gaps = 37/283 (13%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           E+GRG +G     + + + +++A K I  R      +   +  ++ ++        IV  
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTRTIVE-VVQLCHK 170
             A   +    + MEL      FD+              E     +T   V+ +  L   
Sbjct: 87  YGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPEV 225
             +IHRD+KP N L         +K  DFG+S     G+    I      G   YMAPE 
Sbjct: 145 LKIIHRDIKPSNILLDRSGN---IKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPER 196

Query: 226 LK-----RNYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRG----LIDFKRD 275
           +      + Y    D+WS G+ LY L  G  P+    S       +++G    L + +  
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256

Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
            +   S S  + V   L  D   R   K++L+HP++   ++  
Sbjct: 257 EF---SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  138 bits (351), Expect = 3e-38
 Identities = 70/341 (20%), Positives = 121/341 (35%), Gaps = 80/341 (23%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI-SKRKLRTAVDIDDVRREV 102
                + + +LV R++G G FG   LC   D ++  A K + + +K   +  I     E 
Sbjct: 28  KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-----EA 82

Query: 103 AIMKHL----PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAA 156
            I+K +      N++IV         + + L+ E   G  L++ I    +  +       
Sbjct: 83  DILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKL 141

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFAN----------------------KKENSPL 194
               I++ +    K  + H DLKPEN L  +                      + +++ +
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 195 KAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPF 253
           K IDFG + F    +    I+ +  Y APEV L   +    D+WS G +L  L  G   F
Sbjct: 202 KLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259

Query: 254 WAESEQGVAQAILR--GLID---------------FKRDP----WPNVSESAKS------ 286
                      +      I                  +D     WP  + S  S      
Sbjct: 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK 319

Query: 287 ---------------LVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                           +  +L+ DP LR +  ++L+H +L+
Sbjct: 320 CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  136 bits (345), Expect = 2e-37
 Identities = 72/352 (20%), Positives = 122/352 (34%), Gaps = 74/352 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDR-DTRELLACKSI-SKRKLRTAVDIDDVRRE 101
              + +++RY +   LG G FG    C+D    +  +A K I +  K R A      R E
Sbjct: 12  RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLE 66

Query: 102 VAIMKHLPKN-----SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAA 154
           + ++K + +         V + +       + +  EL  G   F+ +       Y     
Sbjct: 67  INVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHV 125

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------------ENSPLKAID 198
             +   +   ++  H++ + H DLKPEN LF N +                +N+ ++  D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185

Query: 199 FGLSIFFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
           FG + F    E  + IV + +Y  PEV L+  +    D+WS G IL+    G   F    
Sbjct: 186 FGSATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243

Query: 258 EQG----------------VAQAILRGLIDFKRDPWPNVSESAKS--------------- 286
            +                 + +   +         W   S   +                
Sbjct: 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303

Query: 287 ---------LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR 329
                    L+R+MLE DP  R+T  + L HP+                 SR
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  136 bits (344), Expect = 2e-37
 Identities = 77/340 (22%), Positives = 120/340 (35%), Gaps = 74/340 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDT-RELLACKSI-SKRKLRTAVDIDDVRRE 101
              + +  RY +   LG G FG    CID       +A K + +  +   A        E
Sbjct: 7   QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-----E 61

Query: 102 VAIMKHLPKN-----SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAA 154
           + +++HL           V + E  E    + +V EL  G   +D I   G   +     
Sbjct: 62  IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHI 120

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------------ENSPLKAID 198
             +   I + V   H + + H DLKPEN LF                     N  +K +D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 199 FGLSIFFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
           FG + +    E  S +V + +Y APEV L   +    D+WS G IL     G   F    
Sbjct: 181 FGSATY--DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238

Query: 258 EQG----------------VAQAILRGLIDFKRDPWPNVSESAKS--------------- 286
            +                 + +   R      R  W   S + +                
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298

Query: 287 ---------LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA 317
                    L+++MLE DP  R+T ++ L+HP+    KK+
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  135 bits (343), Expect = 2e-37
 Identities = 71/303 (23%), Positives = 126/303 (41%), Gaps = 49/303 (16%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
             +D Y + R+LGRG++   +  I+    E +  K +        V    ++RE+ I+++
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILEN 86

Query: 108 LPKNSSIVSLKEACEDDNAVH--LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           L    +I++L +  +D  +    LV E     +           T+         I++ +
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKAL 143

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
             CH  G++HRD+KP N +     E+  L+ ID+GL+ F+ PG+ ++  V S Y+  PE+
Sbjct: 144 DYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201

Query: 226 L--KRNYGPEIDIWSAGVILYILLCGVPPFWA-----------------ESEQGVAQAI- 265
           L   + Y   +D+WS G +L  ++    PF+                  E          
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261

Query: 266 -------LRGLIDFKRDPW---------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
                     L    R  W           VS  A   + ++L  D + RLTA++ +EHP
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321

Query: 310 WLQ 312
           +  
Sbjct: 322 YFY 324

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  136 bits (344), Expect = 2e-37
 Identities = 73/317 (23%), Positives = 124/317 (39%), Gaps = 70/317 (22%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMK 106
            +Y    ++G+G FG  +    R T + +A K     K+    + +       RE+ I++
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ 71

Query: 107 HLPKNSSIVSLKEAC--------EDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAA 156
            L K+ ++V+L E C            +++LV + CE     L   +     +T      
Sbjct: 72  LL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKR 128

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
           V + ++  +   H++ ++HRD+K  N L         LK  DFGL+  F   +       
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQP--- 182

Query: 217 SPY--------YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
           + Y        Y  PE+L  +R+YGP ID+W AG I+  +    P     +EQ     I 
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242

Query: 267 R--GLIDFKRDPWPNVS----------------------------ESAKSLVRQMLEPDP 296
           +  G I    + WPNV                               A  L+ ++L  DP
Sbjct: 243 QLCGSIT--PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 300

Query: 297 KLRLTAKQVLEHPWLQN 313
             R+ +   L H +  +
Sbjct: 301 AQRIDSDDALNHDFFWS 317

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  133 bits (338), Expect = 5e-37
 Identities = 61/277 (22%), Positives = 112/277 (40%), Gaps = 29/277 (10%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELGRG +GV        + +++A K I  R    + +   +  ++ I          V+ 
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71

Query: 118 KEACEDDNAVHLVMELCEGG--ELFDRIVAR-GHYTERAAAAVTRTIVEVVQ-LCHKHGV 173
             A   +  V + MEL +    + + +++ +     E     +  +IV+ ++ L  K  V
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPEVLK- 227
           IHRD+KP N L     +   +K  DFG+S     G    ++      G   YMAPE +  
Sbjct: 132 IHRDVKPSNVLINALGQ---VKMCDFGIS-----GYLVDDVAKDIDAGCKPYMAPERINP 183

Query: 228 ----RNYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLI-DFKRDPWPNVS 281
               + Y  + DIWS G+ +  L     P+ +  +     + ++         D +   S
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF---S 240

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
                   Q L+ + K R T  ++++HP+    +   
Sbjct: 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  135 bits (341), Expect = 8e-37
 Identities = 70/342 (20%), Positives = 124/342 (36%), Gaps = 74/342 (21%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI-SKRKLRTAVDIDDVRREVAIMKH 107
            + RY++ R+LG G F   +L  D      +A K +   +    A +      E+ +++ 
Sbjct: 17  KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED-----EIKLLQR 71

Query: 108 L----------PKNSSIVSLKEA--CEDDNAVH--LVMELCEGGELFDRIVARGH--YTE 151
           +             + I+ L +    +  N VH  +V E+  G  L   I    H     
Sbjct: 72  VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPL 130

Query: 152 RAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKEN---SPLKAIDFGLSIFFKP 207
                +++ ++  +   H+  G+IH D+KPEN L            +K  D G + +   
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--Y 188

Query: 208 GERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV----- 261
            E ++  + +  Y +PEV L   +G   DIWS   +++ L+ G   F  +          
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248

Query: 262 --AQAI-LRGLID-------------FKRD----------PWPNVSESAKS--------- 286
             AQ I L G +              F              WP      +          
Sbjct: 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 308

Query: 287 ----LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD 324
                +  ML+ DP+ R  A  ++ HPWL++      + + D
Sbjct: 309 EISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 350

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  134 bits (339), Expect = 1e-36
 Identities = 67/316 (21%), Positives = 117/316 (37%), Gaps = 59/316 (18%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D +    ELG G  GV +    + +  ++A K I           + + RE+ ++    
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHEC- 88

Query: 110 KNSS-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            NS  IV    A   D  + + ME  +GG L   +   G   E+    V+  +++ +   
Sbjct: 89  -NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 147

Query: 169 H-KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAP 223
             KH ++HRD+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+P
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSP 199

Query: 224 EVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-- 280
           E L+   Y  + DIWS G+ L  +  G  P      + +       +     +  P    
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259

Query: 281 --------------------------------------SESAKSLVRQMLEPDPKLRLTA 302
                                                 S   +  V + L  +P  R   
Sbjct: 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 319

Query: 303 KQVLEHPWLQNAKKAP 318
           KQ++ H +++ +    
Sbjct: 320 KQLMVHAFIKRSDAEE 335

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  135 bits (342), Expect = 2e-36
 Identities = 86/344 (25%), Positives = 135/344 (39%), Gaps = 75/344 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI-SKRKLRTAVDIDDVRREV 102
           VP +++  RY V + +G+G FG      D    + +A K + ++++            E+
Sbjct: 90  VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-----EI 144

Query: 103 AIMKHL----PKNSS-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAA 155
            I++HL      N+  ++ + E     N + +  EL     L++ I       ++     
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVR 203

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
               +I++ +   HK+ +IH DLKPEN L   +   S +K IDFG S +    +R    +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGIKVIDFGSSCY--EHQRVYTYI 260

Query: 216 GSPYYMAPEV-LKRNYGPEIDIWSAGVILYIL---------------------LCGVPPF 253
            S +Y APEV L   YG  ID+WS G IL  L                     L G+P  
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320

Query: 254 W------------------------AESEQGVAQAILRGLIDFKRDP-----WPNVSESA 284
                                      S+  V     R      R P     W N  +  
Sbjct: 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGC 380

Query: 285 -----KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLG 323
                   ++Q LE DP +R+T  Q L HPWL+  ++ P  P G
Sbjct: 381 DDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR--RRLPKPPTG 422

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  130 bits (329), Expect = 3e-35
 Identities = 78/334 (23%), Positives = 123/334 (36%), Gaps = 71/334 (21%)

Query: 31  GANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR 90
           G+         A        DR+ V+R  G+G FG   L  ++ T   +A K + +   R
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-R 61

Query: 91  TAVDIDDVRREVAIMKHLPKNS--SIVSLK-------EACEDDNAVHLVMELCEGGELFD 141
                    RE+ IM+ L      +IV L+       E    D  +++VME      L  
Sbjct: 62  FR------NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHR 114

Query: 142 RIVARGHYTERAAAAVTRTI-VEVVQL-----------CHK--HGVIHRDLKPENFLFAN 187
                     R            ++++            H     V HRD+KP N L  N
Sbjct: 115 CC--------RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL-VN 165

Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
           +  +  LK  DFG +    P E     + S YY APE++   ++Y   +DIWS G I   
Sbjct: 166 E-ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224

Query: 246 LLCGVPPFWAESEQGVAQAILRGL-------IDF-------------KRDPW-------- 277
           ++ G P F  ++  G    I+R L       +               K  PW        
Sbjct: 225 MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHS 284

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              ++ A  L+  +L+  P+ R+   + L HP+ 
Sbjct: 285 LKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  128 bits (325), Expect = 7e-35
 Identities = 81/319 (25%), Positives = 126/319 (39%), Gaps = 70/319 (21%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS-------KRKLRTAVDIDDVRR 100
           ++  RY+  + LG G  G+ +  +D D  + +A K I        K  LR          
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR---------- 57

Query: 101 EVAIMKHL-------------PKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--RIVA 145
           E+ I++ L             P  S +     +  + N+V++V E  E     D   ++ 
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLE 113

Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
           +G   E  A      ++  ++  H   V+HRDLKP N LF N  E+  LK  DFGL+   
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINT-EDLVLKIGDFGLARIM 171

Query: 206 KPGER----FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE- 258
            P        SE + + +Y +P +L    NY   ID+W+AG I   +L G   F    E 
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231

Query: 259 ---------------------QGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLE 293
                                  V    +R  +     P     P +S  A   + Q+L 
Sbjct: 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILT 291

Query: 294 PDPKLRLTAKQVLEHPWLQ 312
             P  RLTA++ L HP++ 
Sbjct: 292 FSPMDRLTAEEALSHPYMS 310

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  128 bits (324), Expect = 2e-34
 Identities = 77/315 (24%), Positives = 128/315 (40%), Gaps = 75/315 (23%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +   Y+    +G G +G     ID+ + E +A K +S R  ++ +      RE+ ++KH
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKH 79

Query: 108 LPKNSSIVSLK------EACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTR 159
           + ++ +++ L        +  +    +LVM   +     D  +I+    ++E        
Sbjct: 80  M-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIM-GLKFSE-------- 125

Query: 160 TIVEVVQ------LC-----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
              E +Q      L      H  GV+HRDLKP N       E+  LK +DFGL+      
Sbjct: 126 ---EKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADA- 178

Query: 209 ERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF------------- 253
              +  V + +Y APEV+    +Y   +DIWS G I+  +L G   F             
Sbjct: 179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

Query: 254 ------------WAESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPK 297
                           +   A++ ++ L    R  +    P  S  A  L+ +MLE D  
Sbjct: 238 KVTGVPGTEFVQKLNDKA--AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD 295

Query: 298 LRLTAKQVLEHPWLQ 312
            RLTA Q L HP+ +
Sbjct: 296 KRLTAAQALTHPFFE 310

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  129 bits (325), Expect = 3e-34
 Identities = 75/338 (22%), Positives = 131/338 (38%), Gaps = 77/338 (22%)

Query: 46  KENIEDRY-LVDRELGRGEFGVTYLCIDRD--TRELLACKSISKRKL-RTAVDIDDVRRE 101
           +E +ED +     ++GRG +G  Y    +D    +  A K I    +  +A       RE
Sbjct: 15  RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC------RE 68

Query: 102 VAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEG--GELFDRIVARGHYTERAAAAV 157
           +A+++ L K+ +++SL++      D  V L+ +  E     +      R     +    +
Sbjct: 69  IALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFH--RASKANKKPVQL 125

Query: 158 TRTIV--------EVVQLCHKHGVIHRDLKPENFLFANKKENS-PLKAIDFGLS-IFFKP 207
            R +V        + +   H + V+HRDLKP N L   +      +K  D G + +F  P
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185

Query: 208 GERFS----EIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
            +  +     +V + +Y APE+L   R+Y   IDIW+ G I   LL   P F    E   
Sbjct: 186 LKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244

Query: 262 AQA---------ILRGL---------------------IDFKRDPWPNV----------- 280
                       I   +                      DF+R+ + N            
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304

Query: 281 --SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                A  L++++L  DP  R+T++Q ++ P+      
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (332), Expect = 3e-34
 Identities = 62/264 (23%), Positives = 100/264 (37%), Gaps = 42/264 (15%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDV---RRE-- 101
           +  +Y V   +  G  G  YL +DR  + R +   K      L  + D +       E  
Sbjct: 78  VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPV-VLKG-----LVHSGDAEAQAMAMAERQ 131

Query: 102 -VAIMKHLPKNSSIVSL-----KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA 155
            +A + H     SIV +           D   ++VME   G  L              A 
Sbjct: 132 FLAEVVH----PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAI 185

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
           A    I+  +   H  G+++ DLKPEN +   ++    LK ID G          F  + 
Sbjct: 186 AYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAV---SRINSFGYLY 238

Query: 216 GSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
           G+P + APE+++       DI++ G  L  L   +P        G+ +           D
Sbjct: 239 GTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------DD 288

Query: 276 PWPNVSESAKSLVRQMLEPDPKLR 299
           P     +S   L+R+ ++PDP+ R
Sbjct: 289 PVLKTYDSYGRLLRRAIDPDPRQR 312

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  125 bits (316), Expect = 7e-34
 Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 20/261 (7%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV---RRE---V 102
           I +RY +  +LG G     YL  D      +A K+I    +      + +    RE    
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI---FIPPREKEETLKRFEREVHNS 65

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           + + H     +IVS+ +  E+D+  +LVME  EG  L + I + G  +   A   T  I+
Sbjct: 66  SQLSH-Q---NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQIL 121

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYY 220
           + ++  H   ++HRD+KP+N L      N  LK  DFG++         + + ++G+  Y
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQY 178

Query: 221 MAPEVLKRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRGLIDFKRDPWP 278
            +PE  K        DI+S G++LY +L G PPF  E+   +A + I   + +   D   
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRK 238

Query: 279 NVSESAKSLVRQMLEPDPKLR 299
           ++ +S  +++ +  E D   R
Sbjct: 239 DIPQSLSNVILRATEKDKANR 259

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  125 bits (317), Expect = 7e-34
 Identities = 68/264 (25%), Positives = 113/264 (42%), Gaps = 28/264 (10%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V+  +GRG FGV      R     +A K     ++ +  +      E+  +  +  + +I
Sbjct: 12  VEEVVGRGAFGVVCKAKWRAK--DVAIK-----QIESESERKAFIVELRQLSRV-NHPNI 63

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ------LC 168
           V L  AC   N V LVME  EGG L++ +          AA      ++  Q        
Sbjct: 64  VKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR 228
               +IHRDLKP N L       + LK  DFG +   +     +   GS  +MAPEV + 
Sbjct: 122 QPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEG 177

Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFW--AESEQGVAQAILRGLIDFKRDPWP-NVSESA 284
           + Y  + D++S G+IL+ ++    PF         +  A+  G     R P   N+ +  
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT----RPPLIKNLPKPI 233

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEH 308
           +SL+ +    DP  R + +++++ 
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKI 257

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  127 bits (320), Expect = 1e-33
 Identities = 70/338 (20%), Positives = 122/338 (36%), Gaps = 88/338 (26%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E    +Y + + LG G FG+     D ++ +  A K + +             RE+ IMK
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMK 55

Query: 107 HLPKNSSIVSLK--------------------------------------EACEDDNAVH 128
            L  + +I+ L                                            +  ++
Sbjct: 56  VL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114

Query: 129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE--VVQL------CHKHGVIHRDLKP 180
           ++ME      L   +        R+  ++   ++   + QL       H  G+ HRD+KP
Sbjct: 115 VIMEYVPD-TLHKVL----KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKP 169

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWS 238
           +N L  N  +++ LK  DFG +    P E     + S +Y APE++     Y P ID+WS
Sbjct: 170 QNLL-VN-SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227

Query: 239 AGVILYILLCGVPPFWAESEQGVAQAILRGL-------IDF-------------KRDPWP 278
            G +   L+ G P F  E+       I++ +       +               K   W 
Sbjct: 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287

Query: 279 NV-----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            +        A  L+ Q+L  +P LR+   + + HP+ 
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  126 bits (318), Expect = 1e-33
 Identities = 78/321 (24%), Positives = 122/321 (38%), Gaps = 82/321 (25%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS--------KRKLRTAVDIDDVR 99
           ++  RY     +G G +G+     D   +  +A K IS        +R LR         
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR--------- 74

Query: 100 REVAIMKHLPKNSSIVSLK-----EACEDDNAVHLVMELCEGGELFD--RIVARGHYTER 152
            E+ I+    ++ +I+ +         E    V++V +L E     D  +++   H +  
Sbjct: 75  -EIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSN- 127

Query: 153 AAAAVTRTIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
                      + Q+       H   V+HRDLKP N L  N      LK  DFGL+    
Sbjct: 128 -----DHICYFLYQILRGLKYIHSANVLHRDLKPSN-LLLN--TTCDLKICDFGLARVAD 179

Query: 207 PGERFS----EIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF------- 253
           P    +    E V + +Y APE++   + Y   IDIWS G IL  +L   P F       
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239

Query: 254 ------------------WAESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQM 291
                                + +  A+  L  L    + PW    PN    A  L+ +M
Sbjct: 240 QLNHILGILGSPSQEDLNCIINLK--ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297

Query: 292 LEPDPKLRLTAKQVLEHPWLQ 312
           L  +P  R+  +Q L HP+L+
Sbjct: 298 LTFNPHKRIEVEQALAHPYLE 318

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  126 bits (318), Expect = 2e-33
 Identities = 75/304 (24%), Positives = 122/304 (40%), Gaps = 52/304 (17%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKH 84

Query: 108 LPKNSSIVSLK------EACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTR 159
           + K+ +++ L        + E+ N V+LV  L       D   IV     T+     +  
Sbjct: 85  M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIY 139

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            I+  ++  H   +IHRDLKP N       E+  LK +DFGL+         +  V + +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTAD--EMTGYVATRW 194

Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF------------------------ 253
           Y APE++    +Y   +DIWS G I+  LL G   F                        
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254

Query: 254 -WAESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
               SE   A+  ++ L    +  +       +  A  L+ +ML  D   R+TA Q L H
Sbjct: 255 KKISSES--ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312

Query: 309 PWLQ 312
            +  
Sbjct: 313 AYFA 316

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  124 bits (313), Expect = 7e-33
 Identities = 85/332 (25%), Positives = 129/332 (38%), Gaps = 96/332 (28%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS--------KRKLRTAVDIDDVR 99
           NI   + +   LG G +GV      + T E++A K I          R LR         
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR--------- 58

Query: 100 REVAIMKHLPKNSSIVSLK-----EACEDDNAVHLVMELCEGGELFD--RIVARGHYTER 152
            E+ I+KH  K+ +I+++      ++ E+ N V+++ EL +     D  R+++    ++ 
Sbjct: 59  -EIKILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSD- 111

Query: 153 AAAAVTRTIVEVVQ------LC-----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGL 201
                     + +Q      L      H   VIHRDLKP N L  N   N  LK  DFGL
Sbjct: 112 ----------DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSN-LLIN--SNCDLKVCDFGL 158

Query: 202 SIFFKPGERFSEIVGSP-----------YYMAPEVL--KRNYGPEIDIWSAGVILYILLC 248
           +         +                 +Y APEV+     Y   +D+WS G IL  L  
Sbjct: 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218

Query: 249 GVPPFWAES------------------------EQGVAQAILRGLIDFKRDPW----PNV 280
             P F                            E   A+  ++ L  +   P     P V
Sbjct: 219 RRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV 278

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           +     L+++ML  DP  R+TAK+ LEHP+LQ
Sbjct: 279 NPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  124 bits (313), Expect = 7e-33
 Identities = 73/310 (23%), Positives = 128/310 (41%), Gaps = 64/310 (20%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +   Y   + +G G +G     +D  T   +A K +  R  ++ +      RE+ ++KH
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKH 80

Query: 108 LPKNSSIVSLK------EACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTR 159
           + ++ +++ L       E  +D    +LVM         D  +++      E       R
Sbjct: 81  M-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGE------DR 129

Query: 160 TIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
               V Q+       H  G+IHRDLKP N       E+  LK +DFGL+         + 
Sbjct: 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADS--EMTG 184

Query: 214 IVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF------------------ 253
            V + +Y APEV+     Y   +DIWS G I+  ++ G   F                  
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244

Query: 254 -------WAESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTA 302
                    +S++  A+  ++GL + ++  +     N S  A +L+ +ML  D + R+TA
Sbjct: 245 PPAEFVQRLQSDE--AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 302

Query: 303 KQVLEHPWLQ 312
            + L HP+ +
Sbjct: 303 GEALAHPYFE 312

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  124 bits (314), Expect = 2e-32
 Identities = 71/311 (22%), Positives = 119/311 (38%), Gaps = 55/311 (17%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +  RY   + +G G  G+     D      +A K +S R  +         RE+ +MK 
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKC 117

Query: 108 LPKNSSIVSLK------EACEDDNAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTRT 160
           +  + +I+SL       +  E+   V+LVMEL +     +   V +        + +   
Sbjct: 118 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLLYQ 172

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           ++  ++  H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229

Query: 221 MAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE--------------------- 258
            APEV L   Y   +DIWS G I+  ++     F                          
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289

Query: 259 -QGVAQAILRGLIDFKRDPW----PNVSESAKS------------LVRQMLEPDPKLRLT 301
            Q   +  +     +    +    P+    A S            L+ +ML  DP  R++
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349

Query: 302 AKQVLEHPWLQ 312
               L+HP++ 
Sbjct: 350 VDDALQHPYIN 360

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  123 bits (311), Expect = 2e-32
 Identities = 66/227 (29%), Positives = 99/227 (43%), Gaps = 20/227 (8%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI-SKRKLRTAVDIDDVRREV 102
              E   DRY +D  +G+G FG      DR  +E +A K I +K+           + EV
Sbjct: 47  KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ-----AQIEV 101

Query: 103 AIMKHLPKN-----SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAA 155
            +++ + K+       IV LK      N + LV E+     L+D +        +     
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTR 160

Query: 156 AVTRTIVEVVQLCH--KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
              + +   +      +  +IH DLKPEN L  N K  S +K +DFG S     G+R  +
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQL--GQRIYQ 217

Query: 214 IVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ 259
            + S +Y +PEV L   Y   ID+WS G IL  +  G P F   +E 
Sbjct: 218 YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  121 bits (305), Expect = 3e-32
 Identities = 63/274 (22%), Positives = 116/274 (42%), Gaps = 33/274 (12%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMKHLPK 110
            ++++G+G FG+ +       + ++A KS+                + +REV IM +L  
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-N 81

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCH 169
           + +IV L       N   +VME    G+L+ R++ + H         +   I   ++   
Sbjct: 82  HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 170 KHG--VIHRDLKPENFLFANKKENSP--LKAIDFGLSIFFKPGERFSE-----IVGSPYY 220
                ++HRDL+  N    +  EN+P   K  DFGLS       + S      ++G+  +
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-------QQSVHSVSGLLGNFQW 192

Query: 221 MAPEVL---KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK--RD 275
           MAPE +   + +Y  + D +S  +ILY +L G  PF    E    +     +I  +  R 
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF---DEYSYGKIKFINMIREEGLRP 249

Query: 276 PWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
             P +     ++++      DPK R     +++ 
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  120 bits (304), Expect = 6e-32
 Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 29/268 (10%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV-----RRE-- 101
           + DRY +   LG G     +L  D      +A K      LR  +  D       RRE  
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV-----LRADLARDPSFYLRFRREAQ 64

Query: 102 -VAIMKHLPKNSSIVSLKEACEDDNAVH----LVMELCEGGELFDRIVARGHYTERAAAA 156
             A + H P   +IV++ +  E +        +VME  +G  L D +   G  T + A  
Sbjct: 65  NAAALNH-P---AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE----RFS 212
           V     + +   H++G+IHRD+KP N + +     + +K +DFG++           + +
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTA 177

Query: 213 EIVGSPYYMAPEVLKRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID 271
            ++G+  Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R    
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237

Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLR 299
                   +S    ++V + L  +P+ R
Sbjct: 238 PPSARHEGLSADLDAVVLKALAKNPENR 265

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  121 bits (306), Expect = 8e-32
 Identities = 60/316 (18%), Positives = 113/316 (35%), Gaps = 64/316 (20%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD------IDDVR-- 99
            ++  Y V R +  G +G     +D      +A K +                    R  
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 100 REVAIMKHLPKNSSIVSLK-----EACEDDNAVHLVMELCEGGELFD--RIVARGHYTER 152
           RE+ ++ H   + +I+ L+           + ++LV EL       D  +++    + +R
Sbjct: 78  REIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVI----HDQR 128

Query: 153 AAAAVTRTIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
              +       +  +       H+ GV+HRDL P N L     +N+ +   DF L+    
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDT 185

Query: 207 PGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----------- 253
                +  V   +Y APE++   + +   +D+WSAG ++  +      F           
Sbjct: 186 ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245

Query: 254 -------------WAESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDP 296
                           S       +   L +     W    P     A  L+ +MLE +P
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305

Query: 297 KLRLTAKQVLEHPWLQ 312
           + R++ +Q L HP+ +
Sbjct: 306 QRRISTEQALRHPYFE 321

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  119 bits (301), Expect = 4e-31
 Identities = 67/311 (21%), Positives = 117/311 (37%), Gaps = 55/311 (17%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +  RY   + +G G  G+     D      +A K +S R  +         RE+ +MK 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKC 80

Query: 108 LPKNSSIVSLKEA------CEDDNAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTRT 160
           +  + +I+ L          E+   V++VMEL +     +   V +        + +   
Sbjct: 81  V-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQ 135

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           ++  ++  H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192

Query: 221 MAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE--------------------- 258
            APEV L   Y   +DIWS G I+  ++ G   F                          
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252

Query: 259 -QGVAQAILRGLIDFKRDPW----------------PNVSESAKSLVRQMLEPDPKLRLT 301
            Q   +  +     +    +                   +  A+ L+ +ML  D   R++
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312

Query: 302 AKQVLEHPWLQ 312
             + L+HP++ 
Sbjct: 313 VDEALQHPYIN 323

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  118 bits (297), Expect = 6e-31
 Identities = 50/295 (16%), Positives = 108/295 (36%), Gaps = 36/295 (12%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL--PKNS 112
           +   +G+G FG  Y          +A + I   +      +   +REV   +        
Sbjct: 37  IGELIGKGRFGQVYHGRWHGE---VAIRLIDIERD-NEDQLKAFKREVMAYRQTRHEN-- 90

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKH 171
            +V    AC     + ++  LC+G  L+  +  A+          + + IV+ +   H  
Sbjct: 91  -VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLS------IFFKPGERFSEIVGSPYYMAPEV 225
           G++H+DLK +N  + N K    +   DFGL          +  ++     G   ++APE+
Sbjct: 150 GILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 226 LKRN----------YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
           +++           +    D+++ G I Y L     PF  +  + +   +  G+   K +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM---KPN 262

Query: 276 -PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR 329
                + +    ++      + + R T  ++++   L+   K            +
Sbjct: 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM--LEKLPKRNRRLSHPGHFWK 315

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  115 bits (290), Expect = 6e-30
 Identities = 62/259 (23%), Positives = 108/259 (41%), Gaps = 24/259 (9%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV-----RRE---VA 103
            Y + R +GRG  G  Y   D     ++A K      +   +  D V     +RE     
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALKL-----MSETLSSDPVFRTRMQREARTAG 89

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
            ++  P    +V + +  E D  +++ M L  G +L   +  +G      A A+ R I  
Sbjct: 90  RLQE-P---HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGS 145

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYM 221
            +   H  G  HRD+KPEN L +    +     +DFG++      +  +    VG+ YYM
Sbjct: 146 ALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYM 202

Query: 222 APEVLKRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APE    ++     DI++   +LY  L G PP+  +    V  A +   I       P +
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGI 261

Query: 281 SESAKSLVRQMLEPDPKLR 299
             +  +++ + +  +P+ R
Sbjct: 262 PVAFDAVIARGMAKNPEDR 280

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  113 bits (285), Expect = 1e-29
 Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 23/267 (8%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLP-KNS 112
           ++  +G G FG  Y          +A K+         +  I++VR+E  +   L   N 
Sbjct: 11  LEEIIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN- 67

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            I++L+  C  +  + LVME   GG L   +++               I   +   H   
Sbjct: 68  -IIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIARGMNYLHDEA 125

Query: 173 ---VIHRDLKPENFLFANKKENSP-----LKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
              +IHRDLK  N L   K EN       LK  DFGL+  +    + S   G+  +MAPE
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWMAPE 184

Query: 225 VLKRN-YGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPWP-NVS 281
           V++ + +    D+WS GV+L+ LL G  PF   +         +  L      P P    
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL----ALPIPSTCP 240

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEH 308
           E    L+     PDP  R +   +L+ 
Sbjct: 241 EPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  114 bits (287), Expect = 1e-29
 Identities = 63/263 (23%), Positives = 107/263 (40%), Gaps = 20/263 (7%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-KNSS 113
           +  ++G G FG  +      +   +A K + ++    A  +++  REVAIMK L   N  
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGS--DVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPN-- 95

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ----L-C 168
           IV    A      + +V E    G L+  +   G   +           +V +    L  
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEVLK 227
               ++HR+LK  N L     +   +K  DFGLS         S+   G+P +MAPEVL+
Sbjct: 156 RNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 228 RN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAK 285
                 + D++S GVIL+ L     P+        AQ +       KR   P N++    
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269

Query: 286 SLVRQMLEPDPKLRLTAKQVLEH 308
           +++      +P  R +   +++ 
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDL 292

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  112 bits (281), Expect = 1e-28
 Identities = 65/303 (21%), Positives = 116/303 (38%), Gaps = 39/303 (12%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL--PKNS 112
               LG+G FG       R+T E++  K + +             +EV +M+ L  P   
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPN-- 68

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKH 171
            ++        D  ++ + E  +GG L   I      Y      +  + I   +   H  
Sbjct: 69  -VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE---------------IVG 216
            +IHRDL   N L    +EN  +   DFGL+      +   E               +VG
Sbjct: 128 NIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 217 SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFK 273
           +PY+MAPE++  R+Y  ++D++S G++L  ++  V     +          +   L    
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL---- 240

Query: 274 RDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN--VPLGDVVRSRL 330
               P N   S   +  +  + DP+ R +  ++    WL+  +      +PLG  +    
Sbjct: 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRMHLAGHLPLGPQLEQLD 298

Query: 331 KQF 333
           + F
Sbjct: 299 RGF 301

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  109 bits (275), Expect = 4e-28
 Identities = 33/257 (12%), Positives = 69/257 (26%), Gaps = 40/257 (15%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE---VAIM 105
              RY +    G       +  +D      +A   +  + +     + +       ++ +
Sbjct: 29  ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
                   +  + +         +V E   GG L +  VA    +   A    +++    
Sbjct: 89  DK----PGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAA 142

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              H+ GV      P     +             G             ++  P  M    
Sbjct: 143 DAAHRAGVALSIDHPSRVRVS-----------IDGDV-----------VLAYPATMPDA- 179

Query: 226 LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---PNVSE 282
                 P+ DI   G  LY LL    P      +       R       +P     ++  
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 283 SAKSLVRQMLEPDPKLR 299
              ++  + ++ D  +R
Sbjct: 235 QISAVAARSVQGDGGIR 251

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  111 bits (279), Expect = 7e-28
 Identities = 79/350 (22%), Positives = 132/350 (37%), Gaps = 107/350 (30%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++  +Y + ++LG+G +G+ +  IDR T E++A K I     + + D     RE+ I+  
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFREIMILTE 64

Query: 108 LPKNSSIVSLKEAC--EDDNAVHLVMELCE--------GGELFDRIVARGHYTERAAAAV 157
           L  + +IV+L      ++D  V+LV +  E           L        H         
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV-----HK-------- 111

Query: 158 TRTIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
            + +V   QL       H  G++HRD+KP N +  N      +K  DFGLS  F    R 
Sbjct: 112 -QYVV--YQLIKVIKYLHSGGLLHRDMKPSN-ILLN--AECHVKVADFGLSRSFVNIRRV 165

Query: 212 SEIVGSP----------------------YYMAPEVL--KRNYGPEIDIWSAGVILYILL 247
           +  +                         +Y APE+L     Y   ID+WS G IL  +L
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

Query: 248 CGVPPF-------------------------WAESEQGVAQAILRGLIDFKRDPW----- 277
           CG P F                           +S    A+ ++  L +           
Sbjct: 226 CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPF--AKTMIESLKEKVEIRQSNKRD 283

Query: 278 ---------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                           + +E A  L+ ++L+ +P  R++A   L+HP++ 
Sbjct: 284 IFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  110 bits (278), Expect = 1e-27
 Identities = 77/362 (21%), Positives = 135/362 (37%), Gaps = 113/362 (31%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ D Y++   +GRG +G  YL  D++T + +A K ++ R     +D   + RE+ I+  
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNR 81

Query: 108 LPKNSSIVSLK-----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           L K+  I+ L      +     + +++V+E+ +  +L          TE           
Sbjct: 82  L-KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTE----------- 128

Query: 163 EVVQ------LC-----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
           E ++      L      H+ G+IHRDLKP N L  N  ++  +K  DFGL+      +  
Sbjct: 129 EHIKTILYNLLLGENFIHESGIIHRDLKPANCL-LN--QDCSVKVCDFGLARTINSEKDT 185

Query: 212 SEIVGSP-----------------------YYMAPEVL--KRNYGPEIDIWSAGVILYIL 246
           + +                           +Y APE++  + NY   IDIWS G I   L
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

Query: 247 LC-----------------GVPPFWAESEQGVAQAILRGLID------------------ 271
           L                  G   F    ++   +   +   D                  
Sbjct: 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK 305

Query: 272 ----------------FKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                            K        P++S+   +L+  ML+ +P  R+T  Q L+HP+L
Sbjct: 306 NINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

Query: 312 QN 313
           ++
Sbjct: 366 KD 367

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  109 bits (274), Expect = 3e-27
 Identities = 68/372 (18%), Positives = 116/372 (31%), Gaps = 112/372 (30%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           +    RY V R+LG G F   +L  D   ++ +A K + K         +    E+ ++K
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVK---SAEHYTETALDEIRLLK 88

Query: 107 HLPKNSS-------IVSLKEACEDD--NAVH--LVMELCEGGELFDRIVARGH--YTERA 153
            +  +         +V L +  +    N  H  +V E+  G  L   I+   +       
Sbjct: 89  SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPC 147

Query: 154 AAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFA-------------------------- 186
              + + +++ +   H    +IH D+KPEN L +                          
Sbjct: 148 VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207

Query: 187 --------------------NKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV- 225
                                  E   +K  D G + +    + F+E + +  Y + EV 
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSLEVL 265

Query: 226 LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-------VAQAI------------- 265
           +   Y    DIWS   + + L  G   F   S +        +A  I             
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA 325

Query: 266 -------------LRGLIDFKRDPWPNVS-----------ESAKSLVRQMLEPDPKLRLT 301
                        L+ +   K      V                  +  MLE  P+ R T
Sbjct: 326 GKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385

Query: 302 AKQVLEHPWLQN 313
           A + L HPWL +
Sbjct: 386 AAECLRHPWLNS 397

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  106 bits (267), Expect = 5e-27
 Identities = 40/267 (14%), Positives = 95/267 (35%), Gaps = 29/267 (10%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-KNSS 113
              +L     G  +    +     +  K +  R   +     D   E   ++     N  
Sbjct: 14  FLTKLNENHSGELWKGRWQGN--DIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPN-- 68

Query: 114 IVSLKEACEDDNAVHL--VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ----L 167
           ++ +  AC+   A H   +      G L++ +    ++    + AV +  +++ +    L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAV-KFALDMARGMAFL 127

Query: 168 -CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
              +  +    L   + +     E+   +     +   F+   R    + +P ++APE L
Sbjct: 128 HTLEPLIPRHALNSRSVMID---EDMTARISMADVKFSFQSPGR----MYAPAWVAPEAL 180

Query: 227 KR----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVS 281
           ++          D+WS  V+L+ L+    PF   ++    +  ++  ++  R   P  +S
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPF---ADLSNMEIGMKVALEGLRPTIPPGIS 237

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEH 308
                L++  +  DP  R     ++  
Sbjct: 238 PHVSKLMKICMNEDPAKRPKFDMIVPI 264

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  106 bits (266), Expect = 8e-27
 Identities = 54/264 (20%), Positives = 104/264 (39%), Gaps = 23/264 (8%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL--PKNSSI 114
           + +G G FG  Y          +A K ++     T   +   + EV +++         I
Sbjct: 30  QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVN---I 82

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           +           + +V + CEG  L+  +  +   +  +    + R     +   H   +
Sbjct: 83  LLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---VGSPYYMAPEVLKRN- 229
           IHRDLK  N       E++ +K  DFGL+          +     GS  +MAPEV++   
Sbjct: 142 IHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 230 ---YGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPWP-NVSESA 284
              Y  + D+++ G++LY L+ G  P+    +   + + + RG +         N  +  
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEH 308
           K L+ + L+     R +  ++L  
Sbjct: 259 KRLMAECLKKKRDERPSFPRILAE 282

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  104 bits (262), Expect = 2e-25
 Identities = 76/401 (18%), Positives = 137/401 (34%), Gaps = 99/401 (24%)

Query: 6   RSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFG 65
            +    +      + S  +  +++   + K   ++        I DRY +   +G G +G
Sbjct: 8   AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYG 67

Query: 66  VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK-----EA 120
                 D+  + ++A K I  R     +D   + RE+AI+  L  +  +V +      + 
Sbjct: 68  HVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKD 125

Query: 121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
            E  + +++V+E+ +  +         + TE     +   ++  V+  H  G++HRDLKP
Sbjct: 126 VEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKP 184

Query: 181 ENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSP--------------------- 218
            N L  N  ++  +K  DFGL+     P    S++  SP                     
Sbjct: 185 ANCL-VN--QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLT 241

Query: 219 ------YYMAPEVL--KRNYGPEIDIWSAGVIL-----------YILLCGVPPF------ 253
                 +Y APE++  + NY   ID+WS G I                   P F      
Sbjct: 242 GHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCF 301

Query: 254 ---WAESEQGVAQAILRGLID-----FK------RDPWPNV-SESAKSLVRQM------- 291
                +      +   RG  D     F        +    +  E AK  +R         
Sbjct: 302 PLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD 361

Query: 292 -------------------LEPDPKLRLTAKQVLEHPWLQN 313
                              L  +P  R+T  + L HP+ + 
Sbjct: 362 LAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  100 bits (251), Expect = 1e-24
 Identities = 62/296 (20%), Positives = 109/296 (36%), Gaps = 63/296 (21%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI-----MKHLPKNSS 113
           +G+G +G  +    +   E +A K  S R      D     RE  +     ++H  +N  
Sbjct: 16  VGKGRYGEVWRGSWQG--ENVAVKIFSSR------DEKSWFRETELYNTVMLRH--EN-- 63

Query: 114 IVSLKEACEDDNAVH----LVMELCEGGELFDRIVARGHYTERAAAAVTRTIV------- 162
           I+    +            L+    E G L+D  +        +   +  +I        
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASGLAHLH 122

Query: 163 -EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VG 216
            E+     K  + HRDLK +N L    K+N      D GL++         ++     VG
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 217 SPYYMAPEVLK-------RNYGPEIDIWSAGVILYILLCGV----------PPFWAESEQ 259
           +  YMAPEVL         +    +DIW+ G++L+ +   +          PPF+     
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239

Query: 260 GVAQAILRGLIDFK--RDPWPNVSESA------KSLVRQMLEPDPKLRLTAKQVLE 307
             +   +R ++     R   PN   S         L+++    +P  RLTA ++ +
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  100 bits (251), Expect = 2e-24
 Identities = 64/291 (21%), Positives = 110/291 (37%), Gaps = 53/291 (18%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG  +    R     +A K  S R+ R+         E+     L ++ +I+   
Sbjct: 50  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFR----EAEIYQTVML-RHENILGFI 102

Query: 119 EACEDDNAVH----LVMELCEGGELFDRIVARGHYTERAAAAVTRTIV--------EVVQ 166
            A   DN       LV +  E G LFD  + R   T      +  +          E+V 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYM 221
              K  + HRDLK +N L    K+N      D GL++         +I     VG+  YM
Sbjct: 162 TQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 222 APEVLKRNYGPE-------IDIWSAGVILYILLCGV----------PPFWAESEQGVAQA 264
           APEVL  +   +        DI++ G++ + +               P++       +  
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 265 ILRGLIDFK--RDPWPNVSESA------KSLVRQMLEPDPKLRLTAKQVLE 307
            +R ++  +  R   PN  +S         ++R+    +   RLTA ++ +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 99.4 bits (248), Expect = 6e-24
 Identities = 65/312 (20%), Positives = 114/312 (36%), Gaps = 65/312 (20%)

Query: 56  DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI-----MKHLPK 110
            +++G+G +G  ++   R   E +A K           +     RE  I     M+H  +
Sbjct: 42  VKQIGKGRYGEVWMGKWRG--EKVAVKVFFTT------EEASWFRETEIYQTVLMRH--E 91

Query: 111 NSSIVSLKEACEDDNAVH----LVMELCEGGELFDRIVARGHYTERAAAAVTRTIV---- 162
           N  I+    A            L+ +  E G L+D  +       ++   +  + V    
Sbjct: 92  N--ILGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVSGLC 148

Query: 163 ----EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---- 214
               E+     K  + HRDLK +N L    K+N      D GL++ F       +I    
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 215 -VGSPYYMAPEVLKRNYGPE-------IDIWSAGVILYILLCGV----------PPFWAE 256
            VG+  YM PEVL  +            D++S G+IL+ +               P+   
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265

Query: 257 SEQGVAQAILRGLIDFK--RDPWPNVSESA------KSLVRQMLEPDPKLRLTAKQVLEH 308
                +   +R ++  K  R  +PN   S         L+ +    +P  RLTA +V + 
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325

Query: 309 PWLQNAKKAPNV 320
             L    ++ ++
Sbjct: 326 --LAKMSESQDI 335

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 97.5 bits (243), Expect = 3e-23
 Identities = 69/302 (22%), Positives = 114/302 (37%), Gaps = 75/302 (24%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
             RG FG  +     +  E +A K    +  ++         EV  +  + K+ +I+   
Sbjct: 32  KARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSW----QNEYEVYSLPGM-KHENILQFI 84

Query: 119 EACEDDNAVH----LVMELCEGGELFD-------------RI---VARG----HYTERAA 154
            A +   +V     L+    E G L D              I   +ARG    H      
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH------ 138

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
                  +  ++  HK  + HRD+K +N L    K N      DFGL++ F+ G+   + 
Sbjct: 139 -----EDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEAGKSAGDT 190

Query: 215 ---VGSPYYMAPEVL------KRNYGPEIDIWSAGVILYILLCG-----------VPPFW 254
              VG+  YMAPEVL      +R+    ID+++ G++L+ L              + PF 
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

Query: 255 AESEQGVAQAILRGLIDFKR------DPWPNVSESAKSLVRQMLE---PDPKLRLTAKQV 305
            E  Q  +   ++ ++  K+      D W         L   + E    D + RL+A  V
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK-HAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 306 LE 307
            E
Sbjct: 310 GE 311

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 75/324 (23%), Positives = 118/324 (36%), Gaps = 62/324 (19%)

Query: 25  HARKEAGANKKQPITVLAGVPKENIE---DRYLVDRELGRGEFGVTYLCIDRDTRELLAC 81
               +    KK  + +   VPK+      +  ++  ++GRG FG  +    R    L+A 
Sbjct: 85  LLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAV 144

Query: 82  KSISKRKLRTAVDIDDVRREVAIMKHL--PKNSSIVSLKEACEDDNAVHLVMELCEGGEL 139
           KS   R+           +E  I+K    P    IV L   C     +++VMEL +GG+ 
Sbjct: 145 KSC--RETLPPDLKAKFLQEARILKQYSHPN---IVRLIGVCTQKQPIYIVMELVQGGDF 199

Query: 140 FDRIVARGHYTERAAAAVTRTIVEVVQLC----------HKHGVIHRDLKPENFLFANKK 189
              +   G             +  ++Q+                IHRDL   N L     
Sbjct: 200 LTFLRTEGARL---------RVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT--- 247

Query: 190 ENSPLKAIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLKRN-YGPEIDI 236
           E + LK  DFG+S       R  E     Y              APE L    Y  E D+
Sbjct: 248 EKNVLKISDFGMS-------R--EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298

Query: 237 WSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEP 294
           WS G++L+     G  P+   S Q   + + +G     R P P    ++   L+ Q    
Sbjct: 299 WSFGILLWETFSLGASPYPNLSNQQTREFVEKGG----RLPCPELCPDAVFRLMEQCWAY 354

Query: 295 DPKLRLTAKQVLEHPWLQNAKKAP 318
           +P  R +   + +   LQ+ +K  
Sbjct: 355 EPGQRPSFSTIYQ--ELQSIRKRH 376

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 90.3 bits (224), Expect = 1e-20
 Identities = 64/306 (20%), Positives = 102/306 (33%), Gaps = 72/306 (23%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI-----MKHLPKNSS 113
           +GRG +G  Y     +    +A K  S        +  +   E  I     M+H   N  
Sbjct: 21  IGRGRYGAVYKGSLDE--RPVAVKVFSFA------NRQNFINEKNIYRVPLMEH--DN-- 68

Query: 114 IVSLKEACEDDNAVH-----LVMELCEGGELFDRIVARGHYTERA---AAAVTRTIV--- 162
           I       E   A       LVME    G L   +         +   A +VTR +    
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLH 128

Query: 163 --EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE------- 213
                   +K  + HRDL   N L    K +      DFGLS+                 
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185

Query: 214 --IVGSPYYMAPEVLK--------RNYGPEIDIWSAGVILYILLCGV------------- 250
              VG+  YMAPEVL+         +   ++D+++ G+I + +                 
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245

Query: 251 PPFWAESEQGVAQAILRGLIDFKR------DPWPNVSESAKSLVRQMLE---PDPKLRLT 301
             F  E         ++ L+  ++      + W   S + +SL   + +    D + RLT
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305

Query: 302 AKQVLE 307
           A+   E
Sbjct: 306 AQXAEE 311

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 85.5 bits (212), Expect = 3e-19
 Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 7/159 (4%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY + R++G G FG  YL  D    E +A K +   K +       +  E  I K +
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQ----LHIESKIYKMM 61

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTRTIVEVVQL 167
                I +++    + +   +VMEL  G  L D        ++ +    +   ++  ++ 
Sbjct: 62  QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
            H    IHRD+KP+NFL    K+ + +  IDFGL+  ++
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 86.6 bits (214), Expect = 6e-19
 Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 21/218 (9%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +++ + R++G G FG  YL  +  T E +A K  + +          +  E  I + L
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRIL 59

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEG---GELFDRIVARGHYTERAAAAVTRTIVEVV 165
              + I +++    + +   LVM+L  G    +LF+        + +    +   ++  V
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRV 116

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI--------VGS 217
           +  H    +HRD+KP+NFL    +  + +  IDFGL+  ++       I         G+
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176

Query: 218 PYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFW 254
             Y +    L        D+ S G +L   L G  P W
Sbjct: 177 ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 83.9 bits (208), Expect = 1e-18
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 25/221 (11%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +   Y V R +G G FGV +   +    + +A K    R+         +R E    K L
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAPQ----LRDEYRTYKLL 62

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTRTIVEVVQL 167
              + I ++    ++     LV++L  G  L D   +    ++ +  A   + ++  VQ 
Sbjct: 63  AGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 168 CHKHGVIHRDLKPENFLF--ANKKENSPLKAIDFGLSIFFKPGERFSEI--------VGS 217
            H+  +++RD+KP+NFL    N K  + +  +DFG+  F++       I         G+
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181

Query: 218 PYYMAPEVLKRNYGPEI----DIWSAGVILYILLCGVPPFW 254
             YM+   +  + G E     D+ + G +    L G  P W
Sbjct: 182 ARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 38/164 (23%), Positives = 65/164 (39%), Gaps = 15/164 (9%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +   + V +++G G FG   L  +  T E +A K +   K R       +  E    K L
Sbjct: 7   VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQ----LHLEYRFYKQL 61

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGG----ELFDRIVARGHYTERAAAAVTRTIVEV 164
                I  +           +V+EL   G    +LFD       ++ +    +   ++  
Sbjct: 62  GSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDL--CDRTFSLKTVLMIAIQLISR 117

Query: 165 VQLCHKHGVIHRDLKPENFLF--ANKKENSPLKAIDFGLSIFFK 206
           ++  H   +I+RD+KPENFL      K    +  IDF L+  + 
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 58/280 (20%), Positives = 113/280 (40%), Gaps = 39/280 (13%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           + + +I     +  +LG G++G  Y  + +     +A K++ +      +++++  +E A
Sbjct: 217 MERTDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAA 268

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +MK + K+ ++V L   C  +   +++ E    G L D +        R       + V 
Sbjct: 269 VMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--------RECNRQEVSAVV 319

Query: 164 VVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
           ++ +            K   IHR+L   N L     EN  +K  DFGLS         + 
Sbjct: 320 LLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 376

Query: 214 IVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL 269
                P  + APE L    +  + D+W+ GV+L+ I   G+ P+       V + + +  
Sbjct: 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 436

Query: 270 IDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
               R   P    E    L+R   + +P  R +  ++ + 
Sbjct: 437 ----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 472

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 64/295 (21%), Positives = 118/295 (40%), Gaps = 53/295 (17%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
           V +E I     + RELG+G FG+ Y      + +D  E   A K++   +  +  +  + 
Sbjct: 22  VAREKIT----MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEF 75

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
             E ++MK       +V L           ++MEL   G+L   + +             
Sbjct: 76  LNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134

Query: 159 RTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
            ++ +++Q+             +  +HRDL   N + A   E+  +K  DFG++      
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT------ 185

Query: 209 ERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFW 254
            R  +I  + YY            M+PE LK   +    D+WS GV+L+ I      P+ 
Sbjct: 186 -R--DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242

Query: 255 AESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
             S + V + ++ G         P N  +    L+R   + +PK+R +  +++  
Sbjct: 243 GLSNEQVLRFVMEG----GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 81.9 bits (203), Expect = 5e-18
 Identities = 53/240 (22%), Positives = 98/240 (40%), Gaps = 36/240 (15%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           + + +I     +  +LG G++G  Y  + +     +A K++ +      +++++  +E A
Sbjct: 10  MERTDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAA 61

Query: 104 IMKHL--PKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTR 159
           +MK +  P    +V L   C  +   +++ E    G L D  R   R   +         
Sbjct: 62  VMKEIKHPN---LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS-------AV 111

Query: 160 TIVEV-VQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
            ++ +  Q+        K   IHRDL   N L     EN  +K  DFGLS         +
Sbjct: 112 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTA 168

Query: 213 EIVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
                 P  + APE L    +  + D+W+ GV+L+ I   G+ P+       V + + + 
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 82.0 bits (203), Expect = 7e-18
 Identities = 69/314 (21%), Positives = 119/314 (37%), Gaps = 61/314 (19%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
           + + +I     +  ELG G FG  +L     +  +  ++L A K++   K  +     D 
Sbjct: 38  IKRRDIV----LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDF 90

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-----RIVARGHYTERA 153
           +RE  ++  L ++  IV     C +   + +V E    G+L          A+       
Sbjct: 91  QREAELLTML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149

Query: 154 AAAVTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI 203
            A     + +++ +                +HRDL   N L     +   +K  DFG+S 
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMS- 205

Query: 204 FFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCG 249
                 R  +I  + YY            M PE +  R +  E D+WS GV+L+ I   G
Sbjct: 206 ------R--DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257

Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
             P++  S       I +G    +    P        +++R   + +P+ R + K V   
Sbjct: 258 KQPWYQLSNTEAIDCITQG----RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313

Query: 309 PWLQNAKKAPNVPL 322
             LQ   +AP V L
Sbjct: 314 --LQALAQAPPVYL 325

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 82.0 bits (203), Expect = 8e-18
 Identities = 67/307 (21%), Positives = 117/307 (38%), Gaps = 55/307 (17%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
           VP++NI     + R LG G FG  Y      +  D   L  A K++   ++ +  D  D 
Sbjct: 27  VPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDF 80

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
             E  I+     + +IV             ++MEL  GG+L   +        + ++   
Sbjct: 81  LMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL-- 137

Query: 159 RTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
             +++++ +            ++  IHRD+   N L          K  DFG++      
Sbjct: 138 -AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------ 190

Query: 209 ERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFW 254
            R  +I  + YY            M PE      +  + D WS GV+L+ I   G  P+ 
Sbjct: 191 -R--DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247

Query: 255 AESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           ++S Q V + +  G     R   P N       ++ Q  +  P+ R     +LE   ++ 
Sbjct: 248 SKSNQEVLEFVTSG----GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEY 301

Query: 314 AKKAPNV 320
             + P+V
Sbjct: 302 CTQDPDV 308

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 80.7 bits (200), Expect = 1e-17
 Identities = 51/248 (20%), Positives = 98/248 (39%), Gaps = 54/248 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           + +E I     + +ELG G+FGV  L   +   ++ A K I +     ++  D+  +E  
Sbjct: 5   LKREEIT----LLKELGSGQFGVVKLGKWKGQYDV-AVKMIKE----GSMSEDEFFQEAQ 55

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
            M  L  +  +V     C  +  +++V E    G L + + + G               +
Sbjct: 56  TMMKL-SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGL---------EPSQ 105

Query: 164 VVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
           ++++C+           H  IHRDL   N L      +  +K  DFG++       R+  
Sbjct: 106 LLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMT-------RY-- 153

Query: 214 IVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQG 260
           ++   Y             APEV     Y  + D+W+ G++++ +   G  P+   +   
Sbjct: 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213

Query: 261 VAQAILRG 268
           V   + +G
Sbjct: 214 VVLKVSQG 221

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 66/307 (21%), Positives = 117/307 (38%), Gaps = 55/307 (17%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
           VP++NI     + R LG G FG  Y      +  D   L  A K++   ++ +  D  D 
Sbjct: 68  VPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDF 121

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
             E  I+     + +IV             +++EL  GG+L   +        + ++   
Sbjct: 122 LMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL-- 178

Query: 159 RTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
             +++++ +            ++  IHRD+   N L          K  DFG++      
Sbjct: 179 -AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------ 231

Query: 209 ERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFW 254
            R  +I  + YY            M PE      +  + D WS GV+L+ I   G  P+ 
Sbjct: 232 -R--DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288

Query: 255 AESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           ++S Q V + +  G     R   P N       ++ Q  +  P+ R     +LE   ++ 
Sbjct: 289 SKSNQEVLEFVTSG----GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEY 342

Query: 314 AKKAPNV 320
             + P+V
Sbjct: 343 CTQDPDV 349

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 62/295 (21%), Positives = 103/295 (34%), Gaps = 52/295 (17%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY--LCIDRDTRELL-ACKSISKRKLRTAVDIDDVRR 100
           +P++       + R LG+GEFG          D   +  A K + K  +  + DI++  R
Sbjct: 20  IPEQQFT----LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLR 74

Query: 101 EVAIMKHLPKNSSIVSLKEACEDD------NAVHLVMELCEGGELFDRIVARGHYTERAA 154
           E A MK    +  +  L                 +++   + G+L   ++A         
Sbjct: 75  EAACMKEF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133

Query: 155 AAVTRTIVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
             +   +  +V +            IHRDL   N + A   E+  +   DFGLS      
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLS------ 184

Query: 209 ERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFW 254
            R  +I    YY            +A E L    Y    D+W+ GV ++ I+  G  P+ 
Sbjct: 185 -R--KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241

Query: 255 AESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
                 +   ++ G     R   P    E    L+ Q    DPK R +   +   
Sbjct: 242 GIENAEIYNYLIGG----NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 80.3 bits (199), Expect = 2e-17
 Identities = 53/250 (21%), Positives = 94/250 (37%), Gaps = 58/250 (23%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +  +++       +ELG G+FGV      R   ++ A K I +     ++  D+   E  
Sbjct: 21  IDPKDLT----FLKELGTGQFGVVKYGKWRGQYDV-AIKMIKE----GSMSEDEFIEEAK 71

Query: 104 IMKHL--PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           +M +L   K   +V L   C     + ++ E    G L + +    H             
Sbjct: 72  VMMNLSHEK---LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---------RFQT 119

Query: 162 VEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
            +++++C               +HRDL   N L     +   +K  DFGLS       R+
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLS-------RY 169

Query: 212 SEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
             ++   Y              PEVL    +  + DIW+ GV+++ I   G  P+   + 
Sbjct: 170 --VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227

Query: 259 QGVAQAILRG 268
              A+ I +G
Sbjct: 228 SETAEHIAQG 237

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 37/217 (17%), Positives = 80/217 (36%), Gaps = 28/217 (12%)

Query: 20  YSSHDHARKEAGANK---KQPITVLAGVPKENIE-DRYLVDRELGRGEFGVTYLCIDRDT 75
           +  H H+       +    Q +    G   +++E +++++ +++G G FG+ YL    + 
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNK 61

Query: 76  RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA----VH--- 128
            E  A   +             +  E+   + + K   I    E  + D       +   
Sbjct: 62  PEKDARHVVKVEYQENGP----LFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117

Query: 129 -----------LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
                      +VME   G +L       G + +     +   +++V++  H++  +H D
Sbjct: 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGD 176

Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
           +K  N L   K  +  +   D+GLS  + P     + 
Sbjct: 177 IKAANLLLGYKNPDQ-VYLADYGLSYRYCPNGNHKQY 212

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 57/257 (22%), Positives = 93/257 (36%), Gaps = 53/257 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI--DRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           +   +I+        +G G FG            R   A K +  ++  +  D  D   E
Sbjct: 22  LDWNDIK----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGE 75

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD------RIVARGHYTERAAA 155
           + ++  L  + +I++L  ACE    ++L +E    G L D       +     +    + 
Sbjct: 76  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 135

Query: 156 AVTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
           A T +  +++              +   IHRDL   N L     EN   K  DFGLS   
Sbjct: 136 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS--- 189

Query: 206 KPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVP 251
               R  E      Y            MA E L    Y    D+WS GV+L+ I+  G  
Sbjct: 190 ----RGQE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240

Query: 252 PFWAESEQGVAQAILRG 268
           P+   +   + + + +G
Sbjct: 241 PYCGMTCAELYEKLPQG 257

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 60/322 (18%), Positives = 114/322 (35%), Gaps = 56/322 (17%)

Query: 21  SSHDHARKEAGANKKQPITVLAG-----VPKENIEDRYLVDRELGRGEFGVTY--LCIDR 73
           SSH H    +G   +    +        + +  +     + + LG GEFG          
Sbjct: 3   SSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLI----LGKILGEGEFGSVMEGNLKQE 58

Query: 74  DTRELL-ACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH---- 128
           D   L  A K++ K    +  +I++   E A MK    + +++ L   C + ++      
Sbjct: 59  DGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKP 116

Query: 129 -LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH------KHGVIHRDLKPE 181
            +++   + G+L   ++     T      +   +  +V +            +HRDL   
Sbjct: 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR 176

Query: 182 NFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-R 228
           N +     ++  +   DFGLS       +  +I    YY            +A E L  R
Sbjct: 177 NCMLR---DDMTVCVADFGLS-------K--KIYSGDYYRQGRIAKMPVKWIAIESLADR 224

Query: 229 NYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKS 286
            Y  + D+W+ GV ++ I   G+ P+       +   +L G     R   P +  +    
Sbjct: 225 VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG----HRLKQPEDCLDELYE 280

Query: 287 LVRQMLEPDPKLRLTAKQVLEH 308
           ++      DP  R T   +   
Sbjct: 281 IMYSCWRTDPLDRPTFSVLRLQ 302

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 50/239 (20%), Positives = 97/239 (40%), Gaps = 36/239 (15%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E++     ++ +LG+G FG  ++     T   +A K++        +  +   +E  
Sbjct: 181 IPRESLR----LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP----GTMSPEAFLQEAQ 231

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +MK L ++  +V L     ++  +++V E    G L D +        +        + +
Sbjct: 232 VMKKL-RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL--------KGETGKYLRLPQ 281

Query: 164 VVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
           +V +            +   +HRDL+  N L     EN   K  DFGL+   +  E  + 
Sbjct: 282 LVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR 338

Query: 214 IVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
                P  + APE      +  + D+WS G++L  +   G  P+     + V   + RG
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 50/239 (20%), Positives = 97/239 (40%), Gaps = 36/239 (15%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E++     ++ +LG+G FG  ++     T   +A K++        +  +   +E  
Sbjct: 264 IPRESLR----LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP----GTMSPEAFLQEAQ 314

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +MK L ++  +V L     ++  +++V E    G L D +        +        + +
Sbjct: 315 VMKKL-RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL--------KGETGKYLRLPQ 364

Query: 164 VVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
           +V +            +   +HRDL+  N L     EN   K  DFGL+   +  E  + 
Sbjct: 365 LVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR 421

Query: 214 IVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
                P  + APE      +  + D+WS G++L  +   G  P+     + V   + RG
Sbjct: 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 77.7 bits (192), Expect = 1e-16
 Identities = 39/258 (15%), Positives = 77/258 (29%), Gaps = 61/258 (23%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV---------D 94
           +  E++      +  LG+G F   +  + R+             +    +          
Sbjct: 5   IRNEDLI----FNESLGQGTFTKIFKGVRREVG-----DYGQLHETEVLLKVLDKAHRNY 55

Query: 95  IDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
            +      ++M  L  +  +V     C   +   LV E  + G L   +    +      
Sbjct: 56  SESFFEAASMMSKL-SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN------ 108

Query: 155 AAVTRTIVEVVQLCH----------KHGVIHRDLKPENFL-----FANKKENSPLKAIDF 199
                 I+  +++            ++ +IH ++  +N L              +K  D 
Sbjct: 109 ---CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165

Query: 200 GLSIFFKPGERFSEIVGSPYY------MAPEVLK--RNYGPEIDIWSAGVILY-ILLCGV 250
           G+SI          ++           + PE ++  +N     D WS G  L+ I   G 
Sbjct: 166 GISIT---------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD 216

Query: 251 PPFWAESEQGVAQAILRG 268
            P  A   Q   Q     
Sbjct: 217 KPLSALDSQRKLQFYEDR 234

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 77.2 bits (191), Expect = 2e-16
 Identities = 57/248 (22%), Positives = 96/248 (38%), Gaps = 54/248 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +    +       +E+G G+FG+ +L    +  ++ A K+I +     A+  +D   E  
Sbjct: 5   IDPSELT----FVQEIGSGQFGLVHLGYWLNKDKV-AIKTIRE----GAMSEEDFIEEAE 55

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +M  L  +  +V L   C +   + LV E  E G L D +  +                 
Sbjct: 56  VMMKL-SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG---------LFAAET 105

Query: 164 VVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
           ++ +C           +  VIHRDL   N L     EN  +K  DFG++       RF  
Sbjct: 106 LLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMT-------RF-- 153

Query: 214 IVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQG 260
           ++   Y             +PEV     Y  + D+WS GV+++ +   G  P+   S   
Sbjct: 154 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

Query: 261 VAQAILRG 268
           V + I  G
Sbjct: 214 VVEDISTG 221

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 56/287 (19%), Positives = 105/287 (36%), Gaps = 66/287 (22%)

Query: 2   GNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGR 61
           G C R       E   +       +                 +  + ++    + + +G+
Sbjct: 162 GLCTRLIKPKVMEGTVAAQDEFYRSGWA--------------LNMKELK----LLQTIGK 203

Query: 62  GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC 121
           GEFG   L   R  +  +A K      ++          E ++M  L ++S++V L    
Sbjct: 204 GEFGDVMLGDYRGNK--VAVKC-----IKNDATAQAFLAEASVMTQL-RHSNLVQLLGVI 255

Query: 122 -EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH----------- 169
            E+   +++V E    G L D + +RG           R+++    L             
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRG-----------RSVLGGDCLLKFSLDVCEAMEY 304

Query: 170 --KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS---IFFKPGERFSEIVGSPY-YMAP 223
              +  +HRDL   N L +   E++  K  DFGL+      +   +       P  + AP
Sbjct: 305 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAP 355

Query: 224 EVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
           E L+   +  + D+WS G++L+ I   G  P+     + V   + +G
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 66/291 (22%), Positives = 110/291 (37%), Gaps = 60/291 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY--LCIDRDTRELL-ACKSISKRKLRTAVDIDDVRR 100
           + +E IE    + R +G G+FG  +  + +  +   +  A K+   +   +    +   +
Sbjct: 387 IQRERIE----LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQ 440

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E   M+    +  IV L     ++  V ++MELC  GEL   +  R           +  
Sbjct: 441 EALTMRQF-DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKF---------SLD 489

Query: 161 IVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
           +  ++   +              +HRD+   N L +    N  +K  DFGLS        
Sbjct: 490 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSR------- 539

Query: 211 FSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
              +  S YY           MAPE +  R +    D+W  GV ++ IL+ GV PF    
Sbjct: 540 --YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

Query: 258 EQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
              V   I  G    +R P P N   +  SL+ +    DP  R    ++  
Sbjct: 598 NNDVIGRIENG----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 52/231 (22%), Positives = 88/231 (38%), Gaps = 46/231 (19%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR---TAVDIDDVRR 100
            P+ N++      + LG G FG           +  A   ++ + L+    A + + +  
Sbjct: 43  FPRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD----RIVARGHYTERAAAA 156
           E+ IM HL ++ +IV+L  AC     V ++ E C  G+L +    +          A A 
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 157 VTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
            T +  +++                  IHRD+   N L          K  DFGL+    
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA---- 211

Query: 207 PGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY 244
              R  +I+    Y            MAPE +    Y  + D+WS G++L+
Sbjct: 212 ---R--DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 76.1 bits (188), Expect = 5e-16
 Identities = 63/260 (24%), Positives = 104/260 (40%), Gaps = 55/260 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
           + + +I     + RELG G FG  +L     +     ++L A K++   K  T     D 
Sbjct: 12  IKRRDIV----LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDF 64

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
           +RE  ++ +L ++  IV     C D + + +V E  + G+L   + A G           
Sbjct: 65  QREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123

Query: 159 R------TIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
           R       + +++ +                +HRDL   N L      N  +K  DFG+S
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS 180

Query: 203 IFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLC 248
                  R  ++  + YY            M PE +  R +  E D+WS GVIL+ I   
Sbjct: 181 -------R--DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231

Query: 249 GVPPFWAESEQGVAQAILRG 268
           G  P++  S   V + I +G
Sbjct: 232 GKQPWFQLSNTEVIECITQG 251

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 77.0 bits (190), Expect = 7e-16
 Identities = 58/258 (22%), Positives = 91/258 (35%), Gaps = 66/258 (25%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV---------- 93
           +   NI     +D+ +G GEFG                K  SK+++  A+          
Sbjct: 42  LDATNIS----IDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEK 88

Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA 153
              D   E +IM     + +I+ L+        V +V E  E G L   +          
Sbjct: 89  QRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA----- 142

Query: 154 AAAVTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI 203
                 T++++V +              G +HRDL   N L      N   K  DFGL  
Sbjct: 143 ----QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLG- 194

Query: 204 FFKPGERFSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGV 250
                 R  E      Y            +PE +  R +    D+WS G++L+ ++  G 
Sbjct: 195 ------RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248

Query: 251 PPFWAESEQGVAQAILRG 268
            P+W  S Q V +A+  G
Sbjct: 249 RPYWEMSNQDVIKAVDEG 266

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191

 Score = 73.8 bits (182), Expect = 9e-16
 Identities = 6/41 (14%), Positives = 18/41 (43%)

Query: 306 LEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           + H    ++ +      G  V    K + ++ +F++ A+ +
Sbjct: 1   MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTI 41

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 75.8 bits (187), Expect = 9e-16
 Identities = 69/250 (27%), Positives = 98/250 (39%), Gaps = 54/250 (21%)

Query: 23  HDHARKEAGANKKQPITVLAGVPKEN--IEDRYLV-DRELGRGEFGVTYLCI----DRDT 75
           H H     GA     + VL   P +      RYL   R+LG G FG   L      +  T
Sbjct: 5   HHHHHHHHGA-----LEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGT 59

Query: 76  RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA--VHLVMEL 133
            E++A K++  +           ++E+ I++ L  +  I+  K  CED  A  + LVME 
Sbjct: 60  GEMVAVKAL--KADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQLVMEY 116

Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC------HKHGVIHRDLKPENFLFAN 187
              G L D       Y  R +  + + ++   Q+C      H    IHRDL   N L   
Sbjct: 117 VPLGSLRD-------YLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD- 168

Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEI 234
              +  +K  DFGL+       +     G  YY             APE LK   +    
Sbjct: 169 --NDRLVKIGDFGLA-------KAVP-EGHEYYRVREDGDSPVFWYAPECLKEYKFYYAS 218

Query: 235 DIWSAGVILY 244
           D+WS GV LY
Sbjct: 219 DVWSFGVTLY 228

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 54/252 (21%), Positives = 90/252 (35%), Gaps = 53/252 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY---LCIDRDTRELL-ACKSISKRKLRTAVDIDDVR 99
           +    +       + +G GEFG  Y   L      +E+  A K++  +   T     D  
Sbjct: 41  IHPSCVT----RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFL 94

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E  IM     + +I+ L+        + ++ E  E G L   +  +             
Sbjct: 95  GEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---------EF 144

Query: 160 TIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           +++++V +                +HRDL   N L      N   K  DFGLS       
Sbjct: 145 SVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLS------- 194

Query: 210 RFSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAE 256
           R  E      Y            APE +  R +    D+WS G++++ ++  G  P+W  
Sbjct: 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254

Query: 257 SEQGVAQAILRG 268
           S   V +AI  G
Sbjct: 255 SNHEVMKAINDG 266

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 60/258 (23%), Positives = 92/258 (35%), Gaps = 52/258 (20%)

Query: 19  NYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRE-------LGRGEFGVTYLC- 70
           +Y  H H         +      A        D    +         LG+G FG   +C 
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCR 61

Query: 71  ---IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA- 126
              +  +T E++A K +   +  T   + D  RE+ I+K L ++ +IV  K  C      
Sbjct: 62  YDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR 117

Query: 127 -VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC------HKHGVIHRDLK 179
            + L+ME    G L D +  + H   +      + +    Q+C           IHRDL 
Sbjct: 118 NLKLIMEYLPYGSLRDYL--QKH---KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK 227
             N L       + +K  DFGL+       +        YY             APE L 
Sbjct: 173 TRNILVE---NENRVKIGDFGLT-------KVLP-QDKEYYKVKEPGESPIFWYAPESLT 221

Query: 228 -RNYGPEIDIWSAGVILY 244
              +    D+WS GV+LY
Sbjct: 222 ESKFSVASDVWSFGVVLY 239

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 64/305 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI-------DRDTRELLACKSISKRKLRTAVDID 96
            P++ +     + + LG G FG   +                +A K +  +   T  D+ 
Sbjct: 32  FPRDKLT----LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLS 85

Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA 156
           D+  E+ +MK + K+ +I++L  AC  D  +++++E    G L + +  R         +
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYS 143

Query: 157 VTRTIVEVVQLCHK------------------HGVIHRDLKPENFLFANKKENSPLKAID 198
                V   Q+  K                     IHRDL   N L     EN+ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIAD 200

Query: 199 FGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY- 244
           FGL+       R  +I    YY            MAPE L  R Y  + D+WS GV+++ 
Sbjct: 201 FGLA-------R--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 251

Query: 245 ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAK 303
           I   G  P+     + + + +  G     R   P N +     ++R      P  R T K
Sbjct: 252 IFTLGGSPYPGIPVEELFKLLKEG----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFK 307

Query: 304 QVLEH 308
           Q++E 
Sbjct: 308 QLVED 312

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 53/244 (21%), Positives = 105/244 (43%), Gaps = 46/244 (18%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E+++    ++++LG G+FG  ++       ++ A K++       ++ ++    E  
Sbjct: 185 IPRESLK----LEKKLGAGQFGEVWMATYNKHTKV-AVKTMKP----GSMSVEAFLAEAN 235

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +MK L ++  +V L      +  ++++ E    G L D + +     E +   + + I  
Sbjct: 236 VMKTL-QHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDF 289

Query: 164 VVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS 217
             Q+        +   IHRDL+  N L +    +   K  DFGL+       R   I  +
Sbjct: 290 SAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLA-------RV--IEDN 337

Query: 218 PYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            Y             APE +   ++  + D+WS G++L  I+  G  P+   S   V +A
Sbjct: 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 397

Query: 265 ILRG 268
           + RG
Sbjct: 398 LERG 401

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 74.9 bits (185), Expect = 1e-15
 Identities = 55/248 (22%), Positives = 101/248 (40%), Gaps = 54/248 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++    +   LG G+FG  ++       + +A KS+ +     ++  D    E  
Sbjct: 10  VPRETLK----LVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQ----GSMSPDAFLAEAN 60

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +MK L ++  +V L      +  ++++ E  E G L D +        +  + +  TI +
Sbjct: 61  LMKQL-QHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFL--------KTPSGIKLTINK 110

Query: 164 VVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
           ++ +            +   IHRDL+  N L +   +    K  DFGL+       R   
Sbjct: 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA-------RL-- 158

Query: 214 IVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQG 260
           I  + Y             APE +    +  + D+WS G++L  I+  G  P+   +   
Sbjct: 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218

Query: 261 VAQAILRG 268
           V Q + RG
Sbjct: 219 VIQNLERG 226

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 54/243 (22%)

Query: 56  DRELGRGEFGVTY--LCIDRDTRELL-ACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           +  +GRG FG  Y    +D D +++  A KS+   ++    ++     E  IMK    + 
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF-SHP 86

Query: 113 SIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-- 169
           +++SL   C   + +  +V+   + G+L + I    H           T+ +++      
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQV 137

Query: 170 --------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY- 220
                       +HRDL   N +     E   +K  DFGL+       R  ++    YY 
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA-------R--DMYDKEYYS 185

Query: 221 -------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAI 265
                        MA E L+ + +  + D+WS GV+L+ ++  G PP+   +   +   +
Sbjct: 186 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245

Query: 266 LRG 268
           L+G
Sbjct: 246 LQG 248

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 46/246 (18%), Positives = 82/246 (33%), Gaps = 51/246 (20%)

Query: 50  EDRYLVDRELGRGEFGV----TYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           E  +   + LG G FG      ++      +  +A K +  R+  +     ++  E  +M
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
             +  N  +  L   C     V L+ +L   G L D +                    ++
Sbjct: 72  ASV-DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD---------NIGSQYLL 120

Query: 166 QLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
             C              ++HRDL   N L         +K  DFGL+       +     
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLA-------KLLG-A 169

Query: 216 GSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVA 262
               Y           MA E +  R Y  + D+WS GV ++ ++  G  P+       ++
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

Query: 263 QAILRG 268
             + +G
Sbjct: 230 SILEKG 235

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 63/251 (25%), Positives = 95/251 (37%), Gaps = 53/251 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           + ++N+    + D ELG G FG     +   R  +  +A K +  ++     D +++ RE
Sbjct: 6   LKRDNLL---IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMRE 60

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
             IM  L  N  IV L   C+ + A+ LVME+  GG L   +V +              +
Sbjct: 61  AQIMHQL-DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEI---------PV 109

Query: 162 VEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
             V +L H          +   +HRDL   N L          K  DFGLS      +  
Sbjct: 110 SNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADD-- 164

Query: 212 SEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
                  YY             APE +  R +    D+WS GV ++  L  G  P+    
Sbjct: 165 ------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

Query: 258 EQGVAQAILRG 268
              V   I +G
Sbjct: 219 GPEVMAFIEQG 229

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 61/249 (24%), Positives = 93/249 (37%), Gaps = 47/249 (18%)

Query: 49  IEDRYLV-DRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L    +LG+G FG   LC       +T  L+A K +   +        D +RE+ 
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQ 76

Query: 104 IMKHLPKNSSIVSLKEACEDDNA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           I+K L  +  IV  +          + LVME    G L D +  + H   RA    +R +
Sbjct: 77  ILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRH---RARLDASRLL 130

Query: 162 VEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
           +   Q+C           +HRDL   N L       + +K  DFGL+      +      
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKD----- 182

Query: 216 GSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGV 261
              YY             APE L    +  + D+WS GV+LY +           +E   
Sbjct: 183 ---YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 239

Query: 262 AQAILRGLI 270
                R + 
Sbjct: 240 MMGCERDVP 248

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 61/245 (24%), Positives = 92/245 (37%), Gaps = 50/245 (20%)

Query: 50  EDRYLVDRELGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++  + D ELG G FG     +   R  +  +A K +  ++     D +++ RE  IM  
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQ 392

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  N  IV L   C+ + A+ LVME+  GG L   +V +              +  V +L
Sbjct: 393 L-DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEI---------PVSNVAEL 441

Query: 168 CH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS 217
            H          +   +HR+L   N L          K  DFGLS      +        
Sbjct: 442 LHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADD-------- 490

Query: 218 PYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
            YY             APE +  R +    D+WS GV ++  L  G  P+       V  
Sbjct: 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 550

Query: 264 AILRG 268
            I +G
Sbjct: 551 FIEQG 555

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 74.2 bits (183), Expect = 2e-15
 Identities = 56/251 (22%), Positives = 91/251 (36%), Gaps = 53/251 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           + ++ +    L D+ELG G FG         +   + +A K + K +       D++  E
Sbjct: 13  LDRKLLT---LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAE 68

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
             +M+ L  N  IV +   CE + +  LVME+ E G L   +    H             
Sbjct: 69  ANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHV----------KD 116

Query: 162 VEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
             +++L H          +   +HRDL   N L          K  DFGLS       + 
Sbjct: 117 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLS-------KA 166

Query: 212 SEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
                  YY             APE +    +  + D+WS GV+++     G  P+    
Sbjct: 167 LR-ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225

Query: 258 EQGVAQAILRG 268
              V   + +G
Sbjct: 226 GSEVTAMLEKG 236

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 52/258 (20%), Positives = 86/258 (33%), Gaps = 66/258 (25%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV---------- 93
           +    I     +++ +G G+ G                +   +R +  A+          
Sbjct: 46  IEASRIH----IEKIIGSGDSGEVCYGR---------LRVPGQRDVPVAIKALKAGYTER 92

Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA 153
              D   E +IM     + +I+ L+          +V E  E G L   +          
Sbjct: 93  QRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG----- 146

Query: 154 AAAVTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI 203
                 TI+++V +              G +HRDL   N L      N   K  DFGLS 
Sbjct: 147 ----QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLS- 198

Query: 204 FFKPGERFSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGV 250
                 R  E      Y            APE +  R +    D+WS GV+++ +L  G 
Sbjct: 199 ------RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252

Query: 251 PPFWAESEQGVAQAILRG 268
            P+W  + + V  ++  G
Sbjct: 253 RPYWNMTNRDVISSVEEG 270

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 71/306 (23%), Positives = 116/306 (37%), Gaps = 66/306 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV---------- 93
           +P++ +     + + LG G FG   L            K    R  + AV          
Sbjct: 66  LPRDRLV----LGKPLGEGAFGQVVLAEAIGLD-----KDKPNRVTKVAVKMLKSDATEK 116

Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD------RIVARG 147
           D+ D+  E+ +MK + K+ +I++L  AC  D  +++++E    G L +            
Sbjct: 117 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 176

Query: 148 HYTERAAAAVTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAI 197
            Y          +  ++V   +              IHRDL   N L     E++ +K  
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 233

Query: 198 DFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY 244
           DFGL+       R  +I    YY            MAPE L  R Y  + D+WS GV+L+
Sbjct: 234 DFGLA-------R--DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284

Query: 245 -ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTA 302
            I   G  P+     + + + +  G     R   P N +     ++R      P  R T 
Sbjct: 285 EIFTLGGSPYPGVPVEELFKLLKEG----HRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 340

Query: 303 KQVLEH 308
           KQ++E 
Sbjct: 341 KQLVED 346

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 55/260 (21%), Positives = 95/260 (36%), Gaps = 54/260 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
           +    +        ELG   FG  Y           +    A K++  +        ++ 
Sbjct: 6   ISLSAVR----FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEF 59

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
           R E  +   L ++ ++V L      D  + ++   C  G+L + +V R  +++  +    
Sbjct: 60  RHEAMLRARL-QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118

Query: 159 RTI---VEVVQLCH-------------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
           RT+   +E     H              H V+H+DL   N L     +   +K  D GL 
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF 175

Query: 203 IFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLC 248
                  R  E+  + YY            MAPE +    +  + DIWS GV+L+ +   
Sbjct: 176 -------R--EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 226

Query: 249 GVPPFWAESEQGVAQAILRG 268
           G+ P+   S Q V + I   
Sbjct: 227 GLQPYCGYSNQDVVEMIRNR 246

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 74.3 bits (183), Expect = 3e-15
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 45/222 (20%)

Query: 49  IEDRYLV-DRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E R+L   R+LG G FG   LC       +T E +A KS+  +       I D+++E+ 
Sbjct: 18  FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIE 75

Query: 104 IMKHLPKNSSIVSLKEACEDDNA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           I+++L  + +IV  K  C +D    + L+ME    G L + +    +   +    + + +
Sbjct: 76  ILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKN---KNKINLKQQL 129

Query: 162 VEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
              VQ+C           +HRDL   N L         +K  DFGL+       +  E  
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLT-------KAIE-T 178

Query: 216 GSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY 244
              YY             APE L    +    D+WS GV L+
Sbjct: 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 64/305 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL---ACKSISKRKLRTAVDID 96
            P++ +     + + LG G FG   +     ID+D  +     A K +  +   T  D+ 
Sbjct: 78  FPRDKLT----LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLS 131

Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA 156
           D+  E+ +MK + K+ +I++L  AC  D  +++++E    G L + +  R         +
Sbjct: 132 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYS 189

Query: 157 VTRTIVEVVQLCHK------------------HGVIHRDLKPENFLFANKKENSPLKAID 198
                V   Q+  K                     IHRDL   N L     EN+ +K  D
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIAD 246

Query: 199 FGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY- 244
           FGL+       R  +I    YY            MAPE L  R Y  + D+WS GV+++ 
Sbjct: 247 FGLA-------R--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 297

Query: 245 ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAK 303
           I   G  P+     + + + +  G     R   P N +     ++R      P  R T K
Sbjct: 298 IFTLGGSPYPGIPVEELFKLLKEG----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFK 353

Query: 304 QVLEH 308
           Q++E 
Sbjct: 354 QLVED 358

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 59/253 (23%), Positives = 98/253 (38%), Gaps = 59/253 (23%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY--LCIDRDTRELL-ACKSISKRKLRTAVDIDDVRR 100
           + +E++     ++R LG G FG  Y  +  +    ++  A K+   +K  T  + +    
Sbjct: 9   IAREDVV----LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMS 62

Query: 101 EVAIMKHL--PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
           E  IMK+L  P    IV L    E++    ++MEL   GEL   +    +         +
Sbjct: 63  EAVIMKNLDHPH---IVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKN---------S 109

Query: 159 RTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
             ++ +V                  +HRD+   N L A       +K  DFGLS      
Sbjct: 110 LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS------ 160

Query: 209 ERFSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWA 255
            R+  I    YY           M+PE +  R +    D+W   V ++ IL  G  PF+ 
Sbjct: 161 -RY--IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217

Query: 256 ESEQGVAQAILRG 268
              + V   + +G
Sbjct: 218 LENKDVIGVLEKG 230

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 73.9 bits (182), Expect = 4e-15
 Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 47/226 (20%)

Query: 45  PKENIEDRYLV-DRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVR 99
           P +  E+R+L   ++LG+G FG   +C    +  +T E++A K +   +  T   + D  
Sbjct: 4   PTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFE 59

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNA--VHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           RE+ I+K L ++ +IV  K  C       + L+ME    G L D +  + H   +     
Sbjct: 60  REIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKH---KERIDH 113

Query: 158 TRTIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
            + +    Q+C           IHRDL   N L       + +K  DFGL+       + 
Sbjct: 114 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLT-------KV 163

Query: 212 SEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY 244
                  ++             APE L    +    D+WS GV+LY
Sbjct: 164 LP-QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 73.4 bits (181), Expect = 4e-15
 Identities = 51/238 (21%), Positives = 99/238 (41%), Gaps = 38/238 (15%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +  + ++    + + +G+GEFG   L   R  +  +A K      ++          E +
Sbjct: 18  LNMKELK----LLQTIGKGEFGDVMLGDYRGNK--VAVKC-----IKNDATAQAFLAEAS 66

Query: 104 IMKHLPKNSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +M  L ++S++V L     E+   +++V E    G L D +  R     R+       + 
Sbjct: 67  VMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSR--GRSVLGGDCLLK 121

Query: 163 EVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS---IFFKPGERFSE 213
             + +C        +  +HRDL   N L +   E++  K  DFGL+      +   +   
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL-- 176

Query: 214 IVGSPY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
               P  + APE L+ + +  + D+WS G++L+ I   G  P+     + V   + +G
Sbjct: 177 ----PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 52/242 (21%), Positives = 86/242 (35%), Gaps = 59/242 (24%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI-----DRDTRELLACKSISKRKLRTAVDIDDV 98
            P+EN+E      + LG G FG                  +A K +  ++   + + + +
Sbjct: 42  FPRENLE----FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREAL 95

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-----RIVARGHYTERA 153
             E+ +M  L  + +IV+L  AC     ++L+ E C  G+L +     R        E  
Sbjct: 96  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155

Query: 154 AAAVTRTIVEVVQLCHK------------------HGVIHRDLKPENFLFANKKENSPLK 195
                    ++  L  +                     +HRDL   N L         +K
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVK 212

Query: 196 AIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVI 242
             DFGL+       R  +I+    Y            MAPE L    Y  + D+WS G++
Sbjct: 213 ICDFGLA-------R--DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263

Query: 243 LY 244
           L+
Sbjct: 264 LW 265

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 73.8 bits (182), Expect = 5e-15
 Identities = 48/237 (20%), Positives = 82/237 (34%), Gaps = 54/237 (22%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDV 98
            P+  +       + LG G FG          I  D    +A K +  +      + + +
Sbjct: 20  FPRNRLS----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREAL 73

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--------RIVARGHYT 150
             E+ ++ +L  + +IV+L  AC       ++ E C  G+L +         I ++    
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 151 ERAAAAVTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFG 200
                 +   + +++   +              IHRDL   N L          K  DFG
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFG 190

Query: 201 LSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY 244
           L+       R  +I     Y            MAPE +    Y  E D+WS G+ L+
Sbjct: 191 LA-------R--DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197

 Score = 71.9 bits (177), Expect = 5e-15
 Identities = 11/44 (25%), Positives = 16/44 (36%), Gaps = 1/44 (2%)

Query: 304 QVLEHPWL-QNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
               H    +N     +V L   +   LK F   N  K+ AL +
Sbjct: 3   HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTI 46

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 58/251 (23%), Positives = 96/251 (38%), Gaps = 55/251 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY---LCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           + +E IE    + R +G G+FG  +        +    +A K+   +   +    +   +
Sbjct: 12  IQRERIE----LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQ 65

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E   M+    +  IV L     ++  V ++MELC  GEL   +  R +         +  
Sbjct: 66  EALTMRQF-DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKY---------SLD 114

Query: 161 IVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
           +  ++   +              +HRD+   N L +    N  +K  DFGLS       R
Sbjct: 115 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS-------R 164

Query: 211 FSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
           +  +  S YY           MAPE +  R +    D+W  GV ++ IL+ GV PF    
Sbjct: 165 Y--MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

Query: 258 EQGVAQAILRG 268
              V   I  G
Sbjct: 223 NNDVIGRIENG 233

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 53/255 (20%), Positives = 99/255 (38%), Gaps = 56/255 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRR 100
           +P E +      DR +G+G FGV Y     D  +     A KS+   ++     ++   R
Sbjct: 16  IPHERVVTH--SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLR 71

Query: 101 EVAIMKHLPKNSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           E  +M+ L  + ++++L       +   H+++     G+L   I +              
Sbjct: 72  EGLLMRGL-NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR---------NP 121

Query: 160 TIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T+ +++              +   +HRDL   N +     E+  +K  DFGL+       
Sbjct: 122 TVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA------- 171

Query: 210 RFSEIVGSPYY--------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPF 253
           R  +I+   YY               A E L+   +  + D+WS GV+L+ +L  G PP+
Sbjct: 172 R--DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

Query: 254 WAESEQGVAQAILRG 268
                  +   + +G
Sbjct: 230 RHIDPFDLTHFLAQG 244

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 51/243 (20%), Positives = 98/243 (40%), Gaps = 54/243 (22%)

Query: 56  DRELGRGEFGVTY--LCIDRDTRELL-ACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           +  +GRG FG  Y    +D D +++  A KS+   ++    ++     E  IMK    + 
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF-SHP 150

Query: 113 SIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-- 169
           +++SL   C   + +  +V+   + G+L + I    H           T+ +++      
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQV 201

Query: 170 --------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY- 220
                       +HRDL   N +     E   +K  DFGL+       R  ++    +  
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA-------R--DMYDKEFDS 249

Query: 221 -------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAI 265
                        MA E L+ + +  + D+WS GV+L+ ++  G PP+   +   +   +
Sbjct: 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309

Query: 266 LRG 268
           L+G
Sbjct: 310 LQG 312

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 64/305 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
            P++ ++    + + LGRG FG         ID+       A K +  ++  T  +   +
Sbjct: 24  FPRDRLK----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRAL 77

Query: 99  RREVAIMKHLPKNSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
             E+ I+ H+  + ++V+L  AC +    + +++E C+ G L   +  R    E     V
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKV 135

Query: 158 TRTIVEVVQLCHK------------------HGVIHRDLKPENFLFANKKENSPLKAIDF 199
               +    L  +                     IHRDL   N L +   E + +K  DF
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDF 192

Query: 200 GLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-I 245
           GL+       R  +I   P Y            MAPE +  R Y  + D+WS GV+L+ I
Sbjct: 193 GLA-------R--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

Query: 246 LLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAK 303
              G  P+   + ++   + +  G     R   P   +      +      +P  R T  
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLKEG----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 299

Query: 304 QVLEH 308
           +++EH
Sbjct: 300 ELVEH 304

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 70.7 bits (174), Expect = 4e-14
 Identities = 53/250 (21%), Positives = 81/250 (32%), Gaps = 51/250 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY---LCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           + ++++     +  +LG G FGV               +A K +    L     +DD  R
Sbjct: 15  IGEKDLR----LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           EV  M  L  + +++ L         + +V EL   G L DR+                 
Sbjct: 71  EVNAMHSL-DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQG---------HFL 119

Query: 161 IVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
           +  + +                 IHRDL   N L A       +K  DFGL        R
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLM-------R 169

Query: 211 FSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
                   Y             APE LK R +    D W  GV L+ +   G  P+   +
Sbjct: 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229

Query: 258 EQGVAQAILR 267
              +   I +
Sbjct: 230 GSQILHKIDK 239

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 42/262 (16%), Positives = 90/262 (34%), Gaps = 40/262 (15%)

Query: 25  HARKEAGANKKQPITVLAGVPKENIE-DRYLVDRELGRGEFGVTYLCIDRDTRELLACKS 83
            A +++ A +        G    ++    + V   +G+G FG  YL  D ++ E +   +
Sbjct: 8   QAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDA 66

Query: 84  ISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA----VH----------- 128
               K+    D   +  E+   +   K   I       +                     
Sbjct: 67  PCVVKV-EPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS 125

Query: 129 ---LVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFL 184
              ++M+   G +L     A    ++ +    ++  I+++++  H+H  +H D+K  N L
Sbjct: 126 YRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL 184

Query: 185 FANKKENSPLKAIDFGLSIFFKPGERFSEI--------VGSPYYMAPEVLKRNYGPEI-- 234
              K  +  +  +D+GL+  + P                G+  + +   +  + G     
Sbjct: 185 LNYKNPDQ-VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTS---IDAHNGVAPSR 240

Query: 235 --DIWSAGVILYILLCGVPPFW 254
             D+   G  +   L G  P W
Sbjct: 241 RGDLEILGYCMIQWLTGHLP-W 261

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 71.2 bits (175), Expect = 4e-14
 Identities = 69/324 (21%), Positives = 110/324 (33%), Gaps = 69/324 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
            P+ NIE      R++G G FG  +      +       + A K +  ++  +A    D 
Sbjct: 44  YPRNNIE----YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADF 97

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--------------FDRIV 144
           +RE A+M     N +IV L   C     + L+ E    G+L                   
Sbjct: 98  QREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156

Query: 145 ARGHYTERAAAAVTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPL 194
                   +      +  E + +            +   +HRDL   N L     EN  +
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVV 213

Query: 195 KAIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGV 241
           K  DFGLS       R   I  + YY            M PE +    Y  E D+W+ GV
Sbjct: 214 KIADFGLS-------R--NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264

Query: 242 ILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLR 299
           +L+ I   G+ P++  + + V   +  G         P N      +L+R      P  R
Sbjct: 265 VLWEIFSYGLQPYYGMAHEEVIYYVRDG----NILACPENCPLELYNLMRLCWSKLPADR 320

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLG 323
            +   +     LQ   +     +G
Sbjct: 321 PSFCSIHRI--LQRMCERAEGTVG 342

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 71.2 bits (175), Expect = 4e-14
 Identities = 47/246 (19%), Positives = 82/246 (33%), Gaps = 51/246 (20%)

Query: 50  EDRYLVDRELGRGEFGV----TYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           E  +   + LG G FG      ++      +  +A K +  R+  +     ++  E  +M
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
             +  N  +  L   C     V L+ +L   G L D +                    ++
Sbjct: 72  ASV-DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD---------NIGSQYLL 120

Query: 166 QLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
             C              ++HRDL   N L         +K  DFGL+      E      
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEE------ 171

Query: 216 GSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVA 262
               Y           MA E +  R Y  + D+WS GV ++ ++  G  P+       ++
Sbjct: 172 --KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

Query: 263 QAILRG 268
             + +G
Sbjct: 230 SILEKG 235

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 46/238 (19%), Positives = 81/238 (34%), Gaps = 47/238 (19%)

Query: 56  DRELGRGEFGV----TYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            + LG G FG      ++      +  +  K I             V   +  +  L  +
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSL-DH 74

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVE-VVQLCH 169
           + IV L   C    ++ LV +    G L D +   RG           + ++   VQ+  
Sbjct: 75  AHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALG-------PQLLLNWGVQIAK 126

Query: 170 ------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY--- 220
                 +HG++HR+L   N L       S ++  DFG++                     
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVA-------DLLP-PDDKQLLYS 175

Query: 221 --------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
                   MA E +    Y  + D+WS GV ++ ++  G  P+       V   + +G
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 66.9 bits (164), Expect = 9e-13
 Identities = 63/317 (19%), Positives = 108/317 (34%), Gaps = 83/317 (26%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV---------- 93
            P++N+     + + LG GEFG                  +  R   T V          
Sbjct: 20  FPRKNLV----LGKTLGEGEFGKVVKAT---------AFHLKGRAGYTTVAVKMLKENAS 66

Query: 94  --DIDDVRREVAIMKHLP-KNSSIVSLKEACEDDNAVHLVMELCEGGELFD------RIV 144
             ++ D+  E  ++K +   +  ++ L  AC  D  + L++E  + G L        ++ 
Sbjct: 67  PSELRDLLSEFNVLKQVNHPH--VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG 124

Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHK------------------HGVIHRDLKPENFLFA 186
                +  +  + +    +   L                       ++HRDL   N L A
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA 184

Query: 187 NKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPE 233
              E   +K  DFGLS       R  ++     Y            MA E L    Y  +
Sbjct: 185 ---EGRKMKISDFGLS-------R--DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232

Query: 234 IDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQM 291
            D+WS GV+L+ I+  G  P+     + +   +  G     R   P N SE    L+ Q 
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG----HRMERPDNCSEEMYRLMLQC 288

Query: 292 LEPDPKLRLTAKQVLEH 308
            + +P  R     + + 
Sbjct: 289 WKQEPDKRPVFADISKD 305

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 26/208 (12%), Positives = 64/208 (30%), Gaps = 26/208 (12%)

Query: 21  SSHDHARKEAGANKKQPI---TVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
              ++   ++     + +   TVL          ++ +     R   G+ Y      T  
Sbjct: 13  LGTENLYFQSMTTSLEALPTGTVLTDKSGR----QWKLKSFQTRDNQGILYEAAPTSTLT 68

Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA---------------CE 122
             +     K  L+       +  E    +   K   +   K+                  
Sbjct: 69  CDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVH 128

Query: 123 DDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
            D    LV+    G  L     +  +   +ER+   V   +++ ++  H++  +H ++  
Sbjct: 129 QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTA 187

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPG 208
           EN     + ++  +    +G +  + P 
Sbjct: 188 ENIFVDPEDQSQ-VTLAGYGFAFRYCPS 214

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.2 bits (125), Expect = 9e-08
 Identities = 23/104 (22%), Positives = 49/104 (47%), Gaps = 12/104 (11%)

Query: 44  VPKENIEDRYLVDRELGRGEFGV----TYLCIDRDTREL-LACKSISKRKLRTAVDIDDV 98
            P++ ++    + + LGRG FG         ID+      +A K +  ++  T  +   +
Sbjct: 19  FPRDRLK----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRAL 72

Query: 99  RREVAIMKHLPKNSSIVSLKEAC-EDDNAVHLVMELCEGGELFD 141
             E+ I+ H+  + ++V+L  AC +    + +++E C+ G L  
Sbjct: 73  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.1 bits (96), Expect = 3e-04
 Identities = 31/95 (32%), Positives = 41/95 (43%), Gaps = 26/95 (27%)

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY----------- 220
             IHRDL   N L +   E + +K  DFGL+       R  +I   P Y           
Sbjct: 213 KCIHRDLAARNILLS---EKNVVKICDFGLA-------R--DIYKDPDYVRKGDARLPLK 260

Query: 221 -MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPP 252
            MAPE +    Y  + D+WS GV+L+ I   G  P
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 51.4 bits (122), Expect = 1e-07
 Identities = 44/319 (13%), Positives = 96/319 (30%), Gaps = 68/319 (21%)

Query: 33  NKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKL 89
           ++K P+     +P E ++       ++G G FG  +  I   T     ++A +       
Sbjct: 6   SQKGPVPFSHCLPTEKLQR----CEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNG 61

Query: 90  RTAVDIDDVRREVAIMKHLP----------------KNSSIV------SLKEACED---- 123
                 +++  E+ I K L                  +   V       L +A +     
Sbjct: 62  SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121

Query: 124 ------------DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
                       D+ + +V+E   GG   +++  +      A + + +    +       
Sbjct: 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL 181

Query: 172 GVIHRDLKPENFLFAN---------------KKENSPLKA--IDFGLSIFFKPGERFSEI 214
              HRDL   N L                     +  L+   ID+ LS   + G     +
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IV 237

Query: 215 VGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
           V     M  ++   +   + DI+   ++          +   S       +   ++    
Sbjct: 238 VFCDVSMDEDLFTGDGDYQFDIYR--LMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT 295

Query: 275 DPWPNVSESAKSLVRQMLE 293
                 + + K + R++ E
Sbjct: 296 FKTKCNTPAMKQIKRKIQE 314

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 46.8 bits (112), Expect = 4e-06
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 7/88 (7%)

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEV 225
           H   +IHRD+K  N L     EN   K  DFG+S      ++    + + G+  Y+ PE 
Sbjct: 156 HTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEY 212

Query: 226 LKRNYGPE-IDIWSAGVILYILLCGVPP 252
             +    E  D++S GV+L+ +LC    
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 43/170 (25%), Positives = 66/170 (38%), Gaps = 49/170 (28%)

Query: 169 HKHGVIHRDLKPENFLFANKKENSPL------KAIDFGLSIFFKPGERF---SEIVGSPY 219
           H++  IHRD+K  N L         L      K  DFGL+   +   +    S IVG+  
Sbjct: 150 HENHHIHRDIKSANIL---------LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTA 200

Query: 220 YMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPF-----------WAE---SEQGVAQAI 265
           YMAPE L+    P+ DI+S GV+L  ++ G+P               E    E+      
Sbjct: 201 YMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT---- 256

Query: 266 LRGLIDFKRDPWPNVSESAKSLVRQM-------LEPDPKLRLTAKQVLEH 308
           +   ID        ++++  + V  M       L      R   K+V + 
Sbjct: 257 IEDYID------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191

 Score = 43.0 bits (102), Expect = 4e-05
 Identities = 3/26 (11%), Positives = 8/26 (30%)

Query: 321 PLGDVVRSRLKQFSMMNRFKRKALRV 346
                    +K+F    +  + A+  
Sbjct: 3   HALTGALGNMKKFQSSQKLAQAAMLF 28

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180

 Score = 39.6 bits (93), Expect = 5e-04
 Identities = 2/25 (8%), Positives = 10/25 (40%)

Query: 322 LGDVVRSRLKQFSMMNRFKRKALRV 346
           +   V + +K +   +  +   + +
Sbjct: 2   ISPNVLNNMKSYMKHSNIRNIIINI 26

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	347
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.49
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.13
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.89
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.86
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.86
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.56
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.49
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.37
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.36
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.17
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.1
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.06
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.94
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.86
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.77
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.76
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.68
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.66
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.54
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.52
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.51
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.5
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.36
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.19
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.88
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.68
3ls8_A	614	Phosphatidylinositol 3-kinase catalytic subunit ty	88.63
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	88.58
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.33

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.2e-63  Score=443.82  Aligned_cols=257  Identities=30%  Similarity=0.510  Sum_probs=234.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+++++.+ +||||+++++++++++.+|+
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEE
Confidence            46799999999999999999999999999999999877665666778899999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.......
T Consensus       110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTT
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCC
Confidence            99999999999999998899999999999999999999999999999999999999   678899999999998764332


Q ss_pred             ---cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          210 ---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       210 ---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                         .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+.......+......++    ..+++++.
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  262 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKAR  262 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTCCHHHH
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----cccCHHHH
Confidence               3455789999999999875 499999999999999999999999999999999988888765543    37899999


Q ss_pred             HHHHHhccCCCCCCCCHHH------HhcCcccccC
Q 019040          286 SLVRQMLEPDPKLRLTAKQ------VLEHPWLQNA  314 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~------ll~h~~~~~~  314 (347)
                      +||.+||+.||++|||+.|      +++||||+..
T Consensus       263 dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             HHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            9999999999999999987      5899999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.3e-63  Score=434.37  Aligned_cols=254  Identities=34%  Similarity=0.629  Sum_probs=214.3

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+++++.+ +||||+++++++.+++.+|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEE
Confidence            6899999999999999999999999999999999877666666678899999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      |||+ +++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|........
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence            9999 67999999998899999999999999999999999999999999999999   6778899999999987766655


Q ss_pred             ccccccCcccccccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      .....||+.|+|||++.+.  ++.++||||||+++|+|++|..||.+.+.....+.+......++    ..+++++.+||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  243 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLI  243 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence            5667899999999998754  46799999999999999999999999998888888887765443    46899999999


Q ss_pred             HHhccCCCCCCCCHHHHhcCccccc
Q 019040          289 RQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                      .+||+.||++|||+.|+++||||+.
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHccCChhHCcCHHHHHcCccccc
Confidence            9999999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.3e-62  Score=441.85  Aligned_cols=259  Identities=31%  Similarity=0.527  Sum_probs=230.1

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ....|++.+.||+|+||+||+|+++.+|+.||||++......   ..+.+.+|+.+++.+ +||||+++++++.+++.+|
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence            346799999999999999999999999999999999765432   345688999999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ||||||+||+|.+++.+ ..+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|......
T Consensus       148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCC
Confidence            99999999999998876 479999999999999999999999999999999999999   67889999999999876543


Q ss_pred             -CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          209 -ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       209 -~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                       ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+..... .....+..+++++.+
T Consensus       224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d  302 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG  302 (346)
T ss_dssp             SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHH
T ss_pred             CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHH
Confidence             34456789999999999874 599999999999999999999999999988888877766532 233345578999999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      ||.+||+.||++|||+.|+|+||||++...
T Consensus       303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          303 FLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            999999999999999999999999998753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.2e-62  Score=440.80  Aligned_cols=257  Identities=26%  Similarity=0.511  Sum_probs=223.3

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+++++.| +||||+++++++.+++.+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEE
Confidence            6899999999999999999999999999999999766443 33467899999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          131 MELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ||||+|++|.+++...+  .+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|+.....
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCC
Confidence            99999999999997653  47999999999999999999999999999999999999   67788999999999876433


Q ss_pred             Cc-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          209 ER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       209 ~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      .. ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+..+...   +.+..+++++.+
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~  255 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---PVSLHYSYDLRS  255 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCCTTSCHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---CCCccCCHHHHH
Confidence            22 244679999999999875 4999999999999999999999999999998888888776532   234578999999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ||.+||+.||++|||+.++|+||||++..
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            99999999999999999999999997643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.1e-61  Score=424.71  Aligned_cols=257  Identities=23%  Similarity=0.395  Sum_probs=219.9

Q ss_pred             ccce-eeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee----C
Q 019040           50 EDRY-LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----D  124 (347)
Q Consensus        50 ~~~y-~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~----~  124 (347)
                      .++| ++.+.||+|+||+||+|.++.+++.||+|++...... ......+.+|+++++.+ +||||+++++++.+    .
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCC
Confidence            3565 7888899999999999999999999999999765433 33467899999999999 99999999999875    3


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      +.+|+||||++|++|.+++.+...+++..+..++.||+.||.|||++|  |+||||||+|||++  +.++.+||+|||+|
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla  179 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCC
Confidence            568999999999999999999889999999999999999999999999  99999999999994  24678999999999


Q ss_pred             cccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccccCCCCCCCC
Q 019040          203 IFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       203 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      +... .......+||+.|+|||++.+.|+.++||||||+++|+|++|..||.+.... .....+..+..  +......++
T Consensus       180 ~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~  256 (290)
T 3fpq_A          180 TLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAI  256 (290)
T ss_dssp             GGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred             EeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCC
Confidence            8643 3344567899999999999888999999999999999999999999765543 44444444332  122234678


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                      +++.+||.+||+.||++|||+.++|+||||++
T Consensus       257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-60  Score=440.80  Aligned_cols=258  Identities=31%  Similarity=0.527  Sum_probs=230.1

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..+.|++++.||+|+||+||+|+++.+|+.||||++.....   ...+.+.+|+.+++.+ +||||+++++++.+.+.+|
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEE
Confidence            45679999999999999999999999999999999975532   3345688999999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ||||||+||+|.+++... .+++..+..++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|......
T Consensus       225 iVmEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EEEECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCC
Confidence            999999999999988654 69999999999999999999999999999999999999   67889999999999876443


Q ss_pred             -CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          209 -ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       209 -~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                       ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+.......+..... .....+..+++++.+
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d  379 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG  379 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHH
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHH
Confidence             34456789999999999874 599999999999999999999999999998888877766532 233445689999999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ||.+||+.||++|||+.++|+||||++..
T Consensus       380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          380 FLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            99999999999999999999999999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.7e-61  Score=427.66  Aligned_cols=256  Identities=29%  Similarity=0.490  Sum_probs=221.3

Q ss_pred             ccceeeeeeecccCCeEEEEEEEC---CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      .++|++++.||+|+||+||+|++.   .+++.||+|++.+...... ....+.+|+++++++ +||||+++++++.+++.
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEV-NHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCC-CCTTEECEEEEEEETTE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCE
Confidence            368999999999999999999884   4678999999976544332 234678899999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +|+||||++|++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+...
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC--
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceecc
Confidence            99999999999999999998899999999999999999999999999999999999999   678889999999998654


Q ss_pred             CC-CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          207 PG-ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       207 ~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      .. ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+.+....++    ..+++++
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~  253 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEA  253 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred             CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHH
Confidence            33 33456789999999999864 599999999999999999999999999999988888887755443    4789999


Q ss_pred             HHHHHHhccCCCCCCCC-----HHHHhcCcccccC
Q 019040          285 KSLVRQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~  314 (347)
                      .+||.+||+.||++|||     +.|+++||||+..
T Consensus       254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            99999999999999998     5799999999865

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-59  Score=422.05  Aligned_cols=256  Identities=25%  Similarity=0.347  Sum_probs=222.4

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      +.|++.+.||+|+||+||+|+++.+|+.||||++..+...        .+|+.+++.+ +||||+++++++.+++.+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l-~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGL-SSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence            5689999999999999999999999999999999765322        3599999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC-CEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS-PLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~-~~~l~Dfg~a~~~~~~~  209 (347)
                      |||++|++|.+++.+.+.+++..+..++.||+.||.|||++|||||||||+|||+   +.++ .+||+|||+|.......
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEEC----
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeEccCCC
Confidence            9999999999999988899999999999999999999999999999999999999   5555 69999999998764332


Q ss_pred             c------ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          210 R------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       210 ~------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .      ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+.......+......+. ..++.+++
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~  284 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAP  284 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCH
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCCH
Confidence            1      123579999999999875 499999999999999999999999988877777777766654322 23458899


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHH-------------hcCcccccCcCCCC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQV-------------LEHPWLQNAKKAPN  319 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~l-------------l~h~~~~~~~~~~~  319 (347)
                      ++.+||.+||+.||++|||+.|+             |+|||+...+++.+
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~  334 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG  334 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence            99999999999999999999997             68999998876543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-57  Score=420.79  Aligned_cols=263  Identities=29%  Similarity=0.420  Sum_probs=226.2

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee----
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----  123 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~----  123 (347)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.+ +||||+++++++..    
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhc-CCCCcceEeeeeeccccc
Confidence            45679999999999999999999999999999999996543 2334456788999999999 99999999998764    


Q ss_pred             --CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          124 --DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       124 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                        .+.+|+||||++ ++|.+++...+.+++..++.+++||+.||.|||++|||||||||+|||+   +.++.+||+|||+
T Consensus       129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGl  204 (398)
T 4b99_A          129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGM  204 (398)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecce
Confidence              368999999996 5899999888899999999999999999999999999999999999999   6788899999999


Q ss_pred             ccccCCC-----CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC
Q 019040          202 SIFFKPG-----ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR  274 (347)
Q Consensus       202 a~~~~~~-----~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  274 (347)
                      |......     ......+||+.|+|||++.+  .++.++||||+||++|+|++|..||.+.+..+.+..+.......+.
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9865332     23345789999999998754  4799999999999999999999999999998888888665443322


Q ss_pred             CC---------------------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          275 DP---------------------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       275 ~~---------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      ..                           ++.+++++.+||.+||+.||++|||+.++|+||||++...
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence            11                           2357899999999999999999999999999999998653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.9e-57  Score=401.86  Aligned_cols=253  Identities=28%  Similarity=0.444  Sum_probs=198.8

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC-----
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-----  125 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~-----  125 (347)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....  .....+.+.+|+++++.+ +||||+++++++.+.+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccc
Confidence            56999999999999999999999999999999986543  334456789999999999 9999999999987544     


Q ss_pred             -------eEEEEEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEE
Q 019040          126 -------AVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (347)
Q Consensus       126 -------~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~  195 (347)
                             .+|+|||||+|++|.+++.....   .+...++.++.||+.||.|||++||+||||||+|||+   +.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEE
Confidence                   47999999999999999987654   4556788999999999999999999999999999999   6778899


Q ss_pred             EEeeccccccCCCCc-------------ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-H
Q 019040          196 AIDFGLSIFFKPGER-------------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-G  260 (347)
Q Consensus       196 l~Dfg~a~~~~~~~~-------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~  260 (347)
                      |+|||+|+.......             ....+||+.|+|||++.+ .|+.++|||||||++|||++   ||...... .
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            999999987644321             133579999999999875 49999999999999999996   77543322 1


Q ss_pred             HHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          261 VAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ....+...  .+ ++.+...++...+||.+||++||++|||+.++|+||||++..
T Consensus       236 ~~~~~~~~--~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          236 TLTDVRNL--KF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHTT--CC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHhcC--CC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            22222221  11 112234566778999999999999999999999999998763

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.4e-56  Score=406.44  Aligned_cols=257  Identities=25%  Similarity=0.461  Sum_probs=211.2

Q ss_pred             CcccceeeeeeecccCCeEEEEEEEC---CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .+.++|++++.||+|+||+||+|+++   .+++.||+|.+...     ....++.+|+++++.+.+||||+++++++.+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            45689999999999999999999875   46788999988543     23456889999999997899999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +++|+||||++|++|.+++   +.+++..++.++.||+.||.|||++||+||||||+|||++  .+.+.+||+|||+|..
T Consensus        93 ~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQG  167 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEE
T ss_pred             CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcc
Confidence            9999999999999999988   3589999999999999999999999999999999999995  3346899999999975


Q ss_pred             cCCCC-----------------------------cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCC
Q 019040          205 FKPGE-----------------------------RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPF  253 (347)
Q Consensus       205 ~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf  253 (347)
                      .....                             .....+||+.|+|||++.+  .++.++||||+||++|+|++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            43221                             1234579999999998764  4899999999999999999999999


Q ss_pred             CCCC-HHHHHHHHHhccc--------------------------------------------------cccCCCCCCCCH
Q 019040          254 WAES-EQGVAQAILRGLI--------------------------------------------------DFKRDPWPNVSE  282 (347)
Q Consensus       254 ~~~~-~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~  282 (347)
                      .... ..+.+..+.....                                                  ....+.|..+++
T Consensus       248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~  327 (361)
T 4f9c_A          248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD  327 (361)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred             CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence            6544 3344433322110                                                  011123557899


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999875

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.2e-57  Score=400.78  Aligned_cols=258  Identities=25%  Similarity=0.409  Sum_probs=220.2

Q ss_pred             ccceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .++|.+.+.||+|+||+||+|++.     .++..||||++...   .....+.+.+|+++++++ +||||+++++++.++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeC
Confidence            468999999999999999999875     35788999998643   334567899999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCC
Q 019040          125 NAVHLVMELCEGGELFDRIVAR-------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~  191 (347)
                      +..++||||+++|+|.+++...             ..+++..+..++.||+.||.|||+++|+||||||+|||+   +.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCC
Confidence            9999999999999999999764             358999999999999999999999999999999999999   677


Q ss_pred             CCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 019040          192 SPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAIL  266 (347)
Q Consensus       192 ~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~  266 (347)
                      +.+||+|||+|+.......   .....||+.|+|||++. +.++.++||||||+++|||+| |..||.+.+..+....+.
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            8899999999986543322   22346899999999886 559999999999999999998 899999999988888887


Q ss_pred             hccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCC
Q 019040          267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                      .+..   .+.+..+|+++.+||..||+.||++|||+.++  |+||++.....+
T Consensus       245 ~~~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~~~~p  292 (299)
T 4asz_A          245 QGRV---LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAKASP  292 (299)
T ss_dssp             HTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHHHHSC
T ss_pred             cCCC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHHhcCC
Confidence            7643   22335789999999999999999999999999  678877654433

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.8e-56  Score=430.83  Aligned_cols=266  Identities=33%  Similarity=0.609  Sum_probs=240.9

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .+.+.++|++++.||+|+||+||+|+++.+|+.||+|++....   ....+.+.+|+++|+.+ +||||+++++++.+.+
T Consensus       152 ~~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~  227 (573)
T 3uto_A          152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDN  227 (573)
T ss_dssp             SSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSS
T ss_pred             CCcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECC
Confidence            3455689999999999999999999999999999999986542   33456789999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      .+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+|..
T Consensus       228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEE
T ss_pred             EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeE
Confidence            999999999999999998654 56999999999999999999999999999999999999953 2347899999999998


Q ss_pred             cCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          205 FKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       205 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      ..........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+......++...+..++++
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  386 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  386 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred             ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            877766677789999999999875 4999999999999999999999999999999999999988887777777889999


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      +.+||.+||+.||++|||+.++|+||||+....
T Consensus       387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            999999999999999999999999999987643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.4e-56  Score=399.84  Aligned_cols=259  Identities=23%  Similarity=0.363  Sum_probs=214.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .++|.+.+.||+|+||+||+|+++     .+++.||||++...   .....+.+.+|+++++++ +||||+++++++.+.
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTML-QHQHIVRFFGVCTEG  115 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC
Confidence            467899999999999999999875     36889999998643   344567899999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC
Q 019040          125 NAVHLVMELCEGGELFDRIVAR---------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~  189 (347)
                      +..++||||+++|+|.+++...               .++++..+..++.||+.||.|||+++||||||||+|||+   +
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---G  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---E
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---C
Confidence            9999999999999999999754               348999999999999999999999999999999999999   6


Q ss_pred             CCCCEEEEeeccccccCCCC---cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 019040          190 ENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQA  264 (347)
Q Consensus       190 ~~~~~~l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  264 (347)
                      +++.+||+|||+|+......   ......||+.|+|||++.+ .++.++||||||+++|||+| |+.||...+..+....
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            77889999999998654332   2234579999999998764 59999999999999999998 8999999998888888


Q ss_pred             HHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCC
Q 019040          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV  320 (347)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  320 (347)
                      +..+..   .+.+..+++++.+||.+||+.||++|||+.+++++  |+.....++.
T Consensus       273 i~~g~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~l~~~pp~  323 (329)
T 4aoj_A          273 ITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR--LQALAQAPPV  323 (329)
T ss_dssp             HHHTCC---CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH--HHHHHHSCC-
T ss_pred             HHcCCC---CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHHhhCCcc
Confidence            776542   23335789999999999999999999999999765  6655544443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.7e-56  Score=425.93  Aligned_cols=256  Identities=27%  Similarity=0.443  Sum_probs=220.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHH---HHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE---VAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e---i~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      -++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|   +.+++.+ +||||+++++++.+.+.
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCE
Confidence            3689999999999999999999999999999999987655444444444444   5566667 89999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|....
T Consensus       267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecC
Confidence            99999999999999999998899999999999999999999999999999999999999   778899999999998765


Q ss_pred             CCCcccccccCcccccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccccccCCCCCCCC
Q 019040          207 PGERFSEIVGSPYYMAPEVLK-R-NYGPEIDIWSAGVILYILLCGVPPFWAESE---QGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ... ....+||+.|+|||++. + .|+.++|||||||++|+|++|..||.+.+.   ......+....    ...+..++
T Consensus       344 ~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~----~~~p~~~S  418 (689)
T 3v5w_A          344 KKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA----VELPDSFS  418 (689)
T ss_dssp             SCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC----CCCCTTSC
T ss_pred             CCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC----CCCCccCC
Confidence            443 34568999999999985 3 599999999999999999999999976432   23344444433    33345789


Q ss_pred             HHHHHHHHHhccCCCCCCCC-----HHHHhcCcccccC
Q 019040          282 ESAKSLVRQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~  314 (347)
                      +++.+||.+||+.||.+|++     +.++++||||+..
T Consensus       419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            99999999999999999998     7999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-55  Score=390.40  Aligned_cols=254  Identities=22%  Similarity=0.357  Sum_probs=207.4

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ++.-.+++.+.+.||+|+||+||+|++..   .||||+++... ......+.+.+|+.+++++ +||||+++++++.. +
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-~  104 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK-D  104 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-S
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC-C
Confidence            45556789999999999999999998753   49999986433 2344567899999999999 99999999998765 5


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      .++|||||++||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||+   ++++.+||+|||+|..
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATV  181 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCcee
Confidence            688999999999999999765 569999999999999999999999999999999999999   6678899999999986


Q ss_pred             cCCC---CcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc--CC
Q 019040          205 FKPG---ERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK--RD  275 (347)
Q Consensus       205 ~~~~---~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~  275 (347)
                      ....   .......||+.|+|||++.    +.|+.++||||||+++|||+||..||.+.+.......+.......+  ..
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~  261 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK  261 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT
T ss_pred             cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence            5432   2234568999999999874    2388899999999999999999999988776554444433322221  23


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+..+++++.+||.+||+.||++|||+.+++++
T Consensus       262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            345789999999999999999999999987654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4e-55  Score=391.11  Aligned_cols=250  Identities=21%  Similarity=0.321  Sum_probs=215.2

Q ss_pred             ccceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .+.+++.+.||+|+||+||+|.+.     .+++.||||++....  .....+.+.+|+.+++++ +||||+++++++.++
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKD  101 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEEC
Confidence            467899999999999999999864     467889999986442  334457899999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC
Q 019040          125 NAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK  188 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~  188 (347)
                      +.+++||||+++|+|.+++...                ..+++..+..++.||+.||.|||+++||||||||+|||+   
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---
Confidence            9999999999999999999653                248899999999999999999999999999999999999   


Q ss_pred             CCCCCEEEEeeccccccCCCC---cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 019040          189 KENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQ  263 (347)
Q Consensus       189 ~~~~~~~l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~  263 (347)
                      ++++.+||+|||+|+......   ......||+.|+|||++. +.++.++||||||+++|||+| |..||.+.+..++..
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            677889999999998653322   234457999999999876 569999999999999999998 899999999888888


Q ss_pred             HHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+..+..   .+....+|+++.+|+..||+.||++|||+.+++++
T Consensus       259 ~i~~~~~---~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQV---LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCC---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8776542   23345789999999999999999999999999765

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.2e-54  Score=404.46  Aligned_cols=297  Identities=36%  Similarity=0.663  Sum_probs=261.0

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      +...+.++|++.+.||.|+||+||+|.++.+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++.+.
T Consensus         5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~   82 (444)
T 3soa_A            5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLL-KHPNIVRLHDSISEE   82 (444)
T ss_dssp             --CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECS
T ss_pred             ccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEEC
Confidence            4556778999999999999999999999999999999998765432 23456789999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +..++||||++|++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.+..++.+||+|||++..
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999999999999988899999999999999999999999999999999999997655778999999999987


Q ss_pred             cCCCC-cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          205 FKPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       205 ~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ..... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+..+...++.+.|..+++
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  242 (444)
T 3soa_A          163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP  242 (444)
T ss_dssp             CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence            65433 2345689999999999875 599999999999999999999999999999999999999988888888889999


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhhhhHHhhHHHHhh
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKA  343 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (347)
                      ++.+||.+||+.||++|||+.++|+||||+.................++.|...+.++...
T Consensus       243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~  303 (444)
T 3soa_A          243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAI  303 (444)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999987765555555667778888887777776653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.6e-54  Score=394.94  Aligned_cols=296  Identities=38%  Similarity=0.703  Sum_probs=257.9

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ....+.++|++.+.||.|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.+ +||||+++++++.+.
T Consensus        23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~  100 (362)
T 2bdw_A           23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEE  100 (362)
T ss_dssp             -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS
T ss_pred             CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC
Confidence            344567899999999999999999999999999999999976543 233456789999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +..|+||||++|++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++.+||+|||++..
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          101 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999999999998888899999999999999999999999999999999999997655667899999999987


Q ss_pred             cCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          205 FKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       205 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      ...........||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+..+...++...|..++++
T Consensus       181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (362)
T 2bdw_A          181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  260 (362)
T ss_dssp             CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred             ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            766555566789999999998875 5999999999999999999999999999988888888888877777777789999


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhhhhHHhhHHHHh
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRK  342 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (347)
                      +.+||.+||+.||++|||+.++|+||||+.............+...++.|...+.++..
T Consensus       261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  319 (362)
T 2bdw_A          261 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGA  319 (362)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999998765444444445566677777665555543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.2e-54  Score=408.65  Aligned_cols=300  Identities=39%  Similarity=0.692  Sum_probs=266.1

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .....+.++|++.+.||.|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+
T Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~   97 (484)
T 3nyv_A           19 HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFED   97 (484)
T ss_dssp             CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred             cCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence            34556788999999999999999999999999999999999876665566778899999999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      .+..++|+||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++..+.++.++|+|||++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999999999999999988889999999999999999999999999999999999999766677899999999998


Q ss_pred             ccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      ............||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+.......+..+...+..+.|..++++
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  257 (484)
T 3nyv_A          178 HFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES  257 (484)
T ss_dssp             HBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred             EcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence            87666665667899999999998888999999999999999999999999999999999999988877777777889999


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC---CCCCChHHHHHHhhhhHHhhHHHHhhh
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA---PNVPLGDVVRSRLKQFSMMNRFKRKAL  344 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (347)
                      +.+||.+||+.||.+|||+.++|+||||+.....   ...+.......++++|.....+++.++
T Consensus       258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l  321 (484)
T 3nyv_A          258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAAL  321 (484)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHH
Confidence            9999999999999999999999999999876532   233444556677777776666665543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.6e-54  Score=407.91  Aligned_cols=299  Identities=38%  Similarity=0.685  Sum_probs=261.2

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .....+.++|++++.||.|+||+||+|.++.+++.||+|++.+.... ......+.+|+.+++.+ +||||+++++++.+
T Consensus        15 ~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~   92 (486)
T 3mwu_A           15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKL-DHPNIMKLFEILED   92 (486)
T ss_dssp             TTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred             cccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhC-CCCCcCeEEEEEEc
Confidence            44556789999999999999999999999999999999998754332 23457789999999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      .+..++|+||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus        93 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            99999999999999999999888889999999999999999999999999999999999999776677889999999998


Q ss_pred             ccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      ............||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+..+....+..+...+..+.|..++++
T Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  252 (486)
T 3mwu_A          173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (486)
T ss_dssp             TBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred             ECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence            77666666667899999999999888999999999999999999999999999999999999888877777777889999


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCC----ChHHHHHHhhhhHHhhHHHHhhh
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP----LGDVVRSRLKQFSMMNRFKRKAL  344 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  344 (347)
                      +.+||.+||+.||.+|||+.++|+||||++.....+..    .......++++|...+.+++.++
T Consensus       253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  317 (486)
T 3mwu_A          253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAAL  317 (486)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999876544322    12345667778877777766654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.4e-53  Score=388.52  Aligned_cols=270  Identities=34%  Similarity=0.626  Sum_probs=240.6

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc---hhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      .....+.++|++.+.||.|+||+||+|.++.+|+.||+|++.+.....   ......+.+|+.+++.+ +||||++++++
T Consensus         5 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~   83 (361)
T 2yab_A            5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDV   83 (361)
T ss_dssp             CBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEE
T ss_pred             ccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEE
Confidence            345677889999999999999999999999999999999997654322   12457799999999999 89999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC-CCCEEEEee
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE-NSPLKAIDF  199 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~-~~~~~l~Df  199 (347)
                      +.+.+..++||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++. ...++|+||
T Consensus        84 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           84 YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999999999988888999999999999999999999999999999999999953221 227999999


Q ss_pred             ccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          200 GLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       200 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      |++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+......++...+.
T Consensus       164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (361)
T 2yab_A          164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS  243 (361)
T ss_dssp             SSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             CCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence            99988766655666789999999998864 59999999999999999999999999999999998888887777666667


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      .+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            899999999999999999999999999999999854

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.2e-54  Score=391.89  Aligned_cols=254  Identities=22%  Similarity=0.347  Sum_probs=212.1

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCC-----ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTR-----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      +.-.++|++.+.||+|+||+||+|.+..++     +.||||.+....  .....+.+.+|++++.++.+||||+++++++
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            344689999999999999999999987543     579999986543  3334567999999999996779999999998


Q ss_pred             ee-CCeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEE
Q 019040          122 ED-DNAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFL  184 (347)
Q Consensus       122 ~~-~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIl  184 (347)
                      .. ++.+++|||||++|+|.++++..                ..+++..+..++.||+.||.|||+++||||||||+|||
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL  217 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  217 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence            65 46789999999999999999763                23789999999999999999999999999999999999


Q ss_pred             eecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 019040          185 FANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQ  259 (347)
Q Consensus       185 i~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  259 (347)
                      +   ++++.+||+|||+|+.......   .....||+.|+|||++. +.|+.++||||||+++|||+| |..||.+....
T Consensus       218 l---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          218 L---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             E---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             e---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            9   6778899999999987644332   23457899999999886 459999999999999999998 89999887644


Q ss_pred             H-HHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          260 G-VAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       260 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      . ....+..+.   ..+....+++++.++|..||+.||++|||+.++++|
T Consensus       295 ~~~~~~i~~g~---~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          295 EEFCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCC---CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4 444444432   222334789999999999999999999999999988

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.4e-53  Score=406.88  Aligned_cols=299  Identities=34%  Similarity=0.630  Sum_probs=255.1

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccch----------hcHHHHHHHHHHHHhCCCCCc
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA----------VDIDDVRREVAIMKHLPKNSS  113 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~ei~~l~~l~~h~~  113 (347)
                      .....+.++|++++.||.|+||+||+|.++.+++.||+|++.+......          .....+.+|+.+++.+ +|||
T Consensus        29 ~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  107 (504)
T 3q5i_A           29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPN  107 (504)
T ss_dssp             EECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTT
T ss_pred             ccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCC
Confidence            3455678999999999999999999999999999999999976543221          3456789999999999 8999


Q ss_pred             eeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCC
Q 019040          114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSP  193 (347)
Q Consensus       114 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~  193 (347)
                      |+++++++.+.+..++||||++|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++....
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999999999999988888999999999999999999999999999999999999965544457


Q ss_pred             EEEEeeccccccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc
Q 019040          194 LKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (347)
Q Consensus       194 ~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  273 (347)
                      ++|+|||++.............||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+.......+..+...++
T Consensus       188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99999999988766666666789999999999888899999999999999999999999999999999999988877776


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCC---ChHHHHHHhhhhHHhhHHHHhh
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP---LGDVVRSRLKQFSMMNRFKRKA  343 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  343 (347)
                      .+.|..+++++.+||.+||+.||.+|||+.++|+||||++.....+..   .......+++.|.....++..+
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~  340 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAA  340 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHH
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHH
Confidence            666778999999999999999999999999999999999876543321   1234455666665555555543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-52  Score=383.44  Aligned_cols=292  Identities=40%  Similarity=0.719  Sum_probs=234.4

Q ss_pred             CCCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           43 GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        43 ~~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      ......+.++|++.+.||.|+||+||+|.+..+++.||+|++....     ..+.+.+|+.+++.+ +||||+++++++.
T Consensus        45 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~  118 (349)
T 2w4o_A           45 GSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRL-SHPNIIKLKEIFE  118 (349)
T ss_dssp             SSBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHC-CCTTBCCEEEEEE
T ss_pred             CcccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhC-CCCCCcceeeeEe
Confidence            3445667889999999999999999999999999999999986432     235678899999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          123 DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       123 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      ..+..++||||+++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||+++..+.++.++|+|||++
T Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             cCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence            99999999999999999999988888999999999999999999999999999999999999975556889999999999


Q ss_pred             cccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccccccCCCCCCC
Q 019040          203 IFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQG-VAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       203 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  280 (347)
                      .............||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ....+......+..+.+..+
T Consensus       199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  278 (349)
T 2w4o_A          199 KIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV  278 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred             cccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence            87655444455679999999998764 58999999999999999999999997766544 56666666666666666789


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhhhhHHhhHHHHh
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRK  342 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (347)
                      +.++.+||.+||+.||++|||+.++|+||||.....  +.........++++|...+.++..
T Consensus       279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  338 (349)
T 2w4o_A          279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA--NFVHMDTAQKKLQEFNARRKLKAA  338 (349)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC--CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc--chhhhcchHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999987643  333345666777888776666655

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.9e-53  Score=405.29  Aligned_cols=299  Identities=37%  Similarity=0.663  Sum_probs=255.9

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .....+.++|++++.||+|+||+||+|+++.++..||+|++.+..... .....+.+|+.+++.+ +||||+++++++.+
T Consensus        30 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  107 (494)
T 3lij_A           30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLL-DHPNIMKLYDFFED  107 (494)
T ss_dssp             CCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred             cCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe
Confidence            345567789999999999999999999999999999999997654322 2356788999999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      .+..++||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus       108 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          108 KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            99999999999999999999888889999999999999999999999999999999999999766667789999999998


Q ss_pred             ccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      ............||+.|+|||++.+.++.++||||||+++|+|++|..||.+.........+..+...+..+.|..+++.
T Consensus       188 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  267 (494)
T 3lij_A          188 VFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG  267 (494)
T ss_dssp             ECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred             ECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence            87766666667899999999998888999999999999999999999999999999999999998888887778899999


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC----CCCCChHHHHHHhhhhHHhhHHHHhhh
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA----PNVPLGDVVRSRLKQFSMMNRFKRKAL  344 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (347)
                      +.+||.+||+.||.+|||+.++|+||||+.....    ............++.|+....+++.++
T Consensus       268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l  332 (494)
T 3lij_A          268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAAL  332 (494)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHH
T ss_pred             HHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHH
Confidence            9999999999999999999999999999875321    222333445666777766666665543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2e-52  Score=378.84  Aligned_cols=259  Identities=35%  Similarity=0.610  Sum_probs=233.1

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...++|++++.||.|+||.||+|.+..+|+.||+|++..... .......+.+|+++++.+ +||||+++++++...+..
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEE
Confidence            345789999999999999999999999999999999976543 334567788999999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSS
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCC
Confidence            9999999999999999888889999999999999999999999999999999999999   6778899999999987766


Q ss_pred             CCcccccccCcccccccccccc-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLKRN-Y-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      ........||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+..+....+    ..+++++.
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  242 (328)
T 3fe3_A          167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCE  242 (328)
T ss_dssp             SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred             CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHH
Confidence            6666677899999999988644 4 4789999999999999999999999998888888887765443    26799999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +||.+||+.||.+|||+.++++||||+...
T Consensus       243 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999999999999999999998654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-53  Score=385.53  Aligned_cols=264  Identities=29%  Similarity=0.626  Sum_probs=236.9

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .+.++|++.+.||.|+||+||+|.++.+++.||+|++...    ......+.+|+.+++.+ +||||+++++++.+.+..
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIA-RHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEE
Confidence            4678999999999999999999999999999999998643    23446688999999999 999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      ++||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+ .++.++|+|||++....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECC
Confidence            99999999999999997653 69999999999999999999999999999999999999531 26789999999998876


Q ss_pred             CCCcccccccCcccccccccccc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          207 PGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      .........+|+.|+|||++.+. ++.++||||||+++|+|++|..||...........+......++...+..++.++.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            66665667899999999988654 78999999999999999999999999999888888888877766666678999999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      ++|.+||+.||.+|||+.++|+||||++....
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  267 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHPWLKQKIER  267 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred             HHHHHHcCCChhHCcCHHHHhcChhhccCccc
Confidence            99999999999999999999999999887544

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-52  Score=383.36  Aligned_cols=258  Identities=29%  Similarity=0.525  Sum_probs=228.9

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++++.||.|+||+||+|+++.+++.||+|++.+...........+.+|..++..+.+||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            47899999999999999999999999999999999876555556677889999999998789999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-C
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-G  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~  208 (347)
                      ||||++|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC--
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccCC
Confidence            99999999999999988889999999999999999999999999999999999999   6778899999999986432 2


Q ss_pred             CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+......++    ..++.++.++
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  254 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATGI  254 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence            33445689999999998864 499999999999999999999999999999999988888765554    3679999999


Q ss_pred             HHHhccCCCCCCCCH------HHHhcCcccccC
Q 019040          288 VRQMLEPDPKLRLTA------KQVLEHPWLQNA  314 (347)
Q Consensus       288 i~~~l~~dp~~Rps~------~~ll~h~~~~~~  314 (347)
                      |.+||+.||.+||++      .++++||||+..
T Consensus       255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            999999999999999      899999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.3e-52  Score=376.36  Aligned_cols=257  Identities=31%  Similarity=0.538  Sum_probs=230.9

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++++.||.|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+..|+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999876544455667889999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC-CC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~-~~  208 (347)
                      ||||++|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ..
T Consensus        83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccCC
Confidence            99999999999999888889999999999999999999999999999999999999   677899999999998643 23


Q ss_pred             CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+......++    ..+++++.++
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  235 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSL  235 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence            34456689999999999864 589999999999999999999999999988888888877655443    3689999999


Q ss_pred             HHHhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          288 VRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       288 i~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      |.+||+.||++||     ++.++++||||+..
T Consensus       236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            9999999999999     99999999999754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-52  Score=384.15  Aligned_cols=294  Identities=35%  Similarity=0.627  Sum_probs=240.0

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc--hhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT--AVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      ...+.++|++.+.||+|+||+||+|.++.+++.||+|++.......  ....+.+.+|+.+++.+ +||||+++++++.+
T Consensus        19 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~   97 (351)
T 3c0i_A           19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSS   97 (351)
T ss_dssp             -CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE
T ss_pred             CCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence            3456789999999999999999999999999999999987543222  22457799999999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          124 DNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                      .+..|+||||++|++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++....++|+||
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence            99999999999999998887543    24899999999999999999999999999999999999976556667999999


Q ss_pred             ccccccCCCCc-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC
Q 019040          200 GLSIFFKPGER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       200 g~a~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  277 (347)
                      |++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.. ......+...........+
T Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~  256 (351)
T 3c0i_A          178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQW  256 (351)
T ss_dssp             TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHH
T ss_pred             cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccc
Confidence            99987654432 345679999999998864 48999999999999999999999998754 4566666666555554455


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhhhhHHhhHHHH
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKR  341 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (347)
                      ..++.++.+||.+||+.||++|||+.++|+||||+...............+.++.|...+.++.
T Consensus       257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  320 (351)
T 3c0i_A          257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKG  320 (351)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC---
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHH
Confidence            6789999999999999999999999999999999876532222222334455666654444443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.5e-52  Score=370.89  Aligned_cols=269  Identities=44%  Similarity=0.813  Sum_probs=242.4

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ...+.++|++.+.||+|+||.||+|.+..++..||+|++.....   ...+.+.+|+++++.+ +||||+++++++.+.+
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   79 (277)
T 3f3z_A            4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNT   79 (277)
T ss_dssp             --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred             hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence            34577899999999999999999999999999999999875432   3457789999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ..++||||+++++|.+++.....+++..++.++.|++.||.|||++||+|+||||+||++..++.++.++|+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            99999999999999999988888999999999999999999999999999999999999976667788999999999887


Q ss_pred             CCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          206 KPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      ..........+|+.|+|||.+.+.++.++||||||+++++|++|..||...........+......++...+..+++.+.
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          160 KPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             CTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             cCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence            66666666789999999999888899999999999999999999999999998888888888776666555567899999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcCcccccCcCCC
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  318 (347)
                      ++|.+||+.||++|||+.++|+||||++....+
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  272 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS  272 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence            999999999999999999999999998765443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-51  Score=366.58  Aligned_cols=269  Identities=41%  Similarity=0.759  Sum_probs=244.0

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ..+.++|++.+.||.|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.+ +||||+++++++...+.
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   79 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESF   79 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCE
Confidence            3567899999999999999999999999999999999876543 334457788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .++|+||+++++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++..+.++|+|||.+....
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999999999999999888889999999999999999999999999999999999999766666779999999998776


Q ss_pred             CCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          207 PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      .........+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+......++.+.+..+++++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T 3kk8_A          160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  239 (284)
T ss_dssp             SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence            6666566789999999998764 489999999999999999999999999999999999888888888777788999999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      ++|..||+.||++|||+.++++||||++....
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          240 SLIDSMLTVNPKKRITADQALKVPWICNRERV  271 (284)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred             HHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence            99999999999999999999999999887644

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-52  Score=377.20  Aligned_cols=270  Identities=36%  Similarity=0.652  Sum_probs=237.7

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc---hhcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      ....+.++|++.+.||.|+||.||+|.++.+++.||+|++.......   ......+.+|+.+++.+ +||||+++++++
T Consensus         5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~   83 (326)
T 2y0a_A            5 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVY   83 (326)
T ss_dssp             BCSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             ccCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEE
Confidence            44567789999999999999999999999999999999997654322   22467899999999999 899999999999


Q ss_pred             eeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC-CCCCEEEEeec
Q 019040          122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFG  200 (347)
Q Consensus       122 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~-~~~~~~l~Dfg  200 (347)
                      ...+..++||||+++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++ ....++|+|||
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           84 ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999999999998888899999999999999999999999999999999999995322 22379999999


Q ss_pred             cccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+......++...+..
T Consensus       164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          164 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             TCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             CCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence            998876555556678999999999886 4589999999999999999999999999988888888777666555545567


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ++..+.+||.+||+.||++|||+.++|+||||+...
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            899999999999999999999999999999998653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-51  Score=366.03  Aligned_cols=267  Identities=36%  Similarity=0.632  Sum_probs=227.7

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .....+.++|.+.+.||.|+||.||+|.+..++..+|+|++....  .....+.+.+|+++++.+ +||||+++++++.+
T Consensus        15 ~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~   91 (285)
T 3is5_A           15 YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFED   91 (285)
T ss_dssp             EESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC
T ss_pred             CCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhC-CCchHHhHHHheec
Confidence            344567789999999999999999999999999999999987654  333467899999999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          124 DNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                      .+..++||||+++++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++.++|+||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            99999999999999999988543    57999999999999999999999999999999999999976666788999999


Q ss_pred             ccccccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          200 GLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       200 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      |++.............+++.|+|||.+.+.++.++||||||+++|+|++|..||..................+... ...
T Consensus       172 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  250 (285)
T 3is5_A          172 GLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRP  250 (285)
T ss_dssp             CCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CC
T ss_pred             ecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCc
Confidence            9998766555556668999999999988889999999999999999999999999988877776666554443322 235


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +++++.++|.+||+.||++|||+.++|+||||+++
T Consensus       251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence            78999999999999999999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-51  Score=378.54  Aligned_cols=273  Identities=33%  Similarity=0.608  Sum_probs=239.6

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ....+.++|++.+.||.|+||.||+|.++.+++.||+|++....   ......+.+|+.+++.+ +||||+++++++.+.
T Consensus        45 ~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~  120 (387)
T 1kob_A           45 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDK  120 (387)
T ss_dssp             BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECS
T ss_pred             cCCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeC
Confidence            34456789999999999999999999999999999999986542   23345788999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      +..++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. +..+.++|+|||++.
T Consensus       121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLAT  199 (387)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccce
Confidence            99999999999999999987653 6999999999999999999999999999999999999953 235679999999998


Q ss_pred             ccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+......++...+..+++
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  279 (387)
T 1kob_A          200 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP  279 (387)
T ss_dssp             ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred             ecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence            8765555555679999999998864 489999999999999999999999999998888888888777777777778999


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL  322 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~  322 (347)
                      ++.+||..||+.||++|||+.++|+||||+.........+
T Consensus       280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~  319 (387)
T 1kob_A          280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI  319 (387)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCCCCB
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhhCccccCCcccccccC
Confidence            9999999999999999999999999999987654433333

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.6e-51  Score=379.57  Aligned_cols=259  Identities=27%  Similarity=0.492  Sum_probs=223.9

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      -.++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|..++..+.+||||+++++++.+.+..|
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            35789999999999999999999999999999999987766555566778899999988778999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc-CC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KP  207 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~-~~  207 (347)
                      +||||++|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++... ..
T Consensus       130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccC
Confidence            999999999999999988889999999999999999999999999999999999999   67889999999999863 33


Q ss_pred             CCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhccccccCCCC
Q 019040          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE---------SEQGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~  277 (347)
                      ........||+.|+|||++.+ .++.++||||||+++|+|++|..||...         ......+.+......++    
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----  282 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----  282 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----
Confidence            344556789999999998764 5999999999999999999999999643         22334455555444333    


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCH------HHHhcCcccccC
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTA------KQVLEHPWLQNA  314 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~h~~~~~~  314 (347)
                      ..++.++.+||.+||+.||.+||++      .++++||||+..
T Consensus       283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            3689999999999999999999985      799999999865

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-51  Score=368.85  Aligned_cols=255  Identities=27%  Similarity=0.523  Sum_probs=230.3

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++.+.||.|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+..|+
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEE
Confidence            47899999999999999999999999999999999876544445667888999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus        84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC-
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCCc-
Confidence            99999999999999988889999999999999999999999999999999999999   67789999999999875432 


Q ss_pred             cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                       .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+......++    ..++.++.++|
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li  234 (318)
T 1fot_A          160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLL  234 (318)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHH
Confidence             344579999999998764 589999999999999999999999999998888888887755443    36799999999


Q ss_pred             HHhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          289 RQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       289 ~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      .+||+.||.+||     ++.++++||||+..
T Consensus       235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            999999999999     89999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-51  Score=374.90  Aligned_cols=259  Identities=24%  Similarity=0.440  Sum_probs=230.9

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|.+.+.||.|+||+||+|+++.+|+.||+|++.+...........+..|..++..+.+||||+++++++.+.+..|
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            35789999999999999999999999999999999987654444556778889999987768999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-  207 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-  207 (347)
                      +||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++..... 
T Consensus        95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcccC
Confidence            999999999999999988889999999999999999999999999999999999999   6778899999999986432 


Q ss_pred             CCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      ........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+......++    ..+++++.+
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  247 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKD  247 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHH
Confidence            233455689999999998764 589999999999999999999999999998888888877654443    368999999


Q ss_pred             HHHHhccCCCCCCCCHH-HHhcCcccccC
Q 019040          287 LVRQMLEPDPKLRLTAK-QVLEHPWLQNA  314 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~-~ll~h~~~~~~  314 (347)
                      ||.+||+.||++||++. ++++||||+..
T Consensus       248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          248 LLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            99999999999999998 99999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.4e-51  Score=374.15  Aligned_cols=258  Identities=26%  Similarity=0.442  Sum_probs=231.3

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++++.||.|+||+||+|+++.+++.||+|++.+...........+.+|..++..+.+||+|+++++++.+.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            47899999999999999999999999999999999876554455667888999999988789999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-C
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-G  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~  208 (347)
                      ||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++..... .
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccccCC
Confidence            99999999999999888889999999999999999999999999999999999999   6778999999999986432 3


Q ss_pred             CcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          209 ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      .......||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+.....+.+......++    ..++.++.+|
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  251 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI  251 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            3345568999999999876 4589999999999999999999999999998888888887765543    3689999999


Q ss_pred             HHHhccCCCCCCCC-----HHHHhcCcccccC
Q 019040          288 VRQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       288 i~~~l~~dp~~Rps-----~~~ll~h~~~~~~  314 (347)
                      |.+||+.||.+||+     +.++++||||+..
T Consensus       252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            99999999999994     6999999999753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-50  Score=370.09  Aligned_cols=258  Identities=28%  Similarity=0.494  Sum_probs=226.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..++..+.+||||+++++++.+.+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            47899999999999999999999999999999999877666666677899999999988789999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC-CC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~-~~  208 (347)
                      ||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.... ..
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccccCCC
Confidence            99999999999999888889999999999999999999999999999999999999   677889999999998643 23


Q ss_pred             CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhccccccCCCCC
Q 019040          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE---------SEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...         ......+.+......++    .
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~  240 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----R  240 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----T
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----C
Confidence            34455689999999998764 5899999999999999999999999652         23344455555443332    3


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCH------HHHhcCcccccC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTA------KQVLEHPWLQNA  314 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~------~~ll~h~~~~~~  314 (347)
                      .++.++.++|.+||+.||.+||++      .++++||||+..
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            689999999999999999999995      899999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.5e-50  Score=361.93  Aligned_cols=260  Identities=29%  Similarity=0.496  Sum_probs=225.5

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ....++|++.+.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.+++.+ +||||+++++++...+.
T Consensus        16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~   91 (297)
T 3fxz_A           16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMREN-KNPNIVNYLDSYLVGDE   91 (297)
T ss_dssp             SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred             CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCE
Confidence            345689999999999999999999999999999999986543   23346788999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .++||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++....
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecC
Confidence            99999999999999998765 68999999999999999999999999999999999999   677889999999988765


Q ss_pred             CCC-cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          207 PGE-RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       207 ~~~-~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      ... ......||+.|+|||.+. ..++.++||||||+++|+|++|..||...+.......+...... .......++..+
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  246 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIF  246 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSCGGGSCHHH
T ss_pred             CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCccccCHHH
Confidence            433 234567999999999876 45899999999999999999999999888877665555443221 122234689999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .++|.+||+.||++|||+.++++||||+...
T Consensus       247 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            9999999999999999999999999999775

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.1e-50  Score=370.53  Aligned_cols=257  Identities=28%  Similarity=0.512  Sum_probs=232.2

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...++|++++.||.|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+..
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEE
Confidence            3457999999999999999999999999999999999876555555677899999999999 999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.....
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccC
Confidence            9999999999999999988889999999999999999999999999999999999999   6778899999999987543


Q ss_pred             CCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      .  .....||+.|+|||++. ..++.++||||||+++|+|++|..||...+.......+..+...++    ..++.++.+
T Consensus       194 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~  267 (350)
T 1rdq_E          194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKD  267 (350)
T ss_dssp             C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHH
T ss_pred             C--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHH
Confidence            3  34467999999999876 4589999999999999999999999999998888888887755443    368999999


Q ss_pred             HHHHhccCCCCCCCC-----HHHHhcCcccccC
Q 019040          287 LVRQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       287 li~~~l~~dp~~Rps-----~~~ll~h~~~~~~  314 (347)
                      +|.+||+.||.+||+     +.++++||||+..
T Consensus       268 li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            999999999999998     9999999999763

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.2e-51  Score=373.14  Aligned_cols=269  Identities=36%  Similarity=0.626  Sum_probs=232.3

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ..+.++|++.+.||.|+||.||+|.++.+++.||+|++.+...       ...+|++++..+.+||||+++++++.+.+.
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   90 (342)
T 2qr7_A           18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKY   90 (342)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence            3567899999999999999999999999999999999965432       134588888888789999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC-CCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK-KENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~-~~~~~~~l~Dfg~a~~~  205 (347)
                      .|+||||++|++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||++...
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999999999999988889999999999999999999999999999999999998532 22346999999999865


Q ss_pred             CCC-CcccccccCcccccccccccc-CCCchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhccccccCCCCCCC
Q 019040          206 KPG-ERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       206 ~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~---~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      ... .......+|+.|+|||++.+. ++.++||||||+++|+|++|..||..   ....+....+..+...+....|..+
T Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence            443 233456789999999998654 88999999999999999999999976   4556777788877777777777889


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCC
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL  322 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~  322 (347)
                      ++++.+||.+||+.||++|||+.++++||||.+....+...+
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~~~~~  292 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQL  292 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGSCCSCC
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccccccccC
Confidence            999999999999999999999999999999987655554444

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.7e-51  Score=368.11  Aligned_cols=271  Identities=34%  Similarity=0.631  Sum_probs=236.6

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc---hhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      .....+.++|++.+.||.|+||.||+|.++.+|+.||+|++.......   ....+.+.+|+.+++.+ .||||++++++
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   83 (321)
T 2a2a_A            5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDV   83 (321)
T ss_dssp             CBCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred             ccchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEE
Confidence            345567889999999999999999999999999999999997654322   12467799999999999 89999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC-CCCEEEEee
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE-NSPLKAIDF  199 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~-~~~~~l~Df  199 (347)
                      +.+.+..++||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||+++.++. ...++|+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           84 YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999999999988888999999999999999999999999999999999999953221 117999999


Q ss_pred             ccccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          200 GLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       200 g~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      |++.............||+.|+|||.+. ..++.++||||||+++|+|++|..||.+.........+......++...+.
T Consensus       164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (321)
T 2a2a_A          164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS  243 (321)
T ss_dssp             TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             ccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence            9998776655556668999999999876 458999999999999999999999999998888888887766555444445


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .++..+.++|.+||+.||++|||+.++++||||+...
T Consensus       244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            7899999999999999999999999999999998653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=373.40  Aligned_cols=260  Identities=26%  Similarity=0.504  Sum_probs=229.6

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ....++|++++.||.|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCE
Confidence            34458999999999999999999999999999999999876655556678899999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .|+||||+.|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeecc
Confidence            99999999999999999988889999999999999999999999999999999999999   678899999999998876


Q ss_pred             CCCcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccccccCCCCCC
Q 019040          207 PGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAES---EQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      .........||+.|+|||++.    ..++.++||||||+++|+|++|..||....   .......+......+    ...
T Consensus       167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----p~~  242 (384)
T 4fr4_A          167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY----PSA  242 (384)
T ss_dssp             TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCC----CTT
T ss_pred             CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCC----CCc
Confidence            666667778999999999875    248999999999999999999999997543   334444444443333    246


Q ss_pred             CCHHHHHHHHHhccCCCCCCCC-HHHHhcCcccccC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLT-AKQVLEHPWLQNA  314 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps-~~~ll~h~~~~~~  314 (347)
                      ++.++.+||.+||+.||.+||+ +.++++||||+..
T Consensus       243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            7999999999999999999998 9999999999764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.8e-51  Score=369.63  Aligned_cols=271  Identities=35%  Similarity=0.631  Sum_probs=213.8

Q ss_pred             cccceeee---eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           49 IEDRYLVD---RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        49 ~~~~y~i~---~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      +.++|++.   +.||+|+||.||+|.++.+++.||+|++...      ....+.+|+.+++.+.+||||+++++++.+.+
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            44677775   7899999999999999999999999998543      34567889999999966999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ..++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++....++|+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            99999999999999999999888999999999999999999999999999999999999976555558999999999865


Q ss_pred             CCCC-cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhccccccCCC
Q 019040          206 KPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGVAQAILRGLIDFKRDP  276 (347)
Q Consensus       206 ~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~  276 (347)
                      .... ......+|+.|+|||.+.+ .++.++||||||+++|+|++|..||.....       .+....+..+...+....
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (325)
T 3kn6_A          160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA  239 (325)
T ss_dssp             CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred             CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence            4332 2345578999999999864 489999999999999999999999976543       456666666665555555


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHH
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDV  325 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~  325 (347)
                      +..+++++.+||.+||+.||++|||+.++++||||+.....+..++..+
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~~~~  288 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTP  288 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCCSHH
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCCCCC
Confidence            5678999999999999999999999999999999998876666665444

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.7e-52  Score=375.89  Aligned_cols=257  Identities=34%  Similarity=0.588  Sum_probs=223.3

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++.+.||.|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++...+..+
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEE
Confidence            447899999999999999999999999999999999765444444556789999999999 8999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||||+ +++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++......
T Consensus        86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTTS
T ss_pred             EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceeccCC
Confidence            999999 67999999888889999999999999999999999999999999999999   67788999999999887666


Q ss_pred             CcccccccCcccccccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          209 ERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      .......||+.|+|||.+.+.  .+.++||||||+++|+|++|..||...........+...    .......+++++.+
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~----~~~~p~~~s~~~~~  237 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC----VYVMPDFLSPGAQS  237 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS----CCCCCTTSCHHHHH
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC----CCCCcccCCHHHHH
Confidence            666667899999999998654  378999999999999999999999776543322222221    12223468999999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ||.+||+.||.+|||+.++++||||+..
T Consensus       238 li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          238 LIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999999764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.3e-51  Score=380.05  Aligned_cols=261  Identities=32%  Similarity=0.474  Sum_probs=230.6

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEE
Confidence            357899999999999999999999999999999999765443334445688899999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       146 lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccC
Confidence            999999999999988764 69999999999999999999999999999999999999   67889999999999876544


Q ss_pred             Cc--ccccccCcccccccccccc-----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          209 ER--FSEIVGSPYYMAPEVLKRN-----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       209 ~~--~~~~~~~~~y~aPE~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ..  .....||+.|+|||++.+.     ++.++||||||+++|+|++|..||.+.+.......+.........+.+..++
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  301 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  301 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence            32  2356899999999987532     7889999999999999999999999999988888888766555555556899


Q ss_pred             HHHHHHHHHhccCCCCC--CCCHHHHhcCcccccC
Q 019040          282 ESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA  314 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~  314 (347)
                      .++.+||.+||+.+|.+  ||++.++++||||+..
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            99999999999999998  9999999999999875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2e-50  Score=362.85  Aligned_cols=268  Identities=27%  Similarity=0.437  Sum_probs=219.6

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEecccccc--chhcHHHHHHHHHHHHhCC--CCCceeEeeeEE
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMKHLP--KNSSIVSLKEAC  121 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~ei~~l~~l~--~h~~i~~~~~~~  121 (347)
                      +..+.++|++.+.||.|+||+||+|++..+++.||+|++......  .......+.+|+.+++.+.  .||||+++++++
T Consensus         4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~   83 (308)
T 3g33_A            4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC   83 (308)
T ss_dssp             ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence            345678999999999999999999999999999999998754321  1122345677888877773  499999999999


Q ss_pred             eeCC-----eEEEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCE
Q 019040          122 EDDN-----AVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (347)
Q Consensus       122 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~  194 (347)
                      ....     ..++++||+.+ +|.+++.....  +++..++.++.||+.||.|||++||+||||||+||++   +.++.+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~  159 (308)
T 3g33_A           84 ATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTV  159 (308)
T ss_dssp             EECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCE
T ss_pred             eccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCE
Confidence            8765     58999999965 99999987654  9999999999999999999999999999999999999   677889


Q ss_pred             EEEeeccccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc
Q 019040          195 KAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (347)
Q Consensus       195 ~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  273 (347)
                      +|+|||++.............+|+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+.......+
T Consensus       160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999998776665666678999999999875 5599999999999999999999999999998888877766543333


Q ss_pred             CCCC-----------------------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          274 RDPW-----------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       274 ~~~~-----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      ...|                       +.+++++.+||.+||+.||++|||+.++|+||||++....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~~  306 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGN  306 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC------
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCCC
Confidence            2222                       3578999999999999999999999999999999986543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-50  Score=358.49  Aligned_cols=267  Identities=31%  Similarity=0.561  Sum_probs=230.7

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEE
Confidence            347899999999999999999999999999999999766554555567899999999999 8999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||||+++++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||++......
T Consensus        86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC---
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCCcc
Confidence            999999999999999888889999999999999999999999999999999999999   67788999999998654433


Q ss_pred             CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                       ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+......++    ..++..+.+|
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l  237 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDL  237 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHH
T ss_pred             -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHH
Confidence             2344578999999998764 488999999999999999999999999888887777766554433    3678999999


Q ss_pred             HHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChH
Q 019040          288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD  324 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~  324 (347)
                      |.+||+.||.+|||+.++++||||+.....+......
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~~  274 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNK  274 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCCCC---
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCccCccccccc
Confidence            9999999999999999999999999887666554433

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.3e-50  Score=375.09  Aligned_cols=270  Identities=37%  Similarity=0.679  Sum_probs=221.8

Q ss_pred             CCCCcccceeee-eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           45 PKENIEDRYLVD-RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        45 ~~~~~~~~y~i~-~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      ....+.++|.+. +.||.|+||+||+|.++.+++.||||++...        ..+.+|+.++.++.+|+||+++++++..
T Consensus        55 ~~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~  126 (400)
T 1nxk_A           55 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN  126 (400)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             CCCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence            344556778877 6899999999999999999999999998532        4567899988666699999999999876


Q ss_pred             ----CCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          124 ----DNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       124 ----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                          .+.+|+||||++|++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.++.+||+
T Consensus       127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEE
Confidence                678999999999999999998753  49999999999999999999999999999999999999754457899999


Q ss_pred             eeccccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccccc
Q 019040          198 DFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ----GVAQAILRGLIDF  272 (347)
Q Consensus       198 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~  272 (347)
                      |||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||......    .....+..+...+
T Consensus       207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  286 (400)
T ss_dssp             CCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred             ecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence            999998766555555668899999999986 45999999999999999999999999766532    2445566666666


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCC
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL  322 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~  322 (347)
                      +...+..++.++.+||.+||+.||++|||+.++++||||......+...+
T Consensus       287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~  336 (400)
T 1nxk_A          287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL  336 (400)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCCCBC
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCCCcc
Confidence            66677789999999999999999999999999999999988765554433

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.2e-50  Score=357.99  Aligned_cols=259  Identities=27%  Similarity=0.495  Sum_probs=217.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||+|+||+||+|.++.+++.||+|++..... .......+.+|+.+++.+ +||||+++++++.+++..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEE
Confidence            589999999999999999999999999999999975542 333456788999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-
Q 019040          131 MELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-  208 (347)
                      |||+++ ++.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...... 
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCC
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCcc
Confidence            999976 66666655 5679999999999999999999999999999999999999   67788999999999876433 


Q ss_pred             CcccccccCccccccccccc-c-CCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhccccccCCC---------
Q 019040          209 ERFSEIVGSPYYMAPEVLKR-N-YGPEIDIWSAGVILYILLCGVPP-FWAESEQGVAQAILRGLIDFKRDP---------  276 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~---------  276 (347)
                      .......+|+.|+|||++.+ . ++.++||||||+++|+|++|..| |...+.......+...........         
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            23345578999999998753 3 79999999999999999987776 566666666666655433222111         


Q ss_pred             ----------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          277 ----------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       277 ----------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                      .+.++.++.+||.+||+.||++|||+.++|+||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                            135789999999999999999999999999999999763

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.1e-50  Score=360.10  Aligned_cols=268  Identities=40%  Similarity=0.726  Sum_probs=235.1

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ...+.++|.+.+.||.|+||.||+|++..+|+.||+|++.....   .....+.+|+.+++.+ +||||+++++++.+.+
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   79 (304)
T 2jam_A            4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKI-KHENIVTLEDIYESTT   79 (304)
T ss_dssp             --CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred             ccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhC-CCCCeeehhhhcccCC
Confidence            44677899999999999999999999999999999999875432   2335688999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ..++|+||+++++|.+++...+.+++..+..++.||+.||.|||+.||+|+||||+||++..++.++.++|+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            99999999999999999988888999999999999999999999999999999999999976567788999999998764


Q ss_pred             CCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          206 KPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      ... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+..+...++.+.+..++.++
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          160 QNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             CCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             CCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence            332 2334568999999998864 48899999999999999999999999999888888888887777666677899999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCcCCC
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  318 (347)
                      .++|..||+.||++|||+.++++||||+......
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  272 (304)
T 2jam_A          239 KDFICHLLEKDPNERYTCEKALSHPWIDGNTALH  272 (304)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSCC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCccccCCCccc
Confidence            9999999999999999999999999998875443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-50  Score=367.25  Aligned_cols=271  Identities=30%  Similarity=0.538  Sum_probs=236.4

Q ss_pred             CCCCCcccceeee-eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           44 VPKENIEDRYLVD-RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        44 ~~~~~~~~~y~i~-~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      ...+.+.++|.+. +.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.+.+||||+++++++.
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            4556678899998 899999999999999999999999999876532 23346778999999999978899999999999


Q ss_pred             eCCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          123 DDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       123 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                      ..+..++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++....++.++|+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            999999999999999999988553  569999999999999999999999999999999999999654447889999999


Q ss_pred             cccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ++.............||+.|+|||.+. ..++.++||||||+++|+|++|..||...+.......+......++...+..
T Consensus       180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  259 (327)
T 3lm5_A          180 MSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS  259 (327)
T ss_dssp             GCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred             cccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence            998876655556678999999999876 4589999999999999999999999999999888888888877777777788


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +++.+.++|..||+.||++|||+.++|+||||+...
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            999999999999999999999999999999998764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.2e-50  Score=363.70  Aligned_cols=266  Identities=35%  Similarity=0.580  Sum_probs=220.1

Q ss_pred             CCcccceeee-eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           47 ENIEDRYLVD-RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        47 ~~~~~~y~i~-~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ..+.++|++. +.||.|+||+||+|.+..+++.||+|++....   ......+.+|+.++.++.+||||+++++++.+.+
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            4567889995 78999999999999999999999999986542   3345778999999999768999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++....++|+|||++...
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999999999988888999999999999999999999999999999999999965444456999999998764


Q ss_pred             CCCC--------cccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------------
Q 019040          206 KPGE--------RFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESE-------------  258 (347)
Q Consensus       206 ~~~~--------~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------------  258 (347)
                      ....        ......||+.|+|||.+.      ..++.++||||||+++|+|++|..||.....             
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            3221        122346899999999875      3488999999999999999999999977542             


Q ss_pred             --HHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          259 --QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       259 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                        ......+......++...+..++.++.+||.+||+.||++|||+.++++||||+...
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence              334555555555444433457899999999999999999999999999999999764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-50  Score=383.17  Aligned_cols=263  Identities=35%  Similarity=0.603  Sum_probs=234.7

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .+....++|.+.+.||.|+||.||+|++..+|+.||+|++.............+.+|+.+++.+ +||||+++++++...
T Consensus        10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~   88 (476)
T 2y94_A           10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTP   88 (476)
T ss_dssp             CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred             CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC
Confidence            3444568999999999999999999999999999999999776544445567899999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +..++||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM  165 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhh
Confidence            9999999999999999999888889999999999999999999999999999999999999   6778899999999988


Q ss_pred             cCCCCcccccccCcccccccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          205 FKPGERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       205 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ...........||+.|+|||++.+.  .+.++||||||+++|+|++|..||...........+..+....+    ..+++
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~  241 (476)
T 2y94_A          166 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNP  241 (476)
T ss_dssp             CCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCH
T ss_pred             ccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCH
Confidence            7665555667899999999988754  46799999999999999999999999888888888877654332    36789


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ++.+||.+||+.||++|||+.++++||||+...
T Consensus       242 ~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            999999999999999999999999999998653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.7e-50  Score=370.74  Aligned_cols=259  Identities=27%  Similarity=0.489  Sum_probs=220.2

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHH-HhCCCCCceeEeeeEEeeCCe
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM-KHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l-~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ...++|++++.||.|+||+||+|+++.+++.||+|++.+...........+.+|..++ +.+ +||||+++++++.+.+.
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCE
Confidence            4457899999999999999999999999999999999877665555556677787764 556 89999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .|+||||++|++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGB
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999   677899999999998643


Q ss_pred             -CCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          207 -PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       207 -~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                       .........||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+......++    +.++.++
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~  266 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSA  266 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHH
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHH
Confidence             2334456689999999998764 489999999999999999999999999998888888877654443    3689999


Q ss_pred             HHHHHHhccCCCCCCCCH----HHHhcCcccccC
Q 019040          285 KSLVRQMLEPDPKLRLTA----KQVLEHPWLQNA  314 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~----~~ll~h~~~~~~  314 (347)
                      .+||.+||+.||.+||++    .++++||||+..
T Consensus       267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            999999999999999986    699999999753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.3e-50  Score=362.00  Aligned_cols=265  Identities=26%  Similarity=0.456  Sum_probs=220.2

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      ...+.+.++|++++.||.|+||+||+|.+. +++.||+|++..... .......+.+|+.+++.+ +||||+++++++.+
T Consensus        14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~   90 (311)
T 3niz_A           14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKEL-HHPNIVSLIDVIHS   90 (311)
T ss_dssp             -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECC
T ss_pred             eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHc-CCCCEeeeeeEEcc
Confidence            345567799999999999999999999995 588999999865432 223346788999999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      .+..++||||+++ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||++
T Consensus        91 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a  166 (311)
T 3niz_A           91 ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLA  166 (311)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred             CCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCc
Confidence            9999999999975 8888887653 49999999999999999999999999999999999999   67788999999999


Q ss_pred             cccCCC-CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCC---
Q 019040          203 IFFKPG-ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP---  276 (347)
Q Consensus       203 ~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  276 (347)
                      ...... .......+|+.|+|||.+.+  .++.++||||||+++|+|++|..||.+....+....+........+..   
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ  246 (311)
T ss_dssp             EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred             eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence            876433 23344578999999998753  489999999999999999999999988887777766655433222211   


Q ss_pred             -----------------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          277 -----------------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       277 -----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                             .+.+++++.+||.+||+.||++|||+.++|+||||++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                                   124678999999999999999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.9e-50  Score=357.39  Aligned_cols=267  Identities=34%  Similarity=0.636  Sum_probs=235.8

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEecccccc------chhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR------TAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      ...+.++|++.+.||.|+||.||+|.++.+++.||+|++......      .......+.+|+.+++.+.+||||+++++
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (298)
T 1phk_A           12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD   91 (298)
T ss_dssp             ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence            445678999999999999999999999999999999998654311      12234568899999999966999999999


Q ss_pred             EEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       120 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                      ++...+..++|+||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||++   +.++.++|+||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~df  168 (298)
T 1phk_A           92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDF  168 (298)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCC
T ss_pred             eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecc
Confidence            999999999999999999999999888889999999999999999999999999999999999999   67788999999


Q ss_pred             ccccccCCCCcccccccCcccccccccc-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc
Q 019040          200 GLSIFFKPGERFSEIVGSPYYMAPEVLK-------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF  272 (347)
Q Consensus       200 g~a~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  272 (347)
                      |.+.............+++.|+|||.+.       ..++.++||||||+++++|++|..||...........+......+
T Consensus       169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (298)
T 1phk_A          169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  248 (298)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence            9998776665556678999999999874       247889999999999999999999999998888888888877766


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +.+.+..++..+.++|..||+.||.+|||+.++++||||++..
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            6666668899999999999999999999999999999998764

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.7e-50  Score=359.68  Aligned_cols=268  Identities=41%  Similarity=0.748  Sum_probs=240.1

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ...+.++|++.+.||.|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.+ +||||+++++++...+
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   94 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKL-DHPNIMKLFEILEDSS   94 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCC
Confidence            345668999999999999999999999999999999998754332 34567899999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ..++|+||+++++|.+.+.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+..++|+|||++...
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            99999999999999999988888999999999999999999999999999999999999976556678999999999876


Q ss_pred             CCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          206 KPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      ..........+++.|+|||.+.+.++.++||||||+++|+|++|..||...........+..+...+..+.+..++.++.
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          175 QQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             CCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             cCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence            65555555678999999999888899999999999999999999999999998888888887766666555668899999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ++|..||+.||++|||+.++++||||++..
T Consensus       255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999999998753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2e-50  Score=371.34  Aligned_cols=262  Identities=35%  Similarity=0.687  Sum_probs=232.4

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc-----hhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-----AVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      +.++|++.+.||.|+||.||+|.++.+|+.||||++.......     ......+.+|+.+++.+.+||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            4578999999999999999999999999999999986543111     12245688899999998789999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      .+..++||||++|++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||++.
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSC  248 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCccc
Confidence            99999999999999999999888889999999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCCCcccccccCccccccccccc-------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCC
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKR-------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP  276 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  276 (347)
                      ............||+.|+|||++.+       .++.++||||||+++|+|++|..||...........+......+..+.
T Consensus       249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  328 (365)
T 2y7j_A          249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE  328 (365)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            8766666666789999999998742       378899999999999999999999999888888888777766655555


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                      +..++..+.++|.+||+.||++|||+.++++||||++
T Consensus       329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            5678999999999999999999999999999999974

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.1e-50  Score=378.23  Aligned_cols=262  Identities=28%  Similarity=0.469  Sum_probs=228.5

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|..++..+ +||||+++++++.+.+..|
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEE
Confidence            357899999999999999999999999999999999765443333445588899999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          129 LVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      +||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhccc
Confidence            99999999999999987 4679999999999999999999999999999999999999   6788999999999976544


Q ss_pred             CCc--ccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC-CCCC
Q 019040          208 GER--FSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-DPWP  278 (347)
Q Consensus       208 ~~~--~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~  278 (347)
                      ...  .....||+.|+|||++.      +.++.++||||||+++|+|++|..||.+.+..+....+......+.. ..+.
T Consensus       228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  307 (437)
T 4aw2_A          228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT  307 (437)
T ss_dssp             TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred             CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence            332  23357999999999874      34899999999999999999999999999988888888765433322 2235


Q ss_pred             CCCHHHHHHHHHhccCCCCC--CCCHHHHhcCcccccC
Q 019040          279 NVSESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA  314 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~--Rps~~~ll~h~~~~~~  314 (347)
                      .+++++.+||.+||..+|++  |+++.++++||||+..
T Consensus       308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            68999999999999998988  9999999999999764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.5e-50  Score=380.35  Aligned_cols=259  Identities=29%  Similarity=0.526  Sum_probs=220.5

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...++|++++.||.|+||.||+|.++.+|+.||+|++.............+.+|+.+++.+ +||||+++++++...+..
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEE
Confidence            3457899999999999999999999999999999999876555555567788899999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      ++||||+++++|.+++.....+++..+..++.||+.||.|||+ +||+||||||+|||+   +.++.+||+|||++....
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTC
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceecc
Confidence            9999999999999999888889999999999999999999998 999999999999999   677889999999997643


Q ss_pred             C-CCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          207 P-GERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       207 ~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      . ........||+.|+|||++. ..++.++||||||+++|+|++|..||...+.......+......++    ..+++++
T Consensus       301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~  376 (446)
T 4ejn_A          301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEA  376 (446)
T ss_dssp             C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred             CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHH
Confidence            2 23345568999999999876 4599999999999999999999999999998888888877655443    3679999


Q ss_pred             HHHHHHhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          285 KSLVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      .+||.+||+.||.+||     ++.++++||||+..
T Consensus       377 ~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            9999999999999999     99999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-50  Score=362.17  Aligned_cols=263  Identities=26%  Similarity=0.374  Sum_probs=215.1

Q ss_pred             ecCCCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           41 LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        41 ~~~~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      .+..+...+.++|++.+.||+|+||+||+|+++.+++.||||++..... ..........|+..+..+.+|+||++++++
T Consensus        47 ~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~  125 (311)
T 3p1a_A           47 DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQA  125 (311)
T ss_dssp             CTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence            3445666677899999999999999999999999999999998765432 223334455566666665599999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                      +.+.+..++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+||
T Consensus       126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DF  201 (311)
T 3p1a_A          126 WEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDF  201 (311)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCC
T ss_pred             EEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccc
Confidence            99999999999999 66898888765 459999999999999999999999999999999999999   66778999999


Q ss_pred             ccccccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          200 GLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       200 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      |++.............||+.|+|||++.+.++.++||||||+++|+|++|..|+....   ....+.....  +......
T Consensus       202 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~--~~~~~~~  276 (311)
T 3p1a_A          202 GLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYL--PPEFTAG  276 (311)
T ss_dssp             TTCEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCC--CHHHHTT
T ss_pred             eeeeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCC--CcccccC
Confidence            9998776555555567999999999988889999999999999999999977665432   2333333321  1122346


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                      +++++.++|..||+.||++|||+.++|+||||++
T Consensus       277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          277 LSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            8999999999999999999999999999999975

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1e-49  Score=361.27  Aligned_cols=262  Identities=29%  Similarity=0.497  Sum_probs=217.6

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEEC---CCCceeEEeEecccccc-chhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      +.....++|++.+.||.|+||.||+|++.   .+++.||+|++.+.... .......+.+|+.+++.+ +||||++++++
T Consensus        11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~   89 (327)
T 3a62_A           11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYA   89 (327)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEE
T ss_pred             CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEE
Confidence            33445689999999999999999999985   68899999999765432 233456688899999999 89999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                      +...+..|+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg  166 (327)
T 3a62_A           90 FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFG  166 (327)
T ss_dssp             EECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCS
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCC
Confidence            99999999999999999999999888889999999999999999999999999999999999999   677889999999


Q ss_pred             cccccCCC-CcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          201 LSIFFKPG-ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       201 ~a~~~~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ++...... .......||+.|+|||++. ..++.++||||||+++|+|++|..||...+.......+......++    +
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~  242 (327)
T 3a62_A          167 LCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----P  242 (327)
T ss_dssp             CC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----T
T ss_pred             cccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----C
Confidence            98754322 2334557999999999876 4589999999999999999999999999988888888877654443    3


Q ss_pred             CCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      .++.++.++|.+||+.||.+||     ++.++++||||+..
T Consensus       243 ~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            6799999999999999999999     89999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.9e-50  Score=370.16  Aligned_cols=262  Identities=35%  Similarity=0.631  Sum_probs=226.6

Q ss_pred             cccceee--eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           49 IEDRYLV--DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        49 ~~~~y~i--~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      +.+.|.+  .+.||.|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQL-DHANLIQLYDAFESKND  160 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCE
Confidence            3455655  668999999999999999999999999987542   23456789999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+.. +.++.++|+|||++...
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceec
Confidence            99999999999999988765 45999999999999999999999999999999999999953 34567999999999887


Q ss_pred             CCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          206 KPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      ..........||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+.......+......++...+..+++++
T Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  319 (373)
T 2x4f_A          240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA  319 (373)
T ss_dssp             CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred             CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence            6666556667999999999876 458889999999999999999999999999888888888877666666667899999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .+||.+||+.||.+|||+.++|+||||++..
T Consensus       320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          320 KEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence            9999999999999999999999999998763

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.8e-50  Score=368.80  Aligned_cols=264  Identities=33%  Similarity=0.526  Sum_probs=210.1

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .+.....++|++++.||.|+||+||+|+++.+++.||+|++.....    ....+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hpniv~~~~~~~~   87 (361)
T 3uc3_A           13 MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSL-RHPNIVRFKEVILT   87 (361)
T ss_dssp             CCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred             ccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhC-CCCCCCcEEEEEee
Confidence            3445567899999999999999999999999999999999865422    235688999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      .+..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++. +..+.+||+|||++.
T Consensus        88 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSK  166 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC-
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCccc
Confidence            9999999999999999999988888999999999999999999999999999999999999942 123359999999998


Q ss_pred             ccCCCCcccccccCccccccccccc-cCCC-chhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccccccCCCC
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKR-NYGP-EIDIWSAGVILYILLCGVPPFWAESEQ----GVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~  277 (347)
                      ............||+.|+|||++.+ .++. ++||||||+++|+|++|..||......    .....+......+  +..
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~  244 (361)
T 3uc3_A          167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI--PDD  244 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC--CTT
T ss_pred             cccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC--CCc
Confidence            6544444455689999999998754 3544 489999999999999999999775543    3333343333322  223


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ..+++++.+||.+||+.||++|||+.++++||||.+..
T Consensus       245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            36899999999999999999999999999999996653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.4e-50  Score=364.03  Aligned_cols=269  Identities=30%  Similarity=0.483  Sum_probs=216.8

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .+.....++|++++.||.|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.+ +||||+++++++..
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKEL-QHRNIIELKSVIHH  104 (329)
T ss_dssp             -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGC-CCTTBCCEEEEEEE
T ss_pred             CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHc-CCCCcceEEEEEec
Confidence            4455667899999999999999999999999999999999965432 223345677899999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC--CCCCCEEEEeecc
Q 019040          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK--KENSPLKAIDFGL  201 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~--~~~~~~~l~Dfg~  201 (347)
                      .+..++||||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+  +..+.++|+|||+
T Consensus       105 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          105 NHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             CCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999999999975 999999998889999999999999999999999999999999999999643  2345699999999


Q ss_pred             ccccCCC-CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          202 SIFFKPG-ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       202 a~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      +...... .......+|+.|+|||++.+  .++.++||||||+++|+|++|..||......+....+...........++
T Consensus       184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP  263 (329)
T ss_dssp             HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence            9865433 23344578999999998764  38999999999999999999999999998887777776554322222211


Q ss_pred             --------------------------CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          279 --------------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       279 --------------------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                                .+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence                                      1678999999999999999999999999999999764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.4e-50  Score=356.05  Aligned_cols=267  Identities=37%  Similarity=0.681  Sum_probs=229.4

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc---hhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      +.++|++.+.||.|+||.||+|.+..+++.||+|++.......   ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKT   81 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCC
Confidence            4578999999999999999999999999999999987654322   22467899999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC-CCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~-~~~~~~l~Dfg~a~~  204 (347)
                      ..++|+||+++++|.+++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++ ....++|+|||.+..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            9999999999999999998888899999999999999999999999999999999999995432 233799999999987


Q ss_pred             cCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          205 FKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       205 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      ...........+++.|+|||.+. ..++.++||||||+++|+|++|..||...........+......++...+..++..
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL  241 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred             ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence            66555555567999999999876 45899999999999999999999999999888877777766555544444578999


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      +.++|.+||+.||++|||+.++++||||+....
T Consensus       242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            999999999999999999999999999987643

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-49  Score=354.44  Aligned_cols=257  Identities=32%  Similarity=0.482  Sum_probs=214.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||.|+||+||+|.+ .+++.||+|++..... .......+.+|+.+++.+ +||||+++++++...+..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEE
Confidence            5899999999999999999999 6789999999865432 222346788999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-  208 (347)
                      |||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC--
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc
Confidence            999976 999988765 569999999999999999999999999999999999999   67788999999999765432 


Q ss_pred             CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC-----------
Q 019040          209 ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD-----------  275 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------  275 (347)
                      .......+|+.|+|||.+.+  .++.++||||||+++|+|++|..||.+....+....+.+........           
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            22344578999999998753  48999999999999999999999999988877776665432211111           


Q ss_pred             --------------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          276 --------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       276 --------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                                    ....+++++.+||.+||+.||++|||+.++++||||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                          123578999999999999999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-49  Score=352.75  Aligned_cols=260  Identities=31%  Similarity=0.603  Sum_probs=230.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   91 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIYL   91 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEEE
Confidence            47899999999999999999999999999999999765544444567899999999999 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |+||+++++|.+++.....+++..++.++.||+.||.|||++||+|+||+|+||++   +.++.++|+|||++...... 
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECSSS-
T ss_pred             EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCccc-
Confidence            99999999999999888889999999999999999999999999999999999999   67788999999998765432 


Q ss_pred             cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+......++    ..++.++.++|
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li  243 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLI  243 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHH
T ss_pred             ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHHH
Confidence            2344578999999998764 489999999999999999999999998888777777766544332    46799999999


Q ss_pred             HHhccCCCCCCCCHHHHhcCcccccCcCCC
Q 019040          289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  318 (347)
                      ..||+.||.+|||+.++++||||+......
T Consensus       244 ~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~  273 (284)
T 2vgo_A          244 SKLLRYHPPQRLPLKGVMEHPWVKANSRRV  273 (284)
T ss_dssp             HHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred             HHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence            999999999999999999999998766443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-49  Score=359.51  Aligned_cols=260  Identities=27%  Similarity=0.471  Sum_probs=208.4

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++++.||.|+||+||+|.++.+|+.||+|++....  .......+.+|+.+++.+ +||||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEE
Confidence            368999999999999999999999999999999986543  223346788999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          130 VMELCEGGELFDRIVAR------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      ||||+++ +|.+++...      ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.
T Consensus        81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCE
T ss_pred             EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccce
Confidence            9999975 999988654      358999999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCC-CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC------
Q 019040          204 FFKPG-ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR------  274 (347)
Q Consensus       204 ~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------  274 (347)
                      ..... .......+|+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+.......+.........      
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            75433 23345578999999998754  4899999999999999999999999999888777766543221111      


Q ss_pred             ------------------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          275 ------------------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       275 ------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                                              .....++.++.+||.+||+.||++|||+.++|+||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence                                    011257889999999999999999999999999999998753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-50  Score=366.20  Aligned_cols=277  Identities=25%  Similarity=0.434  Sum_probs=224.2

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||.|+||+||+|.+..+++.||+|++.......  ....+.+|+.+++.+ +||||+++++++...+..++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEE
Confidence            58999999999999999999999999999999986543211  112345699999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |||+++ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.......
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC----
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCc
Confidence            999975 8999887754 48999999999999999999999999999999999999   677889999999997654332


Q ss_pred             -cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC---------
Q 019040          210 -RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---------  277 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------  277 (347)
                       ......+|+.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+..+....+.+.........|         
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence             2344578999999998753  4899999999999999999999999999988888777665443333222         


Q ss_pred             -----------------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhhhhH
Q 019040          278 -----------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFS  334 (347)
Q Consensus       278 -----------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (347)
                                       +.+++++.+||.+||+.||++|||+.++|+||||..................+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  308 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQ  308 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTCC
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHHH
Confidence                             246889999999999999999999999999999999887766555444444444443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.6e-50  Score=360.45  Aligned_cols=248  Identities=22%  Similarity=0.281  Sum_probs=191.0

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC----
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN----  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~----  125 (347)
                      ..+|.+.+.||+|+||+||+|++  +|+.||||++....    ........|+..+..+ +||||+++++++..++    
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCce
Confidence            46789999999999999999988  58899999986432    1112334566666788 9999999999998653    


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH--------GVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                      .+|+||||+++++|.+++... .+++..+..++.|++.||.|||++        +|+||||||+|||+   +.++.+||+
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~  150 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA  150 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred             EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEE
Confidence            689999999999999999765 689999999999999999999987        99999999999999   778899999


Q ss_pred             eeccccccCCCCc-----ccccccCccccccccccc-------cCCCchhHHHHHHHHHHHHhCCCCCCCC---------
Q 019040          198 DFGLSIFFKPGER-----FSEIVGSPYYMAPEVLKR-------NYGPEIDIWSAGVILYILLCGVPPFWAE---------  256 (347)
Q Consensus       198 Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~-------~~~~~~Di~slG~~l~~l~~g~~pf~~~---------  256 (347)
                      |||+|........     .....||+.|+|||++.+       .++.++||||||+++|||+||..||...         
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            9999986644332     123579999999998753       3667899999999999999997665321         


Q ss_pred             ------CHHHHHHHHHhccccccCC-CC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          257 ------SEQGVAQAILRGLIDFKRD-PW--PNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       257 ------~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                            ........+.........+ .+  ...+..+.+|+.+||+.||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                  1122333332222211111 00  1234578899999999999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.7e-50  Score=357.32  Aligned_cols=257  Identities=31%  Similarity=0.581  Sum_probs=215.7

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc-----------------------hhcHHHHHHHHHHHH
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-----------------------AVDIDDVRREVAIMK  106 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~ei~~l~  106 (347)
                      .++|++.+.||.|+||.||+|.+..+++.||+|++.......                       ....+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            478999999999999999999999999999999997653221                       112456889999999


Q ss_pred             hCCCCCceeEeeeEEee--CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEE
Q 019040          107 HLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFL  184 (347)
Q Consensus       107 ~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIl  184 (347)
                      .+ +||||+++++++.+  .+..++||||+++++|.+++ ....+++..++.++.||+.||.|||++||+||||||+||+
T Consensus        92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            99 99999999999986  67899999999999997754 3457999999999999999999999999999999999999


Q ss_pred             eecCCCCCCEEEEeeccccccCCCC-cccccccCcccccccccccc----CCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 019040          185 FANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKRN----YGPEIDIWSAGVILYILLCGVPPFWAESEQ  259 (347)
Q Consensus       185 i~~~~~~~~~~l~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  259 (347)
                      +   +.++.++|+|||++....... ......||+.|+|||.+.+.    ++.++||||||+++|+|++|..||......
T Consensus       170 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          170 V---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             E---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             E---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            9   677889999999998765432 23445799999999988643    367899999999999999999999988877


Q ss_pred             HHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                      .....+......++  ..+.+++++.++|.+||+.||++|||+.++++||||++
T Consensus       247 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          247 CLHSKIKSQALEFP--DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHHCCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHHhcccCCCC--CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            77666666544433  23478999999999999999999999999999999964

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-50  Score=372.22  Aligned_cols=261  Identities=26%  Similarity=0.438  Sum_probs=225.7

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|..++..+ +|++|+++++++.+.+..|
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEE
Confidence            357899999999999999999999999999999999765443444455688899999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          129 LVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      +||||++|++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRA  214 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccC
Confidence            999999999999999875 479999999999999999999999999999999999999   6788999999999987654


Q ss_pred             CCc--ccccccCcccccccccc--------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC-C
Q 019040          208 GER--FSEIVGSPYYMAPEVLK--------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD-P  276 (347)
Q Consensus       208 ~~~--~~~~~~~~~y~aPE~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~  276 (347)
                      ...  .....||+.|+|||++.        ..++.++||||||+++|+|++|..||...+.......+.........+ .
T Consensus       215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  294 (412)
T 2vd5_A          215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV  294 (412)
T ss_dssp             TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred             CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence            432  23457999999999875        348999999999999999999999999999888888877643322222 2


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCC---CCHHHHhcCcccccC
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLR---LTAKQVLEHPWLQNA  314 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~R---ps~~~ll~h~~~~~~  314 (347)
                      ...+++++.+||.+||. +|.+|   |++.++++||||+..
T Consensus       295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            34789999999999999 99998   599999999999764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-49  Score=351.51  Aligned_cols=263  Identities=36%  Similarity=0.606  Sum_probs=222.3

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .+....++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   83 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTP   83 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC
Confidence            3445568999999999999999999999999999999999765544455667899999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +..++|+||+++++|.+++.....+++..+..++.||+.||.|||++||+|+||+|+||++   +.++.++|+|||++..
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM  160 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGC
T ss_pred             CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccc
Confidence            9999999999999999999888889999999999999999999999999999999999999   6778899999999987


Q ss_pred             cCCCCcccccccCcccccccccccc-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          205 FKPGERFSEIVGSPYYMAPEVLKRN-Y-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       205 ~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ...........+++.|+|||.+.+. + +.++||||||+++++|++|..||...........+.......+    ..++.
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~  236 (276)
T 2h6d_A          161 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNR  236 (276)
T ss_dssp             CCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCH
T ss_pred             cCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCH
Confidence            6655444556789999999998754 3 5789999999999999999999998888777777766543332    36789


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .+.++|.+||+.||++|||+.++++||||++..
T Consensus       237 ~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence            999999999999999999999999999998753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.8e-49  Score=352.05  Aligned_cols=264  Identities=32%  Similarity=0.495  Sum_probs=233.1

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ....++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +|+||+++++++.+.+.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   89 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDF   89 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCE
Confidence            35568999999999999999999999999999999999876655556677899999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .++|+||+++++|.+++.....+++..+..++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++....
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceecc
Confidence            99999999999999999888889999999999999999999999999999999999999   677889999999998754


Q ss_pred             CC-CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          207 PG-ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       207 ~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      .. .......+++.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+.......+    ..++..+
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  242 (294)
T 2rku_A          167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVA  242 (294)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHH
T ss_pred             cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCHHH
Confidence            32 23344578999999998764 488999999999999999999999998888777766666543332    3678999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCcCCC
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  318 (347)
                      .++|.+||+.||++|||+.++++||||.....+.
T Consensus       243 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          243 ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence            9999999999999999999999999998765443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.9e-50  Score=384.80  Aligned_cols=259  Identities=31%  Similarity=0.497  Sum_probs=227.0

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...++|++.+.||.|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+..
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEE
Confidence            3457899999999999999999999999999999999876555555667789999999999 999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          128 HLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      |+||||++|++|.+++.....  +++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceec
Confidence            999999999999999987543  9999999999999999999999999999999999999   67789999999999887


Q ss_pred             CCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccccccCCCCCCC
Q 019040          206 KPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE----QGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      ..........||+.|+|||++.+ .++.++||||||+++|+|++|..||.....    ......+.....    .....+
T Consensus       337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~----~~p~~~  412 (576)
T 2acx_A          337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE----EYSERF  412 (576)
T ss_dssp             CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC----CCCTTS
T ss_pred             ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc----cCCccC
Confidence            66655566789999999998864 599999999999999999999999987642    334444443322    233478


Q ss_pred             CHHHHHHHHHhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          281 SESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      ++++.+||.+||+.||.+||     ++.++++||||+..
T Consensus       413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            99999999999999999999     89999999999873

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-49  Score=356.09  Aligned_cols=263  Identities=32%  Similarity=0.566  Sum_probs=218.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++++.||.|+||+||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...+..++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEE
Confidence            478999999999999999999999999999999986543 2333456788999999999 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||.+.......
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred             EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence            99999999999988888889999999999999999999999999999999999999   677889999999998765332


Q ss_pred             -cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc-------------
Q 019040          210 -RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-------------  273 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------  273 (347)
                       ......+|+.|+|||.+.+  .++.++||||||+++|+|++|..||.+....+....+........             
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence             2345578999999998753  489999999999999999999999999887776655544321110             


Q ss_pred             ------C--------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          274 ------R--------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       274 ------~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                            .        ..++.++.++.+||.+||+.||++|||+.++++||||++....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence                  0        0114678899999999999999999999999999999987644

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.4e-49  Score=359.00  Aligned_cols=263  Identities=32%  Similarity=0.497  Sum_probs=232.5

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ....++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +|+||+++++++.+.+.
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  115 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDF  115 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCe
Confidence            34567999999999999999999999999999999999876655556677899999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .++||||+++++|.+++.....+++..++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++....
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecc
Confidence            99999999999999999888889999999999999999999999999999999999999   677889999999998754


Q ss_pred             CC-CcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          207 PG-ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       207 ~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      .. .......+++.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+.......+    ..++..+
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~  268 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVA  268 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHH
T ss_pred             cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHH
Confidence            32 23344578999999998764 488999999999999999999999998887777776666544332    3678999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      .++|.+||+.||++|||+.++++||||.....+
T Consensus       269 ~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          269 ASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence            999999999999999999999999999876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.7e-50  Score=361.83  Aligned_cols=260  Identities=28%  Similarity=0.510  Sum_probs=217.9

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .+.++|++++.||+|+||+||+|.+..+++.||+|++.....  ....+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~   80 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML-NHENVVKFYGHRREGNIQ   80 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeE
Confidence            356899999999999999999999999999999999864432  22235688999999999 999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      ++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEE
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceecc
Confidence            9999999999999999877789999999999999999999999999999999999999   6778899999999976432


Q ss_pred             CC---cccccccCcccccccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccccccCCCCCCCC
Q 019040          208 GE---RFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQG-VAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       208 ~~---~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ..   ......||+.|+|||++.+.  ++.++||||||+++|+|++|..||....... .........  .....+..++
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~  235 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKID  235 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC--TTSTTGGGSC
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc--ccCCccccCC
Confidence            22   22356799999999987643  4778999999999999999999997765542 222222222  2223345789


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +.+.+||.+||+.||++|||+.++++||||++..
T Consensus       236 ~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            9999999999999999999999999999998754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.1e-49  Score=367.64  Aligned_cols=268  Identities=19%  Similarity=0.270  Sum_probs=218.6

Q ss_pred             Ccccceeeeeeeccc--CCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           48 NIEDRYLVDRELGRG--EFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G--~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .-.++|++++.||.|  +||+||+|+++.+++.||+|++..... .......+.+|+.+++.+ +||||+++++++.+.+
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADN   99 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETT
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECC
Confidence            345799999999999  999999999999999999999976543 234567788999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          126 AVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      ..++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||.+.
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNL  176 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCE
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccce
Confidence            999999999999999999876  569999999999999999999999999999999999999   677889999999876


Q ss_pred             ccCCCC--------cccccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-
Q 019040          204 FFKPGE--------RFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-  271 (347)
Q Consensus       204 ~~~~~~--------~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  271 (347)
                      ......        ......||+.|+|||++.+   .++.++||||||+++|+|++|..||.+.........+...... 
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            432211        1123478999999998764   4899999999999999999999999876654443333221110 


Q ss_pred             -----------------------------------------ccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcc
Q 019040          272 -----------------------------------------FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (347)
Q Consensus       272 -----------------------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  310 (347)
                                                               ...+....+++++.+||.+||+.||++|||+.++|+|||
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence                                                     001122357889999999999999999999999999999


Q ss_pred             cccCcCCCCC
Q 019040          311 LQNAKKAPNV  320 (347)
Q Consensus       311 ~~~~~~~~~~  320 (347)
                      |+........
T Consensus       337 f~~~~~~~~~  346 (389)
T 3gni_B          337 FKQIKRRASE  346 (389)
T ss_dssp             GGGC---CCS
T ss_pred             HHHHhhcchh
Confidence            9987654433

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-49  Score=375.63  Aligned_cols=264  Identities=27%  Similarity=0.437  Sum_probs=203.0

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee--
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--  123 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~--  123 (347)
                      ...+.++|++++.||.|+||+||+|+++.+++.||||++... .........+.+|+.+++.+ +|+||+++++++..  
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           48 DWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKD  125 (458)
T ss_dssp             SCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSC
T ss_pred             cCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCC
Confidence            445678999999999999999999999999999999998643 33445567899999999999 99999999999843  


Q ss_pred             ---CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          124 ---DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       124 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                         .+.+|+||||+ +++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||
T Consensus       126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFG  201 (458)
T 3rp9_A          126 VEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFG  201 (458)
T ss_dssp             TTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCT
T ss_pred             cccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccc
Confidence               36799999998 56999999888889999999999999999999999999999999999999   677889999999


Q ss_pred             cccccCCCC----------------------------cccccccCccccccccc-c-ccCCCchhHHHHHHHHHHHHh--
Q 019040          201 LSIFFKPGE----------------------------RFSEIVGSPYYMAPEVL-K-RNYGPEIDIWSAGVILYILLC--  248 (347)
Q Consensus       201 ~a~~~~~~~----------------------------~~~~~~~~~~y~aPE~~-~-~~~~~~~Di~slG~~l~~l~~--  248 (347)
                      ++.......                            .....+||+.|+|||++ . ..++.++|||||||++|+|++  
T Consensus       202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            998654221                            22345789999999975 3 459999999999999999998  


Q ss_pred             ---------CCCCCCCCCH--------------------HHHHHHHHhccccc---------------------------
Q 019040          249 ---------GVPPFWAESE--------------------QGVAQAILRGLIDF---------------------------  272 (347)
Q Consensus       249 ---------g~~pf~~~~~--------------------~~~~~~~~~~~~~~---------------------------  272 (347)
                               |.++|.+...                    .+.+..+.......                           
T Consensus       282 ~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (458)
T 3rp9_A          282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD  361 (458)
T ss_dssp             TTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCC
T ss_pred             cccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCC
Confidence                     6777755431                    12222222111100                           


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ....++..++++.+||.+||+.||++|||+.++|+||||+...
T Consensus       362 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          362 LAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             GGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            0112346789999999999999999999999999999998874

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.3e-50  Score=370.25  Aligned_cols=264  Identities=30%  Similarity=0.507  Sum_probs=213.2

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--  124 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--  124 (347)
                      ..+.++|++++.||.|+||.||+|.++.+|+.||+|++... .........+.+|+.++..+.+|+||+++++++...  
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            34568999999999999999999999999999999998643 334455677889999999996699999999999754  


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..+|+||||++ ++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++..
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRS  158 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCccccc
Confidence            47999999997 589888876 479999999999999999999999999999999999999   6778899999999976


Q ss_pred             cCCC----------------------CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 019040          205 FKPG----------------------ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQG  260 (347)
Q Consensus       205 ~~~~----------------------~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  260 (347)
                      ....                      .......||+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            4321                      11234579999999998754  58999999999999999999999999998887


Q ss_pred             HHHHHHhccccccC-------------------------------------------CCCCCCCHHHHHHHHHhccCCCC
Q 019040          261 VAQAILRGLIDFKR-------------------------------------------DPWPNVSESAKSLVRQMLEPDPK  297 (347)
Q Consensus       261 ~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~li~~~l~~dp~  297 (347)
                      ....+.........                                           .....+++++.+||.+||+.||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            77776543221110                                           11226789999999999999999


Q ss_pred             CCCCHHHHhcCcccccCcC
Q 019040          298 LRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       298 ~Rps~~~ll~h~~~~~~~~  316 (347)
                      +|||+.++|+||||+....
T Consensus       319 ~R~t~~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          319 KRISANDALKHPFVSIFHN  337 (388)
T ss_dssp             GSCCHHHHTTSTTTTTTCC
T ss_pred             cCCCHHHHhCCHHHHHhcC
Confidence            9999999999999987653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.9e-50  Score=375.83  Aligned_cols=265  Identities=38%  Similarity=0.664  Sum_probs=218.1

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc-----hhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-----AVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      .+.++|.+.+.||+|+||+||+|.++.+++.||+|++.+.....     ......+.+|+.+++.+ +||||+++++++.
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence            34688999999999999999999999999999999997654321     12223578899999999 9999999999986


Q ss_pred             eCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          123 DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       123 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      . +..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+||+|||++
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence            4 457899999999999999988888999999999999999999999999999999999999976666778999999999


Q ss_pred             cccCCCCcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccccCCCC
Q 019040          203 IFFKPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       203 ~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  277 (347)
                      .............||+.|+|||++.    ..++.++||||||+++|+|++|..||...... .....+......+.+..+
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  369 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  369 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence            8876655556678999999999874    34778999999999999999999999765443 344555555555544455


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ..+++.+.+||.+||+.||++|||+.++|+||||++.
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            6789999999999999999999999999999999764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.2e-49  Score=390.31  Aligned_cols=258  Identities=26%  Similarity=0.449  Sum_probs=233.5

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++++.||.|+||+||+|+++.+++.||||++.+...........+..|..++..+.+|++|+.+++++.+.+.+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999876554555667888999999998889999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC-CC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~-~~  208 (347)
                      ||||++|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ..
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTT
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccccCC
Confidence            99999999999999988889999999999999999999999999999999999999   677899999999998643 23


Q ss_pred             CcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          209 ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       209 ~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                      .......||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+..+..+.+......++    ..++.++.+|
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  572 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI  572 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC----TTSCHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHH
Confidence            3445678999999999886 4599999999999999999999999999999999999988766554    3689999999


Q ss_pred             HHHhccCCCCCCCCH-----HHHhcCcccccC
Q 019040          288 VRQMLEPDPKLRLTA-----KQVLEHPWLQNA  314 (347)
Q Consensus       288 i~~~l~~dp~~Rps~-----~~ll~h~~~~~~  314 (347)
                      |.+||+.||++||++     .++++||||+..
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            999999999999997     999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-50  Score=366.66  Aligned_cols=268  Identities=34%  Similarity=0.649  Sum_probs=227.6

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEecccccc--chhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .+.++|++.+.||.|+||.||+|.+..+++.||+|++......  .......+.+|+.+++.+ +||||+++++++.+.+
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCC
Confidence            4578999999999999999999999999999999999765432  234567899999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHH
Q 019040          126 AVHLVMELCEGGELFDRIVAR----------------------------------------GHYTERAAAAVTRTIVEVV  165 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~----------------------------------------~~~~~~~~~~i~~qi~~~l  165 (347)
                      ..++||||+++++|.+++...                                        ..+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999988420                                        1135778889999999999


Q ss_pred             HHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-----cccccccCcccccccccc---ccCCCchhHH
Q 019040          166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYMAPEVLK---RNYGPEIDIW  237 (347)
Q Consensus       166 ~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~---~~~~~~~Di~  237 (347)
                      .|||++||+||||||+||+++. +....++|+|||++.......     ......||+.|+|||.+.   ..++.++|||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw  260 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW  260 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence            9999999999999999999953 122379999999997643211     124457999999999875   4588999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       238 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      |||+++|+|++|..||......+....+......+..+.+..+++++.++|.+||+.||.+|||+.++++||||++....
T Consensus       261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence            99999999999999999999988888888877766666666789999999999999999999999999999999987644

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2e-49  Score=363.94  Aligned_cols=268  Identities=24%  Similarity=0.397  Sum_probs=223.7

Q ss_pred             eeeecCCCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC----CCCc
Q 019040           38 ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP----KNSS  113 (347)
Q Consensus        38 ~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~----~h~~  113 (347)
                      .......++..+.++|++++.||.|+||+||+|++..+++.||+|++...    .........|+.+++.+.    .|+|
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            33344566777889999999999999999999999999999999998632    233456778999999994    3999


Q ss_pred             eeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC---
Q 019040          114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK---  188 (347)
Q Consensus       114 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~---  188 (347)
                      |+++++++...+..++||||+ +++|.+++....  .++...+..++.||+.||.|||++||+||||||+|||++..   
T Consensus        98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A           98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred             eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence            999999999999999999999 889999998764  49999999999999999999999999999999999999531   


Q ss_pred             -------------------CCCCCEEEEeeccccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh
Q 019040          189 -------------------KENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC  248 (347)
Q Consensus       189 -------------------~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~  248 (347)
                                         ..++.++|+|||++......  .....||+.|+|||++. ..++.++||||||+++|+|++
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence                               13678999999999864432  34557899999999876 459999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHhccccccCC---------------------CCC---------------------CCCHHHHH
Q 019040          249 GVPPFWAESEQGVAQAILRGLIDFKRD---------------------PWP---------------------NVSESAKS  286 (347)
Q Consensus       249 g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------~~~---------------------~~~~~~~~  286 (347)
                      |..||...+..+....+.......+..                     .|+                     ..++.+.+
T Consensus       255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  334 (360)
T 3llt_A          255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD  334 (360)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred             CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence            999999988877776665543322110                     000                     12377889


Q ss_pred             HHHHhccCCCCCCCCHHHHhcCcccc
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h~~~~  312 (347)
                      ||.+||+.||.+|||+.++|+||||+
T Consensus       335 li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          335 FLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHhcCChhhCCCHHHHhcCcccC
Confidence            99999999999999999999999996

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.9e-50  Score=362.02  Aligned_cols=266  Identities=38%  Similarity=0.670  Sum_probs=221.1

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEecccccc-----chhcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-----TAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      ..+.++|++.+.||.|+||.||+|.+..+++.||||++......     .......+.+|+.+++.+ +||||+++++++
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~   84 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF   84 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEE
Confidence            45668999999999999999999999999999999998754321     222334588999999999 999999999998


Q ss_pred             eeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       122 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                      ...+ .++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+..++|+|||+
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            7665 899999999999999998888899999999999999999999999999999999999997655566799999999


Q ss_pred             ccccCCCCcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccccCCC
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDP  276 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~  276 (347)
                      +.............||+.|+|||.+.    ..++.++||||||+++|+|++|..||...... .....+..+...+.+..
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (322)
T 2ycf_A          164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  243 (322)
T ss_dssp             CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred             ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence            98765544444557899999999863    45889999999999999999999999765543 33344444444333333


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +..++..+.++|.+||+.||++|||+.++++||||+..
T Consensus       244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            45789999999999999999999999999999999764

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.4e-49  Score=376.38  Aligned_cols=260  Identities=26%  Similarity=0.384  Sum_probs=213.3

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC---
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~---  124 (347)
                      .+.++|++++.||.|+||+||+|.+..+++.||||++... .........+.+|+.+++.+ +||||+++++++...   
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  136 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTL  136 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCST
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcc
Confidence            4568999999999999999999999999999999998654 33445567889999999999 999999999998654   


Q ss_pred             ---CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          125 ---NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       125 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                         +.+|+||||+++ +|.+.+..  .+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus       137 ~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~  210 (464)
T 3ttj_A          137 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  210 (464)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCC
T ss_pred             ccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEe
Confidence               468999999976 56666643  48999999999999999999999999999999999999   6778899999999


Q ss_pred             ccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC---
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---  277 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---  277 (347)
                      +.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+........+..+   
T Consensus       211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            988766655666789999999998764 5999999999999999999999999999887777776554322111000   


Q ss_pred             --------------CC---------------------CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          278 --------------PN---------------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       278 --------------~~---------------------~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                    ..                     .++++.+||.+||+.||++|||+.++|+||||+...
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                          00                     146789999999999999999999999999998643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-49  Score=349.68  Aligned_cols=258  Identities=32%  Similarity=0.521  Sum_probs=200.3

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEE
Confidence            36799999999999999999999999999999999765544444567899999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      |+||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC--
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCC
Confidence            99999999999999875 569999999999999999999999999999999999999   67788999999999875433


Q ss_pred             C-cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          209 E-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      . ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+....    ......++.++.+
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  241 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD----YEMPSFLSIEAKD  241 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC----CCCCTTSCHHHHH
T ss_pred             CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc----cCCccccCHHHHH
Confidence            2 2234578999999998764 48899999999999999999999998766554443332222    1222467899999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +|.+||+.||++|||+.++++||||.+..
T Consensus       242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          242 LIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            99999999999999999999999998765

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.6e-50  Score=361.71  Aligned_cols=269  Identities=24%  Similarity=0.371  Sum_probs=225.9

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ....+.++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~   84 (311)
T 3ork_A            6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAE   84 (311)
T ss_dssp             CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEE
T ss_pred             CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeecc
Confidence            3456778999999999999999999999999999999999876555555667889999999999 999999999998765


Q ss_pred             C----eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          125 N----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       125 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                      .    ..|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||
T Consensus        85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg  161 (311)
T 3ork_A           85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFG  161 (311)
T ss_dssp             ETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCS
T ss_pred             CCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeecc
Confidence            4    359999999999999999888889999999999999999999999999999999999999   566789999999


Q ss_pred             cccccCCCC----cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC
Q 019040          201 LSIFFKPGE----RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD  275 (347)
Q Consensus       201 ~a~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  275 (347)
                      ++.......    ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...................+..
T Consensus       162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (311)
T 3ork_A          162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA  241 (311)
T ss_dssp             CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH
T ss_pred             CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc
Confidence            997654332    2233568999999998764 48899999999999999999999999988887776666665444433


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      ....++.++.++|.+||+.||++||++.+++.|+|++.....
T Consensus       242 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~  283 (311)
T 3ork_A          242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE  283 (311)
T ss_dssp             HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred             ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence            445789999999999999999999999999999999865433

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.6e-48  Score=356.73  Aligned_cols=263  Identities=27%  Similarity=0.457  Sum_probs=223.5

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee----
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----  123 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~----  123 (347)
                      ...++|++++.||.|+||+||+|++..+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++..    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   91 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLL-KHENVVNLIEICRTKASP   91 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC---
T ss_pred             ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhc-cCCCcccHhheeeccccc
Confidence            3458999999999999999999999999999999998655432 22345678899999999 89999999999887    


Q ss_pred             ----CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          124 ----DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       124 ----~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                          .+..++||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||++   +.++.++|+|
T Consensus        92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~D  167 (351)
T 3mi9_A           92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLAD  167 (351)
T ss_dssp             -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECC
T ss_pred             cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEcc
Confidence                4578999999975 777777664 569999999999999999999999999999999999999   6778899999


Q ss_pred             eccccccCCC-----CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 019040          199 FGLSIFFKPG-----ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID  271 (347)
Q Consensus       199 fg~a~~~~~~-----~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  271 (347)
                      ||++......     .......||+.|+|||++.+  .++.++||||||+++|+|++|..||.+.........+......
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  247 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  247 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999765422     22344578999999998753  4899999999999999999999999999988888888776665


Q ss_pred             ccCCCCCCC----------------------------CHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          272 FKRDPWPNV----------------------------SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       272 ~~~~~~~~~----------------------------~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      .+...++..                            ++.+.+||.+||+.||++|||+.++|+||||+....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            555444332                            678999999999999999999999999999987643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.3e-48  Score=350.45  Aligned_cols=256  Identities=27%  Similarity=0.473  Sum_probs=221.4

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ..|...+.||.|+||.||+|+++.+|+.||||++....   ....+.+.+|+.+++.+ +|+||+++++++...+..++|
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEE
Confidence            45888899999999999999999999999999986542   33456788999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      |||+++++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++....... 
T Consensus       121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC
T ss_pred             EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc
Confidence            999999999998754 479999999999999999999999999999999999999   667889999999988654432 


Q ss_pred             cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+....... ......+++.+.++|
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  275 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSHKVSPVLRDFL  275 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGGGSCHHHHHHH
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccccCCHHHHHHH
Confidence            2345679999999998764 48999999999999999999999999888777666665543221 112236789999999


Q ss_pred             HHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          289 RQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .+||+.||++|||+.++++||||.+..
T Consensus       276 ~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          276 ERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHccCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999999998764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=359.86  Aligned_cols=255  Identities=31%  Similarity=0.543  Sum_probs=219.8

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccch-----hcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA-----VDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      ..+.++|++.+.||.|+||+||+|.++.+++.||+|++........     .....+.+|+.+++.+ +||||+++++++
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~   98 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIF   98 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEE
Confidence            4567899999999999999999999999999999999976543221     1334577799999999 999999999999


Q ss_pred             eeCCeEEEEEEecCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          122 EDDNAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       122 ~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                      .+.+..++||||+.++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg  175 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFG  175 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCT
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeecc
Confidence            9999999999999766 999999888889999999999999999999999999999999999999   667889999999


Q ss_pred             cccccCCCCcccccccCcccccccccccc-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLKRN-Y-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ++.............||+.|+|||++.+. + +.++||||||+++|+|++|..||......          .........
T Consensus       176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~~~~~~~~  245 (335)
T 3dls_A          176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------VEAAIHPPY  245 (335)
T ss_dssp             TCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------TTTCCCCSS
T ss_pred             cceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------HhhccCCCc
Confidence            99887666655667899999999987643 4 78899999999999999999999663321          111122233


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .+++++.+||..||+.||++|||+.++++||||++..
T Consensus       246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            6899999999999999999999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.8e-48  Score=347.94  Aligned_cols=268  Identities=26%  Similarity=0.409  Sum_probs=224.8

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      ..+..+.++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++..
T Consensus         4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~   82 (294)
T 4eqm_A            4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEE   82 (294)
T ss_dssp             CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEEC
T ss_pred             chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeee
Confidence            45677889999999999999999999999999999999998766555556677899999999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      .+..++||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~  159 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAK  159 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSST
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCcc
Confidence            99999999999999999999988889999999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCCC--cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-cccCCCCCC
Q 019040          204 FFKPGE--RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPWPN  279 (347)
Q Consensus       204 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~  279 (347)
                      ......  ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+............... .........
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T 4eqm_A          160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD  239 (294)
T ss_dssp             TC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTT
T ss_pred             ccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccC
Confidence            654332  2234578999999998764 488999999999999999999999998887665544444332 222233457


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +++.+.++|.+||+.||.+||+..+.+.+.|..-..
T Consensus       240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            899999999999999999999777777776665444

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-48  Score=357.58  Aligned_cols=262  Identities=25%  Similarity=0.414  Sum_probs=216.7

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--  124 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--  124 (347)
                      ..+.++|++++.||.|+||.||+|.+..+|+.||||++... .........+.+|+.+++.+ +||||+++++++...  
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDET   98 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSS
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCc
Confidence            34578999999999999999999999999999999998653 23344567789999999999 899999999999765  


Q ss_pred             ----CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          125 ----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       125 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                          ..+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg  173 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFG  173 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred             cccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeee
Confidence                3469999999 7899998876 479999999999999999999999999999999999999   677889999999


Q ss_pred             cccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc-----
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-----  273 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----  273 (347)
                      ++.....  ......+|+.|+|||++.+  .++.++||||||+++++|++|..||.+.+..+....+.......+     
T Consensus       174 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          174 LARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             TCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9987543  2345678999999998754  589999999999999999999999999888777666654322111     


Q ss_pred             ----------------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          274 ----------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       274 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                            ...++..++++.+||.+||+.||++|||+.++|+||||+.....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                                  11234678999999999999999999999999999999987543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.3e-49  Score=375.65  Aligned_cols=259  Identities=31%  Similarity=0.514  Sum_probs=225.8

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...++|++.+.||.|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEE
Confidence            3457899999999999999999999999999999999876555555667889999999999 999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          128 HLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      |+||||++|++|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAV  337 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceee
Confidence            9999999999999999764    359999999999999999999999999999999999999   678899999999998


Q ss_pred             ccCCCCc-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccccccCCCC
Q 019040          204 FFKPGER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       204 ~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~  277 (347)
                      ....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||....    .....+.+......++    
T Consensus       338 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----  413 (543)
T 3c4z_A          338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----  413 (543)
T ss_dssp             ECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----
T ss_pred             eccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----
Confidence            7654433 334589999999998865 59999999999999999999999997753    3455555555544332    


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCcccccC
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~  314 (347)
                      ..++.++.+||.+||+.||.+||+     +.++++||||+..
T Consensus       414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            478999999999999999999996     5899999999873

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2e-48  Score=365.77  Aligned_cols=267  Identities=28%  Similarity=0.530  Sum_probs=214.7

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .....+.++|++++.||.|+||.||+|.++.+++.||||++... .........+.+|+.+++.+ +|+||+++++++..
T Consensus        19 ~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~   96 (432)
T 3n9x_A           19 IKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRL-KSDYIIRLYDLIIP   96 (432)
T ss_dssp             GGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCC
T ss_pred             CCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEec
Confidence            34556778999999999999999999999999999999998643 33445567899999999999 89999999999877


Q ss_pred             C-----CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          124 D-----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       124 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      .     +..|+||||++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|
T Consensus        97 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~D  172 (432)
T 3n9x_A           97 DDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCD  172 (432)
T ss_dssp             SCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECC
T ss_pred             CCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEcc
Confidence            6     67999999996 5999999888889999999999999999999999999999999999999   6778899999


Q ss_pred             eccccccCCCC-----------------------cccccccCccccccccc-c-ccCCCchhHHHHHHHHHHHHhC----
Q 019040          199 FGLSIFFKPGE-----------------------RFSEIVGSPYYMAPEVL-K-RNYGPEIDIWSAGVILYILLCG----  249 (347)
Q Consensus       199 fg~a~~~~~~~-----------------------~~~~~~~~~~y~aPE~~-~-~~~~~~~Di~slG~~l~~l~~g----  249 (347)
                      ||++.......                       ......||+.|+|||++ . ..++.++||||||+++|+|++|    
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            99998764332                       12456899999999975 3 4599999999999999999984    


Q ss_pred             -------CCCCCCCC-----------------HHHHHHHHHhccccc--------------------cC-------CCCC
Q 019040          250 -------VPPFWAES-----------------EQGVAQAILRGLIDF--------------------KR-------DPWP  278 (347)
Q Consensus       250 -------~~pf~~~~-----------------~~~~~~~~~~~~~~~--------------------~~-------~~~~  278 (347)
                             .++|.+..                 ..+.+..+.......                    +.       ..++
T Consensus       253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (432)
T 3n9x_A          253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP  332 (432)
T ss_dssp             CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred             ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence                   44444432                 112222222111110                    00       0124


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      .+++++.+||.+||+.||++|||+.++|+||||+....
T Consensus       333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence            68999999999999999999999999999999998753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.2e-48  Score=355.35  Aligned_cols=260  Identities=28%  Similarity=0.449  Sum_probs=224.0

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .....++|++++.||.|+||+||+|++..+++.||||++.............+.+|+.+++.+ +||||+++++++...+
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  127 (348)
T 1u5q_A           49 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREH  127 (348)
T ss_dssp             CSCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETT
T ss_pred             ccchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECC
Confidence            344567899999999999999999999999999999999765444455567789999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..++||||+. ++|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBS
T ss_pred             eEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCcee
Confidence            9999999997 588887754 4579999999999999999999999999999999999999   5677899999999976


Q ss_pred             cCCCCcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          205 FKPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       205 ~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      ....   ....||+.|+|||++.    +.++.++||||||+++|+|++|..||...+.......+......  ......+
T Consensus       204 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  278 (348)
T 1u5q_A          204 MAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHW  278 (348)
T ss_dssp             SSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--CCCCTTS
T ss_pred             cCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCCCCC
Confidence            5432   3457999999999873    45899999999999999999999999888877666666554322  2223467


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ++.+.++|..||+.||++|||+.++++||||....
T Consensus       279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            89999999999999999999999999999998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.8e-48  Score=343.75  Aligned_cols=258  Identities=22%  Similarity=0.375  Sum_probs=218.2

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee----CC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----DN  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~----~~  125 (347)
                      ...|++.+.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+++.+ +||||+++++++..    ..
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCc
Confidence            4568999999999999999999999999999999875443 334567889999999999 99999999998875    46


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      ..++||||+++++|.+++.....++...++.++.||+.||.|||+.|  |+|+||||+||+++  ..++.++|+|||++.
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcc
Confidence            78999999999999999988888999999999999999999999999  99999999999994  267789999999997


Q ss_pred             ccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccccCCCCCCCCH
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ..... ......+++.|+|||.+.+.++.++||||||+++|+|++|..||...... .....+......  .......++
T Consensus       181 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  257 (290)
T 1t4h_A          181 LKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIP  257 (290)
T ss_dssp             GCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCH
T ss_pred             ccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc--cccCCCCCH
Confidence            64433 33445799999999998888999999999999999999999999875544 333444333221  112235678


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ++.++|..||+.||++|||+.++++||||++.
T Consensus       258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            99999999999999999999999999999863

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-48  Score=356.16  Aligned_cols=265  Identities=28%  Similarity=0.421  Sum_probs=216.8

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc--hhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT--AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ...++|++.+.||.|+||.||+|.+..+|+.||+|++.......  ......+.+|+.+++.+ +||||+++++++...+
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTT
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCC
Confidence            34578999999999999999999999999999999987543221  11234678899999999 8999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..++|+||+++ +|..++.... .+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEeccccee
Confidence            99999999976 8888887653 58999999999999999999999999999999999999   6778899999999987


Q ss_pred             cCCC-CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC----
Q 019040          205 FKPG-ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW----  277 (347)
Q Consensus       205 ~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  277 (347)
                      .... .......+|+.|+|||.+.+  .++.++||||||+++|+|++|..||.+....+....+...........|    
T Consensus       162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            6433 23345678999999998753  3888999999999999999999999999888877777665433222221    


Q ss_pred             --------------------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          278 --------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       278 --------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                          ..++.++.+||.+||+.||++|||+.++|+||||++...+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence                                3567899999999999999999999999999999886543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.5e-48  Score=351.80  Aligned_cols=269  Identities=38%  Similarity=0.686  Sum_probs=198.5

Q ss_pred             CCCCCcccceeeee-eecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHH-HHhCCCCCceeEeeeEE
Q 019040           44 VPKENIEDRYLVDR-ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI-MKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        44 ~~~~~~~~~y~i~~-~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~-l~~l~~h~~i~~~~~~~  121 (347)
                      .....+.++|++.+ .||.|+||+||+|.++.+++.||+|++...        ....+|+.. ++.+ +|+|++++++++
T Consensus        21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~-~h~~i~~~~~~~   91 (336)
T 3fhr_A           21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQAS-GGPHIVCILDVY   91 (336)
T ss_dssp             CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHT-TSTTBCCEEEEE
T ss_pred             CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhc-CCCChHHHHHHH
Confidence            44556789999965 699999999999999999999999998542        122334443 4455 999999999998


Q ss_pred             ee----CCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEE
Q 019040          122 ED----DNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (347)
Q Consensus       122 ~~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~  195 (347)
                      ..    ....++||||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.++.++.++
T Consensus        92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~k  171 (336)
T 3fhr_A           92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK  171 (336)
T ss_dssp             EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred             hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEE
Confidence            76    556899999999999999998764  599999999999999999999999999999999999997666677899


Q ss_pred             EEeeccccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccc
Q 019040          196 AIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV----AQAILRGLI  270 (347)
Q Consensus       196 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~  270 (347)
                      |+|||++...... ......+|+.|+|||++. ..++.++||||||+++|+|++|..||........    ...+.....
T Consensus       172 l~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (336)
T 3fhr_A          172 LTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY  250 (336)
T ss_dssp             ECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred             Eeccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence            9999999865432 234457899999999885 4488899999999999999999999977665443    233333444


Q ss_pred             cccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCC
Q 019040          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL  322 (347)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~  322 (347)
                      .++.+.+..++.++.+||..||+.||++|||+.++++||||++....+...+
T Consensus       251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~  302 (336)
T 3fhr_A          251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL  302 (336)
T ss_dssp             CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCBC
T ss_pred             ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCcc
Confidence            4555566789999999999999999999999999999999998776555433

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-47  Score=343.69  Aligned_cols=277  Identities=27%  Similarity=0.447  Sum_probs=234.4

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ....++|++.+.||.|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.+ +||||+++++++...+.
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred             CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCe
Confidence            3456789999999999999999999999999999999865432  33467899999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .++|+||+++++|.+++.. ..++...+..++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||++....
T Consensus        95 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~  170 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLT  170 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECB
T ss_pred             EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecC
Confidence            9999999999999998854 479999999999999999999999999999999999999   677889999999997754


Q ss_pred             CCC-cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          207 PGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       207 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      ... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+.....   ......++..+
T Consensus       171 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  247 (303)
T 3a7i_A          171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPL  247 (303)
T ss_dssp             TTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CCCCSSCCHHH
T ss_pred             ccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC---CCCccccCHHH
Confidence            432 2344578999999998764 588999999999999999999999988887766665554432   22334789999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhhhhHH
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSM  335 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (347)
                      .++|..||+.||.+|||+.++++||||.+.....  ..........++|+-
T Consensus       248 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~--~~~~~~~~~~~~~~~  296 (303)
T 3a7i_A          248 KEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT--SYLTELIDRYKRWKA  296 (303)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCG--GGGHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhhChhhhcCCCcc--HHHHHHHHHHHHhhh
Confidence            9999999999999999999999999998765433  233555566666644

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.2e-48  Score=349.74  Aligned_cols=257  Identities=26%  Similarity=0.501  Sum_probs=213.5

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee--CC
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DN  125 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~--~~  125 (347)
                      ...++|++++.||.|+||+||+|.+..+++.||+|++...      ....+.+|+.+++.+.+|+||+++++++..  ..
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            3458999999999999999999999999999999998532      346788999999999669999999999987  67


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ..++||||+++++|.+++.   .+++..+..++.||+.||.|||++||+||||||+|||++  .+...++|+|||++...
T Consensus       107 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEEC
T ss_pred             ceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEc
Confidence            8999999999999988774   389999999999999999999999999999999999995  23337999999999877


Q ss_pred             CCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccc------------
Q 019040          206 KPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLI------------  270 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~------------  270 (347)
                      ..........+++.|+|||.+.+  .++.++||||||+++|+|++|..||.... ..+....+.....            
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            66666666789999999998754  48999999999999999999999995443 2222222211110            


Q ss_pred             -cc--------------------cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          271 -DF--------------------KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       271 -~~--------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                       ..                    .......+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence             00                    0011123789999999999999999999999999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-48  Score=353.43  Aligned_cols=261  Identities=26%  Similarity=0.462  Sum_probs=217.7

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++++.||.|+||.||+|++..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...+..+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEE
Confidence            3479999999999999999999999999999999986543 2333456688999999999 8999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||||+++++|..++.....+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++......
T Consensus       101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC------
T ss_pred             EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCC
Confidence            999999998898887777789999999999999999999999999999999999999   67788999999999765433


Q ss_pred             -CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc------------
Q 019040          209 -ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK------------  273 (347)
Q Consensus       209 -~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------  273 (347)
                       .......+++.|+|||.+.+  .++.++||||||+++|+|++|..||...........+........            
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence             23344578999999998764  488999999999999999999999998887766655543221110            


Q ss_pred             -----C----------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          274 -----R----------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       274 -----~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                           .          ..++.+++++.+||.+||+.||++|||+.++|+||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                 0          0113578999999999999999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-48  Score=354.00  Aligned_cols=255  Identities=26%  Similarity=0.395  Sum_probs=206.3

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC---
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN---  125 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~---  125 (347)
                      +.++|++.+.||.|+||.||+|+++.+|+.||||++....  .....+.+.+|+.+++.+ +||||+++++++.+..   
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccch
Confidence            4578999999999999999999999999999999986543  333457799999999999 8999999999986543   


Q ss_pred             ------------------------------------------------------eEEEEEEecCCCchHHHHHhcCC---
Q 019040          126 ------------------------------------------------------AVHLVMELCEGGELFDRIVARGH---  148 (347)
Q Consensus       126 ------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~---  148 (347)
                                                                            ..++||||+++++|.+++.....   
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  38999999999999999987643   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-------------cccccc
Q 019040          149 YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-------------RFSEIV  215 (347)
Q Consensus       149 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-------------~~~~~~  215 (347)
                      .+...++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.......             ......
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            5666789999999999999999999999999999999   667889999999998765442             223357


Q ss_pred             cCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccC
Q 019040          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (347)
Q Consensus       216 ~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (347)
                      ||+.|+|||.+.+ .++.++||||||+++|+|++|..|+..  .......+....   .+..+...++++.++|..||+.
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLK---FPLLFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC---CCHHHHHHCHHHHHHHHHHHCS
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC---CCcccccCChhHHHHHHHHccC
Confidence            9999999998764 589999999999999999998766411  111222222221   1111224567889999999999


Q ss_pred             CCCCCCCHHHHhcCcccccC
Q 019040          295 DPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       295 dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ||++|||+.++++||||++.
T Consensus       313 ~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          313 SPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             SGGGSCCHHHHHHSTTCCCC
T ss_pred             CCCcCCCHHHHhhchhhhcC
Confidence            99999999999999999863

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7e-48  Score=357.26  Aligned_cols=259  Identities=26%  Similarity=0.470  Sum_probs=213.7

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCC-CCceeEeeeEEeeCCeEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK-NSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~-h~~i~~~~~~~~~~~~~~  128 (347)
                      ..+|++++.||.|+||+||+|.+.. ++.||||++..... .......+.+|+.+++.+.+ |+||+++++++...+..+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            4579999999999999999999865 88999999875533 33456789999999999954 699999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||| +.+++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++    ++.+||+|||++......
T Consensus       133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC---
T ss_pred             EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCccccccCC
Confidence            9999 55789999999888899999999999999999999999999999999999993    367999999999876433


Q ss_pred             Cc---ccccccCccccccccccc------------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccc
Q 019040          209 ER---FSEIVGSPYYMAPEVLKR------------NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDF  272 (347)
Q Consensus       209 ~~---~~~~~~~~~y~aPE~~~~------------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~  272 (347)
                      ..   .....||+.|+|||++.+            .++.++||||||+++|+|++|..||...... .....+.......
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~  287 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  287 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence            22   234579999999998753            4888999999999999999999999775433 3444444433322


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      .  .....+.++.+||..||+.||++|||+.++|+||||+....+
T Consensus       288 ~--~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~  330 (390)
T 2zmd_A          288 E--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  330 (390)
T ss_dssp             C--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred             C--CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence            2  223457899999999999999999999999999999876543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-47  Score=341.03  Aligned_cols=258  Identities=23%  Similarity=0.331  Sum_probs=213.6

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .+.++|++.+.||.|+||+||+|.+..+++.||+|++..... .......+.+|+..+..+.+||||+++++++.+.+..
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            456889999999999999999999999999999999875432 2334567888999999998899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC--------------
Q 019040          128 HLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK--------------  189 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~--------------  189 (347)
                      ++|+||+++++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+||+++.++              
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999999764    5699999999999999999999999999999999999996433              


Q ss_pred             --CCCCEEEEeeccccccCCCCcccccccCcccccccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 019040          190 --ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI  265 (347)
Q Consensus       190 --~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  265 (347)
                        ....++|+|||.+.......   ...+|+.|+|||.+.+.  ++.++||||||+++++|++|..++....   ....+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~  240 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI  240 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred             cCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence              55679999999998765432   23589999999988643  5579999999999999999988764443   23334


Q ss_pred             HhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          266 LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .....   ......+++++.++|.+||+.||++|||+.++++||||+...
T Consensus       241 ~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          241 RQGRL---PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HTTCC---CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HcCCC---CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            33322   222347899999999999999999999999999999998764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.6e-48  Score=360.43  Aligned_cols=261  Identities=28%  Similarity=0.432  Sum_probs=214.2

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      +......+|++.+.||.|+||.||+|++..+|+.||||++.....       ...+|+++++.+ +|+||+++++++...
T Consensus        48 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l-~hpniv~l~~~~~~~  119 (420)
T 1j1b_A           48 PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKL-DHCNIVRLRYFFYSS  119 (420)
T ss_dssp             SCCCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTC-CCTTBCCEEEEEEEE
T ss_pred             CCCcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHc-CCCCccceeeEEecc
Confidence            344456789999999999999999999999999999999864321       133699999999 999999999988532


Q ss_pred             ------CeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCE
Q 019040          125 ------NAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (347)
Q Consensus       125 ------~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~  194 (347)
                            ...++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||++  .+.+.+
T Consensus       120 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~  196 (420)
T 1j1b_A          120 GEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVL  196 (420)
T ss_dssp             ETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEE
T ss_pred             CCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeE
Confidence                  347799999976 66666543    45699999999999999999999999999999999999995  234568


Q ss_pred             EEEeeccccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-
Q 019040          195 KAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-  271 (347)
Q Consensus       195 ~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  271 (347)
                      ||+|||++.............+|+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+.+..+.+.... 
T Consensus       197 kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p  276 (420)
T 1j1b_A          197 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP  276 (420)
T ss_dssp             EECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             EeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999999987665555556789999999998753  5899999999999999999999999998877766666542211 


Q ss_pred             ----------------ccC---C-----CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          272 ----------------FKR---D-----PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       272 ----------------~~~---~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                                      ++.   .     ....++.++.+||.+||+.||.+|||+.++++||||+....
T Consensus       277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence                            000   0     11356899999999999999999999999999999987653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-48  Score=357.59  Aligned_cols=257  Identities=25%  Similarity=0.418  Sum_probs=214.3

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee----
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----  123 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~----  123 (347)
                      ...++|++++.||.|+||+||+|.+..+|+.||+|++..+..       ...+|+.+++.+ +|+||+++++++..    
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVL-DHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTC-CCTTBCCEEEEEEEC---
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHc-CCCCccchhheeeecCcc
Confidence            345789999999999999999999999999999999864421       123699999999 99999999999843    


Q ss_pred             ----------------------------------CCeEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHH
Q 019040          124 ----------------------------------DNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVV  165 (347)
Q Consensus       124 ----------------------------------~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l  165 (347)
                                                        ....++||||+++ +|.+.+..    ...+++..++.++.||+.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                              3458999999975 77776653    46799999999999999999


Q ss_pred             HHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHH
Q 019040          166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVIL  243 (347)
Q Consensus       166 ~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l  243 (347)
                      .|||++||+||||||+||+++  ..++.++|+|||++.............+|+.|+|||.+.+  .++.++||||||+++
T Consensus       155 ~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          155 GFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            999999999999999999995  2567899999999987766666666789999999998753  489999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhcccccc-----------------C--------CCCCCCCHHHHHHHHHhccCCCCC
Q 019040          244 YILLCGVPPFWAESEQGVAQAILRGLIDFK-----------------R--------DPWPNVSESAKSLVRQMLEPDPKL  298 (347)
Q Consensus       244 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------~--------~~~~~~~~~~~~li~~~l~~dp~~  298 (347)
                      |+|++|..||.+....+....+........                 .        .....+++++.+||.+||+.||++
T Consensus       233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence            999999999999888877777654322110                 0        012357899999999999999999


Q ss_pred             CCCHHHHhcCcccccCc
Q 019040          299 RLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       299 Rps~~~ll~h~~~~~~~  315 (347)
                      |||+.++|+||||+...
T Consensus       313 R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          313 RINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             SCCHHHHHTSGGGHHHH
T ss_pred             CCCHHHHhcCHHHHHHH
Confidence            99999999999998654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.9e-48  Score=353.95  Aligned_cols=261  Identities=28%  Similarity=0.454  Sum_probs=219.5

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC---
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~---  124 (347)
                      .+.++|++++.||.|+||.||+|.+..+++.||+|++....  .......+.+|+++++.+ +||||+++++++...   
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIE  100 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTT
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCcc
Confidence            34579999999999999999999999999999999986432  344457788999999999 899999999998765   


Q ss_pred             --CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 --NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                        ...++|+||+++ +|.+++... .+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++
T Consensus       101 ~~~~~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          101 QMKDVYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA  175 (364)
T ss_dssp             TCCCEEEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred             ccceEEEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcce
Confidence              478999999964 999888664 69999999999999999999999999999999999999   67788999999999


Q ss_pred             cccCCCCc----ccccccCcccccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC--
Q 019040          203 IFFKPGER----FSEIVGSPYYMAPEVLK-R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR--  274 (347)
Q Consensus       203 ~~~~~~~~----~~~~~~~~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--  274 (347)
                      ........    .....||+.|+|||++. . .++.++||||||+++|+|++|..||.+....+....+.........  
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  255 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            86543322    23457999999999864 3 3899999999999999999999999988877766666433221110  


Q ss_pred             -------------------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          275 -------------------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       275 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                                               ...+.+++++.+||.+||+.||++|||+.++|+||||++...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                                     011367899999999999999999999999999999998643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.4e-48  Score=340.75  Aligned_cols=260  Identities=28%  Similarity=0.518  Sum_probs=220.4

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      +.++|++.+.||.|+||.||+|.++.+++.||+|++.....  ......+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML-NHENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEE
Confidence            45789999999999999999999999999999999865432  23457789999999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +|+||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||.+......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCC
Confidence            999999999999998777779999999999999999999999999999999999999   66788999999998765322


Q ss_pred             C---cccccccCcccccccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccccCCCCCCCCH
Q 019040          209 E---RFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       209 ~---~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .   ......+++.|+|||.+.+.  ++.++||||||+++|+|++|..||...... .....+.....  ....+..++.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDS  236 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT--TSTTGGGSCH
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc--ccCchhhcCH
Confidence            2   23345789999999988643  467899999999999999999999776543 22333333222  1223457899


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      .+.++|..||+.||++|||+.++++||||++...
T Consensus       237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            9999999999999999999999999999987753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.4e-48  Score=357.48  Aligned_cols=263  Identities=27%  Similarity=0.441  Sum_probs=205.3

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC-
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD-  124 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~-  124 (347)
                      ...+.++|++++.||.|+||.||+|.+..+|+.||||++... .........+.+|+.+++.+ +||||+++++++... 
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPAR  101 (367)
T ss_dssp             EEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST-TSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCS
T ss_pred             ccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCC
Confidence            345568999999999999999999999999999999998653 23344567788999999999 899999999998654 


Q ss_pred             -----CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          125 -----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       125 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                           ...++++|++ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++   +.++.+||+||
T Consensus       102 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DF  176 (367)
T 2fst_X          102 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDF  176 (367)
T ss_dssp             SGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC-
T ss_pred             ccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeec
Confidence                 5689999999 7799988865 579999999999999999999999999999999999999   67788999999


Q ss_pred             ccccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-----
Q 019040          200 GLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF-----  272 (347)
Q Consensus       200 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----  272 (347)
                      |++.....  ......+|+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+.+.....     
T Consensus       177 G~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          177 GLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99986543  2345679999999998754  58999999999999999999999999988877766665432211     


Q ss_pred             ------------------cC----CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          273 ------------------KR----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       273 ------------------~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                        +.    ..++..++.+.+||.+||+.||++|||+.++|+||||+....+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence                              00    0123568899999999999999999999999999999987644

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6e-48  Score=361.97  Aligned_cols=268  Identities=29%  Similarity=0.456  Sum_probs=218.5

Q ss_pred             cCCCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC-----CCCceeE
Q 019040           42 AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-----KNSSIVS  116 (347)
Q Consensus        42 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~-----~h~~i~~  116 (347)
                      ...+.+.+..+|++++.||.|+||+||+|.+..+++.||||++...    ......+.+|+.+++.+.     .|+||+.
T Consensus        88 ~~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~  163 (429)
T 3kvw_A           88 VQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIH  163 (429)
T ss_dssp             CCCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred             cccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence            3456777889999999999999999999999999999999998643    223356777888888772     5679999


Q ss_pred             eeeEEeeCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCC-
Q 019040          117 LKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSP-  193 (347)
Q Consensus       117 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~-  193 (347)
                      +++++...+..++|+||+. ++|.+++....  .+++..++.++.||+.||.|||+.||+||||||+|||+   +.++. 
T Consensus       164 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl---~~~~~~  239 (429)
T 3kvw_A          164 MLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL---KQQGRS  239 (429)
T ss_dssp             EEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE---SSTTSC
T ss_pred             EEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---ccCCCc
Confidence            9999999999999999996 59999998764  48999999999999999999999999999999999999   44554 


Q ss_pred             -EEEEeeccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 019040          194 -LKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID  271 (347)
Q Consensus       194 -~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  271 (347)
                       +||+|||++.....  ......+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+.+..+......
T Consensus       240 ~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~  317 (429)
T 3kvw_A          240 GIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM  317 (429)
T ss_dssp             CEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ceEEeecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence             99999999976433  2344689999999998764 5999999999999999999999999999888777666543211


Q ss_pred             ccCC-------------------------------------------------------CCCCCCHHHHHHHHHhccCCC
Q 019040          272 FKRD-------------------------------------------------------PWPNVSESAKSLVRQMLEPDP  296 (347)
Q Consensus       272 ~~~~-------------------------------------------------------~~~~~~~~~~~li~~~l~~dp  296 (347)
                      .+..                                                       .....++++.+||.+||+.||
T Consensus       318 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP  397 (429)
T 3kvw_A          318 PSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDP  397 (429)
T ss_dssp             CCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSST
T ss_pred             CCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCCh
Confidence            1000                                                       001247889999999999999


Q ss_pred             CCCCCHHHHhcCcccccCcCCCC
Q 019040          297 KLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       297 ~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                      ++|||+.++|+||||++....+.
T Consensus       398 ~~Rpta~e~L~Hpw~~~~~~~~~  420 (429)
T 3kvw_A          398 AVRMTPGQALRHPWLRRRLPKPP  420 (429)
T ss_dssp             TTSCCHHHHHTSTTTC-------
T ss_pred             hhCCCHHHHhCChhhccCCCCCC
Confidence            99999999999999998764443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-48  Score=358.22  Aligned_cols=259  Identities=32%  Similarity=0.538  Sum_probs=217.0

Q ss_pred             cccceeeeeeecccCCeEEEEEEEC---CCCceeEEeEecccccc-chhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ..++|++++.||.|+||.||+|++.   .+++.||+|++...... .......+.+|+.+++.+.+||||+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            3479999999999999999999984   58899999998764321 2223345677999999997799999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      +..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++..
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred             ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence            9999999999999999999888889999999999999999999999999999999999999   6778899999999976


Q ss_pred             cCCCC--cccccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccccccCC
Q 019040          205 FKPGE--RFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESE----QGVAQAILRGLIDFKRD  275 (347)
Q Consensus       205 ~~~~~--~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~  275 (347)
                      .....  ......||+.|+|||++.+   .++.++||||||+++|+|++|..||.....    ......+...    ...
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----~~~  284 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----EPP  284 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC----CCC
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc----CCC
Confidence            53322  2234579999999998763   378899999999999999999999975432    2333333333    233


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          276 PWPNVSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      ....++..+.+||.+||+.||++||     ++.++++||||++.
T Consensus       285 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            3457899999999999999999999     99999999999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.6e-48  Score=356.42  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=207.9

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC--
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN--  125 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~--  125 (347)
                      .+.++|++++.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+ +||||+++++++...+  
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCST
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhc-CCCCccceEEeecccccc
Confidence            35689999999999999999999999999999999986532 3344567788999999999 9999999999987664  


Q ss_pred             ----eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          126 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       126 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                          ..++||||+++ +|.+.+..  .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       100 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          100 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  173 (371)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC
T ss_pred             ccccceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeec
Confidence                78999999975 78888753  58999999999999999999999999999999999999   6778899999999


Q ss_pred             ccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC------
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR------  274 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------  274 (347)
                      +.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+........+      
T Consensus       174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            987655544555689999999998764 5899999999999999999999999998887777666554322110      


Q ss_pred             -----------CCC--------------C-------CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          275 -----------DPW--------------P-------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       275 -----------~~~--------------~-------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                 +.+              +       ..+.++.+||.+||+.||++|||+.++|+||||+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                       000              0       0146789999999999999999999999999998643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.7e-48  Score=358.98  Aligned_cols=265  Identities=29%  Similarity=0.422  Sum_probs=217.1

Q ss_pred             ecCCCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           41 LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        41 ~~~~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      .....+.....+|++.+.||.|+||+||+|++..+++ ||+|.+......       ..+|+++++.+ +||||++++++
T Consensus        30 ~~~~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l-~h~niv~l~~~  100 (394)
T 4e7w_A           30 SDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIV-KHPNVVDLKAF  100 (394)
T ss_dssp             EESSSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTC-CCTTBCCEEEE
T ss_pred             cCCCCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhC-CCCCcceEEEE
Confidence            4445667778899999999999999999999987776 888877543211       23599999999 99999999999


Q ss_pred             EeeCC------eEEEEEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC
Q 019040          121 CEDDN------AVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE  190 (347)
Q Consensus       121 ~~~~~------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~  190 (347)
                      +...+      ..++||||+++ ++...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++  ..
T Consensus       101 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~  177 (394)
T 4e7w_A          101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PP  177 (394)
T ss_dssp             EEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TT
T ss_pred             EEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CC
Confidence            86543      38899999976 4444443    245799999999999999999999999999999999999994  26


Q ss_pred             CCCEEEEeeccccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 019040          191 NSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG  268 (347)
Q Consensus       191 ~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  268 (347)
                      ++.+||+|||++.............+|+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+...
T Consensus       178 ~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~  257 (394)
T 4e7w_A          178 SGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV  257 (394)
T ss_dssp             TTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             CCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            77899999999988766666666789999999998753  4899999999999999999999999998887777666543


Q ss_pred             ccccc------------C-------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          269 LIDFK------------R-------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       269 ~~~~~------------~-------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      .....            .             .....+++++.+||.+||+.||.+|||+.++++||||+.....
T Consensus       258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence            21110            0             0112478999999999999999999999999999999987544

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.5e-48  Score=353.55  Aligned_cols=262  Identities=24%  Similarity=0.355  Sum_probs=220.7

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .++...++|++.+.||.|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.+ +||||+++++++...
T Consensus        27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  103 (360)
T 3eqc_A           27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD  103 (360)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEET
T ss_pred             ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEEC
Confidence            34556789999999999999999999999999999999986542  334457789999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      +..++||||+++++|.+++.....+++..+..++.|++.||.|||+. ||+|+||||+||++   +.++.++|+|||++.
T Consensus       104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSG  180 (360)
T ss_dssp             TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCH
T ss_pred             CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCc
Confidence            99999999999999999999888899999999999999999999996 99999999999999   667889999999986


Q ss_pred             ccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----------------
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI-----------------  265 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-----------------  265 (347)
                      ..... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+                 
T Consensus       181 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          181 QLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             HHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             ccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence            54322 2234578999999998764 4899999999999999999999999877665432221                 


Q ss_pred             -------------------------HhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          266 -------------------------LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       266 -------------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                               ....  .+......++.++.+||.+||+.||++|||+.++|+||||+...
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                                     1111  11111234789999999999999999999999999999998764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4e-48  Score=349.57  Aligned_cols=261  Identities=23%  Similarity=0.381  Sum_probs=215.0

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC-
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-  125 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~-  125 (347)
                      ....++|++.+.||+|+||+||+|.+..+++.||+|++.....  ....+.+.+|+.+++.+ +||||+++++++...+ 
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTT   81 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTT
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCC
Confidence            3567899999999999999999999999999999999875432  23356788999999999 8999999999988765 


Q ss_pred             -eEEEEEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeec-CCCCCCEEEEeec
Q 019040          126 -AVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN-KKENSPLKAIDFG  200 (347)
Q Consensus       126 -~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~-~~~~~~~~l~Dfg  200 (347)
                       ..++||||+++++|.+++.....   +++..++.++.||+.||.|||+.||+||||||+||++.. ++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence             88999999999999999977533   899999999999999999999999999999999999843 3455679999999


Q ss_pred             cccccCCCCcccccccCcccccccccc---------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLK---------RNYGPEIDIWSAGVILYILLCGVPPFWAESE----QGVAQAILR  267 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~  267 (347)
                      ++.............||+.|+|||++.         ..++.++||||||+++|+|++|..||.....    ......+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            998876666666678999999999874         4588999999999999999999999964332    334444443


Q ss_pred             ccccc-------------------cC--CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcc
Q 019040          268 GLIDF-------------------KR--DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (347)
Q Consensus       268 ~~~~~-------------------~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  310 (347)
                      +....                   +.  .....++..+.++|.+||+.||++|||+.++|+||-
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            32210                   00  011134567889999999999999999999999974

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.4e-47  Score=347.33  Aligned_cols=267  Identities=30%  Similarity=0.454  Sum_probs=220.2

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ....+.++|++.+.||.|+||.||+|.+..+|+.||||++...  ........+.+|+.+++.+ +||||+++++++...
T Consensus         5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   81 (353)
T 2b9h_A            5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHF-KHENIITIFNIQRPD   81 (353)
T ss_dssp             CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCS
T ss_pred             cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhC-cCCCcCCeeeeeccc
Confidence            3456778999999999999999999999999999999998543  2334456788999999999 899999999987654


Q ss_pred             -----CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          125 -----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       125 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                           ...++|+||++ ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+||
T Consensus        82 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Df  156 (353)
T 2b9h_A           82 SFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDF  156 (353)
T ss_dssp             CSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCC
T ss_pred             ccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEec
Confidence                 78999999996 599988876 479999999999999999999999999999999999999   67788999999


Q ss_pred             ccccccCCCCc-----------ccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 019040          200 GLSIFFKPGER-----------FSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL  266 (347)
Q Consensus       200 g~a~~~~~~~~-----------~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  266 (347)
                      |++........           .....||+.|+|||++.  ..++.++||||||+++|+|++|..||.+.+.......+.
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  236 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF  236 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            99986543211           12346899999999864  458899999999999999999999999888766555443


Q ss_pred             hcccccc------------------------C----CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCC
Q 019040          267 RGLIDFK------------------------R----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (347)
Q Consensus       267 ~~~~~~~------------------------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  318 (347)
                      .......                        .    ..++.+++++.+||.+||+.||++|||+.++++||||+......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence            3211110                        0    01246889999999999999999999999999999999876543


Q ss_pred             C
Q 019040          319 N  319 (347)
Q Consensus       319 ~  319 (347)
                      .
T Consensus       317 ~  317 (353)
T 2b9h_A          317 D  317 (353)
T ss_dssp             S
T ss_pred             c
Confidence            3

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=342.72  Aligned_cols=261  Identities=25%  Similarity=0.490  Sum_probs=219.3

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc-hhcHHHHHHHHHHHHhCCCCCceeEeeeEE--eeCC
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-AVDIDDVRREVAIMKHLPKNSSIVSLKEAC--EDDN  125 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~--~~~~  125 (347)
                      +.++|++.+.||.|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.+ +|+||+++++++  ...+
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCC
Confidence            4579999999999999999999999999999999997654322 33457799999999999 899999999998  4556


Q ss_pred             eEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          126 AVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      ..++||||++++ |.+++...  ..+++..+..++.||+.||.|||++||+|+||||+||++   +.++.++|+|||.+.
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeecccccc
Confidence            899999999775 77777663  459999999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCC---CcccccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC
Q 019040          204 FFKPG---ERFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       204 ~~~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  277 (347)
                      .....   .......+++.|+|||.+.+   .++.++||||||+++|+|++|..||...........+.......+    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----  233 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP----  233 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----
Confidence            65432   22234568999999998764   247799999999999999999999999888877777766644332    


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCC
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  318 (347)
                      ..++..+.++|.+||+.||++|||+.++++||||++.....
T Consensus       234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence            36899999999999999999999999999999998876543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-47  Score=342.09  Aligned_cols=260  Identities=27%  Similarity=0.444  Sum_probs=216.4

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee---
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED---  123 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~---  123 (347)
                      ....++|++.+.||.|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.+.+||||+++++++..   
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            345789999999999999999999999999999999986432    2346788999999999789999999999987   


Q ss_pred             ---CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          124 ---DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       124 ---~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                         .+..++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.||+|+||||+||++   +.++.++|+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~D  172 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVD  172 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECC
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEee
Confidence               56899999999999999999875  468999999999999999999999999999999999999   6778899999


Q ss_pred             eccccccCCCC-cccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 019040          199 FGLSIFFKPGE-RFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID  271 (347)
Q Consensus       199 fg~a~~~~~~~-~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  271 (347)
                      ||++....... ......+++.|+|||.+.      ..++.++||||||+++|+|++|..||...........+..... 
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-  251 (326)
T 2x7f_A          173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-  251 (326)
T ss_dssp             CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-
T ss_pred             CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-
Confidence            99987654322 223457899999999874      3488999999999999999999999988887666555544322 


Q ss_pred             ccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                       +......++..+.++|.+||+.||.+|||+.++++||||++..
T Consensus       252 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          252 -PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             -CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             -ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence             2222346799999999999999999999999999999998764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.8e-47  Score=339.05  Aligned_cols=261  Identities=23%  Similarity=0.275  Sum_probs=201.3

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...++|++.+.||.|+||+||+|.+..+++.||+|++..... .......+.++...++.+ +||||+++++++...+..
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCE
Confidence            446899999999999999999999999999999999865421 222233344444456666 999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          128 HLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+||++   +.++.++|+|||++
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGIS  157 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC---
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCc
Confidence            999999975 88777654    45799999999999999999999998 99999999999999   66788999999999


Q ss_pred             cccCCCCcccccccCccccccccc----c-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccccccCCC
Q 019040          203 IFFKPGERFSEIVGSPYYMAPEVL----K-RNYGPEIDIWSAGVILYILLCGVPPFWAE-SEQGVAQAILRGLIDFKRDP  276 (347)
Q Consensus       203 ~~~~~~~~~~~~~~~~~y~aPE~~----~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~  276 (347)
                      .............+|+.|+|||.+    . ..++.++||||||+++|+|++|..||... ..............  +...
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~  235 (290)
T 3fme_A          158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--PQLP  235 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--CCCC
T ss_pred             ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--CCcc
Confidence            876655555555799999999985    2 34888999999999999999999999763 33333333333322  1222


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      ...+++++.++|.+||+.||++|||+.++++||||+....
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~  275 (290)
T 3fme_A          236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES  275 (290)
T ss_dssp             TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence            2468999999999999999999999999999999987643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.6e-47  Score=340.40  Aligned_cols=262  Identities=27%  Similarity=0.438  Sum_probs=219.0

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .....++|++.+.||.|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.+ +||||+++++++...+
T Consensus        14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATC-DHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-
T ss_pred             ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCC
Confidence            345678999999999999999999999999999999998654   234467889999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||||+||++   +.++.++|+|||++..
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAK  166 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCcc
Confidence            99999999999999998876 4569999999999999999999999999999999999999   6678899999998754


Q ss_pred             cCCC-CcccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC
Q 019040          205 FKPG-ERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       205 ~~~~-~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  277 (347)
                      .... .......+++.|+|||.+.      ..++.++||||||+++|+|++|..||...........+....... ....
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~  245 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-LLTP  245 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSG
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-cCCc
Confidence            2211 1123347899999999872      348889999999999999999999999888777666665543221 1122


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ..++..+.++|..||+.||++|||+.++++||||+...
T Consensus       246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            36789999999999999999999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5e-49  Score=363.62  Aligned_cols=253  Identities=16%  Similarity=0.216  Sum_probs=205.0

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC--CCCceeEee-------
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLK-------  118 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~--~h~~i~~~~-------  118 (347)
                      ...++|++.+.||.|+||+||+|+++.+|+.||||++...........+.+.+|+.+++.+.  +||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            34578999999999999999999999999999999998665555556788999996555553  799999988       


Q ss_pred             eEEeeCC-----------------eEEEEEEecCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCcE
Q 019040          119 EACEDDN-----------------AVHLVMELCEGGELFDRIVARGHYTE-------RAAAAVTRTIVEVVQLCHKHGVI  174 (347)
Q Consensus       119 ~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~i~~qi~~~l~~lH~~~iv  174 (347)
                      +++...+                 ..|++|||+ +++|.+++.....+++       ..++.++.||+.||.|||++||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            6665553                 388999999 5799999987654555       78888999999999999999999


Q ss_pred             eeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccccCcccccccccc-c-----------cCCCchhHHHHHHH
Q 019040          175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-R-----------NYGPEIDIWSAGVI  242 (347)
Q Consensus       175 H~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~-----------~~~~~~Di~slG~~  242 (347)
                      ||||||+|||+   +.++.+||+|||++.....  ......| +.|+|||++. .           .++.++||||||++
T Consensus       229 HrDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          229 HTYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             CSCCCGGGEEE---CTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             cCCCCHHHEEE---cCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            99999999999   6678899999999986432  3344567 9999999876 3           58999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          243 LYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       243 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +|+|++|..||...........        ....+..+++++.+||.+||+.||++|||+.++++||||+...
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEW--------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHHHSSCCC------CCSGG--------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             HHHHHHCCCCCcccccccchhh--------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            9999999999976554322211        1222357899999999999999999999999999999998753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-47  Score=346.31  Aligned_cols=260  Identities=26%  Similarity=0.447  Sum_probs=211.0

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCC-CceeEeeeEEeeCCeE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN-SSIVSLKEACEDDNAV  127 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h-~~i~~~~~~~~~~~~~  127 (347)
                      ..++|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++.+.+| +||+++++++...+..
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            4678999999999999999999984 688899999865432 334457789999999999433 9999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      ++|||+ .+++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++    ++.+||+|||++.....
T Consensus        85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC--
T ss_pred             EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccCc
Confidence            999995 5789999999988899999999999999999999999999999999999994    46799999999987643


Q ss_pred             CCc---ccccccCcccccccccc------------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccc
Q 019040          208 GER---FSEIVGSPYYMAPEVLK------------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLID  271 (347)
Q Consensus       208 ~~~---~~~~~~~~~y~aPE~~~------------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~  271 (347)
                      ...   .....||+.|+|||++.            ..++.++||||||+++|+|++|..||...... .....+......
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  239 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  239 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence            322   23457999999999874            34788999999999999999999999775443 333333332221


Q ss_pred             ccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                        .......+.++.++|..||+.||.+|||+.++|+||||+....+
T Consensus       240 --~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          240 --IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             --CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             --cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence              22223567899999999999999999999999999999876543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.7e-47  Score=341.86  Aligned_cols=265  Identities=25%  Similarity=0.416  Sum_probs=218.9

Q ss_pred             CcccceeeeeeecccCCeEEEEEEEC-CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC--CCCceeEeeeEEe--
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDR-DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACE--  122 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~--~h~~i~~~~~~~~--  122 (347)
                      ...++|++.+.||.|+||.||+|.+. .+++.||+|++....... .....+.+|+.+++.+.  .||||+++++++.  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            34589999999999999999999995 678999999987543222 12234556776666553  7999999999987  


Q ss_pred             ---eCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          123 ---DDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       123 ---~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                         .....++|+||+++ +|.+++....  .+++..++.++.||+.||.|||++||+|+||||+||++   +.++.++|+
T Consensus        87 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~  162 (326)
T 1blx_A           87 RTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLA  162 (326)
T ss_dssp             ECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred             ccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEe
Confidence               56789999999974 9999998753  38999999999999999999999999999999999999   677889999


Q ss_pred             eeccccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc---
Q 019040          198 DFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK---  273 (347)
Q Consensus       198 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---  273 (347)
                      |||++.............+++.|+|||.+. ..++.++||||||+++|+|++|..||.+.........+........   
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            999998765444445567899999999876 4589999999999999999999999999888777776654321110   


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          274 --------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       274 --------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                          ...+..++..+.+||.+||+.||++|||+.++++||||++....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence                                11224688999999999999999999999999999999987643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.1e-48  Score=344.54  Aligned_cols=267  Identities=29%  Similarity=0.464  Sum_probs=199.1

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .|.....++|++.+.||.|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.+ +||||+++++++..
T Consensus         8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   84 (303)
T 2vwi_A            8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQC-HHPNIVSYYTSFVV   84 (303)
T ss_dssp             -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCC-CCTTBCCEEEEEES
T ss_pred             cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhc-CCCCEeeEEEEEee
Confidence            4566667899999999999999999999999999999999865432  23356788899999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEE
Q 019040          124 DNAVHLVMELCEGGELFDRIVA--------RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~  195 (347)
                      .+..++|+||+++++|.+++..        ...+++..++.++.||+.||.|||++||+|+||||+||++   +.++.++
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~k  161 (303)
T 2vwi_A           85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQ  161 (303)
T ss_dssp             SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEE
T ss_pred             cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEE
Confidence            9999999999999999999874        3458999999999999999999999999999999999999   6778899


Q ss_pred             EEeeccccccCCCC------cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 019040          196 AIDFGLSIFFKPGE------RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR  267 (347)
Q Consensus       196 l~Dfg~a~~~~~~~------~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  267 (347)
                      |+|||++.......      ......+|+.|+|||.+.+  .++.++||||||+++|+|++|..||..............
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  241 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ  241 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence            99999987654322      1233568999999998763  589999999999999999999999988776655544443


Q ss_pred             cccccc------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          268 GLIDFK------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       268 ~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      ......      ......++.++.++|.+||+.||.+|||+.++++||||++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            332111      1223467899999999999999999999999999999988753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=338.93  Aligned_cols=260  Identities=27%  Similarity=0.444  Sum_probs=215.4

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .....++|++.+.||.|+||.||+|.+..+|+.||+|.+...     .....+.+|+.+++.+ +||||+++++++...+
T Consensus        24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQC-DSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-----SCCHHHHHHHHHHHTC-CCTTBCCEEEEEEETT
T ss_pred             hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-----HHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCC
Confidence            345568899999999999999999999999999999998643     2346788999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..++|+||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||++   +.++.++|+|||++..
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~  174 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchh
Confidence            99999999999999999974 4579999999999999999999999999999999999999   6678899999999976


Q ss_pred             cCCCC-cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          205 FKPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       205 ~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ..... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+...... .......++.
T Consensus       175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  253 (314)
T 3com_A          175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSD  253 (314)
T ss_dssp             CBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCH
T ss_pred             hhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCH
Confidence            54432 2344578999999998764 5899999999999999999999999888776555444433211 1112235789


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .+.++|.+||+.||.+|||+.++++||||+...
T Consensus       254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            999999999999999999999999999998764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.6e-47  Score=351.83  Aligned_cols=264  Identities=28%  Similarity=0.421  Sum_probs=216.9

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCC-----ceeEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-----SIVSLK  118 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~-----~i~~~~  118 (347)
                      ...+.+.++|++.+.||.|+||+||+|.+..+++.||||++...    ......+.+|+.+++.+.+|+     +++.++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            45566789999999999999999999999999999999998643    233456778888888885455     489999


Q ss_pred             eEEeeCCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCcEeeCCCCCcEEeecCCCCCCE
Q 019040          119 EACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCH--KHGVIHRDLKPENFLFANKKENSPL  194 (347)
Q Consensus       119 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dikp~NIli~~~~~~~~~  194 (347)
                      +++...+..++||||+++ +|.+++...  ..+++..+..++.||+.||.|||  +.||+||||||+|||+.. +.++.+
T Consensus       123 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~  200 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAI  200 (382)
T ss_dssp             EEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCE
T ss_pred             eeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcE
Confidence            999999999999999965 999999876  35899999999999999999999  579999999999999953 245779


Q ss_pred             EEEeeccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc
Q 019040          195 KAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (347)
Q Consensus       195 ~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  273 (347)
                      ||+|||++......  .....+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.......+
T Consensus       201 kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  278 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP  278 (382)
T ss_dssp             EECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999999876432  345689999999998764 599999999999999999999999999888777776655322111


Q ss_pred             C------------------CCC-----------------CC-------------------------CCHHHHHHHHHhcc
Q 019040          274 R------------------DPW-----------------PN-------------------------VSESAKSLVRQMLE  293 (347)
Q Consensus       274 ~------------------~~~-----------------~~-------------------------~~~~~~~li~~~l~  293 (347)
                      .                  ..|                 ..                         ..+++.+||.+||+
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  358 (382)
T 2vx3_A          279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD  358 (382)
T ss_dssp             HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence            0                  000                 00                         01378999999999


Q ss_pred             CCCCCCCCHHHHhcCcccccCc
Q 019040          294 PDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       294 ~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .||++|||+.++|+||||++..
T Consensus       359 ~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          359 YDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             SCTTTSCCHHHHTTSGGGCC--
T ss_pred             CChhhCCCHHHHhcCcccccCC
Confidence            9999999999999999998753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.5e-47  Score=343.70  Aligned_cols=265  Identities=28%  Similarity=0.438  Sum_probs=218.8

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEE-CCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCC------ceeE
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS------SIVS  116 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~------~i~~  116 (347)
                      .+++.+.++|++.+.||.|+||+||+|.+ ..+++.||+|++...    ......+.+|+.+++.+ +|+      ++++
T Consensus         7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~   81 (339)
T 1z57_A            7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHL-NTTDPNSTFRCVQ   81 (339)
T ss_dssp             STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHH-HHHCTTCTTCBCC
T ss_pred             ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHh-hhcCCCCceeeEe
Confidence            45667789999999999999999999999 568899999998643    23346688899999888 443      5999


Q ss_pred             eeeEEeeCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC----
Q 019040          117 LKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE----  190 (347)
Q Consensus       117 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~----  190 (347)
                      +++++...+..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+||+++..+.    
T Consensus        82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~  160 (339)
T 1z57_A           82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY  160 (339)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence            999999999999999999 789999998765  5899999999999999999999999999999999999954221    


Q ss_pred             ------------CCCEEEEeeccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 019040          191 ------------NSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES  257 (347)
Q Consensus       191 ------------~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~  257 (347)
                                  ++.++|+|||++......  .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...+
T Consensus       161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          161 NPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             C----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             CCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                        678999999999864432  344578999999998764 58999999999999999999999999888


Q ss_pred             HHHHHHHHHhccccccC----------------------------------------CCCCCCCHHHHHHHHHhccCCCC
Q 019040          258 EQGVAQAILRGLIDFKR----------------------------------------DPWPNVSESAKSLVRQMLEPDPK  297 (347)
Q Consensus       258 ~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~li~~~l~~dp~  297 (347)
                      ..+....+.......+.                                        ......++++.+||.+||+.||.
T Consensus       239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence            77665555433221110                                        00112346788999999999999


Q ss_pred             CCCCHHHHhcCcccccCcC
Q 019040          298 LRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       298 ~Rps~~~ll~h~~~~~~~~  316 (347)
                      +|||+.++++||||+...+
T Consensus       319 ~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          319 KRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             TSCCHHHHTTSGGGGGGGC
T ss_pred             cccCHHHHhcCHHHHHHhc
Confidence            9999999999999998754

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=344.60  Aligned_cols=267  Identities=29%  Similarity=0.442  Sum_probs=214.4

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe-
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-  122 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~-  122 (347)
                      .++..+.++|++++.||.|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.+ +||||+++++++. 
T Consensus         4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~   79 (320)
T 2i6l_A            4 IHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRL-DHDNIVKVFEILGP   79 (320)
T ss_dssp             --CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECT
T ss_pred             cccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhc-CCCCeeEEEEeccc
Confidence            45667889999999999999999999999999999999998643   344567789999999999 9999999998873 


Q ss_pred             -------------eCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC
Q 019040          123 -------------DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (347)
Q Consensus       123 -------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~  189 (347)
                                   ..+..++|+||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++  .
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~  155 (320)
T 2i6l_A           80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--T  155 (320)
T ss_dssp             TSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--T
T ss_pred             cccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--C
Confidence                         4478999999997 599988854 5799999999999999999999999999999999999995  3


Q ss_pred             CCCCEEEEeeccccccCCC----CcccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 019040          190 ENSPLKAIDFGLSIFFKPG----ERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ  263 (347)
Q Consensus       190 ~~~~~~l~Dfg~a~~~~~~----~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  263 (347)
                      +++.++|+|||++......    .......+++.|+|||.+.  ..++.++||||||+++|+|++|..||.+........
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  235 (320)
T 2i6l_A          156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ  235 (320)
T ss_dssp             TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            4568999999999865432    1223346789999999864  458899999999999999999999999988777666


Q ss_pred             HHHhcccccc----------------------C----CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          264 AILRGLIDFK----------------------R----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       264 ~~~~~~~~~~----------------------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      .+........                      .    ..++.++.++.++|.+||+.||++|||+.++++||||+...-+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence            6654332110                      0    0123689999999999999999999999999999999977544


Q ss_pred             C
Q 019040          318 P  318 (347)
Q Consensus       318 ~  318 (347)
                      .
T Consensus       316 ~  316 (320)
T 2i6l_A          316 M  316 (320)
T ss_dssp             -
T ss_pred             c
Confidence            3

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9e-48  Score=351.21  Aligned_cols=262  Identities=24%  Similarity=0.454  Sum_probs=223.3

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcH--------------HHHHHHHHHHHhCCCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI--------------DDVRREVAIMKHLPKN  111 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~--------------~~~~~ei~~l~~l~~h  111 (347)
                      .....++|++.+.||.|+||.||+|.+  +++.||+|++...........              ..+.+|+.+++.+ +|
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  102 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KN  102 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CC
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CC
Confidence            444568999999999999999999999  899999999976543332221              7899999999999 89


Q ss_pred             CceeEeeeEEeeCCeEEEEEEecCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCc
Q 019040          112 SSIVSLKEACEDDNAVHLVMELCEGGELFDR------IVA--RGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPEN  182 (347)
Q Consensus       112 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~N  182 (347)
                      |||+++++++.+.+..++||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ .||+|+||+|+|
T Consensus       103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9999999999999999999999999999988      655  4569999999999999999999999 999999999999


Q ss_pred             EEeecCCCCCCEEEEeeccccccCCCCcccccccCcccccccccccc--CCC-chhHHHHHHHHHHHHhCCCCCCCCCH-
Q 019040          183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--YGP-EIDIWSAGVILYILLCGVPPFWAESE-  258 (347)
Q Consensus       183 Ili~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~-~~Di~slG~~l~~l~~g~~pf~~~~~-  258 (347)
                      |++   +.++.++|+|||.+...... ......+++.|+|||.+.+.  ++. ++||||||+++|+|++|..||..... 
T Consensus       183 il~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          183 ILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             EEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             EEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            999   67788999999999875443 34456789999999988643  555 89999999999999999999988776 


Q ss_pred             HHHHHHHHhccccccCCC---------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          259 QGVAQAILRGLIDFKRDP---------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ......+......++...               ...++.++.++|.+||+.||.+|||+.++++||||+..
T Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            666666666544433210               14689999999999999999999999999999999876

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.7e-47  Score=339.69  Aligned_cols=263  Identities=23%  Similarity=0.330  Sum_probs=212.0

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      ...+...++|++.+.||.|+||+||+|.+  ++..||+|++..... .......+.+|+.+++.+ +||||+++++++..
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~  105 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQ  105 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE
Confidence            44445568999999999999999999987  578899999865432 334456789999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--cEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          124 DNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      .+..++||||+++++|.+++.....   +++..++.++.||+.||.|||+.|  |+||||||+||++   +.++.++|+|
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~D  182 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCD  182 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECC
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECC
Confidence            9999999999999999999987643   899999999999999999999999  9999999999999   6778899999


Q ss_pred             eccccccCCCC-cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCC
Q 019040          199 FGLSIFFKPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP  276 (347)
Q Consensus       199 fg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  276 (347)
                      ||++....... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+.......  ..
T Consensus       183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~  260 (309)
T 3p86_A          183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL--EI  260 (309)
T ss_dssp             CC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC--CC
T ss_pred             CCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CC
Confidence            99997544332 2334578999999998764 48999999999999999999999999988877776664433322  22


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhc--CcccccCc
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE--HPWLQNAK  315 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~~~~~~  315 (347)
                      ...+++++.++|.+||+.||.+|||+.++++  .++++...
T Consensus       261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            3478999999999999999999999999987  56666554

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.1e-47  Score=341.94  Aligned_cols=256  Identities=22%  Similarity=0.323  Sum_probs=216.7

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCc---eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      ...+...++|++.+.||.|+||+||+|.+..+++   .||+|++....  .......+.+|+.+++.+ +||||++++++
T Consensus        42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~  118 (325)
T 3kul_A           42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQF-DHPNIIRLEGV  118 (325)
T ss_dssp             -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEE
T ss_pred             hccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEE
Confidence            3455567899999999999999999999986655   49999986432  333456789999999999 89999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                      +.+.+..++||||+++++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+||
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Df  195 (325)
T 3kul_A          119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDF  195 (325)
T ss_dssp             ECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCC
T ss_pred             EEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCC
Confidence            99999999999999999999999765 569999999999999999999999999999999999999   67788999999


Q ss_pred             ccccccCCCCc----ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccc
Q 019040          200 GLSIFFKPGER----FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK  273 (347)
Q Consensus       200 g~a~~~~~~~~----~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  273 (347)
                      |++........    .....+|+.|+|||.+. ..++.++||||||+++|+|++ |..||...........+.....   
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---  272 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR---  272 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC---
Confidence            99987644322    12234577899999886 458999999999999999999 9999999998888877766532   


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+....++.++.++|..||+.||++|||+.++++.
T Consensus       273 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          273 LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            22334789999999999999999999999999764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.3e-47  Score=348.81  Aligned_cols=262  Identities=27%  Similarity=0.459  Sum_probs=216.6

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ....+.++|.+.+.||.|+||.||+|.++.+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...
T Consensus        36 ~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  113 (371)
T 4exu_A           36 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPA  113 (371)
T ss_dssp             EEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSC
T ss_pred             ceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhc-CCCCchhhhhheecc
Confidence            33456789999999999999999999999999999999986543 2334457788999999999 899999999999877


Q ss_pred             CeE------EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          125 NAV------HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       125 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      +..      ++|+||+. ++|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|
T Consensus       114 ~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~D  187 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILD  187 (371)
T ss_dssp             SSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECS
T ss_pred             CCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEe
Confidence            654      99999996 58877763  359999999999999999999999999999999999999   6778899999


Q ss_pred             eccccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc---
Q 019040          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK---  273 (347)
Q Consensus       199 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---  273 (347)
                      ||++.....  ......+|+.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+..+....+........   
T Consensus       188 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          188 FGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             TTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            999986543  2344578999999998764  589999999999999999999999999887776666644221110   


Q ss_pred             --------------------C----CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          274 --------------------R----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       274 --------------------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                                          .    ..++.+++++.+||.+||+.||++|||+.++|+||||+....
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence                                0    012357899999999999999999999999999999987643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=355.28  Aligned_cols=263  Identities=26%  Similarity=0.447  Sum_probs=199.8

Q ss_pred             CCCcccceeee-eeecccCCeEEEEEEEC--CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           46 KENIEDRYLVD-RELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        46 ~~~~~~~y~i~-~~lg~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      ...+.+.|++. +.||.|+||+||+|+++  .+++.||+|++....     ....+.+|+.+++.+ +||||+++++++.
T Consensus        15 ~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l-~hpniv~~~~~~~   88 (405)
T 3rgf_A           15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-----ISMSACREIALLREL-KHPNVISLQKVFL   88 (405)
T ss_dssp             CCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-----CCHHHHHHHHHHHHC-CCTTBCCCCEEEE
T ss_pred             hhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-----CCHHHHHHHHHHHhc-CCCCeeeEeeEEe
Confidence            34566788884 47999999999999976  568899999986432     224678899999999 8999999999995


Q ss_pred             e--CCeEEEEEEecCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC-CC
Q 019040          123 D--DNAVHLVMELCEGGELFDRIVAR---------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK-KE  190 (347)
Q Consensus       123 ~--~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~-~~  190 (347)
                      .  ....++||||+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +.
T Consensus        89 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           89 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             ETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTT
T ss_pred             cCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCC
Confidence            4  6889999999965 888887532         148999999999999999999999999999999999999643 45


Q ss_pred             CCCEEEEeeccccccCCC----CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----
Q 019040          191 NSPLKAIDFGLSIFFKPG----ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-----  259 (347)
Q Consensus       191 ~~~~~l~Dfg~a~~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----  259 (347)
                      ++.+||+|||++......    .......||+.|+|||++.+  .++.++||||||+++|+|++|..||.+....     
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            688999999999875432    22344678999999998764  4899999999999999999999999766542     


Q ss_pred             ----HHHHHHHhccccccCCCCC----------------------------------CCCHHHHHHHHHhccCCCCCCCC
Q 019040          260 ----GVAQAILRGLIDFKRDPWP----------------------------------NVSESAKSLVRQMLEPDPKLRLT  301 (347)
Q Consensus       260 ----~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~li~~~l~~dp~~Rps  301 (347)
                          +.+..+...........|.                                  ..++.+.+||.+||+.||.+|||
T Consensus       248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence                3444444333222222221                                  22678899999999999999999


Q ss_pred             HHHHhcCcccccCc
Q 019040          302 AKQVLEHPWLQNAK  315 (347)
Q Consensus       302 ~~~ll~h~~~~~~~  315 (347)
                      +.++|+||||+...
T Consensus       328 a~e~L~hp~f~~~~  341 (405)
T 3rgf_A          328 SEQAMQDPYFLEDP  341 (405)
T ss_dssp             HHHHHTSGGGTSSS
T ss_pred             HHHHhcChhhccCC
Confidence            99999999998764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-46  Score=346.75  Aligned_cols=254  Identities=26%  Similarity=0.376  Sum_probs=216.5

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEEC-------CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      ....++|++.+.||+|+||.||+|.+.       .++..||+|++....  .......+.+|+.+++.+.+||||+++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            344689999999999999999999875       345679999986542  33456779999999999988999999999


Q ss_pred             EEeeCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcE
Q 019040          120 ACEDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (347)
Q Consensus       120 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NI  183 (347)
                      ++...+..|+||||+++++|.+++....                .++...+..++.||+.||.|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999998753                378899999999999999999999999999999999


Q ss_pred             EeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 019040          184 LFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESE  258 (347)
Q Consensus       184 li~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  258 (347)
                      |+   +.++.+||+|||++........   .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.....
T Consensus       235 ll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          235 LV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             EE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             EE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99   6778899999999986543322   23345678999999876 458999999999999999999 9999998888


Q ss_pred             HHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ......+.....   ......++.++.++|..||+.||++|||+.+++++
T Consensus       312 ~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          312 EELFKLLKEGHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGHHHHHHTTCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            777766665532   22334789999999999999999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.8e-47  Score=348.35  Aligned_cols=264  Identities=23%  Similarity=0.367  Sum_probs=210.2

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEecccccc--------chhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--------TAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      .+.++|++.+.||.|+||.||+|.+.. ++.||+|++......        .......+.+|+.+++.+ +||||+++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~   96 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRD   96 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceee
Confidence            456899999999999999999999865 899999998654322        222347799999999999 8999999999


Q ss_pred             EEee-----CCeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCC
Q 019040          120 ACED-----DNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSP  193 (347)
Q Consensus       120 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~  193 (347)
                      ++..     ....++||||++ ++|.+.+.... .+++..+..++.||+.||.|||++||+||||||+||++   +.++.
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~  172 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNND  172 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCC
T ss_pred             eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCC
Confidence            9843     347899999997 58888887653 59999999999999999999999999999999999999   67788


Q ss_pred             EEEEeeccccccCCCCcccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 019040          194 LKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID  271 (347)
Q Consensus       194 ~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  271 (347)
                      ++|+|||++.............+|+.|+|||.+.  ..++.++||||||+++|+|++|..||.+.........+......
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (362)
T 3pg1_A          173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT  252 (362)
T ss_dssp             EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            9999999998665555555668999999999875  35899999999999999999999999998877776666443211


Q ss_pred             cc------------------------C----CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          272 FK------------------------R----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       272 ~~------------------------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      ..                        .    ...+..++.+.+||.+||+.||++|||+.++++||||+....+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence            10                        0    0113568899999999999999999999999999999987533

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.8e-47  Score=345.92  Aligned_cols=261  Identities=25%  Similarity=0.350  Sum_probs=205.9

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe---
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA---  126 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~---  126 (347)
                      .++|++.+.||.|+||+||+|.+..+++.||||++.....    ......++++.+..+ +||||+++++++...+.   
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccc
Confidence            4789999999999999999999999999999998855422    223466688888888 99999999999865433   


Q ss_pred             ----EEEEEEecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--HcCcEeeCCCCCcEEeecCCCCCCEEE
Q 019040          127 ----VHLVMELCEGGELFDRIV----ARGHYTERAAAAVTRTIVEVVQLCH--KHGVIHRDLKPENFLFANKKENSPLKA  196 (347)
Q Consensus       127 ----~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dikp~NIli~~~~~~~~~~l  196 (347)
                          .++||||+++ +|...+.    ....+++..++.++.||+.||.|||  +.||+||||||+|||++  ..++.++|
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl  173 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKL  173 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEE
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEE
Confidence                8899999977 5554443    3456899999999999999999999  99999999999999995  23678999


Q ss_pred             EeeccccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccc-
Q 019040          197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-  273 (347)
Q Consensus       197 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-  273 (347)
                      +|||++.............||+.|+|||++.+  .++.++||||||+++|+|++|..||...+.......+.+.....+ 
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR  253 (360)
T ss_dssp             CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence            99999988766666666789999999998753  389999999999999999999999999988877777655322111 


Q ss_pred             ---------------------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCC
Q 019040          274 ---------------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (347)
Q Consensus       274 ---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  318 (347)
                                                 .......++++.+||.+||+.||.+|||+.++|+||||+....+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  325 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA  325 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence                                       011123568899999999999999999999999999999886543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-47  Score=347.64  Aligned_cols=262  Identities=23%  Similarity=0.253  Sum_probs=220.9

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEE-----CCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCID-----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      .+...++|++.+.||+|+||+||+|.+     ..+++.||+|++...  ........+.+|+.+++.+ +||||++++++
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~  142 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKF-NHQNIVRCIGV  142 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhC-CCCCCCeEEEE
Confidence            345568999999999999999999994     456788999998543  2334456788999999999 99999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCC
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSP  193 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~  193 (347)
                      +...+..++||||+++++|.+++....       .++...++.++.||+.||.|||++||+||||||+|||++.++.+..
T Consensus       143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence            999999999999999999999997753       4899999999999999999999999999999999999965556667


Q ss_pred             EEEEeeccccccCC---CCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 019040          194 LKAIDFGLSIFFKP---GERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG  268 (347)
Q Consensus       194 ~~l~Dfg~a~~~~~---~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  268 (347)
                      +||+|||++.....   ........+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+...
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999974321   12223456789999999875 558999999999999999998 99999999988888777765


Q ss_pred             cccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          269 LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                      ...   .....++..+.+||.+||+.||++|||+.+++++.++-.
T Consensus       303 ~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          303 GRM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC---CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            432   223478999999999999999999999999999976643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.6e-47  Score=333.83  Aligned_cols=258  Identities=28%  Similarity=0.487  Sum_probs=219.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe--eCCeE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE--DDNAV  127 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~--~~~~~  127 (347)
                      .++|++.+.||.|+||.||+|.++.+++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++.  ..+..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceE
Confidence            4789999999999999999999999999999999875433 234467799999999999 9999999999874  46789


Q ss_pred             EEEEEecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----cEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          128 HLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHG-----VIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      ++||||+++++|.+++...    ..+++..++.++.||+.||.|||+.|     |+|+||||+||++   +.++.++|+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~d  159 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGD  159 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEec
Confidence            9999999999999999753    24899999999999999999999999     9999999999999   6778899999


Q ss_pred             eccccccCCCCc-ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCC
Q 019040          199 FGLSIFFKPGER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP  276 (347)
Q Consensus       199 fg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  276 (347)
                      ||++........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+..+...   ..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~---~~  236 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---RI  236 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---CC
T ss_pred             CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc---cC
Confidence            999987544322 233468999999998764 4889999999999999999999999998887777777665432   22


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ...++.++.++|.+||+.||++|||+.++++|+|+..-.
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            236899999999999999999999999999999997653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-47  Score=353.75  Aligned_cols=260  Identities=16%  Similarity=0.199  Sum_probs=199.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC-CCCceeEee-------eEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-KNSSIVSLK-------EAC  121 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~-~h~~i~~~~-------~~~  121 (347)
                      ...|.+.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.+. +|||+++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            456999999999999999999999999999999998765545556677888977676663 599977754       444


Q ss_pred             eeC-----------------CeEEEEEEecCCCchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHcCcEeeC
Q 019040          122 EDD-----------------NAVHLVMELCEGGELFDRIVAR-GHYTERAA------AAVTRTIVEVVQLCHKHGVIHRD  177 (347)
Q Consensus       122 ~~~-----------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~------~~i~~qi~~~l~~lH~~~ivH~D  177 (347)
                      ...                 ...|+||||++ ++|.+++... ..++....      ..++.||+.||.|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            333                 34899999998 7999999764 23455555      67779999999999999999999


Q ss_pred             CCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCC
Q 019040          178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFW  254 (347)
Q Consensus       178 ikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~  254 (347)
                      |||+|||+   +.++.+||+|||++......  .....+|+.|+|||++.+   .++.++||||||+++|+|++|..||.
T Consensus       220 ikp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999999   67788999999999875432  224567799999998764   48999999999999999999999997


Q ss_pred             CCCHHHHH--HH---HHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          255 AESEQGVA--QA---ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       255 ~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ........  ..   ..........+.+..+++.+.+||.+||+.||++|||+.++|+||||++..
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            76432100  00   001111222333457899999999999999999999999999999998764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.1e-47  Score=351.01  Aligned_cols=264  Identities=24%  Similarity=0.391  Sum_probs=210.1

Q ss_pred             CCCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC-------CCCcee
Q 019040           43 GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-------KNSSIV  115 (347)
Q Consensus        43 ~~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~-------~h~~i~  115 (347)
                      ...++.+.++|++.+.||.|+||+||+|++..+++.||+|++...    ......+.+|+.+++.+.       +|+||+
T Consensus        29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv  104 (397)
T 1wak_A           29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVV  104 (397)
T ss_dssp             SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred             EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence            345667789999999999999999999999999999999998643    234567888999999983       278899


Q ss_pred             EeeeEEe----eCCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecC
Q 019040          116 SLKEACE----DDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANK  188 (347)
Q Consensus       116 ~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~  188 (347)
                      ++++++.    .....++||||+ +++|.+.+...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus       105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~  183 (397)
T 1wak_A          105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN  183 (397)
T ss_dssp             CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred             eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence            9999987    557899999999 55776776654  4599999999999999999999998 99999999999999532


Q ss_pred             C----------------------------------------------CCCCEEEEeeccccccCCCCcccccccCccccc
Q 019040          189 K----------------------------------------------ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA  222 (347)
Q Consensus       189 ~----------------------------------------------~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~a  222 (347)
                      +                                              ....++|+|||++......  .....||+.|+|
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~a  261 (397)
T 1wak_A          184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCC
T ss_pred             chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccC
Confidence            1                                              1237999999999875432  344578999999


Q ss_pred             cccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhccccccC---------------------
Q 019040          223 PEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES------EQGVAQAILRGLIDFKR---------------------  274 (347)
Q Consensus       223 PE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~---------------------  274 (347)
                      ||++.+ .++.++||||||+++|+|++|..||....      .......+.......+.                     
T Consensus       262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            998764 49999999999999999999999997654      22233333222111100                     


Q ss_pred             -----------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          275 -----------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       275 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                                       ......+..+.+||.+||+.||++|||+.++|+||||+.
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                             001123467889999999999999999999999999974

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.3e-46  Score=334.86  Aligned_cols=255  Identities=26%  Similarity=0.458  Sum_probs=209.6

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee-----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-----  123 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~-----  123 (347)
                      +.++|++.+.||.|+||.||+|++..+++.||+|++...    ......+.+|+.+++.+ +||||+++++++.+     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchh
Confidence            457899999999999999999999999999999998542    33457788999999999 99999999998754     


Q ss_pred             --------CCeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCE
Q 019040          124 --------DNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (347)
Q Consensus       124 --------~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~  194 (347)
                              .+..++|+||+++++|.+++.... .++...++.++.||+.||.|||++||+|+||||+||++   +.++.+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~  155 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV  155 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCE
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCE
Confidence                    467899999999999999998654 47889999999999999999999999999999999999   677889


Q ss_pred             EEEeeccccccCCC---------------CcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCC-
Q 019040          195 KAIDFGLSIFFKPG---------------ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAE-  256 (347)
Q Consensus       195 ~l~Dfg~a~~~~~~---------------~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~-  256 (347)
                      +|+|||++......               .......+++.|+|||.+.+  .++.++||||||+++|+|++   ||... 
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            99999999765422               12234568999999998763  48999999999999999998   55433 


Q ss_pred             CHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          257 SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ........+......++.......+..+.++|.+||+.||++|||+.++++||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            2334445555554555555556778899999999999999999999999999999754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.3e-47  Score=341.50  Aligned_cols=263  Identities=32%  Similarity=0.525  Sum_probs=216.3

Q ss_pred             eecCCCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccch---hcHHHHHHHHHHHHhCC-CCCcee
Q 019040           40 VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREVAIMKHLP-KNSSIV  115 (347)
Q Consensus        40 ~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~ei~~l~~l~-~h~~i~  115 (347)
                      .......+.+.++|++.+.||.|+||.||+|.+..+++.||+|++........   .....+.+|+.+++.+. .|+|++
T Consensus        32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~  111 (320)
T 3a99_A           32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI  111 (320)
T ss_dssp             --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence            34445667788999999999999999999999999999999999976543321   12245667999999995 379999


Q ss_pred             EeeeEEeeCCeEEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCE
Q 019040          116 SLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (347)
Q Consensus       116 ~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~  194 (347)
                      ++++++...+..++|+|++.+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++  .+++.+
T Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~  189 (320)
T 3a99_A          112 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGEL  189 (320)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEE
T ss_pred             EEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCE
Confidence            999999999999999999976 89999998888899999999999999999999999999999999999994  256789


Q ss_pred             EEEeeccccccCCCCcccccccCccccccccccc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc
Q 019040          195 KAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF  272 (347)
Q Consensus       195 ~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  272 (347)
                      +|+|||++...... ......||+.|+|||.+.+ . .+.++||||||+++|+|++|..||....      .+...... 
T Consensus       190 kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~-  261 (320)
T 3a99_A          190 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF-  261 (320)
T ss_dssp             EECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC-
T ss_pred             EEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccc-
Confidence            99999999876533 3344578999999998763 3 4678999999999999999999996532      12222222 


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                         ....+++++.++|.+||+.||++|||+.++++||||++..
T Consensus       262 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          262 ---FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             ---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ---ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence               2247899999999999999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.7e-46  Score=333.59  Aligned_cols=256  Identities=24%  Similarity=0.361  Sum_probs=207.7

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ....++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+.
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCe
Confidence            34457999999999999999999999999999999999766554555567899999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .++|+||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||++....
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC-----
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCcccc
Confidence            99999999999999999988889999999999999999999999999999999999999   667889999999987654


Q ss_pred             CCC--cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          207 PGE--RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       207 ~~~--~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      ...  ......+++.|+|||.+. ..++.++||||||+++|+|++|..||...........+. .....+....+.++.+
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  264 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-QAIPRPSTVRPGIPVA  264 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-SCCCCGGGTSTTCCTH
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-cCCCCccccCCCCCHH
Confidence            332  223457899999999876 458899999999999999999999998776654433333 3332233344578999


Q ss_pred             HHHHHHHhccCCCCCCC-CHHHHhc
Q 019040          284 AKSLVRQMLEPDPKLRL-TAKQVLE  307 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rp-s~~~ll~  307 (347)
                      +.++|.+||+.||++|| ++.++++
T Consensus       265 l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          265 FDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999999 7777764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=341.68  Aligned_cols=260  Identities=27%  Similarity=0.465  Sum_probs=214.9

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe-
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA-  126 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~-  126 (347)
                      .+.++|.+.+.||.|+||.||+|.++.+|+.||||++.... ........+.+|+.+++.+ +||||+++++++...+. 
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSL   98 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSG
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCcccHhheEeccccc
Confidence            45689999999999999999999999999999999986542 2334456788999999999 89999999999987654 


Q ss_pred             -----EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          127 -----VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       127 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                           .++||||++ ++|.+++..  .+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||+
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~  172 (353)
T 3coi_A           99 RNFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGL  172 (353)
T ss_dssp             GGCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTC
T ss_pred             ccceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeeccc
Confidence                 499999997 588777633  58999999999999999999999999999999999999   6778899999999


Q ss_pred             ccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc--------
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID--------  271 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------  271 (347)
                      +......  .....+|+.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+..+....+......        
T Consensus       173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            9865432  334578999999998754  5889999999999999999999999988877666555432111        


Q ss_pred             ---------------cc----CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          272 ---------------FK----RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       272 ---------------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                     .+    ...++.+++++.+||.+||+.||++|||+.++++||||+....+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence                           01    11234678999999999999999999999999999999876543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.4e-46  Score=340.47  Aligned_cols=264  Identities=25%  Similarity=0.419  Sum_probs=216.0

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCC-ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCc------eeE
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTR-ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS------IVS  116 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~------i~~  116 (347)
                      ..++.+.++|++.+.||+|+||+||+|.+..++ +.||+|++...    ......+.+|+.+++.+ .|++      ++.
T Consensus        12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~   86 (355)
T 2eu9_A           12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKI-KEKDKENKFLCVL   86 (355)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHH-HHHCTTSCSCBCC
T ss_pred             ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHH-hhcCCCCceeEEE
Confidence            456677899999999999999999999998777 68999998643    23346678899999988 5444      889


Q ss_pred             eeeEEeeCCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC------
Q 019040          117 LKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK------  188 (347)
Q Consensus       117 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~------  188 (347)
                      +++++...+..++||||+ +++|.+.+....  .+++..++.++.||+.||.|||++||+||||||+|||+...      
T Consensus        87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~  165 (355)
T 2eu9_A           87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY  165 (355)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence            999999999999999999 567777776653  69999999999999999999999999999999999999532      


Q ss_pred             ----------CCCCCEEEEeeccccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 019040          189 ----------KENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAES  257 (347)
Q Consensus       189 ----------~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  257 (347)
                                +.++.++|+|||++......  .....||+.|+|||++. ..++.++||||||+++|+|++|..||....
T Consensus       166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          166 NEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                      35678999999999864332  34457999999999876 458999999999999999999999999888


Q ss_pred             HHHHHHHHHhccccccCC----------------CC------------------------CCCCHHHHHHHHHhccCCCC
Q 019040          258 EQGVAQAILRGLIDFKRD----------------PW------------------------PNVSESAKSLVRQMLEPDPK  297 (347)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~----------------~~------------------------~~~~~~~~~li~~~l~~dp~  297 (347)
                      .......+.......+..                .|                        ...+.++.+||.+||+.||+
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            776655554432221100                00                        11235788999999999999


Q ss_pred             CCCCHHHHhcCcccccCc
Q 019040          298 LRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       298 ~Rps~~~ll~h~~~~~~~  315 (347)
                      +|||+.++|+||||+...
T Consensus       324 ~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          324 QRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             TSCCHHHHTTSGGGGGCC
T ss_pred             hCcCHHHHhcChhhcCCC
Confidence            999999999999999763

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.8e-46  Score=337.91  Aligned_cols=262  Identities=22%  Similarity=0.318  Sum_probs=198.7

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCc---eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ...++|++.+.||+|+||+||+|.+..++.   .||+|++..... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRS   97 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHC-CCCceehhhceeecc
Confidence            446789999999999999999999887765   799999865432 233467899999999999 999999999999877


Q ss_pred             CeE------EEEEEecCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC
Q 019040          125 NAV------HLVMELCEGGELFDRIVARG------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       125 ~~~------~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                      +..      ++|+||+++++|.+++....      .+++..++.++.||+.||.|||++||+||||||+||++   +.++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~  174 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDM  174 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTS
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCC
Confidence            655      99999999999999996542      58999999999999999999999999999999999999   6778


Q ss_pred             CEEEEeeccccccCCCCc---ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 019040          193 PLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILR  267 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~  267 (347)
                      .++|+|||++........   .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||...........+..
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  254 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG  254 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence            899999999986544322   123356788999998764 48999999999999999999 9999998888877777766


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHhccCCCCCCCC-------HHHHhcCcccccCcCC
Q 019040          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT-------AKQVLEHPWLQNAKKA  317 (347)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-------~~~ll~h~~~~~~~~~  317 (347)
                      ....   .....+++++.++|.+||+.||++|||       +.++++|+|+......
T Consensus       255 ~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          255 GNRL---KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             TCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             CCCC---CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence            5422   233478999999999999999999999       8889999999877543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.4e-46  Score=331.54  Aligned_cols=257  Identities=28%  Similarity=0.448  Sum_probs=208.1

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      |.....||.|+||.||+|.+..+++.||+|.+....   ......+.+|+.+++.+ +||||+++++++...+..++|+|
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEE
Confidence            444458999999999999999999999999986542   33456788999999999 99999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          133 LCEGGELFDRIVARG---HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       133 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |+++++|.+++....   .+++..++.++.||+.||.|||++||+|+||||+||+++  ..++.++|+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC--
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCC
Confidence            999999999998752   467889999999999999999999999999999999995  236789999999998654332


Q ss_pred             -cccccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          210 -RFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                       ......+++.|+|||.+.+   .++.++||||||+++|+|++|..||............ .............++.++.
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  256 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHPEIPESMSAEAK  256 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-HHHHCCCCCCCTTSCHHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-hccccccccccccCCHHHH
Confidence             2334578999999998753   2788999999999999999999999765433221111 1111222333457899999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      ++|.+||+.||++|||+.++++||||+....
T Consensus       257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          257 AFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             HHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             HHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            9999999999999999999999999987653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=341.34  Aligned_cols=257  Identities=25%  Similarity=0.371  Sum_probs=220.1

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCC-------CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeE
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDT-------RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS  116 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~  116 (347)
                      ..++...++|.+.+.||+|+||+||+|.+..+       +..||+|++....  .......+.+|+++++.+.+||||++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            34456678999999999999999999997543       3579999986542  34455778999999999988999999


Q ss_pred             eeeEEeeCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCC
Q 019040          117 LKEACEDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP  180 (347)
Q Consensus       117 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp  180 (347)
                      +++++...+..++||||+++++|.+++....                .+++..++.++.||+.||.|||+.||+||||||
T Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            9999999999999999999999999998754                489999999999999999999999999999999


Q ss_pred             CcEEeecCCCCCCEEEEeeccccccCCCC---cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 019040          181 ENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWA  255 (347)
Q Consensus       181 ~NIli~~~~~~~~~~l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~  255 (347)
                      +|||+   +.++.+||+|||++.......   ......+|+.|+|||++.+ .++.++||||||+++++|++ |..||..
T Consensus       220 ~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          220 RNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             GGEEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ceEEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999   677889999999998664432   2233457788999998764 48999999999999999999 9999999


Q ss_pred             CCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .........+......   .....+++++.++|..||+.||++|||+.+++++
T Consensus       297 ~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          297 VPVEELFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CCHHHHHHHHHTTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHcCCCC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8888877777665432   2234789999999999999999999999999887

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=335.88  Aligned_cols=251  Identities=23%  Similarity=0.390  Sum_probs=210.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|.+.+.||.|+||+||+|.+..+++.||+|++...   .......+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEE
Confidence            47899999999999999999999999999999988543   344567899999999999 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++......
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--
T ss_pred             EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceecccc
Confidence            9999999999999987 4569999999999999999999999999999999999999   67788999999999865433


Q ss_pred             Ccc---------------cccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh
Q 019040          209 ERF---------------SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAILR  267 (347)
Q Consensus       209 ~~~---------------~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~  267 (347)
                      ...               ....||+.|+|||.+.+ .++.++||||||+++|+|++|..||.......     .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            221               14579999999998764 48999999999999999999999886543211     0111111


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .      .....+++.+.++|.+||+.||++|||+.++++  +|+...
T Consensus       242 ~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          242 R------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             H------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             c------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence            1      112467889999999999999999999999976  566654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.8e-45  Score=323.91  Aligned_cols=254  Identities=21%  Similarity=0.341  Sum_probs=217.2

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...++|++.+.||.|+||.||+|.+. ++..||+|++.....    ....+.+|+.+++.+ +||||+++++++...+..
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSE
T ss_pred             echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCce
Confidence            34679999999999999999999886 566799999865432    336688999999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      ++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||++   +.++.++|+|||.+....
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVL  155 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecc
Confidence            99999999999999997754 49999999999999999999999999999999999999   677889999999998655


Q ss_pred             CCCcc--cccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          207 PGERF--SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       207 ~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .....  ....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||...........+........+   ...++
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~  232 (268)
T 3sxs_A          156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASD  232 (268)
T ss_dssp             TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCH
T ss_pred             hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChH
Confidence            44322  23346678999998864 58999999999999999998 99999998888777777665433322   36789


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      .+.++|..||+.||++|||+.+++++  ++...
T Consensus       233 ~l~~li~~~l~~~p~~Rps~~~ll~~--L~~l~  263 (268)
T 3sxs_A          233 TIYQIMYSCWHELPEKRPTFQQLLSS--IEPLR  263 (268)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH--HGGGC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH--HHHhh
Confidence            99999999999999999999999987  44443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=331.91  Aligned_cols=262  Identities=24%  Similarity=0.317  Sum_probs=198.6

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .-.++|++++.||.|+||.||+|.++.+|+.||+|++...... ......+..+..+++.+ +||||+++++++...+..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~   99 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDV   99 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEE
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcE
Confidence            3457899999999999999999999999999999998654321 22223344455567777 999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          128 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ++||||+ ++.+..+... ...+++..++.++.||+.||.|||++ ||+|+||||+||++   +.++.++|+|||++...
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC---
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhc
Confidence            9999999 5566555544 45799999999999999999999995 99999999999999   67788999999999776


Q ss_pred             CCCCcccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccccccCCCCC
Q 019040          206 KPGERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAE-SEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ..........+++.|+|||.+.      ..++.++||||||+++|+|++|..||... ........+........ +...
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~  254 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PGHM  254 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CSSS
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-CccC
Confidence            5554445567999999999873      34888999999999999999999999774 44455555554432221 2223


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      .++.++.++|..||+.||.+|||+.++++||||++...
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence            68999999999999999999999999999999987653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.7e-46  Score=342.85  Aligned_cols=255  Identities=23%  Similarity=0.336  Sum_probs=211.3

Q ss_pred             CCcccceeeeeeecccCCeEEEEEE-----ECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCI-----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      +...++|++.+.||.|+||.||+|.     +..+++.||+|++....  .......+.+|+.++..+.+||||+++++++
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            3456899999999999999999999     55667899999996542  3334567999999999998899999999998


Q ss_pred             eeCC-eEEEEEEecCCCchHHHHHhcCC----------------------------------------------------
Q 019040          122 EDDN-AVHLVMELCEGGELFDRIVARGH----------------------------------------------------  148 (347)
Q Consensus       122 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------  148 (347)
                      ...+ ..++||||+++++|.+++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            8754 48999999999999999976533                                                    


Q ss_pred             --------------CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC---cc
Q 019040          149 --------------YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RF  211 (347)
Q Consensus       149 --------------~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~---~~  211 (347)
                                    +++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.......   ..
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccchhc
Confidence                          8899999999999999999999999999999999999   567789999999998654332   22


Q ss_pred             cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          212 SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       212 ~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.................  .....+++++.++|.
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~  330 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAPDYTTPEMYQTML  330 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC--CCCTTCCHHHHHHHH
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC--CCCCCCCHHHHHHHH
Confidence            3456888999999876 458999999999999999998 999998876544443333332222  223468999999999


Q ss_pred             HhccCCCCCCCCHHHHhcC
Q 019040          290 QMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       290 ~~l~~dp~~Rps~~~ll~h  308 (347)
                      .||+.||.+|||+.++++|
T Consensus       331 ~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          331 DCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhhCCCHHHHHHH
Confidence            9999999999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-45  Score=325.13  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=214.6

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...++|++.+.||.|+||.||+|.+. +++.||+|++.....    ..+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSE
T ss_pred             eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCce
Confidence            34578999999999999999999987 467799999865432    336789999999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      ++||||+++++|.+++... ..++...++.++.|++.||.|||+.||+||||||+||++   +.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBC
T ss_pred             EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccc
Confidence            9999999999999999765 458999999999999999999999999999999999999   566789999999998654


Q ss_pred             CCC--cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          207 PGE--RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       207 ~~~--~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ...  ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+.......   ....+++
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  234 (269)
T 4hcu_A          158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLAST  234 (269)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCH
T ss_pred             ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC---CCCcCCH
Confidence            332  122345677899999886 458999999999999999999 999999998888877776653322   2246799


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ++.++|..||+.||++|||+.++++|
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          235 HVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHH
Confidence            99999999999999999999999887

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.4e-45  Score=327.18  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=214.3

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .+....++|++++.||.|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++.+ +|+||+++++++.+.
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   91 (283)
T 3gen_A           18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQ   91 (283)
T ss_dssp             TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSS
T ss_pred             CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcC-CCCCEeeEEEEEecC
Confidence            44555689999999999999999999886 577899999875432    336688999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      +..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++.
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~  168 (283)
T 3gen_A           92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSR  168 (283)
T ss_dssp             SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGG
T ss_pred             CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEccccccc
Confidence            999999999999999999977 4569999999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          204 FFKPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       204 ~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      .......  .....+|+.|+|||.+. ..++.++||||||+++|+|++ |..||...........+........   ...
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  245 (283)
T 3gen_A          169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHL  245 (283)
T ss_dssp             GBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTT
T ss_pred             cccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCc
Confidence            6543321  12335678899999876 458999999999999999998 9999999988888877776643332   246


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +++.+.++|..||+.||++|||+.++++|
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          246 ASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            78999999999999999999999999877

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2e-45  Score=330.42  Aligned_cols=261  Identities=26%  Similarity=0.441  Sum_probs=205.8

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .....++|++.+.||.|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +|+||+++++++...+
T Consensus        27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~  105 (310)
T 2wqm_A           27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDN  105 (310)
T ss_dssp             TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETT
T ss_pred             ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCC
Confidence            344567899999999999999999999999999999999765555555667899999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          126 AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                      ..++|+||+++++|.+++..    ...+++..++.++.||+.||.|||+.|++|+||||+||++   +.++.++|+|||+
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGL  182 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC--
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccc
Confidence            99999999999999999865    3568999999999999999999999999999999999999   6778899999999


Q ss_pred             ccccCCCCc-ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccccccCCCC
Q 019040          202 SIFFKPGER-FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESE--QGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       202 a~~~~~~~~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~  277 (347)
                      +........ .....+++.|+|||.+. ..++.++||||||+++|+|++|..||.+...  ......+....  ++....
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  260 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPS  260 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCT
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCcc
Confidence            876543322 23457899999999876 4588999999999999999999999976532  23333333322  222233


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ..++.++.++|..||+.||++|||+.+++++  +++.
T Consensus       261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~~--l~~l  295 (310)
T 2wqm_A          261 DHYSEELRQLVNMCINPDPEKRPDVTYVYDV--AKRM  295 (310)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             cccCHHHHHHHHHHcCCChhhCCCHHHHHHH--HHHH
Confidence            5789999999999999999999999999864  4444

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.8e-45  Score=328.68  Aligned_cols=258  Identities=20%  Similarity=0.266  Sum_probs=212.2

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ....+.++|++.+.||.|+||.||+|.+..+++.||+|++....     ....+.+|+.+++.+.+|++++.+++++...
T Consensus         4 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   78 (298)
T 1csn_A            4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG   78 (298)
T ss_dssp             --CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             cCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence            34556789999999999999999999999999999999986432     2234778999999998899999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC--CCCCCEEEEeecc
Q 019040          125 NAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK--KENSPLKAIDFGL  201 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~--~~~~~~~l~Dfg~  201 (347)
                      ...++|+||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.+  .....++|+|||+
T Consensus        79 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           79 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            9999999999 889999998754 59999999999999999999999999999999999999543  2234499999999


Q ss_pred             ccccCCCCc--------ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcc
Q 019040          202 SIFFKPGER--------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES---EQGVAQAILRGL  269 (347)
Q Consensus       202 a~~~~~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~  269 (347)
                      +........        .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||....   .......+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            987654322        244579999999998764 48999999999999999999999998743   333444433332


Q ss_pred             cccc-CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          270 IDFK-RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       270 ~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ...+ ......+++++.++|..||+.||++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            2111 12224789999999999999999999999999654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.3e-46  Score=342.57  Aligned_cols=264  Identities=22%  Similarity=0.414  Sum_probs=210.3

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC----------CCCceeEeee
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP----------KNSSIVSLKE  119 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~----------~h~~i~~~~~  119 (347)
                      .++|++.+.||.|+||+||+|.+..+++.||+|++...    ......+.+|+.+++.+.          .|+||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            57999999999999999999999999999999998643    223456788999998883          1789999999


Q ss_pred             EEeeCC----eEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecC---C
Q 019040          120 ACEDDN----AVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANK---K  189 (347)
Q Consensus       120 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~---~  189 (347)
                      ++...+    ..++++|++ +++|.+++...  ..++...+..++.||+.||.|||++ ||+||||||+|||++.+   +
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            988654    889999999 88999999874  4599999999999999999999998 99999999999999643   2


Q ss_pred             CCCCEEEEeeccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHH
Q 019040          190 ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES------EQGVA  262 (347)
Q Consensus       190 ~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~  262 (347)
                      ..+.++|+|||++......  .....+|+.|+|||++.+ .++.++||||||+++|+|++|..||....      .....
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            3447999999999865432  334578999999998764 48999999999999999999999997654      22233


Q ss_pred             HHHHhccccccC--------------------------------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 019040          263 QAILRGLIDFKR--------------------------------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQ  304 (347)
Q Consensus       263 ~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  304 (347)
                      ..+.......+.                                      .....++.++.+||.+||+.||++|||+.+
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            333222111110                                      011134577889999999999999999999


Q ss_pred             HhcCcccccCcCCCCC
Q 019040          305 VLEHPWLQNAKKAPNV  320 (347)
Q Consensus       305 ll~h~~~~~~~~~~~~  320 (347)
                      +|+||||++.......
T Consensus       331 ll~hp~f~~~~~~~~~  346 (373)
T 1q8y_A          331 LVNHPWLKDTLGMEEI  346 (373)
T ss_dssp             HHTCGGGTTCTTCTTC
T ss_pred             HhhChhhhcccCcccc
Confidence            9999999987655443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.8e-46  Score=337.69  Aligned_cols=267  Identities=22%  Similarity=0.310  Sum_probs=195.3

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHH-HHHhCCCCCceeEeeeEEee
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA-IMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~-~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .+....++|++.+.||.|+||.||+|.++.+|+.||+|++....  .......+.+|+. +++.+ +||||+++++++..
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~   92 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFR   92 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEEC
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEe
Confidence            33445689999999999999999999999999999999986542  2233445666666 55556 99999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          124 DNAVHLVMELCEGGELFDRIVA-----RGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                      .+..++||||+++ +|.+++..     ...+++..+..++.|++.||.|||+. ||+||||||+||++   +.++.+||+
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~  168 (327)
T 3aln_A           93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLC  168 (327)
T ss_dssp             SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEEC
T ss_pred             CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEc
Confidence            9999999999975 88887764     45699999999999999999999999 99999999999999   567789999


Q ss_pred             eeccccccCCCCcccccccCcccccccccc-----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcc-c
Q 019040          198 DFGLSIFFKPGERFSEIVGSPYYMAPEVLK-----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGL-I  270 (347)
Q Consensus       198 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~-~  270 (347)
                      |||++.............||+.|+|||.+.     ..++.++||||||+++|+|++|..||...... .....+.... .
T Consensus       169 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  248 (327)
T 3aln_A          169 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP  248 (327)
T ss_dssp             CCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred             cCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence            999998765544444457999999999872     34889999999999999999999999765432 1111111111 1


Q ss_pred             cccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCC
Q 019040          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (347)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  318 (347)
                      .+.......++..+.++|..||+.||++|||+.++++||||.......
T Consensus       249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~  296 (327)
T 3aln_A          249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA  296 (327)
T ss_dssp             CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSC
T ss_pred             CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhH
Confidence            112222346899999999999999999999999999999998775443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2e-45  Score=324.00  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=202.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc-hhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      .++|++.+.||+|+||.||+|.+.  +..||+|++....... ....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceE
Confidence            478999999999999999999984  7889999987543322 33457789999999999 8999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---cEeeCCCCCcEEeecCC-----CCCCEEEEeec
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG---VIHRDLKPENFLFANKK-----ENSPLKAIDFG  200 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~NIli~~~~-----~~~~~~l~Dfg  200 (347)
                      +||||+++++|.+++. ...+++..++.++.|++.||.|||++|   |+||||||+||+++.+.     .++.++|+|||
T Consensus        83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999988874 457999999999999999999999999   89999999999996422     26789999999


Q ss_pred             cccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ++........ ....+++.|+|||.+.+ .++.++||||||+++++|++|..||...........+.......+  ....
T Consensus       162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~  238 (271)
T 3dtc_A          162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP--IPST  238 (271)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--CCTT
T ss_pred             cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--CCcc
Confidence            9986544332 34578999999998764 489999999999999999999999999887776666655543332  2357


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +++.+.++|.+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            89999999999999999999999999876

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.9e-45  Score=331.05  Aligned_cols=264  Identities=26%  Similarity=0.454  Sum_probs=210.4

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCC-CCceeEeeeEEeeCCe
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK-NSSIVSLKEACEDDNA  126 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~-h~~i~~~~~~~~~~~~  126 (347)
                      ...++|++.+.||.|+||.||+|.+. +++.||+|++..... .......+.+|+.+++.+.+ |+||+++++++...+.
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            34578999999999999999999985 588899999865432 33456788999999999943 6999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .+++|| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++    ++.++|+|||++....
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC--
T ss_pred             EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeecccccccc
Confidence            999999 45789999999888899999999999999999999999999999999999994    3679999999998654


Q ss_pred             CCCc---ccccccCccccccccccc------------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccc
Q 019040          207 PGER---FSEIVGSPYYMAPEVLKR------------NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLI  270 (347)
Q Consensus       207 ~~~~---~~~~~~~~~y~aPE~~~~------------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~  270 (347)
                      ....   .....|++.|+|||.+.+            .++.++||||||+++|+|++|..||...... .....+.....
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  257 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  257 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence            3322   234468999999998753            4778999999999999999999999776433 33333333222


Q ss_pred             cccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCC
Q 019040          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV  320 (347)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  320 (347)
                      .  .......+.++.++|.+||+.||.+|||+.++++||||+....+.+.
T Consensus       258 ~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~  305 (313)
T 3cek_A          258 E--IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ  305 (313)
T ss_dssp             C--CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC------
T ss_pred             c--cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchhh
Confidence            2  12223568999999999999999999999999999999987655443

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.4e-45  Score=325.26  Aligned_cols=255  Identities=22%  Similarity=0.345  Sum_probs=209.0

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchh----cHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV----DIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      ....++|++.+.||.|+||+||+|.+..+++.||+|++.........    ....+.+|+.+++.+ +||||+++++++.
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~   93 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMH   93 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEET
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeec
Confidence            34468999999999999999999999999999999998654332222    226789999999999 8999999999987


Q ss_pred             eCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--cEeeCCCCCcEEeecCCC--CCCEEEE
Q 019040          123 DDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKE--NSPLKAI  197 (347)
Q Consensus       123 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~NIli~~~~~--~~~~~l~  197 (347)
                      +..  ++||||+++++|.+.+... ..+++..++.++.|++.||.|||+.|  |+|+||||+||+++.++.  ...++|+
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            665  6899999999999888765 46999999999999999999999999  999999999999953221  2239999


Q ss_pred             eeccccccCCCCcccccccCcccccccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccccc
Q 019040          198 DFGLSIFFKPGERFSEIVGSPYYMAPEVLK---RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV--AQAILRGLIDF  272 (347)
Q Consensus       198 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~  272 (347)
                      |||++.....  ......+|+.|+|||.+.   ..++.++||||||+++|+|++|..||........  ...+...  ..
T Consensus       172 Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~  247 (287)
T 4f0f_A          172 DFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE--GL  247 (287)
T ss_dssp             CCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS--CC
T ss_pred             CCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc--CC
Confidence            9999975433  334567999999999873   3478899999999999999999999977654433  2233222  22


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .......+++++.++|..||+.||.+|||+.++++.
T Consensus       248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  283 (287)
T 4f0f_A          248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE  283 (287)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            333445789999999999999999999999999763

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=337.64  Aligned_cols=261  Identities=28%  Similarity=0.499  Sum_probs=203.7

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccch---hcHHHHHHHHHHHHhCC---CCCceeEe
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREVAIMKHLP---KNSSIVSL  117 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~ei~~l~~l~---~h~~i~~~  117 (347)
                      ...+.+.++|++.+.||.|+||.||+|.+..+++.||+|++........   .....+.+|+.++..+.   +|+||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            4556778999999999999999999999999999999999975533221   12234556888888874   69999999


Q ss_pred             eeEEeeCCeEEEEEEe-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEE
Q 019040          118 KEACEDDNAVHLVMEL-CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (347)
Q Consensus       118 ~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l  196 (347)
                      ++++...+..++|+|+ +.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||+++  ..++.++|
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl  181 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKL  181 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEE
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEE
Confidence            9999999999999999 78899999999888899999999999999999999999999999999999994  25678999


Q ss_pred             EeeccccccCCCCcccccccCccccccccccc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC
Q 019040          197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR  274 (347)
Q Consensus       197 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  274 (347)
                      +|||++...... ......+++.|+|||.+.+ .+ +.++||||||+++|+|++|..||....      .+......   
T Consensus       182 ~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~---  251 (312)
T 2iwi_A          182 IDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELH---  251 (312)
T ss_dssp             CCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCC---
T ss_pred             EEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccC---
Confidence            999999876543 3345678999999998764 33 458999999999999999999996532      12222222   


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                       ....++..+.++|.+||+.||++|||+.++++||||+.....
T Consensus       252 -~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~  293 (312)
T 2iwi_A          252 -FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED  293 (312)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred             -CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence             224789999999999999999999999999999999987644

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1e-45  Score=335.39  Aligned_cols=253  Identities=19%  Similarity=0.214  Sum_probs=207.0

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .+.++|++.+.||.|+||+||+|++..+++.||+|++.....     ...+.+|+.+++.+.+|+||+++++++...+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            456889999999999999999999999999999999864421     235788999999998999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC--CCCEEEEeeccccc
Q 019040          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE--NSPLKAIDFGLSIF  204 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~--~~~~~l~Dfg~a~~  204 (347)
                      ++||||+ +++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+..  ...++|+|||++..
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9999999 88999999874 57999999999999999999999999999999999999953221  12399999999986


Q ss_pred             cCCCCc--------ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccccc
Q 019040          205 FKPGER--------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE---QGVAQAILRGLIDF  272 (347)
Q Consensus       205 ~~~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~  272 (347)
                      ......        .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.....   ......+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            543322        235679999999998764 489999999999999999999999987543   33344443332222


Q ss_pred             cCC-CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          273 KRD-PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       273 ~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      +.. .+..+| ++.++|..||+.||.+||++.++++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            211 112345 9999999999999999999998865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-45  Score=336.75  Aligned_cols=258  Identities=23%  Similarity=0.323  Sum_probs=218.7

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      ....++|++.+.||.|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.+ +||||+++++++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~  119 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVC  119 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE
Confidence            445689999999999999999999997     345889999986542  333457799999999999 999999999999


Q ss_pred             eeCCeEEEEEEecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeC
Q 019040          122 EDDNAVHLVMELCEGGELFDRIVAR------------------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRD  177 (347)
Q Consensus       122 ~~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~D  177 (347)
                      .+.+..++||||+++++|.+++...                        ..+++..++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            9999999999999999999999774                        4689999999999999999999999999999


Q ss_pred             CCCCcEEeecCCCCCCEEEEeeccccccCCCC---cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCC
Q 019040          178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPP  252 (347)
Q Consensus       178 ikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~p  252 (347)
                      |||+||++   +.++.++|+|||++.......   ......+++.|+|||.+. ..++.++||||||+++|+|++ |..|
T Consensus       200 lkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          200 LATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            99999999   667789999999987643221   223346788999999876 458999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          253 FWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       253 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      |...........+......   .....++.++.++|..||+.||++|||+.+++++  |++..
T Consensus       277 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~--L~~~~  334 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI--LQRMC  334 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTT
T ss_pred             CCCCChHHHHHHHhCCCcC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH--HHHHH
Confidence            9999888877777665432   2234789999999999999999999999999765  55543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.2e-45  Score=334.47  Aligned_cols=263  Identities=23%  Similarity=0.262  Sum_probs=217.8

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEE-----ECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCI-----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      ..+...++|++.+.||.|+||.||+|+     +..+++.||+|++....  .......+.+|+.+++.+ +||||+++++
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~  100 (327)
T 2yfx_A           24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKF-NHQNIVRCIG  100 (327)
T ss_dssp             SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEE
T ss_pred             cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhC-CCCCCCeEEE
Confidence            345567899999999999999999999     55678899999986432  334456788999999999 9999999999


Q ss_pred             EEeeCCeEEEEEEecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC
Q 019040          120 ACEDDNAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       120 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                      ++...+..++||||+++++|.+++....       .++...++.++.||+.||.|||+.||+||||||+||+++.++.+.
T Consensus       101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred             EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence            9999999999999999999999998753       388999999999999999999999999999999999997555667


Q ss_pred             CEEEEeeccccccCCCC---cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 019040          193 PLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILR  267 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~  267 (347)
                      .++|+|||++.......   ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+..
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  260 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  260 (327)
T ss_dssp             CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence            89999999987543222   223346788999999875 458999999999999999998 9999998888777776666


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                      ....   .....++..+.++|..||+.||.+|||+.++++|.|+-.
T Consensus       261 ~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          261 GGRM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            5322   223478999999999999999999999999999987643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-45  Score=341.27  Aligned_cols=254  Identities=23%  Similarity=0.325  Sum_probs=215.4

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .+..-.++|.+.+.||.|+||.||+|.++.+++.||+|++....  .......+.+|+++++.+ +||||+++++++...
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQK  184 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSS
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecC
Confidence            34445689999999999999999999999999999999986432  233345688899999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      +..++||||+++++|.+++.... .++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSR  261 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCE
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCce
Confidence            99999999999999999997653 59999999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCCCcc---cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          204 FFKPGERF---SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       204 ~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ........   ....+++.|+|||.+. +.++.++||||||+++|+|++ |..||...........+..+..   .+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~  338 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR---LPCPE  338 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC---CCCCT
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCC
Confidence            64432211   1123567899999876 458999999999999999998 9999999888777766655432   22234


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .+++++.++|..||+.||++|||+.++++
T Consensus       339 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            68999999999999999999999999975

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.8e-45  Score=325.91  Aligned_cols=251  Identities=36%  Similarity=0.667  Sum_probs=203.3

Q ss_pred             CCCCCcccceeee-eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           44 VPKENIEDRYLVD-RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        44 ~~~~~~~~~y~i~-~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      .....+.++|.+. +.||.|+||.||+|.++.+++.||+|++...        ....+|+.++.++.+||||+++++++.
T Consensus        10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~   81 (299)
T 3m2w_A           10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYE   81 (299)
T ss_dssp             CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhh
Confidence            4455667888888 7799999999999999999999999998532        456789998855559999999999998


Q ss_pred             e----CCeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEE
Q 019040          123 D----DNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (347)
Q Consensus       123 ~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l  196 (347)
                      .    .+..++||||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.++.++.++|
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl  161 (299)
T 3m2w_A           82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL  161 (299)
T ss_dssp             EEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred             hhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEE
Confidence            7    778999999999999999998864  5999999999999999999999999999999999999975444789999


Q ss_pred             EeeccccccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----cc
Q 019040          197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI----DF  272 (347)
Q Consensus       197 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----~~  272 (347)
                      +|||++.....                    ..++.++||||||+++|+|++|..||...........+.....    .+
T Consensus       162 ~Dfg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  221 (299)
T 3m2w_A          162 TDFGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  221 (299)
T ss_dssp             CCCTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSS
T ss_pred             ecccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccC
Confidence            99999865321                    2367899999999999999999999977655432221111111    11


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCC
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL  322 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~  322 (347)
                      +...+..+++++.++|.+||+.||++|||+.++++||||++....+....
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~  271 (299)
T 3m2w_A          222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL  271 (299)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBC
T ss_pred             CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCC
Confidence            11112468999999999999999999999999999999998876666544

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.9e-45  Score=330.95  Aligned_cols=254  Identities=23%  Similarity=0.309  Sum_probs=216.3

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      .+...++|.+.+.||.|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.+ +||||++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~   94 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQV-NHPHVIKLYGA   94 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEE
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhC-CCCceeeEEEE
Confidence            3445689999999999999999999983     456889999986432  344567789999999999 99999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCcEee
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVARGH------------------------YTERAAAAVTRTIVEVVQLCHKHGVIHR  176 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~~l~~lH~~~ivH~  176 (347)
                      +...+..++|+||+++++|.+++.....                        +++..++.++.||+.||.|||++||+||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            9999999999999999999999987543                        8899999999999999999999999999


Q ss_pred             CCCCCcEEeecCCCCCCEEEEeeccccccCCCCc---ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCC
Q 019040          177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVP  251 (347)
Q Consensus       177 Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~  251 (347)
                      ||||+||++   +.++.++|+|||++........   .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..
T Consensus       175 dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          175 DLAARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             CCSGGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccchheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999   5667899999999986544322   123356788999998764 48999999999999999999 999


Q ss_pred             CCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          252 PFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       252 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ||...........+.....   ......+++++.++|.+||+.||++|||+.+++++
T Consensus       252 p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          252 PYPGIPPERLFNLLKTGHR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             SSTTCCGGGHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHhhcCCc---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9998888777766655432   22334789999999999999999999999999876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.9e-45  Score=332.14  Aligned_cols=257  Identities=26%  Similarity=0.368  Sum_probs=217.5

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEEC-------CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeE
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS  116 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~  116 (347)
                      ..+....++|++.+.||.|+||.||+|.+.       .+++.||+|++....  .......+.+|+.+++.+.+||||++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~  105 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN  105 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence            344555789999999999999999999986       456789999986542  33456778999999999988999999


Q ss_pred             eeeEEeeCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCC
Q 019040          117 LKEACEDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP  180 (347)
Q Consensus       117 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp  180 (347)
                      +++++...+..++|+||+++++|.+++....                .++...++.++.||+.||.|||++||+|+||||
T Consensus       106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  185 (334)
T 2pvf_A          106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA  185 (334)
T ss_dssp             EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence            9999999999999999999999999998653                388999999999999999999999999999999


Q ss_pred             CcEEeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 019040          181 ENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWA  255 (347)
Q Consensus       181 ~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~  255 (347)
                      +||++   +.++.++|+|||++........   .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||..
T Consensus       186 ~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  262 (334)
T 2pvf_A          186 RNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  262 (334)
T ss_dssp             GGEEE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ceEEE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence            99999   6778899999999987654332   22335678899999876 458999999999999999999 9999998


Q ss_pred             CCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .........+.....   ......++.++.++|..||+.||.+|||+.+++++
T Consensus       263 ~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          263 IPVEELFKLLKEGHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             CCHHHHHHHHHHTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHhcCCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            888777776665532   22234789999999999999999999999999876

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2e-45  Score=330.67  Aligned_cols=256  Identities=21%  Similarity=0.298  Sum_probs=214.9

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEE-----CCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCID-----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      .....++|++.+.||.|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++.+.+||||++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            344568999999999999999999985     4567899999986543  233457799999999999889999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCc
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVARG------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN  182 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~N  182 (347)
                      +...+..++|+||+++++|.+++....                  .+++..++.++.||+.||.|||++||+||||||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  175 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            999999999999999999999998754                  38999999999999999999999999999999999


Q ss_pred             EEeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 019040          183 FLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAES  257 (347)
Q Consensus       183 Ili~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  257 (347)
                      |++   +.++.++|+|||++........   .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||....
T Consensus       176 il~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          176 ILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             EEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             EEE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            999   5677899999999987654432   22345778899999875 458999999999999999998 999998876


Q ss_pred             HHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ..............  ......++..+.++|..||+.||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          253 VDSKFYKMIKEGFR--MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SSHHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHhccCCC--CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            55444444433222  22234789999999999999999999999999876

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-45  Score=334.87  Aligned_cols=256  Identities=20%  Similarity=0.291  Sum_probs=211.8

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEE-----CCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCID-----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      ++...++|++.+.||.|+||.||+|.+     ..++..||+|++....  .......+.+|+.+++.+.+||||++++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            344568999999999999999999997     3456789999986432  233457789999999999889999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeC
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVARG-----------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRD  177 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~D  177 (347)
                      +...+..++||||+++++|.+++....                       .+++..++.++.||+.||.|||+.||+|||
T Consensus       118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  197 (344)
T 1rjb_A          118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD  197 (344)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            999999999999999999999997653                       278999999999999999999999999999


Q ss_pred             CCCCcEEeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCC
Q 019040          178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPP  252 (347)
Q Consensus       178 ikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~p  252 (347)
                      |||+||++   +.++.++|+|||++........   .....+|+.|+|||.+. ..++.++||||||+++|+|++ |..|
T Consensus       198 ikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          198 LAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             CSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CChhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            99999999   5677899999999986543322   23345788999999875 458999999999999999998 9999


Q ss_pred             CCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          253 FWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       253 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      |..................  ......+++++.++|..||+.||.+|||+.++++|
T Consensus       275 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          275 YPGIPVDANFYKLIQNGFK--MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             STTCCCSHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCCcHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            9887765554444443322  22234689999999999999999999999999887

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.1e-45  Score=328.03  Aligned_cols=254  Identities=22%  Similarity=0.346  Sum_probs=203.6

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEE----ECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      +.....++|++++.||.|+||+||+|+    +..+++.||+|++...   .......+.+|+.+++.+ +||||++++++
T Consensus         4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   79 (295)
T 3ugc_A            4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKGV   79 (295)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred             cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeeEEEE
Confidence            445567899999999999999999998    5678999999998643   344456789999999999 89999999999


Q ss_pred             Eee--CCeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          121 CED--DNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       121 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                      +..  ....++||||+++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+
T Consensus        80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~  156 (295)
T 3ugc_A           80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIG  156 (295)
T ss_dssp             ECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEEC
T ss_pred             EecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEc
Confidence            854  356899999999999999998764 49999999999999999999999999999999999999   556779999


Q ss_pred             eeccccccCCCCc----ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------------
Q 019040          198 DFGLSIFFKPGER----FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-------------  259 (347)
Q Consensus       198 Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------------  259 (347)
                      |||++........    .....++..|+|||.+. ..++.++||||||+++|+|++|..||......             
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T 3ugc_A          157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  236 (295)
T ss_dssp             CCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred             cCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence            9999987644322    22335677799999876 45899999999999999999999988544321             


Q ss_pred             ---HHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          260 ---GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       260 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                         .....+..   ....+....+++++.++|..||+.||++|||+.++++.
T Consensus       237 ~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          237 IVFHLIELLKN---NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  285 (295)
T ss_dssp             HHHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHhc---cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence               11111111   12223345789999999999999999999999999754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-45  Score=333.51  Aligned_cols=250  Identities=23%  Similarity=0.306  Sum_probs=210.5

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCcee--EEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELL--ACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ++|++.+.||.|+||.||+|+++.++..+  ++|.+....  .......+.+|+.+++.+.+||||+++++++...+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            78999999999999999999999888765  888876432  23345678899999999988999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC
Q 019040          129 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                      +||||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+||++   +.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCC
Confidence            9999999999999997654                68999999999999999999999999999999999999   5677


Q ss_pred             CEEEEeeccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 019040          193 PLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLI  270 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  270 (347)
                      .++|+|||++.............+++.|+|||.+.+ .++.++||||||+++|+|++ |..||...........+.... 
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-  258 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  258 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC-
Confidence            899999999875433333333457889999998764 48999999999999999998 999999988877766665542 


Q ss_pred             cccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                        .......+++++.++|.+||+.||.+|||+.+++++
T Consensus       259 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          259 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              222334789999999999999999999999999876

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.4e-45  Score=324.48  Aligned_cols=252  Identities=25%  Similarity=0.329  Sum_probs=202.5

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCC---CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      +...++|++.+.||.|+||.||+|.+..+   +..||+|.+....  .......+.+|+.+++.+ +||||+++++++. 
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-   86 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-   86 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCccceEEEEEc-
Confidence            44568999999999999999999998754   4569999876432  334456789999999999 9999999999984 


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      ++..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLS  163 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC----
T ss_pred             cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---CCCCCEEECccccc
Confidence            567889999999999999998764 59999999999999999999999999999999999999   45677999999999


Q ss_pred             cccCCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          203 IFFKPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       203 ~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ........  .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||......+....+.....   .....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~  240 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPP  240 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCT
T ss_pred             cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC---CCCCC
Confidence            87644322  12335678899999876 458899999999999999996 9999998888777777665432   22335


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+++.+.++|..||+.||++|||+.+++++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            789999999999999999999999999765

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.1e-45  Score=323.70  Aligned_cols=253  Identities=21%  Similarity=0.344  Sum_probs=218.4

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .++...++|++.+.||.|+||+||+|.+..+++.||+|++...    ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTRE   81 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC
Confidence            4455678999999999999999999999999999999998643    23456788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      +..++||||+++++|.+++....  .++...++.++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLS  158 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGG
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccc
Confidence            99999999999999999998743  48999999999999999999999999999999999999   56778999999999


Q ss_pred             cccCCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          203 IFFKPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       203 ~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ........  .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||...+.......+.....   .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~  235 (288)
T 3kfa_A          159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPE  235 (288)
T ss_dssp             GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCT
T ss_pred             eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---CCCCC
Confidence            87654332  22345678899999876 458999999999999999999 9999988887777666655432   22335


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+++.+.++|..||+.||.+|||+.++++.
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.2e-45  Score=337.42  Aligned_cols=256  Identities=23%  Similarity=0.343  Sum_probs=206.6

Q ss_pred             CCCCCCcccceeeeeeecccCCeEEEEEEEC---CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           43 GVPKENIEDRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        43 ~~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      ....+...++|.+.+.||+|+||.||+|+++   .++..||+|++....  .......+.+|+.+++.+ +||||+++++
T Consensus        37 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~  113 (373)
T 2qol_A           37 EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQF-DHPNIIRLEG  113 (373)
T ss_dssp             TTSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEE
T ss_pred             HHHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEE
Confidence            3445556689999999999999999999887   467789999986532  334456799999999999 9999999999


Q ss_pred             EEeeCCeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          120 ACEDDNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       120 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      ++...+..++||||+++++|.+++.... .++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|
T Consensus       114 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~D  190 (373)
T 2qol_A          114 VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSD  190 (373)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECC
T ss_pred             EEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECc
Confidence            9999999999999999999999998764 59999999999999999999999999999999999999   6778899999


Q ss_pred             eccccccCCCCcc----cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccc
Q 019040          199 FGLSIFFKPGERF----SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDF  272 (347)
Q Consensus       199 fg~a~~~~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  272 (347)
                      ||++.........    ....+++.|+|||.+. ..++.++||||||+++|++++ |..||...........+.....  
T Consensus       191 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~--  268 (373)
T 2qol_A          191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR--  268 (373)
T ss_dssp             C----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE--
T ss_pred             CccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--
Confidence            9999865433211    1223567899999876 458999999999999999997 9999999888877777765532  


Q ss_pred             cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                       .+....++..+.++|..||+.||++||++.++++
T Consensus       269 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          269 -LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             -CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence             2223478999999999999999999999998875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2e-45  Score=327.03  Aligned_cols=259  Identities=17%  Similarity=0.254  Sum_probs=209.0

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCC-------ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTR-------ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      ...++|.+.+.||.|+||+||+|.+..++       ..||+|++...   .....+.+.+|+.+++.+ +||||++++++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   80 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKL-SHKHLVLNYGV   80 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTS-CCTTBCCEEEE
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhC-CCCCEeEEEEE
Confidence            34679999999999999999999998877       46999998654   234457789999999999 89999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCC-----CCCE
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE-----NSPL  194 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~-----~~~~  194 (347)
                      +...+..++||||+++++|.+++..... +++..+..++.||+.||.|||++||+||||||+||+++.+..     .+.+
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999999987654 999999999999999999999999999999999999964322     1129


Q ss_pred             EEEeeccccccCCCCcccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcccc
Q 019040          195 KAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG-VPPFWAESEQGVAQAILRGLID  271 (347)
Q Consensus       195 ~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~  271 (347)
                      +|+|||.+......   ....+++.|+|||.+.  ..++.++||||||+++|+|++| ..||.......... .......
T Consensus       161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~~  236 (289)
T 4fvq_A          161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRHQ  236 (289)
T ss_dssp             EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTCC
T ss_pred             eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccCC
Confidence            99999998754322   3346889999999876  4489999999999999999995 45555555444333 3333222


Q ss_pred             ccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCC
Q 019040          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV  320 (347)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  320 (347)
                      .    ....+.++.++|..||+.||++|||+.++++|  |+...++...
T Consensus       237 ~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~p~~~  279 (289)
T 4fvq_A          237 L----PAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFTPDLV  279 (289)
T ss_dssp             C----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC-----
T ss_pred             C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcCCCCC
Confidence            2    23557889999999999999999999999988  7777655443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7e-45  Score=328.54  Aligned_cols=256  Identities=21%  Similarity=0.325  Sum_probs=217.6

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK  118 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~  118 (347)
                      ..+....++|++.+.||.|+||.||+|.+.     .+++.||+|.+....  .......+.+|+.+++.+ +|+||++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~   94 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLL   94 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGC-CCTTBCCEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhc-CCCCEeeeE
Confidence            345566789999999999999999999886     457889999986432  333456788999999999 999999999


Q ss_pred             eEEeeCCeEEEEEEecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC
Q 019040          119 EACEDDNAVHLVMELCEGGELFDRIVAR----------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK  188 (347)
Q Consensus       119 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~  188 (347)
                      +++.+.+..++||||+++++|.+++...          ..++...++.++.||+.||.|||++||+||||||+||++   
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---
Confidence            9999999999999999999999998653          356899999999999999999999999999999999999   


Q ss_pred             CCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 019040          189 KENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQ  263 (347)
Q Consensus       189 ~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~  263 (347)
                      +.++.++|+|||++........   .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||..........
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence            6778899999999976543321   12335688999999876 458999999999999999999 899999988887777


Q ss_pred             HHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+......   .....++..+.++|..||+.||++|||+.++++|
T Consensus       252 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          252 FVMEGGLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            77665432   2234789999999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-44  Score=323.52  Aligned_cols=255  Identities=25%  Similarity=0.369  Sum_probs=205.6

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEE----ECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      .+.....++|++++.||.|+||.||+|+    +..+++.||+|++....  .......+.+|+.+++.+ +|+||+++++
T Consensus        14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~   90 (302)
T 4e5w_A           14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKG   90 (302)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred             ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCeeeeee
Confidence            3444456789999999999999999999    56789999999987543  334567899999999999 8999999999


Q ss_pred             EEeeC--CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEE
Q 019040          120 ACEDD--NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (347)
Q Consensus       120 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l  196 (347)
                      ++...  +..++||||+++++|.+++... ..++...++.++.||+.||.|||++||+|+||||+||++   +.++.++|
T Consensus        91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl  167 (302)
T 4e5w_A           91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKI  167 (302)
T ss_dssp             EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEE
T ss_pred             EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEE
Confidence            99876  7789999999999999999554 569999999999999999999999999999999999999   45678999


Q ss_pred             EeeccccccCCCCc----ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------------
Q 019040          197 IDFGLSIFFKPGER----FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAES--------------  257 (347)
Q Consensus       197 ~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------------  257 (347)
                      +|||++........    .....+|..|+|||.+. ..++.++||||||+++|+|++|..|+....              
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (302)
T 4e5w_A          168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM  247 (302)
T ss_dssp             CCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGG
T ss_pred             CcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccccc
Confidence            99999987654432    23346788899999876 458899999999999999999988753221              


Q ss_pred             HH-HHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          258 EQ-GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       258 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .. .....+...   ........+++++.++|.+||+.||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          248 TVTRLVNTLKEG---KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHhcc---CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            11 112222221   122334578999999999999999999999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.7e-45  Score=330.64  Aligned_cols=250  Identities=21%  Similarity=0.285  Sum_probs=204.0

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCcee----EEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELL----ACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ..++|++.+.||.|+||+||+|++..+++.+    |+|.+....  .......+.+|+.+++.+ +||||+++++++...
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS   89 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC
Confidence            3578999999999999999999998888765    666654322  334457899999999999 999999999999876


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      + .++|++|+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAK  165 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHH
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCccee
Confidence            5 77899999999999999874 569999999999999999999999999999999999999   556779999999998


Q ss_pred             ccCCCCcc---cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          204 FFKPGERF---SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       204 ~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ........   ....+|+.|+|||.+. ..++.++||||||+++|+|++ |..||...........+......   ....
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  242 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPP  242 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCT
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC---CCCc
Confidence            65443322   2335678899999876 458999999999999999999 99999988877766666554322   2234


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .++.++.+++.+||+.||++|||+.+++++
T Consensus       243 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          243 ICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            689999999999999999999999999876

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-44  Score=322.46  Aligned_cols=256  Identities=19%  Similarity=0.250  Sum_probs=207.0

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ..+.++|++.+.||.|+||.||+|++..+++.||+|++....     ....+.+|+.+++.+.+++++..+..+....+.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-----chhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            346789999999999999999999999999999999986432     123588899999999555556666555677889


Q ss_pred             EEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .++|+||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++.++|+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99999999 8899999975 356999999999999999999999999999999999999964456788999999999876


Q ss_pred             CCCCc--------ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcccccc
Q 019040          206 KPGER--------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE---QGVAQAILRGLIDFK  273 (347)
Q Consensus       206 ~~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~  273 (347)
                      .....        .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||.....   ......+.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            54322        234579999999998764 588999999999999999999999976432   223333333222222


Q ss_pred             -CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          274 -RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       274 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                       ...+..+++++.++|..||+.||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence             11124689999999999999999999999999764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3e-45  Score=331.65  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=207.2

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCce----eEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTREL----LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ..++|++.+.||.|+||+||+|.+..+++.    ||+|.+....  .......+.+|+.+++.+ +||||+++++++. +
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-G   86 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-B
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-C
Confidence            357899999999999999999999988887    5556553322  222334567799999999 9999999999886 4


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      +..++|+||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVAD  163 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGG
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCccc
Confidence            5688999999999999999775 468999999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          204 FFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       204 ~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      .......   .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||...........+........   ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~  240 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ---PQ  240 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC---CT
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---CC
Confidence            7644332   23446778999999886 558999999999999999999 9999998887777776665532222   23


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .++.++.++|.+||+.||.+|||+.+++++
T Consensus       241 ~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          241 ICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            577889999999999999999999999887

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.7e-44  Score=320.24  Aligned_cols=249  Identities=21%  Similarity=0.315  Sum_probs=209.3

Q ss_pred             ccceeeee-eecccCCeEEEEEEE--CCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           50 EDRYLVDR-ELGRGEFGVTYLCID--RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        50 ~~~y~i~~-~lg~G~~g~V~~a~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      .++|.+.+ .||.|+||.||+|.+  ..+++.||+|++.... ......+.+.+|+.+++.+ +||||+++++++ ..+.
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCC
Confidence            57899998 999999999999954  5677899999987543 2233457799999999999 899999999999 5677


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      .++|+||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||++....
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECC
T ss_pred             cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---eCCCcEEEccCCcceeec
Confidence            88999999999999999988889999999999999999999999999999999999999   456789999999998764


Q ss_pred             CCCcc----cccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          207 PGERF----SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       207 ~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      .....    ....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||...........+.....   ......+
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~  245 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGC  245 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTC
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCC
Confidence            43321    12245688999998764 48889999999999999999 9999999888777766665432   2223478


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ++.+.++|..||+.||++|||+.++++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999975

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.3e-46  Score=344.20  Aligned_cols=258  Identities=24%  Similarity=0.390  Sum_probs=210.7

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC-
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-  125 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~-  125 (347)
                      ....++|++.+.||+|+||+||+|.+..+++.||+|++.....  ....+.+.+|+++++.+ +||||+++++++...+ 
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTT   81 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTT
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCC
Confidence            3567899999999999999999999999999999999975432  23456788999999999 8999999999988765 


Q ss_pred             -eEEEEEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeec-CCCCCCEEEEeec
Q 019040          126 -AVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN-KKENSPLKAIDFG  200 (347)
Q Consensus       126 -~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~-~~~~~~~~l~Dfg  200 (347)
                       ..++||||+++++|.+++.....   +++..++.++.||+.||.|||++||+||||||+||++.. ++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence             78999999999999999976432   999999999999999999999999999999999999843 2445679999999


Q ss_pred             cccccCCCCcccccccCcccccccccc---------ccCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHh
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLK---------RNYGPEIDIWSAGVILYILLCGVPPFWAE----SEQGVAQAILR  267 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~~~~~~~~  267 (347)
                      ++.............||+.|+|||++.         ..++.++||||||+++|+|++|..||...    ........+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            998876665556678999999999875         34778999999999999999999999643    22344444444


Q ss_pred             ccccc-------------------c--CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          268 GLIDF-------------------K--RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       268 ~~~~~-------------------~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      +....                   +  ......++..+.++|..||+.||++|||+.++++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            33210                   0  0001134567889999999999999999998844

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-44  Score=325.93  Aligned_cols=257  Identities=22%  Similarity=0.322  Sum_probs=210.3

Q ss_pred             CCCCCCcccceeeeeeecccCCeEEEEEEECCCC----ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEee
Q 019040           43 GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTR----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK  118 (347)
Q Consensus        43 ~~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~  118 (347)
                      ....+...++|.+.+.||.|+||+||+|.+..++    ..||+|++....  .......+.+|+.+++.+ +||||++++
T Consensus        36 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~  112 (333)
T 1mqb_A           36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLE  112 (333)
T ss_dssp             --CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEE
T ss_pred             hccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEE
Confidence            3445666789999999999999999999987554    359999986432  333456788999999999 999999999


Q ss_pred             eEEeeCCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          119 EACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       119 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                      +++...+..++||||+++++|.+++... ..++...++.++.||+.||.|||++||+||||||+||++   +.++.++|+
T Consensus       113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~  189 (333)
T 1mqb_A          113 GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVS  189 (333)
T ss_dssp             EEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEEC
T ss_pred             EEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEEC
Confidence            9999999999999999999999999775 569999999999999999999999999999999999999   677889999


Q ss_pred             eeccccccCCCCc----ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccc
Q 019040          198 DFGLSIFFKPGER----FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLID  271 (347)
Q Consensus       198 Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  271 (347)
                      |||++........    .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+..... 
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~-  268 (333)
T 1mqb_A          190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-  268 (333)
T ss_dssp             CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-
T ss_pred             CCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc-
Confidence            9999987543321    12234577899999876 458899999999999999998 9999998888777777665532 


Q ss_pred             ccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                        .+....++..+.++|.+||+.||++||++.+++++
T Consensus       269 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          269 --LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             --CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             --CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              22234789999999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.3e-45  Score=335.71  Aligned_cols=257  Identities=14%  Similarity=0.157  Sum_probs=197.0

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCC-----CceeEEeEeccccccchh--------cHHHHHHHHHHHHhCCCCCce
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDT-----RELLACKSISKRKLRTAV--------DIDDVRREVAIMKHLPKNSSI  114 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~-----~~~vavK~~~~~~~~~~~--------~~~~~~~ei~~l~~l~~h~~i  114 (347)
                      ...++|++.+.||.|+||.||+|.+..+     ++.||+|++.........        .......|+..+..+ +|+||
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~i  110 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGV  110 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCS
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCC
Confidence            3456999999999999999999999765     578999998654211000        111233455556666 79999


Q ss_pred             eEeeeEEeeC----CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC
Q 019040          115 VSLKEACEDD----NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (347)
Q Consensus       115 ~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~  189 (347)
                      +++++++...    ...++||||+ |++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. +
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~  188 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K  188 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence            9999998765    5689999999 99999999876 56999999999999999999999999999999999999953 2


Q ss_pred             CCCCEEEEeeccccccCCCCc--------ccccccCcccccccccccc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 019040          190 ENSPLKAIDFGLSIFFKPGER--------FSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQG  260 (347)
Q Consensus       190 ~~~~~~l~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  260 (347)
                      .++.+||+|||++........        .....||+.|+|||++.+. ++.++||||||+++|+|++|..||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            568899999999976543221        1234599999999988654 8999999999999999999999997543222


Q ss_pred             HHH-HHHh----cccccc--CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          261 VAQ-AILR----GLIDFK--RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       261 ~~~-~~~~----~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ... ....    ......  ......++.++.++|..||+.||++||++.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            111 1111    111000  0011477999999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-44  Score=316.39  Aligned_cols=247  Identities=24%  Similarity=0.385  Sum_probs=213.2

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++.+.||.|+||.||+|.+. +++.||+|++.....    ..+.+.+|+.+++.+ +||||+++++++...+..++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEE
Confidence            578999999999999999999986 567899999875432    236788999999999 89999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      |+||+++++|.+++... ..++...+..++.||+.||.|||++|++|+||||+||++   +.++.++|+|||++......
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccc
Confidence            99999999999999875 458999999999999999999999999999999999999   56778999999999865432


Q ss_pred             C--cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          209 E--RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       209 ~--~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      .  ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+.......   ....++..+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l  234 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHV  234 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHHH
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC---CCccCcHHH
Confidence            1  112345678899999886 458899999999999999999 899999888887777776653322   224678999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcC
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .++|.+||+.||++|||+.+++++
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          235 YQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.9e-45  Score=327.14  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=209.8

Q ss_pred             CcccceeeeeeecccCCeEEEEEEE-----CCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCID-----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      ...++|++.+.||.|+||+||+|.+     ..+++.||+|++....  .......+.+|+.++..+.+||||+++++++.
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  101 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT  101 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence            3468999999999999999999985     3567899999986542  33345678999999999988999999999987


Q ss_pred             eC-CeEEEEEEecCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEe
Q 019040          123 DD-NAVHLVMELCEGGELFDRIVARGH----------------YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF  185 (347)
Q Consensus       123 ~~-~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli  185 (347)
                      .. +..++|+||+++++|.+++.....                ++...++.++.||+.||.|||+.||+||||||+||++
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~  181 (316)
T 2xir_A          102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  181 (316)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence            65 458999999999999999987643                7899999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 019040          186 ANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQG  260 (347)
Q Consensus       186 ~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~  260 (347)
                         +.++.++|+|||++........   .....+|+.|+|||.+. ..++.++||||||+++|+|++ |..||.......
T Consensus       182 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          182 ---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             ---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence               5677899999999986543322   23346788999999876 458999999999999999998 999998766443


Q ss_pred             H-HHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          261 V-AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       261 ~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      . ...+.... .  ......+++.+.++|..||+.||.+|||+.++++|
T Consensus       259 ~~~~~~~~~~-~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEGT-R--MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHTC-C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCc-c--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3 33333332 1  12234689999999999999999999999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9.5e-45  Score=329.26  Aligned_cols=256  Identities=21%  Similarity=0.303  Sum_probs=213.3

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCc-----eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeE
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRE-----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~  120 (347)
                      .+...++|++.+.||.|+||.||+|.+..+++     .||+|.+....  .......+.+|+.+++.+.+||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            44456889999999999999999999987664     79999986542  333457789999999999789999999999


Q ss_pred             EeeCCeEEEEEEecCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEee
Q 019040          121 CEDDNAVHLVMELCEGGELFDRIVAR--------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFA  186 (347)
Q Consensus       121 ~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~  186 (347)
                      +...+..++||||+++++|.+++...              ..++...++.++.||+.||.|||+.||+||||||+||++ 
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~-  197 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL-  197 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE-
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE-
Confidence            99999999999999999999999653              357999999999999999999999999999999999999 


Q ss_pred             cCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 019040          187 NKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGV  261 (347)
Q Consensus       187 ~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  261 (347)
                        +.++.++|+|||++........   .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||........
T Consensus       198 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          198 --TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             --EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             --CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence              4567799999999986543322   22345678899999876 458999999999999999998 9999988766555


Q ss_pred             HHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ...+.......  .....++..+.++|..||+.||.+|||+.+++++
T Consensus       276 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          276 FYKLVKDGYQM--AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            54444433222  2234678999999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4e-44  Score=338.12  Aligned_cols=246  Identities=23%  Similarity=0.337  Sum_probs=209.8

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      +....++|++.+.||.|+||.||+|.+.  ++.||||++....     ..+.+.+|+.+++.+ +||||+++++++...+
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  259 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK  259 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTT
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCC
Confidence            3445688999999999999999999885  6789999986432     446789999999999 9999999999987664


Q ss_pred             -eEEEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          126 -AVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       126 -~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                       ..++||||+++++|.+++.....  ++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT  336 (450)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTC
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCc
Confidence             79999999999999999987643  7999999999999999999999999999999999999   67788999999999


Q ss_pred             cccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          203 IFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       203 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      .......  ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||......+....+..+.   .......+
T Consensus       337 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---~~~~p~~~  411 (450)
T 1k9a_A          337 KEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGC  411 (450)
T ss_dssp             EECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC---CCCCCTTC
T ss_pred             ccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCcC
Confidence            8643322  2235788999999876 458999999999999999998 999999888777777776653   22334578


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ++++.++|..||+.||++|||+.++++
T Consensus       412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          412 PPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999975

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.9e-45  Score=332.32  Aligned_cols=254  Identities=20%  Similarity=0.299  Sum_probs=206.0

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ....++|++.+.||.|+||+||+|.+. +++.||+|++...   .......+.+|+.+++.+ +||||+++++++...+.
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---SSQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---CSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTC
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCe
Confidence            445689999999999999999999974 6889999987654   233457789999999999 89999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          127 VHLVMELCEGGELFDRIVARG----HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      .++||||+++++|.+++....    .+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeecccc
Confidence            999999999999999886543    48999999999999999999999999999999999999   67788999999999


Q ss_pred             cccCCCC---cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhccc-
Q 019040          203 IFFKPGE---RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA-------QAILRGLI-  270 (347)
Q Consensus       203 ~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------~~~~~~~~-  270 (347)
                      .......   ......||+.|+|||.+. +.++.++||||||+++|+|++|..||.........       ........ 
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            7643222   223346899999999875 55999999999999999999999999765432211       11111110 


Q ss_pred             cc-----cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          271 DF-----KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       271 ~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ..     .....+.++..+.+++.+||+.||++|||+.+++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            00     011112345678899999999999999999999877

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=326.52  Aligned_cols=252  Identities=21%  Similarity=0.275  Sum_probs=204.4

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEecccc--ccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK--LRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ..++|++++.||.|+||+||+|.+..+++.+++|+..+..  .........+.+|+.+++.+ +||||+++++++...+ 
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS-
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC-
Confidence            3578999999999999999999999888877554433221  12334567899999999999 8999999999998765 


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .++|++++.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC----
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeEc
Confidence            77899999999999999875 469999999999999999999999999999999999999   55677999999999875


Q ss_pred             CCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          206 KPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       206 ~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      .....   .....+|+.|+|||.+. ..++.++||||||+++|+|++ |..||...........+......   +....+
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~  244 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPIC  244 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTB
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccC
Confidence            43322   22335677899999876 458999999999999999999 99999988887777666555422   223468


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +.++.++|..||+.||.+|||+.++++.
T Consensus       245 ~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          245 TIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999999864

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.4e-45  Score=322.31  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=209.7

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee---
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED---  123 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~---  123 (347)
                      ..+.++|++.+.||.|+||.||+|.+..+++.||+|++....       ..+.+|+++++.+ +||||+++++++..   
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKL-DHVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEE
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhC-CCCCEEEEeeeEecccc
Confidence            456789999999999999999999999999999999986432       2466899999999 99999999998864   


Q ss_pred             -------------CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC
Q 019040          124 -------------DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK  188 (347)
Q Consensus       124 -------------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~  188 (347)
                                   ....++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+||++   
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~---  155 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---  155 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE---
Confidence                         45689999999999999999764  569999999999999999999999999999999999999   


Q ss_pred             CCCCCEEEEeeccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 019040          189 KENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR  267 (347)
Q Consensus       189 ~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  267 (347)
                      +.++.++|+|||++.............+++.|+|||.+.+ .++.++||||||+++|+|++|..||...  ......+..
T Consensus       156 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~  233 (284)
T 2a19_B          156 VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD  233 (284)
T ss_dssp             EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT
T ss_pred             cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc
Confidence            4567799999999987766555555679999999998764 4899999999999999999999887321  222233322


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                      ..      ....++..+.++|.+||+.||.+|||+.++++|.+.-.
T Consensus       234 ~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 GI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             TC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             cc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            21      12367899999999999999999999999999976543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.2e-44  Score=320.06  Aligned_cols=260  Identities=19%  Similarity=0.252  Sum_probs=203.8

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .+.++|++.+.||.|+||+||+|.+..+++.||+|++......     ..+.+|+.+++.+.+++++..+..++...+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            4568999999999999999999999999999999986543322     34778999999995555566666666788899


Q ss_pred             EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +++|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++.++|+|||++....
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999999 8899999975 3569999999999999999999999999999999999999655567889999999998764


Q ss_pred             CCCc--------ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcccccc-
Q 019040          207 PGER--------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ---GVAQAILRGLIDFK-  273 (347)
Q Consensus       207 ~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~-  273 (347)
                      ....        .....+|+.|+|||.+.+ .++.++||||||+++|+|++|..||......   .....+.......+ 
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            4322        234578999999998764 5889999999999999999999999764432   22222222222111 


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ......+++++.++|..||+.||++|||+.++++.  |++..
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~--l~~~~  279 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL--FRNLF  279 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH--HHHHH
T ss_pred             hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHH--HHHHH
Confidence            11124679999999999999999999999999763  54443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.2e-44  Score=314.58  Aligned_cols=249  Identities=14%  Similarity=0.202  Sum_probs=211.3

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC--
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--  124 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~--  124 (347)
                      ....++|++.+.||.|+||.||+|.+.  +..||+|++..... .....+.+.+|+.+++.+ +||||+++++++.+.  
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTS
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCC
Confidence            334578999999999999999999984  78899999875432 233456799999999999 999999999999887  


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--cEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          125 NAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                      +..++|+||+++++|.+++....  .+++..++.++.||+.||.|||++|  ++|+||||+||++   +.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~  158 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMAD  158 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGG
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEecc
Confidence            78899999999999999998765  4899999999999999999999999  9999999999999   677889999999


Q ss_pred             cccccCCCCcccccccCcccccccccccc-CC---CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCC
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLKRN-YG---PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP  276 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~---~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  276 (347)
                      ++.....    ....+|+.|+|||.+.+. ++   .++||||||+++|+|++|..||...........+.......  ..
T Consensus       159 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~  232 (271)
T 3kmu_A          159 VKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--TI  232 (271)
T ss_dssp             SCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--CC
T ss_pred             ceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--CC
Confidence            8765332    334789999999987643 33   37999999999999999999999888877766665543332  23


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ...+++++.++|..||+.||++|||+.++++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (271)
T 3kmu_A          233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPI  264 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            35789999999999999999999999999763

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.6e-44  Score=343.09  Aligned_cols=256  Identities=21%  Similarity=0.346  Sum_probs=218.7

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ++...++|.+.+.||.|+||.||+|.++.++..||||++....    ...+.+.+|+.+++.+ +||||+++++++...+
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  289 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREP  289 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhc-CCCCEeeEEEEEecCC
Confidence            3445678999999999999999999999999999999986542    2457799999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          126 AVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      ..++||||+++++|.+++...  ..++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSR  366 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEE
T ss_pred             cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccce
Confidence            999999999999999999874  348999999999999999999999999999999999999   667889999999998


Q ss_pred             ccCCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          204 FFKPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       204 ~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      .......  .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+.+.......+....   .......
T Consensus       367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~  443 (495)
T 1opk_A          367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEG  443 (495)
T ss_dssp             CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---CCCCCTT
T ss_pred             eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCC
Confidence            7543322  12234567899999876 458999999999999999999 999999888777766665543   2233457


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +++.+.+||..||+.||++|||+.++++.  |+..
T Consensus       444 ~~~~l~~li~~cl~~dP~~RPs~~el~~~--L~~~  476 (495)
T 1opk_A          444 CPEKVYELMRACWQWNPSDRPSFAEIHQA--FETM  476 (495)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHTS
T ss_pred             CCHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHH
Confidence            89999999999999999999999999753  5444

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=325.78  Aligned_cols=258  Identities=23%  Similarity=0.337  Sum_probs=207.4

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe----eCC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE----DDN  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~----~~~  125 (347)
                      .++|++.+.||.|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.+ +||||+++++++.    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCc
Confidence            57899999999999999999999999999999998643   344567789999999999 9999999999986    345


Q ss_pred             eEEEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          126 AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                      ..++|+||+++++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||.
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCc
Confidence            78999999999999999876    3569999999999999999999999999999999999999   6778899999998


Q ss_pred             ccccCCCCc----------ccccccCccccccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Q 019040          202 SIFFKPGER----------FSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESE--QGVAQAI  265 (347)
Q Consensus       202 a~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~  265 (347)
                      +........          .....||+.|+|||.+.+    .++.++||||||+++|+|++|..||.....  ......+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            876432111          122357999999998753    278999999999999999999999943211  1111122


Q ss_pred             HhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCC
Q 019040          266 LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  319 (347)
                      .. .  ...+....++.++.++|.+||+.||++|||+.+++++  |+..+.+.+
T Consensus       261 ~~-~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~  309 (317)
T 2buj_A          261 QN-Q--LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ--LEALQPPAP  309 (317)
T ss_dssp             HC-C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTCCCCC
T ss_pred             hc-c--CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH--hhhcCCCCC
Confidence            22 1  2223335789999999999999999999999999987  665554433

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-44  Score=318.43  Aligned_cols=250  Identities=26%  Similarity=0.358  Sum_probs=211.1

Q ss_pred             cccceeeee-eecccCCeEEEEEEEC--CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           49 IEDRYLVDR-ELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        49 ~~~~y~i~~-~lg~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ..++|.+.+ .||+|+||.||+|.+.  .+++.||+|++....  .......+.+|+.+++.+ +||||+++++++ ..+
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESS
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCC
Confidence            356788877 9999999999999864  467889999987542  344567799999999999 999999999999 556


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..++|+||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKA  159 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEE
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---cCCCCEEECcccceee
Confidence            789999999999999998654 459999999999999999999999999999999999999   4567899999999987


Q ss_pred             cCCCCcc----cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          205 FKPGERF----SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       205 ~~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      .......    ....+|+.|+|||.+. ..++.++||||||+++|+|++ |..||...........+.....   .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~---~~~~~  236 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPP  236 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---CCCCT
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc---CCCCC
Confidence            6443221    2234678899999886 458999999999999999998 9999998888777776666432   22334


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+++++.++|..||+.||++|||+.+++++
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999887

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.4e-44  Score=317.91  Aligned_cols=252  Identities=22%  Similarity=0.293  Sum_probs=208.5

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECC---CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRD---TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      ....++|.+.+.||.|+||+||+|.+..   ++..||+|++....  .......+.+|+.+++.+ +||||+++++++..
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE   84 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC
Confidence            3446899999999999999999998754   34569999986542  334457799999999999 99999999999875


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      + ..++|+||+++++|.+++... ..++...+..++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++
T Consensus        85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~  160 (281)
T 3cc6_A           85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLS  160 (281)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---EETTEEEECCCCGG
T ss_pred             C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---CCCCcEEeCccCCC
Confidence            5 568999999999999999775 459999999999999999999999999999999999999   45678999999999


Q ss_pred             cccCCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          203 IFFKPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       203 ~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ........  .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+......   +...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  237 (281)
T 3cc6_A          161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL---PKPD  237 (281)
T ss_dssp             GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---CCCT
T ss_pred             cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---CCCC
Confidence            86544322  22345678899999886 458899999999999999998 99999888777766666554322   2234


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+++.+.++|.+||+.||++|||+.+++++
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            689999999999999999999999999876

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3e-44  Score=319.71  Aligned_cols=256  Identities=23%  Similarity=0.399  Sum_probs=200.2

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      .+++...++|++.+.||+|+||+||+|++..   .||+|++.... ........+.+|+.+++.+ +|+||++++++. .
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~   90 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-T   90 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-C
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-c
Confidence            5567778899999999999999999998654   49999986543 2344567799999999999 999999999965 5


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      .+..++|+||+++++|.+++... ..++...++.++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLA  167 (289)
T ss_dssp             SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC--
T ss_pred             CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceec
Confidence            56688999999999999998654 459999999999999999999999999999999999999   56678999999998


Q ss_pred             cccCCC---CcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccccc-
Q 019040          203 IFFKPG---ERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRGLIDFK-  273 (347)
Q Consensus       203 ~~~~~~---~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~-  273 (347)
                      ......   .......||+.|+|||.+.    ..++.++||||||+++|+|++|..||......... ..+........ 
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL  247 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence            754422   2233457899999999874    34788999999999999999999999876655443 33333332222 


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ......+++.+.++|.+||+.||++|||+.++++.
T Consensus       248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            12234789999999999999999999999999764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.5e-44  Score=337.13  Aligned_cols=251  Identities=21%  Similarity=0.332  Sum_probs=213.7

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      ..+....++|++.+.||.|+||.||+|.+. ++..||||++....    ...+.+.+|+.+++.+ +||||+++++++. 
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-  253 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTL-QHDKLVKLHAVVT-  253 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-
Confidence            344556789999999999999999999986 46779999986532    3457899999999999 9999999999986 


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          124 DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                      .+..++||||+++++|.+++...  ..++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~  330 (454)
T 1qcf_A          254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGL  330 (454)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTG
T ss_pred             CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCC
Confidence            56789999999999999999754  368999999999999999999999999999999999999   6778899999999


Q ss_pred             ccccCCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCC
Q 019040          202 SIFFKPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       202 a~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  277 (347)
                      +........  .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+....+....+..+..   .+..
T Consensus       331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~  407 (454)
T 1qcf_A          331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRP  407 (454)
T ss_dssp             GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC---CCCC
T ss_pred             ceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCC
Confidence            987543221  12234677899999886 558999999999999999999 9999999988888777766532   2233


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ..+++++.++|.+||+.||++|||+.++++
T Consensus       408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          408 ENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            578999999999999999999999999965

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.1e-44  Score=321.71  Aligned_cols=252  Identities=19%  Similarity=0.278  Sum_probs=203.0

Q ss_pred             cccceeeeeeecccCCeEEEEEEECC---CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRD---TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ..++|.+.+.||.|+||.||+|.+..   +++.||+|++..... .......+.+|+.+++.+ +||||+++++++...+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC--
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeecc
Confidence            35789999999999999999998765   456899999865432 334457789999999999 8999999999988754


Q ss_pred             -----eEEEEEEecCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCE
Q 019040          126 -----AVHLVMELCEGGELFDRIVA------RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (347)
Q Consensus       126 -----~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~  194 (347)
                           ..++|+||+++++|.+++..      ...+++..++.++.||+.||.|||++||+||||||+||++   +.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcE
Confidence                 45999999999999999853      2458999999999999999999999999999999999999   677889


Q ss_pred             EEEeeccccccCCCCc---ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 019040          195 KAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGL  269 (347)
Q Consensus       195 ~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  269 (347)
                      +|+|||++........   .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||...........+....
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence            9999999976543321   223456788999998764 48899999999999999999 999998888877777666654


Q ss_pred             ccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       270 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .   ......+++.+.++|..||+.||.+|||+.+++++
T Consensus       267 ~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 R---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             C---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             C---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2   22334789999999999999999999999999876

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.6e-44  Score=335.61  Aligned_cols=259  Identities=25%  Similarity=0.395  Sum_probs=200.5

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ...+.+.|.+.+.||.|+||+||.+. ..+|+.||||++..+      ..+.+.+|+.+++.+.+||||+++++++.+.+
T Consensus        10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            34566788889999999999998754 457999999998543      23457789999988768999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC----------
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYT-------ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK----------  188 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~----------  188 (347)
                      ..++||||+. ++|.+++.......       +..++.++.||+.||.|||++||+||||||+|||++.+          
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            9999999996 59999997764322       22356799999999999999999999999999999643          


Q ss_pred             CCCCCEEEEeeccccccCCCCc-----ccccccCccccccccccc--------cCCCchhHHHHHHHHHHHHh-CCCCCC
Q 019040          189 KENSPLKAIDFGLSIFFKPGER-----FSEIVGSPYYMAPEVLKR--------NYGPEIDIWSAGVILYILLC-GVPPFW  254 (347)
Q Consensus       189 ~~~~~~~l~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~~l~~l~~-g~~pf~  254 (347)
                      +.+..++|+|||++........     .....||+.|+|||++.+        .++.++||||||+++|+|++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence            2456899999999987654322     234579999999998743        48899999999999999998 999997


Q ss_pred             CCCHHHHHHHHHhccccccCCCC---CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          255 AESEQGVAQAILRGLIDFKRDPW---PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ......  ..+............   ..++.++.++|.+||+.||.+|||+.++++||||...
T Consensus       242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          242 DKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             STTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             CchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            665433  334444333222111   1245789999999999999999999999999999753

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.7e-44  Score=314.62  Aligned_cols=250  Identities=23%  Similarity=0.324  Sum_probs=212.0

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .+....++|++.+.||.|+||.||+|.+. ++..||+|++....    ...+.+.+|+++++.+ +||||+++++++.. 
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-   79 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-   79 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhC-CCcCcceEEEEEcC-
Confidence            34556689999999999999999999985 56779999986532    2356789999999999 99999999999874 


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      +..++|+||+++++|.+++....  .+++..+..++.||+.||.|||++||+|+||||+||++   +.++.++|+|||.+
T Consensus        80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLA  156 (279)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTC
T ss_pred             CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCccc
Confidence            46889999999999999986543  68999999999999999999999999999999999999   67788999999999


Q ss_pred             cccCCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          203 IFFKPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       203 ~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ........  .....+++.|+|||.+. +.++.++||||||+++++|++ |..||...........+.....   .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~  233 (279)
T 1qpc_A          157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---MVRPD  233 (279)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCT
T ss_pred             ccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---CCCcc
Confidence            87654322  22345678899999886 458899999999999999999 9999999888877777766532   22334


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .++.++.++|..||+.||++|||+.++++
T Consensus       234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          234 NCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            78999999999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.4e-44  Score=320.25  Aligned_cols=258  Identities=23%  Similarity=0.285  Sum_probs=206.3

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECC-CC--ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRD-TR--ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ...++|++.+.||.|+||+||+|.+.. ++  ..||+|++...........+.+.+|+.+++.+ +||||+++++++...
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP   93 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccC
Confidence            345789999999999999999998643 33  36899998766555555677899999999999 899999999999876


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      + .++|+||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++.
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMR  169 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCE
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEccccccc
Confidence            5 78999999999999999775 469999999999999999999999999999999999999   456779999999998


Q ss_pred             ccCCCCc----ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCC
Q 019040          204 FFKPGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       204 ~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  277 (347)
                      .......    .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||...........+.......+  ..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~  247 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RP  247 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC--CC
Confidence            7654332    123356778999998764 48899999999999999999 9999999988887777766543332  33


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ..++.++.++|..||+.||++|||+.+++++  |++.
T Consensus       248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~--l~~~  282 (291)
T 1u46_A          248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDF--LLEA  282 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             cCcCHHHHHHHHHHccCCcccCcCHHHHHHH--HHHh
Confidence            4789999999999999999999999999874  5444

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.8e-44  Score=324.58  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=208.4

Q ss_pred             ccceeeeeeecccCCeEEEEEE----ECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe--e
Q 019040           50 EDRYLVDRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE--D  123 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~--~  123 (347)
                      .++|++.+.||.|+||.||+|+    +..+++.||+|++...   .....+.+.+|+.+++.+ +|+||+++++++.  .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Confidence            4789999999999999999999    5678899999998654   334456789999999999 9999999999876  5


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      .+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLA  174 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcccccc
Confidence            57799999999999999999774 459999999999999999999999999999999999999   55677999999999


Q ss_pred             cccCCCCc----ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHH
Q 019040          203 IFFKPGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ---------------GVA  262 (347)
Q Consensus       203 ~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------------~~~  262 (347)
                      ........    .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||......               ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            87654332    223457888999998764 4889999999999999999999998554332               111


Q ss_pred             HHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ..+...   ........+++.+.++|..||+.||++|||+.+++++  |+..
T Consensus       255 ~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~  301 (327)
T 3lxl_A          255 ELLEEG---QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ--LDML  301 (327)
T ss_dssp             HHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHC
T ss_pred             HHhhcc---cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHH
Confidence            122221   2223345789999999999999999999999999765  4444

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9.8e-45  Score=330.95  Aligned_cols=262  Identities=17%  Similarity=0.202  Sum_probs=200.4

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECC---CCceeEEeEeccccccc--------hhcHHHHHHHHHHHHhCCCCCceeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRD---TRELLACKSISKRKLRT--------AVDIDDVRREVAIMKHLPKNSSIVS  116 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~--------~~~~~~~~~ei~~l~~l~~h~~i~~  116 (347)
                      ...++|++.+.||.|+||+||+|.+..   ++..+|+|++.......        ......+.+|+..++.+ +|+||++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~  112 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPL  112 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcce
Confidence            345789999999999999999999987   78899999987543111        11223466788899999 9999999


Q ss_pred             eeeEEee----CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC
Q 019040          117 LKEACED----DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       117 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                      +++++..    ....++||||+ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~  190 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PD  190 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-TT
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-CC
Confidence            9999988    78999999999 999999998777899999999999999999999999999999999999996422 23


Q ss_pred             CEEEEeeccccccCCCC--------cccccccCcccccccccccc-CCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHH
Q 019040          193 PLKAIDFGLSIFFKPGE--------RFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAE--SEQGV  261 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~~~  261 (347)
                      .++|+|||++.......        ......||+.|+|||++.+. ++.++||||||+++|+|++|..||...  .....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            89999999997653221        11345789999999988654 899999999999999999999999653  22222


Q ss_pred             HHHHHhccccccC-----CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          262 AQAILRGLIDFKR-----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       262 ~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ...........+.     .....++.++.++|..||+.||++|||+.++++.  |++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--L~~~  326 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI--LNPH  326 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH--HCTT
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH--Hhcc
Confidence            1111111111110     0112688999999999999999999999999764  5444

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.4e-44  Score=324.33  Aligned_cols=248  Identities=22%  Similarity=0.286  Sum_probs=197.4

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC----
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN----  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~----  125 (347)
                      .++|++.+.||+|+||+||+|++.  ++.||+|++....    .......+|+.+++.+ +||||+++++++....    
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCc
Confidence            478999999999999999999885  7899999986432    2234566699999999 8999999999998754    


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CcEeeCCCCCcEEeecCCCCCCEE
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH----------GVIHRDLKPENFLFANKKENSPLK  195 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~----------~ivH~Dikp~NIli~~~~~~~~~~  195 (347)
                      .+++||||+++++|.+++... .+++..++.++.||+.||.|||+.          ||+||||||+|||+   +.++.+|
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~k  171 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTAC  171 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEE
T ss_pred             eEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEE
Confidence            479999999999999999765 699999999999999999999999          99999999999999   6778899


Q ss_pred             EEeeccccccCCCCc---ccccccCccccccccccc------cCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------
Q 019040          196 AIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESE--------  258 (347)
Q Consensus       196 l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------  258 (347)
                      |+|||++........   .....||+.|+|||++.+      .++.++||||||+++|+|++|..||.+...        
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999976544332   233578999999998764      366688999999999999999999965422        


Q ss_pred             --------HHHHHHHHhccccccCCC-C--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          259 --------QGVAQAILRGLIDFKRDP-W--PNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       259 --------~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                              ......+........... +  ...++++.++|.+||+.||++|||+.++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                    122222222111111000 0  1123569999999999999999999999764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-43  Score=316.35  Aligned_cols=250  Identities=21%  Similarity=0.318  Sum_probs=205.9

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCC---ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEE-eeCC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTR---ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC-EDDN  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~-~~~~  125 (347)
                      ..+|++.+.||+|+||+||+|.+..++   ..+|+|.+...  ........+.+|+.+++.+ +||||+++++++ ..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCC
Confidence            357999999999999999999976443   45888887642  2444567789999999999 899999999985 4567


Q ss_pred             eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      ..++||||+++++|.+++... ..++...++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARD  177 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECccccccc
Confidence            889999999999999999764 458999999999999999999999999999999999999   6778899999999986


Q ss_pred             cCCCCc-----ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCC
Q 019040          205 FKPGER-----FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       205 ~~~~~~-----~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  277 (347)
                      ......     .....+|+.|+|||.+. ..++.++||||||+++|+|++ |.+||...........+........   .
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  254 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---P  254 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC---C
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC---C
Confidence            543321     23345778899999876 458999999999999999999 6777877776666666665543322   2


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ..+++.+.++|..||+.||++|||+.++++.
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4679999999999999999999999999763

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=327.36  Aligned_cols=247  Identities=28%  Similarity=0.426  Sum_probs=187.7

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe------
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE------  122 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~------  122 (347)
                      ...+|++.+.||.|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.+.+||||+++++++.      
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            346899999999999999999999999999999998543   33445678899999999966999999999984      


Q ss_pred             --eCCeEEEEEEecCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--cEeeCCCCCcEEeecCCCCCCEE
Q 019040          123 --DDNAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLK  195 (347)
Q Consensus       123 --~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~NIli~~~~~~~~~~  195 (347)
                        .....++++||+. ++|.+++..   ...+++..++.++.||+.||.|||+.|  |+|+||||+|||+   +.++.++
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~k  178 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIK  178 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEE
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEE
Confidence              4456899999996 599888865   456999999999999999999999999  9999999999999   6778899


Q ss_pred             EEeeccccccCCCCcc-------------cccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 019040          196 AIDFGLSIFFKPGERF-------------SEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESE  258 (347)
Q Consensus       196 l~Dfg~a~~~~~~~~~-------------~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  258 (347)
                      |+|||++.........             ....+|+.|+|||++.    ..++.++||||||+++|+|++|..||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            9999999876543221             1345899999999872    3478899999999999999999999976554


Q ss_pred             HHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ....    .....  .......+..+.++|..||+.||.+|||+.++++|
T Consensus       259 ~~~~----~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          259 LRIV----NGKYS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             -----------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHhh----cCccc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3322    22222  22234677889999999999999999999999988

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=338.20  Aligned_cols=255  Identities=24%  Similarity=0.335  Sum_probs=197.3

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .+|.+.+.||.|+||+||. ....+++.||||++.....      ..+.+|+.+++.+.+||||+++++++.+.+..|+|
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            4799999999999999764 3345789999999865432      12457999999997899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC--CCCCEEEEeeccccccCC
Q 019040          131 MELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK--ENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~--~~~~~~l~Dfg~a~~~~~  207 (347)
                      |||+. ++|.+++.... ......+..++.||+.||.|||++||+||||||+|||++.++  ....++|+|||++.....
T Consensus        97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            99996 59999997764 355566789999999999999999999999999999996433  334688999999987654


Q ss_pred             CC----cccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          208 GE----RFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       208 ~~----~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ..    ......||+.|+|||++.    ..++.++||||||+++|+|++ |..||......... .+.............
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~  254 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLGACSLDCLHPEK  254 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTTCCCCTTSCTTC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhccCCccccCccc
Confidence            32    234457999999999885    347789999999999999999 89999655543322 222221111111112


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ..+..+.+||.+||+.||++|||+.++++||||...
T Consensus       255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            345568899999999999999999999999999753

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.5e-43  Score=335.52  Aligned_cols=254  Identities=19%  Similarity=0.254  Sum_probs=209.0

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .+.++|++++.||.|+||.||+|++..+++.||||++.....     ...+.+|+.+++.+.+++++..+..++...+..
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            456899999999999999999999999999999998764432     234778999999997678888888888889999


Q ss_pred             EEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      ++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..++.++.+||+|||++....
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 8899999986 4569999999999999999999999999999999999999655567889999999998765


Q ss_pred             CCCc--------ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcccccc-
Q 019040          207 PGER--------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE---QGVAQAILRGLIDFK-  273 (347)
Q Consensus       207 ~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~-  273 (347)
                      ....        .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||.....   ...+..+........ 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            4322        125679999999998764 589999999999999999999999977543   233333322221111 


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ...+..++.++.++|..||+.||++||++.++++
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1112367999999999999999999999998754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.5e-45  Score=354.07  Aligned_cols=263  Identities=27%  Similarity=0.401  Sum_probs=211.8

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee------
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED------  123 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~------  123 (347)
                      .++|++.+.||.|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++.+ +||||+++++++..      
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccC
Confidence            478999999999999999999999999999999986532  344567789999999999 99999999998765      


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          124 DNAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                      .+..++||||++|++|.+++....   .+++..++.++.||+.||.|||+.||+||||||+||+++.++....++|+|||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            678899999999999999998754   58999999999999999999999999999999999999765555569999999


Q ss_pred             cccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------H-----
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA---------I-----  265 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---------~-----  265 (347)
                      .+.............||+.|+|||.+. ..++.++||||||+++|+|++|..||...........         +     
T Consensus       170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred             cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence            998876666566678999999999886 4599999999999999999999999976543221100         0     


Q ss_pred             Hhccccc------cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          266 LRGLIDF------KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       266 ~~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ..+...+      +......+++.+.++|..||..||++|||+.++++||||+...
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            0000011      1111123678899999999999999999999999999997654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-43  Score=313.78  Aligned_cols=249  Identities=23%  Similarity=0.331  Sum_probs=205.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCc---eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      -.|.+.+.||.|+||+||+|.+..++.   .||+|.+...  ......+.+.+|+.+++.+ +||||+++++++...+..
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCC
Confidence            367888999999999999999765554   7999998643  2344567889999999999 999999999999876554


Q ss_pred             -EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          128 -HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       128 -~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                       ++++||+.+++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDI  174 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTT
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccc
Confidence             8999999999999999774 458999999999999999999999999999999999999   67788999999999765


Q ss_pred             CCCC-----cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          206 KPGE-----RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       206 ~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ....     ......+++.|+|||.+.+ .++.++||||||+++|+|++ +.+||...+.......+......   ....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~  251 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL---PQPE  251 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC---CCCT
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC---CCCc
Confidence            4322     2233467889999998864 48999999999999999999 55556666666666555554322   2234


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+++.+.++|..||+.||.+|||+.++++.
T Consensus       252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            689999999999999999999999998764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1e-43  Score=314.33  Aligned_cols=243  Identities=22%  Similarity=0.347  Sum_probs=200.7

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC-CeE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD-NAV  127 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~-~~~  127 (347)
                      ..++|++.+.||.|+||+||+|.+  +|+.||+|++...     ...+.+.+|+.+++.+ +|||++++++++... +..
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CC
T ss_pred             ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch-----hHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCce
Confidence            357899999999999999999987  4789999998643     2456788999999999 899999999986544 578


Q ss_pred             EEEEEecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          128 HLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ++|+||+++++|.+++.....  +++..+..++.|++.||.|||++|++|+||||+||++   +.++.++|+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccc
Confidence            999999999999999977543  8999999999999999999999999999999999999   67788999999998765


Q ss_pred             CCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          206 KPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      ....  ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+....   .......+++.
T Consensus       168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  242 (278)
T 1byg_A          168 SSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPA  242 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---CCCCCTTCCHH
T ss_pred             cccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCcccCCHH
Confidence            4332  2335788999999876 458899999999999999998 999998888777666665542   22333578999


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhc
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      +.++|..||+.||++|||+.++++
T Consensus       243 l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          243 VYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCChhhCCCHHHHHH
Confidence            999999999999999999999975

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-43  Score=320.47  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=203.8

Q ss_pred             Ccccce-eeeeeecccCCeEEEEEEE----CCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           48 NIEDRY-LVDRELGRGEFGVTYLCID----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        48 ~~~~~y-~i~~~lg~G~~g~V~~a~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      .+.++| ++++.||.|+||+||+|..    ..+++.||+|++....  .......+.+|+.+++.+ +||||+++++++.
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~  103 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTL-YHEHIIKYKGCCE  103 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCcchhhEEEEEe
Confidence            355666 9999999999999988754    4578899999997542  334467789999999999 8999999999998


Q ss_pred             e--CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          123 D--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       123 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                      +  ....++||||+++++|.+++... .+++..++.++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg  179 (318)
T 3lxp_A          104 DAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFG  179 (318)
T ss_dssp             ETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGG
T ss_pred             cCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCcc
Confidence            7  46899999999999999998665 59999999999999999999999999999999999999   677889999999


Q ss_pred             cccccCCCCc----ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---------------
Q 019040          201 LSIFFKPGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQG---------------  260 (347)
Q Consensus       201 ~a~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------------  260 (347)
                      ++........    .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.......               
T Consensus       180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  259 (318)
T 3lxp_A          180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR  259 (318)
T ss_dssp             GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred             ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence            9987654432    233457888999998864 58899999999999999999999986543211               


Q ss_pred             HHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          261 VAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ....+...   ........++.++.++|..||+.||++|||+.++++
T Consensus       260 ~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          260 LTELLERG---ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcc---cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            11111111   122334578999999999999999999999999974

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.8e-44  Score=323.13  Aligned_cols=261  Identities=20%  Similarity=0.227  Sum_probs=205.2

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ....++|++.+.||.|+||+||+|.+. +++.||+|++.......  ....+.+|+.+++.+ +||||+++++++...+.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  101 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE  101 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTC-CCTTBCCCCEEECCSSC
T ss_pred             HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHHhc-cCCCccceEEEEecCCc
Confidence            345689999999999999999999854 68899999987543222  223688999999999 89999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CcEeeCCCCCcEEeecCCCCCCEEEEee
Q 019040          127 VHLVMELCEGGELFDRIVARG----HYTERAAAAVTRTIVEVVQLCHKH---GVIHRDLKPENFLFANKKENSPLKAIDF  199 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~NIli~~~~~~~~~~l~Df  199 (347)
                      .++|+||+++++|.+++....    .+++..+..++.|++.||.|||+.   ||+||||||+||++   +.++.++|+||
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Df  178 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDF  178 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCC
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccC
Confidence            999999999999999997653    389999999999999999999999   99999999999999   67788999999


Q ss_pred             ccccccCCCC--cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcccc
Q 019040          200 GLSIFFKPGE--RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAE-----SEQGVAQAILRGLID  271 (347)
Q Consensus       200 g~a~~~~~~~--~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~  271 (347)
                      |++.......  ......||+.|+|||.+. ..++.++||||||+++|+|++|..||...     ........+......
T Consensus       179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence            9998654332  233456899999999875 45899999999999999999999999421     111111111111100


Q ss_pred             cc----------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          272 FK----------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       272 ~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ..          .......+..+.+++..||+.||.+|||+.++++|-.-...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            00          01111233778999999999999999999999998544333

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.4e-43  Score=332.93  Aligned_cols=250  Identities=22%  Similarity=0.309  Sum_probs=208.1

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .++...++|++.+.||+|+||.||+|.+.. +..||||++....    ...+.+.+|+.+++.+ +||||+++++++.. 
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-  250 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-  250 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-
Confidence            344556889999999999999999999975 4569999986543    2346789999999999 99999999999876 


Q ss_pred             CeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 NAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      +..++||||+++++|.+++...  ..++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA  327 (452)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTT
T ss_pred             CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccc
Confidence            6789999999999999999643  468999999999999999999999999999999999999   56778999999999


Q ss_pred             cccCCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          203 IFFKPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       203 ~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ........  .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+....+....+..+..   .+...
T Consensus       328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~  404 (452)
T 1fmk_A          328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPP  404 (452)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCT
T ss_pred             eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCC
Confidence            86543321  12335678899999876 558999999999999999999 9999999988888777766532   22334


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .+++.+.++|.+||+.||++|||+.++++
T Consensus       405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          405 ECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            78999999999999999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=326.61  Aligned_cols=246  Identities=14%  Similarity=0.185  Sum_probs=198.8

Q ss_pred             ccceeeeeeecccCCeEEEEEEECC--------CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeE-----
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRD--------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS-----  116 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~-----  116 (347)
                      .++|++.+.||.|+||.||+|++..        .++.||+|++...        ..+.+|+.+++.+ +|||+++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRA-AKPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHH-CCHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHh-cccchhhhhhhh
Confidence            5799999999999999999999987        4889999998643        3577899999999 8988876     


Q ss_pred             ----------eeeEEee-CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcE
Q 019040          117 ----------LKEACED-DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (347)
Q Consensus       117 ----------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NI  183 (347)
                                +++++.. .+..++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      5667665 78899999999 99999999886  6799999999999999999999999999999999999


Q ss_pred             EeecCCCCC--CEEEEeeccccccCCCC--------cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCC
Q 019040          184 LFANKKENS--PLKAIDFGLSIFFKPGE--------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPP  252 (347)
Q Consensus       184 li~~~~~~~--~~~l~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p  252 (347)
                      +++   .++  .++|+|||++.......        ......||+.|+|||.+.+ .++.++||||||+++|+|++|..|
T Consensus       191 l~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          191 FVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             EEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            994   455  79999999997654321        1133478999999998865 588999999999999999999999


Q ss_pred             CCCCC--HHHHHHHHH---hcccccc--CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          253 FWAES--EQGVAQAIL---RGLIDFK--RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       253 f~~~~--~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      |....  .........   .....+.  ...+..++.++.++|..||+.||++|||+.++++.
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            97764  222222221   1111111  11123579999999999999999999999999764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.1e-44  Score=318.04  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=196.3

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHh--CCCCCceeEeeeEEee-
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH--LPKNSSIVSLKEACED-  123 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~--l~~h~~i~~~~~~~~~-  123 (347)
                      ..+.++|++.+.||+|+||+||+|.+  +++.||+|++...      ....+.+|.+++..  + +||||+++++++.. 
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASDMTS   74 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEeeccc
Confidence            45678999999999999999999988  6889999998543      33456667777776  6 89999999998654 


Q ss_pred             ---CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCcEeeCCCCCcEEeecCCCCC
Q 019040          124 ---DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH--------KHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       124 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                         .+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||        +.||+||||||+|||+   +.++
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~  150 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNG  150 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTS
T ss_pred             cCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCC
Confidence               3568999999999999999954 47999999999999999999999        9999999999999999   6778


Q ss_pred             CEEEEeeccccccCCCCc-----ccccccCcccccccccccc-------CCCchhHHHHHHHHHHHHhC----------C
Q 019040          193 PLKAIDFGLSIFFKPGER-----FSEIVGSPYYMAPEVLKRN-------YGPEIDIWSAGVILYILLCG----------V  250 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-------~~~~~Di~slG~~l~~l~~g----------~  250 (347)
                      .+||+|||++........     .....||+.|+|||.+.+.       ++.++||||||+++|+|++|          .
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            899999999976543322     1234799999999987643       44689999999999999999          8


Q ss_pred             CCCCCCCH----HHHHHHHHhccccccCCC----CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          251 PPFWAESE----QGVAQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       251 ~pf~~~~~----~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .||.....    ..............+...    ...++.++.++|..||+.||++|||+.++++.
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            88855422    122222222211111110    01245789999999999999999999999763

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-44  Score=327.32  Aligned_cols=249  Identities=21%  Similarity=0.305  Sum_probs=198.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCC---ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe-eCCe
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTR---ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-DDNA  126 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~-~~~~  126 (347)
                      ..|++.+.||.|+||+||+|.+..++   ..||+|.+...  ........+.+|+.+++.+ +||||+++++++. .++.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCC
Confidence            46889999999999999999876433   46899987542  2344567899999999999 9999999999864 4568


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .++||||+++++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDM  242 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccc
Confidence            89999999999999999765 348999999999999999999999999999999999999   67788999999999765


Q ss_pred             CCCCc-----ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          206 KPGER-----FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       206 ~~~~~-----~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      .....     .....+++.|+|||.+. ..++.++||||||+++|+|++ |.+||......+....+..+...   ....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~---~~p~  319 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---LQPE  319 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC---CCCT
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence            33221     12345678899999876 458999999999999999999 78888777766666666555432   2234


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .++..+.++|.+||+.||++|||+.+++++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            689999999999999999999999999865

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.6e-43  Score=317.44  Aligned_cols=251  Identities=25%  Similarity=0.338  Sum_probs=203.7

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEecccc-ccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK-LRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      .|...+.||.|+||.||+|.+  +++.||+|++.... .........+.+|+.+++.+ +||||+++++++...+..++|
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  108 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLV  108 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecCCceEEE
Confidence            355568999999999999986  67889999986543 22334467799999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          131 MELCEGGELFDRIVAR---GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      +||+++++|.+++...   ..++...+..++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||++.....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeeccccccccc
Confidence            9999999999999743   458999999999999999999999999999999999999   6778899999999876543


Q ss_pred             CCc---ccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcccc-------cc
Q 019040          208 GER---FSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV----AQAILRGLID-------FK  273 (347)
Q Consensus       208 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~-------~~  273 (347)
                      ...   .....|++.|+|||.+.+.++.++||||||+++|+|++|..||........    ...+......       ..
T Consensus       186 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (307)
T 2nru_A          186 FAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM  265 (307)
T ss_dssp             CSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred             ccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence            322   233578999999999888899999999999999999999999976544322    2222111110       01


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .......+..+.+++..||+.||.+|||+.+++++
T Consensus       266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            11112345678999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-42  Score=340.24  Aligned_cols=242  Identities=22%  Similarity=0.314  Sum_probs=204.0

Q ss_pred             eeecccCCeEEEEEEE--CCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEec
Q 019040           57 RELGRGEFGVTYLCID--RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (347)
                      +.||.|+||.||+|.+  +.+++.||||++.... ......+.+.+|+++++.+ +||||+++++++.. +..++||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CCEEEEEEcc
Confidence            4799999999999955  4567889999986543 2334467899999999999 89999999999965 4588999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc----
Q 019040          135 EGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----  210 (347)
Q Consensus       135 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~----  210 (347)
                      ++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........    
T Consensus       452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC-------
T ss_pred             CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCccccccCcccccc
Confidence            999999999988889999999999999999999999999999999999999   4567899999999986644322    


Q ss_pred             ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+...   .....+++++.++|
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li  605 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLM  605 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHH
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHH
Confidence            122346788999998864 59999999999999999998 99999999988888777766432   22347899999999


Q ss_pred             HHhccCCCCCCCCHHHHhc
Q 019040          289 RQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~ll~  307 (347)
                      ..||+.||++|||+.++++
T Consensus       606 ~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999975

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=312.28  Aligned_cols=241  Identities=29%  Similarity=0.431  Sum_probs=194.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++.+.||.|+||+||+|.+.  ++.||+|.+...     .....+.+|+.+++.+ +||||+++++++.+  ..++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRV-NHPNIVKLYGACLN--PVCL   76 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHC-CCTTBCCEEEBCTT--TTEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--CcEE
Confidence            468999999999999999999884  788999998532     3456789999999999 99999999998864  4789


Q ss_pred             EEEecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHH---cCcEeeCCCCCcEEeecCCCCCC-EEEEeeccc
Q 019040          130 VMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHK---HGVIHRDLKPENFLFANKKENSP-LKAIDFGLS  202 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~NIli~~~~~~~~-~~l~Dfg~a  202 (347)
                      ||||+++++|.+++.....   ++...+..++.||+.||.|||+   +||+||||||+||+++   .++. +||+|||++
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTA  153 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC-
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEcccccc
Confidence            9999999999999987643   7889999999999999999999   8999999999999994   4454 799999999


Q ss_pred             cccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccccccCCCCCC
Q 019040          203 IFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ--GVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       203 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ......  .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||......  .....+...   ........
T Consensus       154 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~  228 (307)
T 2eva_A          154 CDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG---TRPPLIKN  228 (307)
T ss_dssp             -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT---CCCCCBTT
T ss_pred             cccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC---CCCCcccc
Confidence            765432  233468999999998764 5899999999999999999999999764332  222222222   22333457


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ++..+.++|.+||+.||++|||+.+++++
T Consensus       229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          229 LPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            89999999999999999999999999873

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-43  Score=316.54  Aligned_cols=257  Identities=22%  Similarity=0.336  Sum_probs=204.6

Q ss_pred             CCCCCcccceeeeeeecccCCeEEEEEE----ECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           44 VPKENIEDRYLVDRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        44 ~~~~~~~~~y~i~~~lg~G~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      .+.....++|++++.||.|+||.||+|+    +..+++.||+|++...   .......+.+|+.+++.+ +|+||+++++
T Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~  109 (326)
T 2w1i_A           34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKG  109 (326)
T ss_dssp             ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred             CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeeEEE
Confidence            3445567889999999999999999998    4668999999998653   334557799999999999 8999999999


Q ss_pred             EEeeCC--eEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEE
Q 019040          120 ACEDDN--AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (347)
Q Consensus       120 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l  196 (347)
                      ++...+  ..++|+||+++++|.+++... ..++...++.++.||+.||.+||+.||+|+||||+||++   +.++.++|
T Consensus       110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL  186 (326)
T 2w1i_A          110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKI  186 (326)
T ss_dssp             EECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEE
T ss_pred             EEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEE
Confidence            886653  789999999999999999876 459999999999999999999999999999999999999   45678999


Q ss_pred             EeeccccccCCCCc----ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------------
Q 019040          197 IDFGLSIFFKPGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ------------  259 (347)
Q Consensus       197 ~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------  259 (347)
                      +|||++........    .....++..|+|||.+.+ .++.++||||||+++|+|++|..||......            
T Consensus       187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~  266 (326)
T 2w1i_A          187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ  266 (326)
T ss_dssp             CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTH
T ss_pred             ecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchh
Confidence            99999987654432    122356778999998764 4889999999999999999999988543211            


Q ss_pred             HHHHHHHhcc-ccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          260 GVAQAILRGL-IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       260 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .....+.... .....+....++.++.++|..||+.||++|||+.++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0111111110 01122234578999999999999999999999999975

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=322.40  Aligned_cols=248  Identities=20%  Similarity=0.247  Sum_probs=197.0

Q ss_pred             cccceeeeeeecccCCeEEEEE-----EECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCC--CCceeEeeeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK--NSSIVSLKEAC  121 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~--h~~i~~~~~~~  121 (347)
                      ..++|.+.+.||+|+||+||+|     .+..+++.||+|++...      ....+.+|+++++.+..  |++++.+++++
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            3578999999999999999999     46778999999998543      34567788888888832  89999999999


Q ss_pred             eeCCeEEEEEEecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeec--------C
Q 019040          122 EDDNAVHLVMELCEGGELFDRIVA-----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN--------K  188 (347)
Q Consensus       122 ~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~--------~  188 (347)
                      ...+..++||||+++++|.+++..     ...+++..++.++.||+.||.|||++||+||||||+|||++.        +
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999999974     356999999999999999999999999999999999999954        2


Q ss_pred             CCCCCEEEEeeccccccC---CCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 019040          189 KENSPLKAIDFGLSIFFK---PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA  264 (347)
Q Consensus       189 ~~~~~~~l~Dfg~a~~~~---~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  264 (347)
                      +.++.+||+|||++....   .........||+.|+|||++.+ .++.++||||||+++|+|++|..||.......    
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----  292 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----  292 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence            227889999999996532   3334455679999999998865 48999999999999999999999995543310    


Q ss_pred             HHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcc
Q 019040          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (347)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  310 (347)
                       ......+..   ...++.+.+++..||+.+|.+|++..+.+.+.+
T Consensus       293 -~~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          293 -CKPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             -EEECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             -eeechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence             000001111   134678899999999999999976655554433

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=339.01  Aligned_cols=247  Identities=26%  Similarity=0.360  Sum_probs=204.4

Q ss_pred             ccceeeee-eecccCCeEEEEEEEC--CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           50 EDRYLVDR-ELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        50 ~~~y~i~~-~lg~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      .+++.+.+ .||.|+||.||+|.++  .++..||||++....  .....+.+.+|+++++.+ +||||+++++++.. +.
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SS
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CC
Confidence            34555555 8999999999999876  356679999987542  334567899999999999 99999999999976 56


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTTC
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCcccc
Confidence            89999999999999999754 459999999999999999999999999999999999999   55678999999999875


Q ss_pred             CCCCcc----cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          206 KPGERF----SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       206 ~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ......    ....+++.|+|||++. +.++.++||||||+++|+|++ |..||...+..+....+..+..   ......
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~---~~~p~~  563 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPE  563 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC---CCCCTT
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCCc
Confidence            433221    1223567899999886 559999999999999999998 9999999888888877766542   223347


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHh
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVL  306 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll  306 (347)
                      +++++.++|..||+.||++||++.+++
T Consensus       564 ~~~~l~~li~~cl~~dP~~RPs~~~l~  590 (613)
T 2ozo_A          564 CPPELYALMSDCWIYKWEDRPDFLTVE  590 (613)
T ss_dssp             CCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            899999999999999999999999884

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8.5e-43  Score=335.60  Aligned_cols=251  Identities=22%  Similarity=0.309  Sum_probs=212.5

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .++...++|++.+.||.|+||.||+|.+.. +..||||++....    ...+.+.+|+++++.+ +|+||+++++++.. 
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-  333 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-  333 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----CCHHHHHHHHHHHHhC-CCCCEeeEEEEEee-
Confidence            345557889999999999999999999975 4569999986543    2346789999999999 99999999999876 


Q ss_pred             CeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 NAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      +..++||||+++++|.+++...  ..++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a  410 (535)
T 2h8h_A          334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA  410 (535)
T ss_dssp             SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTST
T ss_pred             ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccc
Confidence            6789999999999999999643  458999999999999999999999999999999999999   56778999999999


Q ss_pred             cccCCCC--cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          203 IFFKPGE--RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       203 ~~~~~~~--~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      .......  ......++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+....+..+..   .....
T Consensus       411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~  487 (535)
T 2h8h_A          411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPP  487 (535)
T ss_dssp             TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC---CCCCT
T ss_pred             eecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCC
Confidence            8654321  112234677899999876 558999999999999999999 9999999988888777766532   22334


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .++..+.+||..||+.||++|||+.++++.
T Consensus       488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          488 ECPESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            789999999999999999999999999764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-42  Score=314.81  Aligned_cols=258  Identities=22%  Similarity=0.305  Sum_probs=197.6

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhC-CCCCceeEeeeEEee
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL-PKNSSIVSLKEACED  123 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l-~~h~~i~~~~~~~~~  123 (347)
                      ....+.++|++.+.||.|+||.||+|++.  ++.||+|++...      ......+|.+++..+ .+|+||+++++++..
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            34566789999999999999999999885  889999998533      223344455555543 289999999999988


Q ss_pred             C----CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEeeCCCCCcEEeecCCCC
Q 019040          124 D----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH--------GVIHRDLKPENFLFANKKEN  191 (347)
Q Consensus       124 ~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~ivH~Dikp~NIli~~~~~~  191 (347)
                      .    +..++||||+++++|.+++... .+++..++.++.|++.||.|||+.        ||+||||||+||++   +.+
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~  178 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKN  178 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTT
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCC
Confidence            7    7899999999999999999665 699999999999999999999999        99999999999999   677


Q ss_pred             CCEEEEeeccccccCCCCcc-----cccccCcccccccccccc-CCCc------hhHHHHHHHHHHHHhC----------
Q 019040          192 SPLKAIDFGLSIFFKPGERF-----SEIVGSPYYMAPEVLKRN-YGPE------IDIWSAGVILYILLCG----------  249 (347)
Q Consensus       192 ~~~~l~Dfg~a~~~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~------~Di~slG~~l~~l~~g----------  249 (347)
                      +.+||+|||++.........     ....||+.|+|||++.+. .+..      +||||||+++|+|++|          
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            88999999999765433221     245799999999988643 4443      8999999999999999          


Q ss_pred             CCCCCCCCHH----HHHHHHHhc-cccccCCC---CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          250 VPPFWAESEQ----GVAQAILRG-LIDFKRDP---WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       250 ~~pf~~~~~~----~~~~~~~~~-~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      ..||......    ......... ......+.   ...+++++.++|..||+.||++|||+.++++|  |+....
T Consensus       259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~l~~  331 (337)
T 3mdy_A          259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT--LAKMSE  331 (337)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred             cccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH--HHHHHh
Confidence            6777543221    122222211 11111000   01456779999999999999999999999987  554443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=316.96  Aligned_cols=259  Identities=18%  Similarity=0.304  Sum_probs=210.1

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ..+...++|++.+.||.|+||.||+|.+..   .+|+|++..... .......+.+|+.+++.+ +|+||+++++++...
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQT-RHENVVLFMGACMSP  101 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECS
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC
Confidence            344556899999999999999999998864   399999865432 222334567799999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      +..++|+||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++    ++.++|+|||++.
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFS  177 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC
T ss_pred             CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCcc
Confidence            99999999999999999997754 589999999999999999999999999999999999993    4689999999987


Q ss_pred             ccCCC------CcccccccCccccccccccc----------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 019040          204 FFKPG------ERFSEIVGSPYYMAPEVLKR----------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR  267 (347)
Q Consensus       204 ~~~~~------~~~~~~~~~~~y~aPE~~~~----------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  267 (347)
                      .....      .......|++.|+|||.+..          .++.++||||||+++|+|++|..||...........+..
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  257 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT  257 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence            54321      12233468999999998753          367899999999999999999999999888877776665


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                      .....  .....++.++.++|..||+.||++|||+.++++.  |+....
T Consensus       258 ~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~--l~~l~~  302 (319)
T 2y4i_B          258 GMKPN--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM--LEKLPK  302 (319)
T ss_dssp             TCCCC--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH--HTTC--
T ss_pred             CCCCC--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH--HHHHHH
Confidence            53322  2223678899999999999999999999999874  555543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.6e-43  Score=317.75  Aligned_cols=251  Identities=23%  Similarity=0.317  Sum_probs=202.0

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhC-CCCCceeEeeeEEeeC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL-PKNSSIVSLKEACEDD  124 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l-~~h~~i~~~~~~~~~~  124 (347)
                      ...+.++|++.+.||.|+||.||+|.+  +++.||+|++...      ....+.+|++++..+ .+||||+++++++...
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            345678999999999999999999988  5889999998543      335677899998883 2899999999999887


Q ss_pred             C----eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCcEeeCCCCCcEEeecCCCCC
Q 019040          125 N----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH--------KHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       125 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                      +    ..++|+||+++++|.+++... .+++..++.++.||+.||.|||        +.||+||||||+||++   +.++
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~  184 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNG  184 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTS
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCC
Confidence            6    899999999999999999764 6899999999999999999999        8999999999999999   6678


Q ss_pred             CEEEEeeccccccCCCCc-----ccccccCcccccccccccc-------CCCchhHHHHHHHHHHHHhC----------C
Q 019040          193 PLKAIDFGLSIFFKPGER-----FSEIVGSPYYMAPEVLKRN-------YGPEIDIWSAGVILYILLCG----------V  250 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-------~~~~~Di~slG~~l~~l~~g----------~  250 (347)
                      .++|+|||++........     .....||+.|+|||.+.+.       ++.++||||||+++|+|++|          .
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            899999999976654432     2345789999999987643       33689999999999999999          7


Q ss_pred             CCCCCCC-----HHHHHHHHHhccccccCC-C--CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          251 PPFWAES-----EQGVAQAILRGLIDFKRD-P--WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       251 ~pf~~~~-----~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .||....     .......+.........+ .  ...++..+.++|..||+.||++|||+.++++|
T Consensus       265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            8886653     223333332222111111 0  01344678999999999999999999999877

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-43  Score=326.81  Aligned_cols=251  Identities=15%  Similarity=0.179  Sum_probs=194.3

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCce---------eE----
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI---------VS----  116 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i---------~~----  116 (347)
                      ...|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+.+.++.         +.    
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34688999999999999999999999999999998755444445577899999999999332321         11    


Q ss_pred             --------eeeEEee-----CCeEEEEEEecCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEee
Q 019040          117 --------LKEACED-----DNAVHLVMELCEGGELFDRIVA-------RGHYTERAAAAVTRTIVEVVQLCHKHGVIHR  176 (347)
Q Consensus       117 --------~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  176 (347)
                              +...+..     ...++++|+++ +++|.+++..       ...+++..+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                    1111111     22467777776 6799988852       1236778889999999999999999999999


Q ss_pred             CCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccccCccccccccc----------cc-cCCCchhHHHHHHHHHH
Q 019040          177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL----------KR-NYGPEIDIWSAGVILYI  245 (347)
Q Consensus       177 Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~----------~~-~~~~~~Di~slG~~l~~  245 (347)
                      ||||+|||+   +.++.+||+|||++......  .....| +.|+|||++          .+ .++.++||||||+++|+
T Consensus       236 DiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            999999999   67778999999998764432  344567 999999987          32 37889999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          246 LLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       246 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      |++|..||...........        ....+..+++++.+||.+||+.||++||++.++++||||+...
T Consensus       310 lltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEW--------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGG--------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHH--------HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence            9999999977654332221        1223347899999999999999999999999999999998764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3e-42  Score=313.16  Aligned_cols=258  Identities=22%  Similarity=0.316  Sum_probs=190.2

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHH--HHhCCCCCceeEeeeEEee---
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI--MKHLPKNSSIVSLKEACED---  123 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~--l~~l~~h~~i~~~~~~~~~---  123 (347)
                      ..++|++.+.||.|+||.||+|++  +++.||+|++....      ...+..|.++  +..+ +|+||+++++.+..   
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTA   81 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECT
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhc-cCcchhhheeccccccc
Confidence            357899999999999999999977  68899999986432      2333444444  4456 89999999875432   


Q ss_pred             --CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CcEeeCCCCCcEEeecCCCCC
Q 019040          124 --DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH---------GVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       124 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------~ivH~Dikp~NIli~~~~~~~  192 (347)
                        ...+++||||+++++|.+++... ..+...+..++.||+.||.|||+.         ||+||||||+|||+   +.++
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~  157 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDG  157 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTS
T ss_pred             CCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCC
Confidence              34678999999999999999765 458899999999999999999999         99999999999999   6678


Q ss_pred             CEEEEeeccccccCCCC---------cccccccCccccccccccc--------cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 019040          193 PLKAIDFGLSIFFKPGE---------RFSEIVGSPYYMAPEVLKR--------NYGPEIDIWSAGVILYILLCGVPPFWA  255 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~~~~---------~~~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~~l~~l~~g~~pf~~  255 (347)
                      .+||+|||++.......         ......||+.|+|||++.+        .++.++||||||+++|+|++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            89999999998654321         1224469999999998764        366789999999999999999776633


Q ss_pred             CCH-----------------HHHHHHHHh-cccccc-CCCCC---CCCHHHHHHHHHhccCCCCCCCCHHHH------hc
Q 019040          256 ESE-----------------QGVAQAILR-GLIDFK-RDPWP---NVSESAKSLVRQMLEPDPKLRLTAKQV------LE  307 (347)
Q Consensus       256 ~~~-----------------~~~~~~~~~-~~~~~~-~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~l------l~  307 (347)
                      ...                 ......... ...... +..+.   .+++++.++|.+||+.||++|||+.++      +-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            221                 111111111 111110 11111   244579999999999999999999999      55


Q ss_pred             CcccccCcCCCC
Q 019040          308 HPWLQNAKKAPN  319 (347)
Q Consensus       308 h~~~~~~~~~~~  319 (347)
                      ++|-++....+.
T Consensus       318 ~~~~~~~~~~~~  329 (336)
T 3g2f_A          318 MIWERNKSVSPT  329 (336)
T ss_dssp             HCCCC-------
T ss_pred             HHHHhcccCCCc
Confidence            777777765543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.9e-42  Score=334.88  Aligned_cols=252  Identities=25%  Similarity=0.339  Sum_probs=209.1

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCC---CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      ....++|++.+.||+|+||.||+|.+..+   +..||+|.+....  .......+.+|+.+++.+ +||||+++++++. 
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-  461 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-  461 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-
Confidence            34467899999999999999999998754   4568999875432  334456789999999999 9999999999985 


Q ss_pred             CCeEEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      ++..++||||+++++|.+++.... .++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLS  538 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCC
T ss_pred             cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCC
Confidence            456899999999999999998654 58999999999999999999999999999999999999   45678999999999


Q ss_pred             cccCCCCcc--cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          203 IFFKPGERF--SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       203 ~~~~~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      .........  ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.+....+....+.....   .+...
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~  615 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPP  615 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC---CCCCT
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---CCCCc
Confidence            876443321  2235678899999876 458999999999999999997 9999999888887777766532   22334


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .+++.+.++|.+||+.||++|||+.++++.
T Consensus       616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          616 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            789999999999999999999999999754

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.5e-42  Score=306.84  Aligned_cols=233  Identities=14%  Similarity=0.115  Sum_probs=191.5

Q ss_pred             CCCC-CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           44 VPKE-NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        44 ~~~~-~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      .++. .+.++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.++..+ +|+||+++++++.
T Consensus        23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~  101 (286)
T 3uqc_A           23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVH  101 (286)
T ss_dssp             CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred             CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEE
Confidence            4455 5678999999999999999999999999999999999866555555667899999999999 9999999999999


Q ss_pred             eCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          123 DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       123 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      ..+..|+||||++|++|.+++...  .....+..++.||+.||.|||++||+||||||+||++   +.++.++|++++  
T Consensus       102 ~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~--  174 (286)
T 3uqc_A          102 TRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA--  174 (286)
T ss_dssp             ETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCC--
T ss_pred             ECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEecc--
Confidence            999999999999999999998543  4666788999999999999999999999999999999   567789987443  


Q ss_pred             cccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhccccccCCCCCC
Q 019040          203 IFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ---AILRGLIDFKRDPWPN  279 (347)
Q Consensus       203 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~  279 (347)
                                       |++      .++.++||||||+++|+|++|..||.+.+......   .........+......
T Consensus       175 -----------------~~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T 3uqc_A          175 -----------------TMP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD  231 (286)
T ss_dssp             -----------------CCT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred             -----------------ccC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence                             222      26789999999999999999999998765432110   0001111111112247


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +++++.++|.+||+.||++| |+.++++.
T Consensus       232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          232 IPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             SCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             CCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            89999999999999999999 99999874

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.3e-44  Score=326.27  Aligned_cols=251  Identities=17%  Similarity=0.233  Sum_probs=192.9

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEecccccc-----chhcHHHHHHHHHHHHhCC--------CCCceeE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-----TAVDIDDVRREVAIMKHLP--------KNSSIVS  116 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~ei~~l~~l~--------~h~~i~~  116 (347)
                      .++|++.+.||+|+||+||+|++  +|+.||||++......     .......+.+|+.+++.+.        .|+|++.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            47899999999999999999998  6899999999765432     2334577889999999884        3666666


Q ss_pred             eeeE-----------------Eee-------------CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 019040          117 LKEA-----------------CED-------------DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ  166 (347)
Q Consensus       117 ~~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~  166 (347)
                      +.++                 +.+             .+..|+||||++++++.+.+.+ ..+++..++.++.||+.||.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            5554                 333             7899999999999877666644 56899999999999999999


Q ss_pred             HHH-HcCcEeeCCCCCcEEeecCC-----------------CCCCEEEEeeccccccCCCCcccccccCccccccccccc
Q 019040          167 LCH-KHGVIHRDLKPENFLFANKK-----------------ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR  228 (347)
Q Consensus       167 ~lH-~~~ivH~Dikp~NIli~~~~-----------------~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~  228 (347)
                      ||| ++||+||||||+|||++.++                 ....+||+|||+|......    ...||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 99999999999999996533                 1127999999999876532    3479999999999987


Q ss_pred             cCCCchhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhcccccc---CCCCCCCCHHHHHHHHHhccCCCCCCCCHH
Q 019040          229 NYGPEIDIWSAGVI-LYILLCGVPPFWAESE-QGVAQAILRGLIDFK---RDPWPNVSESAKSLVRQMLEPDPKLRLTAK  303 (347)
Q Consensus       229 ~~~~~~Di~slG~~-l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  303 (347)
                      ..+.++|||||+.+ .++++.|..||..... ......+........   ...+..+++++.+||.+||+.|     |+.
T Consensus       252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence            67889999998777 6678889999833211 112223222211111   1112246788999999999976     999


Q ss_pred             HHh-cCcccc
Q 019040          304 QVL-EHPWLQ  312 (347)
Q Consensus       304 ~ll-~h~~~~  312 (347)
                      ++| +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.7e-42  Score=340.41  Aligned_cols=247  Identities=25%  Similarity=0.353  Sum_probs=203.3

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECC-CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRD-TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      +++.+.++|++.+.||.|+||+||+|.+.. +++.||||++....  .......+.+|+.++..+ +||||+++++++..
T Consensus        74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~  150 (681)
T 2pzi_A           74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEH  150 (681)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEE
T ss_pred             CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEee
Confidence            455677999999999999999999999986 78999999886432  334456788999999999 89999999999987


Q ss_pred             CCe-----EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          124 DNA-----VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       124 ~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      .+.     .|+||||++|++|.+++..  .+++..+..++.||+.||.|||++||+||||||+||+++   . +.+||+|
T Consensus       151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~D  224 (681)
T 2pzi_A          151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLID  224 (681)
T ss_dssp             ECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECC
T ss_pred             cCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEe
Confidence            665     7999999999999887755  799999999999999999999999999999999999994   3 3799999


Q ss_pred             eccccccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       199 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ||++......   ....||+.|+|||++.+.++.++||||||+++++|++|..||......        ...  ......
T Consensus       225 FG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~--~~~~~~  291 (681)
T 2pzi_A          225 LGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLP--EDDPVL  291 (681)
T ss_dssp             CTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCC--TTCHHH
T ss_pred             cccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc--------ccc--cccccc
Confidence            9999875443   445799999999998877789999999999999999999888643211        000  000001


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                      ..++.+.++|.+||+.||++||+..+++.|+|+.-
T Consensus       292 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          292 KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             HHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            24578999999999999999999999999988753

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.2e-33  Score=270.99  Aligned_cols=186  Identities=18%  Similarity=0.135  Sum_probs=136.2

Q ss_pred             eecccCCeEEEEEEECCCCceeEEeEecccccc-------chhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-------TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        58 ~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ....|+.|.+..++....|+.+++|++.+....       .....+.+.+|+++|+++..|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            456778888888888888999999999764321       2234567999999999998999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC-C
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-E  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~-~  209 (347)
                      |||++|++|.+.+...++++..   .|+.||+.||.|+|++|||||||||+|||+   +.++.+||+|||+|+..... .
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---C
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCCc
Confidence            9999999999999998888765   578999999999999999999999999999   67788999999999865433 3


Q ss_pred             cccccccCccccccccccccCCCchhHHHHHHHHHHHHhC
Q 019040          210 RFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCG  249 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g  249 (347)
                      .....+||+.|+|||++.+.+..++|+||+|++++++.++
T Consensus       395 ~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC-----------------CCCCTT
T ss_pred             cccCceechhhccHHHhCCCCCCcccccccccchhhhccc
Confidence            3455689999999999988888899999999988766544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.2e-27  Score=229.67  Aligned_cols=184  Identities=22%  Similarity=0.219  Sum_probs=142.1

Q ss_pred             eeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc-----hhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-----AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        54 ~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ...+.||+|+||.||+|.  ..+..+++|.........     ....+++.+|+++++++ +||||+.+..++...+..|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccE
Confidence            346689999999999994  457789998865432221     12245689999999999 9999996666666777789


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||||++|++|.+++..        +..++.||+.+|.|||++||+||||||+|||++   .  .+||+|||++......
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCCH
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCCc
Confidence            99999999999998865        568999999999999999999999999999994   3  8999999999986543


Q ss_pred             Ccc--------cccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCC
Q 019040          209 ERF--------SEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPF  253 (347)
Q Consensus       209 ~~~--------~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf  253 (347)
                      ...        ....||+.|+|||++..   .|+...|+|+..+-..+-+.++-+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            221        34579999999999863   4788889999988888877766554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=3.7e-25  Score=195.48  Aligned_cols=146  Identities=20%  Similarity=0.254  Sum_probs=114.1

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccch---------------hcHHHHHHHHHHHHhCCCCCceeEe
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---------------VDIDDVRREVAIMKHLPKNSSIVSL  117 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~ei~~l~~l~~h~~i~~~  117 (347)
                      |.+.+.||.|+||.||+|.+ .+|+.||+|++........               .....+.+|+.+++.+.   | +.+
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~---~-~~v  166 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ---G-LAV  166 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT---T-SSS
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc---C-CCc
Confidence            34459999999999999999 8899999999864322111               13456889999999994   4 556


Q ss_pred             eeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       118 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                      .+++.. +..++||||++|++|.+ +.      ......++.|++.||.|||+.||+||||||+|||+   + ++.++|+
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~vkl~  234 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGIWII  234 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEEEEC
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcEEEE
Confidence            565544 45689999999999987 31      12345799999999999999999999999999999   4 6789999


Q ss_pred             eeccccccCCCCcccccccCcccccccccc
Q 019040          198 DFGLSIFFKPGERFSEIVGSPYYMAPEVLK  227 (347)
Q Consensus       198 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~  227 (347)
                      |||++...            ..+.|||.+.
T Consensus       235 DFG~a~~~------------~~~~a~e~l~  252 (282)
T 1zar_A          235 DFPQSVEV------------GEEGWREILE  252 (282)
T ss_dssp             CCTTCEET------------TSTTHHHHHH
T ss_pred             ECCCCeEC------------CCCCHHHHHH
Confidence            99998643            3467888763

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=9.5e-22  Score=171.48  Aligned_cols=141  Identities=14%  Similarity=0.111  Sum_probs=107.1

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCce--eEEeEeccccccc---------------------hhcHHHHHHHHHHHHhC
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTREL--LACKSISKRKLRT---------------------AVDIDDVRREVAIMKHL  108 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~ei~~l~~l  108 (347)
                      .|.+.+.||.|+||.||+|.+..+|+.  ||||++.......                     ......+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            378999999999999999999778988  9999975432110                     01123678899999999


Q ss_pred             CCCCce--eEeeeEEeeCCeEEEEEEecCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCcEeeCCCC
Q 019040          109 PKNSSI--VSLKEACEDDNAVHLVMELCEG-G----ELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRDLKP  180 (347)
Q Consensus       109 ~~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dikp  180 (347)
                       .|+++  +.++..    +..++||||+.+ +    +|.+....   .++..+..++.||+.+|.+|| +.||+||||||
T Consensus       128 -~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 -KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             -HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             -HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence             66653  333332    356799999942 2    66655432   234567899999999999999 99999999999


Q ss_pred             CcEEeecCCCCCCEEEEeecccccc
Q 019040          181 ENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       181 ~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      +|||++   .  .++|+|||+|...
T Consensus       200 ~NILl~---~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYI---D--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEES---S--SEEECCCTTCEET
T ss_pred             HHEEEc---C--cEEEEECcccccC
Confidence            999994   3  7999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=8.9e-19  Score=159.16  Aligned_cols=145  Identities=18%  Similarity=0.208  Sum_probs=101.5

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc-----------hhcH--------HHHHHHHHHHHhCCCCCc
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-----------AVDI--------DDVRREVAIMKHLPKNSS  113 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-----------~~~~--------~~~~~ei~~l~~l~~h~~  113 (347)
                      |++.+.||.|++|.||+|.+. +|+.||||++.......           ....        ....+|...+.++ .+.+
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~g  174 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEG  174 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTT
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcC
Confidence            899999999999999999985 68999999975432110           0000        1123567777777 4444


Q ss_pred             eeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCC--
Q 019040          114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN--  191 (347)
Q Consensus       114 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~--  191 (347)
                      +....-+.. .. .++||||++|.+|....      ..+....++.||+.+|.+||+.|||||||||.|||++.+++.  
T Consensus       175 v~vp~p~~~-~~-~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          175 FPVPEPIAQ-SR-HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             CSCCCEEEE-ET-TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred             CCCCeeeec-cC-ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence            332221212 22 36999999998885432      223446788999999999999999999999999999653321  


Q ss_pred             -----CCEEEEeeccccccCC
Q 019040          192 -----SPLKAIDFGLSIFFKP  207 (347)
Q Consensus       192 -----~~~~l~Dfg~a~~~~~  207 (347)
                           ..+.|+||+.+.....
T Consensus       247 ~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             TTSEEEEEEECCCTTCEETTS
T ss_pred             ccccccceEEEEeCCcccCCC
Confidence                 1389999998876543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.49  E-value=2.6e-13  Score=118.12  Aligned_cols=141  Identities=20%  Similarity=0.183  Sum_probs=111.4

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      +.|++...++.|+.+.||++..  .+..+++|+.......   ....+.+|+.+++.+..+..+++++++....+..|+|
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            4688899999999999999975  3678999998643211   1235888999999996677888999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK----------------------------------------  170 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~----------------------------------------  170 (347)
                      |||++|.+|.+.+.     +......++.+++.+|..||+                                        
T Consensus        89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999999876521     122335788999999999998                                        


Q ss_pred             -------------------cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          171 -------------------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       171 -------------------~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                                         ..++|||++|.||+++   ++..+.|+||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence                               4589999999999994   334467999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=8e-12  Score=108.22  Aligned_cols=136  Identities=15%  Similarity=0.141  Sum_probs=97.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCc-eeEeeeEEeeCCeEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IVSLKEACEDDNAVHL  129 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~-i~~~~~~~~~~~~~~l  129 (347)
                      ..+.+....+.|..+.||++.. .+|..+++|+....      ....+.+|+.+++.+..+.. +++++.+....+..++
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            3456555445666799999964 45677999987532      12347789999998844432 6678888888888999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-------------------------------------
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG-------------------------------------  172 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-------------------------------------  172 (347)
                      ||||++|.+|.  .   ....   ...++.+++..|..||+..                                     
T Consensus        93 v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           93 LLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             EEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99999998883  1   1122   2356677777777777643                                     


Q ss_pred             ---------------------cEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          173 ---------------------VIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       173 ---------------------ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                                           ++|||++|.||+++   +++.+.|+||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence                                 99999999999994   344466999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=7.2e-11  Score=107.45  Aligned_cols=143  Identities=20%  Similarity=0.362  Sum_probs=103.1

Q ss_pred             eeeeecccCCeEEEEEEECCCCceeEEeEec--cccccchhcHHHHHHHHHHHHhCCC-CCceeEeeeEEeeC---CeEE
Q 019040           55 VDRELGRGEFGVTYLCIDRDTRELLACKSIS--KRKLRTAVDIDDVRREVAIMKHLPK-NSSIVSLKEACEDD---NAVH  128 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~ei~~l~~l~~-h~~i~~~~~~~~~~---~~~~  128 (347)
                      ..+.|+.|.++.||++...  +..+++|+..  ....  ......+.+|..+++.+.. +..+++++.++.+.   +..|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            4667899999999999763  4578888875  3221  1123467889999999843 34478888887766   4588


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK--------------------------------------  170 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~--------------------------------------  170 (347)
                      +||||++|.++.+..  ...++......++.+++..|..||+                                      
T Consensus       118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999999998774311  1236788888999999999999997                                      


Q ss_pred             --------------------cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          171 --------------------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       171 --------------------~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                                          ..++|||+++.||+++.++. ..+.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECcccccc
Confidence                                35899999999999953211 2368999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.13  E-value=7.7e-11  Score=104.74  Aligned_cols=185  Identities=17%  Similarity=0.215  Sum_probs=121.8

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCc--eeEeeeEEeeCC---eEEEE
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS--IVSLKEACEDDN---AVHLV  130 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~--i~~~~~~~~~~~---~~~lv  130 (347)
                      ++.++.|..+.||++.     ..+++|+....     .....+.+|..+++.+..+..  ++.++......+   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4458999999999873     45889986422     234678899999988744333  444544443333   45889


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK----------------------------------------  170 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~----------------------------------------  170 (347)
                      |++++|.+|......  .++......++.+++..|..||+                                        
T Consensus        95 m~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999999988754432  46777788888888888888886                                        


Q ss_pred             ------------------cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccccCccccccccc---ccc
Q 019040          171 ------------------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL---KRN  229 (347)
Q Consensus       171 ------------------~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~---~~~  229 (347)
                                        ..++|||++|.||+++.+ ....+.|+||+.+....+............-..|+..   ...
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                              136999999999999532 1455789999988764332211111100000223221   111


Q ss_pred             CCC------------chhHHHHHHHHHHHHhCCCCC
Q 019040          230 YGP------------EIDIWSAGVILYILLCGVPPF  253 (347)
Q Consensus       230 ~~~------------~~Di~slG~~l~~l~~g~~pf  253 (347)
                      |..            -.+.|+++.+++.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            221            258999999999999997765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.86  E-value=4e-08  Score=85.42  Aligned_cols=133  Identities=17%  Similarity=0.195  Sum_probs=96.8

Q ss_pred             ecccCC-eEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecCCC
Q 019040           59 LGRGEF-GVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGG  137 (347)
Q Consensus        59 lg~G~~-g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~  137 (347)
                      +..|.. +.||+......+..+++|+....      ....+.+|...++.+..+-.+++++.++.+.+..|+|||+++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            333444 47999888777888999986422      34568889999998865555888999999999999999999998


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------------------------------------------
Q 019040          138 ELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH----------------------------------------------  171 (347)
Q Consensus       138 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~----------------------------------------------  171 (347)
                      ++.+.....    ......+..++...|..||..                                              
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            887765432    122334555666666666631                                              


Q ss_pred             ------------CcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          172 ------------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       172 ------------~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                                  .++|||+++.||+++   ..+.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECccccc
Confidence                        168999999999994   445567999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.86  E-value=4.7e-08  Score=86.78  Aligned_cols=139  Identities=19%  Similarity=0.233  Sum_probs=94.5

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCC--ceeEeeeEEe-eCCeEEEEEE
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS--SIVSLKEACE-DDNAVHLVME  132 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~--~i~~~~~~~~-~~~~~~lv~e  132 (347)
                      .+.++.|....||+.     +..+++|+..     .......+.+|..+++.+..+-  .++.++.+.. ..+..++||+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            455788888999988     4568888853     2233467889999999995432  3566666664 4566889999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q 019040          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH-----------------------------------------  171 (347)
Q Consensus       133 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-----------------------------------------  171 (347)
                      +++|.++......  .++......++.++...|..||+.                                         
T Consensus        94 ~i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            9999888663211  234445555555555555555532                                         


Q ss_pred             -------------------CcEeeCCCCCcEEeecCCCCCCE-EEEeeccccccC
Q 019040          172 -------------------GVIHRDLKPENFLFANKKENSPL-KAIDFGLSIFFK  206 (347)
Q Consensus       172 -------------------~ivH~Dikp~NIli~~~~~~~~~-~l~Dfg~a~~~~  206 (347)
                                         .++|+|+++.||+++.++.++.+ .|+||+.+....
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                               35999999999999532224554 899999887643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.49  E-value=5e-07  Score=83.10  Aligned_cols=80  Identities=18%  Similarity=0.170  Sum_probs=50.4

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccc--cc--hhcHHHHHHHHHHHHhCCCC--CceeEeeeEEeeCCeEEE
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKL--RT--AVDIDDVRREVAIMKHLPKN--SSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~--~~~~~~~~~ei~~l~~l~~h--~~i~~~~~~~~~~~~~~l  129 (347)
                      .+.||.|..+.||++.+..+++.+++|.......  ..  .....++..|.++++.+...  ..++.++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            5678999999999998766678899998642210  00  11234567788888877332  345556543  3445679


Q ss_pred             EEEecCCC
Q 019040          130 VMELCEGG  137 (347)
Q Consensus       130 v~e~~~~~  137 (347)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.37  E-value=2.6e-07  Score=83.70  Aligned_cols=86  Identities=9%  Similarity=0.113  Sum_probs=55.5

Q ss_pred             eeeeee-cccCCeEEEEEEEC--C----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCC--CceeEeeeEEeeC
Q 019040           54 LVDREL-GRGEFGVTYLCIDR--D----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN--SSIVSLKEACEDD  124 (347)
Q Consensus        54 ~i~~~l-g~G~~g~V~~a~~~--~----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h--~~i~~~~~~~~~~  124 (347)
                      ...+.| +.|..+.+|+....  .    ++..+++|+..............+.+|..+++.+..+  -.+++++.+..+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345677 88888999988653  1    1567889986543200000113467788888887443  3467777776655


Q ss_pred             ---CeEEEEEEecCCCch
Q 019040          125 ---NAVHLVMELCEGGEL  139 (347)
Q Consensus       125 ---~~~~lv~e~~~~~~L  139 (347)
                         +..|+|||+++|.++
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence               457899999998654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.17  E-value=3e-05  Score=69.37  Aligned_cols=75  Identities=9%  Similarity=0.110  Sum_probs=41.9

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCC-CceeEeee------EEeeCCeEE
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN-SSIVSLKE------ACEDDNAVH  128 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h-~~i~~~~~------~~~~~~~~~  128 (347)
                      .+.|+.|..+.||++...  +..+++|+....       ...+..|..+++.|..+ -.++.++.      +....+..+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~  107 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF  107 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence            345666778899999763  334889988642       12334455555544211 13444443      123467789


Q ss_pred             EEEEecCCCch
Q 019040          129 LVMELCEGGEL  139 (347)
Q Consensus       129 lv~e~~~~~~L  139 (347)
                      ++++|++|.++
T Consensus       108 ~l~~~i~G~~~  118 (346)
T 2q83_A          108 VVYDWIEGRPF  118 (346)
T ss_dssp             EEEECCCCBCC
T ss_pred             EEEEeecCccC
Confidence            99999998643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.10  E-value=1.7e-05  Score=73.47  Aligned_cols=77  Identities=8%  Similarity=0.043  Sum_probs=44.8

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEecccc--ccc----hhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRK--LRT----AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~----~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+.||.|..+.||++..  +++.+++|......  ...    ......+..|+..+..-.....+++++.+.  .+..++
T Consensus        39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            56789999999999954  56779999432110  000    012223344443332211234566776654  566789


Q ss_pred             EEEec-CC
Q 019040          130 VMELC-EG  136 (347)
Q Consensus       130 v~e~~-~~  136 (347)
                      ||||+ +|
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 77

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.06  E-value=2.2e-05  Score=69.55  Aligned_cols=77  Identities=16%  Similarity=0.122  Sum_probs=59.7

Q ss_pred             eeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCC--CCceeEeeeEEeeCCeEEEEEE
Q 019040           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK--NSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~--h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      -.+.|+.|....+|+...  ++..+++|+....      ....+..|...++.|..  ...+++++.+....+..++|||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            356789999999999975  4667889987532      24668889888888733  3568888888888889999999


Q ss_pred             ecCCCch
Q 019040          133 LCEGGEL  139 (347)
Q Consensus       133 ~~~~~~L  139 (347)
                      |++|..+
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9998654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.94  E-value=4.1e-05  Score=67.38  Aligned_cols=73  Identities=10%  Similarity=-0.049  Sum_probs=45.4

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEec-
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC-  134 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-  134 (347)
                      .+.|+.|....+|++      ..+++|+...... ..   -...+|..+++.+..+...++++...  .+.-++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~~---~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-EY---INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-----C---CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc-ce---eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            678888999999999      4488998754211 11   12345777777663333335665443  33346899999 


Q ss_pred             CCCchH
Q 019040          135 EGGELF  140 (347)
Q Consensus       135 ~~~~L~  140 (347)
                      +|.++.
T Consensus        91 ~g~~l~   96 (301)
T 3dxq_A           91 GAQTMS   96 (301)
T ss_dssp             TCEECC
T ss_pred             CCccCC
Confidence            776553

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.86  E-value=0.00018  Score=59.29  Aligned_cols=122  Identities=16%  Similarity=0.040  Sum_probs=79.9

Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCccccc
Q 019040          137 GELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI  214 (347)
Q Consensus       137 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~  214 (347)
                      .+|.++|... .+++++++|.++.|.+.+|..+-. +.-...=+.|..|++   ..+|.|.+.+ +.+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------
Confidence            4899999765 579999999999999999877632 222234445688888   5667777653 1110           


Q ss_pred             ccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccC
Q 019040          215 VGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (347)
Q Consensus       215 ~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (347)
                      .....+.|||......+.+.=|||||+++|..+--..|-    .                 .-..+++.+.+||..|...
T Consensus        98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e----~-----------------eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKE----N-----------------EERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCT----T-----------------EEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCc----c-----------------cchhhCHHHHHHHHHHHhc
Confidence            112346788876545667889999999999877533321    1                 1127899999999999866

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.77  E-value=4.3e-05  Score=70.86  Aligned_cols=76  Identities=12%  Similarity=0.055  Sum_probs=51.1

Q ss_pred             eeeeecccCCeEEEEEEECC-------CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           55 VDRELGRGEFGVTYLCIDRD-------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      -++.|+.|....+|++....       ++..+++|+....  .   ....+.+|..+++.|..+...+++++.+.+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E---TESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            35668888889999998653       2567999987321  1   113455788888888555445677766542    


Q ss_pred             EEEEEecCCCch
Q 019040          128 HLVMELCEGGEL  139 (347)
Q Consensus       128 ~lv~e~~~~~~L  139 (347)
                      .+|+||++|.+|
T Consensus       148 g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEeCCccc
Confidence            289999987443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.76  E-value=4.2e-05  Score=69.54  Aligned_cols=141  Identities=13%  Similarity=0.112  Sum_probs=83.3

Q ss_pred             eeeecccCCeEEEEEEECC-------CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           56 DRELGRGEFGVTYLCIDRD-------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ++.|..|-...+|++....       +++.+++|+....    ......+.+|..+++.|..+...+++++.+.+    .
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            4567778888999998642       3567999986321    12345567899999888555555777766543    2


Q ss_pred             EEEEecCCCchHH--------------HHHh---c-----CCCC--HHHHHHHHHHHHH-------------------HH
Q 019040          129 LVMELCEGGELFD--------------RIVA---R-----GHYT--ERAAAAVTRTIVE-------------------VV  165 (347)
Q Consensus       129 lv~e~~~~~~L~~--------------~l~~---~-----~~~~--~~~~~~i~~qi~~-------------------~l  165 (347)
                      +|+||++|.+|..              .+.+   .     +...  ...+.++..++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            8999999865431              1111   1     0111  2445555544422                   12


Q ss_pred             HHHH----H----cCcEeeCCCCCcEEeecC-CCCCCEEEEeeccccc
Q 019040          166 QLCH----K----HGVIHRDLKPENFLFANK-KENSPLKAIDFGLSIF  204 (347)
Q Consensus       166 ~~lH----~----~~ivH~Dikp~NIli~~~-~~~~~~~l~Dfg~a~~  204 (347)
                      ..|.    .    ..++|+|+.+.||+++.+ +..+.+.|+||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3332    2    248999999999999643 1236799999998864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.68  E-value=0.00034  Score=61.04  Aligned_cols=79  Identities=16%  Similarity=0.043  Sum_probs=54.1

Q ss_pred             ceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCC--ceeEeeeEEeeCCeEEE
Q 019040           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS--SIVSLKEACEDDNAVHL  129 (347)
Q Consensus        52 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~--~i~~~~~~~~~~~~~~l  129 (347)
                      ...-++.+|.|..+.||+... .+|+.|++|+......   .....+..|...|+.|....  .+++++++  ..  .++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence            455678899999999999986 4688899998653321   12245778999998884432  24455443  22  368


Q ss_pred             EEEecCCCc
Q 019040          130 VMELCEGGE  138 (347)
Q Consensus       130 v~e~~~~~~  138 (347)
                      ||||+++..
T Consensus        88 v~e~l~~~~   96 (288)
T 3f7w_A           88 AMEWVDERP   96 (288)
T ss_dssp             EEECCCCCC
T ss_pred             EEEeecccC
Confidence            899998654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.66  E-value=9.1e-05  Score=65.69  Aligned_cols=140  Identities=19%  Similarity=0.173  Sum_probs=76.9

Q ss_pred             eeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCC-ceeEeeeE------EeeCCeE
Q 019040           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-SIVSLKEA------CEDDNAV  127 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~-~i~~~~~~------~~~~~~~  127 (347)
                      -.+.|+.|....+|++... ++ .+++|+.....     ....+..|+.+++.|..+. .++.++..      ....+..
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            3566778888999999763 33 58899875421     1234556777777663221 13444422      1234677


Q ss_pred             EEEEEecCCCchH-----------HH---HHhc-CCC--------CHHHHHHH---------------HHHHHHHHHHHH
Q 019040          128 HLVMELCEGGELF-----------DR---IVAR-GHY--------TERAAAAV---------------TRTIVEVVQLCH  169 (347)
Q Consensus       128 ~lv~e~~~~~~L~-----------~~---l~~~-~~~--------~~~~~~~i---------------~~qi~~~l~~lH  169 (347)
                      ++++++++|..+.           +.   +... ..+        ........               ...+...+..+.
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            8999999986431           11   1110 011        11111110               011334455555


Q ss_pred             H-------cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          170 K-------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       170 ~-------~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      .       .+++|+|+++.||+++   .+..+.|+||+.+..
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN  217 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             hhCcccCCcccCCCCCCccCEEEe---CCceEEEecchhccC
Confidence            2       3689999999999994   334457999998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.54  E-value=0.00014  Score=65.89  Aligned_cols=76  Identities=13%  Similarity=0.102  Sum_probs=44.9

Q ss_pred             eeeecccCCeEEEEEEECC--------CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           56 DRELGRGEFGVTYLCIDRD--------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .+.++.|....+|++....        .+..+++|+......    .......|..+++.+..+..++++++..  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            4567788888999997653        136789998753211    1112356888888774443355666544  22  


Q ss_pred             EEEEEecCCCch
Q 019040          128 HLVMELCEGGEL  139 (347)
Q Consensus       128 ~lv~e~~~~~~L  139 (347)
                      ++|++|++|.++
T Consensus       110 ~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 GRIEEWLYGDPL  121 (369)
T ss_dssp             EEEEECCCSEEC
T ss_pred             cEEEEEecCCcC
Confidence            689999988543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.52  E-value=0.00052  Score=64.02  Aligned_cols=76  Identities=13%  Similarity=0.047  Sum_probs=49.8

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecC
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (347)
                      ++.|+.|....+|++.....+..+++|+..... ...   -...+|..+++.|..+...+++++.+.  +.  +|+||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEI---INREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSC---SCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhh---cCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeC
Confidence            556888888999999875545779999874321 111   112579999998855555577777663  32  5999998


Q ss_pred             CCch
Q 019040          136 GGEL  139 (347)
Q Consensus       136 ~~~L  139 (347)
                      |.+|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            8544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.51  E-value=0.00014  Score=64.91  Aligned_cols=36  Identities=25%  Similarity=0.395  Sum_probs=27.3

Q ss_pred             cCcEeeCCCCCcEEeecCCC-CCCEEEEeeccccccC
Q 019040          171 HGVIHRDLKPENFLFANKKE-NSPLKAIDFGLSIFFK  206 (347)
Q Consensus       171 ~~ivH~Dikp~NIli~~~~~-~~~~~l~Dfg~a~~~~  206 (347)
                      ..++|||+++.||+++.+.. .+.+.|+||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            46999999999999953211 2568999999887643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.50  E-value=0.00044  Score=61.41  Aligned_cols=76  Identities=13%  Similarity=0.121  Sum_probs=47.4

Q ss_pred             eeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCC-ceeEeeeE-----EeeCCeEEEE
Q 019040           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-SIVSLKEA-----CEDDNAVHLV  130 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~-~i~~~~~~-----~~~~~~~~lv  130 (347)
                      ..++ |....||++.. .+|+.+++|+.....    .....+..|..+++.|..+. .++.++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            3456 77789998754 345679999975321    12345667888877773221 14444443     2235667889


Q ss_pred             EEecCCCc
Q 019040          131 MELCEGGE  138 (347)
Q Consensus       131 ~e~~~~~~  138 (347)
                      +++++|.+
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998854

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.19  E-value=0.0027  Score=56.69  Aligned_cols=31  Identities=19%  Similarity=0.348  Sum_probs=26.0

Q ss_pred             CcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       172 ~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .++|+|+.+.||++   +.++.+.|+||+.+...
T Consensus       207 ~~~HgD~~~~N~l~---~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          207 VLCHSDIHAGNVLV---GNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             EEECSCCCGGGEEE---CGGGCEEECCCSSCEEE
T ss_pred             eeEeCCCCcCCEEE---eCCCeEEEEECCCCeeC
Confidence            58999999999999   44567999999887653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.88  E-value=0.0014  Score=60.30  Aligned_cols=77  Identities=10%  Similarity=0.100  Sum_probs=49.8

Q ss_pred             eeeeecccCCeEEEEEEECCC-------CceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           55 VDRELGRGEFGVTYLCIDRDT-------RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      -++.+..|-...+|++.....       +..+++|+.....    ...-...+|..+++.|......+++++.+  .+  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence            345677788889999987521       5779999864321    11112456888888774445566666543  22  


Q ss_pred             EEEEEecCCCch
Q 019040          128 HLVMELCEGGEL  139 (347)
Q Consensus       128 ~lv~e~~~~~~L  139 (347)
                      ++|++|++|.+|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            689999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.68  E-value=0.0056  Score=56.02  Aligned_cols=32  Identities=31%  Similarity=0.459  Sum_probs=26.4

Q ss_pred             cEeeCCCCCcEEeecC---CCCCCEEEEeeccccc
Q 019040          173 VIHRDLKPENFLFANK---KENSPLKAIDFGLSIF  204 (347)
Q Consensus       173 ivH~Dikp~NIli~~~---~~~~~~~l~Dfg~a~~  204 (347)
                      ++|+|+.+.||++..+   ++...+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999642   4567799999998875

>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A

Probab=88.63  E-value=12  Score=35.64  Aligned_cols=85  Identities=15%  Similarity=0.220  Sum_probs=54.9

Q ss_pred             CceeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcC----------C-------CCHHHHHHHHHHHHH--HHHHHHHcC
Q 019040          112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG----------H-------YTERAAAAVTRTIVE--VVQLCHKHG  172 (347)
Q Consensus       112 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~-------~~~~~~~~i~~qi~~--~l~~lH~~~  172 (347)
                      +--+..|.+...+....+ +|++++.++.+.+...+          +       ........+++.++.  .+.|+=  |
T Consensus       399 dL~i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YIL--G  475 (614)
T 3ls8_A          399 DLKLTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYIL--G  475 (614)
T ss_dssp             CCCCCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHH--T
T ss_pred             CceeeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheee--e
Confidence            334566777777766665 57787766666654321          1       123445556665543  344443  4


Q ss_pred             cEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       173 ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      |  ||=+++||++   +.+|.+.=+|||.+..
T Consensus       476 i--gDRH~~NILl---d~tG~v~HIDFG~~f~  502 (614)
T 3ls8_A          476 V--GDRHLDNLLL---TKTGKLFHIDFGYILG  502 (614)
T ss_dssp             C--CCCCTTSEEE---CTTSCEEECCCSSCTT
T ss_pred             c--cCCCCcceeE---cCCCCEeeeehHHhhc
Confidence            4  5999999999   5788999999998854

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=88.58  E-value=10  Score=36.86  Aligned_cols=84  Identities=17%  Similarity=0.268  Sum_probs=53.0

Q ss_pred             ceeEeeeEEeeCCeEEEEEEecCCCchHHHHHhcCC---------------C--CHHHHHHHHHHHH--HHHHHHHHcCc
Q 019040          113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH---------------Y--TERAAAAVTRTIV--EVVQLCHKHGV  173 (347)
Q Consensus       113 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~--~~~~~~~i~~qi~--~~l~~lH~~~i  173 (347)
                      -.+..|.+...+....+ +|+++..+|.+++.+.+.               +  .......+++.++  ..+.|+=  ||
T Consensus       474 L~i~~Y~Vipls~~~GL-IE~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YIL--Gl  550 (696)
T 2x6h_A          474 LKLTPYKVLATSSKHGF-LQYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYLL--GV  550 (696)
T ss_dssp             CCCCCCCEEESSTTCEE-EECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHHH--TC
T ss_pred             cEEeccEEEeccCCCCe-eeeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHHc--cC
Confidence            34555666666655554 477777777776654321               1  1234455555554  3344443  43


Q ss_pred             EeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          174 IHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       174 vH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                        ||=+++||++   +.+|.+.=+|||.+..
T Consensus       551 --GDRH~~NILi---d~tG~v~HIDFG~~f~  576 (696)
T 2x6h_A          551 --GDRHLDNLLL---TTNGKLFHIDFGYILG  576 (696)
T ss_dssp             --CCCCTTTEEE---CTTSCEEECCCCSCTT
T ss_pred             --CCCCCcceEE---eCCCCEEEEeehhhhc
Confidence              6999999999   5689999999998754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.33  E-value=2.7  Score=34.40  Aligned_cols=136  Identities=11%  Similarity=0.130  Sum_probs=85.2

Q ss_pred             EeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEecC-CCchHHHHHhcCCCCHHHHHHHHH
Q 019040           81 CKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCE-GGELFDRIVARGHYTERAAAAVTR  159 (347)
Q Consensus        81 vK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~i~~  159 (347)
                      ++.+.++.+.....     .|+..+..  .+|+++.. .+-.+++.+.+.++.-+ +.++.. +   ..++....++++.
T Consensus        21 ~~~~~ks~ik~~~~-----~el~LL~~--~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~   88 (215)
T 4ann_A           21 MREIPKSSIKPEHF-----HLMYLLEQ--HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLL   88 (215)
T ss_dssp             EEEEEGGGSCGGGG-----GGGGGGGS--CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHH
T ss_pred             HHHhcHhhccccCH-----HHHHHHhc--cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHH
Confidence            44555555443322     15555554  67877765 46666777777666654 334433 2   2468889999999


Q ss_pred             HHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcccccccCccccccccccccCCCchhHHHH
Q 019040          160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA  239 (347)
Q Consensus       160 qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~sl  239 (347)
                      +|+....++  ..=+|=-++|+|+++   +.++.+++.-.|.-....+..                    ++...=+-..
T Consensus        89 ni~~l~~~~--~~r~tf~L~P~NL~f---~~~~~p~i~~RGik~~l~P~~--------------------~~ee~fL~qy  143 (215)
T 4ann_A           89 NIKNLEEVN--RTRYTFVLAPDELFF---TRDGLPIAKTRGLQNVVDPLP--------------------VSEAEFLTRY  143 (215)
T ss_dssp             HGGGGGGGG--GSSEECCCSGGGEEE---CTTSCEEESCCEETTTBSCCC--------------------CCHHHHHHHH
T ss_pred             HHHHHHHHh--cCceEEEEecceEEE---cCCCCEEEEEccCccCCCCCC--------------------CCHHHHHHHH
Confidence            998877443  445677899999999   788889998877644332211                    1112223345


Q ss_pred             HHHHHHHHhCCCCC
Q 019040          240 GVILYILLCGVPPF  253 (347)
Q Consensus       240 G~~l~~l~~g~~pf  253 (347)
                      =+++..++.++..|
T Consensus       144 KAliiall~~K~~F  157 (215)
T 4ann_A          144 KALVICAFNEKQSF  157 (215)
T ss_dssp             HHHHHHHHCTTCCH
T ss_pred             HHHHHHHHcCCCCH
Confidence            56777788887766

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	347
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-93
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-88
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-87
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-86
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-86
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-85
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-84
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-82
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-80
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-80
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-80
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-79
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-79
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-75
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-73
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-72
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-72
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-71
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-71
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-70
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-68
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-66
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-64
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-64
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-64
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-63
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-63
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-63
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-63
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-62
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-62
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-61
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-61
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-60
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-60
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-58
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-55
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-55
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-54
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-50
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-43
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-42
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18
d2pula1	392	d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {	6e-05

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  278 bits (711), Expect = 4e-93
 Identities = 112/296 (37%), Positives = 175/296 (59%), Gaps = 5/296 (1%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E+I D Y     LG G F    L  D+ T++L+A K I+K+ L        +  E+A++ 
Sbjct: 5   EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLH 62

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            + K+ +IV+L +  E    ++L+M+L  GGELFDRIV +G YTER A+ +   +++ V+
Sbjct: 63  KI-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 121

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  G++HRDLKPEN L+ +  E+S +   DFGLS    PG   S   G+P Y+APEVL
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181

Query: 227 K-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
             + Y   +D WS GVI YILLCG PPF+ E++  + + IL+   +F    W ++S+SAK
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKR 341
             +R ++E DP+ R T +Q L+HPW+     A +  +   V  ++K+    +++K+
Sbjct: 242 DFIRHLMEKDPEKRFTCEQALQHPWIAG-DTALDKNIHQSVSEQIKKNFAKSKWKQ 296

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  267 bits (683), Expect = 3e-88
 Identities = 99/334 (29%), Positives = 163/334 (48%), Gaps = 32/334 (9%)

Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           QP+ V  G    ++ D Y +  ELG G FGV + C+++ T  +   K I+       +D 
Sbjct: 18  QPVEVKQG----SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDK 70

Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAA 154
             V+ E++IM  L  +  +++L +A ED   + L++E   GGELFDRI A  +  +E   
Sbjct: 71  YTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV 129

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
               R   E ++  H+H ++H D+KPEN +    K+ S +K IDFGL+    P E     
Sbjct: 130 INYMRQACEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT 188

Query: 215 VGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK 273
             +  + APE++ R   G   D+W+ GV+ Y+LL G+ PF  E +    Q + R   +F 
Sbjct: 189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 248

Query: 274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN-------------------- 313
            D + +VS  AK  ++ +L+ +P+ RLT    LEHPWL+                     
Sbjct: 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 308

Query: 314 -AKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
             +K  + P       R+  FS + + + +  ++
Sbjct: 309 IKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQI 342

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  263 bits (674), Expect = 6e-87
 Identities = 88/271 (32%), Positives = 141/271 (52%), Gaps = 7/271 (2%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +  +++ D Y +  ELG G FGV +   +R T    A K +         D + VR+E+ 
Sbjct: 19  IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQ 75

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTRTIV 162
            M  L ++ ++V+L +A EDDN + ++ E   GGELF+++       +E  A    R + 
Sbjct: 76  TMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           + +   H++  +H DLKPEN +F  K  ++ LK IDFGL+    P +      G+  + A
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193

Query: 223 PEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           PEV + +  G   D+WS GV+ YILL G+ PF  E++    + +     +     +  +S
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           E  K  +R++L  DP  R+T  Q LEHPWL 
Sbjct: 254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  261 bits (669), Expect = 1e-86
 Identities = 81/302 (26%), Positives = 156/302 (51%), Gaps = 12/302 (3%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           + + ++Y++  +LGRGEFG+ + C++  +++    K +  +      D   V++E++I+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVV 165
              ++ +I+ L E+ E    + ++ E   G ++F+RI        ER   +    + E +
Sbjct: 57  IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
           Q  H H + H D++PEN ++  +  +S +K I+FG +   KPG+ F  +  +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 226 LKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            + +      D+WS G ++Y+LL G+ PF AE+ Q + + I+     F  + +  +S  A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKAL 344
              V ++L  + K R+TA + L+HPWL+   +  +  +       LK     +   +K L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV----IRTLKHRRYYHTLIKKDL 290

Query: 345 RV 346
            +
Sbjct: 291 NM 292

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (663), Expect = 4e-86
 Identities = 98/273 (35%), Positives = 151/273 (55%), Gaps = 6/273 (2%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL---RTAVDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+    R  V  +D+ REV
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 65  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183

Query: 222 APEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APE++     G E D+WS GVI YILL G  PF  +++Q     +     +F+ + + N 
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           S  AK  +R++L  DPK R+T +  L+HPW++ 
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  257 bits (658), Expect = 2e-85
 Identities = 91/275 (33%), Positives = 141/275 (51%), Gaps = 16/275 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD------VRREVAI 104
           + Y     LGRG   V   CI + T +  A K I      +    +         +EV I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           ++ +  + +I+ LK+  E +    LV +L + GELFD +  +   +E+    + R ++EV
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           +   HK  ++HRDLKPEN L     ++  +K  DFG S    PGE+  E+ G+P Y+APE
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179

Query: 225 VL-------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           ++          YG E+D+WS GVI+Y LL G PPFW   +  + + I+ G   F    W
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            + S++ K LV + L   P+ R TA++ L HP+ Q
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  252 bits (646), Expect = 6e-84
 Identities = 85/263 (32%), Positives = 139/263 (52%), Gaps = 10/263 (3%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL +
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 64

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  CH 
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RN 229
             VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ R 
Sbjct: 125 KRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 180

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           +  ++D+WS GV+ Y  L G PPF A + Q   + I R    F       V+E A+ L+ 
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLIS 236

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQ 312
           ++L+ +P  R   ++VLEHPW+ 
Sbjct: 237 RLLKHNPSQRPMLREVLEHPWIT 259

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  251 bits (641), Expect = 2e-82
 Identities = 75/304 (24%), Positives = 138/304 (45%), Gaps = 15/304 (4%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K++ E  +   RE+G G FG  Y   D    E++A K +S    ++     D+ +EV  +
Sbjct: 10  KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + L ++ + +  +     ++   LVME C G       V +    E   AAVT   ++ +
Sbjct: 70  QKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              H H +IHRD+K  N L +   E   +K  DFG +    P   F   VG+PY+MAPEV
Sbjct: 129 AYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEV 182

Query: 226 L----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           +    +  Y  ++D+WS G+    L    PP +  +       I +   +       + S
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWS 240

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKR 341
           E  ++ V   L+  P+ R T++ +L+H ++   +  P   + D+++        ++  + 
Sbjct: 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER--PPTVIMDLIQRTKDAVRELDNLQY 298

Query: 342 KALR 345
           + ++
Sbjct: 299 RKMK 302

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (630), Expect = 2e-80
 Identities = 100/291 (34%), Positives = 146/291 (50%), Gaps = 20/291 (6%)

Query: 44  VPKENIEDRY-LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           + K  I D Y +  + LG G  G      ++ T+E  A K +              RREV
Sbjct: 4   IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREV 55

Query: 103 AIMKHLPKNSSIVSLKEACED----DNAVHLVMELCEGGELFDRIVARGH--YTERAAAA 156
            +     +   IV + +  E+       + +VME  +GGELF RI  RG   +TER A+ 
Sbjct: 56  ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
           + ++I E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 175

Query: 217 SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ----GVAQAILRGLID 271
           +PYY+APEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235

Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           F    W  VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 286

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (625), Expect = 2e-80
 Identities = 79/294 (26%), Positives = 130/294 (44%), Gaps = 25/294 (8%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + +   + LG G F    L  +  T    A K + KR +     +  V RE  +
Sbjct: 2   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           M  L  +   V L    +DD  ++  +   + GEL   I   G + E      T  IV  
Sbjct: 62  MSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYM 221
           ++  H  G+IHRDLKPEN L     E+  ++  DFG +    P     R +  VG+  Y+
Sbjct: 121 LEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 222 APEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           +PE+L  ++     D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF        
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKF 233

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQ------VLEHPWLQN-------AKKAPNVP 321
              A+ LV ++L  D   RL  ++      +  HP+ ++        +  P + 
Sbjct: 234 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (623), Expect = 5e-80
 Identities = 77/280 (27%), Positives = 142/280 (50%), Gaps = 11/280 (3%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           V   + + +Y    ++G+G  G  Y  +D  T + +A + ++ ++       + +  E+ 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEIL 69

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R  ++
Sbjct: 70  VMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQ 127

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMA 222
            ++  H + VIHRD+K +N L      +  +K  DFG          + S +VG+PY+MA
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 223 PEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           PEV+ R  YGP++DIWS G++   ++ G PP+  E+       I        ++P   +S
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLS 243

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
              +  + + L+ D + R +AK++L+H +L+ AK   ++ 
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (620), Expect = 1e-79
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 16/279 (5%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N ED + +  ELG G FG  Y   +++T  L A K I  +      +++D   E+ I+  
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILAS 65

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQ 166
              + +IV L +A   +N + +++E C GG +   ++      TE     V +  ++ + 
Sbjct: 66  C-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEV 225
             H + +IHRDLK  N LF     +  +K  DFG+S    +  +R    +G+PY+MAPEV
Sbjct: 125 YLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181

Query: 226 L------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           +       R Y  + D+WS G+ L  +    PP    +   V   I +        P   
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SR 240

Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
            S + K  +++ LE +   R T  Q+L+HP++      P
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (615), Expect = 4e-79
 Identities = 75/271 (27%), Positives = 132/271 (48%), Gaps = 12/271 (4%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + + + + LG G +G   L ++R T E +A K +  ++     +  ++++E+ I K L  
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKML-N 61

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + ++V       + N  +L +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK 227
            G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE+LK
Sbjct: 122 IGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 228 RN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           R   +   +D+WS G++L  +L G  P+   S+     +  +    +  +PW  +  +  
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAPL 237

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           +L+ ++L  +P  R+T   + +  W     K
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWYNKPLK 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 5e-75
 Identities = 61/272 (22%), Positives = 115/272 (42%), Gaps = 15/272 (5%)

Query: 49  IEDRYL-VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            + R+L  D E+GRG F   Y  +D +T   +A   +  RKL T  +    + E  ++K 
Sbjct: 6   NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKG 64

Query: 108 LPKNSSIVSLKEACED----DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           L ++ +IV   ++ E        + LV EL   G L   +        +   +  R I++
Sbjct: 65  L-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123

Query: 164 VVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
            +Q  H     +IHRDLK +N           +K  D GL+   K       ++G+P +M
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATL-KRASFAKAVIGTPEFM 180

Query: 222 APEVLKRNYGPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGLIDFKRDPWPNV 280
           APE+ +  Y   +D+++ G+ +  +     P+   ++   + + +  G+           
Sbjct: 181 APEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVA 238

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
               K ++   +  +   R + K +L H + Q
Sbjct: 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 4e-73
 Identities = 64/266 (24%), Positives = 125/266 (46%), Gaps = 10/266 (3%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + +++ + LG+G FG  +L   + T +  A K++ K  +    D++    E  ++    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  +  +    +    +  VME   GG+L   I +   +    A      I+  +Q  H 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLK-R 228
            G+++RDLK +N L     ++  +K  DFG+      G+ + +   G+P Y+APE+L  +
Sbjct: 122 KGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178

Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            Y   +D WS GV+LY +L G  PF  + E+ +  +I      +       + + AK L+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDLL 234

Query: 289 RQMLEPDPKLRLTAK-QVLEHPWLQN 313
            ++   +P+ RL  +  + +HP  + 
Sbjct: 235 VKLFVREPEKRLGVRGDIRQHPLFRE 260

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 1e-72
 Identities = 66/324 (20%), Positives = 119/324 (36%), Gaps = 50/324 (15%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D +    ELG G  GV +    + +  ++A K I           + + RE+ ++    
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC- 61

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            +  IV    A   D  + + ME  +GG L   +   G   E+    V+  +++ +    
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121

Query: 170 -KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
            KH ++HRD+KP N L  ++ E   +K  DFG+S         +  VG+  YM+PE L+ 
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQG 177

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI----------------- 270
            +Y  + DIWS G+ L  +  G  P      + +       +                  
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 271 -----------------------DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                                     + P    S   +  V + L  +P  R   KQ++ 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

Query: 308 HPWLQNAKKAPNVPLGDVVRSRLK 331
           H +++ +     V     + S + 
Sbjct: 298 HAFIKRSDAEE-VDFAGWLCSTIG 320

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 2e-72
 Identities = 78/274 (28%), Positives = 127/274 (46%), Gaps = 21/274 (7%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + Y V   +G G +G       +   ++L  K +    + T  +   +  EV +++ L K
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-K 61

Query: 111 NSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEV 164
           + +IV   +   D  +  +++VME CEGG+L   I      R +  E     V   +   
Sbjct: 62  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121

Query: 165 VQLCHK-----HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS-EIVGSP 218
           ++ CH+     H V+HRDLKP N           +K  DFGL+        F+   VG+P
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKAFVGTP 178

Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           YYM+PE + R  Y  + DIWS G +LY L   +PPF A S++ +A  I  G     R   
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIP 235

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              S+    ++ +ML      R + +++LE+P +
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 3e-71
 Identities = 83/272 (30%), Positives = 132/272 (48%), Gaps = 20/272 (7%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRREVAIM 105
           +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +   V  EV ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 106 KHL-PKNSSIVSLKEACEDDNAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTRTIVE 163
           K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    ++E
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            V+ CH  GV+HRD+K EN L    +    LK IDFG     K    +++  G+  Y  P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPP 178

Query: 224 EVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           E +   R +G    +WS G++LY ++CG  PF  + E      I+RG + F+      VS
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVS 228

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
              + L+R  L   P  R T +++  HPW+Q+
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  219 bits (560), Expect = 9e-71
 Identities = 60/271 (22%), Positives = 112/271 (41%), Gaps = 7/271 (2%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ DRY +   LG G     +L  D      +A K +     R        RRE      
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63

Query: 108 LPKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           L  + +IV++ +  E +       ++VME  +G  L D +   G  T + A  V     +
Sbjct: 64  L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG-LSIFFKPGERFSEIVGSPYYMA 222
            +   H++G+IHRD+KP N + +       +       ++       + + ++G+  Y++
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 223 PEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           PE  +  +     D++S G +LY +L G PPF  +S   VA   +R            +S
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
               ++V + L  +P+ R      +    ++
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  221 bits (563), Expect = 4e-70
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 14/272 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + + V R +GRG FG  Y C   DT ++ A K + K++++          E  ++  +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 111 NSS--IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
                IV +  A    + +  +++L  GG+L   +   G ++E         I+  ++  
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR 228
           H   V++RDLKP N L     E+  ++  D GL+  F   +     VG+  YMAPEVL++
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQK 179

Query: 229 N--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
              Y    D +S G +L+ LL G  PF     +   + I R  +    +   + S   +S
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRS 238

Query: 287 LVRQMLEPDPKLRLT-----AKQVLEHPWLQN 313
           L+  +L+ D   RL      A++V E P+ ++
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  215 bits (548), Expect = 2e-68
 Identities = 70/271 (25%), Positives = 122/271 (45%), Gaps = 17/271 (6%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           ++D + + R LG G FG  +L   R      A K + K  +     ++    E  ++  +
Sbjct: 3   LQD-FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
             +  I+ +    +D   + ++M+  EGGELF  +     +    A      +   ++  
Sbjct: 62  -THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   +I+RDLKPEN L     +N  +K  DFG + +    +    + G+P Y+APEV+  
Sbjct: 121 HSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVST 175

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           + Y   ID WS G+++Y +L G  PF+  +     + IL   + F     P  +E  K L
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDL 231

Query: 288 VRQMLEPDPKLRL-----TAKQVLEHPWLQN 313
           + +++  D   RL       + V  HPW + 
Sbjct: 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 2e-66
 Identities = 80/270 (29%), Positives = 133/270 (49%), Gaps = 15/270 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + +   + LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-R 63

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  + +LK A +  + +  VME   GGELF  +     +TE  A      IV  ++  H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN 229
             V++RD+K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N
Sbjct: 124 RDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            YG  +D W  GV++Y ++CG  PF+ +  + + + IL   I F       +S  AKSL+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLL 236

Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN 313
             +L+ DPK RL      AK+V+EH +  +
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 2e-64
 Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 33/284 (11%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD--IDDVRREVAIMKHLPKNSSIVS 116
           LG G+F   Y   D++T +++A K I       A D       RE+ +++ L  + +I+ 
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIG 64

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L +A    + + LV +  E              T     A     ++ ++  H+H ++HR
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVLK--RNYGPE 233
           DLKP N L     EN  LK  DFGL+  F  P   ++  V + +Y APE+L   R YG  
Sbjct: 125 DLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP--------------- 278
           +D+W+ G IL  LL  VP    +S+      I   L     + WP               
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241

Query: 279 ---------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                       +    L++ +   +P  R+TA Q L+  +  N
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 3e-64
 Identities = 71/306 (23%), Positives = 124/306 (40%), Gaps = 48/306 (15%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
            +Y    ++G+G FG  +    R T + +A K +     +    I    RE+ I++ L K
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALREIKILQLL-K 67

Query: 111 NSSIVSLKEACED--------DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           + ++V+L E C            +++LV + CE             +T      V + ++
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFSEIVGS 217
             +   H++ ++HRD+K  N L      +  LK  DFGL+  F   +     R++  V +
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 218 PYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
            +Y  PE+L  +R+YGP ID+W AG I+  +    P     +EQ     I +       +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 276 PWPNV----------------------------SESAKSLVRQMLEPDPKLRLTAKQVLE 307
            WPNV                               A  L+ ++L  DP  R+ +   L 
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

Query: 308 HPWLQN 313
           H +  +
Sbjct: 305 HDFFWS 310

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 3e-64
 Identities = 74/334 (22%), Positives = 126/334 (37%), Gaps = 44/334 (13%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++  RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+  
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKILLR 62

Query: 108 LPKNSSIVSLKEACEDDNAVHL----VMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             ++ +I+ + +         +    ++    G +L+  +    H +          I+ 
Sbjct: 63  F-RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILR 120

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE----RFSEIVGSPY 219
            ++  H   V+HRDLKP N L         LK  DFGL+    P        +E V + +
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y APE++   + Y   IDIWS G IL  +L   P F  +        IL  L    ++  
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 278 ---------------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                                      PN    A  L+ +ML  +P  R+  +Q L HP+
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297

Query: 311 LQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKAL 344
           L+      + P+ +       +   + + K K L
Sbjct: 298 LEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 331

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-63
 Identities = 82/277 (29%), Positives = 138/277 (49%), Gaps = 17/277 (6%)

Query: 51  DRYLVDRELGRGEFGVTYLCID---RDTRELLACKSISKRKL-RTAVDIDDVRREVAIMK 106
           + + + + LG G +G  +L       DT +L A K + K  + + A   +  R E  +++
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           H+ ++  +V+L  A + +  +HL+++   GGELF  +  R  +TE         IV  ++
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP--GERFSEIVGSPYYMAPE 224
             HK G+I+RD+K EN L      N  +   DFGLS  F     ER  +  G+  YMAP+
Sbjct: 144 HLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 225 VLK---RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           +++     +   +D WS GV++Y LL G  PF  + E+     I R ++  +      +S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260

Query: 282 ESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQN 313
             AK L++++L  DPK RL      A ++ EH + Q 
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  201 bits (513), Expect = 4e-63
 Identities = 75/332 (22%), Positives = 136/332 (40%), Gaps = 52/332 (15%)

Query: 26  ARKEAGANKKQP---ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           AR     N  +P       + V +   +D Y + R+LGRG++   +  I+    E +  K
Sbjct: 7   ARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK 66

Query: 83  SISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELF 140
            +   K +       ++RE+ I+++L    +I++L +  +D       LV E     +  
Sbjct: 67  ILKPVKKK------KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK 120

Query: 141 DRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG 200
                    T+         I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+G
Sbjct: 121 QLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWG 175

Query: 201 LSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWA-ES 257
           L+ F+ PG+ ++  V S Y+  PE+L   + Y   +D+WS G +L  ++    PF+    
Sbjct: 176 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235

Query: 258 EQGVAQAILRGL---------------------------------IDFKRDPWPNVSESA 284
                  I + L                                      +    VS  A
Sbjct: 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA 295

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
              + ++L  D + RLTA++ +EHP+     K
Sbjct: 296 LDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 4e-63
 Identities = 79/314 (25%), Positives = 122/314 (38%), Gaps = 47/314 (14%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQI 66

Query: 105 MKHLPKNSSIVSLKEAC------EDDNAVHLVMELCEGG---ELFDRIVARGHYTERAAA 155
           M+ L  + +IV L+         +D+  ++LV++               A+         
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
                +   +   H  G+ HRD+KP+N L     + + LK  DFG +     GE     +
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 216 GSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL---- 269
            S YY APE++    +Y   ID+WSAG +L  LL G P F  +S       I++ L    
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 270 ---------------------IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
                                  + +   P     A +L  ++LE  P  RLT  +   H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303

Query: 309 PWLQNAKKAPNVPL 322
            +    +  PNV L
Sbjct: 304 SFFDELRD-PNVKL 316

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  200 bits (508), Expect = 7e-63
 Identities = 84/290 (28%), Positives = 123/290 (42%), Gaps = 34/290 (11%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y    ++G G +GV Y   +       A K I   K    +      RE++I+K L K
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETF-ALKKIRLEKEDEGI-PSTTIREISILKEL-K 58

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +S+IV L +       + LV E  +        V  G      A +    ++  +  CH 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVL--K 227
             V+HRDLKP+N L         LK  DFGL+  F  P  +++  + + +Y AP+VL   
Sbjct: 119 RRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-------- 279
           + Y   IDIWS G I   ++ G P F   SE      I R L       WPN        
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 280 -----------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                            + ES   L+ +ML+ DP  R+TAKQ LEH + +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 1e-62
 Identities = 55/268 (20%), Positives = 108/268 (40%), Gaps = 19/268 (7%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
            +  V + +G G FG  Y          +A K ++     T   +   + EV +++   +
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRKT-R 62

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCH 169
           + +I+           + +V + CEG  L+  + +    +       + R   + +   H
Sbjct: 63  HVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL 226
              +IHRDLK  N       E+  +K  DFGL+          +F ++ GS  +MAPEV+
Sbjct: 122 AKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 227 KRN----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP--WPNV 280
           +      Y  + D+++ G++LY L+ G  P+   + +     ++              N 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEH 308
            ++ K L+ + L+     R    Q+L  
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-62
 Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 37/300 (12%)

Query: 50  EDRYLVDRELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +Y    E+G G +G  +   D ++    +A K +  +     + +    REVA+++HL
Sbjct: 6   DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS-TIREVAVLRHL 64

Query: 109 PKNS--SIVSLKEAC-----EDDNAVHLVMELCEGGEL-FDRIVARGHYTERAAAAVTRT 160
                 ++V L + C     + +  + LV E  +     +   V            +   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           ++  +   H H V+HRDLKP+N L  +  +    K  DFGL+  +      + +V + +Y
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQI---KLADFGLARIYSFQMALTSVVVTLWY 181

Query: 221 MAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP- 278
            APEVL ++ Y   +D+WS G I   +    P F   S+      IL  +     + WP 
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241

Query: 279 ----------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                                 ++ E  K L+ + L  +P  R++A   L HP+ Q+ ++
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  197 bits (502), Expect = 3e-61
 Identities = 79/318 (24%), Positives = 137/318 (43%), Gaps = 25/318 (7%)

Query: 2   GNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGR 61
           GN   +     +E VK   +       +      Q    L         D++   + LG 
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL---------DQFDRIKTLGT 51

Query: 62  GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC 121
           G FG   L   +++    A K + K+K+     I+    E  I++ +     +V L+ + 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSF 110

Query: 122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPE 181
           +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDLKPE
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170

Query: 182 NFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAG 240
           N L         ++  DFG +   K   R   + G+P  +APE++  + Y   +D W+ G
Sbjct: 171 NLLIDQ---QGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKGYNKAVDWWALG 225

Query: 241 VILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           V++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D   R 
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLRNLLQVDLTKRF 281

Query: 301 -----TAKQVLEHPWLQN 313
                    +  H W   
Sbjct: 282 GNLKNGVNDIKNHKWFAT 299

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 3e-61
 Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 34/292 (11%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
            +Y    ++G G +G  +   +R+T E++A K +        V      RE+ ++K L K
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKEL-K 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +IV L +    D  + LV E C+           G        +    +++ +  CH 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--K 227
             V+HRDLKP+N L     E    K  +FGL+  F  P   +S  V + +Y  P+VL   
Sbjct: 120 RNVLHRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 228 RNYGPEIDIWSAGVILYILLCG-VPPFWAESEQGVAQAILRGLIDFKRDPW--------- 277
           + Y   ID+WSAG I   L     P F         + I R L     + W         
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 278 ----------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                           P ++ + + L++ +L+ +P  R++A++ L+HP+  +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 2e-60
 Identities = 82/302 (27%), Positives = 129/302 (42%), Gaps = 35/302 (11%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + +    ++G G +GV Y   ++ T E++A K I        V      RE++++K L  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV-PSTAIREISLLKEL-N 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCE-GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           + +IV L +    +N ++LV E      + F    A          +    +++ +  CH
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVLKR 228
            H V+HRDLKP+N L         +K  DFGL+  F  P   ++  V + +Y APE+L  
Sbjct: 120 SHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 229 N--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--------- 277
              Y   +DIWS G I   ++     F  +SE      I R L       W         
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 278 ----------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA-KKAPNV 320
                           P + E  +SL+ QML  DP  R++AK  L HP+ Q+  K  P++
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 296

Query: 321 PL 322
            L
Sbjct: 297 RL 298

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 3e-60
 Identities = 67/309 (21%), Positives = 123/309 (39%), Gaps = 44/309 (14%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +   Y   + +G G +G     +D  T   +A K +  R  ++ +      RE+ ++KH
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKH 73

Query: 108 LPKNSSIVSLKEACEDDNA------VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           + ++ +++ L +    D         +LVM     G    +++      E     +   +
Sbjct: 74  M-RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           ++ ++  H  G+IHRDLKP N       E+  LK +DFGL+         +  V + +Y 
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ--ADSEMTGYVVTRWYR 185

Query: 222 APEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW-- 277
           APEV+     Y   +DIWS G I+  ++ G   F         + I++       +    
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 278 -------------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                                     N S  A +L+ +ML  D + R+TA + L HP+ +
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305

Query: 313 NAKKAPNVP 321
           +     + P
Sbjct: 306 SLHDTEDEP 314

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  192 bits (489), Expect = 7e-60
 Identities = 49/281 (17%), Positives = 94/281 (33%), Gaps = 21/281 (7%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY + R++G G FG  YL  D    E +A K    +          +  E  I K +
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMM 59

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
                I +++    + +   +VMEL               ++ +    +   ++  ++  
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--------RFSEIVGSPYY 220
           H    IHRD+KP+NFL    K+ + +  IDFGL+  ++               + G+  Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 221 MAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP--- 276
            +             D+ S G +L     G  P+         Q   R        P   
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 277 -WPNVSESAKSLVRQMLEPDPKLRLTA---KQVLEHPWLQN 313
                     + +          +      +Q+  + + + 
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-58
 Identities = 60/280 (21%), Positives = 105/280 (37%), Gaps = 23/280 (8%)

Query: 51  DRYLV---DRELGRGEFGVTYLCIDRDTR--ELLACKSISKRKLRTAVDIDDVRREVAIM 105
           DR L+   D+ELG G FG       +  +  + +A K +       A+  D++  E  +M
Sbjct: 4   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-KDELLAEANVM 62

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + L  N  IV +   CE ++   LVME+ E G L   +    H  ++    +   +   +
Sbjct: 63  QQL-DNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF----SEIVGSPYYM 221
           +   +   +HRDL   N L          K  DFGLS   +  E +    +       + 
Sbjct: 121 KYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           APE +    +  + D+WS GV+++     G  P+       V   + +G    +      
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAG 234

Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQV---LEHPWLQNAKK 316
                  L+      D + R     V   L + +     +
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 1e-57
 Identities = 69/310 (22%), Positives = 122/310 (39%), Gaps = 40/310 (12%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            + +RY     +G G +G      D  T   +A K +S+   ++ +      RE+ ++KH
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKH 73

Query: 108 LPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           + K+ +++ L +      ++     + +     G   + IV     T+     +   I+ 
Sbjct: 74  M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 187

Query: 224 EVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-------- 273
           E++    +Y   +DIWS G I+  LL G   F         + ILR +            
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 274 -------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
                               + +   +  A  L+ +ML  D   R+TA Q L H +    
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

Query: 315 KKAPNVPLGD 324
               + P+ D
Sbjct: 308 HDPDDEPVAD 317

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 1e-57
 Identities = 56/263 (21%), Positives = 107/263 (40%), Gaps = 21/263 (7%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
               + + +G+GEFG   L   R  +  +A K I                E ++M  L +
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDA-----TAQAFLAEASVMTQL-R 58

Query: 111 NSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQL 167
           +S++V L     E+   +++V E    G L D + +RG            +  + E ++ 
Sbjct: 59  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK 227
              +  +HRDL   N L +   E++  K  DFGL+      +          + APE L+
Sbjct: 119 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALR 173

Query: 228 -RNYGPEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            + +  + D+WS G++L+ +   G  P+     + V   + +G   +K D       +  
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVY 230

Query: 286 SLVRQMLEPDPKLRLTAKQVLEH 308
            +++     D  +R +  Q+ E 
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLREQ 253

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-57
 Identities = 65/285 (22%), Positives = 108/285 (37%), Gaps = 25/285 (8%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE--LLACKSISKRKLRTAVDIDDVRRE 101
           + ++N+    + D ELG G FG     + R  ++   +A K + +   +   D +++ RE
Sbjct: 5   LKRDNLL---IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMRE 59

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRT 160
             IM  L  N  IV L   C+ +  + LVME+  GG L   +V  R        A +   
Sbjct: 60  AQIMHQL-DNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE----IVG 216
           +   ++   +   +HRDL   N L          K  DFGLS      + +         
Sbjct: 118 VSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 217 SPYYMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
              + APE +  R +    D+WS GV ++  L  G  P+       V   I +G    + 
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RM 231

Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQV---LEHPWLQNAKK 316
           +  P       +L+        + R     V   +   +   A K
Sbjct: 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 9e-57
 Identities = 59/292 (20%), Positives = 106/292 (36%), Gaps = 26/292 (8%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +       +G G FG       +     +       ++  +  D  D   E+ ++  L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRI----------------VARGHYTERAA 154
           + +I++L  ACE    ++L +E    G L D +                      + +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
                 +   +    +   IHRDL   N L     EN   K  DFGLS   +   + +  
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 215 VGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAILRGLIDF 272
                +MA E L  + Y    D+WS GV+L+ ++  G  P+   +   + + + +G   +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---Y 243

Query: 273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH--PWLQNAKKAPNVPL 322
           + +   N  +    L+RQ     P  R +  Q+L      L+  K   N  L
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTL 295

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-56
 Identities = 53/289 (18%), Positives = 100/289 (34%), Gaps = 36/289 (12%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD---IDDVRREVAIMKH 107
           +     + LG G FG           +      ++ + L+   D    + +  E+ +M  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH------------------- 148
           L  + +IV+L  AC     ++L+ E C  G+L + + ++                     
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 149 ----YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF 204
                T          + + ++       +HRDL   N L         +K  DFGL+  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARD 213

Query: 205 FKPGERFS---EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQ 259
                 +           +MAPE L    Y  + D+WS G++L+ I   GV P+      
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
                +++    FK D     +E    +++     D + R +   +   
Sbjct: 274 ANFYKLIQN--GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (464), Expect = 3e-56
 Identities = 61/284 (21%), Positives = 107/284 (37%), Gaps = 19/284 (6%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK-RKLRTAVDIDDVRREVAI 104
           KE       +++ +G GEFG       +   +     +I   +   T     D   E +I
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVE 163
           M     + +++ L+        V ++ E  E G L   +    G +T      + R I  
Sbjct: 81  MGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE------IVGS 217
            ++       +HRDL   N L      N   K  DFGLS F +                 
Sbjct: 140 GMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196

Query: 218 PYYMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
             + APE ++ R +    D+WS G++++ ++  G  P+W  + Q V  AI +   D++  
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLP 253

Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           P  +   +   L+    + D   R    Q++    L    + PN
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT--LDKMIRNPN 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-55
 Identities = 60/264 (22%), Positives = 104/264 (39%), Gaps = 19/264 (7%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
                 +ELG G+FGV      R   ++ A K I +  +      D+   E  +M +L  
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNL-S 57

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTRTIVEVVQLCH 169
           +  +V L   C     + ++ E    G L + +   R  +  +    + + + E ++   
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVLK 227
               +HRDL   N L     +   +K  DFGLS +    E            +  PEVL 
Sbjct: 118 SKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174

Query: 228 RN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESA 284
            + +  + DIW+ GV+++ I   G  P+   +    A+ I +GL    R   P   SE  
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----RLYRPHLASEKV 230

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEH 308
            +++          R T K +L +
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSN 254

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 1e-55
 Identities = 59/283 (20%), Positives = 111/283 (39%), Gaps = 24/283 (8%)

Query: 42  AGVPKENIE---DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV 98
            G+ K+  E   +   ++ +LG+G FG  ++     T  + A K++    +      +  
Sbjct: 5   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAF 59

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAA 156
            +E  +MK L ++  +V L     ++  +++V E    G L D +      +        
Sbjct: 60  LQEAQVMKKL-RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 117

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE--I 214
           +   I   +    +   +HRDL+  N L     EN   K  DFGL+   +  E  +    
Sbjct: 118 MAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGA 174

Query: 215 VGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDF 272
                + APE      +  + D+WS G++L  L   G  P+     + V   + RG   +
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---Y 231

Query: 273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE--HPWLQN 313
           +    P   ES   L+ Q    +P+ R T + +      +  +
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 2e-55
 Identities = 61/276 (22%), Positives = 98/276 (35%), Gaps = 19/276 (6%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E    +  +LG G FGV               +A K +    L     +DD  REV  M 
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVV 165
            L  + +++ L         + +V EL   G L DR+    GH+     +     + E +
Sbjct: 67  SL-DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE----RFSEIVGSPYYM 221
                   IHRDL   N L A       +K  DFGL       +              + 
Sbjct: 125 GYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 222 APEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           APE LK R +    D W  GV L+ +   G  P+   +   +   I +     +     +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--GERLPRPED 239

Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
             +   +++ Q     P+ R T   + +  +L  A+
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQ 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 7e-55
 Identities = 59/263 (22%), Positives = 106/263 (40%), Gaps = 17/263 (6%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
                 +E+G G+FG+ +L    +  ++ A K+I +  +      +D   E  +M  L  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKL-S 58

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCH 169
           +  +V L   C +   + LV E  E G L D +  +   +       +   + E +    
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGSPYYMAPEVLK 227
           +  VIHRDL   N L     EN  +K  DFG++ F    +    +       + +PEV  
Sbjct: 119 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 228 RN-YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            + Y  + D+WS GV+++ +   G  P+   S   V + I  G   F+       S    
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVY 232

Query: 286 SLVRQMLEPDPKLRLTAKQVLEH 308
            ++    +  P+ R    ++L  
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQ 255

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 8e-55
 Identities = 68/320 (21%), Positives = 116/320 (36%), Gaps = 53/320 (16%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +  RY   + +G G  G+     D      +A K +S+   +         RE+ +MK 
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72

Query: 108 LPKNSSIVSLKEAC------EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           +  + +I+SL          E+   V+LVMEL +          +        + +   +
Sbjct: 73  V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQM 128

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           +  ++  H  G+IHRDLKP N      K +  LK +DFGL+         +  V + YY 
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNI---VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185

Query: 222 APE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL----------- 269
           APE +L   Y   +DIWS G I+  ++     F           ++  L           
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 270 -----------IDFKRDPWPN----------------VSESAKSLVRQMLEPDPKLRLTA 302
                        +    +P                  +  A+ L+ +ML  DP  R++ 
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 303 KQVLEHPWLQNAKKAPNVPL 322
              L+HP++        V  
Sbjct: 306 DDALQHPYINVWYDPAEVEA 325

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 2e-54
 Identities = 57/263 (21%), Positives = 104/263 (39%), Gaps = 19/263 (7%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +   +   LG G+FG  ++       ++ A KS+ +  +      D    E  +MK L +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQL-Q 66

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLC 168
           +  +V L      +  ++++ E  E G L D +        T      +   I E +   
Sbjct: 67  HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE--IVGSPYYMAPEVL 226
            +   IHRDL+  N L ++       K  DFGL+   +  E  +         + APE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182

Query: 227 KRN-YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
               +  + D+WS G++L  ++  G  P+   +   V Q + RG   ++     N  E  
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEEL 239

Query: 285 KSLVRQMLEPDPKLRLTAKQVLE 307
             L+R   +  P+ R T   +  
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRS 262

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  176 bits (447), Expect = 9e-54
 Identities = 49/274 (17%), Positives = 93/274 (33%), Gaps = 20/274 (7%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +   Y V R +G G FGV +   +    + +A K   +R      D   +R E    K L
Sbjct: 3   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLL 57

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
              + I ++    ++     LV++L          +    ++ +  A   + ++  VQ  
Sbjct: 58  AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117

Query: 169 HKHGVIHRDLKPENFLFANK--KENSPLKAIDFGLSIFFKPGE--------RFSEIVGSP 218
           H+  +++RD+KP+NFL      K  + +  +DFG+  F++               + G+ 
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 219 YYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP- 276
            YM+      R      D+ + G +    L G  P+         Q   R     +  P 
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 277 ---WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                   E     +                +  
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  173 bits (439), Expect = 1e-52
 Identities = 55/277 (19%), Positives = 110/277 (39%), Gaps = 17/277 (6%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
               +  +LG G++G  Y  + +     +A K++ +  +    ++++  +E A+MK + K
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-K 71

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY--TERAAAAVTRTIVEVVQLC 168
           + ++V L   C  +   +++ E    G L D +        +      +   I   ++  
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVL 226
            K   IHRDL   N L     EN  +K  DFGLS           +       + APE L
Sbjct: 132 EKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188

Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
             N +  + D+W+ GV+L+ +       +   +      +L    D++ +      E   
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--DYRMERPEGCPEKVY 246

Query: 286 SLVRQMLEPDPKLRLTAKQVLE--HPWLQNAKKAPNV 320
            L+R   + +P  R +  ++ +      Q +  +  V
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 2e-52
 Identities = 59/264 (22%), Positives = 102/264 (38%), Gaps = 14/264 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI-SKRKLRTAVDIDDVRREVAIMKHLP 109
           +R  + R +G G+FG  +  I           +I + +   +    +   +E   M+   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF- 65

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLC 168
            +  IV L     ++  V ++MELC  GEL   +  R       +       +   +   
Sbjct: 66  DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVL 226
                +HRD+   N L ++      +K  DFGLS + +     + S+      +MAPE +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 227 K-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
             R +    D+W  GV ++ IL+ GV PF       V   I  G    +    PN   + 
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTL 238

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEH 308
            SL+ +    DP  R    ++   
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQ 262

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-50
 Identities = 48/266 (18%), Positives = 92/266 (34%), Gaps = 14/266 (5%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK--RKLRTAVDIDDVRREVAIMKH 107
           E  +   + LG G FG  Y  +     E +      K  R+  +     ++  E  +M  
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           +  N  +  L   C       +   +  G  L      + +   +        I + +  
Sbjct: 68  V-DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
                ++HRDL   N L    K    +K  DFGL+      E+            +MA E
Sbjct: 127 LEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 225 VLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
            +  R Y  + D+WS GV ++ L+  G  P+       ++  + +G    +    P  + 
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICTI 240

Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEH 308
               ++ +    D   R   ++++  
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRELIIE 266

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 4e-50
 Identities = 57/283 (20%), Positives = 104/283 (36%), Gaps = 30/283 (10%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRE-------LLACKSISKRKLRTAVDIDDVRREVA 103
           DR ++ + LG G FG   L       +        +A K +         D+ D+  E+ 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI----------------VARG 147
           +MK + K+ +I++L  AC  D  +++++E    G L + +                    
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 148 HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
             + +   +    +   ++       IHRDL   N L                       
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 208 GERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAI 265
            ++ +       +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 266 LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
             G    + D   N +     ++R      P  R T KQ++E 
Sbjct: 251 KEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 6e-49
 Identities = 55/285 (19%), Positives = 100/285 (35%), Gaps = 35/285 (12%)

Query: 51  DRYLVDRELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +R    + LG G FG          I  D    +A K +      T  + + +  E+ ++
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----------------- 148
            +L  + +IV+L  AC       ++ E C  G+L + +  +                   
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 149 -YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
                   + +  + + +        IHRDL   N L          K  DFGL+   K 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLARDIKN 197

Query: 208 GERF---SEIVGSPYYMAPEVLKRNY-GPEIDIWSAGVILYILLC-GVPPFWAESEQGVA 262
              +           +MAPE +       E D+WS G+ L+ L   G  P+         
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
             +++    F+     +       +++   + DP  R T KQ+++
Sbjct: 258 YKMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (404), Expect = 3e-47
 Identities = 59/295 (20%), Positives = 106/295 (35%), Gaps = 43/295 (14%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           E   +     R++G G FG  +       +  +   ++A K + +    +A    D +RE
Sbjct: 9   EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQRE 66

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY------------ 149
            A+M     N +IV L   C     + L+ E    G+L + + +   +            
Sbjct: 67  AALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 150 ------------TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI 197
                       +      + R +   +    +   +HRDL   N L     EN  +K  
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIA 182

Query: 198 DFGLSIFFKPGERF---SEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLC-GVPP 252
           DFGLS      + +           +M PE +  N Y  E D+W+ GV+L+ +   G+ P
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242

Query: 253 FWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           ++  + + V   +  G I        N      +L+R      P  R +   +  
Sbjct: 243 YYGMAHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 5e-47
 Identities = 56/278 (20%), Positives = 112/278 (40%), Gaps = 25/278 (8%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRD---TRELLACKSISKRKLRTAVDIDDVRR 100
           +   ++   +  +  +GRG FG  Y     D    +   A KS+   ++    ++     
Sbjct: 22  IGPSSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLT 77

Query: 101 EVAIMKHLPKNSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVT 158
           E  IMK    + +++SL   C   + +  +V+   + G+L + I    H  T +      
Sbjct: 78  EGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 136

Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE----- 213
             + + ++       +HRDL   N +     E   +K  DFGL+      E  S      
Sbjct: 137 LQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTG 193

Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLID 271
                 +MA E L+   +  + D+WS GV+L+ L+  G PP+   +   +   +L+G   
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--- 250

Query: 272 FKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
            +R   P    +    ++ +   P  ++R +  +++  
Sbjct: 251 -RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 3e-45
 Identities = 58/280 (20%), Positives = 105/280 (37%), Gaps = 22/280 (7%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRE----LLACKSISKRKLRTAVDIDDVRREVAIMK 106
                 + +G GEFG  Y  + + +       +A K++      T     D   E  IM 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMG 64

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVV 165
               + +I+ L+        + ++ E  E G L   +  + G ++      + R I   +
Sbjct: 65  QF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYM 221
           +       +HRDL   N L  +       K  DFGLS   +         S       + 
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 222 APEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           APE +  R +    D+WS G++++ ++  G  P+W  S   V +AI  G   F+     +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMD 237

Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
              +   L+ Q  + +   R     ++    L    +AP+
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSI--LDKLIRAPD 275

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 5e-45
 Identities = 55/278 (19%), Positives = 114/278 (41%), Gaps = 29/278 (10%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTR-----ELLACKSISKRKLRTAVDIDDVRREVAIM 105
           ++  + RELG+G FG+ Y  + +          +A K++++       +  +   E ++M
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----------YTERAAA 155
           K       +V L           ++MEL   G+L   + +              +     
Sbjct: 78  KEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFS 212
            +   I + +   + +  +HRDL   N + A   E+  +K  DFG++      +   +  
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 213 EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI 270
           + +    +M+PE LK   +    D+WS GV+L+ I      P+   S + V + ++ G +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253

Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
               D   N  +    L+R   + +PK+R +  +++  
Sbjct: 254 ---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 3e-44
 Identities = 60/300 (20%), Positives = 108/300 (36%), Gaps = 51/300 (17%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I    ++   +G+G FG  +    +   E +A K  S R+ R+         E+     L
Sbjct: 1   IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWF----REAEIYQTVML 54

Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERA-------AAAV 157
            ++ +I+    A   DN     + LV +  E G LFD +       E         A+ +
Sbjct: 55  -RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 113

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFS 212
               +E+V    K  + HRDLK +N L    K+N      D GL++             +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPN 170

Query: 213 EIVGSPYYMAPEVLKRN-------YGPEIDIWSAGVILYILLCGVPPFWAESEQG----- 260
             VG+  YMAPEVL  +            DI++ G++ + +           +       
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230

Query: 261 ------VAQAILRGLIDFKRDP-------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                   + + + + + K  P                 ++R+    +   RLTA ++ +
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 5e-43
 Identities = 57/283 (20%), Positives = 111/283 (39%), Gaps = 30/283 (10%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 108 LPKNSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY----------------T 150
           +  + ++V+L  AC +    + +++E C+ G L   + ++ +                 T
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE- 209
                  +  + + ++       IHRDL   N L     E + +K  DFGL+        
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPD 189

Query: 210 --RFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
             R  +      +MAPE +    Y  + D+WS GV+L+ +       +   +  + +   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--IDEEFC 247

Query: 267 RGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
           R L +  R   P   +      +      +P  R T  +++EH
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  149 bits (377), Expect = 1e-42
 Identities = 63/335 (18%), Positives = 118/335 (35%), Gaps = 66/335 (19%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL--- 108
           RY++ R+LG G F   +L  D      +A K +   K+ T    +    E+ +++ +   
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 69

Query: 109 -------PKNSSIVSLKEACED--DNAVHLVMELCEGG---ELFDRIVARGHYTERAAAA 156
                     + I+ L +       N VH+VM     G       +              
Sbjct: 70  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129

Query: 157 VTRTIVEVVQ-LCHKHGVIHRDLKPENFLFANKKENSPLKAI-DFGLSIFFKPGERFSEI 214
           +++ ++  +  +  + G+IH D+KPEN L         L  I    L       E ++  
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189

Query: 215 VGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV------------ 261
           + +  Y +PEVL    +G   DIWS   +++ L+ G   F  +                 
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 262 ---------------------AQAILRGLIDFKRDPW-----------PNVSESAKSLVR 289
                                ++ +LR +   K  P             + ++     + 
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD 324
            ML+ DP+ R  A  ++ HPWL++      + + D
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 344

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 80.6 bits (198), Expect = 1e-18
 Identities = 42/202 (20%), Positives = 69/202 (34%), Gaps = 25/202 (12%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACK-----SISKRKLRTAVDIDDVR-REVAIMKHL 108
           + + +G G+    + C      E    K       S +K++   D  D+    +AI    
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGEC-VVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62

Query: 109 PKNSSIVSLKEACE----DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
            +  ++  L+              ++MEL +  E                  V   I+E 
Sbjct: 63  NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMILEE 115

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           V   +  G++H DL   N L + +     +  IDF  S+     E + EI+         
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQSVEVGE-EGWREILERDVRNIIT 170

Query: 225 VLKRNYGPEIDIWSAGVILYIL 246
              R Y  E DI S   I  IL
Sbjct: 171 YFSRTYRTEKDINS--AIDRIL 190

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

 Score = 42.1 bits (98), Expect = 6e-05
 Identities = 23/168 (13%), Positives = 50/168 (29%), Gaps = 4/168 (2%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACK----SISKRKLRTAVDIDDVRREVAIM 105
               L  +E+G G     +   D++    L  K              + ID  R E + +
Sbjct: 25  SKSTLTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSAL 84

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
               ++   +  +    D      VME     ++  + +  G      +  +   + + +
Sbjct: 85  IRQGEHVPHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTL 144

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
                + +  +  K     F N +     + + F    F      F E
Sbjct: 145 FYSSDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDTNDFEE 192

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	347
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.78
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.46
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.24
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.84
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.26
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.91

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.5e-62  Score=433.81  Aligned_cols=283  Identities=39%  Similarity=0.724  Sum_probs=231.7

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      .+.+.++|++++.||+|+||+||+|+++.+|+.||||++.+.....  ....+.+|+.+++.+ +||||+++++++.+++
T Consensus         4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKI-KHPNIVALDDIYESGG   80 (307)
T ss_dssp             CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred             CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECC
Confidence            3567789999999999999999999999999999999997654332  235688999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++...++++.+||+|||+|...
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999999999998888999999999999999999999999999999999999976667889999999999877


Q ss_pred             CCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          206 KPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      ..........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+......++.+.++.+++++
T Consensus       161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  240 (307)
T d1a06a_         161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA  240 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence            66666666789999999999875 48999999999999999999999999999989999998888877777778899999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCChHHHHHHhhh
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQ  332 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~  332 (347)
                      .+||.+||+.||++|||+.|+++||||+...... ..+...+.+++++
T Consensus       241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~-~~~~~~~~~~~~~  287 (307)
T d1a06a_         241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD-KNIHQSVSEQIKK  287 (307)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCC-CCCHHHHHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHhcCHhhCCCCccc-cccchhHHHHHHH
Confidence            9999999999999999999999999998654332 3344444444444

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-61  Score=421.11  Aligned_cols=254  Identities=32%  Similarity=0.592  Sum_probs=231.5

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+++++.+ +||||+++++++.+++..|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEE
Confidence            6799999999999999999999999999999999876655566678899999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      |||+++++|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|...... .
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~-~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS-R  160 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCC-C
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCC-c
Confidence            9999999999999988899999999999999999999999999999999999999   67788999999999876543 3


Q ss_pred             ccccccCcccccccccccc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .....||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+....+.+....++    ..+++++.+||.
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  236 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS  236 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHH
Confidence            3456899999999998754 89999999999999999999999999998888888877655433    368999999999


Q ss_pred             HhccCCCCCCCCHHHHhcCccccc
Q 019040          290 QMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       290 ~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                      +||+.||++|||+.|+|+||||..
T Consensus       237 ~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHccCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-60  Score=418.79  Aligned_cols=258  Identities=29%  Similarity=0.496  Sum_probs=225.7

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||++....   ....+.+.+|+.+++.+ +||||+++++++.+++.+|
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc---ChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEE
Confidence            4568999999999999999999999999999999987653   23456799999999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||||++|++|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|......
T Consensus        94 ivmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred             EEEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccc
Confidence            999999999999887654 79999999999999999999999999999999999999   66788999999999876543


Q ss_pred             C-cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHH
Q 019040          209 E-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (347)
Q Consensus       209 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (347)
                      . ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+..... .....+..+++++.+
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~  248 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRD  248 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCCSSGGGSCHHHHH
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCCCcccCCHHHHH
Confidence            3 3455679999999998875 489999999999999999999999998887776666554422 122333578999999


Q ss_pred             HHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       287 li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      ||.+||+.||++|||+.|+|+||||+...
T Consensus       249 li~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         249 FLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence            99999999999999999999999998654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-60  Score=420.95  Aligned_cols=269  Identities=36%  Similarity=0.651  Sum_probs=240.8

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc---hhcHHHHHHHHHHHHhCCCCCceeEeeeEE
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~  121 (347)
                      ...++.++|++++.||+|+||+||+|+++.+|+.||||++.+.....   ....+.+.+|+.+++++ +||||+++++++
T Consensus         4 ~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~   82 (293)
T d1jksa_           4 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVY   82 (293)
T ss_dssp             BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             cCCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEE
Confidence            34567889999999999999999999999999999999997654322   23467899999999999 999999999999


Q ss_pred             eeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC-CCCCEEEEeec
Q 019040          122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFG  200 (347)
Q Consensus       122 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~-~~~~~~l~Dfg  200 (347)
                      .+.+..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ ....+||+|||
T Consensus        83 ~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          83 ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999999999998888899999999999999999999999999999999999996433 23469999999


Q ss_pred             cccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      +|.............+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+......++...++.
T Consensus       163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (293)
T d1jksa_         163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  242 (293)
T ss_dssp             TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence            9998776666667789999999999875 499999999999999999999999999999998888888776666555568


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ++.++.+||.+||+.||++|||+.++|+||||+..
T Consensus       243 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            89999999999999999999999999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.3e-60  Score=428.25  Aligned_cols=271  Identities=33%  Similarity=0.611  Sum_probs=243.0

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ..+.++|++++.||+|+||+||+|+++.+|+.||||++....   ......+.+|+.+++.+ +||||+++++++.+++.
T Consensus        25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYE  100 (352)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSE
T ss_pred             CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE
Confidence            345678999999999999999999999999999999986542   33456788999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      +|+||||++|++|.+.+.... ++++..++.++.||+.||.|||++||+||||||+|||++. ..++.+||+|||+|...
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceec
Confidence            999999999999998876654 6999999999999999999999999999999999999953 24678999999999988


Q ss_pred             CCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          206 KPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       206 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      ..........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++...+..+++++
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  259 (352)
T d1koba_         180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  259 (352)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            77666666789999999998865 49999999999999999999999999999999999999988888877788999999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCC
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL  322 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~  322 (347)
                      .+||.+||+.||.+|||+.++|+||||+.........+
T Consensus       260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~~~~~  297 (352)
T d1koba_         260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI  297 (352)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCCCCB
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhCCCcchhcccC
Confidence            99999999999999999999999999987765554444

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-60  Score=418.52  Aligned_cols=260  Identities=30%  Similarity=0.507  Sum_probs=230.7

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      ....++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++++++ +||||+++++++.+++.
T Consensus         4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~   82 (288)
T d1uu3a_           4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEK   82 (288)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSE
T ss_pred             CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCE
Confidence            33447899999999999999999999999999999999876655566678899999999999 99999999999999999


Q ss_pred             EEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      +|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   ++++.+||+|||+|....
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecc
Confidence            99999999999999999988899999999999999999999999999999999999999   677889999999998764


Q ss_pred             CCC---cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCH
Q 019040          207 PGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       207 ~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      ...   ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+.+....++    ..+++
T Consensus       160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~  235 (288)
T d1uu3a_         160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFP  235 (288)
T ss_dssp             ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCH
T ss_pred             cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCH
Confidence            332   2344679999999999864 489999999999999999999999999998888888887765443    37899


Q ss_pred             HHHHHHHHhccCCCCCCCCHHH------HhcCcccccC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQ------VLEHPWLQNA  314 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~------ll~h~~~~~~  314 (347)
                      ++.+||.+||+.||++|||+.|      +++||||+..
T Consensus       236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             HHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            9999999999999999999987      5889999765

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-60  Score=418.08  Aligned_cols=259  Identities=28%  Similarity=0.515  Sum_probs=218.2

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++......  ...+.+.+|+++++++ +||||+++++++.+++..|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML-NHENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeE
Confidence            346899999999999999999999999999999999765322  2345688999999999 9999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      +||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   ++++.+||+|||+|......
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccC
Confidence            999999999999999887789999999999999999999999999999999999999   66788999999999875433


Q ss_pred             C---cccccccCcccccccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          209 E---RFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       209 ~---~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      .   ......||+.|+|||++.+.  ++.++||||||+++|+|++|..||................. .....+..++++
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~  235 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLNPWKKIDSA  235 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-TTSTTGGGSCHH
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCccccCCHH
Confidence            2   23456799999999988643  46789999999999999999999977654433222222222 223334578999


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +.+||.+||+.||++|||+.++|+||||++.
T Consensus       236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         236 PLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            9999999999999999999999999999754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.9e-60  Score=426.65  Aligned_cols=265  Identities=33%  Similarity=0.612  Sum_probs=238.7

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ...+.++|++++.||+|+||+||+|+++.+|+.||||++....   ....+.+.+|+.+++++ +||||+++++++.+++
T Consensus        21 ~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~   96 (350)
T d1koaa2          21 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDN   96 (350)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETT
T ss_pred             CCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECC
Confidence            3456689999999999999999999999999999999986542   33457789999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          126 AVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      .+|+||||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||+|..
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchhee
Confidence            99999999999999999854 456999999999999999999999999999999999999953 2357899999999998


Q ss_pred             cCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          205 FKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       205 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                      ...........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+......++...+..++++
T Consensus       176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  255 (350)
T d1koaa2         176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  255 (350)
T ss_dssp             CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred             cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            776666667789999999999865 4899999999999999999999999999999999999888777766666789999


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +.+||.+||+.||++|||+.++|+||||+...
T Consensus       256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999999998764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.6e-59  Score=409.35  Aligned_cols=263  Identities=35%  Similarity=0.645  Sum_probs=238.2

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccch------hcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA------VDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      +.++|++.+.||+|+||+||+|+++.+|+.||||++.+......      ...+.+.+|+.+++++..||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            45799999999999999999999999999999999976543321      223468899999999966999999999999


Q ss_pred             eCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          123 DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       123 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      +++..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a  157 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFS  157 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchhe
Confidence            999999999999999999999998899999999999999999999999999999999999999   67888999999999


Q ss_pred             cccCCCCcccccccCccccccccccc-------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC
Q 019040          203 IFFKPGERFSEIVGSPYYMAPEVLKR-------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD  275 (347)
Q Consensus       203 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  275 (347)
                      .............||+.|+|||.+.+       .++.++||||+|+++|+|++|..||.+.+.......+..+...++.+
T Consensus       158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (277)
T d1phka_         158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  237 (277)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            98776666666789999999998742       36889999999999999999999999999999888888887777777


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      .++.+++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus       238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            777899999999999999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-59  Score=407.00  Aligned_cols=256  Identities=23%  Similarity=0.399  Sum_probs=219.0

Q ss_pred             ccce-eeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee----C
Q 019040           50 EDRY-LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----D  124 (347)
Q Consensus        50 ~~~y-~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~----~  124 (347)
                      .++| ++.+.||+|+||+||+|+++.+++.||+|.+..... .....+.+.+|+++++++ +||||+++++++..    .
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSC
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccC
Confidence            4556 678899999999999999999999999999876543 334467799999999999 89999999999865    4


Q ss_pred             CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      ..+|+||||+++++|.+++.+...+++..+..++.||+.||.|||++|  |+||||||+|||++  ++++.+||+|||+|
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred             CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcc
Confidence            568999999999999999998888999999999999999999999999  99999999999994  34678999999999


Q ss_pred             cccCCCCcccccccCccccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccccccCCCCCCCC
Q 019040          203 IFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       203 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ..... .......||+.|+|||++.+.++.++||||||+++|+|++|..||...... ...+.+..+...  .......+
T Consensus       163 ~~~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~  239 (270)
T d1t4ha_         163 TLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAI  239 (270)
T ss_dssp             GGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCC
T ss_pred             eeccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC--cccCccCC
Confidence            86433 333456899999999999888999999999999999999999999765543 444555443321  22224678


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  312 (347)
                      +++.+||.+||+.||++|||+.|+|+||||+
T Consensus       240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-59  Score=416.80  Aligned_cols=259  Identities=27%  Similarity=0.424  Sum_probs=229.4

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      +...+|++++.||+|+||+||+|+++.+|+.||||++...........+.+.+|+.+++++ +||||+++++++.+++..
T Consensus        12 dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   90 (309)
T d1u5ra_          12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTA   90 (309)
T ss_dssp             CHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEE
T ss_pred             CcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEE
Confidence            3456799999999999999999999999999999999876665666677899999999999 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |+||||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.....
T Consensus        91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS
T ss_pred             EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCC
Confidence            9999999999998777777889999999999999999999999999999999999999   5678899999999986543


Q ss_pred             CCcccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHH
Q 019040          208 GERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (347)
                         .....||+.|+|||++.    +.|+.++||||||+++|+|++|..||.+.........+........  ....++++
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~  242 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEY  242 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTSCHH
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCCCHH
Confidence               23457999999999874    3488999999999999999999999999888877777766543322  23468999


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       284 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +.+||.+||+.||++|||+.++|+||||.+..
T Consensus       243 ~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            99999999999999999999999999998653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=416.58  Aligned_cols=256  Identities=31%  Similarity=0.543  Sum_probs=233.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||.|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccc
Confidence            6899999999999999999999999999999999877665566678899999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC-CC
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~-~~  209 (347)
                      |||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|..... ..
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCCc
Confidence            9999999999999998899999999999999999999999999999999999999   6778999999999987543 33


Q ss_pred             cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                      .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+.......+......++    ..+++++.+||
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli  236 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Confidence            4456789999999999864 599999999999999999999999999999888888887765443    47899999999


Q ss_pred             HHhccCCCCCCCC-----HHHHhcCcccccC
Q 019040          289 RQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       289 ~~~l~~dp~~Rps-----~~~ll~h~~~~~~  314 (347)
                      .+||++||.+|++     +.++++||||+..
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HhhccCCchhhcccccccHHHHHcCcccccC
Confidence            9999999999995     8999999999764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-59  Score=411.68  Aligned_cols=257  Identities=29%  Similarity=0.467  Sum_probs=223.9

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .+.|++++.||+|+||+||+|+++.+|+.||+|++...   .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEE
Confidence            45799999999999999999999999999999998654   233456788999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ||||++|++|.+++.+. +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|......
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCC
Confidence            99999999999987654 569999999999999999999999999999999999999   67788999999999754322


Q ss_pred             -CcccccccCcccccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          209 -ERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       209 -~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                       .......||+.|+|||++.      ..++.++||||||+++|+|++|..||.+.+..+....+....... ...+..++
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s  242 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWS  242 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-CSSGGGSC
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-CCccccCC
Confidence             1234567999999999873      337899999999999999999999999988888877777654322 22234789


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +++.+||.+||+.||++|||+.++|+||||+..
T Consensus       243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999999754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=404.58  Aligned_cols=254  Identities=29%  Similarity=0.498  Sum_probs=212.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee--CCeE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DNAV  127 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~--~~~~  127 (347)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++...... ....+.+.+|+++++++ +||||+++++++.+  .+.+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEE
Confidence            36799999999999999999999999999999999765443 34467799999999999 99999999999864  4678


Q ss_pred             EEEEEecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----cEeeCCCCCcEEeecCCCCCCEEEEe
Q 019040          128 HLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHG-----VIHRDLKPENFLFANKKENSPLKAID  198 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dikp~NIli~~~~~~~~~~l~D  198 (347)
                      |+||||+++++|.+++.+    ...+++..++.++.||+.||.|||++|     |+||||||+|||+   +.++.+||+|
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~D  157 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGD  157 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEee
Confidence            999999999999999864    356999999999999999999999987     9999999999999   6778899999


Q ss_pred             eccccccCCCC-cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCC
Q 019040          199 FGLSIFFKPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP  276 (347)
Q Consensus       199 fg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  276 (347)
                      ||+|....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+..+....   .
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---~  234 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---I  234 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---C
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---C
Confidence            99998765443 2345689999999999864 58999999999999999999999999999888888877664432   2


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  311 (347)
                      ...+++++.+||.+||+.||++|||+.|+|+|||+
T Consensus       235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            34789999999999999999999999999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.1e-58  Score=410.17  Aligned_cols=254  Identities=27%  Similarity=0.529  Sum_probs=231.9

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeE
Confidence            5799999999999999999999999999999999876655556678899999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      |||++|++|...+.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|......  
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc--
Confidence            9999999999999998899999999999999999999999999999999999999   67888999999999876543  


Q ss_pred             ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+......++    +.+++++.++|.
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  233 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS  233 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            345689999999999875 499999999999999999999999999999888888887755443    478999999999


Q ss_pred             HhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          290 QMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       290 ~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      +||+.||.+|+     |+.++++||||++.
T Consensus       234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            99999999996     99999999999874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=414.83  Aligned_cols=264  Identities=29%  Similarity=0.618  Sum_probs=237.0

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .+.++|++++.||+|+||+||+|+++.+++.||+|++....    .....+.+|+++++.+ +||||+++++++.+.+.+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIA-RHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEE
Confidence            35689999999999999999999999999999999997543    2335688999999999 999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      |+||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. +....++|+|||++....
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccc
Confidence            99999999999999997765 6999999999999999999999999999999999999954 244689999999998876


Q ss_pred             CCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          207 PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      .........+|+.|+|||.+.+ .++.++||||||+++|+|++|..||...+..+....+.+....++...++.+++++.
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence            6666666789999999998764 589999999999999999999999999999999999988877776666678999999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                      +||.+||+.||++|||+.++++||||++....
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~~~  267 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQHPWLKQKIER  267 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhccCccc
Confidence            99999999999999999999999999865443

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-58  Score=416.45  Aligned_cols=261  Identities=23%  Similarity=0.357  Sum_probs=217.6

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ...++|++++.||+|+||+||+|+++.+|+.||+|++....  .......+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~   79 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEI   79 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEE
Confidence            34688999999999999999999999999999999987543  233456789999999999 999999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      |+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++ ||+||||||+|||+   +.++.+||+|||+|....
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHH
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccC
Confidence            99999999999999999888899999999999999999999975 99999999999999   677889999999998654


Q ss_pred             CCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------------
Q 019040          207 PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG-----------------  268 (347)
Q Consensus       207 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-----------------  268 (347)
                      .. .....+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+...........                 
T Consensus       157 ~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         157 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             HH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             CC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence            32 2345689999999999864 5999999999999999999999999776543221110000                 


Q ss_pred             ---------------------cccc--cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          269 ---------------------LIDF--KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       269 ---------------------~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                           ....  +.......+.++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                                 0000  0011123678999999999999999999999999999998754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-57  Score=412.40  Aligned_cols=254  Identities=28%  Similarity=0.515  Sum_probs=231.5

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccccccccc
Confidence            7899999999999999999999999999999999876655556678899999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      +||+.|++|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|......  
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc--
Confidence            9999999999999988899999999999999999999999999999999999999   67788999999999876543  


Q ss_pred             ccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHH
Q 019040          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (347)
Q Consensus       211 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (347)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......+    +..+++++.+||.
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~  270 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLR  270 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTCCHHHHHHHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC----CccCCHHHHHHHH
Confidence            344689999999998865 49999999999999999999999999999888888887775443    3478999999999


Q ss_pred             HhccCCCCCCC-----CHHHHhcCcccccC
Q 019040          290 QMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (347)
Q Consensus       290 ~~l~~dp~~Rp-----s~~~ll~h~~~~~~  314 (347)
                      .||+.||.+|+     |+.++++||||+..
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHhhhCHHhccccccccHHHHHcCccccCC
Confidence            99999999995     99999999999764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-58  Score=412.38  Aligned_cols=271  Identities=36%  Similarity=0.661  Sum_probs=226.1

Q ss_pred             CCCCCcccceeeee-eecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           44 VPKENIEDRYLVDR-ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        44 ~~~~~~~~~y~i~~-~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      .....+-++|++.. .||+|+||+||+|+++.+++.||||++...        ..+.+|+.++.++.+||||+++++++.
T Consensus         4 ~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~   75 (335)
T d2ozaa1           4 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYE   75 (335)
T ss_dssp             CBCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             CCCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            34556678999876 599999999999999999999999998532        457789998776658999999999987


Q ss_pred             e----CCeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEE
Q 019040          123 D----DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (347)
Q Consensus       123 ~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l  196 (347)
                      +    .+.+|+|||||+||+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||
T Consensus        76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl  155 (335)
T d2ozaa1          76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL  155 (335)
T ss_dssp             EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred             ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccc
Confidence            6    47799999999999999999875  35999999999999999999999999999999999999986667788999


Q ss_pred             EeeccccccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----cc
Q 019040          197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL----ID  271 (347)
Q Consensus       197 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----~~  271 (347)
                      +|||+|.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+....    ..
T Consensus       156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~  235 (335)
T d2ozaa1         156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  235 (335)
T ss_dssp             CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred             cccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence            99999988776666667789999999999875 49999999999999999999999998776554444433322    23


Q ss_pred             ccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCCCC
Q 019040          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL  322 (347)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~  322 (347)
                      ++.+.+..+++++.+||.+||+.||++|||+.++++||||++....+..++
T Consensus       236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~  286 (335)
T d2ozaa1         236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL  286 (335)
T ss_dssp             CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCEE
T ss_pred             CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCCc
Confidence            333334468999999999999999999999999999999987766655544

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-57  Score=404.62  Aligned_cols=256  Identities=25%  Similarity=0.472  Sum_probs=228.8

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHH-hCCCCCceeEeeeEEeeCCeEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK-HLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~-~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+...........+..|..++. .+ +||||+++++++.+++..|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCceeE
Confidence            57999999999999999999999999999999998765555556677777887766 56 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      ||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence            99999999999999998899999999999999999999999999999999999999   677889999999998654433


Q ss_pred             -cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHH
Q 019040          210 -RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (347)
Q Consensus       210 -~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (347)
                       ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++    ..+++++.+|
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dl  233 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDL  233 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHH
Confidence             3344689999999998864 599999999999999999999999999999888888877654433    3689999999


Q ss_pred             HHHhccCCCCCCCCHH-HHhcCcccccC
Q 019040          288 VRQMLEPDPKLRLTAK-QVLEHPWLQNA  314 (347)
Q Consensus       288 i~~~l~~dp~~Rps~~-~ll~h~~~~~~  314 (347)
                      |.+||+.||++|||+. ++++||||++.
T Consensus       234 i~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         234 LVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            9999999999999996 89999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9e-57  Score=409.51  Aligned_cols=258  Identities=28%  Similarity=0.447  Sum_probs=220.5

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHH---HHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE---VAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e---i~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|   +++++.+ +||||+++++++.+.+.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence            679999999999999999999999999999999976554444444444444   6666677 899999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      |+||||++|++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence            9999999999999999988889999999999999999999999999999999999999   6778899999999987654


Q ss_pred             CCcccccccCcccccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          208 GERFSEIVGSPYYMAPEVLK-R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      . ......||+.|+|||++. + .++.++|||||||++|+|++|..||.......... +.+.....+...+..+++++.
T Consensus       160 ~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~  237 (364)
T d1omwa3         160 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELR  237 (364)
T ss_dssp             S-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSSCHHHH
T ss_pred             C-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCCCHHHH
Confidence            3 334568999999999875 3 48999999999999999999999998765443322 333333344444557999999


Q ss_pred             HHHHHhccCCCCCCCC-----HHHHhcCcccccC
Q 019040          286 SLVRQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps-----~~~ll~h~~~~~~  314 (347)
                      +||.+||+.||++|||     +.++++||||+..
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            9999999999999999     7999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=397.90  Aligned_cols=259  Identities=27%  Similarity=0.383  Sum_probs=216.6

Q ss_pred             eeeeecccCCeEEEEEEECCCCceeEEeEeccccccch--hcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEE
Q 019040           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA--VDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (347)
                      .++.||+|+||+||+|+++.+|+.||||++........  .....+.+|+.+++.+ +||||+++++++.+++..|+|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhh
Confidence            46789999999999999999999999999875533221  1235688999999999 99999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-cc
Q 019040          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RF  211 (347)
Q Consensus       133 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-~~  211 (347)
                      |+.++++..+......+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|....... ..
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcccc
Confidence            99887776666556679999999999999999999999999999999999999   677889999999998764433 33


Q ss_pred             cccccCcccccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCC-------------
Q 019040          212 SEIVGSPYYMAPEVLK-R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP-------------  276 (347)
Q Consensus       212 ~~~~~~~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------  276 (347)
                      ....||+.|+|||++. . .++.++||||||+++|+|++|..||.+.+..+.+..+.+.........             
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            4567999999999875 3 479999999999999999999999999998888877766543222111             


Q ss_pred             -----------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          277 -----------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       277 -----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                 ++.+++++.+||.+||+.||++|||+.|+|+||||++...+
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence                       12568899999999999999999999999999999987643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=389.55  Aligned_cols=261  Identities=30%  Similarity=0.463  Sum_probs=218.1

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+++++++ +||||+++++++.+.+.+|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEE
Confidence            589999999999999999999999999999999965532 233457889999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          131 MELCEGGELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      |||+.+ ++..++..  ...+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||.|......
T Consensus        80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCC
T ss_pred             EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCC
Confidence            999966 55455543  3459999999999999999999999999999999999999   67788999999999876543


Q ss_pred             -CcccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCC---------
Q 019040          209 -ERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP---------  276 (347)
Q Consensus       209 -~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  276 (347)
                       .......||+.|+|||.+.  ..++.++||||||+++|+|++|..||.+.+.......+...........         
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence             3344568999999999765  3368899999999999999999999999888777766654332211111         


Q ss_pred             ----------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          277 ----------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       277 ----------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                      ...+++++.+||.+||+.||++|||+.|+|+||||++...+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence                            12567899999999999999999999999999999988655

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-56  Score=389.66  Aligned_cols=254  Identities=32%  Similarity=0.544  Sum_probs=215.8

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchh---cHHHHHHHHHHHHhCC-CCCceeEeeeEEeeC
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV---DIDDVRREVAIMKHLP-KNSSIVSLKEACEDD  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~ei~~l~~l~-~h~~i~~~~~~~~~~  124 (347)
                      +.++|++.+.||+|+||+||+|+++.+|+.||||++.+.......   ...++.+|+.+++++. .||||+++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            568999999999999999999999999999999999765443221   2234668999999984 389999999999999


Q ss_pred             CeEEEEEEecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      +..++||||+.+ +++.+++.....+++..++.++.||+.||.|||++||+||||||+|||++  .+++.+||+|||+|.
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGA  159 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCE
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccce
Confidence            999999999976 58888888888899999999999999999999999999999999999995  245679999999998


Q ss_pred             ccCCCCcccccccCcccccccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      .... .......||+.|+|||++.+.  ++.++||||||+++|+|++|..||...+      .+.+....+    ...++
T Consensus       160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~----~~~~s  228 (273)
T d1xwsa_         160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF----RQRVS  228 (273)
T ss_dssp             ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC----SSCCC
T ss_pred             eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCC----CCCCC
Confidence            6543 334556899999999987643  4678999999999999999999996532      233443332    24789


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                      +++.+||.+||+.||++|||+.|+++||||++..
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            9999999999999999999999999999998763

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-55  Score=388.45  Aligned_cols=262  Identities=24%  Similarity=0.384  Sum_probs=222.7

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC-
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-  125 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~-  125 (347)
                      ..+.++|++.+.||+|+||+||+|+++.+|+.||||++.++..........+.+|+++++.+ +||||+++++++...+ 
T Consensus         3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECS
T ss_pred             cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccC
Confidence            45678999999999999999999999999999999999877666666677899999999999 9999999999987653 


Q ss_pred             ---eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          126 ---AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       126 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                         .+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||.+
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIA  158 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTC
T ss_pred             CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhh
Confidence               489999999999999999888899999999999999999999999999999999999999   56778999999988


Q ss_pred             cccCCCC----cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC
Q 019040          203 IFFKPGE----RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       203 ~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  277 (347)
                      .......    ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.......+...+
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  238 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence            7543322    2344579999999999875 4899999999999999999999999999988888777777666555566


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  312 (347)
                      +.+|+++.++|.+||+.||++||+..+.+.|+|++
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            78999999999999999999999655555676654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-54  Score=383.09  Aligned_cols=257  Identities=32%  Similarity=0.459  Sum_probs=216.8

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||+|+||+||+|+++ +|+.||||++..... .......+.+|+.+++++ +||||+++++++..++..+++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEE
Confidence            68999999999999999999996 789999999976543 233457899999999999 899999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC-
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~-  209 (347)
                      +|++.++.+..+....+.+++..+..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||.+....... 
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc
Confidence            9999877666666666779999999999999999999999999999999999999   677889999999998765432 


Q ss_pred             cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCC------------
Q 019040          210 RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD------------  275 (347)
Q Consensus       210 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------  275 (347)
                      ......+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+..+....+..........            
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            2344578999999998753  47899999999999999999999999988877777765433322111            


Q ss_pred             -------------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 019040          276 -------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (347)
Q Consensus       276 -------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  313 (347)
                                   ....+++++.+||++||+.||++|||+.|+|+||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                         12357889999999999999999999999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=386.45  Aligned_cols=262  Identities=25%  Similarity=0.396  Sum_probs=216.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCC-CceeEEeEeccccccchhcHHHHHHHHHHHHhCC--CCCceeEeeeEEee---
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACED---  123 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~--~h~~i~~~~~~~~~---  123 (347)
                      .++|++++.||+|+||+||+|++..+ ++.||||++........ ....+.+|+.+++.|.  +||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            57999999999999999999999765 67799999876533222 2234556777766652  79999999999853   


Q ss_pred             --CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeec
Q 019040          124 --DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (347)
Q Consensus       124 --~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg  200 (347)
                        ....++++||++++.+....... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence              35789999999887665444333 458999999999999999999999999999999999999   677889999999


Q ss_pred             cccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC-----
Q 019040          201 LSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----  274 (347)
Q Consensus       201 ~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  274 (347)
                      ++.............||+.|+|||++. ..|+.++||||||+++|+|++|..||.+.+..+....+.........     
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            998766555666778999999999875 55999999999999999999999999999988877777553321111     


Q ss_pred             ------------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          275 ------------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       275 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                        ..+..+++.+.+||.+||+.||++|||+.|+|+||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                              12246789999999999999999999999999999999874

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-53  Score=379.14  Aligned_cols=260  Identities=26%  Similarity=0.429  Sum_probs=216.6

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee------
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED------  123 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~------  123 (347)
                      -++|++++.||+|+||+||+|+++.+|+.||||++...... ......+.+|+.+++.+ +|+|++++++++..      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLL-KHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHh-cCCCccceEeeeeccccccc
Confidence            48999999999999999999999999999999998765433 33456788999999999 89999999998754      


Q ss_pred             --CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          124 --DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       124 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                        .+..+++|||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~  163 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGL  163 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecce
Confidence              45689999999876665554555679999999999999999999999999999999999999   6778899999999


Q ss_pred             ccccCCCC-----cccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC
Q 019040          202 SIFFKPGE-----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR  274 (347)
Q Consensus       202 a~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  274 (347)
                      +.......     ......||+.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+.......+.+....+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            97654322     2233579999999998753  4899999999999999999999999999988888887776655544


Q ss_pred             CCCCC----------------------------CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          275 DPWPN----------------------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       275 ~~~~~----------------------------~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      ..+..                            .++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            33322                            36678899999999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-53  Score=376.26  Aligned_cols=256  Identities=20%  Similarity=0.307  Sum_probs=215.9

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ++...++|++.+.||+|+||+||+|+++.+++.||||++..+.    ...+.+.+|+++++++ +||||+++++++.+++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~   86 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREP   86 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhC-CCCCEecCCccEeeCC
Confidence            4455678999999999999999999999999999999986542    3456799999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          126 AVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      ..++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSR  163 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTT
T ss_pred             eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEcccccee
Confidence            999999999999999999765  458999999999999999999999999999999999999   667889999999998


Q ss_pred             ccCCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhccccccCCCCCC
Q 019040          204 FFKPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPF-WAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       204 ~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      .......  .....|++.|+|||++. +.++.++||||||+++|+|++|..|| ...+.......+..+   ...+.+..
T Consensus       164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~---~~~~~~~~  240 (287)
T d1opja_         164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---YRMERPEG  240 (287)
T ss_dssp             TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT---CCCCCCTT
T ss_pred             ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC---CCCCCCcc
Confidence            7644332  23345889999999876 55999999999999999999966655 455555554444443   23334457


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +++++.+||.+||+.||++|||+.++++  +|+..
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence            8999999999999999999999999965  45544

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-53  Score=379.08  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=206.1

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCc---eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      +...++|++.+.||+|+||+||+|.++.+++   .||||.+....  .....+.+.+|+++++++ +||||+++++++..
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~   98 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTK   98 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhC-CCCCCccEEEEEee
Confidence            3345789999999999999999999987764   57888775432  334456799999999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          124 DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       124 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      .+..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla  175 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLS  175 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC---
T ss_pred             CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccc
Confidence            99999999999999999988775 458999999999999999999999999999999999999   67889999999999


Q ss_pred             cccCCCCcc------cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccC
Q 019040          203 IFFKPGERF------SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKR  274 (347)
Q Consensus       203 ~~~~~~~~~------~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  274 (347)
                      .........      ....+|+.|+|||.+. +.++.++||||||+++|||++ |..||.+....+....+..+..   .
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~---~  252 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR---L  252 (299)
T ss_dssp             --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---C
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---C
Confidence            865433221      1235789999999876 459999999999999999998 8999999998888877766532   3


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +....+++++.+||.+||+.||++|||+.+++++
T Consensus       253 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         253 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            3345789999999999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=375.11  Aligned_cols=253  Identities=23%  Similarity=0.399  Sum_probs=206.6

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      +...++|.+.+.||+|+||+||+|+++.   .||||++..... .....+.+.+|+.+++++ +||||+++++++.. +.
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~-~~   77 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA-PQ   77 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSC-CTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SS
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec-cE
Confidence            3446789999999999999999997643   499999865533 334567899999999999 99999999998754 56


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .++||||+++++|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|...
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC-
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeec
Confidence            88999999999999999765 459999999999999999999999999999999999999   66788999999999765


Q ss_pred             CCCC---cccccccCcccccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hccccc-cCCC
Q 019040          206 KPGE---RFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL-RGLIDF-KRDP  276 (347)
Q Consensus       206 ~~~~---~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~-~~~~  276 (347)
                      ....   ......||+.|+|||++.    +.++.++||||||+++|||++|..||.+.+......... ++.... ....
T Consensus       155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~  234 (276)
T d1uwha_         155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV  234 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred             cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence            4322   234567999999999874    237889999999999999999999998877655444443 332221 1223


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ...+++++.+||.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            45789999999999999999999999999987

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=380.96  Aligned_cols=262  Identities=28%  Similarity=0.402  Sum_probs=214.8

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee-
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-  123 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~-  123 (347)
                      |.....-+|+.++.||+|+||+||+|+++.+|+.||||++..+..       ...+|+.+++++ +|+||+++++++.. 
T Consensus        14 p~~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l-~h~niv~~~~~~~~~   85 (350)
T d1q5ka_          14 PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKL-DHCNIVRLRYFFYSS   85 (350)
T ss_dssp             SCCCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHC-CCTTBCCEEEEEEEC
T ss_pred             CCCcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhc-CCCCCCcEEEEEEec
Confidence            333334579999999999999999999999999999999865432       123699999999 99999999999853 


Q ss_pred             -----CCeEEEEEEecCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEE
Q 019040          124 -----DNAVHLVMELCEGGELFDRI---VARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (347)
Q Consensus       124 -----~~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~  195 (347)
                           ..++++||||++++.+....   .....+++..++.++.||+.||+|||++||+||||||+|||++.  +...+|
T Consensus        86 ~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~--~~~~~k  163 (350)
T d1q5ka_          86 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLK  163 (350)
T ss_dssp             --CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TTCCEE
T ss_pred             CccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec--CCCcee
Confidence                 34689999999765333222   33456999999999999999999999999999999999999942  334799


Q ss_pred             EEeeccccccCCCCcccccccCcccccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-
Q 019040          196 AIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF-  272 (347)
Q Consensus       196 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-  272 (347)
                      |+|||++.............|++.|+|||.+.  ..++.++||||||+++|+|++|..||...+..+.+..+.+..... 
T Consensus       164 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~  243 (350)
T d1q5ka_         164 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT  243 (350)
T ss_dssp             ECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCCh
Confidence            99999998877666666778999999999764  358999999999999999999999999988877776665432110 


Q ss_pred             ------------------------cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcC
Q 019040          273 ------------------------KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (347)
Q Consensus       273 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  316 (347)
                                              ........++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence                                    00112357899999999999999999999999999999988754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-53  Score=382.88  Aligned_cols=259  Identities=25%  Similarity=0.423  Sum_probs=213.9

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC--
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN--  125 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~--  125 (347)
                      .+.++|++++.||+|+||+||+|.++.+|+.||||++.+.. ......+.+.+|+++++.+ +|||++++++++...+  
T Consensus        15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred             ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccc
Confidence            36789999999999999999999999999999999997543 3444567889999999999 9999999999997654  


Q ss_pred             ----eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecc
Q 019040          126 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (347)
Q Consensus       126 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~  201 (347)
                          .+|+||||+ +.+|..+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||+
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGL  167 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             cccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccc
Confidence                579999999 6677776654 579999999999999999999999999999999999999   6788899999999


Q ss_pred             ccccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-------
Q 019040          202 SIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF-------  272 (347)
Q Consensus       202 a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------  272 (347)
                      |.....  ......+|+.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+.......+.......       
T Consensus       168 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         168 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             eeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            987543  3345689999999998753  47899999999999999999999999888776655544322211       


Q ss_pred             ----------------cC----CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          273 ----------------KR----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       273 ----------------~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                      ..    .....+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                            11    12246789999999999999999999999999999998764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-53  Score=369.70  Aligned_cols=247  Identities=24%  Similarity=0.375  Sum_probs=203.8

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (347)
                      .++|++++.||+|+||+||+|.++ ++..||||++....    ...+.+.+|+++++++ +||||+++++++..++..++
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~l   77 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICL   77 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----CcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEE
Confidence            368999999999999999999986 56779999986532    2346789999999999 99999999999999999999


Q ss_pred             EEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCC
Q 019040          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (347)
Q Consensus       130 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~  208 (347)
                      ||||+++++|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+   ++++.+||+|||++......
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC--------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCC
Confidence            99999999999998765 458999999999999999999999999999999999999   67788999999999866443


Q ss_pred             Cc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHH
Q 019040          209 ER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (347)
Q Consensus       209 ~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (347)
                      ..  .....||+.|+|||++. +.++.++||||||+++|||++ |.+||...........+..+...   .....+++++
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---~~p~~~~~~l  231 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---YKPRLASTHV  231 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC---CCCTTSCHHH
T ss_pred             CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHHH
Confidence            32  23357899999999886 459999999999999999999 57777777777777777665332   2234679999


Q ss_pred             HHHHHHhccCCCCCCCCHHHHhcC
Q 019040          285 KSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       285 ~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .++|..||+.||++|||+.++++|
T Consensus       232 ~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         232 YQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=373.47  Aligned_cols=247  Identities=22%  Similarity=0.345  Sum_probs=207.0

Q ss_pred             eeecccCCeEEEEEEEC--CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEEEEec
Q 019040           57 RELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (347)
Q Consensus        57 ~~lg~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (347)
                      +.||+|+||+||+|.+.  .+++.||||++.... ......+.+.+|+.+++++ +||||+++++++..+ ..++||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~-~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESS-SEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccC-CEEEEEEcC
Confidence            46999999999999864  456789999986543 2334457899999999999 999999999998654 578999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCcc---
Q 019040          135 EGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---  211 (347)
Q Consensus       135 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~~---  211 (347)
                      ++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.........   
T Consensus        90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccccc
Confidence            999999999998889999999999999999999999999999999999999   56778999999999865443221   


Q ss_pred             -cccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHHHHH
Q 019040          212 -SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (347)
Q Consensus       212 -~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (347)
                       ....||+.|+|||.+. +.++.++||||||+++|||++ |..||.+.+..+....+.++.   +.+....+|+++.+||
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~---~~~~p~~~~~~~~~li  243 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAGCPREMYDLM  243 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTTCCHHHHHHH
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC---CCCCCcccCHHHHHHH
Confidence             2346899999999876 558999999999999999997 899999998888777776653   2233357899999999


Q ss_pred             HHhccCCCCCCCCHHHH---hcCcccc
Q 019040          289 RQMLEPDPKLRLTAKQV---LEHPWLQ  312 (347)
Q Consensus       289 ~~~l~~dp~~Rps~~~l---l~h~~~~  312 (347)
                      ..||+.||++|||+.++   |+|+|++
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            99999999999999998   4666653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=382.13  Aligned_cols=254  Identities=20%  Similarity=0.295  Sum_probs=212.6

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCc-----eeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEe
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRE-----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~  122 (347)
                      .-.++|++.+.||+|+||+||+|++..+++     .||+|.+....  .......+.+|+.++.++.+||||+++++++.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            345789999999999999999999876554     58999886543  23345678899999999878999999999999


Q ss_pred             eCCeEEEEEEecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCC
Q 019040          123 DDNAVHLVMELCEGGELFDRIVARG-----------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK  179 (347)
Q Consensus       123 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dik  179 (347)
                      +.+..++||||+++|+|.+++....                       .+++..+..++.||+.||.|||++||+|||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK  191 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  191 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence            9999999999999999999997642                       37889999999999999999999999999999


Q ss_pred             CCcEEeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCC
Q 019040          180 PENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFW  254 (347)
Q Consensus       180 p~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~  254 (347)
                      |+||++   +.++.+||+|||+|+.......   .....||+.|+|||++. +.++.++||||||+++|||++ |..||.
T Consensus       192 p~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         192 ARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             GGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             hhcccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            999999   5678899999999986544332   23456799999999876 559999999999999999997 899998


Q ss_pred             CCCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          255 AESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +......+..+......  .+.+..+++++.+||.+||+.||++|||+.+|++|
T Consensus       269 ~~~~~~~~~~~~~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFK--MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TCCCSHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCC--CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            87766666555554333  33345789999999999999999999999999876

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=370.22  Aligned_cols=260  Identities=27%  Similarity=0.472  Sum_probs=219.6

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||+|+||+||+|+++.+++.||||++.... .......++.+|+.+++.+ +||||+++++++.+....+++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEE
Confidence            68999999999999999999999999999999996554 2344567899999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCCc
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~~  210 (347)
                      ++++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||.+........
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence            9999999998888888889999999999999999999999999999999999999   6677899999999987654433


Q ss_pred             -ccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcccccc-------------
Q 019040          211 -FSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGLIDFK-------------  273 (347)
Q Consensus       211 -~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~-------------  273 (347)
                       .....+++.|+|||.+..  .++.++||||||+++|+|++|..||. +.+..+....+........             
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence             334467788999998753  37899999999999999999998864 4444455554433222111             


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          274 ------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       274 ------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                  ......+++.+.+||.+||+.||.+|||+.|+|+||||++.-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                        111235788999999999999999999999999999998753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-53  Score=365.85  Aligned_cols=246  Identities=23%  Similarity=0.342  Sum_probs=215.9

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ++|++++.||+|+||+||+|+++ +++.||||++.+...    ..+.+.+|+.+++++ +||||+++++++.+++.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Confidence            68999999999999999999985 778899999875432    346789999999999 999999999999999999999


Q ss_pred             EEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |||+++++|..++... ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.......
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSS
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCC
Confidence            9999999999987654 568999999999999999999999999999999999999   678899999999997654433


Q ss_pred             c--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCCHHHH
Q 019040          210 R--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (347)
Q Consensus       210 ~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (347)
                      .  .....+|+.|+|||.+. ..++.++||||||+++|||++ |+.||...+..+....+..+..   ...+..+++++.
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~~~~l~  231 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---LYRPHLASEKVY  231 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---CCCCTTCCHHHH
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC---CCCcccccHHHH
Confidence            2  23356899999999886 458999999999999999998 8999999998888888876543   233357899999


Q ss_pred             HHHHHhccCCCCCCCCHHHHhcC
Q 019040          286 SLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       286 ~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +||.+||+.||++|||+.++++|
T Consensus       232 ~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         232 TIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1e-52  Score=378.85  Aligned_cols=255  Identities=27%  Similarity=0.502  Sum_probs=212.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee--CCeE
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DNAV  127 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~--~~~~  127 (347)
                      .++|++++.||.|+||+||+|+++.+|+.||||++...      ..+++.+|+.+++.+.+||||+++++++..  ....
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            47899999999999999999999999999999998542      346788999999999679999999999874  4679


Q ss_pred             EEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      ++||||+++++|....   +.+++..++.++.||+.||.|||++||+||||||+|||++  .++..++|+|||+|.....
T Consensus       108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCT
T ss_pred             eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccC
Confidence            9999999999986643   4699999999999999999999999999999999999995  2344699999999988776


Q ss_pred             CCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccc--------------
Q 019040          208 GERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLI--------------  270 (347)
Q Consensus       208 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~--------------  270 (347)
                      ........+|+.|+|||.+.+  .++.++||||+|++++++++|..||...... .....+.....              
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            666677789999999998653  4899999999999999999999999765533 22222211100              


Q ss_pred             -------------------cccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          271 -------------------DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       271 -------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                         .........+++++.+||++||+.||++|||+.|+|+||||+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                               001111234788999999999999999999999999999998764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=380.32  Aligned_cols=263  Identities=26%  Similarity=0.428  Sum_probs=213.6

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC--
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN--  125 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~--  125 (347)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+.+|+.+++.+ +|||++++++++....  
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIE   81 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTT
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeecccc
Confidence            34578999999999999999999999999999999986533  344456788999999999 9999999999987653  


Q ss_pred             --eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          126 --AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       126 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                        ..+++++++.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        82 ~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          82 QMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLAR  157 (345)
T ss_dssp             TCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred             ccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCcee
Confidence              233444556689999999765 79999999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCCC----cccccccCcccccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-----
Q 019040          204 FFKPGE----RFSEIVGSPYYMAPEVLK-R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF-----  272 (347)
Q Consensus       204 ~~~~~~----~~~~~~~~~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----  272 (347)
                      ......    ......||+.|+|||++. + .++.++||||+|+++|+|++|..||.+.+..+............     
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            654332    234457999999999874 3 47899999999999999999999998887765554443322111     


Q ss_pred             ---------------cC-------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCC
Q 019040          273 ---------------KR-------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (347)
Q Consensus       273 ---------------~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  317 (347)
                                     +.       ..++.+++++.+||.+||+.||++|||+.++|+||||+.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                           00       1124678899999999999999999999999999999977654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-53  Score=370.52  Aligned_cols=255  Identities=22%  Similarity=0.308  Sum_probs=214.3

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .++...++|++.+.||+|+||+||+|.++ ++..||||++....    ...+.+.+|+.+++++ +||||+++++++.+ 
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-   79 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-   79 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhC-CCCCEeEEEeeecc-
Confidence            34445679999999999999999999986 56789999986532    2346799999999999 99999999998755 


Q ss_pred             CeEEEEEEecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          125 NAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                      +..++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||+|
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla  156 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLA  156 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTC
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccce
Confidence            5678999999999999877543  358999999999999999999999999999999999999   67889999999999


Q ss_pred             cccCCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccccccCCCCC
Q 019040          203 IFFKPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCG-VPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (347)
Q Consensus       203 ~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  278 (347)
                      ........  .....||+.|+|||++. +.++.++||||||+++|||+|| .+||......+....+..+..   .....
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~---~~~p~  233 (272)
T d1qpca_         157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---MVRPD  233 (272)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCT
T ss_pred             EEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---CCCcc
Confidence            87654432  23457889999999876 4599999999999999999995 566677777777777766532   22334


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCHHHHhc--Ccccc
Q 019040          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLE--HPWLQ  312 (347)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~~~  312 (347)
                      .+++++.+||.+||+.||++|||+.++++  |+||.
T Consensus       234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            78999999999999999999999999988  77774

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=371.63  Aligned_cols=252  Identities=25%  Similarity=0.340  Sum_probs=212.9

Q ss_pred             cceeeeee-ecccCCeEEEEEEECC--CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           51 DRYLVDRE-LGRGEFGVTYLCIDRD--TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        51 ~~y~i~~~-lg~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      ++|.+.+. ||+|+||+||+|.++.  ++..||||++....  .....+.+.+|+++++++ +||||+++++++.. +.+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeE
Confidence            56788874 9999999999998764  44579999986542  344567899999999999 99999999999865 468


Q ss_pred             EEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccC
Q 019040          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~  206 (347)
                      |+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECT
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhccc
Confidence            8999999999999988654 569999999999999999999999999999999999999   556789999999998765


Q ss_pred             CCCc----ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          207 PGER----FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       207 ~~~~----~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      ....    .....||+.|+|||++. +.++.++||||||+++|||++ |..||......+....+..+..   ++.++.+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~  237 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPEC  237 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---CCCCTTC
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcC
Confidence            4332    22346889999999876 559999999999999999998 8999998888877777766542   2334578


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHH---hcCcccc
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQV---LEHPWLQ  312 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~l---l~h~~~~  312 (347)
                      |+++.+||..||+.||++|||+.++   |+|+|+.
T Consensus       238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999888   6777764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-53  Score=379.09  Aligned_cols=263  Identities=31%  Similarity=0.529  Sum_probs=224.1

Q ss_pred             ccceeeeeeecccCCeEEEEEEEC---CCCceeEEeEecccccc-chhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      -++|++++.||+|+||+||+|++.   .+|+.||||++.+.... .....+.+.+|+++++++.+||||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            378999999999999999999874   46899999999765432 23345668889999999966689999999999999


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      ..++++||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEEC
T ss_pred             ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhh
Confidence            999999999999999999998899999999999999999999999999999999999999   66788999999999765


Q ss_pred             CCCC--cccccccCccccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          206 KPGE--RFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       206 ~~~~--~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      ....  ......|++.|+|||.+.+   .++.++|||||||+||+|++|..||.+.........+.+.......+....+
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            4322  2344679999999998753   3788999999999999999999999887666655566555544455555578


Q ss_pred             CHHHHHHHHHhccCCCCCCC-----CHHHHhcCcccccCc
Q 019040          281 SESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQNAK  315 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~  315 (347)
                      ++++.+||.+||++||++||     |+.|+++||||++..
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            99999999999999999999     589999999998753

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-52  Score=378.20  Aligned_cols=264  Identities=25%  Similarity=0.407  Sum_probs=217.3

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~----  124 (347)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+++++.+ +|+|++++++++...    
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTT
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccc
Confidence            4689999999999999999999999999999999997543 3344556788999999999 999999999998643    


Q ss_pred             -CeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 -NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                       ...+++++++.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++++|||.+.
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR  169 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----
T ss_pred             cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhc
Confidence             334566777779999998854 479999999999999999999999999999999999999   677889999999997


Q ss_pred             ccCCCCcccccccCccccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccC-------
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-------  274 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  274 (347)
                      ...  .......|++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+.......+.........       
T Consensus       170 ~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         170 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             ccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            643  33445679999999997653  3789999999999999999999999998887777666554332211       


Q ss_pred             --------------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCcCCCCC
Q 019040          275 --------------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV  320 (347)
Q Consensus       275 --------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  320 (347)
                                          ..+..+++++.+||.+||+.||.+|||+.|+|+||||++...+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~  313 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE  313 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC
Confidence                                0123578999999999999999999999999999999987654443

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=375.12  Aligned_cols=259  Identities=26%  Similarity=0.362  Sum_probs=205.0

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee-----
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-----  123 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~-----  123 (347)
                      +.++|++++.||+|+||+||+|.++.+|+.||||++.+... ......++.+|+.+++++ +||||+++++++..     
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTT
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccc
Confidence            45789999999999999999999999999999999975533 344567789999999999 99999999999853     


Q ss_pred             -CCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccc
Q 019040          124 -DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (347)
Q Consensus       124 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a  202 (347)
                       .+++|+||||+.+ ++.+.+  ...+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.++++|||++
T Consensus        93 ~~~~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~  166 (355)
T d2b1pa1          93 EFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA  166 (355)
T ss_dssp             TCCEEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-
T ss_pred             cCceeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhh
Confidence             4789999999966 454544  3468999999999999999999999999999999999999   67788999999999


Q ss_pred             cccCCCCcccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccccCCCC----
Q 019040          203 IFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW----  277 (347)
Q Consensus       203 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  277 (347)
                      .............+|+.|+|||++.+ .++.++||||+|+++++|++|..||.+.+.......+...........+    
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            88776666667789999999999764 5999999999999999999999999988877766665443321110000    


Q ss_pred             ----------------------------------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccCc
Q 019040          278 ----------------------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (347)
Q Consensus       278 ----------------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  315 (347)
                                                        ...++++.+||++||+.||++|||+.++|+||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                                              01346788999999999999999999999999998754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-51  Score=360.02  Aligned_cols=250  Identities=22%  Similarity=0.326  Sum_probs=203.4

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCC----ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTR----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      -.+.|.+.+.||+|+||+||+|.++.++    ..||||.+....  .......+.+|+++++++ +||||+++++++.+.
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKY   81 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecC
Confidence            3467999999999999999999987655    469999986432  333456789999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      +..++|+||+.++++.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR  158 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhh
Confidence            9999999999999999888765 569999999999999999999999999999999999999   678899999999998


Q ss_pred             ccCCCCc----ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccccccCCCC
Q 019040          204 FFKPGER----FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCG-VPPFWAESEQGVAQAILRGLIDFKRDPW  277 (347)
Q Consensus       204 ~~~~~~~----~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~  277 (347)
                      .......    .....||+.|+|||++. +.++.++||||||+++|||+++ .+|+...........+..+.   .++..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~---~~~~~  235 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---RLPTP  235 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---CCCCC
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC---CCCCc
Confidence            7543322    22346789999999876 4599999999999999999995 55566666666666665543   23334


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ..++..+.+||..||+.||++|||+.++++
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         236 MDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            578999999999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=359.98  Aligned_cols=257  Identities=22%  Similarity=0.309  Sum_probs=209.6

Q ss_pred             CCCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC
Q 019040           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (347)
Q Consensus        46 ~~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~  125 (347)
                      ++.-.++|++.+.||+|+||+||+|+++.+ +.||||++....    ...+.+.+|+.+++++ +|+||+++++++.+ +
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~-~   84 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-E   84 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-S
T ss_pred             eEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc----CCHHHHHHHHHHHHhc-ccCCEeEEEEEEec-C
Confidence            344457899999999999999999999755 569999986542    2346799999999999 99999999999855 5


Q ss_pred             eEEEEEEecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          126 AVHLVMELCEGGELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      ..++||||+++|+|..++..  ...+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++.
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~  161 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR  161 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC
T ss_pred             CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhh
Confidence            57899999999999988854  3569999999999999999999999999999999999999   667889999999998


Q ss_pred             ccCCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          204 FFKPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCG-VPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       204 ~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      .......  .....+|+.|+|||.+. +.++.++||||||+++|||++| .+|+......+....+..+.   ..+....
T Consensus       162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~---~~~~~~~  238 (285)
T d1fmka3         162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPE  238 (285)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTT
T ss_pred             hccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC---CCCCCcc
Confidence            6543332  23356899999999876 5599999999999999999995 55566666666776666543   2234458


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhc--CcccccCc
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLE--HPWLQNAK  315 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~~~~~~  315 (347)
                      +++++.++|.+||+.||++|||+.++++  ++||....
T Consensus       239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            8999999999999999999999999987  78887653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=367.97  Aligned_cols=256  Identities=22%  Similarity=0.289  Sum_probs=212.9

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCce--eEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTREL--LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ++|++.+.||+|+||+||+|+++.+|..  ||||.+...  ......+.+.+|++++.++.+||||+++++++.+.+..+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            7899999999999999999999988875  566665432  233345679999999999967999999999999999999


Q ss_pred             EEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCC
Q 019040          129 LVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~  192 (347)
                      +||||+++|+|.+++.+.                ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCC
Confidence            999999999999999654                458999999999999999999999999999999999999   6677


Q ss_pred             CEEEEeeccccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHhccc
Q 019040          193 PLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGV-PPFWAESEQGVAQAILRGLI  270 (347)
Q Consensus       193 ~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~~~~~~~~~~~~~  270 (347)
                      .+||+|||++.............||..|+|||.+. +.++.++||||||+++|||++|. +||...+..+....+..+. 
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~-  243 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  243 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-
Confidence            89999999998655444444557899999999886 55999999999999999999965 6788888888777766542 


Q ss_pred             cccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC--cccccC
Q 019040          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH--PWLQNA  314 (347)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h--~~~~~~  314 (347)
                        .++.+..+++++.+||.+||+.||++|||+.++++|  .+++..
T Consensus       244 --~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         244 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             --CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence              333445789999999999999999999999999987  444433

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=361.96  Aligned_cols=256  Identities=23%  Similarity=0.304  Sum_probs=206.0

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCC-C--ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDT-R--ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      .++|++.+.||+|+||.||+|++..+ +  ..||||++.+.........+.+.+|+.+++.+ +||||+++++++.+. .
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~~-~   84 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP-P   84 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS-S
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeec-c
Confidence            46799999999999999999986533 2  46899999877666666678899999999999 999999999999764 6


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .++|+||++++++.+.+... +.+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++...
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~---~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred             hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---cccceeeccchhhhhc
Confidence            78999999999999887664 4699999999999999999999999999999999999994   5667999999999876


Q ss_pred             CCCCcc----cccccCccccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          206 KPGERF----SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       206 ~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      ......    ....++..|+|||.+.+ .++.++||||||+++|||++ |..||.+.+..+....+.+.....  +..+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~  239 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPED  239 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--CCCTT
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC--CCccc
Confidence            544321    23357788999998874 48899999999999999998 899999999998888887765433  33458


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcCcccccC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  314 (347)
                      +++++.+||.+||+.||++|||+.+++  .+|+++
T Consensus       240 ~~~~l~~li~~cl~~dp~~RPt~~ei~--~~L~~~  272 (273)
T d1u46a_         240 CPQDIYNVMVQCWAHKPEDRPTFVALR--DFLLEA  272 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHH--HHHHhc
Confidence            899999999999999999999999995  455543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=360.03  Aligned_cols=251  Identities=24%  Similarity=0.322  Sum_probs=203.3

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCC---ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTR---ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      ...++|++.+.||+|+||+||+|++..++   ..||+|.+...  ........+.+|+.+++++ +||||+++++++. +
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~   79 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-E   79 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-S
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-c
Confidence            34578999999999999999999987554   45888887533  2444567799999999999 9999999999986 4


Q ss_pred             CeEEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      +..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||+|.
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSR  156 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-----
T ss_pred             CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhhe
Confidence            6789999999999999987665 468999999999999999999999999999999999999   556779999999998


Q ss_pred             ccCCCCc--ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCC
Q 019040          204 FFKPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (347)
Q Consensus       204 ~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (347)
                      .......  .....||+.|+|||.+. +.++.++||||||+++|||++ |.+||...+..+....+..+..   .+.++.
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~  233 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPN  233 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCTT
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCC
Confidence            7543322  23346789999999986 558999999999999999997 8999999988888887776542   234458


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +++++.+||.+||+.||++|||+.++++|
T Consensus       234 ~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            89999999999999999999999999876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=362.80  Aligned_cols=248  Identities=21%  Similarity=0.289  Sum_probs=203.7

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCce----eEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCe
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTREL----LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~  126 (347)
                      .+|++++.||+|+||+||+|.+..+|+.    ||+|.+...  ......+.+.+|+.+++++ +||||+++++++.++ .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-C
Confidence            4699999999999999999999888864    667766432  2333467899999999999 999999999999875 4


Q ss_pred             EEEEEEecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccccc
Q 019040          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (347)
Q Consensus       127 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~  205 (347)
                      .+++++++.+++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|...
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHT
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceec
Confidence            56788888899999888765 569999999999999999999999999999999999999   56778999999999876


Q ss_pred             CCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCC
Q 019040          206 KPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (347)
Q Consensus       206 ~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (347)
                      .....   .....||+.|+|||.+. +.++.++||||||+++|||+| |..||.+.+..+....+..+..   .+..+.+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~---~~~p~~~  238 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPIC  238 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC---CCCCTTB
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCccc
Confidence            44332   23346899999999876 559999999999999999998 8999988888777776666532   2333578


Q ss_pred             CHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          281 SESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       281 ~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ++++.+||.+||+.||++|||+.++++|
T Consensus       239 ~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         239 TIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999988

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=359.89  Aligned_cols=253  Identities=23%  Similarity=0.318  Sum_probs=199.5

Q ss_pred             cccceeeeeeecccCCeEEEEEEECC-----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~  123 (347)
                      -.++|++.+.||+|+||+||+|.+..     +++.||||++....  .......+.+|..++.++.+|+||+.+++++..
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            34789999999999999999999764     34689999986433  333456788888888888789999999988765


Q ss_pred             C-CeEEEEEEecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEee
Q 019040          124 D-NAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFA  186 (347)
Q Consensus       124 ~-~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~  186 (347)
                      . +.+++||||+++++|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||+ 
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl-  167 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-  167 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE-
Confidence            4 5789999999999999999753                237899999999999999999999999999999999999 


Q ss_pred             cCCCCCCEEEEeeccccccCCCC---cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHH
Q 019040          187 NKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCG-VPPFWAESEQGV  261 (347)
Q Consensus       187 ~~~~~~~~~l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~  261 (347)
                        +.++.+||+|||+|.......   ......||+.|+|||++. +.++.++||||||+++|||++| ..||........
T Consensus       168 --~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         168 --SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             --CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             --CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence              667889999999997654332   223457899999999876 4589999999999999999986 567877665444


Q ss_pred             HHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      .........  .......+++++.++|.+||+.||++|||+.++++|
T Consensus       246 ~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         246 FCRRLKEGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCC--CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            433333222  223335789999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=352.77  Aligned_cols=246  Identities=22%  Similarity=0.334  Sum_probs=203.4

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee-CC
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-DN  125 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~-~~  125 (347)
                      +.-.++|++.+.||.|+||.||+|.+  +|..||||++..+     ...+.+.+|+++++++ +||||+++++++.+ .+
T Consensus         3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--
T ss_pred             ccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH-----HHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCC
Confidence            34457899999999999999999998  4678999998643     2346789999999999 99999999998854 56


Q ss_pred             eEEEEEEecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeecccc
Q 019040          126 AVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~  203 (347)
                      .+++||||+++++|.+++....  .+++..+..++.||+.||.|||+++|+||||||+||++   +.++.++|+|||++.
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~  151 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK  151 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccce
Confidence            7899999999999999996643  48999999999999999999999999999999999999   678889999999998


Q ss_pred             ccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccccCCCCCCCC
Q 019040          204 FFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (347)
Q Consensus       204 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (347)
                      ......  ....+++.|+|||.+. +.++.++||||||+++|||++ |.+||...+..+....+.++.   .++....++
T Consensus       152 ~~~~~~--~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~  226 (262)
T d1byga_         152 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCP  226 (262)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---CCCCCTTCC
T ss_pred             ecCCCC--ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---CCCCCccCC
Confidence            654332  3346788999999875 569999999999999999998 799998888888877776543   233345789


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          282 ESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       282 ~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      +++.+||.+||+.||++|||+.+++++
T Consensus       227 ~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         227 PAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-50  Score=358.19  Aligned_cols=249  Identities=22%  Similarity=0.312  Sum_probs=212.5

Q ss_pred             ccceeeeeeecccCCeEEEEEEECC-----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeC
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~  124 (347)
                      .++|++.+.||+|+||+||+|+++.     +++.||||++....  .......+.+|+++++++ +|||++++++++...
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVCAVG   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhc-CCCCcccceeeeccC
Confidence            4689999999999999999999753     56789999986543  333456799999999999 999999999999999


Q ss_pred             CeEEEEEEecCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCC
Q 019040          125 NAVHLVMELCEGGELFDRIVARG------------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP  180 (347)
Q Consensus       125 ~~~~lv~e~~~~~~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp  180 (347)
                      +..++++||+++++|.+++....                        .++...+..++.||+.||.|||+.|||||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999996532                        378889999999999999999999999999999


Q ss_pred             CcEEeecCCCCCCEEEEeeccccccCCCC---cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCC-CCCCC
Q 019040          181 ENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGV-PPFWA  255 (347)
Q Consensus       181 ~NIli~~~~~~~~~~l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~-~pf~~  255 (347)
                      +|||+   +.++.+||+|||+|.......   ......+++.|+|||.+.+ .++.++||||||+++|||++|. .||..
T Consensus       169 ~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         169 RNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999   667889999999997653332   2234578899999998764 5999999999999999999985 68999


Q ss_pred             CCHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .+..+....+..+..   ++....+++++.+||.+||+.||++|||+.++++
T Consensus       246 ~~~~e~~~~v~~~~~---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            998888888776643   2233578999999999999999999999999954

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-50  Score=354.53  Aligned_cols=253  Identities=26%  Similarity=0.402  Sum_probs=211.2

Q ss_pred             CCcccceeeeeeecccCCeEEEEEEECCCC-------ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTR-------ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        47 ~~~~~~y~i~~~lg~G~~g~V~~a~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      +...++|++++.||+|+||.||+|++..++       ..||||++....  .......+.+|...+.++.+||||+++++
T Consensus         9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~   86 (299)
T d1fgka_           9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG   86 (299)
T ss_dssp             BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence            344689999999999999999999986554       479999986543  33445778889999988878999999999


Q ss_pred             EEeeCCeEEEEEEecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcE
Q 019040          120 ACEDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (347)
Q Consensus       120 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NI  183 (347)
                      ++.+++..++||||+++|+|.+++....                .+++..+..++.||+.||.|||+.|||||||||+||
T Consensus        87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  166 (299)
T ss_dssp             EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence            9999999999999999999999997543                489999999999999999999999999999999999


Q ss_pred             EeecCCCCCCEEEEeeccccccCCCC---cccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 019040          184 LFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESE  258 (347)
Q Consensus       184 li~~~~~~~~~~l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  258 (347)
                      |+   +.++.+||+|||++.......   ......+++.|+|||.+. +.++.++||||||+++|+|++ |..||...+.
T Consensus       167 Ll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         167 LV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             EE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            99   677889999999998664432   223457899999999876 569999999999999999998 7999998888


Q ss_pred             HHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      ......+..+.   .++....+++++.+||.+||+.||++|||+.++++
T Consensus       244 ~~~~~~i~~~~---~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         244 EELFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHTTC---CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCC---CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            87777766543   22334578999999999999999999999999976

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.2e-50  Score=355.61  Aligned_cols=260  Identities=19%  Similarity=0.254  Sum_probs=207.1

Q ss_pred             cccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        49 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      +.++|++++.||+|+||+||+|++..+|+.||||++.....     ...+.+|+++++.+.+|++++.+..++.+.+..+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            45789999999999999999999999999999999765422     1347789999999966667777778888899999


Q ss_pred             EEEEecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCC
Q 019040          129 LVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (347)
Q Consensus       129 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~  207 (347)
                      +||||+. ++|...+.. ...+++..+..++.|++.||+|||++||+||||||+|||++..+.+..++|+|||+|.....
T Consensus        80 ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          80 MVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9999995 466666654 45799999999999999999999999999999999999997666778899999999987643


Q ss_pred             CC--------cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cccccc-C
Q 019040          208 GE--------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR---GLIDFK-R  274 (347)
Q Consensus       208 ~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~-~  274 (347)
                      ..        ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+..   .....+ .
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            32        2234579999999998775 489999999999999999999999987665543332211   111111 1


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCHH---HHhcCcccccC
Q 019040          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAK---QVLEHPWLQNA  314 (347)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~---~ll~h~~~~~~  314 (347)
                      ..+..+|+++.++|..||+.||++||++.   ++|+|+|.+..
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            22347899999999999999999999987   55778766443

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=352.79  Aligned_cols=254  Identities=21%  Similarity=0.324  Sum_probs=216.7

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEECC-----CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      .++...++|++.+.||+|+||+||+|.++.     ++..||||++....  .......+.+|+++++++ +||||+++++
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l-~h~nIv~~~~   90 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLG   90 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGC-CCTTBCCEEE
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHc-CCCCEeeeee
Confidence            345556899999999999999999998853     35789999986442  334456789999999999 8999999999


Q ss_pred             EEeeCCeEEEEEEecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCC
Q 019040          120 ACEDDNAVHLVMELCEGGELFDRIVAR----------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (347)
Q Consensus       120 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~  189 (347)
                      ++...+..++||||+++|+|.+++...          ..++...+..++.|++.||.|||+++|+||||||+|||+   +
T Consensus        91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d  167 (308)
T d1p4oa_          91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---A  167 (308)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---C
T ss_pred             EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---c
Confidence            999999999999999999999988643          236889999999999999999999999999999999999   6


Q ss_pred             CCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHH
Q 019040          190 ENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCG-VPPFWAESEQGVAQA  264 (347)
Q Consensus       190 ~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~  264 (347)
                      .++.+||+|||++........   .....+|+.|+|||.+. +.++.++||||||+++|||++| ..||.+.+..+....
T Consensus       168 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~  247 (308)
T d1p4oa_         168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF  247 (308)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred             CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            788999999999986543322   23346899999999876 4588899999999999999998 588988888888887


Q ss_pred             HHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      +.++..   .+....+++.+.++|.+||+.||++|||+.++++
T Consensus       248 i~~~~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         248 VMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             HHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhCCC---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            776543   2233578999999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-49  Score=351.91  Aligned_cols=256  Identities=21%  Similarity=0.302  Sum_probs=214.5

Q ss_pred             CCCCcccceeeeeeecccCCeEEEEEEEC-----CCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeee
Q 019040           45 PKENIEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (347)
Q Consensus        45 ~~~~~~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~  119 (347)
                      .++.-.++|++.+.||.|+||.||+|++.     .+++.||||++....  .......+.+|+.+++.+.+||||+++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            34445689999999999999999999863     456789999987543  34455678999999999977999999999


Q ss_pred             EEeeCCeEEEEEEecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCC
Q 019040          120 ACEDDNAVHLVMELCEGGELFDRIVARG------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPE  181 (347)
Q Consensus       120 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~  181 (347)
                      ++.+.+..++||||+++++|.+++....                  .+++..+..++.||+.||.|||+.|++||||||+
T Consensus        95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~  174 (311)
T d1t46a_          95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (311)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence            9999999999999999999999997643                  4889999999999999999999999999999999


Q ss_pred             cEEeecCCCCCCEEEEeeccccccCCCCc---ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 019040          182 NFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAE  256 (347)
Q Consensus       182 NIli~~~~~~~~~~l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~  256 (347)
                      ||++   +.++.++|+|||.+........   .....||+.|+|||.+. +.++.++||||||+++|+|++ |.+||...
T Consensus       175 NIl~---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         175 NILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             GEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cccc---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence            9999   5677899999999987654332   23457899999999886 558999999999999999998 66667666


Q ss_pred             CHHHHHHHHHhccccccCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          257 SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                      .....+..+.....  +......+++++.+||.+||+.||++|||+.++++
T Consensus       252 ~~~~~~~~~i~~~~--~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         252 PVDSKFYKMIKEGF--RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CSSHHHHHHHHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHhcCC--CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            66555555544332  22233468999999999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.9e-48  Score=343.00  Aligned_cols=254  Identities=20%  Similarity=0.266  Sum_probs=208.1

Q ss_pred             CcccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeE
Q 019040           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (347)
Q Consensus        48 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~  127 (347)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++....     ....+.+|++.++.+.++++++.+++++......
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            35689999999999999999999999999999999885432     2234778999999997779999999999999999


Q ss_pred             EEEEEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecC--CCCCCEEEEeeccccc
Q 019040          128 HLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK--KENSPLKAIDFGLSIF  204 (347)
Q Consensus       128 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~--~~~~~~~l~Dfg~a~~  204 (347)
                      ++||||+ +++|.+++...+ .++...+..++.|++.||.|||++||+||||||+||+++..  ...+.++|+|||+|+.
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            9999999 679999887754 69999999999999999999999999999999999999643  2357899999999986


Q ss_pred             cCCCC--------cccccccCccccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccccc
Q 019040          205 FKPGE--------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ---GVAQAILRGLIDF  272 (347)
Q Consensus       205 ~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~  272 (347)
                      .....        ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+....   .....+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            54321        2234579999999998865 4999999999999999999999999755432   2233332222211


Q ss_pred             -cCCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 019040          273 -KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (347)
Q Consensus       273 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  307 (347)
                       ....+..+|+++.+++..|+..+|++||+...+.+
T Consensus       236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence             11223478999999999999999999999887644

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=342.45  Aligned_cols=245  Identities=20%  Similarity=0.304  Sum_probs=199.8

Q ss_pred             eeeeecccCCeEEEEEEECCCC---ceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEee-CCeEEEE
Q 019040           55 VDRELGRGEFGVTYLCIDRDTR---ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-DNAVHLV  130 (347)
Q Consensus        55 i~~~lg~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~-~~~~~lv  130 (347)
                      ..+.||+|+||+||+|++..++   ..||||.+...  ......+.+.+|+++++++ +||||+++++++.. ++..++|
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEE
Confidence            3678999999999999987654   35899988642  3455567899999999999 89999999999765 5689999


Q ss_pred             EEecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEEeeccccccCCCC
Q 019040          131 MELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~~~~~~  209 (347)
                      |||+++++|.+++.... .++...+..++.|++.||.|||+.||+||||||+|||+   ++++.+||+|||++.......
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhccccc
Confidence            99999999999887653 47788899999999999999999999999999999999   677889999999998654332


Q ss_pred             c-----ccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccccccCCCCCCCCH
Q 019040          210 R-----FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDFKRDPWPNVSE  282 (347)
Q Consensus       210 ~-----~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  282 (347)
                      .     .....||+.|+|||.+. +.++.++||||||+++|||++|..||.... ..+....+..+..   ......+++
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~---~~~p~~~~~  261 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD  261 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC---CCCCTTCCH
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCcccCcH
Confidence            2     23346899999999876 569999999999999999999777765543 3344455555432   223347899


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          283 SAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       283 ~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                      ++.+||.+||+.||++|||+.|+++|
T Consensus       262 ~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         262 PLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999988

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=333.22  Aligned_cols=248  Identities=22%  Similarity=0.279  Sum_probs=189.9

Q ss_pred             ccceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCC----
Q 019040           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN----  125 (347)
Q Consensus        50 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~----  125 (347)
                      ..+|.+.+.||+|+||.||+|++  +|+.||||++..+..    .......|+..+..+ +||||+++++++...+    
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVML-RHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcce
Confidence            46789999999999999999986  688999999864321    112233455555677 8999999999987653    


Q ss_pred             eEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK--------HGVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       126 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~--------~~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                      .+++||||+++++|.+++.+. .+++..+..++.|++.||.|||+        +||+||||||+|||+   +.++.+||+
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~  150 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA  150 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEEC
T ss_pred             EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEE
Confidence            689999999999999999765 68999999999999999999996        599999999999999   677899999


Q ss_pred             eeccccccCCCCc-----ccccccCcccccccccccc-------CCCchhHHHHHHHHHHHHhCCCCCCCCC--------
Q 019040          198 DFGLSIFFKPGER-----FSEIVGSPYYMAPEVLKRN-------YGPEIDIWSAGVILYILLCGVPPFWAES--------  257 (347)
Q Consensus       198 Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-------~~~~~Di~slG~~l~~l~~g~~pf~~~~--------  257 (347)
                      |||++........     .....||+.|+|||++.+.       ++.++||||||+++|||++|..||....        
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            9999987644332     2346799999999987542       5668999999999999999987763211        


Q ss_pred             -------HHHHHHHHHhccccccC-CCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 019040          258 -------EQGVAQAILRGLIDFKR-DPW--PNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (347)
Q Consensus       258 -------~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  308 (347)
                             ................. ..+  ...+..+.+|+.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                   12222222222211110 000  1233568899999999999999999999764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-44  Score=330.00  Aligned_cols=270  Identities=24%  Similarity=0.403  Sum_probs=199.6

Q ss_pred             CCCCCcc-cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCC----------CCC
Q 019040           44 VPKENIE-DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP----------KNS  112 (347)
Q Consensus        44 ~~~~~~~-~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~----------~h~  112 (347)
                      ..++.+. +||++++.||+|+||+||+|+++.+|+.||||++.++.    ...+.+.+|+++++.+.          .|+
T Consensus         5 ~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~   80 (362)
T d1q8ya_           5 FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGAN   80 (362)
T ss_dssp             CTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred             CCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence            3456554 57999999999999999999999999999999997543    22356778888888772          257


Q ss_pred             ceeEeeeEEee--CCeEEEEEEecCCCch-HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEeeCCCCCcEEee
Q 019040          113 SIVSLKEACED--DNAVHLVMELCEGGEL-FDRIVA--RGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFA  186 (347)
Q Consensus       113 ~i~~~~~~~~~--~~~~~lv~e~~~~~~L-~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~NIli~  186 (347)
                      ||+++++++..  ....+++++++..... ......  ...+++..++.++.||+.||.|||+ .||+||||||+|||++
T Consensus        81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~  160 (362)
T d1q8ya_          81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME  160 (362)
T ss_dssp             TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred             ceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeee
Confidence            89999988764  3566667766654433 232322  3468999999999999999999998 8999999999999996


Q ss_pred             cCCCC---CCEEEEeeccccccCCCCcccccccCcccccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---
Q 019040          187 NKKEN---SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ---  259 (347)
Q Consensus       187 ~~~~~---~~~~l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---  259 (347)
                      .++..   ..++++|||.+.....  ......||+.|+|||++. ..++.++||||+|+++++|++|..||......   
T Consensus       161 ~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~  238 (362)
T d1q8ya_         161 IVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  238 (362)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccCcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence            53322   2489999999876433  334567999999999876 45899999999999999999999999654321   


Q ss_pred             ---HHHHHHHhccccc--------------------------------------cCCCCCCCCHHHHHHHHHhccCCCCC
Q 019040          260 ---GVAQAILRGLIDF--------------------------------------KRDPWPNVSESAKSLVRQMLEPDPKL  298 (347)
Q Consensus       260 ---~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~  298 (347)
                         .............                                      ....+...++++.+||.+||+.||.+
T Consensus       239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence               1111111111000                                      00011124577899999999999999


Q ss_pred             CCCHHHHhcCcccccCcCCCC
Q 019040          299 RLTAKQVLEHPWLQNAKKAPN  319 (347)
Q Consensus       299 Rps~~~ll~h~~~~~~~~~~~  319 (347)
                      |||+.|+|+||||++......
T Consensus       319 Rpta~e~L~Hp~f~~~~~~~~  339 (362)
T d1q8ya_         319 RADAGGLVNHPWLKDTLGMEE  339 (362)
T ss_dssp             CBCHHHHHTCGGGTTCTTCTT
T ss_pred             CcCHHHHhcCcccCCCCCccc
Confidence            999999999999997754433

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=4.6e-26  Score=187.79  Aligned_cols=167  Identities=21%  Similarity=0.228  Sum_probs=121.5

Q ss_pred             eeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccc---------------hhcHHHHHHHHHHHHhCCCCCceeEe
Q 019040           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---------------AVDIDDVRREVAIMKHLPKNSSIVSL  117 (347)
Q Consensus        53 y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~~ei~~l~~l~~h~~i~~~  117 (347)
                      +.+.+.||+|+||+||+|++. +|+.||||++.......               ........+|...+..+ .+.+++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence            457899999999999999985 68899999875321110               11123456688899999 88888887


Q ss_pred             eeEEeeCCeEEEEEEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcEeeCCCCCcEEeecCCCCCCEEEE
Q 019040          118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (347)
Q Consensus       118 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~NIli~~~~~~~~~~l~  197 (347)
                      +++..    .+++|||+++..+.       .++......++.|++.+|.|||++||+||||||+|||++   + ..++|+
T Consensus        80 ~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~---~-~~~~li  144 (191)
T d1zara2          80 YAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS---E-EGIWII  144 (191)
T ss_dssp             EEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---T-TEEEEC
T ss_pred             EEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee---C-CCEEEE
Confidence            65532    26899999886653       245566778999999999999999999999999999995   2 348999


Q ss_pred             eeccccccCCCCcccccccCccccc------cccccccCCCchhHHHHHHHH
Q 019040          198 DFGLSIFFKPGERFSEIVGSPYYMA------PEVLKRNYGPEIDIWSAGVIL  243 (347)
Q Consensus       198 Dfg~a~~~~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~Di~slG~~l  243 (347)
                      |||.|.....+...       .|..      .+.+.+.|+.++|+||+.--+
T Consensus       145 DFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99999775433221       1111      122345689999999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.78  E-value=1.3e-08  Score=85.91  Aligned_cols=141  Identities=20%  Similarity=0.174  Sum_probs=94.3

Q ss_pred             cceeeeeeecccCCeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEEEE
Q 019040           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (347)
Q Consensus        51 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (347)
                      ..|++.+..+.++.+.||+..  .+++.+++|.........   ...+.+|...+..+..+-.+++++.+...++..++|
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv   88 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence            456777766666668899885  456668888876443222   234677888888885555578888888888999999


Q ss_pred             EEecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 019040          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK----------------------------------------  170 (347)
Q Consensus       131 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~----------------------------------------  170 (347)
                      |++++|.++.+.....  ..   ...++.++...+..||+                                        
T Consensus        89 ~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          89 MSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             EEeccccccccccccc--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            9999998775543211  11   12223333333333331                                        


Q ss_pred             -------------------cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          171 -------------------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       171 -------------------~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                                         ..++|+|+.|.||+++   +++.+.|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec---CCceEEEeechhccc
Confidence                               1278999999999994   444457999998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.46  E-value=2.4e-07  Score=82.88  Aligned_cols=82  Identities=17%  Similarity=0.187  Sum_probs=51.3

Q ss_pred             eeeecccCCeEEEEEEECCCCceeEEeEecccc-c---cchhcHHHHHHHHHHHHhCCCC--CceeEeeeEEeeCCeEEE
Q 019040           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRK-L---RTAVDIDDVRREVAIMKHLPKN--SSIVSLKEACEDDNAVHL  129 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~~~~~vavK~~~~~~-~---~~~~~~~~~~~ei~~l~~l~~h--~~i~~~~~~~~~~~~~~l  129 (347)
                      .+.||.|....||++.+..+++.+++|...... .   .......+...|...++.+..+  ..+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            456899999999999988778889999653211 1   1112344566788888776333  345666544  4455678


Q ss_pred             EEEecCCCch
Q 019040          130 VMELCEGGEL  139 (347)
Q Consensus       130 v~e~~~~~~L  139 (347)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.24  E-value=8.7e-07  Score=73.98  Aligned_cols=69  Identities=13%  Similarity=0.193  Sum_probs=47.8

Q ss_pred             CeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCC-CceeEeeeEEeeCCeEEEEEEecCCCch
Q 019040           64 FGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEGGEL  139 (347)
Q Consensus        64 ~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L  139 (347)
                      .+.||+.... ++..+++|......      ...+..|...++.+..+ -.+++++.+..+.+..++||++++|.++
T Consensus        24 ~~~v~r~~~~-~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          24 DAAVFRLSAQ-GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             SCEEEEEECT-TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             CCeEEEEEeC-CCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4688998763 45568888764332      12356677777766332 2267788888888899999999998665

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.84  E-value=2.3e-05  Score=69.68  Aligned_cols=75  Identities=12%  Similarity=0.054  Sum_probs=53.1

Q ss_pred             eeeecccCCeEEEEEEECC-------CCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCceeEeeeEEeeCCeEE
Q 019040           56 DRELGRGEFGVTYLCIDRD-------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (347)
Q Consensus        56 ~~~lg~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (347)
                      ++.|+.|-.-.+|++....       ..+.|++++....     ...-...+|..+++.+..+.-.+++++++.+    +
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            4678889899999998753       2356778776421     1223466799999988666667788887753    5


Q ss_pred             EEEEecCCCch
Q 019040          129 LVMELCEGGEL  139 (347)
Q Consensus       129 lv~e~~~~~~L  139 (347)
                      +|+||++|.++
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            78999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.26  E-value=0.00065  Score=58.26  Aligned_cols=68  Identities=13%  Similarity=0.099  Sum_probs=43.3

Q ss_pred             CeEEEEEEECCCCceeEEeEeccccccchhcHHHHHHHHHHHHhCCCCCce--eEee-----eEEeeCCeEEEEEEecCC
Q 019040           64 FGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI--VSLK-----EACEDDNAVHLVMELCEG  136 (347)
Q Consensus        64 ~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ei~~l~~l~~h~~i--~~~~-----~~~~~~~~~~lv~e~~~~  136 (347)
                      -..||++.. .+|..|++|+....    ....+.+..|...+..|.. ..+  +..+     ..+...+..+.++++++|
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~----~~s~~~i~~E~~~l~~L~~-~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPE----RWTADQILEEHQFALQLVN-DEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTT----TSCHHHHHHHHHHHHHHHH-TTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCC----CCCHHHHHHHHHHHHHHHh-cCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            358999976 46788999997532    1234567778888877722 222  1111     123456778899999987


Q ss_pred             C
Q 019040          137 G  137 (347)
Q Consensus       137 ~  137 (347)
                      .
T Consensus       109 ~  109 (325)
T d1zyla1         109 R  109 (325)
T ss_dssp             E
T ss_pred             c
Confidence            3

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.91  E-value=0.00086  Score=57.05  Aligned_cols=31  Identities=35%  Similarity=0.471  Sum_probs=25.6

Q ss_pred             cCcEeeCCCCCcEEeecCCCCCCEEEEeeccccc
Q 019040          171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (347)
Q Consensus       171 ~~ivH~Dikp~NIli~~~~~~~~~~l~Dfg~a~~  204 (347)
                      .|+||+|+.++||+++   .+...-|+||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFL---GDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcc---cccceeEeccccccc
Confidence            4799999999999994   445568999998864